PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lechauve, C; Jager, M; Laguerre, L; Kiger, L; Correc, G; Leroux, C; Vinogradov, S; Czjzek, M; Marden, MC; Bailly, X				Lechauve, Christophe; Jager, Muriel; Laguerre, Laurent; Kiger, Laurent; Correc, Gaelle; Leroux, Cedric; Vinogradov, Serge; Czjzek, Mirjam; Marden, Michael C.; Bailly, Xavier			Neuroglobins, Pivotal Proteins Associated with Emerging Neural Systems and Precursors of Metazoan Globin Diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE SUPERFAMILY; NERVOUS-SYSTEM; STEM-CELLS; EVOLUTION; DIVERSIFICATION; HEMOGLOBINS; EXPRESSION; GENOME; NEUROGENESIS; CYTOGLOBIN	Neuroglobins, previously thought to be restricted to vertebrate neurons, were detected in the brain of a photosymbiotic acoel, Symsagittifera roscoffensis, and in neurosensory cells of the jellyfish Clytia hemisphaerica. For the neuroglobin of S. roscoffensis, a member of a lineage that originated either at the base of the bilateria or of the deuterostome clade, we report the ligand binding properties, crystal structure at 2.3 (A) over circle, and brain immunocytochemical pattern. We also describe in situ hybridizations of two neuroglobins specifically expressed in differentiating nematocytes (neurosensory cells) and in statocytes (ciliated mechanosensory cells) of C. hemisphaerica, a member of the early branching animal phylum cnidaria. In silico searches using these neuroglobins as queries revealed the presence of previously unidentified neuroglobin-like sequences in most metazoan lineages. Because neural systems are almost ubiquitous in metazoa, the constitutive expression of neuroglobin-like proteins strongly supports the notion of an intimate association of neuroglobins with the evolution of animal neural systems and hints at the preservation of a vitally important function. Neuroglobins were probably recruited in the first protoneurons in early metazoans from globin precursors. Neuroglobins were identified in choanoflagellates, sponges, and placozoans and were conserved during nervous system evolution. Because the origin of neuroglobins predates the other metazoan globins, it is likely that neuroglobin gene duplication followed by co-option and subfunctionalization led to the emergence of globin families in protostomes and deuterostomes (i.e. convergent evolution).	[Lechauve, Christophe] Univ Paris 06, Ctr Hosp Natl Ophtalmol Quinze Vingts, Inst Vis, INSERM,UMR S 968,CNRS,Unite Mixte Rech UMR 7210, F-75012 Paris, France; [Jager, Muriel] Univ Paris 06, UMR CNRS UPMC Museum Natl Hist Nat IRD 7138, F-75005 Paris, France; [Laguerre, Laurent; Leroux, Cedric; Czjzek, Mirjam; Bailly, Xavier] UPMC CNRS, FR2424, Stn Biol Roscoff, F-29680 Roscoff, France; [Kiger, Laurent; Marden, Michael C.] Univ Paris 11, INSERM, U779, F-94275 Le Kremlin Bicetre, France; [Correc, Gaelle; Czjzek, Mirjam] UPMC CNRS, Stn Biol Roscoff, UMR Marine Plants & Biomol 7139, F-29680 Roscoff, France; [Vinogradov, Serge] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Wayne State University	Bailly, X (corresponding author), UPMC CNRS, FR2424, Stn Biol Roscoff, F-29680 Roscoff, France.	xavier.bailly@sb-roscoff.fr	Marden, Michael/AAA-5923-2020; Lechauve, Christophe/AAH-8873-2019; Kiger, Laurent/Q-1686-2018	LEROUX, Cedric/0000-0001-9225-1234	Region Bretagne; Centre National de la Recherche Scientifique; Universite Pierre et Marie Curie, Paris	Region Bretagne(Region Bretagne); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie, Paris	Crystal structure determination was performed at the crystallography platform of the Station Biologique de Roscoff, supported by the Region Bretagne, the Centre National de la Recherche Scientifique, and Universite Pierre et Marie Curie, Paris 06. We are indebted to the staff of the European Synchrotron Radiation Facilities (ESRF, Grenoble, France), beamline ID23-I and BM30A, for technical support during data collection and treatment. Confocal microscopy was performed in the imaging facility platform Merimage at the Station Biologique de Roscoff. Spectroscopic studies were supported by INSERM and the University Paris 11. We thank Ian Probert from the Marine Resource Center of the Station Biologique de Roscoff for discussions and critical reading of the manuscript.	Bailly X., 2009, CAH BIOL MAR, V50, P106; Bailly Xavier, 2008, V9, P191; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bery A, 2010, DEV GENES EVOL, V220, P61, DOI 10.1007/s00427-010-0328-2; Blank M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025292; Brittain T, 2010, IUBMB LIFE, V62, P878, DOI 10.1002/iub.405; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Cheng CHC, 2009, IUBMB LIFE, V61, P184, DOI 10.1002/iub.138; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Chiori R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004231; Dellavalle B, 2010, GLIA, V58, P1220, DOI 10.1002/glia.21002; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; DOELLER JE, 1988, BIOL BULL, V174, P67, DOI 10.2307/1541760; Droge J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-54; Ertas B, 2011, J BIOL CHEM, V286, P3185, DOI 10.1074/jbc.M110.160341; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Galliot B, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P127; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Ganfornina MD, 1999, BIOESSAYS, V21, P432, DOI 10.1002/(SICI)1521-1878(199905)21:5<432::AID-BIES10>3.0.CO;2-T; Geuens E, 2004, IUBMB LIFE, V56, P653, DOI 10.1080/15216540500037471; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P1735, DOI 10.1093/molbev/mss018; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; Hoffmann FG, 2010, P NATL ACAD SCI USA, V107, P14274, DOI 10.1073/pnas.1006756107; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Houliston E, 2010, TRENDS GENET, V26, P159, DOI 10.1016/j.tig.2010.01.008; Hundahl C, 2006, FEBS J, V273, P1323, DOI 10.1111/j.1742-4658.2006.05158.x; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jager M, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-12; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; KRAUS DW, 1986, SCIENCE, V232, P90, DOI 10.1126/science.232.4746.90; Lechauve C, 2012, BBA-MOL CELL RES, V1823, P2261, DOI 10.1016/j.bbamcr.2012.09.009; Li WG, 2011, PROTEINS, V79, P115, DOI 10.1002/prot.22863; Lowe CJ, 2011, CURR BIOL, V21, pR151, DOI 10.1016/j.cub.2010.12.017; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nosengo N, 2011, NATURE, V470, P444, DOI 10.1038/470444a; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Roesner A, 2005, MOL BIOL EVOL, V22, P12, DOI 10.1093/molbev/msh258; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Semmler H, 2010, DEV GROWTH DIFFER, V52, P701, DOI 10.1111/j.1440-169X.2010.01207.x; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Storz JF, 2011, IUBMB LIFE, V63, P313, DOI 10.1002/iub.482; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vallone B, 2004, PROTEINS, V56, P85, DOI 10.1002/prot.20113; Vinogradov SN, 2005, P NATL ACAD SCI USA, V102, P11385, DOI 10.1073/pnas.0502103102; WITTENBERG BA, 1965, BIOCHEM J, V96, P363, DOI 10.1042/bj0960363; Ye SQ, 2009, ACTA PHARMACOL SIN, V30, P913, DOI 10.1038/aps.2009.70; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	64	27	28	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6957	6967		10.1074/jbc.M112.407601	http://dx.doi.org/10.1074/jbc.M112.407601			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23288852	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000316002400018
J	Frangini, M; Franzolin, E; Chemello, F; Laveder, P; Romualdi, C; Bianchi, V; Rampazzo, C				Frangini, Miriam; Franzolin, Elisa; Chemello, Francesco; Laveder, Paolo; Romualdi, Chiara; Bianchi, Vera; Rampazzo, Chiara			Synthesis of Mitochondrial DNA Precursors during Myogenesis, an Analysis in Purified C2C12 Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIDINE TRIPHOSPHATE POOLS; RIBONUCLEOTIDE REDUCTION; DEOXYNUCLEOTIDE POOLS; CELL-CYCLE; KINASE; EXPRESSION; GENE; SPECIFICITY; FIBROBLASTS; SUBSTRATE	During myogenesis, myoblasts fuse into multinucleated myotubes that acquire the contractile fibrils and accessory structures typical of striated skeletal muscle fibers. To support the high energy requirements of muscle contraction, myogenesis entails an increase in mitochondrial (mt) mass with stimulation of mtDNA synthesis and consumption of DNA precursors (dNTPs). Myotubes are quiescent cells and as such down-regulate dNTP production despite a high demand for dNTPs. Although myogenesis has been studied extensively, changes in dNTP metabolism have not been examined specifically. In differentiating cultures of C2C12 myoblasts and purified myotubes, we analyzed expression and activities of enzymes of dNTP biosynthesis, dNTP pools, and the expansion of mtDNA. Myotubes exibited pronounced post-mitotic modifications of dNTP synthesis with a particularly marked down-regulation of de novo thymidylate synthesis. Expression profiling revealed the same pattern of enzyme down-regulation in adult murine muscles. The mtDNA increased steadily after myoblast fusion, turning over rapidly, as revealed after treatment with ethidium bromide. We individually down-regulated p53R2 ribonucleotide reductase, thymidine kinase 2, and deoxyguanosine kinase by siRNA transfection to examine how a further reduction of these synthetic enzymes impacted myotube development. Silencing of p53R2 had little effect, but silencing of either mt kinase caused 50% mtDNA depletion and an unexpected decrease of all four dNTP pools independently of the kinase specificity. We suggest that during development of myotubes the shortage of even a single dNTP may affect all four pools through dysregulation of ribonucleotide reduction and/or dissipation of the non-limiting dNTPs during unproductive elongation of new DNA chains.	[Frangini, Miriam; Franzolin, Elisa; Chemello, Francesco; Laveder, Paolo; Romualdi, Chiara; Bianchi, Vera; Rampazzo, Chiara] Univ Padua, Dept Biol, I-35131 Padua, Italy	University of Padua	Bianchi, V (corresponding author), Dipartimento Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it; rampazzo@bio.unipd.it	Chemello, Francesco/ABB-3801-2020; Romualdi, Chiara/K-1132-2016; Frangini, Miriam/I-3532-2013	Romualdi, Chiara/0000-0003-4792-9047; Chemello, Francesco/0000-0002-3877-527X	Italian Telethon Grant [GGP09019]; Associazione Italiana per la Ricerca sul Cancro [1091]; University of Padova (Progetti Strategici); University of Padova (Progetto di Ateneo) [CPDA099940]	Italian Telethon Grant(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); University of Padova (Progetti Strategici); University of Padova (Progetto di Ateneo)	This work was supported by Italian Telethon Grant GGP09019, Associazione Italiana per la Ricerca sul Cancro (1091), and the University of Padova (Progetti Strategici 2008) (to V. B.), and from the University of Padova (Progetto di Ateneo CPDA099940) (to P. L.).	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Barbieri Elena, 2011, J Aging Res, V2011, P845379, DOI 10.4061/2011/845379; BIANCHI V, 1987, MOL CELL BIOL, V7, P4218, DOI 10.1128/MCB.7.12.4218; BIANCHI V, 1990, TOXICOL IN VITRO, V4, P9, DOI 10.1016/0887-2333(90)90003-C; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hirano M, 2005, GENE, V354, P152, DOI 10.1016/j.gene.2005.04.041; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; KAUFFMAN MG, 1991, MOL CELL BIOL, V11, P2538, DOI 10.1128/MCB.11.5.2538; Ke PY, 2004, MOL CELL BIOL, V24, P514, DOI 10.1128/MCB.24.2.514-526.2004; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kislinger T, 2005, MOL CELL PROTEOMICS, V4, P887, DOI 10.1074/mcp.M400182-MCP200; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitceathly RDS, 2011, J MED GENET, V48, P610, DOI 10.1136/jmg.2010.088328; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, CELL CYCLE, V11, P4099, DOI 10.4161/cc.22324; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Pontarin G, 2011, J BIOL CHEM, V286, P11132, DOI 10.1074/jbc.M110.202283; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Rylova SN, 2007, BIOCHEM PHARMACOL, V74, P169, DOI 10.1016/j.bcp.2007.03.029; Saada A, 2004, DNA CELL BIOL, V23, P797; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Stern-Straeter J, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-66; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tannu NS, 2004, MOL CELL PROTEOMICS, V3, P1065, DOI 10.1074/mcp.M400020-MCP200; Toy G, 2010, P NATL ACAD SCI USA, V107, P5551, DOI 10.1073/pnas.0913900107; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Wang LY, 1996, FEBS LETT, V390, P39, DOI 10.1016/0014-5793(96)00623-0; Ylikallio E, 2012, ANN MED, V44, P41, DOI 10.3109/07853890.2011.598547; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	58	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5624	5635		10.1074/jbc.M112.441147	http://dx.doi.org/10.1074/jbc.M112.441147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297407	Green Published, hybrid			2022-12-25	WOS:000315342500036
J	Kuno, A; Hori, YS; Hosoda, R; Tanno, M; Miura, T; Shimamoto, K; Horio, Y				Kuno, Atsushi; Hori, Yusuke S.; Hosoda, Ryusuke; Tanno, Masaya; Miura, Tetsuji; Shimamoto, Kazuaki; Horio, Yoshiyuki			Resveratrol Improves Cardiomyopathy in Dystrophin-deficient Mice through SIRT1 Protein-mediated Modulation of p300 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR; ACETYLATION; DEGRADATION; ACTIVATION; SIRTUINS; SURVIVAL; GROWTH; DOMAIN	Cardiomyopathy is the main cause of death in Duchenne muscular dystrophy. Here, we show that oral administration of resveratrol, which leads to activation of an NAD(+)-dependent protein deacetylase SIRT1, suppresses cardiac hypertrophy and fibrosis and restores cardiac diastolic function in dystrophin-deficient mdx mice. The pro-hypertrophic co-activator p300 protein but not p300 mRNA was up-regulated in the mdx heart, and resveratrol administration down-regulated the p300 protein level. In cultured cardiomyocytes, cardiomyocyte hypertrophy induced by the alpha(1)-agonist phenylephrine was inhibited by the overexpression of SIRT1 as well as resveratrol, both of which down-regulated p300 protein levels but not p300 mRNA levels. In addition, activation of atrial natriuretic peptide promoter by p300 was inhibited by SIRT1. We found that SIRT1 induced p300 down-regulation via the ubiquitin-proteasome pathway by deacetylation of lysine residues for ubiquitination. These findings indicate the pathological significance of p300 up-regulation in the dystrophic heart and indicate that SIRT1 activation has therapeutic potential for dystrophic cardiomyopathy.	[Kuno, Atsushi; Hori, Yusuke S.; Hosoda, Ryusuke; Horio, Yoshiyuki] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 0608556, Japan; [Kuno, Atsushi; Tanno, Masaya; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Internal Med 2, Sapporo, Hokkaido 0608556, Japan; [Shimamoto, Kazuaki] Sapporo Med Univ, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 0608556, Japan.	horio@sapmed.ac.jp		Horio, Yoshiyuki/0000-0002-5021-5929; Hori, Yusuke S./0000-0001-9921-6810; KUNO, ATSUSHI/0000-0001-6873-1297; Hori, Yusuke S./0000-0002-8195-8979	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590245]; National Project of Knowledge Cluster Initiative of Second Stage, Sapporo Biocluster Bio-S; Regional R&D Proposal-based Program from the Northern Advancement Center for Science and Technology of Hokkaido; Tubasa Foundation; Hokkaido Heart Association grant for research; Fukuda Foundation for Medical Technology; Akiyama Life Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Project of Knowledge Cluster Initiative of Second Stage, Sapporo Biocluster Bio-S; Regional R&D Proposal-based Program from the Northern Advancement Center for Science and Technology of Hokkaido; Tubasa Foundation; Hokkaido Heart Association grant for research; Fukuda Foundation for Medical Technology(Fukuda Foundation for Medical Technology); Akiyama Life Science Foundation	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid 22590245 (to Y.H.), the National Project of Knowledge Cluster Initiative of Second Stage, Sapporo Biocluster Bio-S (to Y.H.), the Regional R&D Proposal-based Program from the Northern Advancement Center for Science and Technology of Hokkaido (to Y.H.), the Tubasa Foundation (to Y.H.), the Hokkaido Heart Association grant for research (to A.K.), and research grants from the Fukuda Foundation for Medical Technology and the Akiyama Life Science Foundation (to A.K.).	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bish LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010230; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chen JH, 2007, EPIGENETICS-US, V2, P92, DOI 10.4161/epi.2.2.4326; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Gusterson R, 2002, J BIOL CHEM, V277, P2517, DOI 10.1074/jbc.M104626200; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Horio Y, 2011, CLIN SCI, V121, P191, DOI 10.1042/CS20100587; Hosoda R, 2013, J PHARMACOL EXP THER, V344, P124, DOI 10.1124/jpet.112.198937; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; McNally EM, 2007, ANNU REV MED, V58, P75, DOI 10.1146/annurev.med.58.011706.144703; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shin JH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-132; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003	30	67	73	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5963	5972		10.1074/jbc.M112.392050	http://dx.doi.org/10.1074/jbc.M112.392050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297412	Green Published, hybrid			2022-12-25	WOS:000315342500064
J	Mao, W; Miyagishima, KJ; Yao, Y; Soreghan, B; Sampath, AP; Chen, JE				Mao, Wen; Miyagishima, K. J.; Yao, Yun; Soreghan, Brian; Sampath, Alapakkam P.; Chen, Jeannie			Functional Comparison of Rod and Cone G alpha(t) on the Regulation of Light Sensitivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSDUCIN ALPHA-SUBUNIT; HETEROTRIMERIC G-PROTEIN; BETA-GAMMA-COMPLEX; VISUAL PIGMENT; PHOTORECEPTOR SIGNALS; DRIVEN TRANSLOCATION; EXPRESSION LEVELS; TRANSGENIC MICE; MOUSE RETINA; 2.0 ANGSTROM	The signaling cascades mediated byGprotein-coupled receptors (GPCRs) exhibit a wide spectrum of spatial and temporal response properties to fulfill diverse physiological demands. However, the mechanisms that shape the signaling response of the GPCR are not well understood. In this study, we replaced cone transducin alpha (cT alpha) for rod transducin alpha (rT alpha) in rod photoreceptors of transgenic mice, which also express S opsin, to evaluate the role of G alpha subtype on signal amplification from different GPCRs in the same cell; such analysis may explain functional differences between retinal rod and cone photoreceptors. We showed that ectopically expressed cT alpha 1) forms a heterotrimeric complex with rod G beta(1)gamma(1), 2) substitutes equally for rT alpha in generating photoresponses initiated by either rhodopsin or S-cone opsin, and 3) exhibited similar light-activated translocation as endogenous rT alpha in rods and endogenous cT alpha in cones. Thus, rT alpha and cT alpha appear functionally interchangeable. Interestingly, light sensitivity appeared to correlate with the concentration of cT alpha when expression is reduced below 35% of normal. However, quantification of endogenous cT alpha concentration in cones showed a higher level to rT alpha in rods. Thus, reduced sensitivity in cones cannot be explained by reduced coupling efficiency between the GPCR and G protein or a lower concentration of G protein in cones versus rods.	[Mao, Wen; Yao, Yun; Soreghan, Brian; Chen, Jeannie] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA; [Miyagishima, K. J.; Sampath, Alapakkam P.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chen, JE (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, 1501 San Pablo St,Rm 227, Los Angeles, CA 90033 USA.	jeannie@usc.edu		Miyagishima, Kiyoharu/0000-0002-9744-3152	National Institutes of Health [RO1 EY12155, RO1 EY17606]; Doheny Eye Institute [EY03040]; Beckman Initiative for Macular Research; Karl Kirchgessner Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE [R01EY017606, R01EY012155, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doheny Eye Institute; Beckman Initiative for Macular Research; Karl Kirchgessner Foundation; McKnight Endowment Fund for Neurosciences; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants RO1 EY12155 (to J. C.) and RO1 EY17606 (to A. P. S.); a Vision Core grant to Doheny Eye Institute (EY03040); the Beckman Initiative for Macular Research (to J. C.); the Karl Kirchgessner Foundation (to A. P. S.); and the McKnight Endowment Fund for Neurosciences (to A. P. S.).	BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; Betke KM, 2012, PROG NEUROBIOL, V96, P304, DOI 10.1016/j.pneurobio.2012.01.009; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Chen CK, 1996, P NATL ACAD SCI USA, V93, P12885, DOI 10.1073/pnas.93.23.12885; Chen J, 1996, P NATL ACAD SCI USA, V93, P7042, DOI 10.1073/pnas.93.14.7042; Chen JY, 2006, J NEUROSCI, V26, P11929, DOI 10.1523/JNEUROSCI.3212-06.2006; Chen JP, 2007, INVEST OPHTH VIS SCI, V48, P3350, DOI 10.1167/iovs.07-0126; Concepcion F, 2002, VISION RES, V42, P417, DOI 10.1016/S0042-6989(01)00195-X; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; DARTNALL HJ, 1968, VISION RES, V8, P339, DOI 10.1016/0042-6989(68)90104-1; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Herrmann R, 2010, J NEUROSCI, V30, P3239, DOI 10.1523/JNEUROSCI.4775-09.2010; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joseph RM, 1996, INVEST OPHTH VIS SCI, V37, P2434; Kassai H, 2005, NEURON, V47, P529, DOI 10.1016/j.neuron.2005.07.025; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kerov V, 2007, J NEUROSCI, V27, P10270, DOI 10.1523/JNEUROSCI.2494-07.2007; Kerov V, 2011, MOL CELL NEUROSCI, V46, P340, DOI 10.1016/j.mcn.2010.10.006; Kolesnikov AV, 2011, J NEUROSCI, V31, P8067, DOI 10.1523/JNEUROSCI.0174-11.2011; Kosloff M, 2008, J BIOL CHEM, V283, P31197, DOI 10.1074/jbc.M803799200; Krispel CM, 2007, J GEN PHYSIOL, V130, P303, DOI 10.1085/jgp.200709812; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2007, J NEUROSCI, V27, P1151, DOI 10.1523/JNEUROSCI.5010-06.2007; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lomonosova E, 2012, INVEST OPHTH VIS SCI, V53, P1225, DOI 10.1167/iovs.11-9350; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; Mazzoni MR, 1996, J BIOL CHEM, V271, P30034, DOI 10.1074/jbc.271.47.30034; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEUBERT TA, 1992, J BIOL CHEM, V267, P18274; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; Okawa H, 2010, J PHYSIOL-LONDON, V588, P1947, DOI 10.1113/jphysiol.2010.188573; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Starace DM, 1997, J BIOL CHEM, V272, P1095, DOI 10.1074/jbc.272.2.1095; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Tsang SH, 1998, SCIENCE, V282, P117, DOI 10.1126/science.282.5386.117; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang Q, 2008, J BIOL CHEM, V283, P30015, DOI 10.1074/jbc.M803953200; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; Zhang HB, 2003, MOL VIS, V9, P231; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	67	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5257	5267		10.1074/jbc.M112.430058	http://dx.doi.org/10.1074/jbc.M112.430058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288843	Green Published, hybrid			2022-12-25	WOS:000315342500001
J	Diao, HY; Li, XX; Hu, S; Liu, YH				Diao, Hongyu; Li, Xinxing; Hu, Sheng; Liu, Yunhui			Gene Expression Profiling Combined with Bioinformatics Analysis Identify Biomarkers for Parkinson Disease	PLOS ONE			English	Article							DIFFERENTIALLY COEXPRESSED GENES; ALPHA-SYNUCLEIN; CEREBROSPINAL-FLUID; ACTIVATION; DEATH; DJ-1; ENVIRONMENT; DISCOVERY; PATHWAY; STAT4	Parkinson disease (PD) progresses relentlessly and affects approximately 4% of the population aged over 80 years old. It is difficult to diagnose in its early stages. The purpose of our study is to identify molecular biomarkers for PD initiation using a computational bioinformatics analysis of gene expression. We downloaded the gene expression profile of PD from Gene Expression Omnibus and identified differentially coexpressed genes (DCGs) and dysfunctional pathways in PD patients compared to controls. Besides, we built a regulatory network by mapping the DCGs to known regulatory data between transcription factors (TFs) and target genes and calculated the regulatory impact factor of each transcription factor. As the results, a total of 1004 genes associated with PD initiation were identified. Pathway enrichment of these genes suggests that biological processes of protein turnover were impaired in PD. In the regulatory network, HLF, E2F1 and STAT4 were found have altered expression levels in PD patients. The expression levels of other transcription factors, NKX3-1, TAL1, RFX1 and EGR3, were not found altered. However, they regulated differentially expressed genes. In conclusion, we suggest that HLF, E2F1 and STAT4 may be used as molecular biomarkers for PD; however, more work is needed to validate our result.	[Diao, Hongyu; Li, Xinxing; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China; [Hu, Sheng] Second Peoples Hosp Chaoyang City, Dept Neurosurg, Chaoyang, Peoples R China	China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Peoples R China.	liuyh@sj-hospital.org			Liaoning Science and Technology Plan Projects [2008820]	Liaoning Science and Technology Plan Projects	This research is supported by Liaoning Science and Technology Plan Projects (No. 2008820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACON CM, 1995, P NATL ACAD SCI USA, V92, P7307, DOI 10.1073/pnas.92.16.7307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Chade AR, 2006, J NEURAL TRANSM-SUPP, P147; Cooper CS, 2007, NAT CLIN PRACT UROL, V4, P677, DOI 10.1038/ncpuro0946; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Elbaz A, 2007, CR BIOL, V330, P318, DOI 10.1016/j.crvi.2007.02.018; Foulds P, 2010, NAT REV NEUROL, V6, P359, DOI 10.1038/nrneurol.2010.78; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Godau J, 2010, J NEUROL NEUROSUR PS, V81, P536, DOI 10.1136/jnnp.2009.175752; Guttula SV, 2012, INT J ALZHEIMERS DIS, V2012; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Hitzler JK, 1999, BRAIN RES, V820, P1, DOI 10.1016/S0006-8993(98)00999-8; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Honda H, 1999, BLOOD, V93, P2780; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hou ST, 2002, J BIOL CHEM, V277, P48764, DOI 10.1074/jbc.M206336200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; INABA T, 1992, SCIENCE, V257, P531, DOI 10.1126/science.1386162; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Maita C, 2008, NEUROSCI LETT, V431, P86, DOI 10.1016/j.neulet.2007.11.027; Nagatsu T, 2005, CURR PHARM DESIGN, V11, P999, DOI 10.2174/1381612053381620; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sato S, 2005, NEUROLOGY, V64, P1081, DOI 10.1212/01.WNL.0000154597.24838.6B; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith RA, 2003, MOL BRAIN RES, V116, P70, DOI 10.1016/S0169-328X(03)00253-5; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Team R. D. C, 2011, R LANG ENV STAT COMP; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; YAMAMOTO K, 1994, MOL CELL BIOL, V14, P4342, DOI 10.1128/MCB.14.7.4342; Yu H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-315	43	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52319	10.1371/journal.pone.0052319	http://dx.doi.org/10.1371/journal.pone.0052319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284986	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500027
J	Varghese, S; Whipple, R; Martin, SS; Alexander, HR				Varghese, Sheelu; Whipple, Rebecca; Martin, Stuart S.; Alexander, H. Richard			Multipotent Cancer Stem Cells Derived from Human Malignant Peritoneal Mesothelioma Promote Tumorigenesis	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; STEM/PROGENITOR CELLS; COLORECTAL-CANCER; INITIATING CELLS; NEURAL CREST; DIFFERENTIATION; MYC; GENERATION; STATE; RISE	During the progression of malignant peritoneal mesothelioma (MPeM), tumor nodules propagate diffusely within the abdomen and tumors are characterized by distinct phenotypic sub-types. Recent studies in solid organ cancers have shown that cancer stem cells (CSCs) play a pivotal role in the initiation and progression of tumors. However, it is not known whether tumorigenic stem cells exist and whether they promote tumor growth in MPeM. In this study, we developed and characterized a CSC model for MPeM using stably expandable tumorigenic stem cells derived from patient tumors. We found morphologically distinct populations of CSCs that divide asymmetrically or symmetrically in MPeM in vitro cell culture. The MPeM stem cells (MPeMSCs) express stem cell markers c-MYC, NES and VEGFR2 and in the presence of matrix components cells form colony spheres. MPeMSCs are multipotent, differentiate into neuronal, vascular and adipose progeny upon defined induction and the differentiating cells express lineage-specific markers such as TUBB3, an early neuronal marker; vWF, VEGFA, VEGFC and IL-8, endothelial markers; and PPAR gamma and FABP4, adipose markers. Xenotransplantation experiments using MPeMSCs demonstrated early tumor growth compared with parental cells. Limiting dilution experiments using MPeMSCs and endothelial lineage-induced cells derived from a single MPeMSC resulted in early tumor growth in the latter group indicating that endothelial differentiation of MPeMSCs is important for MPeM tumor initiation. Our observation that the MPeM tumors contain stem cells with tumorigenic potential has important implications for understanding the cells of origin and tumor progression in MPeM and hence targeting CSCs may be a useful strategy to inhibit malignant progression.	[Varghese, Sheelu; Alexander, H. Richard] Univ Maryland, Sch Med, Dept Surg, Div Gen & Surg Oncol, Baltimore, MD 21201 USA; [Varghese, Sheelu; Whipple, Rebecca; Martin, Stuart S.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Varghese, S (corresponding author), Univ Maryland, Sch Med, Dept Surg, Div Gen & Surg Oncol, Baltimore, MD 21201 USA.	Svarghese@som.umaryland.edu			NATIONAL CANCER INSTITUTE [P30CA134274] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA134274] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hartl M, 2009, P NATL ACAD SCI USA, V106, P5604, DOI 10.1073/pnas.0812101106; Hill RP, 2007, JNCI-J NATL CANCER I, V99, P1435, DOI 10.1093/jnci/djm136; Kelly RJ, 2012, MOL CANCER THER, V11, P517, DOI 10.1158/1535-7163.MCT-11-0454; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pine SR, 2010, P NATL ACAD SCI USA, V107, P2195, DOI 10.1073/pnas.0909390107; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Varghese S, 2011, CANCER-AM CANCER SOC, V117, P361, DOI 10.1002/cncr.25555; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamazaki H, 2012, BIOCHEM BIOPH RES CO, V419, P529, DOI 10.1016/j.bbrc.2012.02.054; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107	36	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52825	10.1371/journal.pone.0052825	http://dx.doi.org/10.1371/journal.pone.0052825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285196	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500067
J	Banerjee, B; Musk, M; Sutanto, EN; Yerkovich, ST; Hopkins, P; Knight, DA; Lindsey-Temple, S; Stick, SM; Kicic, A; Chambers, DC				Banerjee, Balarka; Musk, Michael; Sutanto, Erika N.; Yerkovich, Stephanie T.; Hopkins, Peter; Knight, Darryl A.; Lindsey-Temple, Suzanna; Stick, Stephen M.; Kicic, Anthony; Chambers, Daniel C.			Regional Differences in Susceptibiity of Bronchial Epithelium to Mesenchymal Transition and Inhibition by the Macrolide Antibiotic Azithromycin	PLOS ONE			English	Article							BRONCHIOLITIS-OBLITERANS-SYNDROME; LUNG-TRANSPLANT RECIPIENTS; GROWTH-FACTOR-BETA; RENAL-ALLOGRAFT RECIPIENTS; MYCOPHENOLATE-MOFETIL; PSEUDOMONAS-AERUGINOSA; PULMONARY-FIBROSIS; TGF-BETA; FIBROBLAST PROLIFERATION; MYOFIBROBLAST TRANSITION	Objective: Dysregulated repair following epithelial injury is a key forerunner of disease in many organs, and the acquisition of a mesenchymal phenotype by the injured epithelial cells (epithelial to mesenchymal transition, EMT) may serve as a source of fibrosis. The macrolide antibiotic azithromycin and the DNA synthesis inhibitor mycophenolate are in clinical use but their mechanism of action remains unknown in post-transplant bronchiolitis obliterans syndrome (BOS). Here we determined if regional variation in the EMT response to TGF beta 1 underlies the bronchiolocentric fibrosis leading to BOS and whether EMT could be inhibited by azithromycin or mycophenolate. Methods/Results: We found that small and large airway epithelial cells from stable lung transplant patients underwent EMT when stimulated with TGF beta 1, however mesenchymal protein expression was higher and loss of epithelial protein expression more complete in small airway epithelial cells. This regional difference was not mediated by changes in expression of the TGF beta RII or Smad3 activation. Azithromycin potentially inhibited EMT in both small and large airway epithelial cells by inhibiting Smad3 expression, but not activation. Conclusion: Collectively, these observations provide a biologic basis for a previously unexplained but widely observed clinical phenomena, and a platform for the development of new approaches to fibrotic diseases.	[Banerjee, Balarka; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia; [Banerjee, Balarka] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Banerjee, Balarka; Musk, Michael] Royal Perth Hosp, Western Australia Lung Transplant Program, Perth, WA, Australia; [Stick, Stephen M.; Kicic, Anthony] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Sutanto, Erika N.; Stick, Stephen M.; Kicic, Anthony] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Knight, Darryl A.] Univ British Columbia, James Hogg Res Ctr Cardiovasc & Pulm Res, Vancouver, BC V5Z 1M9, Canada; [Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Lindsey-Temple, Suzanna] Sir Charles Gairdner Hosp, Lung Inst Western Australia, Ctr Asthma & Allergy Res Inst CAARR, Perth, WA, Australia; [Yerkovich, Stephanie T.; Hopkins, Peter; Chambers, Daniel C.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Chambers, Daniel C.] Prince Charles Hosp, Queensland Lung Transplant Serv, Brisbane, Qld 4032, Australia	University of Western Australia; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of British Columbia; University of British Columbia; University of Queensland; Prince Charles Hospital	Chambers, DC (corresponding author), Univ Queensland, Sch Med, Herston, Qld, Australia.	Daniel_Chambers@health.qld.gov.au	Stick, Stephen/O-5683-2014; Kicic, Anthony/ABA-1252-2021; Yerkovich, Stephanie/A-9004-2011; Chambers, Daniel/B-1325-2011; Stick, Stephen/AAA-5945-2021; Stick, Stephen/GZG-7584-2022; Hopkins, Peter/B-1329-2011	Kicic, Anthony/0000-0002-0008-9733; Stick, Stephen/0000-0002-5386-8482; Sutanto, Erika/0000-0002-4224-2839; Chambers, Daniel/0000-0002-9553-5870; Yerkovich, Stephanie/0000-0003-4163-4782	Western Australian Lung Transplant Foundation, University of Western Australia; McCusker Foundation; Canada Research Chairs program; Michael Smith foundation for Health Research	Western Australian Lung Transplant Foundation, University of Western Australia; McCusker Foundation; Canada Research Chairs program(Canada Research Chairs); Michael Smith foundation for Health Research(Michael Smith Foundation for Health Research)	The project was funded by the Western Australian Lung Transplant Foundation, University of Western Australia and the McCusker Foundation. Stephen M. Stick is an NHMRC practitioner fellow. Darryl A. Knight is supported by the Canada Research Chairs program and Michael Smith foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2005, INT J ARTIF ORGANS, V28, P164, DOI 10.1177/039139880502800213; Angel LF, 2006, AM J RESP CRIT CARE, V173, P465, DOI 10.1164/ajrccm.173.4.465; Asgrimsson V, 2006, ANTIMICROB AGENTS CH, V50, P1805, DOI 10.1128/AAC.50.5.1805-1812.2006; Azzola A, 2004, TRANSPLANTATION, V77, P275, DOI 10.1097/01.TP.0000101822.50960.AB; Banerjee B, 2011, J HEART LUNG TRANSPL, V30, P1175, DOI 10.1016/j.healun.2011.06.007; Banerjee B, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-99; Bonk T, 2003, CLIN CHEM, V49, P552, DOI 10.1373/49.4.552; Borthwick LA, 2011, EUR RESPIR J, V37, P1237, DOI 10.1183/09031936.00088410; Borthwick LA, 2010, AM J TRANSPLANT, V10, P498, DOI 10.1111/j.1600-6143.2009.02953.x; Botha P, 2008, TRANSPLANTATION, V85, P771, DOI 10.1097/TP.0b013e31816651de; Buckley ST, 2010, CELL TISSUE RES, V342, P39, DOI 10.1007/s00441-010-1029-x; Christie JD, 2009, J HEART LUNG TRANSPL, V28, P1031, DOI 10.1016/j.healun.2009.08.004; El-Gamel A, 1999, J HEART LUNG TRANSPL, V18, P828, DOI 10.1016/S1053-2498(99)00047-9; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Forrest IA, 2005, J HEART LUNG TRANSPL, V24, pS48, DOI 10.1016/j.healun.2004.11.040; Friess H, 1998, ANN SURG, V227, P95, DOI 10.1097/00000658-199801000-00014; Gao R, 2006, TRANSPL P, V38, P2154, DOI 10.1016/j.transproceed.2006.06.006; Gerhardt SG, 2003, AM J RESP CRIT CARE, V168, P121, DOI 10.1164/rccm.200212-1424BC; Glanville AR, 2008, AM J RESP CRIT CARE, V177, P1033, DOI 10.1164/rccm.200706-951OC; Groetzner J, 2006, TRANSPLANTATION, V81, P355, DOI 10.1097/01.tp.0000195781.02268.5e; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Halldorsson S, 2010, AM J RESP CELL MOL B, V42; Halloran P, 1997, TRANSPLANTATION, V63, P39, DOI 10.1097/00007890-199701150-00008; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Hodge S, 2009, AM J TRANSPLANT, V9, P727, DOI 10.1111/j.1600-6143.2009.02558.x; Ikegami T, 2007, CELLS TISSUES ORGANS, V185, P213, DOI 10.1159/000101322; Imamura Y, 2004, ANTIMICROB AGENTS CH, V48, P3457, DOI 10.1128/AAC.48.9.3457-3461.2004; Jain R, 2010, J HEART LUNG TRANSPL, V29, P531, DOI 10.1016/j.healun.2009.12.003; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawashima M, 2010, MOL VIS, V16, P2727; Kiss A, 1997, CLIN CANCER RES, V3, P1059; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDyer John F, 2007, Proc Am Thorac Soc, V4, P37, DOI 10.1513/pats.200605-107JG; Ojo AO, 2000, TRANSPLANTATION, V69, P2405, DOI 10.1097/00007890-200006150-00033; Osunkwo I, 2004, BIOL BLOOD MARROW TR, V10, P246, DOI 10.1016/j.bbmt.2003.11.005; Petrova DT, 2010, THER DRUG MONIT, V32, P405, DOI 10.1097/FTD.0b013e3181e44260; Poulalhon N, 2006, J BIOL CHEM, V281, P33045, DOI 10.1074/jbc.M606366200; Qu N, 2005, J HEART LUNG TRANSPL, V24, P882, DOI 10.1016/j.healun.2004.04.020; Quaggin SE, 2011, KIDNEY INT, V80, P41, DOI 10.1038/ki.2011.77; Reka AK, 2011, J THORAC ONCOL, V6, P1784, DOI 10.1097/JTO.0b013e31822adfb0; Remuzzi G, 2004, LANCET, V364, P503, DOI 10.1016/S0140-6736(04)16808-6; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Roos N, 2007, J PHARMACOL EXP THER, V321, P583, DOI 10.1124/jpet.106.117051; Sato M, 2009, AM J TRANSPLANT, V9, P1981, DOI 10.1111/j.1600-6143.2009.02770.x; Scott AIR, 2005, DRUGS, V65, P761, DOI 10.2165/00003495-200565060-00004; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Snell GI, 2006, AM J TRANSPLANT, V6, P169, DOI 10.1111/j.1600-6143.2005.01134.x; Speich R, 1997, TRANSPLANTATION, V64, P533, DOI 10.1097/00007890-199708150-00027; Steinkamp G, 2008, RESP MED, V102, P1643, DOI 10.1016/j.rmed.2008.03.009; Tateda K, 2001, ANTIMICROB AGENTS CH, V45, P1930, DOI 10.1128/AAC.45.6.1930-1933.2001; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Theruvath TP, 2001, TRANSPLANTATION, V72, P77, DOI 10.1097/00007890-200107150-00016; Vanaudenaerde BM, 2008, EUR RESPIR J, V32, P832, DOI 10.1183/09031936.00134307; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; Verleden GM, 2004, TRANSPLANTATION, V77, P1465, DOI 10.1097/01.TP.0000122412.80864.43; Whyte RI, 1997, ANN THORAC SURG, V64, P945, DOI 10.1016/S0003-4975(97)00845-X; Wu Z, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-1; Wuyts WA, 2010, EXP LUNG RES, V36, P602, DOI 10.3109/01902148.2010.492895; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yates B, 2005, AM J RESP CRIT CARE, V172, P772, DOI 10.1164/rccm.200411-1537OC; Yu CH, 2008, EXP LUNG RES, V34, P343, DOI 10.1080/01902140802093238	63	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52309	10.1371/journal.pone.0052309	http://dx.doi.org/10.1371/journal.pone.0052309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284981	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800045
J	Huarte, N; Araujo, A; Arranz, R; Lorizate, M; Quendler, H; Kunert, R; Valpuesta, JM; Nieva, JL				Huarte, Nerea; Araujo, Aitziber; Arranz, Rocio; Lorizate, Maier; Quendler, Heribert; Kunert, Renate; Valpuesta, Jose M.; Nieva, Jose L.			Recognition of Membrane-Bound Fusion-Peptide/MPER Complexes by the HIV-1 Neutralizing 2F5 Antibody: Implications for Anti-2F5 Immunogenicity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; LARGE UNILAMELLAR VESICLES; HUMAN MONOCLONAL-ANTIBODY; COMPLEMENTARITY-DETERMINING REGION; VACCINE DESIGN; ENVELOPE GLYCOPROTEIN; GP41 ECTODOMAIN; CONFORMATIONAL CONSTRAINTS; ANTI-HIV-1 ANTIBODIES	The membrane proximal external region (MPER) of the fusogenic HIV-1 glycoprotein-41 harbors the epitope sequence recognized by 2F5, a broadly neutralizing antibody isolated from an infected individual. Structural mimicry of the conserved MPER 2F5 epitope constitutes a pursued goal in the field of anti-HIV vaccine development. It has been proposed that 2F5 epitope folding into its native state is attained in the vicinity of the membrane interface and might involve interactions with other viral structures. Here we present results indicating that oligomeric complexes established between MPER and the conserved amino-terminal fusion peptide (FP) can partition into lipid vesicles and be specifically bound by the 2F5 antibody at their surfaces. Cryo-transmission electron microscopy of liposomes doped with MPER: FP peptide mixtures provided the structural grounds for complex recognition by antibody at lipid bilayer surfaces. Supporting the immunogenicity of the membrane-bound complex, these MPER: FP peptide-vesicle formulations could trigger cross-reactive anti-MPER antibodies in rabbits. Thus, our observations suggest that contacts with N-terminal regions of gp41 may stabilize the 2F5 epitope as a membrane-surface antigen.	[Huarte, Nerea; Araujo, Aitziber; Lorizate, Maier; Nieva, Jose L.] Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain; [Huarte, Nerea; Araujo, Aitziber; Lorizate, Maier; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao, Spain; [Arranz, Rocio; Valpuesta, Jose M.] Natl Ctr Biotechnol CNB CSIC, Dept Macromol Struct, Madrid, Spain; [Quendler, Heribert; Kunert, Renate] Univ Nat Resources & Life Sci, Inst Appl Microbiol, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Natural Resources & Life Sciences, Vienna	Nieva, JL (corresponding author), Univ Basque Country UPV EHU, Biophys Unit CSIC UPV EHU, Bilbao, Spain.	gbpniesj@lg.ehu.es	Valpuesta, Jose M/AAA-6002-2019; Nieva, Jose L/Q-2063-2019; Kunert, Renate E/B-9185-2018; Valpuesta, José M/T-1977-2017; Lorizate, Maier/S-1151-2018	Nieva, Jose L/0000-0001-6446-5649; Kunert, Renate E/0000-0002-3397-3621; Valpuesta, José M/0000-0001-7468-8053; Lorizate, Maier/0000-0001-8173-2788; HUARTE ARRAYAGO, NEREA/0000-0002-6675-4150; Arranz, Rocio/0000-0001-5321-0915	Ministerio de Ciencia e Innovacion (Spanish MICINN) [BIO2011-29792]; Basque Government [GIU-06/42]; Ministerio de Ciencia e Innovacion (MICINN) [BFU2010-15703/BMC]; CAM (community of Madrid) [S2009MAT-1507]	Ministerio de Ciencia e Innovacion (Spanish MICINN); Basque Government(Basque Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM (community of Madrid)	J.L.N. is supported by grants BIO2011-29792 and GIU-06/42 from The Ministerio de Ciencia e Innovacion (Spanish MICINN) and the Basque Government, respectively. J.M.V. is supported by The Ministerio de Ciencia e Innovacion (MICINN) grant BFU2010-15703/BMC and CAM (community of Madrid) grant S2009MAT-1507. A. A. received a pre-doctoral fellowship from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre A, 2000, BBA-BIOMEMBRANES, V1467, P153, DOI 10.1016/S0005-2736(00)00214-5; Ahmed Z, 2006, BIOCHEMISTRY-US, V45, P9068, DOI 10.1021/bi060858m; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alving CR, 2008, AIDS, V22, P649, DOI 10.1097/QAD.0b013e3282f51922; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Biron Z, 2005, BIOCHEMISTRY-US, V44, P13602, DOI 10.1021/bi0509245; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Breden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016857; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burton DR, 2010, P NATL ACAD SCI USA, V107, P17859, DOI 10.1073/pnas.1012923107; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; de la Arada I, 2009, J PHYS CHEM B, V113, P13626, DOI 10.1021/jp905965h; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Dennison SM, 2009, J VIROL, V83, P10211, DOI 10.1128/JVI.00571-09; Dimitrov AS, 2007, BIOCHEMISTRY-US, V46, P1398, DOI 10.1021/bi062245f; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Ho J, 2005, VACCINE, V23, P1559, DOI 10.1016/j.vaccine.2004.09.037; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Huarte N, 2008, J VIROL, V82, P8986, DOI 10.1128/JVI.00846-08; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kunert R, 2000, BIOTECHNOL BIOENG, V67, P97, DOI 10.1002/(SICI)1097-0290(20000105)67:1<97::AID-BIT11>3.0.CO;2-2; Li YL, 2007, BIOPHYS J, V93, P876, DOI 10.1529/biophysj.106.102335; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; Lorizate M, 2006, BIOCHEMISTRY-US, V45, P14337, DOI 10.1021/bi0612521; Lorizate M, 2006, J MOL BIOL, V360, P45, DOI 10.1016/j.jmb.2006.04.056; Lorizate M, 2006, J BIOL CHEM, V281, P39598, DOI 10.1074/jbc.M605998200; Maeso R, 2011, AIDS RES HUM RETROV, V27, P863, DOI [10.1089/AID.2010.0265, 10.1089/aid.2010.0265]; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; MUI BLS, 1995, BIOPHYS J, V69, P930, DOI 10.1016/S0006-3495(95)79967-2; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Pai E, 2000, FAB EPITOPE COMPLEX; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pereira FB, 1997, BIOPHYS J, V73, P1977, DOI 10.1016/S0006-3495(97)78228-6; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Scherer EM, 2007, AIDS, V21, P2131, DOI 10.1097/QAD.0b013e3282a4a632; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Singh H, 2011, AIDS, V25, P1247, DOI 10.1097/QAD.0b013e32834785cf; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Stiegler G, 2003, J ANTIMICROB CHEMOTH, V51, P757, DOI 10.1093/jac/dkg172; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; Toukam DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038068; Vcelar B, 2007, AIDS, V21, P2161, DOI 10.1097/QAD.0b013e328285da15; Vishwanathan SA, 2008, J VIROL, V82, P5118, DOI 10.1128/JVI.00305-08; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xu HY, 2010, J VIROL, V84, P1076, DOI 10.1128/JVI.02113-09; Ye L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014813; Zhou MK, 2012, VACCINE, V30, P1911, DOI 10.1016/j.vaccine.2012.01.026; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	81	8	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52740	10.1371/journal.pone.0052740	http://dx.doi.org/10.1371/journal.pone.0052740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285173	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800093
J	Ren, HY; Schonbach, P; Wan, HW; Gierus, M; Taube, F				Ren, Haiyan; Schoenbach, Philipp; Wan, Hongwei; Gierus, Martin; Taube, Friedhelm			Effects of Grazing Intensity and Environmental Factors on Species Composition and Diversity in Typical Steppe of Inner Mongolia, China	PLOS ONE			English	Article							GRASSLAND COMMUNITIES; ECOSYSTEM FUNCTION; WATER SOURCES; STOCKING RATE; BIODIVERSITY; VEGETATION; RESPONSES; PRODUCTIVITY; ECOLOGY; RICHNESS	In the present study, we aim to analyze the effect of grazing, precipitation and temperature on plant species dynamics in the typical steppe of Inner Mongolia, P. R. China. By uncoupling biotic and abiotic factors, we provide essential information on the main drivers determining species composition and species diversity. Effects of grazing by sheep were studied in a controlled experiment along a gradient of seven grazing intensities (from ungrazed to very heavily grazed) during six consecutive years (2005-2010). The results show that plant species composition and diversity varied among years but were little affected by grazing intensity, since the experimental years were much dryer than the long term average, the abiotic constraints may have overridden any grazing effect. Among-year differences were predominantly determined by the abiotic factors of precipitation and temperature. Most of the variation in species dynamics and coexistence between C3 and C4 species was explained by seasonal weather conditions, i.e. precipitation and temperature regime during the early-season (March-June) were most important in determining vegetation dynamics. The dominant C3 species Stipa grandis was highly competitive in March-June, when the temperature levels were low and rainfall level was high. In contrast, the most common C4 species Cleistogenes squarrosa benefited from high early-season temperature levels and low early-season rainfall. However, biomass of Stipa grandis was positively correlated with temperature in March, when effective mean temperature ranges from 0 to 5 degrees C and thus promotes vernalization and vegetative sprouting. Our results suggest that, over a six-year term, it is temporal variability in precipitation and temperature rather than grazing that determines vegetation dynamics and species co-existence of grazed steppe ecosystems. Furthermore, our data support that the variability in the biomass of dominant species, rather than diversity, determine ecosystem functioning. The present study provides fundamental knowledge on the complex interaction of grazing - vegetation - climate.	[Ren, Haiyan; Schoenbach, Philipp; Wan, Hongwei; Gierus, Martin; Taube, Friedhelm] Univ Kiel, Inst Crop Sci & Plant Breeding Grass & Forage Sci, Kiel, Germany	University of Kiel	Ren, HY (corresponding author), Univ Kiel, Inst Crop Sci & Plant Breeding Grass & Forage Sci, Kiel, Germany.	hren@email.uni-kiel.de	Gierus, Martin/H-7135-2012	Gierus, Martin/0000-0001-6909-0356; Taube, Friedhelm/0000-0001-7175-2881	National Nature Science Foundation of China; Deutsche Forschungsgemeinschaft (DFG)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Financial support was provided by the National Nature Science Foundation of China and the Deutsche Forschungsgemeinschaft (DFG) for the research group 536 MAGIM (Matter fluxes of grasslands in Inner Mongolia as influenced by stocking rate) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella SR, 2012, FOREST ECOL MANAG, V271, P65, DOI 10.1016/j.foreco.2012.01.035; Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Auerswald K, 2012, BASIC APPL ECOL, V9, P1439; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bullock JM, 2001, J APPL ECOL, V38, P253, DOI 10.1046/j.1365-2664.2001.00599.x; Chen SH, 2001, ROOTS GRASSLAND PLAN; Chen SP, 2005, ENVIRON EXP BOT, V53, P65, DOI 10.1016/j.envexpbot.2004.03.002; Chou WW, 2008, GLOBAL CHANGE BIOL, V14, P1382, DOI 10.1111/j.1365-2486.2008.01572.x; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Cingolani AM, 2005, ECOL APPL, V15, P757, DOI 10.1890/03-5272; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Distel RA, 2005, J ARID ENVIRON, V62, P351, DOI 10.1016/j.jaridenv.2004.12.001; Fanselow N, 2011, PLANT SOIL, V340, P279, DOI 10.1007/s11104-010-0694-6; Fynn RWS, 2000, J APPL ECOL, V37, P491, DOI 10.1046/j.1365-2664.2000.00513.x; Golluscio RA, 1998, GRASS FORAGE SCI, V53, P47, DOI 10.1046/j.1365-2494.1998.00103.x; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lavrenko E. M., 1993, ECOSY WORLD B, P3; Liang C, 2002, J APPL ECOL, V39, P584, DOI 10.1046/j.1365-2664.2002.00735.x; Liu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036434; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lundholm JT, 2004, OECOLOGIA, V141, P346, DOI 10.1007/s00442-003-1454-6; Lyons KG, 2005, CONSERV BIOL, V19, P1019, DOI 10.1111/j.1523-1739.2005.00106.x; Merritt DJ, 2007, AUST J BOT, V55, P336, DOI 10.1071/BT06106; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; MILCHUNAS DG, 1989, VEGETATIO, V80, P11, DOI 10.1007/BF00049137; MILCHUNAS DG, 1988, AM NAT, V132, P87, DOI 10.1086/284839; Murphy BP, 2007, GLOBAL ECOL BIOGEOGR, V16, P160, DOI 10.1111/j.1466-8238.2006.00285.x; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; POTVIN C, 1984, PLANT PHYSIOL, V75, P1054, DOI 10.1104/pp.75.4.1054; REDMANN RE, 1995, PHOTOSYNTHETICA, V31, P251; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Ronnenberg K, 2008, PLANT ECOL, V196, P269, DOI 10.1007/s11258-007-9351-4; Sasaki T, 2009, J ARID ENVIRON, V73, P949, DOI 10.1016/j.jaridenv.2009.04.008; Sasaki T, 2008, J ECOL, V96, P145, DOI 10.1111/j.1365-2745.2007.01315.x; Schiborra A, 2010, J ANIM PHYSIOL AN N, V94, P446, DOI 10.1111/j.1439-0396.2009.00928.x; Schonbach P, 2012, GRASS FORAGE SCI, V67, P535, DOI 10.1111/j.1365-2494.2012.00874.x; Schonbach P, 2009, CROP PASTURE SCI, V60, P963, DOI 10.1071/CP09048; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Stumpp M, 2005, MT RES DEV, V25, P244, DOI 10.1659/0276-4741(2005)025[0244:IOGLAD]2.0.CO;2; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wang YuHui, 2004, Acta Phytoecologica Sinica, V28, P507; Wittmer MHOM, 2010, GLOBAL CHANGE BIOL, V16, P605, DOI 10.1111/j.1365-2486.2009.02033.x; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; Yuan WP, 2005, CHINESE J APPL ECOLO, V16, P605; Zemmrich A, 2010, J ARID ENVIRON, V74, P1271, DOI 10.1016/j.jaridenv.2010.05.014; Zhan X, 2007, J ARID ENVIRON, V68, P298, DOI 10.1016/j.jaridenv.2006.05.012; Zheng SX, 2011, PLANT SOIL, V340, P141, DOI 10.1007/s11104-010-0369-3	57	56	63	7	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52180	10.1371/journal.pone.0052180	http://dx.doi.org/10.1371/journal.pone.0052180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284925	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800038
J	Wilke, M; Bot, A; Jorna, H; Scholte, BJ; de Jonge, HR				Wilke, Martina; Bot, Alice; Jorna, Huub; Scholte, Bob J.; de Jonge, Hugo R.			Rescue of Murine F508del CFTR Activity in Native Intestine by Low Temperature and Proteasome Inhibitors	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; RETICULUM-ASSOCIATED DEGRADATION; DELTA-F508 HOMOZYGOUS TWINS; SMALL-MOLECULE CORRECTORS; CYSTIC-FIBROSIS; CHLORIDE CONDUCTANCE; ENDOCYTIC TRAFFICKING; ANTITUMOR-ACTIVITY; MOUSE MODELS; IN-VITRO	Most patients with Cystic Fibrosis (CF) carry at least one allele with the F508del mutation, resulting in a CFTR chloride channel protein with a processing, gating and stability defect, but with substantial residual activity when correctly sorted to the apical membranes of epithelial cells. New therapies are therefore aimed at improving the folding and trafficking of F508del CFTR, (CFTR correctors) or at enhancing the open probability of the CFTR chloride channel (CFTR potentiators). Preventing premature breakdown of F508del CFTR is an alternative or additional strategy, which is investigated in this study. We established an ex vivo assay for murine F508del CFTR rescue in native intestinal epithelium that can be used as a pre-clinical test for candidate therapeutics. Overnight incubation of muscle stripped ileum in modified William's E medium at low temperature (26 degrees C), and 4 h or 6 h incubation at 37 degrees C with different proteasome inhibitors (PI: ALLN, MG-132, epoxomicin, PS341/bortezomib) resulted in fifty to hundred percent respectively of the wild type CFTR mediated chloride secretion (forskolin induced short-circuit current). The functional rescue was accompanied by enhanced expression of the murine F508del CFTR protein at the apical surface of intestinal crypts and a gain in the amount of complex-glycosylated CFTR (band C) up to 20% of WT levels. Sustained rescue in the presence of brefeldin A shows the involvement of a post-Golgi compartment in murine F508del CFTR degradation, as was shown earlier for its human counterpart. Our data show that proteasome inhibitors are promising candidate compounds for improving rescue of human F508del CFTR function, in combination with available correctors and potentiators.	[Wilke, Martina] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Bot, Alice] Erasmus MC, Dept Biochem, Rotterdam, Netherlands; [Jorna, Huub] Erasmus MC, Erasmus Lab, Anim Sci Ctr, Rotterdam, Netherlands; [Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [de Jonge, Hugo R.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Wilke, M (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	m.wilke@erasmusmc.nl			EU [QLG1-CT-2001-01005]; Cystic Fibrosis Foundation (CFF-USA) [DEJONG04G0]; Dutch Stomach Liver Intestine Society (MLD-Stichting) [6-11]; Sophia-Foundation [506]	EU(European Commission); Cystic Fibrosis Foundation (CFF-USA); Dutch Stomach Liver Intestine Society (MLD-Stichting); Sophia-Foundation	This work was supported by grants from the EU (grant QLG1-CT-2001-01005), the Cystic Fibrosis Foundation (CFF-USA; grant DEJONG04G0), The Dutch Stomach Liver Intestine Society (MLD-Stichting: grant 6-11), and the Sophia-Foundation (grant number 506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Belcher CN, 2010, CURR MOL MED, V10, P82, DOI 10.2174/156652410791065408; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bodas M, 2010, DISCOV MED, V9, P346; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Bronsveld I, 2000, GASTROENTEROLOGY, V119, P32, DOI 10.1053/gast.2000.8524; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Cormet-Boyaka E, 2009, FASEB J; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Davis NB, 2004, J CLIN ONCOL, V22, P115, DOI 10.1200/JCO.2004.07.165; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DeJonge H, 2004, J CYSTIC FI IN PRESS, V3; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; Fisher JT, 2012, J BIOL CHEM, V287, P21673, DOI 10.1074/jbc.M111.336537; French PJ, 1996, J CLIN INVEST, V98, P1304, DOI 10.1172/JCI118917; French PJ, 1997, AM J PHYSIOL-CELL PH, V273, pC747, DOI 10.1152/ajpcell.1997.273.2.C747; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lee EC, 2011, CLIN CANCER RES, V17, P7313, DOI 10.1158/1078-0432.CCR-11-0636; Luciani A, 2010, NAT CELL BIOL; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Owsianik G, 2003, FEBS LETT, V554, P173, DOI 10.1016/S0014-5793(03)01162-1; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pedemonte N, 2010, AM J PHYSIOL-CELL PH, V298, pC866, DOI 10.1152/ajpcell.00404.2009; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rennolds J, 2008, BIOCHEM BIOPH RES CO, V366, P1025, DOI 10.1016/j.bbrc.2007.12.065; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Richardson PG, 2005, CELL CYCLE, V4, P290; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Robert R, 2010, MOL PHARM; Rowe SM, 2010, PULM PHARMACOL THER, V23, P268, DOI 10.1016/j.pupt.2010.02.001; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; VANDOMMELEN FS, 1986, BIOCHEM J, V236, P771, DOI 10.1042/bj2360771; VANDOORNINCK JH, 1995, EMBO J, V14, P4403, DOI 10.1002/j.1460-2075.1995.tb00119.x; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Vij Neeraj, 2010, Journal of Nanobiotechnology, V8, P22, DOI 10.1186/1477-3155-8-22; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Xiao F, 2012, J PHYSL	70	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52070	10.1371/journal.pone.0052070	http://dx.doi.org/10.1371/journal.pone.0052070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284872	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800027
J	Cianciolo, GJ; Pizzo, SV				Cianciolo, George J.; Pizzo, Salvatore V.			Anti-Inflammatory and Vasoprotective Activity of a Retroviral-Derived Peptide, Homologous to Human Endogenous Retroviruses: Endothelial Cell Effects	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PLACENTAL SYNCYTIN EXPRESSION; MESSENGER-RNA EXPRESSION; VASCULAR SMOOTH-MUSCLE; NF-KAPPA-B; ENVELOPE PROTEIN; GENE-EXPRESSION; TNF-ALPHA; LYMPHOCYTE-PROLIFERATION; MACROPHAGE ACCUMULATION	Malignant and inflammatory tissues sometimes express endogenous retroviruses or their proteins. A highly-conserved sequence from retroviral transmembrane (TM) proteins, termed the "immunosuppressive domain (ID)", is associated with inhibition of immune and inflammatory functions. An octadecapeptide (MN10021) from the ID of retroviral TM protein p15E inhibits in vitro release of pro-inflammatory cytokines and increases synthesis of anti-inflammatory IL-10. We sought to determine if MN10021 has significant in vivo effects. MN10021, prepared by solid-phase synthesis, was dimerized through a naturally-occurring, carboxy-terminal cysteine. In vivo anti-inflammatory activity was determined using a murine model of sodium periodate (NalO(4))-induced peritonitis. In vivo vasoprotective effects were determined using: (1) a carrageenan-induced model of disseminated intravascular coagulation (DIC) in mice; (2) a reverse passive Arthus model in guinea pigs; and (3) vasoregulatory effects in spontaneously hypertensive rats (SHR). In vitro studies included: (1) binding/uptake of MN10021 using human monocytes, cultured fibroblasts, and vascular endothelial cells (VEC); (2) gene expression by RT-PCR of MN10021-treated VEC; and (3) apoptosis of MN10021-treated VEC exposed to staurosporine or TNF-alpha. One-tenth nmol MN10021 inhibits 50 percent of the inflammatory response in the mouse peritonitis model. Furthermore, 73 nmol MN10021 completely protects mice in a lethal model of carrageenan-induced DIC and inhibits vascular leak in both the mouse DIC model and a guinea pig reverse passive Arthus reaction. MN10021 binds to and is taken up in a specific manner by both human monocytes and VEC but not by cultured human fibroblasts. Surprisingly, orally-administered MN10021 lowers blood pressure in SHR rats by 10-15% within 1 h suggesting a direct or indirect effect on the vascular endothelium. MN10021 and derived octapeptides induce iNOS (inducible nitric oxide synthase) mRNA in VEC and nitrate in VEC cell culture supernatants and protect VEC from induced apoptosis or necrosis. However, pretreatment of VEC with nitro-L-arginine methyl ester (L-NAME), while inhibiting the release of nitrate, does not block the anti-apoptotic effect of MN10021 and derived octapeptides suggesting that their potent vasoprotective and anti-inflammatory activity is not nitric oxide dependent.	[Cianciolo, George J.; Pizzo, Salvatore V.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Cianciolo, GJ (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	cianc002@mc.duke.edu						Andersson AC, 2002, VIROLOGY, V297, P220, DOI 10.1006/viro.2002.1428; Andersson AC, 1998, INT J ONCOL, V12, P309; BouchierHayes D, 1997, BRIT J SURG, V84, P540; Brown KM, 2003, J AM COLL SURGEONS, V197, P261, DOI 10.1016/S1072-7515(03)00386-7; Buchwalow IB, 2002, FASEB J, V16, P500, DOI 10.1096/fj.01-0842com; Ceneviva GD, 1998, AM J PHYSIOL-LUNG C, V275, pL717, DOI 10.1152/ajplung.1998.275.4.L717; Cerinic MM, 2002, RHEUMATOLOGY, V41, P843; Cerwinka WH, 2002, AM J PHYSIOL-HEART C, V282, pH1111, DOI 10.1152/ajpheart.00391.2001; CIANCIOLO G, 1981, J CLIN INVEST, V68, P831, DOI 10.1172/JCI110338; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; CIANCIOLO GJ, 1984, J EXP MED, V159, P964, DOI 10.1084/jem.159.3.964; CIANCIOLO GJ, 1980, J NATL CANCER I, V65, P829, DOI 10.1093/jnci/65.4.829; CIANCIOLO GJ, 1980, J IMMUNOL, V124, P2900; CIANCIOLO GJ, 1984, NATURE, V311, P515, DOI 10.1038/311515a0; COHEN M, 1985, VIROLOGY, V147, P449, DOI 10.1016/0042-6822(85)90147-3; COHEN M, 1988, J CELL BIOCHEM, V36, P121, DOI 10.1002/jcb.240360203; Cooke JP, 1997, ANNU REV MED, V48, P489, DOI 10.1146/annurev.med.48.1.489; Dash PR, 2003, EXP CELL RES, V287, P314, DOI 10.1016/S0014-4827(03)00156-3; Dash PR, 2003, HUM REPROD, V18, P959, DOI 10.1093/humrep/deg211; Dimmeler S, 1999, ARTERIOSCL THROM VAS, V19, P656, DOI 10.1161/01.ATV.19.3.656; Dimmeler S, 1997, CIRC RES, V81, P970; Farghali H, 2003, INT IMMUNOPHARMACOL, V3, P1627, DOI 10.1016/S1567-5769(03)00185-1; Fiorucci S, 1999, ALIMENT PHARM THER, V13, P421; FOULDS S, 1993, BRIT J CANCER, V68, P610, DOI 10.1038/bjc.1993.395; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; GENARO AM, 1995, J CLIN INVEST, V95, P1884, DOI 10.1172/JCI117869; Gidday JM, 1998, STROKE, V29, P1423, DOI 10.1161/01.STR.29.7.1423; GOTTLIEB RA, 1989, J IMMUNOL, V142, P4321; HARAGUCHI S, 1995, P NATL ACAD SCI USA, V92, P3611, DOI 10.1073/pnas.92.8.3611; HARAGUCHI S, 1992, J LEUKOCYTE BIOL, V52, P469, DOI 10.1002/jlb.52.4.469; HARAGUCHI S, 1993, J IMMUNOL, V151, P2733; HARAGUCHI S, 1995, P NATL ACAD SCI USA, V92, P5568, DOI 10.1073/pnas.92.12.5568; HARRELL RA, 1986, J IMMUNOL, V136, P3517; HARRIS DT, 1987, J IMMUNOL, V138, P889; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; Hickey MJ, 2001, CLIN SCI, V100, P1, DOI 10.1042/CS20000135; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Ialenti A, 2000, INFLAMM RES, V49, P411, DOI 10.1007/s000110050609; Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698; Jourdan KB, 1999, AM J RESP CELL MOL, V21, P105, DOI 10.1165/ajrcmb.21.1.3502; Kajiume T, 2000, J HEMATOTH STEM CELL, V9, P215, DOI 10.1089/152581600319423; KANNAN P, 1991, J VIROL, V65, P6343, DOI 10.1128/JVI.65.11.6343-6348.1991; Katsumata K, 1999, CLIN IMMUNOL, V93, P75, DOI 10.1006/clim.1999.4762; Keith JC, 2002, AM J OBSTET GYNECOL, V187, P1122, DOI 10.1067/mob.2002.128512; Kermarrec N, 1998, AM J RESP CRIT CARE, V158, P833, DOI 10.1164/ajrccm.158.3.9709097; Khan BV, 1996, P NATL ACAD SCI USA, V93, P9114, DOI 10.1073/pnas.93.17.9114; Knerr I, 2002, AM J OBSTET GYNECOL, V186, P210, DOI 10.1067/mob.2002.119636; Kolb H, 1998, IMMUNOL TODAY, V19, P556, DOI 10.1016/S0167-5699(98)01366-8; Kupatt C, 1996, J MOL CELL CARDIOL, V28, P643, DOI 10.1006/jmcc.1996.0060; Kupatt C, 1997, J MOL CELL CARDIOL, V29, P2599, DOI 10.1006/jmcc.1997.0439; KUROSE I, 1994, CIRC RES, V74, P376, DOI 10.1161/01.RES.74.3.376; Larrson E, 1997, LEUKEMIA, V11, P142; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Lefer AM, 1996, CARDIOVASC RES, V32, P743, DOI 10.1016/0008-6363(96)00073-9; Luangwedchakarn V, 2003, PEPTIDES, V24, P631, DOI 10.1016/S0196-9781(03)00137-2; MANNICK JB, 1994, CELL, V79, P1137, DOI 10.1016/0092-8674(94)90005-1; Mehrotra S, 2003, PEPTIDES, V24, P979, DOI 10.1016/S0196-9781(03)00189-X; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MITANI M, 1987, P NATL ACAD SCI USA, V84, P237, DOI 10.1073/pnas.84.1.237; NELSON M, 1990, CANCER IMMUNOL IMMUN, V30, P331, DOI 10.1007/BF01786882; NELSON M, 1989, CANCER IMMUNOL IMMUN, V30, P113, DOI 10.1007/BF01665962; OCONNELL C, 1984, VIROLOGY, V138, P225, DOI 10.1016/0042-6822(84)90347-7; OGASAWARA M, 1990, J IMMUNOL, V145, P456; OGASAWARA M, 1988, J IMMUNOL, V141, P614; Oostendorp R, 1992, DELAYED TYPE HYPERSE, P89; OOSTENDORP RAJ, 1992, J IMMUNOL, V149, P1010; OOSTENDORP RAJ, 1992, EUR J IMMUNOL, V22, P1505, DOI 10.1002/eji.1830220624; Paul-Clark MJ, 2001, J IMMUNOL, V166, P1169, DOI 10.4049/jimmunol.166.2.1169; Perrotta C, 2004, CANCER RES, V64, P3767, DOI 10.1158/0008-5472.CAN-04-0668; POSS WB, 1995, J APPL PHYSIOL, V79, P886, DOI 10.1152/jappl.1995.79.3.886; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; RUEGG CL, 1989, J VIROL, V63, P3250, DOI 10.1128/JVI.63.8.3250-3256.1989; Sibata Masahiko, 1997, Leukemia (Basingstoke), V11, P145; Sprague RS, 1998, J PHARMACOL EXP THER, V284, P443; STOGER H, 1993, CLIN EXP IMMUNOL, V93, P437, DOI 10.1111/j.1365-2249.1993.tb08197.x; Takahashi A, 2001, J IMMUNOL, V166, P6771, DOI 10.4049/jimmunol.166.11.6771; TAKEUCHI K, 1995, CLIN EXP IMMUNOL, V99, P338; TAN IB, 1990, EUR ARCH OTO-RHINO-L, V247, P387; TAS MPR, 1993, CLIN OTOLARYNGOL, V18, P324, DOI 10.1111/j.1365-2273.1993.tb00857.x; Taylor BS, 1998, BIOCHEMISTRY-MOSCOW+, V63, P766; Tzeng E, 1998, SURGERY, V124, P278, DOI 10.1067/msy.1998.90569; VENABLES PJW, 1995, VIROLOGY, V211, P589, DOI 10.1006/viro.1995.1442; Walford G, 2003, J THROMB HAEMOST, V1, P2112, DOI 10.1046/j.1538-7836.2003.00345.x; WANG JM, 1989, J IMMUNOL, V142, P2012; WEINBERG JB, 1981, J NATL CANCER I, V66, P529	85	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52693	10.1371/journal.pone.0052693	http://dx.doi.org/10.1371/journal.pone.0052693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285152	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500232
J	Cole, VJ; Johnson, LG; McQuaid, CD				Cole, Victoria J.; Johnson, Linda G.; McQuaid, Christopher D.			Effects of Patch-Size on Populations of Intertidal Limpets, Siphonaria spp., in a Linear Landscape	PLOS ONE			English	Article							LARVAL DEVELOPMENT; ASSEMBLAGES; DYNAMICS; ORGANISM; FISH; FRAGMENTATION; HETEROGENEITY; AVAILABILITY; COLONIZATION; RECRUITMENT	Organisms with different life-histories and abilities to disperse often utilise habitat patches in different ways. We investigated the influence of the size of patches of rock (separated by stretches of sand) on the density of pulmonate limpets (Siphonaria spp.) along 1500 km of the linear landscape of the South African coastline. We compared the influence of patch-size on two congeneric species with different modes of development, S. serrata a direct developer, and S. concinna a planktonic developer. We tested the spatial and temporal consistency of the effects of patch-size by sampling 7 independent regions spanning the distributional range of both species of limpets, and by sampling one region at monthly intervals for 1 year. Within each region or month, 4 small patches (<20 m in length) interspersed with the 4 large patches (>60 m in length) were sampled. Across the entire geographic range and throughout the year, there were more of both species of limpets in large patches than in small patches. In most regions, there was greater variability in large patches than small patches. Variability within patches in a single region was similar throughout the year, with greater variability of both species in large than in small patches. We found little influence of the mode of development on the response of limpets to patch-size. Our findings highlight the importance of understanding patterns of distribution of species with respect to habitat heterogeneity in linear landscapes, and contradict the idea that organism mobility at an early ontogenetic stage directly affects habitat use.	[Cole, Victoria J.; Johnson, Linda G.; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa	Rhodes University	Cole, VJ (corresponding author), Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa.	victoriajcole@gmail.com	McQuaid, Christopher/AAT-3725-2020; Cole, Victoria/V-2870-2017	McQuaid, Christopher/0000-0002-3473-8308; Cole, Victoria/0000-0002-9594-2775	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Rhodes University	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Rhodes University	Research was funded by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (C. D. M.) and a Rhodes University Postdoctoral Fellowship (V.J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1997, J EXP MAR BIOL ECOL, V215, P269, DOI 10.1016/S0022-0981(96)02770-0; Anderson MJ, 1999, OECOLOGIA, V118, P87, DOI 10.1007/s004420050706; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; BRANCH GM, 1985, J EXP MAR BIOL ECOL, V87, P153, DOI 10.1016/0022-0981(85)90088-7; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P415, DOI 10.1093/mollus/60.4.415; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P263, DOI 10.1093/mollus/60.3.263; Cole VJ, 2007, J EXP MAR BIOL ECOL, V348, P191, DOI 10.1016/j.jembe.2007.05.001; Cole VJ, 2010, ECOLOGY, V91, P3549, DOI 10.1890/09-2152.1; Cole VJ, 2005, MAR ENVIRON RES, V60, P195, DOI 10.1016/j.marenvres.2004.10.004; Connell SD, 1999, J EXP MAR BIOL ECOL, V241, P15, DOI 10.1016/S0022-0981(99)00067-2; Connor EF, 2000, ECOLOGY, V81, P734, DOI 10.2307/177373; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Fagan WF, 2002, ECOLOGY, V83, P3243, DOI 10.2307/3072074; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FORMAN RTT, 1981, BIOSCIENCE, V31, P733, DOI 10.2307/1308780; Goodsell PJ, 2007, MAR ECOL PROG SER, V351, P15, DOI 10.3354/meps07144; Gotelli NJ, 1999, EVOL ECOL RES, V1, P835; Gray DR, 1997, J MOLLUS STUD, V63, P121, DOI 10.1093/mollus/63.2.121; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; HOLT RD, 1985, THEOR POPUL BIOL, V28, P181, DOI 10.1016/0040-5809(85)90027-9; KEOUGH MJ, 1984, ECOLOGY, V65, P423, DOI 10.2307/1941405; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; MCNEILL SE, 1993, J BIOGEOGR, V20, P429, DOI 10.2307/2845591; MCQUAID CD, 1990, OECOLOGIA, V84, P142, DOI 10.1007/BF00665608; McQuaid CD, 1999, J EXP MAR BIOL ECOL, V237, P141, DOI 10.1016/S0022-0981(99)00011-8; Meyer DL, 2009, ESTUAR COAST, V32, P797, DOI 10.1007/s12237-009-9164-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; PICKETT STA, 1985, ECOLOGY NATURAL DIST, P472; Porri F, 2006, MAR ECOL PROG SER, V315, P141, DOI 10.3354/meps315141; POSSINGHAM HP, 1990, ECOLOGY, V71, P973, DOI 10.2307/1937366; QUINN GP, 1988, J EXP MAR BIOL ECOL, V117, P115, DOI 10.1016/0022-0981(88)90221-3; ROBBINS BD, 1994, TRENDS ECOL EVOL, V9, P301, DOI 10.1016/0169-5347(94)90041-8; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; SOUSA WP, 1984, ECOLOGY, V65, P1918, DOI 10.2307/1937789; Underwood A.J., 2002, GMAV 5 WINDOWS ANAL; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 1996, J EXP MAR BIOL ECOL, V197, P63, DOI 10.1016/0022-0981(95)00145-X; Underwood AJ, 1997, EXPT ECOLOGY, P181; Wilson EO, 1967, THEORY ISLAND BIOGEO	42	5	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52076	10.1371/journal.pone.0052076	http://dx.doi.org/10.1371/journal.pone.0052076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284875	gold, Green Published			2022-12-25	WOS:000312794500085
J	Donnenberg, AD; Zimmerlin, L; Landreneau, RJ; Luketich, JD; Donnenberg, VS				Donnenberg, Albert D.; Zimmerlin, Ludovic; Landreneau, Rodney J.; Luketich, James D.; Donnenberg, Vera S.			KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients	PLOS ONE			English	Article							CANCER STEM-CELLS; GASTROINTESTINAL STROMAL TUMORS; C-KIT; IMATINIB MESYLATE; PHASE-II; BREAST-CANCER; MUTATIONS; RECEPTOR; STI571; IDENTIFICATION	We have previously described the expression of CD44, CD90, CD117 and CD133 in NSCLC tumors, adjacent normal lung, and malignant pleural effusions (MPE). Here we describe the unique subset of tumors expressing CD117 (KIT), a potential therapeutic target. Tumor and adjacent tissue were collected from 58 patients. Six MPE were obtained before therapy. Tissue was paraffin embedded for immunofluorescent microscopy, disaggregated and stained for flow cytometry or cryopreserved for later culture. The effect of imatinib on CD117(high)/KIT+ tumors was determined on first passage cells; absolute cell counts and flow cytometry were readouts for drug sensitivity of cell subsets. Primary tumors divided into KITneg and KIT+ by immunofluorescence. By more sensitive flow cytometric analysis, CD117+ cytokeratin+ cells were detected in all tissues (1.1% of cytokeratin+ cells in normal lung, 1.29% in KIT "negative" tumors, 40.7% in KIT+ tumors, and 0.4% in MPE). In KIT+/CD117(high), but not KIT+/CD117(low) tumors, CD117 was overexpressed 3.1-fold compared to normal lung. Primary cultures of CD117(high) tumors were sensitive to imatinib (5 mu M) in short term culture. We conclude that NSCLC tumors divide into CD117(low) and CD117(high). Overexpression of CD117 in CD117(high) NSCLC supports exploring KIT as a therapeutic target in this subset of patients. Citation: Donnenberg AD, Zimmerlin L, Landreneau RJ, Luketich JD, Donnenberg VS (2012) KIT (CD117) Expression in a Subset of Non-Small Cell Lung Carcinoma (NSCLC) Patients. PLoS ONE 7(12): e52885. doi:10.1371/journal.pone.0052885	[Donnenberg, Albert D.; Donnenberg, Vera S.] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15260 USA; [Donnenberg, Albert D.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Zimmerlin, Ludovic; Landreneau, Rodney J.; Luketich, James D.; Donnenberg, Vera S.] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Donnenberg, AD (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15260 USA.	donnenbergad@upmc.edu; donnenbergvs@upmc.edu	luketich, james/AAY-6230-2020		Department of Defense [BC032981, BC044784]; Hillman Foundation; Glimmer of Hope Foundation; Cancer Center [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Hillman Foundation; Glimmer of Hope Foundation; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants BC032981 and BC044784 from the Department of Defense, the Hillman Foundation and the Glimmer of Hope Foundation. Flow cytometry was performed at the UPCI Cytometry Facility and was partially supported by Cancer Center Support Grant P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Albanell J, 1999, DRUGS TODAY, V35, P931; Bumming P, 2003, BRIT J CANCER, V89, P460, DOI 10.1038/sj.bjc.6600965; Campioni D, 2008, CYTOMETRY B; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; de Silva MV, 2003, PATHOL ONCOL RES, V9, P13, DOI 10.1007/BF03033708; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Donnenberg VS, 2007, ERNST SCHERING FOUND, V5, P245, DOI 10.1007/2789_2007_054; Donnenberg VS, 2007, J CONTROL RELEASE, V122, P385, DOI 10.1016/j.jconrel.2007.05.005; Donnenberg VS, 2010, CYTOM PART B-CLIN CY, V78B, P287, DOI 10.1002/cyto.b.20530; Donnenberg VS, 2009, METHODS MOL BIOL, V568, P261, DOI 10.1007/978-1-59745-280-9_17; Donnenberg VS, 2012, CYTOMETRY A; Dy GK, 2005, ANN ONCOL, V16, P1811, DOI 10.1093/annonc/mdi365; Edling CE, 2007, INT J BIOCHEM CELL B, V39, P1995, DOI 10.1016/j.biocel.2006.12.005; Edwards ST, 2005, J PATHOL, V206, P279, DOI 10.1002/path.1780; Fabarius A, 2005, LEUKEMIA, V19, P1573, DOI 10.1038/sj.leu.2403861; Fischer T, 2002, LEUKEMIA, V16, P1220, DOI 10.1038/sj.leu.2402565; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Herpel E, 2011, ANTICANCER RES, V31, P4491; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Humphrey RW, 2011, J NATL CANC I; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson BE, 2003, CLIN CANCER RES, V9, P5880; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kornblith P, 2003, ANTICANCER RES, V23, P3405; Krug LM, 2005, CANCER, V103, P2128, DOI 10.1002/cncr.21000; Krystal GW, 2001, CANCER RES, V61, P3660; Krystal GW, 2000, CLIN CANCER RES, V6, P3319; Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102; Mauro MJ, 2001, ONCOLOGIST, V6, P233, DOI 10.1634/theoncologist.6-3-233; Micke P, 2004, TUMOR BIOL, V25, P235, DOI 10.1159/000081386; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Pandiella A, 2003, BRIT J HAEMATOL, V123, P858, DOI 10.1046/j.1365-2141.2003.04706.x; Pelosi G, 2004, MODERN PATHOL, V17, P711, DOI 10.1038/modpathol.3800110; Ross J. A., 2000, Tissue Antigens, V55, P65; Saglio G, 2004, J BIOL REG HOMEOS AG, V18, P246; Tamborini E, 2004, CLIN CANCER RES, V10, P8214, DOI 10.1158/1078-0432.CCR-04-1013; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186; Zimmerlin L, 2011, FLOW CYTOMETRY PROTO	47	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52885	10.1371/journal.pone.0052885	http://dx.doi.org/10.1371/journal.pone.0052885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285214	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500254
J	Micale, V; Campo, S; D'Ascola, A; Guerrera, MC; Levanti, MB; Germana, A; Muglia, U				Micale, Valeria; Campo, Salvatore; D'Ascola, Angela; Guerrera, M. Cristina; Levanti, M. Beatrice; Germana, Antonino; Muglia, Ugo			Cholecystokinin in White Sea Bream: Molecular Cloning, Regional Expression, and Immunohistochemical Localization in the Gut after Feeding and Fasting	PLOS ONE			English	Article							YELLOWTAIL SERIOLA-QUINQUERADIATA; DIGESTIVE-TRACT; IMMUNOREACTIVE CELLS; ENDOCRINE-CELLS; RAINBOW-TROUT; NEUROENDOCRINE SYSTEM; JAPANESE FLOUNDER; MESSENGER-RNAS; PEPTIDE-Y; ATLANTIC	Background: The peptide hormone cholecystokinin (CCK), secreted by the midgut, plays a key role in digestive physiology of vertebrates including teleosts, by stimulating pancreatic secretion, gut motility, and gallbladder contraction, as well as by delaying gastric emptying. Moreover, CCK is involved in the regulation of food intake and satiation. Secretion of CCK by the hindgut is controversial, and its biological activity remains to be elucidated. The present paper addresses the regional distribution of intestinal CCK in the white sea bream, Diplodus sargus, as well as the possible involvement of hindgut CCK in digestive processes. Methodology/Principal Findings: Full-lengths mRNAs encoding two CCK isoforms (CCK-1 and CCK-2) were sequenced and phylogenetically analyzed. CCK gene and protein expression levels in the different gut segments were measured 3 h and 72 h after feeding, by quantitative real-time RT-PCR and Western blot, respectively. Moreover, endocrine CCK cells were immunoistochemically detected. Fasting induced a significant decrease in CCK-2 in all intestinal segments, including the hindgut. On the other hand, no significant difference was induced by fasting on hindgut CCK-1. Conclusions/Significance: The results demonstrated two CCK isoforms in the hindgut of D. sargus, one of which (CCK-2) may be involved in the feedback control of uncompleted digestive processes. On the other hand, a functional role alternative to regulation of digestive processes may be inferred for D. sargus CCK-1, since its expression was unaffected by feeding or fasting.	[Micale, Valeria] CNR, Ist Ambiente Marino Costiero, Messina, Italy; [Campo, Salvatore; D'Ascola, Angela] Univ Messina, Sch Med, Med Chem Sect, Dept Biochem Physiol & Nutr Sci, Messina, Italy; [Guerrera, M. Cristina; Levanti, M. Beatrice; Germana, Antonino; Muglia, Ugo] Univ Messina, Fac Vet Med, Dept Morphol Biochem Physiol & Anim Prod, Messina, Italy; [Muglia, Ugo] Consorzio Interuniv INBB Ist Nazl Biostrutture &, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Messina; University of Messina	Micale, V (corresponding author), CNR, Ist Ambiente Marino Costiero, Messina, Italy.	valeria.micale@iamc.cnr.it	Germana, Antonino/AAH-2505-2020	Germana, Antonino/0000-0003-0934-3619; d'ascola, angela/0000-0001-7530-1316; CAMPO, Salvatore/0000-0002-7955-8917				ABAD ME, 1987, GEN COMP ENDOCR, V66, P123, DOI 10.1016/0016-6480(87)90357-1; Abellan E, 1999, MARINE FINFISH SPECI; ALDMAN G, 1992, GEN COMP ENDOCR, V86, P20, DOI 10.1016/0016-6480(92)90121-Y; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bermudez R, 2007, FISH SHELLFISH IMMUN, V22, P252, DOI 10.1016/j.fsi.2006.05.006; Bosi G, 2004, GEN COMP ENDOCR, V138, P166, DOI 10.1016/j.ygcen.2004.06.003; Chandra Rashmi, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P63, DOI 10.1097/MED.0b013e3280122850; Chandra R, 2011, CURR OPIN GASTROEN, V27, P439, DOI 10.1097/MOG.0b013e328349e2e1; Chaudhri O, 2006, PHILOS T R SOC B, V361, P1187, DOI 10.1098/rstb.2006.1856; Einarsson S, 1997, COMP BIOCHEM PHYS C, V117, P63, DOI 10.1016/S0742-8413(96)00226-5; ELBAL MT, 1986, GEN COMP ENDOCR, V64, P339, DOI 10.1016/0016-6480(86)90067-5; Forgan LG, 2007, COMP BIOCHEM PHYS C, V146, P343, DOI 10.1016/j.cbpc.2007.04.007; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartviksen MB, 2009, J FISH BIOL, V75, P834, DOI 10.1111/j.1095-8649.2009.02325.x; HERNANDEZ MPG, 1994, CELL TISSUE RES, V277, P373, DOI 10.1007/BF00327785; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jensen H, 2001, BBA-GENE STRUCT EXPR, V1517, P190, DOI 10.1016/S0167-4781(00)00263-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kamisaka Y, 2003, GEN COMP ENDOCR, V134, P116, DOI 10.1016/S0016-6480(03)00242-9; Kamisaka Y, 2002, SARSIA, V87, P258, DOI 10.1080/00364820260294888; Kamisaka Y, 2001, GEN COMP ENDOCR, V123, P31, DOI 10.1006/gcen.2001.7653; Kurokawa T, 2000, GEN COMP ENDOCR, V120, P8, DOI 10.1006/gcen.2000.7512; Kurokawa T, 2003, PEPTIDES, V24, P227, DOI 10.1016/S0196-9781(03)00034-2; Lee JH, 2004, J FISH BIOL, V65, P170, DOI 10.1111/j.0022-1112.2004.00442.x; MARUYAMA K, 1994, GENE, V138, P171; Micale V, 2010, GEN COMP ENDOCR, V169, P23, DOI 10.1016/j.ygcen.2010.07.001; Moran TH, 2009, INT J OBESITY, V33, pS7, DOI 10.1038/ijo.2009.9; Murashita K, 2006, GEN COMP ENDOCR, V145, P287, DOI 10.1016/j.ygcen.2005.09.008; Murashita K, 2007, COMP BIOCHEM PHYS B, V146, P318, DOI 10.1016/j.cbpb.2006.11.009; Murashita K, 2009, GEN COMP ENDOCR, V160, P223, DOI 10.1016/j.ygcen.2008.11.024; Olsson C, 1999, J EXP BIOL, V202, P161; Quemener L, 2002, AQUAT LIVING RESOUR, V15, P293, DOI 10.1016/S0990-7440(02)01187-7; Raybould HE, 2007, CURR OPIN PHARMACOL, V7, P570, DOI 10.1016/j.coph.2007.09.006; Reinecke M, 1997, ANAT EMBRYOL, V195, P87; Ronnestad I, 2007, AQUACULTURE, V268, P82, DOI 10.1016/j.aquaculture.2007.04.031; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Suzuki T, 1999, FISH PHYSIOL BIOCHEM, V21, P73, DOI 10.1023/A:1007703422249; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Volkoff H, 2006, ZEBRAFISH, V3, P131, DOI 10.1089/zeb.2006.3.131; Wang BJ, 2007, AM J PHYSIOL-REG I, V292, pR666, DOI 10.1152/ajpregu.00131.2006; Webb KA, 2010, GEN COMP ENDOCR, V166, P152, DOI 10.1016/j.ygcen.2009.10.010	42	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52428	10.1371/journal.pone.0052428	http://dx.doi.org/10.1371/journal.pone.0052428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285038	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500165
J	Ogiwara, H; Kohno, T				Ogiwara, Hideaki; Kohno, Takashi			CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA END RESECTION; CELL-CYCLE; ACETYLATION; CHROMATIN; PROLIFERATION; NUCLEOSOMES; CHECKPOINT; EXPRESSION; PROTEINS	Histone acetylation at DNA double-strand break (DSB) sites by CBP and p300 histone acetyltransferases (HATs) is critical for the recruitment of DSB repair proteins to chromatin. Here, we show that CBP and p300 HATs also function in DSB repair by transcriptionally activating the BRCA1 and RAD51 genes, which are involved in homologous recombination (HR), a major DSB repair system. siRNA-mediated depletion of CBP and p300 impaired HR activity and downregulated BRCA1 and RAD51 at the protein and mRNA levels. Chromatin immunoprecipitation assays showed that CBP and p300 bind to the promoter regions of the BRCA1 and RAD51 genes, and that depletion of CBP and/or p300 reduces H3 and H4 acetylation and inhibits binding of the transcription factor E2F1 to these promoters. Depletion of CBP and p300 impaired DNA damage-induced phosphorylation and chromatin binding of the single-strand DNA-binding protein RPA following BRCA1-mediated DNA end resection. Consistent with this, subsequent phosphorylation of CHK1 and activation of the G2/M damage checkpoint were also impaired. These results indicate that the HATs CBP and p300 play multiple roles in the activation of the cellular response to DSBs. Citation: Ogiwara H, Kohno T (2012) CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes. PLoS ONE 7(12): e52810. doi:10.1371/journal.pone.0052810	[Ogiwara, Hideaki; Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan	National Cancer Center - Japan	Kohno, T (corresponding author), Natl Canc Ctr, Res Inst, Div Genome Biol, Chuo Ku, Tokyo 104, Japan.	tkkohno@ncc.go.jp		Ogiwara, Hideaki/0000-0003-0860-1807	Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas [22131006]; Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI [23701110]; National Cancer Center Research and Development Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas; Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan for Scientific Research on Innovative Areas(22131006); from the Japan Society for the Promotion of Science for Young Scientists (B) KAKENHI (23701110); and from the National Cancer Center Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bindra RS, 2007, ONCOGENE, V26, P2048, DOI 10.1038/sj.onc.1210001; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Flygare J, 1996, BBA-MOL CELL RES, V1312, P231, DOI 10.1016/0167-4889(96)00040-7; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Morishima K, 2007, BIOCHEM BIOPH RES CO, V362, P872, DOI 10.1016/j.bbrc.2007.08.086; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Ogiwara H, 2011, ONCOGENE, V30, P2135, DOI [10.1038/onc.2010.592, 10.1038/onc.2010.592;]; Osley MA, 2006, TRENDS GENET, V22, P671, DOI 10.1016/j.tig.2006.09.007; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	34	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52810	10.1371/journal.pone.0052810	http://dx.doi.org/10.1371/journal.pone.0052810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285190	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500248
J	Rensen, SS; Bieghs, V; Xanthoulea, S; Arfianti, E; Bakker, JA; Shiri-Sverdlov, R; Hofker, MH; Greve, JW; Buurman, WA				Rensen, Sander S.; Bieghs, Veerle; Xanthoulea, Sofia; Arfianti, Evi; Bakker, Jaap A.; Shiri-Sverdlov, Ronit; Hofker, Marten H.; Greve, Jan Willem; Buurman, Wim A.			Neutrophil-Derived Myeloperoxidase Aggravates Non-Alcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Deficient Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HYPOCHLOROUS ACID; OXIDATIVE STRESS; ATHEROSCLEROTIC LESIONS; SCAVENGER RECEPTORS; ACTIVATION; INFLAMMATION; MATRIX; IMPACT	Background: Chronic inflammation and oxidative stress play fundamental roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). Previously, we reported that myeloperoxidase (MPO), an aggressive oxidant-generating neutrophil enzyme, is associated with NASH severity in man. We now investigated the hypothesis that MPO contributes to the development and progression of NASH. Methodology: Low-density lipoprotein receptor-deficient mice with an MPO-deficient hematopoietic system (LDLR-/-/MPO-/-tp mice) were generated and compared with LDLR-/-/MPO+/+tp mice after induction of NASH by high-fat feeding. Results: High-fat feeding caused a similar to 4-fold induction of liver MPO in LDLR-/-/MPO+/+ mice which was associated with hepatic sequestration of MPO-positive neutrophils and high levels of nitrotyrosine, a marker of MPO activity. Importantly, LDLR-/-/MPO-/-tp mice displayed markedly reduced hepatic neutrophil and T-lymphocyte infiltration (p<0.05), and strong down regulation of pro-inflammatory genes such as TNF-alpha and IL-6 (p<0.05, p<0.01) in comparison with LDLR-/-/MPO+/+tp mice. Next to the generalized reduction of inflammation, liver cholesterol accumulation was significantly diminished in LDLR-/-/MPO-/-tp mice (p = 0.01). Moreover, MPO deficiency appeared to attenuate the development of hepatic fibrosis as evident from reduced hydroxyproline levels (p, 0.01). Interestingly, visceral adipose tissue inflammation was markedly reduced in LDLR-/-/MPO-/-tp mice, with a complete lack of macrophage crown-like structures. In conclusion, MPO deficiency attenuates the development of NASH and diminishes adipose tissue inflammation in response to a high fat diet, supporting an important role for neutrophils in the pathogenesis of metabolic disease.	[Rensen, Sander S.; Xanthoulea, Sofia; Arfianti, Evi; Greve, Jan Willem; Buurman, Wim A.] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Surg, Maastricht, Netherlands; [Bieghs, Veerle; Shiri-Sverdlov, Ronit] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Genet & Cell Biol, Maastricht, Netherlands; [Bakker, Jaap A.] Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Clin Genet, Maastricht, Netherlands; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Med Biol Sect, Groningen, Netherlands; [Greve, Jan Willem] Atrium Med Ctr Parkstad, Dept Surg, Heerlen, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Groningen; Atrium Medical Center	Rensen, SS (corresponding author), Maastricht Univ Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Surg, Maastricht, Netherlands.	s.rensen@maastrichtuniversity.nl	Bakker, J. A./H-7910-2019; Arfianti, Arfianti/GPT-4310-2022; Shiri-Sverdlov, Ronit/X-2642-2019; Rensen, Sander/J-3224-2019; Shiri-Sverdlov, Ronit/E-5571-2017	Arfianti, Arfianti/0000-0003-3331-5044; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Rensen, Sander/0000-0001-5054-8400; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Bakker, Jaap A./0000-0002-2918-7361; xanthoulea, sofia/0000-0003-4700-3404	Senter Novem Innovation Oriented Research Program on Genomics [IGE05012]; Transnational University Limburg grant; Dutch Digestive Foundation [WO 09-46]; VENI grant from the Netherlands Organization for Scientific Research [916.76.070]	Senter Novem Innovation Oriented Research Program on Genomics; Transnational University Limburg grant; Dutch Digestive Foundation; VENI grant from the Netherlands Organization for Scientific Research	Supported by the Senter Novem Innovation Oriented Research Program on Genomics, grant IGE05012 (MH/JWG/WB), a Transnational University Limburg grant and a Dutch Digestive Foundation project grant (WO 09-46) to SR, and VENI grant 916.76.070 from the Netherlands Organization for Scientific Research (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratani Y, 1999, INFECT IMMUN, V67, P1828; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bieghs V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030668; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Collins AR, 2009, CIRC RES, V104, pe42, DOI 10.1161/CIRCRESAHA.108.188771; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu XY, 2003, J BIOL CHEM, V278, P28403, DOI 10.1074/jbc.M304739200; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gaut JP, 2002, J CLIN INVEST, V109, P1311, DOI 10.1172/JCI200215021; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; HAMILTON TA, 1995, J CLIN INVEST, V95, P2020, DOI 10.1172/JCI117887; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hofnagel O, 2007, BBA-MOL CELL BIOL L, V1771, P1117, DOI 10.1016/j.bbalip.2007.06.003; Ikura Y, 2006, HEPATOLOGY, V43, P506, DOI 10.1002/hep.21070; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; LEFKOWITZ DL, 1993, IMMUNOL LETT, V36, P43, DOI 10.1016/0165-2478(93)90067-C; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schoonbroodt S, 1997, BIOCHEM J, V321, P777, DOI 10.1042/bj3210777; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; Tsochatzis E, 2006, AM J GASTROENTEROL, V101, P2629, DOI 10.1111/j.1572-0241.2006.00848.x; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; Videla LA, 2006, TRENDS MOL MED, V12, P555, DOI 10.1016/j.molmed.2006.10.001; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Waterval WAH, 2009, CLIN CHIM ACTA, V407, P36, DOI 10.1016/j.cca.2009.06.023; Woods AA, 2003, BIOCHEM J, V376, P219, DOI 10.1042/BJ20030715; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	46	81	82	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52411	10.1371/journal.pone.0052411	http://dx.doi.org/10.1371/journal.pone.0052411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285030	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500160
J	Wang, H; Yang, YB; Shen, HM; Gu, J; Li, T; Li, XM				Wang, Huan; Yang, Yue-Bo; Shen, Hui-Min; Gu, Jian; Li, Tian; Li, Xiao-Mao			ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells	PLOS ONE			English	Article							TERMINAL KINASE JNK; C-JUN; CANCER-THERAPY; APOPTOSIS; ACTIVATION; BCL-2; INHIBITION; PHOSPHORYLATION; DEXAMETHASONE; INDUCTION	ABT-737 is a BH3 mimetic small molecule inhibitor that can effectively inhibit the activity of antiapoptotic Bcl-2 family proteins including Bcl2, Bcl-xL and Bcl-w, and further enhances the effect of apoptosis by activating the proapoptotic proteins (t-Bid, Bad, Bim). In this study, we demonstrate that ABT-737 improved the radiation sensitivity of cervical cancer HeLa cells and thereby provoked cell apoptosis. Our results show that ABT-737 inhibited HeLa cell proliferation and activated JNK and its downstream target c-Jun, which caused the up-regulation of Bim expression. Blockade of JNK/c-Jun signaling pathway resulted in significant down-regulation of ABT-737-induced Bim mRNA and protein expression level. Also, ABT-737 could evoke the Bim promoter activity, and enhance the radiation sensitivity of HeLa cells via JNK/c-Jun and Bim signaling pathway. Our data imply that combination of ABT-737 and conventional radiation therapy might represent a highly effective therapeutic approach for future treatment of cervical cancer. Citation: Wang H, Yang Y-B, Shen H-M, Gu J, Li T, et al. (2012) ABT-737 Induces Bim Expression via JNK Signaling Pathway and Its Effect on the Radiation Sensitivity of HeLa Cells. PLoS ONE 7(12): e52483. doi:10.1371/journal.pone.0052483	[Wang, Huan; Yang, Yue-Bo; Shen, Hui-Min; Gu, Jian; Li, Tian; Li, Xiao-Mao] Sun Yat Sen Univ, Dept Gynecol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Li, XM (corresponding author), Sun Yat Sen Univ, Dept Gynecol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	tigerlee777@163.com			Guangdong province science and technology department project [2010B031600033]	Guangdong province science and technology department project	The study was supported by a grant from Guangdong province science and technology department project (2010B031600033) (:http://pro.gdstc.gov.cn/stms/main.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Azmi AS, 2011, EXPERT OPIN EMERG DR, V16, P59, DOI 10.1517/14728214.2010.515210; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Dasmahapatra G, 2009, CANCER BIOL THER, V8, P808, DOI 10.4161/cbt.8.9.8131; Howard AN, 2009, CANCER CHEMOTH PHARM, V65, P41, DOI 10.1007/s00280-009-1001-1; Kang MH, 2007, BLOOD, V110, P2057, DOI 10.1182/blood-2007-03-080325; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Keuling AM, 2010, PIGM CELL MELANOMA R, V23, P430, DOI 10.1111/j.1755-148X.2010.00698.x; Konopleva M, 2011, THEOR APPL GENET, V122, P1517; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2006, J MED CHEM, V49, P656, DOI 10.1021/jm0507532; Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376, DOI 10.1128/MCB.14.12.8376; Srivastava RK, 1999, MOL CELL BIOL, V19, P5659; Subramanian SL, 2012, DIABETOLOGIA, V55, P166, DOI 10.1007/s00125-011-2338-7; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Trudel S, 2007, CLIN CANCER RES, V13, P621, DOI 10.1158/1078-0432.CCR-06-1526; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Watson A, 1998, J NEUROSCI, V18, P751; Will B, 2010, BLOOD, V115, P2901, DOI 10.1182/blood-2009-03-209544; Yao HP, 2007, CELL RES, V17, P565, DOI 10.1038/cr.2007.6; Yoon S, 2006, NEUROSCI LETT, V394, P190, DOI 10.1016/j.neulet.2005.10.034	27	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52483	10.1371/journal.pone.0052483	http://dx.doi.org/10.1371/journal.pone.0052483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285061	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500181
J	Longstaff, C; Varju, I; Sotonyi, P; Szabo, L; Krumrey, M; Hoell, A; Bota, A; Varga, Z; Komorowicz, E; Kolev, K				Longstaff, Colin; Varju, Imre; Sotonyi, Peter; Szabo, Laszlo; Krumrey, Michael; Hoell, Armin; Bota, Attila; Varga, Zoltan; Komorowicz, Erzsebet; Kolev, Krasimir			Mechanical Stability and Fibrinolytic Resistance of Clots Containing Fibrin, DNA, and Histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; DEEP-VEIN THROMBOSIS; INNATE IMMUNITY; PLASMINOGEN; PLATELET; GENERATION; RELEASE; LYSIS	Neutrophil extracellular traps are networks of DNA and associated proteins produced by nucleosome release from activated neutrophils in response to infection stimuli and have recently been identified as key mediators between innate immunity, inflammation, and hemostasis. The interaction of DNA and histones with a number of hemostatic factors has been shown to promote clotting and is associated with increased thrombosis, but little is known about the effects of DNA and histones on the regulation of fibrin stability and fibrinolysis. Here we demonstrate that the addition of histone-DNA complexes to fibrin results in thicker fibers (increase in median diameter from 84 to 123 nm according to scanning electron microscopy data) accompanied by improved stability and rigidity (the critical shear stress causing loss of fibrin viscosity increases from 150 to 376 Pa whereas the storage modulus of the gel increases from 62 to 82 pascals according to oscillation rheometric data). The effects of DNA and histones alone are subtle and suggest that histones affect clot structure whereas DNA changes the way clots are lysed. The combination of histones + DNA significantly prolongs clot lysis. Isothermal titration and confocal microscopy studies suggest that histones and DNA bind large fibrin degradation products with 191 and 136 nM dissociation constants, respectively, interactions that inhibit clot lysis. Heparin, which is known to interfere with the formation of neutrophil extracellular traps, appears to prolong lysis time at a concentration favoring ternary histone-DNA-heparin complex formation, and DNase effectively promotes clot lysis in combination with tissue plasminogen activator.	[Longstaff, Colin] Natl Inst Biol Stand & Controls, Haemostasis Sect, Potters Bar EN6 3QG, Herts, England; [Varju, Imre; Komorowicz, Erzsebet; Kolev, Krasimir] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Sotonyi, Peter] Semmelweis Univ, Dept Vasc Surg, H-1122 Budapest, Hungary; [Szabo, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Mat & Environm Chem, H-1025 Budapest, Hungary; [Bota, Attila; Varga, Zoltan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Mol Pharmacol, Dept Biol Nanochem, H-1025 Budapest, Hungary; [Krumrey, Michael] PTB, D-10587 Berlin, Germany; [Hoell, Armin] HZB, D-14109 Berlin, Germany	National Institute for Biological Standards & Control; Semmelweis University; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Physikalisch-Technische Bundesanstalt (PTB); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB)	Longstaff, C (corresponding author), Natl Inst Biol Stand & Controls, Biotherapeut Grp, S Mimms EN6 3QG, Herts, England.	colin.longstaff@nibsc.hpa.org.uk	Longstaff, Colin/D-2413-2013; Kolev, Krasimir/J-7648-2019; Krumrey, Michael/G-6295-2011; Kolev, Krasimir/A-3517-2008; Varga, Zoltan/C-5215-2008	Longstaff, Colin/0000-0001-7608-208X; Kolev, Krasimir/0000-0002-5612-004X; Krumrey, Michael/0000-0001-9591-5462; Kolev, Krasimir/0000-0002-5612-004X; Hoell, Armin/0000-0002-7080-8393; Varga, Zoltan/0000-0002-5741-2669	Wellcome Trust [083174]; Hungarian Scientific Research Fund [OTKA 75430, 83023]; German Academic Exchange Service [DAAD A/12/01760]	Wellcome Trust(Wellcome TrustEuropean Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Wellcome Trust Grant 083174, Hungarian Scientific Research Fund Grants OTKA 75430 and 83023, and German Academic Exchange Service Grant DAAD A/12/01760.	Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Borissoff JI, 2011, J THROMB HAEMOST, V9, P1791, DOI 10.1111/j.1538-7836.2011.04425.x; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; Esmon CT, 2009, BLOOD REV, V23, P225, DOI 10.1016/j.blre.2009.07.002; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gleber G, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012027; Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333; Komissarov AA, 2011, J BIOL CHEM, V286, P41949, DOI 10.1074/jbc.M111.301218; Komorowicz E, 1998, BIOCHEMISTRY-US, V37, P9112, DOI 10.1021/bi980180d; Longstaff C, 2004, J THROMB HAEMOST, V2, P1416, DOI 10.1111/j.1538-7836.2004.00816.x; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; R Development Core Team, 2011, R PROGR STAT COMP; Rabai G, 2010, THROMB RES, V126, pE94, DOI 10.1016/j.thromres.2010.05.007; RACZ Z, 1993, BIOMED TECH, V38, P266; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Ruf W, 2010, NAT MED, V16, P851, DOI 10.1038/nm0810-851; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405; Sands D, 2002, THROMB HAEMOSTASIS, V88, P294; SCRUTTON MC, 1994, BLOOD COAGUL FIBRIN, V5, P719, DOI 10.1097/00001721-199410000-00007; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Silva MMCG, 2012, J THROMB HAEMOST, V10, P2354, DOI 10.1111/j.1538-7836.2012.04925.x; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Tenekedjiev K., 2012, THEORY APPL MONTE CA; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; WEISEL JW, 1986, J ULTRA MOL STRUCT R, V96, P176, DOI 10.1016/0889-1605(86)90019-4; Wohner N, 2010, J THROMB HAEMOST, V8, P1624, DOI 10.1111/j.1538-7836.2010.03890.x; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yeromonahos C, 2010, BIOPHYS J, V99, P2018, DOI 10.1016/j.bpj.2010.04.059	37	162	164	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6946	6956		10.1074/jbc.M112.404301	http://dx.doi.org/10.1074/jbc.M112.404301			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23293023	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000316002400017
J	Tai, LM; Bilousova, T; Jungbauer, L; Roeske, SK; Youmans, KL; Yu, CJ; Poon, WW; Cornwell, LB; Miller, CA; Vinters, HV; Van Eldik, LJ; Fardo, DW; Estus, S; Bu, GJ; Gylys, KH; LaDu, MJ				Tai, Leon M.; Bilousova, Tina; Jungbauer, Lisa; Roeske, Stephen K.; Youmans, Katherine L.; Yu, Chunjiang; Poon, Wayne W.; Cornwell, Lindsey B.; Miller, Carol A.; Vinters, Harry V.; Van Eldik, Linda J.; Fardo, David W.; Estus, Steve; Bu, Guojun; Gylys, Karen Hoppens; LaDu, Mary Jo			Levels of Soluble Apolipoprotein E/Amyloid-beta (A beta) Complex Are Reduced and Oligomeric A beta Increased with APOE4 and Alzheimer Disease in a Transgenic Mouse Model and Human Samples	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOFORM-SPECIFIC BINDING; AMYLOID-BETA; IN-VITRO; PEPTIDE; PROTEIN; BRAIN; DEGRADATION; CLEARANCE; NEURODEGENERATION; COLOCALIZATION	Human apolipoprotein E (apoE) isoforms may differentially modulate amyloid-beta (A beta) levels. Evidence suggests physical interactions between apoE and A beta are partially responsible for these functional effects. However, the apoE/A beta complex is not a single static structure; rather, it is defined by detection methods. Thus, literature results are inconsistent and difficult to interpret. An ELISA was developed to measure soluble apoE/A beta in a single, quantitative method and was used to address the hypothesis that reduced levels of soluble apoE/A beta and an increase in soluble A beta, specifically oligomeric A beta (oA beta), are associated with APOE4 and AD. Previously, soluble A beta 42 and oA beta levels were greater with APOE4 compared with APOE2/APOE3 in hippocampal homogenates from EFAD transgenic mice (expressing five familial AD mutations and human apoE isoforms). In this study, soluble apoE/A beta levels were lower in E4FAD mice compared with E2FAD and E3FAD mice, thus providing evidence that apoE/A beta levels isoform-specifically modulate soluble oA beta clearance. Similar results were observed in soluble preparations of human cortical synaptosomes; apoE/A beta levels were lower in AD patients compared with controls and lower with APOE4 in the AD cohort. In human CSF, apoE/A beta levels were also lower in AD patients and with APOE4 in the AD cohort. Importantly, although total A beta 42 levels decreased in AD patients compared with controls, oA beta levels increased and were greater with APOE4 in the AD cohort. Overall, apoE isoform-specific formation of soluble apoE/A beta modulates oA beta levels, suggesting a basis for APOE4-induced AD risk and a mechanistic approach to AD biomarkers.	[Tai, Leon M.; Jungbauer, Lisa; Roeske, Stephen K.; Youmans, Katherine L.; Yu, Chunjiang; LaDu, Mary Jo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Bilousova, Tina; Gylys, Karen Hoppens] UCLA Sch Nursing, Los Angeles, CA 90095 USA; [Bilousova, Tina; Gylys, Karen Hoppens] Mary S Easton Ctr Alzheimers Res, Los Angeles, CA 90095 USA; [Poon, Wayne W.; Cornwell, Lindsey B.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA; [Miller, Carol A.] Keck Univ Southern Calif, Sch Med, Dept Pathol, Los Angeles, CA 90089 USA; [Miller, Carol A.] Keck Univ Southern Calif, Sch Med, Dept Neurol, Los Angeles, CA 90089 USA; [Miller, Carol A.] Keck Univ Southern Calif, Sch Med, Program Neurosci, Los Angeles, CA 90089 USA; [Vinters, Harry V.] UCLA Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Van Eldik, Linda J.; Fardo, David W.; Estus, Steve] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Van Eldik, Linda J.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Fardo, David W.] Univ Kentucky, Dept Biostat, Lexington, KY 40536 USA; [Estus, Steve] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Mayo Clinic	LaDu, MJ (corresponding author), Univ Illinois, Dept Anat & Cell Biol, 808 S Wood St,M-C 512, Chicago, IL 60612 USA.	mladu@uic.edu		Poon, Wayne/0000-0003-0625-3968; Jungbauer Nikolas, Lisa/0000-0002-5429-3393; LaDu, Mary Jo/0000-0003-2141-1450; Fardo, David/0000-0002-7207-4696	National Institutes of Health from NIA [P01AG030128, AG27465, G18879, 050 AG05142, P50 AG 16970, P50 AG016573, P30 AG028383]; Alzheimer's Association Grant [ZEN-08-899000]; University of Illinois at Chicago Center for Clinical and Translational Science Grant [UL1RR029879]; Alzheimer's Drug Discovery Foundation Grant; Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016573, P01AG030128, R01AG027465, P30AG028383, R56AG027465, RF1AG046205, R01AG046205, P50AG005142, R01AG027924] Funding Source: NIH RePORTER	National Institutes of Health from NIA; Alzheimer's Association Grant(Alzheimer's Association); University of Illinois at Chicago Center for Clinical and Translational Science Grant; Alzheimer's Drug Discovery Foundation Grant; Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG030128 from NIA (to M. J. L. and S. E.), AG27465 (to K. H. G.), and G18879 (to C. A. M.). This work was also supported by Alzheimer's Association Grant ZEN-08-899000 (to M. J. L.), University of Illinois at Chicago Center for Clinical and Translational Science Grant UL1RR029879 (to M. J. L.), and an Alzheimer's Drug Discovery Foundation Grant (to M. J. L. and S. E.).; Supported by the Daljit S. and Elaine Sarkaria Chair in Diagnostic Medicine.; Human post-mortem samples were obtained from the Alzheimer's Disease Research Center Neuropathology Cores of the University of Southern California (supported by National Institutes of Health Grant 050 AG05142 from NIA), UCLA (supported by National Institutes of Health Grant P50 AG 16970 from NIA), and University of California at Irvine (supported by National Institutes of Health Grant P50 AG016573 from NIA). Human CSF samples were obtained from the University of Kentucky Alzheimer's Disease Research Center (supported by National Institutes of Health Grant P30 AG028383 from NIA). We also gratefully acknowledge Maria Corrada and Claudia Kawas and the 90+ Study for providing tissue (University of California at Irvine).	Aleshkov S, 1997, BIOCHEMISTRY-US, V36, P10571, DOI 10.1021/bi9626362; Arold S, 2012, ACTA NEUROPATHOL, V123, P39, DOI 10.1007/s00401-011-0892-1; Bachmeier C, 2013, J MOL NEUROSCI, V49, P270, DOI 10.1007/s12031-012-9866-6; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Ball M, 1997, NEUROBIOL AGING, V18, pS1, DOI 10.1016/s0197-4580(97)00057-2; Basak JM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-14; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cerf E, 2011, FASEB J, V25, P1585, DOI 10.1096/fj.10-175976; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Fein JA, 2008, AM J PATHOL, V172, P1683, DOI 10.2353/ajpath.2008.070829; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; GOLABEK A, 1995, NEUROSCI LETT, V191, P79, DOI 10.1016/0304-3940(95)11565-7; Golabek AA, 1996, J BIOL CHEM, V271, P10602, DOI 10.1074/jbc.271.18.10602; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Grimmer T, 2010, BIOL PSYCHIAT, V68, P879, DOI 10.1016/j.biopsych.2010.05.013; Gylys KH, 2007, NEUROBIOL AGING, V28, P8, DOI 10.1016/j.neurobiolaging.2005.10.018; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; Hawkes CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041636; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hong SY, 2011, J NEUROSCI, V31, P15861, DOI 10.1523/JNEUROSCI.3272-11.2011; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jones PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014586; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaDu MJ, 2012, BBA-MOL CELL BIOL L, V1821, P295, DOI 10.1016/j.bbalip.2011.11.005; LaDu MJ, 1997, J NEUROSCI RES, V49, P9, DOI 10.1002/(SICI)1097-4547(19970701)49:1<9::AID-JNR2>3.0.CO;2-H; LaDu MJ, 2006, BIOCHEMISTRY-US, V45, P381, DOI 10.1021/bi051765s; LADU MJ, 1994, J BIOL CHEM, V269, P23403; LADU MJ, 1995, J BIOL CHEM, V270, P9039, DOI 10.1074/jbc.270.16.9039; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lefterov I, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-20; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Manelli AM, 2004, J MOL NEUROSCI, V23, P235, DOI 10.1385/JMN:23:3:235; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; Morris JC, 2011, NEUROBIOL AGING, V32, pS1, DOI 10.1016/j.neurobiolaging.2011.09.005; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Munson GW, 2000, BIOCHEMISTRY-US, V39, P16119, DOI 10.1021/bi0017475; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Pillot T, 1997, EUR J BIOCHEM, V243, P650, DOI 10.1111/j.1432-1033.1997.00650.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Russo C, 1998, P NATL ACAD SCI USA, V95, P15598, DOI 10.1073/pnas.95.26.15598; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Shoji M, 2011, INT J ALZHEIMERS DIS; Sokolow S, 2012, NEUROBIOL AGING, V33, P1545, DOI 10.1016/j.neurobiolaging.2011.05.011; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1994, P NATL ACAD SCI USA, V91, P11183, DOI 10.1073/pnas.91.23.11183; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Yamauchi K, 2000, J NEUROSCI RES, V62, P608, DOI 10.1002/1097-4547(20001115)62:4<608::AID-JNR16>3.0.CO;2-4; Yang DS, 1997, J NEUROCHEM, V68, P721; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; Youmans KL, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-8; Youmans KL, 2011, J NEUROSCI METH, V196, P51, DOI 10.1016/j.jneumeth.2010.12.025; Zhou ZM, 1996, MOL MED, V2, P175, DOI 10.1007/BF03401614; Zhou ZM, 2002, MOL MED, V8, P376, DOI 10.1007/BF03402018	87	117	119	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5914	5926		10.1074/jbc.M112.442103	http://dx.doi.org/10.1074/jbc.M112.442103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293020	Green Published, hybrid			2022-12-25	WOS:000315342500060
J	Le, BV; Nguyen, JB; Logarajah, S; Wang, B; Marcus, J; Williams, HP; Catteruccia, F; Baxter, RHG				Le, Binh V.; Nguyen, Jennifer B.; Logarajah, Shankar; Wang, Bo; Marcus, Jacob; Williams, Hazel P.; Catteruccia, Flaminia; Baxter, Richard H. G.			Characterization of Anopheles gambiae Transglutaminase 3 (AgTG3) and Its Native Substrate Plugin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIG LIVER TRANSGLUTAMINASE; COAGULATION-FACTOR-XIII; CALCIUM-IONS; BINDING SITE; FIELD; IDENTIFICATION; PURIFICATION; MECHANISM; RELEASE; SYSTEMS	Male Anopheles mosquitoes coagulate their seminal fluids via cross-linking of a substrate, called Plugin, by the seminal transglutaminase AgTG3. Formation of the "mating plug" by cross-linking Plugin is necessary for efficient sperm storage by females. AgTG3 has a similar degree of sequence identity (similar to 30%) to both human Factor XIII (FXIII) and tissue transglutaminase 2 (hTG2). Here we report the solution structure and in vitro activity for the cross-linking reaction of AgTG3 and Plugin. AgTG3 is a dimer in solution and exhibits Ca2+-dependent nonproteolytic activation analogous to cytoplasmic FXIII. The C-terminal domain of Plugin is predominantly alpha-helical with extended tertiary structure and oligomerizes in solution. The specific activity of AgTG3 was measured as 4.25 x 10(-2) units mg(-1). AgTG3 is less active than hTG2 assayed using the general substrate TVQQEL but has 8-10 x higher relative activity when Plugin is the substrate. Mass spectrometric analysis of cross-linked Plugin detects specific peptides including a predicted consensus motif for cross-linking by AgTG3. These results support the development of AgTG3 inhibitors as specific and effective chemosterilants for A. gambiae.	[Le, Binh V.; Logarajah, Shankar; Wang, Bo; Marcus, Jacob; Baxter, Richard H. G.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Nguyen, Jennifer B.; Baxter, Richard H. G.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Williams, Hazel P.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Catteruccia, Flaminia] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Catteruccia, Flaminia] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, I-06123 Perugia, Italy	Yale University; Yale University; Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; University of Perugia	Baxter, RHG (corresponding author), POB 208107, New Haven, CT 06520 USA.	richard.baxter@yale.edu	Nguyen, Jennifer/GVS-4347-2022; Baxter, Richard/F-3027-2013	Baxter, Richard/0000-0001-5140-1726; Catteruccia, Flaminia/0000-0003-3295-6683	National Institutes of Health Career Development Award from NIAID [K22AI085112-01]; European Research Council [260897]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI085112] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award from NIAID; European Research Council(European Research Council (ERC)European Commission); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Career Development Award K22AI085112-01 from the NIAID (to R. H. G. B.). This work was also supported by European Research Council FP7 ERC Starting Grant Project "Anorep" Grant 260897 (to F. C.). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Ahvazi B, 2003, J BIOL CHEM, V278, P23834, DOI 10.1074/jbc.M301162200; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; El Sayed BB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S3; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Fox BA, 1999, J BIOL CHEM, V274, P4917, DOI 10.1074/jbc.274.8.4917; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Helinski MEH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-65; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kratky O., 1982, SMALL ANGLE XRAY SCA, P361; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen GK, 2011, J BIOL CHEM, V286, P9833, DOI 10.1074/jbc.M110.174128; LAI TS, 1994, PROTEIN EXPRES PURIF, V5, P125, DOI 10.1006/prep.1994.1019; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Lehane MJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001495; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lung O, 2001, INSECT BIOCHEM MOLEC, V31, P543, DOI 10.1016/S0965-1748(00)00154-5; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Palopoli MF, 2008, NATURE, V454, P1019, DOI 10.1038/nature07171; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Rogers DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000272; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shibata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013477; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tseng HC, 2012, AMINO ACIDS, V42, P951, DOI 10.1007/s00726-011-1009-9; Tsurupa G, 2012, BIOCHEMISTRY-US, V51, P2526, DOI 10.1021/bi2017848; Tsurupa G, 2011, BIOCHEMISTRY-US, V50, P8028, DOI 10.1021/bi2008189; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Williams-Ashman H G, 1980, Adv Enzyme Regul, V18, P239, DOI 10.1016/0065-2571(80)90018-7; Xu H, 2009, PROTEOMICS, V9, P1548, DOI 10.1002/pmic.200700322; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058	42	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4844	4853		10.1074/jbc.M112.435347	http://dx.doi.org/10.1074/jbc.M112.435347			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288850	Green Published, hybrid			2022-12-25	WOS:000315340400033
J	Partow, S; Siewers, V; Daviet, L; Schalk, M; Nielsen, J				Partow, Siavash; Siewers, Verena; Daviet, Laurent; Schalk, Michel; Nielsen, Jens			Reconstruction and Evaluation of the Synthetic Bacterial MEP Pathway in Saccharomyces cerevisiae	PLOS ONE			English	Article							DEOXYXYLULOSE PHOSPHATE-PATHWAY; ISOPRENOID BIOSYNTHETIC-PATHWAY; ESCHERICHIA-COLI; ISPH PROTEIN; ARABIDOPSIS-THALIANA; 4FE-4S PROTEIN; GENE SYNTHESIS; TRANSFER-RNAS; STEROL LEVELS; IN-VIVO	Isoprenoids, which are a large group of natural and chemical compounds with a variety of applications as e.g. fragrances, pharmaceuticals and potential biofuels, are produced via two different metabolic pathways, the mevalonate (MVA) pathway and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway. Here, we attempted to replace the endogenous MVA pathway in Saccharomyces cerevisiae by a synthetic bacterial MEP pathway integrated into the genome to benefit from its superior properties in terms of energy consumption and productivity at defined growth conditions. It was shown that the growth of a MVA pathway deficient S. cerevisiae strain could not be restored by the heterologous MEP pathway even when accompanied by the co-expression of genes erpA, hISCA1 and CpIscA involved in the Fe-S trafficking routes leading to maturation of IspG and IspH and E. coli genes fldA and fpr encoding flavodoxin and flavodoxin reductase believed to be responsible for electron transfer to IspG and IspH.	[Partow, Siavash; Siewers, Verena; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Daviet, Laurent; Schalk, Michel] Firmenich Co, Corp R&D Div, Geneva, Switzerland	Chalmers University of Technology; Firmenich	Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Siewers, Verena/AAV-4902-2020; Nielsen, Jens/Q-1347-2017	Siewers, Verena/0000-0002-9502-9804; Nielsen, Jens/0000-0002-9955-6003	Knut and Alice Wallenberg Foundation; Chalmers Foundation; Firmenich AG	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Chalmers Foundation; Firmenich AG	The Knut and Alice Wallenberg Foundation, the Chalmers Foundation and Firmenich AG have financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Berges T, 1997, J BACTERIOL, V179, P4664, DOI 10.1128/jb.179.15.4664-4670.1997; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Chen Y, 2012, FEMS YEAST RES, P1; Culotta VC, 2000, J BIOL CHEM, V20, P3918; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; DIHANICH ME, 1987, MOL CELL BIOL, V7, P177, DOI 10.1128/MCB.7.1.177; DimsterDenk D, 1996, MOL CELL BIOL, V16, P3981; Dugar D, 2011, NAT BIOTECHNOL, V29, P1074, DOI 10.1038/nbt.2055; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Flagfeldt DB, 2009, YEAST, V26, P545, DOI 10.1002/yea.1705; Formenti LR, 2011, THESIS DTU DENMARK; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grawert T, 2010, P NATL ACAD SCI USA, V107, P1077, DOI 10.1073/pnas.0913045107; Grawert T, 2004, J AM CHEM SOC, V126, P12847, DOI 10.1021/ja0471727; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Herz S, 2000, P NATL ACAD SCI USA, V97, P2486, DOI 10.1073/pnas.040554697; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; Kaminska J, 2002, FEMS YEAST RES, V2, P31, DOI 10.1111/j.1567-1364.2002.tb00066.x; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Kuranda K, 2010, FEMS YEAST RES, V10, P14, DOI 10.1111/j.1567-1364.2009.00560.x; Kuranda K, 2009, FEMS YEAST RES, V9, P381, DOI 10.1111/j.1567-1364.2009.00485.x; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; LIOCHEV SI, 1994, FREE RADICAL BIO MED, V16, P29, DOI 10.1016/0891-5849(94)90239-9; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; LORENZ RT, 1990, ANTIMICROB AGENTS CH, V34, P1660, DOI 10.1128/AAC.34.9.1660; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; Maury J, 2005, ADV BIOCHEM ENG BIOT, V100, P19, DOI 10.1007/b136410; Maury J, 2008, FEBS LETT, V582, P4032, DOI 10.1016/j.febslet.2008.10.045; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Muhlenhoff U, 2011, J BIOL CHEM, P1; Nookaew I, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-71; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; PANTOPOULOS K, 1995, EMBO J, V14, P2917, DOI 10.1002/j.1460-2075.1995.tb07291.x; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Piddocke MP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-27; Pinske C, 2012, J BACTERIOL, V194, P346, DOI 10.1128/JB.06024-11; Puan KJ, 2005, FEBS LETT, V579, P3802, DOI 10.1016/j.febslet.2005.05.047; Querol J, 2002, FEBS LETT, V514, P343, DOI 10.1016/S0014-5793(02)02402-X; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; ROHMER M, 1993, BIOCHEM J, V295, P517, DOI 10.1042/bj2950517; Seemann M, 2006, FEBS LETT, V580, P1547, DOI 10.1016/j.febslet.2006.01.082; Seemann M, 2005, J BIOL INORG CHEM, V10, P131, DOI 10.1007/s00775-004-0619-z; SERVOUSE M, 1984, BIOCHEM BIOPH RES CO, V123, P424, DOI 10.1016/0006-291X(84)90247-X; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Sharma AK, 2010, J BIOL CHEM, V285, P26745, DOI 10.1074/jbc.R110.122218; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Sprenger GA, 1997, P NATL ACAD SCI USA, V94, P12857, DOI 10.1073/pnas.94.24.12857; Szczebara FM, 2003, NAT BIOTECHNOL, V21, P143, DOI 10.1038/nbt775; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; TSAY YH, 1991, MOL CELL BIOL, V11, P620, DOI 10.1128/MCB.11.2.620; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108; Wolff M, 2003, FEBS LETT, V541, P115, DOI 10.1016/S0014-5793(03)00317-X; Xiao YL, 2008, J AM CHEM SOC, V130, P2164, DOI 10.1021/ja710245d; Xiao YL, 2009, J AM CHEM SOC, V131, P9931, DOI 10.1021/ja903778d; Yan YJ, 2005, APPL ENVIRON MICROB, V71, P5610, DOI 10.1128/AEM.71.9.5610-5613.2005	75	37	38	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52498	10.1371/journal.pone.0052498	http://dx.doi.org/10.1371/journal.pone.0052498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285068	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500031
J	Batsukh, T; Schulz, Y; Wolf, S; Rabe, TI; Oellerich, T; Urlaub, H; Schaefer, IM; Pauli, S				Batsukh, Tserendulam; Schulz, Yvonne; Wolf, Stephan; Rabe, Tamara I.; Oellerich, Thomas; Urlaub, Henning; Schaefer, Inga-Marie; Pauli, Silke			Identification and Characterization of FAM124B as a Novel Component of a CHD7 and CHD8 Containing Complex	PLOS ONE			English	Article							CHROMATIN REMODELING FACTOR; CHARGE SYNDROME; PHENOTYPIC SPECTRUM; MUTATIONS; EXPRESSION; RNA; INTERACTS; PROTEINS; DEFECTS; MICE	Background: Mutations in the chromodomain helicase DNA binding protein 7 gene (CHD7) lead to CHARGE syndrome, an autosomal dominant multiple malformation disorder. Proteins involved in chromatin remodeling typically act in multiprotein complexes. We previously demonstrated that a part of human CHD7 interacts with a part of human CHD8, another chromodomain helicase DNA binding protein presumably being involved in the pathogenesis of neurodevelopmental (NDD) and autism spectrum disorders (ASD). Because identification of novel CHD7 and CHD8 interacting partners will provide further insights into the pathogenesis of CHARGE syndrome and ASD/NDD, we searched for additional associated polypeptides using the method of stable isotope labeling by amino acids in cell culture (SILAC) in combination with mass spectrometry. Principle findings: The hitherto uncharacterized FAM124B (Family with sequence similarity 124B) was identified as a potential interaction partner of both CHD7 and CHD8. We confirmed the result by co-immunoprecipitation studies and showed a direct binding to the CHD8 part by direct yeast two hybrid experiments. Furthermore, we characterized FAM124B as a mainly nuclear localized protein with a widespread expression in embryonic and adult mouse tissues. Conclusion: Our results demonstrate that FAM124B is a potential interacting partner of a CHD7 and CHD8 containing complex. From the overlapping expression pattern between Chd7 and Fam124B at murine embryonic day E12.5 and the high expression of Fam124B in the developing mouse brain, we conclude that Fam124B is a novel protein possibly involved in the pathogenesis of CHARGE syndrome and neurodevelopmental disorders.	[Batsukh, Tserendulam; Schulz, Yvonne; Wolf, Stephan; Pauli, Silke] Univ Med Ctr, Inst Human Genet, Gottingen, Germany; [Rabe, Tamara I.] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany; [Oellerich, Thomas; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr, Dept Clin Chem, Gottingen, Germany; [Schaefer, Inga-Marie] Univ Med Ctr, Dept Pathol, Gottingen, Germany	University of Gottingen; Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen	Pauli, S (corresponding author), Univ Med Ctr, Inst Human Genet, Gottingen, Germany.	spauli@gwdg.de	Schaefer, Inga-Marie/ABA-3951-2020	Schaefer, Inga-Marie/0000-0001-9710-5500; Batsukh, Tserendulam/0000-0002-8409-0968	Deutsche Forschungsgemeinschaft (DFG) [PA 2030/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (www.dfg.de) (PA 2030/1-1) to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki M, 2006, J PEDIATR-US, V148, P410, DOI 10.1016/j.jpeds.2005.10.044; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Bergman JEH, 2010, EUR J HUM GENET, V18, P171, DOI 10.1038/ejhg.2009.158; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nikolov M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005371; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wincent J, 2008, CLIN GENET, V74, P31, DOI 10.1111/j.1399-0004.2008.01014.x; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823; Zentner GE, 2010, HUM MOL GENET, V19, P3491, DOI 10.1093/hmg/ddq265	33	15	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52640	10.1371/journal.pone.0052640	http://dx.doi.org/10.1371/journal.pone.0052640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285124	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800084
J	Kedenko, L; Lamina, C; Kiesslich, T; Kapur, K; Bergmann, S; Waterworth, D; Heid, IM; Wichmann, HE; Kedenko, I; Kronenberg, F; Paulweber, B				Kedenko, Lyudmyla; Lamina, Claudia; Kiesslich, Tobias; Kapur, Karen; Bergmann, Sven; Waterworth, Dawn; Heid, Iris M.; Wichmann, H. -Erich; Kedenko, Igor; Kronenberg, Florian; Paulweber, Bernhard			Genetic Polymorphisms of the Main Transcription Factors for Adiponectin Gene Promoter in Regulation of Adiponectin Levels: Association Analysis in Three European Cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; PLASMA ADIPONECTIN; METABOLIC SYNDROME; PRO12ALA POLYMORPHISM; SERUM ADIPONECTIN; ADIPOSE-TISSUE; JAPANESE POPULATION; PPAR-GAMMA-2 GENE	Adiponectin serum concentrations are an important biomarker in cardiovascular epidemiology with heritability etimates of 30-70%. However, known genetic variants in the adiponectin gene locus (ADIPOQ) account for only 2%-8% of its variance. As transcription factors are thought to play an under-acknowledged role in carrying functional variants, we hypothesized that genetic polymorphisms in genes coding for the main transcription factors for the ADIPOQ promoter influence adiponectin levels. Single nucleotide polymorphisms (SNPs) at these genes were selected based on the haplotype block structure and previously published evidence to be associated with adiponectin levels. We performed association analyses of the 24 selected SNPs at forkhead box O1 (FOXO1), sterol-regulatory-element-binding transcription factor 1 (SREBF1), sirtuin 1 (SIRT1), peroxisome-proliferator-activated receptor gamma (PPARG) and transcription factor activating enhancer binding protein 2 beta (TFAP2B) gene loci with adiponectin levels in three different European cohorts: SAPHIR (n = 1742), KORA F3 (n = 1636) and CoLaus (n = 5355). In each study population, the association of SNPs with adiponectin levels on log-scale was tested using linear regression adjusted for age, sex and body mass index, applying both an additive and a recessive genetic model. A pooled effect size was obtained by meta-analysis assuming a fixed effects model. We applied a significance threshold of 0.0033 accounting for the multiple testing situation. A significant association was only found for variants within SREBF1 applying an additive genetic model (smallest p-value for rs1889018 on log(adiponectin) = 0.002, beta on original scale = -0.217 mu g/ml), explaining similar to 0.4% of variation of adiponectin levels. Recessive genetic models or haplotype analyses of the FOXO1, SREBF1, SIRT1, TFAPB2B genes or sex-stratified analyses did not reveal additional information on the regulation of adiponectin levels. The role of genetic variations at the SREBF1 gene in regulating adiponectin needs further investigation by functional studies.	[Kedenko, Lyudmyla; Kiesslich, Tobias; Kedenko, Igor; Paulweber, Bernhard] Paracelsus Med Univ Salzburg, Univ Clin Internal Med 1, Salzburg, Austria; [Lamina, Claudia] Med Univ Innsbruck, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Kapur, Karen; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Kapur, Karen; Bergmann, Sven] Swiss Inst Bioinformat, Lausanne, Switzerland; [Waterworth, Dawn] GlaxoSmithKline, Genet, Philadelphia, PA USA; [Heid, Iris M.] Univ Regensburg, Med Ctr, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Heid, Iris M.; Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-80539 Munich, Germany	Paracelsus Private Medical University; Medical University of Innsbruck; University of Lausanne; Swiss Institute of Bioinformatics; GlaxoSmithKline; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Kedenko, L (corresponding author), Paracelsus Med Univ Salzburg, Univ Clin Internal Med 1, Salzburg, Austria.	l.kedenko@salk.at; Florian.Kronenberg@i-med.ac.at	Colaus, PsyColaus/K-6607-2013; Wichmann, Heinz Erich/AAA-5695-2022; Lamina, Claudia/F-7608-2010; Kronenberg, Florian/B-1736-2008	Lamina, Claudia/0000-0002-5398-5806; Kronenberg, Florian/0000-0003-2229-1120; Bergmann, Sven/0000-0002-6785-9034; Kiesslich, Tobias/0000-0001-5403-9478	Kamilo-Eisner Stiftung; Salzburger Forschungsgesellschaft; OeNB [13339]; FFF-PMU [E-09/09/055-PAU]; Austrian Genome Research Program GEN-AU; GlaxoSmithKline; Swiss National Science Foundation [33CSCO-122661]; Faculty of Biology and Medicine of Lausanne	Kamilo-Eisner Stiftung; Salzburger Forschungsgesellschaft; OeNB; FFF-PMU; Austrian Genome Research Program GEN-AU; GlaxoSmithKline(GlaxoSmithKline); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine of Lausanne	The SAPHIR population was supported by: Kamilo-Eisner Stiftung, Salzburger Forschungsgesellschaft, OeNB Nr.13339 and FFF-PMU Nr. E-09/09/055-PAU. The KORA study was supported by: "Austrian Genome Research Program GEN-AU" for the project "Genomics of Lipid-associated Disorders - GOLD." The CoLaus study was supported by: grants from GlaxoSmithKline, the Swiss National Science Foundation (Grant 33CSCO-122661) and the Faculty of Biology and Medicine of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorntorp P, 1996, INT J OBESITY, V20, P291; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Bowden DW, 2010, HUM MOL GENET, V19, P4112, DOI 10.1093/hmg/ddq327; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Chuang LM, 2004, J CLIN ENDOCR METAB, V89, P5772, DOI 10.1210/jc.2004-0640; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Comuzzie AG, 2001, J CLIN ENDOCR METAB, V86, P4321, DOI 10.1210/jc.86.9.4321; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; de Courten BV, 2005, DIABETES, V54, P284, DOI 10.2337/diabetes.54.1.284; Felder TK, 2007, INT J OBESITY, V31, P1099, DOI 10.1038/sj.ijo.0803505; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gouda HN, 2010, AM J EPIDEMIOL, V171, P645, DOI 10.1093/aje/kwp450; Guo XQ, 2006, DIABETES, V55, P1723, DOI 10.2337/db05-0428; Harding AH, 2006, DIABETOLOGIA, V49, P2642, DOI 10.1007/s00125-006-0430-1; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Heid IM, 2010, ATHEROSCLEROSIS, V208, P412, DOI 10.1016/j.atherosclerosis.2009.11.035; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Helisalmi S, 2008, J NEUROL, V255, P668, DOI 10.1007/s00415-008-0774-1; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hicks C, 2007, OBESITY, V15, P1207, DOI 10.1038/oby.2007.142; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Ikeda K, 2006, J BIOL CHEM, V281, P31245, DOI 10.1074/jbc.M605132200; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kawada T, 2008, ASIA PAC J CLIN NUTR, V17, P126; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kita A, 2005, BIOCHEM BIOPH RES CO, V331, P484, DOI 10.1016/j.bbrc.2005.03.205; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindsay RS, 2003, DIABETES, V52, P2419, DOI 10.2337/diabetes.52.9.2419; Ling H, 2009, OBESITY, V17, P737, DOI 10.1038/oby.2008.625; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Maeda S, 2005, J HUM GENET, V50, P283, DOI 10.1007/s10038-005-0253-9; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Mousavinasab F, 2005, ENDOCRINE, V27, P307, DOI 10.1385/ENDO:27:3:307; Nishida M, 2007, MED MOL MORPHOL, V40, P55, DOI 10.1007/s00795-007-0366-7; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Rasmussen-Torvik LJ, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-39; Richards JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000768; Ruchat SM, 2008, J HUM GENET, V53, P629, DOI 10.1007/s10038-008-0291-1; Sanchez JLG, 2002, EUR J ENDOCRINOL, V147, P495, DOI 10.1530/eje.0.1470495; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Schaffler A, 1998, BBA-GENE STRUCT EXPR, V1399, P187, DOI 10.1016/S0167-4781(98)00106-7; Segawa K, 2009, J ENDOCRINOL, V200, P107, DOI 10.1677/JOE-08-0376; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Sinnwell JP, 2009, HAPLO STATS STAT ANA; Smith SR, 2001, METABOLISM, V50, P425, DOI 10.1053/meta.2001.21693; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stumvoll M, 2002, DIABETES, V51, P2341, DOI 10.2337/diabetes.51.8.2341; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vidal H, 2001, ANN MED, V33, P547, DOI 10.3109/07853890108995965; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamamoto Y, 2002, METABOLISM, V51, P1407, DOI 10.1053/meta.2002.35586; Yeung E, 2011, INT J MOL EPIDEMIOL, V2, P138	62	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52497	10.1371/journal.pone.0052497	http://dx.doi.org/10.1371/journal.pone.0052497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285067	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800074
J	Merabishvili, M; De Vos, D; Verbeken, G; Kropinski, AM; Vandenheuvel, D; Lavigne, R; Wattiau, P; Mast, J; Ragimbeau, C; Mossong, J; Scheres, J; Chanishvili, N; Vaneechoutte, M; Pirnay, JP				Merabishvili, Maia; De Vos, Daniel; Verbeken, Gilbert; Kropinski, Andrew M.; Vandenheuvel, Dieter; Lavigne, Rob; Wattiau, Pierre; Mast, Jan; Ragimbeau, Catherine; Mossong, Joel; Scheres, Jacques; Chanishvili, Nina; Vaneechoutte, Mario; Pirnay, Jean-Paul			Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany	PLOS ONE			English	Article								In 2011, a novel strain of O104:H4 Escherichia coli caused a serious outbreak of foodborne hemolytic uremic syndrome and bloody diarrhea in Germany. Antibiotics were of questionable use and 54 deaths occurred. Candidate therapeutic bacteriophages that efficiently lyse the E. coli O104:H4 outbreak strain could be selected rather easily from a phage bank or isolated from the environment. It is argued that phage therapy should be more considered as a potential armament against the growing threat of (resistant) bacterial infections.	[Merabishvili, Maia; De Vos, Daniel; Verbeken, Gilbert; Pirnay, Jean-Paul] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium; [Merabishvili, Maia; Chanishvili, Nina] Eliava Inst Bacteriophage Microbiol & Virol, Tbilisi, Georgia; [Merabishvili, Maia; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, B-9000 Ghent, Belgium; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Toronto, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Vandenheuvel, Dieter; Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Heverlee, Belgium; [Wattiau, Pierre] Vet & Agrochem Res Ctr, Unit Highly Pathogen & Foodborne Zoonoses, Brussels, Belgium; [Mast, Jan] Vet & Agrochem 8 Res Ctr, Electron Microscopy Unit, Brussels, Belgium; [Ragimbeau, Catherine; Mossong, Joel] Lab Natl Sante, Luxembourg, Luxembourg; [Scheres, Jacques] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Scheres, Jacques] European Ctr Dis Prevent & Control, Stockholm, Sweden	Queen Astrid Military Hospital; Ghent University; Public Health Agency of Canada; University of Guelph; KU Leuven; Maastricht University; European Centre for Disease Prevention & Control	Pirnay, JP (corresponding author), Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium.	jean-paul.pirnay@mil.be	Chanishvili, Nina/CAG-5114-2022; Merabishvili, Maia/GLU-4387-2022; Mossong, Joël/D-4998-2009; Vaneechoutte, Mario/A-6189-2009; Kropinski, Andrew M/H-7130-2016	Chanishvili, Nina/0000-0002-7859-3032; Merabishvili, Maia/0000-0002-2566-0772; Mossong, Joël/0000-0003-0717-9835; Vaneechoutte, Mario/0000-0002-4586-203X; Kropinski, Andrew M/0000-0002-6871-6799; Lavigne, Rob/0000-0001-7377-1314; Pirnay, Jean-Paul/0000-0002-6863-5219; Mast, Jan/0000-0002-4879-3367; Vandenheuvel, Dieter/0000-0002-4398-1916; Ragimbeau, Catherine/0000-0001-7399-2379	Royal Higher Institute for Defense [MED 12]; FWO Vlaanderen [WO.022.09]	Royal Higher Institute for Defense; FWO Vlaanderen(FWO)	This work was suported by the Royal Higher Institute for Defense (grant MED 12). The authors would like to acknowledge the Research community "Phagebiotics" (WO.022.09) grant from the FWO Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbiol C, 2010, GENOME BIOL EVOL, V2, P140, DOI 10.1093/gbe/evq006; Bezuidt O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025702; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Brussow H, 2012, VIROLOGY; Bruttin A, 2005, ANTIMICROB AGENTS CH, V49, P2874, DOI 10.1128/AAC.49.7.2874-2878.2005; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Casey Pat G, 2011, Bioeng Bugs, V2, P189, DOI 10.4161/bbug.2.4.16961; Edgell DR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-290; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Friedrich AW, 2011, EUROSURVEILLANCE, V16, P2; Goodridge Lawrence D, 2011, Bacteriophage, V1, P130; Imberechts H, 1996, MICROB PATHOGENESIS, V21, P183, DOI 10.1006/mpat.1996.0053; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458, DOI 10.3201/eid0605.000503; Kropinski AM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-102; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Maura D, 2012, ENVIRON MICROBIOL, V14, P1844, DOI 10.1111/j.1462-2920.2011.02644.x; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Michael M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003595.pub2; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Pirnay JP, 2012, FUTURE VIROL, V7, P379, DOI 10.2217/FVL.12.24; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Struelens MJ, 2011, EUROSURVEILLANCE, V16, P2; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418	28	36	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52709	10.1371/journal.pone.0052709	http://dx.doi.org/10.1371/journal.pone.0052709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285164	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800092
J	Morley, SA; Martin, SM; Day, RW; Ericson, J; Lai, CH; Lamare, M; Tan, KS; Thorne, MAS; Peck, LS				Morley, Simon A.; Martin, Stephanie M.; Day, Robert W.; Ericson, Jess; Lai, Chien-Houng; Lamare, Miles; Tan, Koh-Siang; Thorne, Michael A. S.; Peck, Lloyd S.			Thermal Reaction Norms and the Scale of Temperature Variation: Latitudinal Vulnerability of Intertidal Nacellid Limpets to Climate Change	PLOS ONE			English	Article							TOLERANCE; LIMITS; TENACITY; IMPACTS; ECOLOGY; VARIABILITY; SENSITIVITY; PERFORMANCE; STRATEGIES; ECTOTHERMS	The thermal reaction norms of 4 closely related intertidal Nacellid limpets, Antarctic (Nacella concinna), New Zealand (Cellana ornata), Australia (C. tramoserica) and Singapore (C. radiata), were compared across environments with different temperature magnitude, variability and predictability, to test their relative vulnerability to different scales of climate warming. Lethal limits were measured alongside a newly developed metric of "duration tenacity", which was tested at different temperatures to calculate the thermal reaction norm of limpet adductor muscle fatigue. Except in C. tramoserica which had a wide optimum range with two break points, duration tenacity did not follow a typical aerobic capacity curve but was best described by a single break point at an optimum temperature. Thermal reaction norms were shifted to warmer temperatures in warmer environments; the optimum temperature for tenacity (T-opt) increased from 1.0 degrees C (N. concinna) to 14.3 degrees C (C. ornata) to 18.0 degrees C (an average for the optimum range of C. tramoserica) to 27.6 degrees C (C. radiata). The temperature limits for duration tenacity of the 4 species were most consistently correlated with both maximum sea surface temperature and summer maximum in situ habitat logger temperature. Tropical C. radiata, which lives in the least variable and most predictable environment, generally had the lowest warming tolerance and thermal safety margin (WT and TSM; respectively the thermal buffer of CTmax and T-opt over habitat temperature). However, the two temperate species, C. ornata and C. tramoserica, which live in a variable and seasonally unpredictable microhabitat, had the lowest TSM relative to in situ logger temperature. N. concinna which lives in the most variable, but seasonally predictable microhabitat, generally had the highest TSMs. Intertidal animals live at the highly variable interface between terrestrial and marine biomes and even small changes in the magnitude and predictability of their environment could markedly influence their future distributions.	[Morley, Simon A.; Thorne, Michael A. S.; Peck, Lloyd S.] British Antarctic Survey, Nat Environm Res Council, Cambridge, England; [Day, Robert W.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Ericson, Jess; Lamare, Miles] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Lai, Chien-Houng; Tan, Koh-Siang] Natl Univ Singapore, Trop Marine Sci Inst, Singapore 117548, Singapore	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Melbourne; University of Otago; National University of Singapore	Morley, SA (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge, England.	smor@bas.ac.uk	Tan, Koh Siang/GOH-0321-2022; Ericson, Jessica/B-1696-2016; Lamare, Miles M/A-7020-2010; Ericson, Jessica/AAP-1976-2020; Day, Robert William/K-6052-2012	Tan, Koh Siang/0000-0002-4599-9482; Ericson, Jessica/0000-0001-5220-8493; Ericson, Jessica/0000-0001-5220-8493; Day, Robert William/0000-0001-5913-2292; Lamare, Miles/0000-0001-8656-7240; Thorne, Michael/0000-0001-7759-612X	Natural environment research council (United Kingdom) [0821010024]; University of Otago Research Committee; Trans-Antarctic Association [TAA05/08]; Rothera marine team; NERC Scientific Diving Facility; NERC [bas0100025, dml011000] Funding Source: UKRI; Natural Environment Research Council [dml011000, bas0100025] Funding Source: researchfish	Natural environment research council (United Kingdom)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Otago Research Committee; Trans-Antarctic Association; Rothera marine team; NERC Scientific Diving Facility(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Natural environment research council (United Kingdom) core funding to BAS, A*Star proposal (SERC project no. 0821010024), the University of Otago Research Committee and the Trans-Antarctic Association (TAA05/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All experiments conform to the current laws of the country in which they were undertaken. We thank Amanda Bates for intellectual input and Mike Barker for limpet identification in New Zealand. Diving in the Antarctic was supported by the Rothera marine team and the NERC Scientific Diving Facility.	BENNETT AF, 1985, J EXP BIOL, V115, P333; BRANCH GM, 1978, J EXP MAR BIOL ECOL, V34, P111, DOI 10.1016/0022-0981(78)90035-7; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Brown CJ, 2010, GLOBAL CHANGE BIOL, V16, P1194, DOI 10.1111/j.1365-2486.2009.02046.x; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; Compton TJ, 2007, J EXP MAR BIOL ECOL, V352, P200, DOI 10.1016/j.jembe.2007.07.010; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Donelson JM, 2012, NAT CLIM CHANGE, V2, P30, DOI 10.1038/NCLIMATE1323; Finke GR, 2007, MAR ECOL PROG SER, V343, P57, DOI 10.3354/meps06918; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; GRENON JF, 1981, J EXP MAR BIOL ECOL, V54, P277, DOI 10.1016/0022-0981(81)90162-3; Guderley H, 2004, COMP BIOCHEM PHYS B, V139, P371, DOI 10.1016/j.cbpc.2004.04.001; Guderley H, 2010, CAN J ZOOL, V88, P753, DOI 10.1139/Z10-039; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hastie TJ., 1990, GEN ADDITIVE MODELS; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Helmuth B, 2002, INTEGR COMP BIOL, V42, P837, DOI 10.1093/icb/42.4.837; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Lima FP, 2009, LIMNOL OCEANOGR-METH, V7, P347, DOI 10.4319/lom.2009.7.347; Miyazawa K, 2004, ANN BOT-LONDON, V94, P635, DOI 10.1093/aob/mch184; Morley SA, 2011, J EXP MAR BIOL ECOL, V399, P39, DOI 10.1016/j.jembe.2011.01.013; Morley SA, 2010, J EXP MAR BIOL ECOL, V390, P1, DOI 10.1016/j.jembe.2010.04.040; Morley SA, 2009, COMP BIOCHEM PHYS A, V153, P154, DOI 10.1016/j.cbpa.2009.02.001; Munkvik M, 2009, AM J PHYSIOL-REG I, V297, pR900, DOI 10.1152/ajpregu.91043.2008; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Obermuller BE, 2011, J EXP MAR BIOL ECOL, V403, P39, DOI 10.1016/j.jembe.2011.04.003; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2006, BIOL REV, V81, P75, DOI 10.1017/S1464793105006871; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Poloczanska ES, 2008, ECOLOGY, V89, P3138, DOI 10.1890/07-1169.1; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Prosser C.L., 1973, COMP ANIMAL PHYSL, VThird; Richard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034655; ROCKSTEIN M, 1971, BIOL BULL-US, V141, P167, DOI 10.2307/1540001; Sinclair ELE, 2006, J EXP MAR BIOL ECOL, V335, P131, DOI 10.1016/j.jembe.2006.03.010; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Waller CL, 2006, POLAR BIOL, V29, P1077, DOI 10.1007/s00300-006-0152-3; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; WIDDOWS J, 1976, J COMP PHYSIOL, V105, P115, DOI 10.1007/BF00691115; Zeileis A., 2002, J STAT SOFTW, V7, P1, DOI [DOI 10.18637/JSS.V007.I02, 10.18637/jss.v007.i02]	51	20	20	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52818	10.1371/journal.pone.0052818	http://dx.doi.org/10.1371/journal.pone.0052818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285194	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000313158800097
J	Salame, TM; Knop, D; Levinson, D; Mabjeesh, SJ; Yarden, O; Hadar, Y				Salame, Tomer M.; Knop, Doriv; Levinson, Dana; Mabjeesh, Sameer J.; Yarden, Oded; Hadar, Yitzhak			Release of Pleurotus ostreatus Versatile-Peroxidase from Mn2+ Repression Enhances Anthropogenic and Natural Substrate Degradation	PLOS ONE			English	Article							LACCASE MULTIGENE FAMILY; SOLID-STATE FERMENTATION; MANGANESE PEROXIDASE; BIOTECHNOLOGICAL APPLICATIONS; CERIPORIOPSIS-SUBVERMISPORA; PHANEROCHAETE-CHRYSOSPORIUM; HOMOLOGOUS EXPRESSION; LIGNIN DEGRADATION; HEME PEROXIDASES; GENE-EXPRESSION	The versatile-peroxidase (VP) encoded by mnp4 is one of the nine members of the manganese-peroxidase (MnP) gene family that constitutes part of the ligninolytic system of the white-rot basidiomycete Pleurotus ostreatus (oyster mushroom). VP enzymes exhibit dual activity on a wide range of substrates. As Mn2+ supplement to P. ostreatus cultures results in enhanced degradation of recalcitrant compounds and lignin, we examined the effect of Mn2+ on the expression profile of the MnP gene family. In P. ostreatus (monokaryon PC9), mnp4 was found to be the predominantly expressed mnp in Mn2+-deficient media, whereas strongly repressed (to approximately 1%) in Mn2+-supplemented media. Accordingly, in-vitro Mn2+-independent activity was found to be negligible. We tested whether release of mnp4 from Mn2+ repression alters the activity of the ligninolytic system. A transformant over-expressing mnp4 (designated OEmnp4) under the control of the beta-tubulin promoter was produced. Now, despite the presence of Mn2+ in the medium, OEmnp4 produced mnp4 transcript as well as VP activity as early as 4 days after inoculation. The level of expression was constant throughout 10 days of incubation (about 0.4-fold relative to beta-tubulin) and the activity was comparable to the typical activity of PC9 in Mn2+-deficient media. In-vivo decolorization of the azo dyes Orange II, Reactive Black 5, and Amaranth by OEmnp4 preceded that of PC9. OEmnp4 and PC9 were grown for 2 weeks under solid-state fermentation conditions on cotton stalks as a lignocellulosic substrate. [C-14]-lignin mineralization, in-vitro dry matter digestibility, and neutral detergent fiber digestibility were found to be significantly higher (about 25%) in OEmnp4-fermented substrate, relative to PC9. We conclude that releasing Mn2+ suppression of VP4 by over-expression of the mnp4 gene in P. ostreatus improved its ligninolytic functionality.	[Salame, Tomer M.; Knop, Doriv; Levinson, Dana; Yarden, Oded; Hadar, Yitzhak] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Jerusalem, Israel; [Mabjeesh, Sameer J.] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Hadar, Y (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Jerusalem, Israel.	hadar@agri.huji.ac.il	Yarden, Oded/J-5988-2012		Ministry of Science and Technology, Israel; U.S.-Israel Binational Science Foundation (BSF) [2011505]	Ministry of Science and Technology, Israel; U.S.-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was partially supported by the Ministry of Science and Technology, Israel, and by grant No. 2011505 from the U.S.-Israel Binational Science Foundation (BSF). No additional external funding received for this study.	BONNARME P, 1990, APPL ENVIRON MICROB, V56, P210, DOI 10.1128/AEM.56.1.210-217.1990; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025647; Cohen R, 2002, APPL ENVIRON MICROB, V68, P3156, DOI 10.1128/AEM.68.6.3156-3158.2002; Cohen R, 2002, APPL MICROBIOL BIOT, V58, P582, DOI 10.1007/s00253-002-0930-y; Cohen R, 2002, APPL BIOCHEM BIOTECH, V102, P415, DOI 10.1385/ABAB:102-103:1-6:415; Cohen R, 2001, ENVIRON MICROBIOL, V3, P312, DOI 10.1046/j.1462-2920.2001.00197.x; Collins PJ, 1999, APPL ENVIRON MICROB, V65, P1343; Courty PE, 2009, NEW PHYTOL, V182, P736, DOI 10.1111/j.1469-8137.2009.02774.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Garcia-Ruiz E, 2012, BIOCHEM J, V441, P487, DOI 10.1042/BJ20111199; Gettemy JM, 1998, APPL ENVIRON MICROB, V64, P569; Golan-Rozen N, 2011, ENVIRON SCI TECHNOL, V45, P6800, DOI 10.1021/es200298t; Gutierrez M, 2008, CURR GENET, V54, P163, DOI 10.1007/s00294-008-0209-7; Hammel KE, 2008, CURR OPIN PLANT BIOL, V11, P349, DOI 10.1016/j.pbi.2008.02.003; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Honda Y, 2000, CURR GENET, V37, P209, DOI 10.1007/s002940050521; Irie T, 2001, APPL MICROBIOL BIOT, V55, P566, DOI 10.1007/s002530000540; Irie T, 2001, APPL MICROBIOL BIOT, V55, P563, DOI 10.1007/s002530000535; Kamitsuji H, 2004, APPL MICROBIOL BIOT, V65, P287, DOI 10.1007/s00253-003-1543-9; KEREM Z, 1995, APPL ENVIRON MICROB, V61, P3057, DOI 10.1128/AEM.61.8.3057-3062.1995; KEREM Z, 1993, APPL ENVIRON MICROB, V59, P4115, DOI 10.1128/AEM.59.12.4115-4120.1993; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Larraya LM, 1999, APPL ENVIRON MICROB, V65, P3413; MacDonald J, 2012, APPL MICROBIOL BIOT, V94, P339, DOI 10.1007/s00253-012-3937-z; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez MJ, 1996, EUR J BIOCHEM, V237, P424, DOI 10.1111/j.1432-1033.1996.0424k.x; Morgenstern I, 2008, J MOL EVOL, V66, P243, DOI 10.1007/s00239-008-9079-3; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Pezzella C, 2009, CURR GENET, V55, P45, DOI 10.1007/s00294-008-0221-y; Ruiz-Duenas FJ, 2011, CR BIOL, V334, P795, DOI 10.1016/j.crvi.2011.06.004; Salame TM, 2012, APPL ENVIRON MICROB, V78, P5341, DOI 10.1128/AEM.01234-12; Salame TM, 2011, APPL MICROBIOL BIOT, V89, P501, DOI 10.1007/s00253-010-2928-1; Salame TM, 2010, MICROB BIOTECHNOL, V3, P93, DOI 10.1111/j.1751-7915.2009.00154.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sanchez C, 2010, APPL MICROBIOL BIOT, V85, P1321, DOI 10.1007/s00253-009-2343-7; Stajic M, 2009, CRIT REV BIOTECHNOL, V29, P55, DOI 10.1080/07388550802688821; TILLEY J. M. A., 1963, JOUR BRIT GRASSLAND SOC, V18, P104; Tsukihara T, 2006, APPL MICROBIOL BIOT, V71, P114, DOI 10.1007/s00253-005-0136-1; URZUA U, 1995, FEBS LETT, V371, P132, DOI 10.1016/0014-5793(95)00874-9; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	43	28	30	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52446	10.1371/journal.pone.0052446	http://dx.doi.org/10.1371/journal.pone.0052446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285046	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800067
J	Wijgerde, T; Jurriaans, S; Hoofd, M; Verreth, JAJ; Osinga, R				Wijgerde, Tim; Jurriaans, Saskia; Hoofd, Marleen; Verreth, Johan A. J.; Osinga, Ronald			Oxygen and Heterotrophy Affect Calcification of the Scleractinian Coral Galaxea fascicularis	PLOS ONE			English	Article							STYLOPHORA-PISTILLATA; SKELETAL GROWTH; ARTEMIA-SALINA; PHOTOSYNTHESIS; ZOOXANTHELLAE; REEF; RESPIRATION; LIGHT; WATER; STARVATION	Heterotrophy is known to stimulate calcification of scleractinian corals, possibly through enhanced organic matrix synthesis and photosynthesis, and increased supply of metabolic DIC. In contrast to the positive long-term effects of heterotrophy, inhibition of calcification has been observed during feeding, which may be explained by a temporal oxygen limitation in coral tissue. To test this hypothesis, we measured the short-term effects of zooplankton feeding on light and dark calcification rates of the scleractinian coral Galaxea fascicularis (n = 4) at oxygen saturation levels ranging from 13 to 280%. Significant main and interactive effects of oxygen, heterotrophy and light on calcification rates were found (three-way factorial repeated measures ANOVA, p < 0.05). Light and dark calcification rates of unfed corals were severely affected by hypoxia and hyperoxia, with optimal rates at 110% saturation. Light calcification rates of fed corals exhibited a similar trend, with highest rates at 150% saturation. In contrast, dark calcification rates of fed corals were close to zero under all oxygen saturations. We conclude that oxygen exerts a strong control over light and dark calcification rates of corals, and propose that in situ calcification rates are highly dynamic. Nevertheless, the inhibitory effect of heterotrophy on dark calcification appears to be oxygen-independent. We hypothesize that dark calcification is impaired during zooplankton feeding by a temporal decrease of the pH and aragonite saturation state of the calcifying medium, caused by increased respiration rates. This may invoke a transient reallocation of metabolic energy to soft tissue growth and organic matrix synthesis. These insights enhance our understanding of how oxygen and heterotrophy affect coral calcification, both in situ as well as in aquaculture.	[Wijgerde, Tim; Jurriaans, Saskia; Hoofd, Marleen; Verreth, Johan A. J.; Osinga, Ronald] Wageningen Univ, Univ Wageningen & Res Ctr, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Wijgerde, T (corresponding author), Wageningen Univ, Univ Wageningen & Res Ctr, Dept Anim Sci, Aquaculture & Fisheries Grp, NL-6700 AP Wageningen, Netherlands.	tim.wijgerde@wur.nl	Verreth, Johan/ABD-7198-2020	Verreth, Johan/0000-0001-7277-5129; Jurriaans, Saskia/0000-0003-1534-8301	EU [244161]	EU(European Commission)	This study was funded by the EU Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 244161 (FORCE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2007, CORAL REEFS, V26, P531, DOI 10.1007/s00338-007-0250-x; Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 1998, J EXP BIOL, V201, P2001; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BREWER PG, 1976, LIMNOL OCEANOGR, V21, P108, DOI 10.4319/lo.1976.21.1.0108; CHALKER BE, 1975, PROC R SOC SER B-BIO, V190, P323, DOI 10.1098/rspb.1975.0096; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; DUBINSKY Z, 1990, PROC R SOC SER B-BIO, V239, P231, DOI 10.1098/rspb.1990.0015; Ferrier-Pages C, 2003, CORAL REEFS, V22, P229, DOI 10.1007/s00338-003-0312-7; FRIDOVICH I, 1977, BIOSCIENCE, V27, P462, DOI 10.2307/1297527; Furla P, 2000, J EXP BIOL, V203, P3445; Hii YS, 2009, AQUACULT INT, V17, P363, DOI 10.1007/s10499-008-9208-4; Houlbreque F, 2004, J EXP BIOL, V207, P1461, DOI 10.1242/jeb.00911; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IP YK, 1991, MAR BIOL, V111, P191, DOI 10.1007/BF01319700; Kawaguti S., 1948, Bulletin of the Oceanographical Institute of Taiwan, VNo. 4, P65; KINSEY DW, 1967, AUST J MAR FRESH RES, V18, P23, DOI 10.1071/MF9670023; Kraines S, 1996, LIMNOL OCEANOGR, V41, P1790, DOI 10.4319/lo.1996.41.8.1790; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LESSER MP, 1989, J EXP MAR BIOL ECOL, V134, P129, DOI 10.1016/0022-0981(90)90105-L; Marshall AT, 2002, J EXP BIOL, V205, P2107; Marubini F, 1999, LIMNOL OCEANOGR, V44, P716, DOI 10.4319/lo.1999.44.3.0716; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; MATTA JL, 1991, SYMBIOSIS, V11, P31; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; RINKEVICH B, 1984, MAR BIOL, V80, P1, DOI 10.1007/BF00393120; SHASHAR N, 1993, BIOL BULL, V185, P455, DOI 10.2307/1542485; SHASHAR N, 1992, J EXP MAR BIOL ECOL, V163, P277, DOI 10.1016/0022-0981(92)90055-F; SHICK JM, 1985, OECOLOGIA, V66, P33, DOI 10.1007/BF00378549; SZMANTFROELICH A, 1984, MAR BIOL, V81, P153, DOI 10.1007/BF00393114; Titlyanov E, 2000, MAR BIOL, V137, P463, DOI 10.1007/s002270000370; Titlyanov EA, 2000, SYMBIOSIS, V28, P303; Titlyanov EA, 2001, J EXP MAR BIOL ECOL, V257, P163, DOI 10.1016/S0022-0981(00)00308-7; Wangpraseurt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031192; Wijgerde T, 2011, J EXP BIOL, V214, P3351, DOI 10.1242/jeb.058354	37	21	21	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52702	10.1371/journal.pone.0052702	http://dx.doi.org/10.1371/journal.pone.0052702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285159	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800091
J	Guo, SZ; Zhou, YM; Xing, CH; Lok, J; Som, AT; Ning, MM; Ji, XM; Lo, EH				Guo, Shuzhen; Zhou, Yiming; Xing, Changhong; Lok, Josephine; Som, Angel T.; Ning, MingMing; Ji, Xunming; Lo, Eng H.			The Vasculome of the Mouse Brain	PLOS ONE			English	Article							CEREBRAL ENDOTHELIAL-CELLS; UCH37 DEUBIQUITINATING ENZYME; SPINOCEREBELLAR ATAXIA TYPE-1; PSORIASIS SUSCEPTIBILITY GENE; ENDOPLASMIC-RETICULUM STRESS; CHROMATIN-REMODELING COMPLEX; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; 20-LIKE KINASE-3 MST3; C FAMILY-MEMBERS	The blood vessel is no longer viewed as passive plumbing for the brain. Increasingly, experimental and clinical findings suggest that cerebral endothelium may possess endocrine and paracrine properties - actively releasing signals into and receiving signals from the neuronal parenchyma. Hence, metabolically perturbed microvessels may contribute to central nervous system (CNS) injury and disease. Furthermore, cerebral endothelium can serve as sensors and integrators of CNS dysfunction, releasing measurable biomarkers into the circulating bloodstream. Here, we define and analyze the concept of a brain vasculome, i.e. a database of gene expression patterns in cerebral endothelium that can be linked to other databases and systems of CNS mediators and markers. Endothelial cells were purified from mouse brain, heart and kidney glomeruli. Total RNA were extracted and profiled on Affymetrix mouse 430 2.0 micro-arrays. Gene expression analysis confirmed that these brain, heart and glomerular preparations were not contaminated by brain cells (astrocytes, oligodendrocytes, or neurons), cardiomyocytes or kidney tubular cells respectively. Comparison of the vasculome between brain, heart and kidney glomeruli showed that endothelial gene expression patterns were highly organ-dependent. Analysis of the brain vasculome demonstrated that many functionally active networks were present, including cell adhesion, transporter activity, plasma membrane, leukocyte transmigration, Wnt signaling pathways and angiogenesis. Analysis of representative genome-wide-association-studies showed that genes linked with Alzheimer's disease, Parkinson's disease and stroke were detected in the brain vasculome. Finally, comparison of our mouse brain vasculome with representative plasma protein databases demonstrated significant overlap, suggesting that the vasculome may be an important source of circulating signals in blood. Perturbations in cerebral endothelial function may profoundly affect CNS homeostasis. Mapping and dissecting the vasculome of the brain in health and disease may provide a novel database for investigating disease mechanisms, assessing therapeutic targets and exploring new biomarkers for the CNS.	[Guo, Shuzhen; Zhou, Yiming; Xing, Changhong; Lok, Josephine; Som, Angel T.; Ning, MingMing; Lo, Eng H.] Harvard Univ, Sch Med, Dept Radiol, Neuroprotect Res Lab,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Guo, Shuzhen; Zhou, Yiming; Xing, Changhong; Lok, Josephine; Som, Angel T.; Ning, MingMing; Lo, Eng H.] Harvard Univ, Sch Med, Dept Neurol, Neuroprotect Res Lab,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Zhou, Yiming] Broad Inst Massachusetts Inst Technol & Harvard M, Boston, MA USA; [Lok, Josephine] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Ning, MingMing; Lo, Eng H.] Harvard Univ, Sch Med, Dept Neurol, Clin Prote Res Ctr,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Ji, Xunming] Capital Med Univ, Cerebrovasc Res Ctr, XuanWu Hosp, Beijing, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Capital Medical University	Guo, SZ (corresponding author), Harvard Univ, Sch Med, Dept Radiol, Neuroprotect Res Lab,Massachusetts Gen Hosp, Boston, MA 02115 USA.	sguo@partners.org; Lo@helix.mgh.harvard.edu	Ji, Xunming/AAN-3370-2021		NIH [RC2-NS69335, R37-NS37074, R01-NS76694, P01-NS55104]; Claflin award from Massachusetts General Hospital; Phyliss and Jerome Lyle Rappaport MGH Research Scholar award; Beijing Natural Science Foundation; China National Basic Research 973 Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055104, RC2NS069335, K08NS057339, R37NS037074, R01NS076694, R01NS067139] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claflin award from Massachusetts General Hospital; Phyliss and Jerome Lyle Rappaport MGH Research Scholar award; Beijing Natural Science Foundation(Beijing Natural Science Foundation); China National Basic Research 973 Program(National Basic Research Program of China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by studies funded in part by grants from the NIH (RC2-NS69335, R37-NS37074, R01-NS76694, P01-NS55104), the Claflin award from Massachusetts General Hospital, the Phyliss and Jerome Lyle Rappaport MGH Research Scholar award, the Beijing Natural Science Foundation, and the China National Basic Research 973 Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Andras IE, 2007, J CEREBR BLOOD F MET, V27, P1431, DOI 10.1038/sj.jcbfm.9600445; Anveden A, 2012, OBESITY, V20, P708, DOI 10.1038/oby.2011.268; Arese M, 2011, INT J DEV BIOL, V55, P439, DOI 10.1387/ijdb.103242ma; Askarova S, 2011, NEUROSCIENCE, V199, P375, DOI 10.1016/j.neuroscience.2011.09.038; Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Baird JW, 1999, J BIOL CHEM, V274, P33496, DOI 10.1074/jbc.274.47.33496; Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Beard RS, 2011, BLOOD, V118, P2007, DOI 10.1182/blood-2011-02-338269; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bergaya S, 2011, HYPERTENSION, V58, P439, DOI 10.1161/HYPERTENSIONAHA.111.172429; Bijlmakers MJ, 2011, HUM MOL GENET, V20, P3129, DOI 10.1093/hmg/ddr215; Blais V, 2001, J NEUROPATH EXP NEUR, V60, P893, DOI 10.1093/jnen/60.9.893; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Bottos A, 2009, P NATL ACAD SCI USA, V106, P20782, DOI 10.1073/pnas.0809510106; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Buchner DA, 2007, P NATL ACAD SCI USA, V104, P13996, DOI 10.1073/pnas.0700947104; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Cappuzzello C, 2007, CARDIOVASC RES, V75, P608, DOI 10.1016/j.cardiores.2007.04.020; Causeret F, 2009, CEREB CORTEX, V19, P861, DOI 10.1093/cercor/bhn133; Chen SY, 2011, P NATL ACAD SCI USA, V108, P5861, DOI 10.1073/pnas.1018128108; Chong ZZ, 2007, CURR NEUROVASC RES, V4, P194; Chrissobolis S, 2008, TRENDS MOL MED, V14, P495, DOI 10.1016/j.molmed.2008.09.003; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Crack PJ, 2006, J NEURAL TRANSM, V113, P645, DOI 10.1007/s00702-005-0352-y; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; de la Torre-Ubieta L, 2010, GENE DEV, V24, P799, DOI 10.1101/gad.1880510; DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281; DELI MA, 1993, J NEUROCHEM, V60, P1960, DOI 10.1111/j.1471-4159.1993.tb13429.x; Demyanenko GP, 2010, NEUROSCIENCE, V165, P107, DOI 10.1016/j.neuroscience.2009.09.077; Demyanenko GP, 2011, J NEUROSCI, V31, P1545, DOI 10.1523/JNEUROSCI.4467-10.2011; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Dukhanina EA, 2008, B EXP BIOL MED+, V145, P191, DOI 10.1007/s10517-008-0047-0; Enerson BE, 2006, J CEREBR BLOOD F MET, V26, P959, DOI 10.1038/sj.jcbfm.9600249; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; FISCHER I, 1991, J NEUROSCI RES, V28, P81, DOI 10.1002/jnr.490280108; Flatman PW, 2008, CURR OPIN NEPHROL HY, V17, P186, DOI 10.1097/MNH.0b013e3282f5244e; Fleegal MA, 2005, AM J PHYSIOL-HEART C, V289, pH2012, DOI 10.1152/ajpheart.00495.2005; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Gandhi S, 2010, NAT NEUROSCI, V13, P789, DOI 10.1038/nn.2584; Garbuzova-Davis S, 2011, BRAIN RES, V1398, P113, DOI 10.1016/j.brainres.2011.04.049; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Glienke J, 2000, EUR J BIOCHEM, V267, P2820, DOI 10.1046/j.1432-1327.2000.01325.x; Goeckeler ZM, 2000, J BIOL CHEM, V275, P18366, DOI 10.1074/jbc.M001339200; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Guo SZ, 2012, J NEUROCHEM, V123, P58, DOI 10.1111/j.1471-4159.2012.07944.x; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Helms HC, 2012, GLIA, V60, P882, DOI 10.1002/glia.22321; Holton M, 2010, CARDIOVASC RES, V87, P440, DOI 10.1093/cvr/cvq077; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Hutchison RM, 2009, HIPPOCAMPUS, V19, P687, DOI 10.1002/hipo.20582; Irwin N, 2006, P NATL ACAD SCI USA, V103, P18320, DOI 10.1073/pnas.0605135103; Ishibashi N, 2002, J IMMUNOL, V168, P1926, DOI 10.4049/jimmunol.168.4.1926; Ishibashi N, 2002, MOL BRAIN RES, V109, P34, DOI 10.1016/S0169-328X(02)00459-X; Jukkola T, 2004, GENE EXPR PATTERNS, V4, P755, DOI 10.1016/j.modgep.2004.03.006; Jung BP, 2002, NEUROSCIENCE, V115, P515, DOI 10.1016/S0306-4522(02)00383-4; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kalin TV, 2008, AM J RESP CELL MOL, V39, P390, DOI 10.1165/rcmb.2008-0044OC; Kammermeier PJ, 1999, NEURON, V22, P819, DOI 10.1016/S0896-6273(00)80740-0; Kanda S, 2004, CELL SIGNAL, V16, P1273, DOI 10.1016/j.cellsig.2004.03.010; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Ke Y, 2007, CAN J PHYSIOL PHARM, V85, P281, DOI 10.1139/Y06-100; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; KRIZBAI I, 1995, J NEUROCHEM, V65, P459; Krizbai IA, 1998, J NEUROSCI RES, V54, P814; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lanzani C, 2005, J HYPERTENS, V23, P543, DOI 10.1097/01.hjh.0000160210.48479.78; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li C, 2000, AM J PHYSIOL-RENAL, V279, pF785, DOI 10.1152/ajprenal.2000.279.4.F785; Li WQ, 2004, J BIOL CHEM, V279, P32824, DOI 10.1074/jbc.M401878200; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lifschytz T, 2011, INT J NEUROPSYCHOPH, P1; Lim YC, 2006, METH MOL B, V341, P141; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Lu TJ, 2006, J BIOL CHEM, V281, P38405, DOI 10.1074/jbc.M605035200; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Manunta P, 2008, HYPERTENSION, V52, P366, DOI 10.1161/HYPERTENSIONAHA.108.113977; Manunta P, 2007, PHARMACOGENOMICS, V8, P465, DOI 10.2217/14622416.8.5.465; Matilla-Duenas A, 2008, CEREBELLUM, V7, P106, DOI 10.1007/s12311-008-0009-0; Mayo JN, 2012, J CEREBR BLOOD F MET, V32, P825, DOI 10.1038/jcbfm.2011.185; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; Miller AD, 2008, J VIROL, V82, P6862, DOI 10.1128/JVI.00397-08; Morrison AC, 2002, HYPERTENSION, V39, P1053, DOI 10.1161/01.HYP.0000019128.94483.3A; Moy SS, 2009, BEHAV BRAIN RES, V205, P123, DOI 10.1016/j.bbr.2009.06.021; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Nadadur SS, 2009, TOXICOL IN VITRO, V23, P67, DOI 10.1016/j.tiv.2008.10.004; Navaratna D, 2011, DIABETES, V60, P1789, DOI 10.2337/db10-1371; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; Nibbs RJB, 2003, EXPERT OPIN BIOL TH, V3, P15, DOI 10.1517/14712598.3.1.15; Ning MM, 2011, STROKE, V42, P37, DOI 10.1161/STROKEAHA.110.585703; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Pardridge WM, 2007, STROKE, V38, P686, DOI 10.1161/01.STR.0000247887.61831.74; Parfenova H, 2003, J CEREBR BLOOD F MET, V23, P190, DOI 10.1097/01.WCB.000004823561824.C4; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Perticone F, 2007, J HYPERTENS, V25, P2234, DOI 10.1097/HJH.0b013e3282ef3a50; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Pi XC, 2009, P NATL ACAD SCI USA, V106, P5675, DOI 10.1073/pnas.0809568106; Ping PP, 2005, PROTEOMICS, V5, P3506, DOI 10.1002/pmic.200500140; Planutiene M, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-28; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Rao XQ, 2011, CIRCULATION, V123, P2964, DOI 10.1161/CIRCULATIONAHA.110.966408; Rehman A, 2001, CYTOKINE, V13, P8, DOI 10.1006/cyto.2000.0800; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Robson A, 2010, DEV DYNAM, V239, P2435, DOI 10.1002/dvdy.22376; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Roudier E, 2009, J PHYSIOL-LONDON, V587, P4105, DOI 10.1113/jphysiol.2009.175554; Rudrabhatla RS, 2006, MICROBES INFECT, V8, P460, DOI 10.1016/j.micinf.2005.07.012; Rudrabhatla RS, 2003, INFECT IMMUN, V71, P2787, DOI 10.1128/IAI.71.5.2787-2797.2003; Rzymski T, 2012, ONCOGENE, V31, P3621, DOI 10.1038/onc.2011.522; Sakurai A, 2012, CELL RES, V22, P23, DOI 10.1038/cr.2011.198; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Sarzani R, 2006, J HYPERTENS, V24, P697, DOI 10.1097/01.hjh.0000217852.89745.dc; Schmid RS, 2004, NEUROREPORT, V15, P2791; Seifert M, 2007, ONCOL REP, V17, P1207; Sharp FR, 2006, ARCH NEUROL-CHICAGO, V63, P1529, DOI 10.1001/archneur.63.11.1529; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Smoller JW, 2008, ARCH GEN PSYCHIAT, V65, P298, DOI 10.1001/archgenpsychiatry.2007.48; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Stockton R, 2007, MOL BIOL CELL, V18, P2346, DOI 10.1091/mbc.E06-07-0584; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tajima M, 2009, EUR J PHARMACOL, V606, P45, DOI 10.1016/j.ejphar.2009.01.026; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Tripathy D, 2007, J ALZHEIMERS DIS, V11, P447; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsang Sharon, 2010, Front Biosci (Schol Ed), V2, P547; Tsyba L, 2011, GENE, V473, P67, DOI 10.1016/j.gene.2010.11.016; Tudor EL, 2005, J BIOL CHEM, V280, P34735, DOI 10.1074/jbc.M506216200; van Rijn MJE, 2006, STROKE, V37, P2930, DOI 10.1161/01.STR.0000248760.67039.2b; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Wong CHY, 2008, J NEUROCHEM, V107, P241, DOI 10.1111/j.1471-4159.2008.05605.x; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Xie J, 2009, AM J PATHOL, V175, P1315, DOI 10.2353/ajpath.2009.090094; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Yang TZ, 2006, PHARM RES-DORDR, V23, P291, DOI 10.1007/s11095-005-9143-2; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yashin DV, 2011, J BIOL CHEM, V286, P10258, DOI 10.1074/jbc.M110.163436; Yoshikawa T, 2011, CURR EYE RES, V36, P1153, DOI 10.3109/02713683.2011.606592; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Zacchigna S, 2008, CURR TOP DEV BIOL, V80, P1, DOI 10.1016/S0070-2153(07)80001-9; Zach S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013191; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zeng Q, 2000, J CELL SCI, V113, P471; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang ZH, 2009, J BIOL CHEM, V284, P15717, DOI 10.1074/jbc.M808751200; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao W, 2012, J IMMUNOL, V188, P3179, DOI 10.4049/jimmunol.1101175; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	208	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52665	10.1371/journal.pone.0052665	http://dx.doi.org/10.1371/journal.pone.0052665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285140	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500225
J	Adu-Gyamfi, E; Soni, SP; Xue, Y; Digman, MA; Gratton, E; Stahelin, RV				Adu-Gyamfi, Emmanuel; Soni, Smita P.; Xue, Yi; Digman, Michelle A.; Gratton, Enrico; Stahelin, Robert V.			The Ebola Virus Matrix Protein Penetrates into the Plasma Membrane A KEY STEP IN VIRAL PROTEIN 40 (VP40) OLIGOMERIZATION AND VIRAL EGRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MEMBRANES; AMINO-ACIDS; DOMAINS; BINDING; BRIGHTNESS; MARBURG; NUMBER; IDENTIFICATION; LOCALIZATION; MECHANISMS	Ebola, a fatal virus in humans and non-human primates, has no Food and Drug Administration-approved vaccines or therapeutics. The virus from the Filoviridae family causes hemorrhagic fever, which rapidly progresses and in some cases has a fatality rate near 90%. The Ebola genome encodes seven genes, the most abundantly expressed of which is viral protein 40 (VP40), the major Ebola matrix protein that regulates assembly and egress of the virus. It is well established that VP40 assembles on the inner leaflet of the plasma membrane; however, the mechanistic details of plasma membrane association by VP40 are not well understood. In this study, we used an array of biophysical experiments and cellular assays along with mutagenesis of VP40 to investigate the role of membrane penetration in VP40 assembly and egress. Here we demonstrate that VP40 is able to penetrate specifically into the plasma membrane through an interface enriched in hydrophobic residues in its C-terminal domain. Mutagenesis of this hydrophobic region consisting of Leu(213), Ile(293), Leu(295), and Val(298) demonstrated that membrane penetration is critical to plasma membrane localization, VP40 oligomerization, and viral particle egress. Taken together, VP40 membrane penetration is an important step in the plasma membrane localization of the matrix protein where oligomerization and budding are defective in the absence of key hydrophobic interactions with the membrane.	[Soni, Smita P.; Xue, Yi; Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Eck Inst Global Hlth, South Bend, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Ctr Rare & Neglected Dis, South Bend, IN 46556 USA; [Digman, Michelle A.; Gratton, Enrico; Stahelin, Robert V.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	Indiana University System; Indiana University South Bend; University of Notre Dame; University of Notre Dame; University of California System; University of California Irvine	Stahelin, RV (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 143 Raclin Carmichael Hall,1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iupui.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863; , Michelle/0000-0003-4611-7100	National Institutes of Health [AI081077, P41-RRO3155, P50-GM076516]; Notre Dame Center for Rare and Neglected Diseases; Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility; Notre Dame Integrated Imaging Facility; Eck Institute for Global Health; Keck Foundation [44769549507]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame Center for Rare and Neglected Diseases; Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility; Notre Dame Integrated Imaging Facility; Eck Institute for Global Health; Keck Foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081077 (to R. V. S.) and P41-RRO3155 and P50-GM076516 (to E. G. and M. A. D.). This work was also supported by the Notre Dame Center for Rare and Neglected Diseases, the Indiana University School of Medicine-South Bend Imaging and Flow Cytometry Core Facility, and the Notre Dame Integrated Imaging Facility (to R. V. S.).; Supported by a fellowship from the Eck Institute for Global Health.; Supported by Keck Foundation Grant 44769549507.	Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Dessen A, 2000, EMBO J, V19, P4228, DOI 10.1093/emboj/19.16.4228; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; ELLIOTT LH, 1985, VIROLOGY, V147, P169, DOI 10.1016/0042-6822(85)90236-3; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Feldmann H, 1999, ARCH VIROL, P159; Garcia M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003500; Gomis-Roth FX, 2003, STRUCTURE, V11, P423, DOI 10.1016/S0969-2126(03)00050-9; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2009, ANTIVIR RES, V81, P189, DOI 10.1016/j.antiviral.2008.12.003; Hoenen T, 2005, J VIROL, V79, P1898, DOI 10.1128/JVI.79.3.1898-1905.2005; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; JOHNSON KM, 1977, LANCET, V1, P569; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Liu YL, 2010, J VIROL, V84, P2294, DOI 10.1128/JVI.02034-09; Makino A, 2011, J INFECT DIS, V204, pS871, DOI 10.1093/infdis/jir309; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; McCarthy SE, 2007, J VIROL, V81, P11452, DOI 10.1128/JVI.00853-07; Medkova M, 1999, J BIOL CHEM, V274, P19852, DOI 10.1074/jbc.274.28.19852; Neumann G, 2005, J VIROL, V79, P10300, DOI 10.1128/JVI.79.16.10300-10307.2005; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Olejnik J, 2011, VIRUSES-BASEL, V3, P1501, DOI 10.3390/v3081501; Panchal RG, 2003, P NATL ACAD SCI USA, V100, P15936, DOI 10.1073/pnas.2533915100; Reynard O, 2011, J INFECT DIS, V204, pS884, DOI 10.1093/infdis/jir359; Ross JA, 2011, BIOPHYS J, V100, pL15, DOI 10.1016/j.bpj.2010.12.3703; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Scott JL, 2012, INTEGR BIOL-UK, V4, P247, DOI 10.1039/c2ib00143h; Silva LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039978; Stahelin RV, 2003, J BIOL CHEM, V278, P14469, DOI 10.1074/jbc.M212579200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Timmins J, 2003, VIROLOGY, V312, P359, DOI 10.1016/S0042-6822(03)00260-5; Yamayoshi S, 2008, CELL HOST MICROBE, V3, P168, DOI 10.1016/j.chom.2008.02.001	40	61	63	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5779	5789		10.1074/jbc.M112.443960	http://dx.doi.org/10.1074/jbc.M112.443960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297401	Green Published, hybrid			2022-12-25	WOS:000315342500049
J	Walkinshaw, DR; Weist, R; Xiao, L; Yan, KZ; Kim, GW; Yang, XJ				Walkinshaw, Donald R.; Weist, Ryan; Xiao, Lin; Yan, Kezhi; Kim, Go-Woon; Yang, Xiang-Jiao			Dephosphorylation at a Conserved SP Motif Governs cAMP Sensitivity and Nuclear Localization of Class IIa Histone Deacetylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRANSCRIPTION FACTOR; SKELETAL-MUSCLE; CARDIAC-HYPERTROPHY; LYSINE ACETYLATION; PHOSPHORYLATION; HDAC4; GENE; EXPRESSION; EXPORT	Histone deacetylase 4 (HDAC4) and its paralogs, HDAC5, -7, and -9 (all members of class IIa), possess multiple phosphorylation sites crucial for 14-3-3 binding and subsequent nuclear export. cAMP signaling stimulates nuclear import of HDAC4 and HDAC5, but the underlying mechanisms remain to be elucidated. Here we show that cAMP potentiates nuclear localization of HDAC9. Mutation of an SP motif conserved in HDAC4, -5, and -9 prevents cAMP-stimulated nuclear localization. Unexpectedly, this treatment inhibits phosphorylation at the SP motif, indicating an inverse relationship between the phosphorylation event and nuclear import. Consistent with this, leptomycin B-induced nuclear import and adrenocorticotropic hormone (ACTH) treatment result in the dephosphorylation at the motif. Moreover, the modification synergizes with phosphorylation at a nearby site, and similar kinetics was observed for both phosphorylation events during myoblast and adipocyte differentiation. These results thus unravel a previously unrecognized mechanism whereby cAMP promotes dephosphorylation and differentially regulates multisite phosphorylation and the nuclear localization of class IIa HDACs.	[Walkinshaw, Donald R.; Weist, Ryan; Xiao, Lin; Yan, Kezhi; Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Walkinshaw, Donald R.; Weist, Ryan; Xiao, Lin; Yan, Kezhi; Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A3, Canada; [Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Deparment Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Deparment Biochem, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca			Canadian Institutes of Health Research; Canadian Cancer Society; Banting and Best Canada Graduate Scholarship from the CIHR; Rolande and Marcel Gosselin studentship; Canderel studentship from the Goodman Cancer Research Centre; McGill University Health Centre studentship; Cole Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Banting and Best Canada Graduate Scholarship from the CIHR(Canadian Institutes of Health Research (CIHR)); Rolande and Marcel Gosselin studentship; Canderel studentship from the Goodman Cancer Research Centre; McGill University Health Centre studentship; Cole Foundation	This project was supported by operating grants from the Canadian Institutes of Health Research and the Canadian Cancer Society (to X. J. Y.).; Supported in part by a Banting and Best Canada Graduate Scholarship from the CIHR, a Rolande and Marcel Gosselin studentship, and a Canderel studentship from the Goodman Cancer Research Centre as well as a McGill University Health Centre studentship.; Supported in part by a Cole Foundation studentship.	Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Borghi S, 2001, J CELL SCI, V114, P4477; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Choi RCY, 2000, NEUROREPORT, V11, P801, DOI 10.1097/00001756-200003200-00029; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Collins SP, 2000, BIOCHEM J, V345, P673, DOI 10.1042/0264-6021:3450673; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Garren L D, 1971, Recent Prog Horm Res, V27, P433; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Ha CH, 2008, ARTERIOSCL THROM VAS, V28, P1782, DOI 10.1161/ATVBAHA.108.172528; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Illi B, 2008, CIRC RES, V102, P51, DOI 10.1161/CIRCRESAHA.107.157305; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim MS, 2008, MOL CELL BIOL, V28, P3600, DOI 10.1128/MCB.00189-08; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lemercier C, 2000, J BIOL CHEM, V275, P15594, DOI 10.1074/jbc.M908437199; Li XF, 2004, J BIOL CHEM, V279, P34201, DOI 10.1074/jbc.M405179200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Liu YW, 2009, J PHYSIOL-LONDON, V587, P1101, DOI 10.1113/jphysiol.2008.164566; Magun R, 1998, INT J OBESITY, V22, P567, DOI 10.1038/sj.ijo.0800626; Majdzadeh N, 2008, FRONT BIOSCI-LANDMRK, V13, P1072, DOI 10.2741/2745; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Paroni G, 2008, MOL BIOL CELL, V19, P655, DOI 10.1091/mbc.E07-06-0623; Parra M, 2007, GENE DEV, V21, P638, DOI 10.1101/gad.1513107; Parra M, 2010, CURR OPIN PHARMACOL, V10, P454, DOI 10.1016/j.coph.2010.04.004; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Szyf M, 2000, ENDOCR RES, V26, P921, DOI 10.3109/07435800009048618; Taniguchi M, 2012, NEURON, V73, P108, DOI 10.1016/j.neuron.2011.10.032; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdel A, 1999, J BIOL CHEM, V274, P2440, DOI 10.1074/jbc.274.4.2440; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Williams S, 2010, BRIT DENT J, V208, P4, DOI 10.1038/sj.bdj.2010.7; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WOOD HN, 1973, P NATL ACAD SCI USA, V70, P447, DOI 10.1073/pnas.70.2.447; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098; Zhu GZ, 2005, J BIOL CHEM, V280, P10743, DOI 10.1074/jbc.M413159200	87	20	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5591	5605		10.1074/jbc.M112.445668	http://dx.doi.org/10.1074/jbc.M112.445668			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297420	Green Published, hybrid			2022-12-25	WOS:000315342500033
J	Crumling, MA; Liu, LQ; Thomas, PV; Benson, J; Kanicki, A; Kabara, L; Halsey, K; Dolan, D; Duncan, RK				Crumling, Mark A.; Liu, Liqian; Thomas, Paul V.; Benson, Jennifer; Kanicki, Ariane; Kabara, Lisa; Haelsey, Karin; Dolan, David; Duncan, R. Keith			Hearing Loss and Hair Cell Death in Mice Given the Cholesterol-Chelating Agent Hydroxypropyl-beta-Cyclodextrin	PLOS ONE			English	Article							EVERY ORGAN; THRESHOLD; PRESTIN; MOUSE; EXPRESSION; PROTEIN; MOTOR	Cyclodextrins are sugar compounds that are increasingly finding medicinal uses due to their ability to complex with hydrophobic molecules. One cyclodextrin in particular, 2-hydroxypropyl- beta-cyclodextrin (HPbCD), is used as a carrier to solubilize lipophilic drugs and is itself being considered as a therapeutic agent for treatment of Niemann-Pick Type C disease, due to its ability to mobilize cholesterol. Results from toxicological studies suggest that HP beta CD is generally safe, but a recent study has found that it causes hearing loss in cats. Whether the hearing loss occurred via death of cochlear hair cells, rendering it permanent, was unexplored. In the present study, we examined peripheral auditory function and cochlear histology in mice after subcutaneous injection of HP beta CD to test for hearing loss and correlate any observed auditory deficits with histological findings. On average, auditory brainstem response thresholds were elevated at 4, 16, and 32 kHz in mice one week after treatment with 8,000 mg/kg. In severely affected mice all outer hair cells were missing in the basal half of the cochlea. In many cases, surviving hair cells in the cochlear apex exhibited abnormal punctate distribution of the motor protein prestin, suggesting long term changes to membrane composition and integrity. Mice given a lower dose of 4,000 mg/kg exhibited hearing loss only after repeated doses, but these threshold shifts were temporary. Therefore, cyclodextrin-induced hearing loss was complex, involving cell death and other more subtle influences on cochlear physiology.	[Crumling, Mark A.; Liu, Liqian; Thomas, Paul V.; Benson, Jennifer; Kanicki, Ariane; Kabara, Lisa; Haelsey, Karin; Dolan, David; Duncan, R. Keith] Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Duncan, RK (corresponding author), Univ Michigan, Kresge Hearing Res Inst, Dept Otolaryngol Head & Neck Surg, 1301 E Ann St, Ann Arbor, MI 48109 USA.	rkduncan@umich.edu		Duncan, Robert/0000-0002-8949-8727	United States National Institutes of Health [NIDCD R01 DC007432, ARRA R01, DC007432-04S1, P30 DC005188]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007432, P30DC005188] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the United States National Institutes of Health (NIDCD R01 DC007432, ARRA R01 supplement DC007432-04S1, and P30 DC005188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2008, PHYSIOL REV, V88, P173, DOI 10.1152/physrev.00044.2006; Brownell WE, 2011, PFLUG ARCH EUR J PHY, V461, P677, DOI 10.1007/s00424-011-0942-5; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Di Berardino F, 2007, INT J PEDIAT OTOR EX, V2, P169, DOI 10.1016/j.pedex.2007.05.002; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Karolyi IJ, 2007, MAMM GENOME, V18, P596, DOI 10.1007/s00335-007-9038-0; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Levic S, 2011, J BIOL CHEM, V286, P5768, DOI 10.1074/jbc.M110.186486; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Loftsson T, 2010, J PHARM PHARMACOL, V62, P1607, DOI 10.1111/j.2042-7158.2010.01030.x; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Mhatre AN, 2010, HEARING RES, V269, P180, DOI 10.1016/j.heares.2010.06.012; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Muralidhar A, 2011, MOL GENET METAB, V103, P142, DOI 10.1016/j.ymgme.2011.03.001; Nguyen TVN, 1998, OTOLARYNG HEAD NECK, V119, P14, DOI 10.1016/S0194-5998(98)70167-6; Oesterle EC, 2008, JARO-J ASSOC RES OTO, V9, P65, DOI 10.1007/s10162-007-0106-7; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Santos-Sacchi J, 1998, NEUROSCI LETT, V256, P155, DOI 10.1016/S0304-3940(98)00788-5; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Zheng J, 2003, MAMM GENOME, V14, P87, DOI 10.1007/s00335-002-2227-y; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	30	64	67	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53280	10.1371/journal.pone.0053280	http://dx.doi.org/10.1371/journal.pone.0053280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285273	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500127
J	Feng, X; Wang, H; Ye, SC; Guan, JX; Tan, WK; Cheng, S; Wei, GL; Wu, WY; Wu, F; Zhou, Y				Feng, Xiao; Wang, Hao; Ye, Shicai; Guan, Jiaxi; Tan, Wenkai; Cheng, Si; Wei, Guoli; Wu, Weiyun; Wu, Feng; Zhou, Yu			Up-Regulation of microRNA-126 May Contribute to Pathogenesis of Ulcerative Colitis via Regulating NF-kappaB Inhibitor I kappa B alpha	PLOS ONE			English	Article							EXPRESSION PROFILES; CROHNS-DISEASE; SUSCEPTIBILITY; ASSOCIATION; CELLS; SUPPRESSES; ACTIVATION; CARCINOMA; PLAYERS; KINASE	Background: MicroRNAs (miRNAs) are important post-transcriptional regulators. Altered expression of miRNAs has recently demonstrated association with human ulcerative colitis (UC). In this study, we attempted to elucidate the roles of miR-126 in the pathogenesis of UC. Methods: Expression of miR-126, miR-21, miR-375 and the potential targets NF-kappa B inhibitor alpha (I kappa B alpha, IKBA or NFKBIA), Polo-like kinase 2 (PLK2) and v-Crk sarcoma virus CT10 oncogene homolog (CRK) were assessed in 52 colonic biopsies from patients with active UC, inactive UC, irritable bowel syndrome (IBS) and from healthy subjects by quantitative RT-PCR and immunofluorescence analyses. Regulation of gene expression by miR-126 was assessed using luciferase reporter construct assays and specific miRNA mimic transfection. Results: We found that the expression of miR-126 and miR-21 were significantly increased in active UC group compared to the inactive UC, IBS and healthy control groups (P< 0.05). In contrast, the expression of IKBA mRNA and protein was remarkably decreased in the active UC group compared with the other three groups (P<0.05). The expression of miR-126 and IKBA mRNA were inversely correlated in active UC patients (P<0.05). However the expression of miR-375, PLK2 and CRK showed no difference between each group. Furthermore, we demonstrate that endogenous miR-126 and exogenous miR-126 mimic can inhibit I kappa B alpha expression. Finally, mutating the miR-126 binding site of the IKBA 39-UTR reporter construct restored reporter gene expression. Conclusion: miR-126 may play roles in UC inflammatory activity by down-regulating the expression of IKBA, an important inhibitor of NF-kappa B signaling pathway.	[Feng, Xiao; Wang, Hao; Ye, Shicai; Guan, Jiaxi; Tan, Wenkai; Cheng, Si; Wei, Guoli; Wu, Weiyun; Zhou, Yu] Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China; [Wu, Feng] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Guangdong Medical University; University of Chicago	Zhou, Y (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Gastroenterol, Zhanjiang, Guangdong, Peoples R China.	ahdg2005@126.com			National Natural Science Foundation of China [30971350]; Planned Science and Technology Project of Guangdong Province, China [2009B030801332]; Affiliated Hospital of Guangdong Medical College	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China; Affiliated Hospital of Guangdong Medical College	This study was supported by National Natural Science Foundation of China (grant number 30971350 to Yu Zhou) and the Planned Science and Technology Project of Guangdong Province, China (grant number 2009B030801332 to Yu Zhou). This research was also supported by the fund at The Affiliated Hospital of Guangdong Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Farid E., 2009, Cancer Genomics & Proteomics, V6, P281; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian Z, 2011, J PATHOL, V225, P544, DOI 10.1002/path.2907; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Dijkstra G, 2002, SCAND J GASTROENTERO, V37, P37, DOI 10.1080/003655202320621436; Fasseu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013160; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jiang XL, 2002, WORLD J GASTROENTERO, V8, P158, DOI 10.3748/wjg.v8.i1.158; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Li XF, 2009, ONCOGENE, V28, P3937, DOI 10.1038/onc.2009.245; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P6209, DOI 10.1074/jbc.M208905200; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Szamosi T, 2009, DIGEST DIS SCI, V54, P351, DOI 10.1007/s10620-008-0351-6; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takagi T, 2010, J GASTROEN HEPATOL, V25, pS129, DOI 10.1111/j.1440-1746.2009.06216.x; Toedter G, 2011, AM J GASTROENTEROL, V106, P1272, DOI 10.1038/ajg.2011.83; Ukil A, 2006, BRIT J PHARMACOL, V149, P121, DOI 10.1038/sj.bjp.0706847; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu F, 2007, INFLAMM BOWEL DIS, V13, P807, DOI 10.1002/ibd.20110; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Wu F, 2010, INFLAMM BOWEL DIS, V16, P1729, DOI 10.1002/ibd.21267; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	44	89	99	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52782	10.1371/journal.pone.0052782	http://dx.doi.org/10.1371/journal.pone.0052782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285182	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500061
J	Lee, KS; Zhou, WB; Scott-McKean, JJ; Emmerling, KL; Cai, GY; Krah, DL; Costa, AC; Freed, CR; Levin, MJ				Lee, Katherine S.; Zhou, Wenbo; Scott-McKean, Jonah J.; Emmerling, Kaitlin L.; Cai, Guang-yun; Krah, David L.; Costa, Alberto C.; Freed, Curt R.; Levin, Myron J.			Human Sensory Neurons Derived from Induced Pluripotent Stem Cells Support Varicella-Zoster Virus Infection	PLOS ONE			English	Article							NEURAL CREST CELLS; DORSAL-ROOT GANGLIA; FAMILIAL DYSAUTONOMIA; MANNOSE 6-PHOSPHATE; MEDIATED-IMMUNITY; HUMAN FIBROBLASTS; GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; PRECURSORS	After primary infection, varicella-zoster virus (VZV) establishes latency in neurons of the dorsal root and trigeminal ganglia. Many questions concerning the mechanism of VZV pathogenesis remain unanswered, due in part to the strict host tropism and inconsistent availability of human tissue obtained from autopsies and abortions. The recent development of induced pluripotent stem (iPS) cells provides great potential for the study of many diseases. We previously generated human iPS cells from skin fibroblasts by introducing four reprogramming genes with non-integrating adenovirus. In this study, we developed a novel protocol to generate sensory neurons from iPS cells. Human iPS cells were exposed to small molecule inhibitors for 10 days, which efficiently converted pluripotent cells into neural progenitor cells (NPCs). The NPCs were then exposed for two weeks to growth factors required for their conversion to sensory neurons. The iPS cell-derived sensory neurons were characterized by immunocytochemistry, flow cytometry, RT-qPCR, and electrophysiology. After differentiation, approximately 80% of the total cell population expressed the neuron-specific protein, beta III-tubulin. Importantly, 15% of the total cell population co-expressed the markers Brn3a and peripherin, indicating that these cells are sensory neurons. These sensory neurons could be infected by both VZV and herpes simplex virus (HSV), a related alphaherpesvirus. Since limited neuronal populations are capable of supporting the entire VZV and HSV life cycles, our iPS-derived sensory neuron model may prove useful for studying alphaherpesvirus latency and reactivation.	[Lee, Katherine S.; Emmerling, Kaitlin L.; Cai, Guang-yun; Levin, Myron J.] Univ Colorado, Dept Pediat, Infect Dis Sect, Aurora, CO USA; [Zhou, Wenbo; Scott-McKean, Jonah J.; Costa, Alberto C.; Freed, Curt R.] Univ Colorado, Dept Med, Neurosci Training Program, Div Clin Pharmacol & Toxicol, Aurora, CO USA; [Krah, David L.] Merck Sharp & Dohme Corp, West Point, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Merck & Company	Lee, KS (corresponding author), Univ Colorado, Dept Pediat, Infect Dis Sect, Aurora, CO USA.	Katherine.S.Lee@ucdenver.edu		Scott-McKean, Jonah/0000-0002-2604-6635; Costa, Alberto/0000-0002-7855-1190	NIH/NCATS Colorado CTSI Grant [KL2 TR000156, UL1 TR000154]; Brain Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080, KL2TR000156, UL1TR000154] Funding Source: NIH RePORTER	NIH/NCATS Colorado CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Brain Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by NIH/NCATS Colorado CTSI Grant Number KL2 TR000156 (K.S.L.), NIH/NCATS Colorado CTSI Grant Number UL1 TR000154 (W.Z.), and the Brain Research Foundation (C.R.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVIN AM, 1992, J INFECT DIS, V166, pS35, DOI 10.1093/infdis/166.Supplement_1.S35; Arvin AM, 1996, ADV VIRUS RES, V46, P263, DOI 10.1016/S0065-3527(08)60074-3; Baiker A, 2004, P NATL ACAD SCI USA, V101, P10792, DOI 10.1073/pnas.0404016101; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Brokhman I, 2008, DIFFERENTIATION, V76, P145, DOI 10.1111/j.1432-0436.2007.00196.x; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen JJ, 2011, J NEUROVIROL, V17, P578, DOI 10.1007/s13365-011-0070-1; Chen Jason J., 2003, Journal of Medical Virology, V70, pS71, DOI 10.1002/jmv.10325; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Christensen J, 2011, J VIROL, V85, P8436, DOI 10.1128/JVI.00515-11; Cohen JI, 2010, CURR TOP MICROBIOL, V342, P277, DOI 10.1007/82_2010_11; Dasgupta G, 2011, VACCINE, V29, P5824, DOI 10.1016/j.vaccine.2011.06.083; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Dworkin RH, 2007, J AM GERIATR SOC, V55, P1168, DOI 10.1111/j.1532-5415.2007.01231.x; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Fradette J, 2005, MOL THERAPY, V11, pS62; Gershon AA, 2008, J INFECT DIS, V197, pS61, DOI 10.1086/522149; Gowrishankar K, 2007, J VIROL, V81, P6752, DOI 10.1128/JVI.02793-06; Hood C, 2003, J VIROL, V77, P12852, DOI 10.1128/JVI.77.23.12852-12864.2003; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Jang J, 2012, EXP MOL MED, V44, P202, DOI DOI 10.3858/EMM.2012.44.3.015; Jung YW, 2012, CURR OPIN NEUROL, V25, P125, DOI 10.1097/WCO.0b013e3283518226; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kitajima H, 2005, J NEUROSCI RES, V80, P467, DOI 10.1002/jnr.20469; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Lanier J, 2007, DEV BIOL, V302, P703, DOI 10.1016/j.ydbio.2006.10.050; Lee G, 2011, PHILOS T R SOC B, V366, P2286, DOI 10.1098/rstb.2011.0026; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; Manceur AP, 2011, EXP CELL RES, V317, P2086, DOI 10.1016/j.yexcr.2011.06.004; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Messaoudi I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000657; Meyer C, 2011, J NEUROVIROL, V17, P600, DOI 10.1007/s13365-011-0057-y; MOFFAT JF, 1995, J VIROL, V69, P5236, DOI 10.1128/JVI.69.9.5236-5242.1995; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Oxman MN, 2009, J AM OSTEOPATH ASSOC, V109, pS13; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pavan WJ, 2012, DEV BIOL, V366, P55, DOI 10.1016/j.ydbio.2012.02.038; Pomp O, 2008, BRAIN RES, V1230, P50, DOI 10.1016/j.brainres.2008.07.029; Pugazhenthi S, 2011, J VIROL, V85, P6678, DOI 10.1128/JVI.00445-11; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SOMEKH E, 1992, PEDIATR RES, V32, P699, DOI 10.1203/00006450-199212000-00016; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Weinberg A, 2010, CURR TOP MICROBIOL, V342, P341, DOI 10.1007/82_2010_31; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zerboni L, 2005, P NATL ACAD SCI USA, V102, P6490, DOI 10.1073/pnas.0501045102; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201; ZHU ZL, 1995, P NATL ACAD SCI USA, V92, P3546, DOI 10.1073/pnas.92.8.3546	61	51	55	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53010	10.1371/journal.pone.0053010	http://dx.doi.org/10.1371/journal.pone.0053010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285249	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500100
J	Tsunada, J; Sawaguchi, T				Tsunada, Joji; Sawaguchi, Toshiyuki			Neuronal Categorization and Discrimination of Social Behaviors in Primate Prefrontal Cortex	PLOS ONE			English	Article							NEURAL REPRESENTATION; VISUAL CATEGORIZATION; FACIAL EXPRESSIONS; RHESUS MACAQUES; PARIETAL; ATTENTION; RESPONSES; IDENTITY; AMYGDALA; MONKEYS	It has been implied that primates have an ability to categorize social behaviors between other individuals for the execution of adequate social-interactions. Since the lateral prefrontal cortex (LPFC) is involved in both the categorization and the processing of social information, the primate LPFC may be involved in the categorization of social behaviors. To test this hypothesis, we examined neuronal activity in the LPFC of monkeys during presentations of two types of movies of social behaviors (grooming, mounting) and movies of plural monkeys without any eye- or body-contacts between them (no-contacts movies). Although the monkeys were not required to categorize and discriminate the movies in this task, a subset of neurons sampled from the LPFC showed a significantly different activity during the presentation of a specific type of social behaviors in comparison with the others. These neurons categorized social behaviors at the population level and, at the individual neuron level, the majority of the neurons discriminated each movie within the same category of social behaviors. Our findings suggest that a fraction of LPFC neurons process categorical and discriminative information of social behaviors, thereby contributing to the adaptation to social environments.	[Tsunada, Joji; Sawaguchi, Toshiyuki] Hokkaido Univ, Grad Sch Med, Lab Cognit Neurobiol, Sapporo, Hokkaido, Japan; [Tsunada, Joji; Sawaguchi, Toshiyuki] Human Neurosci Inst, Sapporo, Hokkaido, Japan; [Sawaguchi, Toshiyuki] Musashino Gakuin Univ, Sayama, Saitama, Japan	Hokkaido University	Tsunada, J (corresponding author), Univ Penn, Sch Med, Dept Otorhinolaryngol, Philadelphia, PA 19104 USA.	tsunada@mail.med.upenn.edu	Tsunada, Joji/N-8759-2018	Tsunada, Joji/0000-0002-9125-7578	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to T. Sawaguchi, and the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemori K, 2006, EUR J NEUROSCI, V23, P1895, DOI 10.1111/j.1460-9568.2006.04702.x; Amemori K, 2006, CEREB CORTEX, V16, P1002, DOI 10.1093/cercor/bhj042; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Aureli F., 2000, NATURAL CONFLICT RES; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bernstein IS, 1999, AM J PRIMATOL, V48, P283, DOI 10.1002/(SICI)1098-2345(1999)48:4<283::AID-AJP3>3.0.CO;2-4; BRODY EB, 1952, PSYCHOSOM MED, V14, P406, DOI 10.1097/00006842-195209000-00007; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; Byrne R., 1988, MACHIAVELLIAN INTELL; Caruana F, 2011, CURR BIOL, V21, P195, DOI 10.1016/j.cub.2010.12.042; Castles DL, 1996, ANIM BEHAV, V52, P389, DOI 10.1006/anbe.1996.0183; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Cohen YE, 2007, J NEUROPHYSIOL, V97, P1470, DOI 10.1152/jn.00769.2006; Cohen YE, 2006, BIOL LETTERS, V2, P261, DOI 10.1098/rsbl.2005.0436; de Waal F. B. M, 1982, CHIMPANZEE POLITICS; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; DEBRUIN JPC, 1990, PROG BRAIN RES, V85, P485; DUNBAR RIM, 1983, ANIM BEHAV, V31, P565, DOI 10.1016/S0003-3472(83)80080-3; Everling S, 2002, NAT NEUROSCI, V5, P671, DOI 10.1038/nn874; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Freedman DJ, 2011, NAT NEUROSCI, V14, P143, DOI 10.1038/nn.2740; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Fujii N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000397; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2007, CURR BIOL, V17, P425, DOI 10.1016/j.cub.2007.01.029; Gifford GW, 2005, J COGNITIVE NEUROSCI, V17, P1471, DOI 10.1162/0898929054985464; Gifford GW, 2003, BRAIN BEHAV EVOLUT, V61, P213, DOI 10.1159/000070704; Gothard KM, 2007, J NEUROPHYSIOL, V97, P1671, DOI 10.1152/jn.00714.2006; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; Hosokawa T, 2012, J NEUROSCI, V32, P7662, DOI 10.1523/JNEUROSCI.6479-11.2012; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; Kobayashi S, 2006, NEURON, V51, P861, DOI 10.1016/j.neuron.2006.08.031; Kuraoka K, 2006, NEUROREPORT, V17, P9, DOI 10.1097/01.wnr.0000194383.02999.c5; Kuraoka K, 2007, J NEUROPHYSIOL, V97, P1379, DOI 10.1152/jn.00464.2006; Kutsukake N, 2005, INT J PRIMATOL, V26, P775, DOI 10.1007/s10764-005-5308-4; Lebedev MA, 2004, PLOS BIOL, V2, P1919, DOI 10.1371/journal.pbio.0020365; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; MASS R, 1975, Primates, V16, P239, DOI 10.1007/BF02381552; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MYERS RE, 1973, BRAIN RES, V64, P257, DOI 10.1016/0006-8993(73)90182-0; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Perry S, 1998, PRIMATES, V39, P51, DOI 10.1007/BF02557743; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Romanski LM, 2007, CEREB CORTEX, V17, pI61, DOI 10.1093/cercor/bhm099; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 2005, J NEUROPHYSIOL, V93, P734, DOI 10.1152/jn.00675.2004; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2006, ANIM BEHAV, V71, P1069, DOI 10.1016/j.anbehav.2005.07.019; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Shepherd SV, 2009, P NATL ACAD SCI USA, V106, P9489, DOI 10.1073/pnas.0900419106; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; SILK JB, 1982, BEHAVIOUR, V79, P162, DOI 10.1163/156853982X00238; SILK JB, 1994, BEHAVIOUR, V130, P271, DOI 10.1163/156853994X00569; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smuts B. B., 1987, PRIMATE SOC; Smuts B.B., 1985, SEX FRIENDSHIP BABOO; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; TANAKA I, 1993, ANTHROPOL SCI, V101, P187, DOI 10.1537/ase.101.187; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tokuda K., 1964, Primates, V3, P1, DOI 10.1007/BF01795094; Tsao DY, 2008, NAT NEUROSCI, V11, P877, DOI 10.1038/nn.2158; Tsujimoto S, 2004, CEREB CORTEX, V14, P47, DOI 10.1093/cercor/bhg090; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WOLFE L, 1978, ARCH SEX BEHAV, V7, P55, DOI 10.1007/BF01541898; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	83	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52610	10.1371/journal.pone.0052610	http://dx.doi.org/10.1371/journal.pone.0052610			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285110	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500039
J	Hou, XH; Tang, ZL; Liu, HL; Wang, N; Ju, HM; Li, K				Hou, Xinhua; Tang, Zhonglin; Liu, Honglin; Wang, Ning; Ju, Huiming; Li, Kui			Discovery of MicroRNAs Associated with Myogenesis by Deep Sequencing of Serial Developmental Skeletal Muscles in Pigs	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; PROMOTES MIGRATION; EXPRESSION; BONE; INVASION; CELLS; BMP2; MYOD; MYOBLASTS; PROFILES	MicroRNAs (miRNAs) are short, single-stranded non-coding RNAs that repress their target genes by binding their 3' UTRs. These RNAs play critical roles in myogenesis. To gain knowledge about miRNAs involved in the regulation of myogenesis, porcine longissimus muscles were collected from 18 developmental stages (33-, 40-, 45-, 50-, 55-, 60-, 65-, 70-, 75-, 80-, 85-, 90-, 95-, 100- and 105-day post-gestation fetuses, 0 and 10-day postnatal piglets and adult pigs) to identify miRNAs using Solexa sequencing technology. We detected 197 known miRNAs and 78 novel miRNAs according to comparison with known miRNAs in the miRBase (release 17.0) database. Moreover, variations in sequence length and single nucleotide polymorphisms were also observed in 110 known miRNAs. Expression analysis of the 11 most abundant miRNAs were conducted using quantitative PCR (qPCR) in eleven tissues (longissimus muscles, leg muscles, heart, liver, spleen, lung, kidney, stomach, small intestine and colon), and the results revealed that ssc-miR-378, ssc-miR-1 and ssc-miR-206 were abundantly expressed in skeletal muscles. During skeletal muscle development, the expression level of ssc-miR-378 was low at 33 days post-coitus (dpc), increased at 65 and 90 dpc, peaked at postnatal day 0, and finally declined and maintained a comparatively stable level. This expression profile suggested that ssc-miR-378 was a new candidate miRNA for myogenesis and participated in skeletal muscle development in pigs. Target prediction and KEGG pathway analysis suggested that bone morphogenetic protein 2 (BMP2) and mitogen-activated protein kinase 1 (MAPK1), both of which were relevant to proliferation and differentiation, might be the potential targets of miR-378. Luciferase activities of report vectors containing the 3'UTR of porcine BMP2 or MAPK1 were downregulated by miR-378, which suggested that miR-378 probably regulated myogenesis though the regulation of these two genes.	[Hou, Xinhua; Liu, Honglin] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China; [Hou, Xinhua; Tang, Zhonglin; Ju, Huiming; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China; [Wang, Ning] NE Agr Univ, Coll Anim Sci & Technol, Haerbin, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Tang, ZL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China.	zhonglinqy_99@sina.com; liuhonglin@njau.edu.cn	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163	National Natural Science Foundation of China [30830080, 31171192 31000993]; National Basic Research Program of China [2009CB941604]; National Key Project [2009ZX08010-022B, 2011ZX08009-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key Project	This work was supported by National Natural Science Foundation of China (30830080, 31171192 31000993), National Basic Research Program of China (2009CB941604) and National Key Project (2009ZX08010-022B, 2011ZX08009-001). The funders had no role in study design, data collection and analysis, dicision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Aoyama K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-44; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Cardinali B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007607; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Clape C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007542; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Fujita Y, 2010, J BIOL CHEM, V285, P19076, DOI 10.1074/jbc.M109.079525; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Jin H, 2012, APPL MICROBIOL BIOT, V93, P1715, DOI 10.1007/s00253-011-3865-3; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kang MH, 2010, EXP CELL RES, V316, P24, DOI 10.1016/j.yexcr.2009.10.010; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; LEFAUCHEUR L, 1995, DEV DYNAM, V203, P27, DOI 10.1002/aja.1002030104; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu YH, 2004, BIOCHEM BIOPH RES CO, V313, P709, DOI 10.1016/j.bbrc.2003.12.007; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Suga T, 2007, CELL TISSUE RES, V329, P103, DOI 10.1007/s00441-007-0416-4; Suzuki D, 2012, CALCIFIED TISSUE INT, V91, P88, DOI 10.1007/s00223-012-9614-5; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tian YY, 2010, J BIOL CHEM, V285, P7986, DOI 10.1074/jbc.M109.062877; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Wei Q, 2001, FEBS LETT, V490, P171, DOI 10.1016/S0014-5793(01)02120-2; WIGMORE PMC, 1983, J ANAT, V137, P235; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhang JM, 1999, EMBO J, V18, P926, DOI 10.1093/emboj/18.4.926; Zhao SP, 2012, INT J BIOL SCI, V8, P459, DOI 10.7150/ijbs.3821; Zhou B, 2010, ANIM GENET, V41, P499, DOI 10.1111/j.1365-2052.2010.02026.x	53	67	79	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52123	10.1371/journal.pone.0052123	http://dx.doi.org/10.1371/journal.pone.0052123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284895	Green Submitted, gold, Green Published			2022-12-25	WOS:000313158800032
J	Bjorck, HM; Renner, J; Maleki, S; Nilsson, SFE; Kihlberg, J; Folkersen, L; Karlsson, M; Ebbers, T; Eriksson, P; Lanne, T				Bjorck, Hanna M.; Renner, Johan; Maleki, Shohreh; Nilsson, Siv F. E.; Kihlberg, Johan; Folkersen, Lasse; Karlsson, Matts; Ebbers, Tino; Eriksson, Per; Lanne, Toste			Characterization of Shear-Sensitive Genes in the Normal Rat Aorta Identifies Hand2 as a Major Flow-Responsive Transcription Factor	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; DISTURBED FLOW; IN-VIVO; STRESS; EXPRESSION; ACTIVATION; MECHANISMS; CHANNELS; OSCILLATIONS	Objective: Shear forces play a key role in the maintenance of vessel wall integrity. Current understanding regarding shear-dependent gene expression is mainly based on in vitro or in vivo observations with experimentally deranged shear, hence reflecting acute molecular events in relation to flow. Our objective was to combine computational fluid dynamic (CFD) simulations with global microarray analysis to study flow-dependent vessel wall biology in the aortic wall under physiological conditions. Methods and Results: Male Wistar rats were used. Animal-specific wall shear stress (WSS) magnitude and vector direction were estimated using CFD based on aortic geometry and flow information acquired by magnetic resonance imaging. Two distinct flow pattern regions were identified in the normal rat aortic arch; the distal part of the lesser curvature being exposed to low WSS and a non-uniform vector direction, and a region along the greater curvature being subjected to markedly higher levels of WSS and a uniform vector direction. Microarray analysis identified numerous novel mechanosensitive genes, including Trpc4 and Fgf12, and confirmed well-known ones, e. g. Klf2 and Nrf2. Gene ontology analysis revealed an over-representation of genes involved in transcriptional regulation. The most differentially expressed gene, Hand2, is a transcription factor previously shown to be involved in extracellular matrix remodeling. HAND2 protein was endothelial specific and showed higher expression in the regions exposed to low WSS with disturbed flow. Conclusions: Microarray analysis validated the CFD-defined WSS regions in the rat aortic arch, and identified numerous novel shear-sensitive genes. Defining the functional importance of these genes in relation to atherosusceptibility may provide important insight into the understanding of vascular pathology.	[Bjorck, Hanna M.; Kihlberg, Johan; Ebbers, Tino; Lanne, Toste] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Bjorck, Hanna M.; Renner, Johan; Kihlberg, Johan; Karlsson, Matts; Ebbers, Tino; Lanne, Toste] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Renner, Johan; Karlsson, Matts; Ebbers, Tino] Linkoping Univ, Dept Management & Engn, Div Appl Thermodynam & Fluid Mech, Linkoping, Sweden; [Maleki, Shohreh; Folkersen, Lasse; Eriksson, Per] Karolinska Inst, Dept Med, Ctr Mol Med, Atherosclerosis Res Unit, Solna, Sweden; [Nilsson, Siv F. E.] Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden; [Kihlberg, Johan] Linkoping Univ Hosp, Div Radiol, S-58185 Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Karolinska Institutet; Linkoping University; Linkoping University	Bjorck, HM (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden.	hanna.bjorck@ki.se	Ebbers, Tino/ABB-8488-2021; Björck, Hanna/AFU-6554-2022	Ebbers, Tino/0000-0003-1395-8296; Eriksson, Per/0000-0002-5635-2692; Lanne, Toste/0000-0002-9095-403X; Folkersen, Lasse/0000-0003-0708-9530	Swedish Heart-Lung Foundation; Swedish Research Council; European Commission (FAD) [Health-F2-2008-200647]; County Council of Ostergotland; Elanora Demeroutis Foundation, Linkoping; Goljes Memorial Foundation; Linkoping University Heart Foundation	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Commission (FAD)(European CommissionEuropean Commission Joint Research Centre); County Council of Ostergotland; Elanora Demeroutis Foundation, Linkoping; Goljes Memorial Foundation; Linkoping University Heart Foundation	The study was supported by grants from the Swedish Heart-Lung Foundation; the Swedish Research Council; the European Commission (FAD;Health-F2-2008-200647); County Council of Ostergotland; Elanora Demeroutis Foundation, Linkoping; Goljes Memorial Foundation and Linkoping University Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmmed GU, 2005, PFLUG ARCH EUR J PHY, V451, P131, DOI 10.1007/s00424-005-1461-z; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; Chien S, 2008, ANN BIOMED ENG, V36, P554, DOI 10.1007/s10439-007-9426-3; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Civelek M, 2009, CIRC RES, V105, P453, DOI 10.1161/CIRCRESAHA.109.203711; Conway DE, 2010, AM J PHYSIOL-HEART C, V298, pH367, DOI 10.1152/ajpheart.00565.2009; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Di A, 2010, CURR OPIN PHARMACOL, V10, P127, DOI 10.1016/j.coph.2009.11.010; Du J, 2008, AM J PHYSIOL-RENAL, V294, pF909, DOI 10.1152/ajprenal.00606.2007; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Fledderus JO, 2007, BLOOD, V109, P4249, DOI 10.1182/blood-2006-07-036020; Garcia-Cardena G, 2001, ANN NY ACAD SCI, V947, P1; Gautam M, 2006, CELL BIOCHEM BIOPHYS, V46, P277, DOI 10.1385/CBB:46:3:277; Greve JM, 2006, AM J PHYSIOL-HEART C, V291, pH1700, DOI 10.1152/ajpheart.00274.2006; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Helmlinger G, 1996, J VASC RES, V33, P360, DOI 10.1159/000159164; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janiczek RL, 2011, MAGN RESON MED, V66, P1382, DOI 10.1002/mrm.22937; Jow F, 1999, J MEMBRANE BIOL, V171, P127, DOI 10.1007/s002329900565; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LaMack JA, 2010, ANN BIOMED ENG, V38, P2252, DOI 10.1007/s10439-010-0030-6; Liu SQ, 2003, AM J PHYSIOL-HEART C, V285, pH1072, DOI 10.1152/ajpheart.01009.2002; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Metodieva SN, 2011, TUMORI, V97, P86, DOI 10.1177/030089161109700116; Mohan S, 1999, AM J PHYSIOL-CELL PH, V276, pC1100, DOI 10.1152/ajpcell.1999.276.5.C1100; Nagel T, 1999, ARTERIOSCL THROM VAS, V19, P1825, DOI 10.1161/01.ATV.19.8.1825; Nayak L, 2011, ANTIOXID REDOX SIGN, V15, P1449, DOI 10.1089/ars.2010.3647; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; PFEILSCHIFTER J, 1984, BIOCHEM J, V223, P855, DOI 10.1042/bj2230855; Renner J., 2009, WSEAS Transactions on Fluid Mechanics, V4, P148; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Suo J, 2007, ARTERIOSCL THROM VAS, V27, P346, DOI 10.1161/01.ATV.0000253492.45717.46; Tada S, 2002, AM J PHYSIOL-HEART C, V282, pH576, DOI 10.1152/ajpheart.00751.2001; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; WANG DM, 1995, J BIOMECH ENG-T ASME, V117, P358, DOI 10.1115/1.2794192; Wang LY, 2012, CIRC-CARDIOVASC GENE, V5, P234, DOI 10.1161/CIRCGENETICS.111.961763; Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Willett NJ, 2010, ARTERIOSCL THROM VAS, V30, P2099, DOI 10.1161/ATVBAHA.110.211532; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Yamagishi H, 2000, J CLIN INVEST, V105, P261, DOI 10.1172/JCI8856; Yin CY, 2010, DEV CELL, V18, P973, DOI 10.1016/j.devcel.2010.05.009; Yip KP, 2011, AM J PHYSIOL-RENAL, V300, pF540, DOI 10.1152/ajprenal.00544.2009	48	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52227	10.1371/journal.pone.0052227	http://dx.doi.org/10.1371/journal.pone.0052227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284944	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500119
J	Gupta, K; Thakur, VS; Bhaskaran, N; Nawab, A; Babcook, MA; Jackson, MW; Gupta, S				Gupta, Karishma; Thakur, Vijay S.; Bhaskaran, Natarajan; Nawab, Akbar; Babcook, Melissa A.; Jackson, Mark W.; Gupta, Sanjay			Green Tea Polyphenols Induce p53-Dependent and p53-Independent Apoptosis in Prostate Cancer Cells through Two Distinct Mechanisms	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; CONSTITUTIVE ACTIVATION; MEDIATED APOPTOSIS; GROWTH ARREST; RICH EXTRACT; CYCLE ARREST; P53 PROTEIN; PATHWAY; AKT	Inactivation of the tumor suppressor gene p53 is commonly observed in human prostate cancer and is associated with therapeutic resistance. We have previously demonstrated that green tea polyphenols (GTP) induce apoptosis in prostate cancer cells irrespective of p53 status. However, the molecular mechanisms underlying these observations remain elusive. Here we investigated the mechanisms of GTP-induced apoptosis in human prostate cancer LNCaP cells stably-transfected with short hairpin-RNA against p53 (LNCaPshp53) and control vector (LNCaPshV). GTP treatment induced p53 stabilization and activation of downstream targets p21/waf1 and Bax in a dose-dependent manner specifically in LNCaPshV cells. However, GTP-induced FAS upregulation through activation of c-jun-N-terminal kinase resulted in FADD phosphorylation, caspase-8 activation and truncation of BID, leading to apoptosis in both LNCaPshV and LNCaPshp53 cells. In parallel, treatment of cells with GTP resulted in inhibition of survival pathway, mediated by Akt deactivation and loss of BAD phosphorylation more prominently in LNCaPshp53 cells. These distinct routes of cell death converged to a common pathway, leading to loss of mitochondrial transmembrane potential, cytochrome c release and activation of terminal caspases, resulting in PARP-cleavage. GTP-induced apoptosis was attenuated with JNK inhibitor, SP600125 in both cell lines; whereas PI3K-Akt inhibitor, LY294002 resulted in increased cell death prominently in LNCaPshp53 cells, establishing the role of two distinct pathways of GTP-mediated apoptosis. Furthermore, GTP exposure resulted in inhibition of class I HDAC protein, accumulation of acetylated histone-H3 in total cellular chromatin, resulting in increased accessibility of transcription factors to bind with the promoter sequences of p21/waf1 and Bax, regardless of the p53 status of cells, consistent with effects elicited by an HDAC inhibitor, trichostatin A. These results demonstrate that GTP induces prostate cancer cell death by two distinct mechanisms regardless of p53 status, thus identifying specific well-defined molecular mechanisms that may be targeted by chemopreventive and/or therapeutic strategies.	[Gupta, Karishma; Thakur, Vijay S.; Bhaskaran, Natarajan; Nawab, Akbar; Babcook, Melissa A.; Gupta, Sanjay] Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA; [Babcook, Melissa A.; Gupta, Sanjay] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Jackson, Mark W.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Thakur, Vijay S.; Bhaskaran, Natarajan; Nawab, Akbar; Babcook, Melissa A.; Gupta, Sanjay] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Gupta, Sanjay] Case Comprehens Canc Ctr, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University	Gupta, S (corresponding author), Case Western Reserve Univ, Dept Urol, Cleveland, OH 44106 USA.	sanjay.gupta@case.edu	Bhaskaran, Natarajan/AAE-8445-2019	Gupta, Karishma/0000-0002-1501-032X; Gupta, Sanjay/0000-0002-9492-3249	United States Public Health Service [RO1 CA115491, RO1 CA108512, RO1 AT002709, R21 CA109424]; NATIONAL CANCER INSTITUTE [R01CA108512, R21CA109424, R01CA115491] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002709] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	The research work is supported by United States Public Health Service Grants RO1 CA115491, RO1 CA108512, RO1 AT002709, and R21 CA109424 and Endowment funds to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 1998, ONCOGENE, V17, P3287, DOI 10.1038/sj.onc.1202576; Asensi M, 2011, CRIT REV CL LAB SCI, V48, P197, DOI 10.3109/10408363.2011.631268; Blagosklonny MV, 1996, INT J CANCER, V67, P386, DOI 10.1002/(SICI)1097-0215(19960729)67:3<386::AID-IJC13>3.0.CO;2-6; Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Carden CP, 2012, MOL CANCER THER, V11, P1609, DOI 10.1158/1535-7163.MCT-11-0996; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen WJ, 2010, MOL PHARMACOL, V77, P416, DOI 10.1124/mol.109.061226; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies MA, 2011, J CLIN ONCOL, V29, P4715, DOI 10.1200/JCO.2011.37.4751; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Ecke TH, 2007, ANTICANCER RES, V27, P4143; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Griewe GL, 2003, PROSTATE CANCER P D, V6, P281, DOI 10.1038/sj.pcan.4500665; Grignon DJ, 1997, JNCI-J NATL CANCER I, V89, P158, DOI 10.1093/jnci/89.2.158; Hastak K, 2005, FASEB J, V19, P789, DOI 10.1096/fj.04-2226fje; Hastak K, 2003, ONCOGENE, V22, P4851, DOI 10.1038/sj.onc.1206708; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Huo C., 2008, Inflammopharmacology, V16, P248, DOI 10.1007/s10787-008-8031-x; Kaur P, 2008, CARCINOGENESIS, V29, P2210, DOI 10.1093/carcin/bgn201; Keshelava N, 2000, MED PEDIATR ONCOL, V35, P563, DOI 10.1002/1096-911X(20001201)35:6<563::AID-MPO15>3.0.CO;2-J; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kraus AC, 2002, ONCOGENE, V21, P8683, DOI 10.1038/sj.onc.1205939; Lahiry L, 2010, CARCINOGENESIS, V31, P259, DOI 10.1093/carcin/bgp240; Lee DH, 2008, BIOCHEM PHARMACOL, V75, P2345, DOI 10.1016/j.bcp.2008.03.013; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin HH, 2005, MOL CARCINOGEN, V43, P86, DOI 10.1002/mc.20103; Loriot Y, 2012, ANN ONCOL, V23, P1085, DOI 10.1093/annonc/mdr573; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; Mukhtar H, 2000, AM J CLIN NUTR, V71, p1698S, DOI 10.1093/ajcn/71.6.1698S; Nargi Jennifer L., 1999, Neoplasia (New York), V1, P544; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Nawab A, 2012, INT J MOL MED, V29, P277, DOI 10.3892/ijmm.2011.835; Oz Helieh S, 2010, J Cancer Ther, V1, P105; Pandey M, 2010, INT J CANCER, V126, P2520, DOI 10.1002/ijc.24988; Pastorino JG, 1999, J BIOL CHEM, V274, P19411, DOI 10.1074/jbc.274.27.19411; Pesche S, 1998, ONCOGENE, V16, P2879, DOI 10.1038/sj.onc.1202081; Philips BJ, 2009, BIOMED RES-TOKYO, V30, P207, DOI 10.2220/biomedres.30.207; Pommier Y, 2004, ONCOGENE, V23, P2934, DOI 10.1038/sj.onc.1207515; Shimada K, 2004, CARCINOGENESIS, V25, P1089, DOI 10.1093/carcin/bgh130; Shimura T, 2011, INT J RADIAT ONCOL, V80, P540, DOI 10.1016/j.ijrobp.2010.12.065; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Srivastava RK, 2001, NEOPLASIA, V3, P535, DOI 10.1038/sj.neo.7900203; Thakur VS, 2012, INT J ONCOL, V41, P353, DOI 10.3892/ijo.2012.1449; Thakur VS, 2012, CARCINOGENESIS, V33, P377, DOI 10.1093/carcin/bgr277; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Wirth MP, 2007, EUR UROL, V51, P306, DOI 10.1016/j.eururo.2006.08.043; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang GY, 1998, CARCINOGENESIS, V19, P611, DOI 10.1093/carcin/19.4.611; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zeng CW, 2012, MOL PHARMACOL, V81, P578, DOI 10.1124/mol.111.076794; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	58	35	36	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52572	10.1371/journal.pone.0052572	http://dx.doi.org/10.1371/journal.pone.0052572			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285096	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500201
J	Kim, MI; Shin, I; Cho, S; Lee, J; Rhee, S				Kim, Myung-Il; Shin, Inchul; Cho, Suhee; Lee, Jeehyun; Rhee, Sangkee			Structural and Functional Insights into (S)-Ureidoglycolate Dehydrogenase, a Metabolic Branch Point Enzyme in Nitrogen Utilization	PLOS ONE			English	Article							NAD(P)H-DEPENDENT OXIDOREDUCTASES; CRYSTAL-STRUCTURE; ALLANTOIN; FAMILY; DEGRADATION; CATABOLISM; SOFTWARE; PATHWAY; MODEL	Nitrogen metabolism is one of essential processes in living organisms. The catabolic pathways of nitrogenous compounds play a pivotal role in the storage and recovery of nitrogen. In Escherichia coli, two different, interconnecting metabolic routes drive nitrogen utilization through purine degradation metabolites. The enzyme (S)-ureidoglycolate dehydrogenase (AllD), which is a member of L-sulfolactate dehydrogenase-like family, converts (S)-ureidoglycolate, a key intermediate in the purine degradation pathway, to oxalurate in an NAD(P)-dependent manner. Therefore, AllD is a metabolic branch-point enzyme for nitrogen metabolism in E. coli. Here, we report crystal structures of AllD in its apo form, in a binary complex with NADH cofactor, and in a ternary complex with NADH and glyoxylate, a possible spontaneous degradation product of oxalurate. Structural analyses revealed that NADH in an extended conformation is bound to an NADH-binding fold with three distinct domains that differ from those of the canonical NADH-binding fold. We also characterized ligand-induced structural changes, as well as the binding mode of glyoxylate, in the active site near the NADH nicotinamide ring. Based on structural and kinetic analyses, we concluded that AllD selectively utilizes NAD+ as a cofactor, and further propose that His116 acts as a general catalytic base and that a hydride transfer is possible on the B-face of the nicotinamide ring of the cofactor. Other residues conserved in the active sites of this novel L-sulfolactate dehydrogenase-like family also play essential roles in catalysis.	[Kim, Myung-Il; Shin, Inchul; Cho, Suhee; Lee, Jeehyun; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fungal Pathogenesis, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	srheesnu@snu.ac.kr			Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ008059]; Rural Development Administration; National Research Foundation [R11-2008-062-01002-0, 2010-0025883]; Ministry of Education, Science and Technology, Republic of Korea	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation; Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center number PJ008059), Rural Development Administration, and from National Research Foundation (R11-2008-062-01002-0 and 2010-0025883), the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkins C, 2000, PROKARYOTIC NITROGEN FIXATION, P559; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cendron L, 2007, J BIOL CHEM, V282, P18182, DOI 10.1074/jbc.M701297200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; Desimone M, 2002, PLANT CELL, V14, P847, DOI 10.1105/tpc.010458; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forouhar F, 2004, J BIOL CHEM, V279, P13148, DOI 10.1074/jbc.M313580200; French JB, 2010, J BIOL CHEM, V285, P35446, DOI 10.1074/jbc.M110.156034; Goto M, 2005, J BIOL CHEM, V280, P40875, DOI 10.1074/jbc.M507399200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hennebry SC, 2009, FEBS J, V276, P5367, DOI 10.1111/j.1742-4658.2009.07246.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Irimia A, 2004, EMBO J, V23, P1234, DOI 10.1038/sj.emboj.7600147; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim K, 2007, J BIOL CHEM, V282, P23457, DOI 10.1074/jbc.M703211200; Kim K, 2009, J MOL BIOL, V387, P1067, DOI 10.1016/j.jmb.2009.02.041; Muramatsu H, 2005, J BIOL CHEM, V280, P5329, DOI 10.1074/jbc.M411918200; Muramatsu H, 2005, J BIOSCI BIOENG, V99, P541, DOI 10.1263/jbb.99.541; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Ramazzina I, 2008, J BIOL CHEM, V283, P23295, DOI 10.1074/jbc.M801195200; Rintoul MR, 2002, J MOL BIOL, V324, P599, DOI 10.1016/S0022-2836(02)01134-8; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Serventi F, 2010, ACS CHEM BIOL, V5, P203, DOI 10.1021/cb900248n; Shin I, 2012, J BIOL CHEM, V287, P18796, DOI 10.1074/jbc.M111.331819; VANDERDRIFT C, 1971, ARCH BIOCHEM BIOPHYS, V145, P465, DOI 10.1016/S0003-9861(71)80006-1; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Wang WH, 2008, PLANT SCI, V175, P467, DOI 10.1016/j.plantsci.2008.05.018; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]	33	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52066	10.1371/journal.pone.0052066	http://dx.doi.org/10.1371/journal.pone.0052066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284870	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500081
J	Lai, CTM; Chow, PC; Wong, SJ; Chan, KW; Cheung, YF				Lai, Clare T. M.; Chow, Pak-cheong; Wong, Sophia J.; Chan, Koon-wing; Cheung, Yiu-fai			Circulating Annexin A5 Levels after Atrial Switch for Transposition of the Great Arteries: Relationship with Ventricular Deformation and Geometry	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR MAGNETIC-RESONANCE; LATE GADOLINIUM ENHANCEMENT; SYSTEMIC RIGHT VENTRICLE; HEART-FAILURE; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; COLLAGEN; PLASMA; APOPTOSIS	Background: Inflammatory cytokines, cardiomyocyte apoptosis, and altered collagen turnover may contribute to unfavourable ventricular remodeling. This unfavourable ventricular remodelling is well documented in patients after atrial switch operation for complete transposition of the great arteries. We therefore tested if levels of circulating markers of inflammation, apoptosis, collagen synthesis, and extracellular matrix degradation are altered in patients after atrial switch operation for transposition of the great arteries. Methods and Results: Circulating tumour necrosis factor (TNF)-alpha, annexin A5 (AnxA5), carboxy-terminal propeptide of type I procollagen (PICP), amino-terminal propeptide of type III procollagen (PIIINP), matrix metalloproteinase-1 (MMP-1), and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels were determined in 27 patients aged 25.2+/-3.1 years and 20 controls. Ventricular myocardial deformation and left ventricular eccentricity index (EI) were determined by speckle tracking and two-dimensional echocardiography, respectively. Compared with controls, patients had significantly higher circulating AnxA5 (p<0.001) and TNF-alpha (p = 0.018) levels, but similar PICP, PIIINP, MMP-1 and TIMP-1 levels. For the whole cohort, plasma AnxA5 correlated with serum TNF-alpha (p = 0.002), systemic ventricular global longitudinal strain (GLS) and systolic and early diastolic strain rate (all p<0.001), and subpulmonary ventricular GLS and early diastolic strain rate (both p<0.001). In patients, plasma AnxA5 level correlated positively with subpulmonary ventricular EI (p = 0.027). Multiple linear regression analysis identified systemic ventricular GLS (beta = -0.50, p<0.001) and serum TNF-alpha (beta = 0.29, p = 0.022) as significant correlates of plasma AnxA5. Conclusions: Elevated plasma AnxA5 level in patients after atrial switch operation is associated with impaired systemic myocardial deformation, increased subpulmonary ventricular eccentricity, and increased serum TNF-alpha level.	[Lai, Clare T. M.; Chow, Pak-cheong; Wong, Sophia J.; Chan, Koon-wing; Cheung, Yiu-fai] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheung, YF (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	xfcheung@hku.hk	CHOW, PAK CHEONG/GYU-4767-2022; Cheung, Yiu Fai/C-4240-2009	Cheung, Yiu Fai/0000-0002-7279-4992				Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Babu-Narayan SV, 2005, CIRCULATION, V111, P2091, DOI 10.1161/01.CIR.0000162463.61626.3B; Boersma HH, 2005, J NUCL MED, V46, P2035; Boyajyan AS, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-55; Bradham WS, 2002, CARDIOVASC RES, V53, P822, DOI 10.1016/S0008-6363(01)00503-X; Campian ME, 2009, J NUCL MED, V50, P1371, DOI 10.2967/jnumed.108.061366; Chow PC, 2008, HEART, V94, P855, DOI 10.1136/hrt.2007.131862; Chow PC, 2011, INT J CARDIOL, V152, P28, DOI 10.1016/j.ijcard.2010.05.078; DIEZ J, 1995, CIRCULATION, V91, P1450, DOI 10.1161/01.CIR.91.5.1450; Dos L, 2005, HEART, V91, P652, DOI 10.1136/hrt.2003.029769; Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P1, DOI 10.1016/j.carpath.2004.12.002; GENGE BR, 1992, J BONE MINER RES, V7, P807, DOI 10.1002/jbmr.5650070710; George J, 2005, AM HEART J, V150, P484, DOI 10.1016/j.ahj.2004.11.016; Hammerschmidt S, 2004, AM J RESP CELL MOL, V30, P396, DOI 10.1165/rcmb.2003-0136OC; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Hrycek A, 2012, RHEUMATOL INT, V32, P1335, DOI 10.1007/s00296-011-1793-2; Kaneko N, 1996, CLIN CHIM ACTA, V251, P65, DOI 10.1016/0009-8981(96)06294-8; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Khairy P, 2004, CARDIOL YOUNG, V14, P284, DOI 10.1017/S1047951104003063; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Lubiszewska B, 2000, J AM COLL CARDIOL, V36, P1365, DOI 10.1016/S0735-1097(00)00864-0; Matsuda R, 2003, RESUSCITATION, V57, P171, DOI 10.1016/S0300-9572(03)00034-0; Radauceanu A, 2008, J CARD FAIL, V14, P467, DOI 10.1016/j.cardfail.2008.02.014; Ravassa S, 2007, EUR HEART J, V28, P2785, DOI 10.1093/eurheartj/ehm370; Ravassa S, 2010, CARDIOVASC RES, V88, P304, DOI 10.1093/cvr/cvq183; Redheuil A, 2008, J CARDIOVASC MAGN R, pA195; ROMISCH J, 1992, BLOOD COAGUL FIBRIN, V3, P11; Roos-Hesselink JW, 2004, EUR HEART J, V25, P1264, DOI 10.1016/j.ehj.2004.03.009; Rossi A, 2004, HEART, V90, P650, DOI 10.1136/hrt.2002.005371; RYAN T, 1985, J AM COLL CARDIOL, V5, P918, DOI 10.1016/S0735-1097(85)80433-2; Schwartzkopff B, 2002, EUR J HEART FAIL, V4, P439, DOI 10.1016/S1388-9842(02)00092-2; Sharma R, 2003, AM J CARDIOL, V92, P188, DOI 10.1016/S0002-9149(03)00536-8; Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259; Timonen P, 2008, INT J CARDIOL, V124, P293, DOI 10.1016/j.ijcard.2007.02.004; van Tits LJ, 2009, BIOCHEM BIOPH RES CO, V390, P161, DOI 10.1016/j.bbrc.2009.09.102; VANHEERDE WL, 1995, THROMB HAEMOSTASIS, V73, P172; Vohringer M, 2007, HERZ, V32, P129, DOI 10.1007/s00059-007-2972-5; Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352	39	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52125	10.1371/journal.pone.0052125	http://dx.doi.org/10.1371/journal.pone.0052125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284897	Green Published, gold			2022-12-25	WOS:000312794500096
J	Qian, S; Dean, R; Urban, VS; Chaudhuri, BN				Qian, Shuo; Dean, Rebecca; Urban, Volker S.; Chaudhuri, Barnali N.			The Internal Organization of Mycobacterial Partition Assembly: Does the DNA Wrap a Protein Core?	PLOS ONE			English	Article							BACTERIAL CHROMOSOME SEGREGATION; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; NEUTRON-SCATTERING; PLASMID PARTITION; STRUCTURAL BIOLOGY; PARB; COMPLEX; SITES; CAULOBACTER	Before cell division in many bacteria, the ParBs spread on a large segment of DNA encompassing the origin-proximal parS site(s) to form the partition assembly that participates in chromosome segregation. Little is known about the structural organization of chromosomal partition assembly. We report solution X-ray and neutron scattering data characterizing the size parameters and internal organization of a nucleoprotein assembly formed by the mycobacterial chromosomal ParB and a 120-meric DNA containing a parS-encompassing region from the mycobacterial genome. The cross-sectional radii of gyration and linear mass density describing the rod-like ParB-DNA assembly were determined from solution scattering. A "DNA outside, protein inside" mode of partition assembly organization consistent with the neutron scattering hydrogen/deuterium contrast variation data is discussed. In this organization, the high scattering DNA is positioned towards the outer region of the partition assembly. The new results presented here provide a basis for understanding how ParBs organize the parS-proximal chromosome, thus setting the stage for further interactions with the DNA condensins, the origin tethering factors and the ParA.	[Qian, Shuo; Urban, Volker S.] Oak Ridge Natl Lab, Ctr Struct Mol Biol, Biol & Soft Matter Div, Oak Ridge, TN USA; [Dean, Rebecca; Chaudhuri, Barnali N.] Hauptman Woodward Inst, Buffalo, NY USA; [Chaudhuri, Barnali N.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14260 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chaudhuri, BN (corresponding author), S Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	barnalichaudhuri1@gmail.com	Qian, Shuo/AAU-1770-2020; Urban, Volker S/N-5361-2015	Qian, Shuo/0000-0002-4842-828X; Urban, Volker S/0000-0002-7962-3408	John R. Oishei Foundation; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy	John R. Oishei Foundation; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	Funding was provided by The John R. Oishei Foundation. Work at the Stanford Synchrotron Radiation Laboratory was supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. SANS research at Oak Ridge National Laboratory's Center for Structural Molecular Biology was supported by the Office of Biological and Environmental Research, using ORNL's High Flux Isotope Reactor, sponsored by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylett CHS, 2012, P NATL ACAD SCI USA, V109, P16522, DOI 10.1073/pnas.1210899109; Banigan EJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002145; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Breier AM, 2007, MOL MICROBIOL, V64, P703, DOI 10.1111/j.1365-2958.2007.05690.x; Chaudhuri BN, 2011, J MOL BIOL, V413, P901, DOI 10.1016/j.jmb.2011.08.002; Chaudhuri BN, 2011, BIOCHEMISTRY-US, V50, P1799, DOI 10.1021/bi1016759; DICAPUA E, 1989, BIOCHEMISTRY-US, V28, P3287, DOI 10.1021/bi00434a025; Donovan C, 2012, MOL MICROBIOL, V84, P105, DOI 10.1111/j.1365-2958.2012.08011.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; GERCHMAN SE, 1987, P NATL ACAD SCI USA, V84, P7802, DOI 10.1073/pnas.84.22.7802; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; GLATTER O, 1980, J APPL CRYSTALLOGR, V13, P577, DOI 10.1107/S0021889880012794; GRAZIANO V, 1994, NATURE, V368, P351, DOI 10.1038/368351a0; Gruber S, 2009, CELL, V137, P685, DOI 10.1016/j.cell.2009.02.035; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; HJELM RP, 1977, CELL, V10, P139, DOI 10.1016/0092-8674(77)90148-9; IBEL K, 1975, J MOL BIOL, V93, P255, DOI 10.1016/0022-2836(75)90131-X; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; Inoko Y, 1992, J BIOCH, V111, P3106; Jakimowicz D, 2007, MICROBIOL-SGM, V153, P4050, DOI 10.1099/mic.0.2007/011619-0; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kusiak M, 2011, J BACTERIOL, V193, P3342, DOI 10.1128/JB.00328-11; Livny J, 2007, J BACTERIOL, V189, P8693, DOI 10.1128/JB.01239-07; Lutkenhaus J, 2012, TRENDS MICROBIOL, V20, P411, DOI 10.1016/j.tim.2012.05.002; Lynn GW, 2006, PHYSICA B, V385-86, P880, DOI 10.1016/j.physb.2006.05.133; Maloney E, 2009, TUBERCULOSIS, V89, pS65, DOI 10.1016/S1472-9792(09)70015-0; Minnen A, 2011, MOL MICROBIOL, V81, P676, DOI 10.1111/j.1365-2958.2011.07722.x; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Nisa S, 2010, J ANTIMICROB CHEMOTH, V65, P2347, DOI 10.1093/jac/dkq311; PERKINS SJ, 1988, BIOCHEM J, V254, P313, DOI 10.1042/bj2540313; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Schumacher MA, 2010, NUCLEIC ACIDS RES, V38, P4514, DOI 10.1093/nar/gkq161; Shebelut CW, 2010, P NATL ACAD SCI USA, V107, P14194, DOI 10.1073/pnas.1005274107; Smolsky IL, 2007, J APPL CRYSTALLOGR, V40, pS453, DOI 10.1107/S0021889807009624; Sullivan NL, 2009, CELL, V137, P697, DOI 10.1016/j.cell.2009.04.044; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szardenings F, 2011, CURR OPIN MICROBIOL, V14, P712, DOI 10.1016/j.mib.2011.09.008; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thiyagarajan P, 2000, J APPL CRYSTALLOGR, V33, P535, DOI 10.1107/S0021889899014387; Tsuruta H, 1998, J APPL CRYSTALLOGR, V31, P672, DOI 10.1107/S0021889898002702; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Whitten AE, 2008, J APPL CRYSTALLOGR, V41, P222, DOI 10.1107/S0021889807055136; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105	51	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52690	10.1371/journal.pone.0052690	http://dx.doi.org/10.1371/journal.pone.0052690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285150	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500230
J	Uddin, MH; Bae, YM; Choi, MH; Hong, ST				Uddin, Md. Hafiz; Bae, Young Mee; Choi, Min-Ho; Hong, Sung-Tae			Production and Deformation of Clonorchis sinensis Eggs during In Vitro Maintenance	PLOS ONE			English	Article							ECHINOSTOMA-CAPRONI; LIGHT; WORMS	Clonorchis sinensis is a carcinogenic human liver fluke. The present study monitored eggs produced by long-term maintained adult worms of C. sinensis to confirm their egg productivity in vitro. The worms from infected rabbits were incubated in vitro in 1xLocke's solution and broth media (RPMI-1640, DMEM and IMDM). Numbers of expelled eggs were counted sequentially and their morphological changes were monitored by microscopy after 1, 30, 60, and 90 days of cultivation. On the 1-3 days of cultivation, the eggs counted maximum 4,7566202 eggs/worm/day in IMDM medium. The number of eggs gradually decreased less than 1,000 at 7-14 days and below 100 at 21days but continued to pass eggs after 56 days in all media. Length of the eggs were reduced about 1 mm at 30 days, and the length/width ratio was maintained around 1.8 at 30 days but decreased to 1.7 at 60 days and 1.5 at 90 days. Faust-Meleney index (FMI) decreased as the cultivation duration increased and lowest FMI (5662.9 +/- 974.7) observed in IMDM media at day 90 (P=0.001). Microscopic findings of the eggs recognized the miracidium in most of eggs at 60 days but not in those at 90 days. Instead, the eggs contained dark granules or vacuoles in the deformed shell at 90 days. Scanning electron microscopy revealed partial loss of wrinkles on the deformed egg surface and prominent abopercular knob. Eggs viability decreased as the cultivation progressed and showed significant positive correlation with FMI and length/width ratio. In conclusion, the cultivated worms pass only the eggs which are preformed in their uterus before cultivation. One gravid C. sinensis contains about 37,000 eggs in its uterus and produces about 4,000 eggs every day. The deformed eggs with FMI less than 7,000 and length/width ratio lower than 1.7 are non-viable.	[Uddin, Md. Hafiz; Bae, Young Mee; Choi, Min-Ho; Hong, Sung-Tae] Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea	Seoul National University (SNU)	Hong, ST (corresponding author), Seoul Natl Univ, Coll Med, Dept Parasitol & Trop Med, Seoul, South Korea.	hst@snu.ac.kr		Uddin, Md. Hafiz/0000-0002-0188-6857; Hong, Sung-Tae/0000-0002-0300-1944	Seoul National University Hospital [21-2005-0330]	Seoul National University Hospital	The present study was supported by a research grant from Seoul National University Hospital (21-2005-0330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer SA, 1991, MED PARAZITOL MOSK, V6, P32; DITRICH O, 1992, FOLIA PARASIT, V39, P123; Hong ST., 2005, ASIAN PARASITOL, V1, P35; Hong ST, 2012, PARASITOL INT, V61, P17, DOI 10.1016/j.parint.2011.06.007; Khampoosa P, 2012, PARASITOL RES, V110, P799, DOI 10.1007/s00436-011-2557-3; Kim JH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001339; KREJCI KG, 1994, PARASITOL RES, V80, P42, DOI 10.1007/BF00932622; Li Shunyu, 2004, Korean Journal of Parasitology, V42, P169, DOI 10.3347/kjp.2004.42.4.169; Peoples RC, 2009, PARASITOL RES, V104, P471, DOI 10.1007/s00436-008-1209-8; Salikhova ChR, 1989, MED PARAZITOL MOSK, V5, P60; Smyth JD, 1990, IN VITRO CULTIVATION; Uddin MH, 2012, KOREAN J PARASITOL, V50, P309, DOI 10.3347/kjp.2012.50.4.309; WELLS KE, 1991, EXP PARASITOL, V73, P295, DOI 10.1016/0014-4894(91)90101-2	13	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52676	10.1371/journal.pone.0052676	http://dx.doi.org/10.1371/journal.pone.0052676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285144	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500228
J	Zhu, HT; Dong, QZ; Sheng, YY; Wei, JW; Wang, G; Zhou, HJ; Ren, N; Jia, HL; Ye, QH; Qin, LX				Zhu, Hai-Tao; Dong, Qiong-Zhu; Sheng, Yuan-Yuan; Wei, Jin-Wang; Wang, Guan; Zhou, Hai-Jun; Ren, Ning; Jia, Hu-Liang; Ye, Qing-Hai; Qin, Lun-Xiu			MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection	PLOS ONE			English	Article							INTRAHEPATIC RECURRENCE; EXPRESSION PROFILES; CURATIVE RESECTION; GENE-EXPRESSION; CELL-MIGRATION; TISSUES; RISK; IDENTIFICATION; METASTASIS; APOPTOSIS	It is still difficult to predict the probability of tumor recurrence after resection of hepatocellular carcinoma (HCC). In this study, we set out to identify specific microRNA (miRNA) in microdissected hepatitis B virus (HBV)-related HCC tissue from formalin-fixed paraffin-embedded (FFPE) samples which might be used in predicting early recurrence after HCC resection. Taqman low density arrays were used to detect the 667 miRNA profiles in both the microdissected tumorous and adjacent non-tumorous liver tissues from 20 HCC patients (discovery set) including 10 patients with early tumor recurrence and 10 without early tumor recurrence and to identify the differentially expressed miRNAs related to HCC recurrence. Then quantitative real-time PCR (qRT-PCR) was used to verify the findings in 106 patients (training set), and to develop a predictive assay. The identified miRNAs were further validated in an independent cohort of 112 patients (validation set). Thirty seven miRNAs were identified from 20 HCC patients and validated in 106 HCC patients using qRT-PCR. A significant association was found between miR-29a-5p level in HCC tissues and early tumor recurrence (P = 0.0002). This association was further confirmed in the independent validation set of 112 patients (P = 0.0154). MiR-29a-5p level was significantly associated with both time to tumor recurrence (TTR) (P = 0.0015) and overall survival (OS) (P = 0.0079) in validation set. In the multivariate analyses, miR-29a-5p was identified as an independent factor for TTR, particularly for those patients with early stage of HCC. The sensitivity and specificity of miR-29a-5p for the prediction of early HCC recurrence of BCLC 0/A stage HCC were 74.2% and 68.2%, respectively. These suggest that miR-29a-5p might be a useful marker for the prediction of early tumor recurrence after HCC resection, especially in BCLC 0/A stage HCCs.	[Qin, Lun-Xiu] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; Fudan Univ, Inst Biomed Sci, Zhongshan Hosp, Shanghai 200433, Peoples R China; Minist Educ Res, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China	Fudan University; Fudan University	Qin, LX (corresponding author), Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China.	qin.lunxiu@zs-hospital.sh.cn		Zhu, Haitao/0000-0003-1435-9607; Ren, Ning/0000-0001-9776-2471	National Key Projects for Infectious Disease of China [2008ZX10002-021, 2012ZX10002-012]; Program of Shanghai Chief Scientist [08XD14008]; Program for Outstanding Medical Academic Leader [LJ10010]; Major International Joint Research Project [81120108016]; Regular Project of the Natural Science Foundation of China (NSFC), the Research Fund for New Teachers of Fudan University [30600589]	National Key Projects for Infectious Disease of China; Program of Shanghai Chief Scientist; Program for Outstanding Medical Academic Leader; Major International Joint Research Project(National Natural Science Foundation of China (NSFC)); Regular Project of the Natural Science Foundation of China (NSFC), the Research Fund for New Teachers of Fudan University	This article was supported by the National Key Projects for Infectious Disease of China (2008ZX10002-021, 2012ZX10002-012), Program of Shanghai Chief Scientist (08XD14008), Program for Outstanding Medical Academic Leader(LJ10010), Major International Joint Research Project (81120108016) and the Regular Project (30600589) of the Natural Science Foundation of China (NSFC), the Research Fund for New Teachers of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chung GE, 2010, ONCOL REP, V23, P113, DOI 10.3892/or_00000612; Ding J, 2010, NAT CELL BIOL, V12, P390, DOI 10.1038/ncb2039; Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137; Duncavage E, 2010, J THORAC ONCOL, V5, P1755, DOI 10.1097/JTO.0b013e3181f3909d; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fornari F, 2010, CANCER RES, V70, P5184, DOI 10.1158/0008-5472.CAN-10-0145; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hudson RS, 2012, NUCLEIC ACIDS RES, V40, P3689, DOI 10.1093/nar/gkr1222; Iizuka N, 2003, LANCET, V361, P923, DOI 10.1016/S0140-6736(03)12775-4; Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Ji JF, 2010, J HEPATOL, V52, P690, DOI 10.1016/j.jhep.2009.12.025; Kong GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019518; Kurokawa Y, 2004, J HEPATOL, V41, P284, DOI 10.1016/j.jhep.2004.04.031; Lan FF, 2010, INT J CANC; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Livraghi T, 2011, SCAND J SURG, V100, P22, DOI 10.1177/145749691110000105; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Nakashima Y, 2003, HEPATOL RES, V26, P142, DOI 10.1016/S1386-6346(03)00007-X; Patnaik SK, 2010, CANCER RES, V70, P36, DOI 10.1158/0008-5472.CAN-09-3153; Patterson Erin E, 2011, Cancer, V117, P1630, DOI 10.1002/cncr.25724; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Plaisier CL, 2012, GENOME RES, V22, P2302, DOI 10.1101/gr.133991.111; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Sherman M, 2008, NEW ENGL J MED, V359, P2045, DOI 10.1056/NEJMe0807581; Siebolts U, 2009, J CLIN PATHOL, V62, P84, DOI 10.1136/jcp.2008.058339; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun HC, 2007, J HEPATOL, V47, P684, DOI 10.1016/j.jhep.2007.06.019; Toyoda H, 2005, AM J GASTROENTEROL, V100, P1764, DOI 10.1111/j.1572-0241.2005.41943.x; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Van Deusen MA, 2005, EXPERT REV MOL DIAGN, V5, P377, DOI 10.1586/14737159.5.3.377; Villanueva Augusto, 2011, Gastroenterology, V140, P1501, DOI 10.1053/j.gastro.2011.02.006; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yip L, 2011, ANN SURG ONCOL, V18, P2035, DOI 10.1245/s10434-011-1733-0; Yoon SO, 2011, HUM PATHOL, V42, P1391, DOI 10.1016/j.humpath.2010.12.010; Zhou HJ, 2010, GUT, V59, P1699, DOI 10.1136/gut.2010.218404	48	69	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52393	10.1371/journal.pone.0052393	http://dx.doi.org/10.1371/journal.pone.0052393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285022	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500157
J	Ramos-Cejudo, J; Gutierrez-Fernandez, M; Rodriguez-Frutos, B; Alcaide, ME; Sanchez-Cabo, F; Dopazo, A; Diez-Tejedor, E				Ramos-Cejudo, Jaime; Gutierrez-Fernandez, Maria; Rodriguez-Frutos, Berta; Exposito Alcaide, Mercedes; Sanchez-Cabo, Fatima; Dopazo, Ana; Diez-Tejedor, Exuperio			Spatial and Temporal Gene Expression Differences in Core and Periinfarct Areas in Experimental Stroke: A Microarray Analysis	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ARTERY OCCLUSION; UP-REGULATION; HUMAN BRAIN; RAT-BRAIN; MECHANISMS; PENUMBRA; REPAIR; INJURY; OLIGODENDROCYTES	Background: A large number of genes are regulated to promote brain repair following stroke. The thorough analysis of this process can help identify new markers and develop therapeutic strategies. This study analyzes gene expression following experimental stroke. Methodology/Principal Findings: A microarray study of gene expression in the core, periinfarct and contralateral cortex was performed in adult Sprague-Dawley rats (n = 60) after 24 hours (acute phase) or 3 days (delayed stage) of permanent middle cerebral artery (MCA) occlusion. Independent qRT-PCR validation (n = 12) was performed for 22 of the genes. Functional data were evaluated by Ingenuity Pathway Analysis. The number of genes differentially expressed was 2,612 (24 h) and 5,717 (3 d) in the core; and 3,505 (24 h) and 1,686 (3 d) in the periinfarct area (logFC>vertical bar 1 vertical bar; adjP<0.05). Expression of many neurovascular unit development genes was altered at 24 h and 3 d including HES2, OLIG2, LINGO1 and NOGO-A; chemokines like CXCL1 and CXCL12, stress-response genes like HIF-1A, and trophic factors like BDNF or BMP4. Nearly half of the detected genes (43%) had not been associated with stroke previously. Conclusions: This comprehensive study of gene regulation in the core and periinfarct areas at different times following permanent MCA occlusion provides new data that can be helpful in translational research.	[Ramos-Cejudo, Jaime; Gutierrez-Fernandez, Maria; Rodriguez-Frutos, Berta; Exposito Alcaide, Mercedes; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, Dept Neurol, Madrid, Spain; [Ramos-Cejudo, Jaime; Gutierrez-Fernandez, Maria; Rodriguez-Frutos, Berta; Exposito Alcaide, Mercedes; Diez-Tejedor, Exuperio] Univ Autonoma Madrid, Hlth Res Inst, Neurosci Area IdiPAZ, Neurosci & Cerebrovasc Res Lab,La Paz Univ Hosp,S, Madrid, Spain; [Sanchez-Cabo, Fatima] CNIC, Bioinformat Unit, Madrid, Spain; [Dopazo, Ana] CNIC, Genom Unit, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Hospital Universitario La Paz; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Diez-Tejedor, E (corresponding author), Univ Autonoma Madrid, Dept Neurol, Madrid, Spain.	edieztejedor@hotmail.com	Dopazo, Ana/N-1159-2014; Sanchez-Cabo, Fatima/AAC-5563-2020; Sanchez-Cabo, Fatima/N-5030-2014	Dopazo, Ana/0000-0002-4910-1684; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Diez Tejedor, Exuperio/0000-0003-2295-1707; Ramos-Cejudo, Jaime/0000-0002-0993-9909	Spanish Ministry of Science [PS09/01606]; RENEVAS, Carlos III Research Institute, Ministry of Science and Innovation [RD07/0026/2003]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); RENEVAS, Carlos III Research Institute, Ministry of Science and Innovation	This work was supported by grants from PS09/01606 (Spanish Ministry of Science) and by RENEVAS (RD07/0026/2003 - Spanish Neurovascular Network), Carlos III Research Institute, Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2010, STROKE, V41, P898, DOI 10.1161/STROKEAHA.109.572552; Bejot Y, 2011, NEUROCHEM INT, V58, P102, DOI 10.1016/j.neuint.2010.10.019; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Candelario-Jalil E, 2009, CURR OPIN INVEST DR, V10, P644; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Cau E, 2000, DEVELOPMENT, V127, P2323; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cui X, 2009, J NEUROSCI RES, V87, P86, DOI 10.1002/jnr.21836; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; DELOSMONTEROS AE, 1988, J NEUROSCI RES, V21, P181, DOI 10.1002/jnr.490210210; Di Lazzaro V, 2007, NEUROSCI LETT, V422, P128, DOI 10.1016/j.neulet.2007.06.001; Foley LM, 2010, TRANSL STROKE RES, V1, P220, DOI 10.1007/s12975-010-0032-6; Gutierrez M, 2009, CEREBROVASC DIS, V27, P177, DOI 10.1159/000200457; Gutierrez-Fernandez M, 2011, NEUROSCIENCE, V175, P394, DOI 10.1016/j.neuroscience.2010.11.054; Hayashi T, 1997, STROKE, V28, P2039, DOI 10.1161/01.STR.28.10.2039; Hossmann KA, 2008, NEUROPHARMACOLOGY, V55, P257, DOI 10.1016/j.neuropharm.2007.12.004; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lu AG, 2003, J CEREBR BLOOD F MET, V23, P786, DOI 10.1097/01.WCB.0000062340.80057.06; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nagel S, 2011, BRAIN RES, V1368, P264, DOI 10.1016/j.brainres.2010.10.057; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schonemeier B, 2008, J NEUROIMMUNOL, V198, P39, DOI 10.1016/j.jneuroim.2008.04.010; Simon RP, 2012, STROKE, V43, P286, DOI 10.1161/STROKEAHA.111.622225; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sobrado M, 2011, NEUROIMAGE, V57, P45, DOI 10.1016/j.neuroimage.2011.04.045; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tanaka K, 2003, BRAIN RES, V989, P172, DOI 10.1016/S0006-8993(03)03317-1; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Zhan XH, 2010, J CEREBR BLOOD F MET, V30, P110, DOI 10.1038/jcbfm.2009.189; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015	41	51	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52121	10.1371/journal.pone.0052121	http://dx.doi.org/10.1371/journal.pone.0052121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284893	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900077
J	Zhou, CC; Chu, J; Liu, JA; Tobe, RG; Gen, H; Wang, XZ; Zheng, WG; Xu, LZ				Zhou, Chengchao; Chu, Jie; Liu, Jinan; Tobe, Ruoyan Gai; Gen, Hong; Wang, Xingzhou; Zheng, Wengui; Xu, Lingzhong			Adherence to Tuberculosis Treatment among Migrant Pulmonary Tuberculosis Patients in Shandong, China: A Quantitative Survey Study	PLOS ONE			English	Article							BARRIERS; POPULATION; ETHIOPIA; IMPACT; CARE	Adherence to TB treatment is the most important requirement for efficient TB control. Migrant TB patients' "migratory" nature affects the adherence negatively, which presents an important barrier for National TB Control Program in China. Therefore, TB control among migrants is of high importance. The aim of this study is to describe adherence to TB treatment among migrant TB patients and to identify factors associated with adherence. A total of 12 counties/districts of Shandong Province, China were selected as study sites. 314 confirmed smear positive TB patients were enrolled between August 2(nd) 2008 and October 17(th) 2008, 16% of whom were non-adherent to TB therapy. Risk factors for non-adherence were: the divorced or bereft of spouse, patients not receiving TB-related health education before chemotherapy, weak incentives for treatment adherence, and self supervision on treatment. Based on the risk factors identified, measures are recommended such as implementing health education for all migrant patients before chemotherapy and encouraging primary care workers to supervise patients.	[Zhou, Chengchao; Tobe, Ruoyan Gai; Wang, Xingzhou; Zheng, Wengui; Xu, Lingzhong] Shandong Univ, Sch Publ Hlth, Inst Social Med & Hlth Serv Management, Jinan 250100, Peoples R China; [Chu, Jie] Shandong Ctr Dis Control & Prevent, Jinan, Peoples R China; [Liu, Jinan] HealthCore Inc, Wilmington, DE USA; [Gen, Hong] Shandong Ctr TB Prevent & Control, Jinan, Peoples R China	Shandong University; HealthCore, Inc	Xu, LZ (corresponding author), Shandong Univ, Sch Publ Hlth, Inst Social Med & Hlth Serv Management, Jinan 250100, Peoples R China.	lzxu@sdu.edu.cn			Department of Science and Technology of Shandong Province [BS2012SF010]; China Center for Disease Prevention and Control [TB08-004]	Department of Science and Technology of Shandong Province; China Center for Disease Prevention and Control	This study was supported by Department of Science and Technology of Shandong Province (BS2012SF010) and the Global Fund (TB08-004, China Center for Disease Prevention and Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	China Global Fund Project Office, 2006, IMPL FLOAT POP TB CO; General Office of the State Council of PRC, 2010, NAT TUB CONTR PROGR; Haiju D, 2007, CHINESE PREVENTIVE M, V8, P568; Hand CH, 1996, J ASTHMA, V33, P331, DOI 10.3109/02770909609055374; Hoeppner VH, 2007, CANADIAN TUBERCULOSI, P114; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Li XX, 2010, J IMMIGR MINOR HEALT, V12, P811, DOI 10.1007/s10903-010-9336-6; Liam CK, 1999, INT J TUBERC LUNG D, V3, P300; Liefooghe R, 1999, INT J TUBERC LUNG D, V3, P1073; Lipsitch M, 1998, INT J TUBERC LUNG D, V2, P187; Ministry of Health of PRC, 2009, NAT TB CONTR PROGR I; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; National Population and Family Planning Commission China, 2010, REP NAT DEV MIGR CHI; Orr P, 2011, INT J CIRCUMPOL HEAL, V70, P113, DOI 10.3402/ijch.v70i2.17809; Pope DS, 2003, INT J TUBERC LUNG D, V7, P611; Sagbakken M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-11; Sockrider M, 1996, J RESP DIS, V17, P204; Tekle B, 2002, INT J TUBERC LUNG D, V6, P573; Tobe RG, 2011, BIOSCI TRENDS, V5, P226, DOI 10.5582/bst.2011.v5.6.226; Wang HB, 2008, CHIN J HLTH ED, V24, P468; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; *WHO, 2002, COMM DIS; *WHO, 2005, WHOHTMTB2005349; Xu L, 2010, INT J TUBERC LUNG D, V14, P440; Xu WG, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-169; Yancheng Z, 2010, THESIS SHANDONG U CH; Yongming L, 2006, CHINESE J PUBLIC HLT, V22, P1468; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959; Zhao R, 2007, PRACT PREV MED, V14, P322	30	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52334	10.1371/journal.pone.0052334	http://dx.doi.org/10.1371/journal.pone.0052334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284993	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900089
J	Karunakaran, D; Kockx, M; Owen, DM; Burnett, JR; Jessup, W; Kritharides, L				Karunakaran, Denuja; Kockx, Maaike; Owen, Dylan M.; Burnett, John R.; Jessup, Wendy; Kritharides, Leonard			Protein Kinase C Controls Vesicular Transport and Secretion of Apolipoprotein E from Primary Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; HIGH-DENSITY-LIPOPROTEIN; PHORBOL ESTER; MOUSE MACROPHAGES; APOE EXPRESSION; MUCIN SECRETION; MARCKS PROTEIN; PKC ACTIVATION; DEFICIENT MICE; CHOLESTEROL	Macrophage-specific apolipoprotein E (apoE) secretion plays an important protective role in atherosclerosis. However, the precise signaling mechanisms regulating apoE secretion from primary human monocyte-derived macrophages (HMDMs) remain unclear. Here we investigate the role of protein kinase C (PKC) in regulating basal and stimulated apoE secretion from HMDMs. Treatment of HMDMs with structurally distinct pan-PKC inhibitors (calphostin C, Ro-31-8220, Go6976) and a PKC inhibitory peptide all significantly decreased apoE secretion without significantly affecting apoE mRNA or apoE protein levels. The PKC activator phorbol 12-myristate 13-acetate (PMA) stimulated apoE secretion, and both PMA-induced and apoAI-induced apoE secretion were inhibited by PKC inhibitors. PKC regulation of apoE secretion was found to be independent of the ATP binding cassette transporter ABCA1. Live cell imaging demonstrated that PKC inhibitors inhibited vesicular transport of apoE to the plasma membrane. Pharmacological or peptide inhibitor and knockdown studies indicate that classical isoforms PKC alpha/beta and not PKC delta, -epsilon, -theta, or -iota/zeta isoforms regulate apoE secretion from HMDMs. The activity of myristoylated alanine-rich protein kinase C substrate (MARCKS) correlated with modulation of PKC activity in these cells, and direct peptide inhibition of MARCKS inhibited apoE secretion, implicating MARCKS as a downstream effector of PKC in apoE secretion. Comparison with other secreted proteins indicated that PKC similarly regulated secretion of matrix metalloproteinase 9 and chitinase-3-like-1 protein but differentially affected the secretion of other proteins. In conclusion, PKC regulates the secretion of apoE from primary human macrophages.	[Karunakaran, Denuja; Kockx, Maaike; Jessup, Wendy; Kritharides, Leonard] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Macrophage Biol Grp, Sydney, NSW, Australia; [Owen, Dylan M.] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Cellular Membrane Biol Grp, Sydney, NSW, Australia; [Burnett, John R.] Univ Western Australia, Royal Perth Hosp, Dept Core Clin Pathol & Biochem, Perth, WA 6009, Australia; [Kritharides, Leonard] Univ Sydney, Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2139, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Royal Perth Hospital; University of Western Australia; Concord Repatriation General Hospital; University of Sydney	Kritharides, L (corresponding author), Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2139, Australia.	leonard.kritharides@sydney.edu.au	Karunakaran, Denuja/G-2275-2010; Kritharides, Leonard/AAQ-2720-2020	Karunakaran, Denuja/0000-0002-4789-8634; 	National Health and Medical Research Council, Australia [222722]; National Heart Foundation, Australia [PF 10S 5362]; Royal Perth Hospital Medical Research Foundation;  [ExNCR: B7A-AY-V003]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation, Australia(National Heart Foundation of Australia); Royal Perth Hospital Medical Research Foundation; 	This work was supported by a Program Grant 222722 (to L. K and W. J) from the National Health and Medical Research Council, Australia, a Heart Foundation Postdoctoral Fellowship PF 10S 5362 (to D. K) from the National Heart Foundation, Australia, and a Practitioner Fellowship (to J. R. B.) from the Royal Perth Hospital Medical Research Foundation. Eli Lilly Australia provided the LY379196 compound as part of their grant (ExNCR: B7A-AY-V003).	ALITALO K, 1980, J EXP MED, V151, P602, DOI 10.1084/jem.151.3.602; Allan LL, 2009, BLOOD, V114, P2411, DOI 10.1182/blood-2009-04-211417; Arici M, 2002, NEPHROL DIAL TRANSPL, V17, P1751, DOI 10.1093/ndt/17.10.1751; BASHEERUDDIN K, 1992, J BIOL CHEM, V267, P1219; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; BASU SK, 1983, SCIENCE, V219, P871, DOI 10.1126/science.6823554; BASU SK, 1982, J BIOL CHEM, V257, P9788; Bielicki JK, 1999, J LIPID RES, V40, P85; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Chattopadhyay N, 2002, MOL BRAIN RES, V102, P73, DOI 10.1016/S0169-328X(02)00215-2; COFFEY ET, 1994, J NEUROCHEM, V63, P1303; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Damera G, 2010, EXP LUNG RES, V36, P75, DOI 10.3109/01902140903131200; Danis RP, 2009, EXPERT OPIN PHARMACO, V10, P2913, DOI 10.1517/14656560903401620; De Marinis YZ, 2010, DIABETOLOGIA, V53, P717, DOI 10.1007/s00125-009-1635-x; Deeg MA, 1997, ARTERIOSCL THROM VAS, V17, P1667, DOI 10.1161/01.ATV.17.9.1667; Deeney JT, 1996, J BIOL CHEM, V271, P18154, DOI 10.1074/jbc.271.30.18154; DENG JT, 1995, J LIPID RES, V36, P2129; DORY L, 1993, BIOCHEM J, V292, P105, DOI 10.1042/bj2920105; DORY L, 1991, J LIPID RES, V32, P783; Efanov AM, 1997, P NATL ACAD SCI USA, V94, P4435, DOI 10.1073/pnas.94.9.4435; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Fazio S, 1999, J BIOL CHEM, V274, P8247, DOI 10.1074/jbc.274.12.8247; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Garver WS, 1997, ARTERIOSCL THROM VAS, V17, P2698, DOI 10.1161/01.ATV.17.11.2698; Goodall AR, 1997, J NEUROCHEM, V68, P392; Green TD, 2011, BBA-GEN SUBJECTS, V1810, P1110, DOI 10.1016/j.bbagen.2011.01.009; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hasty AH, 2005, J LIPID RES, V46, P1433, DOI 10.1194/jlr.M400418-JLR200; Helal R, 2010, IN VITRO CELL DEV-AN, V46, P492, DOI 10.1007/s11626-010-9273-7; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hofmann J, 1997, FASEB J, V11, P649, DOI 10.1096/fasebj.11.8.9240967; Hong DH, 1997, AM J PHYSIOL-GASTR L, V272, pG31, DOI 10.1152/ajpgi.1997.272.1.G31; Hooper AJ, 2009, CLIN CHIM ACTA, V409, P136, DOI 10.1016/j.cca.2009.08.017; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Huang ZH, 2013, J LIPID RES, V54, P202, DOI 10.1194/jlr.M031906; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kanda Y, 1998, MOL CELL ENDOCRINOL, V143, P125, DOI 10.1016/S0303-7207(98)00125-7; KAYDEN HJ, 1985, ARCH BIOCHEM BIOPHYS, V239, P388, DOI 10.1016/0003-9861(85)90704-0; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2008, ARTERIOSCL THROM VAS, V28, P1060, DOI 10.1161/ATVBAHA.108.164350; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Liu JF, 2002, BIOCHEM BIOPH RES CO, V293, P1174, DOI 10.1016/S0006-291X(02)00350-9; Ludowyke RI, 1996, J IMMUNOL, V157, P5130; Ma HT, 2006, BIOCHEM BIOPH RES CO, V349, P214, DOI 10.1016/j.bbrc.2006.08.018; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Maioli E, 2006, CELL MOL LIFE SCI, V63, P637, DOI 10.1007/s00018-005-5541-1; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; Mocsai A, 2000, J IMMUNOL, V164, P4321, DOI 10.4049/jimmunol.164.8.4321; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Osto E, 2008, CIRCULATION, V118, P2174, DOI 10.1161/CIRCULATIONAHA.108.789537; Park J, 2008, AM J RESP CELL MOL, V39, P68, DOI 10.1165/rcmb.2007-0139OC; Park MJ, 2003, INT J ONCOL, V22, P137; Pollack IF, 1997, J NEURO-ONCOL, V31, P255, DOI 10.1023/A:1005729626354; Raufman JP, 1997, J CELL BIOCHEM, V64, P514; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rees D, 1999, J BIOL CHEM, V274, P27925, DOI 10.1074/jbc.274.39.27925; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; ROUIS M, 1990, EUR J BIOCHEM, V189, P447, DOI 10.1111/j.1432-1033.1990.tb15509.x; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1, DOI 10.1152/ajpcell.1984.246.1.C1; Tanaka AR, 2003, J BIOL CHEM, V278, P8815, DOI 10.1074/jbc.M206885200; Turner NA, 1996, J NEUROCHEM, V66, P2381; van den Elzen P, 2005, NATURE, V437, P906, DOI 10.1038/nature04001; Vaughan PFT, 1998, MOL NEUROBIOL, V18, P125, DOI 10.1007/BF02914269; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WERB Z, 1986, CIBA F SYMP, V118, P155, DOI 10.1002/9780470720998.ch11; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; ZAWALICH W, 1983, BIOCHEM BIOPH RES CO, V117, P448, DOI 10.1016/0006-291X(83)91221-4; Zhang WY, 1996, J BIOL CHEM, V271, P28641, DOI 10.1074/jbc.271.45.28641; Zhao YW, 2002, J BIOL CHEM, V277, P29477, DOI 10.1074/jbc.M200219200	88	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5186	5197		10.1074/jbc.M112.428961	http://dx.doi.org/10.1074/jbc.M112.428961			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288845	Green Published, hybrid			2022-12-25	WOS:000315340400066
J	Lee, JO; Lee, SK; Kim, N; Kim, JH; You, GY; Moon, JW; Jie, S; Kim, SJ; Lee, YW; Kang, HJ; Lim, Y; Park, SH; Kim, HS				Lee, Jung Ok; Lee, Soo Kyung; Kim, Nami; Kim, Ji Hae; You, Ga Young; Moon, Ji Wook; Jie, Sha; Kim, Su Jin; Lee, Yong Woo; Kang, Ho Jin; Lim, Yongchul; Park, Sun Hwa; Kim, Hyeon Soo			E3 Ubiquitin Ligase, WWP1, Interacts with AMPK alpha 2 and Down-regulates Its Expression in Skeletal Muscle C2C12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLUCOSE-TRANSPORT; FATTY-ACID; GLUT4 TRANSLOCATION; UP-REGULATION; AMP KINASE; FIBER-TYPE; INCREASES; INSULIN; RAT	It is known that the activity of AMP-activated protein kinase (AMPK alpha 2) was depressed under high glucose conditions. However, whether protein expression of AMPK alpha 2 is also down-regulated or not remains unclear. In this study, we showed that the expression of AMPK alpha 2 was down-regulated in cells cultured under high glucose conditions. Treatment of proteasome inhibitor, MG132, blocked high glucose-induced AMPK alpha 2 downregulation. Endogenous AMPK alpha 2 ubiquitination was detected by immunoprecipitation of AMPK alpha 2 followed by immunoblotting detection of ubiquitin. The yeast-two hybrid (YTH) approach identified WWP1, an E3 ubiquitin ligase, as the AMPK alpha 2-interacting protein in skeletal muscle cells. Interaction between AMPK alpha 2 and WWP1 was validated by co-immunoprecipitation. Knockdown of WWP1 blocked high glucose-induced AMPK alpha 2 down-regulation. The overexpression of WWP1 down-regulated AMPK alpha 2. In addition, the expression of WWP1 is increased under high glucose culture conditions in both mRNA and protein levels. The level of AMPK alpha 2 was downregulated in the quadriceps muscle of diabetic animal model db/db mice. Expression of WWP1 blocked metformin-induced glucose uptake. Taken together, our results demonstrated that WWP1 down-regulated AMPK alpha 2 under high glucose culture conditions via the ubiquitin-proteasome pathway.	[Lee, Jung Ok; Lee, Soo Kyung; Kim, Nami; Kim, Ji Hae; You, Ga Young; Moon, Ji Wook; Jie, Sha; Kim, Su Jin; Lee, Yong Woo; Kang, Ho Jin; Lim, Yongchul; Park, Sun Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine)	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, 126-1,Anam Dong 5 Ga, Seoul 136705, South Korea.	anatomykim@korea.ac.kr			National Research Foundation of Korea; Korean government [2010-0011053]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government)	This study was supported by the National Research Foundation of Korea funded by the Korean government (2010-0011053).	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Joly E, 2009, J DIABETES, V1, P263, DOI 10.1111/j.1753-0407.2009.00043.x; Karlsson HKR, 2009, DIABETES, V58, P847, DOI 10.2337/db08-1539; Koistinen HA, 2003, DIABETES, V52, P1066, DOI 10.2337/diabetes.52.5.1066; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Moreno D, 2009, INT J BIOCHEM CELL B, V41, P2431, DOI 10.1016/j.biocel.2009.07.002; Nishino Y, 2004, CARDIOVASC RES, V61, P610, DOI 10.1016/j.cardiores.2003.10.022; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Saha AK, 2010, DIABETES, V59, P2426, DOI 10.2337/db09-1870; Shi LH, 2011, DIABETES RES CLIN PR, V92, pE41, DOI 10.1016/j.diabres.2011.02.009; Song HY, 2010, BIOCHEM BIOPH RES CO, V396, P961, DOI 10.1016/j.bbrc.2010.05.033; Thomson David M, 2008, Biochem J, V411, pe9, DOI 10.1042/BJ20080459; Yamaguchi S, 2005, AM J PHYSIOL-ENDOC M, V289, pE643, DOI 10.1152/ajpendo.00456.2004; Yang J, 2005, J BIOL CHEM, V280, P4070, DOI 10.1074/jbc.M410213200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599; Zungu M, 2011, AM J PATHOL, V178, P4, DOI 10.1016/j.ajpath.2010.11.030	31	22	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4673	4680		10.1074/jbc.M112.406009	http://dx.doi.org/10.1074/jbc.M112.406009			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293026	Green Published, hybrid			2022-12-25	WOS:000315340400016
J	Velez, N; Brautigam, CA; Phillips, MA				Velez, Nahir; Brautigam, Chad A.; Phillips, Margaret A.			Trypanosoma brucei S-Adenosylmethionine Decarboxylase N Terminus Is Essential for Allosteric Activation by the Regulatory Subunit Prozyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; POLYAMINE METABOLISM; PUTRESCINE ACTIVATION; SEDIMENTATION; INHIBITORS; KINASE; ULTRACENTRIFUGATION; TRYPANOTHIONE; COMPLEX; TARGET	Human African trypanosomiasis is caused by a single-celled protozoan parasite, Trypanosoma brucei. Polyamine biosynthesis is a clinically validated target for the treatment of human African trypanosomiasis. Metabolic differences between the parasite and thehumanpolyamine pathway are thought to contribute to species selectivity of pathway inhibitors. S- adenosylmethionine decarboxylase ( AdoMetDC) catalyzes a key step in the production of the polyamine spermidine. We previously showed that trypanosomatid AdoMetDC differs from other eukaryotic enzymes in that it is regulated by heterodimer formation with a catalytically dead paralog, designated prozyme, which binds with high affinity to the enzyme and increases its activity by up to 103- fold. Herein, we examine the role of specific residues involved in AdoMetDC activation by prozyme through deletion and site- directed mutagenesis. Results indicate that 12 key amino acids at the N terminus of AdoMetDC are essential for prozyme- mediated activation with Leu- 8, Leu- 10, Met- 11, and Met- 13 identified as the key residues. These N- terminal residues are fully conserved in the trypanosomatids but are absent from other eukaryotic homologs lacking the prozyme mechanism, suggesting co- evolution of these residues with the prozyme mechanism. Heterodimer formation between AdoMetDC and prozyme was not impaired by mutation of Leu- 8 and Leu- 10 to Ala, suggesting that these residues are involved in a conformational change that is essential for activation. Ourfindings provide the first insight into the mechanisms that influence catalytic regulation ofAdoMetDCandmayhave potential implications for the development of new inhibitors against this enzyme.	[Velez, Nahir; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Brautigam, Chad A.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Phillips, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	margaret.phillips@UTSouthwestern.edu		Brautigam, Chad/0000-0001-6563-1338	National Institutes of Health [R01 AI34432, R37AI034432]; Welch Foundation [I-1257]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034432, R01AI034432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI34432 and R37AI034432 (to M. A. P.). This work was also supported by Welch Foundation Grant I-1257 (to M. A. P.).	BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372; BACCHI CJ, 1992, ANTIMICROB AGENTS CH, V36, P2736, DOI 10.1128/AAC.36.12.2736; Bale S, 2010, AMINO ACIDS, V38, P451, DOI 10.1007/s00726-009-0404-y; Bale S, 2008, BIOCHEMISTRY-US, V47, P13404, DOI 10.1021/bi801732m; Barker RH, 2009, ANTIMICROB AGENTS CH, V53, P2052, DOI 10.1128/AAC.01674-08; Barrett MP, 2011, FUTURE MICROBIOL, V6, P1037, DOI [10.2217/FMB.11.88, 10.2217/fmb.11.88]; Bevington PR., 2002, DATA REDUCTION ERROR; Brautigam CA, 2011, METHODS, V54, P4, DOI 10.1016/j.ymeth.2010.12.029; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Brun R, 2011, FUTURE MICROBIOL, V6, P677, DOI [10.2217/FMB.11.44, 10.2217/fmb.11.44]; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Cherry M, 2004, CURR MED CHEM, V11, P663, DOI 10.2174/0929867043455792; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Clyne T, 2002, BIOCHEMISTRY-US, V41, P13207, DOI 10.1021/bi026541d; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ekstrom JL, 1999, STRUCTURE, V7, P583, DOI 10.1016/S0969-2126(99)80074-4; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; GILBERT GA, 1956, NATURE, V177, P853, DOI 10.1038/177853a0; Hanfrey C, 2005, J BIOL CHEM, V280, P39229, DOI 10.1074/jbc.M509340200; Jacobs RT, 2011, CURR TOP MED CHEM, V11, P1255; JOHNSON ML, 1992, ANAL BIOCHEM, V206, P215, DOI 10.1016/0003-2697(92)90356-C; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Nagar B, 2002, CANCER RES, V62, P4236; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; PEGG AE, 1983, METHOD ENZYMOL, V94, P234; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Pegg AE, 2009, ESSAYS BIOCHEM, V46, P25, DOI [10.1042/BSE0460003, 10.1042/bse0460003]; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Phillips MA, 2012, MOL MICROBIOL, V86, P10, DOI 10.1111/mmi.12001; Regan J, 2002, J MED CHEM, V45, P2994, DOI 10.1021/jm020057r; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Spinks D, 2012, CHEMMEDCHEM, V7, P95, DOI 10.1002/cmdc.201100420; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tolbert WD, 2003, BIOCHEMISTRY-US, V42, P2386, DOI 10.1021/bi0268854; Willert E, 2012, TRENDS PARASITOL, V28, P66, DOI 10.1016/j.pt.2011.11.001; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Willert EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000183; Yun O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000720	48	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5232	5240		10.1074/jbc.M112.442475	http://dx.doi.org/10.1074/jbc.M112.442475			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288847	Green Published, hybrid			2022-12-25	WOS:000315340400070
J	Li, H; Wang, YY; Zhang, HQ; Jia, BY; Wang, DA; Li, HM; Lu, DX; Qi, RB; Yan, YX; Wang, HD				Li, Hui; Wang, Yiyang; Zhang, Haoqing; Jia, Baoyin; Wang, Daan; Li, Hongmei; Lu, Daxiang; Qi, Renbin; Yan, Yuxia; Wang, Huadong			Yohimbine Enhances Protection of Berberine against LPS-Induced Mouse Lethality through Multiple Mechanisms	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MOLECULAR-MECHANISMS; GENE-EXPRESSION; ENDOTOXIN-SHOCK; MICE LACKING; LIPOPOLYSACCHARIDE; SEPSIS; PATHOGENESIS; MACROPHAGES; INJURY	Sepsis remains a major cause of mortality in intensive care units, better therapies are urgently needed. Gram-negative bacterial lipopolysaccharide (LPS) is an important trigger of sepsis. We have demonstrated that berberine (Ber) protects against lethality induced by LPS, which is enhanced by yohimbine (Y) pretreatment, and Ber combined with Y also improves survival in septic mice. However, the precise mechanisms by which Y enhances protection of Ber against LPS - induced lethality remain unclear. The present study confirmed that simultaneously administered Y also enhanced protection of Ber against LPS-induced lethality. Ber or/and Y attenuated liver injury, but not renal injury in LPS-challenged mice. Ber or/and Y all inhibited LPS-stimulated I kappa B alpha, JNK and ERK phosphorylation, NF-kappa B activation as well as TNF-alpha production. Ber also increased IL-10 production in LPS-challenged mice, which was enhanced by Y. Furthermore, Ber or/and Y all suppressed LPS-induced IRF3, TyK2 and STAT1 phosphorylation, as well as IFN-beta and IP-10 mRNA expression in spleen of mice at 1 h after LPS challenge. Especially, Y enhanced the inhibitory effect of Ber on LPS-induced IP-10 mRNA expression. In vitro experiments further demonstrated that Y significantly enhanced the inhibitory effect of Ber on TNF-alpha production in LPS-treated peritoneal macrophages, Ber combined with Y promoted LPS-induced IL-10 production and LPS-stimulated I kappa B alpha, JNK, ERK and IRF3 phosphorylation and NF-kappa B activation were also suppressed by Ber or/and Y pretreatment in peritoneal macrophages. Taken together, these results demonstrate that Y enhances the protection of Ber against LPS-induced lethality in mice via attenuating liver injury, upregulating IL-10 production and suppressing I kappa B alpha, JNK, ERK and IRF3 phosphorylation. Ber combined with Y may be an effective immunomodulator agent for the prevention of sepsis.	[Wang, Yiyang; Jia, Baoyin; Wang, Daan; Li, Hongmei; Lu, Daxiang; Qi, Renbin; Wang, Huadong] Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Li, Hui] Jinan Univ, Sch Med, Guangzhou Overseas Chinese Hosp, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China; [Yan, Yuxia] Jinan Univ, Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China; [Zhang, Haoqing] Chenzhou 1 Peoples Hosp, Ctr Prenatal Diag, Chenzhou, Hunan, Peoples R China	Jinan University; Jinan University; Jinan University	Wang, HD (corresponding author), Jinan Univ, Sch Med, Key Lab State Adm Tradit Chinese Med Peoples Repu, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	owanghd@jnu.edu.cn		wang, yiyang/0000-0002-0318-6715	National Natural Science Foundation of China [30670826, 30971191]; Science and Technology Foundation from Ministry of Education of the People's Republic of China [207140]; Guangzhou Science and Technology Projects [12C22071599]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation from Ministry of Education of the People's Republic of China; Guangzhou Science and Technology Projects	This work was supported by grants from the National Natural Science Foundation of China (grant no. 30670826, 30971191), the Science and Technology Foundation from Ministry of Education of the People's Republic of China (grant no. 207140) and the Guangzhou Science and Technology Projects (grant no. 12C22071599). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anas AA, 2010, NETH J MED, V68, P147; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Delsesto D, 2011, CONTRIB MICROBIOL, V17, P137, DOI 10.1159/000324030; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; Hochholzer P, 2000, INFECT IMMUN, V68, P3502, DOI 10.1128/IAI.68.6.3502-3508.2000; HOWARD M, 1993, J EXP MED, V177, P1205, DOI 10.1084/jem.177.4.1205; Kamezaki K, 2004, INT IMMUNOL, V16, P1173, DOI 10.1093/intimm/dxh118; Kang BY, 2002, BIOCHEM PHARMACOL, V63, P1901, DOI 10.1016/S0006-2952(02)00982-6; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Li F, 2006, ACTA PHARMACOL SIN, V27, P1199, DOI 10.1111/j.1745-7254.2006.00368.x; Li HM, 2011, ACTA PHARMACOL SIN, V32, P1364, DOI 10.1038/aps.2011.102; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marshall JC, 2010, CONTRIB NEPHROL, V167, P1, DOI 10.1159/000315914; Miksa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005504; Moore LJ, 2010, ARCH SURG-CHICAGO, V145, P695, DOI 10.1001/archsurg.2010.107; Negishi M, 2011, AM J REPROD IMMUNOL, V65, P20, DOI 10.1111/j.1600-0897.2010.00856.x; O'Sullivan JB, 2010, J NEUROIMMUNOL, V220, P34, DOI 10.1016/j.jneuroim.2009.12.007; Ponte CB, 2012, INT IMMUNOPHARMACOL, V13, P114, DOI 10.1016/j.intimp.2012.03.016; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang YY, 2011, SHOCK, V35, P322, DOI 10.1097/SHK.0b013e3181facf73; Zhang HQ, 2008, SHOCK, V29, P617, DOI 10.1097/SHK.0b013e318157ea14	32	15	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52863	10.1371/journal.pone.0052863	http://dx.doi.org/10.1371/journal.pone.0052863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285207	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500072
J	Wang, K; Han, GC; Dou, Y; Wang, Y; Liu, GJ; Wang, RX; Xiao, H; Li, XY; Hou, CM; Shen, BF; Guo, RF; Li, Y; Shi, YC; Chen, GJ				Wang, Ke; Han, Gencheng; Dou, Yan; Wang, Yi; Liu, Guijun; Wang, Renxi; Xiao, He; Li, Xinying; Hou, Chunmei; Shen, Beifen; Guo, Renfeng; Li, Yan; Shi, Yanchun; Chen, Guojiang			Opposite Role of Tumor Necrosis Factor Receptors in Dextran Sulfate Sodium-Induced Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; TNF RECEPTORS; ACTIVATION; EXPRESSION; NEUTROPHILS; CYTOKINES; IMMUNITY; THERAPY; MODELS	Tumor necrosis factor-alpha (TNF-alpha) is a key factor for the pathogenesis of inflammatory bowel diseases (IBD), whose function is known to be mediated by TNF receptor 1 (TNFR1) or 2. However, the precise role of the two receptors in IBD remains poorly understood. Herein, acute colitis was induced by dextran sulfate sodium (DSS) instillation in TNFR1 or 2-/- mice. TNFR1 ablation led to exacerbation of signs of colitis, including more weight loss, increased mortality, colon shortening and oedema, severe intestinal damage, and higher levels of myeloperoxidase compared to wild-type counterparts. While, TNFR2 deficiency had opposite effects. This discrepancy was reflected by alteration of proinflammatory cytokine and chemokine production in the colons. Importantly, TNFR1 ablation rendered enhanced apoptosis of colonic epithelial cells and TNFR2 deficiency conferred pro-apoptotic effects of lamina propria (LP)-immune cells, as shown by the decreased ratio of Bcl-2/Bax and enhanced nuclear factor (NF)-kappa B activity.	[Liu, Guijun; Shi, Yanchun] Inner Mongolia Med Coll, Ctr Mol Biol, Hohhot, Peoples R China; [Guo, Renfeng] InflaRx GmbH, Jena, Germany; [Wang, Ke] Cent S Univ, Sch Basic Med Sci, Dept Immunol, Changsha, Hunan, Peoples R China; [Wang, Ke; Han, Gencheng; Wang, Yi; Wang, Renxi; Xiao, He; Li, Xinying; Hou, Chunmei; Shen, Beifen; Li, Yan; Chen, Guojiang] Inst Basic Med Sci, Dept Immunol, Beijing 100730, Peoples R China; [Dou, Yan] Gen Hosp PLA, Dept Gastroenterol, Beijing, Peoples R China	Inner Mongolia Medical University; Central South University; Chinese People's Liberation Army General Hospital	Shi, YC (corresponding author), Inner Mongolia Med Coll, Ctr Mol Biol, Hohhot, Peoples R China.	ycshi5388@yahoo.com.cn; guogangch@yahoo.com	Wang, Ke/GXM-9831-2022; Ke, Wang/AAI-4120-2020; Wang, Renxi/AAM-1326-2020; li, xin/HHS-9461-2022	Wang, Renxi/0000-0003-4130-3334	National Key Basic Research Program of China [2007CB512406, 2009CB522408]; National Natural Science Foundation of China [30801029, 81072475, 81172800]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key Basic Research Program of China (2007CB512406; 2009CB522408) and the National Natural Science Foundation of China (30801029, 81072475 and 81172800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspalter RM, 2003, J LEUKOCYTE BIOL, V74, P572, DOI 10.1189/jlb.0303112; Blam ME, 2001, AM J GASTROENTEROL, V96, P1977, DOI 10.1016/S0002-9270(01)02494-7; Ebach DR, 2005, INFLAMM BOWEL DIS, V11, P533, DOI 10.1097/01.MIB.0000163698.34592.30; Ellerin T, 2003, ARTHRITIS RHEUM-US, V48, P3013, DOI 10.1002/art.11301; GRISHAM MB, 1992, ANN NY ACAD SCI, V664, P103, DOI 10.1111/j.1749-6632.1992.tb39753.x; Hehlgans T, 2005, IMMUNOLOGY, V182, P1281; Holtmann MH, 2002, EUR J IMMUNOL, V32, P3142, DOI 10.1002/1521-4141(200211)32:11<3142::AID-IMMU3142>3.0.CO;2-4; Jacobs M, 2000, PATHOBIOLOGY, V68, P68, DOI 10.1159/000028116; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kollias G, 1999, IMMUNOL REV, V169, P175, DOI 10.1111/j.1600-065X.1999.tb01315.x; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Legrand-Poels S, 2000, BIOCHEM J, V349, P765, DOI 10.1042/bj3490765; Lochman I, 2011, AUTOIMMUN REV, V10, P295, DOI 10.1016/j.autrev.2010.11.003; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Nakai M, 2005, DIGEST DIS SCI, V50, P1669, DOI 10.1007/s10620-005-2913-1; Paland N, 2008, J BIOL CHEM, V283, P6438, DOI 10.1074/jbc.M708422200; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; RACHMILEWITZ D, 1989, GASTROENTEROLOGY, V97, P326, DOI 10.1016/0016-5085(89)90068-1; Sashio H, 2002, IMMUNOGENETICS, V53, P1020, DOI 10.1007/s00251-001-0423-7; Schneider JD, 2009, EUR J IMMUNOL, V39, P1743, DOI 10.1002/eji.200839132; Stillie R, 2009, INFLAMM BOWEL DIS, V15, P1515, DOI 10.1002/ibd.20951; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sydora BC, 2012, DIGEST DIS SCI, V57, P345, DOI 10.1007/s10620-011-1878-5; Weisman MH, 2002, J RHEUMATOL, V29, P33; Westbrook AM, 2010, CANCER RES, V70, P1875, DOI 10.1158/0008-5472.CAN-09-2584; Xu J, 2007, BLOOD, V109, P3333, DOI 10.1182/blood-2006-06-026385; Yang Y, 2011, CLIN EXP IMMUNOL, V165, P372, DOI 10.1111/j.1365-2249.2011.04413.x; Zhao XQ, 2007, CANCER RES, V67, P4443, DOI 10.1158/0008-5472.CAN-07-0185; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	34	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52924	10.1371/journal.pone.0052924	http://dx.doi.org/10.1371/journal.pone.0052924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285227	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500082
J	Lin, JF; Pan, HC; Ma, LP; Shen, YQ; Schachner, M				Lin, Jin-Fei; Pan, Hong-Chao; Ma, Li-Ping; Shen, Yan-Qin; Schachner, Melitta			The Cell Neural Adhesion Molecule Contactin-2 (TAG-1) Is Beneficial for Functional Recovery after Spinal Cord Injury in Adult Zebrafish	PLOS ONE			English	Article							SECRETED PROTEIN AXONIN-1; RETINAL GANGLION-CELLS; NEURITE OUTGROWTH; NERVOUS-SYSTEM; EXPRESSION; REGENERATION; AXONS; PATHWAY; GROWTH; NEUROGENESIS	The cell neural adhesion molecule contactin-2 plays a key role in axon extension and guidance, fasciculation, and myelination during development. We thus asked, whether contactin-2 is also important in nervous system regeneration after trauma. In this study, we used an adult zebrafish spinal cord transection model to test the functions of contactin-2 in spinal cord regeneration. The expression patterns of contactin-2 at different time points after spinal cord injury were studied at the mRNA level by qPCR and in situ hybridization, and contactin-2 protein levels and immunohistological localization were detected by Western blot and immunofluorescence analyses, respectively. Contactin-2 mRNA and protein levels were increased along the central canal at 6 days and 11 days after spinal cord injury, suggesting a requirement for contactin-2 in spinal cord regeneration. Co-localization of contactin-2 and islet-1 (a motoneuron marker) was observed in spinal cords before and after injury. To further explore the functions of contactin-2 in regeneration, an anti-sense morpholino was used to knock down the expression of contactin-2 protein by application at the time of injury. Motion analysis showed that inhibition of contactin-2 retarded the recovery of swimming functions when compared to standard control morpholino. Anterograde and retrograde tracing at 6 weeks after injury showed that knock down of contactin-2 inhibited axonal regrowth from NMLF neurons beyond lesion site. The combined observations indicate that contactin-2 contributes to locomotor recovery and successful regrowth of axons after spinal cord injury in adult zebrafish.	[Lin, Jin-Fei; Pan, Hong-Chao; Shen, Yan-Qin; Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Ma, Li-Ping; Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Ma, Li-Ping; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shen, YQ (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China.	yqshen@stu.edu.cn; schachner@stu.edu.cn			Li Ka Shing Foundation; NSFC [81072622, 31271580]; NSF of Guangdong [S2012010009480]	Li Ka Shing Foundation; NSFC(National Natural Science Foundation of China (NSFC)); NSF of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by Li Ka Shing Foundation to M. Schachner and NSFC (81072622 and 31271580), NSF of Guangdong (S2012010009480) to Y.Q. Shen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeriswyl T, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-7; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Chatzopoulou E, 2008, J NEUROSCI, V28, P7624, DOI 10.1523/JNEUROSCI.1103-08.2008; Denaxa M, 2001, DEVELOPMENT, V128, P4635; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Goff LA, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-76; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; HALFTER W, 1994, DEV BRAIN RES, V78, P87, DOI 10.1016/0165-3806(94)90013-2; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Jung M, 1997, MOL CELL NEUROSCI, V9, P116, DOI 10.1006/mcne.1997.0611; Karagogeos D, 1997, J COMP NEUROL, V379, P415, DOI 10.1002/(SICI)1096-9861(19970317)379:3<415::AID-CNE7>3.0.CO;2-6; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; Lang DM, 2001, MOL CELL NEUROSCI, V17, P398, DOI 10.1006/mcne.2000.0936; Ma LP, 2012, EUR J NEUROSCI, V35, P353, DOI 10.1111/j.1460-9568.2011.07958.x; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Pei DS, 2007, ANAL BIOCHEM, V363, P291, DOI 10.1016/j.ab.2006.12.005; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; RUEGG MA, 1989, J CELL BIOL, V109, P2363, DOI 10.1083/jcb.109.5.2363; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Savvaki M, 2010, J NEUROSCI, V30, P13943, DOI 10.1523/JNEUROSCI.2574-10.2010; Soares S, 2005, EUR J NEUROSCI, V21, P1169, DOI 10.1111/j.1460-9568.2005.03961.x; STOECKLI ET, 1991, J CELL BIOL, V112, P449, DOI 10.1083/jcb.112.3.449; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Traka M, 2002, J NEUROSCI, V22, P3016, DOI 10.1523/JNEUROSCI.22-08-03016.2002; Wolfer DP, 1998, ANAT EMBRYOL, V197, P177, DOI 10.1007/s004290050129; Wolman MA, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-6; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	35	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52376	10.1371/journal.pone.0052376	http://dx.doi.org/10.1371/journal.pone.0052376			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285014	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800056
J	Yu, F; Li, BY; Li, XL; Cai, Q; Zhang, Z; Cheng, M; Yin, M; Wang, JF; Zhang, JH; Lu, WD; Zhou, RH; Gao, HQ				Yu, Fei; Li, Bao-ying; Li, Xiao-li; Cai, Qian; Zhang, Zhen; Cheng, Mei; Yin, Mei; Wang, Jun-fu; Zhang, Jian-hua; Lu, Wei-da; Zhou, Rui-hai; Gao, Hai-qing			Proteomic Analysis of Aorta and Protective Effects of Grape Seed Procyanidin B2 in db/db Mice Reveal a Critical Role of Milk Fat Globule Epidermal Growth Factor-8 in Diabetic Arterial Damage	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; NF-KAPPA-B; MUSCLE-CELL PROLIFERATION; PROANTHOCYANIDIN EXTRACTS; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; ANGIOTENSIN-II; ACTIVATION; EXPRESSION	Background: Atherosclerosis is one of the major complications of type 2 diabetic patients (T2DM), leading to morbidity and mortality. Grape seed procyanidin B2 (GSPB2) has demonstrated protective effect against atherosclerosis, which is believed to be, at least in part, a result of its antioxidative effects. The aim of this study is to identify the target protein of GSPB2 responsible for the protective effect against atherosclerosis in patients with DM. Methods and Results: GSPB2 (30 mg/kg body weight/day) were administrated to db/db mice for 10 weeks. Proteomics of the aorta extracts by iTRAQ analysis was obtained from db/db mice. The results showed that expression of 557 proteins were either up-or down-regulated in the aorta of diabetic mice. Among those proteins, 139 proteins were normalized by GSPB2 to the levels comparable to those in control mice. Among the proteins regulated by GSPB2, the milk fat globule epidermal growth factor-8 (MFG-E8) was found to be increased in serum level in T2DM patients; the serum level of MFG-E8 was positively correlated with carotid-femoral pulse wave velocity (CF-PWV). Inhibition of MFG-E8 by RNA interference significantly suppressed whereas exogenous recombinant MFG-E8 administration exacerbated atherogenesis the db/db mice. To gain more insights into the mechanism of action of MFG-E8, we investigated the effects of MFG-E8 on the signal pathway involving the extracellular signal-regulated kinase (ERK) and monocyte chemoattractant protein-1 (MCP-1). Treatment with recombinant MFG-E8 led to increased whereas inhibition of MFG-E8 to decreased expression of MCP-1 and phosphorylation of ERK1/2. Conclusion: Our data suggests that MFG-E8 plays an important role in atherogenesis in diabetes through both ERK and MCP-1 signaling pathways. GSPB2, a well-studied antioxidant, significantly inhibited the arterial wall changes favoring atherogenesis in db/db mice by down-regulating MFG-E8 expression in aorta and its serum level. Measuring MFG-E8 serum level could be a useful clinical surrogate prognosticating atherogenesis in DM patients.	[Yu, Fei; Li, Bao-ying; Li, Xiao-li; Cai, Qian; Zhang, Zhen; Cheng, Mei; Yin, Mei; Lu, Wei-da; Gao, Hai-qing] Shandong Univ, Qi Lu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China; [Wang, Jun-fu; Zhang, Jian-hua] Med Sci Acad Shandong, Inst Basic Sci, Jinan, Peoples R China; [Zhou, Rui-hai] Univ N Carolina, Div Cardiol, Chapel Hill, NC USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill	Gao, HQ (corresponding author), Shandong Univ, Qi Lu Hosp, Dept Geriatr, Key Lab Cardiovasc Prote Shandong Prov, Jinan 250100, Peoples R China.	gaohaiqingdr@yahoo.com.cn			National Natural Science Foundation of China [30873145, 81000340, 81100595]; Outstanding Young Scientist Research Award Fund of Shandong Province [BS2009YY046]; China Postdoctoral Science Foundation [20100471520, 2011M500748]; Natural Science Foundation of Shandong Province [Y2008C100, ZR2010HQ067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Scientist Research Award Fund of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China (30873145, 81000340 and 81100595), Outstanding Young Scientist Research Award Fund of Shandong Province (BS2009YY046), China Postdoctoral Science Foundation (20100471520, 2011M500748) and Natural Science Foundation of Shandong Province (Y2008C100, ZR2010HQ067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Bayraktutan U, 2002, DIABETES OBES METAB, V4, P224, DOI 10.1046/j.1463-1326.2002.00184.x; Cai K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019559; Cai Q, 2011, BIOSCI BIOTECH BIOCH, V75, P1692, DOI 10.1271/bbb.110194; Calabro P, 2004, CIRCULATION, V110, P3335, DOI 10.1161/01.CIR.0000147825.97879.E7; Casagrande V, 2012, ARTERIOSCL THROM VAS, V32, P74, DOI 10.1161/ATVBAHA.111.238402; Castrillejo VM, 2011, NUTRITION, V27, P1172, DOI 10.1016/j.nut.2010.12.010; Chen DM, 2006, J CARDIOVASC PHARM, V48, P54, DOI 10.1097/01.fjc.0000242052.60502.21; Chen JL, 2011, J ETHNOPHARMACOL, V136, P217, DOI 10.1016/j.jep.2011.04.052; Cheng M, 2012, DIABETES RES CLIN PR, V95, P125, DOI 10.1016/j.diabres.2011.09.030; Cheng SL, 2010, CIRC RES, V107, P271, DOI 10.1161/CIRCRESAHA.110.219899; Cu XP, 2008, J NUTR SCI VITAMINOL, V54, P321; Devi SA, 2011, EXP GERONTOL, V46, P958, DOI 10.1016/j.exger.2011.08.006; Doney ASF, 2005, CIRCULATION, V111, P2927, DOI 10.1161/CIRCULATIONAHA.104.509224; Fens MHAM, 2012, HAEMATOL-HEMATOL J, V97, P500, DOI 10.3324/haematol.2011.048694; Fu ZM, 2009, CIRC RES, V104, P1337, DOI 10.1161/CIRCRESAHA.108.187088; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Houde V, 2006, J PERIODONTOL, V77, P1371, DOI 10.1902/jop.2006.050419; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Jia ZY, 2011, MOL VIS, V17, P210; Khanna S, 2002, FREE RADICAL BIO MED, V33, P1089, DOI 10.1016/S0891-5849(02)00999-1; King GL, 1996, DIABETES, V45, pS105, DOI 10.2337/diab.45.3.S105; Koyama H, 1998, CIRC RES, V82, P713, DOI 10.1161/01.RES.82.6.713; Kushwaha S, 2011, MUTAT RES-GEN TOX EN, V726, P242, DOI 10.1016/j.mrgentox.2011.10.004; Lee Yong-Ho, 2005, Curr Diab Rep, V5, P70; Lee YA, 2008, J AGR FOOD CHEM, V56, P7781, DOI 10.1021/jf800639m; Li BY, 2008, J CELL BIOCHEM, V104, P668, DOI 10.1002/jcb.21658; Li BY, 2011, APOPTOSIS, V16, P732, DOI 10.1007/s10495-011-0602-4; Li BY, 2011, CELL BIOL INT, V35, P663, DOI 10.1042/CBI20100656; Li XL, 2010, INT J MOL MED, V25, P237, DOI 10.3892/ijmm_00000336; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Lin JG, 2012, LAB INVEST, V92, P827, DOI 10.1038/labinvest.2012.53; Lu M, 2010, J NUTR SCI VITAMINOL, V56, P87, DOI 10.3177/jnsv.56.87; Ma L, 2007, J CARDIOVASC PHARM, V49, P293, DOI 10.1097/FJC.0b013e31803c5616; Mackenzie GG, 2008, BIOCHEM PHARMACOL, V75, P1461, DOI 10.1016/j.bcp.2007.12.013; Miura T, 2008, CARCINOGENESIS, V29, P585, DOI 10.1093/carcin/bgm198; Okudan N, 2011, J MED FOOD, V14, P1298, DOI 10.1089/jmf.2010.0030; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Terry JG, 2003, CIRCULATION, V107, P1146, DOI 10.1161/01.CIR.0000051461.92839.F7; Vayalil PK, 2004, CARCINOGENESIS, V25, P987, DOI 10.1093/carcin/bgh095; Wakabayashi I, 2010, EUR J PHARMACOL, V629, P1, DOI 10.1016/j.ejphar.2009.11.054; Wang MY, 2010, CURR HYPERTENS REV, V6, P266, DOI 10.2174/157340210793611668; Werle M, 2002, CARDIOVASC RES, V56, P284, DOI 10.1016/S0008-6363(02)00600-4; Yokozawa T, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/623879; Zhang FL, 2006, J CARDIOVASC PHARM, V48, P47, DOI 10.1097/01.fjc.0000242058.72471.0c; ZHANG YJ, 1995, MOL CELL BIOL, V15, P4851; Zunino SJ, 2009, J NUTR, V139, p1794S, DOI 10.3945/jn.109.107631	51	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52541	10.1371/journal.pone.0052541	http://dx.doi.org/10.1371/journal.pone.0052541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285083	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800076
J	Alhaddad, A; Durieu, C; Dantelle, G; Le Cam, E; Malvy, C; Treussart, F; Bertrand, JR				Alhaddad, Anna; Durieu, Catherine; Dantelle, Geraldine; Le Cam, Eric; Malvy, Claude; Treussart, Francois; Bertrand, Jean-Remi			Influence of the Internalization Pathway on the Efficacy of siRNA Delivery by Cationic Fluorescent Nanodiamonds in the Ewing Sarcoma Cell Model	PLOS ONE			English	Article							IN-VIVO; DIAMOND NANOPARTICLES; QUANTUM DOTS; EXPRESSION; VECTOR; GROWTH; GENE; SIZE	Small interfering RNAs (siRNAs) are powerful tools commonly used for the specific inhibition of gene expression. However, vectorization is required to facilitate cell penetration and to prevent siRNA degradation by nucleases. We have shown that diamond nanocrystals coated with cationic polymer can be used to carry siRNAs into Ewing sarcoma cells, in which they remain traceable over long periods, due to their intrinsic stable fluorescence. We tested two cationic polymers, polyallylamine and polyethylenimine. The release of siRNA, accompanied by Ewing sarcoma EWS-Fli1 oncogene silencing, was observed only with polyethylenimine. We investigated cell penetration and found that the underlying mechanisms accounted for these differences in behavior. Using drugs selectively inhibiting particular pathways and a combination of fluorescence and electronic microscopy, we showed that siRNA gene silencing occurred only if the siRNA: cationic nanodiamond complex followed the macropinocytosis route. These results have potential implications for the design of efficient drug-delivery vectors.	[Treussart, Francois] Ecole Normale Super, Lab Photon Quant & Mol, CNRS, UMR 8537, Cachan, France; [Alhaddad, Anna; Malvy, Claude; Bertrand, Jean-Remi] Univ Paris 11, Vectorol & Therapeut Anticancereuses UMR 8203, CNRS, Inst Gustave Roussy, Villejuif, France; [Durieu, Catherine; Le Cam, Eric] Univ Paris 11, Signalisat Noyaux & Innovat Cancerol UMR 8126, CNRS, Inst Gustave Roussy, Villejuif, France; [Dantelle, Geraldine] Ecole Polytech, Phys Mat Condensee Lab, CNRS, UMR 7643, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite	Treussart, F (corresponding author), Ecole Normale Super, Lab Photon Quant & Mol, CNRS, UMR 8537, Cachan, France.	francois.treussart@ens-cachan.fr; jean-remi.bertrand@igr.fr	, Dantelle/C-8296-2017; TREUSSART, François/M-3274-2013	, Dantelle/0000-0001-5499-8070; TREUSSART, François/0000-0002-1755-0688; Le cam, Eric/0000-0002-6832-6117; Durieu, Catherine/0000-0003-0988-1169	Pole de Recherche et d'Enseignement Superieur "UniverSud Paris"; Centre National de la Recherche Scientifique (CNRS) "international joint project for scientific cooperation" grant; Region Ile-de-France in the framework of C'Nano IdF; CNRS; CEA; Ministry of Higher Education and Research; Region Ile-de-France, France	Pole de Recherche et d'Enseignement Superieur "UniverSud Paris"; Centre National de la Recherche Scientifique (CNRS) "international joint project for scientific cooperation" grant; Region Ile-de-France in the framework of C'Nano IdF(Region Ile-de-France); CNRS(Centre National de la Recherche Scientifique (CNRS)); CEA(French Atomic Energy Commission); Ministry of Higher Education and Research(Ministry of Higher Education & Scientific Research (MHESR)); Region Ile-de-France, France(Region Ile-de-France)	This work has been supported by the Pole de Recherche et d'Enseignement Superieur "UniverSud Paris", by a Centre National de la Recherche Scientifique (CNRS) "international joint project for scientific cooperation" grant, and by the Region Ile-de-France in the framework of C'Nano IdF. C'Nano IdF is the nanoscience competence center of Paris Region, supported by CNRS, CEA, Ministry of Higher Education and Research and Region Ile-de-France, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaddad A, 2011, SMALL, V7, P3087, DOI 10.1002/smll.201101193; Amsellem V, 2005, EXP CELL RES, V304, P443, DOI 10.1016/j.yexcr.2004.10.035; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528; Chang YR, 2008, NAT NANOTECHNOL, V3, P284, DOI 10.1038/nnano.2008.99; Chow EK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001713; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Creusat G, 2010, BIOCONJUGATE CHEM, V21, P994, DOI 10.1021/bc100010k; Dantelle G, 2010, J LUMIN, V130, P1655, DOI 10.1016/j.jlumin.2009.12.003; Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j; Faklaris O, 2008, SMALL, V4, P2236, DOI 10.1002/smll.200800655; Fang CY, 2011, SMALL; Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104; Fuchs B, 2004, CLIN CANCER RES, V10, P1344, DOI 10.1158/1078-0432.CCR-03-0038; Hillaireau H, 2009, CELL MOL LIFE SCI, V66, P2873, DOI 10.1007/s00018-009-0053-z; KANASEKI T, 1969, J CELL BIOL, V42, P202, DOI 10.1083/jcb.42.1.202; Kontny U, 2006, HEMATOL ONCOL, V24, P14, DOI 10.1002/hon.766; Krueger A, 2012, ADV FUNCT MATER, V22, P890, DOI 10.1002/adfm.201102670; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Lunov O, 2011, ACS NANO, V5, P1657, DOI 10.1021/nn2000756; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mohan N, 2010, NANO LETT, V10, P3692, DOI 10.1021/nl1021909; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Paulussen M, 2001, Paediatr Drugs, V3, P899, DOI 10.2165/00128072-200103120-00003; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Rondin L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115449; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Schrand AM, 2011, NANOSCALE, V3, P435, DOI 10.1039/c0nr00408a; Scotlandi K, 1998, CANCER RES, V58, P4127; Shen JN, 2011, NANOSCALE, V3, P4314, DOI 10.1039/c1nr10580a; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6; Thomas V, 2012, ACTA BIOMATER, V8, P1939, DOI 10.1016/j.actbio.2012.01.033; Toub N, 2006, OLIGONUCLEOTIDES, V16, P158, DOI 10.1089/oli.2006.16.158; Treussart F, 2006, PHYSICA B, V376, P926, DOI 10.1016/j.physb.2005.12.232; Vaijayanthimala V, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/42/425103; Zhang XQ, 2009, ACS NANO, V3, P2609, DOI 10.1021/nn900865g; Zhu Y, 2012, THERANOSTICS, V2, P302, DOI 10.7150/thno.3627; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	42	48	49	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52207	10.1371/journal.pone.0052207	http://dx.doi.org/10.1371/journal.pone.0052207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284935	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500112
J	Gao, P; Ma, HY; Luan, FS; Song, HB				Gao, Peng; Ma, Hongyan; Luan, Feishi; Song, Haibin			DNA Fingerprinting of Chinese Melon Provides Evidentiary Support of Seed Quality Appraisal	PLOS ONE			English	Article							SIMPLE-SEQUENCE REPEATS; GENETIC DIVERSITY; MOLECULAR MARKERS; LINKAGE MAP; PCR MARKERS; L.; SSR; TRAITS; BARLEY; RAPD	Melon, Cucumis melo L. is an important vegetable crop worldwide. At present, there are phenomena of homonyms and synonyms present in the melon seed markets of China, which could cause variety authenticity issues influencing the process of melon breeding, production, marketing and other aspects. Molecular markers, especially microsatellites or simple sequence repeats (SSRs) are playing increasingly important roles for cultivar identification. The aim of this study was to construct a DNA fingerprinting database of major melon cultivars, which could provide a possibility for the establishment of a technical standard system for purity and authenticity identification of melon seeds. In this study, to develop the core set SSR markers, 470 polymorphic SSRs were selected as the candidate markers from 1219 SSRs using 20 representative melon varieties (lines). Eighteen SSR markers, evenly distributed across the genome and with the highest contents of polymorphism information (PIC) were identified as the core marker set for melon DNA fingerprinting analysis. Fingerprint codes for 471 melon varieties (lines) were established. There were 51 materials which were classified into17 groups based on sharing the same fingerprint code, while field traits survey results showed that these plants in the same group were synonyms because of the same or similar field characters. Furthermore, DNA fingerprinting quick response (QR) codes of 471 melon varieties (lines) were constructed. Due to its fast readability and large storage capacity, QR coding melon DNA fingerprinting is in favor of read convenience and commercial applications.	[Gao, Peng; Ma, Hongyan; Luan, Feishi; Song, Haibin] NE Agr Univ, Coll Hort, Harbin, Heilongjiang Pr, Peoples R China	Northeast Agricultural University - China	Luan, FS (corresponding author), NE Agr Univ, Coll Hort, Harbin, Heilongjiang Pr, Peoples R China.	luanfeishi@sina.com			China Agriculture Research System, Ministry of Agriculture, People's Republic of China [CARS-26-02]	China Agriculture Research System, Ministry of Agriculture, People's Republic of China	This work was funded by China Agriculture Research System (CARS-26-02), Ministry of Agriculture, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtar S, 2010, Genetika, V46, P1500; Arif IA, 2010, INT J MOL SCI, V11, P2079, DOI 10.3390/ijms11052079; Ashfaq M, 2012, Genetika, V48, P62; Baek HJ, 2003, THEOR APPL GENET, V106, P397, DOI 10.1007/s00122-002-1029-7; Bornet B, 2002, GENOME, V45, P481, DOI 10.1139/G02-002; Danin-Poleg Y, 2000, GENOME, V43, P963, DOI 10.1139/gen-43-6-963; Danin-Poleg Y, 2001, THEOR APPL GENET, V102, P61, DOI 10.1007/s001220051618; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Fazio G, 2002, J AM SOC HORTIC SCI, V127, P545, DOI 10.21273/JASHS.127.4.545; Fernandez-Silva I, 2008, THEOR APPL GENET, V118, P139, DOI 10.1007/s00122-008-0883-3; Gao MeiLing, 2011, Acta Horticulturae Sinica, V38, P1308; Garcia-Mas J, 2000, THEOR APPL GENET, V101, P860, DOI 10.1007/s001220051553; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Joobeur T, 2006, THEOR APPL GENET, V112, P1553, DOI 10.1007/s00122-006-0258-6; Katzir N, 1996, THEOR APPL GENET, V93, P1282, DOI 10.1007/BF00223461; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Krishna GK, 2004, CELL MOL BIOL LETT, V9, P685; Luan F, 2008, EUPHYTICA, V164, P445, DOI 10.1007/s10681-008-9699-0; Luan FS, 2010, EUPHYTICA, V173, P1, DOI 10.1007/s10681-009-0110-6; Ma HB, 2010, FUJIAN J AGR SCI, V25, P33; Maestri E, 2002, MOL GENET GENOMICS, V267, P186, DOI 10.1007/s00438-002-0650-0; Matus IA, 2002, GENOME, V45, P1095, DOI 10.1139/G02-071; Monforte AJ, 2003, PLANT BREEDING, V122, P153, DOI 10.1046/j.1439-0523.2003.00848.x; Mujaju C, 2010, HEREDITAS, V147, P142, DOI 10.1111/j.1601-5223.2010.02165.x; Naito Y, 2008, BREEDING SCI, V58, P293, DOI 10.1270/jsbbs.58.293; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; Ng'uni D, 2011, HEREDITAS, V148, P52, DOI 10.1111/j.1601-5223.2011.02208.x; Nunez-Palenius HG, 2008, CRIT REV BIOTECHNOL, V28, P13, DOI [10.1080/07388550801891111, 10.1080/07388550801891111 ]; Pavlicek A, 1999, FOLIA BIOL-PRAGUE, V45, P97; Reif J, 2006, THEOR APPL GENET, V113, P177, DOI 10.1007/s00122-006-0283-5; Silberstein L, 2003, GENOME, V46, P761, DOI [10.1139/g03-060, 10.1139/G03-060]; Staub J. E., 2001, Cucurbit Genetics Cooperative, P29; Staub JE, 2000, EUPHYTICA, V115, P225, DOI 10.1023/A:1004054014174; Stepansky A, 1999, PLANT SYST EVOL, V217, P313, DOI 10.1007/BF00984373; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang JingYi, 2009, Journal of Fruit Science, V26, P733; Yu RH, 2012, GENET MOL RES, V11, P254, DOI 10.4238/2012.February.3.5; Zalapa JE, 2007, THEOR APPL GENET, V114, P1185, DOI 10.1007/s00122-007-0510-8; Zhang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027565; Zhu ZiCheng, 2011, Acta Horticulturae Sinica, V38, P1753	43	16	19	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52431	10.1371/journal.pone.0052431	http://dx.doi.org/10.1371/journal.pone.0052431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285039	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500166
J	Gunne, M; Urlacher, VB				Gunne, Matthias; Urlacher, Vlada B.			Characterization of the Alkaline Laccase Ssl1 from Streptomyces sviceus with Unusual Properties Discovered by Genome Mining	PLOS ONE			English	Article							FUNGAL LACCASES; BACILLUS-SUBTILIS; BACTERIAL LACCASE; ESCHERICHIA-COLI; COPPER TOLERANCE; PHENOL OXIDASE; COELICOLOR; INHIBITION; EXPRESSION; STABILITY	Fungal laccases are well investigated enzymes with high potential in diverse applications like bleaching of waste waters and textiles, cellulose delignification, and organic synthesis. However, they are limited to acidic reaction conditions and require eukaryotic expression systems. This raises a demand for novel laccases without these constraints. We have taken advantage of the laccase engineering database LccED derived from genome mining to identify and clone the laccase Ssl1 from Streptomyces sviceus which can circumvent the limitations of fungal laccases. Ssl1 belongs to the family of small laccases that contains only few characterized enzymes. After removal of the twin-arginine signal peptide Ssl1 was readily expressed in E. coli. Ssl1 is a small laccase with 32.5 kDa, consists of only two cupredoxin-like domains, and forms trimers in solution. Ssl1 oxidizes 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) and phenolic substrates like 2,6-dimethoxy phenol, guaiacol, and syringaldazine. The k(cat) value for ABTS oxidation was at least 20 times higher than for other substrates. The optimal pH for oxidation reactions is substrate dependent: for phenolic substrates the highest activities were detected at alkaline conditions (pH 9.0 for 2,6-dimethoxy phenol and guaiacol and pH 8.0 for syringaldazine), while the highest reaction rates with ABTS were observed at pH 4.0. Though originating from a mesophilic organism, Ssl demonstrates remarkable stability at elevated temperatures (T-1/2,T-60 degrees C = 88 min) and in a wide pH range (pH 5.0 to 11.0). Notably, the enzyme retained 80% residual activity after 5 days of incubation at pH 11. Detergents and organic co-solvents do not affect Ssl1 stability. The described robustness makes Ssl1 a potential candidate for industrial applications, preferably in processes that require alkaline reaction conditions.	[Gunne, Matthias; Urlacher, Vlada B.] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Urlacher, VB (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	Vlada.Urlacher@uni-duesseldorf.de	Urlacher, Vlada B./AAV-5999-2021	Urlacher, Vlada B./0000-0003-1312-4574	Heinrich-Heine-University Dusseldorf	Heinrich-Heine-University Dusseldorf	This work was funded by the Heinrich-Heine-University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalde M, 2007, IND ENZYM STRUCT FUN, P461, DOI [10.1007/1-4020-5377-0-26, DOI 10.1007/1-4020-5377-0, DOI 10.1007/1-4020-5377-0_26]; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BOLLAG JM, 1984, APPL ENVIRON MICROB, V48, P849, DOI 10.1128/AEM.48.4.849-854.1984; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Eiben S, 2007, APPL MICROBIOL BIOT, V75, P1055, DOI 10.1007/s00253-007-0922-z; Endo K, 2003, J BIOCHEM, V133, P671, DOI 10.1093/jb/mvg086; Endo K, 2002, MICROBIOL-SGM, V148, P1767, DOI 10.1099/00221287-148-6-1767; Festa G, 2008, PROTEINS, V72, P25, DOI 10.1002/prot.21889; Grass G, 2001, BIOCHEM BIOPH RES CO, V286, P902, DOI 10.1006/bbrc.2001.5474; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; HANKA LJ, 1973, ANTIMICROB AGENTS CH, V3, P425, DOI 10.1128/AAC.3.3.425; Heinzkill M, 1998, APPL ENVIRON MICROB, V64, P1601; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kurniawati S, 2007, ENZYME MICROB TECH, V41, P353, DOI 10.1016/j.enzmictec.2007.03.003; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Miyazaki K, 2005, EXTREMOPHILES, V9, P415, DOI 10.1007/s00792-005-0458-z; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Santhanam N, 2011, TRENDS BIOTECHNOL, V29, P480, DOI 10.1016/j.tibtech.2011.04.005; Schelder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022143; Sirim D., 2011, DATABASE, V2011; Skalova T, 2009, J MOL BIOL, V385, P1165, DOI 10.1016/j.jmb.2008.11.024; Solomon EI, 2008, DALTON T, P3921, DOI 10.1039/b800799c; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Xu F, 1997, J BIOL CHEM, V272, P924, DOI 10.1074/jbc.272.2.924	35	68	71	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52360	10.1371/journal.pone.0052360	http://dx.doi.org/10.1371/journal.pone.0052360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285009	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500153
J	Hsu, CH; Shen, TL; Chang, CF; Chang, YY; Huang, LY				Hsu, Chun-Hua; Shen, Tang-Long; Chang, Chi-Fon; Chang, Yu-Yung; Huang, Lin-Ya			Solution Structure of the Oncogenic MIEN1 Protein Reveals a Thioredoxin-Like Fold with a Redox-Active Motif	PLOS ONE			English	Article							MULTIDIMENSIONAL NMR METHODS; 17Q12 AMPLICON; KINASE-B; ACTIVATION; C17ORF37; CANCER; SUPERFAMILY; ASSIGNMENTS; MIGRATION; STRATEGY	The novel tumor biomarker MIEN1, identified by representational difference analysis, is overexpressed in breast cancer and prostate cancer. MIEN1 is considered an oncogenic protein, because MIEN1 overexpression functionally enhances migration and invasion of tumor cells via modulating the activity of AKT. However, the structure and molecular function of MIEN1 is little understood. Here, we report the solution structure of MIEN1, which adopts a thioredoxin-like fold with a redox-active motif. Comparison of backbone chemical shifts showed that most of the residues for both oxidized and reduced MIEN1 possessed the same backbone conformation, with differences limited to the active motif and regions in proximity. The redox potential of this disulfide bond was measured as -225 mV, which compares well with that of disulfides for other thioredoxin-like proteins. Overall, our results suggest that MIEN1 may have an important regulatory role in phosphorylation of AKT with its redox potential.	[Hsu, Chun-Hua; Chang, Yu-Yung] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan; [Hsu, Chun-Hua] Natl Taiwan Univ, Degree Program Genome & Syst Biol, Taipei 10764, Taiwan; [Shen, Tang-Long; Huang, Lin-Ya] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan; [Chang, Chi-Fon] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Hsu, CH (corresponding author), Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan.	andyhsu@ntu.edu.tw	HSU, CHUN-HUA/W-4554-2019	HSU, CHUN-HUA/0000-0002-0008-7383; Chang, Chi-Fon/0000-0002-2961-0748; Shen, Tang-Long/0000-0001-6264-3608	National Science Council in Taiwan [NSC99-2119-M-002-010]; Excellent Research Projects of National Taiwan University [ERP-101R8600]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Excellent Research Projects of National Taiwan University	The work was supported by grants from National Science Council in Taiwan awarded to CHH (NSC99-2119-M-002-010), and partial grants to CHH (ERP-101R8600) from Excellent Research Projects of National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Dasgupta S, 2011, J BIOL CHEM, V286, P25935, DOI 10.1074/jbc.M111.254599; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Fomenko DE, 2007, SCIENCE, V315, P387, DOI 10.1126/science.1133114; Gardner KH, 1998, ANNU REV BIOPH BIOM, V27, P357, DOI 10.1146/annurev.biophys.27.1.357; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hancock John T., 2008, V476, P1, DOI 10.1007/978-1-59745-129-1_1; Hiraoka D, 2011, ONCOGENE, V30, P4487, DOI 10.1038/onc.2011.155; Hsu CH, 2003, J MOL BIOL, V326, P1189, DOI 10.1016/S0022-2836(02)01472-9; Hsu CH, 2011, NUCLEIC ACIDS RES, V39, P6764, DOI 10.1093/nar/gkr283; Hsu CH, 2010, J BIOCHEM, V148, P209, DOI 10.1093/jb/mvq058; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P; LYONS BA, 1993, BIOCHEMISTRY-US, V32, P7839, DOI 10.1021/bi00082a001; Maqani N, 2006, MOL CANCER RES, V4, P449, DOI 10.1158/1541-7786.MCR-06-0058; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mossner E, 1998, PROTEIN SCI, V7, P1233; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; Pedone E, 2010, CELL MOL LIFE SCI, V67, P3797, DOI 10.1007/s00018-010-0449-9; Qi Y, 2005, PROTEINS, V58, P376, DOI 10.1002/prot.20329; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger L., 2020, PYMOL; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Yang CJ, 2010, BIOMOL NMR ASSIGN, V4, P191, DOI 10.1007/s12104-010-9218-9; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	49	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52292	10.1371/journal.pone.0052292	http://dx.doi.org/10.1371/journal.pone.0052292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284973	Green Published, gold			2022-12-25	WOS:000312794500135
J	Conde, J; Scotece, M; Lopez, V; Gomez, R; Lago, F; Pino, J; Gomez-Reino, J; Gualillo, O				Conde, Javier; Scotece, Morena; Lopez, Veronica; Gomez, Rodolfo; Lago, Francisca; Pino, Jesus; Gomez-Reino, Jesus; Gualillo, Oreste			Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes	PLOS ONE			English	Article							CELL-ADHESION MOLECULE-1; SYNTHASE TYPE-II; RHEUMATOID-ARTHRITIS; INTEGRIN VLA-4; OSTEOARTHRITIS; INFLAMMATION; LEUKOCYTE; INTERVENTION; ACTIVATION; CYTOKINES	Background: Osteoarthritis (OA) and rheumatoid arthritis (RA), the most common rheumatic diseases, are characterized by irreversible degeneration of the joint tissues. There are several factors involved in the pathogenesis of these diseases including pro-inflammatory cytokines, adipokines and adhesion molecules. Objective: Up to now, the relationship between adipokines and adhesion molecules at cartilage level was not explored. Thus, the aim of this article was to study the effect of leptin and adiponectin on the expression of VCAM-1 in human and murine chondrocytes. For completeness, intracellular signal transduction pathway was also explored. Methods: VCAM-1 expression was assessed by quantitative RT-PCR and western blot analysis upon treatment with leptin, adiponectin and other pertinent reagents in cultured human primary chondrocytes. Signal transduction pathways have been explored by using specific pharmacological inhibitors in the adipokine-stimulated human primary chondrocytes and ATDC5 murine chondrocyte cell line. Results: Herein, we demonstrate, for the first time, that leptin and adiponectin increase VCAM-1 expression in human and murine chondrocytes. In addition, both adipokines have additive effect with IL-1 beta. Finally, we demonstrate that several kinases, including JAK2, PI3K and AMPK are at a play in the intracellular signalling of VCAM-1 induction. Conclusions: Taken together, our results suggest that leptin and adiponectin could perpetuate cartilage-degrading processes by inducing also factors responsible of leukocyte and monocyte infiltration at inflamed joints.	[Conde, Javier; Scotece, Morena; Lopez, Veronica; Gomez-Reino, Jesus; Gualillo, Oreste] Univ Santiago, Clin Hosp, Inst Med Res IDIS, NEIRID Lab,SERGAS, Santiago De Compostela, Spain; [Gomez, Rodolfo] Fdn Jimenez Diaz, Div Rheumatol, Madrid, Spain; [Lago, Francisca] Univ Santiago, Clin Hosp, Inst Med Res IDIS, Res Lab Mol & Cellular Cardiol 7,SERGAS, Santiago De Compostela, Spain; [Pino, Jesus] Univ Santiago, Clin Hosp, Inst Med Res IDIS, Div Orthopaed Surg & Traumatol,SERGAS, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Gualillo, O (corresponding author), Univ Santiago, Clin Hosp, Inst Med Res IDIS, NEIRID Lab,SERGAS, Santiago De Compostela, Spain.	oreste.gualillo@sergas.es	Scotece, Morena/ABI-6561-2020; Gualillo, Oreste/B-8223-2008; Gomez, Rodolfo/B-4642-2012; Aranda, Javier Conde/P-5537-2015	Scotece, Morena/0000-0002-1150-2933; Gualillo, Oreste/0000-0002-7154-1328; Gomez, Rodolfo/0000-0002-1309-1023; Aranda, Javier Conde/0000-0002-2187-479X; Gomez-Reino, Juan/0000-0001-5229-6294; Pino, Jesus/0000-0002-1847-1199	Instituto de Salud Carlos III; Xunta de Galicia (SERGAS); Xunta de Galicia; Instituto de Salud Carlos III (ISCIII) [RD08/0075]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Xunta de Galicia (SERGAS)(Xunta de Galicia); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission)	The work of O.G. and F.L. is funded by the Instituto de Salud Carlos III and the Xunta de Galicia (SERGAS) through a research-staff stabilization contract. O.G. is supported by Instituto de Salud Carlos III and Xunta de Galicia. This work was also partially supported by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), within the VI NP of R+D+I 2008-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1991, AM J RESP CELL MOL, V4, P195, DOI 10.1165/ajrcmb/4.3.195; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Felson DT, 2005, J RHEUMATOL, V32, P1133; Francin PJ, 2011, J CELL PHYSIOL, V226, P2790, DOI 10.1002/jcp.22627; Golias C, 2007, IN VIVO, V21, P757; Gomez R, 2009, ARTHRITIS RHEUM-US, V60, P1704, DOI 10.1002/art.24522; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Iliopoulos D, 2007, ANN RHEUM DIS, V66, P1616, DOI 10.1136/ard.2007.069377; Kalichman L, 2011, CLIN EXP RHEUMATOL, V29, P544; Kienzle G, 1998, ARTHRITIS RHEUM-US, V41, P1296, DOI 10.1002/1529-0131(199807)41:7<1296::AID-ART21>3.0.CO;2-8; Kluger Martin S, 2004, Adv Dermatol, V20, P163; Koskinen A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3512; KRIEGSMANN J, 1995, LAB INVEST, V72, P209; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Lago R, 2008, OSTEOARTHR CARTILAGE, V16, P1101, DOI 10.1016/j.joca.2007.12.008; Martel-Pelletier Johanne, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS31; Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126; MORALESDUCRET J, 1992, J IMMUNOL, V149, P1424; Otero M, 2005, ARTHRITIS RES THER, V7, pR581, DOI 10.1186/ar1708; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Salmi M, 2001, J IMMUNOL, V166, P4650, DOI 10.4049/jimmunol.166.7.4650; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2381, DOI 10.1002/art.24757; Smith MD, 1997, J RHEUMATOL, V24, P365; Sommaggio R, 2009, CELL TRANSPLANT, V18, P1381, DOI 10.3727/096368909X474249; TAK PP, 1995, CLIN IMMUNOL IMMUNOP, V77, P236, DOI 10.1006/clin.1995.1149; Thomas DP, 2000, J CELL SCI, V113, P439; Tokuhira M, 2000, ARTHRITIS RHEUM, V43, P1122, DOI 10.1002/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7	28	75	77	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52533	10.1371/journal.pone.0052533	http://dx.doi.org/10.1371/journal.pone.0052533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285079	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300090
J	Berglund, ED; Li, CY; Ayala, JE; McGuinness, OP; Wasserman, DH				Berglund, Eric D.; Li, Candice Y.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.			Regulation of Endogenous Glucose Production in Glucose Transporter 4 Over-Expressing Mice	PLOS ONE			English	Article							TRANSGENIC MICE; CONSCIOUS MOUSE; GLUT4; TRANSPORTER; PROTEIN; GENE; METABOLISM; TOLERANCE	Strategies to amplify whole-body glucose disposal are key therapies to treat type 2 diabetes. Mice that over-express glucose transporter 4 (Glut4) in skeletal muscle, heart, and adipose tissue (G4Tg) exhibit increased fasting glucose disposal and thus lowered blood glucose. Intriguingly, G4Tg mice also exhibit improved insulin-stimulated suppression of endogenous glucose production even though Glut4 is not present in the liver. It is unclear, however, if hepatic gluco-regulation is altered in G4Tg mice in the basal, non-insulin-stimulated state. The current studies were performed to examine fasting hepatic glucose metabolism in G4Tg mice and to determine whether gluco-regulatory adaptations exist in the non-insulin-stimulated condition. To test this question, phloridzin-glucose clamps were used to match blood glucose and pancreatic hormone levels while tracer dilution techniques were used to measure glucose flux. These techniques were performed in chronically-catheterized, conscious, and un-stressed 5h-fasted G4Tg and wild-type (WT) littermates. Results show reduced blood glucose, hepatic glycogen content, and hepatic glucokinase (GK) activity/expression as well as higher endogenous glucose production, glucose disposal, arterial glucagon, and hepatic glucose-6-phosphatase (G6Pase) activity/expression in G4Tg mice versus WT controls. Clamping blood glucose for 90 min at,115 mg/dLin G4Tg and WT mice normalized nearly all variables. Notably, however, net hepatic glycogen synthetic rates were disproportionately elevated compared to changes in blood glucose. In conclusion, these studies demonstrate that basal improvements in glucose tolerance due to increased uptake in extra-hepatic sites provoke important gluco-regulatory adaptations in the liver. Although changes in blood glucose underlie the majority of these adaptations, net hepatic glycogen synthesis is sensitized. These data emphasize that anti-diabetic therapies that target skeletal muscle, heart, and/or adipose tissue likely positively impact the liver.	[Berglund, Eric D.; Li, Candice Y.; Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Ayala, Julio E.; McGuinness, Owen P.; Wasserman, David H.] Vanderbilt Univ, Sch Med, Mouse Metab Phenotyping Ctr, Nashville, TN 37212 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University	Berglund, ED (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	berglunde@gmail.com			NIH [DK050277, DK059637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK050277, U2CDK059637, R01DK050277, T32DK007563, U24DK059637] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH DK050277 and DK059637 (awarded to DHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Berglund ED, 2009, ENDOCRINOLOGY; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Fueger PT, 2004, J BIOL CHEM, V279, P50956, DOI 10.1074/jbc.M408312200; HANSEN PA, 1995, J BIOL CHEM, V270, P1679; LIU ML, 1993, P NATL ACAD SCI USA, V90, P11346, DOI 10.1073/pnas.90.23.11346; Marshall BA, 1999, AM J PHYSIOL-ENDOC M, V276, pE390, DOI 10.1152/ajpendo.1999.276.2.E390; MORGAN CR, 1962, P SOC EXP BIOL MED, V110, P29; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; OLSON AL, 1993, J BIOL CHEM, V268, P9839; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; TREADWAY JL, 1994, J BIOL CHEM, V269, P29956; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008	17	5	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52355	10.1371/journal.pone.0052355	http://dx.doi.org/10.1371/journal.pone.0052355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285006	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900091
J	Flynn, AN; Hoffman, J; Tillu, DV; Sherwood, CL; Zhang, ZY; Patek, R; Asiedu, MNK; Vagner, J; Price, TJ; Boitano, S				Flynn, Andrea N.; Hoffman, Justin; Tillu, Dipti V.; Sherwood, Cara L.; Zhang, Zhenyu; Patek, Renata; Asiedu, Marina N. K.; Vagner, Josef; Price, Theodore J.; Boitano, Scott			Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering	FASEB JOURNAL			English	Article						PAR(2); G-protein coupled receptor; Ca2+ signaling; MAPK; xCELLigence RTCA	RESPONSES IN-VITRO; SIGNALING PATHWAYS; SERINE PROTEASES; INFLAMMATION; MEMBRANE; LIGANDS; HYPERALGESIA; ANTAGONISTS; PEPTIDE; SYSTEM	Protease-activated receptor-2 (PAR(2)) is a G-protein coupled receptor (GPCR) associated with a variety of pathologies. However, the therapeutic potential of PAR(2) is limited by a lack of potent and specific ligands. Following proteolytic cleavage, PAR(2) is activated through a tethered ligand. Hence, we reasoned that lipidation of peptidomimetic ligands could promote membrane targeting and thus significantly improve potency and constructed a series of synthetic tethered ligands (STLs). STLs contained a peptidomimetic PAR(2) agonist (2-aminothiazol-4-yl-LIGRL-NH2) bound to a palmitoyl group (Pam) via polyethylene glycol (PEG) linkers. In a high-throughput physiological assay, these STL agonists displayed EC50 values as low as 1.47 nM, representing a similar to 200 fold improvement over the untethered parent ligand. Similarly, these STL agonists were potent activators of signaling pathways associated with PAR(2): EC50 for Ca2+ response as low as 3.95 nM; EC50 for MAPK response as low as 9.49 nM. Moreover, STLs demonstrated significant improvement in potency in vivo, evoking mechanical allodynia with an EC50 of 14.4 pmol. STLs failed to elicit responses in PAR(2)(-/-) cells at agonist concentrations of >300-fold their EC50 values. Our results demonstrate that the STL approach is a powerful tool for increasing ligand potency at PAR(2) and represent opportunities for drug development at other protease activated receptors and across GPCRs.-Flynn, A. N., Hoffman, J., Tillu, D. V., Sherwood, C. L., Zhang, Z., Patek, R., Asiedu, M. N. K., Vagner, J., Price, T. J., Boitano, S. Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering. FASEB J. 27, 1498-1510 (2013). www.fasebj.org	[Flynn, Andrea N.; Hoffman, Justin; Boitano, Scott] Arizona Hlth Sci Ctr, Dept Physiol, Tucson, AZ 85724 USA; [Flynn, Andrea N.; Hoffman, Justin; Sherwood, Cara L.; Zhang, Zhenyu; Patek, Renata; Vagner, Josef; Price, Theodore J.; Boitano, Scott] Arizona Hlth Sci Ctr, Collaborat Res Inst Bio5, Tucson, AZ 85724 USA; [Flynn, Andrea N.; Hoffman, Justin; Sherwood, Cara L.; Boitano, Scott] Arizona Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Tillu, Dipti V.; Asiedu, Marina N. K.; Price, Theodore J.] Arizona Hlth Sci Ctr, Dept Pharmacol, Tucson, AZ 85724 USA; [Vagner, Josef] Arizona Hlth Sci Ctr, Arizona Canc Ctr, Tucson, AZ 85724 USA	University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences; University of Arizona Health Sciences; Arizona Center Cancer Care; University of Arizona Health Sciences	Boitano, S (corresponding author), Arizona Hlth Sci Ctr, Arizona Resp Ctr, Dept Physiol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	sboitano@email.arizona.edu	Price, Theodore/M-3810-2018	Price, Theodore/0000-0002-6971-6221	U.S. National Institutes of Health [NS073664, T32-HL007249, R01NS065926, R01AI083403, ES 04940]; State of Arizona Technology and Research Initiative [Bio5]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, T32ES007091, P42ES004940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073664, R01NS065926] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Arizona Technology and Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Daniel X. Sherwood for his program that allowed for quick quantification of Ca<SUP>2+</SUP> data, Michael O. Daines for discussion on development and execution of the experiments, Aubrey M. Cunningham for her help with the PAR<INF>2</INF> mice and Terri Boitano for help in editing this manuscript. This work was primarily funded by a multi-PI grant (NS073664 to S. B., J.V., and T.J.P.) and a training grant (T32-HL007249 to A.N.F. and C.L.S.), both from the U.S. National Institutes of Health. Additional support for this work was from the following grants: U.S. National Institutes of Health R01NS065926 (T.J.P.) and R01AI083403 (S. B.; Michael O. Daines, PI), State of Arizona Technology and Research Initiative Fund Awarded through Bio5 (J.V.). Funds to purchase the RTCA were provided through U. S. National Institutes of Health Grant ES 04940 (NIEHS Superfund) and by the State of Arizona Technology and Research Initiative Fund awarded through the Water Sustainability Program. This work is part of a Multi-Principal Investigator group; all PIs contributed equally to this work.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Agarwal A, 2008, MOL CANCER THER, V7, P2746, DOI 10.1158/1535-7163.MCT-08-0177; Alier KA, 2008, J PHARMACOL EXP THER, V324, P224, DOI 10.1124/jpet.107.129171; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Canto I, 2012, MINI-REV MED CHEM, V12, P804, DOI 10.2174/138955712800959116; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen CP, 2012, PROTEIN ENG DES SEL, V25, P367, DOI 10.1093/protein/gzs033; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Davidson DJ, 2000, AM J PHYSIOL-LUNG C, V279, pL766, DOI 10.1152/ajplung.2000.279.4.L766; DIRKSEN ER, 1995, METHOD CELL BIOL, V47, P65, DOI 10.1016/S0091-679X(08)60792-X; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Flynn AN, 2011, J BIOL CHEM, V286, P19076, DOI 10.1074/jbc.M110.185264; Fortin JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024693; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Gardell LR, 2008, J PHARMACOL EXP THER, V327, P799, DOI 10.1124/jpet.108.142570; Gough SCL, 2012, DIABETES OBES METAB, V14, P33, DOI 10.1111/j.1463-1326.2012.01576.x; GOZES I, 1995, J PHARMACOL EXP THER, V273, P161; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Helyes Z, 2010, EUR J PAIN, V14, P351, DOI 10.1016/j.ejpain.2009.07.005; Hollenberg MD, 2008, J PHARMACOL EXP THER, V326, P453, DOI 10.1124/jpet.108.136432; Ibanez-Tallon I, 2012, CURR OPIN NEUROBIOL, V22, P72, DOI 10.1016/j.conb.2011.11.003; Josan JS, 2011, BIOCONJUGATE CHEM, V22, P1270, DOI 10.1021/bc1004284; Josan JS, 2008, INT J PEPT RES THER, V14, P293, DOI 10.1007/s10989-008-9150-3; Kanke T, 2009, BRIT J PHARMACOL, V158, P361, DOI 10.1111/j.1476-5381.2009.00342.x; Kawabata A, 2005, J PHARMACOL SCI, V97, P20, DOI 10.1254/jphs.FMJ04005X4; Kawabata A, 2006, BRIT J PHARMACOL, V148, P54, DOI 10.1038/sj.bjp.0706708; Kawabata A, 2004, J PHARMACOL EXP THER, V309, P1098, DOI 10.1124/jpet.103.061010; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lam DK, 2010, PAIN, V149, P263, DOI 10.1016/j.pain.2010.02.010; Li X, 2011, BIOCHEM SOC T, V39, P1895, DOI 10.1042/BST20110736; Lindner JR, 2000, J IMMUNOL, V165, P6504, DOI 10.4049/jimmunol.165.11.6504; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Means CK, 2011, P NATL ACAD SCI USA, V108, pE1227, DOI 10.1073/pnas.1107182108; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Rothmeier AS, 2012, SEMIN IMMUNOPATHOL, V34, P133, DOI 10.1007/s00281-011-0289-1; Schaffner F, 2009, ARTERIOSCL THROM VAS, V29, P1999, DOI 10.1161/ATVBAHA.108.177428; Schmidlin F, 2002, J IMMUNOL, V169, P5315, DOI 10.4049/jimmunol.169.9.5315; Sevigny LM, 2011, P NATL ACAD SCI USA, V108, P8491, DOI 10.1073/pnas.1017091108; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Suen JY, 2012, BRIT J PHARMACOL, V165, P1413, DOI 10.1111/j.1476-5381.2011.01610.x; Vagner J, 2008, ANGEW CHEM INT EDIT, V47, P1685, DOI 10.1002/anie.200702770; Vergnolle N, 2001, TRENDS PHARMACOL SCI, V22, P146, DOI 10.1016/S0165-6147(00)01634-5; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zhang L, 2012, CURR MED CHEM, V19, P1602	64	21	24	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1498	1510		10.1096/fj.12-217323	http://dx.doi.org/10.1096/fj.12-217323			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23292071	Green Published			2022-12-25	WOS:000316940800022
J	Ennemann, EC; Radhakrishnan, K; Mariappan, M; Wachs, M; Pringle, TH; Schmidt, B; Dierks, T				Ennemann, Eva C.; Radhakrishnan, Karthikeyan; Mariappan, Malaiyalam; Wachs, Michaela; Pringle, Thomas H.; Schmidt, Bernhard; Dierks, Thomas			Proprotein Convertases Process and Thereby Inactivate Formylglycine-generating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SULFATASE DEFICIENCY; ENDOPLASMIC-RETICULUM; CLEAVAGE SITES; FURIN; CELLS; GENE; SUMF1; TRAFFICKING; PREDICTION; RETENTION	Formylglycine-generating enzyme (FGE) post-translationally converts a specific cysteine in newly synthesized sulfatases to formylglycine (FGly). FGly is the key catalytic residue of the sulfatase family, comprising 17 nonredundant enzymes in human that play essential roles in development and homeostasis. FGE, a resident protein of the endoplasmic reticulum, is also secreted. A major fraction of secreted FGE is N-terminally truncated, lacking residues 34-72. Here we demonstrate that this truncated form is generated intracellularly by limited proteolysis mediated by proprotein convertase(s) (PCs) along the secretory pathway. The cleavage site is represented by the sequence RYSR72 down arrow, a motif that is conserved in higher eukaryotic FGEs, implying important functionality. Residues Arg-69 and Arg-72 are critical because their mutation abolishes FGE processing. Furthermore, residues Tyr-70 and Ser-71 confer an unusual property to the cleavage motif such that endogenous as well as overexpressed FGE is only partially processed. FGE is cleaved by furin, PACE4, and PC5a. Processing is disabled in furin-deficient cells but fully restored upon transient furin expression, indicating that furin is the major protease cleaving FGE. Processing by endogenous furin occurs mostly intracellularly, although also extracellular processing is observed in HEK293 cells. Interestingly, the truncated form of secreted FGE no longer possesses FGly-generating activity, whereas the unprocessed form of secreted FGE is active. As always both forms are secreted, we postulate that furin-mediated processing of FGE during secretion is a physiological means of higher eukaryotic cells to regulate FGE activity upon exit from the endoplasmic reticulum.	[Ennemann, Eva C.; Radhakrishnan, Karthikeyan; Wachs, Michaela; Dierks, Thomas] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Radhakrishnan, Karthikeyan; Mariappan, Malaiyalam; Schmidt, Bernhard] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Pringle, Thomas H.] Sperling Fdn, Eugene, OR 97405 USA	University of Bielefeld; University of Gottingen	Dierks, T (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	thomas.dierks@uni-bielefeld.de	Dierks, Thomas/A-3596-2012; mariappan, malaiyalam/K-9024-2012	Dierks, Thomas/0000-0001-6426-1339; Radhakrishnan, Karthikeyan/0000-0003-1731-7410	Deutsche Forschungsgemeinschaft [DI 575/7, SCHM 830/2, SFB 860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants DI 575/7, SCHM 830/2, and SFB 860.	Annunziata Ida, 2007, Hum Mutat, V28, P928, DOI 10.1002/humu.9504; Buono M, 2010, J EXP MED, V207, P1647, DOI 10.1084/jem.20091022; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Cosma MP, 2004, HUM MUTAT, V23, P576, DOI 10.1002/humu.20040; Cosma MP, 2003, CELL, V113, P445, DOI 10.1016/S0092-8674(03)00348-9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dierks T, 2005, CELL, V121, P541, DOI 10.1016/j.cell.2005.03.001; Dierks T, 2003, CELL, V113, P435, DOI 10.1016/S0092-8674(03)00347-7; Dierks T, 2009, BBA-MOL CELL RES, V1793, P710, DOI 10.1016/j.bbamcr.2008.11.015; Diez-Roux G, 2005, ANNU REV GENOM HUM G, V6, P355, DOI 10.1146/annurev.genom.6.080604.162334; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Fey J, 2001, J BIOL CHEM, V276, P47021, DOI 10.1074/jbc.M108943200; Fraldi A, 2008, HUM MOL GENET, V17, P2610, DOI 10.1093/hmg/ddn161; GIESELMANN V, 1992, J BIOL CHEM, V267, P13262; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Mariappan M, 2005, J BIOL CHEM, V280, P15173, DOI 10.1074/jbc.M413698200; Mariappan M, 2008, J BIOL CHEM, V283, P11556, DOI 10.1074/jbc.M707858200; Mariappan M, 2008, J BIOL CHEM, V283, P6375, DOI 10.1074/jbc.M709171200; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Plaimauer B, 2001, BIOCHEM J, V354, P689, DOI 10.1042/0264-6021:3540689; Preusser-Kunze A, 2005, J BIOL CHEM, V280, P14900, DOI 10.1074/jbc.M413383200; Remacle AG, 2008, J BIOL CHEM, V283, P20897, DOI 10.1074/jbc.M803762200; Schlotawa Lars, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9515; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; Sun T, 2010, INT J BIOL SCI, V6, P89; Tian S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00261; von Figura K, 1998, BIOESSAYS, V20, P505, DOI 10.1002/(SICI)1521-1878(199806)20:6<505::AID-BIES9>3.0.CO;2-K; Wu P, 2009, P NATL ACAD SCI USA, V106, P3000, DOI 10.1073/pnas.0807820106; Zito E, 2007, EMBO J, V26, P2443, DOI 10.1038/sj.emboj.7601695	36	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5828	5839		10.1074/jbc.M112.405159	http://dx.doi.org/10.1074/jbc.M112.405159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288839	hybrid, Green Published			2022-12-25	WOS:000315342500053
J	Nanda, JS; Saini, AK; Munoz, AM; Hinnebusch, AG; Lorsch, JR				Nanda, Jagpreet S.; Saini, Adesh K.; Munoz, Antonio M.; Hinnebusch, Alan G.; Lorsch, Jon R.			Coordinated Movements of Eukaryotic Translation Initiation Factors eIF1, eIF1A, and eIF5 Trigger Phosphate Release from eIF2 in Response to Start Codon Recognition by the Ribosomal Preinitiation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; SELECTION IN-VIVO; SITE SELECTION; MULTIFACTOR COMPLEX; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; AUG SELECTION; SUBUNIT; REVEALS; BINDING	Accurate recognition of the start codon in an mRNA by the eukaryotic translation preinitiation complex (PIC) is essential for proper gene expression. The process is mediated by eukaryotic translation initiation factors (eIFs) in conjunction with the 40 S ribosomal subunit and (initiator) tRNA(i). Here, we provide evidence that the C-terminal tail (CTT) of eIF1A, which we previously implicated in start codon recognition, moves closer to the N-terminal domain of eIF5 when the PIC encounters an AUG codon. Importantly, this movement is coupled to dissociation of eIF1 from the PIC, a critical event in start codon recognition, and is dependent on the scanning enhancer elements in the eIF1A CTT. The data further indicate that eIF1 dissociation must be accompanied by the movement of the eIF1A CTT toward eIF5 in order to trigger release of phosphate from eIF2, which converts the latter to its GDP-bound state. Our results also suggest that release of eIF1 from the PIC and movement of the CTT of eIF1A are triggered by the same event, most likely accommodation of tRNA(i) in the P site of the 40 S subunit driven by base pairing between the start codon in the mRNA and the anticodon in tRNA(i). Finally, we show that the C-terminal domain of eIF5 is responsible for the factor's activity in antagonizing eIF1 binding to the PIC. Together, our data provide a more complete picture of the chain of molecular events that is triggered when the scanning PIC encounters an AUG start codon in the mRNA.	[Nanda, Jagpreet S.; Munoz, Antonio M.; Lorsch, Jon R.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Saini, Adesh K.; Hinnebusch, Alan G.] Eunice K Shriver NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Lorsch, JR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	jlorsch@jhmi.edu	Saini, Adesh/AAY-6016-2020	Saini, Adesh/0000-0002-5445-5786; Nanda, Jagpreet/0000-0002-6629-4641; Lorsch, Jon/0000-0002-4521-4999	National Institutes of Health [GM 62128]; National Institutes of Health Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 62128 (to J.R.L.) and by the National Institutes of Health Intramural Research Program (to A.G.H.).	Acker MG, 2007, METHOD ENZYMOL, V430, P111, DOI 10.1016/S0076-6879(07)30006-2; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Alone PV, 2008, MOL CELL BIOL, V28, P6877, DOI 10.1128/MCB.01147-08; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; Fekete CA, 2005, EMBO J, V24, P3588, DOI 10.1038/sj.emboj.7600821; Fekete CA, 2007, EMBO J, V26, P1602, DOI 10.1038/sj.emboj.7601613; Hashimoto NN, 2002, BIOCHEM J, V367, P359, DOI 10.1042/BJ20020556; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kolitz SE, 2009, RNA, V15, P138, DOI 10.1261/rna.1318509; Lakowicz JR, 1999, PRINCIPLES FLUORESCE, P353; Laurino JP, 1999, MOL CELL BIOL, V19, P173; Lomakin IB, 2003, GENE DEV, V17, P2786, DOI 10.1101/gad.1141803; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Loughran G, 2012, NUCLEIC ACIDS RES, V40, P2898, DOI 10.1093/nar/gkr1192; Luna RE, 2012, CELL REPORTS, V1, P689, DOI 10.1016/j.celrep.2012.04.007; Maag D, 2006, J MOL BIOL, V356, P724, DOI 10.1016/j.jmb.2005.11.083; Maag D, 2005, MOL CELL, V17, P265, DOI 10.1016/j.molcel.2004.11.051; Maag D, 2003, J MOL BIOL, V330, P917, DOI 10.1016/S0022-2836(03)00665-X; Martin-Marcos P, 2011, MOL CELL BIOL, V31, P4814, DOI 10.1128/MCB.05819-11; Nanda J., 2011, METHODS NAVIGATOR; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Reibarkh M, 2008, J BIOL CHEM, V283, P1094, DOI 10.1074/jbc.M708155200; Saini AK, 2010, GENE DEV, V24, P97, DOI 10.1101/gad.1871910; Shih WM, 2000, CELL, V102, P683, DOI 10.1016/S0092-8674(00)00090-8; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Singh CR, 2004, J BIOL CHEM, V279, P31910, DOI 10.1074/jbc.M313940200; Valasek L, 2004, MOL CELL BIOL, V24, P9437, DOI 10.1128/MCB.24.21.9437-9455.2004; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037; Yamamoto Y, 2005, P NATL ACAD SCI USA, V102, P16164, DOI 10.1073/pnas.0507960102; Yatime L, 2007, P NATL ACAD SCI USA, V104, P18445, DOI 10.1073/pnas.0706784104; Yu YP, 2009, NUCLEIC ACIDS RES, V37, P5167, DOI 10.1093/nar/gkp519	43	58	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5316	5329		10.1074/jbc.M112.440693	http://dx.doi.org/10.1074/jbc.M112.440693			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293029	hybrid, Green Published			2022-12-25	WOS:000315342500006
J	Zhang, H; Zhang, H; Gao, ZQ; Wang, WJ; Liu, GF; Xu, JH; Su, XD; Dong, YH				Zhang, Heng; Zhang, Heng; Gao, Zeng-Qiang; Wang, Wen-Jia; Liu, Guang-Feng; Xu, Jian-Hua; Su, Xiao-Dong; Dong, Yu-Hui			Structure of the Type VI Effector-Immunity Complex (Tae4-Tai4) Provides Novel Insights into the Inhibition Mechanism of the Effector by Its Immunity Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY SOLUTION SCATTERING; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; SECRETION SYSTEM; PEPTIDOGLYCAN; BACTERIAL; AMIDASE; DOMAIN; MACROMOLECULES; RECOGNITION	The type VI secretion system (T6SS), a multisubunit needle-like apparatus, has recently been found to play a role in interspecies interactions. The Gram-negative bacteria harboring T6SS (donor) deliver the effectors into their neighboring cells (recipient) to kill them. Meanwhile, the cognate immunity proteins were employed to protect the donor cells against the toxic effectors. Tae4 (type VI amidase effector 4) and Tai4 (type VI amidase immunity 4) are newly identified T6SS effector-immunity pairs. Here, we report the crystal structures of Tae4 from Enterobacter cloacae and Tae4-Tai4 complexes from both E. cloacae and Salmonella typhimurium. Tae4 acts as a DL-endopeptidase and displays a typical N1pC/P60 domain. Unlike Tsi1 (type VI secretion immunity 1), Tai4 is an all-helical protein and forms a dimer in solution. The small angle x-ray scattering study combined with the analytical ultracentrifugation reveal that the Tae4-Tai4 complex is a compact heterotetramer that consists of a Tai4 dimer and two Tae4 molecules in solution. Structure-based mutational analysis of the Tae4-Tai4 interface shows that a helix (alpha 3) of one subunit in dimeric Tai4 plays a major role in binding of Tae4, whereas a protruding loop (L4) in the other subunit is mainly responsible for inhibiting Tae4 activity. The inhibition process requires collaboration between the Tai4 dimer. These results reveal a novel and unique inhibition mechanism in effector-immunity pairs and suggest a new strategy to develop antipathogen drugs.	[Zhang, Heng; Su, Xiao-Dong] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Zhang, Heng; Gao, Zeng-Qiang; Wang, Wen-Jia; Liu, Guang-Feng; Xu, Jian-Hua; Dong, Yu-Hui] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing 100049, Peoples R China	Peking University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Su, XD (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, 5 Yiheyuan Rd, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn; dongyh@ihep.ac.cn	zhang, heng/O-2665-2013	zhang, heng/0000-0003-1112-7149; Dong, Yuhui/0000-0002-4422-4685; Zhang, Heng/0000-0003-3208-6489; Gao, Zengqiang/0000-0002-9100-9929	National Basic Research Program of China [2012CB917203]; National Natural Science Foundation of China [10979005, 31200552]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2012CB917203 and National Natural Science Foundation of China Grants 10979005 and 31200552.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002613; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036; Zhang H, 2012, FEBS LETT, V586, P1147, DOI 10.1016/j.febslet.2012.03.029; Zou TT, 2012, J MOL BIOL, V417, P351, DOI 10.1016/j.jmb.2012.01.040	36	46	47	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5928	5939		10.1074/jbc.M112.434357	http://dx.doi.org/10.1074/jbc.M112.434357			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288853	hybrid, Green Published			2022-12-25	WOS:000315342500061
J	Chen, JD; Waltenspiel, B; Warren, WD; Wagner, EJ				Chen, Jiandong; Waltenspiel, Bernhard; Warren, William D.; Wagner, Eric J.			Functional Analysis of the Integrator Subunit 12 Identifies a Microdomain That Mediates Activation of the Drosophila Integrator Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' END FORMATION; ESCHERICHIA-COLI; SMALL NUCLEAR; MESSENGER-RNA; U1 SNRNA; GLOBAL ANALYSIS; U2 SNRNA; PROTEIN; TRANSCRIPTION; 3'-END	The Drosophila integrator complex consists of 14 subunits that associate with the C terminus of Rpb1 and catalyze the endonucleolytic cleavage of nascent snRNAs near their 3' ends. Although disruption of almost any integrator subunit causes snRNA misprocessing, very little is known about the role of the individual subunits or the network of structural and functional interactions that exist within the complex. Here we developed an RNAi rescue assay in Drosophila S2 cells to identify functional domains within integrator subunit 12 (IntS12) required for snRNA 3' end formation. Surprisingly, the defining feature of the Ints12 protein, a highly conserved and centrally located plant homeodomain finger domain, is not required for reporter snRNA 3' end cleavage. Rather, we find a small, 45-amino acid N-terminal microdomain to be both necessary and nearly sufficient for snRNA biogenesis in cells depleted of endogenous IntS12 protein. This IntS12 microdomain can function autonomously, restoring full integrator processing activity when introduced into a heterologous protein. Moreover, mutations within the microdomain not only disrupt IntS12 function but also abolish binding to other integrator subunits. Finally, the IntS12 microdomain is sufficient to interact and stabilize the putative scaffold integrator subunit, IntS1. Collectively, these results identify an unexpected interaction between the largest and smallest integrator subunits that is essential for the 3' end formation of Drosophila snRNA.	[Chen, Jiandong; Wagner, Eric J.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, Jiandong; Wagner, Eric J.] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Waltenspiel, Bernhard; Warren, William D.] James Cook Univ, Sch Pharm & Mol Sci, Comparat Genom Ctr, Townsville, Qld 4811, Australia	University of Texas System; University of Texas Health Science Center Houston; James Cook University	Wagner, EJ (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, MSB 6-200,6431 Fannin, Houston, TX 77030 USA.	Eric.J.Wagner@uth.tmc.edu	Warren, William/D-4419-2009; Chen, Jiandong/H-4016-2019	Warren, William/0000-0002-3753-1871; Chen, Jiandong/0000-0002-5144-7537	National Institutes of Health [5R00GM080447]; T. C. Hsu faculty development award; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM080447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T. C. Hsu faculty development award; Queensland Cancer Fund; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R00GM080447 (to E. J. W.). This work was also supported by the T. C. Hsu faculty development award and by the Queensland Cancer Fund (to E. J. W.), and by the National Health and Medical Research Council (NHMRC) through the Australian Drosophila Biomedical Research Support Facility.	ACH RA, 1987, MOL CELL BIOL, V7, P2070, DOI 10.1128/MCB.7.6.2070; Albrecht TR, 2012, MOL CELL BIOL, V32, P1112, DOI 10.1128/MCB.06511-11; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Boyd DC, 2000, GENE, V247, P33, DOI 10.1016/S0378-1119(00)00134-7; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Cazalla D, 2011, MOL CELL, V43, P982, DOI 10.1016/j.molcel.2011.07.025; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Chen JD, 2012, RNA, V18, P2148, DOI 10.1261/rna.035725.112; Chen JD, 2010, BIOCHEM SOC T, V38, P1082, DOI 10.1042/BST0381082; Colledge VL, 2011, J MOL BIOL, V411, P597, DOI 10.1016/j.jmb.2011.06.004; DEVEGVAR HEN, 1986, CELL, V47, P259; Dominski Z, 1995, RNA, V1, P915; Dominski Z, 2005, MOL CELL BIOL, V25, P1489, DOI 10.1128/MCB.25.4.1489-1500.2005; Dominski Z, 2003, P NATL ACAD SCI USA, V100, P9422, DOI 10.1073/pnas.1533509100; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Egloff S, 2009, MOL CELL BIOL, V29, P4002, DOI 10.1128/MCB.00189-09; Ezzeddine N, 2011, MOL CELL BIOL, V31, P328, DOI 10.1128/MCB.00943-10; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Hernandez G, 2007, NUCLEIC ACIDS RES, V35, P21, DOI 10.1093/nar/gkl982; HERNANDEZ N, 1986, CELL, V47, P249, DOI 10.1016/0092-8674(86)90447-2; Hernandez N, 2001, J BIOL CHEM, V276, P26733, DOI 10.1074/jbc.R100032200; HERNANDEZ N, 1985, EMBO J, V4, P1827, DOI 10.1002/j.1460-2075.1985.tb03857.x; Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Nurmohamed S, 2010, ACTA CRYSTALLOGR D, V66, P1036, DOI 10.1107/S0907444910030015; Pavelitz T, 2008, MOL CELL BIOL, V28, P3573, DOI 10.1128/MCB.00087-08; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schulz JG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp450; Stunkel W, 1997, MOL CELL BIOL, V17, P4397; Sullivan KD, 2009, MOL CELL, V34, P322, DOI 10.1016/j.molcel.2009.04.024; Zhao XY, 2001, MOL CELL, V7, P539, DOI 10.1016/S1097-2765(01)00201-5	43	20	24	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4867	4877		10.1074/jbc.M112.425892	http://dx.doi.org/10.1074/jbc.M112.425892			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288851	Green Published, hybrid			2022-12-25	WOS:000315340400035
J	Deng, XD; Morris, J; Chaton, C; Schroder, GF; Davidson, WS; Thompson, TB				Deng, Xiaodi; Morris, Jamie; Chaton, Catherine; Schroeder, Gunnar F.; Davidson, W. Sean; Thompson, Thomas B.			Small-angle X-ray Scattering of Apolipoprotein A-IV Reveals the Importance of Its Termini for Structural Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; CRYSTAL-STRUCTURE; SELF-ASSOCIATION; FOOD-INTAKE; N-TERMINI; PROTEINS; MACROMOLECULES; REFINEMENT; DOMAINS; SIZE	ApoA-IV is an amphipathic protein that can emulsify lipids and has been linked to protective roles against cardiovascular disease and obesity. We previously reported an x-ray crystal structure of apoA-IV that was truncated at its N and C termini. Here, we have extended this work by demonstrating that self-associated states of apoA-IV are stable and can be structurally studied using small-angle x-ray scattering. Both the full-length monomeric and dimeric forms of apoA-IV were examined, with the dimer showing an elongated rod core with two nodes at opposing ends. The monomer is roughly half the length of the dimer with a single node. Small-angle x-ray scattering visualization of several deletion mutants revealed that removal of both termini can have substantial conformational effects throughout the molecule. Additionally, the F334A point mutation, which we previously showed increases apoA-IV lipid binding, also exhibited large conformational effects on the entire dimer. Merging this study's low-resolution structural information with the crystal structure provides insight on the conformation of apoA-IV as a monomer and as a dimer and further defines that a clasp mechanism may control lipid binding and, ultimately, protein function.	[Deng, Xiaodi; Chaton, Catherine; Thompson, Thomas B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Morris, Jamie; Davidson, W. Sean] Univ Cincinnati, Metab Dis Inst, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45215 USA; [Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Complex Syst ICS 6, D-52425 Julich, Germany	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Helmholtz Association; Research Center Julich	Thompson, TB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way,MSB 3005B, Cincinnati, OH 45267 USA.	tom.thompson@uc.edu	Schröder, Gunnar F/H-5261-2013	Schröder, Gunnar F/0000-0003-1803-5431; Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989	National Institutes of Health [R01 GM098458, HL67093, T32 HL007382]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007382, R01HL067093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM098458 (to T. B. T. and W. S. D.), Grant HL67093 (to W. S. D.), and Training Grant T32 HL007382 (to X. D.).	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Culnan DM, 2009, OBESITY, V17, P46, DOI 10.1038/oby.2008.428; Davidson WS, 1996, P NATL ACAD SCI USA, V93, P13605, DOI 10.1073/pnas.93.24.13605; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; Deng XD, 2012, ACTA CRYSTALLOGR F, V68, P105, DOI [10.1107/S1744309111048706, 10.1107/S1744309111048706105]; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Pearson K, 2005, J BIOL CHEM, V280, P38576, DOI 10.1074/jbc.M506802200; Pearson K, 2004, BIOCHEMISTRY-US, V43, P10719, DOI 10.1021/bi048978m; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tabet F, 2009, CLIN SCI, V116, P87, DOI 10.1042/CS20080106; Tso P, 1999, J NUTR, V129, P1503, DOI 10.1093/jn/129.8.1503; Tso P, 2004, PHYSIOL BEHAV, V83, P631, DOI 10.1016/j.physbeh.2004.07.032; Tso P, 2004, AM J PHYSIOL-GASTR L, V286, pG885, DOI 10.1152/ajpgi.00511.2003; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Visiers I, 2000, PROTEIN ENG, V13, P603, DOI 10.1093/protein/13.9.603; VITELLO LB, 1976, J BIOL CHEM, V251, P1131; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang Z, 2012, BIOPOLYMERS, V97, P687, DOI 10.1002/bip.22046; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; Weinberg RB, 2012, J LIPID RES, V53, P736, DOI 10.1194/jlr.M019992; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107	38	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4854	4866		10.1074/jbc.M112.436709	http://dx.doi.org/10.1074/jbc.M112.436709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288849	Green Published, hybrid			2022-12-25	WOS:000315340400034
J	Yamazaki, J; Okamura, K; Uehara, K; Hatta, M				Yamazaki, Jun; Okamura, Kazuhiko; Uehara, Kiyoko; Hatta, Mitsutoki			CLCA Splicing Isoform Associated with Adhesion through beta(1)-Integrin and Its Scaffolding Protein SPECIFIC EXPRESSION IN UNDIFFERENTIATED EPITHELIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; BETA(1) INTEGRIN; KINASE-C; EXTRACELLULAR-MATRIX; MEMBRANE-PROTEINS; ANION TRANSPORT; RACK1; CLONING; GROWTH; GENERATION	We previously found that a rat CLCA homologue (rCLCA-f) modulates Ca2+-dependent Cl- transport in the ductal cells of the rat submandibular gland. CLCA proteins have been shown to be multifunctional, with roles in, for example, cell adhesion. Here, we describe the mRNA and protein expressions of a splicing isoform of rat rCLCA (rCLCA-t). This isoform is a 514-amino acid protein containing a C-terminal 59-amino acid that is distinct from the rCLCA-f sequence. Immunohistochemistry revealed rCLCA-t to be located in the basal cells of the rat submandibular gland excretory duct and the stratum basale of rat epidermis, whereas rCLCA-f was detected in cells during the process of differentiation. In a heterologous expression system, rCLCA-t was found to be a membrane protein present predominantly in the perinuclear region, and not to be either present on the cell surface or secreted. rCLCA-t failed to enhance ionomycin-induced Cl- conductance (unlike rCLCA-f). When compared with rCLCA-f, it weakened cell attachment to a greater extent and in a manner that was evidently modulated by intracellular Ca2+, protein kinase C, and beta(1)-integrin. rCLCA-t was found to associate with RACK1 (receptor for activated C kinase) and to reduce expression of mature beta(1)-integrin. Treatment of rat skin with rCLCA-t siRNA increased the expression of beta(1)-integrin in the stratum basale of the epidermis. These results are consistent with cell-specific splicing of rCLCA mRNA playing a role in the modulation of the adhesive potential of undifferentiated epithelial cells.	[Yamazaki, Jun] Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, Fukuoka 8140193, Japan; [Okamura, Kazuhiko] Fukuoka Dent Coll, Dept Morphol Biol, Sawara Ku, Fukuoka 8140193, Japan; [Uehara, Kiyoko] Fukuoka Univ, Sch Med, Dept Cell Biol, Jonan Ku, Fukuoka 8140180, Japan	Fukuoka Dental College (FDC); Fukuoka Dental College (FDC); Fukuoka University	Yamazaki, J (corresponding author), Fukuoka Dent Coll, Dept Physiol Sci & Mol Biol, Sawara Ku, 2-15-1 Tamura, Fukuoka 8140193, Japan.	junyama@college.fdcnet.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (to J. Y.) and by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (to J. Y. and K. O).	Abdel-Ghany M, 2003, J BIOL CHEM, V278, P49406, DOI 10.1074/jbc.M309086200; Abdel-Ghany M, 2001, J BIOL CHEM, V276, P25438, DOI 10.1074/jbc.M100478200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; BREZILLON S, 1995, LAB INVEST, V72, P191; Connon CJ, 2005, ACTA HISTOCHEM, V106, P421, DOI 10.1016/j.acthis.2004.08.003; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Elble RC, 2006, J BIOL CHEM, V281, P29448, DOI 10.1074/jbc.M605919200; Elble RC, 1997, J BIOL CHEM, V272, P27853, DOI 10.1074/jbc.272.44.27853; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; Fuller CM, 2000, CLIN EXP PHARMACOL P, V27, P906, DOI 10.1046/j.1440-1681.2000.03359.x; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; Gruber AD, 1999, BBA-GENE STRUCT EXPR, V1444, P418, DOI 10.1016/S0167-4781(99)00008-1; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; HEINO J, 1989, J BIOL CHEM, V264, P380; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; Hume JR, 2000, PHYSIOL REV, V80, P31, DOI 10.1152/physrev.2000.80.1.31; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishibashi K, 2006, J DENT RES, V85, P1101, DOI 10.1177/154405910608501207; Jensen PJ, 1996, CELL DEATH DIFFER, V3, P357; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Kiely PA, 2008, J BIOL CHEM, V283, P22952, DOI 10.1074/jbc.M800802200; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kunzelmann K, 2011, PFLUG ARCH EUR J PHY, V462, P195, DOI 10.1007/s00424-011-0975-9; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lee I, 2004, J BIOL CHEM, V279, P53007, DOI 10.1074/jbc.M405717200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Mundhenk L, 2006, J BIOL CHEM, V281, P30072, DOI 10.1074/jbc.M606489200; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Ritzka M, 2004, HUM GENET, V115, P483, DOI 10.1007/s00439-004-1190-y; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Salicioni AM, 2004, J BIOL CHEM, V279, P10005, DOI 10.1074/jbc.M306625200; Shenoy PS, 2001, BIOCHEM CELL BIOL, V79, P399, DOI 10.1139/bcb-79-4-399; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; VANDEWIELVANKEMENADE E, 1992, J CELL BIOL, V117, P461, DOI 10.1083/jcb.117.2.461; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Xia Z, 2008, AM J NEPHROL, V28, P34, DOI 10.1159/000108759; Yamazaki J, 2005, BBA-BIOMEMBRANES, V1715, P132, DOI 10.1016/j.bbamem.2005.08.001; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zaslavsky A, 2005, FEBS LETT, V579, P3899, DOI 10.1016/j.febslet.2005.06.006; ZHU DZ, 1991, J HISTOCHEM CYTOCHEM, V39, P1137, DOI 10.1177/39.8.1856462; ZHU DZ, 1991, P NATL ACAD SCI USA, V88, P9568, DOI 10.1073/pnas.88.21.9568	49	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4831	4843		10.1074/jbc.M112.396481	http://dx.doi.org/10.1074/jbc.M112.396481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297403	hybrid, Green Published			2022-12-25	WOS:000315340400032
J	Abuhammad, A; Fullam, E; Lowe, ED; Staunton, D; Kawamura, A; Westwood, IM; Bhakta, S; Garner, AC; Wilson, DL; Seden, PT; Davies, SG; Russell, AJ; Garman, EF; Sim, E				Abuhammad, Areej; Fullam, Elizabeth; Lowe, Edward D.; Staunton, David; Kawamura, Akane; Westwood, Isaac M.; Bhakta, Sanjib; Garner, Alun Christopher; Wilson, David L.; Seden, Peter T.; Davies, Stephen G.; Russell, Angela J.; Garman, Elspeth F.; Sim, Edith			Piperidinols That Show Anti-Tubercular Activity as Inhibitors of Arylamine N-Acetyltransferase: An Essential Enzyme for Mycobacterial Survival Inside Macrophages	PLOS ONE			English	Article							CHOLESTEROL CATABOLISM; RESISTANT TUBERCULOSIS; LATENT TUBERCULOSIS; MAXIMUM-LIKELIHOOD; DRUG DISCOVERY; ACIDS; EXPRESSION; MECHANISM; TARGET; SPECIFICITY	Latent M. tuberculosis infection presents one of the major obstacles in the global eradication of tuberculosis (TB). Cholesterol plays a critical role in the persistence of M. tuberculosis within the macrophage during latent infection. Catabolism of cholesterol contributes to the pool of propionyl-CoA, a precursor that is incorporated into cell-wall lipids. Arylamine N-acetyltransferase (NAT) is encoded within a gene cluster that is involved in the cholesterol sterol-ring degradation and is essential for intracellular survival. The ability of the NAT from M. tuberculosis (TBNAT) to utilise propionyl-CoA links it to the cholesterol-catabolism pathway. Deleting the nat gene or inhibiting the NAT enzyme prevents intracellular survival and results in depletion of cell-wall lipids. TBNAT has been investigated as a potential target for TB therapies. From a previous high-throughput screen, 3-benzoyl-4-phenyl-1-methylpiperidinol was identified as a selective inhibitor of prokaryotic NAT that exhibited antimycobacterial activity. The compound resulted in time-dependent irreversible inhibition of the NAT activity when tested against NAT from M. marinum (MMNAT). To further evaluate the antimycobacterial activity and the NAT inhibition of this compound, four piperidinol analogues were tested. All five compounds exert potent antimycobacterial activity against M. tuberculosis with MIC values of 2.3-16.9 mu M. Treatment of the MMNAT enzyme with this set of inhibitors resulted in an irreversible time-dependent inhibition of NAT activity. Here we investigate the mechanism of NAT inhibition by studying protein-ligand interactions using mass spectrometry in combination with enzyme analysis and structure determination. We propose a covalent mechanism of NAT inhibition that involves the formation of a reactive intermediate and selective cysteine residue modification. These piperidinols present a unique class of antimycobacterial compounds that have a novel mode of action different from known anti-tubercular drugs.	[Abuhammad, Areej; Fullam, Elizabeth; Kawamura, Akane; Westwood, Isaac M.; Bhakta, Sanjib; Russell, Angela J.; Sim, Edith] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Abuhammad, Areej] Univ Jordan, Fac Pharm, Amman, Jordan; [Abuhammad, Areej; Lowe, Edward D.; Staunton, David; Garman, Elspeth F.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Fullam, Elizabeth; Kawamura, Akane; Westwood, Isaac M.; Garner, Alun Christopher; Wilson, David L.; Seden, Peter T.; Davies, Stephen G.; Russell, Angela J.] Univ Oxford, Dept Chem, Oxford, England; [Sim, Edith] Kingston Univ, Fac Sci Engn & Comp, Kingston upon Thames, Surrey, England	University of Oxford; University of Jordan; University of Oxford; University of Oxford; Kingston University	Sim, E (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	E.Sim@kingston.ac.uk	Abuhammad, Areej/C-3492-2015; Kawamura, Akane/I-4047-2018; Lowe, Edward/AAP-5381-2021	Abuhammad, Areej/0000-0003-4978-5059; Kawamura, Akane/0000-0003-1169-5082; Lowe, Edward/0000-0002-1757-0208; Garman, Elspeth/0000-0001-8329-5665; Russell, Angela/0000-0003-3610-9369	Wellcome Trust; Medical Research Council; University of Jordan	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Jordan	The authors thank the Wellcome Trust and the Medical Research Council for financial support. The authors are also grateful to the University of Jordan for a studentship (A.A.). E.S. and S.B. are members of the MRC UK TB Drug Discovery consortium, TBD-UK (http://www.tbd-uk.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhammad A, 2011, PROTEIN EXPRES PURIF, V80, P246, DOI 10.1016/j.pep.2011.06.021; Accelrys LLC, 2010, DS VISUALIZER ACTIVE, V3, P1; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Astarie-Dequeker C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000289; Bhakta S, 2004, J EXP MED, V199, P1191, DOI 10.1084/jem.20031956; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Copeland R. A., 2005, EVALUATION ENZYME IN; Cwik A, 2004, J MOL CATAL A-CHEM, V219, P377, DOI 10.1016/j.molcata.2004.06.002; Davioud-Charvet E, 2003, BIOCHEMISTRY-US, V42, P13319, DOI 10.1021/bi0353629; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espinoza-Fonseca LM, 2006, BIOORGAN MED CHEM, V14, P896, DOI 10.1016/j.bmc.2005.09.011; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fullam E, 2008, J MOL BIOL, V375, P178, DOI 10.1016/j.jmb.2007.10.019; Gideon HP, 2011, IMMUNOL RES, V50, P202, DOI 10.1007/s12026-011-8229-7; Ginsberg A, 2011, FUTURE MED CHEM, V3, P1247, DOI [10.4155/fmc.11.82, 10.4155/FMC.11.82]; Gul M, 2005, ARZNEIMITTELFORSCH, V55, P332; Huang HH, 2005, J AM SOC MASS SPECTR, V16, P324, DOI 10.1016/j.jasms.2004.11.016; JENEY E, 1956, Zentralbl Bakteriol Orig, V167, P55; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kaul D, 2004, MOL CELL BIOCHEM, V258, P219, DOI 10.1023/B:MCBI.0000012851.42642.be; Kawamura A, 2005, BIOCHEM PHARMACOL, V69, P347, DOI 10.1016/j.bcp.2004.09.014; KELLY SL, 1991, HUM EXP TOXICOL, V10, P33, DOI 10.1177/096032719101000106; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; KITZ R, 1962, J BIOL CHEM, V237, P3245; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lack NA, 2009, BIOCHEM J, V418, P369, DOI 10.1042/BJ20082011; Laurieri N, 2010, J AM CHEM SOC, V132, P3238, DOI 10.1021/ja909165u; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndungu JM, 2005, ORG LETT, V7, P5845, DOI 10.1021/ol052382p; Ouellet H, 2011, TRENDS MICROBIOL, V19, P530, DOI 10.1016/j.tim.2011.07.009; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Payton M, 1999, J BACTERIOL, V181, P1343, DOI 10.1128/JB.181.4.1343-1347.1999; Plati JT, 1951, TETRAHYDROPYRIDINES; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Russell AJ, 2009, BIOORGAN MED CHEM, V17, P905, DOI 10.1016/j.bmc.2008.11.032; Sarkar S, 2011, J PHARM PHARM SCI, V14, P148, DOI 10.18433/J33591; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Schrodinger L., 2020, PYMOL; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Sim E, 2008, DRUG METAB REV, V40, P479, DOI [10.1080/03602530802186603, 10.1080/03602530802186603 ]; Sim E, 2008, CURR DRUG METAB, V9, P510, DOI 10.2174/138920008784892100; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Thomas ST, 2011, J BIOL CHEM, V286, P43668, DOI 10.1074/jbc.M111.313643; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wang HQ, 2005, BIOCHEMISTRY-US, V44, P11295, DOI 10.1021/bi047564q; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Westwood I, 2005, STRUCTURE ACTIVITY A; Westwood IM, 2011, COMB CHEM HIGH T SCR, V14, P117; Westwood IM, 2010, PROTEIN CELL, V1, P82, DOI 10.1007/s13238-010-0006-1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2019, GLOB TUB REP; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005	67	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52790	10.1371/journal.pone.0052790	http://dx.doi.org/10.1371/journal.pone.0052790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285185	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500063
J	Cartana, T; Saftoiu, A; Gruionu, LG; Gheonea, DI; Pirici, D; Georgescu, CV; Ciocalteu, A; Gruionu, G				Cartana, Tatiana; Saftoiu, Adrian; Gruionu, Lucian Gheorghe; Gheonea, Dan Ionut; Pirici, Daniel; Georgescu, Claudia Valentina; Ciocalteu, Adriana; Gruionu, Gabriel			Confocal Laser Endomicroscopy for the Morphometric Evaluation of Microvessels in Human Colorectal Cancer Using Targeted Anti-CD31 Antibodies	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; IN-VIVO; TUMOR ANGIOGENESIS	Introduction: Numerous anti-angiogenic agents are currently developed to limit tumor growth and metastasis. While these drugs offer hope for cancer patients, their transient effect on tumor vasculature is difficult to assess in clinical settings. Confocal laser endomicroscopy (CLE) is a novel endoscopic imaging technology that enables histological examination of the gastrointestinal mucosa. The aim of the present study was to evaluate the feasibility of using CLE to image the vascular network in fresh biopsies of human colorectal tissue. For this purpose we have imaged normal and malignant biopsy tissue samples and compared the vascular network parameters obtained with CLE with established histopathology techniques. Materials and Methods: Fresh non-fixed biopsy samples of both normal and malignant colorectal mucosa were stained with fluorescently labeled anti-CD31 antibodies and imaged by CLE using a dedicated endomicroscopy system. Corresponding biopsy samples underwent immunohistochemical staining for CD31, assessing the microvessel density (MVD) and vascular areas for comparison with CLE data, which were measured offline using specific software. Results: The vessels were imaged by CLE in both normal and tumor samples. The average diameter of normal vessels was 8.5 +/- 0.9 mu m whereas in tumor samples it was 13.5 +/- 0.7 mu m (p = 0.0049). Vascular density was 188.7 +/- 24.9 vessels/mm(2) in the normal tissue vs. 242.4 +/- 16.1 vessels/mm(2) in the colorectal cancer samples (p = 0.1201). In the immunohistochemistry samples, the MVD was 211.2 +/- 42.9/mm(2) and 351.3 +/- 39.6/mm(2) for normal and malignant mucosa, respectively. The vascular area was 2.9 +/- 0.5% of total tissue area for the normal mucosa and 8.5 +/- 2.1% for primary colorectal cancer tissue. Conclusion: Selective imaging of blood vessels with CLE is feasible in normal and tumor colorectal tissue by using fluorescently labeled antibodies targeted against an endothelial marker. The method could be translated into the clinical setting for monitoring of anti-angiogenic therapy.	[Cartana, Tatiana; Saftoiu, Adrian; Gruionu, Lucian Gheorghe; Gheonea, Dan Ionut; Ciocalteu, Adriana; Gruionu, Gabriel] Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania; [Gruionu, Lucian Gheorghe] Univ Craiova, Dept Mech Engn, Craiova, Romania; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Histol, Craiova, Romania; [Georgescu, Claudia Valentina] Emergency Cty Hosp, Dept Pathol, Craiova, Romania; [Gruionu, Gabriel] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab Tumor Biol,Dept Radiat Oncol, Boston, MA USA	University of Medicine & Pharmacy of Craiova; University of Craiova; University of Medicine & Pharmacy of Craiova; Harvard University; Harvard Medical School; Massachusetts General Hospital	Saftoiu, A (corresponding author), Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania.	adrian.saftoiu@webmail.umfcv.ro	Saftoiu, Adrian/C-2792-2011; Gheonea, Dan Ionut/C-3578-2012; GRUIONU, Lucian Gheorghe/F-6121-2011; Ciocalteu, Adriana/AAF-8592-2021; Gruionu, Gabriel/C-5152-2011; Pirici, Daniel/C-5760-2012	Saftoiu, Adrian/0000-0001-7993-8269; GRUIONU, Lucian Gheorghe/0000-0002-4526-0864; Pirici, Daniel/0000-0001-9192-7319; Ciocalteu, Adriana/0000-0002-8668-4946; Pirici, Daniel/0000-0002-0196-0949	National Research Council (CNCS), Romania [PN-II-ID-PCE-2011-3-0664]	National Research Council (CNCS), Romania	This work was supported from the research grant entitled "Clinical and Biomathematical Modeling of Vascular Changes Following Anti-Angiogenic Therapy in Advanced Colorectal Carcinoma", funded by the National Research Council (CNCS), Romania, contract number PN-II-ID-PCE-2011-3-0664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown AP, 2008, CANCER METAST REV, V27, P415, DOI 10.1007/s10555-008-9143-x; DeLisser H, 2010, P NATL ACAD SCI USA, V107, P18616, DOI 10.1073/pnas.1004654107; Foersch S, 2010, GUT, V59, P1046, DOI 10.1136/gut.2009.202986; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukumura D, 2008, APMIS, V116, P695, DOI 10.1111/j.1600-0463.2008.01148.x; Gheonea DI, 2011, WORLD J GASTROENTERO, V17, P21, DOI 10.3748/wjg.v17.i1.21; Goetz M, 2010, AM J PHYSIOL-GASTR L, V298, pG797, DOI 10.1152/ajpgi.00027.2010; Goetz M, 2010, GASTROENTEROLOGY, V138, P435, DOI 10.1053/j.gastro.2009.10.032; Hasan J, 2002, BRIT J CANCER, V86, P1566, DOI 10.1038/sj.bjc.6600315; Jain RK, 2008, SCI AM, V298, P56, DOI 10.1038/scientificamerican0108-56; Kachlik D, 2010, J ANAT, V216, P335, DOI 10.1111/j.1469-7580.2009.01199.x; Kiesslich R, 2004, GASTROENTEROLOGY, V127, P706, DOI 10.1053/j.gastro.2004.06.050; Kiesslich R, 2007, GASTROINTEST ENDOSC, V66, P150, DOI 10.1016/j.gie.2006.12.031; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; Konerding MA, 2001, BRIT J CANCER, V84, P1354, DOI 10.1054/bjoc.2001.1809; Meining A, 2008, GASTROENTEROLOGY, V134, P915, DOI 10.1053/j.gastro.2008.02.049; Mizuno K, 2011, DIGEST DIS SCI, V56, P1811, DOI 10.1007/s10620-010-1519-4; Nakai Y, 2012, J PHYSIOL PHARMACOL, V63, P303; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Rmali KA, 2007, COLORECTAL DIS, V9, P3, DOI 10.1111/j.1463-1318.2006.01089.x; Sanduleanu S, 2010, CLIN GASTROENTEROL H, V8, P371, DOI 10.1016/j.cgh.2009.08.006; Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	23	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52815	10.1371/journal.pone.0052815	http://dx.doi.org/10.1371/journal.pone.0052815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285192	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500065
J	Conlon, EM; Postier, BL; Methe, BA; Nevin, KP; Lovley, DR				Conlon, Erin M.; Postier, Bradley L.; Methe, Barbara A.; Nevin, Kelly P.; Lovley, Derek R.			A Bayesian Model for Pooling Gene Expression Studies That Incorporates Co-Regulation Information	PLOS ONE			English	Article							MICROARRAY DATA; OPERON; METAANALYSIS; BENEFITS	Current Bayesian microarray models that pool multiple studies assume gene expression is independent of other genes. However, in prokaryotic organisms, genes are arranged in units that are co-regulated (called operons). Here, we introduce a new Bayesian model for pooling gene expression studies that incorporates operon information into the model. Our Bayesian model borrows information from other genes within the same operon to improve estimation of gene expression. The model produces the gene-specific posterior probability of differential expression, which is the basis for inference. We found in simulations and in biological studies that incorporating co-regulation information improves upon the independence model. We assume that each study contains two experimental conditions: a treatment and control. We note that there exist environmental conditions for which genes that are supposed to be transcribed together lose their operon structure, and that our model is best carried out for known operon structures.	[Conlon, Erin M.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Postier, Bradley L.; Methe, Barbara A.; Nevin, Kelly P.; Lovley, Derek R.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Conlon, EM (corresponding author), Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA.	econlon@mathstat.umass.edu	Nevin, Kelly/AAA-4626-2019		Office of Science (BER), United States Department of Energy [DE-FC02-02ER63446]	Office of Science (BER), United States Department of Energy(United States Department of Energy (DOE))	This research was supported by the Office of Science (BER), United States Department of Energy, grant number DE-FC02-02ER63446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bockhorst J, 2003, BIOINFORMATICS, V19, P1227, DOI 10.1093/bioinformatics/btg147; Broet P, 2002, J COMPUT BIOL, V9, P671, DOI 10.1089/106652702760277381; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Conlon EM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-247; Conlon EM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-80; de Hoon MJL, 2004, BIOINFORMATICS, V20, P101, DOI 10.1093/bioinformatics/bth927; Do KA, 2005, J R STAT SOC C-APPL, V54, P627, DOI 10.1111/j.1467-9876.2005.05593.x; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Genovese C, 2002, J ROY STAT SOC B, V64, P499, DOI 10.1111/1467-9868.00347; Genovese C, 2003, BAYESIAN STAT; Gottardo R, 2003, BIOSTATISTICS, V4, P597, DOI 10.1093/biostatistics/4.4.597; Iber D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100084; Ibrahim JG, 2002, J AM STAT ASSOC, V97, P88, DOI 10.1198/016214502753479257; Ishwaran H, 2003, J AM STAT ASSOC, V98, P438, DOI 10.1198/016214503000224; Ishwaran H, 2005, J AM STAT ASSOC, V100, P764, DOI 10.1198/016214505000000051; Jung YY, 2006, BIOMETRICAL J, V48, P435, DOI 10.1002/bimj.200410230; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Lonnstedt I, 2002, STAT SINICA, V12, P31; Lonnstedt I, 2005, BIOSTATISTICS, V6, P279, DOI 10.1093/biostatistics/kxi009; Methe BA, 2005, APPL ENVIRON MICROB, V71, P2530, DOI 10.1128/AEM.71.5.2530-2538.2005; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Pin C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-455; Postier B, 2008, J MICROBIOL METH, V74, P26, DOI 10.1016/j.mimet.2007.07.004; Price MN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-19; Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388; Scharpf RB, 2009, J AM STAT ASSOC, V104, P1295, DOI 10.1198/jasa.2009.ap07611; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; STOREY J, 2003, ANAL GENE EXPRESSION; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Townsend JP, 2002, GENOME BIOL, V3; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2011, P NATL ACAD SCI USA, V108, pE67, DOI 10.1073/pnas.1100059108; Xiao GH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-87	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52137	10.1371/journal.pone.0052137	http://dx.doi.org/10.1371/journal.pone.0052137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284902	Green Published, gold			2022-12-25	WOS:000313051500023
J	Gupta, S; Marcel, N; Sarin, A; Shivashankar, GV				Gupta, Soumya; Marcel, Nimi; Sarin, Apurva; Shivashankar, G. V.			Role of Actin Dependent Nuclear Deformation in Regulating Early Gene Expression	PLOS ONE			English	Article							T-CELL-ACTIVATION; SHAPE; MECHANOTRANSDUCTION; KINASE; MODULATION; INDUCTION; MECHANICS; MATRIX	The nucleus of a living cell is constantly undergoing changes in shape and size as a result of various mechanical forces in physiology. These changes correlate with alterations in gene expression, however it is unclear whether nuclear deformation alone is sufficient to elicit these alterations. We used T-cell activation as a model system to test the coupling between nuclear deformation (elongation) and gene expression. Naive T-cell activation with surrogate antigens resulted in actin dependent nuclear elongation. This was accompanied with Erk and NF-kappa B signaling to the nucleus to induce CD69 expression. Importantly, inhibiting actin polymerization abolished both nuclear elongation and CD69 expression, while inhibiting Erk, NF-kappa B or microtubule depolymerization only abolished expression but not elongation. Immobilization of antigen-coated beads, under conditions where actin polymerization was inhibited, rescued both nuclear elongation and CD69 expression. In addition, fibroblast cells plated on fibronectin micropatterns of different sizes showed correlation between nuclear shape index and tenascin C expression. Upon inhibiting the signaling intermediate Erk, tenascin C expression was down regulated although the nuclear shape index remained unaltered. Our results highlight the importance of specific signaling intermediates accompanied with nuclear deformation in the modulation of cellular genomic programs.	[Gupta, Soumya; Marcel, Nimi; Sarin, Apurva; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Marcel, Nimi] Manipal Univ, Dept Hlth Sci, Manipal, Karnataka, India; [Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, MechanoBiol Inst, Singapore 117548, Singapore; [Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Manipal Academy of Higher Education (MAHE); National University of Singapore; National University of Singapore	Shivashankar, GV (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	dbsgvs@nus.edu.sg			Nanoscience Initiative and Swarnajayanti Grant (Department of Science and Technology, India); Nanoscience Initiative and Swarnajayanti Grant MechanoBiology Institute, Singapore	Nanoscience Initiative and Swarnajayanti Grant (Department of Science and Technology, India); Nanoscience Initiative and Swarnajayanti Grant MechanoBiology Institute, Singapore	Funding was obtained from Nanoscience Initiative and Swarnajayanti Grants (Department of Science and Technology, India), and MechanoBiology Institute, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babich A, 2012, J CELL BIOL, V197, P775, DOI 10.1083/jcb.201201018; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; LOPEZCABRERA M, 1995, J BIOL CHEM, V270, P21545, DOI 10.1074/jbc.270.37.21545; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; Maschler S, 2004, ONCOGENE, V23, P3622, DOI 10.1038/sj.onc.1207403; Mazumder A, 2010, J R SOC INTERFACE, V7, pS321, DOI 10.1098/rsif.2010.0039.focus; Olins AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-30; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schuh K, 1998, J EXP MED, V188, P1369, DOI 10.1084/jem.188.7.1369; Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; TESTI R, 1989, J IMMUNOL, V142, P1854; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594	26	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53031	10.1371/journal.pone.0053031	http://dx.doi.org/10.1371/journal.pone.0053031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285252	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500103
J	Harris, RS; Fujii-Rios, H; Winkler, T; Musch, G; Melo, MFV; Venegas, JG				Harris, R. Scott; Fujii-Rios, Hanae; Winkler, Tilo; Musch, Guido; Melo, Marcos F. Vidal; Venegas, Jose G.			Ventilation Defect Formation in Healthy and Asthma Subjects Is Determined by Lung Inflation	PLOS ONE			English	Article							HE-3 MAGNETIC-RESONANCE; REGIONAL VENTILATION; PULMONARY PERFUSION; BRONCHOCONSTRICTION; METHACHOLINE; PET; DYSFUNCTION; HISTAMINE; RESPONSES; PATCHY	Background: Imaging studies have demonstrated that ventilation during bronchoconstriction in subjects with asthma is patchy with large ventilation defective areas (Vdefs). Based on a theoretical model, we postulated that during bronchoconstriction, as smooth muscle force activation increases, a patchy distribution of ventilation should emerge, even in the presence of minimal heterogeneity the lung. We therefore theorized that in normal lungs, Vdefs should also emerge in regions of the lung with reduced expansion. Objective: We studied 12 healthy subjects to evaluate whether Vdefs formed during bronchoconstriction, and compared their Vdefs with those observed in 9 subjects with mild asthma. Methods: Spirometry, low frequency (0.15 Hz) lung elastance and resistance, and regional ventilation by intravenous (NN)-N-13-saline positron emission tomography were measured before and after a challenge with nebulized methacholine. Vdefs were defined as regions with elevated residual (NN)-N-13 after a period of washout. The average location, ventilation, volume, and fractional gas content of the Vdefs, relative to those of the rest of the lung, were calculated for both groups. Results: Consistent with the predictions of the theoretical model, both healthy subjects and those with asthma developed Vdefs. These Vdefs tended to form in regions that, at baseline, had a lower degree of lung inflation and, in healthy subjects, tended to occur in more dependent locations than in subjects with asthma. Conclusion: The formation of Vdefs is determined by the state of inflation prior to bronchoconstriction.	[Harris, R. Scott; Fujii-Rios, Hanae] Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Harris, R. Scott; Fujii-Rios, Hanae; Winkler, Tilo; Musch, Guido; Melo, Marcos F. Vidal; Venegas, Jose G.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Harris, RS (corresponding author), Massachusetts Gen Hosp, Dept Med, Pulm & Crit Care Unit, Boston, MA 02114 USA.	rsharris@mgh.harvard.edu	Melo, Marcos F Vidal/C-3452-2013; Melo, Marcos Vidal/AAN-7219-2020; Winkler, Tilo/B-5337-2009	Winkler, Tilo/0000-0002-7276-5550	National Institutes of Health [HL-68011, HL-04501]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068011, K08HL004501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health: HL-68011 to JGV and HL-04501 to RSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altes TA, 2001, J MAGN RESON IMAGING, V13, P378, DOI 10.1002/jmri.1054; Bayat S, 2009, J APPL PHYSIOL, V106, P1949, DOI 10.1152/japplphysiol.90550.2008; Busk M, 2012, EUR RESP J; CARTIER A, 1983, J APPL PHYSIOL, V54, P821, DOI 10.1152/jappl.1983.54.3.821; Ciftci TU, 2005, RESP MED, V99, P529, DOI 10.1016/j.rmed.2004.10.011; de Lange EE, 2007, J ALLERGY CLIN IMMUN, V119, P1072, DOI 10.1016/j.jaci.2006.12.659; de Lange EE, 2006, CHEST, V130, P1055, DOI 10.1378/chest.130.4.1055; Froese AB, 2006, ANESTHESIOLOGY, V104, P193, DOI 10.1097/00000542-200601000-00026; Harris RS, 2006, AM J RESP CRIT CARE, V174, P245, DOI 10.1164/rccm.200510-1634OC; Harris RS, 2009, J APPL PHYSIOL, V107, P266, DOI 10.1152/japplphysiol.91386.2008; Kraft M, 2001, AM J RESP CRIT CARE, V163, P1551, DOI 10.1164/ajrccm.163.7.2008013; Lafond C, 2007, EUR RESPIR J, V29, P307, DOI 10.1183/09031936.00059706; Melo MFV, 2005, AM J RESP CRIT CARE, V171, P714, DOI 10.1164/rccm.200409-1296OC; Melo MFV, 2003, J NUCL MED, V44, P1982; MUNKNER T, 1986, EUR J RESPIR DIS, V68, P62; Musch G, 2002, J APPL PHYSIOL, V93, P1841, DOI 10.1152/japplphysiol.00223.2002; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Samee S, 2003, J ALLERGY CLIN IMMUN, V111, P1205, DOI 10.1067/mai.2003.1544; SHARDONOFSKY FR, 1992, AM REV RESPIR DIS, V145, P750, DOI 10.1164/ajrccm/145.4_Pt_1.750; Tgavalekos NT, 2007, EUR RESPIR J, V29, P1174, DOI 10.1183/09031936.00113606; Tgavalekos NT, 2005, J APPL PHYSIOL, V99, P2388, DOI 10.1152/japplphysiol.00391.2005; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; Tzeng YS, 2009, J APPL PHYSIOL, V106, P813, DOI 10.1152/japplphysiol.01133.2007; Venegas JG, 2005, RESP PHYSIOL NEUROBI, V148, P57, DOI 10.1016/j.resp.2005.05.023; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007	26	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53216	10.1371/journal.pone.0053216	http://dx.doi.org/10.1371/journal.pone.0053216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285270	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500124
J	Jayaratne, YSN; Deutsch, CK; McGrath, CPJ; Zwahlen, RA				Jayaratne, Yasas S. N.; Deutsch, Curtis K.; McGrath, Colman P. J.; Zwahlen, Roger A.			Are Neoclassical Canons Valid for Southern Chinese Faces?	PLOS ONE			English	Article							FACIAL CANONS; PHOTOGRAMMETRIC IMAGES; POPULATIONS; ATTRACTIVENESS; PRECISION; REVISION	Background: Proportions derived from neoclassical canons, initially described by Renaissance sculptors and painters, are still being employed as aesthetic guidelines during the clinical assessment of the facial morphology. Objective: 1. to determine the applicability of neoclassical canons for Southern Chinese faces and 2. to explore gender differences in relation to the applicability of the neoclassical canons and their variants. Methodology: 3-D photographs acquired from 103 young adults (51 males and 52 females) without facial dysmorphology were used to test applicability of four neoclassical canons. Standard anthropometric measurements that determine the facial canons were made on these 3-D images. The validity of the canons as well as their different variants were quantified. Principal Findings: The neoclassical cannons seldom applied to these individuals, and facial three-section and orbital canons did not apply at all. The orbitonasal canon was most frequently applicable, with a frequency of 19%. Significant sexual dimorphism was found relative to the prevalence of the variants of facial three-section and orbitonasal canons. Conclusion: The neoclassical canons did not appear to apply to our sample when rigorous quantitative measurements were employed. Thus, they should not be used as esthetic goals for craniofacial surgical interventions.	[Jayaratne, Yasas S. N.; Zwahlen, Roger A.] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China; [Deutsch, Curtis K.] Univ Massachusetts, Sch Med, Eunice Kennedy Shriver Ctr, Waltham, MA USA; [Deutsch, Curtis K.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [McGrath, Colman P. J.] Univ Hong Kong, Fac Dent, Discipline Periodontol & Publ Hlth, Sai Ying Pun, Hong Kong, Peoples R China	University of Hong Kong; University of Massachusetts System; Harvard University; Harvard Medical School; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China.	zwahlen@hku.hk		Jayaratne, Yasas/0000-0002-4813-648X; McGrath, Colman Patrick Joseph/0000-0001-9379-0889; ZWAHLEN, Roger Arthur/0000-0003-4666-7567				Aldridge K, 2005, AM J MED GENET A, V138A, P247, DOI 10.1002/ajmg.a.30959; Bashour M, 2006, PLAST RECONSTR SURG, V118, P741, DOI 10.1097/01.prs.0000233051.61512.65; Borman H, 1999, ANN PLAS SURG, V42, P280, DOI 10.1097/00000637-199903000-00009; Buggio L, 2012, GYNECOL ENDOCRINOL, V28, P753, DOI 10.3109/09513590.2012.662545; Choe Kyle S, 2004, Arch Facial Plast Surg, V6, P244, DOI 10.1001/archfaci.6.4.244; Edler R J, 2001, J Orthod, V28, P159, DOI 10.1093/ortho/28.2.159; Farkas L G, 1987, ANTHROPOMETRIC FACIA; Farkas LG, 2000, AESTHET PLAST SURG, V24, P179, DOI 10.1007/s002660010029; FARKAS LG, 1985, PLAST RECONSTR SURG, V75, P328, DOI 10.1097/00006534-198503000-00005; Gill DS, 2008, DENT UPDATE, V35, P164; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Jayaratne YSN, 2012, PLAST RECONSTR SURG, V129, p164E, DOI 10.1097/PRS.0b013e3182362e3f; JEFFRIES JM, 1995, ANN PLAS SURG, V34, P318, DOI 10.1097/00000637-199503000-00016; Kolar JC., 1997, CRANIOFACIAL ANTHROP; Le TT, 2002, AESTHET PLAST SURG, V26, P64, DOI 10.1007/s00266-001-0033-7; Lieberman DE, 2008, EVOL ANTHROPOL, V17, P55, DOI 10.1002/evan.20154; Naini Farhad B, 2008, Dent Update, V35, P102; Naini Farhad B, 2008, Dent Update, V35, P159; Naini FB, 2008, DENT UPDATE, V35, P106; Naini FB, 2008, DENT UPDATE, V35, P169; Noback ML, 2011, AM J PHYS ANTHROPOL, V145, P599, DOI 10.1002/ajpa.21523; Okazaki K, 2011, ANTHROPOL SCI, V119, P49, DOI 10.1537/ase.100202; Porter J P, 2001, Arch Facial Plast Surg, V3, P191; Swennen GRJ, 2005, 3 DIMENSIONAL CEPHAL; Wang DW, 1997, AESTHET PLAST SURG, V21, P265; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015; Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI 10.1597/06-175; Wu XJ, 2007, CHINESE SCI BULL, V52, P1661, DOI 10.1007/s11434-007-0227-8	29	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52593	10.1371/journal.pone.0052593	http://dx.doi.org/10.1371/journal.pone.0052593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285105	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500037
J	Sandeu, MM; Moussiliou, A; Moiroux, N; Padonou, GG; Massougbodji, A; Corbel, V; Ndam, NT				Sandeu, Maurice Marcel; Moussiliou, Azizath; Moiroux, Nicolas; Padonou, Gilles G.; Massougbodji, Achille; Corbel, Vincent; Ndam, Nicaise Tuikue			Optimized Pan-species and Speciation Duplex Real-time PCR Assays for Plasmodium Parasites Detection in Malaria Vectors	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LINKED IMMUNOSORBENT-ASSAY; CIRCUMSPOROZOITE PROTEIN; ANOPHELES-GAMBIAE; FALCIPARUM; ELISA; SPOROZOITES; MOSQUITOS; SENSITIVITY; BLOOD	Background: An accurate method for detecting malaria parasites in the mosquito's vector remains an essential component in the vector control. The Enzyme linked immunosorbent assay specific for circumsporozoite protein (ELISA-CSP) is the gold standard method for the detection of malaria parasites in the vector even if it presents some limitations. Here, we optimized multiplex real-time PCR assays to accurately detect minor populations in mixed infection with multiple Plasmodium species in the African malaria vectors Anopheles gambiae and Anopheles funestus. Methods: Complementary TaqMan-based real-time PCR assays that detect Plasmodium species using specific primers and probes were first evaluated on artificial mixtures of different targets inserted in plasmid constructs. The assays were further validated in comparison with the ELISA-CSP on 200 field caught Anopheles gambiae and Anopheles funestus mosquitoes collected in two localities in southern Benin. Results: The validation of the duplex real-time PCR assays on the plasmid mixtures demonstrated robust specificity and sensitivity for detecting distinct targets. Using a panel of mosquito specimen, the real-time PCR showed a relatively high sensitivity (88.6%) and specificity (98%), compared to ELISA-CSP as the referent standard. The agreement between both methods was "excellent'' (k = 0.8, P < 0.05). The relative quantification of Plasmodium DNA between the two Anopheles species analyzed showed no significant difference (P = 0, 2). All infected mosquito samples contained Plasmodium falciparum DNA and mixed infections with P. malariae and/or P. ovale were observed in 18.6% and 13.6% of An. gambiae and An. funestus respectively. Plasmodium vivax was found in none of the mosquito samples analyzed. Conclusion: This study presents an optimized method for detecting the four Plasmodium species in the African malaria vectors. The study highlights substantial discordance with traditional ELISA-CSP pointing out the utility of employing an accurate molecular diagnostic tool for detecting malaria parasites in field mosquito populations.	[Sandeu, Maurice Marcel; Moussiliou, Azizath; Massougbodji, Achille; Ndam, Nicaise Tuikue] FSS, CERPAGE, Cotonou, Benin; [Sandeu, Maurice Marcel; Moiroux, Nicolas; Padonou, Gilles G.; Corbel, Vincent] Univ Abomey Calavi, CREC, Cotonou, Benin; [Sandeu, Maurice Marcel; Moiroux, Nicolas; Corbel, Vincent] Inst Rech Dev IRD 224, Cotonou, Benin; [Moussiliou, Azizath; Ndam, Nicaise Tuikue] Inst Rech Dev IRD 216, Cotonou, Benin; [Ndam, Nicaise Tuikue] Univ Paris 05, Fac Pharm, PRES Sorbonne Paris Cite, Paris, France	Entomological Research Center of Cotonou (CREC); University of Abomey Calavi; UDICE-French Research Universities; Universite Paris Cite	Ndam, NT (corresponding author), FSS, CERPAGE, Cotonou, Benin.	nicaise.ndam@ird.fr	Corbel, VIncent/G-9576-2016; Moiroux, Nicolas/AFT-2925-2022	Moiroux, Nicolas/0000-0001-6755-6167; PADONOU, Germain Gil/0000-0002-3802-6439; Tuikue Ndam, Nicaise/0000-0003-2646-2513; corbel, vincent/0000-0003-0995-3257	LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de recherche pour le developpement; Institut des sciences biomedicales - ISBA (Cotonou, BENIN); Faculte des sciences de la sante - FSS (Cotonou, BENIN); Centre de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID); DPF/IRD	LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de recherche pour le developpement; Institut des sciences biomedicales - ISBA (Cotonou, BENIN); Faculte des sciences de la sante - FSS (Cotonou, BENIN); Centre de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID)(United States Agency for International Development (USAID)); DPF/IRD	The current study was financially supported by the LMI LLIP "Laboratoire de lutte integree contre le paludisme: Institut de recherche pour le developpement, Institut des sciences biomedicales - ISBA (Cotonou, BENIN), Faculte des sciences de la sante - FSS (Cotonou, BENIN), Centre de Recherche Entomologique de Cotonou - CREC (Cotonou, BENIN) -(USAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Plasmodium genomic DNAs of P. vivax, P. malariae or P. ovale and plasmids containing insert of the 18S gene of each of those species were kindly provided by Dr Stephanie Yanow at the Provincial Laboratory for Public Health, Edmonton, Alberta, Canada. We thank all the inhabitants of the districts (Adjarra, Adjohoun, Dangbo, Misserete, and Seme) who agreed to participate in the study. We are very grateful to the mosquito collectors staff. MS was supported by PhD studentships from DPF/IRD.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; [Anonymous], 1968, ANOPHELINAE AFR S SA; Arez AP, 2000, EXP PARASITOL, V94, P269, DOI 10.1006/expr.2000.4496; BEIER JC, 1991, MED VET ENTOMOL, V5, P81, DOI 10.1111/j.1365-2915.1991.tb00524.x; Bigoga JD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-5; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; COLLINS FH, 1988, AM J TROP MED HYG, V38, P283, DOI 10.4269/ajtmh.1988.38.283; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; de Monbrison F, 2003, J MICROBIOL METH, V54, P391, DOI 10.1016/s0167-7012(03)00086-1; Diallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031100; Dicko A, 2011, LANCET INFECT DIS, V11, P722, DOI 10.1016/S1473-3099(11)70186-4; Durnez L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-195; Edwards FR, 1941, BRIT MED J, V1941, P901, DOI 10.1136/bmj.2.4225.901; Figtree M, 2010, EMERG INFECT DIS, V16, P672, DOI 10.3201/eid1604.091624; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lochouarn L, 1999, T ROY SOC TROP MED H, V93, P101, DOI 10.1016/S0035-9203(99)90198-0; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Mouatcho JC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-30; POSTHUMA G, 1989, EUR J CELL BIOL, V49, P66; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; SNIGS, 2010, RAPP ACT 2010 IRD BE; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SOMBOON P, 1993, T ROY SOC TROP MED H, V87, P322, DOI 10.1016/0035-9203(93)90148-J; Sylla EHK, 2000, T ROY SOC TROP MED H, V94, P652, DOI 10.1016/S0035-9203(00)90219-0; TASSANAKAJON A, 1993, T ROY SOC TROP MED H, V87, P273, DOI 10.1016/0035-9203(93)90124-9; Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004; WHO, 2011, WORLD MALARIA REPORT 2011, P1; *WHO UN CHILDR FUN, 2005, WORLD MAL REP 2005; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39	35	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52719	10.1371/journal.pone.0052719	http://dx.doi.org/10.1371/journal.pone.0052719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285168	Green Published, gold			2022-12-25	WOS:000313051500052
J	Schayowitz, A; Bertenshaw, G; Jeffries, E; Schatz, T; Cotton, J; Villanueva, J; Herlyn, M; Krepler, C; Vultur, A; Xu, W; Yu, GH; Schuchter, L; Clark, DP				Schayowitz, Adam; Bertenshaw, Greg; Jeffries, Emiko; Schatz, Timothy; Cotton, James; Villanueva, Jessie; Herlyn, Meenhard; Krepler, Clemens; Vultur, Adina; Xu, Wei; Yu, Gordon H.; Schuchter, Lynn; Clark, Douglas P.			Functional Profiling of Live Melanoma Samples Using a Novel Automated Platform	PLOS ONE			English	Article							RAF INHIBITOR RESISTANCE; TARGETED CANCER-THERAPY; ACQUIRED-RESISTANCE; IMPROVED SURVIVAL; OPEN-LABEL; BRAF; KINASE; MEK; BRAF(V600E); VEMURAFENIB	Aims: This proof-of-concept study was designed to determine if functional, pharmacodynamic profiles relevant to targeted therapy could be derived from live human melanoma samples using a novel automated platform. Methods: A series of 13 melanoma cell lines was briefly exposed to a BRAF inhibitor (PLX-4720) on a platform employing automated fluidics for sample processing. Levels of the phosphoprotein p-ERK in the mitogen-activated protein kinase (MAPK) pathway from treated and untreated sample aliquots were determined using a bead-based immunoassay. Comparison of these levels provided a determination of the pharmacodynamic effect of the drug on the MAPK pathway. A similar ex vivo analysis was performed on fine needle aspiration (FNA) biopsy samples from four murine xenograft models of metastatic melanoma, as well as 12 FNA samples from patients with metastatic melanoma. Results: Melanoma cell lines with known sensitivity to BRAF inhibitors displayed marked suppression of the MAPK pathway in this system, while most BRAF inhibitor-resistant cell lines showed intact MAPK pathway activity despite exposure to a BRAF inhibitor (PLX-4720). FNA samples from melanoma xenografts showed comparable ex vivo MAPK activity as their respective cell lines in this system. FNA samples from patients with metastatic melanoma successfully yielded three categories of functional profiles including: MAPK pathway suppression; MAPK pathway reactivation; MAPK pathway stimulation. These profiles correlated with the anticipated MAPK activity, based on the known BRAF mutation status, as well as observed clinical responses to BRAF inhibitor therapy. Conclusion: Pharmacodynamic information regarding the ex vivo effect of BRAF inhibitors on the MAPK pathway in live human melanoma samples can be reproducibly determined using a novel automated platform. Such information may be useful in preclinical and clinical drug development, as well as predicting response to targeted therapy in individual patients.	[Schayowitz, Adam; Bertenshaw, Greg; Jeffries, Emiko; Schatz, Timothy; Cotton, James; Clark, Douglas P.] BioMarker Strategies, Baltimore, MD USA; [Villanueva, Jessie; Herlyn, Meenhard; Krepler, Clemens; Vultur, Adina] Wistar Inst Anat & Biol, Melanoma Res Ctr, Philadelphia, PA 19104 USA; [Xu, Wei; Schuchter, Lynn] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Yu, Gordon H.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Clark, DP (corresponding author), BioMarker Strategies, Baltimore, MD USA.	dpclark@biomarkerstrategies.com		Vultur, Adina/0000-0003-0068-9496	National Cancer Institute (SBIR) [HHSN261200900075C, HHSN261201100112C]; NIH [PO1 CA114046]; Abramson Cancer Center Helbert Institute [461505]; NATIONAL CANCER INSTITUTE [P01CA114046, P30CA016520] Funding Source: NIH RePORTER	National Cancer Institute (SBIR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abramson Cancer Center Helbert Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors DPC, AS, GB, EJ, TS, JC and the SnapPath (TM) platform are supported by the National Cancer Institute (SBIR Contract ID: HHSN261200900075C and HHSN261201100112C). Authors JV, AV, CK, WX, LS and MH are supported by NIH PO1 CA114046 - Targeted Therapies in Melanoma. Authors LS, WX and GHY are supported by Abramson Cancer Center Helbert Institute fund (#461505) and Gift & Endowment funds within the Abramson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clark DP, 2009, EXPERT REV MOL DIAGN, V9, P787, DOI 10.1586/ERM.09.62; Clark DP, 2009, CANCER CYTOPATHOL, V117, P289, DOI 10.1002/cncy.20045; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218; Fojo T, 2010, CLIN CANCER RES, V16, P5972, DOI 10.1158/1078-0432.CCR-10-1277; Greger JG, 2012, MOL CANCER THER, V11, P909, DOI 10.1158/1535-7163.MCT-11-0989; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Herlyn M, 2010, J INVEST DERMATOL, V130, P911, DOI 10.1038/jid.2009.441; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Kirkwood JM, 2012, CLIN CANCER RES, V18, P555, DOI 10.1158/1078-0432.CCR-11-1491; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Parkinson DR, 2009, CURR OPIN MOL THER, V11, P252; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Shi HB, 2011, CANCER RES, V71, P5067, DOI 10.1158/0008-5472.CAN-11-0140; Sikorski R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001087; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	34	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52760	10.1371/journal.pone.0052760	http://dx.doi.org/10.1371/journal.pone.0052760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285177	Green Published, gold			2022-12-25	WOS:000313051500057
J	Wang, YM; Qu, RB; Hu, SF; Xiao, Y; Jiang, XH; Xu, GY				Wang, Yongmeng; Qu, Ruobing; Hu, Shufen; Xiao, Ying; Jiang, Xinghong; Xu, Guang-Yin			Upregulation of Cystathionine beta-Synthetase Expression Contributes to Visceral Hyperalgesia Induced by Heterotypic Intermittent Stress in Rats	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DORSAL-ROOT GANGLIA; ENDOGENOUS HYDROGEN-SULFIDE; K-ATP CHANNELS; GASTROINTESTINAL-TRACT; ESCHERICHIA-COLI; SODIUM CURRENTS; ION CHANNELS; SMALL-CELLS; GUINEA-PIG	Background: Hydrogen sulfide (H2S) functions as a neuromodulator, but whether it modulates visceral pain is not well known. This study was designed to determine the role for the endogenous H2S producing enzyme cystathionine beta-synthetase (CBS) and cystathionine gamma-lyase (CSE) in a validated rat model of visceral hyperalgesia (VH). Methods: VH was induced by nine-day heterotypic intermittent stress (HIS). Abdominal withdrawal reflex (AWR) scores were determined by measuring the visceromoter responses to colorectal distension (CRD). Dorsal root ganglia (DRG) neurons innervating the colon were labeled by injection of DiI (1,1'-dioleyl-3,3,3',3-tetramethylindocarbocyanine methanesulfonate) into the colon wall. Patch clamp recording techniques were employed to examine excitability and sodium channel currents of colon specific DRG neurons. Tissues from colon related thoracolumbar DRGs were analyzed for CBS, CSE and sodium channel expression. Results: HIS significantly increased the visceromotor responses to CRD in association with an upregulated expression of CBS not CSE proteins in colon related DRGs. Administration of O-(Carboxymethyl)hydroxylamine hemihydrochloride (AOAA), an inhibitor of CBS, attenuated the AWR scores in HIS-treated rats, in a dose dependent fashion. In contrast, AOAA did not produce any effect on AWR scores in healthy control rats. AOAA reversed the potentiation of sodium channel current densities of colon specific DRG neurons of HIS rats. To further confirm the role for CBS-H2S signaling, NaHS was used to mimic the production of H2S by CBS. Application of NaHS significantly enhanced neuronal excitability and potentiated sodium channel current densities of colon DRG neurons from healthy control rats. Furthermore, AOAA reversed the upregulation of Na(V)1.7 and Na(V)1.8 in colon related DRGs of HIS rats. Conclusion: Our results suggest that upregulation of CBS expression might play an important role in developing VH via sensitization of sodium channels in peripheral nociceptors, thus identifying a specific neurobiological target for the treatment of VH in functional bowel syndromes.	[Wang, Yongmeng; Qu, Ruobing; Hu, Shufen; Xiao, Ying; Jiang, Xinghong; Xu, Guang-Yin] Soochow Univ, Dept Neurobiol, Key Lab Pain Basic Res & Clin Therapy, Inst Neurosci, Suzhou, Peoples R China	Soochow University - China	Xu, GY (corresponding author), Soochow Univ, Dept Neurobiol, Key Lab Pain Basic Res & Clin Therapy, Inst Neurosci, Suzhou, Peoples R China.	guangyinxu@suda.edu.cn			National Natural Science Foundation of China [81070884, 81230024]; Jiangsu Distinguished Professor Program of Jiangsu Province [SR21500111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Distinguished Professor Program of Jiangsu Province	This work was supported by grants from National Natural Science Foundation of China (81070884; 81230024) and from Jiangsu Distinguished Professor Program of Jiangsu Province (SR21500111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Beyak MJ, 2005, NEUROGASTROENT MOTIL, V17, P175, DOI 10.1111/j.1365-2982.2004.00596.x; BUKOVSKA G, 1994, PROTEIN EXPRES PURIF, V5, P442, DOI 10.1006/prep.1994.1063; Distrutti E, 2006, J PHARMACOL EXP THER, V316, P325, DOI 10.1124/jpet.105.091595; Distrutti E, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-36; DROSSMAN DA, 1995, ANN INTERN MED, V123, P782, DOI 10.7326/0003-4819-123-10-199511150-00007; DROSSMAN DA, 1995, SCAND J GASTROENTERO, V30, P90, DOI 10.3109/00365529509107768; Drossman DA, 1997, GASTROENTEROLOGY, V112, P2120, DOI 10.1053/gast.1997.v112.agast972120; ELLIOTT AA, 1993, J PHYSIOL-LONDON, V463, P39, DOI 10.1113/jphysiol.1993.sp019583; ERICKSON PF, 1990, BIOCHEM J, V269, P335, DOI 10.1042/bj2690335; Eto K, 2002, J BIOL CHEM, V277, P42680, DOI 10.1074/jbc.M205835200; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Julian D, 2002, COMP BIOCHEM PHYS A, V133, P105, DOI 10.1016/S1095-6433(02)00122-8; Kataoka H, 2002, BIOL PHARM BULL, V25, P1436, DOI 10.1248/bpb.25.1436; Kawabata A, 2007, PAIN, V132, P74, DOI 10.1016/j.pain.2007.01.026; Lai J, 2002, PAIN, V95, P143, DOI 10.1016/S0304-3959(01)00391-8; Lembo T, 1997, DIGEST DIS SCI, V42, P1112, DOI 10.1023/A:1018817132213; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lowicka E, 2007, PHARMACOL REP, V59, P4; Maeda Y, 2009, PAIN, V142, P127, DOI 10.1016/j.pain.2008.12.021; Matsunami M, 2009, GUT, V58, P751, DOI 10.1136/gut.2007.144543; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Rush AM, 1998, J PHYSIOL-LONDON, V511, P771, DOI 10.1111/j.1469-7793.1998.771bg.x; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Stewart T, 2003, J PHYSIOL-LONDON, V552, P797, DOI 10.1113/jphysiol.2003.046409; Streng T, 2008, EUR UROL, V53, P391, DOI 10.1016/j.eururo.2007.10.024; Strickland IT, 2008, EUR J PAIN, V12, P564, DOI 10.1016/j.ejpain.2007.09.001; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; TALLEY NJ, 1994, GASTROENTEROLOGY, V107, P1040, DOI 10.1016/0016-5085(94)90228-3; Tang GH, 2005, MOL PHARMACOL, V68, P1757, DOI 10.1124/mol.105.017467; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Winston J, 2007, GASTROENTEROLOGY, V132, P615, DOI 10.1053/j.gastro.2006.11.014; Winston JH, 2010, GASTROENTEROLOGY, V138, P294, DOI 10.1053/j.gastro.2009.09.054; Xu GY, 2008, GUT, V57, P1230, DOI 10.1136/gut.2007.134221; Xu GY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-44; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	43	28	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53165	10.1371/journal.pone.0053165	http://dx.doi.org/10.1371/journal.pone.0053165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285261	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500113
J	De Rosa, A; Pellegatta, S; Rossi, M; Tunici, P; Magnoni, L; Speranza, MC; Malusa, F; Miragliotta, V; Mori, E; Finocchiaro, G; Bakker, A				De Rosa, Antonella; Pellegatta, Serena; Rossi, Marco; Tunici, Patrizia; Magnoni, Letizia; Speranza, Maria Carmela; Malusa, Federico; Miragliotta, Vincenzo; Mori, Elisa; Finocchiaro, Gaetano; Bakker, Annette			A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells	PLOS ONE			English	Article							MALIGNANT-GLIOMA-CELL; HUMAN BRAIN-TUMORS; CANCER STEM-CELL; B-FABP; EXPRESSION; LINES; PROGNOSIS; IDENTIFICATION; DOUBLECORTIN; PROFILES	Glioblastoma multiforme (GBM) is among the most deadly cancers. A number of studies suggest that a fraction of tumor cells with stem cell features (Glioma Stem-like Cells, GSC) might be responsible for GBM recurrence and aggressiveness. GSC similarly to normal neural stem cells, can form neurospheres (NS) in vitro, and seem to mirror the genetic features of the original tumor better than glioma cells growing adherently in the presence of serum. Using cDNA microarray analysis we identified a number of relevant genes for glioma biology that are differentially expressed in adherent cells and neurospheres derived from the same tumor. Fatty acid-binding protein 7 (FABP7) was identified as one of the most highly expressed genes in NS compared to their adherent counterpart. We found that down-regulation of FABP7 expression in NS by small interfering RNAs significantly reduced cell proliferation and migration. We also evaluated the potential involvement of FABP7 in response to radiotherapy, as this treatment may cause increased tumor infiltration. Migration of irradiated NS was associated to increased expression of FABP7. In agreement with this, in vivo reduced tumorigenicity of GBM cells with down-regulated expression of FABP7 was associated to decreased expression of the migration marker doublecortin. Notably, we observed that PPAR antagonists affect FABP7 expression and decrease the migration capability of NS after irradiation. As a whole, the data emphasize the role of FABP7 expression in GBM migration and provide translational hints on the timing of treatment with anti-FABP7 agents like PPAR antagonists during GBM evolution.	[De Rosa, Antonella; Rossi, Marco; Tunici, Patrizia; Magnoni, Letizia; Malusa, Federico; Mori, Elisa; Bakker, Annette] Siena Biotech Spa, Siena, Italy; [Pellegatta, Serena; Speranza, Maria Carmela; Finocchiaro, Gaetano] Neurol Inst C Besta, Unit Mol Neurooncol, Milan, Italy; [Pellegatta, Serena; Speranza, Maria Carmela; Finocchiaro, Gaetano] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Miragliotta, Vincenzo] Univ Pisa, Dept Anim Pathol Prophylaxis & Food Hyg, Pisa, Italy	Siena Biotech; IRCCS Istituto Neurologico Besta; IRCCS European Institute of Oncology (IEO); University of Pisa	De Rosa, A (corresponding author), Siena Biotech Spa, Siena, Italy.	aderosa@sienabiotech.it	Finocchiaro, Gaetano/B-6898-2013; Pellegatta, Serena/AAL-3693-2021; Miragliotta, Vincenzo/K-7361-2015	Pellegatta, Serena/0000-0001-7804-9486; Miragliotta, Vincenzo/0000-0001-7896-5695; bakker, annette/0000-0001-8420-7831; Rossi, Marco/0000-0002-3601-3343; Finocchiaro, Gaetano/0000-0003-3583-4040; Speranza, Maria Carmela/0000-0001-8531-9739	Monte Dei Paschi Foundation	Monte Dei Paschi Foundation	The work was supported by Monte Dei Paschi Foundation that is a funder of Siena Biotech S. P. A. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The collaboration between Siena Biotech and IRCCS Besta has only a scientific purpose without any financial contribution.	Arai Y, 2005, J NEUROSCI, V25, P9752, DOI 10.1523/JNEUROSCI.2512-05.2005; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Daou MC, 2005, ACTA NEUROPATHOL, V110, P472, DOI 10.1007/s00401-005-1070-0; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Godbout R, 1998, ONCOGENE, V16, P1955, DOI 10.1038/sj.onc.1201740; Hau P, 2007, DIS MARKERS, V23, P97, DOI 10.1155/2007/159242; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Josephson R, 1998, DEVELOPMENT, V125, P3087; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li AG, 2008, MOL CANCER RES, V6, P21, DOI 10.1158/1541-7786.MCR-07-0280; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Llaguno SRA, 2009, CLIN CANCER RES, V15, P7124, DOI 10.1158/1078-0432.CCR-09-0433; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Masui K, 2008, BRAIN TUMOR PATHOL, V25, P1, DOI 10.1007/s10014-007-0225-1; Mita R, 2007, NEOPLASIA, V9, P734, DOI 10.1593/neo.07439; Mita R, 2010, J BIOL CHEM, V285, P37005, DOI 10.1074/jbc.M110.170076; Montemayor C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008910; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Oeemig JS, 2009, BIOMOL NMR ASSIGN, V3, P89, DOI 10.1007/s12104-009-9148-6; Pelizzola M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-335; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Shimizu F, 1997, BBA-GENE STRUCT EXPR, V1354, P24, DOI 10.1016/S0167-4781(97)00115-2; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Singh SK, CANC RES, V63, P5821; Slipicevic A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-276; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Tunici P, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-25; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130	41	72	75	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52113	10.1371/journal.pone.0052113	http://dx.doi.org/10.1371/journal.pone.0052113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284888	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800030
J	Diomede, L; Soria, C; Romeo, M; Giorgetti, S; Marchese, L; Mangione, PP; Porcari, R; Zorzoli, I; Salmona, M; Bellotti, V; Stoppini, M				Diomede, Luisa; Soria, Cristina; Romeo, Margherita; Giorgetti, Sofia; Marchese, Loredana; Mangione, Patrizia Palma; Porcari, Riccardo; Zorzoli, Irene; Salmona, Mario; Bellotti, Vittorio; Stoppini, Monica			C. elegans Expressing Human beta(2)-Microglobulin: A Novel Model for Studying the Relationship between the Molecular Assembly and the Toxic Phenotype	PLOS ONE			English	Article							TRANSGENIC CAENORHABDITIS-ELEGANS; AMYLOID-INDUCED TOXICITY; LIFE-SPAN; BETA-2-MICROGLOBULIN; PROTEIN; AGGREGATION; NEMATODE; VARIANT; MITOCHONDRIA; HEMODIALYSIS	Availability of living organisms to mimic key step of amyloidogenesis of human protein has become an indispensable tool for our translation approach aiming at filling the deep gap existing between the biophysical and biochemical data obtained in vitro and the pathological features observed in patients. Human beta(2)-microglobulin (beta(2)-m) causes systemic amyloidosis in haemodialysed patients. The structure, misfolding propensity, kinetics of fibrillogenesis and cytotoxicity of this protein, in vitro, have been studied more extensively than for any other globular protein. However, no suitable animal model for beta(2)-m amyloidosis has been so far reported. We have now established and characterized three new transgenic C. elegans strains expressing wild type human beta(2)-m and two highly amyloidogenic isoforms: P32G variant and the truncated form Delta N6 lacking of the 6 N-terminal residues. The expression of human beta(2)-m affects the larval growth of C. elegans and the severity of the damage correlates with the intrinsic propensity to self-aggregate that has been reported in previous in vitro studies. We have no evidence of the formation of amyloid deposits in the body-wall muscles of worms. However, we discovered a strict correlation between the pathological phenotype and the presence of oligomeric species recognized by the A11 antibody. The strains expressing human beta(2)-m exhibit a locomotory defect quantified with the body bends assay. Here we show that tetracyclines can correct this abnormality confirming that these compounds are able to protect a living organism from the proteotoxicity of human beta(2)-m.	[Diomede, Luisa; Romeo, Margherita; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Soria, Cristina; Giorgetti, Sofia; Marchese, Loredana; Mangione, Patrizia Palma; Porcari, Riccardo; Bellotti, Vittorio; Stoppini, Monica] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy; [Mangione, Patrizia Palma; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, London, England; [Zorzoli, Irene] Univ Pavia, Dept Internal Med & Clin Therapeut, I-27100 Pavia, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Pavia; University of London; University College London; University of Pavia	Bellotti, V (corresponding author), Univ Pavia, Inst Biochem, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	vbellot@unipv.it	Diomede, Luisa/P-3417-2014; salmona, mario/AAA-7116-2020; Giorgetti, Sofia/AAD-4341-2019; salmona, mario/ABI-4066-2020; Bellotti, Vittorio/A-6201-2014	Diomede, Luisa/0000-0002-2258-0531; salmona, mario/0000-0002-9098-9873; Giorgetti, Sofia/0000-0001-9438-6511; Bellotti, Vittorio/0000-0001-8678-662X; Mangione, Palma/0000-0003-0260-1400; Romeo, Margherita/0000-0002-3020-8545	Cariplo Foundation [2009-2543, 2011-2096]; Intesa San Paolo Foundation; Italian Ministry of University and Research [FIRB RBFR109EOS, PRIN 20083ERXWS]; Regione Lombardia; Fondazione Banca del Monte di Lombardia; MRC UK; Medical Research Council [MR/K000187/1] Funding Source: researchfish; MRC [MR/K000187/1] Funding Source: UKRI	Cariplo Foundation(Fondazione Cariplo); Intesa San Paolo Foundation; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); Fondazione Banca del Monte di Lombardia; MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly supported by Cariplo Foundation (Project n. 2009-2543, and 2011-2096), Intesa San Paolo Foundation, the Italian Ministry of University and Research (Projects FIRB RBFR109EOS and PRIN 20083ERXWS), Regione Lombardia, Fondazione Banca del Monte di Lombardia and MRC UK: strategic award to Vittorio Bellotti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; Diomede L, 2010, NEUROBIOL DIS, V40, P424, DOI 10.1016/j.nbd.2010.07.002; Domanska K, 2011, P NATL ACAD SCI USA, V108, P1314, DOI 10.1073/pnas.1008560108; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Fogolari F, 2007, BIOPHYS J, V92, P1673, DOI 10.1529/biophysj.106.098483; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; GEJYO F, 1986, NEW ENGL J MED, V314, P585; Giorgetti S, 2011, J BIOL CHEM, V286, P2121, DOI 10.1074/jbc.M110.178376; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Liao VHC, 2011, MECH AGEING DEV, V132, P480, DOI 10.1016/j.mad.2011.07.008; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2001, NEUROBIOL AGING, V22, P217, DOI 10.1016/S0197-4580(00)00237-2; Link CD, 2005, GENES BRAIN BEHAV, V4, P147, DOI 10.1111/j.1601-183X.2004.00105.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo Y, 2006, LIFE SCI, V78, P2066, DOI 10.1016/j.lfs.2005.12.004; Luo Y, 2009, METHODS BEHAV ANAL N; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Pagani L, 2011, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2011/925050; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Sosa MAG, 2012, HUM GENET, V131, P535, DOI 10.1007/s00439-011-1119-1; Stoppini M, 2005, BBA-PROTEINS PROTEOM, V1753, P23, DOI 10.1016/j.bbapap.2005.07.019; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Wolozin B, 2011, PROG MOL BIOL TRANSL, V100, P499, DOI 10.1016/B978-0-12-384878-9.00015-7; Zhang PY, 2010, AMYLOID, V17, P50, DOI 10.3109/13506129.2010.483116	40	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52314	10.1371/journal.pone.0052314	http://dx.doi.org/10.1371/journal.pone.0052314			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284985	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800047
J	Miramon, P; Dunker, C; Windecker, H; Bohovych, IM; Brown, AJP; Kurzai, O; Hube, B				Miramon, Pedro; Dunker, Christine; Windecker, Hanna; Bohovych, Iryna M.; Brown, Alistair J. P.; Kurzai, Oliver; Hube, Bernhard			Cellular Responses of Candida albicans to Phagocytosis and the Extracellular Activities of Neutrophils Are Critical to Counteract Carbohydrate Starvation, Oxidative and Nitrosative Stress	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE; TRANSCRIPTIONAL RESPONSE; PATHOGEN; GENE; INDUCTION; VIRULENCE; PATHWAYS	Neutrophils are key players during Candida albicans infection. However, the relative contributions of neutrophil activities to fungal clearance and the relative importance of the fungal responses that counteract these activities remain unclear. We studied the contributions of the intra- and extracellular antifungal activities of human neutrophils using diagnostic Green Fluorescent Protein (GFP)-marked C. albicans strains. We found that a carbohydrate starvation response, as indicated by up-regulation of glyoxylate cycle genes, was only induced upon phagocytosis of the fungus. Similarly, the nitrosative stress response was only observed in internalised fungal cells. In contrast, the response to oxidative stress was observed in both phagocytosed and non-phagocytosed fungal cells, indicating that oxidative stress is imposed both intra- and extracellularly. We assessed the contributions of carbohydrate starvation, oxidative and nitrosative stress as antifungal activities by analysing the resistance to neutrophil killing of C. albicans mutants lacking key glyoxylate cycle, oxidative and nitrosative stress genes. We found that the glyoxylate cycle plays a crucial role in fungal resistance against neutrophils. The inability to respond to oxidative stress (in cells lacking superoxide dismutase 5 or glutathione reductase 2) renders C. albicans susceptible to neutrophil killing, due to the accumulation of reactive oxygen species (ROS). We also show that neutrophil-derived nitric oxide is crucial for the killing of C. albicans: a yhb1 Delta/Delta mutant, unable to detoxify NO center dot, was more susceptible to neutrophils, and this phenotype was rescued by the nitric oxide scavenger carboxy-PTIO. The stress responses of C. albicans to neutrophils are partially regulated via the stress regulator Hog1 since a hog1 Delta/Delta mutant was clearly less resistant to neutrophils and unable to respond properly to neutrophil-derived attack. Our data indicate that an appropriate fungal response to all three antifungal activities, carbohydrate starvation, nitrosative stress and oxidative stress, is essential for full wild type resistance to neutrophils.	[Miramon, Pedro; Dunker, Christine; Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Windecker, Hanna; Kurzai, Oliver] Univ Jena, Sept Res Ctr, Jena, Germany; [Bohovych, Iryna M.; Brown, Alistair J. P.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [Hube, Bernhard] Univ Klinikum Jena, Ctr Sepsis Control & Care, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University of Aberdeen; Friedrich Schiller University of Jena	Hube, B (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Product Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	Bernhard.Hube@hki-jena.de	Brown, Alistair J.P./B-6627-2014	Miramon, Pedro/0000-0002-6867-7697; Kurzai, Oliver/0000-0002-7277-2646; Hube, Bernhard/0000-0002-6028-0425; Brown, Alistair JP/0000-0003-1406-4251	European Commission [PITN-GA-2008-214004, ERC-2009-AdG-249793]; UK Biotechnology and Biological Research Council [BB/F00513X/1]; Wellcome Trust [080088]; BBSRC [BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/06679, BB/F00513X/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The European Commission funded the FINSysB Marie Curie Initial Training Network (PITN-GA-2008-214004). AJPB is also supported by funding from the European Commission (STRIFE, ERC-2009-AdG-249793), the UK Biotechnology and Biological Research Council (BB/F00513X/1), and from the Wellcome Trust (080088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Arana DM, 2007, CELL MICROBIOL, V9, P1647, DOI 10.1111/j.1462-5822.2007.00898.x; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; BELLAMY W, 1993, MED MICROBIOL IMMUN, V182, P97, DOI 10.1007/BF00189377; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Cederlund A, 2010, J INNATE IMMUN, V2, P508, DOI 10.1159/000317665; Chaves GM, 2007, GENET MOL RES, V6, P1051; Cheetham J, 2011, J BIOL CHEM, V286, P42002, DOI 10.1074/jbc.M111.265231; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Chiranand W, 2008, EUKARYOT CELL, V7, P268, DOI 10.1128/EC.00240-07; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; de Jesus-Berrios M, 2003, CURR BIOL, V13, P1963, DOI 10.1016/j.cub.2003.10.029; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Enjalbert B, 2007, INFECT IMMUN, V75, P2143, DOI 10.1128/IAI.01680-06; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Hube B, 2009, CURR OPIN MICROBIOL, V12, P347, DOI 10.1016/j.mib.2009.06.009; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kaloriti D, 2012, MED MYCOL; LEHRER RI, 1990, BLOOD, V76, P2169; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Martchenko M, 2004, MOL BIOL CELL, V15, P456, DOI 10.1091/mbc.E03-03-0179; Moyes DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026580; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Nordenfelt P, 2011, J LEUKOCYTE BIOL, V90, P271, DOI 10.1189/jlb.0810457; Odds FC., 1988, CANDIDA CANDIDOSIS; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Stevanin TM, 2007, GENE, V398, P62, DOI 10.1016/j.gene.2007.03.021; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Wilson D, 2009, FEMS YEAST RES, V9, P688, DOI 10.1111/j.1567-1364.2009.00524.x; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; Wysong DR, 1998, INFECT IMMUN, V66, P1953, DOI 10.1128/IAI.66.5.1953-1961.1998; Youseff BH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002713	46	80	90	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52850	10.1371/journal.pone.0052850	http://dx.doi.org/10.1371/journal.pone.0052850			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285201	Green Published, gold			2022-12-25	WOS:000313158800101
J	Pany, S; Majhi, A; Das, J				Pany, Satyabrata; Majhi, Anjoy; Das, Joydip			PKC Activation by Resveratrol Derivatives with Unsaturated Aliphatic Chain	PLOS ONE			English	Article							PROTEIN-KINASE-C; ALCOHOL-BINDING-SITE; FATTY-ACIDS; PLATELET-AGGREGATION; MOLECULAR-BASIS; LINOLEIC-ACID; RED WINE; IN-VITRO; APOPTOSIS; ALPHA	Resveratrol (1) is a naturally occurring phytoalexin that affects a variety of human disease models, including cardio- and neuroprotection, immune regulation, and cancer chemoprevention. One of the possible mechanisms by which resveratrol affects these disease states is by affecting the cellular signaling network involving protein kinase C (PKC). PKC is the family of serine/threonine kinases, whose activity is inhibited by resveratrol. To develop PKC isotype selective molecules on the resveratrol scaffold, several analogs (2-5) of resveratrol with a long aliphatic chain varying with number of unsaturated doubled bonds have been synthesized, their cytotoxic effects on CHO-K1 cells are measured and their effects on the membrane translocation properties of PKC alpha and PKC epsilon have been determined. The analogs showed less cytotoxic effects on CHO-K1 cells. Analog 4 with three unsaturated double bonds in its aliphatic chain activated PKC alpha, but not PKC epsilon. Analog 4 also activated ERK1/2, the downstream proteins in the PKC signaling pathway. Resveratrol analogs 2-5, however, did not show any inhibition of the phorbol ester-induced membrane translocation for either PKC alpha or PKC epsilon. Molecular docking of 4 into the activator binding site of PKC alpha revealed that the resveratrol moiety formed hydrogen bonds with the activator binding residues and the aliphatic chain capped the activator binding loops making its surface hydrophobic to facilitate its interaction with the plasma membrane. The present study shows that subtle changes in the resveratrol structure can have profound impact on the translocation properties of PKCs. Therefore, resveratrol scaffold can be used to develop PKC selective modulators for regulating associated disease states.	[Pany, Satyabrata; Majhi, Anjoy; Das, Joydip] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA	University of Houston System; University of Houston	Das, J (corresponding author), Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA.	jdas@uh.edu		MAJHI, ANJOY/0000-0003-0142-4940				Aires V, 2007, MOL PHARMACOL, V72, P1545, DOI 10.1124/mol.107.039792; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Atten MJ, 2005, INVEST NEW DRUG, V23, P111, DOI 10.1007/s10637-005-5855-8; Babich H, 2000, TOXICOL LETT, V114, P143, DOI 10.1016/S0378-4274(99)00288-X; Banci L, 2002, J BIOL CHEM, V277, P12988, DOI 10.1074/jbc.M106875200; Battaini F, 2007, PHARMACOL RES, V55, P461, DOI 10.1016/j.phrs.2007.05.005; Belguendouz L, 1997, BIOCHEM PHARMACOL, V53, P1347, DOI 10.1016/S0006-2952(96)00820-9; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Bright R, 2005, STROKE, V36, P2781, DOI 10.1161/01.STR.0000189996.71237.f7; Chen CK, 1996, GEN PHARMACOL-VASC S, V27, P363; Chou WH, 2005, TRENDS CARDIOVAS MED, V15, P47, DOI 10.1016/j.tcm.2005.01.003; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Das J, 2004, J BIOL CHEM, V279, P37964, DOI 10.1074/jbc.M405137200; Das J, 2006, PROTEIN SCI, V15, P2107, DOI 10.1110/ps.062237606; Das J, 2011, BIOORGAN MED CHEM, V19, P5321, DOI 10.1016/j.bmc.2011.08.008; Das J, 2009, BIOCHEM J, V421, P405, DOI 10.1042/BJ20082271; Endo Y, 2000, BIOORG MED CHEM LETT, V10, P63, DOI 10.1016/S0960-894X(99)00580-6; Ferrero ME, 1998, AM J CLIN NUTR, V68, P1208, DOI 10.1093/ajcn/68.6.1208; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Geczy T, 2012, J BIOL CHEM, V287, P13137, DOI 10.1074/jbc.M111.320010; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; Hofmann J, 2004, CURR CANCER DRUG TAR, V4, P125, DOI 10.2174/1568009043481579; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kim HFS, 2001, MOL PSYCHIATR, V6, P246, DOI 10.1038/sj.mp.4000837; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Konopatskaya O, 2010, TRENDS PHARMACOL SCI, V31, P8, DOI 10.1016/j.tips.2009.10.006; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Maccarrone M, 1999, EUR J BIOCHEM, V265, P27, DOI 10.1046/j.1432-1327.1999.00630.x; Majhi A, 2010, BIOORGAN MED CHEM, V18, P1591, DOI 10.1016/j.bmc.2009.12.075; Mgbonyebi OP, 1998, INT J ONCOL, V12, P865; Morris GZ, 2002, PROSTATE, V52, P319, DOI 10.1002/pros.10122; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; Nakashima S, 2002, J BIOCHEM, V132, P669, DOI 10.1093/oxfordjournals.jbchem.a003272; Nelson TJ, 2009, J BIOL CHEM, V284, P34514, DOI 10.1074/jbc.M109.016683; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; PACEASCIAK CR, 1995, CLIN CHIM ACTA, V235, P207, DOI 10.1016/0009-8981(95)06045-1; PaceAsciak CR, 1996, CLIN CHIM ACTA, V246, P163, DOI 10.1016/0009-8981(96)06236-5; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Petrovski G, 2011, ANN NY ACAD SCI, V1215, P22, DOI 10.1111/j.1749-6632.2010.05843.x; Pi YQ, 2000, AM J PHYSIOL-HEART C, V279, pH26, DOI 10.1152/ajpheart.2000.279.1.H26; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Prades J, 2003, J LIPID RES, V44, P1720, DOI 10.1194/jlr.M300092-JLR200; Ratan HL, 2002, UROL ONCOL, V7, P223, DOI 10.1016/S1078-1439(02)00194-1; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Richard T, 2011, ANN NY ACAD SCI, V1215, P103, DOI 10.1111/j.1749-6632.2010.05865.x; Sabri A, 2003, MOL CELL BIOCHEM, V251, P97, DOI 10.1023/A:1025490017780; Schneider Y, 2000, CANCER LETT, V158, P85, DOI 10.1016/S0304-3835(00)00511-5; Schwedhelm E, 2003, CLIN PHARMACOKINET, V42, P437, DOI 10.2165/00003088-200342050-00003; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; Shirai Y, 1998, J CELL BIOL, V143, P511, DOI 10.1083/jcb.143.2.511; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Slater SJ, 2003, BBA-MOL BASIS DIS, V1637, P59, DOI 10.1016/S0925-4439(02)00214-4; Sodeoka M, 1998, J AM CHEM SOC, V120, P457, DOI 10.1021/ja971270t; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stewart JR, 1999, BIOCHEMISTRY-US, V38, P13244, DOI 10.1021/bi990875u; Stewart JR, 2004, INVEST NEW DRUG, V22, P107, DOI 10.1023/B:DRUG.0000011787.75522.ec; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Surh YJ, 1999, CANCER LETT, V140, P1, DOI 10.1016/S0304-3835(99)00039-7; Szekeres T, 2011, ANN NY ACAD SCI, V1215, P89, DOI 10.1111/j.1749-6632.2010.05864.x; Teicher BA, 2006, CLIN CANCER RES, V12, P5336, DOI 10.1158/1078-0432.CCR-06-0945; Wada R, 2002, J AM CHEM SOC, V124, P10658, DOI 10.1021/ja027048s; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; WOOTEN MW, 1988, BIOCHEM BIOPH RES CO, V153, P67, DOI 10.1016/S0006-291X(88)81190-2; Wu JM, 2011, ANN NY ACAD SCI, V1215, P16, DOI 10.1111/j.1749-6632.2010.05854.x; Yaguchi T, 2005, MOL BRAIN RES, V133, P320, DOI 10.1016/j.molbrainres.2004.10.031; Yamatsugu K, 2006, CHEM-ASIAN J, V1, P314, DOI 10.1002/asia.200600185; Yang YM, 2008, AM J CHINESE MED, V36, P603, DOI 10.1142/S0192415X08006016	80	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52888	10.1371/journal.pone.0052888	http://dx.doi.org/10.1371/journal.pone.0052888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285216	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800105
J	Prado, JRM; Chen, X; Fuller, MT				Prado, Jose Rafael Morillo; Chen, Xin; Fuller, Margaret T.			Polycomb Group Genes Psc and Su(z)2 Maintain Somatic Stem Cell Identity and Activity in Drosophila	PLOS ONE			English	Article							POSTERIOR SEX COMBS; SELF-RENEWAL; BITHORAX COMPLEX; GROUP PROTEIN; SPATIAL EXPRESSION; TUMOR-SUPPRESSOR; ABDOMINAL-B; BMI-1; MEL-18; ENCODES	Adult stem cells are essential for the proper function of many tissues, yet the mechanisms that maintain the proper identity and regulate proliferative capacity in stem cell lineages are not well understood. Polycomb group (PcG) proteins are transcriptional repressors that have recently emerged as important regulators of stem cell maintenance and differentiation. Here we describe the role of Polycomb Repressive Complex 1 (PRC1) genes Posterior sex combs (Psc) and Suppressor of zeste two (Su(z)2) in restricting the proliferation and maintaining the identity of the Cyst Stem Cell (CySC) lineage in the Drosophila testis. In contrast, Psc and Su(z)2 seem to be dispensable for both germline stem cell (GSC) maintenance and germ cell development. We show that loss of Psc and Su(z)2 function in the CySC lineage results in the formation of aggregates of mutant cells that proliferate abnormally, and display abnormal somatic identity correlated with derepression of the Hox gene Abdominal-B. Furthermore, we show that tumorigenesis in the CySC lineage interferes non-cell autonomously with maintenance of GSCs most likely by displacing them from their niche.	[Prado, Jose Rafael Morillo; Fuller, Margaret T.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Stanford University; Johns Hopkins University	Fuller, MT (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	mtfuller@stanford.edu		Fuller, Margaret T/0000-0002-3804-4987	NIH [GM61986, K-99/R00 HD055052]; NSF; Stanford University DARE; Reed-Hodgson Professorship in Human Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD055052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford University DARE; Reed-Hodgson Professorship in Human Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM61986 to M. T. F. J.R.M.P. was supported by an NSF Graduate Research Fellowship and a Stanford University DARE Doctoral Fellowship. X. C. was supported by NIH K-99/R00 HD055052 award. M. T. F. gratefully acknowledges the Reed-Hodgson Professorship in Human Biology, which partially supported this work. [http://www.nih.gov/, http://www.nsfgrfp.org/, http://vpge.stanford.edu/fellowships/dare.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuchle D, 2001, DEVELOPMENT, V128, P993; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; BOYLE M, 1995, DEVELOPMENT, V121, P1815; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; CELNIKER SE, 1993, P NATL ACAD SCI USA, V90, P1566, DOI 10.1073/pnas.90.4.1566; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; DeFalco T, 2004, MECH DEVELOP, V121, P1323, DOI 10.1016/j.mod.2004.07.001; DeFalco TJ, 2003, DEV CELL, V5, P205, DOI 10.1016/S1534-5807(03)00204-1; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DiNardo S, 2011, DEVELOPMENT, V138, P1687, DOI 10.1242/dev.057364; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; GOEBL MG, 1991, CELL, V66, P623, DOI 10.1016/0092-8674(91)90106-9; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Guo WJ, 2007, MOL BIOL CELL, V18, P536, DOI 10.1091/mbc.E06-05-0447; HAUPT Y, 1993, ONCOGENE, V8, P3161; IRMINGERFINGER I, 1995, GENE, V163, P203, DOI 10.1016/0378-1119(95)00326-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kajiume T, 2004, EXP HEMATOL, V32, P571, DOI 10.1016/j.exphem.2004.03.001; KANNO M, 1995, EMBO J, V14, P5672, DOI 10.1002/j.1460-2075.1995.tb00254.x; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kim JH, 2004, BREAST, V13, P383, DOI 10.1016/j.breast.2004.02.010; Kyba M, 1998, MOL CELL BIOL, V18, P2712, DOI 10.1128/MCB.18.5.2712; LAWRENCE PA, 1983, CELL, V35, P27, DOI 10.1016/0092-8674(83)90204-0; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Li XH, 2010, GENE DEV, V24, P933, DOI 10.1101/gad.1901510; Lovato TL, 2002, DEVELOPMENT, V129, P5019; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; MARTIN EC, 1993, DEVELOPMENT, V117, P641; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Nanda S, 2009, SEX DEV, V3, P26, DOI 10.1159/000200079; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; SOTO MC, 1995, GENETICS, V140, P231; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317; XU T, 1993, DEVELOPMENT, V117, P1223; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680	55	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52892	10.1371/journal.pone.0052892	http://dx.doi.org/10.1371/journal.pone.0052892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285219	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800106
J	Sachse, D; Sletner, L; Morkrid, K; Jenum, AK; Birkeland, KI; Rise, F; Piehler, AP; Berg, JP				Sachse, Daniel; Sletner, Line; Morkrid, Kjersti; Jenum, Anne Karen; Birkeland, Kare I.; Rise, Frode; Piehler, Armin P.; Berg, Jens Petter			Metabolic Changes in Urine during and after Pregnancy in a Large, Multiethnic Population-Based Cohort Study of Gestational Diabetes	PLOS ONE			English	Article							NMR-BASED METABONOMICS; ANALYTICAL REPRODUCIBILITY; MAGNETIC-RESONANCE; MATERNAL URINE; INBORN-ERRORS; BLOOD-PLASMA; OUTCOME HAPO; SPECTROSCOPY; PREECLAMPSIA; BIOMARKERS	This study aims to identify novel markers for gestational diabetes (GDM) in the biochemical profile of maternal urine using NMR metabolomics. It also catalogs the general effects of pregnancy and delivery on the urine profile. Urine samples were collected at three time points (visit V1: gestational week 8-20; V2: week 28 +/- 62; V3: 10-16 weeks post partum) from participants in the STORK Groruddalen program, a prospective, multiethnic cohort study of 823 healthy, pregnant women in Oslo, Norway, and analyzed using H-1-NMR spectroscopy. Metabolites were identified and quantified where possible. PCA, PLS-DA and univariate statistics were applied and found substantial differences between the time points, dominated by a steady increase of urinary lactose concentrations, and an increase during pregnancy and subsequent dramatic reduction of several unidentified NMR signals between 0.5 and 1.1 ppm. Multivariate methods could not reliably identify GDM cases based on the WHO or graded criteria based on IADPSG definitions, indicating that the pattern of urinary metabolites above micromolar concentrations is not influenced strongly and consistently enough by the disease. However, univariate analysis suggests elevated mean citrate concentrations with increasing hyperglycemia. Multivariate classification with respect to ethnic background produced weak but statistically significant models. These results suggest that although NMR-based metabolomics can monitor changes in the urinary excretion profile of pregnant women, it may not be a prudent choice for the study of GDM.	[Sachse, Daniel; Berg, Jens Petter] Univ Oslo, Dept Med Biochem, Oslo, Norway; [Sachse, Daniel; Piehler, Armin P.; Berg, Jens Petter] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Sachse, Daniel; Rise, Frode] Univ Oslo, Dept Chem, Oslo, Norway; [Sletner, Line; Morkrid, Kjersti; Birkeland, Kare I.] Oslo Univ Hosp, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Sletner, Line] Akershus Univ Hosp, Dept Child & Adolescents Med, Lorenskog, Norway; [Sletner, Line; Morkrid, Kjersti; Birkeland, Kare I.] Univ Oslo, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Jenum, Anne Karen] Univ Oslo, Dept Gen Practice, Oslo, Norway; [Jenum, Anne Karen] Oslo & Akershus Univ, Coll Appl Sci, Oslo, Norway; [Piehler, Armin P.] Furst Med Lab, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Sachse, D (corresponding author), Univ Oslo, Dept Med Biochem, Oslo, Norway.	daniel.sachse@medisin.uio.no	Berg, Jens P/G-1455-2012; Birkeland, Kåre I/E-9750-2010	Berg, Jens P/0000-0003-0157-5888; Sachse, Daniel/0000-0002-3121-1236; Rise, Frode/0000-0002-7871-3962	University of Oslo; Oslo Diabetes Research Centre	University of Oslo; Oslo Diabetes Research Centre	The study was supported by grants from the University of Oslo and the Oslo Diabetes Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 2010, R LANG ENV STAT COMP; Ashwood ER, 2006, TIETZ TXB CLIN CHEM, P2153; Banfi D, 2008, CHIMIA, V62, P280, DOI 10.2533/chimia.2008.280; Barkauskas DA, 2009, FTICRMS PROGR AN FOU; Barkauskas DA, 2010, ANAL CHIM ACTA, V657, P191, DOI 10.1016/j.aca.2009.10.043; Beaglehole R, 2012, LANCET, V379, P1873, DOI 10.1016/S0140-6736(12)60800-9; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; BELL JD, 1988, CHEM BRIT, V24, P1021; Buchanan TA, 2012, NAT REV ENDOCRINOL, V8, P639, DOI 10.1038/nrendo.2012.96; Carraro S, 2007, AM J RESP CRIT CARE, V175, P986, DOI 10.1164/rccm.200606-769OC; Castillo AM, 2011, J MAGN RESON, V209, P123, DOI 10.1016/j.jmr.2010.12.008; Constantinou MA, 2005, ANAL CHIM ACTA, V542, P169, DOI 10.1016/j.aca.2005.03.059; Contreras M, 2002, INT J GYNECOL OBSTET, V78, P69; Cox DB, 1999, EXP PHYSIOL, V84, P421, DOI 10.1017/S0958067099018072; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; DATE JW, 1964, SCAND J CLIN LAB INV, V16, P589, DOI 10.3109/00365516409055221; Diaz SO, 2011, J PROTEOME RES, V10, P3732, DOI 10.1021/pr200352m; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; Dunn WB, 2011, BIOANALYSIS, V3, P2205, DOI [10.4155/BIO.11.223, 10.4155/bio.11.223]; Eaton J.W., 2002, GNU OCTAVE MANUAL; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gallery EDM, 1996, HYPERTENS PREGNANCY, V15, P257, DOI 10.3109/10641959609015709; Graca G, 2012, MOL BIOSYST, V8, P1243, DOI 10.1039/c2mb05424h; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; HAMMAR ML, 1987, SCAND J UROL NEPHROL, V21, P51, DOI 10.3109/00365598709180291; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Horgan RP, 2009, BJOG-INT J OBSTET GY, V116, P173, DOI 10.1111/j.1471-0528.2008.01997.x; Horgan RP, 2011, J PROTEOME RES, V10, P3660, DOI 10.1021/pr2002897; International Diabetes Federation, 2011, IDF DIAB ATL; Ishikawa H, 1999, J LIPID RES, V40, P1920; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jenum AK, 2010, SCAND J PUBLIC HEALT, V38, P60, DOI 10.1177/1403494810378921; Kenny LC, 2008, REPROD SCI, V15, P591, DOI 10.1177/1933719108316908; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Keun HC, 2002, CHEM RES TOXICOL, V15, P1380, DOI 10.1021/tx0255774; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lind T, 1980, ADV CLIN CHEM, P1; Maher AD, 2007, ANAL CHEM, V79, P5204, DOI 10.1021/ac070212f; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Mevik B.H., 2011, PLS PARTIAL LEAST SQ; Morkrid K, 2012, EUR J ENDOCRINOL, V167, P579, DOI 10.1530/EJE-12-0452; Naismith DJ, 2003, ENCY FOOD SCI NUTR, P4723, DOI DOI 10.1016/B0-12-227055-X/00961-5; Nicholson G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.57; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; PETRARULO M, 1995, CLIN CHEM, V41, P1518; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Reynolds WF, 2002, J NAT PROD, V65, P221, DOI 10.1021/np010444o; Risberg A, 2004, SCAND J CLIN LAB INV, V64, P17, DOI 10.1080/00365510410003714; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Saude EJ, 2007, METABOLOMICS, V3, P439, DOI 10.1007/s11306-007-0091-1; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Trump S, 2006, MAGN RESON MATER PHY, V19, P305, DOI 10.1007/s10334-006-0058-7; Turner E, 2007, HYPERTENS PREGNANCY, V26, P329, DOI 10.1080/10641950701436073; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wishart DS, 2009, BIOANALYSIS, V1, P1579, DOI 10.4155/BIO.09.138; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z; Zhao XJ, 2010, METABOLOMICS, V6, P362, DOI 10.1007/s11306-010-0203-1	67	59	60	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52399	10.1371/journal.pone.0052399	http://dx.doi.org/10.1371/journal.pone.0052399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285025	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800063
J	Wang, JM; Bai, ZK; Yang, PL				Wang, Jinman; Bai, Zhongke; Yang, Peiling			Sodic Soil Properties and Sunflower Growth as Affected by Byproducts of Flue Gas Desulfurization	PLOS ONE			English	Article							GYPSUM; RECLAMATION; RESTORATION	The main component of the byproducts of flue gas desulfurization (BFGD) is CaSO4, which can be used to improve sodic soils. The effects of BFGD on sodic soil properties and sunflower growth were studied in a pot experiment. The experiment consisted of eight treatments, at four BFGD rates (0, 7.5, 15 and 22.5 t ha(-1)) and two leaching levels (750 and 1200 m(3) ha(-1)). The germination rate and yield of the sunflower increased, and the exchangeable sodium percentage (ESP), pH and total dissolved salts (TDS) in the soils decreased after the byproducts were applied. Excessive BFGD also affected sunflower germination and growth, and leaching improved reclamation efficiency. The physical and chemical properties of the reclaimed soils were best when the byproducts were applied at 7.5 t ha(-1) and water was supplied at 1200 m(3).ha(-1). Under these conditions, the soil pH, ESP, and TDS decreased from 9.2, 63.5 and 0.65% to 7.8, 2.8 and 0.06%, and the germination rate and yield per sunflower reached 90% and 36.4 g, respectively. Salinity should be controlled by leaching when sodic soils are reclaimed with BFGD as sunflower growth is very sensitive to salinity during its seedling stage.	[Wang, Jinman; Bai, Zhongke] China Univ Geosci, Coll Land Sci & Technol, Beijing, Peoples R China; [Wang, Jinman; Bai, Zhongke] Minist Land & Resources, Key Lab Land Consolidat & Land Rehabil, Beijing, Peoples R China; [Yang, Peiling] China Agr Univ, Coll Hydraul & Civil Engn, Beijing 100094, Peoples R China	China University of Geosciences; Ministry of Natural Resources of the People's Republic of China; China Agricultural University	Wang, JM (corresponding author), China Univ Geosci, Coll Land Sci & Technol, Beijing, Peoples R China.	wangjinman2002@163.com		Wang, Jinman/0000-0002-8140-997X	Fundamental Research Funds for the Central Universities of China; National Natural Science Foundation of China [50749032]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Fundamental Research Funds for the Central Universities of China, and the National Natural Science Foundation of China (50749032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLSON CL, 1993, J ENVIRON QUAL, V22, P227, DOI 10.2134/jeq1993.00472425002200020002x; Carter M. R., 1989, Arid Soil Research and Rehabilitation, V3, P1, DOI 10.1080/15324988909381184; Chen LM, 2009, FUEL, V88, P1167, DOI 10.1016/j.fuel.2008.07.015; Chorom M, 1994, AUSTR J SOIL RES, V32, P1152; Chun S, 2001, ENVIRON POLLUT, V114, P453, DOI 10.1016/S0269-7491(00)00226-8; Clark RB, 2001, FUEL, V80, P821, DOI 10.1016/S0016-2361(00)00162-9; FRENKEL H, 1989, J SOIL SCI, V40, P599, DOI 10.1111/j.1365-2389.1989.tb01301.x; Ilyas M, 1997, SOIL TECHNOL, V10, P247, DOI 10.1016/S0933-3630(96)00121-3; Katerji N, 1997, AGR WATER MANAGE, V34, P57, DOI 10.1016/S0378-3774(96)01294-2; Ministry of Agriculture and fisheries, 1984, GB428484 MIN AGR FIS; Ministry of Agriculture and fisheries, 1987, GB817387 MIN AGR FIS; OSTER JD, 1980, SOIL SCI SOC AM J, V44, P41, DOI 10.2136/sssaj1980.03615995004400010010x; Pandey V. C., 2011, Ecological Restoration, V29, P322, DOI 10.3368/er.29.4.322; Rhoades J. D., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P149; Sakai Y, 2004, SOIL SEDIMENT CONTAM, V13, P65, DOI 10.1080/10588330490269840; Shannon MC, 1997, ADV AGRON, V60, P75, DOI 10.1016/S0065-2113(08)60601-X; Singh K, 2012, CATENA, V96, P57, DOI 10.1016/j.catena.2012.04.007; Sloan JJ, 1999, FUEL, V78, P169, DOI 10.1016/S0016-2361(98)00135-5; Stuczynski TI, 1998, SOIL SCI, V163, P952, DOI 10.1097/00010694-199812000-00005; Truman CC, 2010, CATENA, V81, P234, DOI 10.1016/j.catena.2010.04.003; Wang JinMan, 2005, Acta Pedologica Sinica, V42, P98; Wang JM, 2004, Land and Water Management: Decision Tools and Practices, Vols 1 and 2, P1015; Wang SJ, 2008, ENVIRON POLLUT, V151, P200, DOI 10.1016/j.envpol.2007.02.014	23	11	12	7	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52437	10.1371/journal.pone.0052437	http://dx.doi.org/10.1371/journal.pone.0052437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285042	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800066
J	Baitaluk, M; Kozhenkov, S; Ponomarenko, J				Baitaluk, Michael; Kozhenkov, Sergey; Ponomarenko, Julia			An Integrative Approach to Inferring Gene Regulatory Module Networks	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SYSTEMS-BIOLOGY; EXPRESSION DATA; DNA-BINDING; GENOME; DATABASE; BIOLOGICALNETWORKS; PLURIPOTENCY; ASTHMA; MOUSE	Background: Gene regulatory networks (GRNs) provide insight into the mechanisms of differential gene expression at a system level. However, the methods for inference, functional analysis and visualization of gene regulatory modules and GRNs require the user to collect heterogeneous data from many sources using numerous bioinformatics tools. This makes the analysis expensive and time-consuming. Results: In this work, the BiologicalNetworks application-the data integration and network based research environment-was extended with tools for inference and analysis of gene regulatory modules and networks. The backend database of the application integrates public data on gene expression, pathways, transcription factor binding sites, gene and protein sequences, and functional annotations. Thus, all data essential for the gene regulation analysis can be mined publicly. In addition, the user's data can either be integrated in the database and become public, or kept private within the application. The capabilities to analyze multiple gene expression experiments are also provided. Conclusion: The generated modular networks, regulatory modules and binding sites can be visualized and further analyzed within this same application. The developed tools were applied to the mouse model of asthma and the OCT4 regulatory network in embryonic stem cells. Developed methods and data are available through the Java application from BiologicalNetworks program at http://www.biologicalnetworks.org. Citation: Baitaluk M, Kozhenkov S, Ponomarenko J (2012) An Integrative Approach to Inferring Gene Regulatory Module Networks. PLoS ONE 7(12): e52836. doi:10.1371/journal.pone.0052836	[Baitaluk, Michael; Kozhenkov, Sergey; Ponomarenko, Julia] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Ponomarenko, Julia] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Ponomarenko, J (corresponding author), Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.	jpon@sdsc.edu	Gallardo, Julie/H-8878-2013; Ponomarenko, Julia/K-8105-2015	Ponomarenko, Julia/0000-0002-1477-9444	National Institute of Health [R01GM084881, R01GM085325]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084881, R01GM085325] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health grants R01GM084881 to MB, and R01GM085325 to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Baitaluk M, 2006, NUCLEIC ACIDS RES, V34, pW466, DOI 10.1093/nar/gkl308; Baitaluk M, 2010, BIOINFORMATICS, V26, P1651, DOI 10.1093/bioinformatics/btq231; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cochrane GR, 2010, NUCLEIC ACIDS RES, V38, pD1, DOI 10.1093/nar/gkp1077; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Garcia E, 2011, METAANALYSIS INFOR 1; Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD116, DOI 10.1093/nar/gkl1011; Joshi A, 2009, BIOINFORMATICS, V25, P490, DOI 10.1093/bioinformatics/btn658; Jung M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010709; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kozhenkov S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-7; Kozhenkov S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-610; Lemmens K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r27; Liu A, TEASE TREE EASE METH; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Melen E, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-86; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Novershtern N, 2011, BIOINFORMATICS, V27, pI177, DOI 10.1093/bioinformatics/btr222; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Noverstern N, 2008, AM J RESP CELL MOL, V38, P324, DOI 10.1165/rcmb.2007-0151OC; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Pattaro C, 2006, ALLERGY, V61, P239, DOI 10.1111/j.1398-9995.2006.00988.x; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Romero P, 2005, GENOME BIOL, V6; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zwir I, 2005, BIOINFORMATICS, V21, P4073, DOI 10.1093/bioinformatics/bti672	49	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52836	10.1371/journal.pone.0052836	http://dx.doi.org/10.1371/journal.pone.0052836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285197	Green Published, gold			2022-12-25	WOS:000312794500250
J	Brugger, SD; Frei, L; Frey, PM; Aebi, S; Muhlemann, K; Hilty, M				Brugger, Silvio D.; Frei, Laurence; Frey, Pascal M.; Aebi, Suzanne; Muehlemann, Kathrin; Hilty, Markus			16S rRNA Terminal Restriction Fragment Length Polymorphism for the Characterization of the Nasopharyngeal Microbiota	PLOS ONE			English	Article							1ST 2 YEARS; STREPTOCOCCUS-PNEUMONIAE; OTITIS-MEDIA; T-RFLP; DIVERSITY; CHILDREN; COLONIZATION; EPIDEMIOLOGY; COMMUNITIES; LIFE	A novel non-culture based 16S rRNA Terminal Restriction Fragment Length Polymorphism (T-RFLP) method using the restriction enzymes Tsp509I and Hpy166II was developed for the characterization of the nasopharyngeal microbiota and validated using recently published 454 pyrosequencing data. 16S rRNA gene T-RFLP for 153 clinical nasopharyngeal samples from infants with acute otitis media (AOM) revealed 5 Tsp509I and 6 Hpy166II terminal fragments (TFs) with a prevalence of >10%. Cloning and sequencing identified all TFs with a prevalence >6% allowing a sufficient description of bacterial community changes for the most important bacterial taxa. The conjugated 7-valent pneumococcal polysaccharide vaccine (PCV-7) and prior antibiotic exposure had significant effects on the bacterial composition in an additive main effects and multiplicative interaction model (AMMI) in concordance with the 16S rRNA 454 pyrosequencing data. In addition, the presented T-RFLP method is able to discriminate S. pneumoniae from other members of the Mitis group of streptococci, which therefore allows the identification of one of the most important human respiratory tract pathogens. This is usually not achieved by current high throughput sequencing protocols. In conclusion, the presented 16S rRNA gene T-RFLP method is a highly robust, easy to handle and a cheap alternative to the computationally demanding next-generation sequencing analysis. In case a lot of nasopharyngeal samples have to be characterized, it is suggested to first perform 16S rRNA T-RFLP and only use next generation sequencing if the T-RFLP nasopharyngeal patterns differ or show unknown TFs.	[Brugger, Silvio D.; Frei, Laurence; Frey, Pascal M.; Aebi, Suzanne; Muehlemann, Kathrin; Hilty, Markus] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Brugger, Silvio D.] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Muehlemann, Kathrin; Hilty, Markus] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Hilty, M (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	markus.hilty@ifik.unibe.ch	Hilty, Markus/H-9560-2019; Kummer, Juerg/B-3322-2011; Brugger, Silvio Daniel/AAY-7090-2020	Hilty, Markus/0000-0002-2418-6474; Brugger, Silvio Daniel/0000-0001-9492-9088; Frey, Pascal/0000-0001-6161-0919	Swiss National Science Foundation [323500-119214]; Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases	This study was supported by the Swiss National Science Foundation (M.D.-Ph.D. scholarship 323500-119214 to S. D. B.) and the 2012 Award of the Swiss Society of Hospital Hygiene & the Swiss Society for Infectious Diseases to M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brugger SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011638; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Cabrera-Rubio R, 2012, J CLIN MICROBIOL; Camarinha-Silva A, 2012, FEMS MICROBIOL ECOL, V79, P98, DOI 10.1111/j.1574-6941.2011.01197.x; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Culman SW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-171; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hathaway LJ, 2007, J CLIN MICROBIOL, V45, P803, DOI 10.1128/JCM.02169-06; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Horz HP, 2012, ENV MICROBIOL REP, V4, P390, DOI 10.1111/j.1758-2229.2012.00340.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; Muhlemann K, 2003, J INFECT DIS, V187, P589, DOI 10.1086/367994; Scholz CFP, 2012, J CLIN MICROBIOL, V50, P1968, DOI 10.1128/JCM.00365-12; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Smith CJ, 2005, FEMS MICROBIOL ECOL, V54, P375, DOI 10.1016/j.femsec.2005.05.002; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	24	13	16	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52241	10.1371/journal.pone.0052241	http://dx.doi.org/10.1371/journal.pone.0052241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284951	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500123
J	Eba, H; Murasawa, Y; Iohara, K; Isogai, Z; Nakamura, H; Nakamura, H; Nakashima, M				Eba, Hisanori; Murasawa, Yusuke; Iohara, Koichiro; Isogai, Zenzo; Nakamura, Hiroshi; Nakamura, Hiroyuki; Nakashima, Misako			The Anti-Inflammatory Effects of Matrix Metalloproteinase-3 on Irreversible Pulpitis of Mature Erupted Teeth	PLOS ONE			English	Article							ALPHA-TRYPSIN INHIBITOR; HYALURONAN; CELLS; MICROLEAKAGE; ACTIVATION; COMPLEX; PROTEIN; CANCER; TH1	Matrix metalloproteinases (MMPs) are involved in extracellular matrix degradation and the modulation of cell behavior. These proteinases have also been implicated in tissue repair and regeneration. Our previous studies have demonstrated that MMP-3 elicits stimulatory effects on the proliferation and the migration of endothelial cells as well as anti-apoptotic effects on these cells in vitro. In addition, we found that MMP-3 enhanced the regeneration of lost pulp tissue in a rat incisor pulp injury model. However, continuously erupting rodent incisors exhibit significantly different pulp organization compared with mature erupted teeth. Therefore, we have further extended these studies using a canine irreversible pulpitis model to investigate the effects of MMP-3. In this study, the crowns of the canine mature premolars were removed and the pulp tissues were amputated. The amputated pulp tissues remained exposed for 24 or 72 hours to induce mild or severe irreversible pulpitis, respectively, followed by sealing of the cavities. In both models, the whole pulp tissues became necrotic by day 14. In this mild pulpitis model, the regeneration of pulp tissue with vasculature and nerves was observed until 14 days after sealing with MMP-3, followed by extracellular matrix formation in the regenerated pulp tissues until day 28. The treatment with MMP-3 resulted in a decrease in the number of macrophage and antigen-presenting cells and a significant inhibition of IL-6 expression on day 3. The inhibition of MMP-3 activity abolished these anti-inflammatory effects. Immunofluorescence staining demonstrated that MMP-3 was involved in the modification of serum-derived hyaluronan-associated proteins and hyaluronan (SHAP-HA) complexes possibly through the degradation of versican. These results demonstrate that MMP-3 can act as an anti-inflammatory agent and suggest that MMP-3 might represent a useful therapy for the treatment of mild irreversible pulpitis.	[Eba, Hisanori; Iohara, Koichiro; Nakamura, Hiroyuki; Nakashima, Misako] Natl Ctr Geriatr & Gerontol, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi, Japan; [Murasawa, Yusuke; Isogai, Zenzo] Natl Ctr Geriatr & Gerontol, Dept Adv Med, Obu, Aichi, Japan; [Eba, Hisanori; Nakamura, Hiroshi] Aichi Gakuin Univ, Dept Endodont, Sch Dent, Nagoya, Aichi 464, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Aichi Gakuin University	Nakamura, H (corresponding author), Natl Ctr Geriatr & Gerontol, Ctr Adv Med Dent & Oral Dis, Dept Dent Regenerat Med, Obu, Aichi, Japan.	hnak@me.com	Isogai, Zenzo/AAD-3690-2022; nakamura, hiroyuki/A-2953-2013	nakamura, hiroyuki/0000-0002-2524-3063	Japan Science and Technology Agency (JST) [AS232Z01229F]; Ministry of Education, Science, Sports and Culture, Japan [20390504, 21390512, 22592030]; Ministry of Health, Labour, and Welfare [21A-7]; Grants-in-Aid for Scientific Research [22592030] Funding Source: KAKEN	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Adaptable and Seamless Technology transfer Program through target-driven R&D (A-STEP) by Japan Science and Technology Agency (JST) (AS232Z01229F to Hiroyuki N), a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (#20390504 to MN, #21390512 to Hiroshi Nakamura, #22592030 to Hiroyuki Nakamura), and by the Research Grant for Longevity Sciences (21A-7) from the Ministry of Health, Labour, and Welfare (MN). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Byers MR, 1999, CRIT REV ORAL BIOL M, V10, P4, DOI 10.1177/10454411990100010101; BYERS MR, 1984, INT REV NEUROBIOL, V25, P39, DOI 10.1016/S0074-7742(08)60677-7; Caplan DJ, 2005, J PUBLIC HEALTH DENT, V65, P90, DOI 10.1111/j.1752-7325.2005.tb02792.x; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Demirel F, 2005, INT J PERIODONT REST, V25, P73; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eriksen GV, 1999, BIOCHEM J, V340, P613, DOI 10.1042/0264-6021:3400613; Hahn CL, 2007, J ENDODONT, V33, P643, DOI 10.1016/j.joen.2007.01.001; IMAI M, 1993, J ORAL PATHOL MED, V22, P411, DOI 10.1111/j.1600-0714.1993.tb00132.x; Katoh S, 2011, EUR J IMMUNOL, V41, P3198, DOI 10.1002/eji.201141521; Kimura A, 2011, INT IMMUNOPHARMACOL, V11, P319, DOI 10.1016/j.intimp.2010.10.004; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Le NTV, 2007, FRONT BIOSCI, V12, P1475, DOI 10.2741/2161; Milner Jennifer M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P363, DOI 10.2174/1568010054022141; NAGASE H, 1994, J BIOL CHEM, V269, P20952; Nakamura H, 1998, EUR J BIOCHEM, V253, P67, DOI 10.1046/j.1432-1327.1998.2530067.x; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pappen AF, 2005, J PROSTHET DENT, V94, P214, DOI 10.1016/j.prosdent.2005.05.022; Pashley DH, 1996, CRIT REV ORAL BIOL M, V7, P104, DOI 10.1177/10454411960070020101; PERIDES G, 1995, BIOCHEM J, V312, P377, DOI 10.1042/bj3120377; Piwowarczyk A, 2005, DENT MATER, V21, P445, DOI 10.1016/j.dental.2004.07.009; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Sjolander A, 1998, J IMMUNOL, V160, P3949; Staquet M-J, 2011, Adv Dent Res, V23, P296, DOI 10.1177/0022034511405390; Torabinejad M, 2008, ENDODNTICS PRINCIPLE; Zero Domenick T, 2011, Dent Clin North Am, V55, P29, DOI 10.1016/j.cden.2010.08.010; Zheng L, 2009, AM J PATHOL, V175, P1905, DOI 10.2353/ajpath.2009.080705; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200	32	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52523	10.1371/journal.pone.0052523	http://dx.doi.org/10.1371/journal.pone.0052523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285075	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500188
J	Finn, TP; Stewart, BT; Reid, HL; Petty, N; Sabasio, A; Oguttu, D; Lado, M; Brooker, SJ; Kolaczinski, JH				Finn, Timothy P.; Stewart, Barclay T.; Reid, Heidi L.; Petty, Nora; Sabasio, Anthony; Oguttu, David; Lado, Mounir; Brooker, Simon J.; Kolaczinski, Jan H.			Integrated Rapid Mapping of Neglected Tropical Diseases in Three States of South Sudan: Survey Findings and Treatment Needs	PLOS ONE			English	Article							URINARY SCHISTOSOMIASIS; EPIDEMIOLOGY; FILARIASIS	Background: Integrated rapid mapping to target interventions for schistosomiasis, soil-transmitted helminthiasis (STH) and lymphatic filariasis (LF) is ongoing in South Sudan. From May to September 2010, three states - Unity, Eastern Equatoria and Central Equatoria - were surveyed with the aim of identifying which administrative areas are eligible for mass drug administration (MDA) of preventive chemotherapy (PCT). Methods and Principal Findings: Payams (third administrative tier) were surveyed for Schistosoma mansoni, S. haematobium and STH infections while counties (second administrative tier) were surveyed for LF. Overall, 12,742 children from 193 sites were tested for schistosome and STH infection and, at a subset of 50 sites, 3,980 adults were tested for LF. Either S. mansoni or S. haematobium or both species were endemic throughout Unity State and occurred in foci in Central and Eastern Equatoria. STH infection was endemic throughout Central Equatoria and the western counties of Eastern Equatoria, while LF was endemic over most of Central- and Eastern Equatoria, but only in selected foci in Unity. All areas identified as STH endemic were co-endemic for schistosomiasis and/or LF. Conclusions: The distribution and prevalence of major NTDs, particularly schistosomiasis, varies considerably throughout South Sudan. Rapid mapping is therefore important in identifying (co)-endemic areas. The present survey established that across the three surveyed states between 1.2 and 1.4 million individuals are estimated to be eligible for regular MDA with PCT to treat STH and schistosomiasis, respectively, while approximately 1.3 million individuals residing in Central- and Eastern Equatoria are estimated to require MDA for LF. Citation: Finn TP, Stewart BT, Reid HL, Petty N, Sabasio A, et al. (2012) Integrated Rapid Mapping of Neglected Tropical Diseases in Three States of South Sudan: Survey Findings and Treatment Needs. PLoS ONE 7(12): e52789. doi:10.1371/journal.pone.0052789	[Stewart, Barclay T.; Brooker, Simon J.; Kolaczinski, Jan H.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Finn, Timothy P.; Stewart, Barclay T.; Reid, Heidi L.; Petty, Nora; Sabasio, Anthony] S Sudan Country Off, Malaria Consortium, Juba, Sudan; [Stewart, Barclay T.] Med Univ S Carolina, Charleston, SC 29425 USA; [Reid, Heidi L.] Univ Queensland, Sch Populat Hlth, Herston, Qld, Australia; [Oguttu, David] Minist Hlth, Vector Control Div, Kampala, Uganda; [Lado, Mounir] Minist Hlth, Juba, Sudan; [Brooker, Simon J.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya; [Kolaczinski, Jan H.] Africa Reg Off, Malaria Consortium, Kampala, Uganda	University of London; London School of Hygiene & Tropical Medicine; Medical University of South Carolina; University of Queensland; Kenya Medical Research Institute	Kolaczinski, JH (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England.	jan_kolaczinski@mac.com			USAID through RTI International; Wellcome Trust through a Research Career Development Fellowship [081673]	USAID through RTI International(United States Agency for International Development (USAID)); Wellcome Trust through a Research Career Development Fellowship(Wellcome Trust)	The work presented in this publication was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. USAID funding was provided through RTI International to Malaria Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SB is supported by the Wellcome Trust through a Research Career Development Fellowship (081673).	Brooker S, 2004, EPIDEMIOL INFECT, V132, P1065, DOI 10.1017/S0950268804003024; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Ekpo UF, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-74; KIRK R, 1957, Bull World Health Organ, V16, P593; Kolaczinski JH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000745; Mectizan Expert Committee, 2006, REC MECT EXP COMM MA; *MOH GOSS, 2008, NEGL TROP DIS SO SUD; MORE SJ, 1990, TROP MED PARASITOL, V41, P403; Ngondi J, 2009, B WORLD HEALTH ORGAN, V87, P143, DOI 10.2471/BLT.07.046326; Rumunu J, 2009, TRENDS PARASITOL, V25, P301, DOI 10.1016/j.pt.2009.03.011; Simoonga C, 2008, GEOSPATIAL HEALTH, V3, P57, DOI 10.4081/gh.2008.232; Srividya A, 2002, AM J TROP MED HYG, V67, P480, DOI 10.4269/ajtmh.2002.67.480; Sturrock HJW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000537; TDR, 2002, GUID RAP LOA LOA; WHO, 2006, PREV CHEM HUM HELM; WOODMAN H. M., 1941, TRANS ROY SOC TROP MED AND HYG, V35, P77, DOI 10.1016/S0035-9203(41)90014-7	16	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52789	10.1371/journal.pone.0052789	http://dx.doi.org/10.1371/journal.pone.0052789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285184	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000312794500245
J	Gellert, A; Salanki, K; Tombacz, K; Tuboly, T; Balazs, E				Gellert, Akos; Salanki, Katalin; Tombacz, Kata; Tuboly, Tamas; Balazs, Ervin			A Cucumber Mosaic Virus Based Expression System for the Production of Porcine Circovirus Specific Vaccines	PLOS ONE			English	Article							B SURFACE-ANTIGEN; CAPSID PROTEIN; TRANSGENIC PLANTS; DISEASE VIRUS; I-TASSER; TYPE-2; IMMUNOGENICITY; IDENTIFICATION; RECOGNITION; PARTICLES	Potential porcine circovirus type 2 (PCV2) capsid protein epitopes, suitable for expression on the surface of cucumber mosaic virus (CMV) particles were determined by a thorough analysis of the predicted PCV capsid protein structure. The ab initio protein structure prediction was carried out with fold recognition and threading methods. The putative PCV epitopes were selected on the basis of PCV virion models and integrated into the plant virus coat protein, after amino acid position 131. The recombinants were tested for infectivity and stability on different Nicotiana species and stable recombinant virus particles were purified. The particles were tested for their ability to bind to PCV induced porcine antibodies and used for specific antibody induction in mice and pigs. The results showed that PCV epitopes expressed on the CMV surface were recognized by the porcine antibodies and they were also able to induce PCV specific antibody response. Challenge experiment with PCV2 carried out in immunized pigs showed partial protection against the infection. Based on these results it was concluded that specific antiviral vaccine production for the given pathogen was feasible, offering an inexpensive way for the mass production of such vaccines.	[Gellert, Akos; Balazs, Ervin] Hungarian Acad Sci, Dept Appl Genom, Inst Agr, Agr Res Ctr, H-2462 Martonvasar, Brunszvik, Hungary; [Salanki, Katalin] Agr Biotechnol Ctr, H-2100 Godollo, Szent Gyorgyi, Hungary; [Tombacz, Kata; Tuboly, Tamas] Szent Istvan Univ, Dept Microbiol & Infect Dis, Fac Vet Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian University of Agriculture & Life Sciences	Balazs, E (corresponding author), Hungarian Acad Sci, Dept Appl Genom, Inst Agr, Agr Res Ctr, H-2462 Martonvasar, Brunszvik, Hungary.	balazs.ervin@agrar.mta.hu	Salanki, Katalin/AAY-1834-2021	Salanki, Katalin/0000-0002-0128-4338; Tombacz, Kata/0000-0003-4062-1664	consortial Hungarian research grant OTKA-NKTH [78317, 78675, 78608]	consortial Hungarian research grant OTKA-NKTH(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The research in this paper was financed by the consortial Hungarian research grant OTKA-NKTH 78317, 78675, 78608. (http://www.otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun A, 2011, VIRUS RES, V157, P1, DOI 10.1016/j.virusres.2011.02.006; Carrillo C, 1998, J VIROL, V72, P1688, DOI 10.1128/JVI.72.2.1688-1690.1998; Csagola A, 2009, EPIDEMIOLOGICAL EXAM; Gellert A, 2006, J MOL GRAPH MODEL, V24, P319, DOI 10.1016/j.jmgm.2005.09.015; Gil F, 2006, PLANT BIOTECHNOL J, V4, P135, DOI 10.1111/j.1467-7652.2005.00172.x; Gilpin DF, 2003, VET IMMUNOL IMMUNOP, V94, P149, DOI 10.1016/S0165-2427(03)00087-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khayat R, 2011, J VIROL, V85, P7856, DOI 10.1128/JVI.00737-11; Kristensen CS, 2011, PREV VET MED, V98, P250, DOI 10.1016/j.prevetmed.2010.11.015; Lekcharoensuk P, 2004, J VIROL, V78, P8135, DOI 10.1128/JVI.78.15.8135-8145.2004; Llamas S, 2006, J GEN VIROL, V87, P2085, DOI 10.1099/vir.0.81871-0; LOT H, 1972, Annales de Phytopathologie, V4, P25; Loza-Rubio E, 2010, ACTA VET HUNG, V58, P511, DOI 10.1556/AVet.58.2010.4.11; Mahe D, 2000, J GEN VIROL, V81, P1815, DOI 10.1099/0022-1317-81-7-1815; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Mason HS, 1996, P NATL ACAD SCI USA, V93, P5335, DOI 10.1073/pnas.93.11.5335; Pacios LF, 2006, J GEN VIROL, V87, P2073, DOI 10.1099/vir.0.81621-0; Patterson AR, 2011, VET MICROBIOL, V149, P91, DOI 10.1016/j.vetmic.2010.10.020; PEDEN KWC, 1973, VIROLOGY, V53, P487, DOI 10.1016/0042-6822(73)90232-8; Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salanki K, 1997, J VIROL, V71, P3597; Salanki K, 2011, ARCH VIROL, V156, P2279, DOI 10.1007/s00705-011-1104-y; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106; Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007; Shang SB, 2009, RES VET SCI, V84, P150; SHANKARAPPA B, 1992, BIOTECHNIQUES, V12, P882; Streatfield SJ, 2001, VACCINE, V19, P2742, DOI 10.1016/S0264-410X(00)00512-0; Thompson JR, 2006, J VIROL, V80, P7740, DOI 10.1128/JVI.00436-06; TISCHER I, 1974, ZBL BAKT-INT J MED M, V226, P153; Truong C, 2011, ARCH VIROL, V46, P1197; Tuboly T, 2000, VACCINE, V18, P2023, DOI 10.1016/S0264-410X(99)00525-3; Vitti A, 2010, J VIROL METHODS, V169, P332, DOI 10.1016/j.jviromet.2010.07.039; WHITE JL, 1989, J VIROL METHODS, V23, P83, DOI 10.1016/0166-0934(89)90122-5; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	37	16	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52688	10.1371/journal.pone.0052688	http://dx.doi.org/10.1371/journal.pone.0052688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285149	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500229
J	Lin, CW; Song, H; Huang, C; Yao, E; Gacayan, R; Xu, SM; Chuang, PT				Lin, Chuwen; Song, Hai; Huang, Cecilia; Yao, Erica; Gacayan, Rhodora; Xu, Shan-Mei; Chuang, Pao-Tien			Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development	PLOS ONE			English	Article							MOUSE MODELS; K-RAS; CRE RECOMBINASE; EGFR MUTATIONS; CANCER MODELS; MICE; ADENOCARCINOMA; P53; PROGRESSION; EXPRESSION	Identifying cells of tumor origin is a fundamental question in tumor biology. Answers to this central question will not only advance our understanding of tumor initiation and progression but also have important therapeutic implications. In this study, we aimed to uncover the cells of origin of lung adenocarcinoma, a major subtype of non-small cell lung cancer. To this end, we developed new mouse models of lung adenocarcinoma that enabled selective manipulation of gene activity in surfactant associated protein C (SPC)-expressing cells, including alveolar type II cells and bronchioalveolar stem cells (BASCs) that reside at the bronchioalveolar duct junction (BADJ). Our findings showed that activation of oncogenic Kras alone or in combination with the removal of the tumor suppressor p53 in SPC+ cells resulted in development of alveolar tumors. Similarly, sustained EGF signaling in SPC+ cells led to alveolar tumors. By contrast, BASCs failed to proliferate or produce tumors under these conditions. Importantly, in a mouse strain in which Kras/p53 activity was selectively altered in type II cells but not BASCs, alveolar tumors developed while BADJs retained normal architecture. These results confirm and extend previous findings and support a model in which lung adenocarcinoma can initiate in alveolar type II cells. Our results establish the foundation for elucidating the molecular mechanisms by which lung cancer initiates and progresses in a specific lung cell type. Citation: Lin C, Song H, Huang C, Yao E, Gacayan R, et al. (2012) Alveolar Type II Cells Possess the Capability of Initiating Lung Tumor Development. PLoS ONE 7(12): e53817. doi:10.1371/journal.pone.0053817	[Lin, Chuwen; Song, Hai; Huang, Cecilia; Yao, Erica; Gacayan, Rhodora; Xu, Shan-Mei; Chuang, Pao-Tien] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chuang, PT (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	pao-tien.chuang@ucsf.edu	Lin, Chuwen/I-3287-2018					Andreeva AV, 2007, AM J PHYSIOL-LUNG C, V293, pL259, DOI 10.1152/ajplung.00112.2007; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Cheng L, 2012, MOD PATHOL; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de Seranno S, 2010, EUR RESPIR J, V35, P426, DOI 10.1183/09031936.00124709; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Eliasz S, 2010, ONCOGENE, V29, P2488, DOI 10.1038/onc.2010.7; Frese KK, 2007, NAT REV CANCER, V7, P645, DOI 10.1038/nrc2192; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; Greulich Heidi, 2010, Genes Cancer, V1, P1200, DOI 10.1177/1947601911407324; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Joyner AL, 2000, GENE TARGETING PRACT; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kitamura H, 1997, VIRCHOWS ARCH, V431, P415, DOI 10.1007/s004280050118; Kwak I, 2004, ANNU REV PHYSIOL, V66, P647, DOI 10.1146/annurev.physiol.66.032102.134301; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McErlean A, 2011, SEMIN ROENTGENOL, V46, P173, DOI 10.1053/j.ro.2011.02.002; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murala Sanjay, 2010, J Thorac Dis, V2, P237, DOI 10.3978/j.issn.2072-1439.2010.11.6; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nagy A., 2003, MANIPULATING MOUSE E; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Regales L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000810; Reungwetwattana T, 2011, CLIN LUNG CANC; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Vahakangas KH, 2001, CANCER RES, V61, P4350; Vallieres E, 2011, THORAX; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Xu X, 2012, P NATL ACAD SCI USA, V109, P4910, DOI 10.1073/pnas.1112499109; Yang YN, 2011, J CLIN INVEST, V121, P1373, DOI 10.1172/JCI42579	47	65	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e53817	10.1371/journal.pone.0053817	http://dx.doi.org/10.1371/journal.pone.0053817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285300	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500259
J	Morrison, BJ; Hastie, ML; Grewal, YS; Bruce, ZC; Schmidt, C; Reynolds, BA; Gorman, JJ; Lopez, JA				Morrison, Brian J.; Hastie, Marcus L.; Grewal, Yadveer S.; Bruce, Zara C.; Schmidt, Chris; Reynolds, Brent A.; Gorman, Jeffrey J.; Lopez, J. Alejandro			Proteomic Comparison of MCF-7 Tumoursphere and Monolayer Cultures	PLOS ONE			English	Article							CARCINOMA-ASSOCIATED PROTEIN; MODIFIED CITRUS PECTIN; IN-VITRO PROPAGATION; BREAST-CANCER CELLS; CARCINOEMBRYONIC ANTIGEN; STEM-CELLS; STEM/PROGENITOR CELLS; MOLECULAR-BIOLOGY; CYCLE ARREST; GALECTIN-3	Breast cancer is a heterogenous disease, composed of tumour cells with differing gene expressions and phenotypes. Very few antigens have been identified and a better understanding of tumour initiating-cells as targets for therapy is critically needed. Recently, a rare subpopulation of cells within tumours has been described with the ability to: (i) initiate and sustain tumour growth; (ii) resist traditional therapies and allow for secondary tumour dissemination; and (iii) display some of the characteristics of stem cells such as self-renewal. These cells are termed tumour-initiating cells or cancer stem cells, or alternatively, in the case of breast cancer, breast cancer stem cells. Previous studies have demonstrated that breast cancer stem cells can be enriched for in "tumoursphere" culture. Proteomics represents a novel way to investigate protein expression between cells. We hypothesise that characterisation of the proteome of the breast cancer line MCF-7 tumourspheres compared to adherent/differentiated cells identifies proteins of novel interest for further isolating or targeting breast cancer stem cells. We present evidence that: (i) the proteome of adherent cells is different to the proteome of cells grown in sphere medium from either early passage (passage 2) or late passage (passage 5) spheres; (ii) that spheres are enriched in expression of a variety of tumour-relevant proteins (including MUC1 and Galectin-3); and (iii) that targeting of one of these identified proteins (galectin-3) using an inhibitor (N-acetyllactosamine) decreases sphere formation/self-renewal of MCF-7 cancer stem cells in vitro and tumourigenicity in vivo. Hence, proteomic analysis of tumourspheres may find use in identifying novel targets for future therapy. The therapeutic targeting of breast cancer stem cells, a highly clinically relevant sub-population of tumour cells, has the potential to eliminate residual disease and may become an important component of a multi-modality treatment of cancer.	[Morrison, Brian J.; Bruce, Zara C.; Lopez, J. Alejandro] Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia; [Morrison, Brian J.; Hastie, Marcus L.; Grewal, Yadveer S.; Bruce, Zara C.; Schmidt, Chris; Gorman, Jeffrey J.; Lopez, J. Alejandro] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA	Griffith University; QIMR Berghofer Medical Research Institute; State University System of Florida; University of Florida	Lopez, JA (corresponding author), Griffith Univ, Sch Biomol & Phys Sci, Brisbane, Qld 4111, Australia.	a.lopez@griffith.edu.au	Lopez, J. Alejandro/P-4129-2019; Hastie, Marcus L/L-4366-2016; Lopez, J. Alejandro/B-9290-2008; Schmidt, Christopher/A-4353-2009	Lopez, J. Alejandro/0000-0001-9370-1516; Hastie, Marcus L/0000-0002-8386-5549; Lopez, J. Alejandro/0000-0001-9370-1516; Schmidt, Christopher/0000-0002-3955-5076; Grewal, Yadveer/0000-0003-3621-2753	Australian Government National Collaborative Infrastructure Scheme via Bioplatforms Australia; Queensland State Government; Cancer Council Queensland; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER	Australian Government National Collaborative Infrastructure Scheme via Bioplatforms Australia(Australian Government); Queensland State Government; Cancer Council Queensland(Cancer Council Queensland); National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Access to proteomic infrastructure funding was made possible through funds from the Australian Government National Collaborative Infrastructure Scheme provided via Bioplatforms Australia and the Queensland State Government. Funding for this research was obtained from the Cancer Council Queensland and the National Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1989, CANCER RES, V49, P2834; Agrawal B, 1998, MOL MED TODAY, V4, P397, DOI 10.1016/S1357-4310(98)01322-7; Ahn SM, 2008, PROTEOMICS, V8, P4946, DOI 10.1002/pmic.200800312; Aka JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031532; Akahani S, 1997, CANCER RES, V57, P5272; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ao A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018810; Aplander K, 2006, CARBOHYD RES, V341, P1363, DOI 10.1016/j.carres.2006.04.027; Beatson RE, 2010, IMMUNOTHERAPY-UK, V2, P305, DOI 10.2217/IMT.10.17; Blumenthal RD, 2005, CANCER RES, V65, P8809, DOI 10.1158/0008-5472.CAN-05-0420; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; CROKER AK, 2008, J CELL MOL MED; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; Elgaaen BV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013837; Engelmann K, 2008, CANCER RES, V68, P2419, DOI 10.1158/0008-5472.CAN-07-2249; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gilewski T, 2000, CLIN CANCER RES, V6, P1693; Goydos JS, 1996, J SURG RES, V63, P298, DOI 10.1006/jsre.1996.0264; Grkovic S, 2012, ONCOGENE; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hastie ML, 2012, MOL CELL PROTEOMICS, V11, P108, DOI 10.1074/mcp.M111.015909; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; Hondermarck H, 2002, J MAMMARY GLAND BIOL, V7, P395, DOI 10.1023/A:1024086015542; Hubner NC, 2008, PROTEOMICS, V8, P4862, DOI 10.1002/pmic.200800351; Hughes RC, 2001, BIOCHIMIE, V83, P667; INOHARA H, 1995, CANCER RES, V55, P3267; Kanojia D, 2012, PROTEOMICS; Kim HRC, 1999, CANCER RES, V59, P4148; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LeMarer N, 1996, J CELL PHYSIOL, V168, P51, DOI 10.1002/(SICI)1097-4652(199607)168:1<51::AID-JCP7>3.0.CO;2-7; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Magnifico A, 2009, CLIN CANCER RES, V15, P2010, DOI 10.1158/1078-0432.CCR-08-1327; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Moiseeva EV, 2005, BREAST CANCER RES TR, V91, P227, DOI 10.1007/s10549-005-0289-8; Morrison BJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2111; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2008, CANCER MICROENVIRON, V1, P43, DOI 10.1007/s12307-008-0003-6; Ordonez C, 2000, CANCER RES, V60, P3419; Patterson RJ, 2002, GLYCOCONJUGATE J, V19, P499, DOI 10.1023/B:GLYC.0000014079.87862.c7; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; PIENTA KJ, 1995, J NATL CANCER I, V87, P348, DOI 10.1093/jnci/87.5.348; PLATT D, 1992, J NATL CANCER I, V84, P438, DOI 10.1093/jnci/84.6.438; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; RAZ A, 1987, CANCER METAST REV, V6, P433, DOI 10.1007/BF00144274; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Scott Ken, 2004, Glycoconjugate Journal, V19, P467; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; SHIVELY JE, 1985, CRC CR REV ONCOL-HEM, V2, P355, DOI 10.1016/S1040-8428(85)80008-1; Song YK, 2002, AM J PATHOL, V160, P1069, DOI 10.1016/S0002-9440(10)64927-9; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; THOMPSON JA, 1991, J CLIN LAB ANAL, V5, P344, DOI 10.1002/jcla.1860050510; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilkins MR, 1996, BIO-TECHNOL, V14, P61, DOI 10.1038/nbt0196-61; Yoshii T, 2002, J BIOL CHEM, V277, P6852, DOI 10.1074/jbc.M107668200; Zotter S, 1988, CANCER REV, P11	72	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52692	10.1371/journal.pone.0052692	http://dx.doi.org/10.1371/journal.pone.0052692			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285151	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500231
J	Shields, RK; Clancy, CJ; Gillis, LM; Kwak, EJ; Silveira, FP; Massih, RCA; Eschenauer, GA; Potoski, BA; Nguyen, MH				Shields, Ryan K.; Clancy, Cornelius J.; Gillis, Louise M.; Kwak, Eun J.; Silveira, Fernanda P.; Massih, Rima C. Abdel; Eschenauer, Gregory A.; Potoski, Brian A.; Nguyen, M. Hong			Epidemiology, Clinical Characteristics and Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Infections among Solid Organ Transplant Recipients	PLOS ONE			English	Article							IN-VITRO ACTIVITIES; POLYMYXIN-B; COMBINATION THERAPY; VS. COLISTIN; TIGECYCLINE; RIFAMPICIN; MORTALITY; SYNERGY; LUNG; MEROPENEM	Background: Extensively drug-resistant Acinetobacter baumannii (XDR-Ab) has emerged as a major nosocomial pathogen, but optimal treatment regimens are unknown. Although solid organ transplant (SOT) recipients are particularly susceptible to XDR-Ab infections, studies in this population are limited. Our objectives were to determine the epidemiology, clinical characteristics and outcomes of XDR-Ab infections among SOT patients. Methods: A retrospective study of SOT recipients at our center who were colonized or infected with XDR-Ab between November 2006 and December 2011 was conducted. Among infected patients, the primary outcome was survival at 28 days. Secondary outcomes included survival at 90 days and clinical success at 28 days, and XDR-Ab infection recurrence. Results: XDR-Ab was isolated from 69 SOT patients, of whom 41% (28) and 59% (41) were colonized and infected, respectively. Infections were significantly more common among cardiothoracic than abdominal transplant recipients (p = 0.0004). Ninety-eight percent (40/41) of patients had respiratory tract infections, most commonly ventilator-associated pneumonia (VAP; 88% [36/41]). Survival rates at 28 and 90 days were 54% (22/41) and 46% (19/41), respectively. Treatment with a colistin-carbapenem regimen was an independent predictor of 28-day survival (p = 0.01; odds ratio = 7.88 [95% CI: 1.60-38.76]). Clinical success at 28 days was achieved in 49% (18/37) of patients who received antimicrobial therapy, but 44% (8/18) of successes were associated with infection recurrence within 3 months. Colistin resistance emerged in 18% (2/11) and 100% (3/3) of patients treated with colistin-carbapenem and colistin-tigecycline, respectively (p = 0.03). Conclusions: XDR-Ab causes VAP and other respiratory infections following SOT that are associated with significant recurrence and mortality rates. Cardiothoracic transplant recipients are at greatest risk. Results from this retrospective study suggest that colistin-carbapenem combinations may result in improved clinical responses and survival compared to other regimens and may also limit the emergence of colistin resistance.	[Shields, Ryan K.; Clancy, Cornelius J.; Kwak, Eun J.; Silveira, Fernanda P.; Massih, Rima C. Abdel; Potoski, Brian A.; Nguyen, M. Hong] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Shields, Ryan K.; Gillis, Louise M.; Kwak, Eun J.; Massih, Rima C. Abdel; Eschenauer, Gregory A.; Potoski, Brian A.; Nguyen, M. Hong] Univ Pittsburgh, Med Ctr, Antibiot Management Program, Pittsburgh, PA USA; [Clancy, Cornelius J.] VA Healthcare Syst Pittsburgh, Pittsburgh, PA USA; [Gillis, Louise M.; Potoski, Brian A.] Univ Pittsburgh, Dept Pharm & Therapeut, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Clancy, CJ (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	cjc76@pitt.edu	Silveira, Fernanda/K-4465-2012; Eschenauer, Gregory/O-9008-2019	Eschenauer, Gregory/0000-0001-5971-0531	National Center for Advancing Translational Sciences of the National Institutes of Health [KL2 RR024154, KL2TR000146]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award numbers KL2 RR024154 and KL2TR000146 to R. K. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Haduch JM, 2008, ANTIMICROB AGENTS CH, V52, P3837, DOI 10.1128/AAC.00570-08; American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; Arroyo LA, 2009, ANTIMICROB AGENTS CH, V53, P1295, DOI 10.1128/AAC.01097-08; Bassetti M, 2008, J ANTIMICROB CHEMOTH, V61, P417, DOI 10.1093/jac/dkm509; Benden C, 2011, J HEART LUNG TRANSPL, V30, P1123, DOI 10.1016/j.healun.2011.08.011; Betrosian AP, 2008, J INFECTION, V56, P432, DOI 10.1016/j.jinf.2008.04.002; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Choi JY, 2004, CLIN MICROBIOL INFEC, V10, P1098, DOI 10.1111/j.1469-0691.2004.00987.x; Clinical and Laboratory Standards Institute, 2009, M07A8 CLSI; Deris ZZ, 2012, ANTIMICROB AGENTS CH; Duarte AG, 2011, LUNG; Esterly JS, 2011, ANTIMICROB AGENTS CH, V55, P4844, DOI 10.1128/AAC.01728-10; Falagas ME, 2008, EPIDEMIOL INFECT, V136, P1009, DOI 10.1017/S0950268807009478; Falagas ME, 2006, CLIN MICROBIOL INFEC, V12, P1227, DOI 10.1111/j.1469-0691.2006.01559.x; Falagas ME, 2008, INT J ANTIMICROB AG, V32, P450, DOI 10.1016/j.ijantimicag.2008.05.016; Giamarellos-Bourboulis EJ, 2001, DIAGN MICR INFEC DIS, V40, P117, DOI 10.1016/S0732-8893(01)00258-9; Giamarellou H, 2008, INT J ANTIMICROB AG, V32, P106, DOI 10.1016/j.ijantimicag.2008.02.013; Haddad FA, 2005, EUR J CLIN MICROBIOL, V24, P577, DOI 10.1007/s10096-005-1366-y; Ho J, 2010, CURR OPIN INFECT DIS, V23, P546, DOI 10.1097/QCO.0b013e32833f0d3e; Hogg GM, 1998, J ANTIMICROB CHEMOTH, V41, P494, DOI 10.1093/jac/41.4.494; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Husain S, 2011, J HEART LUNG TRANSPL, V30, P361, DOI 10.1016/j.healun.2011.01.701; Kalin G, 2012, J INFECT CHEMOTHER; Kempf M, 2012, INT J ANTIMICROB AG, V39, P180, DOI 10.1016/j.ijantimicag.2011.10.001; Kiffer CRV, 2005, DIAGN MICR INFEC DIS, V52, P317, DOI 10.1016/j.diagmicrobio.2005.03.003; Kim YJ, 2011, TRANSPL P, V43, P2397, DOI 10.1016/j.transproceed.2011.06.011; Ku K, 2012, AM J INFECT CONTROL; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mak JK, 2009, J ANTIMICROB CHEMOTH, V63, P47, DOI 10.1093/jac/dkn454; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mortensen BL, 2012, CELL MICROBIOL; Motaouakkil S, 2006, J INFECTION, V53, P274, DOI 10.1016/j.jinf.2005.11.019; Mouton JW, 1999, INFECTION, V27, pS24, DOI 10.1007/BF02561666; Nunley DR, 2010, LUNG, V188, P381, DOI 10.1007/s00408-010-9250-7; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pankey GA, 2009, DIAGN MICR INFEC DIS, V63, P228, DOI 10.1016/j.diagmicrobio.2008.11.002; Peleg AY, 2007, J ANTIMICROB CHEMOTH, V59, P128, DOI 10.1093/jac/dkl441; Principe L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-18; Reddy P, 2010, TRANSPL INFECT DIS, V12, P87, DOI 10.1111/j.1399-3062.2009.00445.x; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Sands M, 2007, EUR J CLIN MICROBIOL, V26, P521, DOI 10.1007/s10096-007-0330-4; Saner FH, 2008, TRANSPLANTATION, V85, P1564, DOI 10.1097/TP.0b013e31816f61a6; Scheetz MH, 2007, ANTIMICROB AGENTS CH, V51, P1621, DOI 10.1128/AAC.01099-06; Shields RK, 2011, DIAGN MICR INFEC DIS, V70, P246, DOI 10.1016/j.diagmicrobio.2010.12.023; Shyu S, 2011, J HEART LUNG TRANSPL, V30, P743, DOI 10.1016/j.healun.2011.01.714; Siempos II, 2010, SHOCK, V33, P590, DOI 10.1097/SHK.0b013e3181cc0418; Song JY, 2007, J ANTIMICROB CHEMOTH, V60, P317, DOI 10.1093/jac/dkm136; Sopirala MM, 2008, J HEART LUNG TRANSPL, V27, P804, DOI 10.1016/j.healun.2008.03.023; Sopirala MM, 2010, ANTIMICROB AGENTS CH, V54, P4678, DOI 10.1128/AAC.00497-10; Tascini C, 1998, J ANTIMICROB CHEMOTH, V42, P270, DOI 10.1093/jac/42.2.270; Tripodi MF, 2007, INT J ANTIMICROB AG, V30, P537, DOI 10.1016/j.ijantimicag.2007.07.007; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Yoon J, 2004, ANTIMICROB AGENTS CH, V48, P753, DOI 10.1128/AAC.48.3.753-757.2004	56	96	98	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52349	10.1371/journal.pone.0052349	http://dx.doi.org/10.1371/journal.pone.0052349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285002	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500149
J	Song, WT; Li, YZ; Zhao, YW; Liu, Y; Niu, YZ; Pang, RY; Miao, GD; Liao, XL; Shao, CW; Gao, FT; Chen, SL				Song, Wentao; Li, Yangzhen; Zhao, Yongwei; Liu, Yang; Niu, Yuze; Pang, Renyi; Miao, Guidong; Liao, Xiaolin; Shao, Changwei; Gao, Fengtao; Chen, Songlin			Construction of a High-Density Microsatellite Genetic Linkage Map and Mapping of Sexual and Growth-Related Traits in Half-Smooth Tongue Sole (Cynoglossus semilaevis)	PLOS ONE			English	Article							COMPARATIVE GENOME ANALYSIS; TROUT ONCORHYNCHUS-MYKISS; JAPANESE FLOUNDER; AFLP MARKERS; SEA-BASS; LINKED MARKERS; LOCI; IDENTIFICATION; FISH; QTL	High-density genetic linkage maps of half-smooth tongue sole were developed with 1007 microsatellite markers, two SCAR markers and an F1 family containing 94. The female map was composed of 828 markers in 21 linkage groups, covering a total of 1447.3 cM, with an average interval 1.83 cM between markers. The male map consisted of 794 markers in 21 linkage groups, spanning 1497.5 cM, with an average interval of 1.96 cM. The female and male maps had 812 and 785 unique positions, respectively. The genome length of half-smooth tongue sole was estimated to be 1527.7 cM for the females and 1582.1 cM for the males. Based on estimations of the map lengths, the female and male maps covered 94.74 and 94.65% of the genome, respectively. The consensus map was composed of 1007 microsatellite markers and two SCAR markers in 21 linkage groups, covering a total of 1624 cM with an average interval of 1.67 cM. Furthermore, 159 sex-linked SSR markers were identified. Five sex-linked microsatellite markers were confirmed in their association with sex in a large number of individuals selected from different families. These sex-linked markers were mapped on the female map LG1f with zero recombination. Two QTLs that were identified for body weight, designated as We-1 and We-2, accounted for 26.39% and 10.60% of the phenotypic variation. Two QTLs for body width, designated Wi-1 and Wi-2, were mapped in LG4f and accounted for 14.33% and 12.83% of the phenotypic variation, respectively. Seven sex-related loci were mapped in LG1f, LG14f and LG1m by CIM, accounting for 12.5-25.2% of the trait variation. The results should prove to be very useful for improving growth traits using molecular MAS.	[Song, Wentao; Li, Yangzhen; Zhao, Yongwei; Liu, Yang; Niu, Yuze; Pang, Renyi; Miao, Guidong; Liao, Xiaolin; Shao, Changwei; Gao, Fengtao; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Song, Wentao] Weihai Vocat Coll, Dept Biol & Chem Engn, Weihai, Peoples R China; [Li, Yangzhen; Liu, Yang; Niu, Yuze] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Shanghai Ocean University	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203; Liu, Yang/0000-0002-8195-7706	Special Fund for Agro-Scientific Research in the Public Interest of China [200903046]; State 863 High-Technology R&D Project of China [2012AA092203, 2012AA10A403-2]; National Nature Science Foundation of China [31130057]; Taishan Scholar Project Fund of Shandong of China	Special Fund for Agro-Scientific Research in the Public Interest of China; State 863 High-Technology R&D Project of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Project Fund of Shandong of China	This work was supported by grants from Special Fund for Agro-Scientific Research in the Public Interest (200903046) of China, State 863 High-Technology R&D Project of China (2012AA092203, 2012AA10A403-2), National Nature Science Foundation of China (31130057), and Taishan Scholar Project Fund of Shandong of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Cervantes-Flores JC, 2008, MOL BREEDING, V21, P511, DOI 10.1007/s11032-007-9150-6; Cervera MT, 2001, GENETICS, V158, P787; CHAKRAVARTI A, 1991, GENETICS, V128, P175; Chen SL, 2008, AQUACULTURE, V283, P7, DOI 10.1016/j.aquaculture.2008.07.015; Chen SL, 2007, MAR BIOTECHNOL, V9, P273, DOI 10.1007/s10126-006-6081-x; Chen SL, 2009, MAR BIOTECHNOL, V11, P243, DOI 10.1007/s10126-008-9139-0; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chistiakov DA, 2005, GENETICS, V170, P1821, DOI 10.1534/genetics.104.039719; Cnaani A, 2003, AQUACULTURE, V223, P117, DOI 10.1016/S0044-8486(03)00163-7; Cnaani A, 2008, BIOL LETTERS, V4, P700, DOI 10.1098/rsbl.2008.0286; Coimbra MRM, 2003, AQUACULTURE, V220, P203, DOI 10.1016/S0044-8486(02)00353-8; Deng SP, 2009, AQUACULTURE, V287, P211, DOI 10.1016/j.aquaculture.2008.10.034; Ezaz MT, 2004, MAR BIOTECHNOL, V6, P435, DOI 10.1007/s10126-004-3004-6; Falconer D. S, 1996, INTRO QUANTITATIVE G; Faris JD, 1998, GENETICS, V149, P319; Felip A, 2005, AQUACULTURE, V247, P35, DOI 10.1016/j.aquaculture.2005.02.014; Fishman L, 2001, GENETICS, V159, P1701; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Fuji K, 2010, AQUACULTURE, V308, pS51, DOI 10.1016/j.aquaculture.2010.06.035; Gilbey J, 2004, ANIM GENET, V35, P98, DOI 10.1111/j.1365-2052.2004.01091.x; Guyomard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-302; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Kai W, 2005, GENETICS, V171, P227, DOI 10.1534/genetics.105.042051; Kang JH, 2008, INT J BIOL SCI, V4, P143, DOI 10.7150/ijbs.4.143; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Liao M, 2007, ANIM GENET, V38, P364, DOI 10.1111/j.1365-2052.2007.01617.x; Liao X, 2007, MOL ECOL NOTES, V7, P1147, DOI 10.1111/j.1471-8286.2007.01812.x; Liao XL, 2009, MAR BIOTECHNOL, V11, P699, DOI 10.1007/s10126-009-9184-3; Liu YG, 2008, MOL ECOL RESOUR, V8, P202, DOI 10.1111/j.1471-8286.2007.01923.x; Liu YG, 2007, MOL ECOL NOTES, V7, P1242, DOI 10.1111/j.1471-8286.2007.01844.x; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Liu ZJ, 2003, GENETICS, V165, P687; Maliepaard C, 1997, GENET RES, V70, P237, DOI 10.1017/S0016672397003005; Massault C, 2010, ANIM GENET, V41, P337, DOI 10.1111/j.1365-2052.2009.02010.x; Matsuda M, 2003, ZOOL SCI, V20, P159, DOI 10.2108/zsj.20.159; Miao GD, 2011, J WORLD AQUACULT SOC, V42, P462, DOI 10.1111/j.1749-7345.2011.00487.x; Moen T, 2004, ANIM GENET, V35, P81, DOI 10.1111/j.1365-2052.2004.01097.x; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Reid DP, 2007, GENETICS, V177, P1193, DOI 10.1534/genetics.107.075374; Reid DP, 2005, HEREDITY, V94, P166, DOI 10.1038/sj.hdy.6800590; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Sakamoto T, 2000, GENETICS, V155, P1331; Sambrook J., 2001, MOL CLONING LAB MAMU; Senger F, 2006, GENOMICS, V87, P793, DOI 10.1016/j.ygeno.2005.11.019; Sha ZX, 2011, J FISH BIOL, V78, P322, DOI 10.1111/j.1095-8649.2010.02793.x; Shao CW, 2010, MAR BIOTECHNOL, V12, P558, DOI 10.1007/s10126-009-9242-x; Shikano Takahito, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-119; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Wang CM, 2011, MAR BIOTECHNOL, V13, P74, DOI 10.1007/s10126-010-9271-5; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang WJ, 2010, AQUACULT INT, V18, P825, DOI 10.1007/s10499-009-9303-1; Wang XB, 2008, MOL ECOL RESOUR, V8, P1303, DOI 10.1111/j.1755-0998.2008.02137.x; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; You EM, 2010, ANIM GENET, V41, P365, DOI 10.1111/j.1365-2052.2009.02014.x; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8; Zhong QW, 2009, CONSERV GENET, V10, P1617, DOI 10.1007/s10592-009-9809-0; Zhuang ZM, 2006, J APPL ICHTHYOL, V22, P437, DOI 10.1111/j.1439-0426.2006.00765.x	68	48	61	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52097	10.1371/journal.pone.0052097	http://dx.doi.org/10.1371/journal.pone.0052097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284884	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500089
J	Bhattacharjee, PS; Huq, TS; Potter, V; Young, A; Davenport, IR; Graves, R; Mandal, TK; Clement, C; McFerrin, HE; Muniruzzaman, S; Ireland, SK; Hill, JM				Bhattacharjee, Partha S.; Huq, Tashfin S.; Potter, Valencia; Young, Anna; Davenport, Ian R.; Graves, Richard; Mandal, Tarun K.; Clement, Christian; McFerrin, Harris E.; Muniruzzaman, Syed; Ireland, Shubha K.; Hill, James M.			High-Glucose-Induced Endothelial Cell Injury Is Inhibited by a Peptide Derived from Human Apolipoprotein E	PLOS ONE			English	Article							E MIMETIC PEPTIDE; DIABETIC-NEPHROPATHY; BARRIER FUNCTION; GROWTH-FACTOR; HEPARAN; PROTEIN; PROTEOGLYCANS; PERMEABILITY; ACTIVATION; MECHANISM	Although the importance of human apolipoprotein E (apoE) in vascular diseases has clearly been established, most of the research on apoE has focused on its role in cholesterol metabolism. In view of the observation that apoE and its functional domains impact extracellular matrix (ECM) remodeling, we hypothesized that apoE could also confer protection against ECM degradation by mechanisms independent of its role in cholesterol and lipoprotein transport. The ECM degrading enzyme, heparanase, is secreted by cells as pro-heparanase that is internalized through low-density lipoprotein (LDL) receptor-related protein-1 (LRP-1) to become enzymatically active. Both apoE and pro-heparanase bind the LRP-1. We further hypothesized that an apoE mimetic peptide (apoEdp) would inhibit the production of active heparanase by blocking LRP-1-mediated uptake of pro-heparanase and thereby decrease degradation of the ECM. To test this hypothesis, we induced the expression of heparanase by incubating human retinal endothelial cells (hRECs) with high glucose (30 mM) for 72 hours. We found that elevated expression of heparanase by high glucose was associated with increased shedding of heparan sulfate (Delta HS) and the tight junction protein occludin. Treatment of hRECs with 100 mM apoEdp in the presence of high glucose significantly reduced the expression of heparanase, shedding of DHS, and loss of occludin as detected by Western blot analysis. Either eye drop treatment of 1% apoEdp topically 4 times a day for 14 consecutive days or intraperitoneal injection (40 mg/kg) of apoEdp daily for 14 consecutive days in an in vivo mouse model of streptozotocin-induced diabetes inhibited the loss of tight junction proteins occludin and zona occludin- 1 (ZO-1). These findings imply a functional relationship between apoE and endothelial cell matrix because the deregulation of these molecules can be inhibited by a short peptide derived from the receptor-binding region of apoE. Thus, strategies targeting ECM-degrading enzymes could be therapeutically beneficial for treating diabetic retinopathy.	[Bhattacharjee, Partha S.; Davenport, Ian R.; McFerrin, Harris E.; Muniruzzaman, Syed; Ireland, Shubha K.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA; [Bhattacharjee, Partha S.; Clement, Christian; Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA USA; [Potter, Valencia] Univ S Alabama, Sch Med, Mobile, AL 36688 USA; [Huq, Tashfin S.] Tulane Sch Med, New Orleans, LA USA; [Young, Anna] Allegheny Coll, Meadville, PA 16335 USA; [Graves, Richard; Mandal, Tarun K.] Xavier Univ Louisiana, Coll Pharm, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Hill, James M.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of South Alabama; Tulane University; Allegheny College; Xavier University of Louisiana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Bhattacharjee, PS (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA.	pbhattac@xula.edu		Young, Anna/0000-0003-2900-8228; Mandal, Tarun/0000-0002-4966-2094	National Eye Institute (NEI), National Institutes of Health (NIH) [R01-EY006311, R01-EY14289, NIH-R21-EY019144]; National Center of Research Resources (NCRR) [P20RR016456]; National Institute of General Medical Sciences (NIGMS) [P20GM103424]; NIH-RCMI from the National Institute on Minority Health and Health Disparities [5G12RR026260]; Louisiana States University (LSU) Health Sciences Center; Transitional Research Initiative Grant; Research to Prevent Blindness (RPB) Senior Scientific Investigator Award; RPB, New York, New York; Louisiana Biotechnology Research Network; Louisiana Lions Eye Foundation, New Orleans; Louisiana Board of Regents; Lions International United States of America; Louisiana Cancer Research Consortium; Direct For Mathematical & Physical Scien [1005026] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR026260, P20RR016456] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY019144, R01EY006311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Eye Institute (NEI), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Center of Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-RCMI from the National Institute on Minority Health and Health Disparities; Louisiana States University (LSU) Health Sciences Center; Transitional Research Initiative Grant; Research to Prevent Blindness (RPB) Senior Scientific Investigator Award; RPB, New York, New York; Louisiana Biotechnology Research Network; Louisiana Lions Eye Foundation, New Orleans; Louisiana Board of Regents; Lions International United States of America; Louisiana Cancer Research Consortium; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was made possible in part by grant numbers R01-EY006311 and R01-EY14289 (JMH), NIH-R21-EY019144 (PSB) from the National Eye Institute (NEI), National Institutes of Health (NIH); grant number P20RR016456 from the National Center of Research Resources (NCRR); and P20GM103424 (HEM, JMH) from the National Institute of General Medical Sciences (NIGMS); the NIH-RCMI grant #5G12RR026260 from the National Institute on Minority Health and Health Disparities. This research was funded in part by an unrestricted research grant from the Louisiana States University (LSU) Health Sciences Center; Transitional Research Initiative Grant (JMH); Research to Prevent Blindness (RPB) Senior Scientific Investigator Award (JMH); an unrestricted grant to the LSU Eye Center from RPB, New York, New York; the Louisiana Biotechnology Research Network (JMH); the Louisiana Lions Eye Foundation, New Orleans (JMH); the Louisiana Vaccine Center (JMH) sponsored by the Louisiana Board of Regents; and Lions International United States of America (JMH); and Louisiana Cancer Research Consortium (PSB). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NEI, NCRR, NIGMS, or NIH. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Amand HL, 2012, BIOCH BIOPHYS ACTA; Barber AJ, 2003, INVEST OPHTH VIS SCI, V44, P5410, DOI 10.1167/iovs.03-0244; Bhattacharjee PS, 2008, INVEST OPHTH VIS SCI, V49, P4263, DOI 10.1167/iovs.08-2077; Bhattacharjee PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015905; Bhattacharjee PS, 2009, CURR EYE RES, V34, P99, DOI 10.1080/02713680802647662; Dobson CB, 2006, J INFECT DIS, V193, P442, DOI 10.1086/499280; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Haas AK, 2012, BIOCHEM J, V442, P583, DOI 10.1042/BJ20111973; HARDEBO JE, 1985, ACTA PHYSIOL SCAND, V125, P495, DOI 10.1111/j.1748-1716.1985.tb07746.x; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; HEDMAN K, 1982, CELL, V28, P663, DOI 10.1016/0092-8674(82)90221-5; HOOK M, 1984, ANNU REV BIOCHEM, V53, P847; Joussen Antonia M, 2007, Dev Ophthalmol, V39, P1, DOI 10.1159/000098495; KAMATA K, 1992, LIFE SCI, V50, P1379, DOI 10.1016/0024-3205(92)90256-O; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; KRAEMER PM, 1971, BIOCHEMISTRY-US, V10, P1437, DOI 10.1021/bi00784a026; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Muir H, 1977, Soc Gen Physiol Ser, V32, P87; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Roider J, 2000, BRIT J OPHTHALMOL, V84, P40, DOI 10.1136/bjo.84.1.40; RUDERMAN NB, 1992, FASEB J, V6, P2905, DOI 10.1096/fasebj.6.11.1644256; Shafat I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017312; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Zhu YJ, 2003, J BIOL CHEM, V278, P36257, DOI 10.1074/jbc.M303171200	31	19	19	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52152	10.1371/journal.pone.0052152	http://dx.doi.org/10.1371/journal.pone.0052152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284911	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300076
J	Barreda, VD; Cuneo, NR; Wilf, P; Currano, ED; Scasso, RA; Brinkhuis, H				Barreda, Viviana D.; Cuneo, Nestor R.; Wilf, Peter; Currano, Ellen D.; Scasso, Roberto A.; Brinkhuis, Henk			Cretaceous/Paleogene Floral Turnover in Patagonia: Drop in Diversity, Low Extinction, and a Classopollis Spike	PLOS ONE			English	Article							TERTIARY BOUNDARY; MASS EXTINCTION; END; VEGETATION; SEDIMENTS; ECOSYSTEM; POLLEN; RECORD	Nearly all data regarding land-plant turnover across the Cretaceous/Paleogene boundary come from western North America, relatively close to the Chicxulub, Mexico impact site. Here, we present a palynological analysis of a section in Patagonia that shows a marked fall in diversity and abundance of nearly all plant groups across the K/Pg interval. Minimum diversity occurs during the earliest Danian, but only a few palynomorphs show true extinctions. The low extinction rate is similar to previous observations from New Zealand. The differing responses between the Southern and Northern hemispheres could be related to the attenuation of damage with increased distance from the impact site, to hemispheric differences in extinction severity, or to both effects. Legacy effects of the terminal Cretaceous event also provide a plausible, partial explanation for the fact that Paleocene and Eocene macrofloras from Patagonia are among the most diverse known globally. Also of great interest, earliest Danian assemblages are dominated by the gymnosperm palynomorphs Classopollis of the extinct Mesozoic conifer family Cheirolepidiaceae. The expansion of Classopollis after the boundary in Patagonia is another example of typically Mesozoic plant lineages surviving into the Cenozoic in southern Gondwanan areas, and this greatly supports previous hypotheses of high latitude southern regions as biodiversity refugia during the end-Cretaceous global crisis.	[Barreda, Viviana D.] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, RA-1033 Buenos Aires, DF, Argentina; [Cuneo, Nestor R.] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Wilf, Peter] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Currano, Ellen D.] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Scasso, Roberto A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Geol, Buenos Aires, DF, Argentina; [Brinkhuis, Henk] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Miami University; University of Buenos Aires; Utrecht University	Barreda, VD (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat Bernardino Rivadavia, Div Paleobot, RA-1033 Buenos Aires, DF, Argentina.	vbarreda@macn.gov.ar		Brinkhuis, Henk/0000-0003-0253-6610; Barreda, Viviana Dora/0000-0002-1560-1277	National Science Foundation [DEB-0919071]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Direct For Biological Sciences [0919071] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided through National Science Foundation grant DEB-0919071 and the Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; ALVIN KL, 1982, REV PALAEOBOT PALYNO, V37, P71, DOI 10.1016/0034-6667(82)90038-0; [Anonymous], 1991, EXTINCTION BAD GENES; ARCHANGELSKY S, 1973, Ameghiniana, V10, P339; Askin R.A., 1988, GEOLOGICAL SOC AM ME, V169, P155, DOI 10.1130/mem169-p155; Baldoni Alicia M., 1992, Palynology, V16, P117; Baldoni Alicia M., 1993, Palynology, V17, P241; Barreda V., 2004, 10 REUN ARG SED, P185; BERRY EDWARD W., 1935, TORREYA, V35, P11; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CASE J A, 1986, Palaios, V1, P413, DOI 10.2307/3514478; Cuneo N. R., 2010, BOT SOC AM ANN M PRO; Gelfo Javier N., 2001, Geodiversitas, V23, P369; Grimm E, 2004, TILIA SOFTWARE 2 0 2; Hill RS, 1999, AUST J BOT, V47, P717, DOI 10.1071/BT98018; Hotton CL, 2002, GEOL S AM S, P473; Iglesias A, 2007, GEOLOGY, V35, P947, DOI 10.1130/G23889A.1; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kunzmann L, 2007, ZOOL ANZ, V246, P257, DOI 10.1016/j.jcz.2007.08.001; Macphail MK, 1994, PALAEOAUSTRAL, V1, P9; McLoughlin S, 2008, AM J BOT, V95, P465, DOI 10.3732/ajb.95.4.465; McLoughlin S, 2011, INT J PLANT SCI, V172, P574, DOI 10.1086/658920; Medina FA, 1994, RAGA, V48, P100; Medina FA., 1990, 5 C ARG PAL BIOESTR, P137; Nichols DJ, 2008, PLANTS AND THE K-T BOUNDARY, P1, DOI 10.1017/CBO9780511535536; ORTH CJ, 1981, SCIENCE, V214, P1341, DOI 10.1126/science.214.4527.1341; Panti C, 2012, ALCHERINGA, V36, P1, DOI 10.1080/03115518.2011.564562; Punt W, 2007, REV PALAEOBOT PALYNO, V143, P1, DOI 10.1016/j.revpalbo.2006.06.008; Quattrocchio, 1997, REV ESP MICROPALEONT, V29, P115; Scasso RA, 2012, CRETACEOUS RES, V36, P37, DOI 10.1016/j.cretres.2012.02.002; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Sokal RR, 1995, BIOMETRY; SRIVASTAVA SK, 1976, LETHAIA, V9, P437, DOI 10.1111/j.1502-3931.1976.tb00985.x; TSCHUDY RH, 1984, SCIENCE, V225, P1030, DOI 10.1126/science.225.4666.1030; Vajda V, 2004, SCIENCE, V303, P1489, DOI 10.1126/science.1093807; Vajda V, 2003, NEW ZEAL J GEOL GEOP, V46, P255, DOI 10.1080/00288306.2003.9515008; Vajda V, 2001, SCIENCE, V294, P1700, DOI 10.1126/science.1064706; Vajda V, 2007, REV PALAEOBOT PALYNO, V144, P99, DOI 10.1016/j.revpalbo.2005.09.007; Volkheimer W., 2007, REV ESPA NOLA MICROP, V39, P117; Wappler T, 2009, P ROY SOC B-BIOL SCI, V276, P4271, DOI 10.1098/rspb.2009.1255; Watson J., 1988, ORIGIN EVOLUTION GYM, P382; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2004, PALEOBIOLOGY, V30, P347, DOI 10.1666/0094-8373(2004)030<0347:LPEATE>2.0.CO;2; Wing SL, 2009, P NATL ACAD SCI USA, V106, P18627, DOI 10.1073/pnas.0905130106; WOLFE JA, 1986, NATURE, V324, P148, DOI 10.1038/324148a0	45	92	100	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52455	10.1371/journal.pone.0052455	http://dx.doi.org/10.1371/journal.pone.0052455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285049	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900094
J	Han, KD; Ahn, DH; Lee, SA; Min, YH; Kwon, AR; Ahn, HC; Lee, BJ				Han, Kyung-Doo; Ahn, Do-Hwan; Lee, Seung-A; Min, Yu-Hong; Kwon, Ae-Ran; Ahn, Hee-Chul; Lee, Bong-Jin			Identification of Chromosomal HP0892-HP0893 Toxin-Antitoxin Proteins in Helicobacter pylori and Structural Elucidation of Their Protein-Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RIBONUCLEASE; BACTERIA; SYSTEM; YAFQ; MECHANISM; AUTOPHAGY; ALIGNMENT; RIBOSOME	Bacterial chromosomal toxin-antitoxin (TA) systems have been proposed not only to play an important role in the stress response, but also to be associated with antibiotic resistance. Here, we identified the chromosomal HP0892-HP0893 TA proteins in the gastric pathogen, Helicobacter pylori, and structurally characterized their protein-protein interaction. Previously, HP0892 protein was suggested to be a putative TA toxin based on its structural similarity to other RelE family TA toxins. In this study, we demonstrated that HP0892 binds to HP0893 strongly with a stoichiometry of 1:1, and HP0892-HP0893 interaction occurs mainly between the N-terminal secondary structure elements of HP0892 and the C-terminal region of HP0893. HP0892 cleaved mRNA in vitro, preferentially at the 5' end of A or G, and the RNase activity of HP0892 was inhibited by HP0893. In addition, heterologous expression of HP0892 in Escherichia coli cells led to cell growth arrest, and the cell toxicity of HP0892 was neutralized by co-expression with HP0893. From these results and a structural comparison with other TA toxins, it is concluded that HP0892 is a toxin with intrinsic RNase activity and HP0893 is an antitoxin against HP0892 from a TA system of H. pylori. It has been known that hp0893 gene and another TA antitoxin gene, hp0895, of H. pylori, are both genomic open reading frames that correspond to genes that are potentially expressed in response to interactions with the human gastric mucosa. Therefore, it is highly probable that TA systems of H. pylori are involved in virulence of H. pylori.	[Han, Kyung-Doo] Korea Inst Sci & Technol, Adv Anal Ctr, Seoul 136791, South Korea; [Ahn, Do-Hwan; Lee, Seung-A; Lee, Bong-Jin] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea; [Min, Yu-Hong; Kwon, Ae-Ran] Daegu Haany Univ, Dept Herbal Skin Care, Gyongsan 712715, Gyeongsangbuk D, South Korea; [Ahn, Hee-Chul] Dongguk Univ, Coll Pharm, Dept Pharm, Goyang 410820, Geonggi, South Korea	Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Daegu Haany University; Dongguk University	Lee, BJ (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea.	lbj@nmr.snu.ac.kr	Lee, Bong-Jin/AAQ-1609-2020	Lee, Bong-Jin/0000-0001-7896-2961	National Research Foundation of Korea [20110001207, 2012R1A2A1A01003569]; Korean Government (MEST); Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A084420, A092006]; Korea Healthcare Technology RD Project; Project for Medicine, Dentistry, and Pharmacy [2011 BK21]; Korea Institute of Science and Technology [2V02900]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Healthcare Technology RD Project; Project for Medicine, Dentistry, and Pharmacy; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	This work was supported by National Research Foundation of Korea Grants 20110001207 and 2012R1A2A1A01003569 funded by the Korean Government (MEST); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grants A084420 and A092006; 2011 BK21 Project for Medicine, Dentistry, and Pharmacy; and Korea Institute of Science and Technology Grant 2V02900.	Armalyte J, 2012, J BACTERIOL, V194, P1523, DOI 10.1128/JB.06104-11; Blower TR, 2009, J BACTERIOL, V191, P6029, DOI 10.1128/JB.00720-09; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cover T. L., 2001, PRINCIPLES BACTERIAL, P509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Fineran PC, 2009, P NATL ACAD SCI USA, V106, P894, DOI 10.1073/pnas.0808832106; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2007, CURR OPIN MICROBIOL, V10, P117, DOI 10.1016/j.mib.2007.03.003; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Graham JE, 2002, GASTROENTEROLOGY, V123, P1637, DOI 10.1053/gast.2002.36589; Han KD, 2005, PROTEINS, V61, P1114, DOI 10.1002/prot.20691; Han KD, 2008, PROTEINS, V70, P599, DOI 10.1002/prot.21701; Han KD, 2011, J BIOL CHEM, V286, P4842, DOI 10.1074/jbc.M109.097840; Hu Ming-Xi, 2010, Int J Microbiol, V2010, P781430, DOI 10.1155/2010/781430; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Matin A, 1996, INFECT IMMUN, V64, P1434, DOI 10.1128/IAI.64.4.1434-1436.1996; Motiejunaite R, 2007, FEMS MICROBIOL LETT, V268, P112, DOI 10.1111/j.1574-6968.2006.00563.x; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Rothenbacher D, 2003, MICROBES INFECT, V5, P693, DOI 10.1016/S1286-4579(03)00111-4; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; Sevcik J, 1996, ACTA CRYSTALLOGR D, V52, P327, DOI 10.1107/S0907444995007669; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Terry CE, 2005, INFECT IMMUN, V73, P3794, DOI 10.1128/IAI.73.6.3794-3798.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Yakovlev GI, 2003, PROTEIN SCI, V12, P2367, DOI 10.1110/ps.03176803; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	48	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					6004	6013		10.1074/jbc.M111.322784	http://dx.doi.org/10.1074/jbc.M111.322784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297406	hybrid, Green Published			2022-12-25	WOS:000315342500068
J	Arhzaouy, K; Ramezani-Rad, M				Arhzaouy, Khalid; Ramezani-Rad, Massoud			Nuclear Import of UBL-Domain Protein Mdy2 Is Required for Heat-Induced Stress Response in Saccharomyces cerevisiae	PLOS ONE			English	Article							MESSENGER-RNA; CYTOPLASMIC GRANULES; MEMBRANE INSERTION; UBIQUITIN; IDENTIFICATION; COMPLEX; YEAST; SGT2; LOCALIZATION; TRANSPORT	Ubiquitin (Ub) and ubiquitin-like (UBL) proteins regulate a diverse array of cellular pathways through covalent as well as non-covalent interactions with target proteins. Yeast protein Mdy2 (Get5) and its human homolog GdX (Ubl4a) belong to the class of UBL proteins which do not form conjugates with other proteins. Mdy2 is required for cell survival under heat stress and for efficient mating. As part of a complex with Sgt2 and Get4 it has been implicated in the biogenesis of tail-anchored proteins. Interestingly, in response to heat stress, Mdy2 protein that is predominantly localized in the nucleus co-localized with poly(A)-binding protein Pab1 to cytoplasmic stress granules suggesting that nucleocytoplasmic shuttling is of functional importance. Here we investigate the nuclear import of Mdy2, a process that is independent of the Get4/Sgt2 complex but required for stress response. Nuclear import is mediated by an N-terminal nuclear localization signal (NLS) and this process is essential for the heat stress response. In contrast, cells expressing Mdy2 lacking a nuclear export signal (NES) behave like wild type. Importantly, both Mdy2 and Mdy2-Delta NES, but not Mdy2-Delta NLS, physically interact with Pab1 and this interaction correlates with the accumulation in cytoplasmic stress granules. Thus, the nuclear history of the UBL Mdy2 appears to be essential for its function in cytoplasmic stress granules during the rapid cellular response to heat stress.	[Arhzaouy, Khalid; Ramezani-Rad, Massoud] Univ Dusseldorf, Inst Microbiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Ramezani-Rad, M (corresponding author), Univ Dusseldorf, Inst Microbiol, D-40225 Dusseldorf, Germany.	ramezani@uni-duesseldorf.de						Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Battle A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.27; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Brune C, 2005, RNA, V11, P517, DOI 10.1261/rna.7291205; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2012, J BIOL CHEM, V287, P8310, DOI 10.1074/jbc.M111.333252; Chartron JW, 2011, J BIOL CHEM, V286, P34325, DOI 10.1074/jbc.M111.277798; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cohnen A, 2010, CYTOSKELETON, V67, P635, DOI 10.1002/cm.20477; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Hu Z, 2006, J CELL SCI, V119, P326, DOI 10.1242/jcs.02754; Iwanejko L, 1999, YEAST, V15, P1529, DOI 10.1002/(SICI)1097-0061(199910)15:14<1529::AID-YEA457>3.3.CO;2-P; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Simpson PJ, 2010, STRUCTURE, V18, P897, DOI 10.1016/j.str.2010.07.003; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; TONIOLO D, 1988, EMBO J, V7, P401, DOI 10.1002/j.1460-2075.1988.tb02827.x; Tran EJ, 2007, CELL, V131, DOI 10.1016/j.cell.2007.10.015; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010	43	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52956	10.1371/journal.pone.0052956	http://dx.doi.org/10.1371/journal.pone.0052956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285234	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500089
J	Holm, I; Lavazec, C; Garnier, T; Mitri, C; Riehle, MM; Bischoff, E; Brito-Fravallo, E; Takashima, E; Thiery, I; Zettor, A; Petres, S; Bourgouin, C; Vernick, KD; Eiglmeier, K				Holm, Inge; Lavazec, Catherine; Garnier, Thierry; Mitri, Christian; Riehle, Michelle M.; Bischoff, Emmanuel; Brito-Fravallo, Emma; Takashima, Eizo; Thiery, Isabelle; Zettor, Agnes; Petres, Stephane; Bourgouin, Catherine; Vernick, Kenneth D.; Eiglmeier, Karin			Diverged Alleles of the Anopheles gambiae Leucine-Rich Repeat Gene APL1A Display Distinct Protective Profiles against Plasmodium falciparum	PLOS ONE			English	Article							MALARIA PARASITES; PROTEINS; COMPLEMENT; RESISTANCE; INFECTION; IMMUNITY; SYSTEM; GENOME; REGION	Functional studies have demonstrated a role for the Anopheles gambiae APL1A gene in resistance against the human malaria parasite, Plasmodium falciparum. Here, we exhaustively characterize the structure of the APL1 locus and show that three structurally different APL1A alleles segregate in the Ngousso colony. Genetic association combined with RNAi-mediated gene silencing revealed that APL1A alleles display distinct protective profiles against P. falciparum. One APL1A allele is sufficient to explain the protective phenotype of APL1A observed in silencing experiments. Epitope-tagged APL1A isoforms expressed in an in vitro hemocyte-like cell system showed that under assay conditions, the most protective APL1A isoform (APL1A(2)) localizes within large cytoplasmic vesicles, is not constitutively secreted, and forms only one protein complex, while a less protective isoform (APL1A(1)) is constitutively secreted in at least two protein complexes. The tested alleles are identical to natural variants in the wild A. gambiae population, suggesting that APL1A genetic variation could be a factor underlying natural heterogeneity of vector susceptibility to P. falciparum.	[Holm, Inge; Lavazec, Catherine; Garnier, Thierry; Mitri, Christian; Bischoff, Emmanuel; Brito-Fravallo, Emma; Takashima, Eizo; Vernick, Kenneth D.; Eiglmeier, Karin] Inst Pasteur, Dept Parasitol & Mycol, Unit Hosts Vectors & Infect Agents URA3012, Unit Insect Vector Genet & Genom,CNRS, Paris, France; [Riehle, Michelle M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN USA; [Thiery, Isabelle; Zettor, Agnes; Bourgouin, Catherine] Inst Pasteur, Ctr Prod & Infect Anopheles CEPIA, Paris, France; [Petres, Stephane] Inst Pasteur, Ctr Prod Prot Recombinantes & Anticorps, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eiglmeier, K (corresponding author), Inst Pasteur, Dept Parasitol & Mycol, Unit Hosts Vectors & Infect Agents URA3012, Unit Insect Vector Genet & Genom,CNRS, Paris, France.	kei@pasteur.fr	Lavazec, Catherine/AAD-9206-2020; Bischoff, Emmanuel/F-1197-2011; Lavazec, Catherine/A-4285-2016; Bourgouin, Catherine/F-1253-2014	Lavazec, Catherine/0000-0003-1533-7282; Bischoff, Emmanuel/0000-0003-4655-4247; Lavazec, Catherine/0000-0003-1533-7282; Bourgouin, Catherine/0000-0002-9209-845X; petres, stephane/0000-0002-4716-565X; Mitri, Christian/0000-0003-3882-2029; Takashima, Eizo/0000-0001-9070-8499	NIAID/NIH [AI042361, AI073685]; Ile de France DIM (Domain d'Interet Majeur Maladies Infectieuses, Parasitaires et Nocosomiales Emergentes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073685, R01AI042361] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ile de France DIM (Domain d'Interet Majeur Maladies Infectieuses, Parasitaires et Nocosomiales Emergentes); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by NIAID/NIH AI042361 and AI073685 to KDV, and by Ile de France DIM (Domain d'Interet Majeur Maladies Infectieuses, Parasitaires et Nocosomiales Emergentes) to CL. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Crawford JE, 2012, GENES GENOM IN PRESS; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Garver LS, 2008, DEV COMP IMMUNOL, V32, P519, DOI 10.1016/j.dci.2007.09.007; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Harris C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001112; Harris C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-81; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Mendes AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11; Menge DM, 2006, GENETICS, V173, P235, DOI 10.1534/genetics.105.055129; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-87; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; TDR/WHO, 2012, MAL; Waterhouse RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-531; Wilding CS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-320	32	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52684	10.1371/journal.pone.0052684	http://dx.doi.org/10.1371/journal.pone.0052684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285147	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500047
J	Ma, XQ; Yao, YW; Yuan, DM; Liu, HB; Wang, SJ; Zhou, CS; Song, Y				Ma, Xingqun; Yao, Yanwen; Yuan, Dongmei; Liu, Hongbing; Wang, Shouju; Zhou, Changsheng; Song, Yong			Recombinant Human Endostatin Endostar Suppresses Angiogenesis and Lymphangiogenesis of Malignant Pleural Effusion in Mice	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; I CLINICAL-TRIAL; GROWTH-FACTOR-C; INHIBITS LYMPHANGIOGENESIS; DOWN-REGULATION; TUMOR-CELLS; THERAPY; CANCER; MANAGEMENT; VEGF	Background: Malignant pleural effusion (MPE) is a common complication of lung cancer. One widely used treatment for MPE is Endostar, a recombined humanized endostatin based treatment. However, the mechanism of this treatment is still unclear. The aim of this study was to investigate the effects of Endostar in mice with MPE. Methods and Materials: Lewis lung carcinoma (LLC) cell line expressing enhanced green fluorescent protein (EGFP) was injected into pleural cavity to establish MPE mice model. Mice were randomly divided into four groups. High dose of Endostar (30 mg/kg), low dose of Endostar (8 mg/kg), normal saline, or Bevacizumab (5 mg/kg) was respectively injected into pleural cavity three times with 3-day interval in each group. Transverse computed tomography (CT) was performed to observe pleural fluid formation 14 days after LLC cells injection. Mice were anesthetized and sacrificed 3 days after final administration. The volume of pleural effusion n was measured using 1 ml syringe. Micro blood vessel density (MVD), Lymphatic micro vessel density (LMVD), the expression level of vascular endothelial growth factor A (VEGF-A) and VEGF-C were observed by immunohistochemistry (IHC) staining. Results: The volume of pleural effusion as well as the number of pleural tumor foci, MVD and the expression of VEGF- A were significantly reduced in high dose of Endostar treat group. More importantly, LMVD and the expression of VEGF-C were markedly lower in treat group than those in the other three control groups. Conclusion: Our work demonstrated that Endostar played an efficient anti-cancer role in MPE through its suppressive effect on angiogenesis and lymphangiogenesis, which provided a certain theoretical basis for the effectiveness of Endostar on the MPE treatment.	[Ma, Xingqun; Yao, Yanwen; Yuan, Dongmei; Liu, Hongbing; Song, Yong] Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Shouju; Zhou, Changsheng] Nanjing Univ, Sch Med, Dept Med Imaging, Jinling Hosp, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Song, Y (corresponding author), Nanjing Univ, Sch Med, Dept Resp Med, Jinling Hosp, Nanjing, Jiangsu, Peoples R China.	yong_song6310@yahoo.com	Liu, Hongbing/F-5980-2015	Liu, Hongbing/0000-0003-1404-0647; Wang, Shouju/0000-0001-9213-6818	Natural Science Fund of Jiangsu Province [BK2011658]	Natural Science Fund of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the Natural Science Fund of Jiangsu Province (BK2011658) to Song Yong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Bose D, 2010, LANCET ONCOL, V11, P373, DOI 10.1016/S1470-2045(09)70341-9; Brideau G, 2007, CANCER RES, V67, P11528, DOI 10.1158/0008-5472.CAN-07-1458; CHERNOW B, 1977, AM J MED, V63, P695, DOI 10.1016/0002-9343(77)90154-1; Dong X, 2011, THORAC CARDIOV SURG, V59, P133, DOI 10.1055/s-0030-1250152; Eder JP, 2002, J CLIN ONCOL, V20, P3772, DOI 10.1200/JCO.2002.02.082; Fang F, 2009, J CANCER RES CLIN, V135, P1149, DOI 10.1007/s00432-009-0555-y; Fukumoto S, 2005, CLIN EXP METASTAS, V22, P31, DOI 10.1007/s10585-005-3973-5; Gerber HP, 2005, CANCER RES, V65, P671; Hajitou A, 2002, FASEB J, V16, P1802, DOI 10.1096/fj.02-0109fje; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Juttner S, 2006, J CLIN ONCOL, V24, P228, DOI 10.1200/JCO.2004.00.3467; Kaifi JT, 2012, J SURG ONCOL, V105, P731, DOI 10.1002/jso.22100; Kobold S, 2009, ONCOLOGIST, V14, P1242, DOI 10.1634/theoncologist.2009-0109; Lee YCG, 2004, RESPIROLOGY, V9, P148, DOI 10.1111/j.1440-1843.2004.00566.x; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; LYNCH TJ, 1993, CHEST, V103, pS385; Ma X, 2012, ZHONGGUO FEI AI ZA Z, V15, P317; Mohammed RAA, 2007, BRIT J CANCER, V96, P1092, DOI 10.1038/sj.bjc.6603678; Mundhenke C, 2001, CLIN CANCER RES, V7, P3366; Nagahashi M, 2010, WORLD J GASTROENTERO, V16, P4003, DOI 10.3748/wjg.v16.i32.4003; Najmunnisa N, 2007, EUR RESPIR J, V29, P761, DOI 10.1183/09031936.00061606; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Presta LG, 1997, CANCER RES, V57, P4593; Reck M, 2009, LUNG CANCER, V63, P1, DOI 10.1016/j.lungcan.2008.05.015; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stathopoulos GT, 2007, CANCER RES, V67, P9825, DOI 10.1158/0008-5472.CAN-07-1064; Stathopoulos GT, 2006, AM J RESP CELL MOL, V34, P142, DOI 10.1165/rcmb.2005-0130OC; Wei Hong-mei, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1509; Wei Shuzhen, 2010, Zhongguo Fei Ai Za Zhi, V13, P670, DOI 10.3779/j.issn.1009-3419.2010.07.03	33	31	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53449	10.1371/journal.pone.0053449	http://dx.doi.org/10.1371/journal.pone.0053449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285296	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500151
J	Nausch, H; Mischofsky, H; Koslowski, R; Meyer, U; Broer, I; Huckauf, J				Nausch, Henrik; Mischofsky, Heike; Koslowski, Roswitha; Meyer, Udo; Broer, Inge; Huckauf, Jana			Expression and Subcellular Targeting of Human Complement Factor C5a in Nicotiana species	PLOS ONE			English	Article							PLANT-MADE PHARMACEUTICALS; HIGH-YIELD PRODUCTION; HETEROLOGOUS PROTEINS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; N-GLYCOSYLATION; SEVERE SEPSIS; TOBACCO; STRATEGIES	We evaluated transgenic tobacco plants as an alternative to Escherichia coli for the production of recombinant human complement factor 5a (C5a). C5a has not been expressed in plants before and is highly unstable in vivo in its native form, so it was necessary to establish the most suitable subcellular targeting strategy. We used the strong and constitutive CaMV 35S promoter to drive transgene expression and compared three different subcellular compartments. The yields of C5a in the T-0 transgenic plants were low in terms of the proportion of total soluble protein (TSP) when targeted to the apoplast (0.0002% TSP) or endoplasmic reticulum (0.0003% TSP) but was one order of magnitude higher when targeted to the vacuole (0.001% TSP). The yields could be increased by conventional breeding (up to 0.014% TSP in the T-2 generation). C5a accumulated to the same level in seeds and leaves when targeted to the apoplast but was up to 1.7-fold more abundant in the seeds when targeted to the ER or vacuole, although this difference was less striking in the better-performing lines. When yields were calculated as an amount per gram fresh weight of transgenic plant tissue, the vacuole targeting strategy was clearly more efficient in seeds, reaching 35.8 mu g C5a per gram of fresh seed weight compared to 10.62 mu g C5a per gram fresh weight of leaves. Transient expression of C5aER and C5aVac in N. benthamiana, using MagnICON vectors, reached up to 0.2% and 0.7% of TSP, respectively, but was accompanied by cytotoxic effects and induced leaf senescence. Western blot of the plant extracts revealed a band matching the corresponding glycosylated native protein and the bioassay demonstrated that recombinant C5a was biologically active.	[Nausch, Henrik; Mischofsky, Heike; Broer, Inge; Huckauf, Jana] Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, Rostock, Germany; [Koslowski, Roswitha; Meyer, Udo] Bioserv GmbH, Rostock, Germany	University of Rostock	Broer, I (corresponding author), Univ Rostock, Agr & Environm Fac, Dept Agrobiotechnol, Rostock, Germany.	inge.broer@uni-rostock.de		Nausch, Henrik/0000-0001-5393-3267	doctorate program of the University of Rostock	doctorate program of the University of Rostock	The first author appreciated the grant from the doctorate program of the University of Rostock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This work was supported by the doctorate program of the University of Rostock. The authors thank Dr. Anatoli Giritch and Prof. Dr. Juri Gleba for providing the MagnICON vectors for research purposes.	ALI H, 1993, J BIOL CHEM, V268, P24247; Avesani L, 2010, EXPERT REV VACCINES, V9, P957, DOI [10.1586/erv.10.82, 10.1586/ERV.10.82]; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Boehm R, 2007, ANN NY ACAD SCI, V1102, P121, DOI 10.1196/annals.1408.009; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Christie M, 2011, PLANT J, V68, P159, DOI 10.1111/j.1365-313X.2011.04676.x; Cohen J, 2009, CLIN MICROBIOL INFEC, V15, P302, DOI 10.1111/j.1469-0691.2009.02753.x; Conrad U, 1998, PLANT MOL BIOL, V38, P101, DOI 10.1023/A:1006029617949; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Davies HM, 2010, PLANT BIOTECHNOL J, V8, P845, DOI 10.1111/j.1467-7652.2010.00550.x; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; Flierl MA, 2009, CRITICAL CARE, P13; FRANKE AE, 1988, METHOD ENZYMOL, V162, P653; FREGA N, 1991, J AM OIL CHEM SOC, V68, P29, DOI 10.1007/BF02660305; Frigerio L, 2001, J PLANT PHYSIOL, V158, P499, DOI 10.1078/0176-1617-00362; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; GOLDSTEI.IM, 1974, J IMMUNOL, V113, P1583; Goulet C, 2012, PLANT BIOTECHNOL J, V10, P83, DOI 10.1111/j.1467-7652.2011.00643.x; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hausmann L, 1999, VORT PFLANZENZUCHTG, V45, P155; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; HERRERAESTRELLA L, 1983, EMBO J, V2, P987, DOI 10.1002/j.1460-2075.1983.tb01532.x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Huang Z, 2006, VACCINE, V24, P2506, DOI 10.1016/j.vaccine.2005.12.024; Huang Z, 2008, PLANT BIOTECHNOL J, V6, P202, DOI 10.1111/j.1467-7652.2007.00316.x; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huhns M, 2009, PLANT BIOTECHNOL J, V7, P883, DOI 10.1111/j.1467-7652.2009.00451.x; HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193; Jacobs PP, 2009, CURR MOL MED, V9, P774, DOI 10.2174/156652409789105552; Khan I, 2012, J BIOTECHNOL; Khanuja SPS, 1999, PLANT MOL BIOL REP, V17, P74, DOI 10.1023/A:1007528101452; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; MANDECKI W, 1986, GENE, V43, P131, DOI 10.1016/0378-1119(86)90016-8; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Mikschofsky H, 2012, TRANSGENIC RES, V21, P715, DOI 10.1007/s11248-011-9573-z; Mikschofsky H, 2009, PLANT BIOTECHNOL J, V7, P537, DOI 10.1111/j.1467-7652.2009.00422.x; MOLLISON KW, 1987, AGENTS ACTIONS, V21, P366, DOI 10.1007/BF01966518; MOLLISON KW, 1991, AGENT ACTION SUPPL, V35, P17; Morandini F, 2011, PLANT BIOTECHNOL J, V9, P911, DOI 10.1111/j.1467-7652.2011.00605.x; Nagels B, 2012, CRIT REV PLANT SCI, V31, P148, DOI 10.1080/07352689.2011.616075; Nausch H, 2012, AFRICAN J BIOT UNPUB; Nausch H, 2012, PLOS ONE UNPUB; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pagny S, 2003, PLANT CELL PHYSIOL, V44, P173, DOI 10.1093/pcp/pcg027; Parrish WR, 2008, ANN NY ACAD SCI, V1144, P210, DOI 10.1196/annals.1418.011; Paul M, 2011, BIOTECHNOL APPL BIOC, V58, P58, DOI 10.1002/bab.6; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sawant SV, 2001, PLANT PHYSIOL, V126, P1630, DOI 10.1104/pp.126.4.1630; Schillberg S, 1999, TRANSGENIC RES, V8, P255, DOI 10.1023/A:1008937011213; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Thomas DR, 2011, INT J MOL SCI, V12, P3220, DOI 10.3390/ijms12053220; Tiwari S, 2009, PLANT CELL REP, V28, P1827, DOI 10.1007/s00299-009-0782-3; Torikaiu K, 2005, FOOD CHEM TOXICOL, V43, P559, DOI 10.1016/j.fct.2004.12.011; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Tripathi NK, 2009, DEFENCE SCI J, V59, P137, DOI 10.14429/dsj.59.1501; Twyman RM, 2012, CURRENT PHA IN PRESS; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Ward PA, 2008, J LEUKOCYTE BIOL, V83, P467, DOI 10.1189/jlb.0607376; Webster DE, 2012, BIOTECHNOL ADV, V30, P410, DOI 10.1016/j.biotechadv.2011.07.015; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101	75	18	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53023	10.1371/journal.pone.0053023	http://dx.doi.org/10.1371/journal.pone.0053023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285250	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500101
J	Roddy, P; Howard, N; Van Kerkhove, MD; Lutwama, J; Wamala, J; Yoti, Z; Colebunders, R; Palma, PP; Sterk, E; Jeffs, B; Van Herp, M; Borchert, M				Roddy, Paul; Howard, Natasha; Van Kerkhove, Maria D.; Lutwama, Julius; Wamala, Joseph; Yoti, Zabulon; Colebunders, Robert; Palma, Pedro Pablo; Sterk, Esther; Jeffs, Benjamin; Van Herp, Michel; Borchert, Matthias			Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever Caused by a Newly Identified Virus Strain, Bundibugyo, Uganda, 2007-2008	PLOS ONE			English	Article							SUBTYPE RESTON VIRUS; RISK-FACTORS; FILOVIRUS INFECTIONS; MARBURG; DISEASE; EPIDEMIC; KIKWIT; CONGO; TRANSMISSION; OUTBREAK	A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%). Study objectives are to describe clinical manifestations and case management for 26 hospitalised laboratory-confirmed EHF patients. Clinical findings are congruous with previously reported EHF infections. The most frequently experienced symptoms were non-bloody diarrhoea (81%), severe headache (81%), and asthenia (77%). Seven patients reported or were observed with haemorrhagic symptoms, six of whom died. Ebola care remains difficult due to the resource-poor setting of outbreaks and the infection-control procedures required. However, quality data collection is essential to evaluate case definitions and therapeutic interventions, and needs improvement in future epidemics. Organizations usually involved in EHF case management have a particular responsibility in this respect.	[Roddy, Paul; Palma, Pedro Pablo; Jeffs, Benjamin] Med Dept Med Sans Frontieres, Barcelona, Spain; [Sterk, Esther] Med Dept Med Sans Frontieres, Geneva, Switzerland; [Van Herp, Michel] Med Dept Med Sans Frontieres, Brussels, Belgium; [Howard, Natasha] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Van Kerkhove, Maria D.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Med Res Council Ctr Outbreak Anal & Modelling, London, England; [Lutwama, Julius] Uganda Virus Res Inst, Dept Arbovirol Emerging & Re Emerging Viral Infec, Entebbe, Uganda; [Wamala, Joseph] Uganda Minist Hlth, Natl Dis Control, Kampala, Uganda; [Yoti, Zabulon] World Hlth Org Reg Off Africa, Kampala, Uganda; [Colebunders, Robert] Univ Antwerp, Dept Clin Sci, Inst Trop Med Antwerp, B-2020 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium; [Borchert, Matthias] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Borchert, Matthias] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; Uganda Virus Research Institute; World Health Organization; Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Roddy, P (corresponding author), Med Dept Med Sans Frontieres, Barcelona, Spain.	roddypd@gmail.com		Howard, Natasha/0000-0003-4174-7349; Van Kerkhove, Maria/0000-0002-6135-0018	Medical Research Council UK; Bill and Melinda Gates Foundation; Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MDVK acknowledges funding from the Medical Research Council UK and the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baert B, 2001, EBOLA OUTBREAK PREPA; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Bausch DG, 2008, ANTIVIR RES, V78, P150, DOI 10.1016/j.antiviral.2008.01.152; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bausch DG, 2007, J INFECT DIS, V196, pS136, DOI 10.1086/520542; Bausch DG, 2006, NEW ENGL J MED, V355, P909, DOI 10.1056/NEJMoa051465; Bausch DG, 2003, EMERG INFECT DIS, V9, P1531, DOI 10.3201/eid0912.030355; BECKER S, 1992, MED MICROBIOL IMMUN, V181, P43, DOI 10.1007/BF00193395; Bonnet MJ, 1998, EMERG INFECT DIS, V4, P508, DOI 10.3201/eid0403.980349; Borchert M, 2002, TROP MED INT HEALTH, V7, P902, DOI 10.1046/j.1365-3156.2002.00945.x; Bray M, 2003, J INFECT DIS, V188, P1613, DOI 10.1086/379727; Bray M, 2007, J INFECT DIS, V196, pS438, DOI 10.1086/520552; Buhler S, 2008, THESIS LONDON SCH HY; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Casillas Adrian M, 2003, Biol Res Nurs, V4, P268, DOI 10.1177/1099800403252603; CDC, 2007, EB HEM FEV OUTBR UG; CDC, 2010, KNOWN CAS OUTBR EB H; Colebunders R, 2007, J INFECT DIS, V196, pS148, DOI 10.1086/520543; CONRAD JL, 1978, AM J TROP MED HYG, V27, P1210, DOI 10.4269/ajtmh.1978.27.1210; Davis KJ, 1997, ARCH PATHOL LAB MED, V121, P805; Deng IM, 1978, B WORLD HEALTH ORGAN, V56, P247; Dowell SF, 1996, PEDIATR INFECT DIS J, V15, P189, DOI 10.1097/00006454-199603000-00002; Egbring R, 1971, MARBURG VIRUS DIS, P42; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Feldmann H., 2004, VIRUS TAXONOMY 8 REP, P645; FISHERHOCH SP, 1992, J INFECT DIS, V166, P753, DOI 10.1093/infdis/166.4.753; Formenty P, 1999, J INFECT DIS, V179, pS48, DOI 10.1086/514285; Formenty P, 2003, Med Trop (Mars), V63, P291; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Fujita N., 2009, Morbidity and Mortality Weekly Report, V58, P1377; GEAR JSS, 1975, BRIT MED J, V4, P489, DOI 10.1136/bmj.4.5995.489; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Grolla A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001183; Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242; HEYMANN DL, 1980, J INFECT DIS, V142, P372, DOI 10.1093/infdis/142.3.372; Isaacson M, 1978, EBOLA VIRUS HAEMORRH, P15; Jaax NK, 1996, ARCH PATHOL LAB MED, V120, P140; Jeffs B, 2007, J INFECT DIS, V196, pS154, DOI 10.1086/520548; Johnson ED, 1996, ARCH VIROL, P101; Kalongi Y, 1999, J INFECT DIS, V179, pS15, DOI 10.1086/514301; Kibadi K, 1999, J INFECT DIS, V179, pS13, DOI 10.1086/514288; Kuhn JH, 2008, FILOVIRUSES COMPENDI; LEGUENNO B, 1995, LANCET, V345, P1271, DOI 10.1016/S0140-6736(95)90925-7; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Leroy EM, 2002, LANCET, V359, P712, DOI 10.1016/S0140-6736(02)07796-6; MacNeil A, 2010, EMERG INFECT DIS, V16, P1969, DOI 10.3201/eid1612.100627; Martini G A, 1968, Ger Med Mon, V13, P457; MARTINI G A, 1971, P1; MARTINI GA, 1969, T ROY SOC TROP MED H, V63, P295, DOI 10.1016/0035-9203(69)90001-7; Miranda ME, 1999, J INFECT DIS, V179, pS115, DOI 10.1086/514314; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Mupapa K, 1999, J INFECT DIS, V179, pS11, DOI 10.1086/514289; Mupere E, 2001, Afr Health Sci, V1, P60; Ndambi R, 1999, J INFECT DIS, V179, pS8, DOI 10.1086/514297; Nikiforov V V, 1994, Zh Mikrobiol Epidemiol Immunobiol, P104; Piot P, 1978, EBOLA VIRUS HAEMORRH, P7; Roddy P, J INFECT DIS UNPUB; Roddy P, 2010, J INFECT DIS, V201, P1909, DOI 10.1086/652748; Roels TH, 1999, J INFECT DIS, V179, pS92, DOI 10.1086/514286; Rollin PE, 1999, J INFECT DIS, V179, pS108, DOI 10.1086/514303; SIEGERT R, 1967, DEUT MED WOCHENSCHR, V92, P2341, DOI 10.1055/s-0028-1106144; SMITH DH, 1982, LANCET, V1, P816; Sterk E, 2008, FILOVIRUS HAEMORRHAG; STILLE W, 1971, P10; Stroher U, 2006, EXPERT OPIN INV DRUG, V15, P1523, DOI 10.1517/13543784.15.12.1523; SUREAU PH, 1989, REV INFECT DIS, V11, pS790; TODOROVITCH K, 1971, P19; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Tuffs A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1223; *WHO, 2007, EB HAEM FEV UG; WHO, 2008, END EB OUTBR DEM REP; WHO, 2005, MARB HAEM FEV ANG, P25; WHO, 2008, EB HAEM FEV DEM REP; WHO, 2008, EB OUTBR CONT UG; WHO, 1995, WEEKLY EPIDEMIOLOGIC, V70, P137; WHO, 2011, EB UG; WHO, 2007, END EB OUTBR UG; WHO, 2004, WHO ANN END EB OUTBR; WHO, 2008, CAS MARB HAEM FEV IM; WHO CDC, 1998, INF CONTR VIR HAEM F; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	82	51	53	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52986	10.1371/journal.pone.0052986	http://dx.doi.org/10.1371/journal.pone.0052986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285243	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000313051500095
J	Jiang, WM; Liu, S; Hou, GY; Li, JP; Zhuang, QY; Wang, SC; Zhang, P; Chen, JM				Jiang, Wenming; Liu, Shuo; Hou, Guangyu; Li, Jinping; Zhuang, Qingye; Wang, Suchun; Zhang, Peng; Chen, Jiming			Chinese and Global Distribution of H9 Subtype Avian Influenza Viruses	PLOS ONE			English	Article							LIVE-POULTRY MARKETS; WILD BIRDS; A VIRUS; HEMAGGLUTININ; INFECTION; LINEAGE; SURVEILLANCE; TRANSMISSION; REPLICATION; EVOLUTION	H9 subtype avian influenza viruses (AIVs) are of significance in poultry and public health, but epidemiological studies about the viruses are scarce. In this study, phylogenetic relationships of the viruses were analyzed based on 1233 previously reported sequences and 745 novel sequences of the viral hemagglutinin gene. The novel sequences were obtained through large-scale surveys conducted in 2008-2011 in China. The results revealed distinct distributions of H9 subtype AIVs in different hosts, sites and regions in China and in the world: (1) the dominant lineage of H9 subtype AIVs in China in recent years is lineage h9.4.2.5 represented by A/chicken/Guangxi/55/2005; (2) the newly emerging lineage h9.4.2.6, represented by A/chicken/Guangdong/FZH/2011, has also become prevalent in China; (3) lineages h9.3.3, h9.4.1 and h9.4.2, represented by A/duck/Hokkaido/26/99, A/quail/Hong Kong/G1/97 and A/chicken/Hong Kong/G9/97, respectively, have become globally dominant in recent years; (4) lineages h9.4.1 and h9.4.2 are likely of more risk to public health than others; (5) different lineages have different transmission features and host tropisms. This study also provided novel experimental data which indicated that the Leu-234 (H9 numbering) motif in the viral hemagglutinin gene is an important but not unique determinant in receptor-binding preference. This report provides a detailed and updated panoramic view of the epidemiological distributions of H9 subtype AIVs globally and in China, and sheds new insights for the prevention of infection in poultry and preparedness for a potential pandemic caused by the viruses.	[Jiang, Wenming; Liu, Shuo; Hou, Guangyu; Li, Jinping; Zhuang, Qingye; Wang, Suchun; Zhang, Peng; Chen, Jiming] China Anim Hlth & Epidemiol Ctr, Lab Avian Dis Surveillance, Qingdao, Peoples R China	China Animal Health & Epidemiology Center	Chen, JM (corresponding author), China Anim Hlth & Epidemiol Ctr, Lab Avian Dis Surveillance, Qingdao, Peoples R China.	jmchen66@yahoo.cn	Chen, Ji-Ming/AHD-7398-2022; Chen, Jiming/AAA-3575-2020	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Ministry of Science and Technology [SQ2012FY3260033]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work is supported by the Sci-tech Basic Work Project of Ministry of Science and Technology (SQ2012FY3260033). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolnik C, 2010, AVIAN DIS, V54, P313, DOI 10.1637/8781-040109-Reg.1; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P93; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P457; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baumer A, 2010, AVIAN DIS, V54, P875, DOI 10.1637/9119-110209-Reg.1; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chen JM, 2007, ARCH VIROL, V152, P415, DOI 10.1007/s00705-006-0852-6; Chen JM, 2007, AM J INFECT CONTROL, V35, P351, DOI 10.1016/j.ajic.2006.07.016; Chu YC, 2011, INFLUENZA OTHER RESP, V5, P68; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo Y, 1997, INFLUENZA VIRUSES RE, P65; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ji K, 2010, J VIROL METHODS, V163, P186, DOI 10.1016/j.jviromet.2009.09.013; Kang HM, 2010, J WILDLIFE DIS, V46, P878, DOI 10.7589/0090-3558-46.3.878; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lee DH, 2011, INFECT GENET EVOL, V11, P232, DOI 10.1016/j.meegid.2010.09.012; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li W.H., 1997, MOL EVOLUTION, P149, DOI [10.1371/journal.pone.0052671, DOI 10.1371/JOURNAL.PONE.0052671]; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Liu YH, 2009, AVIAN PATHOL, V38, P263, DOI 10.1080/03079450903055363; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Moon HJ, 2010, ARCH VIROL, V155, P229, DOI 10.1007/s00705-009-0577-4; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Negovetich NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019311; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Roussan DA, 2009, PREV VET MED, V88, P77, DOI 10.1016/j.prevetmed.2008.06.021; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Suptawiwat O, 2008, J CLIN VIROL, V42, P186, DOI 10.1016/j.jcv.2008.01.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang Q, 2010, INFLUENZA MOL VIROLO, P69; World Organization for Animal Health, 2011, TERR AN HLTH COD 201; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07	48	46	57	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52671	10.1371/journal.pone.0052671	http://dx.doi.org/10.1371/journal.pone.0052671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285143	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800089
J	Klutsch, CFC; Manseau, M; Wilson, PJ				Kluetsch, Cornelya F. C.; Manseau, Micheline; Wilson, Paul J.			Phylogeographical Analysis of mtDNA Data Indicates Postglacial Expansion from Multiple Glacial Refugia in Woodland Caribou (Rangifer tarandus caribou)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; TIME DEPENDENCY; MODEL SELECTION; ICE; EXTIRPATION; PERSISTENCE; PHYLOGENIES; NEUTRALITY; RESPONSES	Glacial refugia considerably shaped the phylogeographical structure of species and may influence intra-specific morphological, genetic, and adaptive differentiation. However, the impact of the Quaternary ice ages on the phylogeographical structure of North American temperate mammalian species is not well-studied. Here, we surveyed similar to 1600 individuals of the widely distributed woodland caribou (Rangifer tarandus caribou) using mtDNA control region sequences to investigate if glacial refugia contributed to the phylogeographical structure in this subspecies. Phylogenetic tree reconstruction, a median-joining network, and mismatch distributions supported postglacial expansions of woodland caribou from three glacial refugia dating back to 13544-22005 years. These three lineages consisted almost exclusively of woodland caribou mtDNA haplotypes, indicating that phylogeographical structure was mainly shaped by postglacial expansions. The putative centres of these lineages are geographically separated; indicating disconnected glacial refugia in the Rocky Mountains, east of the Mississippi, and the Appalachian Mountains. This is in congruence with the fossil record that caribou were distributed in these areas during the Pleistocene. Our results suggest that the last glacial maximum substantially shaped the phylogeographical structure of this large mammalian North American species that will be affected by climatic change. Therefore, the presented results will be essential for future conservation planning in woodland caribou.	[Kluetsch, Cornelya F. C.; Wilson, Paul J.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Manseau, Micheline] Pk Canada, No & Western Serv Ctr, Winnipeg, MB, Canada; [Manseau, Micheline] Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada	Trent University; University of Manitoba	Wilson, PJ (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	pawilson@trentu.ca	Klutsch, Cornelya/G-8944-2019	Klutsch, Cornelya/0000-0001-8238-2484	NSERC; Parks Canada; Manitoba Conservation; Manitoba Hydro; Prince Albert Model Forest; Saskatchewan Environment; Ontario Ministry of Natural Resources; Species at Risk Recovery Fund	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parks Canada; Manitoba Conservation; Manitoba Hydro; Prince Albert Model Forest; Saskatchewan Environment; Ontario Ministry of Natural Resources; Species at Risk Recovery Fund	Funding for this study was provided by NSERC through the Collaborative, Strategic and Discovery Programs. Additional funding and in-kind support was provided by Parks Canada, Manitoba Conservation, Manitoba Hydro, Prince Albert Model Forest, Saskatchewan Environment, Ontario Ministry of Natural Resources, and the Species at Risk Recovery Fund. The funders contributed to the field work but had no role in study design, lab and data analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Arsenault A. Alan, 2011, Rangifer, V31, P33; Ball MC, 2010, CONSERV GENET, V11, P2131, DOI 10.1007/s10592-010-0099-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banfield, 1961, NATL MUSEUM CANADA B, V177; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bergerud A. T., 2008, RETURN CARIBOU UNGAV; Brant SV, 2003, MOL ECOL, V12, P1435, DOI 10.1046/j.1365-294X.2003.01789.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHURCHER CS, 1989, CAN J ZOOL, V67, P1210, DOI 10.1139/z89-175; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; COSEWIC, 2011, DES UN CAR RANG TAR; Cronin MRA, 2005, J MAMMAL, V86, P495, DOI 10.1644/1545-1542(2005)86[495:VIMDAM]2.0.CO;2; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; Delcourt P.A., 1981, GEOBOTANY, P123; DEVOS A, 1951, J MAMMAL, V32, P329, DOI 10.2307/1375665; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dueck GS, 1998, THESIS U ALBERTA CAN; Dyke AS, 2003, 1574 GEOL SURV CAN; Eger JL, 2009, P CAR GEN REL WORKSH, P45; ELLSWORTH DL, 1994, EVOLUTION, V48, P122, DOI 10.1111/j.1558-5646.1994.tb01299.x; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/Z11-025, 10.1139/z11-025]; Flagstad O, 2003, EVOLUTION, V57, P658; Fu YX, 1997, GENETICS, V147, P915; Geist V., 1998, DEER WORLD THEIR EVO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harding LE, 2003, CAR GEN REL WORKSH M, P6; Harington C.R., 2003, ANNOTATED BIBLIO QUA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hebblewhite Mark, 2007, Rangifer, P79; Hettinga PN, 2012, J WILDLIFE MANAGE, V76, P1153, DOI 10.1002/jwmg.380; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hins C, 2009, FOREST ECOL MANAG, V257, P636, DOI 10.1016/j.foreco.2008.09.049; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hopkins M. L, 1969, Tebiwa, V12, P1; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Kuhn TS, 2010, MOL ECOL, V19, P1312, DOI 10.1111/j.1365-294X.2010.04565.x; Kurten B., 1980, PLEISTOCENE MAMMALS; Latch EK, 2009, MOL ECOL, V18, P1730, DOI 10.1111/j.1365-294X.2009.04153.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lister AM, 2004, PHILOS T R SOC B, V359, P221, DOI 10.1098/rstb.2003.1436; Lorenzen ED, 2011, NATURE, V479, P359, DOI 10.1038/nature10574; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roed Knut H., 2005, Rangifer, V25, P19; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sullivan J, 2005, ANNU REV ECOL EVOL S, V36, P445, DOI 10.1146/annurev.ecolsys.36.102003.152633; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson Mark D., 2005, P205, DOI 10.1007/3-540-26604-6_8; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Weckworth BV, 2012, MOL ECOL, V21, P3610, DOI 10.1111/j.1365-294X.2012.05621.x; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2010, BIOL CONSERV, V143, P86, DOI 10.1016/j.biocon.2009.09.007; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y; Woolley SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001913	73	34	36	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52661	10.1371/journal.pone.0052661	http://dx.doi.org/10.1371/journal.pone.0052661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285137	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800087
J	Liu, X; Wang, SY; Xia, XW; Chen, YS; Zhou, Y; Wu, XM; Zhang, JB; He, S; Tan, YF; Qiang, FL; Roe, OD; Li, G; Zhou, JW				Liu, Xin; Wang, Shouyu; Xia, Xiaowei; Chen, Yansu; Zhou, Yan; Wu, Xuming; Zhang, Jianbing; He, Song; Tan, Yongfei; Qiang, Fulin; Roe, Oluf Dimitri; Li, Gang; Zhou, Jianwei			Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer	PLOS ONE			English	Article							MUTANT P53; BREAST-CANCER; TARGETED THERAPIES; POOR-PROGNOSIS; WILD-TYPE; CELLS; CHEMOTHERAPY; EXPRESSION; STRESS; METASTASIS	Expression of p53 appears to be correlated to prognosis in patients with malignancy, but its role in gastric carcinoma has remained controversial. Recently we reported that JWA, an ADP-ribosylation-like factor 6 interacting protein 5 (ARL6ip5), was both prognostic for overall survival and predictive for platinum-based treatment of gastric cancer. In this study, we aimed to investigate p53 expression as a prognostic and predictive marker in resectable gastric cancer, alone and in combination with JWA. Expression of p53 was examined in three large patient cohorts (total n = 1155) of gastric cancer. High expression of p53 was significantly correlated with unfavorable clinicopathologic parameters and decreased overall patient survival. Furthermore, patients with high p53 expression in tumors acquired remarkable survival benefit from adjuvant first-line platinum-based-chemotherapy. The synergy between p53 and JWA in predicting patient outcome was demonstrated, while no significantly elevated predictive value concerning chemotherapy was observed. Thus, p53 expression is a potent prognostic and predictive factor for resectable gastric cancer with adjuvant platinum-based chemotherapy. A combined effect of p53 with JWA as efficient prognostic indicators was found for the first time.	[Liu, Xin; Wang, Shouyu; Xia, Xiaowei; Chen, Yansu; Wu, Xuming; Zhang, Jianbing; Zhou, Jianwei] Nanjing Med Univ, Sch Publ Hlth, Prevent & Treatment Canc Ctr, Dept Mol Cell Biol & Toxicol,Jiangsu Key Lab Canc, Nanjing, Jiangsu, Peoples R China; [Zhou, Yan; Tan, Yongfei] Yixing Hosp, Dept Oncol, Yixing, Jiangsu, Peoples R China; [Wu, Xuming; Zhang, Jianbing; He, Song; Qiang, Fulin] Nantong Canc Hosp, Dept Pathol, Nantong, Jiangsu, Peoples R China; [Roe, Oluf Dimitri] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Li, Gang] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada	Nanjing Medical University; Norwegian University of Science & Technology (NTNU); University of British Columbia; Vancouver Coastal Health Research Institute	Zhou, JW (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Prevent & Treatment Canc Ctr, Dept Mol Cell Biol & Toxicol,Jiangsu Key Lab Canc, Nanjing, Jiangsu, Peoples R China.	jwzhou@njmu.edu.cn		Roe, Oluf Dimitri/0000-0002-4870-5822; Liu, Xin/0000-0003-4094-1211	Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; National Natural Science Foundation of China [30930080, 81110027]; Foundation of Cancer Center of Nanjing Medical University [08ZLKF08]	Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Cancer Center of Nanjing Medical University	This study was supported in part by the project funded by the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn); the National Natural Science Foundation of China (30930080 and 81110027) (http://www.nsfc.gov.cn); the Foundation of Cancer Center of Nanjing Medical University (08ZLKF08) (http://202.195.178.127/zlsys). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiko Takashi, 1998, Gastric Cancer, V1, P25, DOI 10.1007/s101200050052; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Alsner J, 2008, ACTA ONCOL, V47, P600, DOI 10.1080/02841860802047411; Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022; Bai J, 2010, ONCOGENE, V29, P1227, DOI 10.1038/onc.2009.408; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bourdon JC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2811; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Chang FL, 2000, ANTICANCER RES, V20, P329; Chen HR, 2007, CELL SIGNAL, V19, P1315, DOI 10.1016/j.cellsig.2007.01.007; Chen R, 2007, FREE RADICAL BIO MED, V42, P1704, DOI 10.1016/j.freeradbiomed.2007.02.018; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Coutant C, 2011, CLIN CANCER RES, V17, P2591, DOI 10.1158/1078-0432.CCR-10-1045; Cunningham D, 2007, NEW ENGL J MED, V357, P1863, DOI 10.1056/NEJMe078182; Ferreira CG, 1999, ANN ONCOL, V10, P1011, DOI 10.1023/A:1008361818480; Gamboa-Dominguez A, 2007, J CLIN PATHOL, V60, P756, DOI 10.1136/jcp.2006.038976; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Huang S, 2006, BIOCHEM BIOPH RES CO, V341, P440, DOI 10.1016/j.bbrc.2005.12.197; Huang YP, 2012, CELL CYCLE, V11, P2367, DOI 10.4161/cc.20863; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027; Li X., 2011, ONCOGENE; Liu XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029670; Machado-Silva A, 2010, SEMIN CANCER BIOL, V20, P57, DOI 10.1016/j.semcancer.2010.02.005; Maehara Y, 1999, BRIT J CANCER, V79, P1255, DOI 10.1038/sj.bjc.6690201; Mallette FA, 2007, CELL CYCLE, V6, P1831, DOI 10.4161/cc.6.15.4516; Maslon MM, 2010, TRENDS CELL BIOL, V20, P542, DOI 10.1016/j.tcb.2010.06.005; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Sakamoto H, 2008, NAT GENET, V40, P730, DOI 10.1038/ng.152; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Tang WY, 2007, J TOXICOL ENV HEAL A, V70, P885, DOI 10.1080/15287390701285915; Ueno Y, 2006, CANCER LETT, V241, P289, DOI 10.1016/j.canlet.2005.10.035; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wagner AD, 2009, CURR OPIN ONCOL, V21, P381, DOI 10.1097/CCO.0b013e32832c42e0; Wang SY, 2012, CLIN CANCER RES, V18, P2987, DOI 10.1158/1078-0432.CCR-11-2863; Wang SY, 2009, NUCLEIC ACIDS RES, V37, P1936, DOI 10.1093/nar/gkp054; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Wu AW, 2008, JNCI-J NATL CANCER I, V100, P376, DOI 10.1093/jnci/djn055; Wu CW, 1999, BRIT J CANCER, V80, P483, DOI 10.1038/sj.bjc.6690382; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Zhang J, 2010, J INT MED RES, V38, P423, DOI 10.1177/147323001003800205; Zurer I, 2004, CARCINOGENESIS, V25, P11, DOI 10.1093/carcin/bgg186	48	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52348	10.1371/journal.pone.0052348	http://dx.doi.org/10.1371/journal.pone.0052348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285001	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800052
J	Matulis, SM; Morales, AA; Yehiayan, L; Lee, KP; Cai, Y; Boise, LH				Matulis, Shannon M.; Morales, Alejo A.; Yehiayan, Lucy; Lee, Kelvin P.; Cai, Yong; Boise, Lawrence H.			Alterations in Glutathione Levels and Apoptotic Regulators Are Associated with Acquisition of Arsenic Trioxide Resistance in Multiple Myeloma	PLOS ONE			English	Article							CELL-CYCLE ARREST; ASCORBIC-ACID; COMBINATION THERAPY; SIGNALING PATHWAYS; LINES; MELPHALAN; CYTOTOXICITY; ACTIVATION; MECHANISMS; EXPRESSION	Arsenic trioxide (ATO) has been tested in relapsed/refractory multiple myeloma with limited success. In order to better understand drug mechanism and resistance pathways in myeloma we generated an ATO-resistant cell line, 8226/S-ATOR05, with an IC50 that is 2-3-fold higher than control cell lines and significantly higher than clinically achievable concentrations. Interestingly we found two parallel pathways governing resistance to ATO in 8226/S-ATOR05, and the relevance of these pathways appears to be linked to the concentration of ATO used. We found changes in the expression of Bcl-2 family proteins Bfl-1 and Noxa as well as an increase in cellular glutathione (GSH) levels. At low, clinically achievable concentrations, resistance was primarily associated with an increase in expression of the anti-apoptotic protein Bfl-1 and a decrease in expression of the pro-apoptotic protein Noxa. However, as the concentration of ATO increased, elevated levels of intracellular GSH in 8226/S-ATOR05 became the primary mechanism of ATO resistance. Removal of arsenic selection resulted in a loss of the resistance phenotype, with cells becoming sensitive to high concentrations of ATO within 7 days following drug removal, indicating changes associated with high level resistance (elevated GSH) are dependent upon the presence of arsenic. Conversely, not until 50 days without arsenic did cells once again become sensitive to clinically relevant doses of ATO, coinciding with a decrease in the expression of Bfl-1. In addition we found cross-resistance to melphalan and doxorubicin in 8226/S-ATOR05, suggesting ATO-resistance pathways may also be involved in resistance to other chemotherapeutic agents used in the treatment of multiple myeloma.	[Matulis, Shannon M.; Boise, Lawrence H.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Matulis, Shannon M.; Boise, Lawrence H.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Matulis, Shannon M.; Boise, Lawrence H.] Winship Canc Inst, Atlanta, GA USA; [Morales, Alejo A.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Yehiayan, Lucy; Cai, Yong] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	Emory University; Emory University; University of Miami; State University System of Florida; Florida International University; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Boise, LH (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	lboise@emory.edu	Boise, Lawrence/AAD-2314-2019; Cai, Yong/K-9868-2015	Cai, Yong/0000-0002-2811-4638; Boise, Lawrence/0000-0001-9436-8815	National Institutes of Health [NIH R01 CA129986, NIH R01 CA97243]; T. J. Martell Foundation; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE [R01CA129968, R01CA097243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T. J. Martell Foundation; Georgia Cancer Coalition; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health, NIH R01 CA129986 and NIH R01 CA97243, the T. J. Martell Foundation, and the Georgia Cancer Coalition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Jawde RM, 2006, MED ONCOL, V23, P263, DOI 10.1385/MO:23:2:263; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Akay C, 2003, CELL CYCLE, V2, P358, DOI 10.4161/cc.2.4.417; Anderson KC, 2002, CANCER J, V8, P12, DOI 10.1097/00130404-200201000-00003; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; BELLAMY WT, 1988, CANCER RES, V48, P6360; Berenson JR, 2006, BRIT J HAEMATOL, V135, P174, DOI 10.1111/j.1365-2141.2006.06280.x; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Chen SJ, 2011, BLOOD, V117, P6425, DOI 10.1182/blood-2010-11-283598; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chonghaile TN, 2008, ONCOGENE, V27, pS149, DOI 10.1038/onc.2009.52; Davison K, 2003, LEUKEMIA, V17, P931, DOI 10.1038/sj.leu.2402876; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Ge F, 2009, J PROTEOME RES, V8, P3006, DOI 10.1021/pr9001004; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Hazlehurst LA, 2003, CANCER RES, V63, P7900; Kircelli F, 2007, INT J ONCOL, V30, P993; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Matulis SM, 2009, MOL CANCER THER, V8, P1197, DOI 10.1158/1535-7163.MCT-08-1072; MAZARS GR, 1992, ONCOGENE, V7, P1015; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, ONCOLOGIST, V7, P14; Miller WH, 2002, CANCER RES, V62, P3893; Morales AA, 2005, INT J CANCER, V113, P730, DOI 10.1002/ijc.20614; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Morales AA, 2009, J BIOL CHEM, V284, P12886, DOI 10.1074/jbc.M806546200; MULCAHY RT, 1994, CANCER CHEMOTH PHARM, V34, P67, DOI 10.1007/s002800050105; Munshi NC, 2002, LEUKEMIA, V16, P1835, DOI 10.1038/sj.leu.2402599; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Park WH, 2000, CANCER RES, V60, P3065; Rousselot P, 2004, LEUKEMIA, V18, P1518, DOI 10.1038/sj.leu.2403424; Rousselot P, 1999, CANCER RES, V59, P1041; UOTILA L, 1974, J BIOL CHEM, V249, P7653; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Watts GS, 2001, J PHARMACOL EXP THER, V299, P434; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	42	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52662	10.1371/journal.pone.0052662	http://dx.doi.org/10.1371/journal.pone.0052662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285138	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800088
J	Rojas, M; Farr, GW; Fernandez, CF; Lauden, L; McCormack, JC; Wolin, SL				Rojas, Marta; Farr, George W.; Fernandez, Cesar F.; Lauden, Laura; McCormack, John C.; Wolin, Sandra L.			Yeast Gis2 and Its Human Ortholog CNBP Are Novel Components of Stress-Induced RNP Granules	PLOS ONE			English	Article							ACID-BINDING-PROTEIN; TANDEM AFFINITY PURIFICATION; EUKARYOTIC MESSENGER-RNAS; ZINC-FINGER PROTEIN; P-BODIES; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; PROCESSING BODIES; MASS-SPECTROMETRY; C-MYC	Although a CCTG expansion in the gene encoding the zinc knuckle protein CNBP causes a common form of muscular dystrophy, the function of both human CNBP and its putative budding yeast ortholog Gis2 remain poorly understood. Here we report the protein interactions of Gis2 and the subcellular locations of both Gis2 and CNBP. We found that Gis2 exhibits RNA-dependent interactions with two proteins involved in mRNA recognition, the poly(A) binding protein and the translation initiation factor eIF4G. We show that Gis2 is a component of two large RNA-protein granules, processing bodies and stress granules, which contain translationally repressed mRNAs. Consistent with a functional ortholog, CNBP also associates with the poly(A) binding protein and accumulates in stress granules during arsenite treatment of human cells. These results implicate both Gis2 and CNBP in mRNA handling during stress.	[Rojas, Marta; Fernandez, Cesar F.; Lauden, Laura; McCormack, John C.; Wolin, Sandra L.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Farr, George W.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Farr, George W.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Wolin, SL (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	sandra.wolin@yale.edu	Wolin, Sandra/H-2333-2016	Wolin, Sandra/0000-0001-6730-0399	National Institutes of Health (NIH) [R01-GM048410, R01-GM073863]; NIH [F32-ES017387]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES017387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073863, R01GM048410] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health (NIH) Grants R01-GM048410 and R01-GM073863 to SLW, NIH Postdoctoral fellowship F32-ES017387 to JCM and Howard Hughes Medical Institute (GWF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTMANN M, 1985, BIOCHEMISTRY-US, V24, P6085, DOI 10.1021/bi00343a009; ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Balagopal V, 2009, GENETICS, V181, P93, DOI 10.1534/genetics.108.092601; Balciunas D, 1999, MOL GEN GENET, V262, P589; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Botta A, 2006, BBA-MOL BASIS DIS, V1762, P329, DOI 10.1016/j.bbadis.2005.11.004; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2010, METHOD ENZYMOL, V470, P619, DOI 10.1016/S0076-6879(10)70025-2; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Calcaterra NB, 2010, IUBMB LIFE, V62, P707, DOI 10.1002/iub.379; Chen W, 2003, DEVELOPMENT, V130, P1367, DOI 10.1242/dev.00349; Chen W, 2007, J MOL BIOL, V368, P8, DOI 10.1016/j.jmb.2007.01.088; Clarkson BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009114; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller J, 2008, METHOD ENZYMOL, V448, P267, DOI 10.1016/S0076-6879(08)02614-1; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; D'Souza V, 2004, NATURE, V431, P586, DOI 10.1038/nature02944; Damgaard CK, 2011, GENE DEV, V25, P2057, DOI 10.1101/gad.17355911; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gerbasi VR, 2007, MOL CELL PROTEOMICS, V6, P1049, DOI 10.1074/mcp.M600384-MCP200; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gobeil LA, 2008, FRONT BIOSCI-LANDMRK, V13, P2203, DOI 10.2741/2835; Hamill S, 2010, P NATL ACAD SCI USA, V107, P15045, DOI 10.1073/pnas.1003505107; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Holmes LEA, 2004, MOL CELL BIOL, V24, P2998, DOI 10.1128/MCB.24.7.2998-3010.2004; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Konicek BW, 1998, DNA CELL BIOL, V17, P799, DOI 10.1089/dna.1998.17.799; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Liu MF, 1998, VIRUS RES, V58, P73, DOI 10.1016/S0168-1702(98)00108-7; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Muhlrad D, 2005, EMBO J, V24, P1033, DOI 10.1038/sj.emboj.7600560; Niedowicz DM, 2010, NEUROSCI LETT, V482, P57, DOI 10.1016/j.neulet.2010.07.006; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Park EH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-68; Pellizzoni L, 1997, J MOL BIOL, V267, P264, DOI 10.1006/jmbi.1996.0888; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Raheem O, 2010, AM J PATHOL, V177, P3025, DOI 10.2353/ajpath.2010.100179; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Sammons MA, 2011, BIOCHEM BIOPH RES CO, V406, P13, DOI 10.1016/j.bbrc.2011.01.086; Sammons MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009301; Scherrer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r3; Segal SP, 2006, MOL CELL BIOL, V26, P5120, DOI 10.1128/MCB.01913-05; Shevchenko A, 2002, MOL CELL PROTEOMICS, V1, P204, DOI 10.1074/mcp.M200005-MCP200; Sim S, 2012, RNA, V18, P100, DOI 10.1261/rna.029207.111; Sobel SG, 1999, MOL BIOL CELL, V10, P3849, DOI 10.1091/mbc.10.11.3849; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; TARN WY, 1995, RNA, V1, P644; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Windgassen M, 2004, MOL CELL BIOL, V24, P10479, DOI 10.1128/MCB.24.23.10479-10491.2004; XU HP, 1992, MOL BIOL CELL, V3, P721, DOI 10.1091/mbc.3.7.721; Yasuda J, 1995, DNA Res, V2, P45, DOI 10.1093/dnares/2.1.45; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; YOO CJ, 1994, MOL CELL BIOL, V14, P5412, DOI 10.1128/MCB.14.8.5412	73	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52824	10.1371/journal.pone.0052824	http://dx.doi.org/10.1371/journal.pone.0052824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285195	gold, Green Published			2022-12-25	WOS:000313158800098
J	Schnitzer, SA; Mangan, SA; Dalling, JW; Baldeck, CA; Hubbell, SP; Ledo, A; Muller-Landau, H; Tobin, MF; Aguilar, S; Brassfield, D; Hernandez, A; Lao, S; Perez, R; Valdes, O; Yorke, SR				Schnitzer, Stefan A.; Mangan, Scott A.; Dalling, James W.; Baldeck, Claire A.; Hubbell, Stephen P.; Ledo, Alicia; Muller-Landau, Helene; Tobin, Michael F.; Aguilar, Salomon; Brassfield, David; Hernandez, Andres; Lao, Suzanne; Perez, Rolando; Valdes, Oldemar; Yorke, Suzanne Rutishauser			Liana Abundance, Diversity, and Distribution on Barro Colorado Island, Panama	PLOS ONE			English	Article							TROPICAL FOREST; HABITAT ASSOCIATIONS; TREE REGENERATION; RAIN-FOREST; CANOPY LIANAS; SPECIES-AREA; PATTERNS; BIOMASS; GAPS; MORTALITY	Lianas are a key component of tropical forests; however, most surveys are too small to accurately quantify liana community composition, diversity, abundance, and spatial distribution - critical components for measuring the contribution of lianas to forest processes. In 2007, we tagged, mapped, measured the diameter, and identified all lianas >= 1 cm rooted in a 50-ha plot on Barro Colorado Island, Panama (BCI). We calculated liana density, basal area, and species richness for both independently rooted lianas and all rooted liana stems (genets plus clones). We compared spatial aggregation patterns of liana and tree species, and among liana species that varied in the amount of clonal reproduction. We also tested whether liana and tree densities have increased on BCI compared to surveys conducted 30-years earlier. This study represents the most comprehensive spatially contiguous sampling of lianas ever conducted and, over the 50 ha area, we found 67,447 rooted liana stems comprising 162 species. Rooted lianas composed nearly 25% of the woody stems (trees and lianas), 35% of woody species richness, and 3% of woody basal area. Lianas were spatially aggregated within the 50-ha plot and the liana species with the highest proportion of clonal stems more spatially aggregated than the least clonal species, possibly indicating clonal stem recruitment following canopy disturbance. Over the past 30 years, liana density increased by 75% for stems >= 1 cm diameter and nearly 140% for stems >= 5 cm diameter, while tree density on BCI decreased 11.5%; a finding consistent with other neotropical forests. Our data confirm that lianas contribute substantially to tropical forest stem density and diversity, they have highly clumped distributions that appear to be driven by clonal stem recruitment into treefall gaps, and they are increasing relative to trees, thus indicating that lianas will play a greater role in the future dynamics of BCI and other neotropical forests.	[Schnitzer, Stefan A.; Mangan, Scott A.; Ledo, Alicia; Tobin, Michael F.; Valdes, Oldemar; Yorke, Suzanne Rutishauser] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Schnitzer, Stefan A.; Mangan, Scott A.; Dalling, James W.; Hubbell, Stephen P.; Muller-Landau, Helene; Aguilar, Salomon; Brassfield, David; Hernandez, Andres; Lao, Suzanne; Perez, Rolando; Valdes, Oldemar] Smithsonian Trop Res Inst, Balboa, Panama; [Dalling, James W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Baldeck, Claire A.] Univ Illinois, Program Ecol Evolut & Conservat Biol, Urbana, IL 61801 USA; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Ledo, Alicia] Univ Politecn Madrid, ETSI Montes, Madrid, Spain	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; Universidad Politecnica de Madrid	Schnitzer, SA (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	S1@uwm.edu	HERNANDEZ-GARCIA, ANDRES/B-9051-2014	HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; Muller-Landau, Helene C./0000-0002-3526-9021; Dalling, James/0000-0002-6488-9895; Schnitzer, Stefan/0000-0002-2715-9455	National Science Foundation [DEB-0613666, DEB-0845071]; UWM Research Growth Initiative; UWM Office for Undergraduate Research; UWM Center for Latin American and Caribbean Studies	National Science Foundation(National Science Foundation (NSF)); UWM Research Growth Initiative; UWM Office for Undergraduate Research; UWM Center for Latin American and Caribbean Studies	The study was made possible by financial support from the National Science Foundation (DEB-0613666, DEB-0845071), UWM Research Growth Initiative, UWM Office for Undergraduate Research, and the UWM Center for Latin American and Caribbean Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BP, 2007, FOREST ECOL MANAG, V242, P17, DOI 10.1016/j.foreco.2007.01.027; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andrade JL, 2005, TREES-STRUCT FUNCT, V19, P282, DOI 10.1007/s00468-004-0388-x; Benitez-Malvido J, 2003, CONSERV BIOL, V17, P389, DOI 10.1046/j.1523-1739.2003.01120.x; Cai ZQ, 2009, OECOLOGIA, V161, P25, DOI 10.1007/s00442-009-1355-4; Chave J, 2008, J TROP ECOL, V24, P355, DOI 10.1017/S0266467408005075; Condit R, 1996, J ECOL, V84, P549, DOI 10.2307/2261477; Condit R, 1998, TROPICAL FOREST CENS; Croat T.B., 1978, FLORA BARRO COLORADO; Dalling JW, 2012, J ECOL, V100, P1174, DOI 10.1111/j.1365-2745.2012.01989.x; DeWalt SJ, 2010, BIOTROPICA, V42, P309, DOI 10.1111/j.1744-7429.2009.00589.x; Enquist BJ, 2011, GLOBAL CHANGE BIOL, V17, P1408, DOI 10.1111/j.1365-2486.2010.02326.x; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Foster JR, 2008, REMOTE SENS ENVIRON, V112, P2104, DOI 10.1016/j.rse.2007.07.027; Foster PF, 1997, AM J BOT, V84, P1078, DOI 10.2307/2446151; Gentry A.H., 1991, BIOL VINES, P3; Gerwing JJ, 2006, BIOTROPICA, V38, P256, DOI 10.1111/j.1744-7429.2006.00134.x; Gerwing JJ, 2004, FOREST ECOL MANAG, V190, P57, DOI 10.1016/j.foreco.2003.10.006; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; LEIGH EG, 1999, TROPICAL FOREST ECOL; Londre RA, 2006, ECOLOGY, V87, P2973, DOI 10.1890/0012-9658(2006)87[2973:TDOLAT]2.0.CO;2; Mascaro J, 2004, FOREST ECOL MANAG, V190, P3, DOI 10.1016/j.foreco.2003.10.002; Mohan JE, 2006, P NATL ACAD SCI USA, V103, P9086, DOI 10.1073/pnas.0602392103; Ohser J., 1983, MATH OPER STAT, V14, P63, DOI [10.1080/02331888308801687, DOI 10.1080/02331888308801687]; PENALOSA J, 1984, BIOTROPICA, V16, P1, DOI 10.2307/2387886; Perez-Salicrup DR, 2001, BIOTROPICA, V33, P34, DOI 10.1111/j.1744-7429.2001.tb00155.x; Phillips OL, 2005, ECOLOGY, V86, P1250, DOI 10.1890/04-1446; Phillips OL, 2002, NATURE, V418, P770, DOI 10.1038/nature00926; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Powers JS, 2004, J TROP ECOL, V20, P587, DOI 10.1017/S0266467404001877; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Romero-Saltos HG., 2011, THESIS U MIAMI; Russo SE, 2008, J ECOL, V96, P192, DOI 10.1111/j.1365-2745.2007.01330.x; Schnitzer SA, 2000, J ECOL, V88, P655, DOI 10.1046/j.1365-2745.2000.00489.x; Schnitzer SA, 2000, TRENDS ECOL EVOL, V15, P375, DOI 10.1016/S0169-5347(00)01913-3; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Schnitzer SA, 2005, AM NAT, V166, P262, DOI 10.1086/431250; Schnitzer SA, 2005, J ECOL, V93, P1115, DOI 10.1111/j.1365-2745.2005.01056.x; Schnitzer SA, 2004, FOREST ECOL MANAG, V190, P87, DOI 10.1016/j.foreco.2003.10.008; Schnitzer SA, 2001, ECOLOGY, V82, P913, DOI 10.1890/0012-9658(2001)082[0913:TGATMO]2.0.CO;2; Schnitzer SA, BIOTROPICA IN PRESS; Schnitzer SA, 2008, TROPICAL FOREST COMM, P196; Schnitzer SA, 2008, FOREST ECOL MANAG, V255, P1044, DOI 10.1016/j.foreco.2007.10.012; Schnitzer SA, 2006, BIOTROPICA, V38, P581, DOI 10.1111/j.1744-7429.2006.00187.x; Schnitzer SA, 2011, PLANT SIGNAL BEHAV, V6, P598, DOI 10.4161/psb.6.4.15373; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; Schnitzer SA, 2010, ECOL LETT, V13, P849, DOI 10.1111/j.1461-0248.2010.01480.x; STOYAN D, 1984, MATH NACHR, V116, P197, DOI 10.1002/mana.19841160115; Stoyan D., 1994, FRACTALS RANDOM SHAP; Swaine MD, 2007, PLANT ECOL, V192, P271, DOI 10.1007/s11258-007-9319-4; Tobin MF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00322.1; Toledo-Aceves T, 2008, J VEG SCI, V19, P717, DOI 10.3170/2008-8-18444; van der Heijden GMF, 2009, J BIOGEOGR, V36, P1561, DOI 10.1111/j.1365-2699.2009.02099.x; van der Heijden GMF, 2008, J VEG SCI, V19, P747, DOI 10.3170/2008-8-18459; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 2005, J TROP ECOL, V21, P307, DOI 10.1017/S0266467405002294; Wright SJ, 2004, ECOLOGY, V85, P484, DOI 10.1890/02-0757; Zhu SD, 2009, PLANT ECOL, V204, P295, DOI 10.1007/s11258-009-9592-5	65	124	130	2	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52114	10.1371/journal.pone.0052114	http://dx.doi.org/10.1371/journal.pone.0052114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284889	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800031
J	Chung, MH; Severynen, AO; Hals, MP; Harrington, RD; Spach, DH; Kim, HN				Chung, Michael H.; Severynen, Anneleen O.; Hals, Matthew P.; Harrington, Robert D.; Spach, David H.; Kim, H. Nina			Offering an American Graduate Medical HIV Course to Health Care Workers in Resource-Limited Settings via the Internet	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; PUBLIC-HEALTH; EDUCATION; HIV/AIDS	Background: Western accredited medical universities can offer graduate-level academic courses to health care workers (HCWs) in resource-limited settings through the internet. It is not known whether HCWs are interested in these online courses, whether they can perform as well as matriculated students, or whether such courses are educationally or practically relevant. Methods and Findings: In 2011, the University of Washington (UW) Schools of Medicine and Nursing offered the graduate course, "Clinical Management of HIV", to HCWs that included a demographic survey, knowledge assessment, and course evaluation. UW faculty delivered HIV clinical topics through ten 2-hour weekly sessions from the perspectives of practicing HIV medicine in developed and developing settings. HCWs viewed lectures through Adobe Acrobat Connect Pro (Adobe Systems, San Jose, CA), and completed online homework on HIV Web Study (http://depts.washington.edu/hivaids/) and online quizzes. HCWs, who met the same passing requirements as UW students by attending 80% lectures, completing >= 90% homework, and achieving a cumulative >= 70% grade on quizzes, were awarded a certificate. 369 HCWs at 33 sites in 21 countries joined the course in 2011, a >15-fold increase since the course was first offered in 2007. The majority of HCWs came from Africa (72%), and most were physicians (41%), nurses (22%), or midlevel practitioners (20%). 298 HCWs (81%) passed all requirements and earned a certificate. In a paired analysis of pre- and post-course HIV knowledge assessments, 56% of HCWs improved their post-course score (p<0.0001) with 27% improving by at least 30%. In the course evaluation, most HCWs rated the course as excellent (53%) or very good (39%). Conclusions: This online HIV course demonstrated that opening a Western graduate medical and nursing curriculum to HCWs in resource-limited settings is feasible, popular, and valuable, and may address logistic and economic barriers to the provision of high quality education in these settings.	[Chung, Michael H.; Hals, Matthew P.; Kim, H. Nina] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Chung, Michael H.; Severynen, Anneleen O.; Harrington, Robert D.; Spach, David H.; Kim, H. Nina] Univ Washington, Dept Med, Seattle, WA USA; [Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chung, MH (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	mhchung@uw.edu			Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services [H4AHA00051]	Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	HIV Web Study is supported with funding through the Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (Grant No. H4AHA00051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2007, AIDS PATIENT CARE ST, V21, P799, DOI 10.1089/apc.2007.0193; Brigley S, 2009, MED TEACH, V31, pE169, DOI 10.1080/01421590802590546; Cohen J, 2004, AIDS, V18, P2105, DOI 10.1097/00002030-200410210-00024; Coomarasamy A, 2004, BMJ-BRIT MED J, V329, P1017, DOI 10.1136/bmj.329.7473.1017; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Heller RF, 2007, B WORLD HEALTH ORGAN, V85, P930, DOI 10.2471/BLT.07.044388; Kiviat AD, 2007, J INFECT DIS, V196, pS512, DOI 10.1086/521117; Knapp H, 2011, TELEMED E-HEALTH, V17, P335, DOI 10.1089/tmj.2010.0187; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Marchal B, 2005, TROP MED INT HEALTH, V10, P300, DOI 10.1111/j.1365-3156.2005.01397.x; McCarthy EA, 2006, PLOS MED, V3, P989, DOI 10.1371/journal.pmed.0030304	11	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52663	10.1371/journal.pone.0052663	http://dx.doi.org/10.1371/journal.pone.0052663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285139	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500224
J	Dave, H; Anver, MR; Butcher, DO; Brown, P; Khan, J; Wayne, AS; Baskar, S; Rader, C				Dave, Hema; Anver, Miriam R.; Butcher, Donna O.; Brown, Patrick; Khan, Javed; Wayne, Alan S.; Baskar, Sivasubramanian; Rader, Christoph			Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MOUSE DEVELOPMENT; RNAI SCREEN; BLINATUMOMAB; PHENOTYPE; CHILDREN; SURVIVAL; DISEASE; TARGET; CLL	Background: Despite high cure rates for pediatric B-lineage acute lymphoblastic leukemia (B-ALL), short-term and long-term toxicities and chemoresistance are shortcomings of standard chemotherapy. Immunotherapy and chemoimmunotherapy based on monoclonal antibodies (mAbs) that target cell surface antigens with restricted expression in pediatric B-ALL may offer the potential to reduce toxicities and prevent or overcome chemoresistance. The receptor tyrosine kinase ROR1 has emerged as a candidate for mAb targeting in select B-cell malignancies. Methodology and Principal Findings: Using flow cytometry, Western blotting, immunohistochemistry, and confocal immunofluorescence microscopy, we analyzed the cell surface expression of ROR1 across major pediatric ALL subtypes represented by 14 cell lines and 56 primary blasts at diagnosis or relapse as well as in normal adult and pediatric tissues. Cell surface ROR1 expression was found in 45% of pediatric ALL patients, all of which were B-ALL, and was not limited to any particular genotype. All cell lines and primary blasts with E2A-PBX1 translocation and a portion of patients with other high risk genotypes, such as MLL rearrangement, expressed cell surface ROR1. Importantly, cell surface ROR1 expression was found in many of the pediatric B-ALL patients with multiply relapsed and refractory disease and normal karyotype or low risk cytogenetics, such as hyperdiploidy. Notably, cell surface ROR1 was virtually absent in normal adult and pediatric tissues. Conclusions and Significance: Collectively, this study suggests that ROR1 merits preclinical and clinical investigations as a novel target for mAb-based therapies in pediatric B-ALL. We propose cell surface expression of ROR1 detected by flow cytometry as primary inclusion criterion for pediatric B-ALL patients in future clinical trials of ROR1-targeted therapies.	[Dave, Hema; Wayne, Alan S.; Baskar, Sivasubramanian; Rader, Christoph] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Dave, Hema; Khan, Javed; Wayne, Alan S.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Anver, Miriam R.; Butcher, Donna O.] NCI, Pathol Histotechnol Lab, Sci Applicat Int Corp Frederick, Frederick Natl Lab Canc Res,NIH, Frederick, MD 21701 USA; [Brown, Patrick] Johns Hopkins Univ Hosp, Dept Oncol & Pediat, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Rader, Christoph] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Rader, Christoph] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Johns Hopkins University; Johns Hopkins Medicine; Scripps Research Institute; Scripps Research Institute	Rader, C (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	crader@scripps.edu		Rader, Christoph/0000-0001-9955-3454; Dave, Hema/0000-0001-5530-0201	Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH); NCI; NIH [HHSN261200800001E]	Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), and in part with federal funds from the NCI and NIH under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Ariffin Hany, 2003, SMJ Singapore Medical Journal, V44, P517; Barna G, 2011, HEMATOL ONCOL, V29, P17, DOI 10.1002/hon.948; Barth M, 2012, BRIT J HAEMATOL, V159, P3, DOI 10.1111/bjh.12002; Baskar S, 2008, CLIN CANCER RES, V14, P396, DOI 10.1158/1078-0432.CCR-07-1823; Baskar S, 2012, MABS-AUSTIN, V4, P349, DOI 10.4161/mabs.19870; Broome HE, 2011, LEUKEMIA RES, V35, P1390, DOI 10.1016/j.leukres.2011.06.021; Carroll William L, 2003, Hematology Am Soc Hematol Educ Program, P102; CRIST WM, 1990, BLOOD, V76, P117; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; de Vries JF, 2011, LEUKEMIA; DiJoseph JF, 2007, LEUKEMIA, V21, P2240, DOI 10.1038/sj.leu.2404866; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Gashaw I, 2011, DRUG DISCOVERY TODAY, V00; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Handgretinger R, 2011, LEUKEMIA, V25, P181, DOI 10.1038/leu.2010.239; Hudecek M, 2010, BLOOD, V116, P4532, DOI 10.1182/blood-2010-05-283309; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Lapalombella R, 2010, BLOOD, V115, P2619, DOI 10.1182/blood-2009-09-242438; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Raetz EA, 2008, J CLIN ONCOL, V26, P3756, DOI 10.1200/JCO.2007.15.3528; Rebagay G, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00034; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sanchez-Solana B, 2012, MOL ENDOCRINOL, V26, P110, DOI 10.1210/me.2011-1027; Shabani M, 2008, LEUKEMIA LYMPHOMA, V49, P1360, DOI 10.1080/10428190802124000; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; Wayne AS, 2010, CLIN CANCER RES, V16, P1894, DOI 10.1158/1078-0432.CCR-09-2980; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021018; Zhang SP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031127, 10.1371/journal.pone.0046853]; ZHOU MX, 1994, LEUKEMIA, V8, P659	36	36	44	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52655	10.1371/journal.pone.0052655	http://dx.doi.org/10.1371/journal.pone.0052655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285131	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500220
J	Gu, JM; Qian, H; Shen, L; Zhang, X; Zhu, W; Huang, L; Yan, YM; Mao, F; Zhao, CH; Shi, YY; Xu, WR				Gu, Jianmei; Qian, Hui; Shen, Li; Zhang, Xu; Zhu, Wei; Huang, Ling; Yan, Yongmin; Mao, Fei; Zhao, Chonghui; Shi, Yunyan; Xu, Wenrong			Gastric Cancer Exosomes Trigger Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells to Carcinoma-Associated Fibroblasts through TGF-beta/Smad Pathway	PLOS ONE			English	Article							PROMOTE TUMOR-GROWTH; TRANSITION	Background: Mesenchymal stem cells (MSCs) promote tumor growth by differentiating into carcinoma-associated fibroblasts (CAFs) and composing the tumor microenvironment. However, the mechanisms responsible for the transition of MSCs to CAFs are not well understood. Exosomes regulate cellular activities by mediating cell-cell communication. In this study, we aimed to investigate whether cancer cell-derived exosomes were involved in regulating the differentiation of human umbilical cord-derived MSCs (hucMSCs) to CAFs. Methodology/Principal Findings: We first showed that gastric cancer cell-derived exosomes induced the expression of CAF markers in hucMSCs. We then demonstrated that gastric cancer cell-derived exosomes stimulated the phosphorylation of Smad-2 in hucMSCs. We further confirmed that TGF-beta receptor 1 kinase inhibitor attenuated Smad-2 phosphorylation and CAF marker expression in hucMSCs after exposure to gastric cancer cell-derived exosomes. Conclusion/Significance: Our results suggest that gastric cancer cells triggered the differentiation of hucMSCs to CAFs by exosomes-mediated TGF-beta transfer and TGF-beta/Smad pathway activation, which may represent a novel mechanism for MSCs to CAFs transition in cancer.	[Gu, Jianmei; Qian, Hui; Shen, Li; Zhang, Xu; Zhu, Wei; Huang, Ling; Yan, Yongmin; Mao, Fei; Zhao, Chonghui; Shi, Yunyan; Xu, Wenrong] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China; [Xu, Wenrong] Jiangsu Univ, Affiliated Hosp, Dept Clin Lab Med, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Qian, H (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang, Jiangsu, Peoples R China.	lstmmmlst@163.com; icls@ujs.edu.cn		Zhao, Chonghui/0000-0002-6837-8902	Major Research Plan of the National Natural Science Foundation of China [91129718]; National Natural Science Foundation of China [81071421, 31140063]; Jiangsu Province's Scientific and Technological Supporting Program [BE2010703]; 333 Project of Jiangsu Province [2009055]; Sci-Tech Innovation Team and Talents of Jiangsu University [2008-018-02]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Scientific and Technological Supporting Program; 333 Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Sci-Tech Innovation Team and Talents of Jiangsu University	This work was supported by the Major Research Plan of the National Natural Science Foundation of China (Grant no. 91129718), the National Natural Science Foundation of China (Grant no. 81071421, 31140063), Jiangsu Province's Scientific and Technological Supporting Program (Grant no. BE2010703), 333 Project of Jiangsu Province (Grant no. 2009055) and the Sci-Tech Innovation Team and Talents of Jiangsu University (Grant no. 2008-018-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarenque SM, 2011, STEM CELL RES, V7, P163, DOI 10.1016/j.scr.2011.05.002; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cao HL, 2009, CANCER LETT, V274, P61, DOI 10.1016/j.canlet.2008.08.036; Cat B, 2006, J CELL SCI, V119, P2727, DOI 10.1242/jcs.03011; Cho JA, 2012, INT J ONCOL, V40, P130, DOI 10.3892/ijo.2011.1193; Cho JA, 2011, GYNECOL ONCOL, V123, P379, DOI 10.1016/j.ygyno.2011.08.005; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; De Bruyn C, 2011, STEM CELLS DEV, V20, P547, DOI 10.1089/scd.2010.0260; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hao S., 2006, Experimental Oncology, V28, P126; Haubeiss S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-168; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Qiao C, 2008, CELL BIOL INT, V32, P8, DOI 10.1016/j.cellbi.2007.08.002; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Yu SH, 2007, J IMMUNOL, V178, P6867, DOI 10.4049/jimmunol.178.11.6867; Zhu W, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.17638; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	39	73	86	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52465	10.1371/journal.pone.0052465	http://dx.doi.org/10.1371/journal.pone.0052465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285052	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500176
J	Villamizar, N; Ribas, L; Piferrer, F; Vera, LM; Sanchez-Vazquez, FJ				Villamizar, Natalia; Ribas, Laia; Piferrer, Francesc; Vera, Luisa M.; Javier Sanchez-Vazquez, Francisco			Impact of Daily Thermocycles on Hatching Rhythms, Larval Performance and Sex Differentiation of Zebrafish	PLOS ONE			English	Article							CYCLING TEMPERATURE CONDITIONS; SOLE SOLEA-SENEGALENSIS; ANTI-MULLERIAN HORMONE; DANIO-RERIO; LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; EMBRYONIC-DEVELOPMENT; GONAD DEVELOPMENT; GENE-EXPRESSION; LIGHT	In the wild, water temperature cycles daily: it warms up after sunrise, and cools rapidly after sunset. Surprisingly, the impact of such daily thermocycles during the early development of fish remains neglected. We investigated the influence of constant vs daily thermocycles in zebrafish, from embryo development to sexual differentiation, by applying four temperature regimens: two constant (24 degrees C and 28 degrees C) and two daily thermocycles: 28:24 degrees C, TC (thermophase coinciding with daytime, and cryophase coinciding with night-time) and 24:28 degrees C, CT (opposite to TC) in a 12:12 h light: dark cycle (LD). Embryo development was temperature-dependent but enhanced at 28 degrees C and TC. Hatching rhythms were diurnal (around 4 h after lights on), but temperature-and cycle-sensitive, since hatching occurred sooner at 28 degrees C (48 hours post fertilization; hpf) while it was delayed at 24 degrees C (96 hpf). Under TC, hatching occurred at 72 hpf, while under CT hatching displayed two peaks (at 70 hpf and 94 hpf). In constant light (LL) or darkness (DD), hatching rhythms persisted with tau close to 24 h, suggesting a clock-controlled "gating" mechanism. Under 28 degrees C or TC, larvae showed the best performance (high growth and survival, and low malformations). The sex ratio was strongly influenced by temperature, as the proportion of females was higher in CT and TC (79 and 83% respectively), contrasting with 28 degrees C and 24 degrees C, which led to more males (83 and 76%). Ovarian aromatase (cyp19a) expression in females was highest in TC and CT (6.5 and 4.6 fold higher than at 28 degrees C, respectively); while anti-mullerian hormone (amh) expression in males increased in testis at 24 degrees C (3.6 fold higher compared to TC) and particularly at 28 degrees C (14.3 fold increase). Taken together, these findings highlight the key role of environmental cycles during early development, which shaped the daily rhythms in fish embryo and larvae, and ultimately influenced sex differentiation.	[Villamizar, Natalia; Vera, Luisa M.; Javier Sanchez-Vazquez, Francisco] Univ Murcia, Dept Physiol, Fac Biol, Murcia, Spain; [Ribas, Laia; Piferrer, Francesc] CSIC, Inst Ciencies Mar, Barcelona, Spain	University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Sanchez-Vazquez, FJ (corresponding author), Univ Murcia, Dept Physiol, Fac Biol, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain.	javisan@um.es	Ribas, Laia/E-1466-2013; Piferrer, Francesc/A-5634-2012; Vera, Luisa María/L-6972-2014; Sanchez Vazquez, Francisco Javier/J-7712-2016	Ribas, Laia/0000-0001-5538-6236; Piferrer, Francesc/0000-0003-0903-4736; Vera, Luisa María/0000-0003-0999-055X; Villamizar, Natalia/0000-0002-3673-233X; Sanchez Vazquez, Francisco Javier/0000-0002-2366-9714	Spanish Ministry of Economic Affairs and Competitiveness (MINECO) [AGL2010-22139-C03-01, CDS2007-0002]	Spanish Ministry of Economic Affairs and Competitiveness (MINECO)	This research was funded by the Spanish Ministry of Economic Affairs and Competitiveness (MINECO) by projects "Circasole" AGL2010-22139-C03-01 granted to FJSV (http://www.mineco.gob.es), and AQUAGENOMICS (Consolider-Ingenio Program; CDS2007-0002) granted to FJSV and FP (http://www.idi.mineco.gob.es). Thanks are also due to COST ACTION FA0801 (Larvanet)(http://www.larvanet.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abozaid H, 2011, SEX DEV, V5, P259, DOI 10.1159/000330120; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Ayson FG, 2006, GEN COMP ENDOCR, V149, P261, DOI 10.1016/j.ygcen.2006.06.006; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Bennett WA, 1997, COPEIA, P77; BERGMAN E, 1987, ENVIRON BIOL FISH, V19, P45, DOI 10.1007/BF00002736; Blanco-Vives B, 2012, J BIOL RHYTHM, V27, P135, DOI 10.1177/0748730411435303; Blanco-Vives B, 2011, CHRONOBIOL INT, V28, P300, DOI 10.3109/07420528.2011.560316; Blanco-Vives B, 2009, PHYSIOL BEHAV, V98, P268, DOI 10.1016/j.physbeh.2009.05.015; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; BROOKS S, 1994, J FISH BIOL, V45, P699, DOI 10.1006/jfbi.1994.1169; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; del Pozo A, 2011, CHRONOBIOL INT, V28, P39, DOI 10.3109/07420528.2010.530728; DIANA JS, 1984, J FISH BIOL, V24, P165, DOI 10.1111/j.1095-8649.1984.tb04787.x; Dunlap JC, 2004, CHRONOBIOLOGY, P89; Fenske M, 2005, ENVIRON TOXICOL CHEM, V24, P1088, DOI 10.1897/04-096R1.1; Lopez-Olmeda JF, 2009, CHRONOBIOL INT, V26, P200, DOI 10.1080/07420520902765928; Godwin J, 2003, EVOL DEV, V5, P40, DOI 10.1046/j.1525-142X.2003.03007.x; GOOLISH EM, 1984, AQUACULTURE, V36, P27, DOI 10.1016/0044-8486(84)90051-6; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; HENRY JAC, 1984, COMP BIOCHEM PHYS A, V77, P727, DOI 10.1016/0300-9629(84)90193-2; HUEY RB, 1993, AM NAT, V142, pS21, DOI 10.1086/285521; Hurd MW, 2002, J BIOL RHYTHM, V17, P307, DOI 10.1177/074873002129002618; Hurd MW, 1998, PHYSIOL BEHAV, V65, P465, DOI 10.1016/S0031-9384(98)00183-8; Idda ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034203; JOHNSTON IA, 1995, J EXP BIOL, V198, P1389; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; LAURENCE GC, 1976, J CONSEIL, V36, P220; Leet JK, 2011, J APPL TOXICOL, V31, P379, DOI 10.1002/jat.1682; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Olmeda JF, 2011, J THERM BIOL, V36, P91, DOI 10.1016/j.jtherbio.2010.12.005; Lopez-Olmeda JF, 2006, CHRONOBIOL INT, V23, P537, DOI 10.1080/07420520600651065; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Meseguer C, 2008, CHRONOBIOL INT, V25, P666, DOI 10.1080/07420520802380018; Myers EM, 2003, CHRONOBIOL INT, V20, P775, DOI 10.1081/CBI-120024214; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Nusslein-Volhard C, 2002, ZEBRAFISH PRACTICAL, P303, DOI [10.1017/S0016672303216384, DOI 10.1017/S0016672303216384]; Oliveira C, 2009, COMP BIOCHEM PHYS A, V152, P168, DOI 10.1016/j.cbpa.2008.09.012; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Ospina-Alvarez N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002837; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; QUI J, 1996, J BIOL RHYTHM, V11, P75; REFINETTI R, 1988, PHYSIOL BEHAV, V43, P121, DOI 10.1016/0031-9384(88)90107-2; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Saunders DS, 2002, INSECT CLOCKS; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Shimizu T, 2011, BIOCHEM BIOPH RES CO, V412, P132, DOI 10.1016/j.bbrc.2011.07.058; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Tsukuda H, 1974, ENV CONTROL BIOL, V12, P93; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vera LM, 2010, AQUACULTURE, V307, P29, DOI 10.1016/j.aquaculture.2010.06.028; Villamizar N, 2012, AQUACULTURE, V354, P117, DOI 10.1016/j.aquaculture.2012.03.028; Villamizar N, 2011, AQUACULTURE, V315, P86, DOI 10.1016/j.aquaculture.2010.10.036; Wang XG, 2007, DEV DYNAM, V236, P1329, DOI 10.1002/dvdy.21129; WOOD A, 1994, DEV DYNAM, V201, P151, DOI 10.1002/aja.1002010206	66	42	42	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52153	10.1371/journal.pone.0052153	http://dx.doi.org/10.1371/journal.pone.0052153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284912	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500104
J	Ritchie, IRW; Dyck, DJ				Ritchie, Ian R. W.; Dyck, David J.			Rapid Loss of Adiponectin-Stimulated Fatty Acid Oxidation in Skeletal Muscle of Rats Fed a High Fat Diet Is Not Due to Altered Muscle Redox State	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; INSULIN-RESISTANCE; SOLEUS MUSCLE; MITOCHONDRIAL DYSFUNCTION; GLOBULAR ADIPONECTIN; GLUCOSE-TRANSPORT; STRESS; GLUTATHIONYLATION; ACETYLCYSTEINE	A high fat (HF) diet rapidly impairs the ability of adiponectin (Ad) to stimulate fatty acid (FA) oxidation in oxidative soleus muscle, but the underlying mechanism remains elusive. Mere days of HF feeding also increase the muscle's production and accumulation of reactive oxygen species (ROS) and shift cellular redox to a more oxidized state. It seems plausible that this shift towards a more oxidized state might act as negative feedback to suppress the ability of Ad to stimulate FA oxidation and generate more ROS. Therefore, we sought to determine whether i)a shift towards a more oxidized redox state (reduction in GSH/2GSSG) coincided with impaired Ad-stimulated palmitate oxidation in oxidative and glycolytic rodent muscle after 5 days of HF feeding (60% kCal), and ii)if supplementation with the antioxidant, N-acetylcysteine (NAC) could prevent the HF-diet induced impairment in Ad-response. Globular Ad (gAd) increased palmitate oxidation in isolated soleus and EDL muscles by 42% and 34%, respectively (P<0.05) but this was attenuated with HF feeding in both muscles. HF feeding decreased total GSH (-26%, p<0.05) and GSH/2GSSG (-49%, p<0.05) in soleus, but not EDL. Supplementation with NAC prevented the HF diet-induced reductions in GSH and GSH/2GSSG in soleus, but did not prevent the loss of Ad response in either muscle. Furthermore, direct incubations with H2O2 did not impair Ad-stimulated FA oxidation in either muscle. In conclusion, our data indicates that skeletal muscle Ad resistance is rapidly induced in both oxidative and glycolytic muscle, independently of altered cellular redox state.	[Ritchie, Ian R. W.; Dyck, David J.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Dyck, DJ (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	ddyck@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN 217437-11]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by Natural Sciences and Engineering Research Council of Canada (RGPIN 217437-11). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Bonen A, 2009, AM J PHYSIOL-REG I, V297, pR1202, DOI 10.1152/ajpregu.90820.2008; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bruce CR, 2005, DIABETES, V54, P3154, DOI 10.2337/diabetes.54.11.3154; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Horowitz JF, 1999, AM J PHYSIOL-ENDOC M, V276, pE278, DOI 10.1152/ajpendo.1999.276.2.E278; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; Matuszczak Y, 2005, MUSCLE NERVE, V32, P633, DOI 10.1002/mus.20385; Mullen KL, 2007, AM J PHYSIOL-ENDOC M, V293, pE83, DOI 10.1152/ajpendo.00545.2006; Mullen KL, 2009, AM J PHYSIOL-REG I, V296, pR243, DOI 10.1152/ajpregu.90774.2008; NEMANI R, 1993, ARCH BIOCHEM BIOPHYS, V300, P24, DOI 10.1006/abbi.1993.1004; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Pinheiro CHJ, 2012, SCAND J MED SCI SPOR, V22, P24, DOI 10.1111/j.1600-0838.2010.01143.x; Raddatz E, 2011, AM J PHYSIOL-HEART C, V300, pH820, DOI 10.1152/ajpheart.00827.2010; Ritchie IRW, 2011, AM J PHYSIOL-REG I, V300, pR492, DOI 10.1152/ajpregu.00602.2010; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Steinberg GR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1374, DOI 10.1152/ajpendo.2000.279.6.E1374; Tishinsky JM, 2012, AM J PHYSIOL-REG I, V302, pR598, DOI 10.1152/ajpregu.00328.2011; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Wouters MA, 2011, INT J BIOCHEM CELL B, V43, P1079, DOI 10.1016/j.biocel.2011.04.002; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557	32	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52193	10.1371/journal.pone.0052193	http://dx.doi.org/10.1371/journal.pone.0052193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284930	gold, Green Submitted, Green Published			2022-12-25	WOS:000312435900084
J	Cho, SW; Pirih, FQ; Koh, AJ; Michalski, M; Eber, MR; Ritchie, K; Sinder, B; Oh, S; Al-Dujaili, SA; Lee, J; Kozloff, K; Danciu, T; Wronski, TJ; McCauley, LK				Cho, Sun Wook; Pirih, Flavia Q.; Koh, Amy J.; Michalski, Megan; Eber, Matthew R.; Ritchie, Kathryn; Sinder, Benjamin; Oh, Seojin; Al-Dujaili, Saja A.; Lee, JoonHo; Kozloff, Ken; Danciu, Theodora; Wronski, Thomas J.; McCauley, Laurie K.			The Soluble Interleukin-6 Receptor Is a Mediator of Hematopoietic and Skeletal Actions of Parathyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; BONE-RESORPTION; IN-VIVO; OSTEOBLASTIC DIFFERENTIATION; ANABOLIC ACTIONS; CELL-LINE; ACTIVATION; GP130; PROTEIN; IMMUNE	Both PTH and IL-6 signaling play pivotal roles in hematopoiesis and skeletal biology, but their interdependence is unclear. The purpose of this study was to evaluate the effect of IL-6 and soluble IL-6 receptor (sIL-6R) on hematopoietic and skeletal actions of PTH. In the bone microenvironment, PTH stimulated sIL-6R protein levels in primary osteoblast cultures in vitro and bone marrow in vivo in both IL-6 (+/+) and IL-6 (-/-) mice. PTH-mediated hematopoietic cell expansion was attenuated in IL-6(-/-) compared with IL-6(+/+) bone marrow, whereas sIL-6R treatment amplified PTH actions in IL-6(-/-) earlier than IL-6(+/+) marrow cultures. Blocking sIL-6R signaling with sgp130 (soluble glycoprotein 130 receptor) inhibited PTH-dependent hematopoietic cell expansion in IL-6(-/-) marrow. In the skeletal system, although intermittent PTH administration to IL-6(+/+) and IL-6(-/-) mice resulted in similar anabolic actions, blocking sIL-6R significantly attenuated PTH anabolic actions. sIL-6R showed no direct effects on osteoblast proliferation or differentiation in vitro; however, it up-regulated myeloid cell expansion and production of the mesenchymal stem cell recruiting agent, TGF-beta 1 in the bone marrow microenvironment. Collectively, sIL-6R demonstrated orphan function and mediated PTH anabolic actions in bone in association with support of myeloid lineage cells in the hematopoietic system.	[Cho, Sun Wook; Pirih, Flavia Q.; Koh, Amy J.; Michalski, Megan; Eber, Matthew R.; Ritchie, Kathryn; Oh, Seojin; Al-Dujaili, Saja A.; Lee, JoonHo; Danciu, Theodora; McCauley, Laurie K.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [McCauley, Laurie K.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Sinder, Benjamin; Kozloff, Ken] Univ Michigan, Sch Med, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Wronski, Thomas J.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32611 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	McCauley, LK (corresponding author), Univ Michigan, Sch Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	mccauley@umich.edu			National Institutes of Health [DK53904, PO1 CA093900]; NATIONAL CANCER INSTITUTE [P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK53904 and PO1 CA093900 (to L. K. M.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bashutski JD, 2010, NEW ENGL J MED, V363, P2396, DOI 10.1056/NEJMoa1005361; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chang JK, 2009, ARTHRITIS RHEUM-US, V60, P3049, DOI 10.1002/art.24843; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; DIAMANT M, 1994, J IMMUNOL METHODS, V173, P229, DOI 10.1016/0022-1759(94)90301-8; Ellegaard M, 2010, CALCIFIED TISSUE INT, V87, P1, DOI 10.1007/s00223-010-9360-5; Erices A, 2002, EXP CELL RES, V280, P24, DOI 10.1006/excr.2002.5627; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; GABAY C, 1995, EUR J IMMUNOL, V25, P2378, DOI 10.1002/eji.1830250838; Grey A, 1999, ENDOCRINOLOGY, V140, P4683, DOI 10.1210/en.140.10.4683; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Holub MC, 2002, IMMUNOL LETT, V82, P79, DOI 10.1016/S0165-2478(02)00022-6; Igaz P, 1998, CYTOKINE, V10, P620, DOI 10.1006/cyto.1997.0330; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kinjyo I, 2006, J EXP MED, V203, P1021, DOI 10.1084/jem.20052333; Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980; Koh AJ, 2011, ENDOCRINOLOGY, V152, P4525, DOI 10.1210/en.2011-1515; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Li X, 2007, J BIOL CHEM, V282, P33098, DOI 10.1074/jbc.M611781200; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Matsumoto S, 2010, J IMMUNOL, V184, P1543, DOI 10.4049/jimmunol.0801217; McGregor NE, 2010, CALCIFIED TISSUE INT, V86, P261, DOI 10.1007/s00223-010-9337-4; MICHALEVICZ R, 1989, SCANNING MICROSCOPY, V3, P1143; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; NARAZAKI M, 1993, BLOOD, V82, P1120, DOI 10.1182/blood.V82.4.1120.bloodjournal8241120; Nishimura R, 1998, J BONE MINER RES, V13, P777, DOI 10.1359/jbmr.1998.13.5.777; ONYIA JE, 1995, BONE, V17, P479, DOI 10.1016/8756-3282(95)00332-2; Palmqvist P, 2002, J IMMUNOL, V169, P3353, DOI 10.4049/jimmunol.169.6.3353; Pirih FQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013657; Pollock JH, 1996, J BONE MINER RES, V11, P754; Servet-Delprat Christine, 2002, BMC Immunol, V3, P15, DOI 10.1186/1471-2172-3-15; Sims NA, 2005, J BONE MINER RES, V20, P1093, DOI 10.1359/JBMR.050209; Sims NA, 2004, J CLIN INVEST, V113, P379, DOI 10.1172/JCI200419872; Sui XW, 1996, J EXP MED, V183, P837, DOI 10.1084/jem.183.3.837; Taguchi Y, 1998, P ASSOC AM PHYSICIAN, V110, P559; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012; Younce CW, 2010, CARDIOVASC RES, V87, P665, DOI 10.1093/cvr/cvq102	49	29	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6814	6825		10.1074/jbc.M112.393363	http://dx.doi.org/10.1074/jbc.M112.393363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23297399	Green Published, hybrid			2022-12-25	WOS:000316002400004
J	Gonzalez, D; Rojas, A; Herrera, MB; Conlan, RS				Gonzalez, Deyarina; Rojas, Armando; Herrera, Maria Beatriz; Conlan, R. Steven			iNOS Activation Regulates beta-catenin Association with Its Partners in Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COLON-CANCER CELLS; NO-DONATING ASPIRIN; TYROSINE PHOSPHORYLATION; KAPPA-B; CADHERIN COMPLEX; TIGHT JUNCTIONS; EXPRESSION; GROWTH; P120-CATENIN	Background: Signals that disrupt beta-catenin association to cadherins may influence the translocation of beta-catenin to the nucleus to regulate transcription. Post-translational modification of proteins is a signalling event that may lead to changes in structural conformation, association or function of the target proteins. NO and its derivatives induce nitration of proteins during inflammation. It has been described that animals treated with NO donors showed increased permeability due to modulation of VE-cadherin/catenin complex. We, therefore, aim to evaluate the effect of iNOS activation on the expression, nuclear localisation and function of beta-catenin in endothelial cells. Methodology/Principal Findings: Expression, nuclear localisation, post-translational modifications and function of beta-catenin was analysed by cell fractionation, immunoprecipitation, immunoblots, QRT-PCR and permeability assays in murine endothelial cells (H5V). Influence of macrophage activation on expression of VE-cadherin/p120-catenin/beta-catenin complex in co-cultured H5V cells was also assessed. Activation of macrophages to produce NO provoked a decrease in VE-cadherin/ p120-catenin/beta-catenin expression in H5V cells. Phosphorylation of beta-catenin, p120-catenin and VE-cadherin, and reduction in the barrier properties of the cell monolayer was associated with iNOS induction. Moreover, high NO levels provoked nitration of beta-catenin, and induced its translocation to the nucleus. In the nucleus of NOS activated cells, nitration levels of beta-catenin influenced its association with TCF4 and p65 proteins. High levels of NO altered beta-catenin mediated gene expression of NFkB and Wnt target genes without affecting cell viability. Conclusions: NOS activity modulates beta-catenin post-translational modifications, function and its association with different partners to promote endothelial cell survival. Therapeutic manipulation of iNOS levels may remove a critical cytoprotective mechanism of importance in tumour angiogenesis.	[Gonzalez, Deyarina; Conlan, R. Steven] Swansea Univ, Coll Med, Ctr NanoHlth, Swansea, W Glam, Wales; [Rojas, Armando] Catholic Univ Maule, Sch Med, Biomed Res Lab, Talca, Chile; [Herrera, Maria Beatriz] Univ Turin, Dept Internal Med, Res Ctr Expt Med, Turin, Italy	Swansea University; Universidad Catolica del Maule; University of Turin	Gonzalez, D (corresponding author), Swansea Univ, Coll Med, Ctr NanoHlth, Swansea, W Glam, Wales.	d.gonzalez@swansea.ac.uk	Rojas, Armando/D-2647-2014	Gonzalez, Deyarina/0000-0002-1838-6752; Conlan, Robert/0000-0002-2562-3461; Rojas, Armando/0000-0001-9911-7142	Royal Society, UK [2005/R4]; Fondo de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [1090340]; Welsh Asembly Government	Royal Society, UK(Royal Society of London); Fondo de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Welsh Asembly Government	This work was supported in part by grants from Royal Society, UK (grant 2005/R4) and Fondo de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile (grant 1090340). DG and RSC are supported by the Welsh Asembly Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; BALLIGAND JL, 1995, AM J PHYSIOL-HEART C, V268, pH1293, DOI 10.1152/ajpheart.1995.268.3.H1293; Beckers CML, 2008, CARDIOVASC RES, V79, P679, DOI 10.1093/cvr/cvn127; Chang K, 2004, EXP MOL MED, V36, P311, DOI 10.1038/emm.2004.42; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Dighiero P, 1997, INVEST OPHTH VIS SCI, V38, P2045; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Esser S, 1998, J CELL SCI, V111, P1853; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Gonzalez D, 2004, J BIOL CHEM, V279, P43345, DOI 10.1074/jbc.M401889200; Gonzalez D, 2003, BIOCHEM BIOPH RES CO, V304, P113, DOI 10.1016/S0006-291X(03)00546-1; Gow AJ, 2004, AM J PHYSIOL-LUNG C, V287, pL262, DOI 10.1152/ajplung.00295.2003; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Huber P, 1996, GENOMICS, V32, P21, DOI 10.1006/geno.1996.0072; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Kanwar JR, 2009, CURR MED CHEM, V16, P2373, DOI 10.2174/092986709788682155; Kibbe M, 1999, CARDIOVASC RES, V43, P650, DOI 10.1016/S0008-6363(99)00130-3; Kimura H, 2000, BLOOD, V95, P189, DOI 10.1182/blood.V95.1.189.001k05_189_197; Knepler JL, 2001, AM J PHYSIOL-CELL PH, V281, pC1064, DOI 10.1152/ajpcell.2001.281.3.C1064; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lin JZ, 2010, CLIN CANCER RES, V16, P77, DOI 10.1158/1078-0432.CCR-08-2362; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mariner DJ, 2004, J CELL SCI, V117, P1339, DOI 10.1242/jcs.01001; Monteiro HP, 2005, METHOD ENZYMOL, V396, P350, DOI 10.1016/S0076-6879(05)96029-1; Nath N, 2005, BIOCHEM BIOPH RES CO, V326, P93, DOI 10.1016/j.bbrc.2004.11.009; Nath N, 2003, P NATL ACAD SCI USA, V100, P12584, DOI 10.1073/pnas.2134840100; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965; Otero K, 2001, BIOCHEM J, V359, P567, DOI 10.1042/0264-6021:3590567; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Prevotat L, 2006, GASTROENTEROLOGY, V131, P1142, DOI 10.1053/j.gastro.2006.07.017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sossa Rojas A, 2010, CURRENT ENZYME INHIB, V6, P34, DOI [DOI 10.2174/157340810790712050, 10.2174/157340810790712050]; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Udhayakumar G, 2011, MOL CELL BIOCHEM, V357, P283, DOI 10.1007/s11010-011-0899-x; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Williams JL, 2011, EXP CELL RES, V317, P1359, DOI 10.1016/j.yexcr.2011.03.001; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; XIE QW, 1994, J BIOL CHEM, V269, P4705; Zhu HX, 2010, CANCER SCI, V101, P1156, DOI 10.1111/j.1349-7006.2010.01528.x	54	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52964	10.1371/journal.pone.0052964	http://dx.doi.org/10.1371/journal.pone.0052964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285236	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500090
J	Hua, N; Wei, XL; Liu, XY; Ma, XY; He, XH; Zhuo, RG; Zhao, Z; Wang, LY; Yan, HT; Zhong, BH; Zheng, JQ				Hua, Nan; Wei, Xiaoli; Liu, Xiaoyan; Ma, Xiaoyun; He, Xinhua; Zhuo, Rengong; Zhao, Zhe; Wang, Liyun; Yan, Haitao; Zhong, Bohua; Zheng, Jianquan			A Novel Muscarinic Antagonist R2HBJJ Inhibits Non-Small Cell Lung Cancer Cell Growth and Arrests the Cell Cycle in G0/G1	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; ALPHA-7-NICOTINIC ACETYLCHOLINE-RECEPTOR; ACTIVATED PROTEIN-KINASE; PROLIFERATION; CARCINOMA; AUTOCRINE; HYDROCHLORIDE; SYNTHESIZE; APOPTOSIS; PATHWAY	Lung cancers express the cholinergic autocrine loop, which facilitates the progression of cancer cells. The antagonists of mAChRs have been demonstrated to depress the growth of small cell lung cancers (SCLCs). In this study we intended to investigate the growth inhibitory effect of R2HBJJ, a novel muscarinic antagonist, on non-small cell lung cancer (NSCLC) cells and the possible mechanisms. The competitive binding assay revealed that R2HBJJ had a high affinity to M3 and M1 AChRs. R2HBJJ presented a strong anticholinergic activity on carbachol-induced contraction of guinea-pig trachea. R2HBJJ markedly suppressed the growth of NSCLC cells, such as H1299, H460 and H157. In H1299 cells, both R2HBJJ and its leading compound R2-PHC displayed significant anti-proliferative activity as M3 receptor antagonist darifenacin. Exogenous replenish of ACh could attenuate R2HBJJ-induced growth inhibition. Silencing M3 receptor or ChAT by specific-siRNAs resulted in a growth inhibition of 55.5% and 37.9% on H1299 cells 96 h post transfection, respectively. Further studies revealed that treatment with R2HBJJ arrested the cell cycle in G0/G1 by down-regulation of cyclin D1-CDK4/6-Rb. Therefore, the current study reveals that NSCLC cells express an autocrine and paracrine cholinergic system which stimulates the growth of NSCLC cells. R2HBJJ, as a novel mAChRs antagonist, can block the local cholinergic loop by antagonizing predominantly M3 receptors and inhibit NSCLC cell growth, which suggest that M3 receptor antagonist might be a potential chemotherapeutic regimen for NSCLC.	[Hua, Nan; Wei, Xiaoli; Liu, Xiaoyan; Ma, Xiaoyun; He, Xinhua; Zhuo, Rengong; Zhao, Zhe; Wang, Liyun; Yan, Haitao; Zhong, Bohua; Zheng, Jianquan] Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Zheng, JQ (corresponding author), Beijing Inst Pharmacol & Toxicol, Beijing, Peoples R China.	zhengjq@bmi.ac.cn		He, Xinhua/0000-0001-7826-2973				Betticher DC, 1997, INT J CANCER, V74, P556, DOI 10.1002/(SICI)1097-0215(19971021)74:5<556::AID-IJC14>3.0.CO;2-4; Calleja-Macias IE, 2009, INT J CANCER, V124, P1090, DOI 10.1002/ijc.24053; Catassi A, 2008, EUR J CANCER, V44, P2296, DOI 10.1016/j.ejca.2008.06.045; Chen CS, 2011, BREAST CANCER RES TR, V125, P73, DOI 10.1007/s10549-010-0821-3; Chen RJ, 2008, TOXICOL SCI, V104, P283, DOI 10.1093/toxsci/kfn086; Cheng KR, 2008, AM J PHYSIOL-GASTR L, V295, pG591, DOI 10.1152/ajpgi.00055.2008; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Haberberger RV, 2000, HISTOCHEM CELL BIOL, V113, P379; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hei TK, 1997, ENVIRON HEALTH PERSP, V105, P1085, DOI 10.2307/3433513; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Kim ES, 2011, CANCER PREV RES, V4, P779, DOI 10.1158/1940-6207.CAPR-11-0143; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; LIN CH, 1994, BRIT J PHARMACOL, V113, P275, DOI 10.1111/j.1476-5381.1994.tb16205.x; Martinez-Moreno P, 2006, CARCINOGENESIS, V27, P429, DOI 10.1093/carcin/bgi250; NIU WZ, 1990, ARCH INT PHARMACOD T, V304, P64; Oppitz M, 2002, GYNECOL ONCOL, V85, P159, DOI 10.1006/gyno.2002.6597; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Paleari L, 2008, CELL PROLIFERAT, V41, P936, DOI 10.1111/j.1365-2184.2008.00566.x; Proskocil BJ, 2004, ENDOCRINOLOGY, V145, P2498, DOI 10.1210/en.2003-1728; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rayford W, 1997, PROSTATE, V30, P160, DOI 10.1002/(SICI)1097-0045(19970215)30:3<160::AID-PROS3>3.0.CO;2-Q; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Shah N, 2009, AM J PHYSIOL-CELL PH, V296, pC221, DOI 10.1152/ajpcell.00514.2008; Shen WF, 2009, PHARMACOL RES, V60, P296, DOI 10.1016/j.phrs.2009.04.007; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Song PF, 2003, CANCER RES, V63, P214; Song PF, 2008, CANCER RES, V68, P4693, DOI 10.1158/0008-5472.CAN-08-0183; Song P, 2007, CANCER RES, V67, P3936, DOI 10.1158/0008-5472.CAN-06-2484; Wang YA, 2005, LIFE SCI, V78, P210, DOI 10.1016/j.lfs.2005.04.071; Wessler I, 1997, N-S ARCH PHARMACOL, V356, P694, DOI 10.1007/PL00005107; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P9; WILLEY JC, 1991, CANCER RES, V51, P5370; Wong HPS, 2007, TOXICOL APPL PHARM, V221, P261, DOI 10.1016/j.taap.2007.04.002; Yagle K, 2001, GLIA, V35, P111, DOI 10.1002/glia.1076	37	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53170	10.1371/journal.pone.0053170	http://dx.doi.org/10.1371/journal.pone.0053170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285263	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500116
J	Qin, XY; Sone, H; Kojima, Y; Mizuno, K; Ueoka, K; Muroya, K; Miyado, M; Hisada, A; Zaha, H; Fukuda, T; Yoshinaga, J; Yonemoto, J; Kohri, K; Hayashi, Y; Fukami, M; Ogata, T				Qin, Xian-Yang; Sone, Hideko; Kojima, Yoshiyuki; Mizuno, Kentaro; Ueoka, Katsuhiko; Muroya, Koji; Miyado, Mami; Hisada, Aya; Zaha, Hiroko; Fukuda, Tomokazu; Yoshinaga, Jun; Yonemoto, Junzo; Kohri, Kenjiro; Hayashi, Yutaro; Fukami, Maki; Ogata, Tsutomu			Individual Variation of the Genetic Response to Bisphenol A in Human Foreskin Fibroblast Cells Derived from Cryptorchidism and Hypospadias Patients	PLOS ONE			English	Article							TESTICULAR DYSGENESIS SYNDROME; NUCLEAR TRANSLOCATOR ARNT; BREAST-CANCER CELLS; ANDROGEN RECEPTOR; EXPRESSION; ABNORMALITIES; POPULATION; METABOLISM; EXPOSURE; HYPOXIA	Background/Purpose: We hypothesized that polymorphic differences among individuals might cause variations in the effect that environmental endocrine disruptors (EEDs) have on male genital malformations (MGMs). In this study, individual variation in the genetic response to low-dose bisphenol A (BPA) was investigated in human foreskin fibroblast cells (hFFCs) derived from child cryptorchidism (CO) and hypospadias (HS) patients. Methodology/Principal Findings: hFFCs were collected from control children without MGMs (n = 5) and child CO and HS patients (n = 8 and 21, respectively). BPA exposure (10 nM) was found to inhibit matrix metalloproteinase-11 (MMP11) expression in the HS group (0.74-fold, P = 0.0034) but not in the control group (0.93- fold, P = 0.84) and CO group (0.94-fold, P = 0.70). Significantly lower levels of MMP11 expression were observed in the HS group compared with the control group (0.80-fold, P = 0.0088) and CO group (0.79-fold, P = 0.039) in response to 10 nM BPA. The effect of single-nucleotide polymorphism rs5000770 (G. A), located within the aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) locus, on individual sensitivity to low-dose BPA was investigated in the HS group. A significant difference in neurotensin receptor 1 (NTSR1) expression in response to 10 nM BPA was observed between AA and AG/GG groups (n = 6 and 15, respectively. P = 0.031). However, no significant difference in ARNT2 expression was observed (P = 0.18). Conclusions/Significance: This study advances our understanding of the specificity of low-dose BPA effects on human reproductive health. Our results suggest that genetic variability among individuals affects susceptibility to the effects of EEDs exposure as a potential cause of HS.	[Qin, Xian-Yang; Sone, Hideko; Zaha, Hiroko; Yonemoto, Junzo] Natl Inst Environm Studies, Res Ctr Environm Risk, Hlth Risk Res Sect, Tsukuba, Ibaraki, Japan; [Qin, Xian-Yang; Hisada, Aya; Yoshinaga, Jun] Univ Tokyo, Grad Sch Frontier Sci, Dept Environm Studies, Kashiwa, Chiba, Japan; [Kojima, Yoshiyuki] Fukushima Med Univ, Sch Med, Dept Urol, Fukushima, Japan; [Mizuno, Kentaro; Kohri, Kenjiro; Hayashi, Yutaro] Nagoya City Univ, Grad Sch Med Sci, Dept Nephrourol, Nagoya, Aichi, Japan; [Ueoka, Katsuhiko] Natl Res Ctr Child Hlth & Dev, Dept Surg Subspecialties, Tokyo, Japan; [Muroya, Koji] Kanagawa Childrens Med Ctr, Div Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Miyado, Mami; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo, Japan; [Fukuda, Tomokazu] Tohoku Univ, Grad Sch Agr Sci, Dept Anim Prod Sci, Sendai, Miyagi 980, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Univ Hosp, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	National Institute for Environmental Studies - Japan; University of Tokyo; Fukushima Medical University; Nagoya City University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Tohoku University; Hamamatsu University School of Medicine	Sone, H (corresponding author), Natl Inst Environm Studies, Res Ctr Environm Risk, Hlth Risk Res Sect, Tsukuba, Ibaraki, Japan.	hsone@nies.go.jp	Muroya, Koji/J-1304-2016; Fukami, Maki/ABE-4694-2020; Qin, Xian-Yang/AAB-5628-2020; Mizuno, Kentaro/H-8950-2019; Fukuda, Tomokazu/O-1257-2018	Muroya, Koji/0000-0002-1810-9894; Fukami, Maki/0000-0001-9971-4035; Mizuno, Kentaro/0000-0002-9624-2009; Fukuda, Tomokazu/0000-0001-8456-0483; Ogata, Tsutomu/0000-0001-7178-9991	Environmental Technology Development Fund from the Ministry of the Environment, Japan	Environmental Technology Development Fund from the Ministry of the Environment, Japan	This study was supported by the Environmental Technology Development Fund from the Ministry of the Environment, Japan. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alifano M, 2010, CLIN CANCER RES, V16, P4401, DOI 10.1158/1078-0432.CCR-10-0659; Andrieux J, 2009, AM J MED GENET A, V149A, P2813, DOI 10.1002/ajmg.a.33097; Barrow LL, 2002, TERATOLOGY, V66, P85, DOI 10.1002/tera.10062; Baskin LS, 2001, CELL TISSUE RES, V305, P379, DOI 10.1007/s004410000345; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Dupouy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004223; Hankinson O, 2008, TOXICOL SCI, V103, P1, DOI 10.1093/toxsci/kfn032; Hill AJ, 2009, ZEBRAFISH, V6, P79, DOI 10.1089/zeb.2008.0536; Hirose K, 1996, MOL CELL BIOL, V16, P1706; Hsu HJ, 2001, BIOCHEM BIOPH RES CO, V282, P487, DOI 10.1006/bbrc.2001.4525; Klopocki E, 2008, EUR J PEDIATR, V167, P903, DOI 10.1007/s00431-007-0616-7; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Maltepe E, 2000, BIOCHEM BIOPH RES CO, V273, P231, DOI 10.1006/bbrc.2000.2928; Martin OV, 2008, ENVIRON HEALTH PERSP, V116, P149, DOI 10.1289/ehp.10545; McInnes LA, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-5; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Qiao L, 2012, PEDIATR RES, V71, P393, DOI 10.1038/pr.2011.49; Qin XY, 2012, J HUM GENET, V57, P434, DOI 10.1038/jhg.2012.48; Qin XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036711; Qin XY, 2011, FEBS LETT, V585, P3310, DOI 10.1016/j.febslet.2011.09.017; Qin XY, 2011, TOXICOL LETT, V206, P152, DOI 10.1016/j.toxlet.2011.07.007; Sekine H, 2006, J BIOL CHEM, V281, P37507, DOI 10.1074/jbc.M606910200; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Vidaeff AC, 2005, REPROD TOXICOL, V20, P5, DOI 10.1016/j.reprotox.2004.12.015; Virtanen HE, 2007, ACTA PAEDIATR, V96, P611, DOI 10.1111/j.1651-2227.2007.00241.x; Vottero A, 2011, J CLIN ENDOCR METAB, V96, pE1953, DOI 10.1210/jc.2011-0511; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010	32	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52756	10.1371/journal.pone.0052756	http://dx.doi.org/10.1371/journal.pone.0052756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285176	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500056
J	Lun, SWM; Cheung, ST; Cheung, PFY; To, KF; Woo, JKS; Choy, KW; Chow, C; Cheung, CCM; Chung, GTY; Cheng, ASH; Ko, CW; Tsao, SW; Busson, P; Ng, MHL; Lo, KW				Lun, Samantha Wei-Man; Cheung, Siu Tim; Cheung, Phyllis Fung Yi; To, Ka-Fai; Woo, John Kong-Sang; Choy, Kwong-Wai; Chow, Chit; Cheung, Chartia Ching-Mei; Chung, Grace Tin-Yun; Cheng, Alice Suk-Hang; Ko, Chun-Wai; Tsao, Sai-Wah; Busson, Pierre; Ng, Margaret Heung-Ling; Lo, Kwok-Wai			CD44+Cancer Stem-Like Cells in EBV-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER; CONFERS RESISTANCE; INITIATING CELLS; ABC TRANSPORTERS; IDENTIFICATION; LINE; POPULATION; EXPRESSION	Nasopharyngeal carcinoma (NPC) is a unique EBV-associated epithelial malignancy, showing highly invasive and metastatic phenotype. Despite increasing evidence demonstrating the critical role of cancer stem-like cells (CSCs) in the maintenance and progression of tumors in a variety of malignancies, the existence and properties of CSC in EBV-associated NPC are largely unknown. Our study aims to elucidate the presence and role of CSCs in the pathogenesis of this malignant disease. Sphere-forming cells were isolated from an EBV-positive NPC cell line C666-1 and its tumor-initiating properties were confirmed by in vitro and in vivo assays. In these spheroids, up-regulation of multiple stem cell markers were found. By flow cytometry, we demonstrated that both CD44 and SOX2 were overexpressed in a majority of sphere-forming C666-1 cells. The CD44+SOX2+ cells was detected in a minor population in EBV-positive xenografts and primary tumors and considered as potential CSC in NPC. Notably, the isolated CD44+ NPC cells were resistant to chemotherapeutic agents and with higher spheroid formation efficiency, showing CSC properties. On the other hand, microarray analysis has revealed a number of differentially expressed genes involved in transcription regulation (e. g. FOXN4, GLI1), immune response (CCR7, IL8) and transmembrane transport (e. g. ABCC3, ABCC11) in the spheroids. Among these genes, increased expression of CCR7 in CD44+ CSCs was confirmed in NPC xenografts and primary tumors. Importantly, blocking of CCR7 abolished the sphere-forming ability of C666-1 in vitro. Expression of CCR7 was associated with recurrent disease and distant metastasis. The current study defined the specific properties of a CSC subpopulation in EBV-associated NPC. Our findings provided new insights into developing effective therapies targeting on CSCs, thereby potentiating treatment efficacy for NPC patients.	[Lun, Samantha Wei-Man; To, Ka-Fai; Chow, Chit; Cheung, Chartia Ching-Mei; Chung, Grace Tin-Yun; Cheng, Alice Suk-Hang; Ko, Chun-Wai; Ng, Margaret Heung-Ling; Lo, Kwok-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China; [Lun, Samantha Wei-Man; To, Ka-Fai; Chung, Grace Tin-Yun; Ng, Margaret Heung-Ling; Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Cheung, Siu Tim; Cheung, Phyllis Fung Yi] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Woo, John Kong-Sang] Chinese Univ Hong Kong, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Hong Kong, Peoples R China; [Choy, Kwong-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai-Wah] Univ Hong Kong, Dept Anat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Busson, Pierre] Univ Paris 11, CNRS UMR 8126, Villejuif, France; [Busson, Pierre] Inst Cancerol Gustave Roussy, Villejuif, France	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Lo, KW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk	Choy, Richard/AAW-8230-2020; Cheung, Siu-Tim/C-4238-2009	Choy, Richard/0000-0002-3616-6200; Cheung, Siu-Tim/0000-0003-2147-315X; Busson, Pierre/0000-0003-1027-3400; Lo, Kwok Wai/0000-0002-3488-6124	Research Grants Council of Hong Kong (GRF) [470321, 471610, 471211, 471709, CUHK8/CRF/11R, AoE/M-06/08]; Research Grant Council [GRF776608M, GRF777809M]	Research Grants Council of Hong Kong (GRF)(Hong Kong Research Grants Council); Research Grant Council(Hong Kong Research Grants Council)	The study was supported by the Research Grants Council of Hong Kong (GRF: Grant No. 470321, 471610, 471211, 471709; GRF: Grant No. CUHK8/CRF/11R; AoE/M-06/08) and Research Grant Council (GRF776608M; GRF777809M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auner V, 2010, GYNECOL ONCOL, V117, P198, DOI 10.1016/j.ygyno.2009.10.077; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chia MC, 2008, CLIN CANCER RES, V14, P984, DOI 10.1158/1078-0432.CCR-07-0828; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Driessens G, 2011, CELL STEM CELL, V9, P283, DOI 10.1016/j.stem.2011.09.007; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Garvalov BK, 2011, J MOL MED, V89, P95, DOI 10.1007/s00109-010-0685-3; Ho FCH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-98; Horikawa T, 2011, BRIT J CANCER, V104, P1160, DOI 10.1038/bjc.2011.38; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; HUANG DP, 1989, INT J CANCER, V43, P936, DOI 10.1002/ijc.2910430535; Hui ABY, 1998, CANCER GENET CYTOGEN, V101, P83, DOI 10.1016/S0165-4608(97)00231-8; Joshua B, 2012, HEAD NECK-J SCI SPEC, V34, P42, DOI 10.1002/hed.21699; Kang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033919; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mine T, 2010, ONCOL REP, V23, P1537, DOI 10.3892/or_00000793; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oguri T, 2007, MOL CANCER THER, V6, P122, DOI 10.1158/1535-7163.MCT-06-0529; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wong HL, 2005, MOL CARCINOGEN, V44, P92, DOI 10.1002/mc.20133; Young LC, 2001, CLIN CANCER RES, V7, P1798; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang Y, 2010, J OTOLARYNGOL-HEAD N, V39, P157, DOI 10.2310/7070.2009.090150	38	64	70	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52426	10.1371/journal.pone.0052426	http://dx.doi.org/10.1371/journal.pone.0052426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285037	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800065
J	Brines, R; Maicas, N; Ferrandiz, ML; Loboda, A; Jozkowicz, A; Dulak, J; Alcaraz, MJ				Brines, Rita; Maicas, Nuria; Luisa Ferrandiz, Maria; Loboda, Agnieszka; Jozkowicz, Alicja; Dulak, Jozef; Jose Alcaraz, Maria			Heme Oxygenase-1 Regulates the Progression of K/BxN Serum Transfer Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; CARBON-MONOXIDE; INFLAMMATORY RESPONSES; MURINE MODEL; T-CELLS; EXPRESSION; INDUCTION; DISEASE	Background: Heme oxygenase-1 (HO-1) is induced in many cell types as a defense mechanism against stress. We have investigated the possible role of endogenous HO-1 in the effector phase of arthritis using the K/BxN serum transfer model of arthritis in HO-1 heterozygous and homozygous knock-out mice. Methodology/Principal Findings: Arthritis was induced in C57/Black-6 xFVB (HO-1(+/+), HO-1(+/-) and HO-1(-/-)) mice by intraperitoneal injection of 150 mu l serum from arthritic K/BxN mice at days 0 and 2. Blood was collected and animals were sacrificed at day 10. Histological analysis was performed in ankle sections. The levels of inflammatory mediators were measured in serum and paw homogenates by enzyme-linked immunosorbent assay or Multiplex technology. The incidence of arthritis was higher in HO-1(+/-) and HO-1(-/-) groups compared with HO-1(+/+). The inflammatory response was aggravated in HO-1(+/-) mice as shown by arthritic score and the migration of inflammatory cells that could be related to the enhancement of CXCL-1 production. In addition, the HO-1(+/-) group showed proteoglycan depletion significantly higher than HO-1(+/+) mice. Serum levels of matrix metalloproteinase-3, monocyte chemotactic protein-1, plasminogen activator inhibitor-1, E-selectin and intercellular adhesion molecule-1 were increased in arthritic HO-1(-/-) mice, whereas vascular endothelial growth factor and some cytokines such as interferon-gamma showed a reduction compared to HO-1(+/+) or HO-1(+/-) mice. In addition, down-regulated gene expression of ferritin, glutathione S-reductase A1 and superoxide dismutase-2 was observed in the livers of arthritic HO-1(+/-) animals. Conclusion/Significance: Endogenous HO-1 regulates the production of systemic and local inflammatory mediators and plays a protective role in K/BxN serum transfer arthritis.	[Brines, Rita; Maicas, Nuria; Luisa Ferrandiz, Maria; Jose Alcaraz, Maria] Univ Valencia, Dept Pharmacol, Valencia, Spain; [Brines, Rita; Maicas, Nuria; Luisa Ferrandiz, Maria; Jose Alcaraz, Maria] Univ Valencia, IDM, Valencia, Spain; [Loboda, Agnieszka; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland	University of Valencia; University of Valencia; Jagiellonian University	Alcaraz, MJ (corresponding author), Univ Valencia, Dept Pharmacol, Valencia, Spain.	maria.j.alcaraz@uv.es	Alcaraz, Maria Jose/D-8195-2018; Ferrandiz/K-9323-2017	Ferrandiz/0000-0003-4059-0175	Ministerio de Ciencia e Innovacion, ISCIII, FEDER [SAF2010-22048, RETICEF RD06/0013/2001]; Generalitat Valenciana [Prometeo2010-047]; Foundation for Polish Science - Parent-Bridge Programme; European Union within European Regional Development Fund; European Union; Polish Ministry of Science and Higher Education [POIG.02.01.00-12 064/08, POIG.02.02.00-014/08]	Ministerio de Ciencia e Innovacion, ISCIII, FEDER(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Foundation for Polish Science - Parent-Bridge Programme; European Union within European Regional Development Fund; European Union(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was funded by grants SAF2010-22048, RETICEF RD06/0013/2001 (Ministerio de Ciencia e Innovacion, ISCIII, FEDER), and Prometeo2010-047 (Generalitat Valenciana). AL is supported by the Foundation for Polish Science - Parent-Bridge Programme co-financed by the European Union within European Regional Development Fund. The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union and the Polish Ministry of Science and Higher Education (grants no: POIG.02.01.00-12 064/08 and POIG.02.02.00-014/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLA G, 1992, J BIOL CHEM, V267, P18148; Benallaoua M, 2007, ARTHRITIS RHEUM, V56, P2585, DOI 10.1002/art.22749; Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; Devesa I, 2005, ARTHRITIS RHEUM-US, V52, P3230, DOI 10.1002/art.21356; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Ferrandiz ML, 2008, ANN RHEUM DIS, V67, P1211, DOI 10.1136/ard.2007.082412; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Grundemar L, 1997, TRENDS PHARMACOL SCI, V18, P193, DOI 10.1016/S0165-6147(97)90622-2; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Jacobs JP, 2010, ARTHRITIS RHEUM-US, V62, P1921, DOI 10.1002/art.27470; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Jozkowicz A, 2003, ACTA BIOCHIM POL, V50, P69, DOI 10.18388/abp.2003_3715; Kaieda S, 2007, ARTHRITIS RHEUM, V56, P1836, DOI 10.1002/art.22714; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kirino Y, 2005, ARTHRITIS RES THER, V7, pR616, DOI 10.1186/ar1721; Kirino Y, 2007, ARTHRITIS RHEUM-US, V56, P464, DOI 10.1002/art.22370; Kitamura A, 2011, MOD RHEUMATOL, V21, P150, DOI 10.1007/s10165-010-0372-9; Kobayashi H, 2006, ARTHRITIS RHEUM-US, V54, P1132, DOI 10.1002/art.21754; Lin HH, 2009, J THROMB HAEMOST, V7, P1401, DOI 10.1111/j.1538-7836.2009.03478.x; Maicas N, 2010, EUR J PHARMACOL, V634, P184, DOI 10.1016/j.ejphar.2010.02.028; Matsumoto H, 2006, MOL CELL BIOCHEM, V291, P21, DOI 10.1007/s11010-006-9190-y; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Paya M, 1996, BRIT J PHARMACOL, V117, P1773, DOI 10.1111/j.1476-5381.1996.tb15353.x; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Pittock ST, 2005, KIDNEY INT, V68, P611, DOI 10.1111/j.1523-1755.2005.00439.x; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Remy S, 2009, J IMMUNOL, V182, P1877, DOI 10.4049/jimmunol.0802436; Rueda B, 2007, ARTHRITIS RHEUM-US, V56, P3953, DOI 10.1002/art.23048; Shah D, 2011, IMMUNOBIOLOGY, V216, P1010, DOI 10.1016/j.imbio.2011.04.001; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Solomon S, 2005, EUR J IMMUNOL, V35, P3064, DOI 10.1002/eji.200526167; Tzima S, 2009, J EXP MED, V206, P1167, DOI 10.1084/jem.20081582; Vachharajani TJ, 2000, AM J PHYSIOL-HEART C, V278, pH1613, DOI 10.1152/ajpheart.2000.278.5.H1613; Wagener FADTG, 2008, ARTHRITIS RHEUM, V58, P3388, DOI 10.1002/art.23970; Was H, 2011, FREE RADICAL BIO MED, V51, P1717, DOI 10.1016/j.freeradbiomed.2011.07.025; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601	37	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52435	10.1371/journal.pone.0052435	http://dx.doi.org/10.1371/journal.pone.0052435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285041	Green Published, gold			2022-12-25	WOS:000312794500168
J	Chakrabarti, S; Davidge, ST				Chakrabarti, Subhadeep; Davidge, Sandra T.			G-Protein Coupled Receptor 30 (GPR30): A Novel Regulator of Endothelial Inflammation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ESTROGEN-RECEPTOR; TNF-ALPHA; ADHESION MOLECULES; VCAM-1 EXPRESSION; INDUCED APOPTOSIS; E-SELECTIN; ESTRADIOL; CELLS; 17-BETA-ESTRADIOL	Estrogen, the female sex hormone, is known to exert anti-inflammatory and anti-atherogenic effects. Traditionally, estrogen effects were believed to be largely mediated through the classical estrogen receptors (ERs). However, there is increasing evidence that G-protein coupled receptor 30 (GPR30), a novel estrogen receptor, can mediate many estrogenic effects on the vasculature. Despite this, the localization and functional significance of GPR30 in the human vascular endothelium remains poorly understood. Given this background, we examined the subcellular location and potential anti-inflammatory roles of GPR30 using human umbilical vein endothelial cells as a model system. Inflammatory changes were induced by treatment with tumor necrosis factor (TNF), a pro-inflammatory cytokine involved in atherogenesis and many other inflammatory conditions. We found that GPR30 was located predominantly in the endothelial cell nuclei. Treatment with the selective GPR30 agonist G-1 partially attenuated the TNF induced upregulation of pro-inflammatory proteins such as intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). This effect was completely abolished by the selective GPR30 antagonist G-15, suggesting that it was indeed mediated in a GPR30 dependent manner. Interestingly, estrogen alone had no effects on TNF-treated endothelium. Concomitant activation of the classical ERs blocked the anti-inflammatory effects of G-1, indicating opposing effects of GPR30 and the classical ERs. Our findings demonstrate that endothelial GPR30 is a novel regulator of the inflammatory response which could be a potential therapeutic target against atherosclerosis and other inflammatory diseases.	[Chakrabarti, Subhadeep; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Davidge, Sandra T.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Chakrabarti, Subhadeep; Davidge, Sandra T.] Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada.	sandra.davidge@ualberta.ca	Chakrabarti, Subhadeep/AAD-1078-2022	Davidge, Sandra/0000-0002-5559-4905	Heart and Stroke Foundation of Alberta, Northwest Territories Nunavut; Canadian Institutes for Health Research (CIHR); Alberta Innovates - Health Solutions (AIHS)	Heart and Stroke Foundation of Alberta, Northwest Territories Nunavut; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions (AIHS)	The study was supported by grants from the Heart and Stroke Foundation of Alberta, Northwest Territories & Nunavut and the Canadian Institutes for Health Research (CIHR). S. Chakrabarti is supported by a CIHR fellowship. S. Davidge is a Canada Research Chair (CRC) in Women's Cardiovascular Health and is funded by Alberta Innovates - Health Solutions (AIHS) as an Alberta Heritage Foundation for Medical Research (AHFMR) Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi AA, 2004, EUR J CLIN INVEST, V34, P349, DOI 10.1111/j.1365-2362.2004.01339.x; Arenas IA, 2004, AM J PHYSIOL-CELL PH, V286, pC779, DOI 10.1152/ajpcell.00398.2003; Arnal JF, 2007, CURR OPIN LIPIDOL, V18, P554, DOI 10.1097/MOL.0b013e3282ef3bca; Aziz KE, 1996, CELL IMMUNOL, V167, P79, DOI 10.1006/cimm.1996.0010; Ba ZF, 2008, AM J PHYSIOL-HEART C, V295, pH2061, DOI 10.1152/ajpheart.00707.2008; Balhuizen A, 2010, MOL CELL ENDOCRINOL, V320, P16, DOI 10.1016/j.mce.2010.01.030; Barton M, 2012, STEROIDS, V77, P935, DOI 10.1016/j.steroids.2012.04.001; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Brouchet L, 2001, CIRCULATION, V103, P423; Broughton BRS, 2010, AM J PHYSIOL-HEART C, V298, pH1055, DOI 10.1152/ajpheart.00878.2009; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Chakrabarti S, 2009, J STEROID BIOCH MOL; Chakrabarti S, 2013, J VASC RES, V50, P21, DOI 10.1159/000342736; Chakrabarti S, 2012, J LEUKOCYTE BIOL, V91, P947, DOI 10.1189/jlb.1011513; Chakrabarti S, 2010, CARDIOVASC RES, V85, P796, DOI 10.1093/cvr/cvp368; Coma M, 2005, BRAIN, V128, P1613, DOI 10.1093/brain/awh492; Dean SA, 2005, AM J PHYSIOL-REG I, V288, pR759, DOI 10.1152/ajpregu.00595.2004; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Florian M, 2008, STEROIDS, V73, P47, DOI 10.1016/j.steroids.2007.08.010; Foster CA, 1996, J ALLERGY CLIN IMMUN, V98, pS270, DOI 10.1016/S0091-6749(96)70075-1; Gao F, 2011, ENDOCRINOLOGY, V152, P1434, DOI 10.1210/en.2010-1368; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P373; Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96; Holm A, 2011, J VASC RES, V48, P327, DOI 10.1159/000322578; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Ihionkhan CE, 2002, CIRC RES, V91, P814, DOI 10.1161/01.RES.0000038304.62046.4C; KORPELAINEN EI, 1993, P NATL ACAD SCI USA, V90, P11137, DOI 10.1073/pnas.90.23.11137; Li ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038787; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Merchant SJ, 2004, HYPERTENS PREGNANCY, V23, P47, DOI 10.1081/PRG-120028281; Miller AP, 2007, MENOPAUSE, V14, P251, DOI 10.1097/01.gme.0000235366.39726.f6; Mori M, 2004, LIFE SCI, V75, P599, DOI 10.1016/j.lfs.2003.12.023; Mukherjee TK, 2005, BBA-MOL CELL RES, V1745, P300, DOI 10.1016/j.bbamcr.2005.03.012; Narumiya H, 2001, HYPERTENS PREGNANCY, V20, P185, DOI 10.1081/PRG-100106968; Nilsson BO, 2011, BRIT J PHARMACOL, V163, P1131, DOI 10.1111/j.1476-5381.2011.01235.x; Pare G, 2002, CIRC RES, V90, P1087, DOI 10.1161/01.RES.0000021114.92282.FA; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Qiao XY, 2008, GENDER MED, V5, pS46, DOI 10.1016/j.genm.2008.03.006; Rahman A, 2008, ANTIOXID REDOX SIGNA; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; Sanchez AM, 2011, MOL HUM REPROD, V17, P219, DOI 10.1093/molehr/gaq097; Sankaralingam S, 2009, HYPERTENSION, V53, P270, DOI 10.1161/HYPERTENSIONAHA.108.122630; Seok YM, 2012, NAUNYN SCHMIEDEBERGS; Sherwood A, 2007, ARTERIOSCL THROM VAS, V27, P1782, DOI 10.1161/ATVBAHA.107.145383; Somjen D, 2004, J STEROID BIOCHEM, V88, P101, DOI 10.1016/j.jsbmb.2003.11.002; Stork S, 2004, TRENDS ENDOCRIN MET, V15, P66, DOI 10.1016/j.tem.2004.01.005; Taylor PC, 2000, ARTHRITIS RHEUM-US, V43, P38, DOI 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Wollin M, 2009, TRANSPL INT, V22, P342, DOI 10.1111/j.1432-2277.2008.00802.x; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339; Zhang X, 2002, METHOD FIND EXP CLIN, V24, P125, DOI 10.1358/mf.2002.24.3.802295; Zhang X, 2002, LIFE SCI, V71, P15, DOI 10.1016/S0024-3205(02)01567-9; Zhou ZG, 2007, CELL SIGNAL, V19, P1238, DOI 10.1016/j.cellsig.2006.12.013	61	90	96	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52357	10.1371/journal.pone.0052357	http://dx.doi.org/10.1371/journal.pone.0052357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285008	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500152
J	Lim, H; Kim, YU; Drouin, SM; Mueller-Ortiz, S; Yun, K; Morschl, E; Wetsel, RA; Chung, Y				Lim, Hoyong; Kim, Young Uk; Drouin, Scott M.; Mueller-Ortiz, Stacey; Yun, Kyoungah; Morschl, Eva; Wetsel, Rick A.; Chung, Yeonseok			Negative Regulation of Pulmonary Th17 Responses by C3a Anaphylatoxin during Allergic Inflammation in Mice	PLOS ONE			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; BRONCHOALVEOLAR LAVAGE FLUID; T-HELPER-CELLS; GAMMA-DELTA-T; AIRWAY INFLAMMATION; COMPLEMENT C3A; NEUTROPHIL RECRUITMENT; RHEUMATOID-ARTHRITIS; LUNG INFLAMMATION; DENDRITIC CELLS	Activation of complement is one of the earliest immune responses to exogenous threats, resulting in various cleavage products including anaphylatoxin C3a. In addition to its contribution to host defense, C3a has been shown to mediate Th2 responses in animal models of asthma. However, the role of C3a on pulmonary Th17 responses during allergic inflammation remains unclear. Here, we show that mice deficient in C3a receptor (C3aR) exhibited (i) higher percentages of endogenous IL-17-producing CD4(+) T cells in the lungs, (ii) higher amounts of IL-17 in the bronchoalveolar lavage fluid, and (iii) more neutrophils in the lungs than wild-type mice when challenged with intranasal allergens. Moreover, adoptive transfer experiments showed that the frequencies of antigen-specific IL-17-producing CD4+ T cells were significantly higher in the lungs and bronchial lymph nodes of C3aR-deficient recipients than those of wild-types recipients. Bone-marrow reconstitution study indicated that C3aR-deficiency on hematopoietic cells was required for the increased Th17 responses. Furthermore, C3aR-deficient mice exhibited increased percentages of Foxp3(+) regulatory T cells; however, depletion of these cells minimally affected the induction of antigen-specific Th17 cell population in the lungs. Neutralization of IL-17 significantly reduced the number of neutrophils in bronchoalveolar lavage fluid of C3aR-deficient mice. Our findings demonstrate that C3a signals negatively regulate antigen-specific Th17 responses during allergic lung inflammation and the size of Foxp3(+) regulatory T cell population in the periphery.	[Lim, Hoyong; Kim, Young Uk; Drouin, Scott M.; Mueller-Ortiz, Stacey; Yun, Kyoungah; Morschl, Eva; Wetsel, Rick A.; Chung, Yeonseok] Univ Texas Med Sch Houston, Ctr Immunol & Autoimmune Dis, Inst Mol Med, Houston, TX 77030 USA; [Kim, Young Uk; Drouin, Scott M.; Wetsel, Rick A.; Chung, Yeonseok] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Yun, Kyoungah] Daejon Hlth Sci Coll, Taejon, South Korea	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Chung, Y (corresponding author), Univ Texas Med Sch Houston, Ctr Immunol & Autoimmune Dis, Inst Mol Med, Houston, TX 77030 USA.	Yeonseok.Chung@uth.tmc.edu		Chung, Yeonseok/0000-0001-5780-4841; Kim, Young Uk/0000-0002-2518-0189	American Heart Association [10SDG3860046]; National Institutes of Health [R01 HL081398, 5 R01 AI025011-17]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP 110776]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025011] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work is supported by research grant 10SDG3860046 from the American Heart Association (to Y.C.), R01 HL081398 (to S. D.) and 5 R01 AI025011-17 (to R.A.W.) from National Institutes of Health. The Flow Cytometry Core Facility is supported in part by the shared instrumentation grant (RP 110776) from the Cancer Prevention and Research Institute of Texas (CPRIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2010, ANNU REV PHYSIOL, V72, P495, DOI 10.1146/annurev-physiol-021909-135926; Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Baelder R, 2005, J IMMUNOL, V174, P783, DOI 10.4049/jimmunol.174.2.783; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chung Y, 2005, J LEUKOCYTE BIOL, V77, P906, DOI 10.1189/jlb.1004599; Chung Y, 2002, IMMUNOBIOLOGY, V206, P408, DOI 10.1078/0171-2985-00190; Chung Y, 2008, J IMMUNOL, V180, P2276, DOI 10.4049/jimmunol.180.4.2276; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Corry David B, 2002, Am J Respir Med, V1, P185; Dillard P, 2007, AM J RESP CRIT CARE, V175, P1250, DOI 10.1164/rccm.200701-049OC; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Eustace A, 2011, CHEST, V139, P1089, DOI 10.1378/chest.10-0779; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Gutzmer R, 2004, IMMUNOLOGY, V111, P435, DOI 10.1111/j.1365-2567.2004.01829.x; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; HANSCH GM, 1984, J IMMUNOL, V133, P2145; HARTUNG HP, 1983, J IMMUNOL, V130, P1345; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hellings PW, 2003, AM J RESP CELL MOL, V28, P42, DOI 10.1165/rcmb.4832; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Humbles AA, 2000, NATURE, V406, P998, DOI 10.1038/35023175; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Kiss A, 2007, J ALLERGY CLIN IMMUN, V120, P334, DOI 10.1016/j.jaci.2007.04.025; Kohl J, 2006, IMMUNOL RES, V34, P157, DOI 10.1385/IR:34:2:157; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krug N, 2001, AM J RESP CRIT CARE, V164, P1841, DOI 10.1164/ajrccm.164.10.2010096; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Laan M, 1999, J IMMUNOL, V162, P2347; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Larche M, 2006, CURR OPIN IMMUNOL, V18, P745, DOI 10.1016/j.coi.2006.09.013; Lee SH, 2004, J ALLERGY CLIN IMMUN, V113, P72, DOI 10.1016/j.jaci.2003.09.039; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; Monsinjon T, 2001, FEBS LETT, V487, P339, DOI 10.1016/S0014-5793(00)02320-6; Mucida D, 2009, J ALLERGY CLIN IMMUN, V123, P997, DOI 10.1016/j.jaci.2009.03.016; Murdoch JR, 2010, AM J RESP CRIT CARE, V182, P464, DOI 10.1164/rccm.200911-1775OC; Reca R, 2003, BLOOD, V101, P3784, DOI 10.1182/blood-2002-10-3233; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Sarma VJ, 2006, AUTOIMMUNITY, V39, P387, DOI 10.1080/08916930600739456; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Sheerin NS, 2008, FASEB J, V22, P1065, DOI 10.1096/fj.07-8719com; Souwer Y, 2010, CURR OPIN IMMUNOL, V22, P821, DOI 10.1016/j.coi.2010.10.013; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; VANDEGRAAF EA, 1992, J IMMUNOL METHODS, V147, P241, DOI 10.1016/S0022-1759(12)80014-7; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wang YH, 2010, J EXP MED, V207, P2479, DOI 10.1084/jem.20101376; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Werfel T, 2000, J IMMUNOL, V165, P6599, DOI 10.4049/jimmunol.165.11.6599; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Woodruff PG, 2001, J ALLERGY CLIN IMMUN, V108, P753, DOI 10.1067/mai.2001.119411; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yu SH, 2011, J IMMUNOL, V187, P4907, DOI 10.4049/jimmunol.1101519	82	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52666	10.1371/journal.pone.0052666	http://dx.doi.org/10.1371/journal.pone.0052666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285141	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500226
J	Zhao, ZY; Worthylake, D; LeCour, L; Maresh, GA; Pincus, SH				Zhao, Zhiyu; Worthylake, David; LeCour, Louis, Jr.; Maresh, Grace A.; Pincus, Seth H.			Crystal Structure and Computational Modeling of the Fab Fragment from a Protective Anti-Ricin Monoclonal Antibody	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURES; STRUCTURE VALIDATION; CANONICAL STRUCTURES; PROTEINS; ERRORS; IMMUNOGLOBULINS; CRYSTALLOGRAPHY; RECOGNITION; MOLPROBITY; ACCURACY	Background: Many antibody crystal structures have been solved. Structural modeling programs have been developed that utilize this information to predict 3-D structures of an antibody based upon its sequence. Because of the problem of self-reference, the accuracy and utility of these predictions can only be tested when a new structure has not yet been deposited in the Protein Data Bank. Methods: We have solved the crystal structure of the Fab fragment of RAC18, a protective anti-ricin mAb, to 1.9 angstrom resolution. We have also modeled the Fv structure of RAC18 using publicly available Ab modeling tools Prediction of Immunoglobulin Structures (PIGS), RosettaAntibody, and Web Antibody Modeling (WAM). The model structures underwent energy minimization. We compared results to the crystal structure on the basis of root-mean-square deviation (RMSD), template modeling score (TM-score), Z-score, and MolProbity analysis. Findings: The crystal structure showed a pocket formed mainly by AA residues in each of the heavy chain complementarity determining regions (CDRs). There were differences between the crystal structure and structures predicted by the modeling tools, particularly in the CDRs. There were also differences among the predicted models, although the differences were small and within experimental error. No one modeling program was clearly superior to the others. In some cases, choosing structures based only on sequence homology to the crystallized Ab yielded RMSDs comparable to the models. Conclusions: Molecular modeling programs accurately predict the structure of most regions of antibody variable domains of RAC18. The hypervariable CDRs proved most difficult to model, particularly H chain CDR3. Because CDR3 is most often involved in contact with antigen, this defect must be considered when using models to identify potential contacts between antibody and antigen. Because this study represents only a single case, the results cannot be generalized. Rather they highlight the utility and limitations of modeling programs.	[Zhao, Zhiyu; Maresh, Grace A.; Pincus, Seth H.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Zhao, Zhiyu] Louisiana Opt Network Initiat Inst, Baton Rouge, LA USA; [Zhao, Zhiyu] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA; [Worthylake, David; LeCour, Louis, Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA	Children's Hospital of New Orleans; University of Louisiana System; University of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Pincus, SH (corresponding author), Childrens Hosp, Res Inst Children, New Orleans, LA USA.	spincus@chnola-research.org			LONI Institute; Research Institute for Children at Children's Hospital New Orleans; National Institutes of Health from National Institute of Allergy and Infectious Diseases [AI059376]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084072] Funding Source: NIH RePORTER	LONI Institute; Research Institute for Children at Children's Hospital New Orleans; National Institutes of Health from National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were funded by the LONI Institute (http://institute.loni.org/), Research Institute for Children at Children's Hospital New Orleans (chnola-research.org) and National Institutes of Health grant AI059376 from National Institute of Allergy and Infectious Diseases (niaid.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, 2011, ANT DEV DISC STUD; Akdis CA, 2009, J ALLERGY CLIN IMMUN, V123, P735, DOI 10.1016/j.jaci.2009.02.030; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Almagro JC, 2011, PROTEINS, V79, P3050, DOI 10.1002/prot.23130; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chemical Computing Group, 2012, PROT ANT MOD; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Keedy DA, 2009, PROTEINS, V77, P29, DOI 10.1002/prot.22551; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; MARTINI A, 2001, POSITIVE HLTH PREVEN, P33; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sircar A, 2009, NUCLEIC ACIDS RES, V37, pW474, DOI 10.1093/nar/gkp387; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	25	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52613	10.1371/journal.pone.0052613	http://dx.doi.org/10.1371/journal.pone.0052613			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285112	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300094
J	Ben-Yona, A; Kanner, BI				Ben-Yona, Assaf; Kanner, Baruch I.			Functional Defects in the External and Internal Thin Gates of the gamma-Aminobutyric Acid (GABA) Transporter GAT-1 Can Compensate Each Other	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; ALTERNATING ACCESS; SUBTYPE-A; RAT-BRAIN; IDENTIFICATION; SITE; BINDING; PERMEATION; EXPRESSION	The GABA transporter GAT-1 belongs to the neurotransmitter: sodium: symporters which are crucial for synaptic transmission. GAT-1 mediates electrogenic transport of GABA together with sodium and chloride. Structure-function studies indicate that the bacterial homologue LeuT, which possess extra-and intracellular thin gates, is an excellent model for this class of neurotransmitter transporters. We recently showed that a conserved aspartate residue of GAT-1, Asp-451, whose LeuT equivalent participates in its thin extracellular gate, is functionally irreplaceable in GAT-1. Only the D451E mutant exhibited residual transport activity but with an elevated apparent sodium affinity as a consequence of an increased proportion of outward-facing transporters. Because during transport the opening and closing of external and internal gates should be tightly coupled, we have addressed the question of whether mutations of the intracellular thin gate residues Arg-44 and Asp-410 can compensate for the effects of their extracellular counterparts. Mutation of Asp-410 to glutamate resulted in impaired transport activity and a reduced apparent affinity for sodium. However, the transport activity of the double mutant D410E/D451E was increased by approximately 10-fold of that of each of the single mutants. Similar compensatory effects were also seen when other combinations of intra-and extracellular thin gate mutants were analyzed. Moreover, the introduction of D410E into the D451E background resulted in lower apparent sodium affinity than that of D451E alone. Our results indicate that a functional interaction of the external and internal gates of GAT-1 is essential for transport.	[Ben-Yona, Assaf; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			Israel Science Foundation; European Union Consortium European Drug Initiative on Channels and Transporters	Israel Science Foundation(Israel Science Foundation); European Union Consortium European Drug Initiative on Channels and Transporters(European Commission)	This work was supported by grants from the Israel Science Foundation and the European Union Consortium European Drug Initiative on Channels and Transporters.	Ben-Yona A, 2012, J BIOL CHEM, V287, P7159, DOI 10.1074/jbc.M111.323634; Ben-Yona A, 2011, J BIOL CHEM, V286, P2826, DOI 10.1074/jbc.M110.149732; Ben-Yona A, 2009, J BIOL CHEM, V284, P9727, DOI 10.1074/jbc.M809423200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Bennett ER, 1997, J BIOL CHEM, V272, P1203, DOI 10.1074/jbc.272.2.1203; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Dodd JR, 2007, J BIOL CHEM, V282, P15528, DOI 10.1074/jbc.M611705200; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mari SA, 2006, CELL MOL LIFE SCI, V63, P100, DOI 10.1007/s00018-005-5512-6; Nelson N, 1998, J NEUROCHEM, V71, P1785; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; PANTANOWITZ S, 1993, J BIOL CHEM, V268, P3222; Rosenberg A, 2008, J BIOL CHEM, V283, P14376, DOI 10.1074/jbc.M801093200; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200	31	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4549	4556		10.1074/jbc.M112.430215	http://dx.doi.org/10.1074/jbc.M112.430215			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288838	Green Published, hybrid			2022-12-25	WOS:000315340400005
J	Mast, N; Zheng, WC; Stout, CD; Pikuleva, IA				Mast, Natalia; Zheng, Wenchao; Stout, C. David; Pikuleva, Irina A.			Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1 UNUSUAL FEATURES AND SPECTRAL RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC-MICROSOMAL CYTOCHROME-P-450; CHOLESTEROL HOMEOSTASIS; CRYSTAL-STRUCTURE; DIFFERENCE SPECTRA; STRUCTURAL BASIS; HUMAN BRAIN; SPIN-STATE; TURNOVER; COMPLEXES; ENZYME	Cytochrome P450 46A1 (CYP46A1) is the cholesterol 24-hydroxylase initiating the major pathways of cholesterol removal from the brain, and bicalutamide (BIC) is a drug of choice for the treatment of progressive androgen-dependent prostate cancer. We evaluated the interactions of BIC with CYP46A1 by x-ray crystallography and by conducting solution and mutagenesis studies. Because BIC is administered to patients as a racemic mixture of the S and R isomers, we studied all three, racemic BIC as well as the S and R isomers. Co-crystallization of CYP46A1 with racemic BIC led to structure determinations at 2.1A resolution with the drug complexes exhibiting novel properties. Both BIC isomers bind to the CYP46A1 active site in very similar single orientation and adopt an energetically unfavorable folded conformation. This folded BIC conformation is correlated with drug-induced localized shifts of amino acid side chains in CYP46A1 and unusual interactions in the CYP46A1-BIC complex. One of these interactions involves a water molecule that is coordinated to the P450 heme iron and also hydrogen-bonded to the BIC nitrile. Due to polarization of the water in this environment, the heme elicits previously unreported types of P450 spectral responses. We also observed that access to the P450 active site was affected by differential recognition of S versus R isomers at the CYP46A1 surface arising from BIC conformational polymorphism.	Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Visual Sci, Cleveland, OH 44106 USA; [Stout, C. David] Scripps Res Inst, La Jolla, CA 92037 USA	Case Western Reserve University; Case Western Reserve University; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	dave@scripps.edu; iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232	United States Public Health Service [GM62882]; Department of Energy Office of Biological and Environmental Research; NIGMS, National Institutes of Health [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882, P41GM103393] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grant GM62882 (to I. A. P.). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS, Center for Research Resources, or the National Institutes of Health.; We thank Dr. A. T. Hagler (Department of Chemistry, University of Massachusetts) for providing the coordinates of the computed BIC structure mentioned in Ref. (42) and Dr. M. Shimoji for generating the T306A CYP46A1 mutant. Portions of this research were carried out at Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the NIGMS, National Institutes of Health (including Grant P41GM103393) and the National Center for Research Resources (Grant P41RR001209). We thank the staff at the Stanford Synchrotron Radiation Lightsource for assistance in data collection.	ANDERSSON LA, 1984, XENOBIOTICA, V14, P49, DOI 10.3109/00498258409151398; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bis JA, 2007, MOL PHARMACEUT, V4, P401, DOI 10.1021/mp070012s; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bohl CE, 2005, P NATL ACAD SCI USA, V102, P6201, DOI 10.1073/pnas.0500381102; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleming FF, 2010, J MED CHEM, V53, P7902, DOI 10.1021/jm100762r; GIGON PL, 1968, BIOCHEM BIOPH RES CO, V31, P558, DOI 10.1016/0006-291X(68)90514-7; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hu XR, 2005, ACTA CRYSTALLOGR E, V61, pO3897, DOI 10.1107/S1600536805034501; Isoherranen N, 2004, DRUG METAB DISPOS, V32, P1121, DOI 10.1124/dmd.104.000315; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; KUMAKI K, 1978, J BIOL CHEM, V253, P1048; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; MAILMAN RB, 1974, DRUG METAB DISPOS, V2, P301; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee A, 1996, XENOBIOTICA, V26, P117, DOI 10.3109/00498259609046693; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2370; Osguthorpe DJ, 2011, BIOCHEMISTRY-US, V50, P4105, DOI 10.1021/bi102059z; Pearson J, 2011, ARCH BIOCHEM BIOPHYS, V511, P69, DOI 10.1016/j.abb.2011.04.008; POULOS TL, 1987, BIOCHEMISTRY-US, V26, P8165, DOI 10.1021/bi00399a022; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; REMMER H, 1966, MOL PHARMACOL, V2, P187; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Shafaati M, 2010, J LIPID RES, V51, P318, DOI 10.1194/jlr.M900174-JLR200; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; SONO M, 1982, J BIOL CHEM, V257, P5496; Vega DR, 2007, INT J PHARM, V328, P112, DOI 10.1016/j.ijpharm.2006.08.001; White MA, 2008, ACTA CRYSTALLOGR D, V64, P487, DOI 10.1107/S0907444908004046	44	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4613	4624		10.1074/jbc.M112.438754	http://dx.doi.org/10.1074/jbc.M112.438754			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288837	Green Published, hybrid			2022-12-25	WOS:000315340400011
J	Altenburg, TM; Hofsteenge, GH; Weijs, PJM; Delemarre-van de Waal, HA; Chinapaw, MJM				Altenburg, Teatske M.; Hofsteenge, Geesje H.; Weijs, Peter J. M.; Delemarre-van de Waal, Henriette A.; Chinapaw, Mai J. M.			Self-Reported Screen Time and Cardiometabolic Risk in Obese Dutch Adolescents	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; CHILDHOOD OVERWEIGHT; HEALTH CONSEQUENCES; CARDIOVASCULAR RISK; METABOLIC SYNDROME; CHILDREN; YOUTH; RELIABILITY; WORLDWIDE	Background: It is not clear whether the association between sedentary time and cardiometabolic risk exists among obese adolescents. We examined the association between screen time (TV and computer time) and cardiometabolic risk in obese Dutch adolescents. Methods and Findings: For the current cross-sectional study, baseline data of 125 Dutch overweight and obese adolescents (12-18 years) participating in the Go4it study were included. Self-reported screen time (Activity Questionnaire for Adolescents and Adults) and clustered and individual cardiometabolic risk (i.e. body composition, systolic and diastolic blood pressure, low-density (LDL-C), high-density (HDL-C) and total cholesterol (TC), triglycerides, glucose and insulin) were assessed in all participants. Multiple linear regression analyses were used to assess the association between screen time and cardiometabolic risk, adjusting for age, gender, pubertal stage, ethnicity and moderate-to-vigorous physical activity. We found no significant relationship between self-reported total screen time and clustered cardiometabolic risk or individual risk factors in overweight and obese adolescents. Unexpectedly, self-reported computer time, but not TV time, was slightly but significantly inversely associated with TC (B = -0.002; CI = [-0.003; -0.000]) and LDL-C (B = -0.002; CI = [-0.001; 0.000]). Conclusions: In obese adolescents we could not confirm the hypothesised positive association between screen time and cardiometabolic risk. Future studies should consider computer use as a separate class of screen behaviour, thereby also discriminating between active video gaming and other computer activities.	[Altenburg, Teatske M.; Chinapaw, Mai J. M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Med Ctr, Amsterdam, Netherlands; [Hofsteenge, Geesje H.; Weijs, Peter J. M.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Nutr & Dietet, Med Ctr, Amsterdam, Netherlands; [Delemarre-van de Waal, Henriette A.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Altenburg, TM (corresponding author), Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Med Ctr, Amsterdam, Netherlands.	t.altenburg@vumc.nl	Paw, Mai Chin A/N-1665-2019; Altenburg, Teatske/S-2059-2016	Paw, Mai Chin A/0000-0001-6259-2441; Altenburg, Teatske/0000-0002-8764-5631; Weijs, Peter/0000-0001-8281-0426	ZONMW [50-50110-98-255]	ZONMW(Netherlands Organization for Health Research and Development)	This study was funded by ZONMW (no: 50-50110-98-255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Carson V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-274; Chinapaw MJM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-58; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels SR, 2006, FUTURE CHILD, V16, P47, DOI 10.1353/foc.2006.0004; Dietz WH, 1998, PEDIATRICS, V101, P518; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Goldfield Gary S, 2011, PLoS One, V6, pe26643, DOI 10.1371/journal.pone.0026643; Hofsteenge GH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-410; Lambert M, 2008, CAN J CARDIOL, V24, P575, DOI 10.1016/S0828-282X(08)70639-1; MAFFEIS C, 1994, J PEDIATR-US, V124, P348, DOI 10.1016/S0022-3476(94)70355-8; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Martinez-Gomez D, 2009, ARCH PEDIAT ADOL MED, V163, P724, DOI 10.1001/archpediatrics.2009.90; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Nathan BM, 2008, CURR OPIN ENDOCRINOL, V15, P21, DOI 10.1097/MED.0b013e3282f43d19; Pardee PE, 2007, AM J PREV MED, V33, P439, DOI 10.1016/j.amepre.2007.07.036; Reilly JJ, 2005, BEST PRACT RES CL EN, V19, P327, DOI 10.1016/j.beem.2005.04.002; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Slootmaker SM, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-17; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Twisk JWR, 1997, AM J EPIDEMIOL, V145, P888, DOI 10.1093/oxfordjournals.aje.a009048; Wang XW, 2006, ARCH PEDIAT ADOL MED, V160, P411, DOI 10.1001/archpedi.160.4.411; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	26	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53333	10.1371/journal.pone.0053333	http://dx.doi.org/10.1371/journal.pone.0053333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285284	Green Published, gold			2022-12-25	WOS:000313051500138
J	Azrad, M; Zhang, K; Vollmer, RT; Madden, J; Polascik, TJ; Snyder, DC; Ruffin, MT; Moul, JW; Brenner, D; Hardy, RW; Demark-Wahnefried, W				Azrad, Maria; Zhang, Kui; Vollmer, Robin T.; Madden, John; Polascik, Thomas J.; Snyder, Denise C.; Ruffin, Mack T.; Moul, Judd W.; Brenner, Dean; Hardy, Robert W.; Demark-Wahnefried, Wendy			Prostatic Alpha-Linolenic Acid (ALA) Is Positively Associated with Aggressive Prostate Cancer: A Relationship Which May Depend on Genetic Variation in ALA Metabolism	PLOS ONE			English	Article							FATTY-ACIDS; RISK; DIET; MEN; METAANALYSIS; EXPRESSION; VARIANTS; RECEPTOR; SUPPLEMENTATION; DESATURASE	Previous observational studies have reported associations between prostate cancer and alpha-linolenic acid (ALA). However, few investigations have been able to study this relationship prospectively and in well-controlled settings. Moreover, no studies have determined whether single nucleotide polymorphisms (SNPs) that influence ALA metabolism are associated with this common cancer. The purpose of this study was to explore associations between prostatic levels of ALA, SNPs and prostate cancer-specific biomarkers in samples collected from a previous randomized clinical trial conducted using a presurgical model and which tested the effects of flaxseed supplementation, a rich source of ALA, prior to prostatectomy (n = 134). Serum prostate-specific antigen (PSA) was determined and immunohistochemistry was used to assess tumor proliferation rate (Ki67). Prostatic ALA was determined with gas chromatography. Seven previously identified SNPs associated with delta-6 desaturase activity (rs99780, rs174537, rs174545, rs174572, rs498793, rs3834458 and rs968567) were tested for associations with prostatic ALA, PSA and Ki67. Despite consuming seven times more ALA per day, men in the flaxseed arm had similar amounts of prostatic ALA relative to men not consuming flaxseed. In unadjusted analysis, there were significant positive associations between prostatic ALA and PSA (rho = 0.191, p = 0.028) and Ki67 (rho = 0.186, p = 0.037). After adjusting for covariates (flaxseed, age, race, BMI and statin-use) the association between ALA and PSA remained (p = 0.004) but was slightly attenuated for Ki67 (p = 0.051). We did not observe associations between any of the SNPs studied and prostatic ALA; however, in models for PSA there was a significant interaction between rs498793 and ALA and for Ki67 there were significant interactions with ALA and rs99780 and rs174545. Independent and inverse associations were observed between rs174572 and Ki67. This study provides evidence that prostatic ALA, independent of the amount of ALA consumed, is positively associated with biomarkers of aggressive prostate cancer and that genetic variation may modify this relationship.	[Azrad, Maria; Hardy, Robert W.; Demark-Wahnefried, Wendy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Zhang, Kui; Vollmer, Robin T.; Madden, John] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Vollmer, Robin T.] Durham Vet Affair Med Ctr, Dept Surg Pathol & Cytopathol, Durham, NC USA; [Polascik, Thomas J.; Moul, Judd W.] Duke Univ, Med Ctr, Dept Surg, Duke Canc Inst, Durham, NC 27710 USA; [Polascik, Thomas J.; Moul, Judd W.] Duke Univ, Med Ctr, Duke Canc Inst, Duke Prostate Ctr, Durham, NC USA; [Snyder, Denise C.] Duke Univ, Med Ctr, Dept Clin Res, Durham, NC USA; [Ruffin, Mack T.; Brenner, Dean] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Brenner, Dean] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hardy, Robert W.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Duke University; Duke University; Duke University; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham	Azrad, M (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA.	maria123@uab.edu		Ruffin, Mack/0000-0001-8336-478X	National Institutes of Health [CA85740, CA07464830, M01-RR-30]; NATIONAL CANCER INSTITUTE [R25CA047888, R01CA085740] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this study was provided by the National Institutes of Health (CA85740, CA07464830, and M01-RR-30). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson WJ, 2011, CANCER PREV RES, V4, P2062, DOI 10.1158/1940-6207.CAPR-11-0298; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Carayol M, 2010, CANCER CAUSE CONTROL, V21, P347, DOI 10.1007/s10552-009-9465-1; Carey AM, 2007, INT J CANCER, V121, P520, DOI 10.1002/ijc.22715; Chan JM, 2005, J CLIN ONCOL, V23, P8152, DOI 10.1200/JCO.2005.03.1492; Chen YF, 2001, INT J CANCER, V91, P41, DOI 10.1002/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Christensen JH, 2006, BJU INT, V97, P270, DOI 10.1111/j.1464-410X.2006.05951.x; Chung CC, 2012, PROSTATE, V72, P476, DOI 10.1002/pros.21450; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; Demark-Wahnefried W, 2008, CANCER EPIDEM BIOMAR, V17, P3577, DOI 10.1158/1055-9965.EPI-08-0008; Demark-Wahnefried W, 2008, CLIN TRIALS, V5, P262, DOI 10.1177/1740774508091676; Farmer KC, 1999, CLIN THER, V21, P1074, DOI 10.1016/S0149-2918(99)80026-5; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Heymach JV, 2011, CANCER PREV RES, V4, P1590, DOI 10.1158/1940-6207.CAPR-10-0136; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Merino DM, 2011, MOL GENET METAB, V103, P171, DOI 10.1016/j.ymgme.2011.02.012; NIENDORF A, 1995, INT J CANCER, V61, P461, DOI 10.1002/ijc.2910610405; POMFRET EA, 1989, ANAL BIOCHEM, V180, P85, DOI 10.1016/0003-2697(89)90091-2; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Simon JA, 2009, AM J CLIN NUTR, V89, pS1558, DOI 10.3945/ajcn.2009.26736E; Simopoulos AP, 2010, EXP BIOL MED, V235, P785, DOI 10.1258/ebm.2010.009298; Sonn GA, 2005, PROSTATE CANCER P D, V8, P304, DOI 10.1038/sj.pcan.4500825; STASSEWOLTHUIS M, 1979, AM J CLIN NUTR, V32, P1881, DOI 10.1093/ajcn/32.9.1881; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338	34	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53104	10.1371/journal.pone.0053104	http://dx.doi.org/10.1371/journal.pone.0053104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285256	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500108
J	Larkin, JR; Zhang, F; Godfrey, L; Molostvov, G; Zehnder, D; Rabbani, N; Thornalley, PJ				Larkin, James R.; Zhang, Fang; Godfrey, Lisa; Molostvov, Guerman; Zehnder, Daniel; Rabbani, Naila; Thornalley, Paul J.			Glucose-Induced Down Regulation of Thiamine Transporters in the Kidney Proximal Tubular Epithelium Produces Thiamine Insufficiency in Diabetes	PLOS ONE			English	Article							HIGH-DOSE THIAMINE; PHOSPHATE-ESTERS; VASCULAR-DISEASE; HUMAN INTESTINE; IN-VITRO; EXPRESSION; PLASMA; FAMILY; MICROALBUMINURIA; ABSORPTION	Increased renal clearance of thiamine (vitamin B-1) occurs in experimental and clinical diabetes producing thiamine insufficiency mediated by impaired tubular re-uptake and linked to the development of diabetic nephropathy. We studied the mechanism of impaired renal re-uptake of thiamine in diabetes. Expression of thiamine transporter proteins THTR-1 and THTR-2 in normal human kidney sections examined by immunohistochemistry showed intense polarised staining of the apical, luminal membranes in proximal tubules for THTR-1 and THTR-2 of the cortex and uniform, diffuse staining throughout cells of the collecting duct for THTR-1 and THTR-2 of the medulla. Human primary proximal tubule epithelial cells were incubated with low and high glucose concentration, 5 and 26 mmol/l, respectively. In high glucose concentration there was decreased expression of THTR-1 and THTR-2 (transporter mRNA: -76% and -53% respectively, p<0.001; transporter protein -77% and -83% respectively, p<0.05), concomitant with decreased expression of transcription factor specificity protein-1. High glucose concentration also produced a 37% decrease in apical to basolateral transport of thiamine transport across cell monolayers. Intensification of glycemic control corrected increased fractional excretion of thiamine in experimental diabetes. We conclude that glucose-induced decreased expression of thiamine transporters in the tubular epithelium may mediate renal mishandling of thiamine in diabetes. This is a novel mechanism of thiamine insufficiency linked to diabetic nephropathy.	[Larkin, James R.; Zhang, Fang; Godfrey, Lisa; Molostvov, Guerman; Zehnder, Daniel; Rabbani, Naila; Thornalley, Paul J.] Univ Warwick, Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick	Thornalley, PJ (corresponding author), Univ Warwick, Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	P.J.Thornalley@warwick.ac.uk		Larkin, James/0000-0002-4169-8447; Rabbani, Naila/0000-0002-5819-2506; Thornalley, Paul/0000-0001-7659-443X	Diabetes UK; University of Warwick; British Heart Foundation	Diabetes UK(Diabetes UK); University of Warwick; British Heart Foundation(British Heart Foundation)	This study was funded by a grant from Diabetes UK to NR and PJT which provided a PhD studentship to FZ. JRL thanks the University of Warwick for a PhD studentship. It was also supported by a grant from British Heart Foundation to NR and PJT supporting a postdoctoral fellowship to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaikalakoteswari A, 2008, DIABETOLOGIA, V51, pS98; Adaikalakoteswari A, 2012, DIABETES RES CLIN PR, V95, P415, DOI 10.1016/j.diabres.2011.10.042; Ashokkumar B, 2006, AM J PHYSIOL-RENAL, V291, pF796, DOI 10.1152/ajprenal.00078.2006; Babaei-Jadidi R, 2003, DIABETES, V52, P2110, DOI 10.2337/diabetes.52.8.2110; Boulware MJ, 2003, BIOCHEM J, V376, P43, DOI 10.1042/BJ20031220; Chamberlain BR, 1996, ANN CLIN BIOCHEM, V33, P352, DOI 10.1177/000456329603300413; Dutta B, 1999, J BIOL CHEM, V274, P31925, DOI 10.1074/jbc.274.45.31925; Eudy JD, 2000, MOL GENET METAB, V71, P581, DOI 10.1006/mgme.2000.3112; Gastaldi G, 2000, KIDNEY INT, V57, P2043, DOI 10.1046/j.1523-1755.2000.00053.x; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; LUM H, 1996, J PHYSIOL PHARMACOL, V74, P787; Makino A, 2008, AM J PHYSIOL-CELL PH, V295, pC221, DOI 10.1152/ajpcell.00433.2007; Nabokina SM, 2004, AM J PHYSIOL-GASTR L, V287, pG822, DOI 10.1152/ajpgi.00234.2004; Page GLJ, 2011, INT J CLIN PRACT, V65, P684, DOI 10.1111/j.1742-1241.2011.02680.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips Aled O, 2003, Curr Diab Rep, V3, P491, DOI 10.1007/s11892-003-0013-1; Rabbani N, 2009, DIABETOLOGIA, V52, P208, DOI 10.1007/s00125-008-1224-4; Rabbani N, 2011, DIABETES OBES METAB, V13, P577, DOI 10.1111/j.1463-1326.2011.01384.x; Reidling JC, 2010, GASTROENTEROLOGY, V138, P1802, DOI 10.1053/j.gastro.2009.10.042; Reidling JC, 2003, AM J PHYSIOL-CELL PH, V285, pC633, DOI 10.1152/ajpcell.00076.2003; Reidling JC, 2002, BBA-BIOMEMBRANES, V1561, P180, DOI 10.1016/S0005-2736(02)00341-3; Rieck J, 1999, J LAB CLIN MED, V134, P238, DOI 10.1016/S0022-2143(99)90203-2; ROBINSON KA, 1995, DIABETES, V44, P1438, DOI 10.2337/diabetes.44.12.1438; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Said HM, 2004, AM J PHYSIOL-GASTR L, V286, pG491, DOI 10.1152/ajpgi.00361.2003; SANDER S, 1991, J CHROMATOGR, V558, P115, DOI 10.1016/0021-9673(91)80116-X; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; Sihag B, 2010, DIABETES OBES METAB, V12, P87; Smithline Howard A, 2012, BMC Clin Pharmacol, V12, P4, DOI 10.1186/1472-6904-12-4; Subramanian VS, 2010, AM J PHYSIOL-RENAL, V299, pF28, DOI 10.1152/ajprenal.00140.2010; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; TALLAKSEN CME, 1993, EUR J CLIN PHARMACOL, V44, P73, DOI 10.1007/BF00315284; Tasevska N, 2008, EUR J CLIN NUTR, V62, P1139, DOI 10.1038/sj.ejcn.1602829; Thornalley PJ, 2007, DIABETOLOGIA, V50, P2164, DOI 10.1007/s00125-007-0771-4; Thornalley PJ, 2011, OXID STRESS APPL BAS, P93, DOI 10.1007/978-1-60761-857-7_5; TURANO A, 1982, ANN NY ACAD SCI, V378, P91, DOI 10.1111/j.1749-6632.1982.tb31188.x	36	35	40	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53175	10.1371/journal.pone.0053175	http://dx.doi.org/10.1371/journal.pone.0053175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285265	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500118
J	Mutka, SC; Green, LH; Verderber, EL; Richards, JP; Looker, DL; Chlipala, EA; Rosenthal, GJ				Mutka, Sarah C.; Green, Lucia H.; Verderber, Evie L.; Richards, Jane P.; Looker, Doug L.; Chlipala, Elizabeth A.; Rosenthal, Gary J.			ADH IB Expression, but Not ADH III, Is Decreased in Human Lung Cancer	PLOS ONE			English	Article							S-NITROSOGLUTATHIONE REDUCTASE; ASTHMA; GSNOR	Endogenous S-nitrosothiols, including S-nitrosoglutathione (GSNO), mediate nitric oxide (NO)-based signaling, inflammatory responses, and smooth muscle function. Reduced GSNO levels have been implicated in several respiratory diseases, and inhibition of GSNO reductase, (GSNOR) the primary enzyme that metabolizes GSNO, represents a novel approach to treating inflammatory lung diseases. Recently, an association between decreased GSNOR expression and human lung cancer risk was proposed in part based on immunohistochemical staining using a polyclonal GSNOR antibody. GSNOR is an isozyme of the alcohol dehydrogenase (ADH) family, and we demonstrate that the antibody used in those studies cross reacts substantially with other ADH proteins and may not be an appropriate reagent. We evaluated human lung cancer tissue arrays using monoclonal antibodies highly specific for human GSNOR with minimal cross reactivity to other ADH proteins. We verified the presence of GSNOR in >= 85% of specimens examined, and extensive analysis of these samples demonstrated no difference in GSNOR protein expression between cancerous and normal lung tissues. Additionally, GSNOR and other ADH mRNA levels were evaluated quantitatively in lung cancer cDNA arrays by qPCR. Consistent with our immunohistochemical findings, GSNOR mRNA levels were not changed in lung cancer tissues, however the expression levels of other ADH genes were decreased. ADH IB mRNA levels were reduced (>10-fold) in 65% of the lung cancer cDNA specimens. We conclude that the previously reported results showed an incorrect association of GSNOR and human lung cancer risk, and a decrease in ADH IB, rather than GSNOR, correlates with human lung cancer.	[Mutka, Sarah C.; Green, Lucia H.; Verderber, Evie L.; Richards, Jane P.; Looker, Doug L.; Rosenthal, Gary J.] N30 Pharmaceut Inc, Boulder, CO USA; [Chlipala, Elizabeth A.] Premier Lab LLC, Longmont, CO USA		Mutka, SC (corresponding author), N30 Pharmaceut Inc, Boulder, CO USA.	sarah.mutka@n30pharma.com		Mutka, Sarah/0000-0002-9744-8439	N30 Pharmaceuticals	N30 Pharmaceuticals	All authors except Elizabeth Chlipala are or were employees of N30 Pharmaceuticals, the funder of this study. Elizabeth Chlipala (Premier Laboratory) was paid to perform the immunohistochemistry work reported in this manuscript. N30 Pharma is developing a novel class of disease modifying therapies that preserve intracellular GSNO (Snitrosoglutathione), a key regulator of organ repair, regeneration, and healing. There are no further patents, products in development or marketed products relevant to this paper to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	DANIELSSON O, 1992, P NATL ACAD SCI USA, V89, P9247, DOI 10.1073/pnas.89.19.9247; Green LS, 2012, BIOCHEMISTRY-US, V51, P2157, DOI 10.1021/bi201785u; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; Lee SP, 2006, ALCOHOL, V39, P13, DOI 10.1016/j.alcohol.2006.06.012; Marozkina NV, 2012, AM J RESP CELL MOL, V46, P63, DOI 10.1165/rcmb.2011-0147OC; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Straub AC, 2011, ARTERIOSCL THROM VAS, V31, P399, DOI 10.1161/ATVBAHA.110.215939; Sun XC, 2012, BIOORG MED CHEM LETT, V22, P2338, DOI 10.1016/j.bmcl.2012.01.047; Sun XC, 2011, BIOORG MED CHEM LETT, V21, P5849, DOI 10.1016/j.bmcl.2011.07.103; Sun XC, 2011, BIOORG MED CHEM LETT, V21, P3671, DOI 10.1016/j.bmcl.2011.04.086; Wang LS, 2010, NUCLEIC ACIDS RES, V38, pD665, DOI 10.1093/nar/gkp945; Wei W, 2011, CARCINOGENESIS, V32, P973, DOI 10.1093/carcin/bgr041; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022; Wu XL, 2010, J PHARMACOL SCI, V113, P32, DOI 10.1254/jphs.09279FP; Yang SJ, 2010, WORLD J GASTROENTERO, V16, P4210, DOI 10.3748/wjg.v16.i33.4210	16	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52995	10.1371/journal.pone.0052995	http://dx.doi.org/10.1371/journal.pone.0052995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285246	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500098
J	Rowse, AL; Naves, R; Cashman, KS; McGuire, DJ; Mbana, T; Raman, C; De Sarno, P				Rowse, Amber L.; Naves, Rodrigo; Cashman, Kevin S.; McGuire, Donald J.; Mbana, Tethia; Raman, Chander; De Sarno, Patrizia			Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-gamma Signaling	PLOS ONE			English	Article							INTERFERON-GAMMA; TH17 CELLS; DIFFERENTIAL REGULATION; EFFECTOR PHASE; T-CELLS; T(H)17; BETA; PATHWAYS; IL-17; RECEPTOR	Inhibitors of glycogen synthase kinase 3 (GSK3) are being explored as therapy for chronic inflammatory diseases. We previously demonstrated that the GSK inhibitor lithium is beneficial in experimental autoimmune encephalomyelitis (EAE), the mouse model of multiple sclerosis. In this study we report that lithium suppresses EAE induced by encephalitogenic interferon-gamma (IFN-gamma)-producing T helper (Th1) cells but not by interleukin (IL)-17-producing T helper (Th17) cells. The therapeutic activity of lithium required functional IFN-gamma-signaling, but not the receptor for type I IFN (IFNAR). Inhibitor/s of GSK3 attenuated IFN-gamma dependent activation of the transcription factor STAT1 in naive T cells as well as in encephalitogenic T cells and Th1 cells. The inhibition of STAT1 activation was associated with reduced IFN-gamma production and decreased expansion of encephalitogenic Th1 cells. Furthermore, lithium treatment induced Il27 expression within the spinal cords of mice with EAE. In contrast, such treatment of Ifngr(-)/(-) mice did not induce Il27 and was associated with lack of therapeutic response. Our study reveals a novel mechanism for the efficacy of GSK3 targeting in EAE, through the IFN-gamma-STAT1 axis that is independent IFNAR-STAT1 axis. Overall our findings set the framework for the use of GSK3 inhibitors as therapeutic agents in autoimmune neuroinflammation.	[De Sarno, Patrizia] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; [Rowse, Amber L.; Cashman, Kevin S.; McGuire, Donald J.; Raman, Chander] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Naves, Rodrigo; Mbana, Tethia; Raman, Chander] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	De Sarno, P (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	desarno@uab.edu	Naves, Rodrigo/H-4829-2014	Naves, Rodrigo/0000-0002-1203-3593; McGuire, Donald/0000-0002-3742-9594	National Institutes of Health [NS064261, AI1076562]; National Multiple Sclerosis Society Collaborative Research Center Trainee Award; UAB Animal Resources Program [G20 RR025858, G20 RR022807-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR022807, G20RR025858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076562, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society Collaborative Research Center Trainee Award; UAB Animal Resources Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health Grants NS064261 (to PD), AI1076562 (to CR) and, National Multiple Sclerosis Society Collaborative Research Center Trainee Award (to ALR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Robin Lorenz for Stat1<SUP>-</SUP>/<SUP>-</SUP> mice, Dr. John D. Mountz for Ifnar1<SUP>-</SUP>/<SUP>-</SUP> mice, Dr. Casey Weaver for IL-17F-Thy1.1 mice, and KyungHee Hong for her help. We acknowledge the UAB CAMAC Comprehensive Flow Cytometry Core (P30 AR48311) and the UAB Animal Resources Program (G20 RR025858 and G20 RR022807-01).	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Beeton Christine, 2007, J Vis Exp, P527, DOI 10.3791/527; Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2011, J IMMUNOL, V186, P1391, DOI 10.4049/jimmunol.1003511; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Dardalhon V, 2008, J AUTOIMMUN, V31, P252, DOI 10.1016/j.jaut.2008.04.017; De Sarno P, 2008, J IMMUNOL, V181, P338, DOI 10.4049/jimmunol.181.1.338; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Haak S, 2009, IMMUNOTHERAPY-UK, V1, P199, DOI 10.2217/1750743X.1.2.199; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Nylander A, 2012, J CLIN INVEST, V122, P1180, DOI 10.1172/JCI58649; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Prinz M, 2010, TRENDS MOL MED, V16, P379, DOI 10.1016/j.molmed.2010.06.001; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Tsai CJ, 2009, J NANOPART RES, V11, P1, DOI 10.1007/s11051-008-9474-0; Wang HZ, 2011, CYTOKINE, V53, P130, DOI 10.1016/j.cyto.2010.10.009; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953, 10.1371/journal.pone.0028432]	37	31	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52658	10.1371/journal.pone.0052658	http://dx.doi.org/10.1371/journal.pone.0052658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285134	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500044
J	Guo, SC; Li, YQ; Tong, Q; Gu, F; Zhu, TH; Fu, L; Yang, S				Guo, Shaocong; Li, Yaqing; Tong, Qi; Gu, Feng; Zhu, Tianhui; Fu, Li; Yang, Shuang			delta EF1 Down-Regulates ER-alpha Expression and Confers Tamoxifen Resistance in Breast Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; ENDOCRINE THERAPY RESISTANCE; TRANSCRIPTION FACTOR ZEB1; E-CADHERIN; MESENCHYMAL TRANSITION; PROTEIN DELTA-EF1; ZINC-FINGER; CELLS; GENE; MECHANISMS	Resistance to tamoxifen therapy represents a major barrier to the successful treatment of breast cancer, where a loss of or reduced ER-alpha level is considered a primary mechanism. Understanding how ER-alpha expression is regulated would provide insights into new intervention points to overcome tamoxifen resistance. In this study, we report that the expression of delta EF1 is up-regulated by 17 beta-estradiol (E2) in MCF-7 cells in an ER-alpha-dependent manner, through either PI3K or NF-kappa B pathway. Ectopic expression of delta EF1 in turn repressed ER-alpha transcription by binding to the E-2-box on the ER-alpha promoter. At the tissue level of breast cancer, there is a strong and inverse correlation between the expression levels of delta EF1 and ER-alpha. In MCF-7 cells, an elevated expression of delta EF1 made the cells less sensitive to tamoxifen treatment, whereas overexpression of ER-alpha compromised the effects of delta EF1 and restored the sensitivity. Also, depletion of delta EF1 by RNA interference in MDA-MB-231 cells restored the expression of ER-alpha and tamoxifen sensitivity. In conclusion, we have identified an important role of delta EF1 in the development of tamoxifen resistance in breast cancer. Inhibiting delta EF1 to restore ER-alpha expression might represent a potential therapeutic strategy for overcoming endocrine resistance in breast cancer.	[Guo, Shaocong; Tong, Qi; Zhu, Tianhui; Yang, Shuang] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China; [Li, Yaqing; Gu, Feng; Fu, Li] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Yang, S (corresponding author), Nankai Univ, Coll Med, Tianjin 300071, Peoples R China.	yangshuang@nankai.edu.cn			China National Nature Science Foundation [81072153, 81272184]; New Century Excellent Talents Supporting Program [NCET-11-0260]; China National Basic Research Program [2009CB521705]; Yangtze Scholar and Innovative Team Development Program [IRT0743]; Tianjin Natural Science Foundation [11JCYBJC12400]	China National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Supporting Program; China National Basic Research Program(National Basic Research Program of China); Yangtze Scholar and Innovative Team Development Program; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin)	This work is supported by grants from the China National Nature Science Foundation (No. 81072153, No. 81272184), the New Century Excellent Talents Supporting Program (No. NCET-11-0260), the China National Basic Research Program (No. 2009CB521705), the Yangtze Scholar and Innovative Team Development Program (No. IRT0743), and the Tianjin Natural Science Foundation (11JCYBJC12400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Barone I, 2010, CLIN CANCER RES, V16, P2702, DOI 10.1158/1078-0432.CCR-09-1753; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; Darling DS, 2003, GENE EXPR PATTERNS, V3, P709, DOI 10.1016/S1567-133X(03)00147-9; Dillner NB, 2002, MOL CELL ENDOCRINOL, V192, P85, DOI 10.1016/S0303-7207(02)00088-6; Dillner NB, 2002, J BIOL CHEM, V277, P33890, DOI 10.1074/jbc.M204399200; Du J, 2009, CELL RES, V19, P487, DOI 10.1038/cr.2009.34; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; FUNAHASHI J, 1991, NUCLEIC ACIDS RES, V19, P3543, DOI 10.1093/nar/19.13.3543; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gururaj AE, 2006, CLIN CANCER RES, V12, p1001S, DOI 10.1158/1078-0432.CCR-05-2110; Haddad Y, 2009, CLIN CANCER RES, V15, P532, DOI 10.1158/1078-0432.CCR-08-1733; Higashi Y, 1997, J EXP MED, V185, P1467, DOI 10.1084/jem.185.8.1467; Higgins MJ, 2011, ANNU REV MED, V62, P281, DOI 10.1146/annurev-med-070909-182545; Hu F, 2011, BBA-GENE REGUL MECH, V1809, P200, DOI 10.1016/j.bbagrm.2011.01.003; Hu F, 2010, BBA-MOL BASIS DIS, V1802, P301, DOI 10.1016/j.bbadis.2009.12.002; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Lapidus RG, 1998, CANCER RES, V58, P2515; Lorenzatti G, 2011, J CELL SCI, V124, P1752, DOI 10.1242/jcs.084194; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Sanchez CG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2833; Spoelstra NS, 2006, CANCER RES, V66, P3893, DOI 10.1158/0008-5472.CAN-05-2881; Takagi T, 1998, DEVELOPMENT, V125, P21; Terraz C, 2001, J BIOL CHEM, V276, P37011, DOI 10.1074/jbc.M104185200; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Yamamoto H, 2011, BIOL PHARM BULL, V34, P324, DOI 10.1248/bpb.34.324; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7; Yang S, 2007, J BIOMED SCI, V14, P663, DOI 10.1007/s11373-007-9155-5; Yang S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-211; Yang XW, 2001, CANCER RES, V61, P7025	41	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52380	10.1371/journal.pone.0052380	http://dx.doi.org/10.1371/journal.pone.0052380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285017	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800058
J	Buschard, K; Mansson, JE; Roep, BO; Nikolic, T				Buschard, Karsten; Mansson, Jan-Eric; Roep, Bart O.; Nikolic, Tatjana			Self-Glycolipids Modulate Dendritic Cells Changing the Cytokine Profiles of Committed Autoreactive T Cells	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; II NKT CELLS; BETA-CELLS; INSULIN EPITOPE; NOD MICE; SULFATIDE; GALACTOSYLCERAMIDE; PREVENTS; AUTOIMMUNITY; PATHOGENESIS	The impact of glycolipids of non-mammalian origin on autoimmune inflammation has become widely recognized. Here we report that the naturally occurring mammalian glycolipids, sulfatide and beta-GalCer, affect the differentiation and the quality of antigen presentation by monocyte-derived dendritic cells (DCs). In response to sulfatide and beta-GalCer, monocytes develop into immature DCs with higher expression of HLA-DR and CD86 but lower expression of CD80, CD40 and CD1a and lower production of IL-12 compared to non-modulated DCs. Self-glycolipid-modulated DCs responded to lipopolysaccharide (LPS) by changing phenotype but preserved low IL-12 production. Sulfatide, in particular, reduced the capacity of DCs to stimulate autoreactive Glutamic Acid Decarboxylase (GAD65) - specific T cell response and promoted IL-10 production by the GAD65-specific clone. Since sulfatide and beta-GalCer induced toll-like receptor (TLR)-mediated signaling, we hypothesize that self-glycolipids deliver a (tolerogenic) polarizing signal to differentiating DCs, facilitating the maintenance of self-tolerance under proinflammatory conditions.	[Buschard, Karsten] Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark; [Mansson, Jan-Eric] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Roep, Bart O.; Nikolic, Tatjana] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Rigshospitalet; University of Copenhagen; University of Gothenburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Buschard, K (corresponding author), Rigshosp, Bartholin Inst, DK-2100 Copenhagen, Denmark.	buschard@dadlnet.dk	NIkolic, Tatjana/I-2162-2012; Roep, Bart/AAD-7609-2021	Buschard, Karsten/0000-0002-0126-7423	Dutch Diabetes Research Foundation (Expert Center) [2008.40.001]; Juvenile Diabetes Research Foundation; Netherlands Organization for Scientific Research (NWO-VICI) [918.86.611]; European Union (FP7-NAIMIT) [241447]; Lundbeck Foundation; Danish Council for Independent Research \ Medical Sciences [271-06-0424]	Dutch Diabetes Research Foundation (Expert Center); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Netherlands Organization for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO)); European Union (FP7-NAIMIT); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research \ Medical Sciences(Det Frie Forskningsrad (DFF))	This work has been supported by the Dutch Diabetes Research Foundation (Expert Center Grant 2008.40.001), the Juvenile Diabetes Research Foundation, the Netherlands Organization for Scientific Research (NWO-VICI, 918.86.611), the European Union (FP7-NAIMIT, number 241447), the Lundbeck Foundation, and the Danish Council for Independent Research vertical bar Medical Sciences (number 271-06-0424). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrenberg P, 2011, GASTROENTEROLOGY, V140, P646, DOI 10.1053/j.gastro.2010.10.003; Arrenberg P, 2010, P NATL ACAD SCI USA, V107, P10984, DOI 10.1073/pnas.1000576107; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; Blomqvist M, 2009, EUR J IMMUNOL, V39, P1726, DOI 10.1002/eji.200839001; BUSCHARD K, 1991, AUTOIMMUNITY, V10, P65, DOI 10.3109/08916939108997149; BUSCHARD K, 1993, LANCET, V342, P840, DOI 10.1016/0140-6736(93)92697-R; Buschard K, 1996, APMIS, V104, P938, DOI 10.1111/j.1699-0463.1996.tb04962.x; BUSCHARD K, 1994, DIABETOLOGIA, V37, P1000; Buschard K, 2001, AUTOIMMUNITY, V34, P9, DOI 10.3109/08916930108994121; Buschard K, 1999, DIABETOLOGIA, V42, P1212, DOI 10.1007/s001250051294; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; Fredman P, 2000, GLYCOBIOLOGY, V10, P39, DOI 10.1093/glycob/10.1.39; Hiemstra HS, 2001, P NATL ACAD SCI USA, V98, P3988, DOI 10.1073/pnas.071050898; HOLLANDER PH, 1982, DIABETES, V31, P149, DOI 10.2337/diabetes.31.2.149; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Jahng AW, 2001, J EXP MED, V194, P1789, DOI 10.1084/jem.194.12.1789; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Kleijwegt FS, 2010, J IMMUNOL, V185, P1412, DOI 10.4049/jimmunol.1000560; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Mahnke K, 2002, IMMUNOL CELL BIOL, V80, P477, DOI 10.1046/j.1440-1711.2002.01115.x; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; NORTON WT, 1966, J NEUROCHEM, V13, P213, DOI 10.1111/j.1471-4159.1966.tb06794.x; Osterbye T, 2001, GLYCOBIOLOGY, V11, P473, DOI 10.1093/glycob/11.6.473; Osterbye T, 2010, DIABETES-METAB RES, V26, P656, DOI 10.1002/dmrr.1134; Roeske-Nielsen A, 2004, IMMUNOL LETT, V91, P205, DOI 10.1016/j.imlet.2003.12.010; Roeske-Nielsen A, 2010, DIABETES-METAB RES, V26, P631, DOI 10.1002/dmrr.1130; Schloot NC, 1999, J AUTOIMMUN, V12, P289, DOI 10.1006/jaut.1999.0280; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Shimada A, 1996, J AUTOIMMUN, V9, P263, DOI 10.1006/jaut.1996.0033; Subramanian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037771; SVENNERHOLM L, 1992, BIOCHIM BIOPHYS ACTA, V1128, P1, DOI 10.1016/0005-2760(92)90250-Y; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Halteren AGS, 2002, DIABETES, V51, P2119, DOI 10.2337/diabetes.51.7.2119; Wu D, 2005, P NATL ACAD SCI USA, V102, P1351, DOI 10.1073/pnas.0408696102; ZUCKERFRANKLIN D, 1983, P NATL ACAD SCI-BIOL, V80, P6977, DOI 10.1073/pnas.80.22.6977	40	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52639	10.1371/journal.pone.0052639	http://dx.doi.org/10.1371/journal.pone.0052639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285123	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500216
J	Chen, CY; Wei, RX; Qiao, RM; Ren, J; Yang, H; Liu, CL; Huang, LS				Chen, Congying; Wei, Rongxing; Qiao, Ruimin; Ren, Jun; Yang, Hui; Liu, Chenlong; Huang, Lusheng			A Genome-Wide Investigation of Expression Characteristics of Natural Antisense Transcripts in Liver and Muscle Samples of Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; SENSE; IDENTIFICATION; INTERFERENCE; METHYLATION; LOCUS; MAP	Natural antisense transcripts are endogenous transcripts that are complementary to the sense-strand of DNA. These transcripts have been identified in various eukaryotic species and are involved in a broad range of regulatory events and biological processes. However, their general biological functions, expression characteristics and regulatory mechanisms are still unclear. In this study, 497 liver and 586 muscle samples were harvested from a White DurocxErhualian F-2 resource population. The expression profiles of sense and antisense transcripts were determined by tag-based RNA sequencing. We identified 33.7% and 20.4% of transcripts having both sense and antisense expression, and 12.5% and 6.1% of transcripts only expressing antisense transcripts in liver and muscle, respectively. More than 32.2% of imprinting or predicted imprinting genes in the geneimprint database were detected with both sense and antisense expression. The correlations between sense and antisense expression in sense-antisense pairs were diverse in both liver and muscle, showing positive, negative or absent correlation. Antisense expression increases gene expression variability. More interestingly, compared to eQTL mapping of sense transcripts in which more than one eQTL was mapped for a transcript, only one eQTL was identified for each antisense transcript, and the percentage of cis-eQTL in antisense eQTL was higher than that in sense eQTL. This suggests that the expressions of antisense transcripts tend to be cis-regulated by a single genomic locus. To our knowledge, this study is the first systematical investigation of antisense transcription in pigs. The findings improve our understanding of the complexity of porcine transcriptome.	[Chen, Congying; Wei, Rongxing; Qiao, Ruimin; Ren, Jun; Yang, Hui; Liu, Chenlong; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Chen, Congying; Wei, Rongxing; Qiao, Ruimin; Ren, Jun; Yang, Hui; Liu, Chenlong; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Wei, Rongxing] Nanchang Working Canine Base, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	Lushenghuang@hotmail.com	Ren, Jun/H-9793-2019; Chen, Congying/AFU-8515-2022; Chen, Congying/ABB-7384-2021		National Natural Science Foundation of China [31160225]; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This subject was supported by the National Natural Science Foundation of China (31160225), the Jiangxi Project for Cultivating Young Scientists and Key Project for Scientific Research from the Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2011, J BIOL CHEM, V286, P45093, DOI 10.1074/jbc.M111.310250; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; BARRELL BG, 1976, NATURE, V264, P34, DOI 10.1038/264034a0; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Braunschweig MH, 2004, GENOMICS, V84, P1021, DOI 10.1016/j.ygeno.2004.09.006; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen JJ, 2005, TRENDS GENET, V21, P326, DOI 10.1016/j.tig.2005.04.006; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Gyorffy A, 2007, J GENET, V86, P103, DOI 10.1007/s12041-007-0015-x; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Holmes R, 2003, GENOME RES, V13, P1410, DOI 10.1101/gr.955503; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Kerin T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003479; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Knee R, 1997, NEUROCHEM INT, V31, P379, DOI 10.1016/S0197-0186(96)00108-8; Lavorgna G, 2004, TRENDS BIOCHEM SCI, V29, P88, DOI 10.1016/j.tibs.2003.12.002; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Li AW, 2000, MOL CELL ENDOCRINOL, V170, P231, DOI 10.1016/S0303-7207(00)00440-8; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Morrissy AS, 2011, GENOME RES, V21, P1203, DOI 10.1101/gr.113431.110; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Okada Y, 2008, HUM MOL GENET, V17, P1631, DOI 10.1093/hmg/ddn051; OKANO H, 1991, J NEUROCHEM, V56, P560, DOI 10.1111/j.1471-4159.1991.tb08186.x; Osato N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2003-5-1-r5; Peters NT, 2003, RNA, V9, P698, DOI 10.1261/rna.2120703; Poole RL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-475; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Seitz A, 2005, HUM MOL GENET, V14, P2661, DOI 10.1093/hmg/ddi296; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Span PN, 2011, ENDOCR-RELAT CANCER, V18, P323, DOI 10.1530/ERC-10-0184; Sun M, 2006, GENOME RES, V16, P922, DOI 10.1101/gr.5210006; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vanhee-Brossollet C, 1998, GENE, V211, P1, DOI 10.1016/S0378-1119(98)00093-6; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473; ZHOU BS, 1992, CANCER RES, V52, P4280	50	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52433	10.1371/journal.pone.0052433	http://dx.doi.org/10.1371/journal.pone.0052433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285040	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500167
J	Jo, YK; Kim, SC; Park, IJ; Park, SJ; Jin, DH; Hong, SW; Cho, DH; Kim, JC				Jo, Yoon Kyung; Kim, Seung Cheol; Park, In Ja; Park, So Jung; Jin, Dong-Hoon; Hong, Seung-Woo; Cho, Dong-Hyung; Kim, Jin Cheon			Increased Expression of ATG10 in Colorectal Cancer Is Associated with Lymphovascular Invasion and Lymph Node Metastasis	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; METABOLIC STRESS; GASTRIC-CANCER; BREAST-CANCER; CELL-SURVIVAL; RECTAL-CANCER; AUTOPHAGY; TUMORIGENESIS; MACROAUTOPHAGY; DISEASE	Background: Autophagy has paradoxical and complex functions in cancer development, and autophagy-related genes (ATG) are key regulators in autophagy. Until now, more than 30 different ATG proteins have been identified in yeast, and their mammalian counterparts also have been reported. Although the roles of a few ATG proteins in cancer have been characterized, the role of ATG10 is almost completely unknown. Methodology/Principal Findings: To investigate the clinicopathological role of ATG10 in colorectal cancer, we analyzed ATG10 expression in colorectal cancer tissues and cell lines. Protein expression analysis showed that ATG10 is highly increased in colorectal cancer (tissue - 18/37 cases, 48%; cell line - 8/12 cell lines, 66%). Immunohistochemical analysis with clinicopathological features indicated a strong association of the up-regulation of ATG10 with tumor lymph node metastasis (p = 0.005) and invasion (p<0.001). Moreover, both 5-year disease free survival and overall survival rates of patients bearing tumors that did not express ATG10 were significantly higher than those of patients bearing ATG10-expressing tumors (p = 0.012). Conclusion/Significance: Increased expression of ATG10 in colorectal cancer is associated with lymphovascular invasion and lymph node metastasis indicating that ATG10 may be a potential prognostic maker in colorectal cancer.	[Jo, Yoon Kyung; Park, So Jung; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch EW Med Sci, Gyeonggi Do, South Korea; [Jo, Yoon Kyung; Kim, Seung Cheol; Jin, Dong-Hoon; Hong, Seung-Woo; Kim, Jin Cheon] Asan Med Ctr, Inst Innovat Canc Res, Seoul, South Korea; [Kim, Seung Cheol; Park, In Ja; Kim, Jin Cheon] Univ Ulsan, Dept Surg, Coll Med, Seoul, South Korea; [Jin, Dong-Hoon; Hong, Seung-Woo] Univ Ulsan, Dept Oncol, Coll Med, Seoul, South Korea	Kyung Hee University; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch EW Med Sci, Gyeonggi Do, South Korea.	dhcho@khu.ac.kr; jckim@amc.seoul.kr	Park, In Ja/U-2371-2019	Park, In Ja/0000-0001-5355-3969	Center for Development and Commercialization of Anti-Cancer Therapeutics; Korean Health 21 RD Project [A062254, A102059]; Ministry of Health, Welfare and Family Affairs, Korea; Asan Institute for Life Sciences [2011-069]; Basic Science Research Program (the National Research Foundation, Korea) [2010-0009164]	Center for Development and Commercialization of Anti-Cancer Therapeutics; Korean Health 21 RD Project; Ministry of Health, Welfare and Family Affairs, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences; Basic Science Research Program (the National Research Foundation, Korea)	This work was supported by the Center for Development and Commercialization of Anti-Cancer Therapeutics and the Korean Health 21 R&D Project (A062254 and A102059, Ministry of Health, Welfare and Family Affairs, Korea), the Asan Institute for Life Sciences (2011-069), and the Basic Science Research Program (2010-0009164, the National Research Foundation, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Lee WS, 2012, HEPATO-GASTROENTEROL, V59, P1313, DOI 10.5754/hge11610; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-98; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Mantripragada KK, 2009, GENE CHROMOSOME CANC, V48, P897, DOI 10.1002/gcc.20695; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Moschos SJ, 2010, HUM PATHOL, V41, P1286, DOI 10.1016/j.humpath.2010.02.007; Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Oga A, 2001, CYTOMETRY, V46, P57, DOI 10.1002/1097-0320(20010215)46:1<57::AID-CYTO1038>3.3.CO;2-X; Okamoto Y, 2003, CANCER RES, V63, P4167; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramus SJ, 2003, CANCER RES, V63, P417; Shiraishi K, 2001, ONCOLOGY-BASEL, V60, P151, DOI 10.1159/000055313; Tedesco D, 2007, NEOPLASIA, V9, P601, DOI 10.1593/neo.07385; Tilney HS, 2007, DIS COLON RECTUM, V50, P29, DOI 10.1007/s10350-006-0744-6	30	53	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52705	10.1371/journal.pone.0052705	http://dx.doi.org/10.1371/journal.pone.0052705			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285162	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500237
J	Sanchez-Barrena, MJ; Vallis, Y; Clatworthy, MR; Doherty, GJ; Veprintsev, DB; Evans, PR; McMahon, HT				Jose Sanchez-Barrena, Maria; Vallis, Yvonne; Clatworthy, Menna R.; Doherty, Gary J.; Veprintsev, Dmitry B.; Evans, Philip R.; McMahon, Harvey T.			Bin2 Is a Membrane Sculpting N-BAR Protein That Influences Leucocyte Podosomes, Motility and Phagocytosis	PLOS ONE			English	Article							ACTIN CYTOSKELETON; MOLECULAR-GRAPHICS; ALPHA-PIX; DOMAIN; CURVATURE; DEGRADATION; INVADOPODIA; ADHESIONS; PAK	Cell motility, adhesion and phagocytosis are controlled by actin and membrane remodelling processes. Bridging integrator-2 (Bin2) also called Breast cancer-associated protein 1 (BRAP1) is a predicted N-BAR domain containing protein with unknown function that is highly expressed in leucocytic cells. In the present study we solved the structure of Bin2 BAR domain and studied its membrane binding and bending properties in vitro and in vivo. Live-cell imaging experiments showed that Bin2 is associated with actin rich structures on the plasma membrane, where it was targeted through its N-BAR domain. Pull-down experiments and immunoprecipitations showed that Bin2 C-terminus bound SH3 domain containing proteins such as Endophilin A2 and alpha-PIX. siRNA of endogenous protein led to decreased cell migration, increased phagocytosis and reduced podosome density and dynamics. In contrast, overexpression of Bin2 led to decreased phagocytosis and increased podosome density and dynamics. We conclude that Bin2 is a membrane-sculpting protein that influences podosome formation, motility and phagocytosis in leucocytes. Further understanding of this protein may be key to understand the behaviour of leucocytes under physiological and pathological conditions.	[Jose Sanchez-Barrena, Maria; Vallis, Yvonne; Doherty, Gary J.; Veprintsev, Dmitry B.; Evans, Philip R.; McMahon, Harvey T.] MRC Lab Mol Biol, Cambridge, England; [Clatworthy, Menna R.] Univ Cambridge Sch Clin Med, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England	MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	McMahon, HT (corresponding author), MRC Lab Mol Biol, Cambridge, England.	xmjose@iqfr.csic.es; hmm@mrc-lmb.cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Sanchez-Barrena, Maria Jose/E-6842-2015	Veprintsev, Dmitry B/0000-0002-3583-5409; Sanchez-Barrena, Maria Jose/0000-0002-5986-1804; Doherty, Gary/0000-0002-8158-8111	FEBS; "Ramon y Cajal" contract in Spain; Medical Research Council UK [U105178795, U105178845]; Wellcome Trust Intermediate Fellowship [WT081020]; Medical Research Council [MC_U105178795, MC_U105178845] Funding Source: researchfish; MRC [MC_U105178845, MC_U105178795] Funding Source: UKRI	FEBS; "Ramon y Cajal" contract in Spain; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Intermediate Fellowship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MJS-B was funded by a FEBS postdoctoral fellowship during her stay in Cambridge (UK) and by a "Ramon y Cajal" contract in Spain. HMM, GD, and YV were funded by the Medical Research Council UK (grant number U105178795), PRE was funded by the Medical Research Council UK (grant number U105178845). MRC was funded by a Wellcome Trust Intermediate Fellowship (WT081020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Calle Y, 2006, EUR J CELL BIOL, V85, P151, DOI 10.1016/j.ejcb.2005.09.003; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; Dovas A, 2011, CELL SIGNAL, V23, P1225, DOI 10.1016/j.cellsig.2011.02.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Gringel A, 2006, J CELL PHYSIOL, V209, P568, DOI 10.1002/jcp.20777; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Jaffer ZM, 2002, INT J BIOCHEM CELL B, V34, P713, DOI 10.1016/S1357-2725(01)00158-3; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Masuda M, 2006, EMBO J, V25, P2889, DOI 10.1038/sj.emboj.7601176; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Oikawa T, 2009, CELL ADHES MIGR, V3, P195, DOI 10.4161/cam.3.2.7510; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Wernimont SA, 2008, EUR J CELL BIOL, V87, P507, DOI 10.1016/j.ejcb.2008.01.011; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	36	29	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52401	10.1371/journal.pone.0052401	http://dx.doi.org/10.1371/journal.pone.0052401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285027	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500159
J	Knies, K; Schuster, B; Ameziane, N; Rooimans, M; Bettecken, T; de Winter, J; Schindler, D				Knies, Kerstin; Schuster, Beatrice; Ameziane, Najim; Rooimans, Martin; Bettecken, Thomas; de Winter, Johan; Schindler, Detlev			Genotyping of Fanconi Anemia Patients by Whole Exome Sequencing: Advantages and Challenges	PLOS ONE			English	Article							MUTATIONS; DIAGNOSIS; CANCER; GENE; LEUKEMIA; FANCD2	Fanconi anemia (FA) is a rare genomic instability syndrome. Disease-causing are biallelic mutations in any one of at least 15 genes encoding members of the FA/BRCA pathway of DNA-interstrand crosslink repair. Patients are diagnosed based upon phenotypical manifestationsand the diagnosis of FA is confirmed by the hypersensitivity of cells to DNA interstrand crosslinking agents. Customary molecular diagnostics has become increasingly cumbersome, time-consuming and expensive the more FA genes have been identified. We performed Whole Exome Sequencing (WES) in four FA patients in order to investigate the potential of this method for FA genotyping. In search of an optimal WES methodology we explored different enrichment and sequencing techniques. In each case we were able to identify the pathogenic mutations so that WES provided both, complementation group assignment and mutation detection in a single approach. The mutations included homozygous and heterozygous single base pair substitutions and a two-base-pair duplication in FANCJ, -D1, or -D2. Different WES strategies had no critical influence on the individual outcome. However, database errors and in particular pseudogenes impose obstacles that may prevent correct data perception and interpretation, and thus cause pitfalls. With these difficulties in mind, our results show that WES is a valuable tool for the molecular diagnosis of FA and a sufficiently safe technique, capable of engaging increasingly in competition with classical genetic approaches.	[Knies, Kerstin; Schuster, Beatrice; Schindler, Detlev] Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany; [Ameziane, Najim; Rooimans, Martin; de Winter, Johan] Vrije Univ, Dept Clin Genet, Med Ctr, Amsterdam, Netherlands; [Bettecken, Thomas] Max Planck Inst Psychiat, Ctr Appl Genotyping Munic, D-80804 Munich, Germany	University of Wurzburg; Vrije Universiteit Amsterdam; Max Planck Society	Knies, K (corresponding author), Univ Wurzburg, Dept Human Genet, D-8700 Wurzburg, Germany.	kerstin.knies@uni-wuerzburg.de; beatrice.schuster@biozentrum.uni-wuerzburg.de			German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter B. P., 1993, GENEREVIEWS; Ameziane N, 2012, ANEMIA, V2012, DOI 10.1155/2012/132856; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; CERVENKA J, 1981, PEDIATRICS, V67, P119; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182/blood-2003-06-1970; Kalb R, 2007, AM J HUM GENET, V80, P895, DOI 10.1086/517616; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Rosenberg PS, 2003, BLOOD, V101, P822, DOI 10.1182/blood-2002-05-1498; SCHINDLER D, 1987, AM J PEDIAT HEMATOL, V9, P172; SCHINDLER D, 2007, FANCONI ANEMIA PARAD, P110; SCHROEDER TM, 1964, HUMANGENETIK, V1, P194, DOI 10.1007/BF00389636; Seif AE, 2011, CANCER GENET-NY, V204, P227, DOI 10.1016/j.cancergen.2011.04.005; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vuorela M, 2011, BREAST CANCER RES TR, V130, P1003, DOI 10.1007/s10549-011-1677-x; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	25	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52648	10.1371/journal.pone.0052648	http://dx.doi.org/10.1371/journal.pone.0052648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285130	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500219
J	Powell, DJ; Schlotz, W				Powell, Daniel J.; Schlotz, Wolff			Daily Life Stress and the Cortisol Awakening Response: Testing the Anticipation Hypothesis	PLOS ONE			English	Article							COEFFICIENT ALPHA; PSYCHOSOCIAL STRESS; ASSOCIATIONS; GLUCOCORTICOIDS; COVARIANCE; SECRETION; SYMPTOMS; WEEKEND; WOMEN; RISE	The cortisol awakening response (CAR) is a distinct facet of the circadian cortisol rhythm associated with various health conditions and risk factors. It has repeatedly been suggested that the CAR could be a result of the anticipated demands of the upcoming day (stress anticipation) and could support coping with daily life stress. In a sample of 23 healthy participants CARs were assessed on two consecutive days by measures of salivary cortisol upon awakening (S1) and 30 and 45 minutes later, which were aggregated to the area under the curve increase (AUCI). Stress anticipation was assessed immediately after awakening. On the same days, daily life stress and distress were assessed six times per day based on a quasi-randomized design using handheld computers. Associations were tested by day using regression analysis and standard multilevel/mixed effects models for longitudinal data. The CAR AUCI moderated the effect of daily life stress on distress; higher CAR increases were associated with attenuated distress responses to daily life stress on both days (day 1: p = .039; day 2: p = .004) adjusted for age, gender, sleep quality, time of awakening and oral contraceptive use. Lagged-effects and redundancy models showed that this effect was not due to prior-day CAR increases but specific for same day CARs. On day 2, associations between daily life stress and distress were stronger when individuals showed a higher S1 cortisol level, but this effect was similar for S1 on day 1, and the day 2 effect of S1 became non-significant when S1 on day 1 was controlled. No associations were found between stress anticipation and CARs. Findings indicate that the CAR increase is associated with successful coping with same-day daily life stress.	[Powell, Daniel J.; Schlotz, Wolff] Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England; [Schlotz, Wolff] Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany	University of Southampton; University of Regensburg	Schlotz, W (corresponding author), Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England.	wolff.schlotz@ur.de	Schlotz, Wolff/AAI-9549-2020	Schlotz, Wolff/0000-0003-2356-7766; Powell, Daniel/0000-0003-4995-6057	School of Psychology, University of Southampton; German Research Foundation (DFG)	School of Psychology, University of Southampton; German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financially supported by the School of Psychology, University of Southampton. Publication of this work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2006, P NATL ACAD SCI USA, V103, P17058, DOI 10.1073/pnas.0605053103; Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Asparouhov T, 2009, STRUCT EQU MODELING, V16, P397, DOI 10.1080/10705510903008204; Bengtsson I, 2010, METABOLISM, V59, P1012, DOI 10.1016/j.metabol.2009.10.024; Bohmelt AH, 2005, PSYCHOSOM MED, V67, P288, DOI 10.1097/01.psy.0000157064.72831.ba; Bruehl H, 2009, PSYCHONEUROENDOCRINO, V34, P815, DOI 10.1016/j.psyneuen.2008.12.010; Bryk A. S., 1992, HIERARCHICAL LINEAR; Buchanan TW, 2004, BIOL PSYCHIAT, V56, P651, DOI 10.1016/j.biopsych.2004.08.014; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Costanzo ES, 2012, HEALTH PSYCHOL, V31, P360, DOI 10.1037/a0027018; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DeSantis AS, 2012, PSYCHONEUROENDOCRINO, V37, P1009, DOI 10.1016/j.psyneuen.2011.11.009; DRESSENDORFER RA, 1992, J STEROID BIOCHEM, V43, P683, DOI 10.1016/0960-0760(92)90294-S; Edwards S, 2003, PSYCHOSOM MED, V65, P320, DOI 10.1097/01.PSY.0000033123.70631.8E; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gouin JP, 2012, HEALTH PSYCHOL, V31, P264, DOI 10.1037/a0025536; Hedeker D., 2006, LONGITUDINAL DATA AN; Hellhammer J, 2007, PSYCHONEUROENDOCRINO, V32, P80, DOI 10.1016/j.psyneuen.2006.10.005; Henckens MJAG, 2010, J NEUROSCI, V30, P12725, DOI 10.1523/JNEUROSCI.3112-10.2010; Het S, 2007, BEHAV NEUROSCI, V121, P11, DOI 10.1037/0735-7044.121.1.11; Het S, 2012, PSYCHOSOM MED, V74, P23, DOI 10.1097/PSY.0b013e31823a4a25; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inslicht SS, 2011, BIOL PSYCHIAT, V70, P1055, DOI 10.1016/j.biopsych.2011.06.030; Kern S, 2011, PSYCHONEUROENDOCRINO, V36, P1505, DOI 10.1016/j.psyneuen.2011.04.004; Kunz-Ebrecht SR, 2004, PSYCHONEUROENDOCRINO, V29, P516, DOI 10.1016/S0306-4530(03)00072-6; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Long JS, 1997, REGRESSION MODELS CA; Mikolajczak M, 2010, PSYCHONEUROENDOCRINO, V35, P752, DOI 10.1016/j.psyneuen.2009.11.003; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Nater UM, 2008, J CLIN ENDOCR METAB, V93, P703, DOI 10.1210/jc.2007-1747; Powell D, 2009, THESIS U SOUTHAMPTON; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roberts ADL, 2004, BRIT J PSYCHIAT, V184, P136, DOI 10.1192/bjp.184.2.136; Rohleder N, 2007, PERS SOC PSYCHOL B, V33, P69, DOI 10.1177/0146167206293986; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schlotz W, 2004, PSYCHOSOM MED, V66, P207, DOI 10.1097/01.psy.0000116715.78238.56; Schlotz W., 2011, HDB RES METHODS STUD, P193; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schulz P, 1998, STRESS MEDICINE, V14, P91, DOI 10.1002/(SICI)1099-1700(199804)14:2<91::AID-SMI765>3.0.CO;2-S; Sheng YY, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00034; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Stalder T, 2010, PSYCHONEUROENDOCRINO, V35, P209, DOI 10.1016/j.psyneuen.2009.06.006; Steptoe A, 2004, INT J OBESITY, V28, P1168, DOI 10.1038/sj.ijo.0802715; Stetler C, 2004, PSYCHONEUROENDOCRINO, V29, P1250, DOI 10.1016/j.psyneuen.2004.03.003; Thorn L, 2006, PSYCHONEUROENDOCRINO, V31, P1009, DOI 10.1016/j.psyneuen.2006.05.012; Wilhelm I, 2007, PSYCHONEUROENDOCRINO, V32, P358, DOI 10.1016/j.psyneuen.2007.01.008; Wirtz PH, 2007, PSYCHONEUROENDOCRINO, V32, P430, DOI 10.1016/j.psyneuen.2007.02.006; Wolf OT, 2005, PSYCHONEUROENDOCRINO, V30, P101, DOI 10.1016/j.psyneuen.2004.05.001; Zoccola PM, 2011, PSYCHONEUROENDOCRINO, V36, P592, DOI 10.1016/j.psyneuen.2010.10.004	55	70	70	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52067	10.1371/journal.pone.0052067	http://dx.doi.org/10.1371/journal.pone.0052067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284871	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500082
J	Wu, LM; Hu, MH; Tong, XH; Han, H; Shen, N; Jin, RT; Wang, W; Zhou, GX; He, GP; Liu, YS				Wu, Li-Min; Hu, Mei-Hong; Tong, Xian-Hong; Han, Hui; Shen, Ni; Jin, Ren-Tao; Wang, Wei; Zhou, Gui-Xiang; He, Guo-Ping; Liu, Yu-Sheng			Chronic Unpredictable Stress Decreases Expression of Brain-Derived Neurotrophic Factor (BDNF) in Mouse Ovaries: Relationship to Oocytes Developmental Potential	PLOS ONE			English	Article							FOLLICULAR-FLUID; EMBRYO DEVELOPMENT; GROWTH-FACTOR; DEPRESSION; GONADOTROPIN; RECEPTOR; IMPACT; MODEL; RAT; INFERTILITY	Background: Brain-derived neurotropic factor (BDNF) was originally described in the nervous system but has been shown to be expressed in ovary tissues recently, acting as a paracrine/autocrine regulator required for developments of follicles and oocytes. Although it is generally accepted that chronic stress impairs female reproduction and decreases the expression of BDNF in limbic structures of central nervous system, which contributes to mood disorder. However, it is not known whether chronic stress affects oocytes developments, nor whether it affects expression of BDNF in ovary. Methods: Mice were randomly assigned into control group, stressed group, BDNF-treated group and BDNF-treated stressed group. The chronic unpredictable mild stress model was used to produce psychosocial stress in mice, and the model was verified by open field test and hypothalamic-pituitary-adrenal (HPA) axis activity. The methods of immunohistochemistry and western blotting were used to detect BDNF protein level and distribution. The number of retrieved oocytes, oocyte maturation, embryo cleavage and the rates of blastocyst formation after parthenogenetic activation were evaluated. Results: Chronic unpredictable stress decreased the BDNF expression in antral follicles, but didn't affect the BDNF expression in primordial, primary and secondary follicles. Chronic unpredictable stress also decreased the number of retrieved oocytes and the rate of blastocyst formation, which was rescued by exogenous BDNF treatment. Conclusion: BDNF in mouse ovaries may be related to the decreased number of retrieved oocytes and impaired oocytes developmental potential induced by chronic unpredictable stress.	[Wu, Li-Min; Hu, Mei-Hong; Tong, Xian-Hong; Shen, Ni; Jin, Ren-Tao; Zhou, Gui-Xiang; He, Guo-Ping; Liu, Yu-Sheng] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China; [Han, Hui] Anhui Coll Tradit Chinese Med, Dept Neurol, Affiliated Hosp 1, Hefei, Peoples R China; [Wang, Wei] Anhui Med Univ, Anhui Prov Hosp, Dept Endocrinol, Hefei, Peoples R China	Anhui Medical University; Anhui University of Chinese Medicine; Anhui Medical University	Wu, LM (corresponding author), Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China.	wlm@ustc.edu.cn; shengzhizhongxin@126.com	Wang, Wei/AAC-4057-2019	Wang, Wei/0000-0002-4123-8280	National Natural Science Foundation of China 20 [81000237, 81001519, 81100558]; Natural Science 2 Foundation of Anhui Provincial of China [090413262X]	National Natural Science Foundation of China 20; Natural Science 2 Foundation of Anhui Provincial of China	This research was supported by the National Natural Science Foundation of China 20 (NO. 81000237, NO. 81001519 and 1 NO. 81100558) and the Natural Science 2 Foundation of Anhui Provincial of China (NO. 090413262X).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2010, FERTIL STERIL, V93, P1394, DOI 10.1016/j.fertnstert.2009.04.007; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Boivin J, 1996, HUM REPROD, V11, P903; Boivin J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d223; Breen KM, 2007, ENDOCRINOLOGY, V148, P1882, DOI 10.1210/en.2006-0973; Chand D, 2011, GEN COMP ENDOCR, V171, P253, DOI 10.1016/j.ygcen.2011.02.022; Cousineau TM, 2007, BEST PRACT RES CL OB, V21, P293, DOI 10.1016/j.bpobgyn.2006.12.003; da Silva SJM, 2005, REPRODUCTION, V129, P423, DOI 10.1530/rep.1.00471; Delafoy L, 2006, GUT, V55, P940, DOI 10.1136/gut.2005.064063; Dorfman A, 2003, BIOL REPROD, V68, P2038, DOI 10.1095/biolreprod.102.008318; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gore AC, 2006, MOL CELL ENDOCRINOL, V256, P40, DOI 10.1016/j.mce.2006.06.002; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; Jensen T, 2001, J EXP BIOL, V204, P2087; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Larsen MH, 2010, J PSYCHIATR RES, V44, P808, DOI 10.1016/j.jpsychires.2010.01.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCUS GJ, 1990, MOL REPROD DEV, V26, P159, DOI 10.1002/mrd.1080260210; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Russo N, 2012, GYNECOL ENDOCRINOL, V28, P241, DOI 10.3109/09513590.2011.613969; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Sadeu JC, 2012, REPROD BIOMED ONLINE, V24, P174, DOI 10.1016/j.rbmo.2011.11.011; Seifer DB, 2002, J CLIN ENDOCR METAB, V87, P655, DOI 10.1210/jc.87.2.655; Shooshtary F.Z., 2009, J FAM REPROD HLTH, V3, P101; Wang X, 2011, J ASSIST REPROD GEN, V28, P1053, DOI 10.1007/s10815-011-9635-4; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wu LM, 2007, NEUROPSYCHOPHARMACOL, V32, P2500, DOI 10.1038/sj.npp.1301386; Wu LM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093468; Yu Y, 2012, HUM REPROD, V27, P2146, DOI 10.1093/humrep/des099; Zhao P, 2011, HUM REPROD, V26, P695, DOI 10.1093/humrep/deq390	34	31	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52331	10.1371/journal.pone.0052331	http://dx.doi.org/10.1371/journal.pone.0052331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284991	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500145
J	Carvalho, GMD; Brazil, RP; Saraiva, L; Quaresma, PF; Botelho, HA; Ramos, MCDF; Zenobio, APLD; Meira, PCLSE; Sanguinette, CD; Andrade, JD				de Lima Carvalho, Gustavo Mayr; Brazil, Reginaldo Pecanha; Saraiva, Lara; Quaresma, Patricia Flavia; Botelho, Helbert Antonio; das Neves Farah Ramos, Mariana Campos; Lusardo de Almeida Zenobio, Ana Paula; Lamy Serra e Meira, Paula Cavalcante; Sanguinette, Cristiani de Castilho; Andrade Filho, Jose Dilermando			Hourly Activity and Natural Infection of Sandflies (Diptera: Psychodidae) Captured from the Aphotic Zone of a Cave, Minas Gerais State, Brazil	PLOS ONE			English	Article							LUTZOMYIA-NEIVAI; PHLEBOTOMINAE; LEISHMANIA	Sandflies are holometabolous insects that are of great epidemiological importance in the neotropical region as vectors of leishmaniases. Caves are ecotopes that significantly differ from external environments and, among the insects that live or visit their internal area and adjacent environment, sandflies are commonly found. Based on this context, the objective of this work was to examine the period of activity of sandflies in the cave environment in the aphotic zone. Thus, four sandfly captures were conducted, one in each season of the year, in a cave where studies on the bioecological aspects of sandfly fauna have been conducted since 2008. In this same study, we have also noticed the presence of flagellates in some captured females. Catches were carried out for 24 hours using a Shannon trap, light bait, and cave walls were actively searched. We collected a total of 638 sandflies, representing 11 species. The most abundant species and with more intense period of activity were, in descending order: Lu. cavernicola (62%), Ev. spelunca (16%) and Ev. sallesi (14%). A total of 69 females were dissected to check for natural infection, and in five specimens we found living flagellated forms: two Ev. spelunca, two Ev. sallesi and one Sc. sordellii. This study shows that the activity of some species caught in the aphotic zone of the cave, especially Lu. cavernicola, differs from what has already been reported in previous sandfly captures, which are almost always conducted at night and during twilight. The existence of sandflies that were naturally infected with flagellates and the lack of awareness regarding the behaviour of sandflies in cave environments are strong indicators of the need for further study on this group of insects in this ecotope, as a safety measure to protect the visitors of such environment.	[de Lima Carvalho, Gustavo Mayr; Saraiva, Lara; Quaresma, Patricia Flavia; Botelho, Helbert Antonio; das Neves Farah Ramos, Mariana Campos; Lusardo de Almeida Zenobio, Ana Paula; Lamy Serra e Meira, Paula Cavalcante; Sanguinette, Cristiani de Castilho; Andrade Filho, Jose Dilermando] Ctr Pesquisas Rene Rachou Portuguese Fundacao Osw, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil; [Brazil, Reginaldo Pecanha] Inst Oswaldo Cruz Portuguese Fundacao Oswaldo Cru, Dept Fisiol & Bioquim Insetos, Rio De Janeiro, Brazil		Andrade, JD (corresponding author), Ctr Pesquisas Rene Rachou Portuguese Fundacao Osw, Grp Estudos Leishmanioses, Belo Horizonte, MG, Brazil.	jandrade@cpqrr.fiocruz.br	Quaresma, Patricia/W-3876-2019; Brazil, Reginaldo Peçanha/AAF-6777-2019; Andrade Filho, José Dilermando/B-7852-2013	Andrade Filho, José Dilermando/0000-0002-9754-8464	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-0235709]; Programa Pesquisador Mineiro (FAPEMIG) [00130-12]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Programa Pesquisador Mineiro (FAPEMIG)	Funding provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (Process: APQ-0235709);Programa Pesquisador Mineiro (FAPEMIG)-00130-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves VR, 2008, MEM I OSWALDO CRUZ, V103, P251, DOI 10.1590/S0074-02762008005000012; Alves VR, 2011, MEM I OSWALDO CRUZ, V106, P353, DOI 10.1590/S0074-02762011000300016; Bermudez H., 1991, Parassitologia (Rome), V33, P127; Brazil RP, 1999, MED VET ENTOMOL, V13, P463, DOI 10.1046/j.1365-2915.1999.00181.x; Carvalho GML, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-158; Chance ML, 1985, LEISHMANIASIS; Culver DC, 1982, CAVE LIFE EVOLUTION; Carvalho GMD, 2010, MEM I OSWALDO CRUZ, V105, P336, DOI 10.1590/S0074-02762010000300017; Fuenzalida AD, 2011, MEM I OSWALDO CRUZ, V106, P635, DOI 10.1590/S0074-02762011000500020; FORATTINI OP, 1953, ARQ FAC HIG S PUB U, V7, P158; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 2006, MEM I OSWALDO CRUZ, V101, P175, DOI 10.1590/S0074-02762006000200010; Galati Eunice A. B., 2003, Rev. Bras. entomol., V47, P283, DOI 10.1590/S0085-56262003000200017; Galati EAB, 2010, REV BRAS ENTOMOL, V54, P677, DOI 10.1590/S0085-56262010000400021; Galati Eunice A. Bianchi, 2003, Rev. Bras. entomol., V47, P455, DOI 10.1590/S0085-56262003000300016; Galati Eunice Aparecida Bianchi, 2003, Rev. Bras. entomol., V47, P63, DOI 10.1590/S0085-56262003000100010; Gontijo Célia Maria Ferreira, 2004, Rev. bras. epidemiol., V7, P338; HOLSINGER JR, 1988, BRIMLEYANA, P1; Instituto Brasileiro de Geografia e Estat o A stica (IBGE), CENS DEM; Lino CF, 2007, PROVINCIAS ESPELEOLO; POULSON TL, 1969, SCIENCE, V165, P971; Saraiva L, 2009, J MED ENTOMOL, V46, P1159, DOI 10.1603/033.046.0525; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Shannon RC, 1939, METHODS COLLECTING F; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52254	10.1371/journal.pone.0052254	http://dx.doi.org/10.1371/journal.pone.0052254			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284957	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300084
J	Soennesyn, H; Nilsen, DW; Oppedal, K; Greve, OJ; Beyer, MK; Aarsland, D				Soennesyn, Hogne; Nilsen, Dennis W.; Oppedal, Ketil; Greve, Ole Jacob; Beyer, Mona K.; Aarsland, Dag			Relationship between Orthostatic Hypotension and White Matter Hyperintensity Load in Older Patients with Mild Dementia	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; LATE-LIFE DEPRESSION; E EPSILON-4 ALLELE; LEWY BODIES; BLOOD-PRESSURE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SIGNAL HYPERINTENSITIES; CARDIOVASCULAR-DISEASE; DIAGNOSTIC-CRITERIA	Background/Objectives: White matter hyperintensities (WMH) in magnetic resonance imaging (MRI) scans of the brain, and orthostatic hypotension (OH) are both common in older people. We tested the hypothesis that OH is associated with WMH. Design: Cross-sectional study. Setting: Secondary care outpatient clinics in geriatric medicine and old age psychiatry in western Norway. Participants: 160 older patients with mild dementia, diagnosed according to standardised criteria. Measurements: OH was diagnosed according to the consensus definition, measuring blood pressure (BP) in the supine position and within 3 minutes in the standing position. MRI scans were performed according to a common protocol at three centres, and the volumes of WMH were quantified using an automated method (n = 82), followed by manual editing. WMH were also quantified using the visual Scheltens scale (n = 139). Multiple logistic regression analyses were applied, with highest vs. lowest WMH quartile as response. Results: There were no significant correlations between WMH volumes and systolic or diastolic orthostatic BP drops, and no significant correlations between Scheltens scores of WMH and systolic or diastolic BP drops. In the multivariate analyses, only APOE epsilon 4 status remained a significant predictor for WMH using the automated method (p = 0.037, OR 0.075 (0.007-0.851)), whereas only age remained a significant predictor for WMH scores (p = 0.019, OR 1.119 (1.018-1.230)). Conclusion: We found no association between OH and WMH load in a sample of older patients with mild dementia.	[Soennesyn, Hogne; Oppedal, Ketil; Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Nilsen, Dennis W.] Stavanger Univ Hosp, Dept Cardiol, Stavanger, Norway; [Nilsen, Dennis W.] Univ Bergen, Inst Med, Bergen, Norway; [Oppedal, Ketil] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway; [Greve, Ole Jacob] Stavanger Univ Hosp, Dept Radiol, Stavanger, Norway; [Beyer, Mona K.] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Soennesyn, Hogne] Stavanger Univ Hosp, MoodNet Res Grp, Stavanger, Norway; [Aarsland, Dag] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Ward Sci & Soc, Stockholm, Sweden	Stavanger University Hospital; Stavanger University Hospital; University of Bergen; Universitetet i Stavanger; Stavanger University Hospital; University of Oslo; Stavanger University Hospital; Karolinska Institutet	Soennesyn, H (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway.	hogne.soennesyn@sus.no	Nilsen, Dennis/AAM-4344-2020	Aarsland, Dag/0000-0001-6314-216X	Western Norway Regional Health Authority [911694]; MoodNet Research Group	Western Norway Regional Health Authority; MoodNet Research Group	This study was supported financially by Grant 911694 from the Western Norway Regional Health Authority (http://www.helse-vest.no/fagfolk/forskning/det-regionale-samarbeidsorganet/Sider/side.aspx), and by two grants from MoodNet Research Group (http://www.helse-bergen.no/moodnet) (grant numbers not available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; Aarsland D, 2008, DEMENT GERIATR COGN, V26, P445, DOI 10.1159/000165917; AD Oppedal K, 2012, DEMENT GERI IN PRESS; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; Andersson M, 2008, INT J GERIATR PSYCH, V23, P192, DOI 10.1002/gps.1861; Appel J, 2009, AM J NEURORADIOL, V30, P1870, DOI 10.3174/ajnr.A1693; Ballard C, 2000, ANN NY ACAD SCI, V903, P442, DOI 10.1111/j.1749-6632.2000.tb06396.x; Barber R, 1999, J NEUROL NEUROSUR PS, V67, P66, DOI 10.1136/jnnp.67.1.66; Barber R, 1999, ARCH NEUROL-CHICAGO, V56, P961, DOI 10.1001/archneur.56.8.961; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; BRUN A, 1994, J NEUROL NEUROSUR PS, V57, P416; Colloby SJ, 2011, BRIT J PSYCHIAT, V199, P404, DOI 10.1192/bjp.bp.110.090423; CONWELL Y, 1993, J AM GERIATR SOC, V41, P38, DOI 10.1111/j.1532-5415.1993.tb05945.x; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; Crisby M, 2010, CURR ALZHEIMER RES, V7, P534, DOI 10.2174/156720510792231694; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Dufouil C, 2001, NEUROLOGY, V56, P921, DOI 10.1212/WNL.56.7.921; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Firbank MJ, 2004, AM J GERIAT PSYCHIAT, V12, P606, DOI 10.1176/appi.ajgp.12.6.606; Godin O, 2008, BIOL PSYCHIAT, V63, P663, DOI 10.1016/j.biopsych.2007.09.006; Ha AD, 2011, PARKINSONISM RELAT D, V17, P625, DOI 10.1016/j.parkreldis.2011.05.020; Hajjar I, 2011, CIRCULATION, V123, P858, DOI 10.1161/CIRCULATIONAHA.110.978114; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hirono N, 2000, STROKE, V31, P1263, DOI 10.1161/01.STR.31.6.1263; Hogh P, 2007, ACTA NEUROL SCAND, V115, P248, DOI 10.1111/j.1600-0404.2006.00779.x; Holland CM, 2008, STROKE, V39, P1127, DOI 10.1161/STROKEAHA.107.497438; Hong YJ, 2011, J ALZHEIMERS DIS, V24, P519, DOI 10.3233/JAD-2011-101611; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kenny RA, 2004, J NEUROL NEUROSUR PS, V75, P966, DOI 10.1136/jnnp.2003.023812; Knopman DS, 2011, NEUROLOGY, V76, P1879, DOI 10.1212/WNL.0b013e31821d753f; Liao DP, 1997, NEUROEPIDEMIOLOGY, V16, P149, DOI 10.1159/000368814; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehrabian S, 2010, J NEUROL SCI, V299, P45, DOI 10.1016/j.jns.2010.08.056; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Passant U, 1997, INT J GERIATR PSYCH, V12, P395, DOI 10.1002/(SICI)1099-1166(199703)12:3<395::AID-GPS527>3.3.CO;2-R; Paternoster L, 2009, STROKE, V40, P2020, DOI 10.1161/STROKEAHA.108.542050; RAIHA I, 1993, ACTA NEUROL SCAND, V87, P286; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Richardson J, 2009, AM J GERIAT PSYCHIAT, V17, P996, DOI 10.1097/JGP.0b013e3181b4bf35; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; RUTAN GH, 1992, HYPERTENSION, V19, P508, DOI 10.1161/01.HYP.19.6.508; Schatz IJ, 1996, NEUROLOGY, V46, P1470, DOI 10.1212/wnl.46.5.1470; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; SCHELTENS P, 1995, NEUROLOGY, V45, P883, DOI 10.1212/WNL.45.5.883; Schmidt R, 1997, STROKE, V28, P951, DOI 10.1161/01.STR.28.5.951; Soennesyn H, 2012, DEMENT GER COGN D EX, V2, P97, DOI 10.1159/000335497; Sonnesyn H, 2009, DEMENT GERIATR COGN, V28, P307, DOI 10.1159/000247586; Teodorczuk A, 2010, PSYCHOL MED, V40, P603, DOI 10.1017/S0033291709990857; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; Verwoert GC, 2008, J AM GERIATR SOC, V56, P1816, DOI 10.1111/j.1532-5415.2008.01946.x; Vuorinen M, 2011, DEMENT GERIATR COGN, V31, P119, DOI 10.1159/000323810; Wakefield DB, 2010, J AM GERIATR SOC, V58, P275, DOI 10.1111/j.1532-5415.2009.02699.x; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171	56	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52196	10.1371/journal.pone.0052196	http://dx.doi.org/10.1371/journal.pone.0052196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284932	Green Published, gold			2022-12-25	WOS:000312694300079
J	Andrassy, M; Volz, HC; Schuessler, A; Gitsioudis, G; Hofmann, N; Laohachewin, D; Wienbrandt, AR; Kaya, Z; Bierhaus, A; Giannitsis, E; Katus, HA; Korosoglou, G				Andrassy, Martin; Volz, H. Christian; Schuessler, Alena; Gitsioudis, Gitsios; Hofmann, Nina; Laohachewin, Danai; Wienbrandt, Alexandra R.; Kaya, Ziya; Bierhaus, Angelika; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios			HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MOBILITY GROUP BOX-1; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; SMOOTH-MUSCLE-CELLS; HEART-DISEASE; HIGH-MOBILITY-GROUP-BOX-1 PROTEIN; INFLAMMATION; LESIONS; RISK; MECHANISMS	Objectives: The role of inflammation in atherosclerosis is widely appreciated. High mobility group box 1 (HMGB1), an injury-associated molecular pattern molecule acting as a mediator of inflammation, has recently been implicated in the development of atherosclerosis. In this study, we sought to investigate the association of plasma HMGB1 with coronary plaque composition in patients with suspected or known coronary artery disease (CAD). Design: HMGB1, high sensitive troponin T (hsTnT) and high sensitive C-reactive protein (hsCRP) were determined in 152 consecutive patients with suspected or known stable CAD who underwent clinically indicated 256-slice coronary computed tomography angiography (CCTA). Using CCTA, we assessed 1) coronary calcification, 2) non-calcified plaque burden and 3) the presence of vascular remodeling in areas of non-calcified plaques. Results: Using univariate analysis, hsCRP, hsTnT and HMGB1 as well as age, and atherogenic risk factors were associated with non-calcified plaque burden (r = 0.21, p = 0.009; r = 0.48, p<0.001 and r = 0.34, p<0.001, respectively). By multivariate analysis, hsTnT and HMGB1 remained independent predictors of the non-calcified plaque burden (r = 0.48, p<0.01 and r = 0.34, p<0.001, respectively), whereas a non-significant trend was noticed for hs-CRP (r = 0.21, p = 0.07). By combining hsTnT and HMGB1, a high positive predictive value for the presence of non-calcified and remodeled plaque (96% and 77%, respectively) was noted in patients within the upper tertiles for both biomarkers, which surpassed the positive predictive value of each marker separately. Conclusions: In addition to hs-TnT, a well-established cardiovascular risk marker, HMGB1 is independently associated with non-calcified plaque burden in patients with stable CAD, while the predictive value of hs-CRP is lower. Complementary value was observed for hs-TnT and HMGB1 for the prediction of complex coronary plaque.	[Andrassy, Martin; Volz, H. Christian; Schuessler, Alena; Gitsioudis, Gitsios; Hofmann, Nina; Laohachewin, Danai; Wienbrandt, Alexandra R.; Kaya, Ziya; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios] Heidelberg Univ, Dept Cardiol, D-6900 Heidelberg, Germany; [Bierhaus, Angelika] Heidelberg Univ, Dept Internal Med & Clin Chem 3, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Andrassy, M (corresponding author), Heidelberg Univ, Dept Cardiol, Bergheimer Str 58, D-6900 Heidelberg, Germany.	martin.andrassy@med.uni-heidelberg.de; gkorosoglou@hotmail.com	Gitsioudis, Gitsios/GSJ-4171-2022		Carl Baresel Stiftung; German Research Foundation [403/2-1]; German Heart Foundation [F/36/08]; European Foundation for the Study of Diabetes	Carl Baresel Stiftung; German Research Foundation(German Research Foundation (DFG)); German Heart Foundation; European Foundation for the Study of Diabetes	This study was supported by the Carl Baresel Stiftung (MA), the German Research Foundation (MA, 403/2-1), the German Heart Foundation (MA, F/36/08) and the European Foundation for the Study of Diabetes (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy M, 2011, J INTERN MED, V270, P245, DOI 10.1111/j.1365-2796.2011.02369.x; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DEFEYTER PJ, 1995, CIRCULATION, V92, P1408, DOI 10.1161/01.CIR.92.6.1408; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Hadamitzky M, 2011, CIRC-CARDIOVASC IMAG, V4, P16, DOI 10.1161/CIRCIMAGING.110.955351; Hammer-Hansen S, 2009, AM HEART J, V157, P481, DOI 10.1016/j.ahj.2008.10.011; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Heusch G, 2004, J MOL CELL CARDIOL, V37, P23, DOI 10.1016/j.yjmcc.2004.04.011; Hoffmann U, 2006, J AM COLL CARDIOL, V47, P1655, DOI 10.1016/j.jacc.2006.01.041; Hosch W, 2011, EUR J RADIOL; Inoue K, 2007, CARDIOVASC PATHOL, V16, P136, DOI 10.1016/j.carpath.2006.11.006; Ito T, 2007, J THROMB HAEMOST, V5, P109, DOI 10.1111/j.1538-7836.2006.02255.x; Jeremias A, 2005, ANN INTERN MED, V142, P786, DOI 10.7326/0003-4819-142-9-200505030-00015; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Korosoglou G, 2010, EUR RADIOL, V20, P1841, DOI 10.1007/s00330-010-1753-3; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mann J, 1999, HEART, V82, P265, DOI 10.1136/hrt.82.3.265; Motoyama S, 2007, J AM COLL CARDIOL, V50, P319, DOI 10.1016/j.jacc.2007.03.044; Motoyama S, 2009, J AM COLL CARDIOL, V54, P49, DOI 10.1016/j.jacc.2009.02.068; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pohle K, 2007, ATHEROSCLEROSIS, V190, P174, DOI 10.1016/j.atherosclerosis.2006.01.013; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Schlueter C, 2005, AM J PATHOL, V166, P1259, DOI 10.1016/S0002-9440(10)62344-9; Soro-Paavonen A, 2008, DIABETES, V57, P2461, DOI 10.2337/db07-1808; Volz HC, 2010, SEMIN THROMB HEMOST, V36, P185, DOI 10.1055/s-0030-1251503; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yamada S, 2006, CLIN CHIM ACTA, V372, P173, DOI 10.1016/j.cca.2006.04.016; Yan XX, 2009, ATHEROSCLEROSIS, V205, P544, DOI 10.1016/j.atherosclerosis.2008.12.016	43	42	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52081	10.1371/journal.pone.0052081	http://dx.doi.org/10.1371/journal.pone.0052081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284878	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900074
J	de Mulder, M; Yebra, G; Navas, A; de Jose, MI; Gurbindo, MD; Gonzalez-Tome, MI; Mellado, MJ; Saavedra-Lozano, J; Munoz-Fernandez, MA; de Ory, SJ; Ramos, JT; Holguin, A				de Mulder, Miguel; Yebra, Gonzalo; Navas, Adriana; Isabel de Jose, Maria; Dolores Gurbindo, Maria; Isabel Gonzalez-Tome, Maria; Jose Mellado, Maria; Saavedra-Lozano, Jesus; Angeles Munoz-Fernandez, Maria; Jimenez de Ory, Santiago; Tomas Ramos, Jose; Holguin, Africa		Madrid Cohort HIV Infected Childre	High Drug Resistance Prevalence among Vertically HIV-Infected Patients Transferred from Pediatric Care to Adult Units in Spain	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PERINATALLY ACQUIRED HIV; TO-CHILD-TRANSMISSION; VIROLOGICAL RESPONSE; ADOLESCENTS; IRELAND; KINGDOM; MUTATIONS; OUTCOMES; NAIVE	Background: Antiretroviral treatment (ART) has contributed to increased life expectancy of HIV-1 infected children. In developed countries, an increasing number of children reaching adulthood are transferred to adult units. The objectives were to describe the demographic and clinical features, ART history, antiviral drug resistance and drug susceptibility in HIV-1 perinatally infected adolescents transferred to adult care units in Spain from the Madrid Cohort of HIV-1 infected children. Methods: Clinical, virological and immunological features of HIV-1 vertically infected patients in the Madrid Cohort of HIV-infected children were analyzed at the time of transfer. Pol sequences from each patient were recovered before transfer. Resistance mutations according to the InternationaI AIDS Society 2011 list were identified and interpreted using the Stanford algorithm. Results were compared to the non-transferred HIV-1 infected pediatric cohort from Madrid. Results: One hundred twelve infected patients were transferred to adult units between 1997 and 2011. They were mainly perinatally infected (93.7%), with a mean nadir CD4+-T-cells count of 10% and presented moderate or severe clinical symptoms (75%). By the time of transfer, the mean age was 18.9 years, the mean CD4+T-cells count was 627.5 cells/ml, 64.2% presented more than 350 CD4+T-cells/ml and 47.3% had <= 200 RNA-copies/ml. Most (97.3%) were ART experienced receiving Highly Active ART (HAART) (84.8%). Resistance prevalence among pretreated was 50.9%, 76.9% and 36.5% for Protease Inhibitors (PI), Nucleoside Reverse Transcriptase Inhibitors (NRTI) and Non-NRTI (NNRTI), respectively. Resistance mutations were significantly higher among transferred patients compared to non-transferred for the PI+NRTI combination (19% vs. 8.4%). Triple resistance was similar to non-transferred pediatric patients (17.3% vs. 17.6%). Conclusion: Despite a good immunological and virological control before transfer, we found high levels of resistance to PI, NRTI and triple drug resistance in HIV-1 infected adolescents transferred to adult units.	[de Mulder, Miguel; Yebra, Gonzalo; Holguin, Africa] Hosp Univ Ramon & Cajal, Dept Microbiol & Parasitol, Mol Epidemiol Lab HIV 1, IRYCIS, Madrid, Spain; [Navas, Adriana] Hosp Univ Infanta Leonor, Dept Pediat, Madrid, Spain; [Isabel de Jose, Maria] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Dolores Gurbindo, Maria; Saavedra-Lozano, Jesus] Hosp Gen Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Isabel Gonzalez-Tome, Maria] Hosp Univ Doce Octubre, Dept Pediat, Madrid, Spain; [Jose Mellado, Maria] Hosp Carlos III, Dept Pediat, Madrid, Spain; [Angeles Munoz-Fernandez, Maria; Jimenez de Ory, Santiago] Hosp Gen Univ Gregorio Maranon, Mol Immunobiol Lab, Madrid, Spain; [Tomas Ramos, Jose] Hosp Univ Getafe, Dept Pediat, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Infanta Leonor; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Hospital Universitario 12 de Octubre; Hospital Carlos III; General University Gregorio Maranon Hospital; Hospital Universitario de Getafe	Holguin, A (corresponding author), Hosp Univ Ramon & Cajal, Dept Microbiol & Parasitol, Mol Epidemiol Lab HIV 1, IRYCIS, Madrid, Spain.	aholguin.hciii@salud.madrid.org	Roa, Miguel Angel/D-1088-2016; Delgado, Rafael/C-4910-2016; de Mulder Rougvie, Miguel/AAG-6224-2020; Holguín, Africa/AAF-9001-2021	Roa, Miguel Angel/0000-0003-1933-3000; Delgado, Rafael/0000-0002-6912-4736; de Mulder Rougvie, Miguel/0000-0002-8026-7076; Holguín, Africa/0000-0002-1330-8050; Munoz-Fernandez/0000-0002-0813-4500; Blazquez-Gamero, Daniel/0000-0001-6483-8329; Yebra, Gonzalo/0000-0002-3472-3667; Mellado Pena, Maria Jose/0000-0003-2251-9666	Fondo de Investigaciones Sanitarias (FIS) from Ministerio de Ciencia e Innovacion [PI09/00284, PI07/0236]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [360829/09]; Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE); Agencia Lain Entralgo	Fondo de Investigaciones Sanitarias (FIS) from Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos III); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE)(European Social Fund (ESF)); Agencia Lain Entralgo	This work was supported in part by grants from Fondo de Investigaciones Sanitarias (FIS) from Ministerio de Ciencia e Innovacion (grants PI09/00284 and PI07/0236) and from Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE, grant 360829/09). MDM is supported by PI09/00284 and PI07/0236. GY is supported by Consejeria de Educacion de la Comunidad de Madrid and Fondo Social Europeo (FSE). AH is supported by Agencia Lain Entralgo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammaranond P, 2012, FUND CLIN PHARMACOL, V26, P146, DOI 10.1111/j.1472-8206.2011.01009.x; Andiman WA, 2011, J PEDIATR-US, V159, P714, DOI 10.1016/j.jpeds.2011.06.040; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; Bain-Brickley D., 2011, COCHRANE DB SYST REV, V12; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Briz V, 2012, PEDIATR INFECT DIS J, V31, P1048, DOI 10.1097/INF.0b013e3182684d8e; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Charpentier C, 2012, AIDS RES HUM RETROV, V28, P87, DOI [10.1089/aid.2011.0035, 10.1089/AID.2011.0035]; de Mulder M, 2012, PEDIATR INFECT DIS J, V31, pE213, DOI 10.1097/INF.0b013e3182678c7c; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Descamps D, 2010, J ANTIMICROB CHEMOTH, V65, P2620, DOI 10.1093/jac/dkq380; Ding H, 2009, ARCH PEDIAT ADOL MED, V163, P1100, DOI 10.1001/archpediatrics.2009.204; Dollfus C, 2010, CLIN INFECT DIS, V51, P214, DOI 10.1086/653674; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Fernandez-Ibieta M, 2007, An Pediatr (Barc), V67, P109; Foster C, 2010, EXPERT REV ANTI-INFE, V8, P1403, DOI 10.1586/ERI.10.129; Foster C, 2009, AIDS PATIENT CARE ST, V23, P159, DOI 10.1089/apc.2008.0153; Frange P, 2010, AIDS, V24, P1771, DOI 10.1097/QAD.0b013e32833a0993; Garcia-Merino I, 2010, AIDS RES HUM RETROV, V26, P241, DOI 10.1089/aid.2009.0122; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Germanaud D, 2010, J ANTIMICROB CHEMOTH, V65, P118, DOI 10.1093/jac/dkp412; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gordon DE, 2012, PAEDIATR PERINAT EP, V26, P131, DOI 10.1111/j.1365-3016.2011.01243.x; Guillen S, 2012, ENFERM INFEC MICR CL, V30, P131, DOI 10.1016/j.eimc.2011.09.007; Holguin A, 2008, J MED VIROL, V80, P383, DOI 10.1002/jmv.21105; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Judd A, 2009, HIV MED, V10, P253, DOI 10.1111/j.1468-1293.2008.00676.x; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kapogiannis BG, 2011, CLIN INFECT DIS, V53, P1024, DOI 10.1093/cid/cir641; Karchava M, 2006, JAIDS-J ACQ IMM DEF, V42, P614, DOI 10.1097/01.qai.0000225871.87456.e7; Kenny J, 2012, HIV MED, V13, P304, DOI 10.1111/j.1468-1293.2011.00967.x; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Nglazi MD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-21; Palladino C, 2008, AIDS, V22, P2199, DOI 10.1097/QAD.0b013e328310fa96; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Rutstein RM, 2005, MED CARE, V43, P15; Saavedra-Lozano J, 2011, 18 C RETR OPP INF FE; Schmid J, 2005, SCAND J INFECT DIS, V37, P344, DOI 10.1080/00365540510031700; SINIVIH, 2011, AR VIG VIH COND RIES; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; US Public Health Service Task Force, REC US ANT DRUGS PRE; van Rossum AMC, 2002, LANCET INFECT DIS, V2, P93, DOI 10.1016/S1473-3099(02)00183-4; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; World Health Organization (WHO), 2011, EP UPD HLTH SECT PRO; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11	46	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52155	10.1371/journal.pone.0052155	http://dx.doi.org/10.1371/journal.pone.0052155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284913	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000312435900081
J	Brown, A; Turner, L; Christoffersen, S; Andrews, KA; Szestak, T; Zhao, YG; Larsen, S; Craig, AG; Higgins, MK				Brown, Alan; Turner, Louise; Christoffersen, Stig; Andrews, Katrina A.; Szestak, Tadge; Zhao, Yuguang; Larsen, Sine; Craig, Alister G.; Higgins, Matthew K.			Molecular Architecture of a Complex between an Adhesion Protein from the Malaria Parasite and Intracellular Adhesion Molecule 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; CHONDROITIN-SULFATE; STRUCTURAL BASIS; BINDING DOMAIN; PLASMODIUM; ICAM-1; RECEPTOR; VARIANT; DIMERIZATION; PFEMP1	The adhesion of Plasmodium falciparum-infected erythrocytes to human tissues or endothelium is central to the pathology caused by the parasite during malaria. It contributes to the avoidance of parasite clearance by the spleen and to the specific pathologies of cerebral and placental malaria. The PfEMP1 family of adhesive proteins is responsible for this sequestration by mediating interactions with diverse human ligands. In addition, as the primary targets of acquired, protective immunity, the PfEMP1s are potential vaccine candidates. PfEMP1s contain large extracellular ectodomains made from CIDR (cysteine-rich interdomain regions) and DBL (Duffy-binding-like) domains and show extensive variation in sequence, size, and domain organization. Here we use biophysical methods to characterize the entire similar to 300-kDa ectodomain from IT4VAR13, a protein that interacts with the host receptor, intercellular adhesion molecule-1 (ICAM-1). We show through small angle x-ray scattering that IT4VAR13 is rigid, elongated, and monomeric. We also show that it interacts with ICAM-1 through the DBL beta domain alone, forming a 1: 1 complex. These studies provide a first low resolution structural view of a PfEMP1 ectodomain in complex with its ligand. They show that it combines a modular domain arrangement consisting of individual ligand binding domains, with a defined higher order architecture that exposes the ICAM-1 binding surface to allow adhesion.	[Brown, Alan; Andrews, Katrina A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Turner, Louise; Christoffersen, Stig] Univ Copenhagen, Ctr Mol Parasitol, DK-221014 Copenhagen, Denmark; [Christoffersen, Stig; Larsen, Sine] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Szestak, Tadge; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Zhao, Yuguang] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Cambridge; University of Copenhagen; University of Copenhagen; Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; University of Oxford	Higgins, MK (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	matthew.higgins@bioch.ox.ac.uk	Brown, Alan/I-1473-2019; Larsen, Sine/A-4487-2017	Brown, Alan/0000-0002-0021-0476; Larsen, Sine/0000-0003-3848-1789; Turner, Louise/0000-0003-4494-2289; Craig, Alister/0000-0003-0914-6164; Higgins, Matthew/0000-0002-2870-1955	Wellcome Trust [087692/Z/08/Z]; University of Copenhagen Program of Excellence	Wellcome Trust(Wellcome TrustEuropean Commission); University of Copenhagen Program of Excellence	This work was supported by Wellcome Trust Grant 087692/Z/08/Z and the University of Copenhagen Program of Excellence.	Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BERENDT AR, 1992, CELL, V68, P71, DOI 10.1016/0092-8674(92)90207-S; Bernado P, 2010, EUR BIOPHYS J BIOPHY, V39, P769, DOI 10.1007/s00249-009-0549-3; Bertonati C, 2007, PROTEINS, V69, P215, DOI 10.1002/prot.21691; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; CASASNOVAS JM, 1995, J BIOL CHEM, V270, P13216, DOI 10.1074/jbc.270.22.13216; Chattopadhyay R, 2004, MOL BIOCHEM PARASIT, V133, P255, DOI 10.1016/j.molbiopara.2003.08.014; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Clausen TM, 2012, J BIOL CHEM, V287, P23332, DOI 10.1074/jbc.M112.348839; Duffy Patrick E., 2001, Trends in Parasitology, V17, P354, DOI 10.1016/S1471-4922(01)02022-0; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gamain B, 2002, P NATL ACAD SCI USA, V99, P10020, DOI 10.1073/pnas.152321599; Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; GRUENBERG J, 1983, J CELL BIOL, V97, P795, DOI 10.1083/jcb.97.3.795; Guinier A., 1955, SMALL ANGLE SCATTERI; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Hughes KR, 2010, MOL BIOCHEM PARASIT, V169, P71, DOI 10.1016/j.molbiopara.2009.09.007; Janes JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002032; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; Ochola LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014741; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Owens RM, 2010, J BIOL CHEM, V285, P15906, DOI 10.1074/jbc.M110.104349; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; Porod G., 1982, GEN THEORY SMALL ANG; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Singh K, 2008, NAT STRUCT MOL BIOL, V15, P932, DOI 10.1038/nsmb.1479; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Springer AL, 2004, MOL BIOCHEM PARASIT, V137, P55, DOI 10.1016/j.molbiopara.2004.03.019; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xiao CA, 2005, STRUCTURE, V13, P1019, DOI 10.1016/j.str.2005.04.011; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	60	33	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5992	6003		10.1074/jbc.M112.416347	http://dx.doi.org/10.1074/jbc.M112.416347			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297413	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000315342500067
J	Hosokawa, H; Dip, PV; Merkulova, M; Bakulina, A; Zhuang, ZJ; Khatri, A; Jian, XY; Keating, SM; Bueler, SA; Rubinstein, JL; Randazzo, PA; Ausiello, DA; Gruber, G; Marshansky, V				Hosokawa, Hiroyuki; Dip, Phat Vinh; Merkulova, Maria; Bakulina, Anastasia; Zhuang, Zhenjie; Khatri, Ashok; Jian, Xiaoying; Keating, Shawn M.; Bueler, Stephanie A.; Rubinstein, John L.; Randazzo, Paul A.; Ausiello, Dennis A.; Grueber, Gerhard; Marshansky, Vladimir			The N Termini of a-Subunit Isoforms Are Involved in Signaling between Vacuolar H+-ATPase (V-ATPase) and Cytohesin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; EXCHANGE FACTOR ARNO; NUCLEOTIDE EXCHANGE; VESICULAR TRAFFICKING; ARF ACTIVATION; PH; A2-SUBUNIT; RECEPTOR; DOMAINS	Previously, we reported an acidification-dependent interaction of the endosomal vacuolar H+-ATPase (V-ATPase) with cytohesin-2, a GDP/GTP exchange factor (GEF), suggesting that it functions as a pH-sensing receptor. Here, we have studied the molecular mechanism of signaling between the V-ATPase, cytohesin-2, and Arf GTP-binding proteins. We found that part of the N-terminal cytosolic tail of the V-ATPase a2-subunit (a2N), corresponding to its first 17 amino acids (a2N(1-17)), potently modulates the enzymatic GDP/GTP exchange activity of cytohesin-2. Moreover, this peptide strongly inhibits GEF activity via direct interaction with the Sec7 domain of cytohesin-2. The structure of a2N(1-17) and its amino acids Phe(5), Met(10), and Gln(14) involved in interaction with Sec7 domain were determined by NMR spectroscopy analysis. In silico docking experiments revealed that part of the V-ATPase formed by its a2N(1-17) epitope competes with the switch 2 region of Arf1 and Arf6 for binding to the Sec7 domain of cytohesin-2. The amino acid sequence alignment and GEF activity studies also uncovered the conserved character of signaling between all four (a1-a4) a-subunit isoforms of mammalian V-ATPase and cytohesin-2. Moreover, the conserved character of this phenomenon was also confirmed in experiments showing binding of mammalian cytohesin-2 to the intact yeast V-ATPase holo-complex. Thus, here we have uncovered an evolutionarily conserved function of the V-ATPase as a novel cytohesin-signaling receptor.	[Hosokawa, Hiroyuki; Merkulova, Maria; Zhuang, Zhenjie; Ausiello, Dennis A.; Marshansky, Vladimir] Massachusetts Gen Hosp, Simches Res Ctr, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA; [Hosokawa, Hiroyuki; Merkulova, Maria; Zhuang, Zhenjie; Ausiello, Dennis A.; Marshansky, Vladimir] Massachusetts Gen Hosp, Simches Res Ctr, Div Nephrol, Boston, MA 02114 USA; [Ausiello, Dennis A.; Marshansky, Vladimir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Dip, Phat Vinh; Grueber, Gerhard] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 637551, Singapore; [Bakulina, Anastasia] State Res Ctr Virol & Biotechnol VECTOR, Koltsov 630559, Novosibirsk Reg, Russia; [Khatri, Ashok] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Khatri, Ashok] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Jian, Xiaoying; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Keating, Shawn M.; Bueler, Stephanie A.; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Keating, Shawn M.; Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; State Research Center of Virology & Biotechnology VECTOR; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Marshansky, V (corresponding author), Massachusetts Gen Hosp, Simches Res Ctr, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA.	Marshansky.Vladimir@mgh.harvard.edu	Marshansky, Vladimir/AAZ-7890-2020; Bakulina, Anastasia/A-6215-2014; Dip, Phat Vinh/AAA-2730-2022; Dip, Phat Vinh/D-1288-2019	Dip, Phat Vinh/0000-0002-1535-9644; Dip, Phat Vinh/0000-0002-1535-9644; Zhuang, Zhenjie/0000-0002-3688-1669; Rubinstein, John/0000-0003-0566-2209	National Institutes of Health Grant [DK038452, DK57521]; Boston Area Diabetes Endocrinology Research Center Grant [DK057521-08]; National Institutes of Health Intramural Program of NCI; Canadian Institutes of Health Research Grant [MOP 81294]; A*STAR Biomedical Research Council Grant [09/1/22/19/609]; Center for the Study of Inflammatory Bowel Disease [DK43351]; Singapore International Graduate Award (SINGA) [20092010S10303]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038452, P30DK043351, P30DK057521] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes Endocrinology Research Center Grant; National Institutes of Health Intramural Program of NCI; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); A*STAR Biomedical Research Council Grant(Agency for Science Technology & Research (A*STAR)); Center for the Study of Inflammatory Bowel Disease; Singapore International Graduate Award (SINGA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK038452. This work was also supported by Boston Area Diabetes Endocrinology Research Center Grant DK057521-08 (to V. M.).; Recipient of a Singapore International Graduate Award (SINGA, 20092010S10303).; Supported by the National Institutes of Health Intramural Program of NCI.; Supported by Canadian Institutes of Health Research Grant MOP 81294.; Supported by A*STAR Biomedical Research Council Grant 09/1/22/19/609.; We thank Dr. Dennis Brown for critical reading and constructive suggestions during the preparation of this manuscript. We are grateful to Dr. Masamitsu Futai and Dr. James Casanova for providing cDNA encoding V-ATPase a2-isoform and cytohesin-2, respectively. We are also grateful to Dr. Sylvain Bourgoin for the generous gift of SecinH3 inhibitor. The Microscopy Core Facility of the Program in Membrane Biology received additional support from National Institutes of Health Grant DK57521 to BADERC and Grant DK43351 to Center for the Study of Inflammatory Bowel Disease.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Beaman K, 1996, AM J REPROD IMMUNOL, V35, P338; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Bill A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041179; Bill A, 2010, CELL, V143, P201, DOI 10.1016/j.cell.2010.09.011; Boger CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002989; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dip PV, 2012, J BIOENERG BIOMEMBR, V44, P341, DOI 10.1007/s10863-012-9442-3; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; FIELDS C G, 1991, Peptide Research, V4, P95; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Goddard T. D., 1997, SPARKY VERSION 3 110; Gruber G, 2008, BIOESSAYS, V30, P1096, DOI 10.1002/bies.20827; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hafner M, 2008, NAT PROTOC, V3, P579, DOI 10.1038/nprot.2008.15; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jackson C, 2006, NATURE, V444, P833, DOI 10.1038/444833a; KING DS, 1990, INT J PEPT PROT RES, V36, P255; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; LEE CK, 1990, MOL IMMUNOL, V27, P1137; Liu Z, 2011, ENDOCRINOLOGY, V152, P1222, DOI 10.1210/en.2010-1034; Macia E, 2000, BIOCHEMISTRY-US, V39, P5893, DOI 10.1021/bi992795w; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Merkulova M, 2011, AM J PHYSIOL-CELL PH, V300, pC1442, DOI 10.1152/ajpcell.00076.2010; Merkulova M, 2010, PROTEIN SCI, V19, P1850, DOI 10.1002/pro.470; Merkulova M, 2010, BBA-BIOENERGETICS, V1797, P1398, DOI 10.1016/j.bbabio.2010.02.009; Montagnac G, 2011, CURR BIOL, V21, P574, DOI 10.1016/j.cub.2011.02.034; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; NICHOLS TC, 1994, CELL IMMUNOL, V155, P219, DOI 10.1006/cimm.1994.1114; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ntrivalas E, 2010, J REPROD IMMUNOL, V85, P106, DOI 10.1016/j.jri.2009.10.010; Panchapakesan U, 2011, CLIN EXP PHARMACOL P, V38, P84, DOI 10.1111/j.1440-1681.2010.05472.x; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Randazzo P A, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.59.re1; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rishikesan S, 2008, MOL MEMBR BIOL, V25, P400, DOI 10.1080/09687680802183434; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Santy LC, 1999, CURR BIOL, V9, P1173, DOI 10.1016/S0960-9822(00)80019-6; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Smith AB, 2000, ORG LETT, V2, P1; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Thaker YR, 2009, FEBS LETT, V583, P1090, DOI 10.1016/j.febslet.2009.03.013; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Viaud J, 2007, P NATL ACAD SCI USA, V104, P10370, DOI 10.1073/pnas.0700773104; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P146; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	68	33	34	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5896	5913		10.1074/jbc.M112.409169	http://dx.doi.org/10.1074/jbc.M112.409169			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288846	hybrid, Green Published			2022-12-25	WOS:000315342500059
J	Nguyen, TTN; Kim, YM; Kim, TD; Le, OTT; Kim, JJ; Kang, HC; Hasegawa, H; Kanaho, Y; Jou, I; Lee, SY				Tu Thi Ngoc Nguyen; Kim, Yong Min; Kim, T. Doohun; Oanh Thi Tu Le; Kim, Jae Jin; Kang, Ho Chul; Hasegawa, Hiroshi; Kanaho, Yasunori; Jou, Ilo; Lee, Sang Yoon			Phosphatidylinositol 4-Phosphate 5-Kinase alpha Facilitates Toll-like Receptor 4-mediated Microglial Inflammation through Regulation of the Toll/Interleukin-1 Receptor Domain-containing Adaptor Protein (TIRAP) Location	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; ALZHEIMERS-DISEASE; IMMUNE-RESPONSES; MURINE MICROGLIA; INNATE IMMUNITY; NADPH OXIDASE; TOLL-LIKE-RECEPTOR-4; BRAIN; LIPOPOLYSACCHARIDE	Phosphatidylinositol (PI) 4,5-bisphosphate (PIP2), generated by PI 4-phosphate 5-kinase (PIP5K), regulates many critical cellular events. PIP2 is also known to mediate plasma membrane localization of the Toll/IL-1 receptor domain-containing adaptor protein (TIRAP), required for the MyD88-dependent Toll-like receptor (TLR) 4 signaling pathway. Microglia are the primary immune competent cells in brain tissue, and TLR4 is important for microglial activation. However, a functional role for PIP5K and PIP2 in TLR4-dependent microglial activation remains unclear. Here, we knocked down PIP5K alpha, a PIP5K isoform, in a BV2 microglial cell line using stable expression of lentiviral shRNA constructs or siRNA transfection. PIP5K alpha knockdown significantly suppressed induction of inflammatory mediators, including IL-6, IL-1 beta, and nitric oxide, by lipopolysaccharide. PIP5K alpha knockdown also attenuated signaling events downstream of TLR4 activation, including p38 MAPK and JNK phosphorylation, NF-kappa B p65 nuclear translocation, and I kappa B-alpha degradation. Complementation of the PIP5K alpha knockdown cells with wild type but not kinase-dead PIP5K alpha effectively restored the LPS-mediated inflammatory response. Wefound that PIP5K alpha and TIRAP colocalized at the cell surface and interacted with each other, whereas kinase-dead PIP5K alpha rendered TIRAP soluble. Furthermore, in LPS-stimulated con- trol cells, plasma membrane PIP2 increased and subsequently declined, and TIRAP underwent bi-directional translocation between the membrane and cytosol, which temporally correlated with the changes in PIP2. In contrast, PIP5K alpha knockdown that reduced PIP2 levels disrupted TIRAP membrane targeting by LPS. Together, our results suggest that PIP5K alpha promotes TLR4-associated microglial inflammation by mediating PIP2-dependent recruitment of TIRAP to the plasma membrane.	[Tu Thi Ngoc Nguyen; Kim, Yong Min; Oanh Thi Tu Le; Jou, Ilo; Lee, Sang Yoon] Ajou Univ, Neurosci Grad Program, Chron Inflammatory Dis Res Ctr, Suwon 443721, Gyeonggi, South Korea; [Jou, Ilo] Ajou Univ, Dept Pharmacol, Suwon 443721, Gyeonggi, South Korea; [Kim, Jae Jin; Kang, Ho Chul] Ajou Univ, Dept Physiol, Sch Med, Suwon 443721, Gyeonggi, South Korea; [Kim, T. Doohun] Ajou Univ, Dept Mol Sci & Technol, Grad Sch Interdisciplinary Programs, Suwon 443721, Gyeonggi, South Korea; [Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Dept Physiol Chem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058571, Japan; [Hasegawa, Hiroshi; Kanaho, Yasunori] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058571, Japan	Ajou University; Ajou University; Ajou University; Ajou University; University of Tsukuba; University of Tsukuba	Lee, SY (corresponding author), Ajou Univ, Sch Med, Chron Inflammatory Dis Res Ctr, San 5, Suwon 443721, Gyeonggi, South Korea.	sangyoon@ajou.ac.kr	kim, doohun/AAC-4528-2019		Basic Science Research Program through the National Research Foundation of Korea [2011-0013962]; Ministry of Education, Science, and Technology from Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University [2012048183]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology from Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University	This work was supported by Research Grant 2011-0013962 from Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (to S. Y. L.) and Grant 2012048183 from Korea Science and Engineering Foundation through the Chronic Inflammatory Disease Research Center at Ajou University.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Balla T, 2005, J CELL SCI, V118, P2093, DOI 10.1242/jcs.02387; Barbieri MA, 2001, J BIOL CHEM, V276, P47212, DOI 10.1074/jbc.C100490200; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jin JJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-23; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanaho Y, 2007, BIOL PHARM BULL, V30, P1605, DOI 10.1248/bpb.30.1605; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lee SY, 2010, NEUROCHEM INT, V57, P600, DOI 10.1016/j.neuint.2010.07.008; Lehnardt S, 2008, J NEUROSCI, V28, P2320, DOI 10.1523/JNEUROSCI.4760-07.2008; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Lund S, 2006, J NEUROIMMUNOL, V180, P71, DOI 10.1016/j.jneuroim.2006.07.007; Marek LR, 2012, IMMUNITY, V36, P612, DOI 10.1016/j.immuni.2012.01.019; Min KJ, 2004, GLIA, V48, P197, DOI 10.1002/glia.20069; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; O'Neill LAJ, 2003, J ENDOTOXIN RES, V9, P55, DOI 10.1179/096805103125001351; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Payrastre B, 2001, CELL SIGNAL, V13, P377, DOI 10.1016/S0898-6568(01)00158-9; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Quinn KV, 2008, J PHYSIOL-LONDON, V586, P2855, DOI 10.1113/jphysiol.2008.153791; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vicinanza M, 2008, CELL MOL LIFE SCI, V65, P2833, DOI 10.1007/s00018-008-8353-2; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; Weernink PAO, 2004, J BIOL CHEM, V279, P7840, DOI 10.1074/jbc.M312737200; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yang MS, 2007, J NEUROSCI RES, V85, P2298, DOI 10.1002/jnr.21254; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	60	36	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5645	5659		10.1074/jbc.M112.410126	http://dx.doi.org/10.1074/jbc.M112.410126			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297396	hybrid, Green Published			2022-12-25	WOS:000315342500038
J	Zhou, RF; Tomkovicz, VR; Butler, PL; Ochoa, LA; Peterson, ZJ; Snyder, PM				Zhou, Ruifeng; Tomkovicz, Vivian R.; Butler, Phillip L.; Ochoa, Luis A.; Peterson, Zerubbabel J.; Snyder, Peter M.			Ubiquitin-specific Peptidase 8 (USP8) Regulates Endosomal Trafficking of the Epithelial Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; LIDDLES-SYNDROME; MEDIATED DEUBIQUITINATION; FUNCTIONAL REGULATION; PROTEOLYTIC CLEAVAGE; SURFACE EXPRESSION; MEMBRANE-PROTEINS; LIGASE NEDD4-2; ENAC; DEUBIQUITYLATION	Ubiquitination plays a key role in trafficking of the epithelial Na+ channel (ENaC). Previous work indicated that ubiquitination enhances ENaC endocytosis and sorting to lysosomes for degradation. Moreover, a defect in ubiquitination causes Liddle syndrome, an inherited form of hypertension. In this work, we identified a role for USP8 in the control of ENaC ubiquitination and trafficking. USP8 increased ENaC current in Xenopus oocytes and collecting duct epithelia and enhanced ENaC abundance at the cell surface in HEK 293 cells. This resulted from altered endocytic sorting; USP8 abolished ENaC degradation in the endocytic pathway, but it had no effect on ENaC endocytosis. USP8 interacted with ENaC, as detected by co-immunoprecipitation, and it deubiquitinated ENaC. Consistent with a functional role for deubiquitination, mutation of the cytoplasmic lysines of ENaC reduced the effect of USP8 on ENaC cell surface abundance. In contrast to USP8, USP2-45 increased ENaC surface abundance by reducing endocytosis but not degradation. Thus, USP8 and USP2-45 selectively modulate ENaC trafficking at different steps in the endocytic pathway. Together with previous work, the data indicate that the ubiquitination state of ENaC is critical for the regulation of epithelial Na+ absorption.	[Zhou, Ruifeng; Tomkovicz, Vivian R.; Butler, Phillip L.; Peterson, Zerubbabel J.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zhou, Ruifeng; Tomkovicz, Vivian R.; Butler, Phillip L.; Peterson, Zerubbabel J.; Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Ochoa, Luis A.] Univ Iowa, Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu		Ochoa Nunez, Luis/0000-0002-6156-610X	National Institutes of Health [HL058812, HL072256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL058812, R01HL072256, R01HL058812] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL058812 and HL072256 (to P. M. S.).	Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BOUCHER RC, 1988, J PHYSIOL-LONDON, V405, P77, DOI 10.1113/jphysiol.1988.sp017322; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Goulet CC, 1998, J BIOL CHEM, V273, P30012, DOI 10.1074/jbc.273.45.30012; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ruffieux-Daidie D, 2008, J AM SOC NEPHROL, V19, P2170, DOI 10.1681/ASN.2007101130; Ruffieux-Daidie D, 2011, J BIOL CHEM, V286, P2416, DOI 10.1074/jbc.M110.176156; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Whelton PK, 2011, JAMA-J AM MED ASSOC, V306, P2262, DOI 10.1001/jama.2011.1746; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	41	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5389	5397		10.1074/jbc.M112.425272	http://dx.doi.org/10.1074/jbc.M112.425272			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297398	Green Published, hybrid			2022-12-25	WOS:000315342500014
J	Chambers, KT; Chen, ZJ; Crawford, PA; Fu, XR; Burgess, SC; Lai, L; Leone, TC; Kelly, DP; Finck, BN				Chambers, Kari T.; Chen, Zhouji; Crawford, Peter A.; Fu, Xiaorong; Burgess, Shawn C.; Lai, Ling; Leone, Teresa C.; Kelly, Daniel P.; Finck, Brian N.			Liver-Specific PGC-1beta Deficiency Leads to Impaired Mitochondrial Function and Lipogenic Response to Fasting-Refeeding	PLOS ONE			English	Article							FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR; HEPATIC GLUCONEOGENESIS; INSULIN-RESISTANCE; ADAPTIVE THERMOGENESIS; INDUCIBLE COACTIVATOR; ENERGY-METABOLISM; LIPID-METABOLISM; RECEPTOR-ALPHA; MICE	PGC-1 beta plays pleiotropic roles in regulating intermediary metabolism and has been shown to regulate both catabolic and anabolic processes in liver. We sought to evaluate the effects of PGC-1 beta on liver energy metabolism by generating mice with postnatal, liver-specific deletion of PGC-1 beta (LS-PGC-1 beta(-)/(-) mice). LS-PGC-1 beta(-)/(-) mice were outwardly normal, but exhibited a significant increase in hepatic triglyceride content at 6 weeks of age. Hepatic steatosis was due, at least in part, to impaired capacity for fatty acid oxidation and marked mitochondrial dysfunction. Mitochondrial DNA content and the expression of genes encoding multiple steps in mitochondrial fatty acid oxidation and oxidative phosphorylation pathways were significantly diminished in LS-PGC-1 beta(-/-) mice. Liquid chromatography mass spectrometry-based analyses also revealed that acetylcarnitine and butyrylcarnitine levels were depleted whereas palmitoylcarnitine content was increased in LS-PGC-1 beta(-/-) liver, which is consistent with attenuated rates of fatty acid oxidation. Interestingly, loss of PGC-1 beta also significantly impaired inducible expression of glycolytic and lipogenic enzymes that occurs with high carbohydrate diet refeeding after a prolonged fast. These results suggest that PGC-1 beta plays dual roles in regulating hepatic fatty acid metabolism by controlling the expression of programs of genes involved in both fatty acid oxidation and de novo fatty acid synthesis.	[Chambers, Kari T.; Chen, Zhouji; Crawford, Peter A.; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Fu, Xiaorong; Burgess, Shawn C.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Fu, Xiaorong; Burgess, Shawn C.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Lai, Ling; Leone, Teresa C.; Kelly, Daniel P.] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA	Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sanford Burnham Prebys Medical Discovery Institute	Finck, BN (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	bfinck@dom.wustl.edu	Kelly, Daniel/ABG-2056-2021	Crawford, Peter/0000-0001-8597-4426; Finck, Brian/0000-0001-5411-3674	American Liver Foundation; NIH [R01 DK078187, R01 DK078184, R01 HL058493]; Digestive Diseases Research Core [P30 DK52574]; Nutrition Obesity Research Center [P30 DK56341]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078187, P30DK052574, R01DK045416, P30DK056341, P30DK020579, R01DK091538, R01DK078184] Funding Source: NIH RePORTER	American Liver Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core; Nutrition Obesity Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the American Liver Foundation (www.liverfoundation.org); NIH R01 DK078187, R01 DK078184, R01 HL058493; Digestive Diseases Research Core P30 DK52574; Nutrition Obesity Research Center P30 DK56341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; ESSER V, 1993, J BIOL CHEM, V268, P5810; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Lelliott CJ, 2006, PLOS BIOL, V4, P2042, DOI 10.1371/journal.pbio.0040369; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; MILLINGTON DS, 1990, J INHERIT METAB DIS, V13, P321, DOI 10.1007/BF01799385; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Vianna CR, 2006, CELL METAB, V4, P453, DOI 10.1016/j.cmet.2006.11.003; Wueest S, 2010, J CLIN INVEST, V120, P191, DOI 10.1172/JCI38388; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	36	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52645	10.1371/journal.pone.0052645	http://dx.doi.org/10.1371/journal.pone.0052645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285128	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500043
J	Morner, A; Brave, A; Kling, AM; Kuhlmann-Berenzon, S; Krook, K; Hedenskog, M; Silhammar, I; Ljungman, M; Ortqvist, A; Andersson, S; Brytting, M; Thorstensson, R; Linde, A				Morner, Andreas; Brave, Andreas; Kling, Anna-Maria; Kuhlmann-Berenzon, Sharon; Krook, Katarina; Hedenskog, Mona; Silhammar, Irene; Ljungman, Margaretha; Ortqvist, Ake; Andersson, Soren; Brytting, Maria; Thorstensson, Rigmor; Linde, Annika			Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009	PLOS ONE			English	Article							IMMUNE-RESPONSE; ANTIBODY-RESPONSE; ELDERLY-PEOPLE; INFECTION	The immunity to pandemic influenza A(H1N1)pdm09 in Sweden before and after the outbreaks in 2009 and 2010 was investigated in a seroepidemiological study. Serum samples were collected at four time points: during 2007 (n = 1968), in October 2009 (n = 2218), in May 2010 (n = 2638) and in May 2011 (n = 2513) and were tested for hemagglutination inhibition (HI) antibodies. In 2007, 4.9% of the population had pre-existing HI titres >= 40, with the highest prevalence (20.0%) in 15-24 year-olds, followed by >= 80 year-olds (9.3%). The overall prevalence of HI titres >= 40 had not changed significantly in October 2009. In May 2010 the prevalence had increased to 48.6% with the highest percentages in 5-14 year-olds (76.2%) andlowest in 75-79 year-olds (18.3%). One year later the prevalence of HI titres >= 40 had increased further to 52.2%. Children 5-14 years had the highest incidence of infection and vaccine uptake as well as the highest post-pandemic protective antibody levels. In contrast, the elderly had high vaccine uptake and low attack rate but low levels of protective antibodies, underlining that factors other than HI antibodies are involved in protection against influenza A(H1N1) pdm09. However, for all age-groups the seroprevalence was stable or increasing between 2010 and 2011, indicating that both vaccine- and infection-induced antibodies were long-lived.	[Morner, Andreas; Krook, Katarina; Hedenskog, Mona; Silhammar, Irene; Ljungman, Margaretha; Andersson, Soren; Brytting, Maria; Thorstensson, Rigmor] Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden; [Brave, Andreas] Swedish Inst Communicable Dis Control, Dept Preparedness, Solna, Sweden; [Kling, Anna-Maria; Kuhlmann-Berenzon, Sharon; Linde, Annika] Swedish Inst Communicable Dis Control, Dept Anal & Prevent, Solna, Sweden; [Ortqvist, Ake] Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Swedish Institute for Infectious Disease Control; Swedish Institute for Infectious Disease Control; Karolinska Institutet	Morner, A (corresponding author), Swedish Inst Communicable Dis Control, Dept Diagnost & Vaccinol, Solna, Sweden.	andreas.morner@smi.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Morner, Andreas/0000-0002-3654-1728	Swedish Civil Contingencies Agency [2:4]	Swedish Civil Contingencies Agency	This study was funded by grant 2:4 from the Swedish Civil Contingencies Agency (www.msb.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2011, J CLIN VIROL, V52, P300, DOI 10.1016/j.jcv.2011.08.019; Adamson WE, 2011, EUROSURVEILLANCE, V16, P5; Brown F, 2003, LAB CORRELATES IMMUN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dudareva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021340; [(EMEA) TEAftEoMP Unit HME], 1997, NOT GUID HARM REQ IN; Garcia-Sicilia J, 2011, VACCINE; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; GOVAERT TME, 1994, VACCINE, V12, P1185, DOI 10.1016/0264-410X(94)90241-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Khurana S, 2012, J INFECT DIS, V205, P610, DOI 10.1093/infdis/jir791; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Liu W, 2012, VACCINE, V30, P4785, DOI 10.1016/j.vaccine.2012.05.030; Maltezou HC, 2011, VACCINE, V29, P6664, DOI 10.1016/j.vaccine.2011.06.098; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Reinheimer C, 2012, EUR J CLIN MICROBIOL, V31, P1467, DOI 10.1007/s10096-011-1465-x; Remarque EJ, 1998, J MED VIROL, V55, P82, DOI 10.1002/(SICI)1096-9071(199805)55:1&lt;82::AID-JMV13&gt;3.0.CO;2-1; Verma N, 2012, J VIROL; Walker WT, 2010, EXPERT REV VACCINES, V9, P1385, DOI [10.1586/erv.10.141, 10.1586/ERV.10.141]; [No title captured]	28	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53511	10.1371/journal.pone.0053511	http://dx.doi.org/10.1371/journal.pone.0053511			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285299	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500154
J	Nadai, M; Palu, G; Palumbo, M; Richter, SN				Nadai, Matteo; Palu, Giorgio; Palumbo, Manlio; Richter, Sara N.			Differential Targeting of Unpaired Bases within Duplex DNA by the Natural Compound Clerocidin: A Valuable Tool to Dissect DNA Secondary Structure	PLOS ONE			English	Article							CONTAINING DEOXYTRIDECANUCLEOTIDE DUPLEXES; CONFORMATIONAL TRANSITIONS; BULGE; RECOGNITION; MISMATCH; SEQUENCE; BINDING; LOOPS; TEMPERATURE; REACTIVITY	Non-canonical DNA structures have been postulated to mediate protein-nucleic acid interactions and to function as intermediates in the generation of frame-shift mutations when errors in DNA replication occur, which result in a variety of diseases and cancers. Compounds capable of binding to non-canonical DNA conformations may thus have significant diagnostic and therapeutic potential. Clerocidin is a natural diterpenoid which has been shown to selectively react with single-stranded bases without targeting the double helix. Here we performed a comprehensive analysis on several non-canonical DNA secondary structures, namely mismatches, nicks, bulges, hairpins, with sequence variations in both the single-stranded region and the double-stranded flanking segment. By analysis of clerocidin reactivity, we were able to identify the exposed reactive residues which provided information on both the secondary structure and the accessibility of the non-paired sites. Mismatches longer than 1 base were necessary to be reached by clerocidin reactive groups, while 1-base nicks were promptly targeted by clerocidin; in hairpins, clerocidin reactivity increased with the length of the hairpin loop, while, interestingly, reactivity towards bulges reached a maximum in 3-base-long bulges and declined in longer bulges. Electrophoretic mobility shift analysis demonstrated that bulges longer than 3 bases (i.e. 5- and 7-bases) folded or stacked on the duplex region therefore being less accessible by the compound. Clerocidin thus represents a new valuable diagnostic tool to dissect DNA secondary structures.	[Nadai, Matteo; Palu, Giorgio; Richter, Sara N.] Univ Padua, Dept Mol Med, Padua, Italy; [Palumbo, Manlio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy	University of Padua; University of Padua	Richter, SN (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	sara.richter@unipd.it	Richter, Sara/A-5578-2012	Richter, Sara/0000-0002-5446-9029; Palumbo, Manlio/0000-0002-3163-1564	Italian Ministry of University and Research [FIRB-Ideas] [RBID082ATK_001]; University of Padua	Italian Ministry of University and Research [FIRB-Ideas]; University of Padua	This work was supported by the Italian Ministry of University and Research [FIRB-Ideas RBID082ATK_001] and by the University of Padua. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN NR, 1984, TETRAHEDRON LETT, V25, P469, DOI 10.1016/S0040-4039(00)99913-1; ANDERSEN NR, 1983, J ANTIBIOT, V36, P753, DOI 10.7164/antibiotics.36.753; ANDERSEN NR, 1984, TETRAHEDRON LETT, V25, P465, DOI 10.1016/S0040-4039(00)99912-X; Baase WA, 2009, NUCLEIC ACIDS RES, V37, P1682, DOI 10.1093/nar/gkn1042; Bahr M, 2008, NUCLEIC ACIDS RES, V36, P5000, DOI 10.1093/nar/gkn392; Belmont P, 2001, CHEM SOC REV, V30, P70, DOI 10.1039/a904630e; Dohno C, 2012, NUCLEIC ACIDS RES, V40, P2771, DOI 10.1093/nar/gkr1148; Dornberger U, 1999, BIOCHEMISTRY-US, V38, P12860, DOI 10.1021/bi9906874; Granzhan A, 2010, CHEM-EUR J, V16, P878, DOI 10.1002/chem.200901989; Hong CF, 2011, ANGEW CHEM INT EDIT, V50, P4390, DOI 10.1002/anie.201100075; Jones GB, 2008, CURR TOP MED CHEM, V8, P436, DOI 10.2174/156802608783955692; Jourdan M, 2012, NUCLEIC ACIDS RES, V40, P5115, DOI 10.1093/nar/gks067; KALNIK MW, 1989, BIOCHEMISTRY-US, V28, P294, DOI 10.1021/bi00427a040; KALNIK MW, 1990, J BIOL CHEM, V265, P636; Kamashev D, 2008, NUCLEIC ACIDS RES, V36, P1026, DOI 10.1093/nar/gkm667; Maxam A M, 1980, Methods Enzymol, V65, P499; MORDEN KM, 1990, BIOCHEMISTRY-US, V29, P8835, DOI 10.1021/bi00489a047; Nakatani K, 2001, J AM CHEM SOC, V123, P12650, DOI 10.1021/ja0109186; Nakatani K, 1999, ANGEW CHEM INT EDIT, V38, P3378, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3378::AID-ANIE3378>3.3.CO;2-D; NIKONOWICZ E, 1989, BIOCHEMISTRY-US, V28, P8714, DOI 10.1021/bi00448a007; NIKONOWICZ EP, 1990, BIOCHEMISTRY-US, V29, P4193, DOI 10.1021/bi00469a024; Ong HC, 2009, CHEM COMMUN, P668, DOI 10.1039/b817733n; PATEL DJ, 1982, BIOCHEMISTRY-US, V21, P445, DOI 10.1021/bi00532a004; Peng T, 2005, ANGEW CHEM INT EDIT, V44, P7280, DOI 10.1002/anie.200502282; Pierre VC, 2007, P NATL ACAD SCI USA, V104, P429, DOI 10.1073/pnas.0610170104; Richter S, 2004, CHEM RES TOXICOL, V17, P492, DOI 10.1021/tx034210b; Richter S, 2003, NUCLEIC ACIDS RES, V31, P5149, DOI 10.1093/nar/gkg696; Richter SN, 2009, ORG BIOMOL CHEM, V7, P976, DOI 10.1039/b819049f; Richter SN, 2004, NUCLEIC ACIDS RES, V32, P5658, DOI 10.1093/nar/gkh898; ROSEN MA, 1992, BIOCHEMISTRY-US, V31, P4004, DOI 10.1021/bi00131a016; Smith GR, 2008, GENE DEV, V22, P2612, DOI 10.1101/gad.1724708; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Svozil D, 2008, NUCLEIC ACIDS RES, V36, P3690, DOI 10.1093/nar/gkn260; Tippin B, 2004, J BIOL CHEM, V279, P45360, DOI 10.1074/jbc.M408600200; VANDENHOOGEN YT, 1988, NUCLEIC ACIDS RES, V16, P5013, DOI 10.1093/nar/16.11.5013; WOODSON SA, 1988, BIOCHEMISTRY-US, V27, P436, DOI 10.1021/bi00401a065; Xiang AX, 1998, J ORG CHEM, V63, P6774, DOI 10.1021/jo981331l	37	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52994	10.1371/journal.pone.0052994	http://dx.doi.org/10.1371/journal.pone.0052994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285245	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500097
J	Tsai, D; Chen, S; Protti, DA; Morley, JW; Suaning, GJ; Lovell, NH				Tsai, David; Chen, Spencer; Protti, Dario A.; Morley, John W.; Suaning, Gregg J.; Lovell, Nigel H.			Responses of Retinal Ganglion Cells to Extracellular Electrical Stimulation, from Single Cell to Population: Model-Based Analysis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PHYSIOLOGICAL-PROPERTIES; ACTION-POTENTIALS; CORTICAL-NEURONS; ACTIVATION; MECHANISMS; MORPHOLOGY; MIDGET; MICROSTIMULATION; PROSTHESIS	Retinal ganglion cells (RGCs), which survive in large numbers following neurodegenerative diseases, could be stimulated with extracellular electric pulses to elicit artificial percepts. How do the RGCs respond to electrical stimulation at the subcellular level under different stimulus configurations, and how does this influence the whole-cell response? At the population level, why have experiments yielded conflicting evidence regarding the extent of passing axon activation? We addressed these questions through simulations of morphologically and biophysically detailed computational RGC models on high performance computing clusters. We conducted the analyses on both large-field RGCs and small-field midget RGCs. The latter neurons are unique to primates. We found that at the single cell level the electric potential gradient in conjunction with neuronal element excitability, rather than the electrode center location per se, determined the response threshold and latency. In addition, stimulus positioning strongly influenced the location of RGC response initiation and subsequent activity propagation through the cellular structure. These findings were robust with respect to inhomogeneous tissue resistivity perpendicular to the electrode plane. At the population level, RGC cellular structures gave rise to low threshold hotspots, which limited axonal and multi-cell activation with threshold stimuli. Finally, due to variations in neuronal element excitability over space, following supra-threshold stimulation some locations favored localized activation of multiple cells, while others favored axonal activation of cells over extended space.	[Tsai, David; Chen, Spencer; Suaning, Gregg J.; Lovell, Nigel H.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Tsai, David] Columbia Univ, Dept Biol Sci, Howard Hughes Med Inst, New York, NY 10027 USA; [Tsai, David] Columbia Univ, Dept Elect Engn, Bioelect Syst Lab, New York, NY 10027 USA; [Protti, Dario A.] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Protti, Dario A.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Morley, John W.] Univ Western Sydney, Sch Med, Sydney, NSW, Australia	University of New South Wales Sydney; Columbia University; Howard Hughes Medical Institute; Columbia University; University of Sydney; University of Sydney; Western Sydney University	Lovell, NH (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.	n.lovell@unsw.edu.au	Lovell, Nigel H/AGF-6679-2022	Lovell, Nigel H/0000-0003-1637-1079; Suaning, Gregg/0000-0003-1918-3313	Australian Research Council Special Research Initiative in Bionic Vision Technologies	Australian Research Council Special Research Initiative in Bionic Vision Technologies(Australian Research Council)	This research was supported in part by an Australian Research Council (www.arc.gov.au) Special Research Initiative in Bionic Vision Technologies to Bionic Vision Australia. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AK, 2008, IEEE T BIO-MED ENG, V55, P1744, DOI 10.1109/TBME.2008.919126; Barbeau H, 1999, BRAIN RES REV, V30, P27, DOI 10.1016/S0165-0173(99)00008-9; Behrend MR, 2009, J NEUROSCI METH, V179, P166, DOI 10.1016/j.jneumeth.2009.01.019; Butterwick A, 2009, EXP EYE RES, V88, P22, DOI 10.1016/j.exer.2008.09.018; Carnevale NT, 2006, NEURON BOOK; Chan LLH, 2011, J NEUROPHYSIOL, V105, P2687, DOI 10.1152/jn.00619.2010; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Eickenscheidt M, 2012, J NEUROPHYSIOL, V107, P2742, DOI 10.1152/jn.00909.2011; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1948, DOI 10.1152/jn.1997.78.4.1948; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Fried SI, 2006, J NEUROPHYSIO; Fujikado T, 2007, GRAEF ARCH CLIN EXP, V245, P1411, DOI 10.1007/s00417-007-0563-z; Ghosh KK, 1996, J COMP NEUROL, V366, P76, DOI 10.1002/(SICI)1096-9861(19960226)366:1<76::AID-CNE6>3.0.CO;2-H; Greenberg RJ, 1999, IEEE T BIO-MED ENG, V46, P505, DOI 10.1109/10.759051; Hines ML, 2008, J NEUROSCI METH, V169, P425, DOI 10.1016/j.jneumeth.2007.09.010; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Holt GR, 1999, J COMPUT NEUROSCI, V6, P169, DOI 10.1023/A:1008832702585; Horsager A, 2009, INVEST OPHTH VIS SCI, V50, P1483, DOI 10.1167/iovs.08-2595; Jeng J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036022; Jensen RJ, 2005, J NEURAL ENG, V2, pS16, DOI 10.1088/1741-2560/2/1/003; Jensen RJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035004; Jensen RJ, 2003, INVEST OPHTH VIS SCI, V44, P3533, DOI 10.1167/iovs.02-1041; Karwoski CJ, 1999, VISUAL NEUROSCI, V16, P369, DOI 10.1017/S0952523899162163; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Lopez-Aguado L, 2001, NEUROSCIENCE, V108, P249, DOI 10.1016/S0306-4522(01)00417-1; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Mazzoni F, 2008, J NEUROSCI, V28, P14282, DOI 10.1523/JNEUROSCI.4968-08.2008; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; Moore DR, 2009, NAT NEUROSCI, V12, P686, DOI 10.1038/nn.2326; MURASUGI CM, 1993, J NEUROSCI, V13, P1719; Nanduri D, 2008, 30 ANN INT IEEE EMBS; Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Plonsey R., 2007, BIOELECTRICITY QUANT; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rattay F, 2003, NEUROMODULATION, V6, P42, DOI 10.1046/j.1525-1403.2003.03006.x; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Rizzo JF, 2003, INVEST OPHTH VIS SCI, V44, P5362, DOI 10.1167/iovs.02-0817; Rodieck R.W., 1998, 1 STEPS SEEING; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Sekirnjak C, 2008, J NEUROSCI, V28, P4446, DOI 10.1523/JNEUROSCI.5138-07.2008; Sekirnjak C, 2006, J NEUROPHYSIOL, V95, P3311, DOI 10.1152/jn.01168.2005; Sekirnjak C, 2011, J NEUROPHYSIOL, V105, P2560, DOI 10.1152/jn.01061.2010; Sekirnjak C, 2009, J NEUROPHYSIOL, V102, P3260, DOI 10.1152/jn.00663.2009; Sheasby BW, 1999, J NEUROPHYSIOL, V81, P1685, DOI 10.1152/jn.1999.81.4.1685; Stett A, 2000, VISION RES, V40, P1785, DOI 10.1016/S0042-6989(00)00005-5; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 2008, DENDRITES; Tehovnik EJ, 2006, J NEUROPHYSIOL, V96, P512, DOI 10.1152/jn.00126.2006; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Velte TJ, 1999, J NEUROPHYSIOL, V81, P1412, DOI 10.1152/jn.1999.81.3.1412; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WATANABE M, 1989, J COMP NEUROL, V289, P434, DOI 10.1002/cne.902890308; Wei XFF, 2005, J NEURAL ENG, V2, P139, DOI 10.1088/1741-2560/2/4/010; Zhou JA, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/547428; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	65	39	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53357	10.1371/journal.pone.0053357	http://dx.doi.org/10.1371/journal.pone.0053357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285287	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500142
J	Xie, P; Zhang, WW; Yuan, ST; Chen, ZQ; Yang, Q; Yuan, DQ; Wang, F; Liu, QH				Xie, Ping; Zhang, WeiWei; Yuan, Songtao; Chen, Zhiqiang; Yang, Qin; Yuan, DongQing; Wang, Feng; Liu, QingHuai			Suppression of Experimental Choroidal Neovascularization by Curcumin in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; TNF-ALPHA; ADHESION MOLECULES; MACROPHAGE INFILTRATION; INFLAMMATORY RESPONSES; MACULAR DEGENERATION; MCP-1 SECRETION; DOWN-REGULATION; EXPRESSION	Purpose: To investigate the effects of curcumin on the development of experimental choroidal neovascularization (CNV) with underlying cellular and molecular mechanisms. Methods: C57BL/6N mice were pretreated with intraperitoneal injections of curcumin daily for 3 days prior to laser-induced CNV, and the drug treatments were continued until the end of the study. The CNV area was analyzed by fluorescein-labeled dextran angiography of retinal pigment epithelium (RPE)-choroid flat mounts on day 7 and 14, and CNV leakage was evaluated by fluorescein angiography (FA) on day 14 after laser photocoagulation. The infiltration of F4/80 positive macrophages and GR-1 positive granulocytes were evaluated by immunohistochemistry on RPE-choroid flat mounts on day 3. Their expression in RPE-choroid complex was quantified by real-time PCR (F4/80) and Western blotting (GR-1) on day 3. RPE-choroid levels of vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-alpha, monocyte chemotactic protein (MCP)-1, and intercellular adhesion molecule (ICAM)-1 were examined by ELISA on day 3. Double immunostaining of F4/80 and VEGF was performed on cryo-sections of CNV lesions on day 3. The expression of nuclear factor (NF)-kappa B and hypoxia-inducible factor (HIF)-1 alpha in the RPE-choroid was determined by Western blotting. Results: Curcumin-treated mice had significantly less CNV area (P<0.05) and CNV leakage (P<0.001) than vehicle-treated mice. Curcumin treatment led to significant inhibition of F4/80 positive macrophages (P<0.05) and GR-1 positive granulocytes infiltration (P<0.05). VEGF mainly expressed in F4/80 positive macrophages in laser injury sites, which was suppressed by curcumin treatment (P<0.01). Curcumin inhibited the RPE-choroid levels of TNF-alpha (P<0.05), MCP-1 (P<0.05) and ICAM-1 (P<0.05), and suppressed the activation of NF-kappa B in nuclear extracts (P<0.05) and the activation of HIF-1 alpha (P<0.05). Conclusion: Curcumin treatment led to the suppression of CNV development together with inflammatory and angiogenic processes including NF-kappa B and HIF-1 alpha activation, the up-regulation of inflammatory and angiogenic cytokines, and infiltrating macrophages and granulocytes. This provides molecular and cellular evidence of the validity of curcumin supplementation as a therapeutic strategy for the suppression of age-related macular degeneration(AMD)-associated CNV.	[Xie, Ping; Zhang, WeiWei; Yuan, Songtao; Yang, Qin; Yuan, DongQing; Wang, Feng; Liu, QingHuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Chen, Zhiqiang] JiangSu Prov Official Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn		Xie, Ping/0000-0003-4257-8970; Liu, Qinghuai/0000-0003-1605-1964	National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China [81170855, 30973257]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Basic Research Program of China (973 Program, No. 2011CB510200 http://www.973.gov.cn/English/Index.aspx) and National Natural Science Foundation of China (No. 81170855 and No. 30973257 http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegri P, 2010, CLIN OPHTHALMOL, V4, P1201, DOI 10.2147/OPTH.S13271; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Bae MK, 2006, ONCOL REP, V15, P1557; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Bian ZM, 1999, CURR EYE RES, V18, P349, DOI 10.1076/ceyr.18.5.349.5353; Bian ZM, 2001, INVEST OPHTH VIS SCI, V42, P1660; Caicedo A, 2005, EXP EYE RES, V81, P38, DOI 10.1016/j.exer.2005.01.013; Chen D, 2008, PHARMACOLOGY, V82, P264, DOI 10.1159/000161127; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Chen WH, 2005, CHINESE MED J-PEKING, V118, P2052; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; DEODHAR SD, 1980, INDIAN J MED RES, V71, P632; ELNER SG, 1991, LAB INVEST, V64, P819; ELNER SG, 1992, LAB INVEST, V66, P200; Espinosa-Heidmann DG, 2005, EXP EYE RES, V80, P413, DOI 10.1016/j.exer.2004.10.008; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; FURIE MB, 1995, AM J PATHOL, V146, P1287; Grossniklaus HE, 2002, MOL VIS, V8, P119; Gukovsky I, 2003, AM J PHYSIOL-GASTR L, V284, pG85, DOI 10.1152/ajpgi.00138.2002; Gupta SK, 2011, J OCUL PHARMACOL TH, V27, P123, DOI 10.1089/jop.2010.0123; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Hangai M, 2006, J NEUROIMMUNOL, V171, P45, DOI 10.1016/j.jneuroim.2005.09.018; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heng MCY, 2000, BRIT J DERMATOL, V143, P937, DOI 10.1046/j.1365-2133.2000.03767.x; Holt PR, 2005, DIGEST DIS SCI, V50, P2191, DOI 10.1007/s10620-005-3032-8; Inoue Y, 2007, BRIT J OPHTHALMOL, V91, P1720, DOI 10.1136/bjo.2006.111583; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Jackson JK, 2006, INFLAMM RES, V55, P168, DOI 10.1007/s00011-006-0067-z; Jain SK, 2009, ANTIOXID REDOX SIGN, V11, P241, DOI 10.1089/ars.2008.2140; Jung HJ, 2010, J BIOL CHEM, V285, P25867, DOI 10.1074/jbc.M110.135632; Kent D, 2003, MOL VIS, V9, P747; Kim JS, 2010, CURR EYE RES, V35, P274, DOI 10.3109/02713680903528345; Kim YS, 2007, J CARDIOVASC PHARM, V50, P41, DOI 10.1097/FJC.0b013e31805559b9; Kowluru RA, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-8; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kulkarni AD, 2005, ADV DRUG DELIVER REV, V57, P1994, DOI 10.1016/j.addr.2005.09.003; Kumar A, 1998, BIOCHEM PHARMACOL, V55, P775, DOI 10.1016/S0006-2952(97)00557-1; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Kuwabara N, 2006, UROLOGY, V67, P440, DOI 10.1016/j.urology.2005.09.028; Lal B, 2000, PHYTOTHER RES, V14, P443, DOI 10.1002/1099-1573(200009)14:6&lt;443::AID-PTR619&gt;3.0.CO;2-V; Lal B, 1999, PHYTOTHER RES, V13, P318, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;318::AID-PTR445&gt;3.0.CO;2-7; Larmonier CB, 2011, INFLAMM BOWEL DIS, V17, P503, DOI 10.1002/ibd.21391; Lichtlen P, 2010, INVEST OPHTH VIS SCI, V51, P4738, DOI 10.1167/iovs.09-4890; Lin MK, 2012, INVEST OPHTH VIS SCI, V53, P6197, DOI 10.1167/iovs.11-8936; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Madan B, 2003, SHOCK, V19, P91, DOI 10.1097/00024382-200301000-00017; Markomichelakis NN, 2005, AM J OPHTHALMOL, V139, P537, DOI 10.1016/j.ajo.2004.09.058; Moghaddam SJ, 2009, CARCINOGENESIS, V30, P1949, DOI 10.1093/carcin/bgp229; Mrudula T, 2007, BIOCHEM BIOPH RES CO, V361, P528, DOI 10.1016/j.bbrc.2007.07.059; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Olson JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P1221, DOI 10.1001/archopht.125.9.1221; Pan Y, 2012, BRIT J PHARMACOL, V166, P1169, DOI 10.1111/j.1476-5381.2012.01854.x; Regatieri CV, 2009, INVEST OPHTH VIS SCI, V50, P5487, DOI 10.1167/iovs.08-3171; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P2743, DOI 10.1167/iovs.02-1246; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Sawatpanich Tarinee, 2010, J Med Assoc Thai, V93 Suppl 2, pS1; Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063; Sheridan CM, 2009, GRAEF ARCH CLIN EXP, V247, P1361, DOI 10.1007/s00417-009-1133-3; Shi X, 2006, EXP EYE RES, V83, P1325, DOI 10.1016/j.exer.2006.07.007; Shoskes D, 2005, TRANSPLANTATION, V80, P1556, DOI 10.1097/01.tp.0000183290.64309.21; Sikora E, 2010, Immun Ageing, V7, P1, DOI 10.1186/1742-4933-7-1; Singh S, 2007, CELL, V130, P765, DOI 10.1016/j.cell.2007.08.024; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Song SJ, 2008, OPHTHALMIC RES, V40, P35, DOI 10.1159/000111157; Sugimoto H, 1997, DIABETES, V46, P2075, DOI 10.2337/diabetes.46.12.2075; Takahashi M, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/10767; Takehana Y, 1999, INVEST OPHTH VIS SCI, V40, P459; Theodossiadis PG, 2009, AM J OPHTHALMOL, V147, P825, DOI 10.1016/j.ajo.2008.12.004; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Woo HM, 2007, LIFE SCI, V80, P926, DOI 10.1016/j.lfs.2006.11.030; Xiong M, 1998, AM J PATHOL, V153, P587, DOI 10.1016/S0002-9440(10)65601-5; Yamada K, 2007, INVEST OPHTH VIS SCI, V48, P1839, DOI 10.1167/iovs.06-1085; Yeh DC, 2004, INVEST OPHTH VIS SCI, V45, P2368, DOI 10.1167/iovs.03-0981; Yoshida T, 2010, FASEB J, V24, P1759, DOI 10.1096/fj.09-145664; Zhang Y, 2011, INT J MOL MED, V27, P87, DOI 10.3892/ijmm.2010.552; Zhong F, 2011, BIOL PHARM BULL, V34, P226, DOI 10.1248/bpb.34.226; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou JH, 2005, MOL VIS, V11, P414	85	25	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53329	10.1371/journal.pone.0053329	http://dx.doi.org/10.1371/journal.pone.0053329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285282	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500136
J	Antonenko, YN; Horner, A; Pohl, P				Antonenko, Yuri N.; Horner, Andreas; Pohl, Peter			Electrostatically Induced Recruitment of Membrane Peptides into Clusters Requires Ligand Binding at Both Interfaces	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; GRAMICIDIN CHANNELS; LIPID-BILAYERS; DIFFUSION-COEFFICIENTS; RECEPTOR ACTIVATION; ION CHANNELS; KINETICS; INACTIVATION; ENERGETICS; PHOTOINACTIVATION	Protein recruitment to specific membrane locations may be governed or facilitated by electrostatic attraction, which originates from a multivalent ligand. Here we explored the energetics of a model system in which this simple electrostatic recruitment mechanism failed. That is, basic poly-L-lysine binding to one leaflet of a planar lipid bilayer did not recruit the triply-charged peptide (O-Pyromellitylgramicidin). Clustering was only observed in cases where PLL was bound to both channel ends. Clustering was indicated (i) by the decreased diffusional PLL mobility D-PLL and (ii) by an increased lifetime tau(PLL) of the clustered channels. In contrast, if PLL was bound to only one leaflet, neither D-PLL nor tau(P) changed. Simple calculations suggest that electrostatic repulsion of the unbound ends prevented neighboring OPg dimers from approaching each other. We believe that a similar mechanism may also operate in cell signaling and that it may e. g. contribute to the controversial results obtained for the ligand driven dimerization of G protein-coupled receptors.	[Antonenko, Yuri N.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Horner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Lomonosov Moscow State University; Johannes Kepler University Linz	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Antonenko, Yuri N/K-1323-2013; Pohl, Peter/A-5361-2008	Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314	Upper Austrian government; Austrian Science Fund [W1201]; Russian Foundation for Basic Research [09-04-00890]; Russian-Austria exchange program of the OAAD [15/2006]; Johannes Kepler University	Upper Austrian government; Austrian Science Fund(Austrian Science Fund (FWF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian-Austria exchange program of the OAAD; Johannes Kepler University	This work was supported by the Upper Austrian government, by the Austrian Science Fund (W1201 to PP), by the Russian Foundation for Basic Research (09-04-00890 to YNA), by the Russian-Austria exchange program of the OAAD (15/2006), and a research fellowship from the Johannes Kepler University to YA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Momani L, 2005, BIOCHEM BIOPH RES CO, V328, P342, DOI 10.1016/j.bbrc.2004.12.170; Andersen OS, 1999, NAT STRUCT BIOL, V6, P609, DOI 10.1038/10648; BAMBERG E, 1974, BIOCHIM BIOPHYS ACTA, V367, P127, DOI 10.1016/0005-2736(74)90037-6; BAMBERG E, 1973, J MEMBRANE BIOL, V11, P177, DOI 10.1007/BF01869820; Benda A, 2003, LANGMUIR, V19, P4120, DOI 10.1021/la0270136; Borisenko V, 2003, BIOPHYS J, V84, P612, DOI 10.1016/S0006-3495(03)74881-4; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; CEVC G, 1990, BIOCHIM BIOPHYS ACTA, V1031, P311, DOI 10.1016/0304-4157(90)90015-5; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; Ehrenberg B, 1998, PHOTOCHEM PHOTOBIOL, V68, P135, DOI 10.1111/j.1751-1097.1998.tb02479.x; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; Hawtin SR, 2006, J BIOL CHEM, V281, P38478, DOI 10.1074/jbc.M607639200; Horner A, 2012, J BIOL CHEM IN PRESS; Horner A, 2009, BIOPHYS J, V96, P2689, DOI 10.1016/j.bpj.2008.12.3931; Kota Z, 2004, BIOPHYS J, V86, P1521, DOI 10.1016/S0006-3495(04)74220-4; Krylov AV, 1998, FEBS LETT, V440, P235, DOI 10.1016/S0014-5793(98)01462-8; Krylov AV, 2002, J MEMBRANE BIOL, V189, P119, DOI 10.1007/s00232-002-1007-7; Krylov AV, 2000, BBA-BIOMEMBRANES, V1509, P373, DOI 10.1016/S0005-2736(00)00320-5; KUNZ L, 1995, BIOCHEMISTRY-US, V34, P11895, DOI 10.1021/bi00037a030; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lougheed T, 2001, BIOCONJUGATE CHEM, V12, P594, DOI 10.1021/bc010006t; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Maier B, 1999, PHYS REV LETT, V82, P1911, DOI 10.1103/PhysRevLett.82.1911; Martinac B, 2002, P NATL ACAD SCI USA, V99, P4308, DOI 10.1073/pnas.072632899; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Missner A, 2008, BBA-BIOMEMBRANES, V1778, P2154, DOI 10.1016/j.bbamem.2008.05.001; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Przybylo M, 2006, LANGMUIR, V22, P9096, DOI 10.1021/la061934p; Rokitskaya TI, 2000, BIOPHYS J, V78, P2572, DOI 10.1016/S0006-3495(00)76801-9; Rokitskaya TI, 1996, BBA-BIOENERGETICS, V1275, P221, DOI 10.1016/0005-2728(96)00025-4; Rokitskaya TI, 2003, J GEN PHYSIOL, V121, P463, DOI 10.1085/jgp.200208780; Sackmann E, 2012, LEHRBUCH BIOPHYSIK; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Serowy S, 2003, BIOPHYS J, V84, P1031, DOI 10.1016/S0006-3495(03)74919-4; Sokolov VS, 2009, BIOPHYS J, V96, P77, DOI 10.1529/biophysj.108.135145; Tian AW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.208102; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Woolf TB, 1996, PROTEINS, V24, P92	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52839	10.1371/journal.pone.0052839	http://dx.doi.org/10.1371/journal.pone.0052839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285199	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800099
J	Bygrave, H; Mtangirwa, J; Ncube, K; Ford, N; Kranzer, K; Munyaradzi, D				Bygrave, Helen; Mtangirwa, Judith; Ncube, Kwenzakwenkosi; Ford, Nathan; Kranzer, Katharina; Munyaradzi, Dhodho			Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe	PLOS ONE			English	Article							YOUNG-ADULTS; ADHERENCE; CARE	Around 2 million adolescents and 3 million youth are estimated to be living with HIV worldwide. Antiretroviral outcomes for this group appear to be worse compared to adults. We report antiretroviral therapy outcomes from a rural setting in Zimbabwe among patients aged 10-30 years who were initiated on ART between 2005 and 2008. The cohort was stratified into four age groups: 10-15 (young adolescents) 15.1-19 years (adolescents), 19.1-24 years (young adults) and 24.1-29.9 years (older adults). Survival analysis was used to estimate rates of deaths and loss to follow-up stratified by age group. Endpoints were time from ART initiation to death or loss to follow-up. Follow-up of patients on continuous therapy was censored at date of transfer, or study end (31 December 2008). Sex-adjusted Cox proportional hazards models were used to estimate hazard ratios for different age groups. 898 patients were included in the analysis; median duration on ART was 468 days. The risk of death were highest in adults compared to young adolescents (aHR 2.25, 95% CI 1.17-4.35). Young adults and adolescents had a 2-3 times higher risk of loss to follow-up compared to young adolescents. When estimating the risk of attrition combining loss to follow-up and death, young adults had the highest risk (aHR 2.70, 95% CI 1.62-4.52). This study highlights the need for adapted adherence support and service delivery models for both adolescents and young adults. Citation: Bygrave H, Mtangirwa J, Ncube K, Ford N, Kranzer K, et al. (2012) Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe. PLoS ONE 7(12): e52856. doi:10.1371/journal.pone.0052856	[Bygrave, Helen; Mtangirwa, Judith; Ford, Nathan] Medecins Sans Frontieres, So Africa Med Unit, Cape Town, South Africa; [Ncube, Kwenzakwenkosi] Minist Hlth & Child Welf Zimbabwe, Buhera Dist, Zimbabwe; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Kranzer, Katharina] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Munyaradzi, Dhodho] Medecins Sans Frontieres, Med Unit, Harare, Zimbabwe	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Bygrave, H (corresponding author), Medecins Sans Frontieres, So Africa Med Unit, Cape Town, South Africa.	Helen.bygrave@joburg.msf.org	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270	M�decins Sans Fronti�res [OCA_pilot_00_Bygrave] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2011, OPPORTUNITY CRISIS P; Arrive E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033690; Bakanda C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019261; Belzer ME, 1999, J ADOLESCENT HEALTH, V25, P316, DOI 10.1016/S1054-139X(99)00052-X; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Cremin I, 2009, SEX TRANSM INFECT, V85, pI34, DOI 10.1136/sti.2008.033431; Demissie S, 2003, STAT MED, V22, P545, DOI 10.1002/sim.1340; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Khan M, 2009, ARCH DIS CHILD, V94, P970, DOI 10.1136/adc.2008.156232; Knol MJ, 2010, J CLIN EPIDEMIOL, V63, P728, DOI 10.1016/j.jclinepi.2009.08.028; Maturo D, 2011, J PEDIATR HEALTH CAR, V25, P16, DOI 10.1016/j.pedhc.2009.12.005; Moodley K, 2006, SAMJ S AFR MED J, V96, pA201; Nachega JB, 2011, PATIENT PREFER ADHER, V5, P357, DOI 10.2147/PPA.S22771; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Report G., 2010, UNAIDS REPORT GLOBAL; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Van Cutsem G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014684	18	59	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52856	10.1371/journal.pone.0052856	http://dx.doi.org/10.1371/journal.pone.0052856			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285204	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000312794500251
J	Magen, S; Magnani, R; Haziza, S; Hershkovitz, E; Houtz, R; Cambi, F; Parvari, R				Magen, Sophia; Magnani, Roberta; Haziza, Sitvanit; Hershkovitz, Eli; Houtz, Robert; Cambi, Franca; Parvari, Ruti			Human Calmodulin Methyltransferase: Expression, Activity on Calmodulin, and Hsp90 Dependence	PLOS ONE			English	Article							MOLECULAR CHAPERONE; MITOCHONDRIAL DISEASE; KINASE ACTIVATION; METHYLATION; BINDING; PURIFICATION; DELETION; COMPLEX; CLIENT; CANCER	Deletion of the first exon of calmodulin-lysine N-methyltransferase (CaM KMT, previously C2orf34) has been reported in two multigene deletion syndromes, but additional studies on the gene have not been reported. Here we show that in the cells from 2p21 deletion patients the loss of CaM KMT expression results in accumulation of hypomethylated calmodulin compared to normal controls, suggesting that CaM KMT is essential for calmodulin methylation and there are no compensatory mechanisms for CaM methylation in humans. We have further studied the expression of this gene at the transcript and protein levels. We have identified 2 additional transcripts in cells of the 2p21 deletion syndrome patients that start from alternative exons positioned outside the deletion region. One of them starts in the 2nd known exon, the other in a novel exon. The transcript starting from the novel exon was also identified in a variety of tissues from normal individuals. These new transcripts are not expected to produce proteins. Immunofluorescent localization of tagged CaM KMT in HeLa cells indicates that it is present in both the cytoplasm and nucleus of cells whereas the short isoform is localized to the Golgi apparatus. Using Western blot analysis we show that the CaM KMT protein is broadly expressed in mouse tissues. Finally we demonstrate that the CaM KMT interacts with the middle portion of the Hsp90 molecular chaperon and is probably a client protein since it is degraded upon treatment of cells with the Hsp90 inhibitor geldanamycin. These findings suggest that the CaM KMT is the major, possibly the single, methyltransferase of calmodulin in human cells with a wide tissue distribution and is a novel Hsp90 client protein. Thus our data provides basic information for a gene potentially contributing to the patient phenotype of two contiguous gene deletion syndromes.	[Magen, Sophia; Haziza, Sitvanit; Parvari, Ruti] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Virol & Genet, Beer Sheva, Israel; [Magnani, Roberta; Houtz, Robert] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA; [Hershkovitz, Eli] Soroka Med Ctr, Pediat Endocrinol & Metab Unit, IL-84101 Beer Sheva, Israel; [Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Parvari, Ruti] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; University of Kentucky; Ben Gurion University; Soroka Medical Center; University of Kentucky; Ben Gurion University	Parvari, R (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Virol & Genet, Beer Sheva, Israel.	ruthi@bgu.ac.il	Herskowitz, eli/F-1922-2012	Herskowitz, eli/0000-0003-1624-1960	Israel Science Foundation [787/05]	Israel Science Foundation(Israel Science Foundation)	This study was supported by Grant 787/05 of the Israel Science Foundation to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chabrol B, 2008, J MED GENET, V45, P314, DOI 10.1136/jmg.2007.055475; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; de Barreda EG, 2011, BIOCHEM BIOPH RES CO, V408, P500, DOI 10.1016/j.bbrc.2011.04.082; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; Magnani R, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1044; MOLLA A, 1981, J BIOL CHEM, V256, P15; OH SH, 1990, PLANT PHYSIOL, V93, P880, DOI 10.1104/pp.93.3.880; OH SH, 1992, ARCH BIOCHEM BIOPHYS, V297, P28, DOI 10.1016/0003-9861(92)90636-B; Panina S, 2012, J BIOL CHEM, V287, P18173, DOI 10.1074/jbc.M112.339382; Parvari R, 2005, GENOMICS, V86, P195, DOI 10.1016/j.ygeno.2005.04.001; Parvari R, 2001, AM J HUM GENET, V69, P869, DOI 10.1086/323624; Parvari R, 2007, EUR J HUM GENET, V15, P997, DOI 10.1038/sj.ejhg.5201894; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; ROBERTS DM, 1986, J BIOL CHEM, V261, P1491; ROWE PM, 1986, J BIOL CHEM, V261, P7060; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shames DS, 2008, P NATL ACAD SCI USA, V105, P1389, DOI 10.1073/pnas.0711993105; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Siddique A, 2011, FEBS J, V278, P2055, DOI 10.1111/j.1742-4658.2011.08121.x; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sugiana C, 2008, AM J HUM GENET, V83, P468, DOI 10.1016/j.ajhg.2008.09.009; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; SZILAK L, 1994, NUCLEIC ACIDS RES, V22, P2876, DOI 10.1093/nar/22.15.2876; Taherian A, 2008, BIOCHEM CELL BIOL, V86, P37, DOI [10.1139/O07-154, 10.1139/o07-154]; Takemori N, 2007, PROTEOMICS, V7, P2651, DOI 10.1002/pmic.200700343; Tian GL, 2006, P NATL ACAD SCI USA, V103, P13491, DOI 10.1073/pnas.0602798103; Vaughan CK, 2010, NAT STRUCT MOL BIOL, V17, P1400, DOI 10.1038/nsmb1210-1400; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Zhang MH, 2006, MOL CELL BIOCHEM, V281, P111, DOI 10.1007/s11010-006-0638-x	41	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52425	10.1371/journal.pone.0052425	http://dx.doi.org/10.1371/journal.pone.0052425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285036	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500164
J	Prabhu, A; Sarcar, B; Kahali, S; Shan, Y; Chinnaiyan, P				Prabhu, Antony; Sarcar, Bhaswati; Kahali, Soumen; Shan, Yuan; Chinnaiyan, Prakash			Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA	PLOS ONE			English	Article							STRESS CHAPERONE GRP78/BIP; MALIGNANT GLIOMAS; TUMOR-DEVELOPMENT; CANCER; INDUCTION; CYTOTOXIN; LINES	Rapidly growing tumors require efficient means to allow them to adapt to fluctuating microenvironments consisting of hypoxia, nutrient deprivation, and acidosis. The unfolded protein response (UPR) represents a defense mechanism allowing cells to respond to these adverse conditions. The chaperone protein GRP78 serves as a master UPR regulator that is aberrantly expressed in a variety of cancers, including glioma. Therefore, cancer cells may be particularly reliant upon the adaptive mechanisms offered by the UPR and targeting GRP78 may represent a unique therapeutic strategy. Here we report that diffuse expression of GRP78 protein is present in Grade III-IV, but not Grade I-II glioma. To determine the role GRP78 plays in glioblastoma tumorigenesis, we explored the anti-tumor activity of the novel fusion protein EGF-SubA, which combines EGF with the cytotoxin SubA that has been recently shown to selectively cleave GRP78. EGF-SubA demonstrated potent tumor-specific proteolytic activity and cytotoxicity in glioblastoma lines and potentiated the anti-tumor activity of both temozolomide and ionizing radiation. To determine if the tumor microenvironment influences EGF-SubA activity, we maintained cells in acidic conditions that led to both UPR activation and increased EGF-SubA induced cytotoxicity. EGF-SubA was well tolerated in mice and led to a significant tumor growth delay in a glioma xenograft mouse model. The UPR is emerging as an important adaptive pathway contributing to glioma tumorigenesis. Targeting its primary mediator, the chaperone protein GRP78, through specific, proteolytic cleavage with the immunotoxin EGF-SubA represents a novel and promising multi-targeted approach to cancer therapy.	[Prabhu, Antony; Sarcar, Bhaswati; Kahali, Soumen; Shan, Yuan; Chinnaiyan, Prakash] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Chinnaiyan, P (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	prakash.chinnaiyan@moffitt.org	Dayalan, Antony Herold Prabhu Packiam/J-8625-2019	Dayalan, Antony Herold Prabhu Packiam/0000-0003-2401-0118	Ben and Catherine Ivy Foundation; American Cancer Society [RSG-11-029-01-CSM]	Ben and Catherine Ivy Foundation; American Cancer Society(American Cancer Society)	PC is currently funded by The Ben and Catherine Ivy Foundation and The American Cancer Society (RSG-11-029-01-CSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2009, NEOPLASIA, V11, P1165, DOI 10.1593/neo.09878; Backer MV, 2011, METHOD ENZYMOL, V491, P37, DOI 10.1016/B978-0-12-385928-0.00003-1; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dong DZ, 2005, CANCER RES, V65, P5785, DOI 10.1158/0008-5472.CAN-05-0754; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Sarcar B, 2011, MOL CANCER THER, V10, P2405, DOI 10.1158/1535-7163.MCT-11-0469; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	23	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52265	10.1371/journal.pone.0052265	http://dx.doi.org/10.1371/journal.pone.0052265			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284962	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500130
J	Di Luca, M; Bottai, D; Batoni, G; Orgeur, M; Aulicino, A; Counoupas, C; Campa, M; Brosch, R; Esin, S				Di Luca, Mariagrazia; Bottai, Daria; Batoni, Giovanna; Orgeur, Mickael; Aulicino, Anna; Counoupas, Claudio; Campa, Mario; Brosch, Roland; Esin, Semih			The ESX-5 Associated eccB(5)-eccC(5) Locus Is Essential for Mycobacterium tuberculosis Viability	PLOS ONE			English	Article							PE-PGRS PROTEINS; COMPLETE GENOME SEQUENCE; SECRETION SYSTEM; PPE; VIRULENCE; MARINUM; SURFACE; INSIGHTS; GENE	The recently described ESX-5 secretion system of Mycobacterium tuberculosis is one of the most important modulators of host-pathogen interactions due to its crucial impact on PPE protein secretion, cell wall stability and virulence. Although various components of the ESX-5 secretion machinery have been defined, other ESX-5 core components still remain to be characterized. In this study, we focused on EccB(5) and EccC(5), a transmembrane protein (EccB(5)) and a membrane-bound ATPase (EccC(5)), both predicted to be building blocks of the M. tuberculosis ESX-5 membrane-associated complex. In vitro expression studies demonstrated that EccB(5) and EccC(5) encoding genes constitute an operon. The expression of this operon is essential for M. tuberculosis, since the deletion of the eccB(5)-eccC(5) genomic segment at the ESX-5 locus is possible only after the integration of a second functional copy of eccB(5)-eccC(5) genes into the M. tuberculosis chromosome. The characterization of two M. tuberculosis conditional mutant strains (Mtb(Pptr)eccB(5) and Mtb(Pptr)eccC(5)), in which the eccB(5)-eccC(5) operon or the eccC(5) gene, respectively, were expressed under the control of an anhydrotetracycline-repressible promoter, confirmed that the repression of eccB(5)-eccC(5) genes is detrimental for growth of M. tuberculosis both in vitro and in THP-1 human macrophage cell line. Moreover, analysis of the secretome of Mtb(Pptr)eccB(5)-eccC(5) and Mtb(Pptr)eccC(5) strains revealed that both EccB(5) and EccC(5) are required for secretion of ESX-5 specific substrates, thus confirming that they are indeed components of the ESX-5 secretion machinery. Taken together these findings demonstrate the importance of an intact and functional ESX-5 system for viability of M. tuberculosis, thus opening new interesting options for alternative antimycobacterial control strategies.	[Di Luca, Mariagrazia; Bottai, Daria; Batoni, Giovanna; Aulicino, Anna; Counoupas, Claudio; Campa, Mario; Esin, Semih] Univ Pisa, Dipartimento Patol Sperimentale Biotecnol Med Inf, Pisa, Italy; [Di Luca, Mariagrazia; Bottai, Daria; Batoni, Giovanna; Aulicino, Anna; Campa, Mario; Esin, Semih] Univ Pisa, Dipartimento Ric Traslaz & Nuove Tecnol Med & Chi, Pisa, Italy; [Orgeur, Mickael; Brosch, Roland] Inst Pasteur, Unit Integrated Mycobacterial Pathogenom, Paris, France	University of Pisa; University of Pisa; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bottai, D (corresponding author), Univ Pisa, Dipartimento Patol Sperimentale Biotecnol Med Inf, Pisa, Italy.	d.bottai@biomed.unipi.it	Counoupas, Claudio/AAH-6664-2019; Brosch, Roland/ABB-4108-2021; Brosch, Roland/AAZ-3850-2021; Esin, Semih/B-7566-2013; Bottai, Daria/HFZ-9009-2022; Batoni, Giovanna/ABF-9668-2020	Brosch, Roland/0000-0003-2587-3863; Esin, Semih/0000-0002-4358-5294; Batoni, Giovanna/0000-0002-4448-2385; Di Luca, Mariagrazia/0000-0002-0688-034X; Counoupas, Claudio/0000-0002-0283-4004; Aulicino, Anna/0000-0002-3407-2796	European Community [201762, 260872]; Progetti P.R.I.N., Rome, Italy [2008WY739B]	European Community(European Commission); Progetti P.R.I.N., Rome, Italy	This work received the financial support from the European Community's Seventh Framework Programme ([FP7/2007-2013]) under grant agreement numbers 201762 and 260872, and Progetti P.R.I.N. protocol number 2008WY739B, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Blasco B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002621; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Bottai D, 2011, J INFECT DIS, V203, P1155, DOI 10.1093/infdis/jiq089; Bottai D, 2009, MOL MICROBIOL, V73, P325, DOI 10.1111/j.1365-2958.2009.06784.x; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM, V286, P19024, DOI 10.1074/jbc.M110.204966; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Houben EN, 2012, MOL MICROBIOL; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Joshi SA, 2012, CHEM BIOL, V19, P372, DOI 10.1016/j.chembiol.2012.01.008; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Li YJ, 2005, CELL MICROBIOL, V7, P539, DOI 10.1111/j.1462-5822.2004.00484.x; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Serafini A, 2009, J BACTERIOL, V191, P6340, DOI 10.1128/JB.00756-09; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Weerdenburg EM, 2012, CELL MICROBIOL, V14, P728, DOI 10.1111/j.1462-5822.2012.01755.x	39	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52059	10.1371/journal.pone.0052059	http://dx.doi.org/10.1371/journal.pone.0052059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284869	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900073
J	Cao, MH; Li, YY; Xu, J; Feng, YJ; Lin, XH; Li, K; Han, T; Chen, CJ				Cao, Ming-Hua; Li, Yong-yu; Xu, Jing; Feng, Ya-jing; Lin, Xu-hong; Li, Kun; Han, Tong; Chen, Chang-Jie			Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis	PLOS ONE			English	Article							ASCITIC FLUID; ENDOCANNABINOID SYSTEM; ACINAR-CELLS; INFLAMMATION; NECROSIS; DISEASE; INJURY; PATHOPHYSIOLOGY; SOMATOSTATIN; INHIBITION	Acute pancreatitis (AP), especially severe acute pancreatitis often causes extra-pancreatic complications, such as acute gastrointestinal mucosal lesion (AGML) which is accompanied by a considerably high mortality, yet the pathogenesis of AP-induced AGML is still not fully understood. In this report, we investigated the alterations of serum components and gastric endocrine and exocrine functions in rats with experimental acute pancreatitis, and studied the possible contributions of these alterations in the pathogenesis of AGML. In addition, we explored the intervention effects of cannabinoid receptor agonist HU210 and antagonist AM251 on isolated and serum-perfused rat stomach. Our results showed that the AGML occurred after 5 h of AP replication, and the body homeostasis was disturbed in AP rat, with increased levels of pancreatic enzymes, lipopolysaccharide (LPS), proinflammtory cytokines and chemokines in the blood, and an imbalance of the gastric secretion function. Perfusing the isolated rat stomach with the AP rat serum caused morphological changes in the stomach, accompanied with a significant increment of pepsin and [H+] release, and increased gastrin and decreased somatostatin secretion. HU210 reversed the AP-serum-induced rat pathological alterations, including the reversal of transformation of the gastric morphology to certain degree. The results from this study prove that the inflammatory responses and the imbalance of the gastric secretion during the development of AP are responsible for the pathogenesis of AGML, and suggest the therapeutic potential of HU210 for AGML associated with acute pancreatitis.	[Cao, Ming-Hua; Li, Yong-yu; Xu, Jing; Feng, Ya-jing; Lin, Xu-hong; Li, Kun; Han, Tong; Chen, Chang-Jie] Tongji Univ, Inst Digest Dis, Dept Pathophysiol, Sch Med, Shanghai 200092, Peoples R China	Tongji University	Li, YY (corresponding author), Tongji Univ, Inst Digest Dis, Dept Pathophysiol, Sch Med, Shanghai 200092, Peoples R China.	liyongyu@tongji.edu.cn	xu, jing/GRR-8698-2022		National Natural Science Foundation of China [81270477, 81141050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81270477 and 81141050 to Dr. Yong-yu Li). http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; AHO HJ, 1983, EUR SURG RES, V15, P28, DOI 10.1159/000128330; Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Andican G, 2005, WORLD J GASTROENTERO, V11, P2340, DOI 10.3748/wjg.v11.i15.2340; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Browne GW, 2006, WORLD J GASTROENTERO, V12, P7087, DOI 10.3748/wjg.v12.i44.7087; Chen TA, 2007, J CLIN GASTROENTEROL, V41, P630, DOI 10.1097/01.mcg.0000225638.37533.8c; Coruzzi G, 1999, N-S ARCH PHARMACOL, V360, P715, DOI 10.1007/s002109900135; Dembinski A, 2006, J PHYSIOL PHARMACOL, V57, P137; Di Marzo V, 2009, PHARMACOL RES, V60, P77, DOI 10.1016/j.phrs.2009.02.010; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Germano MP, 2001, N-S ARCH PHARMACOL, V363, P241, DOI 10.1007/s002100000360; Lee KM, 2011, WORLD J GASTROENTERO, V17, P1058, DOI 10.3748/wjg.v17.i8.1058; Li XL, 2009, CELL STRESS CHAPERON, V14, P199, DOI 10.1007/s12192-008-0074-9; Li YY, 2010, CELL STRESS CHAPERON, V15, P583, DOI 10.1007/s12192-010-0170-5; Li YY, 2009, J GASTROEN HEPATOL, V24, P155, DOI 10.1111/j.1440-1746.2008.05592.x; Li YY, 2003, WORLD J GASTROENTERO, V9, P129, DOI 10.3748/wjg.v9.i1.129; Lin XH, 2011, NEUROGASTROENT MOTIL, V23, P862, DOI 10.1111/j.1365-2982.2011.01742.x; Masamune A, 1999, PANCREAS, V18, P141, DOI 10.1097/00006676-199903000-00005; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Massa F, 2005, J MOL MED, V83, P944, DOI 10.1007/s00109-005-0698-5; Michalski CW, 2007, GASTROENTEROLOGY, V132, P1968, DOI 10.1053/j.gastro.2007.02.035; Muddana V, 2009, AM J GASTROENTEROL, V104, P164, DOI 10.1038/ajg.2008.66; Nathan JD, 2002, AM J PHYSIOL-GASTR L, V283, pG938, DOI 10.1152/ajpgi.00105.2002; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Ramudo L, 2005, CRIT CARE MED, V33, P143, DOI 10.1097/01.CCM.0000150654.13653.5B; Sathyanarayan G, 2007, J GASTROEN HEPATOL, V22, P550, DOI 10.1111/j.1440-1746.2006.04752.x; Seerden TC, 2005, NEUROGASTROENT MOTIL, V17, P671, DOI 10.1111/j.1365-2982.2005.00689.x; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Sun FP, 2002, WORLD J GASTROENTERO, V8, P375; Tyler K, 2000, EUR J PHARMACOL, V409, P207, DOI 10.1016/S0014-2999(00)00843-8; Ueda T, 2002, SURGERY, V131, P66, DOI 10.1067/msy.2002.118317; Yang J, 2003, J GASTROINTEST SURG, V7, P200, DOI 10.1016/S1091-255X(02)00134-8	34	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52921	10.1371/journal.pone.0052921	http://dx.doi.org/10.1371/journal.pone.0052921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285225	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500080
J	Forrester, HB; Li, J; Hovan, D; Ivashkevich, AN; Sprung, CN				Forrester, Helen B.; Li, Jason; Hovan, Daniel; Ivashkevich, Alesia N.; Sprung, Carl N.			DNA Repair Genes: Alternative Transcription and Gene Expression at the Exon Level in Response to the DNA Damaging Agent, Ionizing Radiation	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; RIBONUCLEOTIDE REDUCTASE GENE; HUMAN LYMPHOBLASTOID-CELLS; DOUBLE-STRAND BREAKS; XERODERMA-PIGMENTOSUM; TARGETED DISRUPTION; HUMAN FIBROBLASTS; CANCER-PATIENTS; EMBRYONIC MICE; COLON-CANCER	DNA repair is an essential cellular process required to maintain genomic stability. Every cell is subjected to thousands of DNA lesions daily under normal physiological conditions. Ionizing radiation (IR) is a major DNA damaging agent that can be produced by both natural and man-made sources. A common source of radiation exposure is through its use in medical diagnostics or treatments such as for cancer radiotherapy where relatively high doses are received by patients. To understand the detailed DNA repair gene transcription response to high dose IR, gene expression exon array studies have been performed and the response to radiation in two divergent cell types, lymphoblastoid cell lines and primary fibroblasts, has been examined. These exon arrays detect expression levels across the entire gene, and have the advantage of high sensitivity and the ability to identify alternative transcripts. We found a selection of DNA repair genes, including some not previously reported, that are modulated in response to radiation. Detailed dose and time course kinetics of DNA repair transcription was conducted and results have been validated utilizing PCR methods. Alternative transcription products in response to IR were identified in several DNA repair genes including RRM2B and XPC where alternative initiation sites were found. These investigations have advanced the knowledge about the transcriptional response of DNA repair.	[Forrester, Helen B.; Hovan, Daniel; Ivashkevich, Alesia N.; Sprung, Carl N.] Monash Univ, Ctr Innate Immun & Infect Dis, Monash Inst Med Res, Clayton, Vic, Australia; [Li, Jason] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic, Australia	Monash University; Peter Maccallum Cancer Center	Sprung, CN (corresponding author), Monash Univ, Ctr Innate Immun & Infect Dis, Monash Inst Med Res, Clayton, Vic, Australia.	Carl.Sprung@med.monash.edu.au		Li, Jason/0000-0002-1150-3549	Collaborative Cancer Research Scheme [1002743]; Australian Government Department of Health and Ageing; Cancer Australia; Australian National Health and Medical Research Council [145780, 288713]; Australian National Breast Cancer Foundation [PG-08-06]; National Institutes of Health [5U19AI067773-07]; Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	Collaborative Cancer Research Scheme; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Cancer Australia; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Victorian Government's Operational Infrastructure Support Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported through the 2010 round of the priority-driven Collaborative Cancer Research Scheme (grant 1002743) and funded by the Australian Government Department of Health and Ageing with the assistance of Cancer Australia. Also, this work was supported by the Australian National Health and Medical Research Council (grant numbers 145780, 288713; http://www.nhmrc.gov.au/); the Australian National Breast Cancer Foundation (grant PG-08-06; http://www.nbcf.org.au/); and the National Institutes of Health (grant 5U19AI067773-07). Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh F, 2010, J MED GENET, V47, P176, DOI 10.1136/jmg.2009.068866; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 2002, CANCER BIOL THER, V1, P145, DOI 10.4161/cbt.59; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Batty D, 2000, J MOL BIOL, V300, P275, DOI 10.1006/jmbi.2000.3857; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Bohr VA, 1999, BIOCHIMIE, V81, P155, DOI 10.1016/S0300-9084(99)80048-0; Bunick CG, 2006, BIOCHEMISTRY-US, V45, P14965, DOI 10.1021/bi061370o; Buterin T, 2005, CHEM BIOL, V12, P913, DOI 10.1016/j.chembiol.2005.06.011; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Ding LH, 2005, RADIAT RES, V164, P523, DOI 10.1667/RR3350.1; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Kimura T, 2003, CANCER SCI, V94, P431, DOI 10.1111/j.1349-7006.2003.tb01460.x; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Long XH, 2007, INT J MOL MED, V19, P607; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Radhakrishnan SK, 2006, ONCOGENE, V25, P1812, DOI 10.1038/sj.onc.1209195; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Tachiiri S, 2006, INT J RADIAT ONCOL, V64, P272, DOI 10.1016/j.ijrobp.2005.08.030; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Tsai MH, 2006, ONCOGENE, V25, P622, DOI 10.1038/sj.onc.1209082; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang QE, 2012, CANCER RES, V72, P666, DOI 10.1158/0008-5472.CAN-11-2774; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xu J, 1999, MOL CELL BIOL, V19, P12; Xue LJ, 2007, CANCER RES, V67, P16, DOI 10.1158/0008-5472.CAN-06-3200; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584	51	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53358	10.1371/journal.pone.0053358	http://dx.doi.org/10.1371/journal.pone.0053358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285288	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500143
J	Jung, CH; Lee, WJ; Hwang, JY; Lee, MJ; Seol, SM; Kim, YM; La Lee, Y; Kim, HS; Kim, MS; Park, JY				Jung, Chang Hee; Lee, Woo Je; Hwang, Jenie Yoonoo; Lee, Min Jung; Seol, So Mi; Kim, Yun Mi; La Lee, Yoo; Kim, Hyun Sik; Kim, Min-Seon; Park, Joong-Yeol			Vaspin Increases Nitric Oxide Bioavailability through the Reduction of Asymmetric Dimethylarginine in Vascular Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; INSULIN SENSITIVITY; STAT3; DYSFUNCTION; MIGRATION; GENE; PHOSPHORYLATION; ADIPOCYTOKINE; MACROPHAGES; RESISTANCE	Vaspin is an adipocytokine recently identified in the visceral adipose tissue of diabetic rats and having anti-diabetic effects. We have recently shown that vaspin has anti-atherogenic effect through Akt-mediated inhibition of endothelial cell apoptosis. Decreased activity of endothelial nitric oxide synthase (eNOS) plays an important role in the pathogenesis of atherosclerosis. Asymmetric dimethylarginine (ADMA) is a well-known endogenous competitive inhibitor of eNOS and risk factor of cardiovascular diseases. The aim of this study was to examine whether vaspin might protect against atherosclerosis through its beneficial effects on the ADMA-eNOS system. Treatment of vaspin significantly increased NO secretion from endothelial cells and isolated aorta from Sprague-Dawley (SD) rats. Furthermore, treatment of vaspin prevented fatty acid-induced decrease in endothelium-dependent vasorelaxation in isolated aorta of SD rat. For the mechanism of vaspin-induced NO biosynthesis, vaspin activated the STAT3 signaling pathway and stimulated eNOS phosphorylation (Ser 1177), a marker of eNOS activation, through STAT3-dependent mechanism. Furthermore, vaspin treatment increased the expression of dimethylarginine dimethylaminohydrolase (DDAH) II, the responsible enzyme for the degradation of ADMA, leading to a reduction in ADMA levels. Vaspin-induced increase in DDAH II gene expression was through STAT3-mediated stimulation of DDAH II promoter activity. These results suggest that vaspin increases eNOS activity by reducing ADMA level through STAT3-mediated regulation of DDAH II expression. Our findings provide a novel molecular mechanism of antiatherogenic actions of vaspin.	[Jung, Chang Hee; Lee, Woo Je; Hwang, Jenie Yoonoo; Lee, Min Jung; Kim, Min-Seon; Park, Joong-Yeol] Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea; [Seol, So Mi; Kim, Yun Mi; La Lee, Yoo; Kim, Hyun Sik] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; University of Ulsan	Park, JY (corresponding author), Univ Ulsan, Coll Med, Dept Internal Med, Seoul, South Korea.	jypark@amc.seoul.kr	Jung, Chang Hee/AAU-7897-2020	Jung, Chang Hee/0000-0003-4043-2396	Asan Institute of Life Sciences, Republic of Korea [2011-122, 2012-122]	Asan Institute of Life Sciences, Republic of Korea	This work was supported by grants (2011-122, 2012-122) from the Asan Institute of Life Sciences, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2002, CIRC RES, V90, P764, DOI 10.1161/01.RES.0000014450.40853.2B; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Boger RH, 2003, CLIN CHEM LAB MED, V41, P1467, DOI 10.1515/CCLM.2003.225; Burdelya L, 2005, J IMMUNOL, V174, P3925, DOI 10.4049/jimmunol.174.7.3925; Chan NN, 2002, DIABETOLOGIA, V45, P1609, DOI 10.1007/s00125-002-0975-6; Cho JK, 2010, EUR J APPL PHYSIOL, V108, P347, DOI 10.1007/s00421-009-1238-8; Choi SH, 2011, CLIN ENDOCRINOL OXF; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Fu XY, 2006, CELL RES, V16, P214, DOI 10.1038/sj.cr.7310029; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Inoue H, 2004, NAT MED, V10, P168, DOI 10.1038/nm980; Ito A, 1999, CIRCULATION, V99, P3092, DOI 10.1161/01.CIR.99.24.3092; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Kadoglou NPE, 2011, CLIN CHIM ACTA, V412, P48, DOI 10.1016/j.cca.2010.09.012; Kajimoto H, 2012, KIDNEY INT, V81, P762, DOI 10.1038/ki.2011.476; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kawashima S, 2004, ARTERIOSCL THROM VAS, V24, P998, DOI 10.1161/01.ATV.0000125114.88079.96; Kira M, 2002, J BIOL CHEM, V277, P12931, DOI 10.1074/jbc.M110795200; Koiou E, 2011, ENDOCR J, V58, P237, DOI 10.1507/endocrj.K10E-330; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V332, P885, DOI 10.1016/j.bbrc.2005.05.035; Lee WJ, 2010, BIOCHEM BIOPH RES CO, V398, P653, DOI 10.1016/j.bbrc.2010.06.127; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; MacAllister RJ, 1996, BRIT J PHARMACOL, V119, P1533, DOI 10.1111/j.1476-5381.1996.tb16069.x; Malin DH, 1998, PSYCHOPHARMACOLOGY, V140, P371, DOI 10.1007/s002130050778; Matsukawa A, 2005, J IMMUNOL, V175, P3354, DOI 10.4049/jimmunol.175.5.3354; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Paiva H, 2002, J AM COLL CARDIOL, V40, P1241, DOI 10.1016/S0735-1097(02)02174-5; Phalitakul S, 2012, BIOCHEM BIOPH RES CO, V423, P844, DOI 10.1016/j.bbrc.2012.06.052; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Steinberg HO, 1997, J CLIN INVEST, V100, P1230, DOI 10.1172/JCI119636; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tan BK, 2008, DIABETES, V57, P1501, DOI 10.2337/db08-0127; Tan B, 2007, VASC PHARMACOL, V46, P338, DOI 10.1016/j.vph.2006.11.006; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Wada J, 2008, EXPERT OPIN INV DRUG, V17, P327, DOI 10.1517/13543784.17.3.327 ; Wadham C, 2009, EXPERT OPIN DRUG MET, V5, P303, DOI [10.1517/17425250902785172 , 10.1517/17425250902785172]; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Won JC, 2010, ARTERIOSCL THROM VAS, V30, P290, DOI 10.1161/ATVBAHA.109.198721; Yang TL, 2005, N-S ARCH PHARMACOL, V371, P401, DOI 10.1007/s00210-005-1060-8; Yin QF, 2005, J CARDIOVASC PHARM, V45, P525, DOI 10.1097/01.fjc.0000159642.44523.7f; You BS, 2008, DIABETES, V57, P372, DOI 10.2337/db07-1045; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zanetti M, 2001, AM J PHYSIOL-HEART C, V280, pH2516, DOI 10.1152/ajpheart.2001.280.6.H2516; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje	51	47	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52346	10.1371/journal.pone.0052346	http://dx.doi.org/10.1371/journal.pone.0052346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284999	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500028
J	Gillmaier, N; Gotz, A; Schulz, A; Eisenreich, W; Goebel, W				Gillmaier, Nadine; Goetz, Andreas; Schulz, Anette; Eisenreich, Wolfgang; Goebel, Werner			Metabolic Responses of Primary and Transformed Cells to Intracellular Listeria monocytogenes	PLOS ONE			English	Article							CARBON METABOLISM; GLUTAMINE-METABOLISM; PYRUVATE-CARBOXYLASE; ENERGY-METABOLISM; INTERFERON-GAMMA; GENE-EXPRESSION; NITRIC-OXIDE; IFN-GAMMA; MYC; ACTIVATION	The metabolic response of host cells, in particular of primary mammalian cells, to bacterial infections is poorly understood. Here, we compare the carbon metabolism of primary mouse macrophages and of established J774A.1 cells upon Listeria monocytogenes infection using C-13-labelled glucose or glutamine as carbon tracers. The C-13-profiles of protein-derived amino acids from labelled host cells and intracellular L. monocytogenes identified active metabolic pathways in the different cell types. In the primary cells, infection with live L. monocytogenes increased glycolytic activity and enhanced flux of pyruvate into the TCA cycle via pyruvate dehydrogenase and pyruvate carboxylase, while in J774A.1 cells the already high glycolytic and glutaminolytic activities hardly changed upon infection. The carbon metabolism of intracellular L. monocytogenes was similar in both host cells. Taken together, the data suggest that efficient listerial replication in the cytosol of the host cells mainly depends on the glycolytic activity of the hosts.	[Gillmaier, Nadine; Eisenreich, Wolfgang] Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany; [Goetz, Andreas; Schulz, Anette; Goebel, Werner] Univ Munich, Max von Pettenkofer Inst, Munich, Germany	Technical University of Munich; University of Munich	Eisenreich, W (corresponding author), Tech Univ Munich, Lehrstuhl Biochem, Garching, Germany.	wolfgang.eisenreich@mytum.de; goebel@biozentrum.uni-wuerzburg.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Goebel, Werner/0000-0003-4851-2083	German Research Foundation (DFG) [Go168/28-1, EI 384/5-2 (SPP1316)]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the grants Go168/28-1 and EI 384/5-2 (SPP1316) from the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, INT MICROBIOL, V7, P181; Beiting DP, 2011, IMMUNOL REV, V240, P117, DOI 10.1111/j.1600-065X.2010.00998.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Daye D, 2012, SEMIN CELL DEV BIOL, V23, P362, DOI 10.1016/j.semcdb.2012.02.002; De Stefano D, 2006, J MOL MED, V84, P65, DOI 10.1007/s00109-005-0713-x; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; FAN K, 1993, J CELL PHYSIOL, V154, P535, DOI 10.1002/jcp.1041540312; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Fuchs TM, 2012, FEMS MICROBIOL REV, V36, P435, DOI 10.1111/j.1574-6976.2011.00301.x; Gao D, 2009, BIOCHEM BIOPH RES CO, V388, P278, DOI 10.1016/j.bbrc.2009.07.160; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Holleran AL, 1995, MOL CELL BIOCHEM, V152, P95, DOI 10.1007/BF01076071; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jarasch N, 2005, VIRAL IMMUNOL, V18, P355, DOI 10.1089/vim.2005.18.355; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; LEE WNP, 1991, BIOL MASS SPECTROM, V20, P451, DOI 10.1002/bms.1200200804; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; MATEO RB, 1995, AM J PHYSIOL-CELL PH, V268, pC669, DOI 10.1152/ajpcell.1995.268.3.C669; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; PICKUP JF, 1976, ANAL CHEM, V48, P1885, DOI 10.1021/ac50007a019; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; RALPH P, 1975, NATURE, V257, P393, DOI 10.1038/257393a0; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; WARBURG O, 1956, SCIENCE, V124, P269; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yin CQ, 2012, CRIT REV EUKAR GENE, V22, P17, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.20; Zamboni N, 2009, CURR OPIN MICROBIOL, V12, P553, DOI 10.1016/j.mib.2009.08.003	52	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52378	10.1371/journal.pone.0052378	http://dx.doi.org/10.1371/journal.pone.0052378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285016	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800057
J	Moodley, A; Rae, W; Bhigjee, A; Connolly, C; Devparsad, N; Michowicz, A; Harrison, T; Loyse, A				Moodley, Anand; Rae, William; Bhigjee, Ahmed; Connolly, Cathy; Devparsad, Natasha; Michowicz, Andrew; Harrison, Thomas; Loyse, Angela			Early Clinical and Subclinical Visual Evoked Potential and Humphrey's Visual Field Defects in Cryptococcal Meningitis	PLOS ONE			English	Article							VAR GATTII MENINGITIS; AIDS PATIENTS; OPTIC-NERVE; SUDDEN BLINDNESS; SOUTH-AFRICA; INFECTION; PRESSURE; PATIENT	Cryptococcal induced visual loss is a devastating complication in survivors of cryptococcal meningitis (CM). Early detection is paramount in prevention and treatment. Subclinical optic nerve dysfunction in CM has not hitherto been investigated by electrophysiological means. We undertook a prospective study on 90 HIV sero-positive patients with culture confirmed CM. Seventy-four patients underwent visual evoked potential (VEP) testing and 47 patients underwent Humphrey's visual field (HVF) testing. Decreased best corrected visual acuity (BCVA) was detected in 46.5% of patients. VEP was abnormal in 51/74 (68.9%) right eyes and 50/74 (67.6%) left eyes. VEP P100 latency was the main abnormality with mean latency values of 118.9 (+/-16.5) ms and 119.8 (+/-15.7) ms for the right and left eyes respectively, mildly prolonged when compared to our laboratory references of 104 (+/-10) ms (p<0.001). Subclinical VEP abnormality was detected in 56.5% of normal eyes and constituted mostly latency abnormality. VEP amplitude was also significantly reduced in this cohort but minimally so in the visually unimpaired. HVF was abnormal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The predominant field defect was peripheral constriction with an enlarged blind spot suggesting the greater impact by raised intracranial pressure over that of optic neuritis. Whether this was due to papilloedema or a compartment syndrome is open to further investigation. Subclinical HVF abnormalities were minimal and therefore a poor screening test for early optic nerve dysfunction. However, early optic nerve dysfunction can be detected by testing of VEP P100 latency, which may precede the onset of visual loss in CM.	[Moodley, Anand; Devparsad, Natasha] Greys Hosp, Dept Neurol, Pietermaritzburg, South Africa; [Rae, William] Univ Free State, Dept Med Phys, Bloemfontein, South Africa; [Moodley, Anand; Bhigjee, Ahmed] Univ KwaZulu Natal, Dept Neurol, Durban, South Africa; [Connolly, Cathy] MRC, Biostat Unit, Durban, South Africa; [Michowicz, Andrew] Edendale Hosp, Dept Med, Pietermaritzburg, South Africa; [Harrison, Thomas; Loyse, Angela] St Georges Univ London, Div Clin Sci, Res Ctr Infect & Immun, Cryptococcal Meningitis Grp, London, England	University of the Free State; University of Kwazulu Natal; St Georges University London	Moodley, A (corresponding author), Greys Hosp, Dept Neurol, Pietermaritzburg, South Africa.	anand.moodley@kznhealth.gov.za		Loyse, Angela/0000-0001-7853-1344; Moodley, Anand/0000-0002-8205-9342; Harrison, Thomas/0000-0003-3619-4348	Medical Research Council [RN 2721]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was partly sponsored by the Medical Research Council, grant number RN 2721. No additional external funding received for this study. Sponsorship was for technical and statistical costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claus JJ, 1998, CLIN NEUROL NEUROSUR, V100, P51, DOI 10.1016/S0303-8467(97)00119-4; COHEN DB, 1993, OPHTHALMOLOGY, V100, P1689, DOI 10.1016/S0161-6420(93)31416-8; Corti M, 2010, REV IBEROAM MICOL, V27, P207, DOI 10.1016/j.riam.2010.09.002; De Schacht C, 2005, ACTA CLIN BELG, V60, P10, DOI 10.1179/acb.2005.003; Ferreira RC, 1997, AM J OPHTHALMOL, V124, P558, DOI 10.1016/S0002-9394(14)70877-3; Jabs D A, 1995, Trans Am Ophthalmol Soc, V93, P623; JOHNSTON SRD, 1992, J INFECTION, V24, P185, DOI 10.1016/0163-4453(92)92954-H; Kestelyn P, 1997, T ROY SOC TROP MED H, V91, P727, DOI 10.1016/S0035-9203(97)90542-3; Killer HE, 2011, ACTA OPHTHALMOL, V89, pE472, DOI 10.1111/j.1755-3768.2011.02182.x; Lightowler JVJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008630; LIPSON BK, 1989, AM J OPHTHALMOL, V107, P523, DOI 10.1016/0002-9394(89)90498-4; MALESSA R, 1995, J NEUROL SCI, V130, P82, DOI 10.1016/0022-510X(95)00002-J; Milman T, 2008, CLIN OPHTHALMOL, V2, P637; Moodley A, 2012, NEURO-OPHTHALMOLOGY, V36, P186, DOI 10.3109/01658107.2012.715716; Moosa MYS, 1997, CLIN INFECT DIS, V24, P131, DOI 10.1093/clinids/24.2.131; Mwanza JC, 2004, BRIT J OPHTHALMOL, V88, P1455, DOI 10.1136/bjo.2004.044289; Ng C. W., 2000, SMJ, V41, P80; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Orem J, 2005, TROP DOCT, V35, P19, DOI 10.1258/0049475053001967; REX JH, 1993, MEDICINE, V72, P207, DOI 10.1097/00005792-199307000-00001; Seaton RA, 1997, T ROY SOC TROP MED H, V91, P50, DOI 10.1016/S0035-9203(97)90393-X; Seaton RA, 1997, T ROY SOC TROP MED H, V91, P44, DOI 10.1016/S0035-9203(97)90391-6; Torres OH, 1999, AIDS, V13, P530, DOI 10.1097/00002030-199903110-00018	23	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52895	10.1371/journal.pone.0052895	http://dx.doi.org/10.1371/journal.pone.0052895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285220	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000313158800107
J	Pascual, G; Sotomayor, S; Rodriguez, M; Perez-Kohler, R; Bellon, JM				Pascual, Gemma; Sotomayor, Sandra; Rodriguez, Marta; Perez-Koehler, Rarbara; Bellon, Juan M.			Repair of Abdominal Wall Defects with Biodegradable Laminar Prostheses: Polymeric or Biological?	PLOS ONE			English	Article							HERNIA REPAIR; CROSS-LINKING; TISSUE; MESHES; ACTIVATION; MODEL	Introduction: Biological and synthetic laminar absorbable prostheses are available for the repair of hernia defects in the abdominal wall. They share the important feature of being gradually degraded in the host, resulting in place the formation of a neotissue. This study was designed to assess the host tissue's incorporation of collagen bioprostheses and a synthetic absorbable prosthesis. Methods: Partial defects were created in the abdominal walls of 72 New Zealand rabbits and repaired using collagen bioprostheses Tutomesh (R) and Strattice (R) or a synthetic prosthesis Bio-A (R). Specimens were collected for light microscopy, collagens gene and protein expression, macrophage response and biomechanical resistance at 14, 30, 90 and 180 days post-implantation. Results: Tutomesh (R) and Bio-A (R) were gradually infiltrated by the host tissue and almost completely degraded by 180 days post-implantation. In contrast, Strattice (R) exhibited material encapsulation, no prosthetic degradation and low cell infiltration at earlier timepoints, whereas at later study time, collagen deposition could be observed within the mesh. In the short term, Bio-A (R) exhibited higher level of collagen 1 and 3 mRNA expression compared with the two other biological prostheses, which exhibited two peaks of higher expression at 14 and 90 days. The expression of collagen III was homogeneous throughout the study and collagen I deposition was more evident in Strattice (R). Macrophage response decreased over time in biomeshes. However, in the synthetic mesh remained high and homogeneous until 90 days. The biomechanical analysis demonstrated the progressively increasing tensile strength of all biomaterials. Conclusions: The tissue infiltration of laminar absorbable prostheses is affected by the structure and composition of the mesh. The synthetic prosthesis exhibited a distinct pattern of tissue incorporation and a greater macrophage response than did the biological prostheses. Of all of the laminar, absorbable biomaterials that were tested in this study, StratticeH demonstrated the optimal levels of integration and degradation.	[Rodriguez, Marta; Bellon, Juan M.] Alcala Univ, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Surg, Madrid, Spain; [Pascual, Gemma; Sotomayor, Sandra; Perez-Koehler, Rarbara] Alcala Univ, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Med Specialties, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala	Bellon, JM (corresponding author), Alcala Univ, Fac Med, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Dept Surg, Madrid, Spain.	juanm.bellon@uah.es	Köhler, Bárbara Pérez/M-1858-2019; PASCUAL, GEMMA/M-6564-2016	Köhler, Bárbara Pérez/0000-0002-5061-1526; BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384; Sotomayor Nunez, Sandra/0000-0003-4998-762X	Fundacion Mutua Madrilena, Madrid, Spain [FMM08]; Spanish Ministry of Science and Technology [DPI2011-27939-C02-02]	Fundacion Mutua Madrilena, Madrid, Spain; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by a grant from the Fundacion Mutua Madrilena 2008 (FMM08), Madrid, Spain, and by the Spanish Ministry of Science and Technology through the research project DPI2011-27939-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellows CF, 2012, AM J SURG, V3; Bellows CF, 2007, AM J SURG, V194, P192, DOI 10.1016/j.amjsurg.2006.11.012; Buchberg B, 2010, AM SURGEON, V76, P1150; Burgess PL, 2011, J SURG EDUC, V68, P62, DOI 10.1016/j.jsurg.2010.09.006; Butler CE, 2010, J AM COLL SURGEONS, V211, P368, DOI 10.1016/j.jamcollsurg.2010.04.024; Campbell KT, 2011, PLAST RECONSTR SURG, V127, P2321, DOI 10.1097/PRS.0b013e318213a053; Cavallaro A, 2010, WORLD J GASTROENTERO, V16, P1928, DOI 10.3748/wjg.v16.i15.1928; Connor J, 2009, REGEN MED, V4, P185, DOI 10.2217/17460751.4.2.185; Efthimiou M, 2011, HERNIA, V15, P181, DOI 10.1007/s10029-010-0765-x; Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2; Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609; Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397; Jenkins ED, 2010, J AM COLL SURGEONS, V210, P402, DOI 10.1016/j.jamcollsurg.2009.12.001; Kapan S, 2003, Hernia, V7, P39; Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109; Limpert JN, 2009, AM J SURG, V198, P60; Losanoff J E, 2002, Hernia, V6, P144; Ngo MD, 2011, CELL TISSUE BANK, V12, P135, DOI 10.1007/s10561-011-9245-5; Mulier KE, 2011, HERNIA, V15, P315, DOI 10.1007/s10029-010-0777-6; Orenstein SB, 2010, HERNIA, V14, P401, DOI 10.1007/s10029-010-0634-7; Orenstein SB, 2010, SURG ENDOSC, V24, P805, DOI 10.1007/s00464-009-0664-3; Pascual G, 2012, WOUND REPAIR REGEN, V20, P402, DOI 10.1111/j.1524-475X.2012.00781.x; Petter-Puchner AH, 2008, J SURG RES, V145, P105, DOI 10.1016/j.jss.2007.03.090; Ratto C, 2012, COLORECTAL DIS, V14, pe264, DOI 10.1111/j.1463-1318.2012.02964.x; Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317	25	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52628	10.1371/journal.pone.0052628	http://dx.doi.org/10.1371/journal.pone.0052628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285119	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800083
J	Klenke, C; Janowski, S; Borck, D; Widera, D; Ebmeyer, J; Kalinowski, J; Leichtle, A; Hofestadt, R; Upile, T; Kaltschmidt, C; Kaltschmidt, B; Sudhoff, H				Klenke, Christin; Janowski, Sebastian; Borck, Daniela; Widera, Darius; Ebmeyer, Joerg; Kalinowski, Joern; Leichtle, Anke; Hofestaedt, Ralf; Upile, Tahwinder; Kaltschmidt, Christian; Kaltschmidt, Barbara; Sudhoff, Holger			Identification of Novel Cholesteatoma-Related Gene Expression Signatures Using Full-Genome Microarrays	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; GROWTH; EPITHELIUM; INHIBITOR; REGULATOR; PATTERNS; PROLIFERATION; INFLAMMATION; LAMININ-5; MIGRATION	Background: Cholesteatoma is a gradually expanding destructive epithelial lesion within the middle ear. It can cause extensive local tissue destruction in the temporal bone and can initially lead to the development of conductive hearing loss via ossicular erosion. As the disease progresses, sensorineural hearing loss, vertigo or facial palsy may occur. Cholesteatoma may promote the spread of infection through the tegmen of the middle ear and cause meningitis or intracranial infections with abscess formation. It must, therefore, be considered as a potentially life-threatening middle ear disease. Methods and Findings: In this study, we investigated differentially expressed genes in human cholesteatomas in comparison to regular auditory canal skin using Whole Human Genome Microarrays containing 19,596 human genes. In addition to already described up-regulated mRNAs in cholesteatoma, such as MMP9, DEFB2 and KRT19, we identified 3558 new cholesteatoma-related transcripts. 811 genes appear to be significantly differentially up-regulated in cholesteatoma. 334 genes were down-regulated more than 2-fold. Significantly regulated genes with protein metabolism activity include matrix metalloproteinases as well as PI3, SERPINB3 and SERPINB4. Genes like SPP1, KRT6B, PRPH, SPRR1B and LAMC2 are known as genes with cell growth and/or maintenance activity. Transport activity genes and signal transduction genes are LCN2, GJB2 and CEACAM6. Three cell communication genes were identified; one CDH19 and two from the S100 family. Conclusions: This study demonstrates that the expression profile of cholesteatoma is similar to a metastatic tumour and chronically inflamed tissue. Based on the investigated profiles we present novel protein-protein interaction and signal transduction networks, which include cholesteatoma-regulated transcripts and may be of great value for drug targeting and therapy development.	[Klenke, Christin; Ebmeyer, Joerg; Leichtle, Anke; Sudhoff, Holger] Klinikum Bielefeld, Dept Otolaryngol & Head & Neck Surg, Bielefeld, Germany; [Janowski, Sebastian; Borck, Daniela; Hofestaedt, Ralf] Univ Bielefeld, Bioinformat Dept, D-33615 Bielefeld, Germany; [Upile, Tahwinder] Univ Coll London Hosp, Dept Otolaryngol & Head & Neck Surg, London, England; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany	University of Bielefeld; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Bielefeld	Klenke, C (corresponding author), Klinikum Bielefeld, Dept Otolaryngol & Head & Neck Surg, Bielefeld, Germany.	christin.zander@klinikumbielefeld.de	Leichtle, Anke/AAA-3505-2020; Sudhoff, Holger/AAV-9741-2020; Widera, Darius/J-4237-2012; Leichtle, Anke/GPW-7895-2022	Sudhoff, Holger/0000-0002-9274-5645; Widera, Darius/0000-0003-1686-130X; 	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany	This study was sponsored by Klosterfrau Healthcare Group, Cassella-med GmbH & Co. KG, Cologne, Germany. The study sponsor did not participate in study design and data analysis. Cassella-med had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Alam SR, 2012, BIOCHEM PHARMACOL, V83, P695, DOI 10.1016/j.bcp.2011.11.003; Blake J, 2003, HISTOL HISTOPATHOL, V18, P529, DOI 10.14670/HH-18.529; Blons H, 2002, ONCOGENE, V21, P5016, DOI 10.1038/sj.onc.1205626; Carey JPW, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-173; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chen SS, 2011, BLOOD, V117, P862, DOI 10.1182/blood-2010-05-284638; Dornelles Cristina, 2006, Braz J Otorhinolaryngol, V72, P641; Dremmen MHG, 2012, AM J NEURORADIOL, V33, P439, DOI 10.3174/ajnr.A2824; Duxbury MS, 2004, BRIT J CANCER, V91, P1384, DOI 10.1038/sj.bjc.6602113; Elek J, 2000, IN VIVO, V14, P173; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Himoudi N, 2007, CANCER IMMUNOL IMMUN, V56, P1381, DOI 10.1007/s00262-007-0294-3; Huisman MA, 2008, LARYNGOSCOPE, V118, P94, DOI 10.1097/MLG.0b013e31814faafa; Janowski Sebastian, 2011, Stud Health Technol Inform, V162, P182; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim HJ, 2002, J KOREAN MED SCI, V17, P381, DOI 10.3346/jkms.2002.17.3.381; Kim HJ, 2002, OTOL NEUROTOL, V23, P840, DOI 10.1097/00129492-200211000-00005; Kojima H, 1999, ARCH OTOLARYNGOL, V125, P738, DOI 10.1001/archotol.125.7.738; Kwon KH, 2006, ACTA OTO-LARYNGOL, V126, P691, DOI 10.1080/00016480500475633; Lee HM, 2004, J PERIODONTOL, V75, P453, DOI 10.1902/jop.2004.75.3.453; LEE RJ, 1994, CLIN OTOLARYNGOL, V19, P516, DOI 10.1111/j.1365-2273.1994.tb01280.x; Li C, 2011, CYTOKINE, V56, P435, DOI 10.1016/j.cyto.2011.07.021; Li S, 2008, INVEST OPHTH VIS SCI, V49, P34, DOI 10.1167/iovs.07-0685; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; LIM DJ, 1972, ANN OTO RHINOL LARYN, V81, P2, DOI 10.1177/000348947208100102; Makiishi-Shimobayashi C, 2004, AURIS NASUS LARYNX, V31, P3, DOI 10.1016/j.anl.2003.11.010; Masui T, 2003, CLIN CANCER RES, V9, P1779; Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977; Nunes LMA, 2010, INT ARCH OTORHINOLAR; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Oka T, 2009, WORLD J GASTROENTERO, V15, P3865, DOI 10.3748/wjg.15.3865; Olszewska E, 2007, HISTOL HISTOPATHOL, V22, P37, DOI 10.14670/HH-22.37; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Shunyu NB, 2011, OTOLARYNG HEAD NECK, V145, P628, DOI 10.1177/0194599811409303; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sudhoff H, 2000, AM J OTOL, V21, P793; Sudhoff H, 1999, LARYNGO RHINO OTOL, V78, P63, DOI 10.1055/s-2007-996832; Sudhoff H, 2007, EUR ARCH OTO-RHINO-L, V264, P1137, DOI 10.1007/s00405-007-0340-y; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; WELLS MD, 1991, J LARYNGOL OTOL, V105, P261, DOI 10.1017/S0022215100115567; Xu JD, 2010, J ORTHOP RES, V28, P1621, DOI 10.1002/jor.21178; Yoshikawa M, 2006, ARCH OTOLARYNGOL, V132, P734, DOI 10.1001/archotol.132.7.734; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420	50	29	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52718	10.1371/journal.pone.0052718	http://dx.doi.org/10.1371/journal.pone.0052718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285167	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000312794500240
J	Ruffing, U; Akulenko, R; Bischoff, M; Helms, V; Herrmann, M; von Muller, L				Ruffing, Ulla; Akulenko, Ruslan; Bischoff, Markus; Helms, Volkhard; Herrmann, Mathias; von Mueller, Lutz			Matched-Cohort DNA Microarray Diversity Analysis of Methicillin Sensitive and Methicillin Resistant Staphylococcus aureus Isolates from Hospital Admission Patients	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CATABOLIC MOBILE ELEMENT; LOCUS VARIABLE-NUMBER; MULTIPLE-LOCUS; CLONAL COMPLEXES; SEQUENCE; MRSA; ASSIGNMENT; VIRULENCE; STRAINS	As genotyping of S. aureus is important for epidemiologic research and for hygiene management, methods are required for standardized fast and easily applicable evaluation of closely related epidemic strains with high prevalence in hospitals. In this single centre matched control study we compared a new commercially available DNA microarray (IdentiBAC) with standard spa-typing for S. aureus genotyping. Included in the study was a subgroup of 46 MRSA and matched 46 MSSA nasal isolates of the Saarland University Medical Center collected during a state-wide admission prevalence screening. Microarray (MA) and also spa-typing could easily differentiate the genetically diverse MSSA group. However, due to the predominance of CC5/t003 in the MRSA group a sufficient subtyping required analysis of more complex genetic profiles as was shown here by the MA comprising a total number of 334 different hybridization probes. The genetic repertoire of the MRSA group was characterized by more virulence genes as compared to the MSSA group. The standard evaluation of MA results by the original software into CCs, agr-, SCCmec- and capsule-types was substituted in the present study by implementation of multivariate subtyping of closely related CC5 isolates using three different bioinformatic methods (splits graph, cluster dendrogram, and principal component analysis). Each method used was applicable for standardized and highly discriminative subtyping with high concordance. We propose that the identified S. aureus subtypes with characteristic virulence gene profiles are presumably associated also with virulence and pathogenicity in vivo; however, this remains to be analyzed in future studies. MA was superior to spa-typing for epidemiologic and presumably also provide functional respectively virulence associated characterization of S. aureus isolates. This is of specific importance for the hospital setting. In future, MA could become a new standard test for S. aureus typing in combination with multivariate bioinformatic analysis. Citation: Ruffing U, Akulenko R, Bischoff M, Helms V, Herrmann M, et al. (2012) Matched-Cohort DNA Microarray Diversity Analysis of Methicillin Sensitive and Methicillin Resistant Staphylococcus aureus Isolates from Hospital Admission Patients. PLoS ONE 7(12): e52487. doi:10.1371/journal.pone.0052487	[Ruffing, Ulla; Bischoff, Markus; Herrmann, Mathias; von Mueller, Lutz] Univ Saarland, Inst Med Microbiol & Hyg, Med Ctr, D-6650 Homburg, Germany; [Akulenko, Ruslan; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany	Saarland University; Saarland University	von Muller, L (corresponding author), Univ Saarland, Inst Med Microbiol & Hyg, Med Ctr, D-6650 Homburg, Germany.	lutz.mueller@uks.eu	Bischoff, Markus/D-2130-2014; Herrmann, Mathias/B-6475-2013	Bischoff, Markus/0000-0001-6734-2732; Herrmann, Mathias/0000-0003-2638-2257; von Muller, Lutz/0000-0001-9013-4245; Helms, Volkhard/0000-0002-2180-9154	Deutsche Forschungsgemeinschaft [1850/9-1]; Federal Ministry for Education and Science (BMBF grant) [01KI1014B]; State of Saarland; German Ministry of Health [IIA5-2509NIK008/321-4532-04/21]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry for Education and Science (BMBF grant); State of Saarland; German Ministry of Health	This study was supported by the Deutsche Forschungsgemeinschaft (He 1850/9-1 to M.H.) and the Federal Ministry for Education and Science (BMBF grant #01KI1014B to MH and MB). Alere Inc. contributed to the study by supplying the IdentiBAC ArrayMateTM Reader and the imaging software Iconoclust. The isolates were collected in the context of the admission prevalence screening carried out by the MRSA Network Saarland (www.mrsaar.net) funded by the State of Saarland and the German Ministry of Health (IIA5-2509NIK008/321-4532-04/21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Beiko RG, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-34; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Deurenberg RH, 2009, DIAGN MICR INFEC DIS, V65, P116, DOI 10.1016/j.diagmicrobio.2009.07.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Dunman PM, 2004, J CLIN MICROBIOL, V42, P4275, DOI 10.1128/JCM.42.9.4275-4283.2004; Francois P, 2005, J CLIN MICROBIOL, V43, P3346, DOI 10.1128/JCM.43.7.3346-3355.2005; Friedrich A W, 2008, Euro Surveill, V13; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Goering RV, 2007, J CLIN MICROBIOL, V45, P1981, DOI 10.1128/JCM.00273-07; Gorwitz RJ, 2008, PEDIATR INFECT DIS J, V27, P1, DOI 10.1097/INF.0b013e31815819bb; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P326, DOI 10.1093/jac/dkr499; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holmes A, 2010, J CLIN MICROBIOL, V48, P3600, DOI 10.1128/JCM.01039-10; Horvath A, 2012, EUR J CLIN MICROBIOL, V31, P2029, DOI 10.1007/s10096-011-1536-z; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kawaguchiya M, 2011, MICROB DRUG RESIST, V17, P241, DOI 10.1089/mdr.2010.0136; Kock R, 2011, J HOSP INFECT, V79, P292, DOI 10.1016/j.jhin.2011.08.011; Kock R, 2010, EUROSURVEILLANCE, V15, P12, DOI 10.2807/ese.15.41.19688-en; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Lamy B, 2012, EUR J CLIN MICROBIOL, V31, P1279, DOI 10.1007/s10096-011-1441-5; Lina G, 2004, J INFECT DIS, V189, P2334, DOI 10.1086/420852; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2005, CLIN MICROBIOL INFEC, V11, P825, DOI 10.1111/j.1469-0691.2005.01243.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1383, DOI 10.1007/s10096-009-0796-3; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2011, VET MICROBIOL, V150, P309, DOI 10.1016/j.vetmic.2011.02.001; Moore PCL, 2001, J CLIN MICROBIOL, V39, P2760, DOI 10.1128/JCM.39.8.2760-2767.2001; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; Nuebel U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032698; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pryer JA, 2001, J EPIDEMIOL COMMUN H, V55, P29, DOI 10.1136/jech.55.1.29; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Sakwinska O, 2009, APPL ENVIRON MICROB, V75, P175, DOI 10.1128/AEM.01860-08; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Young BC, 2012, P NATL ACAD SCI USA, V109, P4550, DOI 10.1073/pnas.1113219109; Zhang MH, 2000, CRIT CARE MED, V28, pN60, DOI 10.1097/00003246-200004001-00007	56	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52487	10.1371/journal.pone.0052487	http://dx.doi.org/10.1371/journal.pone.0052487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285062	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500182
J	Simister, R; Taylor, MW; Tsai, P; Webster, N				Simister, Rachel; Taylor, Michael W.; Tsai, Peter; Webster, Nicole			Sponge-Microbe Associations Survive High Nutrients and Temperatures	PLOS ONE			English	Article							GREAT-BARRIER-REEF; AMMONIA-OXIDIZING ARCHAEA; 16S RIBOSOMAL-RNA; WATER-QUALITY; CORAL-REEFS; RHOPALOEIDES-ODORABILE; BACTERIAL COMMUNITIES; SUSPENDED SEDIMENTS; NITROGEN-FIXATION; ORGANIC-MATTER	Coral reefs are under considerable pressure from global stressors such as elevated sea surface temperature and ocean acidification, as well as local factors including eutrophication and poor water quality. Marine sponges are diverse, abundant and ecologically important components of coral reefs in both coastal and offshore environments. Due to their exceptionally high filtration rates, sponges also form a crucial coupling point between benthic and pelagic habitats. Sponges harbor extensive microbial communities, with many microbial phylotypes found exclusively in sponges and thought to contribute to the health and survival of their hosts. Manipulative experiments were undertaken to ascertain the impact of elevated nutrients and seawater temperature on health and microbial community dynamics in the Great Barrier Reef sponge Rhopaloeides odorabile. R. odorabile exposed to elevated nutrient levels including 10 mu mol/L total nitrogen at 31 degrees C appeared visually similar to those maintained under ambient seawater conditions after 7 days. The symbiotic microbial community, analyzed by 16S rRNA gene pyrotag sequencing, was highly conserved for the duration of the experiment at both phylum and operational taxonomic unit (OTU) (97% sequence similarity) levels with 19 bacterial phyla and 1743 OTUs identified across all samples. Additionally, elevated nutrients and temperatures did not alter the archaeal associations in R. odorabile, with sequencing of 16S rRNA gene libraries revealing similar Thaumarchaeota diversity and denaturing gradient gel electrophoresis (DGGE) revealing consistent amoA gene patterns, across all experimental treatments. A conserved eukaryotic community was also identified across all nutrient and temperature treatments by DGGE. The highly stable microbial associations indicate that R. odorabile symbionts are capable of withstanding short-term exposure to elevated nutrient concentrations and sub-lethal temperatures.	[Webster, Nicole] Australian Inst Marine Sci, Townsville Mail Ctr, Townsville, Qld 4810, Australia; [Simister, Rachel; Taylor, Michael W.] Univ Auckland, Ctr Microbial Innovat, Auckland 1, New Zealand; [Tsai, Peter] Univ Auckland, Sch Biol Sci, Bioinformat Inst, Auckland 1, New Zealand	Australian Institute of Marine Science; University of Auckland; University of Auckland	Webster, N (corresponding author), Australian Inst Marine Sci, Townsville Mail Ctr, PMB 3, Townsville, Qld 4810, Australia.	n.webster@aims.gov.au	Webster, Nicole S/G-4980-2011	Webster, Nicole S/0000-0002-4753-5278; Taylor, Michael/0000-0002-0463-7813; Tsai, Peter/0000-0002-9930-9029	University of Auckland Doctoral Scholarship; University of Auckland [3622989]	University of Auckland Doctoral Scholarship; University of Auckland	Research was supported by a University of Auckland Doctoral Scholarship to RLS and University of Auckland grant 3622989 to MWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2001, GBRMPA RES PUBLICATI; Bainbridge ZT, 2012, MAR POLLUT BULL, V65, P236, DOI 10.1016/j.marpolbul.2012.01.043; Bannister R, 2008, THESIS JCU TOWNSVILL; Bannister RJ, 2012, CONT SHELF RES, V32, P86, DOI 10.1016/j.csr.2011.10.018; Bannister RJ, 2010, MAR FRESHWATER RES, V61, P389, DOI 10.1071/MF09067; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bell JJ, 2008, ESTUAR COAST SHELF S, V79, P341, DOI 10.1016/j.ecss.2008.05.002; BRODIE J, 1996, DOWNSTREAM EFFECTS L, P367; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie JE, 2011, BIOGEOCHEMISTRY, V106, P281, DOI 10.1007/s10533-010-9542-2; Brodie JE, 2005, MAR FRESHWATER RES, V56, P279, DOI 10.1071/MF04081; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Brodie J, 2010, MAR FRESHWATER RES, V61, P651, DOI 10.1071/MF08030; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Carlson CA, 2002, AQUAT MICROB ECOL, V30, P19, DOI 10.3354/ame030019; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Caron DA, 2000, AQUAT MICROB ECOL, V22, P175, DOI 10.3354/ame022175; Cebrian E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020211; Cervino JM, 2006, MAR ECOL PROG SER, V324, P139, DOI 10.3354/meps324139; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Crow JM, 2011, NATURE, DOI [10.1038/news.2011.21, DOI 10.1038/NEWS.2011.21]; Crump BC, 2007, APPL ENVIRON MICROB, V73, P6802, DOI 10.1128/AEM.00648-07; De'ath G, 2010, ECOL APPL, V20, P840, DOI 10.1890/08-2023.1; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Devlin MJ, 2005, MAR POLLUT BULL, V51, P9, DOI 10.1016/j.marpolbul.2004.10.037; Diaz MC, 2004, B MUS I BIOL U GEN, V68, P279; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Fiore CL, 2010, TRENDS MICROBIOL, V18, P455, DOI 10.1016/j.tim.2010.07.001; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garren M, 2012, ISME J, V6, P1159, DOI 10.1038/ismej.2011.180; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Gochfeld DJ, 2012, MAR ECOL PROG SER, V456, P101, DOI 10.3354/meps09716; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Humphrey C, 2008, CORAL REEFS, V27, P837, DOI 10.1007/s00338-008-0408-1; Hyde KD, 1998, BIODIVERS CONSERV, V7, P1147, DOI 10.1023/A:1008823515157; IPCC, 2007, CLIM CHANG 2007 PHYS; Joachimiak MP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-225; Kaczmarsky L, 2011, CORAL REEFS, V30, P253, DOI 10.1007/s00338-010-0686-2; Kim K, 2002, ASPERGILLOSIS SEA FA, P813; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Klotzbach PJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025881; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Kroon FJ, 2012, MAR POLLUT BULL, V65, P261, DOI 10.1016/j.marpolbul.2011.10.030; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lemoine N, 2007, PORIFERA RES BIODIVE; Looney EE, 2010, ENVIRON MICROBIOL, V12, P2479, DOI 10.1111/j.1462-2920.2010.02221.x; Lopez-Legentil S, 2008, MOL ECOL, V17, P1840, DOI 10.1111/j.1365-294X.2008.03667.x; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Louden D, 2007, AQUACULTURE, V270, P57, DOI 10.1016/j.aquaculture.2007.02.038; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MARTINEZMURCIA AJ, 1995, FEMS MICROBIOL ECOL, V17, P247, DOI 10.1111/j.1574-6941.1995.tb00149.x; Maso M, 2006, MAR POLLUT BULL, V53, P620, DOI 10.1016/j.marpolbul.2006.08.006; Massaro AJ, 2012, J EXP MAR BIOL ECOL, V416, P55, DOI 10.1016/j.jembe.2012.02.008; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Meyer-Reil LA, 2000, MAR POLLUT BULL, V41, P255, DOI 10.1016/S0025-326X(00)00114-4; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Negri AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019703; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Off S, 2010, APPL ENVIRON MICROB, V76, P4640, DOI 10.1128/AEM.00320-10; Ovreas L, 2003, AQUAT MICROB ECOL, V31, P109, DOI 10.3354/ame031109; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pantile R, 2011, MAR ECOL PROG SER, V431, P97, DOI 10.3354/meps09128; Preston CM, 1996, P NATL ACAD SCI USA, V93, P6241, DOI 10.1073/pnas.93.13.6241; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; Riegman R, 1995, WATER SCI TECHNOL, V32, P63, DOI 10.1016/0273-1223(95)00682-6; Roberts DE, 2006, MAR ECOL PROG SER, V307, P143, DOI 10.3354/meps307143; RYLE VD, 1981, AIMS OCEANOGRAPHY SE, V3; Schafer H, 2001, FEMS MICROBIOL ECOL, V34, P243, DOI 10.1016/S0168-6496(00)00102-1; Schaffelke B, 2012, MAR POLLUT BULL, V65, P249, DOI 10.1016/j.marpolbul.2011.10.031; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; Shi YM, 2012, ENVIRON MICROBIOL, V14, P191, DOI 10.1111/j.1462-2920.2011.02598.x; Simister R, 2012, ENVIRON MICROBIOL, V14, P3232, DOI 10.1111/1462-2920.12010; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Simister RL, 2011, J EXP MAR BIOL ECOL, V397, P38, DOI 10.1016/j.jembe.2010.11.004; Sipura J, 2005, J PLANKTON RES, V27, P1261, DOI 10.1093/plankt/fbi092; Smit E, 1997, FEMS MICROBIOL ECOL, V23, P249, DOI 10.1111/j.1574-6941.1997.tb00407.x; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Steger D, 2008, ENVIRON MICROBIOL, V10, P1087, DOI 10.1111/j.1462-2920.2007.01515.x; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Teira E, 2010, AQUAT MICROB ECOL, V60, P299, DOI 10.3354/ame01435; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Uthicke S, 2012, CORAL REEFS, V31, P401, DOI 10.1007/s00338-011-0851-2; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Webster AJ, 2012, MAR POLLUT BULL, V65, P128, DOI 10.1016/j.marpolbul.2012.02.023; Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42; Webster NS, 2011, ENV MICROBIOL REP, V3, P756, DOI 10.1111/j.1758-2229.2011.00296.x; Webster NS, 2011, MAR BIOTECHNOL, V13, P296, DOI 10.1007/s10126-010-9300-4; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Whalan S, 2007, MAR BIOL, V153, P163, DOI 10.1007/s00227-007-0792-z; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; Wilkinson Clive R., 1992, P111; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Witt V, 2012, AQUAT MICROB ECOL, V66, P117, DOI 10.3354/ame01562; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	121	52	52	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52220	10.1371/journal.pone.0052220	http://dx.doi.org/10.1371/journal.pone.0052220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284943	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500118
J	Staniszewska, AD; Pensa, S; Caffarel, MM; Anderson, LH; Poli, V; Watson, CJ				Staniszewska, Anna D.; Pensa, Sara; Caffarel, Maria M.; Anderson, Lisa H.; Poli, Valeria; Watson, Christine J.			Stat3 Is Required to Maintain the Full Differentiation Potential of Mammary Stem Cells and the Proliferative Potential of Mammary Luminal Progenitors	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; SERIAL TRANSPLANTATION; GLAND INVOLUTION; EPITHELIAL-CELLS; TRANSGENIC MICE; SELF-RENEWAL; LIFE SPAN; IN-VIVO; ACTIVATION; GENE	Stat3 has a defined role in mammary gland where it is a critical mediator of cell death during post-lactational regression. On the other hand, Stat3 is required for the self-renewal of embryonic stem cells and is sufficient for the induction of a naive pluripotent state in epiblast stem cells. Mammary stem cells (MaSCs) have a high capacity for self-renewal and can grow robustly in transplantation experiments in vivo. However, a role for Stat3 in MaSCs has not been investigated. Here we show that depletion of Stat3 from basal cells results in reduced primary transplantation efficiency and diminishes the potential to generate ductal, but not alveolar, outgrowths. In addition, Stat3 is required for maximal proliferation of luminal progenitors.	[Staniszewska, Anna D.; Pensa, Sara; Caffarel, Maria M.; Anderson, Lisa H.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Poli, Valeria] Univ Turin, Ctr Mol Biotechnol, Dept Genet Biol & Biochem, Turin, Italy	University of Cambridge; University of Turin	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	cjw53@cam.ac.uk	Poli, Valeria/A-9215-2012	Poli, Valeria/0000-0002-3739-3966; Staniszewska, Anna/0000-0003-1328-1959; Caffarel, Maria/0000-0002-7442-6827; Anderson, Lisa/0000-0001-9541-1950	Breast Cancer Campaign; Marie Curie Intra-European fellowship FP7-PEOPLE-IEF; MRC [G0900980] Funding Source: UKRI; Medical Research Council [G0900980] Funding Source: researchfish	Breast Cancer Campaign; Marie Curie Intra-European fellowship FP7-PEOPLE-IEF; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a PhD studentship grant from the Breast Cancer Campaign to A. D. S. and C.J.W. S. P. is the recipient of a Marie Curie Intra-European fellowship FP7-PEOPLE-2010-IEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Asselin-Labat ML, 2008, COLD SH Q B, V73, P469, DOI 10.1101/sqb.2008.73.020; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Boulanger CA, 2005, ONCOGENE, V24, P552, DOI 10.1038/sj.onc.1208185; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hirai H, 2011, BIOCHEM J, V438, P11, DOI 10.1042/BJ20102152; HOSHINO K, 1967, NATURE, V213, P193, DOI 10.1038/213193a0; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Matulka LA, 2007, DEV BIOL, V303, P29, DOI 10.1016/j.ydbio.2006.12.017; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oh IH, 2002, ONCOGENE, V21, P4778, DOI 10.1038/sj.onc.1205592; Selbert S, 1998, TRANSGENIC RES, V7, P387, DOI 10.1023/A:1008848304391; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Van Keymeulen A, 2011, NATURE; Wagner KU, 2002, DEVELOPMENT, V129, P1377; WARLEY A, 1995, DIABETOLOGIA, V38, P413, DOI 10.1007/s001250050300; WHITELAW CBA, 1992, BIOCHEM J, V286, P31, DOI 10.1042/bj2860031; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamaji D, 2009, GENE DEV, V23, P2382, DOI 10.1101/gad.1840109	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52608	10.1371/journal.pone.0052608	http://dx.doi.org/10.1371/journal.pone.0052608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285109	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500209
J	Steiner, CF				Steiner, Christopher F.			Environmental Noise, Genetic Diversity and the Evolution of Evolvability and Robustness in Model Gene Networks	PLOS ONE			English	Article							HETEROGENEOUS ENVIRONMENT; DELETERIOUS MUTATIONS; CANALIZATION; VARIABILITY; EPISTASIS; FITNESS; POLYMORPHISM; MODULARITY; COLOR	The ability of organisms to adapt and persist in the face of environmental change is accepted as a fundamental feature of natural systems. More contentious is whether the capacity of organisms to adapt (or "evolvability") can itself evolve and the mechanisms underlying such responses. Using model gene networks, I provide evidence that evolvability emerges more readily when populations experience positively autocorrelated environmental noise (red noise) compared to populations in stable or randomly varying (white noise) environments. Evolvability was correlated with increasing genetic robustness to effects on network viability and decreasing robustness to effects on phenotypic expression; populations whose networks displayed greater viability robustness and lower phenotypic robustness produced more additive genetic variation and adapted more rapidly in novel environments. Patterns of selection for robustness varied antagonistically with epistatic effects of mutations on viability and phenotypic expression, suggesting that trade-offs between these properties may constrain their evolutionary responses. Evolution of evolvability and robustness was stronger in sexual populations compared to asexual populations indicating that enhanced genetic variation under fluctuating selection combined with recombination load is a primary driver of the emergence of evolvability. These results provide insight into the mechanisms potentially underlying rapid adaptation as well as the environmental conditions that drive the evolution of genetic interactions.	Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Steiner, CF (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	csteiner@wayne.edu			National Science Foundation [DEB-0610532]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation, nsf.gov, (grant DEB-0610532). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MATLAB VERS 7 10; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Cuddington KM, 1999, P ROY SOC B-BIOL SCI, V266, P969, DOI 10.1098/rspb.1999.0731; Davidson EH, 2006, REG GEN GEN REG; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Draghi J, 2009, J EVOLUTION BIOL, V22, P599, DOI 10.1111/j.1420-9101.2008.01663.x; Drake JW, 1998, GENETICS, V148, P1667; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Elena SF, 2007, EVOLUTION, V61, P666, DOI 10.1111/j.1558-5646.2007.00064.x; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Emlen J., 1973, ECOLOGY EVOLUTIONARY; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; HEDRICK PW, 1976, GENETICS, V84, P145; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; HOEKSTRA RF, 1985, GENET RES, V45, P299, DOI 10.1017/S001667230002228X; Inchausti P, 2002, EVOL ECOL RES, V4, P1033; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kawecki TJ, 2000, EVOLUTION, V54, P1, DOI 10.1111/j.0014-3820.2000.tb00001.x; Kawecki TJ, 2000, P ROY SOC B-BIOL SCI, V267, P1315, DOI 10.1098/rspb.2000.1144; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kondrashov AS, 1996, GENET RES, V68, P157, DOI 10.1017/S0016672300034042; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; LEVINS R, 1967, GENETICS, V56, P163; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Petchey OL, 2000, P ROY SOC B-BIOL SCI, V267, P747, DOI 10.1098/rspb.2000.1066; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranta E, 2008, EVOL ECOL RES, V10, P1; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wigley TML, 1998, SCIENCE, V282, P1676, DOI 10.1126/science.282.5394.1676; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690	50	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52204	10.1371/journal.pone.0052204	http://dx.doi.org/10.1371/journal.pone.0052204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284934	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500111
J	Xu, HF; Bihan, D; Chang, F; Huang, PH; Farndale, RW; Leitinger, B				Xu, Huifang; Bihan, Dominique; Chang, Francis; Huang, Paul H.; Farndale, Richard W.; Leitinger, Birgit			Discoidin Domain Receptors Promote alpha 1 beta 1-and alpha 2 beta 1-Integrin Mediated Cell Adhesion to Collagen by Enhancing Integrin Activation	PLOS ONE			English	Article							TYROSINE KINASE DDR1; STRUCTURAL BASIS; GLYCOPROTEIN-VI; MIMETIC PEPTIDE; MATRIX METALLOPROTEINASE-2; EXTRACELLULAR-MATRIX; THROMBUS FORMATION; PLATELET-ADHESION; AFFINITY BINDING; CANCER CELLS	The discoidin domain receptors, DDR1 and DDR2, are receptor tyrosine kinases that bind to and are activated by collagens. Similar to collagen-binding beta 1 integrins, the DDRs bind to specific motifs within the collagen triple helix. However, these two types of collagen receptors recognize distinct collagen sequences. While GVMGFO (O is hydroxyproline) functions as a major DDR binding motif in fibrillar collagens, integrins bind to sequences containing Gxx'GEx ''. The DDRs are thought to regulate cell adhesion, but their roles have hitherto only been studied indirectly. In this study we used synthetic triple-helical collagen-derived peptides that incorporate either the DDR-selective GVMGFO motif or integrin-selective motifs, such as GxOGER and GLOGEN, in order to selectively target either type of receptor and resolve their contributions to cell adhesion. Our data using HEK293 cells show that while cell adhesion to collagen I was completely inhibited by anti-integrin blocking antibodies, the DDRs could mediate cell attachment to the GVMGFO motif in an integrin-independent manner. Cell binding to GVMGFO was independent of DDR receptor signalling and occurred with limited cell spreading, indicating that the DDRs do not mediate firm adhesion. However, blocking the interaction of DDR-expressing cells with collagen I via the GVMGFO site diminished cell adhesion, suggesting that the DDRs positively modulate integrin-mediated cell adhesion. Indeed, overexpression of the DDRs or activation of the DDRs by the GVMGFO ligand promoted alpha 1 beta 1 and alpha 2 beta 1 integrin-mediated cell adhesion to medium-and low-affinity integrin ligands without regulating the cell surface expression levels of alpha 1 beta 1 or alpha 2 beta 1. Our data thus demonstrate an adhesion-promoting role of the DDRs, whereby overexpression and/or activation of the DDRs leads to enhanced integrin-mediated cell adhesion as a result of higher integrin activation state.	[Xu, Huifang; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Chang, Francis; Huang, Paul H.] Inst Canc Res, Div Canc Biol, London SW3 6JB, England	Imperial College London; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Leitinger, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	b.leitinger@imperial.ac.uk	Huang, Paul H./H-8591-2015	Huang, Paul H./0000-0003-3972-5087	Medical Research Council United Kingdom; BBSRC UK; Wellcome Trust; MRC [G0701121, G0500707]; BBSRC [BB/I011226/1, BB/I014276/1, WT089028]; Biotechnology and Biological Sciences Research Council [BB/I014276/1, BB/I011226/1] Funding Source: researchfish; Medical Research Council [G0500707, G0701121] Funding Source: researchfish	Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the following grants from the Medical Research Council United Kingdom (www.mrc.ac.uk), BBSRC UK (www.bbsrc.ac.uk) and the Wellcome Trust (www.wellcome.ac.uk): MRC G0701121 (to BL and RWF), MRC G0500707 (to RWF), BBSRC BB/I011226/1 (to BL), BB/I014276/1 (to PHH) and WT089028 (to PHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bargal R, 2009, AM J HUM GENET, V84, P80, DOI 10.1016/j.ajhg.2008.12.004; Bazzoni G, 1998, J BIOL CHEM, V273, P6670, DOI 10.1074/jbc.273.12.6670; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Chetoui N, 2011, J CELL BIOCHEM, V112, P3666, DOI 10.1002/jcb.23300; Curat CA, 2002, J AM SOC NEPHROL, V13, P2648, DOI 10.1097/01.ASN.0000032419.13208.0C; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Franco C, 2009, CIRC RES, V105, P1141, DOI 10.1161/CIRCRESAHA.109.207357; Fukunaga-Kalabis M, 2006, J CELL BIOL, V175, P563, DOI 10.1083/jcb.200602132; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Hou GP, 2012, CARDIOVASC PATHOL, V21, P214, DOI 10.1016/j.carpath.2011.07.006; Huang Y, 2009, J CELL SCI, V122, P1637, DOI 10.1242/jcs.046219; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Kato K, 2003, BLOOD, V102, P1701, DOI 10.1182/blood-2003-03-0717; Khew ST, 2007, TISSUE ENG, V13, P2451, DOI 10.1089/ten.2007.0063; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; MOROI M, 1989, J CLIN INVEST, V84, P1440, DOI 10.1172/JCI114318; MORTON LF, 1989, BIOCHEM J, V258, P157, DOI 10.1042/bj2580157; Munnix ICA, 2008, J THROMB HAEMOST, V6, P2132, DOI 10.1111/j.1538-7836.2008.03167.x; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; NIEUWENHUIS HK, 1985, NATURE, V318, P470, DOI 10.1038/318470a0; Nilsson S, 2006, EXP CELL RES, V312, P844, DOI 10.1016/j.yexcr.2005.12.001; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Pugh N, 2010, BLOOD, V115, P5069, DOI 10.1182/blood-2010-01-260778; Ram R, 2006, J NEURO-ONCOL, V76, P239, DOI 10.1007/s11060-005-6874-1; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; SANTORO SA, 1991, CELL REGUL, V2, P905, DOI 10.1091/mbc.2.11.905; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Siljander PRM, 2004, J BIOL CHEM, V279, P47763, DOI 10.1074/jbc.M404685200; Suh HN, 2011, J CELL PHYSIOL, V226, P3422, DOI 10.1002/jcp.22697; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Vonk LA, 2011, RHEUMATOLOGY, V50, P463, DOI 10.1093/rheumatology/keq305; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Yeh YC, 2009, J CELL PHYSIOL, V218, P146, DOI 10.1002/jcp.21578; Yoshida D, 2007, J NEURO-ONCOL, V82, P29, DOI 10.1007/s11060-006-9246-6	72	171	172	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52209	10.1371/journal.pone.0052209	http://dx.doi.org/10.1371/journal.pone.0052209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284937	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500114
J	Atkinson, PJ; Wise, AK; Flynn, BO; Nayagam, BA; Hume, CR; O'Leary, SJ; Shepherd, RK; Richardson, RT				Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; Hume, Clifford R.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T.			Neurotrophin Gene Therapy for Sustained Neural Preservation after Deafness	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; SENSORINEURAL HEARING-LOSS; GUINEA-PIG COCHLEA; ELECTRICAL-STIMULATION; AUDITORY NEURONS; SURVIVAL; EXPRESSION; ADENOVIRUS; RECEPTOR; CELLS	The cochlear implant provides auditory cues to profoundly deaf patients by electrically stimulating the residual spiral ganglion neurons. These neurons, however, undergo progressive degeneration after hearing loss, marked initially by peripheral fibre retraction and ultimately culminating in cell death. This research aims to use gene therapy techniques to both hold and reverse this degeneration by providing a sustained and localised source of neurotrophins to the deafened cochlea. Adenoviral vectors containing green fluorescent protein, with or without neurotrophin-3 and brain derived neurotrophic factor, were injected into the lower basal turn of scala media of guinea pigs ototoxically deafened one week prior to intervention. This single injection resulted in localised and sustained gene expression, principally in the supporting cells within the organ of Corti. Guinea pigs treated with adenoviral neurotrophin-gene therapy had greater neuronal survival compared to contralateral non-treated cochleae when examined at 7 and 11 weeks post injection. Moreover; there was evidence of directed peripheral fibre regrowth towards cells expressing neurotrophin genes after both treatment periods. These data suggest that neurotrophin-gene therapy can provide sustained protection of spiral ganglion neurons and peripheral fibres after hearing loss.	[Atkinson, Patrick J.; Wise, Andrew K.; Flynn, Brianna O.; Nayagam, Bryony A.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T.] Bion Inst, Melbourne, Vic, Australia; [Atkinson, Patrick J.; Wise, Andrew K.; Nayagam, Bryony A.; O'Leary, Stephen J.; Shepherd, Robert K.; Richardson, Rachael T.] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia; [Wise, Andrew K.; Shepherd, Robert K.; Richardson, Rachael T.] Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia; [Hume, Clifford R.] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA	Bionics Institute; University of Melbourne; University of Melbourne; University of Washington; University of Washington Seattle	Richardson, RT (corresponding author), Bion Inst, Melbourne, Vic, Australia.	rrichardson@bionicsinstitute.org	Shepherd, Robert/I-6276-2012; Shepherd, Robert/G-1332-2013; Wise, Andrew/B-5943-2014	Wise, Andrew/0000-0001-9715-8784; Richardson, Rachael/0000-0002-2412-8354; O'Leary, Stephen/0000-0001-6926-2103; Nayagam, Bryony/0000-0003-1069-6059; Shepherd, Robert/0000-0002-4239-3362	Action on Hearing Loss; Garnett Passe and Rodney Williams Memorial Foundation; National Institutes of Health [NIDCD HHS-N-263-2007-00053-c, NIDCD DC-006437, NIDCD P30 DC-04661, NICHHD P30 HD-02774]; University Of Melbourne Department Of Otolaryngology; Royal Victorian Eye and Ear Hospital; Hearing Regeneration Initiative; Veterans' Hospital Administration; State Government of Victoria's Operational Infrastructure Program; RNID [G39] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC006437, P30DC004661] Funding Source: NIH RePORTER	Action on Hearing Loss; Garnett Passe and Rodney Williams Memorial Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Of Melbourne Department Of Otolaryngology; Royal Victorian Eye and Ear Hospital; Hearing Regeneration Initiative; Veterans' Hospital Administration; State Government of Victoria's Operational Infrastructure Program; RNID; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Action on Hearing Loss (http://www.actiononhearingloss.org.uk/, The Garnett Passe and Rodney Williams Memorial Foundation, The National Institutes of Health (http://www.nih.gov/)(NIDCD HHS-N-263-2007-00053-c, NIDCD DC-006437, NIDCD P30 DC-04661, NICHHD P30 HD-02774), The University Of Melbourne Department Of Otolaryngology (http://www.unimelb.edu.au/), The Royal Victorian Eye and Ear Hospital (http://www.eyeandear.org.au/), The Hearing Regeneration Initiative (http://www.hearingregeneration.com/), The Veterans' Hospital Administration, The State Government of Victoria's Operational Infrastructure Program (http://www.business.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2008, HEARING RES, V244, P25, DOI 10.1016/j.heares.2008.07.004; Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Amalfitano A, 1998, J VIROL, V72, P926, DOI 10.1128/JVI.72.2.926-933.1998; Backhouse S, 2008, EXP NEUROL, V214, P193, DOI 10.1016/j.expneurol.2008.08.002; BICHLER E, 1983, ARCH OTO-RHINO-LARYN, V237, P201, DOI 10.1007/BF00453725; Chikar JA, 2008, HEARING RES, V245, P24, DOI 10.1016/j.heares.2008.08.005; Clark GM, 2003, AIP SER MOD AC SIG, P160; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; Davis A C, 1990, Acta Otolaryngol Suppl, V476, P23; Dodson HC, 2000, J NEUROCYTOL, V29, P525, DOI 10.1023/A:1007201913730; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; Ernfors P, 1996, NAT MED, V2, P463, DOI 10.1038/nm0496-463; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Feghali J G, 1998, Ear Nose Throat J, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P282; Feghali JG, 1998, ENT-EAR NOSE THROAT, V77, P280; Fritzsch B, 1998, INT J DEV NEUROSCI, V16, P493, DOI 10.1016/S0736-5748(98)00043-4; Fritzsch B, 1997, TRENDS NEUROSCI, V20, P159, DOI 10.1016/S0166-2236(96)01007-7; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Glueckert R, 2008, J COMP NEUROL, V507, P1602, DOI 10.1002/cne.21619; Hardie NA, 1999, HEARING RES, V128, P147, DOI 10.1016/S0378-5955(98)00209-3; James DP, 2008, AUDIOL NEURO-OTOL, V13, P86, DOI 10.1159/000111780; Keithley EM, 1996, LARYNGOSCOPE, V106, P341, DOI 10.1097/00005537-199603000-00019; KOITCHEV K, 1982, ACTA OTO-LARYNGOL, V94, P431, DOI 10.3109/00016488209128931; Landry TG, 2011, THESIS U MELBOURNE M; LEAKE PA, 1988, HEARING RES, V33, P11, DOI 10.1016/0378-5955(88)90018-4; Leake PA, 2011, J COMP NEUROL, V519, P1526, DOI 10.1002/cne.22582; Lin DW, 1997, OTOLARYNG HEAD NECK, V117, P530, DOI 10.1016/S0194-5998(97)70026-3; NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602; Nakaizumi T, 2004, AUDIOL NEURO-OTOL, V9, P135, DOI 10.1159/000077264; RAPHAEL Y, 1991, CELL MOTIL CYTOSKEL, V18, P215, DOI 10.1002/cm.970180307; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Richardson RT, 2004, HEARING RES, V198, P25, DOI 10.1016/j.heares.2004.02.012; Sellick P, 2008, J NEUROSCI METH, V167, P237, DOI 10.1016/j.jneumeth.2007.08.026; SHEPHERD RK, 1985, HEARING RES, V18, P105, DOI 10.1016/0378-5955(85)90001-2; SHEPHERD RK, 1993, HEARING RES, V66, P108, DOI 10.1016/0378-5955(93)90265-3; Shibata SB, 2010, EXP NEUROL, V223, P464, DOI 10.1016/j.expneurol.2010.01.011; Slevin JT, 2007, J NEUROSURG, V106, P614, DOI 10.3171/jns.2007.106.4.614; SPOENDLIN H, 1975, ACTA OTO-LARYNGOL, V79, P266, DOI 10.3109/00016487509124683; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Taylor RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030577; Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002; van den Honert C, 2007, J ACOUST SOC AM, V121, P3703, DOI 10.1121/1.2722047; Venail F, 2007, GENE THER, V14, P30, DOI 10.1038/sj.gt.3302826; Versnel H, 2007, HEARING RES, V231, P1, DOI 10.1016/j.heares.2007.03.003; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Wilson DH, 1999, INT J EPIDEMIOL, V28, P247, DOI 10.1093/ije/28.2.247; Wise AK, 2005, J COMP NEUROL, V487, P147, DOI 10.1002/cne.20563; Wise AK, 2011, HEARING RES, V278, P69, DOI 10.1016/j.heares.2011.04.010; Wise AK, 2010, MOL THER, V18, P1111, DOI 10.1038/mt.2010.28; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C	53	40	41	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52338	10.1371/journal.pone.0052338	http://dx.doi.org/10.1371/journal.pone.0052338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284995	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900090
J	Liu, YC; Han, YH; Zhang, H; Nie, LP; Jiang, ZM; Fa, PP; Gui, YT; Cai, ZM				Liu, Yuchen; Han, Yonghua; Zhang, Hu; Nie, Liping; Jiang, Zhimao; Fa, Pingping; Gui, Yaoting; Cai, Zhiming			Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; HYPOXIA; EXPRESSION; MICRORNA; PROLIFERATION; SURVIVAL; IDENTIFICATION; ASSAY; GENE	Background: MicroRNAs (miRNAs) function as endogenous regulators of biological behaviors of human cancers. Several natural non-coding RNAs are reported to inhibit miRNAs by base-pairing interactions. These phenomena raise questions about the ability of artificial device to regulate miRNAs. The purpose of this study is to create synthetic devices that target a single miRNA or a miRNA cluster and to ascertain their therapeutic effects on the phenotypes of bladder cancer cells. Methodology/Principal Findings: Tandem bulged miRNA binding sites were inserted into the 39 untranslated region (UTR) of the SV-40 promoter-driven Renilla luciferase gene to construct two "miRNA-mowers" for suppression of miR-183-96-182 cluster or miR-210. A third device with tandem repeat sequences not complementary to any known miRNA was generated as an untargeted-control. In functional analyses, bladder cancer T24 and UM-UC-3 cells were transfected with each of the three devices, followed by assays for detection of their impacts. Luciferase assays indicated that the activities of the luciferase reporters in the miRNA-mowers were decreased to 30-50% of the untargeted-control. Using Real-Time qPCR, the expression levels of the target miRNAs were shown to be reduced 2-3-fold by the corresponding miRNA-mower. Cell growth, apoptosis, and migration were tested by MTT assay, flow cytometry assay, and in vitro scratch assay, respectively. Cell growth inhibition, increased apoptosis, and decreased motility were observed in miRNA-mowers-transfected bladder cancer cells. Conclusions/Significance: Not only a single target miRNA but also the whole members of a target miRNA cluster can be blocked using this modular design strategy. Anti-cancer effects are induced by the synthetic miRNA-mowers in the bladder cancer cell lines. miR-183/96/182 cluster and miR-210 are shown to play oncogenic roles in bladder cancer. A potentially useful synthetic biology platform for miRNA loss-of-function study and cancer treatment has been established in this work.	[Liu, Yuchen; Han, Yonghua; Zhang, Hu; Jiang, Zhimao; Fa, Pingping; Gui, Yaoting; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China; [Liu, Yuchen; Zhang, Hu] Anhui Med Univ, Hefei, Peoples R China; [Liu, Yuchen; Han, Yonghua; Cai, Zhiming] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Genitourinary Tumor, Shenzhen, Peoples R China; [Nie, Liping] Peking Univ, Shenzhen Hosp, Dept Clin Lab, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Anhui Medical University; Shenzhen University; Peking University	Gui, YT (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen PKU HKUST Med Ctr,Inst Urol, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen, Peoples R China.	guiyaoting2007@yahoo.com.cn; caizhiming2000@yahoo.com.cn	gui, yaoting/GLT-3684-2022; liu, yuchen/GYQ-6286-2022		Ph.D. Programs Foundation of Ministry of Education of China [20100001110100]; promotion Program for Shenzhen Key Laboratory, Shenzhen, People's Republic of China [CXB201005250016A]	Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); promotion Program for Shenzhen Key Laboratory, Shenzhen, People's Republic of China	This work was funded by the Ph.D. Programs Foundation of Ministry of Education of China(20100001110100 to ZC); the promotion Program for Shenzhen Key Laboratory, Shenzhen, People's Republic of China (CXB201005250016A to ZC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Carradori S, 2012, ANTI-CANCER AGENT ME, V12, P589, DOI 10.2174/187152012800617768; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cho WCS, 2012, EXPERT OPIN THER TAR, V16, P747, DOI 10.1517/14728222.2012.696102; Cho WCS, 2012, EXPERT OPIN THER TAR, V16, P345, DOI 10.1517/14728222.2012.663354; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Karlsson M, 2012, CURR OPIN BIOTECH, V23, P1; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Lehmann U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-109; Lei AQ, 2011, EXPERT REV ANTICANC, V11, P1851, DOI [10.1586/ERA.11.181, 10.1586/era.11.181]; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Marta GN, 2012, INT BRAZ J UROL, V38, P144, DOI 10.1590/S1677-55382012000200002; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muro EM, 2011, BIOCHIMIE, V93, P1916, DOI 10.1016/j.biochi.2011.07.024; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Nissim L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.99; Noman MZ, 2012, CANCER RES, V72, P4629, DOI 10.1158/0008-5472.CAN-12-1383; Parekh DJ, 2006, J CLIN ONCOL, V24, P5519, DOI 10.1200/JCO.2006.08.5431; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Racioppi M, 2012, UROL INT, V88, P249, DOI 10.1159/000335556; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Shankar S, 2011, MOL BIOSYST, V7, P1802, DOI 10.1039/c1mb05016h; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Wu P, 2010, CURR MED CHEM, V17, P4326, DOI 10.2174/092986710793361234; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Yamada Y, 2011, CANCER SCI, V102, P522, DOI 10.1111/j.1349-7006.2010.01816.x; Yang W, 2012, EXP CELL RES, V318, P944, DOI 10.1016/j.yexcr.2012.02.010; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	41	79	89	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52280	10.1371/journal.pone.0052280	http://dx.doi.org/10.1371/journal.pone.0052280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284967	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900086
J	Cui, S; Fukao, Y; Mano, S; Yamada, K; Hayashi, M; Nishimura, M				Cui, Songkui; Fukao, Yoichiro; Mano, Shoji; Yamada, Kenji; Hayashi, Makoto; Nishimura, Mikio			Proteomic Analysis Reveals That the Rab GTPase RabE1c Is Involved in the Degradation of the Peroxisomal Protein Receptor PEX7 (Peroxin 7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING SIGNAL TYPE-2; ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; CYTOSOLIC CHAPERONIN; MAMMALIAN-CELLS; LONGER ISOFORM; PTS1 RECEPTOR; IMPORT; BIOGENESIS; MUTANT	The biogenesis of peroxisomes is mediated by peroxins (PEXs). PEX7 is a cytosolic receptor that imports peroxisomal targeting signal type 2 (PTS2)-containing proteins. Although PEX7 is important for protein transport, the mechanisms that mediate its function are unknown. In this study, we performed proteomic analysis to identify PEX7-binding proteins using transgenic Arabidopsis expressing green fluorescent protein (GFP)-tagged PEX7. Our analysis identified RabE1c, a small GTPase, as a PEX7 binding partner. In vivo analysis revealed that GTP-bound RabE1c binds to PEX7 and that a subset of RabE1c localizes to peroxisomes and interacts with PEX7 on the peroxisome membrane. Unlike endogenous PEX7, which is predominantly localized to the cytosol, GFP-PEX7 accumulates abnormally on the peroxisomal membrane and induces degradation of endogenous PEX7, concomitant with a reduction in import of PTS2-containing proteins and decreased peroxisomal beta-oxidation activity. Thus, GFP-PEX7 on the peroxisomal membrane exerts a dominant negative effect. Mutation of RabE1c restored endogenous PEX7 protein expression and import of PTS2-containing proteins as well as peroxisomal beta-oxidation activity. Treatment with proteasome inhibitors also restored endogenous PEX7 protein levels in GFP-PEX7-expressing seedlings. Based on these findings, we conclude that RabE1c binds PEX7 and facilitates PEX7 degradation in the presence of immobile GFP-PEX7 accumulated at the membrane.	[Cui, Songkui; Mano, Shoji; Yamada, Kenji; Hayashi, Makoto; Nishimura, Mikio] Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; [Cui, Songkui; Mano, Shoji; Yamada, Kenji; Hayashi, Makoto; Nishimura, Mikio] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Fukao, Yoichiro] Nara Inst Sci & Technol, Plant Global Educ Project, Ikoma 6300192, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Nara Institute of Science & Technology	Nishimura, M (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Dept Cell Biol, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	mikosome@nibb.ac.jp	Fukao, Yoichiro/E-7137-2013; Cui, Songkui/ABF-4552-2021; Yamada, Kenji/C-4336-2018	Cui, Songkui/0000-0001-7777-6681; Yamada, Kenji/0000-0003-4872-3729; Nishimura, Mikio/0000-0001-7960-9721; Mano, Shoji/0000-0003-1323-3308	Ministry of Education, Science, Sports, and Culture of Japan [22120007]; Grants-in-Aid for Scientific Research [25440146, 23770050, 22112523] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 22120007 from the Ministry of Education, Science, Sports, and Culture of Japan (to M.N.).	Anthonio EA, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-58; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; Ghys K, 2002, BIOCHEM J, V365, P41, DOI 10.1042/BJ20011432; Hayashi H, 1998, J BIOL CHEM, V273, P8301, DOI 10.1074/jbc.273.14.8301; Hayashi M, 2005, J BIOL CHEM, V280, P14829, DOI 10.1074/jbc.M411005200; Hayashi M, 1996, PLANT J, V10, P225, DOI 10.1046/j.1365-313X.1996.10020225.x; Hayashi M, 1998, PLANT CELL, V10, P183, DOI 10.1105/tpc.10.2.183; Hayashi M, 2000, EMBO J, V19, P5701, DOI 10.1093/emboj/19.21.5701; Hino T, 2011, BIOSCI BIOTECH BIOCH, V75, P1848, DOI 10.1271/bbb.110331; Karnik SK, 2005, PLANT PHYSIOL, V138, P1967, DOI [10.1104/pp.105.061291, 10.1104/PP.105.061291]; Kato A, 1998, PLANT CELL PHYSIOL, V39, P186, DOI 10.1093/oxfordjournals.pcp.a029356; Kato A, 1996, PLANT MOL BIOL, V31, P843, DOI 10.1007/BF00019471; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; KUBOTA H, 1995, GENE, V154, P231, DOI 10.1016/0378-1119(94)00880-2; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Lin Y, 2004, PLANT PHYSIOL, V135, P814, DOI 10.1104/pp.103.036772; Ling QH, 2012, SCIENCE, V338, P655, DOI 10.1126/science.1225053; Mano S, 2002, PLANT CELL PHYSIOL, V43, P331, DOI 10.1093/pcp/pcf037; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Mukai S, 2002, J BIOL CHEM, V277, P9548, DOI 10.1074/jbc.M108635200; Nair DM, 2004, J CELL BIOL, V167, P599, DOI 10.1083/jcb.200407119; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nito K, 2002, PLANT CELL PHYSIOL, V43, P355, DOI 10.1093/pcp/pcf057; Nito K, 2007, PLANT CELL PHYSIOL, V48, P763, DOI 10.1093/pcp/pcm053; Okumoto K, 2000, J BIOL CHEM, V275, P25700, DOI 10.1074/jbc.M003303200; Otera H, 2000, J BIOL CHEM, V275, P21703, DOI 10.1074/jbc.M000720200; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Purdue PE, 2001, J BIOL CHEM, V276, P47684, DOI 10.1074/jbc.M106823200; Rutherford S, 2002, CURR OPIN PLANT BIOL, V5, P518, DOI 10.1016/S1369-5266(02)00307-2; Schollenberger L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013886; Schuhmann H, 2008, PLANT PHYSIOL, V148, P1847, DOI 10.1104/pp.108.125377; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Singh T, 2009, PLANT J, V60, P488, DOI 10.1111/j.1365-313X.2009.03970.x; Tamura K, 2010, PLANT CELL, V22, P4084, DOI 10.1105/tpc.110.079947; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Woodward AW, 2005, MOL BIOL CELL, V16, P573, DOI 10.1091/mbc.E04-05-0422; Woollard AAD, 2008, CURR OPIN PLANT BIOL, V11, P610, DOI 10.1016/j.pbi.2008.09.010; Yahraus T, 1996, EMBO J, V15, P2914, DOI 10.1002/j.1460-2075.1996.tb00654.x; Yi CL, 2006, INT J BIOCHEM CELL B, V38, P1076, DOI 10.1016/j.biocel.2005.12.019; ZHANG JW, 1995, J CELL BIOL, V129, P65, DOI 10.1083/jcb.129.1.65; Zheng HQ, 2005, PLANT CELL, V17, P2020, DOI 10.1105/tpc.105.031112; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691; Zolman BK, 2004, P NATL ACAD SCI USA, V101, P1786, DOI 10.1073/pnas.0304368101; Zolman BK, 2000, GENETICS, V156, P1323	50	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					6014	6023		10.1074/jbc.M112.438143	http://dx.doi.org/10.1074/jbc.M112.438143			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297417	Green Published, hybrid			2022-12-25	WOS:000315342500069
J	Tiwari, S; Siddiqi, S; Siddiqi, SA				Tiwari, Samata; Siddiqi, Shaila; Siddiqi, Shadab A.			CideB Protein Is Required for the Biogenesis of Very Low Density Lipoprotein (VLDL) Transport Vesicle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; PLASMA-MEMBRANE ATPASE; ENDOPLASMIC-RETICULUM; APOLIPOPROTEIN-B; APO-B; RETENTION DISEASE; SELECTIVE EXPORT; GOLGI-APPARATUS; SAR1B GENE; EFFECTOR B	Nascent very low density lipoprotein (VLDL) exits the endoplasmic reticulum (ER) in a specialized ER-derived vesicle, the VLDL transport vesicle (VTV). Similar to protein transport vesicles (PTVs), VTVs require coat complex II (COPII) proteins for their biogenesis from the ER membranes. Because the size of the VTV is large, we hypothesized that protein(s) in addition to COPII components might be required for VTV biogenesis. Our proteomic analysis, supported by Western blotting data, shows that a 26-kDa protein, CideB, is present in the VTV but not in other ER-derived vesicles such as PTV and pre-chylomicron transport vesicle. Western blotting and immunoelectron microscopy analyses suggest that CideB is concentrated in the VTV. Our co-immunoprecipitation data revealed that CideB specifically interacts with VLDL structural protein, apolipoprotein B100 (apoB100), but not with albumin, a PTV cargo protein. Confocal microscopic data indicate that CideB co-localizes with apoB100 in the ER. Additionally, CideB interacts with COPII components, Sar1 and Sec24. To investigate the role of CideB in VTV biogenesis, we performed an in vitro ER budding assay. We show that the blocking of CideB inhibits VTV budding, indicating a direct requirement of CideB in VTV formation. To confirm our findings, we knocked down CideB in primary hepatocytes and isolated ER and cytosol to examine whether they support VTV budding. Our data suggest that CideB knockdown significantly reduces VTV biogenesis. These findings suggest that CideB forms an intricate COPII coat and regulates the VTV biogenesis.	[Tiwari, Samata; Siddiqi, Shaila; Siddiqi, Shadab A.] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32827 USA	State University System of Florida; University of Central Florida	Siddiqi, SA (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, 6900 Lake Nona Blvd,Rm 349, Orlando, FL 32827 USA.	shadab.siddiqi@ucf.edu			National Institutes of Health through the NIDDK [RO1 DK-81413]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081413] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK-81413 through the NIDDK (to S.A.S.).	Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; BAMBERGER MJ, 1990, P NATL ACAD SCI USA, V87, P2390, DOI 10.1073/pnas.87.7.2390; BARLOWE C, 1993, J BIOL CHEM, V268, P873; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Barlowe C, 1998, BBA-MOL CELL RES, V1404, P67, DOI 10.1016/S0167-4889(98)00047-0; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; Charcosset M, 2008, MOL GENET METAB, V93, P74, DOI 10.1016/j.ymgme.2007.08.120; Chen ZJ, 2010, J BIOL CHEM, V285, P25996, DOI 10.1074/jbc.M110.141598; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Gusarova V, 2007, J BIOL CHEM, V282, P19453, DOI 10.1074/jbc.M700475200; HIGGINS JA, 1988, FEBS LETT, V232, P405, DOI 10.1016/0014-5793(88)80780-4; Hughes H, 2008, HISTOCHEM CELL BIOL, V129, P129, DOI 10.1007/s00418-007-0363-x; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Hussain MM, 1998, J BIOL CHEM, V273, P25612, DOI 10.1074/jbc.273.40.25612; Jamil H, 1996, P NATL ACAD SCI USA, V93, P11991, DOI 10.1073/pnas.93.21.11991; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim SD, 2012, J BIOL CHEM, V287, P10134, DOI 10.1074/jbc.M111.283382; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Levy E, 2011, ARTERIOSCL THROM VAS, V31, P2692, DOI 10.1161/ATVBAHA.111.233908; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; Mansbach CM, 2010, ANNU REV PHYSIOL, V72, P315, DOI 10.1146/annurev-physiol-021909-135801; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Oh HY, 2006, CELL DEATH DIFFER, V13, P512, DOI 10.1038/sj.cdd.4401771; Okada T, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-78; OLOFSSON SO, 1987, ATHEROSCLEROSIS, V68, P1, DOI 10.1016/0021-9150(87)90088-8; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Rahim A, 2012, J PROTEOMICS, V75, P2225, DOI 10.1016/j.jprot.2012.01.026; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; RUSINOL A, 1993, J BIOL CHEM, V268, P3555; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Sehayek Ephraim, 1994, Current Opinion in Lipidology, V5, P350, DOI 10.1097/00041433-199410000-00006; Shelness GS, 1999, J NUTR, V129, p456S, DOI 10.1093/jn/129.2.456S; Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973; Shoulders CC, 2004, CURR OPIN LIPIDOL, V15, P191, DOI 10.1097/00041433-200404000-00012; Siddiqi SA, 2006, J CELL SCI, V119, P943, DOI 10.1242/jcs.02803; Siddiqi SA, 2003, J CELL SCI, V116, P415, DOI 10.1242/jcs.00215; Siddiqi SA, 2008, J CELL SCI, V121, P2327, DOI 10.1242/jcs.022780; Siddiqi SA, 2008, BIOCHEM J, V413, P333, DOI 10.1042/BJ20071469; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; Siddiqi S, 2010, J LIPID RES, V51, P1918, DOI 10.1194/jlr.M005611; Siddiqi S, 2010, J LIPID RES, V51, P1093, DOI 10.1194/jlr.M002758; Siddiqi S, 2010, BIOCHEM J, V429, P391, DOI 10.1042/BJ20100336; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Swift LL, 1996, J BIOL CHEM, V271, P31491; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; THORNGATE FE, 1994, P NATL ACAD SCI USA, V91, P5392, DOI 10.1073/pnas.91.12.5392; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200	62	28	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5157	5165		10.1074/jbc.M112.434258	http://dx.doi.org/10.1074/jbc.M112.434258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297397	Green Published, hybrid			2022-12-25	WOS:000315340400063
J	Borges, R; Johnson, WE; O'Brien, SJ; Vasconcelos, V; Antunes, A				Borges, Rui; Johnson, Warren E.; O'Brien, Stephen J.; Vasconcelos, Vitor; Antunes, Agostinho			The Role of Gene Duplication and Unconstrained Selective Pressures in the Melanopsin Gene Family Evolution and Vertebrate Circadian Rhythm Regulation	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; RETINAL GANGLION-CELLS; FUNCTIONAL DIVERGENCE; MOLECULAR ADAPTATION; CRYSTAL-STRUCTURE; PHOTOTRANSDUCTION; EXPRESSION; PHYLOGENIES; INFERENCE; RHODOPSIN	Melanopsin is a photosensitive cell protein involved in regulating circadian rhythms and other non-visual responses to light. The melanopsin gene family is represented by two paralogs, OPN4x and OPN4m, which originated through gene duplication early in the emergence of vertebrates. Here we studied the melanopsin gene family using an integrated gene/protein evolutionary approach, which revealed that the rhabdomeric urbilaterian ancestor had the same amino acid patterns (DRY motif and the Y and E conterions) as extant vertebrate species, suggesting that the mechanism for light detection and regulation is similar to rhabdomeric rhodopsins. Both OPN4m and OPN4x paralogs are found in vertebrate genomic paralogons, suggesting that they diverged following this duplication event about 600 million years ago, when the complex eye emerged in the vertebrate ancestor. Melanopsins generally evolved under negative selection (omega = 0.171) with some minor episodes of positive selection (proportion of sites = 25%) and functional divergence (theta(I) = 0.349 and theta(II) = 0.126). The OPN4m and OPN4x melanopsin paralogs show evidence of spectral divergence at sites likely involved in melanopsin light absorbance (200F, 273S and 276A). Also, following the teleost lineage-specific whole genome duplication (3R) that prompted the teleost fish radiation, type I divergence (theta(I) = 0.181) and positive selection (affecting 11% of sites) contributed to amino acid variability that we related with the photo-activation stability of melanopsin. The melanopsin intracellular regions had unexpectedly high variability in their coupling specificity of G-proteins and we propose that Gq/11 and Gi/o are the two G-proteins most-likely to mediate the melanopsin phototransduction pathway. The selection signatures were mainly observed on retinal-related sites and the third and second intracellular loops, demonstrating the physiological plasticity of the melanopsin protein group. Our results provide new insights on the phototransduction process and additional tools for disentangling and understanding the links between melanopsin gene evolution and the specializations observed in vertebrates, especially in teleost fish.	[Borges, Rui; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, P-4100 Oporto, Portugal; [Borges, Rui; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Dept Biol, Fac Ciencias, P-4100 Oporto, Portugal; [Johnson, Warren E.; O'Brien, Stephen J.; Antunes, Agostinho] NCI, Lab Genom Divers, Frederick, MD 21701 USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg, Russia	Universidade do Porto; Universidade do Porto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Petersburg State University	Antunes, A (corresponding author), Univ Porto, CIMAR CIIMAR, Ctr Interdisciplinar Invest Marinha & Ambiental, Rua Bragas, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008; OBRIEN, STEPHEN/ABD-1346-2020; Borges, Rui/H-5873-2016; Johnson, Warren/D-4149-2016	Vasconcelos, Vitor/0000-0003-3585-2417; Borges, Rui/0000-0002-5905-3778; Johnson, Warren/0000-0002-5954-186X; Antunes, Agostinho/0000-0002-1328-1732; O'Brien, Stephen J./0000-0001-7353-8301; Borges, Rui/0000-0003-3931-9476; OBRIEN, STEPHEN/0000-0001-7857-0757	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/79850/2011, PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]; Intramural Research Program of the National Institutes of Health, National Cancer Institute	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the Portuguese Foundation for Science and Technology (FCT) for financial support to RB (SFRH/BD/79850/2011) and the projects PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610) and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490) to AA. This research received support by the Intramural Research Program of the National Institutes of Health, National Cancer Institute to WEJ and SJO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angueyra JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029813; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arendt D, 2003, INT J DEV BIOL, V47, P563; Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Bellingham J, 2006, PLOS BIOL, V4, P1334, DOI 10.1371/journal.pbio.0040254; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; Davies WL, 2010, PHOTOCH PHOTOBIO SCI, V9, P1444, DOI 10.1039/c0pp00203h; Davies WIL, 2011, CELLULAR MOL LIFE SC; Davies WL, 2010, EXPT EYE RES, P110; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dong C, 2011, BIOCH GENETICS; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frigato E, 2006, NATURWISSENSCHAFTEN, V93, P379, DOI 10.1007/s00114-006-0119-9; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Gojobori J, 2009, TRENDS GENET, V25, P198, DOI 10.1016/j.tig.2009.03.008; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Heesy CP, 2010, BRAIN BEHAV EVOLUT, V75, P195, DOI 10.1159/000314278; HOLLAND PWH, 1994, DEVELOPMENT, P125; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Kusakabe T, 2001, FEBS LETT, V506, P69, DOI 10.1016/S0014-5793(01)02877-0; Kusakabe T, 2003, PHOTOCHEM PHOTOBIOL, V83, P248; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lamb Trevor D., 2008, Evolution Education and Outreach, V1, P415, DOI 10.1007/s12052-008-0091-2; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pires SS, 2007, P R SOC B, V274, P2791, DOI 10.1098/rspb.2007.0976; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schrodinger L., PYMOL MOL GRAPHICS S; Sgourakis NG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-104; Shimamura T, 2008, J BIOL CHEM, V283, P17753, DOI 10.1074/jbc.C800040200; Spagnuolo A, 2003, GENE, V309, P71, DOI 10.1016/S0378-1119(03)00488-8; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Vopalensky P, 2009, PHILOS T R SOC B, V364, P2819, DOI 10.1098/rstb.2009.0079; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	82	18	18	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52413	10.1371/journal.pone.0052413	http://dx.doi.org/10.1371/journal.pone.0052413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285031	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800064
J	Lee, H; Kim, HJ; Lee, YJ; Lee, MY; Choi, H; Lee, H; Kim, JW				Lee, Haemi; Kim, Hyo Jung; Lee, Yoo Jeong; Lee, Min-Young; Choi, Hyeonjin; Lee, Hyemin; Kim, Jae-Woo			Kruppel-Like Factor KLF8 Plays a Critical Role in Adipocyte Differentiation	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; BINDING PROTEIN-BETA; C/EBP-ALPHA GENE; TRANSCRIPTIONAL REGULATION; 3T3-L1 PREADIPOCYTES; ADIPOGENESIS; CELLS; ACTIVATION; EXPRESSION; PHOSPHORYLATION	KLF8 (Kruppel-like factor 8) is a zinc-finger transcription factor known to play an essential role in the regulation of the cell cycle, apoptosis, and differentiation. However, its physiological roles and functions in adipogenesis remain unclear. In the present study, we show that KLF8 acts as a key regulator controlling adipocyte differentiation. In 3T3-L1 preadipocytes, we found that KLF8 expression was induced during differentiation, which was followed by expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) and CCAAT/enhancer-binding protein alpha (C/EBP alpha). Adipocyte differentiation was significantly attenuated by the addition of siRNA against KLF8, whereas overexpression of KLF8 resulted in enhanced differentiation. Furthermore, luciferase reporter assays demonstrated that overexpression of KLF8 induced PPAR gamma 2 and C/EBP alpha promoter activity, suggesting that KLF8 is an upstream regulator of PPAR gamma and C/EBP alpha. The KLF8 binding sites were localized by site mutation analysis to -191 region in C/EBP alpha promoter and -303 region in PPAR gamma promoter, respectively. Taken together, these data reveal that KLF8 is a key component of the transcription factor network that controls terminal differentiation during adipogenesis.	[Lee, Haemi; Kim, Hyo Jung; Lee, Yoo Jeong; Lee, Min-Young; Choi, Hyeonjin; Lee, Hyemin; Kim, Jae-Woo] Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul, South Korea; [Lee, Haemi; Lee, Yoo Jeong; Lee, Min-Young; Choi, Hyeonjin; Kim, Jae-Woo] Yonsei Univ, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Hyemin; Kim, Jae-Woo] Yonsei Univ, Grad Sch, WCU Program, Dept Integrated OMICS Biomed Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Kim, JW (corresponding author), Yonsei Univ, Coll Med, Inst Genet Sci, Dept Biochem & Mol Biol,Integrated Genom Res Ctr, Seoul, South Korea.	japol13@yuhs.ac		Choi, Hyeonjin/0000-0002-5055-5093; Kim, Jae-woo/0000-0001-5456-9495; KIM, HYO JUNG/0000-0002-3514-1247	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A100475]	Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A100475). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200	31	12	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52474	10.1371/journal.pone.0052474	http://dx.doi.org/10.1371/journal.pone.0052474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285057	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800069
J	Armeni, T; Ercolani, L; Urbanelli, L; Magini, A; Magherini, F; Pugnaloni, A; Piva, F; Modesti, A; Emiliani, C; Principato, G				Armeni, Tatiana; Ercolani, Luisa; Urbanelli, Lorena; Magini, Alessandro; Magherini, Francesca; Pugnaloni, Armanda; Piva, Francesco; Modesti, Alessandra; Emiliani, Carla; Principato, Giovanni			Cellular Redox Imbalance and Changes of Protein S-glutathionylation Patterns Are Associated with Senescence Induced by Oncogenic H-Ras	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; IDENTIFICATION; QUANTITATION; ANTIOXIDANTS; INVOLVEMENT; ACTIVATION; PROTEOMICS; MIGRATION; REQUIRES; PATHWAYS	H-Ras oncogene requires deregulation of additional oncogenes or inactivation of tumor suppressor proteins to increase cell proliferation rate and transform cells. In fact, the expression of the constitutively activated H-RasV12 induces cell growth arrest and premature senescence, which act like barriers in pre-neoplastic lesions. In our experimental model, human fibroblasts transfected with H-RasV12 show a dramatic modification of morphology. H-RasV12 expressing cells also show premature senescence followed by cell death, induced by autophagy and apoptosis. In this context, we provide evidence that in H-RasV12 expressing cells, the premature senescence is associated with cellular redox imbalance as well as with altered post-translation protein modification. In particular, redox imbalance is due to a strong reduction of total antioxidant capacity, and significant decrease of glutathione level. As the reversible addition of glutathione to cysteinyl residues of proteins is an important post-translational regulative modification, we investigated S-glutathionylation in cells expressing active H-Ras. In this contest we observed different S-glutathionylation patterns in control and H-RasV12 expressing cells. Particularly, the GAPDH enzyme showed S-glutathionylation increase and significant enzyme activity depletion in H-Ras V12 cells. In conclusion, we proposed that antioxidant defense reduction, glutathione depletion and subsequent modification of S-glutathionylation of target proteins contribute to arrest cell growth, leading to death of fibroblasts expressing constitutively active H-Ras oncogene, thus acting as oncogenic barriers that obstacle the progression of cell transformation.	[Armeni, Tatiana; Ercolani, Luisa; Piva, Francesco; Principato, Giovanni] Univ Politecn Marche, Dept Clin Sci, Biochem Sect, Ancona, Italy; [Urbanelli, Lorena; Magini, Alessandro; Emiliani, Carla] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Magherini, Francesca; Modesti, Alessandra] Univ Florence, Dept Biochem, Florence, Italy; [Pugnaloni, Armanda] Univ Politecn Marche, Dept Mol & Clin Sci, Ancona, Italy	Marche Polytechnic University; University of Perugia; University of Florence; Marche Polytechnic University	Armeni, T (corresponding author), Univ Politecn Marche, Dept Clin Sci, Biochem Sect, Ancona, Italy.	t.armeni@univpm.it	Modesti, Alessandra/L-3276-2017; Pugnaloni, Armanda/AAE-9049-2020; Magini, Alessandro/P-1201-2019; Emiliani, Carla/G-3738-2010; Magini, Alessandro/L-9175-2015; Armeni, Tatiana/J-8228-2013; magherini, francesca/A-2991-2014	Modesti, Alessandra/0000-0002-1290-2285; Emiliani, Carla/0000-0002-6368-1515; Magini, Alessandro/0000-0002-2750-6226; Armeni, Tatiana/0000-0003-0931-1342; magherini, francesca/0000-0001-8388-0952; PIVA, Francesco/0000-0003-1850-2482; Urbanelli, Lorena/0000-0003-0621-8476; Ercolani, Luisa/0000-0002-0418-3460; PRINCIPATO, Giovanni/0000-0001-8800-0301	Universita Politecnica delle Marche; "Fondazione Cassa di Risparmio di Perugia" [2008.021.375]	Universita Politecnica delle Marche; "Fondazione Cassa di Risparmio di Perugia"(Fondazione Cassa Risparmio Perugia)	This work was supported by Universita Politecnica delle Marche and by "Fondazione Cassa di Risparmio di Perugia" (2008.021.375) grants to C. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Andrei D, 2008, J MED CHEM, V51, P7944, DOI 10.1021/jm800831y; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bartkova J, 2010, ONCOGENE, V29, P5095, DOI 10.1038/onc.2010.249; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P466; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Borras C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIGELIUS R, 1983, BIOCHEM PHARMACOL, V32, P2529, DOI 10.1016/0006-2952(83)90014-X; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Duan HM, 2005, INT J BIOCHEM CELL B, V37, P1407, DOI 10.1016/j.biocel.2005.01.010; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Ghezzi P, 2007, CURR OPIN PHARMACOL, V7, P398, DOI 10.1016/j.coph.2007.04.006; Giles GI, 2006, CURR PHARM DESIGN, V12, P4427, DOI 10.2174/138161206779010549; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Giustarini D, 2004, J CELL MOL MED, V8, P201, DOI 10.1111/j.1582-4934.2004.tb00275.x; HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Kagawa Y, 1997, BIOSCIENCE REP, V17, P115, DOI 10.1023/A:1027329328504; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Liu RG, 2001, ONCOGENE, V20, P1486, DOI 10.1038/sj.onc.1204214; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Magherini F, 2009, CELL MOL LIFE SCI, V66, P933, DOI 10.1007/s00018-009-8574-z; Markovic J, 2010, FREE RADICAL RES, V44, P721, DOI 10.3109/10715762.2010.485989; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Regoli F, 1999, TOXICOL APPL PHARM, V156, P96, DOI 10.1006/taap.1999.8637; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Shlush LI, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-16; Tew KD, 2011, CURR OPIN CHEM BIOL, V15, P156, DOI 10.1016/j.cbpa.2010.10.016; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Townsend DM, 2006, MOL PHARMACOL, V69, P501, DOI 10.1124/mol.105.018523; Tu SH, 2010, BREAST CANCER RES TR, V121, P539, DOI 10.1007/s10549-009-0492-0; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Vayalil PK, 2007, AM J PHYSIOL-LUNG C, V293, pL1281, DOI 10.1152/ajplung.00128.2007; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yusuf MA, 2010, FREE RADICAL BIO MED, V49, P908, DOI 10.1016/j.freeradbiomed.2010.06.020	60	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52151	10.1371/journal.pone.0052151	http://dx.doi.org/10.1371/journal.pone.0052151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284910	Green Published, gold			2022-12-25	WOS:000312794500103
J	Hou, EQ; Chen, CR; McGroddy, ME; Wen, DZ				Hou, Enqing; Chen, Chengrong; McGroddy, Megan E.; Wen, Dazhi			Nutrient Limitation on Ecosystem Productivity and Processes of Mature and Old-Growth Subtropical Forests in China	PLOS ONE			English	Article							N-P RATIOS; LEAF-LITTER DECOMPOSITION; NET PRIMARY PRODUCTIVITY; TROPICAL RAIN-FOREST; PHOSPHORUS LIMITATION; MINERAL-NUTRITION; ORGANIC-MATTER; NITROGEN; BIOMASS; CLIMATE	Nitrogen (N) is considered the dominant limiting nutrient in temperate regions, while phosphorus (P) limitation frequently occurs in tropical regions, but in subtropical regions nutrient limitation is poorly understood. In this study, we investigated N and P contents and N: P ratios of foliage, forest floors, fine roots and mineral soils, and their relationships with community biomass, litterfall C, N and P productions, forest floor turnover rate, and microbial processes in eight mature and old-growth subtropical forests (stand age >80 yr) at Dinghushan Biosphere Reserve, China. Average N: P ratios (mass based) in foliage, litter (L) layer and mixture of fermentation and humus (F/H) layer, and fine roots were 28.3, 42.3, 32.0 and 32.7, respectively. These values are higher than the critical N: P ratios for P limitation proposed (16-20 for foliage, ca. 25 for forest floors). The markedly high N: P ratios were mainly attributed to the high N concentrations of these plant materials. Community biomass, litterfall C, N and P productions, forest floor turnover rate and microbial properties were more strongly related to measures of P than N and frequently negatively related to the N: P ratios, suggesting a significant role of P availability in determining ecosystem production and productivity and nutrient cycling at all the study sites except for one prescribed disturbed site where N availability may also be important. We propose that N enrichment is probably a significant driver of the potential P limitation in the study area. Low P parent material may also contribute to the potential P limitation. In general, our results provided strong evidence supporting a significant role for P availability, rather than N availability, in determining ecosystem primary productivity and ecosystem processes in subtropical forests of China.	[Hou, Enqing; Chen, Chengrong] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia; [Hou, Enqing; Wen, Dazhi] Chinese Acad Sci, S China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [McGroddy, Megan E.] Univ Virginia, Dept Environm Sci, NASA, Charlottesville, VA 22903 USA; [Hou, Enqing; Wen, Dazhi] Univ Chinese Acad Sci, Beijing, Peoples R China	Griffith University; Chinese Academy of Sciences; South China Botanical Garden, CAS; National Aeronautics & Space Administration (NASA); University of Virginia; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, CR (corresponding author), Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia.	c.chen@griffith.edu.au; dzwen@scbg.ac.cn	Chen, Chengrong/B-3814-2009; Hou, Enqing/A-2056-2016; chen, chengrong/K-8188-2019; , Enqing/G-4629-2013	Chen, Chengrong/0000-0001-6377-4001; Hou, Enqing/0000-0003-4864-2347; chen, chengrong/0000-0001-6377-4001; , Enqing/0000-0002-5162-488X	National Natural Science Foundation of China [31070409]; Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences [XDA05050205]; Australian Research Council [FT0990547]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences(Chinese Academy of Sciences); Australian Research Council(Australian Research Council); China Scholarship Council(China Scholarship Council)	This study was supported by National Natural Science Foundation of China (No. 31070409), Strategic Priority Research Program - Climate Change: Carbon Budget and Relevant Issues of the Chinese Academy of Sciences (No. XDA05050205 and the Australian Research Council (FT0990547). The support from China Scholarship Council through an overseas joint doctoral fellowship to Enqing Hou is also kindly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; AERTS R, 1989, OECOLOGIA, V78, P115, DOI 10.1007/BF00377206; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Campo J, 2003, J TROP ECOL, V19, P525, DOI 10.1017/S0266467403003572; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Chen CR, 2005, AUST J SOIL RES, V43, P515, DOI 10.1071/SR04132; Cleveland CC, 2002, ECOSYSTEMS, V5, P680, DOI 10.1007/s10021-002-0202-9; Cleveland CC, 2011, ECOL LETT, V14, P939, DOI 10.1111/j.1461-0248.2011.01658.x; CREWS TE, 1995, ECOLOGY, V76, P1407, DOI 10.2307/1938144; Curtin D, 2006, SOIL SCI SOC AM J, V70, P1512, DOI 10.2136/sssaj2005.0338; DELAUNE RD, 1979, ESTUAR COAST MAR SCI, V8, P477, DOI 10.1016/0302-3524(79)90063-X; EDWARDS PJ, 1982, J ECOL, V70, P807, DOI 10.2307/2260106; Eivazi F., 1995, METHODS APPL SOIL MI, V1st ed., P350; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Fang YT, 2008, BIOGEOSCIENCES, V5, P339, DOI 10.5194/bg-5-339-2008; [方运霆 Fang Yunting], 2002, [广西植物, Guihaia], V22, P305; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gusewell S, 2006, PLANT SOIL, V287, P131, DOI 10.1007/s11104-006-9050-2; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; HERBERT DA, 1995, BIOGEOCHEMISTRY, V29, P223, DOI 10.1007/BF02186049; Hobbie SE, 2000, ECOLOGY, V81, P1867, DOI 10.1890/0012-9658(2000)081[1867:NLODIH]2.0.CO;2; Huang WJ, 2011, ACTA OECOLOGICA INT, DOI DOI 10.1016/J.ACTA0; JENNY H, 1949, SOIL SCI, V68, P419, DOI 10.1097/00010694-194912000-00001; KENK G, 1988, ENVIRON POLLUT, V54, P199, DOI 10.1016/0269-7491(88)90112-1; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Lipson DA, 1996, ECOLOGY, V77, P1277, DOI 10.2307/2265597; Liu JC, 2007, ENVIRON SCI POLLUT R, V14, P123, DOI 10.1065/espr2006.07.325; Liu JX, 2002, TROPICAL SUBTROPICAL, P125; Liu L, 2012, SOIL BIOL BIOCHEM, V44, P31, DOI 10.1016/j.soilbio.2011.08.017; [刘申 LIU Shen], 2007, [生态科学, Ecologic Science], V26, P387; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Lu XK, 2009, PEDOSPHERE, V19, P189, DOI 10.1016/S1002-0160(09)60108-9; Lu XK, 2011, ENVIRON POLLUT, V159, P2228, DOI 10.1016/j.envpol.2010.10.037; Lu XK, 2010, GLOBAL CHANGE BIOL, V16, P2688, DOI 10.1111/j.1365-2486.2010.02174.x; MacDonald JA, 2002, GLOBAL CHANGE BIOL, V8, P1028, DOI 10.1046/j.1365-2486.2002.00532.x; McDowell RW, 2000, NUTR CYCL AGROECOSYS, V57, P225, DOI 10.1023/A:1009838424935; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Mo J, 2008, GLOBAL CHANGE BIOL, V14, P403, DOI 10.1111/j.1365-2486.2007.01503.x; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; MO JM, 1995, BIOTROPICA, V27, P290, DOI 10.2307/2388915; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; OHNO T, 1991, SOIL SCI SOC AM J, V55, P892, DOI 10.2136/sssaj1991.03615995005500030046x; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; PENG SL, 1995, SCI CHINA SER B, V38, P67; Penuelas J, 2012, GLOBAL CHANGE BIOL, V18, P3, DOI 10.1111/j.1365-2486.2011.02568.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; Schuur EAG, 2003, ECOLOGY, V84, P1165, DOI 10.1890/0012-9658(2003)084[1165:PAGCRT]2.0.CO;2; Shen CD, 2001, RADIOCARBON, V43, P671; Sparling G, 1998, SOIL BIOL BIOCHEM, V30, P1469, DOI 10.1016/S0038-0717(98)00040-6; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tanner EVJ, 1998, ECOLOGY, V79, P10, DOI 10.1890/0012-9658(1998)079[0010:EIONLO]2.0.CO;2; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Van Duren IC, 2000, PLANT SOIL, V220, P35, DOI 10.1023/A:1004735618905; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; VERMEER JG, 1983, VEGETATIO, V53, P121, DOI 10.1007/BF00043032; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; VITOUSEK PM, 1975, BIOSCIENCE, V25, P376, DOI 10.2307/1297148; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; von Oheimb G, 2010, ECOSYSTEMS, V13, P317, DOI 10.1007/s10021-010-9320-y; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang SQ, 2011, J ENVIRON MANAGE, V92, P1651, DOI 10.1016/j.jenvman.2011.01.024; Wang Z. H., 1982, Tropical and Subtropical Forest Ecosystem, Ding Hu Shan Forest Ecosystem Reserve, China, P77; Wieder WR, 2009, ECOLOGY, V90, P3333, DOI 10.1890/08-2294.1; Wood TE, 2006, ECOSYSTEMS, V9, P700, DOI 10.1007/s10021-005-0016-7; Wood TE, 2009, ECOLOGY, V90, P109, DOI 10.1890/07-1146.1; Wright SJ, 2011, ECOLOGY, V92, P1616, DOI 10.1890/10-1558.1; Yan JH, 2009, SOIL BIOL BIOCHEM, V41, P991, DOI 10.1016/j.soilbio.2008.12.018; [赵同谦 Zhao Tongqian], 2004, [自然资源学报, Journal of Natural Resources], V19, P480; Zhou GY, 2007, PLANT ECOL, V188, P77, DOI 10.1007/s11258-006-9149-9; Zhou GY, 2011, GLOBAL CHANGE BIOL, V17, P3736, DOI 10.1111/j.1365-2486.2011.02499.x	85	29	37	6	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52071	10.1371/journal.pone.0052071	http://dx.doi.org/10.1371/journal.pone.0052071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284873	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500083
J	Nava, S; Dossena, M; Pogliani, S; Pellegatta, S; Antozzi, C; Baggi, F; Gellera, C; Pollo, B; Parati, EA; Finocchiaro, G; Frigerio, S				Nava, Sara; Dossena, Marta; Pogliani, Simona; Pellegatta, Serena; Antozzi, Carlo; Baggi, Fulvio; Gellera, Cinzia; Pollo, Bianca; Parati, Eugenio A.; Finocchiaro, Gaetano; Frigerio, Simona			An Optimized Method for Manufacturing a Clinical Scale Dendritic Cell-Based Vaccine for the Treatment of Glioblastoma	PLOS ONE			English	Article							ANTITUMOR IMMUNITY; MALIGNANT GLIOMAS; TUMOR; CANCER; GENERATION; IMMUNOTHERAPY; ANTIGEN; INDUCE; MICE; VIVO	Immune-based treatments represent a promising new class of therapy designed to boost the immune system to specifically eradicate malignant cells. Immunotherapy may generate specific anti-tumor immune responses, and dendritic cells (DC), professional antigen-presenting cells, are widely used in experimental cancer immunotherapy. Several reports describe methods for the generation of mature, antigen-pulsed DC for clinical use. Improved quality and standardization are desirable to obtain GMP-compliant protocols. In this study we describe the generation of DC from 31 Glioblastoma (GB) patients starting from their monocytes isolated by immunomagnetic CD14 selection using the CliniMACS (R) device. Upon differentiation of CD14+ with IL-4 and GM-CSF, DC were induced to maturation with TNF-alpha, PGE(2), IL-1 beta, and IL-6. Whole tumor lysate was obtained, for the first time, in a closed system using the semi-automated dissociator GentleMACS (R). The yield of proteins improved by 130% compared to the manual dissociation method. Interestingly the Mean Fluorescence Intensity for CD83 increased significantly in DC pulsed with "new method" lysate compared to DC pulsed with "classical method" lysate. Our results indicate that immunomagnetic isolation of CD14(+) monocytes using the CliniMACS (R) device and their pulsing with whole tumor lysate proteins is a suitable method for clinical-scale generation of high quality, functional DC under GMP-grade conditions.	[Nava, Sara; Dossena, Marta; Pogliani, Simona; Parati, Eugenio A.; Frigerio, Simona] Fdn IRCCS Ist Neurol Carlo Besta, Cell Therapy Prod Unit UPTC, Milan, Italy; [Pellegatta, Serena; Finocchiaro, Gaetano] Fdn IRCCS Ist Neurol Carlo Besta, Unit Mol Neurooncol, Milan, Italy; [Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Dept Genet Neurodegenerat & Metab Dis, Milan, Italy; [Pollo, Bianca] Fdn IRCCS Ist Neurol Carlo Besta, Neuropathol Unit, Milan, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Frigerio, S (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Cell Therapy Prod Unit UPTC, Milan, Italy.	uptc@istituto-besta.it	Frigerio, Simona/AAI-3264-2021; Parati, Eugenio Agostino/AAN-5893-2021; Pellegatta, Serena/AAL-3693-2021; Nava, Sara/J-8740-2016; Antozzi, Carlo/AAB-8787-2019; Gellera, Cinzia/J-7887-2016; Pogliani, Simona/AAQ-4826-2021; Baggi, Fulvio/AAX-4132-2020; Pollo, Bianca/K-5347-2018; Dossena, Marta/I-2125-2012; Finocchiaro, Gaetano/B-6898-2013	Frigerio, Simona/0000-0001-7078-075X; Parati, Eugenio Agostino/0000-0001-5020-6523; Pellegatta, Serena/0000-0001-7804-9486; Nava, Sara/0000-0001-9912-8255; Antozzi, Carlo/0000-0001-9270-5224; Gellera, Cinzia/0000-0002-3582-665X; Pogliani, Simona/0000-0002-5714-6225; Baggi, Fulvio/0000-0002-4618-0102; Pollo, Bianca/0000-0002-5523-4256; Finocchiaro, Gaetano/0000-0003-3583-4040; Dossena, Marta/0000-0003-1717-8350	Italian Ministry of Health; Regione Lombardia; "il Fondo di Gio", a charity affiliated to the International Brain Tumor Alliance	Italian Ministry of Health(Ministry of Health, Italy); Regione Lombardia(Regione Lombardia); "il Fondo di Gio", a charity affiliated to the International Brain Tumor Alliance	This work was supported by the Italian Ministry of Health, by Regione Lombardia and by a grant from "il Fondo di Gio", a charity affiliated to the International Brain Tumor Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshna KM, 2000, VOX SANG, V79, P46; Ardon H, 2012, CANC IMMUNOL IMMUNOT; Ashley DM, 1997, J EXP MED, V186, P1177, DOI 10.1084/jem.186.7.1177; Babatz J, 2003, J HEMATOTH STEM CELL, V12, P515, DOI 10.1089/152581603322448222; Bauer C, 2011, CANCER IMMUNOL IMMUN, V60, P1097, DOI 10.1007/s00262-011-1023-5; Bohnenkamp HR, 2003, CYTOTECHNOLOGY, V42, P121, DOI 10.1023/B:CYTO.0000015833.34696.03; Daga A, 2011, CURR PHARM DESIGN, V17, P2439, DOI 10.2174/138161211797249206; Dauer M, 2008, J IMMUNOL METHODS, V337, P97, DOI 10.1016/j.jim.2008.07.003; de Heusch M, 2004, EUR J IMMUNOL, V34, P1861, DOI 10.1002/eji.200424878; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Holtl L, 1998, LANCET, V352, P1358, DOI 10.1016/S0140-6736(05)60748-9; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Kim W, 2010, NEUROSURG CLIN N AM, V21, P139, DOI 10.1016/j.nec.2009.09.005; Lee JJ, 2008, J LEUKOCYTE BIOL, V84, P319, DOI 10.1189/jlb.1107737; Liau L M, 2000, Neurosurg Focus, V9, pe8; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; MAYORDOMO JI, 1995, NAT MED, V1, P1297, DOI 10.1038/nm1295-1297; Pellegatta S, 2006, NEUROL RES, V28, P527, DOI 10.1179/016164106X116809; Pellegatta S, 2006, CANCER RES, V66, P10247, DOI 10.1158/0008-5472.CAN-06-2048; Pellegatta S, 2009, METHODS MOL BIOL, V568, P233, DOI 10.1007/978-1-59745-280-9_15; Reardon DA, 2006, J CLIN ONCOL, V24, P1253, DOI 10.1200/JCO.2005.04.5302; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shakar G, 2004, J IMMUNOL METHODS, V285, P293; STEINMAN RM, 1978, P NATL ACAD SCI USA, V75, P5132, DOI 10.1073/pnas.75.10.5132; Tan JKH, 2005, J LEUKOCYTE BIOL, V78, P319, DOI 10.1189/jlb.1104664; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; Tittarelli A, 2012, CANC IMMUNOL IMMUNOT; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wheeler Christopher J, 2004, Clin Neurosurg, V51, P132; Yamanaka R, 2008, TRENDS MOL MED, V14, P228, DOI 10.1016/j.molmed.2008.03.003	31	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52301	10.1371/journal.pone.0052301	http://dx.doi.org/10.1371/journal.pone.0052301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284979	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500140
J	Remedio, L; Carvalho, T; Caiado, F; Bastos-Carvalho, A; Martins, D; Duarte, A; Yagita, H; Dias, S				Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Bastos-Carvalho, Ana; Martins, Diana; Duarte, Antonio; Yagita, Hideo; Dias, Sergio			Context- and Cell-Dependent Effects of Delta-Like 4 Targeting in the Bone Marrow Microenvironment	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; INHIBITS TUMOR-GROWTH; ENDOTHELIAL-CELLS; NOTCH LIGAND; PROGENITOR CELLS; VASCULAR NICHE; SELF-RENEWAL; INDUCED MOBILIZATION; IN-VITRO; DIFFERENTIATION	Delta-like 4 (Dll4) is a ligand of the Notch pathway family which has been widely studied in the context of tumor angiogenesis, its blockade shown to result in non-productive angiogenesis and halted tumor growth. As Dll4 inhibitors enter the clinic, there is an emerging need to understand their side effects, namely the systemic consequences of Dll4: Notch blockade in tissues other than tumors. The present study focused on the effects of systemic anti-Dll4 targeting in the bone marrow (BM) microenvironment. Here we show that Dll4 blockade with monoclonal antibodies perturbs the BM vascular niche of sub-lethally irradiated mice, resulting in increased CD31(+), VE-Cadherin(+) and c-kit(+) vessel density, and also increased megakaryocytes, whereas CD105(+), VEGFR3(+), SMA(+) and lectin(+) vessel density remained unaltered. We investigated also the expression of angiocrine genes upon Dll4 treatment in vivo, and demonstrate that IGFbp2, IGFbp3, Angpt2, Dll4, DHH and VEGF-A are upregulated, while FGF1 and CSF2 are reduced. In vitro treatment of endothelial cells with anti-Dll4 reduced Akt phosphorylation while maintaining similar levels of Erk 1/2 phosphorylation. Besides its effects in the BM vascular niche, anti-Dll4 treatment perturbed hematopoiesis, as evidenced by increased myeloid (CD11b(+)), decreased B (B220(+)) and T (CD3(+)) lymphoid BM content of treated mice, with a corresponding increase in myeloid circulating cells. Moreover, anti-Dll4 treatment also increased the number of CFU-M and -G colonies in methylcellulose assays, independently of Notch1. Finally, anti-Dll4 treatment of donor BM improved the hematopoietic recovery of lethally irradiated recipients in a transplant setting. Together, our data reveals the hematopoietic (BM) effects of systemic anti-Dll4 treatment result from qualitative vascular changes and also direct hematopoietic cell modulation, which may be favorable in a transplant setting.	[Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Bastos-Carvalho, Ana; Dias, Sergio] Portuguese Inst Oncol, IPOLFG, EPE, Angiogenesis Lab,CIPM, Lisbon, Portugal; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Duarte, Antonio] Univ Tecn Lisboa, Fac Med Vet, CIISA, Lisbon, Portugal; [Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Bastos-Carvalho, Ana; Dias, Sergio] Univ Nova Lisboa, CEDOC, FCM, P-1200 Lisbon, Portugal; [Remedio, Leonor; Carvalho, Tania; Caiado, Francisco; Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Bastos-Carvalho, Ana] Ctr Hosp Lisboa Norte, Programme Adv Med Educ, Lisbon, Portugal; [Bastos-Carvalho, Ana] Fac Med Lisbon, Lisbon, Portugal; [Bastos-Carvalho, Ana] Ctr Hosp Lisboa Norte, Dept Ophthalmol, Lisbon, Portugal; [Martins, Diana] Hosp Santa Maria, Dept Obstet & Gynecol, Lisbon, Portugal	Universidade de Coimbra; Juntendo University; Universidade de Lisboa; Universidade Nova de Lisboa; Instituto Gulbenkian de Ciencia; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Dias, S (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, Neovascularizat Unit, P-1699 Lisbon, Portugal.	sergiodias@fm.ul.pt	Carvalho, Tânia/GNM-6203-2022; Carvalho, Tânia/X-2873-2019; Dias, Sergio/L-1250-2014; Duarte, Antonio/V-1178-2018	Carvalho, Tânia/0000-0002-5283-5013; Dias, Sergio/0000-0002-7603-4616; Duarte, Antonio/0000-0002-9255-3635; Caiado, Francisco/0000-0003-4096-4448	FCT [PTDC/SAU-ORG/113617/2009]; Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia, Portugal; Fundação para a Ciência e a Tecnologia [PTDC/SAU-ORG/113617/2009] Funding Source: FCT	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Ministerio da Saude; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundação para a Ciência e a Tecnologia	This work was supported by FCT PTDC/SAU-ORG/113617/2009 (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank other members of the Angiogenesis Lab for their input and suggestions. The Program for Advanced Medical Education is sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and Fundacao para a Ciencia e Tecnologia, Portugal.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bassil R, 2011, J IMMUNOL, V187, P2322, DOI 10.4049/jimmunol.1100725; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Bird IN, 1999, J CELL SCI, V112, P1989; Broxmeyer HE, 2011, BLOOD, V117, P4773, DOI 10.1182/blood-2011-01-330514; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Candal FJ, 1996, MICROVASC RES, V52, P221, DOI 10.1006/mvre.1996.0060; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; de La Coste A, 2005, J IMMUNOL, V174, P2730, DOI 10.4049/jimmunol.174.5.2730; Dhanjal TS, 2007, BLOOD, V109, P4237, DOI 10.1182/blood-2006-10-050740; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Fragoso R, 2008, EXP HEMATOL, V36, P1329, DOI 10.1016/j.exphem.2008.04.023; GALMICHE MC, 1993, BLOOD, V82, P66, DOI 10.1182/blood.V82.1.66.bloodjournal82166; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Heemskerk VH, 1999, CYTOKINE GROWTH F R, V10, P5, DOI 10.1016/S1359-6101(98)00022-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714; Ishida W, 2011, INVEST OPHTH VIS SCI, V52, P8224, DOI 10.1167/iovs.11-7756; Itoi M, 2007, INT IMMUNOL, V19, P127, DOI 10.1093/intimm/dxl129; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026918; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Kostyak JC, 2012, BLOOD, V119, P838, DOI 10.1182/blood-2011-04-346098; Lahmar M, 2008, STEM CELLS, V26, P621, DOI 10.1634/stemcells.2007-0428; Lamorte S, 2009, HEMATOL REP, V1, P80, DOI 10.4081/hr.2009.e14; Lau CI, 2012, BLOOD, V119, P4741, DOI 10.1182/blood-2011-10-387266; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lofqvist C, 2007, P NATL ACAD SCI USA, V104, P10589, DOI 10.1073/pnas.0702031104; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843; Nakamura-Ishizu A, 2008, J MOL HISTOL, V39, P471, DOI 10.1007/s10735-008-9186-x; Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Pitchford SC, 2012, BLOOD, V120, P2787, DOI 10.1182/blood-2011-09-378174; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Real C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018323; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sekine C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3758; Shutter JR, 2000, GENE DEV, V14, P1313; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sunamura M, 2008, NEUTRALIZING MONOCLO; Sunamura M, 2008, UK Patent Application, Patent No. [1-85, 185]; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tian ZG, 1998, STEM CELLS, V16, P193, DOI 10.1002/stem.160193; TODD RF, 1981, J IMMUNOL, V126, P1435; VAINCHENKER W, 1982, BLOOD, V59, P514; van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; Wu Y, 2007, BLOOD, V110, P851, DOI 10.1182/blood-2006-05-022087; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	82	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52450	10.1371/journal.pone.0052450	http://dx.doi.org/10.1371/journal.pone.0052450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285048	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500173
J	Satizabal, P; Mignucci-Giannoni, AA; Duchene, S; Caicedo-Herrera, D; Perea-Sicchar, CM; Garcia-Davila, CR; Trujillo, F; Caballero, SJ				Satizabal, Paula; Mignucci-Giannoni, Antonio A.; Duchene, Sebastian; Caicedo-Herrera, Dalila; Perea-Sicchar, Carlos M.; Garcia-Davila, Carmen R.; Trujillo, Fernando; Caballero, Susana J.			Phylogeography and Sex-Biased Dispersal across Riverine Manatee Populations (Trichechus inunguis and Trichechus manatus) in South America	PLOS ONE			English	Article							WEST-INDIAN MANATEE; MICROSATELLITE DNA MARKERS; FLORIDA MANATEE; MITOCHONDRIAL-DNA; GENETIC-ANALYSIS; COALESCENT; MIGRATION; DIFFERENTIATION; CHROMOSOME; SEQUENCES	Phylogeographic patterns and sex-biased dispersal were studied in riverine populations of West Indian (Trichechus manatus) and Amazonian manatees (T. inunguis) in South America, using 410bp D-loop (Control Region, Mitochondrial DNA) sequences and 15 nuclear microsatellite loci. This multi-locus approach was key to disentangle complex patterns of gene flow among populations. D-loop analyses revealed population structuring among all Colombian rivers for T. manatus, while microsatellite data suggested no structure. Two main populations of T. inunguis separating the Colombian and Peruvian Amazon were supported by analysis of the D-loop and microsatellite data. Overall, we provide molecular evidence for differences in dispersal patterns between sexes, demonstrating male-biased gene flow dispersal in riverine manatees. These results are in contrast with previously reported levels of population structure shown by microsatellite data in marine manatee populations, revealing low habitat restrictions to gene flow in riverine habitats, and more significant dispersal limitations for males in marine environments.	[Satizabal, Paula; Duchene, Sebastian; Caballero, Susana J.] Univ Los Andes, Dept Ciencias Biol, Lab Ecol Mol Vertebrados Acuat LEMVA, Bogota, Colombia; [Mignucci-Giannoni, Antonio A.] Inter Amer Univ Puerto Rico, Puerto Rico Manatee Conservat Ctr, Bayamon, PR USA; [Duchene, Sebastian] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Caicedo-Herrera, Dalila; Trujillo, Fernando] Fdn Omacha, Bogota, Cundinamarca, Colombia; [Perea-Sicchar, Carlos M.] Direcc Reg Prod Loreto, Iquitos, Peru; [Garcia-Davila, Carmen R.] Inst Invest Amazonia Peruana, LBGM, Iquitos, Peru	Universidad de los Andes (Colombia); Inter American University of Puerto Rico-San German; University of Sydney	Satizabal, P (corresponding author), Univ Los Andes, Dept Ciencias Biol, Lab Ecol Mol Vertebrados Acuat LEMVA, Bogota, Colombia.	paula.satizabal@gmail.com		Satizabal, Paula/0000-0003-0284-3573; Duchene, Sebastian/0000-0002-2863-0907; Garcia-Davila, Carmen/0000-0003-4125-5563; Mignucci-Giannoni, Antonio A./0000-0003-1443-4873	Programa de Jovenes Investigadores de Colciencias, Virginia Gutierrez de Pineda; Proyecto Semilla-Universidad de los Andes; Proyecto Profesor Asistente-Universidad de los Andes	Programa de Jovenes Investigadores de Colciencias, Virginia Gutierrez de Pineda; Proyecto Semilla-Universidad de los Andes; Proyecto Profesor Asistente-Universidad de los Andes	Funders: Programa de Jovenes Investigadores de Colciencias, Virginia Gutierrez de Pineda (2010), the Proyecto Semilla-Universidad de los Andes, and the Proyecto Profesor Asistente-Universidad de los Andes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Paul K., 2002, Journal of Mammalian Evolution, V9, P55, DOI 10.1023/A:1021383827946; [Anonymous], 2010, LATIN AM J AQUAT MAM, DOI DOI 10.5597/lajam00155; Arraut EM, 2010, J ZOOL, V280, P247, DOI 10.1111/j.1469-7998.2009.00655.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bengtson JL, 1981, ECOLOGY MANATEES; Best R.C., 1984, Monographiae Biologicae, V56, P371; BEST RC, 1983, BIOTROPICA, V15, P61, DOI 10.2307/2388000; Bossart GD, 1999, J AM VET MED ASSOC, V214, P1178; Cantanhede AM, 2005, MOL ECOL, V14, P401, DOI 10.1111/j.1365-294X.2004.02413.x; Cassens I, 2005, MOL ECOL, V14, P107, DOI 10.1111/j.1365-294X.2004.02407.x; Deutsch C. J., 2008, TRICHECHUS MANATUS I; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; DeWoody JA, 2006, MOL ECOL NOTES, V6, P951, DOI 10.1111/j.1471-8286.2006.01449.x; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; DOMNING DP, 1986, MAR MAMMAL SCI, V2, P87, DOI 10.1111/j.1748-7692.1986.tb00034.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Escorza-Trevino S, 2000, MOL ECOL, V9, P1049, DOI 10.1046/j.1365-294x.2000.00959.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Garcia-Rodriguez AI, 2000, MOL ECOL, V9, P2161, DOI 10.1046/j.1365-294X.2000.10534.x; Garcia-Rodriguez AI, 1998, MOL ECOL, V7, P1137, DOI 10.1046/j.1365-294x.1998.00430.x; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hartman DS, 1979, SPECIAL PUBLICATION, P28; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hellborg L, 2003, MOL ECOL, V12, P283, DOI 10.1046/j.1365-294X.2003.01702.x; Hollatz C, 2011, BIOL J LINN SOC, V102, P812, DOI 10.1111/j.1095-8312.2011.01616.x; Hrbek T, 2005, ANIM CONSERV, V8, P297, DOI 10.1017/S1367943005002210; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hunter M, 2012, CONSERVATIO IN PRESS; Hunter ME, 2010, ANIM CONSERV, V13, P592, DOI 10.1111/j.1469-1795.2010.00383.x; Hurles ME, 2001, MOL ECOL, V10, P1599, DOI 10.1046/j.0962-1083.2001.01314.x; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Kellogg ME, 2008, SIRENIAN CONSERVATIO; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; MADDISON DR, 2000, MACCLADE 4; Marmontel M, 2008, TRICHECHUS INUNGUIS; Montoya-Ospina RA, 2001, BIOL CONSERV, V102, P117, DOI 10.1016/S0006-3207(00)00062-8; Muschett G, 2009, MAR MAMMAL SCI, V25, P955, DOI 10.1111/j.1748-7692.2009.00310.x; Naranjo LG, 1992, WATERFOWL WETLAND CO, P132; Nei M, 1987, MOL EVOLUTIONARY GEN; Nourisson C, 2011, GENETICA, V139, P833, DOI 10.1007/s10709-011-9583-z; Oksanen J., 2007, VEGAN PACKAGE COMMUN; Oosterhout C, 2003, MICROCHECKER VERSION; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pause KC, 2007, MOL ECOL NOTES, V7, P1073, DOI 10.1111/j.1471-8286.2007.01781.x; Peters JL, 2012, MOL ECOL, V21, P3562, DOI 10.1111/j.1365-294X.2012.05612.x; Pritchard JK, 2000, GENETICS, V155, P945; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Rambaut A, 2009, FIGTREE V1 3 1; RAMBAUT A, 2003, TRACER PROGRAM ANAL; Rathbun GB, 1995, REPROD FREE RANGING; REYNOLDS JE, 1981, MAMMALIA, V45, P431; ROSAS FCW, 1994, MAMMAL REV, V24, P49, DOI 10.1111/j.1365-2907.1994.tb00134.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING LAB MANU; Santos MCF, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01514.x; Self-Sullivan Caryn, 2003, Aquatic Mammals, V29, P342, DOI 10.1578/01675420360736514; Thornback J, 1982, IUCN MAMMAL RED DA 1; Tringali MD, 2008, MAR MAMMAL SCI, V24, P218, DOI 10.1111/j.1748-7692.2007.00147.x; Tringali MD, 2008, MOL ECOL RESOUR, V8, P328, DOI 10.1111/j.1471-8286.2007.01944.x; Vasconcelos WR, 2006, GENET MOL BIOL, V29, P220, DOI 10.1590/S1415-47572006000200006; Vianna JA, 2006, MOL ECOL, V15, P433, DOI 10.1111/j.1365-294X.2005.02771.x; Wu CH, 2011, GENETICS, V188, P151, DOI 10.1534/genetics.110.125260	73	20	20	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52468	10.1371/journal.pone.0052468	http://dx.doi.org/10.1371/journal.pone.0052468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285054	gold, Green Published			2022-12-25	WOS:000312794500177
J	Wang, X; Jiang, CM; Wan, HY; Wu, JL; Quan, WQ; Bals, R; Wu, KY; Li, D				Wang, Xuan; Jiang, Cui-Min; Wan, Hai-Ying; Wu, Jun-Lu; Quan, Wen-Qiang; Bals, Robert; Wu, Kai-Yin; Li, Dong			CDA-2, a Urinary Preparation, Inhibits Lung Cancer Development through the Suppression of NF-kappaB Activation in Myeloid Cell	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INNATE IMMUNITY; INFLAMMATORY CYTOKINES; MOUSE MODEL; IKK-BETA; TUMORIGENESIS; ANGIOGENESIS; APOPTOSIS; EXTRACT; TARGETS	CDA-2 (cell differentiation agent 2), a urinary preparation, has potent anti-proliferative and pro-apoptotic properties in cancer cells. However, the mechanisms of tumor inhibitory action of CDA-2 are far from clear, and especially there was no report on lung cancer. Here we demonstrate that CDA-2 and its main component phenylacetylglutamine (PG) reduce the metastatic lung tumor growth, and increases survival time after inoculation with Lewis lung carcinoma (LLC) cells in a dose-dependent manner in C57BL6 mice. Proliferative program analysis in cancer cells revealed a fundamental impact of CDA-2 and PG on proliferation and apoptosis, including Bcl-2, Bcl-XL, cIAP1, Survivin, PCNA, Ki-67 proteins and TUNEL assays. CDA-2 and PG significantly reduced NF-kappa B DNA-binding activity in lung cancer cells and in alveolar macrophages of tumor bearing mice and especially decreased the release of inflammatory factors including TNF alpha, IL-6, and KC. Furthermore, CDA-2 and PG decrease the expressions of TLR2, TLR6, and CD14, but not TLR1, TLR3, TLR4, and TLR9 in bone-marrow-derived macrophages (BMDM) of mice stimulated by LLC-conditioned medium (LLC-CM). Over-expressing TLR2 in BMDM prevented CDA-2 and PG from inhibiting NF-kappa B activation, as well as induction of TNF alpha and IL-6. TLR2: TLR6 complexes mediate the effect of NF-kappa B inactivation by CDA-2. In conclusion, CDA-2 potently inhibits lung tumor development by reduction of the inflammation in lung through suppression of NF-kappa B activation in myeloid cells, associating with modulation of TLR2 signaling.	[Wan, Hai-Ying; Wu, Jun-Lu; Quan, Wen-Qiang; Li, Dong] Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China; [Wang, Xuan; Jiang, Cui-Min] Putuo Peoples Hosp, Dept Pharm, Shanghai, Peoples R China; [Bals, Robert] Saarland Univ Hosp, Dept Internal Med Pulmonol 5, Homburg, Germany; [Wu, Kai-Yin] Charite, Inst Pathol, Berlin, Germany	Tongji University; Universitatsklinikum des Saarlandes; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Li, D (corresponding author), Tongji Univ, Tongji Hosp, Dept Clin Lab, Shanghai 200092, Peoples R China.	186ld@163.com			Research Program of the Committee of Science and Technology of Putuo District, Shanghai [PTKW09-B02]	Research Program of the Committee of Science and Technology of Putuo District, Shanghai	This work was supported by the Research Program of the Committee of Science and Technology of Putuo District, Shanghai (PTKW09-B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hess C, 2010, EUR RESPIR J, V35, P343, DOI 10.1183/09031936.00196408; Huang J, 2008, ACTA PHARMACOL SIN, V29, P951, DOI 10.1111/j.1745-7254.2008.00826.x; Huang J, 2009, FOOD CHEM TOXICOL, V47, P40, DOI 10.1016/j.fct.2008.08.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Li D, MYELOID CEL IN PRESS; Lin CL, 2009, J NEURO-ONCOL, V95, P29, DOI 10.1007/s11060-009-9900-x; Lin WC, 2006, FOOD CHEM TOXICOL, V44, P546, DOI 10.1016/j.fct.2005.08.029; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Smolinska MJ, 2011, J IMMUNOL, V187, P6043, DOI 10.4049/jimmunol.1100967; SOLTYSIAKPAWLUCZUK D, 1995, CANCER LETT, V88, P107, DOI 10.1016/0304-3835(94)03621-O; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Takahashi H, 2010, CANCER CELL, V17, P89, DOI 10.1016/j.ccr.2009.12.008; Takanami I, 1999, ONCOLOGY-BASEL, V57, P138, DOI 10.1159/000012021; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; von Haussen J, 2008, LUNG CANCER, V59, P12, DOI 10.1016/j.lungcan.2007.07.014; Xia YF, 2012, NAT CELL BIOL, V14, P257, DOI 10.1038/ncb2428; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Yao CJ, 2005, J ALTERN COMPLEM MED, V11, P903, DOI 10.1089/acm.2005.11.903; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x; Zaynagetdinov R, 2012, ONCOGENE, V31, P3164, DOI 10.1038/onc.2011.480	43	2	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52117	10.1371/journal.pone.0052117	http://dx.doi.org/10.1371/journal.pone.0052117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284890	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900076
J	Wang, DH; Hoing, S; Patterson, HC; Ahmad, UM; Rathinam, VAK; Rajewsky, K; Fitzgerald, KA; Golenbock, DT				Wang, Donghai; Hoeing, Susanne; Patterson, Heide Christine; Ahmad, Umtul M.; Rathinam, Vijay A. K.; Rajewsky, Klaus; Fitzgerald, Katherine A.; Golenbock, Douglas T.			Inflammation in Mice Ectopically Expressing Human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T Mutant Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; AUTOINFLAMMATORY DISEASES; PYRIN; ASC; ACTIVATION; MUTATIONS; CRE; IL-1-BETA; ANAKINRA; FEVER	Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome) is an autoinflammatory disease caused by aberrant production of the proinflammatory cytokine interleukin-1. Mutations in the gene encoding proline serine threonine phosphatase-interacting protein-1 (PSTPIP1) have been linked to PAPA syndrome. PSTPIP1 is an adaptor protein that interacts with PYRIN, the protein encoded by the Mediterranean Fever (MEFV) gene whose mutations cause Familial Mediterranean Fever (FMF). However, the pathophysiological function of PSTPIP1 remains to be elucidated. We have generated mouse strains that either are PSTPIP1 deficient or ectopically express mutant PSTPIP1. Results from analyzing these mice suggested that PSTPIP1 is not an essential regulator of the Nlrp3, Aim2, or Nlrc4 inflammasomes. Although common features of human PAPA syndrome such as pyogenic arthritis and skin inflammation were not recapitulated in the mouse model, ectopic expression of the mutant but not the wild type PSTPIP1 in mice lead to partial embryonic lethality, growth retardation, and elevated level of circulating proinflammatory cytokines.	[Wang, Donghai; Ahmad, Umtul M.; Rathinam, Vijay A. K.; Fitzgerald, Katherine A.; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Hoeing, Susanne; Rajewsky, Klaus] Harvard Univ, Sch Med, Immune Dis Inst, Boston Childrens Hosp, Boston, MA 02115 USA; [Hoeing, Susanne; Rajewsky, Klaus] Harvard Univ, Sch Med, Program Cellular & Mol Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Patterson, Heide Christine] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Patterson, Heide Christine] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Patterson, Heide Christine] Tech Univ Muenchen, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, D-81675 Munich, Germany	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Technical University of Munich	Wang, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.	donghai.wang@umassmed.edu; douglas.golenbock@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Rathinam, Vijay/ABE-7544-2020	Rathinam, Vijay/0000-0002-8009-3977; Rajewsky, Klaus/0000-0002-6633-6370; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health [1 R21 AI095871-01]; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases postdoctoral fellowship (National Institutes of Health) [U54 AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R21AI095871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM102718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases postdoctoral fellowship (National Institutes of Health); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 AI095871-01 (to D. G. and D. W.).; Supported by the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases postdoctoral fellowship (National Institutes of Health U54 AI057159).	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Aksentijevich I, 2011, NAT REV RHEUMATOL, V7, P468, DOI 10.1038/nrrheum.2011.94; Brenner M, 2009, BRIT J DERMATOL, V161, P1199, DOI 10.1111/j.1365-2133.2009.09404.x; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Chae JJ, 2011, IMMUNITY, V34, P755, DOI 10.1016/j.immuni.2011.02.020; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Demidowich AP, 2012, ARTHRITIS RHEUM-US, V64, P2022, DOI 10.1002/art.34332; Dierselhuis MP, 2005, RHEUMATOLOGY, V44, P406, DOI 10.1093/rheumatology/keh479; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Fantuzzi G, 1997, J IMMUNOL, V158, P1818; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Kozak W, 1998, ANN NY ACAD SCI, V856, P33, DOI 10.1111/j.1749-6632.1998.tb08310.x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Richards N, 2001, J BIOL CHEM, V276, P39320, DOI 10.1074/jbc.M104730200; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Xu YY, 2008, GENE, V419, P70, DOI 10.1016/j.gene.2008.04.020; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734	23	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4594	4601		10.1074/jbc.M112.443077	http://dx.doi.org/10.1074/jbc.M112.443077			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293022	Green Published, hybrid			2022-12-25	WOS:000315340400009
J	Armstrong, AW; Schupp, C; Wu, JL; Bebo, B				Armstrong, April W.; Schupp, Clayton; Wu, Julie; Bebo, Bruce			Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003-2011	PLOS ONE			English	Article							EXPERIENCE; SEVERITY; MODERATE	Objective: To ascertain impairment in quality of life and work productivity among patients with psoriasis and psoriatic arthritis. Design: From 2003 through 2011, the National Psoriasis Foundation collected survey data from patients with psoriasis and psoriatic arthritis via email and telephone correspondences. Setting: Survey data were collected from psoriasis and psoriatic arthritis patients in the general community in the U.S. Main Outcome Measures: Quality of life focusing on emotional impact (anger, frustration, helplessness, etc.) and physical impact (pain, pruritus, physical irritation, etc.); employment status. Patients: The surveys were performed through random sampling of participants from a database of over 75,000 patients. Results: From 2003 to 2011, 5,604 patients completed the surveys. Psoriasis and psoriatic arthritis affected overall emotional wellbeing in 88% of patients, and they interfered with enjoyment of life in 82%. Most patients reported experiencing anger (89%), frustration (89%), helplessness (87%), embarrassment (87%), and self-consciousness (89%). Many patients also actively concealed physical manifestations of their diseases (83%), and experienced pain (83%) and pruritus (93%) regularly. Of note, 12% of patients were unemployed, and 11% worked part-time. Among unemployed patients, 92% cited psoriasis and/or psoriatic arthritis as the sole reasons for not working. Among working patients, 49% missed work days regularly due to psoriasis. Compared to patients with mild psoriasis, patients with severe psoriasis have 1.8 times greater odds to be unemployed after adjusting for age and gender (Adjusted OR = 1.7, 95% CI 1.4-2.3). Conclusion: Patients with psoriasis and psoriatic arthritis continue to experience significant impairment of quality of life and work productivity.	[Armstrong, April W.; Schupp, Clayton; Wu, Julie] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA; [Bebo, Bruce] Natl Psoriasis Fdn, Portland, OR USA	University of California System; University of California Davis	Armstrong, AW (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	aprilarmstrong@post.harvard.edu			Abbott; Amgen; Janssen	Abbott(Abbott Laboratories); Amgen(Amgen); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	AWA has received research grants and/or consultant honoraria from Abbott, Amgen, and Janssen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronsard V, 2010, J EUR ACAD DERMATOL, V24, P17, DOI 10.1111/j.1468-3083.2009.03563.x; Feldman SR, 2005, J AM ACAD DERMATOL, V53, P101, DOI 10.1016/j.jaad.2005.03.050; Gupta MA, 1998, CUTIS, V61, P339; Horn EJ, 2007, J AM ACAD DERMATOL, V57, P957, DOI 10.1016/j.jaad.2007.06.042; Horn EJ, 2007, J AM ACAD DERMATOL, V57, P963, DOI 10.1016/j.jaad.2007.07.023; Kimball Alexa Boer, 2012, J Am Acad Dermatol, V66, pe67, DOI 10.1016/j.jaad.2010.10.020; Ortonne JP, 2009, J EUR ACAD DERMATOL, V23, P919, DOI 10.1111/j.1468-3083.2009.03221.x; Palotai T, 2010, ACTA DERMATOVENER CR, V18, P151; Pariser DM, 2007, ARCH DERMATOL, V143, P239, DOI 10.1001/archderm.143.2.239; Pearce DJ, 2006, J DERMATOL TREAT, V17, P24, DOI 10.1080/09546630500482886; Reich K, 2008, ARCH DERMATOL RES, V300, P537, DOI 10.1007/s00403-008-0885-7; Revicki DA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-75; Saad AA, 2010, ARTHRIT CARE RES, V62, P345, DOI 10.1002/acr.20104; SchmidOtt G, 1996, DERMATOLOGY, V193, P304, DOI 10.1159/000246275; Spandonaro F, 2011, GIORN ITAL DERMAT V, V146, P169; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x	16	172	180	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52935	10.1371/journal.pone.0052935	http://dx.doi.org/10.1371/journal.pone.0052935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285231	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500086
J	Firdessa, R; Tschopp, R; Wubete, A; Sombo, M; Hailu, E; Erenso, G; Kiros, T; Yamuah, L; Vordermeier, M; Hewinson, RG; Young, D; Gordon, SV; Sahile, M; Aseffa, A; Berg, S				Firdessa, Rebuma; Tschopp, Rea; Wubete, Alehegne; Sombo, Melaku; Hailu, Elena; Erenso, Girume; Kiros, Teklu; Yamuah, Lawrence; Vordermeier, Martin; Hewinson, R. Glyn; Young, Douglas; Gordon, Stephen V.; Sahile, Mesfin; Aseffa, Abraham; Berg, Stefan			High Prevalence of Bovine Tuberculosis in Dairy Cattle in Central Ethiopia: Implications for the Dairy Industry and Public Health	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; PATHOLOGY; INFECTION; HUSBANDRY; LIVESTOCK; DISEASE	Background: Ethiopia has the largest cattle population in Africa. The vast majority of the national herd is of indigenous zebu cattle maintained in rural areas under extensive husbandry systems. However, in response to the increasing demand for milk products and the Ethiopian government's efforts to improve productivity in the livestock sector, recent years have seen increased intensive husbandry settings holding exotic and cross breeds. This drive for increased productivity is however threatened by animal diseases that thrive under intensive settings, such as bovine tuberculosis (BTB), a disease that is already endemic in Ethiopia. Methodology/Principal Findings: An extensive study was conducted to: estimate the prevalence of BTB in intensive dairy farms in central Ethiopia; identify associated risk factors; and characterize circulating strains of the causative agent, Mycobacterium bovis. The comparative intradermal tuberculin test (CIDT), questionnaire survey, post-mortem examination, bacteriology, and molecular typing were used to get a better understanding of the BTB prevalence among dairy farms in the study area. Based on the CIDT, our findings showed that around 30% of 2956 tested dairy cattle from 88 herds were positive for BTB while the herd prevalence was over 50%. Post-mortem examination revealed gross tuberculous lesions in 34/36 CIDT positive cattle and acid-fast bacilli were recovered from 31 animals. Molecular typing identified all isolates as M. bovis and further characterization by spoligotyping and MIRU-VNTR typing indicated low strain diversity within the study area. Conclusions/Significance: This study showed an overall BTB herd prevalence of 50% in intensive dairy farms in Addis Ababa and surroundings, signalling an urgent need for intervention to control the disease and prevent zoonotic transmission of M. bovis to human populations consuming dairy products coming from these farms. It is suggested that government and policy makers should work together with stakeholders to design methods for the control of BTB in intensive farms in Ethiopia.	[Vordermeier, Martin; Hewinson, R. Glyn; Berg, Stefan] Anim Hlth & Vet Labs Agcy, Dept Bovine TB, Weybridge, Surrey, England; [Firdessa, Rebuma; Tschopp, Rea; Hailu, Elena; Erenso, Girume; Kiros, Teklu; Yamuah, Lawrence; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Wubete, Alehegne; Sombo, Melaku; Sahile, Mesfin] Natl Anim Hlth Diagnost & Invest Ctr, Addis Ababa, Ethiopia; [Gordon, Stephen V.] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland; [Tschopp, Rea; Young, Douglas] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England; [Tschopp, Rea] Swiss Trop & Publ Hlth, Basel, Switzerland	Veterinary Laboratories Agency; University College Dublin; Imperial College London; University of Basel; Swiss Tropical & Public Health Institute	Berg, S (corresponding author), Anim Hlth & Vet Labs Agcy, Dept Bovine TB, Weybridge, Surrey, England.	Stefan.berg@ahvla.gsi.gov.uk	Aseffa, Abraham/J-3248-2016; Berg, Stefan/AAU-6463-2020; Berg, Stefan O/D-3847-2011; Firdessa, Rebuma/P-6238-2019; Hewinson, Glyn/AAA-2364-2019; Vordermeier, H Martin/C-6936-2011; Yirsaw, Alehegne/AGG-9696-2022; Hewinson, Glyn/J-1902-2014	Aseffa, Abraham/0000-0002-8028-1150; Berg, Stefan/0000-0002-3470-7579; Firdessa, Rebuma/0000-0003-2523-165X; Gordon, Stephen/0000-0002-4833-5542; Hewinson, Glyn/0000-0002-5517-4281	Wellcome Trust (UK) under their "Animal health in the developing world initiative" [075833/A/04/Z]; Schweizerische Stiftung fur Medizinisch-Biologische Stipendien (SSMBS); Swiss National Science Foundation (SNSF); MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: researchfish	Wellcome Trust (UK) under their "Animal health in the developing world initiative"; Schweizerische Stiftung fur Medizinisch-Biologische Stipendien (SSMBS); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was sponsored by the Wellcome Trust (UK) under their "Animal health in the developing world initiative" (grant number 075833/A/04/Z). The authors acknowledge the Schweizerische Stiftung fur Medizinisch-Biologische Stipendien (SSMBS) and the Swiss National Science Foundation (SNSF) for their financial support of Rea Tschopp during the analysis and writing phase. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreha T, 2006, REG WORKSH ORG ASARE; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Ameni G, 2011, VET J, V188, P359, DOI 10.1016/j.tvjl.2010.05.005; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Berg S, 2011, J BACTERIOL, V193, P670, DOI 10.1128/JB.00750-10; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Bureau PR, 2010, WORLD POPULATION DAT; CARMICHAEL J., 1939, JOUR COMP PATH AND THERAP, V52, P322, DOI 10.1016/S0368-1742(39)80029-7; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; CSA, 2011, REP LIV LIV CHAR AGR; CSA, 2007, REP LIV LIV CHAR AGR; de la Rua-Domenech R, 2006, TUBERCULOSIS, V86, P77, DOI 10.1016/j.tube.2005.05.002; Demelash B, 2009, TROP ANIM HEALTH PRO, V41, P755, DOI 10.1007/s11250-008-9248-9; Elias K, 2008, REV SCI TECH OIE, V27, P915, DOI 10.20506/rst.27.3.1850; Firdessa R, 2013, EMERGING IN IN PRESS; GALLAGHER J, 1977, J HYG-CAMBRIDGE, V79, P155, DOI 10.1017/S0022172400052943; Grange JM, 2001, TUBERCULOSIS, V81, P71, DOI 10.1054/tube.2000.0263; Gumi B, 2012, ECOHEALTH, V9, P139, DOI 10.1007/s10393-012-0754-x; Gumi B, 2011, TROP ANIM HEALTH PRO, V43, P1081, DOI 10.1007/s11250-010-9777-x; Halderman M, 2004, POLITICAL EC PRO POO, P1; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Liebana E, 2008, VET J, V176, P354, DOI 10.1016/j.tvjl.2007.07.001; Meisinger G, 1970, Monatsh Veterinarmed, V25, P7; OIE, 2009, BOV TUB TERR MAN; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Phillips CJC, 2003, RES VET SCI, V74, P1, DOI 10.1016/S0034-5288(02)00145-5; SNV, 2008, DAIR INV OPP ETH, P1; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; Tegegne A, 2002, SCOPING STUDY URBA 1; Thoen C., 1995, MYCOBACTERIUM BOVIS; Thoen CO., 1995, MYCOBACTERIUM BOVIS, P3; Tschopp R, 2010, VET REC, V167, P250, DOI 10.1136/vr.c3381; Tschopp R, 2013, CURR TOP MICROBIOL, V365, P249, DOI 10.1007/82_2012_245; Tschopp R, 2010, MT RES DEV, V30, P381, DOI 10.1659/MRD-JOURNAL-D-09-00072.1; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; Tsegaye W, 2010, INT J APPL RES VET M, V8, P143; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002	42	59	64	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52851	10.1371/journal.pone.0052851	http://dx.doi.org/10.1371/journal.pone.0052851			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285202	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500069
J	Gandolfi, B; Gruffydd-Jones, TJ; Malik, R; Cortes, A; Jones, BR; Helps, CR; Prinzenberg, EM; Erhardt, G; Lyons, LA				Gandolfi, Barbara; Gruffydd-Jones, Timothy J.; Malik, Richard; Cortes, Alejandro; Jones, Boyd R.; Helps, Chris R.; Prinzenberg, Eva M.; Erhardt, George; Lyons, Leslie A.			First WNK4-Hypokalemia Animal Model Identified by Genome-Wide Association in Burmese Cats	PLOS ONE			English	Article							HYPERKALEMIC PERIODIC PARALYSIS; DISTAL CONVOLUTED TUBULE; CHANNEL ALPHA-SUBUNIT; NA-CL COTRANSPORTER; HYPOKALEMIC POLYMYOPATHY; POTASSIUM-DEPLETION; GITELMANS-SYNDROME; MUSCLE WEAKNESS; FELIS-CATUS; WNK KINASES	Burmese is an old and popular cat breed, however, several health concerns, such as hypokalemia and a craniofacial defect, are prevalent, endangering the general health of the breed. Hypokalemia, a subnormal serum potassium ion concentration ([K+]), most often occurs as a secondary problem but can occur as a primary problem, such as hypokalaemic periodic paralysis in humans, and as feline hypokalaemic periodic polymyopathy primarily in Burmese. The most characteristic clinical sign of hypokalemia in Burmese is a skeletal muscle weakness that is frequently episodic in nature, either generalized, or sometimes localized to the cervical and thoracic limb girdle muscles. Burmese hypokalemia is suspected to be a single locus autosomal recessive trait. A genome wide case-control study using the illumina Infinium Feline 63K iSelect DNA array was performed using 35 cases and 25 controls from the Burmese breed that identified a locus on chromosome E1 associated with hypokalemia. Within approximately 1.2 Mb of the highest associated SNP, two candidate genes were identified, KCNH4 and WNK4. Direct sequencing of the genes revealed a nonsense mutation, producing a premature stop codon within WNK4 (c.2899C>T), leading to a truncated protein that lacks the C-terminal coiled-coil domain and the highly conserved Akt1/SGK phosphorylation site. All cases were homozygous for the mutation. Although the exact mechanism causing hypokalemia has not been determined, extrapolation from the homologous human and mouse genes suggests the mechanism may involve a potassium-losing nephropathy. A genetic test to screen for the genetic defect within the active breeding population has been developed, which should lead to eradication of the mutation and improved general health within the breed. Moreover, the identified mutation may help clarify the role of the protein in K+ regulation and the cat represents the first animal model for WNK4-associated hypokalemia.	[Gandolfi, Barbara; Cortes, Alejandro; Lyons, Leslie A.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Gruffydd-Jones, Timothy J.] Univ Bristol, Feline Ctr, Bristol, Avon, England; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW 2006, Australia; [Jones, Boyd R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Helps, Chris R.] Univ Bristol, Mol Diagnost Unit, Bristol, Avon, England; [Prinzenberg, Eva M.; Erhardt, George] Univ Giessen, Inst Anim Breeding & Genet, Giessen, Germany	University of California System; University of California Davis; University of Bristol; University of Sydney; Massey University; University of Bristol; Justus Liebig University Giessen	Lyons, LA (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	lalyons@ucdavis.edu	Malik, Richard/I-2009-2019	Lyons, Leslie/0000-0002-1628-7726; Helps, Chris/0000-0003-3405-4843	National Center for Research Resources [R24 RR016094]; Office of Research Infrastructure Programs/OD [R24OD010928]; Cat Health Network grant [D12FE-508]; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis; Valentine Charlton Bequest from the University of Sydney; Morris Animal Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR016094] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010928] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD; Cat Health Network grant; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); Valentine Charlton Bequest from the University of Sydney; Morris Animal Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funding from the National Center for Research Resources R24 RR016094 and is currently supported by the Office of Research Infrastructure Programs/OD R24OD010928, the Cat Health Network grant D12FE-508, and the Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis. Richard Malik is supported by the Valentine Charlton Bequest from the University of Sydney. Support for the development of the Illumina Infinium Feline 63K iSelect DNA array was provided by the Morris Animal Foundation (http://www.morrisanimalfoundation.org) via a donation from Hill's Pet Food, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2008, NEUROMUSCULAR DISORD, V18, P277, DOI 10.1016/j.nmd.2008.01.001; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bighignoli B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-27; BLAXTER A, 1986, VET REC, V118, P619, DOI 10.1136/vr.118.22.619; BRADLEY WG, 1990, ARCH NEUROL-CHICAGO, V47, P1013, DOI 10.1001/archneur.1990.00530090091018; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Cox JH, 1986, P ANN CONV AM ASS EQ, P383; DOW SW, 1987, J AM VET MED ASSOC, V191, P1563; DOW SW, 1989, J AM VET MED ASSOC, V194, P1604; DOW SW, 1987, J AM VET MED ASSOC, V191, P1569; FETTMAN MJ, 1989, VET CLIN N AM-SMALL, V19, P415, DOI 10.1016/S0195-5616(89)50053-6; Finsterer J, 2008, ACTA NEUROL SCAND, V117, P145, DOI 10.1111/j.1600-0404.2007.00963.x; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; Gabow PA, 1986, DISORDERS POTASSIUM, P207; GAMSTORP I, 1957, Acta Genet Stat Med, V7, P325; Golbang AP, 2005, HYPERTENSION, V46, P295, DOI 10.1161/01.HYP.0000174326.96918.d6; Harrington ML, 1996, PROG VET NEUROL, V7, P130; Heath S, 2001, VET REC, V149, P660; Helps CR, 2007, MOL CELL PROBE, V21, P31, DOI 10.1016/j.mcp.2006.07.003; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Holtzapple GE, 1905, J AMER MED ASSOC, V45, P1224; HOPKINS AL, 1989, VET REC, V125, P17, DOI 10.1136/vr.125.1.17; Hubner CA, 2002, HUM MOL GENET, V11, P2435, DOI 10.1093/hmg/11.20.2435; JONES BR, 1988, NEW ZEAL VET J, V36, P150, DOI 10.1080/00480169.1988.35514; JONES BR, 1990, CORNELL VET, V80, P13; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lantinga E, 1998, TIJDSCHR DIERGENEESK, V123, P435; LAYZER RB, 1982, ANN NEUROL, V11, P547, DOI 10.1002/ana.410110602; Lehmann-Horn F, 1999, PHYSIOL REV, V79, P1317, DOI 10.1152/physrev.1999.79.4.1317; LEVITT LP, 1972, NEW ENGL J MED, V286, P253, DOI 10.1056/NEJM197202032860507; Lipinski MJ, 2007, ANIM GENET, V38, P371, DOI 10.1111/j.1365-2052.2007.01632.x; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; LUTZ TA, 1995, VET CLIN N AM-SMALL, V25, P527, DOI 10.1016/S0195-5616(95)50051-8; MASON KV, 1988, J AM ANIM HOSP ASSOC, V24, P481; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; McCormick JA, 2011, PHYSIOL REV, V91, P177, DOI 10.1152/physrev.00017.2010; NAYLOR JM, 1994, CAN VET J, V35, P279; NODEN DM, 1986, J CRAN GENET DEV BIO, P249; OBrien SJ, 1997, J HERED, V88, P408, DOI 10.1093/oxfordjournals.jhered.a023127; OBrien SJ, 1997, TRENDS GENET, V13, P393, DOI 10.1016/S0168-9525(97)01297-3; PAVER WK, 1964, MED J AUSTRALIA, V35, P305; Proctor G, 2006, AM J KIDNEY DIS, V48, P674, DOI 10.1053/j.ajkd.2006.06.014; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ring AM, 2007, P NATL ACAD SCI USA, V104, P4025, DOI 10.1073/pnas.0611728104; ROCHE GM, 1994, VET REC, V134, P360, DOI 10.1136/vr.134.14.360-a; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; Schaefer TJ, 2005, EMERG MED CLIN N AM, V23, P723, DOI 10.1016/j.emc.2005.03.016; SCHAER M, 1982, VET CLIN N AM-SMALL, V12, P399, DOI 10.1016/S0195-5616(82)50052-6; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; SCHUNK KL, 1984, P 2 ANN FOR AM COLL, P197; Sielman ES, 1997, J AM VET MED ASSOC, V210, P240; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; SMITH SG, 1950, ARCH PATHOL, V49, P185; SPIER SJ, 1990, J AM VET MED ASSOC, V197, P1009; STEISS JE, 1986, CAN VET J, V27, P332; STERNS RH, 1981, MEDICINE, V60, P339, DOI 10.1097/00005792-198109000-00002; Stolze M, 2001, KLEINTIERPRAXIS, V46, P517; Sturgess CP, 1997, VET REC, V141, P566, DOI 10.1136/vr.141.22.566; Talbott JH, 1941, MEDICINE, V20, P85, DOI 10.1097/00005792-194102000-00002; THIER SO, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90334-7; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; Wang ZH, 2004, BIOCHEM BIOPH RES CO, V317, P939, DOI 10.1016/j.bbrc.2004.03.132; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	69	35	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53173	10.1371/journal.pone.0053173	http://dx.doi.org/10.1371/journal.pone.0053173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285264	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500117
J	Mary, C; Duek, P; Salleron, L; Tienz, P; Bumann, D; Bairoch, A; Lane, L				Mary, Camille; Duek, Paula; Salleron, Lisa; Tienz, Petra; Bumann, Dirk; Bairoch, Amos; Lane, Lydie			Functional Identification of APIP as Human mtnB, a Key Enzyme in the Methionine Salvage Pathway	PLOS ONE			English	Article							ESCHERICHIA-COLI; METHYLTHIOADENOSINE PHOSPHORYLASE; ORNITHINE-DECARBOXYLASE; L-RIBULOSE-5-PHOSPHATE 4-EPIMERASE; CELL-LINES; BACILLUS-SUBTILIS; ABC TRANSPORTER; CANCER-CELLS; GENE; DEPENDENCY	The methionine salvage pathway is widely distributed among some eubacteria, yeast, plants and animals and recycles the sulfur-containing metabolite 5-methylthioadenosine (MTA) to methionine. In eukaryotic cells, the methionine salvage pathway takes place in the cytosol and usually involves six enzymatic activities: MTA phosphorylase (MTAP, EC 2.4.2.28), 5'-methylthioribose-1-phosphate isomerase (mtnA, EC 5.3.1.23), 5'-methylthioribulose-1-phosphate dehydratase (mtnB, EC: 4.2.1.109), 2,3-dioxomethiopentane-1-phosphate enolase/phosphatase (mtnC, EC 3.1.3.77), aci-reductone dioxygenase (mtnD, EC 1.13.11.54) and 4-methylthio-2-oxo-butanoate (MTOB) transaminase (EC 2.6.1.-). The aim of this study was to complete the available information on the methionine salvage pathway in human by identifying the enzyme responsible for the dehydratase step. Using a bioinformatics approach, we propose that a protein called APIP could perform this role. The involvement of this protein in the methionine salvage pathway was investigated directly in HeLa cells by transient and stable short hairpin RNA interference. We show that APIP depletion specifically impaired the capacity of cells to grow in media where methionine is replaced by MTA. Using a Shigella mutant auxotroph for methionine, we confirm that the knockdown of APIP specifically affects the recycling of methionine. We also show that mutation of three potential phosphorylation sites does not affect APIP activity whereas mutation of the potential zinc binding site completely abrogates it. Finally, we show that the N-terminal region of APIP that is missing in the short isoform is required for activity. Together, these results confirm the involvement of APIP in the methionine salvage pathway, which plays a key role in many biological functions like cancer, apoptosis, microbial proliferation and inflammation.	[Mary, Camille; Duek, Paula; Bairoch, Amos; Lane, Lydie] Univ Geneva, SIB, CALIPHO Grp, Geneva, Switzerland; [Salleron, Lisa; Bairoch, Amos; Lane, Lydie] Univ Geneva, Dept Human Prot Sci, Geneva, Switzerland; [Tienz, Petra; Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland	Swiss Institute of Bioinformatics; University of Geneva; University of Geneva; University of Basel	Mary, C (corresponding author), Univ Geneva, SIB, CALIPHO Grp, Geneva, Switzerland.	camille.mary@isb-sib.ch	Duek, Paula/AAV-2308-2020; Bairoch, Amos/X-7411-2019; Lane, Lydie/AAQ-4896-2021	Bairoch, Amos/0000-0003-2826-6444; Lane, Lydie/0000-0002-9818-3030; Duek Roggli, Paula/0000-0002-0819-0473	Swiss SystemsX.ch initiative (BattleX)	Swiss SystemsX.ch initiative (BattleX)	This project was financed with a grant from the Swiss SystemsX.ch initiative (BattleX), evaluated by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akana J, 2006, BIOCHEMISTRY-US, V45, P2493, DOI 10.1021/bi052474m; Albers E, 2009, IUBMB LIFE, V61, P1132, DOI 10.1002/iub.278; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; [Anonymous], INT J ONCOLOGY, V40, P2111; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Ashida H, 2008, BIOSCI BIOTECH BIOCH, V72, P959, DOI 10.1271/bbb.70651; BACKLUND PS, 1982, J BIOL CHEM, V257, P4196; Basu I, 2007, J BIOL CHEM, V282, P21477, DOI 10.1074/jbc.M702287200; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Behrmann I, 2003, AM J PATHOL, V163, P683, DOI 10.1016/S0002-9440(10)63695-4; Cavuoto P, 2012, CANCER TREAT REV, V38, P726, DOI 10.1016/j.ctrv.2012.01.004; Cellarier E, 2003, CANCER TREAT REV, V29, P489, DOI 10.1016/S0305-7372(03)00118-X; Chattopadhyay MK, 2005, P NATL ACAD SCI USA, V102, P16158, DOI 10.1073/pnas.0507299102; Cho DH, 2007, ONCOGENE, V26, P2809, DOI 10.1038/sj.onc.1210080; Cho DH, 2004, J BIOL CHEM, V279, P39942, DOI 10.1074/jbc.M405747200; Chow WA, 2006, CANCER GENET CYTOGEN, V166, P95, DOI 10.1016/j.cancergencyto.2005.10.009; Collins CC, 2012, MOL CANCER THER, V11, P775, DOI 10.1158/1535-7163.MCT-11-0826; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Cooper AJL, 2012, COMP BIOCHEM PHYS B, V163, P108, DOI 10.1016/j.cbpb.2012.05.010; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DellaRagione F, 1996, BIOCHEM BIOPH RES CO, V223, P514, DOI 10.1006/bbrc.1996.0926; DELLARAGIONE F, 1992, BIOCHEM J, V281, P533, DOI 10.1042/bj2810533; DREYER MK, 1993, J MOL BIOL, V231, P549, DOI 10.1006/jmbi.1993.1307; Durando X, 2008, B CANCER, V95, P69, DOI 10.1684/bdc.2008.0550; Gal J, 2002, J BACTERIOL, V184, P4930, DOI 10.1128/JB.184.17.4930-4932.2002; Hirano W, 2005, GENES CELLS, V10, P565, DOI 10.1111/j.1365-2443.2005.00859.x; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Johnson AE, 1998, BIOCHEMISTRY-US, V37, P5746, DOI 10.1021/bi972984j; Kabuyama Y, 2009, MOL CELL PROTEOMICS, V8, P2308, DOI 10.1074/mcp.M900178-MCP200; KADNER RJ, 1974, J BACTERIOL, V119, P401, DOI 10.1128/JB.119.2.401-409.1974; Ko DC, 2012, P NATL ACAD SCI US; Komatsu A, 2008, INT J ONCOL, V33, P261, DOI 10.3892/ijo_00000005; KREIS W, 1991, J NATL CANCER I, V83, P725, DOI 10.1093/jnci/83.10.725; Kroemer M, 2003, BIOCHEMISTRY-US, V42, P10560, DOI 10.1021/bi0349266; Lee LV, 2000, BIOCHEMISTRY-US, V39, P4821, DOI 10.1021/bi9928952; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Luo Y, 2001, BIOCHEMISTRY-US, V40, P14763, DOI 10.1021/bi0112513; Mantis N, 1996, INFECT IMMUN, V64, P2474, DOI 10.1128/IAI.64.7.2474-2482.1996; MECHAM JO, 1983, BIOCHEM BIOPH RES CO, V117, P429, DOI 10.1016/0006-291X(83)91218-4; Merlin C, 2002, J BACTERIOL, V184, P5513, DOI 10.1128/JB.184.19.5513-5517.2002; Miki K, 2000, CANCER RES, V60, P2696; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pirkov I, 2008, FEBS J, V275, P4111, DOI 10.1111/j.1742-4658.2008.06552.x; Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570; Salim HMW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000701; Sekowska A, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-9; Sekowska A, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SODA K, 1987, METHOD ENZYMOL, V143, P453; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Subhi AL, 2004, CLIN CANCER RES, V10, P7290, DOI 10.1158/1078-0432.CCR-04-0972; Subhi AL, 2003, J BIOL CHEM, V278, P49868, DOI 10.1074/jbc.M308451200; Tang BQ, 2006, BIOCHEM PHARMACOL, V72, P806, DOI 10.1016/j.bcp.2006.06.018; Tang BQ, 2000, CANCER RES, V60, P5543; Thivat E, ANTICANCER RES, V27, P2779; TRACKMAN PC, 1983, J BIOL CHEM, V258, P6717; Wang H, 2005, J MOL BIOL, V348, P917, DOI 10.1016/j.jmb.2005.01.072; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Zhang ZG, 2003, ARCH MICROBIOL, V180, P88, DOI 10.1007/s00203-003-0561-4	60	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52877	10.1371/journal.pone.0052877	http://dx.doi.org/10.1371/journal.pone.0052877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285211	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000313051500075
J	Ortega-Hernandez, J; Brena, C				Ortega-Hernandez, Javier; Brena, Carlo			Ancestral Patterning of Tergite Formation in a Centipede Suggests Derived Mode of Trunk Segmentation in Trilobites	PLOS ONE			English	Article							MILLIPEDE GLOMERIS-MARGINATA; SIRIUS PASSET FAUNA; GENE-EXPRESSION; ENGRAILED EXPRESSION; BOUNDARY FORMATION; DROSOPHILA; ARTHROPOD; EVOLUTION; ORGANIZATION; COMPARTMENT	Trilobites have a rich and abundant fossil record, but little is known about the intrinsic mechanisms that orchestrate their body organization. To date, there is disagreement regarding the correspondence, or lack thereof, of the segmental units that constitute the trilobite trunk and their associated exoskeletal elements. The phylogenetic position of trilobites within total-group Euarthropoda, however, allows inferences about the underlying organization in these extinct taxa to be made, as some of the fundamental genetic processes for constructing the trunk segments are remarkably conserved among living arthropods. One example is the expression of the segment polarity gene engrailed, which at embryonic and early postembryonic stages is expressed in extant panarthropods (i.e. tardigrades, onychophorans, euarthropods) as transverse stripes that define the posteriormost region of each trunk segment. Due to its conservative morphology and allegedly primitive trunk tagmosis, we have utilized the centipede Strigamia maritima to study the correspondence between the expression of engrailed during late embryonic to postembryonic stages, and the development of the dorsal exoskeletal plates (i.e. tergites). The results corroborate the close correlation between the formation of the tergite borders and the dorsal expression of engrailed, and suggest that this association represents a symplesiomorphy within Euarthropoda. This correspondence between the genetic and phenetic levels enables making accurate inferences about the dorsoventral expression domains of engrailed in the trunk of exceptionally preserved trilobites and their close relatives, and is suggestive of the widespread occurrence of a distinct type of genetic segmental mismatch in these extinct arthropods. The metameric organization of the digestive tract in trilobites provides further support to this new interpretation. The wider evolutionary implications of these findings suggest the presence of a derived morphogenetic patterning mechanism responsible for the reiterated occurrence of different types of trunk dorsoventral segmental mismatch in several phylogenetically distant, extinct and extant, arthropod groups.	[Ortega-Hernandez, Javier] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Brena, Carlo] Univ Cambridge, Dept Zool, Cambridge CB2 3EQ, England	University of Cambridge; University of Cambridge	Ortega-Hernandez, J (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	jo314@cam.ac.uk			Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT); University of Cambridge Trusts (UK); Darwin College (UK); University of Cambridge	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Cambridge Trusts (UK); Darwin College (UK); University of Cambridge(University of Cambridge)	JOH is funded by Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), the University of Cambridge Trusts (UK) and Darwin College (UK). This study was supported by the University of Cambridge funding to Michael Akam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; [Anonymous], 1991, HETEROCHRONY EVOLUTI; Becker S, 1997, DEVELOPMENT, V124, P2615; Bergstrom J., 1973, Fossils Strata, V2, P1; BERGSTROM J, 1973, Acta Geologica Polonica, V23, P207; BERGSTROM J, 1984, LETHAIA, V17, P67, DOI 10.1111/j.1502-3931.1984.tb00668.x; Bergstrom J, 2008, GFF, V130, P189; Bonato L, 2010, ZOOKEYS, P17, DOI 10.3897/zookeys.69.737; Bortolin F, 2011, DEV GENES EVOL, V221, P105, DOI 10.1007/s00427-011-0359-3; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; BROADIE KS, 1991, DEVELOPMENT, V113, P103; Bruton David L., 1997, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V245, P1; Bruton David L., 1999, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V253, P29; BRUTON DL, 2003, SP PALAEONT, P331; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Budd GE, 2011, J SYST PALAEONTOL, V9, P217, DOI 10.1080/14772019.2010.492644; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; CAMPBELL GL, 1989, DEVELOPMENT, V106, P727; Chen Jun-Yuan, 1997, Records of the Australian Museum, V49, P1; Chen JY, 2007, PALAEOGEOGR PALAEOCL, V254, P250, DOI 10.1016/j.palaeo.2007.03.018; Chipman AD, 2004, EVOL DEV, V6, P78, DOI 10.1111/j.1525-142X.2004.04016.x; CISNE J L, 1975, Fossils and Strata, V4, P45; Cotton TJ, 2004, T ROY SOC EDIN-EARTH, V94, P169, DOI 10.1017/S0263593300000596; Cronier C, 2010, HIST BIOL, V22, P341, DOI 10.1080/08912960903548712; CURRIE DA, 1991, DEVELOPMENT, V113, P91; Damen WGM, 2002, DEVELOPMENT, V129, P1239; Deutsch JS, 2004, BIOESSAYS, V26, P1117, DOI 10.1002/bies.20111; Edgecombe GD, 1999, J PALEONTOL, V73, P263, DOI 10.1017/S0022336000027761; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Fusco G, 2004, AM NAT, V163, P167, DOI 10.1086/381042; Fusco G, 2012, EVOLUTION, V66, P314, DOI 10.1111/j.1558-5646.2011.01447.x; Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5; HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079; Haug JT, 2010, EARTH ENV SCI T R SO, V100, P311, DOI 10.1017/S1755691010008145; Hertzler PL, 2009, ARTHROPOD STRUCT DEV, V38, P235, DOI 10.1016/j.asd.2008.12.003; HESSLER RR, 1962, J PALEONTOL, V36, P1305; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou Xianguang, 1997, Fossils and Strata, V45, P1; Hughes NC, 2005, EVOLVING FORM AND FUNCTION: FOSSILS AND DEVELOPMENT, P139; Hughes NC, 2003, INTEGR COMP BIOL, V43, P185, DOI 10.1093/icb/43.1.185; Hughes NC, 1999, EVOL DEV, V1, P24, DOI 10.1046/j.1525-142x.1999.99005.x; Hughes NC, 2003, BIOESSAYS, V25, P386, DOI 10.1002/bies.10270; HUGHES NC, 1991, GEOLOGY, V19, P913, DOI 10.1130/0091-7613(1991)019<0913:MPAGFI>2.3.CO;2; Hughes NC, 2007, ANNU REV EARTH PL SC, V35, P401, DOI 10.1146/annurev.earth.35.031306.140258; Hughes NC, 2006, PALEOBIOLOGY, V32, P602, DOI 10.1666/06017.1; Jacobs DK, 2000, EVOL DEV, V2, P340, DOI 10.1046/j.1525-142x.2000.00077.x; Janssen R, 2004, DEV BIOL, V268, P89, DOI 10.1016/j.ydbio.2003.12.021; Janssen R, 2008, DEV GENES EVOL, V218, P361, DOI 10.1007/s00427-008-0231-2; Janssen R, 2011, EVOL DEV, V13, P477, DOI 10.1111/j.1525-142X.2011.00504.x; Janssen R, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-5; Kettle C, 2003, EVOL DEV, V5, P198, DOI 10.1046/j.1525-142X.2003.03027.x; KORNBERG T, 1981, DEV BIOL, V86, P363, DOI 10.1016/0012-1606(81)90194-9; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; Krzemien J, 2012, DEVELOPMENT, V139, P75, DOI 10.1242/dev.073692; Lagebro L, 2009, J PALEONTOL, V83, P820, DOI 10.1666/09-011.1; Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867; Lawrence PA, 2002, DEVELOPMENT, V129, P2749; Lerosey-Aubril R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032934; Linder F., 1952, Proceedings of the United States National Museum, V102, P1; McNamara K.J., 1983, Special Papers in Palaeontology, P59; McNamara KJ, 2011, J PALEONTOL, V85, P106, DOI 10.1666/10-049.1; Mittmann B, 2012, DEV GENES EVOL, V222, P189, DOI 10.1007/s00427-012-0401-0; Nielsen C, 2003, DEV GENES EVOL, V213, P149, DOI 10.1007/s00427-003-0301-4; Nulsen C, 1999, DEV GENES EVOL, V209, P340, DOI 10.1007/s004270050262; Ortega-Hernandez J, 2013, CLADISTICS, V29, P15, DOI 10.1111/j.1096-0031.2012.00413.x; PALMER AR, 1957, J PALEONTOL, V31, P105; RAW FRANK, 1953, JOUR PALEONTOL, V27, P82; Rogers BT, 1996, DEVELOPMENT, V122, P3419; Shen J, 2005, DEV BIOL, V279, P31, DOI 10.1016/j.ydbio.2004.11.033; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Stormer L., 1942, NORSK GEOLOGISK TIDD, V21, P50; Struhl G, 1997, DEVELOPMENT, V124, P2143; Sturmer W., 1973, Palaeontologische Z, V47, P104; Svensson ME, 2004, DEV GENES EVOL, V214, P418, DOI 10.1007/s00427-004-0416-2; Vedel V, 2008, EVOL DEV, V10, P487, DOI 10.1111/j.1525-142X.2008.00259.x; VOLK T, 1994, DEVELOPMENT, V120, P59; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Walossek D, 1987, FOSSILS STRATA, V19, P1; Warnock RCM, 2012, BIOL LETTERS, V8, P156, DOI 10.1098/rsbl.2011.0710; Webster M, 2007, SCIENCE, V317, P499, DOI 10.1126/science.1142964; WHITTINGTON H B, 1975, Fossils and Strata, V4, P97; WHITTINGTON HB, 1993, PHILOS T ROY SOC B, V339, P109, DOI 10.1098/rstb.1993.0008; WHITTINGTON HB, 1957, BIOL REV, V32, P421, DOI 10.1111/j.1469-185X.1957.tb00779.x; WHITTINGTON HB, 1987, PHILOS T ROY SOC B, V317, P1, DOI 10.1098/rstb.1987.0046; Zhang XL, 2007, J PALEONTOL, V81, P1, DOI 10.1666/06-082.1; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; ZRZAVY J, 1995, Q REV BIOL, V70, P279, DOI 10.1086/419072	88	30	30	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52623	10.1371/journal.pone.0052623	http://dx.doi.org/10.1371/journal.pone.0052623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285116	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500041
J	Pan, XH; Zhang, QJ; Yan, WG; Jia, M; Jackson, A; Li, XB; Jia, LM; Huang, BH; Xu, PZ; Correa-Victoria, F; Li, SG				Pan, Xuhao; Zhang, Qijun; Yan, Wengui; Jia, Melissa; Jackson, Aaron; Li, Xiaobai; Jia, Limeng; Huang, Bihu; Xu, Peizhou; Correa-Victoria, Fernando; Li, Shigui			Development of Genetic Markers Linked to Straighthead Resistance through Fine Mapping in Rice (Oryza sativa L.)	PLOS ONE			English	Article							CULTIVARS; DIVERSITY; GENOTYPE; MINERALS; LOCUS; QTL	Straighthead, a physiological disorder characterized by sterile florets and distorted spikelets, causes significant yield losses in rice, and occurs in many countries. The current control method of draining paddies early in the season stresses plants, is costly, and wastes water. Development of resistant cultivar is regarded as the most efficient way for its control. We mapped a QTL for straighthead resistance using two recombinant inbred line (RIL) F-9 populations that were phenotyped over two years using monosodium methanearsonate (MSMA) to induce the symptoms. One population of 170 RILs was genotyped with 136 SSRs and the other population of 91 RILs was genotyped with 159 SSRs. A major QTL qSH-8 was identified in an overlapping region in both populations, and explained 46% of total variation in one and 67% in another population for straighthead resistance. qSH-8 was fine mapped from 1.0 Mbp to 340 kb using 7 SSR markers and further mapped to 290 kb in a population between RM22573 and InDel 27 using 4 InDel markers. SSR AP3858-1 and InDel 11 were within the fine mapped region, and co-segregated with straighthead resistance in both RIL populations, as well as in a collection of diverse global accessions. These results demonstrate that AP3858-1 and InDel 11 can be used for marker-assisted selection (MAS) for straighthead resistant cultivars, which is especially important because there is no effective way to directly evaluate straighthead resistance.	[Pan, Xuhao; Yan, Wengui; Jia, Melissa; Jackson, Aaron; Li, Shigui] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA; [Pan, Xuhao; Xu, Peizhou] Sichuan Agr Univ, Rice Res Inst, Chengdu, Peoples R China; [Pan, Xuhao] Univ Arkansas, Rice Res & Extens Ctr, Stuttgart, AR USA; [Zhang, Qijun] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China; [Li, Xiaobai] Zhejiang Univ, Inst Nucl Agr Sci, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Limeng] Zhejiang Acad Agr Sci, Inst Virol & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Huang, Bihu] Univ Arkansas, Pine Bluff, AR USA; [Correa-Victoria, Fernando] RiceTec Inc, Alvin, TX USA	United States Department of Agriculture (USDA); Sichuan Agricultural University; University of Arkansas System; University of Arkansas Fayetteville; Jiangsu Academy of Agricultural Sciences; Zhejiang University; Zhejiang Academy of Agricultural Sciences; University of Arkansas System; University of Arkansas Fayetteville	Yan, WG (corresponding author), ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR USA.	Wengui.Yan@ars.usda.gov; lishigui_sc@263.net	Li, Xiaobai/AAB-7604-2021	Li, Xiaobai/0000-0001-9615-3543; Jackson, Aaron/0000-0002-5540-9255	USDA; National Natural Science Foundation of China [31025017, 30971763]; RiceTec, Inc.	USDA(United States Department of Agriculture (USDA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); RiceTec, Inc.	This work was supported by USDA in-house funds and partially by a grant from the National Natural Science Foundation of China (No. 31025017 and 30971763) and by RiceTec, Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CR, 1973, USDA289 AGR HDB, V289, P47; Agrama HA, 2009, PLANT BREEDING, V128, P551, DOI 10.1111/j.1439-0523.2009.01631.x; Agrama HA, 2010, PLANT BREEDING, V129, P304, DOI 10.1111/j.1439-0523.2009.01688.x; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; ATKINS J. G., 1957, International Rice Commission Newsletter, V6, P12; BABA I, 1954, PHYSL DIS RICE PLANT; Belefant-Miller H, 2007, AGRON J, V99, P1675, DOI 10.2134/agronj2007.0032N; Collier JS, 1912, 156 EXP STN, P19; CUNHA J. M. DE ARRIAGA E., 1958, AGRON LUSITANA, V20, P17; Dunn BW, 2006, AUST J EXP AGR, V46, P1077, DOI 10.1071/EA05004; FRANS R, 1988, ARKANSAS AES REP SER, V302, P1; HORTON DK, 1983, WEED SCI, V31, P648, DOI 10.1017/S0043174500070120; Hua B, 2011, ENV ENG SCI, V28; Hua W, 2009, THEOR APPL GENET, V119, P223, DOI 10.1007/s00122-009-1031-4; HULBERT SH, 1991, MOL GEN GENET, V226, P377, DOI 10.1007/BF00260649; Jones JW, 1938, USDA FARMERS B, V1808; Kim MY, 2004, EUPHYTICA, V135, P169, DOI 10.1023/B:EUPH.0000014909.40136.20; Linscombe SD, 2000, CROP SCI, V40, P294, DOI 10.2135/cropsci2000.0007rcv; Liu XH, 2010, AFR J BIOTECHNOL, V9, P950; Mackill DJ, 2002, W CROP SCI, P87; McCord PH, 2011, CROP SCI, V51, P771, DOI 10.2135/cropsci2010.02.0108; Nelson JC, 1997, MOL BREEDING, V3, P239, DOI 10.1023/A:1009604312050; Norton GJ, 2010, ENVIRON SCI TECHNOL, V44, P1471, DOI 10.1021/es902992d; PATERSON AH, 1990, GENETICS, V124, P735; Pillai TR, 2010, CROP SCI, V50, P2065, DOI 10.2135/cropsci2009.10.0568; RASAMIVELONA A, 1995, CROP SCI, V35, P1365, DOI 10.2135/cropsci1995.0011183X003500050017x; Slaton N. A., 2000, Research Series - Arkansas Agricultural Experiment Station, P313; Somenahally AC, 2011, ENVIRON SCI TECHNOL, V45, P8328, DOI 10.1021/es2012403; Somenahally AC, 2011, SOIL BIOL BIOCHEM, V43, P1220, DOI 10.1016/j.soilbio.2011.02.011; TAKEOKA Y, 1990, JPN J CROP SCI, V59, P785, DOI 10.1626/jcs.59.785; USEPA, 2009, 0037 USEPA; Weerapat P., 1979, International Rice Research Newsletter, V4, P6; WELLS BR, 1977, AGRON J, V69, P451, DOI 10.2134/agronj1977.00021962006900030029x; Wilson C. E. Jr., 2001, Research Series - Arkansas Agricultural Experiment Station, P428; Wilson Jr C. E., 2010, BR WELLS RICE RES ST, V581, P11; Wilson Jr. CE, 2010, MY RICE FIELD IS NO; Wilson Jr. CE, 2010, MANAGING STRAIGHTHEA; Wilson Jr CE, 2008, ARKANSAS AGR EXP STA, P11; Yan W. G., 2002, Research Series - Arkansas Agricultural Experiment Station, P359; Yan W. G., 2010, P 33 RIC TECHN WORK; Yan WG, 2010, CROP SCI, V50, P2406, DOI 10.2135/cropsci2010.02.0096; Yan WG, 2008, AGRON J, V100, P1655, DOI 10.2134/agronj2008.0108; Yan WG, 2005, CROP SCI, V45, P1223, DOI 10.2135/cropsci2004.0348	44	7	7	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52540	10.1371/journal.pone.0052540	http://dx.doi.org/10.1371/journal.pone.0052540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285082	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500034
J	Patillon, B; Luisi, P; Blanche, H; Patin, E; Cann, HM; Genin, E; Sabbagh, A				Patillon, Blandine; Luisi, Pierre; Blanche, Helene; Patin, Etienne; Cann, Howard M.; Genin, Emmanuelle; Sabbagh, Audrey			Positive Selection in the Chromosome 16 VKORC1 Genomic Region Has Contributed to the Variability of Anticoagulant Response in Humans	PLOS ONE			English	Article							VITAMIN-K; NATURAL-SELECTION; POPULATION DIFFERENTIATION; GENETIC-DETERMINANTS; WARFARIN-RESISTANCE; WIDE ASSOCIATION; POLYMORPHISMS; HAPLOTYPES; DIVERSITY; SWEEPS	VKORC1 (vitamin K epoxide reductase complex subunit 1, 16p11.2) is the main genetic determinant of human response to oral anticoagulants of antivitamin K type (AVK). This gene was recently suggested to be a putative target of positive selection in East Asian populations. In this study, we genotyped the HGDP-CEPH Panel for six VKORC1 SNPs and downloaded chromosome 16 genotypes from the HGDP-CEPH database in order to characterize the geographic distribution of footprints of positive selection within and around this locus. A unique VKORC1 haplotype carrying the promoter mutation associated with AVK sensitivity showed especially high frequencies in all the 17 HGDP-CEPH East Asian population samples. VKORC1 and 24 neighboring genes were found to lie in a 505 kb region of strong linkage disequilibrium in these populations. Patterns of allele frequency differentiation and haplotype structure suggest that this genomic region has been submitted to a near complete selective sweep in all East Asian populations and only in this geographic area. The most extreme scores of the different selection tests are found within a smaller 45 kb region that contains VKORC1 and three other genes (BCKDK, MYST1 (KAT8), and PRSS8) with different functions. Because of the strong linkage disequilibrium, it is not possible to determine if VKORC1 or one of the three other genes is the target of this strong positive selection that could explain present-day differences among human populations in AVK dose requirement. Our results show that the extended region surrounding a presumable single target of positive selection should be analyzed for genetic variation in a wide range of genetically diverse populations in order to account for other neighboring and confounding selective events and the hitchhiking effect.	[Patillon, Blandine; Sabbagh, Audrey] Univ Paris Diderot, Inst Univ Hematol, UMRS 946, INSERM, Paris, France; [Patillon, Blandine] Univ Paris 11, Le Kremlin Bicetre, France; [Luisi, Pierre] CEXS UPF PRBB, Inst Evolutionary Biol, Barcelona, Spain; [Blanche, Helene; Cann, Howard M.] Fdn Jean Dausset CEPH, Paris, France; [Patin, Etienne] Inst Pasteur, CNRS, URA3012, Paris, France; [Sabbagh, Audrey] Univ Paris Diderot, UMR IRD 216, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Pompeu Fabra University; Foundation Jean Dausset-CEPH; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Patillon, B (corresponding author), Univ Paris Diderot, Inst Univ Hematol, UMRS 946, INSERM, Paris, France.	blandine.patillon@inserm.fr	Genin, Emmanuelle/C-4974-2013	Genin, Emmanuelle/0000-0003-4117-2813; Patin, Etienne/0000-0002-9911-4459; SABBAGH, Audrey/0000-0003-0283-8803	Spanish National Institute for Bioinformatics; "Accion Estrategica de Salud, en el Marco del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from Instituto de Salud Carlos III; doctoral program in Public Health from Paris Sud University [ED420]	Spanish National Institute for Bioinformatics; "Accion Estrategica de Salud, en el Marco del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica'' from Instituto de Salud Carlos III; doctoral program in Public Health from Paris Sud University	This work was supported by the Spanish National Institute for Bioinformatics (www.inab.org). PL is supported by a PhD fellowship from "Accion Estrategica de Salud, en el Marco del Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011'' from Instituto de Salud Carlos III. BP is supported by a PhD fellowship from the doctoral program in Public Health (ED420: www.ed-sante-publique.u-psud.fr) from Paris Sud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bardowel SA, 2010, J NUTR, V140, P1901, DOI 10.3945/jn.110.128579; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beavan SR, 2005, EUR J CLIN NUTR, V59, P72, DOI 10.1038/sj.ejcn.1602037; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Cann HM, 1998, CR ACAD SCI III-VIE, V321, P443, DOI 10.1016/S0764-4469(98)80774-9; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Cha PC, 2010, HUM MOL GENET, V19, P4735, DOI 10.1093/hmg/ddq389; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cooper GM, 2008, BLOOD, V112, P1022, DOI 10.1182/blood-2008-01-134247; D'Andrea G, 2008, BLOOD REV, V22, P127, DOI 10.1016/j.blre.2007.11.004; Diaz JC, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-43; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita Y, 2011, OSTEOPOROS INT; Gardner M, 2008, AM J MED GENET B, V147B, P1070, DOI 10.1002/ajmg.b.30717; Geisen C, 2005, THROMB HAEMOSTASIS, V94, P773, DOI 10.1160/TH05-04-0290; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Hyers TM, 1998, CHEST, V114, p561S, DOI 10.1378/chest.114.5_Supplement.561S; Jarvinen TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014212; Kaneki M, 2001, NUTRITION, V17, P315, DOI 10.1016/S0899-9007(00)00554-2; Kohn MH, 2003, GENETICS, V164, P1055; Kohn MH, 2000, P NATL ACAD SCI USA, V97, P7911, DOI 10.1073/pnas.97.14.7911; LEWONTIN RC, 1964, GENETICS, V49, P49; Li J, 2011, HUM MOL GENET, V20, P528, DOI 10.1093/hmg/ddq498; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Limdi NA, 2008, PHARMACOGENOMICS, V9, P1445, DOI 10.2217/14622416.9.10.1445; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Marsh S, 2006, J THROMB HAEMOST, V4, P473, DOI 10.1111/j.1538-7836.2006.01759.x; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MUELLER RL, 1994, CIRCULATION, V89, P432, DOI 10.1161/01.CIR.89.1.432; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Ross KA, 2010, J HUM GENET, V55, P582, DOI 10.1038/jhg.2010.73; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scheinfeldt Laura B., 2011, Frontiers in Genetics, V2, P50, DOI 10.3389/fgene.2011.00050; Schwarz UI, 2008, NEW ENGL J MED, V358, P999, DOI 10.1056/NEJMoa0708078; Shriver Mark D, 2004, Hum Genomics, V1, P274; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Song Y, 2011, CURR BIOL, V21, P1296, DOI 10.1016/j.cub.2011.06.043; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stec DE, 2007, PHYSIOL GENOMICS, V30, P74, DOI 10.1152/physiolgenomics.00003.2007; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Storz JF, 2004, MOL BIOL EVOL, V21, P1800, DOI 10.1093/molbev/msh192; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; TAJIMA F, 1989, GENETICS, V123, P585; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Teo YY, 2009, GENOME RES, V19, P2154, DOI 10.1101/gr.095000.109; Vermeer C, 2004, EUR J NUTR, V43, P325, DOI 10.1007/s00394-004-0480-4; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wardrop D, 2008, BRIT J HAEMATOL, V141, P757, DOI 10.1111/j.1365-2141.2008.07119.x; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu AHB, 2008, PHARMACOGENOMICS, V9, P169, DOI 10.2217/14622416.9.2.169; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yan LY, 2004, BRIT J NUTR, V92, P939, DOI 10.1079/BJN20041261; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017	84	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53049	10.1371/journal.pone.0053049	http://dx.doi.org/10.1371/journal.pone.0053049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285254	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500105
J	Spear, G; Rothaeulser, K; Fritts, L; Gillevet, PM; Miller, CJ				Spear, Gregory; Rothaeulser, Kristina; Fritts, Linda; Gillevet, Patrick M.; Miller, Christopher J.			In Captive Rhesus Macaques, Cervicovaginal Inflammation Is Common but Not Associated with the Stable Polymicrobial Microbiome	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HERPES-SIMPLEX-VIRUS; BACTERIAL VAGINOSIS; VAGINAL FLORA; INTRAVAGINAL INOCULATION; LYMPHOID-TISSUES; ANIMAL-MODEL; HIV; TRANSMISSION; INFECTION	Vaginal inoculation of rhesus macaques (RM) with simian immunodeficiency virus (SIV) has been used to study the biology of HIV transmission. Although the results of vaginal SIV transmission experiments could be affected by vaginal inflammation, studies to date have been conducted without regard to levels of pre-existing genital inflammation present in RM. We collected cevicovaginal secretions (CVS) from 33-36 RM during the mid menstrual cycle (day 10-20) at 2 time points approximately 8 months apart and characterized the mRNA and protein levels of inflammatory cytokines, chemokines and interferon-stimulated genes. There was extreme variability in the levels of inflammatory mediators (IFN-alpha, IFN-gamma, IL-6, TNF, IL-1b, IP-10, MIG, IL-12 and IL-17). In most animals, the mRNA levels of the inflammatory mediators were similar in the 2 CVS samples collected 8 months apart, suggesting that genital inflammation is stable in a subset of captive female RM. At both time points the cervicovaginal microbiota had low levels of Lactobacillus and was relatively diverse with an average of 13 genera in the samples from the first time point (median 13, range 7-21) and an average of 11.5 genera in the samples from the second time point (median 11, range 5-20). Many of the macaques had similar microbiota in the samples collected 8 months apart. However, we found no correlation between specific bacterial genera and the mRNA or protein levels of the inflammatory mediators in the genital tract of RM in this study. It seems likely that results of published vaginal SIV transmission experiments in RM have been influenced by pre-existing inflammation in the animals used for the experiments.	[Rothaeulser, Kristina; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Spear, Gregory] Rush Univ, Dept Immunol Microbiol, Med Ctr, Chicago, IL 60612 USA; [Rothaeulser, Kristina; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Gillevet, Patrick M.] George Mason Univ, Microbiome Anal Ctr, Manassas, VA USA; [Gillevet, Patrick M.] George Mason Univ, Dept Environm Sci & Policy, Manassas, VA USA	University of California System; University of California Davis; Rush University; University of California System; University of California Davis; George Mason University; George Mason University	Miller, CJ (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu			Public Health Service grant from the National Center for Research Resources [P51RR00169]; National Institute of Allergy and Infectious Disease [AI076981]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076981, P30AI082151] Funding Source: NIH RePORTER	Public Health Service grant from the National Center for Research Resources; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant P51RR00169 from the National Center for Research Resources and grant AI076981 from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2004, J VIROL, V78, P841, DOI 10.1128/JVI.78.2.841-854.2004; Abel K, 2003, J VIROL, V77, P3099, DOI 10.1128/JVI.77.5.3099-3118.2003; Abel K, 2001, CYTOKINE, V16, P191, DOI 10.1006/cyto.2001.0961; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; COHEN CR, 1995, AIDS, V9, P1093, DOI 10.1097/00002030-199509000-00017; Conaway CH, 1964, J MAMMAL, V45, P577; Corey L, 2007, J INFECT DIS, V195, P1242, DOI 10.1086/513570; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Du YH, 2010, J AM ASSOC LAB ANIM, V49, P289; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; GORDON TP, 1981, AM ZOOL, V21, P185; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Johnson KE, 2011, J INFECT DIS, V203, P602, DOI 10.1093/infdis/jiq091; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Kyongo JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043951; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; LIAO F, 1995, J EXP MED, V182, P1301, DOI 10.1084/jem.182.5.1301; Mares D, 2008, J REPROD IMMUNOL, V77, P91, DOI 10.1016/j.jri.2007.04.004; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Miller CJ, 1998, J VIROL, V72, P3248, DOI 10.1128/JVI.72.4.3248-3258.1998; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mirmonsef P, 2012, AIDS RES HUM RETROV, V28, P76, DOI [10.1089/AID.2011.0071, 10.1089/aid.2011.0071]; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffield JS, 2007, J INFECT DIS, V196, P1509, DOI 10.1086/522518; Spear GT, 2012, AIDS RES HUM RETROV, V28, P1244, DOI 10.1089/aid.2011.0382; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Stone M, 2009, VIROLOGY, V392, P260, DOI 10.1016/j.virol.2009.06.052; Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; VALERIO DA, 1969, ANN NY ACAD SCI, V162, P282, DOI 10.1111/j.1749-6632.1969.tb56375.x; Van de Perre P, 2008, LANCET INFECT DIS, V8, P490, DOI 10.1016/S1473-3099(08)70181-6; WALKER ML, 1983, BIOL REPROD, V29, P841, DOI 10.1095/biolreprod29.4.841; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	43	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52992	10.1371/journal.pone.0052992	http://dx.doi.org/10.1371/journal.pone.0052992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285244	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500096
J	van de Wolfshaar, KE; Schellekens, T; Poos, JJ; van Kooten, T				van de Wolfshaar, Karen E.; Schellekens, Tim; Poos, Jan-Jaap; van Kooten, Tobias			Interspecific Resource Competition Effects on Fisheries Revenue	PLOS ONE			English	Article							STAGE-SPECIFIC BIOMASS; NORTH-SEA; CONVERSION FACTORS; MORTALITY; GROWTH; PLAICE; REPRODUCTION; ECOSYSTEMS; MANAGEMENT; WEIGHT	In many fisheries multiple species are simultaneously caught while stock assessments and fishing quota are defined at species level. Yet species caught together often share habitat and resources, resulting in interspecific resource competition. The consequences of resource competition on population dynamics and revenue of simultaneously harvested species has received little attention due to the historical single stock approach in fisheries management. Here we present the results of a modelling study on the interaction between resource competition of sole (Solea solea) and slaice (Pleuronectus platessa) and simultaneous harvesting of these species, using a stage-structured population model. Three resources were included of which one is shared with a varied competition intensity. We find that plaice is the better competitor of the two species and adult plaice are more abundant than adult sole. When competition is high sole population biomass increases with increasing fishing effort prior to plaice extinction. As a result of this increase in the sole population, the revenue of the stocks combined as function of effort becomes bimodal with increasing resource competition. When considering a single stock quota for sole, its recovery with increasing effort may result in even more fishing effort that would drive the plaice population to extinction. When sole and plaice compete for resources the highest revenue is obtained at effort levels at which plaice is extinct. Ignoring resource competition promotes overfishing due to increasing stock of one species prior to extinction of the other species. Consequently, efforts to mitigate the decline in one species will not be effective if increased stock in the other species leads to increased quota. If a species is to be protected against extinction, management should not only be directed at this one species, but all species that compete with it for resource as well.	[van de Wolfshaar, Karen E.; Poos, Jan-Jaap; van Kooten, Tobias] Wageningen UR IJmuiden, Dept Fish, Inst Marine Resource & Ecosyst Studies IMARES, Wageningen, Netherlands; [Schellekens, Tim] Wageningen UR, Dept Delta, Inst Marine Resource & Ecosyst Studies IMARES, Yerseke, Netherlands	Wageningen University & Research; Wageningen University & Research	van de Wolfshaar, KE (corresponding author), Wageningen UR IJmuiden, Dept Fish, Inst Marine Resource & Ecosyst Studies IMARES, Wageningen, Netherlands.	Karen.vandewolfshaar@wur.nl	van de Wolfshaar, Karen E./AAM-9875-2020; Poos, Jan Jaap/B-9940-2009; van de Wolfshaar, Karen E./B-7508-2008	van de Wolfshaar, Karen E./0000-0003-4190-6717; Poos, Jan Jaap/0000-0002-8507-5751; van de Wolfshaar, Karen E./0000-0003-4190-6717	KBWOT [2011 4301900330]	KBWOT	This research was financed by KBWOT 2011 4301900330. IMARES (Institute for Marine Resources and Ecosystem Studies), made available by the Dutch Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KH, 2010, P ROY SOC B-BIOL SCI, V277, P795, DOI 10.1098/rspb.2009.1512; BERGMAN MJN, 1992, ICES J MAR SCI, V49, P5, DOI 10.1093/icesjms/49.1.5; BREY T, 1988, J EXP MAR BIOL ECOL, V117, P271, DOI 10.1016/0022-0981(88)90062-7; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Daan N, 1997, J SEA RES, V37, P321, DOI 10.1016/S1385-1101(97)00026-9; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; De Roos AM, 2008, THEOR POPUL BIOL, V73, P47, DOI 10.1016/j.tpb.2007.09.004; de Roos AM, 2007, AM NAT, V170, pE59, DOI 10.1086/520119; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Eichinger M, 2010, J SEA RES, V64, P373, DOI 10.1016/j.seares.2010.05.005; FONDS M, 1979, MAR ECOL PROG SER, V1, P91, DOI 10.3354/meps001091; Geffen AJ, 2011, J EXP MAR BIOL ECOL, V400, P108, DOI 10.1016/j.jembe.2011.02.030; Gillis DM, 2008, CAN J FISH AQUAT SCI, V65, P27, DOI 10.1139/F07-147; Hiddink JG, 2006, ICES J MAR SCI, V63, P822, DOI 10.1016/j.icesjms.2006.02.006; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; ICES, 2011, 2011AC3713 ICEM CM, V13; Link JS, 2012, MAR ECOL PROG SER, V459, P293, DOI 10.3354/meps09829; Mackinson S, 2009, CAN J FISH AQUAT SCI, V66, P1107, DOI 10.1139/F09-057; MCCLANAHAN TR, 1995, ECOL MODEL, V80, P21, DOI 10.1016/0304-3800(94)00035-G; Nilsson KA, 2010, J ANIM ECOL, V79, P871, DOI 10.1111/j.1365-2656.2010.01679.x; Poos JJ, 2010, ICES J MAR SCI, V67, P323, DOI 10.1093/icesjms/fsp241; Ricciardi A, 1998, MAR ECOL PROG SER, V163, P245, DOI 10.3354/meps163245; RIJNSDORP AD, 1989, J FISH BIOL, V35, P401, DOI 10.1111/j.1095-8649.1989.tb02992.x; Rijnsdorp AD, 2001, J SEA RES, V45, P219, DOI 10.1016/S1385-1101(01)00047-8; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Taal C, 2010, VISSERIJ CIJFERS 201; van de Wolfshaar KE, 2011, MAR ECOL PROG SER, V438, P175, DOI 10.3354/meps09304; van der Veer HW, 2001, J SEA RES, V45, P303, DOI 10.1016/S1385-1101(01)00061-2; Van Keeken O, 2004, 04024 CTR FISH RES; Van Leeuwen A, 2008, J SEA RES, V60, P89, DOI 10.1016/j.seares.2008.02.008; VANBEEK FA, 1990, NETH J SEA RES, V26, P151, DOI 10.1016/0077-7579(90)90064-N	32	2	2	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53352	10.1371/journal.pone.0053352	http://dx.doi.org/10.1371/journal.pone.0053352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285285	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500140
J	West, SD; Goldberg, D; Ziegler, A; Krencicki, M; Du Clos, TW; Mold, C				West, Sonlee D.; Goldberg, Daniel; Ziegler, Anna; Krencicki, Michael; Du Clos, Terry W.; Mold, Carolyn			Transforming Growth Factor-beta, Macrophage Colony-Stimulating Factor and C-Reactive Protein Levels Correlate with CD14(high)CD16(+) Monocyte Induction and Activation in Trauma Patients	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; DENDRITIC CELLS; IN-VITRO; EXPRESSION; INHIBITOR; RESPONSES; FAILURE; SEPSIS; INNATE; ALPHA	Severe injury remains a leading cause of death and morbidity in patients under 40, with the number of annual trauma-related deaths approaching 160,000 in the United States. Patients who survive the initial trauma and post-traumatic resuscitation are at risk for immune dysregulation, which contributes to late mortality and accounts for approximately 20% of deaths after traumatic injury. This post-traumatic immunosuppressed state has been attributed to over-expression of anti-inflammatory mediators in an effort to restore host homeostasis. We measured a panel of monocyte markers and cytokines in 50 severely injured trauma patients for 3 days following admission. We made the novel observation that the subpopulation of monocytes expressing high levels of CD14 and CD16 was expanded in the majority of patients. These cells also expressed CD163 consistent with differentiation into alternatively activated macrophages with potential regulatory or wound-healing activity. We examined factors in trauma plasma that may contribute to the generation and activation of these cells. The percentage of CD14(high)CD16(+) monocytes after trauma correlated strongly with plasma C-reactive protein (CRP) transforming growth factor-beta (TGF-beta), and macrophage colony-stimulating factor (M-CSF) levels. We demonstrate a role for TGF-beta and M-CSF, but not CRP in generating these cells using monocytes from healthy volunteers incubated with plasma from trauma patients. CD16 is a receptor for CRP and IgG, and we showed that monocytes differentiated to the CD14(high)CD16(+) phenotype produced anti-inflammatory cytokines in response to acute phase concentrations of CRP. The role of these cells in immunosuppression following trauma is an area of ongoing investigation.	[West, Sonlee D.; Ziegler, Anna; Krencicki, Michael] Univ New Mexico, Hlth Sci Ctr, Dept Surg, Albuquerque, NM 87131 USA; [Goldberg, Daniel; Mold, Carolyn] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med, Albuquerque, NM 87131 USA; [Du Clos, Terry W.] Univ New Mexico, Hlth Sci Ctr, VA Med Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	West, SD (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Surg, Albuquerque, NM 87131 USA.	sowest@salud.unm.edu			National Center for Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health [KL2TR000041]; DHHS/NIH/NCRR [UL1TR000041]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000089, UL1TR000041] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); DHHS/NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number KL2TR000041. Orrin Myers provided statistical assistance through DHHS/NIH/NCRR Grant Number UL1TR000041, and The University of New Mexico Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Chen Y, 2008, J LEUKOCYTE BIOL, V83, P1165, DOI 10.1189/jlb.0807521; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Brunialti MKC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037393; De AK, 2003, J IMMUNOL, V170, P6355, DOI 10.4049/jimmunol.170.12.6355; Devaraj S, 2009, J LEUKOCYTE BIOL, V85, P262, DOI 10.1189/jlb.0808458; Feng AL, 2011, CLIN EXP IMMUNOL, V164, P57, DOI 10.1111/j.1365-2249.2011.04321.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Kampalath B, 2003, ARCH PATHOL LAB MED, V127, P1580; Kumpf O, 2010, J INNATE IMMUN, V2, P381, DOI 10.1159/000314269; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Martin C, 1997, CRIT CARE MED, V25, P1813, DOI 10.1097/00003246-199711000-00018; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mokart D, 2002, BRIT J SURG, V89, P1450, DOI 10.1046/j.1365-2168.2002.02218.x; Mold C, 2002, J IMMUNOL, V169, P7019, DOI 10.4049/jimmunol.169.12.7019; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munn DH, 1996, BLOOD, V88, P1215, DOI 10.1182/blood.V88.4.1215.bloodjournal8841215; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Ohno H, 2006, MOL CANCER THER, V5, P2634, DOI 10.1158/1535-7163.MCT-05-0313; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Roach JP, 2009, SHOCK, V31, P251, DOI 10.1097/SHK.0b013e3181834115; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; WELCH GR, 1990, J IMMUNOL, V144, P3444; West SD, 2012, J SURG RES, V172, P5, DOI 10.1016/j.jss.2011.04.016; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	38	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52406	10.1371/journal.pone.0052406	http://dx.doi.org/10.1371/journal.pone.0052406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285029	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500030
J	Chen, JC; Krasnow, MA				Chen, Jichao; Krasnow, Mark A.			Integrin Beta 1 Suppresses Multilayering of a Simple Epithelium	PLOS ONE			English	Article							LUNG BRANCHING MORPHOGENESIS; EPIDERMAL MORPHOGENESIS; EXPRESSION; SKIN; BETA-1-INTEGRIN; STRATIFICATION; MOUSE; P63; DIFFERENTIATION; PROLIFERATION	Epithelia are classified as either simple, a single cell layer thick, or stratified (multilayered). Stratified epithelia arise from simple epithelia during development, and transcription factor p63 functions as a key positive regulator of epidermal stratification. Here we show that deletion of integrin beta 1 (Itgb1) in the developing mouse airway epithelium abrogates airway branching and converts this monolayer epithelium into a multilayer epithelium with more than 10 extra layers. Mutant lung epithelial cells change mitotic spindle orientation to seed outer layers, and cells in different layers become molecularly and functionally distinct, hallmarks of normal stratification. However, mutant lung epithelial cells do not activate p63 and do not switch to the stratified keratin profile of epidermal cells. These data, together with previous data implicating Itgb1 in regulation of epidermal stratification, suggest that the simple-versus-stratified developmental decision may involve not only stratification inducers like p63 but suppressors like Itgb1 that prevent simple epithelia from inappropriately activating key steps in the stratification program.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, HHMI, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Chen, JC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.	jchen16@mdanderson.org; krasnow@stanford.edu			Jane Coffin Childs Memorial Fund for Medical Research; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999, U01HL099995] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Jane Coffin Childs Memorial Fund for Medical Research (J.C.) (http://www.jccfund.org/) and the Howard Hughes Medical Institute (M.A.K.) (http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Chen J, 2007, DEV CELL, V13, P325, DOI 10.1016/j.devcel.2007.07.011; Coraux C, 1998, J HISTOCHEM CYTOCHEM, V46, P803, DOI 10.1177/002215549804600703; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Pozzi A, 2011, CURR OPIN CELL BIOL; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Ray S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-12; ROMAN J, 1991, DEVELOPMENT, V112, P551; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Winklbauer R, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045001; Wu JE, 1996, DEV DYNAM, V206, P169, DOI 10.1002/(SICI)1097-0177(199606)206:2<169::AID-AJA6>3.0.CO;2-G; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	32	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52886	10.1371/journal.pone.0052886	http://dx.doi.org/10.1371/journal.pone.0052886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285215	Green Published, gold			2022-12-25	WOS:000313158800104
J	Fujita, H; Hamazaki, Y; Noda, Y; Oshima, M; Minato, N				Fujita, Harumi; Hamazaki, Yoko; Noda, Yumi; Oshima, Masanobu; Minato, Nagahiro			Claudin-4 Deficiency Results in Urothelial Hyperplasia and Lethal Hydronephrosis	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; RECESSIVE DEAFNESS DFNB29; TIGHT JUNCTIONS; CHLORIDE CHANNEL; GROWTH-FACTOR; RAT-KIDNEY; WATER CHANNEL; MICE; EXPRESSION; CELLS	Claudin (Cld)-4 is one of the dominant Clds expressed in the kidney and urinary tract, including selective segments of renal nephrons and the entire urothelium from the pelvis to the bladder. We generated Cldn4(-/-) mice and found that these mice had increased mortality due to hydronephrosis of relatively late onset. While the renal nephrons of Cldn4(-/-) mice showed a concomitant diminution of Cld8 expression at tight junction (TJ), accumulation of Cld3 at TJ was markedly enhanced in compensation and the overall TJ structure was unaffected. Nonetheless, Cldn4(-/-) mice showed slightly yet significantly increased fractional excretion of Ca2+ and Cl-, suggesting a role of Cld4 in the specific reabsorption of these ions via a paracellular route. Although the urine volume tended to be increased concordantly, Cldn4(-/-) mice were capable of concentrating urine normally on dehydration, with no evidence of diabetes insipidus. In the urothelium, the formation of TJs and uroplaques as well as the gross barrier function were also unaffected. However, intravenous pyelography analysis indicated retarded urine flow prior to hydronephrosis. Histological examination revealed diffuse hyperplasia and a thickening of pelvic and ureteral urothelial layers with markedly increased BrdU uptake in vivo. These results suggest that progressive hydronephrosis in Cldn4(-/-) mice arises from urinary tract obstruction due to urothelial hyperplasia, and that Cld4 plays an important role in maintaining the homeostatic integrity of normal urothelium.	[Fujita, Harumi; Minato, Nagahiro] Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto, Japan; [Fujita, Harumi; Hamazaki, Yoko; Minato, Nagahiro] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Noda, Yumi] Tokyo Med & Dent Univ, Dept Nephrol, Tokyo, Japan; [Oshima, Masanobu] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 920, Japan	Kyoto University; Kyoto University; Tokyo Medical & Dental University (TMDU); Kanazawa University	Hamazaki, Y (corresponding author), Kyoto Univ, Grad Sch Med, Kyoto, Japan.	hamazaki@imm.med.kyoto-u.ac.jp	Oshima, Masanobu/F-9958-2014; Hamazaki, Y*/Q-3076-2019	Oshima, Masanobu/0000-0002-3304-0004; Hamazaki, Y*/0000-0001-5866-7340; Fujita, Harumi/0000-0003-2133-845X	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government	Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government	This work was supported by grants from the Ministry of Education, Culture, Science, Sports and Technology of the Japanese Government to Y.H. and N.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; Ben-Yosef T, 2003, HUM MOL GENET, V12, P2049, DOI 10.1093/hmg/ddg210; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Freeman MR, 1997, J CLIN INVEST, V99, P1028, DOI 10.1172/JCI119230; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; Hayashi D, 2012, GASTROENTEROLOGY, V142, P292, DOI 10.1053/j.gastro.2011.10.040; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Hou JH, 2010, CURR OPIN NEPHROL HY, V19, P483, DOI 10.1097/MNH.0b013e32833b7125; Hou JH, 2009, P NATL ACAD SCI USA, V106, P15350, DOI 10.1073/pnas.0907724106; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Kawai Y, 2011, P NATL ACAD SCI USA, V108, P4075, DOI 10.1073/pnas.1014178108; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Lloyd DJ, 2005, PLOS GENET, V1, P171, DOI 10.1371/journal.pgen.0010020; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; McDill BW, 2006, P NATL ACAD SCI USA, V103, P6952, DOI 10.1073/pnas.0602087103; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Muto S, 2012, CLIN EXP NEPHROL, V16, P61, DOI 10.1007/s10157-011-0491-4; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; SABOLIC I, 1992, AM J PHYSIOL, V263, pC1225, DOI 10.1152/ajpcell.1992.263.6.C1225; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Swisshelm K, 2005, ADV DRUG DELIVER REV, V57, P919, DOI 10.1016/j.addr.2005.01.006; Tamura A, 2008, GASTROENTEROLOGY, V134, P523, DOI 10.1053/j.gastro.2007.11.040; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Tatum R, 2010, AM J PHYSIOL-RENAL, V298, pF24, DOI 10.1152/ajprenal.00450.2009; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676; Wilcox ER, 2001, CELL, V104, P165, DOI 10.1016/S0092-8674(01)00200-8; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005	49	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52272	10.1371/journal.pone.0052272	http://dx.doi.org/10.1371/journal.pone.0052272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284964	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800041
J	Imam, JS; Plyler, JR; Bansal, H; Prajapati, S; Bansal, S; Rebeles, J; Chen, HIH; Chang, YF; Panneerdoss, S; Zoghi, B; Buddavarapu, KC; Broaddus, R; Hornsby, P; Tomlinson, G; Dome, J; Vadlamudi, RK; Pertsemlidis, A; Chen, YD; Rao, MK				Imam, J. Saadi; Plyler, Jason R.; Bansal, Hima; Prajapati, Suresh; Bansal, Sanjay; Rebeles, Jennifer; Chen, Hung-I Harry; Chang, Yao-Fu; Panneerdoss, Subbarayalu; Zoghi, Behyar; Buddavarapu, Kalyan C.; Broaddus, Russell; Hornsby, Peter; Tomlinson, Gail; Dome, Jeffrey; Vadlamudi, Ratna K.; Pertsemlidis, Alexander; Chen, Yidong; Rao, Manjeet K.			Genomic Loss of Tumor Suppressor miRNA-204 Promotes Cancer Cell Migration and Invasion by Activating AKT/mTOR/Rac1 Signaling and Actin Reorganization	PLOS ONE			English	Article							OVARIAN-CANCER; IN-VITRO; EXPRESSION; MICRORNAS; MOTILITY; TARGET; GROWTH; TRKB; EZRIN; RAC1	Increasing evidence suggests that chromosomal regions containing microRNAs are functionally important in cancers. Here, we show that genomic loci encoding miR-204 are frequently lost in multiple cancers, including ovarian cancers, pediatric renal tumors, and breast cancers. MiR-204 shows drastically reduced expression in several cancers and acts as a potent tumor suppressor, inhibiting tumor metastasis in vivo when systemically delivered. We demonstrated that miR-204 exerts its function by targeting genes involved in tumorigenesis including brain-derived neurotrophic factor (BDNF), a neurotrophin family member which is known to promote tumor angiogenesis and invasiveness. Analysis of primary tumors shows that increased expression of BDNF or its receptor tropomyosin-related kinase B (TrkB) parallel a markedly reduced expression of miR-204. Our results reveal that loss of miR-204 results in BDNF overexpression and subsequent activation of the small GTPase Rac1 and actin reorganization through the AKT/mTOR signaling pathway leading to cancer cell migration and invasion. These results suggest that microdeletion of genomic loci containing miR-204 is directly linked with the deregulation of key oncogenic pathways that provide crucial stimulus for tumor growth and metastasis. Our findings provide a strong rationale for manipulating miR-204 levels therapeutically to suppress tumor metastasis.	[Imam, J. Saadi; Plyler, Jason R.; Bansal, Hima; Prajapati, Suresh; Bansal, Sanjay; Rebeles, Jennifer; Chen, Hung-I Harry; Chang, Yao-Fu; Panneerdoss, Subbarayalu; Buddavarapu, Kalyan C.; Tomlinson, Gail; Pertsemlidis, Alexander; Chen, Yidong; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Plyler, Jason R.; Chang, Yao-Fu; Rao, Manjeet K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Zoghi, Behyar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Hornsby, Peter] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Vadlamudi, Ratna K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Chen, Yidong] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostatist, San Antonio, TX 78229 USA; [Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Dome, Jeffrey] Childrens Natl Med Ctr, Ctr Canc & Immunol Res, Washington, DC 20010 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; Children's National Health System	Rao, MK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.	raom@uthscsa.edu	Pertsemlidis, Alexander/Q-7899-2017; Dome, Jeffrey/AAH-7825-2019	Pertsemlidis, Alexander/0000-0003-1624-9372; Imam, J Saadi/0000-0003-3463-838X	William and Ella Medical Research Foundation; GCCRI start up fund; CPRIT fellowship; National Institutes of Health (NIH); NIH/National Cancer Institute cancer center [P30 CA054174-17]; NATIONAL CANCER INSTITUTE [T32CA148724, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007686] Funding Source: NIH RePORTER	William and Ella Medical Research Foundation; GCCRI start up fund; CPRIT fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute cancer center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by The William and Ella Medical Research Foundation grant (MKR), GCCRI start up fund (MKR), CPRIT fellowship (BZ), National Institutes of Health (NIH) T32 training grant (YFC), and NIH/National Cancer Institute cancer center grant (P30 CA054174-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami J, 2003, J CLIN PATHOL-MOL PA, V56, P218, DOI 10.1136/mp.56.4.218; Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Au CWH, 2009, CANCER LETT, V281, P151, DOI 10.1016/j.canlet.2009.02.025; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Cui RR, 2012, CARDIOVASC RES, V96, P320, DOI 10.1093/cvr/cvs258; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Edsjo A, 2003, LAB INVEST, V83, P813, DOI 10.1097/01.LAB.0000074895.48776.D8; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gong M, 2012, NEURO-ONCOLOGY, V14, P1007, DOI 10.1093/neuonc/nos124; Grille SJ, 2003, CANCER RES, V63, P2172; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Imam JS, 2010, ONCOGENE, V29, P4971, DOI 10.1038/onc.2010.233; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krishnan K, 2006, CLIN EXP METASTAS, V23, P227, DOI 10.1007/s10585-006-9033-y; Lewin GR, 1996, PHILOS T ROY SOC B, V351, P405, DOI 10.1098/rstb.1996.0035; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Liu H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S12; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Qiu LH, 2006, INT J ONCOL, V29, P1003; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Shen C, 2008, BIOLOGICALS, V36, P263, DOI 10.1016/j.biologicals.2008.02.002; Siu MKY, 2009, EXPERT OPIN THER TAR, V13, P1169, DOI 10.1517/14728220903196787; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Troca-Marin JA, 2010, MOL CELL NEUROSCI, V43, P308, DOI 10.1016/j.mcn.2009.12.004; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wan XL, 2005, CANCER RES, V65, P2406, DOI 10.1158/0008-5472.CAN-04-3135; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Yue D, 2010, ACM INT C BIOINF COM; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	43	122	130	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52397	10.1371/journal.pone.0052397	http://dx.doi.org/10.1371/journal.pone.0052397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285024	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800062
J	Chen, RX; Barphagha, IK; Karki, HS; Ham, JH				Chen, Ruoxi; Barphagha, Inderjit K.; Karki, Hari S.; Ham, Jong Hyun			Dissection of Quorum-Sensing Genes in Burkholderia glumae Reveals Non-Canonical Regulation and the New Regulatory Gene tofM for Toxoflavin Production	PLOS ONE			English	Article							CLONING; CONSTRUCTION; MUTAGENESIS; INHIBITION; INSERTION; PATHOGEN; BACTERIA; VECTOR; SYSTEM	Burkholderia glumae causes bacterial panicle blight of rice and produces major virulence factors, including toxoflavin, under the control of the quorum-sensing (QS) system mediated by the luxI homolog, tofI, and the luxR homolog, tofR. In this study, a series of markerless deletion mutants of B. glumae for tofI and tofR were generated using the suicide vector system, pKKSacB, for comprehensive characterization of the QS system of this pathogen. Consistent with the previous studies by other research groups, Delta tofI and Delta tofR strains of B. glumae did not produce toxoflavin in Luria-Bertani (LB) broth. However, these mutants produced high levels of toxoflavin when grown in a highly dense bacterial inoculum (similar to 10(11) CFU/ml) on solid media, including LB agar and King's B (KB) agar media. The Delta tofI/Delta tofR strain of B. glumae, LSUPB201, also produced toxoflavin on LB agar medium. These results indicate the presence of previously unknown regulatory pathways for the production of toxoflavin that are independent of tofI and/or tofR. Notably, the conserved open reading frame (locus tag: bglu_2g14480) located in the intergenic region between tofI and tofR was found to be essential for the production of toxoflavin by tofI and tofR mutants on solid media. This novel regulatory factor of B. glumae was named tofM after its homolog, rsaM, which was recently identified as a novel negative regulatory gene for the QS system of another rice pathogenic bacterium, Pseudomonas fuscovaginae. The Delta tofM strain of B. glumae, LSUPB286, produced a less amount of toxoflavin and showed attenuated virulence when compared with its wild type parental strain, 336gr-1, suggesting that tofM plays a positive role in toxoflavin production and virulence. In addition, the observed growth defect of the Delta tofI strain, LSUPB145, was restored by 1 mu M N-octanoyl homoserine lactone (C8-HSL).	[Chen, Ruoxi; Barphagha, Inderjit K.; Karki, Hari S.; Ham, Jong Hyun] Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Ham, JH (corresponding author), Louisiana State Univ, Ctr Agr, Dept Plant Pathol & Crop Physiol, Baton Rouge, LA 70803 USA.	jham@agcenter.lsu.edu	Karki, Hari Sharan/AAB-5819-2020		Louisiana State University Agricultural Center; Research and Development Program of the Louisiana Board of Regents Support Fund [LEQSF(2008-11)-RD-A-02]; Pilot Funding for New Research (Pfund) Program of the National Science Foundation; Louisiana Board of Regents [NSF(2010)-PFUND-194]; Louisiana Board of Regents	Louisiana State University Agricultural Center; Research and Development Program of the Louisiana Board of Regents Support Fund; Pilot Funding for New Research (Pfund) Program of the National Science Foundation; Louisiana Board of Regents; Louisiana Board of Regents	This work was supported by the Louisiana State University Agricultural Center, the Research and Development Program of the Louisiana Board of Regents Support Fund (Grant number: LEQSF(2008-11)-RD-A-02), and the Pilot Funding for New Research (Pfund) Program of the National Science Foundation and the Louisiana Board of Regents (Grant number: NSF(2010)-PFUND-194). RC was supported by the Economic Development Assistantship of the Louisiana Board of Regents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Devescovi G, 2007, APPL ENVIRON MICROB, V73, P4950, DOI 10.1128/AEM.00105-07; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; Dunlap Paul V., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P5; EBERHARD A, 1972, J BACTERIOL, V109, P1101, DOI 10.1128/JB.109.3.1101-1105.1972; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Iiyama Kazuhiro, 1995, Annals of the Phytopathological Society of Japan, V61, P470, DOI 10.3186/jjphytopath.61.470; Jacobs JL, 2008, APPL ENVIRON MICROB, V74, P3121, DOI 10.1128/AEM.01941-07; Jung WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022443; Karki HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045376; Karki HS, 2012, MOL PLANT PATHOL; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Mattiuzzo M, 2011, ENVIRON MICROBIOL, V13, P145, DOI 10.1111/j.1462-2920.2010.02316.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nagamatsu T, 2002, CHEM INFORM, V33, P261; Nandakumar R, 2009, PLANT DIS, V93, P896, DOI 10.1094/PDIS-93-9-0896; PENFOLD RJ, 1992, GENE, V118, P145, DOI 10.1016/0378-1119(92)90263-O; Sambrook J, 2001, MOL CLONING LAB MANU; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Suzuki Fumihiko, 2004, Journal of General Plant Pathology, V70, P97, DOI 10.1007/s10327-003-0096-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Venturi V, 2011, MOL MICROBIOL, V82, P1060, DOI 10.1111/j.1365-2958.2011.07890.x	32	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52150	10.1371/journal.pone.0052150	http://dx.doi.org/10.1371/journal.pone.0052150			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284909	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500102
J	Fang, CL; Hseu, YC; Lin, YF; Hung, ST; Tai, C; Uen, YH; Lin, KY				Fang, Chia-Lang; Hseu, You-Cheng; Lin, Yi-Feng; Hung, Shih-Ting; Tai, Chein; Uen, Yih-Huei; Lin, Kai-Yuan			Clinical and Prognostic Association of Transcription Factor SOX4 in Gastric Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR INVASION; EXPRESSION; GENES; OVEREXPRESSION; CARCINOMA; PREDICTORS; MICRORNAS; APOPTOSIS; SURVIVAL	Gastric cancer (GC) is one of the most common malignant cancers worldwide. However, little is known about the molecular process by which this disease develops and progresses. This study investigated correlations between the expression of nuclear transcription factor SOX4 and various clinicopathologic parameters as well as patients' survival. Expression levels of nuclear SOX4 were analyzed by immunohistochemistry; the data comprised gastric tissues from 168 patients with GC. Paired t tests were used to analyze the differences in nuclear SOX4 expression between tumor and non-tumor tissues from each patient. Two-tailed X-2 tests were performed to determine whether the differences in nuclear SOX4 expression and clinicopathologic parameters were significant. Time-to-event endpoints for clinicopathologic parameters were plotted using the Kaplan-Meier method, and statistical significance was determined using univariate log-rank tests. Cox proportional hazard model was used for multivariate analysis to determine the independence of prognostic effects of nuclear SOX4 expression. Overexpression of nuclear SOX4 was significantly correlated with depth of invasion (P<0.0001), nodal status (P=0.0055), distant metastasis (P=0.0195), stage (P=0.0003), and vascular invasion (P=0.0383). Patients who displayed high expression levels of nuclear SOX4 achieved a significantly poorer disease-free survival rate, compared with patients with low SOX4 expression levels (P=0.003). Univariate Cox regression analysis showed that overexpression of nuclear SOX4 was a clear prognostic marker for GC (P=0.004). Overexpression of nuclear SOX4 can be used as a marker to predict the outcome of patients with GC. Citation: Fang C-L, Hseu Y-C, Lin Y-F, Hung S-T, Tai C, et al. (2012) Clinical and Prognostic Association of Transcription Factor SOX4 in Gastric Cancer. PLoS ONE 7(12): e52804. doi:10.1371/journal.pone.0052804	[Hung, Shih-Ting; Uen, Yih-Huei; Lin, Kai-Yuan] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan; [Fang, Chia-Lang] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung, Taiwan; [Lin, Yi-Feng] Chi Mei Hosp Chiali, Dept Surg, Div Gen Surg, Tainan, Taiwan; [Lin, Yi-Feng; Uen, Yih-Huei] Chi Mei Med Ctr, Dept Surg, Div Gen Surg, Tainan, Taiwan; [Tai, Chein] So Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Uen, Yih-Huei] Chi Mei Hosp Chiali, Superintendents Off, Tainan, Taiwan; [Uen, Yih-Huei] So Taiwan Univ Sci & Technol, Inst Biomed Engn, Tainan, Taiwan; [Lin, Kai-Yuan] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	Chi Mei Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan; Chi Mei Hospital; Southern Taiwan University of Science & Technology; Southern Taiwan University of Science & Technology; Chia Nan University of Pharmacy & Science	Lin, KY (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	d84306@yahoo.com.tw			Chi Mei Medical Center [CMFHR10020, CMFHR10064]	Chi Mei Medical Center	This work was supported by two grants (CMFHR10020 and CMFHR10064) from Chi Mei Medical Center (www.chimei.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Andersen CL, 2009, BRIT J CANCER, V100, P511, DOI 10.1038/sj.bjc.6604884; Baba K, 2012, J SURG ONCOL, V105, P195, DOI 10.1002/jso.22024; Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Begnami MD, 2011, J CLIN ONCOL, V29, P3030, DOI 10.1200/JCO.2010.33.6313; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dicken BJ, 2004, ANN SURG ONCOL, V11, P629, DOI 10.1245/ASO.2004.09.002; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang YW, 2009, CANCER RES, V69, P9038, DOI 10.1158/0008-5472.CAN-09-1499; Hundahl SA, 2000, CANCER-AM CANCER SOC, V88, P921, DOI 10.1002/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.3.CO;2-J; Hur W, 2010, CARCINOGENESIS, V31, P1298, DOI 10.1093/carcin/bgq072; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Lin KY, 2008, J SURG ONCOL, V97, P538, DOI 10.1002/jso.20997; Lin KY, 2012, MOL CANCER RES, V10, P750, DOI 10.1158/1541-7786.MCR-11-0598-T; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Oliveira Fernando Jose, 1998, Gastric Cancer, V1, P51, DOI 10.1007/s101200050054; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shen RZ, 2010, BIOCHEM BIOPH RES CO, V394, P1047, DOI 10.1016/j.bbrc.2010.03.121; Shin MS, 2004, CANCER RES, V64, P4419, DOI 10.1158/0008-5472.CAN-03-3885; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Voulgari A, 2009, BIOCHIM BIOPHYS ACTA, V1796, P5; Wang CG, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-41; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045	41	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52804	10.1371/journal.pone.0052804	http://dx.doi.org/10.1371/journal.pone.0052804			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285187	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500247
J	Hosokawa, M; Arai, T; Masuda-Suzukake, M; Nonaka, T; Yamashita, M; Akiyama, H; Hasegawa, M				Hosokawa, Masato; Arai, Tetsuaki; Masuda-Suzukake, Masami; Nonaka, Takashi; Yamashita, Makiko; Akiyama, Haruhiko; Hasegawa, Masato			Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice	PLOS ONE			English	Article							SEPTIC SHOCK; INHIBITION; PROTEIN; PHENOTHIAZINES; AGGREGATION; DRUGS; RATS; DYES	In neurodegenerative disorders, abnormally hyperphosphorylated and aggregated tau accumulates intracellularly, a mechanism which is thought to induce neuronal cell death. Methylene blue, a type of phenothiazine, has been reported to inhibit tau aggregation in vitro. However, the effect of methylene blue in vivo has remained unknown. Therefore, we examined whether methylene blue suppresses abnormal tau accumulation using P301L tau transgenic mice. At 8 to 11 months of age, these mice were orally administered methylene blue for 5 months. Subsequent results of Western blotting analysis revealed that this agent reduced detergent-insoluble phospho-tau. Methylene blue may have potential as a drug candidate for the treatment of tauopathy.	[Hosokawa, Masato; Arai, Tetsuaki; Akiyama, Haruhiko] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 113, Japan; [Masuda-Suzukake, Masami; Nonaka, Takashi; Yamashita, Makiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Pathol & Cell Biol, Tokyo 113, Japan; [Arai, Tetsuaki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Psychiat, Tsukuba, Ibaraki, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; University of Tsukuba	Akiyama, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Bunkyo Ku, Tokyo 113, Japan.	akiyama-hr@igakuken.or.jp	Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403; Hosokawa, Masato/0000-0003-2377-9232	Japan Society for the Promotion of Science [21591536, 24591738]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was partially supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (C), grant number 21591536 to HA and 24591738 to M. Hosokawa. The additional part of the funding of the authors' study has come from institute budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Chies AB, 2003, POL J PHARMACOL, V55, P573; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Gonzalez-Lima F, 2004, LEARN MEMORY, V11, P633, DOI 10.1101/lm.82404; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Harrington C., 2008, ALZHEIMERS DEMENT, V4, pT120, DOI DOI 10.1016/J.JALZ.2008.05.259; Heiberg IL, 2002, BEHAV BRAIN RES, V134, P479, DOI 10.1016/S0166-4328(02)00084-0; KRISTIANSEN JE, 1989, DAN MED BULL, V36, P178; Kucukkilinc T, 2007, ARCH BIOCHEM BIOPHYS, V461, P294, DOI 10.1016/j.abb.2007.02.029; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; MANSOURI A, 1993, AM J HEMATOL, V42, P7, DOI 10.1002/ajh.2830420104; Medina DX, 2011, BRAIN PATHOL, V21, P140, DOI 10.1111/j.1750-3639.2010.00430.x; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; PREISER JC, 1995, CRIT CARE MED, V23, P259, DOI 10.1097/00003246-199502000-00010; Rengelshausen J, 2004, EUR J CLIN PHARMACOL, V60, P709, DOI 10.1007/s00228-004-0818-0; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; SCHNEIDER F, 1992, INTENS CARE MED, V18, P309, DOI 10.1007/BF01706481; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; van Bebber F, 2010, NEUROBIOL DIS, V39, P265, DOI 10.1016/j.nbd.2010.03.023; Visarius TM, 1997, FEBS LETT, V412, P157, DOI 10.1016/S0014-5793(97)00767-9; Wischik CM, 1996, P NATL ACAD SCI USA, V93, P11213, DOI 10.1073/pnas.93.20.11213; Wischik CM, 2008, ALZHEIMERS DEMENT, V8, pT167; WOLOZIN B, 1987, ANN NEUROL, V22, P521, DOI 10.1002/ana.410220412; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Yamashita M, 2009, FEBS LETT, V583, P2419, DOI 10.1016/j.febslet.2009.06.042	26	68	72	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52389	10.1371/journal.pone.0052389	http://dx.doi.org/10.1371/journal.pone.0052389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285020	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500156
J	Lemaitre, N; Ricard, I; Pradel, E; Foligne, B; Courcol, R; Simonet, M; Sebbane, F				Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent			Efficacy of Ciprofloxacin-Gentamicin Combination Therapy in Murine Bubonic Plague	PLOS ONE			English	Article							YERSINIA-PESTIS INFECTION; PNEUMONIC PLAGUE; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PHARMACOKINETICS; AMINOGLYCOSIDES; ANTIBIOTICS; STRAINS; MODEL	Potential benefits of combination antibiotic therapy for the treatment of plague have never been evaluated. We compared the efficacy of a ciprofloxacin (CIN) and gentamicin (GEN) combination therapy with that of each antibiotic administered alone (i) against Yersinia pestis in vitro and (ii) in a mouse model of bubonic plague in which animals were intravenously injected with antibiotics for five days, starting at two different times after infection (44 h and 56 h). In vitro, the CIN+GEN combination was synergistic at 0.5x the individual drugs' MICs and indifferent at 1x- or 2x MIC. In vivo, the survival rate for mice treated with CIN+GEN was similar to that observed with CIN alone and slightly higher than that observed for GEN alone 100, 100 and 85%, respectively when treatment was started 44 h post challenge, 100% of survivors were recorded in the CIN+GEN group vs 86 and 83% in the CIN and GEN groups, respectively when treatment was delayed to 56 h post-challenge. However, these differences were not statistically significant. Five days after the end of treatment, Y. pestis were observed in lymph nodes draining the inoculation site (but not in the spleen) in surviving mice in each of the three groups. The median lymph node log(10) CFU recovered from persistently infected lymph nodes was significantly higher with GEN than with CIN (5.8 vs. 3.2, p = 0.04) or CIN+GEN (5.8 vs. 2.8, p = 0.01). Taken as the whole, our data show that CIN+GEN combination is as effective as CIN alone but, regimens containing CIN are more effective to eradicate Y. pestis from the draining lymph node than the recommended GEN monotherapy. Moreover, draining lymph nodes may serve as a reservoir for the continued release of Y. pestis into the blood - even after five days of intravenous antibiotic treatment. Citation: Lemaitre N, Ricard I, Pradel E, Foligne B, Courcol R, et al. (2012) Efficacy of Ciprofloxacin-Gentamicin Combination Therapy in Murine Bubonic Plague. PLoS ONE 7(12): e52503. doi:10.1371/journal.pone.0052503	[Lemaitre, Nadine; Courcol, Rene; Simonet, Michel] CHU Lille, Lab Bacteriol Hyg, F-59037 Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Univ Lille Nord France, Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Univ Lille 2, Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] INSERM, U1019, F-59045 Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Ctr Natl Rech Sci, UMR8204, Lille, France; [Lemaitre, Nadine; Ricard, Isabelle; Pradel, Elizabeth; Foligne, Benoit; Courcol, Rene; Simonet, Michel; Sebbane, Florent] Inst Pasteur, F-59019 Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Lemaitre, N (corresponding author), CHU Lille, Lab Bacteriol Hyg, F-59037 Lille, France.	nadine.lemaitre@chru-lille.fr	Sebbane, Florent/D-4213-2009; Pradel, Elizabeth/R-5026-2018; Sebbane, Florent/ABA-2213-2020; Foligne, Benoit/B-2754-2014	Pradel, Elizabeth/0000-0003-3563-9325; Sebbane, Florent/0000-0003-3811-9691; Foligne, Benoit/0000-0001-9263-9706; Ricard, Isabelle/0000-0002-2142-6807; Lemaitre, Nadine/0000-0002-0011-3596	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Universite Lille Nord de France; Institut Pasteur de Lille	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Lille Nord de France; Institut Pasteur de Lille	This work was supported by Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, Universite Lille Nord de France and Institut Pasteur de Lille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGAN T, 1986, EUR J CLIN MICROBIOL, V5, P458, DOI 10.1007/BF02075709; BONACORSI SP, 1994, ANTIMICROB AGENTS CH, V38, P481, DOI 10.1128/AAC.38.3.481; BORNER K, 1986, EUR J CLIN MICROBIOL, V5, P179, DOI 10.1007/BF02013983; BUTLER T, 1994, CLIN INFECT DIS, V19, P655, DOI 10.1093/clinids/19.4.655; Byrne WR, 1998, ANTIMICROB AGENTS CH, V42, P675, DOI 10.1128/AAC.42.3.675; CHALKLEY LJ, 1985, ANTIMICROB AGENTS CH, V28, P331, DOI 10.1128/AAC.28.2.331; Craig WA, 2011, CRIT CARE CLIN, V27, P107, DOI 10.1016/j.ccc.2010.11.006; Demczar DJ, 1997, ANTIMICROB AGENTS CH, V41, P1115, DOI 10.1128/AAC.41.5.1115; EASMON CSF, 1985, J CLIN PATHOL, V38, P442, DOI 10.1136/jcp.38.4.442; HALLER I, 1985, ANTIMICROB AGENTS CH, V28, P663, DOI 10.1128/AAC.28.5.663; Heine HS, 2007, J INFECT DIS, V196, P782, DOI 10.1086/520547; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; JOLLEY ME, 1981, CLIN CHEM, V27, P1190; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; KUSSER WC, 1988, ANTIMICROB AGENTS CH, V32, P1247, DOI 10.1128/AAC.32.8.1247; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Mandal S, 2003, JPN J INFECT DIS, V56, P156; National Committee for Clinical and Laboratory Standards Institute, 2006, M7A7 NCCLS I; Nham T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034714; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; PEARSON RD, 1980, ANTIMICROB AGENTS CH, V18, P699, DOI 10.1128/AAC.18.5.699; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; REYNOLDS AV, 1976, LANCET, V1, P447; Russell P, 1998, J ANTIMICROB CHEMOTH, V41, P301, DOI 10.1093/jac/41.2.301; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; SMITH MD, 1995, ANTIMICROB AGENTS CH, V39, P2153, DOI 10.1128/AAC.39.9.2153; Wang H, 2011, CLIN INFECT DIS, V52, P185, DOI 10.1093/cid/ciq107; WEBER A, 1985, ANTIMICROB AGENTS CH, V27, P531, DOI 10.1128/AAC.27.4.531; World Health Organization, 2008, WHOHSEEPR20083; ZEILER HJ, 1984, EUR J CLIN MICROBIOL, V3, P339, DOI 10.1007/BF01977490	30	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52503	10.1371/journal.pone.0052503	http://dx.doi.org/10.1371/journal.pone.0052503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285069	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500184
J	Sun, HJ; Li, P; Chen, WW; Xiong, XQ; Han, Y				Sun, Hai-Jian; Li, Peng; Chen, Wei-Wei; Xiong, Xiao-Qing; Han, Ying			Angiotensin II and Angiotensin-(1-7) in Paraventricular Nucleus Modulate Cardiac Sympathetic Afferent Reflex in Renovascular Hypertensive Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; NITRIC-OXIDE SYNTHASE; SUPEROXIDE ANIONS; BLOOD-PRESSURE; HEART-FAILURE; BRAIN; ACTIVATION; RECEPTORS; LOCALIZATION; PATHOGENESIS	Background: The enhanced cardiac sympathetic afferent reflex (CSAR) is involved in the sympathetic activation that contributes to the pathogenesis and progression of hypertension. Activation of AT(1) receptors by angiotension (Ang) II in the paraventricular nucleus (PVN) augments the enhanced CSAR and sympathetic outflow in hypertension. The present study is designed to determine whether Ang-(1-7) in PVN plays the similar roles as Ang II and the interaction between Ang-(1-7) and Ang II on CSAR in renovascular hypertension. Methodology/Principal Findings: The two-kidney, one-clip (2K1C) method was used to induce renovascular hypertension. The CSAR was evaluated by the renal sympathetic nerve activity (RSNA) and mean arterial pressure (MAP) responses to epicardial application of capsaicin in sinoaortic-denervated and cervical-vagotomized rats with urethane and alpha-chloralose anesthesia. Either Ang II or Ang-(1-7) in PVN caused greater increases in RSNA and MAP, and enhancement in CSAR in 2K1C rats than in sham-operated (Sham) rats. Mas receptor antagonist A-779 and AT(1) receptor antagonist losartan induced opposite effects to Ang-(1-7) or Ang II respectively in 2K1C rats, but losartan had no effects in Sham rats. Losartan but not the A-779 abolished the effects of Ang II, while A-779 but not the losartan blocked the effects of Ang-(1-7). PVN pretreatment with Ang-(1-7) dose-dependently augmented the RSNA, MAP, and CSAR responses to the Ang II in 2K1C rats. Ang II level, AT(1) receptor and Mas receptor protein expression in PVN increased in 2K1C rats compared with Sham rats but Ang-(1-7) level did not. Conclusions: Ang-(1-7) in PVN is as effective as Ang II in enhancing the CSAR and increasing sympathetic outflow and both endogenous Ang-(1-7) and Ang II in PVN contribute to the enhanced CSAR and sympathetic outflow in renovascular hypertension. Ang-(1-7) in PVN potentiates the effects of Ang II in renovascular hypertension.	[Sun, Hai-Jian; Li, Peng; Chen, Wei-Wei; Xiong, Xiao-Qing; Han, Ying] Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Han, Y (corresponding author), Nanjing Med Univ, Dept Physiol, Nanjing, Jiangsu, Peoples R China.	yhancn@njmu.edu.cn		Han, Ying/0000-0001-8591-7894	Chinese National Natural Science Fund [81100182]; Natural Science Foundation from Department of Education of Jiangsu Province [11KJB310002]; Science and Technology Foundation from Nanjing Medical University [2010NJMUZ23]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Natural Science Foundation from Department of Education of Jiangsu Province; Science and Technology Foundation from Nanjing Medical University; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Chinese National Natural Science Fund (81100182), Natural Science Foundation from Department of Education of Jiangsu Province (11KJB310002), Science and Technology Foundation from Nanjing Medical University (2010NJMUZ23), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2000, AM J HYPERTENS, V13, p31S, DOI 10.1016/S0895-7061(99)00249-6; Alzamora AC, 2006, AM J PHYSIOL-REG I, V290, pR1027, DOI 10.1152/ajpregu.00852.2004; Badoer E, 2001, CLIN EXP PHARMACOL P, V28, P95, DOI 10.1046/j.1440-1681.2001.03413.x; Becker LK, 2007, AM J PHYSIOL-HEART C, V293, pH1416, DOI 10.1152/ajpheart.00141.2007; BLOCK CH, 1988, PEPTIDES, V9, P1395, DOI 10.1016/0196-9781(88)90208-2; Campese VM, 2002, HYPERTENSION, V39, P519, DOI 10.1161/hy0202.102815; Capettini LSA, 2012, CURR PHARM DESIGN, V18, P963; Cassis P, 2010, PFLUG ARCH EUR J PHY, V459, P325, DOI 10.1007/s00424-009-0725-4; Cato MJ, 2005, J NEUROPHYSIOL, V93, P403, DOI 10.1152/jn.01055.2003; CHAPPELL MC, 1989, J BIOL CHEM, V264, P16518; Chen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040748; Chen AD, 2011, EXP PHYSIOL, V96, P94, DOI 10.1113/expphysiol.2010.054353; COHN JN, 1977, MED CLIN N AM, V61, P581, DOI 10.1016/S0025-7125(16)31318-9; da Silva AQG, 2005, HYPERTENSION, V46, P341, DOI 10.1161/01.HYP.0000179216.04357.49; Del Colle S, 2007, J CARDIOVASC PHARM, V50, P487; Dilauro M, 2010, AM J PHYSIOL-RENAL, V298, pF1523, DOI 10.1152/ajprenal.00426.2009; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Ehlers PI, 2011, LIFE SCI, V88, P206, DOI 10.1016/j.lfs.2010.11.001; Esler M, 2010, J APPL PHYSIOL, V109, P1996, DOI 10.1152/japplphysiol.00182.2010; Fan ZD, 2012, GENE THER, V19, P810, DOI 10.1038/gt.2011.145; Ferreira PM, 2008, NEUROSCIENCE, V151, P1208, DOI 10.1016/j.neuroscience.2007.11.042; Fisher JP, 2010, EXP PHYSIOL, V95, P572, DOI 10.1113/expphysiol.2009.047332; FONTES MAP, 1994, BRAIN RES, V665, P175, DOI 10.1016/0006-8993(94)91171-1; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; da Silva AQG, 2012, BRAIN RES, V1448, P101, DOI 10.1016/j.brainres.2012.02.021; da Silva AQG, 2011, BRAIN RES, V1368, P231, DOI 10.1016/j.brainres.2010.10.087; Grassi G, 2010, EXP PHYSIOL, V95, P581, DOI 10.1113/expphysiol.2009.047381; Gwathmey TM, 2012, AM J PHYSIOL-REG I, V302, pR518, DOI 10.1152/ajpregu.00525.2011; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Han Y, 2011, J APPL PHYSIOL, V110, P646, DOI 10.1152/japplphysiol.00908.2010; Han Y, 2011, PFLUG ARCH EUR J PHY, V461, P437, DOI 10.1007/s00424-011-0932-7; Hogarth AJ, 2007, J HUM HYPERTENS, V21, P239, DOI 10.1038/sj.jhh.1002132; KATHOLI RE, 1982, HYPERTENSION, V4, P166, DOI 10.1161/01.HYP.4.3_Pt_2.166; Krob HA, 1998, BRAIN RES, V798, P36, DOI 10.1016/S0006-8993(98)00384-9; Li DP, 2007, J PHARMACOL EXP THER, V320, P615, DOI 10.1124/jpet.106.109538; Li P, 2012, NEUROSCIENCE, V223, P388, DOI 10.1016/j.neuroscience.2012.07.048; Li YF, 2006, AM J PHYSIOL-REG I, V290, pR1035, DOI 10.1152/ajpregu.00338.2004; Li YF, 2003, ACTA PHYSIOL SCAND, V177, P17, DOI 10.1046/j.1365-201X.2003.01043.x; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Mancia G, 1999, HYPERTENSION, V34, P724, DOI 10.1161/01.HYP.34.4.724; Morise T, 2000, J HUM HYPERTENS, V14, P807, DOI 10.1038/sj.jhh.1001114; Neumann J, 2007, HYPERTENSION, V49, P506, DOI 10.1161/01.HYP.0000256530.39695.a3; Nie WC, 2009, MOL IMMUNOL, V46, P355, DOI 10.1016/j.molimm.2008.10.022; Qi YF, 2011, EXP PHYSIOL, V96, P863, DOI 10.1113/expphysiol.2011.056994; Rahn KH, 1999, J HYPERTENS, V17, pS11; Remuzzi G, 1999, NEW ENGL J MED, V340, P1360, DOI 10.1056/NEJM199904293401711; Rossi NF, 2010, EXP PHYSIOL, V95, P845, DOI 10.1113/expphysiol.2009.051789; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2003, HYPERTENSION, V41, P737, DOI 10.1161/01.HYP.0000052947.60363.24; Shi Z, 2009, PFLUG ARCH EUR J PHY, V458, P247, DOI 10.1007/s00424-008-0627-x; Silva-Barcellos NM, 2001, HYPERTENSION, V38, P1266, DOI 10.1161/hy1201.096056; Wang ZV, 2010, J BIOL CHEM, V285, P8509, DOI 10.1074/jbc.R109.025023; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhou LM, 2010, PFLUG ARCH EUR J PHY, V459, P681, DOI 10.1007/s00424-010-0793-5; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2009, EXP PHYSIOL, V94, P785, DOI 10.1113/expphysiol.2008.046565; Zimmerman MC, 2011, CURR OPIN PHARMACOL, V11, P138, DOI 10.1016/j.coph.2011.01.001	59	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52557	10.1371/journal.pone.0052557	http://dx.doi.org/10.1371/journal.pone.0052557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285085	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500194
J	Waltz, X; Pichon, A; Lemonne, N; Mougenel, D; Lalanne-Mistrih, ML; Lamarre, Y; Tarer, V; Tressieres, B; Etienne-Julan, M; Hardy-Dessources, MD; Hue, O; Connes, P				Waltz, Xavier; Pichon, Aurelien; Lemonne, Nathalie; Mougenel, Daniele; Lalanne-Mistrih, Marie-Laure; Lamarre, Yann; Tarer, Vanessa; Tressieres, Benoit; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Hue, Olivier; Connes, Philippe			Normal Muscle Oxygen Consumption and Fatigability in Sickle Cell Patients Despite Reduced Microvascular Oxygenation and Hemorheological Abnormalities	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW; IN-VIVO; WAVELET ANALYSIS; OSCILLATIONS; EXERCISE; AGGREGATION; FLOWMOTION; VASOMOTION; TURNOVER	Background/Aim: Although it has been hypothesized that muscle metabolism and fatigability could be impaired in sickle cell patients, no study has addressed this issue. Methods: We compared muscle metabolism and function (muscle microvascular oxygenation, microvascular blood flow, muscle oxygen consumption and muscle microvascular oxygenation variability, which reflects vasomotion activity, maximal muscle force and local muscle fatigability) and the hemorheological profile at rest between 16 healthy subjects (AA), 20 sickle cell-hemoglobin C disease (SC) patients and 16 sickle cell anemia (SS) patients. Results: Muscle microvascular oxygenation was reduced in SS patients compared to the SC and AA groups and this reduction was not related to hemorhelogical abnormalities. No difference was observed between the three groups for oxygen consumption and vasomotion activity. Muscle microvascular blood flow was higher in SS patients compared to the AA group, and tended to be higher compared to the SC group. Multivariate analysis revealed that muscle oxygen consumption was independently associated with muscle microvascular blood flow in the two sickle cell groups (SC and SS). Finally, despite reduced muscle force in sickle cell patients, their local muscle fatigability was similar to that of the healthy subjects. Conclusions: Sickle cell patients have normal resting muscle oxygen consumption and fatigability despite hemorheological alterations and, for SS patients only, reduced muscle microvascular oxygenation and increased microvascular blood flow. Two alternative mechanisms can be proposed for SS patients: 1) the increased muscle microvascular blood flow is a way to compensate for the lower muscle microvascular oxygenation to maintain muscle oxygen consumption to normal values or 2) the reduced microvascular oxygenation coupled with a normal resting muscle oxygen consumption could indicate that there is slight hypoxia within the muscle which is not sufficient to limit mitochondrial respiration but increases muscle microvascular blood flow.	[Waltz, Xavier; Lalanne-Mistrih, Marie-Laure; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Connes, Philippe] Univ Antilles Guyane, Inserm 665, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Pichon, Aurelien; Lamarre, Yann; Hardy-Dessources, Marie-Dominique; Connes, Philippe] PRES, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Waltz, Xavier; Hue, Olivier; Connes, Philippe] Univ Antilles Guyane, Lab ACTES, Dept Physiol, EA 3596, Pointe A Pitre, Guadeloupe, France; [Pichon, Aurelien] Univ Paris 13, PRES, EA2363, Lab Reponses Cellulaires & Fonct Hypoxie, Bobigny, France; [Lemonne, Nathalie; Mougenel, Daniele; Etienne-Julan, Maryse] Ctr Hosp & Univ, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Lalanne-Mistrih, Marie-Laure; Tressieres, Benoit] Ctr Hosp & Univ, CIC EC Inserm 802, Pointe A Pitre, Guadeloupe, France; [Tarer, Vanessa] Ctr Hosp & Univ, Ctr Reference Malad Rares Drepanocytose Antilles, Pointe A Pitre, Guadeloupe, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; Universite Paris 13; CHU Guadeloupe; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe	Connes, P (corresponding author), Univ Antilles Guyane, Inserm 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	Pichon, Aurélien/AAD-3320-2021; , Hardy-dessources/K-9189-2017; Connes, Philippe/J-7835-2019; TRESSIERES, Benoit/ABH-1085-2020; WALTZ, Xavier/M-3606-2016; Lamarre, Yann/ABC-2074-2020	, Hardy-dessources/0000-0003-0861-3648; Connes, Philippe/0000-0002-9232-0268; WALTZ, Xavier/0000-0002-0838-290X; Lamarre, Yann/0000-0003-0669-793X; Philippe, Connes/0000-0001-8449-7998; Hue, Olivier/0000-0002-2155-0816; ETIENNE-JULAN, Maryse/0000-0003-1339-6545	Academic Hospital of Pointe-a-Pitre (PHRC CHU de Pointe a Pitre); association "Ensemble contre la drepanocytose"; regional council of Guadeloupe	Academic Hospital of Pointe-a-Pitre (PHRC CHU de Pointe a Pitre); association "Ensemble contre la drepanocytose"; regional council of Guadeloupe	This work was supported by local grants from the Academic Hospital of Pointe-a-Pitre (PHRC CHU de Pointe a Pitre). PhD funding of X. W. was supported by the association "Ensemble contre la drepanocytose" and by the regional council of Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2011, ACTA PHYSIOL, V202, P253, DOI 10.1111/j.1748-1716.2011.02320.x; BADALOO A, 1989, CLIN SCI, V77, P93, DOI 10.1042/cs0770093; Balayssac-Siransy E, 2011, BRIT J HAEMATOL, V154, P398, DOI 10.1111/j.1365-2141.2011.08728.x; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; Baskurt OK, 2007, INDIAN J EXP BIOL, V45, P25; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; Buchowski MS, 2001, AM J PHYSIOL-ENDOC M, V280, pE518, DOI 10.1152/ajpendo.2001.280.3.E518; Buison AM, 2005, PEDIATRICS, V116, P943, DOI 10.1542/peds.2004-2582; Callahan LA, 2002, AM J RESP CRIT CARE, V165, P1309, DOI 10.1164/rccm.2002036; Connes P, C R BIOL IN PRESS; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Dougherty KA, 2011, J PEDIAT HEMATOL ONC, V33, P93, DOI 10.1097/MPH.0b013e318200ef49; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Hamaoka T, 2003, ADV EXP MED BIOL, V530, P475; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Kaul DK, 2004, MICROCIRCULATION, V11, P153, DOI 10.1080/10739680490278457; Kislukhin VV, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-29; Kvandal P, 2003, MICROVASC RES, V65, P160, DOI 10.1016/S0026-2862(03)00006-2; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; Lamarre Y., HAEMATOLOGI IN PRESS; Li ZY, 2006, ARCH PHYS MED REHAB, V87, P1207, DOI 10.1016/j.apmr.2006.05.025; Nahavandi M, 2004, EUR J CLIN INVEST, V34, P143, DOI 10.1111/j.1365-2362.2004.01307.x; Nahavandi M, 2009, HEMATOLOGY, V14, P46, DOI 10.1179/102453309X385133; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; Parthasarathi K, 1999, AM J PHYSIOL-HEART C, V277, pH2145, DOI 10.1152/ajpheart.1999.277.6.H2145; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; Pittman RN, 2011, INTEGRATED SYSTEMS P; Raj A, 2004, J PEDIAT HEMATOL ONC, V26, P279, DOI 10.1097/00043426-200405000-00004; RODGERS GP, 1984, NEW ENGL J MED, V311, P1534, DOI 10.1056/NEJM198412133112403; Rossi M, 2006, BIOMED PHARMACOTHER, V60, P437, DOI 10.1016/j.biopha.2006.07.012; SEAKINS M, 1973, J CLIN INVEST, V52, P422, DOI 10.1172/JCI107199; Soderstrom T, 2003, AM J PHYSIOL-HEART C, V284, pH1638, DOI 10.1152/ajpheart.00826.2000; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Tavakkoli F, 2005, CLIN THER, V27, P1083, DOI 10.1016/j.clinthera.2005.07.002; Thorn CE, 2011, AM J PHYSIOL-HEART C, V301, pH442, DOI 10.1152/ajpheart.01316.2010; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; TSAI AG, 1993, INT J MICROCIRC, V12, P75; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; van Beekvelt MCP, 2001, J APPL PHYSIOL, V90, P511, DOI 10.1152/jappl.2001.90.2.511; Waltz X., CLIN HEMORH IN PRESS; Waypa GB, 2010, RESP PHYSIOL NEUROBI, V174, P201, DOI 10.1016/j.resp.2010.08.007	45	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52471	10.1371/journal.pone.0052471	http://dx.doi.org/10.1371/journal.pone.0052471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285055	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500178
J	Hinder, MR; Fujiyama, H; Summers, JJ				Hinder, Mark R.; Fujiyama, Hakuei; Summers, Jeffery J.			Premotor-Motor Interhemispheric Inhibition Is Released during Movement Initiation in Older but Not Young Adults	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; AGE-RELATED DIFFERENCES; CROSS-LIMB TRANSFER; DORSAL PREMOTOR; CORTICOSPINAL EXCITABILITY; PERFORMANCE GAINS; CORTEX; TASK; BRAIN; CONNECTIVITY	Neural interactions between contralateral motor regions are thought to be instrumental in the successful preparation, and execution, of volitional movements. Here we investigated whether healthy ageing is associated with a change in functional connectivity, as indicated by the ability to modulate interhemispheric interactions during movement preparation in a manner that assists rapid movement responses. Thirteen young (mean age 22.2 years) and thirteen older (68.5 years) adults rapidly abducted their left index finger as soon as possible in response to a visual imperative signal, presented 500 ms after a visual warning signal. Interactions between left dorsal premotor cortex (LPMd) and right primary motor cortex (RM1) and between left primary motor cortex (LM1) and RM1 were investigated at six time points between the warning signal and the volitional response using paired-pulse transcranial magnetic stimulation. Relative to the inhibitory interactions measured at rest, both young and older adults released LM1-RM1 inhibition beginning 250 ms after the warning signal, with no significant differences between groups. LPMd-RM1 interactions became facilitatory (from the onset of the imperative signal onwards) in the older, but not the young, group. Regression analyses revealed that for the older adults, modulation of LPMd-RM1 interactions early in the preparation period was associated with faster responses, suggesting that specifically timed modulation of these pathways may be a compensatory mechanism to offset, at least in part, slowing of motor responses. The results suggest a greater reliance on premotor regions during the preparation of simple motor actions with advancing age.	[Hinder, Mark R.; Fujiyama, Hakuei; Summers, Jeffery J.] Univ Tasmania, Sch Psychol, Motor Control Lab, Hobart, Tas 7001, Australia	University of Tasmania	Hinder, MR (corresponding author), Univ Tasmania, Sch Psychol, Motor Control Lab, Hobart, Tas 7001, Australia.	Mark.Hinder@utas.edu.au	Fujiyama, Hakuei/O-4025-2019	Hinder, Mark/0000-0002-5240-4790; Fujiyama, Hakuei/0000-0002-7546-6636	Australian Research Council [DP0770568, DE120100729]	Australian Research Council(Australian Research Council)	Funding provided by the Australian Research Council Discovery Project DP0770568 and Discovery Early Career Researcher Award Fellowship DE120100729. www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeumer T, 2006, J PHYSIOL-LONDON, V572, P857, DOI 10.1113/jphysiol.2006.104901; Baliz Y, 2005, J INT NEUROPSYCH SOC, V11, P855, DOI 10.1017/S1355617705051003; Bodwell JA, 2003, J AM GERIATR SOC, V51, P1735, DOI 10.1046/j.1532-5415.2003.51557.x; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carroll TJ, 2008, J APPL PHYSIOL, V104, P1656, DOI 10.1152/japplphysiol.01351.2007; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Civardi C, 2001, NEUROIMAGE, V14, P1444, DOI 10.1006/nimg.2001.0918; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; Daskalakis ZJ, 2002, J PHYSIOL-LONDON, V543, P317, DOI 10.1113/jphysiol.2002.017673; Davranche K, 2007, EUR J NEUROSCI, V25, P3766, DOI 10.1111/j.1460-9568.2007.05588.x; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Duque J, 2007, J COGNITIVE NEUROSCI, V19, P204, DOI 10.1162/jocn.2007.19.2.204; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fujiyama H, 2012, J COGNITIVE NEUROSCI, V24, P1253, DOI 10.1162/jocn_a_00201; Fujiyama H, 2011, PSYCHOPHYSIOLOGY, V48, P1448, DOI 10.1111/j.1469-8986.2011.01201.x; Fujiyama H, 2010, PSYCHOPHYSIOLOGY, V47, P501, DOI 10.1111/j.1469-8986.2009.00954.x; Garry MI, 2005, EXP BRAIN RES, V163, P118, DOI 10.1007/s00221-005-2226-9; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; Gerloff C, 1998, J PHYSIOL-LONDON, V510, P249, DOI 10.1111/j.1469-7793.1998.249bz.x; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hinder MR, 2012, J NEUROPHYSIOL, V107, P1791, DOI 10.1152/jn.00822.2011; Hinder MR, 2011, J APPL PHYSIOL, V110, P166, DOI 10.1152/japplphysiol.00958.2010; Hinder MR, 2010, EXP BRAIN RES, V205, P423, DOI 10.1007/s00221-010-2379-z; Hinder MR, 2010, EXP BRAIN RES, V201, P229, DOI 10.1007/s00221-009-2029-5; Hoy KE, 2004, BRAIN RES REV, V46, P315, DOI 10.1016/j.brainresrev.2004.07.013; Jung P, 2012, J NEUROSCI, V32, P5667, DOI 10.1523/JNEUROSCI.5957-11.2012; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Kroeger J, 2010, EUR J NEUROSCI, V32, P1771, DOI 10.1111/j.1460-9568.2010.07442.x; Kukaswadia S, 2005, J PHYSIOL-LONDON, V563, P915, DOI 10.1113/jphysiol.2004.080010; Lee H, 2007, J PHYSIOL-LONDON, V580, P1021, DOI 10.1113/jphysiol.2006.126011; Lee M, 2010, J PHYSIOL-LONDON, V588, P201, DOI 10.1113/jphysiol.2009.183855; Levin O, 2011, NEUROSCI LETT, V487, P53, DOI 10.1016/j.neulet.2010.09.072; Liuzzi G, 2011, J NEUROSCI, V31, P9111, DOI 10.1523/JNEUROSCI.0046-11.2011; Liuzzi G, 2010, CEREB CORTEX, V20, P1323, DOI 10.1093/cercor/bhp196; Meyer-Lindenberg A, 2002, P NATL ACAD SCI USA, V99, P10948, DOI 10.1073/pnas.162114799; Mochizuki H, 2005, EXP BRAIN RES, V167, P414, DOI 10.1007/s00221-005-0047-5; Ni Z, 2009, CEREB CORTEX, V19, P1654, DOI 10.1093/cercor/bhn201; O'Shea J, 2007, EUR J NEUROSCI, V26, P2085, DOI 10.1111/j.1460-9568.2007.05795.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Rogasch NC, 2009, J APPL PHYSIOL, V107, P1874, DOI 10.1152/japplphysiol.00443.2009; Schambra HM, 2003, CLIN NEUROPHYSIOL, V114, P130, DOI 10.1016/S1388-2457(02)00342-5; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sinclair C, 2008, EXP BRAIN RES, V186, P385, DOI 10.1007/s00221-007-1241-4; Talelli P, 2008, EXP BRAIN RES, V186, P59, DOI 10.1007/s00221-007-1205-8; Tandonnet C, 2010, BIOL PSYCHOL, V85, P481, DOI 10.1016/j.biopsycho.2010.08.016; Vercauteren K, 2008, NEUROSCI LETT, V445, P209, DOI 10.1016/j.neulet.2008.09.013; Ward NS, 2008, NEUROBIOL AGING, V29, P1434, DOI 10.1016/j.neurobiolaging.2007.04.017	54	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52573	10.1371/journal.pone.0052573	http://dx.doi.org/10.1371/journal.pone.0052573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285097	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300093
J	Rong, X; Lu, L; Wang, JZ; Xiong, HP; Huang, JT; Chen, JY; Huang, K; Xu, R; Wang, M; Zhang, XM; Guo, T; Liu, YY; Gao, GQ; Fu, YS; Nelson, KE				Rong, Xia; Lu, Ling; Wang, Junzhi; Xiong, Huaping; Huang, Jieting; Chen, Jinyan; Huang, Ke; Xu, Ru; Wang, Min; Zhang, Xuemei; Guo, Tai; Liu, Yueyue; Gao, Guoquan; Fu, Yongshui; Nelson, Kenrad E.			Correlation of Viral Loads with HCV Genotypes: Higher Levels of Virus Were Revealed among Blood Donors Infected with 6a Strains	PLOS ONE			English	Article							HEPATITIS-C VIRUS; PEGYLATED INTERFERON; ESTROGEN-RECEPTOR; RISK-FACTORS; TRANSMISSION; PREVALENCE; CHINA; RIBAVIRIN; SEQUENCE; THERAPY	Background: Both HCV genotypes and viral loads are predictors of therapeutic outcomes among patients treated with alpha-interferon plus ribavirin; however, such correlation has only been studied for genotypes 1, 2, and 3 but not for genotype 6. Methodology/Findings: 299 voluntary blood donors were recruited who were HCV viremic. Their mean age was 31.8; the male/female ratio was 3.82 (225/59). The viral loads of HCV were measured using the COBAS AmpliPrep/COBAS TaqMan test (CAP/CTM) while HCV genotypes were determined by direct sequencing the partial NS5B region. HCV genotypes 1, 2, 3, and 6 were determined in 48.9%, 8.7%, 12.3%, and 30.1% of the donors, respectively, and the levels of mean viral loads in genotype 1 and 6 significantly higher than that of 2 and 3 (P < 0.001). As a whole, the viral loads in male donors were higher than in female (P = 0.006). Moreover, the donors' gender and HCV genotypes are independently correlated with the measured viral loads. Conclusion: HCV genotype 1 and 6 had significantly higher viral loads than genotype 2 and 3.	[Rong, Xia; Xiong, Huaping; Huang, Jieting; Chen, Jinyan; Huang, Ke; Xu, Ru; Wang, Min; Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China; [Rong, Xia; Zhang, Xuemei; Gao, Guoquan] Sun Yat Sen Univ, Coll Med, Dept Biochem, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Ling] Univ Kansas, Med Ctr, Ctr Viral Oncol, Kansas City, KS 66103 USA; [Wang, Junzhi; Guo, Tai; Liu, Yueyue] Natl Inst Food & Drug Control, Beijing, Peoples R China; [Nelson, Kenrad E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Guangzhou Blood Center; Sun Yat Sen University; University of Kansas; University of Kansas Medical Center; National Institute of Food & Drug Control - China; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fu, YS (corresponding author), Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China.	fuyongshui1969@yahoo.com		Xu, Ru/0000-0001-5926-9213; Chen, Jinyan/0000-0003-4103-7056	National Institute of Allergy and Infectious Diseases [5 R01 AI080734-03A]; Science and Technology Bureau, Guangzhou Municipality, China [2010UI-E00661]; 12th Five-year National Science & Technology Major Project [2012ZX10004702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080734] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Science and Technology Bureau, Guangzhou Municipality, China; 12th Five-year National Science & Technology Major Project; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from The National Institute of Allergy and Infectious Diseases (5 R01 AI080734-03A), a grant from The Science and Technology Bureau, Guangzhou Municipality, China (No. 2010UI-E00661, Dr YF) (http://www.gzsi.gov.cn/) and a grant from The 12th Five-year National Science & Technology Major Project (No. 2012ZX10004702) (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-293; Ali L, 2010, J GEN VIROL, V91, P1931, DOI 10.1099/vir.0.018119-0; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P425; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Berger A, 1996, J MED VIROL, V48, P339, DOI 10.1002/(SICI)1096-9071(199604)48:4&lt;339::AID-JMV7&gt;3.0.CO;2-8; Chamberlain RW, 1997, J GEN VIROL, V78, P1341, DOI 10.1099/0022-1317-78-6-1341; Chevaliez S, 2007, HEPATOLOGY, V46, P22, DOI 10.1002/hep.21656; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 1997, HEPATOLOGY, V26, pS122, DOI 10.1002/hep.510260721; Ponde RAD, 2011, MED MICROBIOL IMMUN, V200, P7, DOI 10.1007/s00430-010-0159-9; Dev AT, 2002, HEPATOLOGY, V36, P1259, DOI 10.1053/jhep.2002.36781; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Fu YS, 2010, TRANSFUSION, V50, P1505, DOI 10.1111/j.1537-2995.2010.02616.x; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Fung J, 2008, J INFECT DIS, V198, P808, DOI 10.1086/591252; Hayashida K, 2010, MICROBIOL IMMUNOL, V54, P684, DOI 10.1111/j.1348-0421.2010.00268.x; Hillung J, 2012, J GEN VIROL, V93, P780, DOI 10.1099/vir.0.039396-0; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, pE30, DOI 10.1111/j.1469-0691.2011.03665.x; Hui CK, 2003, J INFECT DIS, V187, P1071, DOI 10.1086/368217; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; MAHANEY K, 1994, HEPATOLOGY, V20, P1405, DOI 10.1002/hep.1840200605; Marongiu A, 2012, SEX TRANSM INFECT; Mauss S, 2012, Z GASTROENTEROL, V50, P441, DOI 10.1055/s-0031-1282072; Mellor J, 1999, J CLIN MICROBIOL, V37, P2525, DOI 10.1128/JCM.37.8.2525-2532.1999; Nguyen M. H., 2005, CLIN LIVER DIS, V9, pvi; Nguyen Mindie H, 2005, Clin Liver Dis, V9, P411, DOI 10.1016/j.cld.2005.05.010; Nguyen NH, 2010, J VIRAL HEPATITIS, V17, P691, DOI 10.1111/j.1365-2893.2009.01226.x; Nguyen NH, 2010, HEPATOL INT, V4, P523, DOI 10.1007/s12072-010-9181-7; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Prati D, 2006, J HEPATOL, V45, P607, DOI 10.1016/j.jhep.2006.07.003; Pybus OG, 2007, INT J PARASITOL, V37, P839, DOI 10.1016/j.ijpara.2007.04.009; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Sarrazin C, 2006, J CLIN MICROBIOL, V44, P729, DOI 10.1128/JCM.44.3.729-737.2006; Scott JD, 2007, JAMA-J AM MED ASSOC, V297, P724, DOI 10.1001/jama.297.7.724; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SMUTS HM, 1995, J CLIN MICROBIOL, V33, P1679, DOI 10.1128/JCM.33.6.1679-1681.1995; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V287, P2406, DOI 10.1001/jama.287.18.2406; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Uccellini L, 2012, HEPATOLOGY; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Watashi K, 2007, J BIOL CHEM, V282, P32765, DOI 10.1074/jbc.M704418200; World Health Organization, 2011, HEP C FACT SHEET; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; YAMADA G, 1995, HEPATOLOGY, V22, P1351, DOI 10.1002/hep.1840220502; Yeung LTF, 2001, HEPATOLOGY, V34, P223, DOI 10.1053/jhep.2001.25885	50	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52467	10.1371/journal.pone.0052467	http://dx.doi.org/10.1371/journal.pone.0052467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285053	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900095
J	Lee, JJ; Park, JK; Jeong, J; Jeon, H; Yoon, JB; Kim, EE; Lee, KJ				Lee, Jae-Jin; Park, Joon Kyu; Jeong, Jaeho; Jeon, Hyesung; Yoon, Jong-Bok; Kim, Eunice EunKyeong; Lee, Kong-Joo			Complex of Fas-associated Factor 1 (FAF1) with Valosin-containing Protein (VCP)-Npl4-Ufd1 and Polyubiquitinated Proteins Promotes Endoplasmic Reticulum-associated Degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA ATPASE P97/VCP; POSTTRANSLATIONAL MODIFICATIONS; UBIQUITIN LIGASES; UBX DOMAIN; BINDING; IDENTIFICATION; CDC48/P97; COFACTORS; INTERACTS; STRATEGY	Fas-associated factor 1 (FAF1) is a ubiquitin receptor containing multiple ubiquitin-related domains including ubiquitin-associated (UBA), ubiquitin-like (UBL) 1, UBL2, and ubiquitin regulatory X (UBX). We previously showed that N-terminal UBA domain recognizes Lys(48)-ubiquitin linkage to recruit polyubiquitinated proteins and that a C-terminal UBX domain interacts with valosin-containing protein (VCP). This study shows that FAF1 interacts only with VCP complexed with Npl4-Ufd1 heterodimer, a requirement for the recruitment of polyubiquitinated proteins to UBA domain. Intriguingly, VCP association to C-terminal UBX domain regulates ubiquitin binding to N-terminal UBA domain without direct interaction between UBA and UBX domains. These interactions are well characterized by structural and biochemical analysis. VCP-Npl4-Ufd1 complex is known as the machinery required for endoplasmic reticulum-associated degradation. We demonstrate here that FAF1 binds to VCP-Npl4-Ufd1 complex via UBX domain and polyubiquitinated proteins via UBA domain to promote endoplasmic reticulum-associated degradation.	[Lee, Jae-Jin; Jeong, Jaeho; Lee, Kong-Joo] Ewha Womans Univ, Dept Bioinspired Sci, Div Life & Pharmaceut Sci, Ctr Cell Signaling & Drug Discovery Res,Coll Phar, Seoul 120750, South Korea; [Park, Joon Kyu; Jeon, Hyesung; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea; [Yoon, Jong-Bok] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Yoon, Jong-Bok] Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea	Ewha Womans University; Korea Institute of Science & Technology (KIST); Yonsei University; Yonsei University	Kim, EE (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Seoul 136791, South Korea.	eunice@kist.re.kr; kjl@ewha.ac.kr		Lee, Kong-Joo/0000-0001-7972-6020; Yoon, Jong-Bok/0000-0002-3563-0702	Center for Cell Signaling Research and Drug Discovery Research Grant at Ewha Womans University from the National Core Research Center program, [R15-2006-020]; Global Research Laboratory Program [2012045441]; Bio and Medical Technology Development Program of the National Research Foundation of Korea [2012035580]; Functional Proteomics Center; Korea Ministry of Science and Technology, and an institutional grant from the Korea Institute of Science and Technology; Korea Institute of Science and Technology	Center for Cell Signaling Research and Drug Discovery Research Grant at Ewha Womans University from the National Core Research Center program,; Global Research Laboratory Program; Bio and Medical Technology Development Program of the National Research Foundation of Korea(National Research Foundation of Korea); Functional Proteomics Center; Korea Ministry of Science and Technology, and an institutional grant from the Korea Institute of Science and Technology; Korea Institute of Science and Technology(Korea Institute of Science & Technology (KIST))	This work was supported in part by Center for Cell Signaling Research and Drug Discovery Research Grant R15-2006-020 at Ewha Womans University from the National Core Research Center program, Global Research Laboratory Program Grant 2012045441, Bio and Medical Technology Development Program Grant 2012035580 of the National Research Foundation of Korea, the Functional Proteomics Center, the 21C Frontier Research and Development Program and Global Research Laboratory Program of the Korea Ministry of Science and Technology, and an institutional grant from the Korea Institute of Science and Technology.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Hanzelmann P, 2011, STRUCTURE, V19, P833, DOI 10.1016/j.str.2011.03.018; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Kang Y, 2007, J MOL BIOL, V365, P1093, DOI 10.1016/j.jmb.2006.10.056; Kim HJ, 2005, J BIOL CHEM, V280, P8125, DOI 10.1074/jbc.M406297200; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kim M, 2006, P NATL ACAD SCI USA, V103, P16358, DOI 10.1073/pnas.0603238103; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040361; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Na S, 2008, MOL CELL PROTEOMICS, V7, P2452, DOI 10.1074/mcp.M800101-MCP200; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nowis D, 2006, EXP CELL RES, V312, P2921, DOI 10.1016/j.yexcr.2006.05.013; Park MY, 2007, J BIOL CHEM, V282, P27572, DOI 10.1074/jbc.C700106200; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Song EJ, 2005, MOL CELL BIOL, V25, P2511, DOI 10.1128/MCB.25.6.2511-2524.2005; Song J, 2009, PROTEIN SCI, V18, P2265, DOI 10.1002/pro.237; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Woodman PG, 2003, J CELL SCI, V116, P4283, DOI 10.1242/jcs.00817; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	42	36	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					6998	7011		10.1074/jbc.M112.417576	http://dx.doi.org/10.1074/jbc.M112.417576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23293021	Green Published, hybrid			2022-12-25	WOS:000316002400022
J	Anderson, BR; Bogomolovas, J; Labeit, S; Granzier, H				Anderson, Brian R.; Bogomolovas, Julius; Labeit, Siegfried; Granzier, Henk			Single Molecule Force Spectroscopy on Titin Implicates Immunoglobulin Domain Stability as a Cardiac Disease Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; WOOLLY HAIR; PROTEIN; MUTATIONS; STIFFNESS; IDENTIFICATION; MODULATION; EXPRESSION; MYOSIN	Titin plays crucial roles in sarcomere organization and cardiac elasticity by acting as an intrasarcomeric molecular spring. A mutation in the tenth Ig-like domain of titin's spring region is associated with arrhythmogenic cardiomyopathy, a disease characterized by ventricular arrhythmias leading to cardiac arrest and sudden death. Titin is the first sarcomeric protein linked to arrhythmogenic cardiomyopathy. To characterize the disease mechanism, we have used atomic force microscopy to directly measure the effects that the disease-linked point mutation (T16I) has on the mechanical and kinetic stability of Ig10 at the single molecule level. The mutation decreases the force needed to unfold Ig10 and increases its rate of unfolding 4-fold. We also found that T16I Ig10 is more prone to degradation, presumably due to compromised local protein structure. Overall, the disease-linked mutation weakens the structural integrity of titin's Ig10 domain and suggests an Ig domain disease mechanism.	[Anderson, Brian R.] Univ Arizona, Dept Phys, Tucson, AZ 85724 USA; [Anderson, Brian R.; Granzier, Henk] Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; [Anderson, Brian R.; Granzier, Henk] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Bogomolovas, Julius; Labeit, Siegfried] Univ Med Mannheim, Inst Integrat Pathophysiol, D-68167 Mannheim, Germany	University of Arizona; University of Arizona; University of Arizona; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Physiol, MRB 340,1656 E Mabel St, Tucson, AZ 85724 USA.	granzier@email.arizona.edu	Bogomolovas, Julius/HGD-2595-2022; Bogomolovas, Julius/AAS-3642-2020	Bogomolovas, Julius/0000-0001-8344-1909	National Institutes of Health [GM084905, HL062881]; American Heart Association [11PRE7370083]; European Union; DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM084905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); European Union(European Commission); DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant GM084905 and Grant HL062881 (to H. G.). This work was also supported by American Heart Association Grant 11PRE7370083 (to B. A.) and grants from European Union FP7 SarcoSi, the DZHK (German Center for Cardiovascular Research), and the BMBF (German Ministry of Education and Research) (to J. B. and S. L.).	Basso C, 1999, Cardiol Rev, V7, P127, DOI 10.1097/00045415-199905000-00009; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cazorla O, 2000, CIRC RES, V86, P59, DOI 10.1161/01.RES.86.1.59; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chung CS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/310791; Chung CS, 2011, J MOL CELL CARDIOL, V50, P731, DOI 10.1016/j.yjmcc.2011.01.005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DUBOIS LH, 1992, ANNU REV PHYS CHEM, V43, P437, DOI 10.1146/annurev.pc.43.100192.002253; Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7; Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Grutzner A, 2009, BIOPHYS J, V97, P825, DOI 10.1016/j.bpj.2009.05.037; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6; Irving T, 2011, BIOPHYS J, V100, P1499, DOI 10.1016/j.bpj.2011.01.059; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; MARGOSSIAN SS, 1992, CIRCULATION, V85, P1720, DOI 10.1161/01.CIR.85.5.1720; Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nedrud J, 2011, BIOPHYS J, V101, P1385, DOI 10.1016/j.bpj.2011.06.054; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Park Chiwook, 2006, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2011s46; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Schroeder MA, 2010, CARDIOVASC RES, V86, P82, DOI 10.1093/cvr/cvp396; Sen-Chowdhry S, 2010, ANNU REV MED, V61, P233, DOI 10.1146/annurev.med.052208.130419; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000306; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Von Castelmur E, 2008, P NATL ACAD SCI USA, V105, P1186, DOI 10.1073/pnas.0707163105; Watanabe K, 2002, J STRUCT BIOL, V137, P248, DOI 10.1006/jsbi.2002.4458; Zhmurov A, 2010, BIOPHYS J, V99, P1959, DOI 10.1016/j.bpj.2010.07.012; Zhu Y, 2009, J BIOL CHEM, V284, P13914, DOI 10.1074/jbc.M809743200	47	26	26	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5303	5315		10.1074/jbc.M112.401372	http://dx.doi.org/10.1074/jbc.M112.401372			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297410	Green Published, hybrid			2022-12-25	WOS:000315342500005
J	Hawley, DF; Morch, K; Christie, BR; Leasure, JL				Hawley, Darby F.; Morch, Kristin; Christie, Brian R.; Leasure, J. Leigh			Differential Response of Hippocampal Subregions to Stress and Learning	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; LONG-TERM POTENTIATION; DENTATE GYRUS; NEUROTROPHIC FACTOR; ADULT NEUROGENESIS; RATS; MAZE; ANXIETY; LESIONS; DORSAL	The hippocampus has two functionally distinct subregions-the dorsal portion, primarily associated with spatial navigation, and the ventral portion, primarily associated with anxiety. In a prior study of chronic unpredictable stress (CUS) in rodents, we found that it selectively enhanced cellular plasticity in the dorsal hippocampal subregion while negatively impacting it in the ventral. In the present study, we determined whether this adaptive plasticity in the dorsal subregion would confer CUS rats an advantage in a spatial task-the radial arm water maze (RAWM). RAWM exposure is both stressful and requires spatial navigation, and therefore places demands simultaneously upon both hippocampal subregions. Therefore, we used Western blotting to investigate differential expression of plasticity-associated proteins (brain derived neurotrophic factor [BDNF], proBDNF and postsynaptic density-95 [PSD-95]) in the dorsal and ventral subregions following RAWM exposure. Lastly, we used unbiased stereology to compare the effects of CUS on proliferation, survival and neuronal differentiation of cells in the dorsal and ventral hippocampal subregions. We found that CUS and exposure to the RAWM both increased corticosterone, indicating that both are stressful; nevertheless, CUS animals had significantly better long-term spatial memory. We also observed a subregion-specific pattern of protein expression following RAWM, with proBDNF increased in the dorsal and decreased in the ventral subregion, while PSD-95 was selectively upregulated in the ventral. Finally, consistent with our previous study, we found that CUS most negatively affected neurogenesis in the ventral (compared to the dorsal) subregion. Taken together, our data support a dual role for the hippocampus in stressful experiences, with the more resilient dorsal portion undergoing adaptive plasticity (perhaps to facilitate escape from or neutralization of the stressor), and the ventral portion involved in affective responses.	[Hawley, Darby F.; Leasure, J. Leigh] Univ Houston, Dept Psychol, Houston, TX 77004 USA; [Morch, Kristin; Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada; [Christie, Brian R.] Univ British Columbia, Isl Med Program, Victoria, BC, Canada; [Leasure, J. Leigh] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; University of Victoria; University of British Columbia; University of Houston System; University of Houston	Leasure, JL (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77004 USA.	jlleasure@uh.edu	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; Leasure, J. Leigh/0000-0002-9014-2525	University of Houston Department of Psychology; Canadian Institutes for Health Research; Natural Sciences and Engineering Research Council	University of Houston Department of Psychology; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the University of Houston Department of Psychology, the Canadian Institutes for Health Research and the Natural Sciences and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleisa AM, 2011, HIPPOCAMPUS, V21, P899, DOI 10.1002/hipo.20806; Alessio HM, 2005, PHYSIOL BEHAV, V84, P65, DOI 10.1016/j.physbeh.2004.10.010; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; BURESOVA O, 1985, PHYSIOL BEHAV, V34, P1003, DOI 10.1016/0031-9384(85)90028-9; Callaghan CK, 2012, HIPPOCAMPUS; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Eadie BD, 2009, NEUROBIOL DIS, V36, P361, DOI 10.1016/j.nbd.2009.08.001; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hawley DF, 2012, HIPPOCAMPUS, V22, P1338, DOI 10.1002/hipo.20970; Hawley DF, 2010, STRESS, V13, P172, DOI 10.3109/10253890903144621; Ho YC, 2010, NEUROSCIENCE, V171, P153, DOI 10.1016/j.neuroscience.2010.08.062; Hock BJ, 1998, J NEUROSCI, V18, P7027; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Hunt CA, 1996, J NEUROSCI, V16, P1380; KANT GJ, 1988, PHARMACOL BIOCHEM BE, V31, P487, DOI 10.1016/0091-3057(88)90378-4; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maurer AP, 2005, HIPPOCAMPUS, V15, P841, DOI 10.1002/hipo.20114; Mirescu C, 2006, HIPPOCAMPUS, V16, P233, DOI 10.1002/hipo.20155; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shors TJ, 2004, LEARN MEMORY, V11, P137, DOI 10.1101/lm.66604; Snyder JS, 2009, HIPPOCAMPUS, V19, P360, DOI 10.1002/hipo.20525; Thanos PK, 2009, PHYSIOL RES, V58, P219, DOI 10.33549/physiolres.931434; Tran TT, 2010, NEUROBIOL DIS, V37, P756, DOI 10.1016/j.nbd.2009.12.016; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; von Bohlen und Halbach O, 2006, BIOL PSYCHIAT, V59, P793, DOI 10.1016/j.biopsych.2005.08.025; Watt MJ, 2009, BEHAV NEUROSCI, V123, P564, DOI 10.1037/a0015752; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Wolf OT, 2002, BRAIN RES PROTOC, V10, P41; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zoladz PR, 2012, HIPPOCAMPUS, V22, P577, DOI 10.1002/hipo.20922	42	38	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53126	10.1371/journal.pone.0053126	http://dx.doi.org/10.1371/journal.pone.0053126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285257	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500109
J	Jiang, D; Nelson, ML; Gally, F; Smith, S; Wu, Q; Minor, M; Case, S; Thaikoottathil, J; Chu, HW				Jiang, Di; Nelson, Mark L.; Gally, Fabienne; Smith, Sean; Wu, Qun; Minor, Maisha; Case, Stephanie; Thaikoottathil, Jyoti; Chu, Hong Wei			Airway Epithelial NF-kappa B Activation Promotes Mycoplasma pneumoniae Clearance in Mice	PLOS ONE			English	Article							IN-VITRO ACTIVITY; LUNG INFLAMMATION; ALLERGIC INFLAMMATION; MURINE MODEL; INFECTION; DOXYCYCLINE; HYPERRESPONSIVENESS; ASTHMA; EXPRESSION; DEFENSE	Background/Objective: Respiratory infections including atypical bacteria Mycoplasma pneumoniae (Mp) contribute to the pathobiology of asthma and chronic obstructive pulmonary disease (COPD). Mp infection mainly targets airway epithelium and activates various signaling pathways such as nuclear factor kappa B (NF-kappa B). We have shown that short palate, lung, and nasal epithelium clone 1 (SPLUNC1) serves as a novel host defense protein and is up-regulated upon Mp infection through NF-kappa B activation in cultured human and mouse primary airway epithelial cells. However, the in vivo role of airway epithelial NF-kappa B activation in host defense against Mp infection has not been investigated. In the current study, we investigated the effects of in vivo airway epithelial NF-kappa B activation on lung Mp clearance and its association with airway epithelial SPLUNC1 expression. Methodology/Main Results: Non-antimicrobial tetracycline analog 9-t-butyl doxycycline (9-TB) was initially optimized in mouse primary tracheal epithelial cell culture, and then utilized to induce in vivo airway epithelial specific NF-kappa B activation in conditional NF-kappa B transgenic mice (CC10-CAIKK beta) with or without Mp infection. Lung Mp load and inflammation were evaluated, and airway epithelial SPLUNC1 protein was examined by immunohistochemistry. We found that 9-TB treatment in NF-kappa B transgene positive (Tg+), but not transgene negative (Tg-) mice significantly reduced lung Mp load. Moreover, 9-TB increased airway epithelial SPLUNC1 protein expression in NF-kappa B Tg+ mice. Conclusion: By using the non-antimicrobial 9-TB, our study demonstrates that in vivo airway epithelial NF-kappa B activation promotes lung bacterial clearance, which is accompanied by increased epithelial SPLUNC1 expression.	[Jiang, Di; Gally, Fabienne; Smith, Sean; Wu, Qun; Minor, Maisha; Case, Stephanie; Thaikoottathil, Jyoti; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Jiang, Di; Nelson, Mark L.; Gally, Fabienne; Smith, Sean; Wu, Qun; Minor, Maisha; Case, Stephanie; Thaikoottathil, Jyoti; Chu, Hong Wei] Univ Colorado, Denver, CO 80202 USA; [Nelson, Mark L.] Natl Jewish Hlth, Dept Immunol, Denver, CO USA; [Chu, Hong Wei] Echelon Biosci Inc, Business & Sci Dev, Salt Lake City, UT USA	National Jewish Health; University of Colorado System; University of Colorado Denver; National Jewish Health	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	chuhw@njhealth.org		Gally, Fabienne/0000-0003-0503-7411	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) [R01HL088264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088264] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI) R01HL088264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash M, 1999, J ANTIMICROB CHEMOTH, V44, P385, DOI 10.1093/jac/44.3.385; Alvarez JI, 2009, AM J PATHOL, V175, P685, DOI 10.2353/ajpath.2009.081073; Ather JL, 2011, AM J RESP CELL MOL, V44, P631, DOI 10.1165/rcmb.2010-0106OC; BEBEAR C, 1985, PATHOL BIOL, V33, P577; Bebear CM, 2000, ANTIMICROB AGENTS CH, V44, P2557, DOI 10.1128/AAC.44.9.2557-2560.2000; Bouchillon SK, 2005, DIAGN MICR INFEC DIS, V51, P291, DOI 10.1016/j.diagmicrobio.2004.11.006; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Cheng DS, 2007, J IMMUNOL, V178, P6504, DOI 10.4049/jimmunol.178.10.6504; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Chu HW, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-155; Chu HW, 1998, AM J RESP CRIT CARE, V158, P1936, DOI 10.1164/ajrccm.158.6.9712073; Chu HW, 2003, INFECT IMMUN, V71, P1520, DOI 10.1128/IAI.71.3.1520-1526.2003; COHEN MA, 1991, DIAGN MICR INFEC DIS, V14, P245, DOI 10.1016/0732-8893(91)90039-I; Esposito S, 2002, PEDIATR PULM, V34, P122, DOI 10.1002/ppul.10139; Gally F, 2011, J INNATE IMMUN; Gally F, 2011, AM J PATHOL, V178, P2159, DOI 10.1016/j.ajpath.2011.01.026; Halterman MW, 2011, J BIOMOL SCREEN, V16, P332, DOI 10.1177/1087057110397355; Hannan PCT, 2000, J ANTIMICROB CHEMOTH, V45, P367, DOI 10.1093/jac/45.3.367; Hardy RD, 2002, INFECT IMMUN, V70, P649, DOI 10.1128/IAI.70.2.649-654.2002; Heine HS, 2007, ANTIMICROB AGENTS CH, V51, P1373, DOI 10.1128/AAC.01050-06; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; MALINVERNI R, 1995, ANTIMICROB AGENTS CH, V39, P45, DOI 10.1128/AAC.39.1.45; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Poynter ME, 2003, J IMMUNOL, V170, P6257, DOI 10.4049/jimmunol.170.12.6257; Poynter ME, 2002, AM J PATHOL, V160, P1325, DOI 10.1016/S0002-9440(10)62559-X; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Sheller JR, 2009, EXP LUNG RES, V35, P883, DOI 10.3109/01902140903019710; Thaikoottathil J, 2011, MOL IMMUNOL, V49, P415, DOI 10.1016/j.molimm.2011.08.005; Vieira RP, 2011, RESP PHYSIOL NEUROBI, V175, P383, DOI 10.1016/j.resp.2011.01.002; Wu Q, 2011, AM J PHYSL LUNG CELL; Wu Q, 2008, AM J RESP CRIT CARE, V177, P720, DOI 10.1164/rccm.200709-1387OC; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533	36	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52969	10.1371/journal.pone.0052969	http://dx.doi.org/10.1371/journal.pone.0052969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285237	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500091
J	Park, S; Oh, S; van Nocker, S				Park, Sunchung; Oh, Sookyung; van Nocker, Steve			Genomic and Gene-Level Distribution of Histone H3 Dimethyl Lysine-27 (H3K27me2) in Arabidopsis	PLOS ONE			English	Article							DNA METHYLATION; ACTIVE GENES; MODIFICATION PATTERNS; IN-VIVO; CHROMATIN; THALIANA; TRIMETHYLATION; MAP; REPLICATION; ACETYLATION	Histone lysine methylation patterns underlie much of the functional diversity of nucleosomes in eukaryotes, and an interesting aspect of histone methylation is the potential functional specificity for different methylation states on a given lysine. Trimethylation of histone H3 (H3K27me3) is intimately related to developmental gene silencing through the so-called Polycomb Group (PcG) mechanism. How this modification becomes established at PcG-repressed loci is generally not known, but it has been suggested that it may be facilitated by prior occupancy by H3K27me2. In this study we mapped the genomic and gene-level distribution of H3K27me2 in Arabidopsis thaliana using ChIP and a high-density tiling microarray, and integrated this with previous maps of other chromatin features and gene expression data. At the genome level, H3K27me2 enrichment sites were sparsely distributed across chromosomes, within an average size expected for a single nucleosome, and contrasted with the longer domains seen for H3K27me3. In both heterochromatic and euchromatic segments of the genome, H3K27me2 enrichment was often localized within transposon-related genes, with the longest genomic stretches of this modification corresponding to retroelements. However, H3K27me2 was more frequently found within protein-coding genes. These genes generally also showed moderate enrichment for H3K27me3, but H3K27me2 was strongly depleted within those genes most enriched in H3K27me3. H3K27me2 within highly transcribed genes was at highest levels at transcriptional starts and was strongly depleted throughout the transcribed regions, and reached higher levels at active than at silent promoters.	[van Nocker, Steve] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Park, Sunchung; Oh, Sookyung] Michigan State Univ, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	van Nocker, S (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.	vannocke@msu.edu		Park, Sunchung/0000-0002-7398-9476	National Science Foundation (NSF) [IOS-0922447]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) through a grant (IOS-0922447) to SVN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Fischer A, 2006, J PLANT PHYSIOL, V163, P358, DOI 10.1016/j.jplph.2005.10.015; Jacob Y, 2010, NATURE, V466, P987, DOI 10.1038/nature09290; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krichevsky A, 2007, DEV BIOL, V303, P259, DOI 10.1016/j.ydbio.2006.11.012; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Li H, 2007, PLANT CELL, V19, P2403, DOI 10.1105/tpc.107.053579; Li XY, 2008, PLANT CELL, V20, P259, DOI 10.1105/tpc.107.056879; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Oh SY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000077; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Reynolds N, 2012, EMBO J, V31, P593, DOI 10.1038/emboj.2011.431; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Yanowitz J, 2010, CURR OPIN CELL BIOL, V22, P744, DOI 10.1016/j.ceb.2010.08.016; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001210; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	48	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52855	10.1371/journal.pone.0052855	http://dx.doi.org/10.1371/journal.pone.0052855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285203	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500070
J	Reed, AJ; Thatje, S; Linse, K				Reed, Adam J.; Thatje, Sven; Linse, Katrin			Shifting Baselines in Antarctic Ecosystems; Ecophysiological Response to Warming in Lissarca miliaris at Signy Island, Antarctica	PLOS ONE			English	Article							CLIMATE-CHANGE; ANTHROPOGENIC IMPACTS; THERMAL TOLERANCE; MARINE ECOSYSTEMS; SHELL; GROWTH; TEMPERATURE; PENINSULA; SEA; PHILOBRYIDAE	The Antarctic Peninsula has experienced a rapid increase in atmospheric temperature over the last 50 years. Whether or not marine organisms thriving in this cold stenothermal environment are able to cope with warming is of concern. Here, we present changes to the growth and shell characteristics of the ecologically important, small and short lived brooding bivalve Lissarca miliaris from Signy Island, Antarctica. Using material collected from the 1970's to the present day, we show an increase in growth rate and adult shell deterioration accompanied by a decrease in offspring size, associated with an increase in annual average temperatures. Critical changes to the bivalve's ecology seen today evidence the problem of a shift in baseline since the onset of warming recorded in Antarctica. These small bivalves are demonstrating ecophysiological responses to subtle warming that, provided warming continues, could soon surpass a physiological tipping point, adding to warming associated threats such as increased predatory pressure and ocean acidification.	[Reed, Adam J.; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Linse, Katrin] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England	NERC National Oceanography Centre; University of Southampton; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Reed, AJ (corresponding author), Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England.	ajr04@soton.ac.uk	; Reed, Adam/Q-7276-2017	Linse, Katrin/0000-0003-3477-3047; Reed, Adam/0000-0003-2200-5067	Natural Environment Research Council PhD studentship; NERC [bas0100026] Funding Source: UKRI; Natural Environment Research Council [bas0100026] Funding Source: researchfish	Natural Environment Research Council PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AJR was supported through a Natural Environment Research Council PhD studentship. This study is part of the British Antarctic Survey Polar Science for Planet Earth Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELDOORN RS, 1983, FISH B-NOAA, V81, P75; Arntz Wolf E., 2003, Berichte zur Polar- und Meeresforschung, V462, P1; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Aronson RB, 2011, ANN NY ACAD SCI, V1223, P82, DOI 10.1111/j.1749-6632.2010.05926.x; BREY T, 1992, MAR ECOL PROG SER, V82, P219, DOI 10.3354/meps082219; Brey T, 1999, ADV MAR BIOL, V35, P153, DOI 10.1016/S0065-2881(08)60005-X; Brey T, 2011, J MARINE SYST, V88, P542, DOI 10.1016/j.jmarsys.2011.07.004; Cerrano C, 2001, POLAR BIOL, V24, P790, DOI 10.1007/s003000100294; Clarke A, 1996, LIMNOL OCEANOGR, V41, P1281, DOI 10.4319/lo.1996.41.6.1281; CLARKE A, 1988, BRIT ANTARCT SURV B, P65; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Cramer KL, 2012, ECOL LETT, V15, P561, DOI 10.1111/j.1461-0248.2012.01768.x; DEVILLIERS S, 1995, SCIENCE, V269, P1247, DOI 10.1126/science.269.5228.1247; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Fraser WR, 2003, MAR ECOL PROG SER, V265, P1, DOI 10.3354/meps265001; GELLER JB, 1990, J EXP MAR BIOL ECOL, V136, P77, DOI 10.1016/0022-0981(90)90101-H; GOODSELL JG, 1992, NAUTILUS, V106, P119; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harper EM, 2000, J ZOOL, V251, P179, DOI 10.1111/j.1469-7998.2000.tb00602.x; Heilmayer O, 2004, FUNCT ECOL, V18, P641, DOI 10.1111/j.0269-8463.2004.00905.x; Higgs ND, 2009, MAR BIOL, V156, P1073, DOI 10.1007/s00227-009-1154-9; Huber M, 2010, LISSARCA MILIARIS PH; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaehler S, 1999, MAR BIOL, V135, P505, DOI 10.1007/s002270050651; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; NICOL DAVID, 1967, J PALEONTOL, V41, P1330; NOLAN CP, 1991, J MOLLUS STUD, V57, P225, DOI 10.1093/mollus/57.2.225; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Reed AJ, 2013, POLAR BIOL, V36, P1, DOI 10.1007/s00300-012-1233-0; Richardson M.G., 1979, BR ANTARCTIC SURVEY, V49, P91; Rosenheim BE, 2004, GEOLOGY, V32, P145, DOI 10.1130/G20117.1; Roy K, 2003, ECOL LETT, V6, P205, DOI 10.1046/j.1461-0248.2003.00419.x; Schofield O, 2010, SCIENCE, V328, P1520, DOI 10.1126/science.1185779; Schone BR, 2005, PALAEOGEOGR PALAEOCL, V228, P130, DOI 10.1016/j.palaeo.2005.03.049; Sosdian S, 2006, GEOCHEM GEOPHY GEOSY, V7, P1; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Taskinen J, 1999, J PARASITOL, V85, P588, DOI 10.2307/3285806; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Villas A, 2011, ECOL APPL, V21, P2172, DOI 10.1890/10-1473.1; Watson EB, 2004, GEOCHIM COSMOCHIM AC, V68, P1473, DOI 10.1016/j.gca.2003.10.003; WEBB SC, 1994, J SHELLFISH RES, V13, P11	48	3	3	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53477	10.1371/journal.pone.0053477	http://dx.doi.org/10.1371/journal.pone.0053477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285298	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000313051500153
J	Zhang, XY; Chen, DC; Xiu, MH; Luo, XG; Zuo, LJ; Haile, CN; Kosten, TA; Kosten, TR				Zhang, Xiang Yang; Chen, Da Chun; Xiu, Mei Hong; Luo, Xingguang; Zuo, Lingjun; Haile, Colin N.; Kosten, Therese A.; Kosten, Thomas R.			BDNF Val66Met Variant and Smoking in a Chinese Population	PLOS ONE			English	Article							ACTIVITY-DEPENDENT SECRETION; GENOME-WIDE METAANALYSES; NEUROTROPHIC FACTOR BDNF; ANTEROGRADE TRANSPORT; NICOTINE DEPENDENCE; MALE SMOKERS; ASSOCIATION; BRAIN; POLYMORPHISM; BEHAVIOR	Several recent studies have supported the hypothesis that brain-derived neurotrophic factor (BDNF), a member of the neurotrophic factor family, might be associated with nicotine addiction. Association studies have also suggested that the BDNF gene might play a role in the susceptibility to nicotine dependence but results appear contradictory. The present work was therefore undertaken to examine the association of smoking with the BDNF Val66Met gene polymorphism in Chinese population. The BDNF Val66Met gene polymorphism was examined in 628 healthy male volunteers including 322 smokers and 306 non-smokers. Also, the BDNF serum levels were measured in 136 smokers and 97 nonsmokers. Our results showed no significant association between the BDNF Val66Met polymorphism or serum levels among smokers and nonsmokers. Smokers with the Met allele however started smoking significantly earlier than those with the Val/Val genotype (mean age at smoking initiation of 17.4, 17.9 and 21.2 years for Met/Met, Met/Val, and Val/Val, respectively; both p<0.05). No other significant differences between other variables such as number of cigarettes per day, smoking severity as measured by the Fagerstrom Test for Nicotine Dependence (FTND) score and carbon monoxide (CO) levels (all p>0.05). In addition, there was no main effect of genotype on serum BDNF levels. Our findings suggest that the BDNF Val66Met polymorphism may not be involved in susceptibility to smoking among the Chinese male population, but may influence the age at which smoking is initiated. However, the findings must be interpreted with caution because of the relatively small sample size for an association study. Results should be confirmed in a larger cohort.	[Zhang, Xiang Yang; Haile, Colin N.; Kosten, Therese A.; Kosten, Thomas R.] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Zhang, Xiang Yang; Chen, Da Chun; Xiu, Mei Hong; Kosten, Thomas R.] Peking Univ, Beijing Hui Long Guan Hosp, Psychiat Res Ctr, Beijing 100871, Peoples R China; [Luo, Xingguang; Zuo, Lingjun] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	Baylor College of Medicine; Peking University; Yale University	Zhang, XY (corresponding author), Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	xyzhang@bcm.edu; kosten@bcm.edu	KOSTEN, Therese/R-2506-2019; Kosten, Thomas/AAI-5998-2021	Haile, Colin/0000-0001-8293-7291	National Natural Science Foundation of China [81000509]; Beijing Municipal Excellent Talents Foundation [2010D003034000032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Excellent Talents Foundation	This study was funded by National Natural Science Foundation of China (81000509) and Beijing Municipal Excellent Talents Foundation (2010D003034000032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Beuten J, 2005, AM J MED GENET B, V139B, P73, DOI 10.1002/ajmg.b.30231; Bhang SY, 2010, NEUROSCI LETT, V468, P7, DOI 10.1016/j.neulet.2009.10.046; Breetvelt EJ, 2012, PSYCHIAT GENET, V22, P96, DOI 10.1097/YPG.0b013e32834c0c75; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; David SP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.41; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Gratacos M, 2007, BIOL PSYCHIAT, V61, P911, DOI 10.1016/j.biopsych.2006.08.025; Guillin O, 2001, NATURE, V411, P86, DOI 10.1038/35075076; Guo S, 2007, PSYCHOPHARMACOLOGY, V190, P449, DOI 10.1007/s00213-006-0628-4; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; Kenny PJ, 2000, MOL BRAIN RES, V85, P234, DOI 10.1016/S0169-328X(00)00246-1; Lang UE, 2007, PSYCHOPHARMACOLOGY, V190, P433, DOI 10.1007/s00213-006-0647-1; Lee S, 2009, ADDICT BEHAV, V34, P969, DOI 10.1016/j.addbeh.2009.05.005; Lerman C, 2003, AM J MED GENET B, V118B, P48, DOI 10.1002/ajmg.b.10003; Li MD, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S103; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Montag C, 2008, NEUROSCI LETT, V442, P30, DOI 10.1016/j.neulet.2008.06.064; Montag C, 2010, NEUROPSYCHOPHARMACOL, V35, P1860, DOI 10.1038/npp.2010.55; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nishio T, 1998, NEUROREPORT, V9, P2847, DOI 10.1097/00001756-199808240-00030; Pontieri FE, 1996, NATURE, V382, P255, DOI 10.1038/382255a0; Seidah NG, 1996, FEBS LETT, V379, P247, DOI 10.1016/0014-5793(95)01520-5; Suchanek R, 2012, J MOL NEUROSCI, V46, P217, DOI 10.1007/s12031-011-9582-7; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467; Xiu MH, 2009, PROG NEURO-PSYCHOPH, V33, P1508, DOI 10.1016/j.pnpbp.2009.08.011; Zhang XY, 2008, NEUROPSYCHOPHARMACOL, V33, P2200, DOI 10.1038/sj.npp.1301619	36	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53295	10.1371/journal.pone.0053295	http://dx.doi.org/10.1371/journal.pone.0053295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285275	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500129
J	Lalwani, MK; Sharma, M; Singh, AR; Chauhan, RK; Patowary, A; Singh, N; Scaria, V; Sivasubbu, S				Lalwani, Mukesh Kumar; Sharma, Meenakshi; Singh, Angom Ramcharan; Chauhan, Rajendra Kumar; Patowary, Ashok; Singh, Naresh; Scaria, Vinod; Sivasubbu, Sridhar			Reverse Genetics Screen in Zebrafish Identifies a Role of miR-142a-3p in Vascular Development and Integrity	PLOS ONE			English	Article							VE-CADHERIN; IN-VIVO; CELL JUNCTIONS; MICRORNA EXPRESSION; LMO2; ANGIOGENESIS; MATURATION	MicroRNAs are a well-studied class of non-coding RNA and are known to regulate developmental processes in eukaryotes. Their role in key biological processes such as vasculature development has attracted interest. However, a comprehensive understanding of molecular regulation of angiogenesis and vascular integrity during development remains less explored. Here we identified miRNAs involved in the development and maintenance of vasculature in zebrafish embryos using a reverse genetics approach. Using a combination of bioinformatics predictions and literature based evidences we mined over 701 Human and 329 Zebrafish miRNAs to derive a list of 29 miRNAs targeting vascular specific genes in zebrafish. We shortlisted eight miRNAs and investigated their potential role in regulating vascular development in zebrafish transgenic model. In this screen we identified three miRNAs, namely miR-1, miR-144 and miR-142a-3p that have the potential to influence vascular development in zebrafish. We show that miR-142a-3p mediates vascular integrity and developmental angiogenesis in vivo. Overexpression of miR-142a-3p results in loss of vascular integrity, hemorrhage and vascular remodeling during zebrafish embryonic development, while loss of function of miR-142a-3p causes abnormal vascular remodeling. MiR-142a-3p functions in part by directly repressing cdh5 (VE-cadherin). The vascular abnormalities that results from modulation of miR-142a-3p are reminiscent of cdh5 perturbation in zebrafish embryos. We also demonstrate that the action of miR-142a on cdh5 is potentially regulated by Lmo2, an important transcription factor, known for its role in vasculature development. The miR142a-3p mediated control of cdh5 constitutes an additional layer of regulation for maintaining vascular integrity and developmental angiogenesis. These findings have implications in development, wound repair and tumor growth.	[Sharma, Meenakshi; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Scaria, V (corresponding author), CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.res.in; s.sivasubbu@igib.res.in	Patowary, Ashok/AAT-5305-2020; Scaria, Vinod/B-2819-2008; Scaria, Vinod/AAS-3151-2021	Patowary, Ashok/0000-0001-7507-3907; Scaria, Vinod/0000-0001-7644-7181; Chauhan, Rajendra Kumar/0000-0002-3904-5332	Council of Scientific and Industrial Research (CSIR), India [NWP0036, FAC002]; CSIR, India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge funding from the Council of Scientific and Industrial Research (CSIR), India through the NWP0036 and FAC002 Grant. MKL acknowledges senior research fellowships from CSIR, India. The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahary N, 2007, BLOOD, V110, P3627, DOI 10.1182/blood-2006-04-016378; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deleuze V, 2007, MOL CELL BIOL, V27, P2687, DOI 10.1128/MCB.00493-06; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hyatt TM, 1999, METHOD CELL BIOL, V59, P117; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HQ, 2010, J NEUROSCI, V30, P3254, DOI 10.1523/JNEUROSCI.4948-09.2010; Mishima Y, 2009, GENE DEV, V23, P619, DOI 10.1101/gad.1760209; Mitchell IC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008807; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Nishiyama T, 2012, BIOCHEM BIOPH RES CO, V425, P755, DOI 10.1016/j.bbrc.2012.07.148; Nyqvist D, 2008, EMBO REP, V9, P742, DOI 10.1038/embor.2008.123; Pase Luke, 2009, V546, P227, DOI 10.1007/978-1-60327-977-2_14; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Yuan W, 2008, LEUKEMIA, V22, P1067, DOI 10.1038/sj.leu.2405001; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zou J, 2011, CIRC RES, V108, P201, DOI 10.1161/CIRCRESAHA.110.225045	48	33	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52588	10.1371/journal.pone.0052588	http://dx.doi.org/10.1371/journal.pone.0052588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285103	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800078
J	Padmanabhan, PK; Dumas, C; Samant, M; Rochette, A; Simard, MJ; Papadopoulou, B				Padmanabhan, Prasad K.; Dumas, Carole; Samant, Mukesh; Rochette, Annie; Simard, Martin J.; Papadopoulou, Barbara			Novel Features of a PIWI-Like Protein Homolog in the Parasitic Protozoan Leishmania	PLOS ONE			English	Article							RNA INTERFERENCE RNAI; APOPTOSIS-LIKE DEATH; PIRNA PATHWAY; ARGONAUTE PROTEINS; GENE-EXPRESSION; MESSENGER-RNAS; LOCALIZATION; TRANSLATION; DEFENSE; GENOME	In contrast to nearly all eukaryotes, the Old World Leishmania species L. infantum and L. major lack the bona fide RNAi machinery genes. Interestingly, both Leishmania genomes code for an atypical Argonaute-like protein that possesses a PIWI domain but lacks the PAZ domain found in Argonautes from RNAi proficient organisms. Using sub-cellular fractionation and confocal fluorescence microscopy, we show that unlike other eukaryotes, the PIWI-like protein is mainly localized in the single mitochondrion in Leishmania. To predict PIWI function, we generated a knockout mutant for the PIWI gene in both L. infantum (Lin) and L. major species by double-targeted gene replacement. Depletion of PIWI has no effect on the viability of insect promastigote forms but leads to an important growth defect of the mammalian amastigote lifestage in vitro and significantly delays disease pathology in mice, consistent with a higher expression of the PIWI transcript in amastigotes. Moreover, amastigotes lacking PIWI display a higher sensitivity to apoptosis inducing agents than wild type parasites, suggesting that PIWI may be a sensor for apoptotic stimuli. Furthermore, a whole-genome DNA microarray analysis revealed that loss of LinPIWI in Leishmania amastigotes affects mostly the expression of specific subsets of developmentally regulated genes. Several transcripts encoding surface and membrane-bound proteins were found downregulated in the LinPIWI ((-/-)) mutant whereas all histone transcripts were upregulated in the null mutant, supporting the possibility that PIWI plays a direct or indirect role in the stability of these transcripts. Although our data suggest that PIWI is not involved in the biogenesis or the stability of small noncoding RNAs, additional studies are required to gain further insights into the role of this protein on RNA regulation and amastigote development in Leishmania.	[Padmanabhan, Prasad K.; Dumas, Carole; Samant, Mukesh; Papadopoulou, Barbara] Univ Laval, Fac Med, Res Ctr Infect Dis, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada; [Padmanabhan, Prasad K.; Dumas, Carole; Samant, Mukesh; Papadopoulou, Barbara] Univ Laval, Fac Med, Dept Microbiol & Immunol, Quebec City, PQ G1K 7P4, Canada; [Rochette, Annie] INRS Inst Armand Frappier, Laval, PQ, Canada; [Simard, Martin J.] Univ Laval, Canc Res Ctr, Hotel Dieu Quebec CHUQ, Quebec City, PQ, Canada	Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS); Laval University	Papadopoulou, B (corresponding author), Univ Laval, Fac Med, Res Ctr Infect Dis, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada.	barbara.papadopoulou@crchul.ulaval.ca		Simard, Martin/0000-0002-3189-9309	CIHR [MOP-12182]; Canadian Institutes of Health Research (CIHR) [STP-53924]; Centre for Host-Parasite Interactions (CHPI)	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Centre for Host-Parasite Interactions (CHPI)	This work was supported by CIHR operating grant MOP-12182 awarded to BP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to Dr Osvaldo de Melo Neto for providing us with an antibody against the mitochondrial HSP70 protein. PP was a recipient of a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program STP-53924 and the Centre for Host-Parasite Interactions (CHPI). M.J.S. is a Fonds de Recherche du Quebec-Sante Junior 2 Scholar supported by CIHR. BP is a member of the Centre for Host-Parasite Interactions 'Programme Regroupements Strategiques' of the Fonds de Quebec pour la Recherche sur la Nature et les Technologies.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Bringaud F, 2007, PLOS PATHOG, V3, P1291, DOI 10.1371/journal.ppat.0030136; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Campos RM, 2008, MOL BIOCHEM PARASIT, V160, P157, DOI 10.1016/j.molbiopara.2008.04.013; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chung WJ, 2008, CURR BIOL, V18, P795, DOI 10.1016/j.cub.2008.05.006; Cox DN, 2000, DEVELOPMENT, V127, P503; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; DaRocha WD, 2004, MOL BIOCHEM PARASIT, V133, P175, DOI 10.1016/j.molbiopara.2003.10.005; Das M, 2001, J CELL SCI, V114, P2461; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dumas C, 2006, EUKARYOT CELL, V5, P2033, DOI 10.1128/EC.00147-06; Foucher AL, 2006, J PROTEOME RES, V5, P1741, DOI 10.1021/pr060081j; Silva MRG, 2010, GENE, V466, P26, DOI 10.1016/j.gene.2010.06.012; GENSKE JE, 1991, MOL CELL BIOL, V11, P240, DOI 10.1128/MCB.11.1.240; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; GueirosFilho FJ, 1996, MOL CELL BIOL, V16, P5655; Haile S, 2007, CURR OPIN MICROBIOL, V10, P569, DOI 10.1016/j.mib.2007.10.001; HAJDUK SL, 1993, FASEB J, V7, P54, DOI 10.1096/fasebj.7.1.8422975; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lim AK, 2009, J CELL BIOL, V186, P333, DOI 10.1083/jcb.200904063; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; McNicoll F, 2005, J BIOL CHEM, V280, P35238, DOI 10.1074/jbc.M507511200; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Muller M, 2010, NUCLEIC ACIDS RES, V38, P5867, DOI 10.1093/nar/gkq349; Noll TM, 1997, MOL BIOCHEM PARASIT, V84, P215, DOI 10.1016/S0166-6851(96)02801-0; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Ohrt T, 2012, CURR TOP MED CHEM, V12, P79, DOI 10.2174/156802612798919132; Olivier M, 2012, MICROBES INFECT; Padmanabhan PK, 2012, CELL DEATH DIFFER, V19, P1972, DOI 10.1038/cdd.2012.85; PAPADOPOULOU B, 1994, MOL BIOCHEM PARASIT, V65, P39, DOI 10.1016/0166-6851(94)90113-9; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Rochette A, 2009, MOL BIOCHEM PARASIT, V165, P32, DOI 10.1016/j.molbiopara.2008.12.012; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Rodriguez-Contreras D, 2006, J BIOL CHEM, V281, P20068, DOI 10.1074/jbc.M603265200; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Sambrook J, 2001, MOL CLONING LAB MANU; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P1168, DOI 10.1128/AAC.45.4.1168-1173.2001; Sereno D, 2001, ANTIMICROB AGENTS CH, V45, P2064, DOI 10.1128/AAC.45.7.2064-2069.2001; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; Simonelig M, 2011, RNA BIOL, V8; Soto M, 2003, PARASITOLOGY, V127, P95, DOI 10.1017/S0031182003003445; Soto M, 1997, MOL BIOCHEM PARASIT, V90, P439, DOI 10.1016/S0166-6851(97)00178-3; Soto M, 1996, BIOCHEM J, V318, P813, DOI 10.1042/bj3180813; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52612	10.1371/journal.pone.0052612	http://dx.doi.org/10.1371/journal.pone.0052612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285111	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800081
J	Rouault, A; Banneau, G; MacGrogan, G; Jones, N; Elarouci, N; Barouk-Simonet, E; Venat, L; Coupier, I; Letouze, E; de Reynies, A; Bonnet, F; Iggo, R; Sevenet, N; Longy, M				Rouault, Audrey; Banneau, Guillaume; MacGrogan, Gaetan; Jones, Natalie; Elarouci, Nabila; Barouk-Simonet, Emmanuelle; Venat, Laurence; Coupier, Isabelle; Letouze, Eric; de Reynies, Aurelien; Bonnet, Francoise; Iggo, Richard; Sevenet, Nicolas; Longy, Michel			Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER; EXPRESSION PROFILES; GENE; PATTERNS; CARRIERS; DISPLAY	Introduction: Germline BRCA1 or BRCA2 mutations account for 20-30% of familial clustering of breast cancer. The main indication for BRCA2 screening is currently the family history but the yield of mutations identified in patients selected this way is low. Methods: To develop more efficient approaches to screening we have compared the gene expression and genomic profiles of BRCA2-mutant breast tumors with those of breast tumors lacking BRCA1 or BRCA2 mutations. Results: We identified a group of 66 genes showing differential expression in our training set of 7 BRCA2-mutant tumors and in an independent validation set of 19 BRCA2-mutant tumors. The differentially expressed genes include a prominent cluster of genes from chromosomes 13 and 14 whose expression is reduced. Gene set enrichment analysis confirmed that genes in specific bands on 13q and 14q showed significantly reduced expression, suggesting that the affected bands may be preferentially deleted in BRCA2-mutant tumors. Genomic profiling showed that the BRCA2-mutant tumors indeed harbor deletions on chromosomes 13q and 14q. To exploit this information we have created a simple fluorescence in situ hybridization (FISH) test and shown that it detects tumors with deletions on chromosomes 13q and 14q. Conclusion: Together with previous reports, this establishes that deletions on chromosomes 13q and 14q are a hallmark of BRCA2-mutant tumors. We propose that FISH to detect these deletions would be an efficient and cost-effective first screening step to identify potential BRCA2-mutation carriers among breast cancer patients without a family history of breast cancer.	[Rouault, Audrey; Banneau, Guillaume; MacGrogan, Gaetan; Jones, Natalie; Bonnet, Francoise; Iggo, Richard; Sevenet, Nicolas; Longy, Michel] Univ Bordeaux, Bergonie Canc Inst, French Natl Inst Hlth & Med Res INSERM, U916, Bordeaux, France; [MacGrogan, Gaetan] Bergonie Canc Inst, Dept Pathol, Bordeaux, France; [Elarouci, Nabila; Letouze, Eric; de Reynies, Aurelien] Ligue Natl Canc, Cartes Ident Tumeurs CIT Program, Paris, France; [Barouk-Simonet, Emmanuelle; Bonnet, Francoise; Sevenet, Nicolas; Longy, Michel] Bergonie Canc Inst, Canc Genet Unit, Bordeaux, France; [Venat, Laurence] Dupuytren Univ Hosp, Dept Med Oncol, Limoges, France; [Coupier, Isabelle] Val dAurelle Reg Canc Ctr, Canc Genet Unit, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; CHU Limoges	Iggo, R (corresponding author), Univ Bordeaux, Bergonie Canc Inst, French Natl Inst Hlth & Med Res INSERM, U916, Bordeaux, France.	r.iggo@bordeaux.unicancer.fr	Jones, Natalie/L-2455-2014; Iggo, Richard/G-3546-2014; Letouzé, Eric/AAP-9924-2020; Feillet, Francois/A-3648-2017; de Reyniès, Aurélien/Q-8640-2017	Letouzé, Eric/0000-0002-6369-2839; Feillet, Francois/0000-0002-8717-469X; de Reyniès, Aurélien/0000-0002-1328-5290; MacGrogan, Gaetan/0000-0002-3483-9758	Charente-Maritime committee of the French Cancer League; Pyrenees-Atlantiques committee of the French Cancer League; Bergerac Lions Club; French National Research Agency (ANR); French National Cancer League program grant; Ligue nationale contre le cancer	Charente-Maritime committee of the French Cancer League; Pyrenees-Atlantiques committee of the French Cancer League; Bergerac Lions Club; French National Research Agency (ANR)(French National Research Agency (ANR)); French National Cancer League program grant; Ligue nationale contre le cancer(Ligue nationale contre le cancer)	The work was funded by grants from the Charente-Maritime and Pyrenees-Atlantiques committees of the French Cancer League and the Bergerac Lions Club to M. L.; the French National Research Agency (ANR) to R. I.; and a French National Cancer League program grant to M. L. and R. I. This work is part of the national program Cartes d'Identite des Tumeurs (CIT) [http://cit.ligue-cancer.net/] funded and developed by the Ligue nationale contre le cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banneau G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2626; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; CAPweb, COP NUMB ARR AN PLAT; COLLINS N, 1995, ONCOGENE, V10, P1673; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fackenthal JD, 2007, NAT REV CANCER, V7, P937, DOI 10.1038/nrc2054; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonsson G, 2005, CANCER RES, V65, P7612, DOI 10.1158/0008-5472.CAN-05-0570; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Joosse SA, 2012, BREAST CANCER RES TR, V132, P379, DOI 10.1007/s10549-010-1016-7; Moller P, 2007, EUR J CANCER, V43, P1713, DOI 10.1016/j.ejca.2007.04.023; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; R Core Team, 2012, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stefansson OA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2334; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tirkkonen M, 1997, CANCER RES, V57, P1222; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234	28	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52079	10.1371/journal.pone.0052079	http://dx.doi.org/10.1371/journal.pone.0052079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284877	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800028
J	Sanchez-Chavez, G; Pena-Rangel, MT; Riesgo-Escovar, JR; Martinez-Martinez, A; Salceda, R				Sanchez-Chavez, Gustavo; Teresa Pena-Rangel, Ma.; Riesgo-Escovar, Juan R.; Martinez-Martinez, Alejandro; Salceda, Rocio			Insulin Stimulated-Glucose Transporter Glut 4 Is Expressed in the Retina	PLOS ONE			English	Article							RECEPTOR BETA-SUBUNIT; IN-VIVO REGULATION; PLASMA-MEMBRANE; OUTER SEGMENTS; GROWTH-FACTORS; RAT RETINA; HUMAN EYE; PIGMENT EPITHELIUM; DIABETIC-RATS; MOUSE-BRAIN	The vertebrate retina is a very metabolically active tissue whose energy demands are normally met through the uptake of glucose and oxygen. Glucose metabolism in this tissue relies upon adequate glucose delivery from the systemic circulation. Therefore, glucose transport depends on the expression of glucose transporters. Here, we show retinal expression of the Glut 4 glucose transporter in frog and rat retinas. Immunohistochemistry and in situ hybridization studies showed Glut 4 expression in the three nuclear layers of the retina: the photoreceptor, inner nuclear and ganglionar cell layers. In the rat retina immunoprecipitation and Western blot analysis revealed a protein with an apparent molecular mass of 45 kDa. C-14-glucose accumulation by isolated rat retinas was significantly enhanced by physiological concentrations of insulin, an effect blocked by inhibitors of phosphatidyl-inositol 3-kinase (PI3K), a key enzyme in the insulin-signaling pathway in other tissues. Also, we observed an increase in 3(H)-cytochalasin binding sites in the presence of insulin, suggesting an increase in transporter recruitment at the cell surface. Besides, insulin induced phosphorylation of Akt, an effect also blocked by PI3K inhibition. Expression of Glut 4 was not modified in retinas of a type 1 diabetic rat model. To our knowledge, our results provide the first evidence of Glut4 expression in the retina, suggesting it as an insulin-responsive tissue.	[Sanchez-Chavez, Gustavo; Salceda, Rocio] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico; [Teresa Pena-Rangel, Ma.; Riesgo-Escovar, Juan R.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Dept Neurobiol Desarrollo & Neurofisiol, Queretaro, Mexico; [Martinez-Martinez, Alejandro] Univ Autonoma Ciudad Juarez, Juarez, Chihuahua, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de Ciudad Juarez	Salceda, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico.	rsalceda@ifc.unam.mx	Martinez-Martinez, Alejandro/N-1161-2018	Martinez-Martinez, Alejandro/0000-0003-3448-910X; Sanchez-Chavez, Gustavo/0000-0002-1331-9358	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica UNAM/DGAPA/PAPIIT [IN207810-3]; Consejo Nacional de Ciencia y Tecnologia CONACYT [81864]	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica UNAM/DGAPA/PAPIIT; Consejo Nacional de Ciencia y Tecnologia CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially supported by a grant from the Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacione Innovacion Tecnologica UNAM/DGAPA/PAPIIT (IN207810-3) to Rocio Salceda; and from Consejo Nacional de Ciencia y Tecnologia CONACYT protect # 81864 to Juan Rafael Riesgo-Escovar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Velazquez-Flores MA, 2011, SYNAPSE, V65, P1231, DOI 10.1002/syn.20963; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barrett D, 2003, J NEUROSCI, V23, P5740; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; BETZ AL, 1983, EXP EYE RES, V36, P269, DOI 10.1016/0014-4835(83)90011-8; Bugner V, 2011, DEV DYNAM, V240, P1705, DOI 10.1002/dvdy.22659; Choeiri C, 2006, BEHAV BRAIN RES, V172, P233, DOI 10.1016/j.bbr.2006.05.005; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DEPABLO F, 1995, TRENDS NEUROSCI, V18, P143, DOI 10.1016/0166-2236(95)93892-2; Diaz B, 2000, DEVELOPMENT, V127, P1641; Diggs-Andrews KA, 2010, DIABETES, V59, P2271, DOI 10.2337/db10-0401; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; FRANK RN, 1995, PROG RETIN EYE RES, V14, P361, DOI 10.1016/1350-9462(94)00011-4; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; Graymore C., 1970, BIOCH RETINA; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; HARDIN DS, 1993, METABOLISM, V42, P1310, DOI 10.1016/0026-0495(93)90130-G; HAYES KC, 1975, SCIENCE, V188, P949, DOI 10.1126/science.1138364; HSU SC, 1991, J BIOL CHEM, V266, P21745; Im SS, 2007, IUBMB LIFE, V59, P134, DOI 10.1080/15216540701313788; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; KING GL, 1985, J CLIN INVEST, V75, P1028, DOI 10.1172/JCI111764; KOIVISTO VA, 1993, J APPL PHYSIOL, V74, P1755, DOI 10.1152/jappl.1993.74.4.1755; KUMAGAI AK, 1994, INVEST OPHTH VIS SCI, V35, P2887; LI XB, 1994, EXP EYE RES, V59, P351, DOI 10.1006/exer.1994.1117; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Piroli GG, 2007, NEUROENDOCRINOLOGY, V85, P71, DOI 10.1159/000101694; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; Rajala RVS, 2001, INVEST OPHTH VIS SCI, V42, P3110; ROSENZWEIG SA, 1990, J BIOL CHEM, V265, P18030; Salceda R, 1998, NEUROCHEM RES, V23, P893, DOI 10.1023/A:1022467230259; Salceda R, 1999, NEUROCHEM INT, V35, P301, DOI 10.1016/S0197-0186(99)00072-8; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanchez-Chavez G, 2008, NEUROCHEM RES, V33, P1301, DOI 10.1007/s11064-007-9583-7; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TAKATA K, 1990, BIOCHEM BIOPH RES CO, V173, P67, DOI 10.1016/S0006-291X(05)81022-8; Pena-Rangel MT, 2008, NEUROREPORT, V19, P1295, DOI 10.1097/WNR.0b013e32830a9618; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Vilchis C, 1996, NEUROCHEM INT, V28, P213, DOI 10.1016/0197-0186(95)00068-2; WALDBILLIG RJ, 1987, EXP EYE RES, V45, P837, DOI 10.1016/S0014-4835(87)80100-8; WATANABE T, 1994, BRAIN RES, V655, P128, DOI 10.1016/0006-8993(94)91606-3	47	18	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52959	10.1371/journal.pone.0052959	http://dx.doi.org/10.1371/journal.pone.0052959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285235	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800109
J	Abella, V; Valladares, M; Rodriguez, T; Haz, M; Blanco, M; Tarrio, N; Iglesias, P; Aparicio, LA; Figueroa, A				Abella, Vanessa; Valladares, Manuel; Rodriguez, Teresa; Haz, Mar; Blanco, Moises; Tarrio, Nuria; Iglesias, Pilar; Aparicio, Luis A.; Figueroa, Angelica			miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression	PLOS ONE			English	Article							MOLECULE E-CADHERIN; MICRORNA TARGETS; BLADDER-CANCER; ADHESION; PROTEIN; MIRNA; RNA; INVASIVENESS; INHIBITION; MECHANISM	Gene expression is potently regulated through the action of microRNAs (miRNAs). Here, we present evidence of a miRNA regulating Hakai protein. Hakai was discovered as an E3 ubiquitin-ligase that mediates the posttranslational downregulation of E-cadherin, a major component of adherens junctions in epithelial cells and a potent tumour suppressor. Recent data have provided evidence that Hakai affects cell proliferation in an E-cadherin-independent manner, thus revealing a role for Hakai in the early stages of tumour progression. Furthermore, Hakai is highly up-regulated in human colon adenocarcinomas compared to normal tissues. However, the molecular mechanisms that regulate Hakai abundance are unknown. We identified two putative sites of miR-203 interaction on the Hakai mRNA, in its 3'-untranslated region (UTR). In several human carcinoma cell lines tested, overexpression of a miR-203 precursor (Pre-miR-203) reduced Hakai abundance, while inhibiting miR-203 by using an antisense RNA (Anti-miR-203) elevated Hakai levels. The repressive influence of miR-203 on the Hakai 3'-UTR was confirmed using heterologous reporter constructs. In keeping with Hakai's proliferative influence, Anti-miR-203 significantly increased cell number and BrdU incorporation, while Pre-miR-203 reduced these parameters. Importantly, the growth-promoting effects of anti-miR-203 required the presence of Hakai, because downregulation of Hakai by siRNA suppressed its proliferative action. Finally, in situ hybridization showed that miR-203 expression is attenuated in colon tumour tissues compared to normal colon tissues, suggesting that miR-203 could be a potential new prognostic marker and therapeutic target to explore in colon cancer. In conclusion, our findings reveal, for the first time, a post-transcriptional regulator of Hakai expression. Furthermore, by lowering Hakai abundance, miR-203 also reduces Hakai-regulated-cell division.	[Abella, Vanessa; Valladares, Manuel; Rodriguez, Teresa; Haz, Mar; Blanco, Moises; Aparicio, Luis A.; Figueroa, Angelica] Complexo Hosp Univ A Coruna CHUAC SERGAS, Inst Invest Biomed A Coruna INIBIC, Translat Canc Res Grp, La Coruna, Spain; [Valladares, Manuel; Aparicio, Luis A.] CHUAC SERGAS, Med Oncol Unit, La Coruna, Spain; [Tarrio, Nuria] Hosp Univ Marques de Valdecilla, Clin Trials Serv, Santander, Cantabria, Spain; [Iglesias, Pilar] CHUAC SERGAS, Dept Pathol, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Hospital Universitario Marques de Valdecilla (HUMV); Complejo Hospitalario Universitario A Coruna	Figueroa, A (corresponding author), Complexo Hosp Univ A Coruna CHUAC SERGAS, Inst Invest Biomed A Coruna INIBIC, Translat Canc Res Grp, La Coruna, Spain.	angelica.figueroa.conde-valvis@sergas.es	Figueroa, Angelica/ABD-7705-2020; Martín, Teresa Rodríguez/GZL-1938-2022; Blanco-Calvo, Moisés/F-5476-2013; Valladares-Ayerbes, Manuel/K-8986-2014	Figueroa, Angelica/0000-0001-5530-5213; Blanco-Calvo, Moisés/0000-0001-9153-6895; Valladares-Ayerbes, Manuel/0000-0002-7950-9584; Abella Cajigal, Vanessa/0000-0002-3658-7208	Conselleria de Sanidade from Xunta de Galicia, Spain [PS09/24]; Secretaria Xeral I+D+I from Xunta de Galicia, Spain [10CSA916023PR]; Rede Galega de Investigacion sobre Cancro Colorrectal (REGICC), Xunta de Galicia, Spain; Instituto de Salud Carlos III, Spain [CA09/00116]; Secretaria Xeral I+D+I, Xunta de Galicia, Spain [IPP.08-07]	Conselleria de Sanidade from Xunta de Galicia, Spain; Secretaria Xeral I+D+I from Xunta de Galicia, Spain; Rede Galega de Investigacion sobre Cancro Colorrectal (REGICC), Xunta de Galicia, Spain; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Secretaria Xeral I+D+I, Xunta de Galicia, Spain(Xunta de Galicia)	This work is supported by a grant from Conselleria de Sanidade (PS09/24) and from Secretaria Xeral I+D+I, (10CSA916023PR), both from Xunta de Galicia, Spain. V.A. is the recipient of a grant from Secretaria Xeral I+D+I, Xunta de Galicia, Spain (10CSA916023PR). T. R. was the recipient of a grant from Rede Galega de Investigacion sobre Cancro Colorrectal (REGICC), Xunta de Galicia, Spain. M. H. is supported by Instituto de Salud Carlos III, Spain (CA09/00116). A. F. is the recipient of a grant from Secretaria Xeral I+D+I, Xunta de Galicia, Spain (IPP.08-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, P NATL ACAD SCI USA, V105, P20297, DOI 10.1073/pnas.0809376106; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Aparicio LA, 2012, CANC METASTASIS REV; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berx G., 2009, COLD SPRING HARB PER, V1; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bo JJ, 2011, FEBS J, V278, P786, DOI 10.1111/j.1742-4658.2010.07997.x; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fan SJ, 2001, ONCOGENE, V20, P77, DOI 10.1038/sj.onc.1204073; Figueroa A, 2009, CELL CYCLE, V8, P3648, DOI 10.4161/cc.8.22.9909; Figueroa A, 2009, MOL BIOL CELL, V20, P3533, DOI 10.1091/mbc.E08-08-0845; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Gong E, 2010, CANC SCI; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartsock A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037476; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Kaido M, 2009, GENES CELLS, V14, P1067, DOI 10.1111/j.1365-2443.2009.01335.x; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JA, 2011, CANCER LETT, V304, P52, DOI 10.1016/j.canlet.2011.02.003; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Mukherjee M., 2012, EMBO J, DOI emboj2011496; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rodriguez-Rigueiro T, 2011, PROTEOMICS; Rodriguez-Rigueiro T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-474; Saini S, 2011, CANCER PREV RES, V4, P1698, DOI 10.1158/1940-6207.CAPR-11-0267; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	48	31	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52568	10.1371/journal.pone.0052568	http://dx.doi.org/10.1371/journal.pone.0052568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285092	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500198
J	Chan, DW; Hui, WWY; Cai, PCH; Liu, MX; Yung, MMH; Mak, CSL; Leung, THY; Chan, KKL; Ngan, HYS				Chan, David W.; Hui, Winnie W. Y.; Cai, Patty C. H.; Liu, Michelle X.; Yung, Mingo M. H.; Mak, Celia S. L.; Leung, Thomas H. Y.; Chan, Karen K. L.; Ngan, Hextan Y. S.			Targeting GRB7/ERK/FOXM1 Signaling Pathway Impairs Aggressiveness of Ovarian Cancer Cells	PLOS ONE			English	Article							CYCLIC PEPTIDE INHIBITOR; GROWTH-FACTOR RECEPTOR; RAF-MEK-ERK; TRANSCRIPTION FACTOR; TRANSDUCTION PROTEIN; ESOPHAGEAL-CARCINOMA; GRB7 FAMILY; SH2 DOMAIN; LOW-GRADE; IN-VITRO	Ovarian cancer is a highly lethal disease with poor prognosis and especially in high-grade tumor. Emerging evidence has reported that aberrant upregulation and activation of GRB7, ERK as well as FOXM1 are closely associated with aggresivenesss of human cancers. However, the interplay between these factors in the pathogenesis of human cancers still remains unclear. In this study, we found that GRB7 (P<0.0001), ERK phosphorylation (P<0.0001) and FOXM1 (P = 0.001) were frequently increased and associated with high-grade tumors, as well as a high tendency in association with advanced stage ovarian cancer by immunohistochemical analysis. Intriguingly, the expressions of GRB7 (P<0.0001), ERK phosphorylation (P<0.001) and FOXM1 (P<0.001) showed a significant stepwise increase pattern along Grade 1 to Grade 3 ovarian cancers. Biochemical studies using western blot analysis demonstrated that enforced expression or knockdown of GRB7 showed GRB7 could elevate the levels of ERK phosphorylation and FOXM1, whereas enforced expression of FOXM1 could not alter levels of GRB7 and ERK phosphorylation. But inhibition of ERK signaling by U0126 or PD98059 could reduce the level of FOXM1 in GRB7-overexpressing ovarian cancer cells, suggesting that GRB7, ERK and FOXM1 are regulated orderly. Moreover, inhibition of ERK activity by U0126 or PD98059, or decreased FOXM1 expression by Thiostrepton significantly inhibited cell migration/invasion, tumor growth in vitro and in vivo. Collectively, our findings confer that targeting GRB7/ERK/FOXM1 signaling cascade may be a promising molecular therapeutic choice in combating ovarian cancer.	[Chan, David W.; Hui, Winnie W. Y.; Cai, Patty C. H.; Liu, Michelle X.; Yung, Mingo M. H.; Mak, Celia S. L.; Leung, Thomas H. Y.; Chan, Karen K. L.; Ngan, Hextan Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Chan, DW (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; hysngan@hku.hk	Chan, David/O-9896-2018; YUNG, Mingo Ming Ho/AHB-5775-2022; Chan, Karen/E-4041-2015	Chan, David/0000-0002-6951-3467; YUNG, Mingo Ming Ho/0000-0003-0903-1164; Chan, Karen/0000-0001-9947-4713; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation	Wong Check She Charitable Foundation	This study was supported by the Wong Check She Charitable Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambaye ND, 2011, J MOL BIOL, V412, P397, DOI 10.1016/j.jmb.2011.07.030; Ambaye ND, 2011, BIOORGAN MED CHEM, V19, P693, DOI 10.1016/j.bmc.2010.10.030; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bristow RE, 2010, GYNECOL ONCOL, V118, P262, DOI 10.1016/j.ygyno.2010.05.025; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chan DW, 2008, CARCINOGENESIS, V29, P1742, DOI 10.1093/carcin/bgn167; CY Koo, 2011, BIOCH BIOPHYS ACTA; D'Alo D, 2010, EUR J GYNAECOL ONCOL, V31, P174; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Giricz O, 2011, BREAST CANC RES TREA; Gunzburg MJ, 2012, J MOL RECOGNIT, V25, P57, DOI 10.1002/jmr.2148; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Johnson TR, 2008, MOL CANCER RES, V6, P1639, DOI 10.1158/1541-7786.MCR-08-0052; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Lo HW, 2010, CURR CANCER DRUG TAR, V10, P840, DOI 10.2174/156800910793357970; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; McCubrey JA, 2010, EXPERT OPIN EMERG DR, V15, P203, DOI 10.1517/14728210903282760; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; Pero SC, 2007, BRIT J CANCER, V96, P1520, DOI 10.1038/sj.bjc.6603732; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Pero Stephanie C, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006227; Porter CJ, 2007, BIOPOLYMERS, V88, P174, DOI 10.1002/bip.20667; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Priller M, 2011, CLIN CANCER RES, V17, P6791, DOI 10.1158/1078-0432.CCR-11-1214; Ramsey B, 2011, BREAST CANCER RES TR, V127, P659, DOI 10.1007/s10549-010-1010-0; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Saad Antonio F., 2010, Hormones & Cancer, V1, P277, DOI 10.1007/s12672-010-0054-2; Schneiderman D, 1999, APOPTOSIS, V4, P271, DOI 10.1023/A:1008186323178; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Tanaka S, 2000, J CELL PHYSIOL, V183, P411, DOI 10.1002/(SICI)1097-4652(200006)183:3<411::AID-JCP14>3.0.CO;2-Z; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tanaka S, 1997, CANCER RES, V57, P28; Trujillo JI, 2011, EXPERT OPIN THER PAT, V21, P1045, DOI 10.1517/13543776.2011.577068; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Walch A, 2004, INT J CANCER, V112, P747, DOI 10.1002/ijc.20411; Wang YJ, 2010, CLIN CANCER RES, V16, P2529, DOI 10.1158/1078-0432.CCR-10-0018; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Wu QF, 2010, ACTA PHARMACOL SIN, V31, P361, DOI 10.1038/aps.2010.4; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zebisch A, 2007, CURR MED CHEM, V14, P601, DOI 10.2174/092986707780059670; Zhang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029902; ZYLBERBERG B, 1991, PRESSE MED, V20, P1320	50	41	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52578	10.1371/journal.pone.0052578	http://dx.doi.org/10.1371/journal.pone.0052578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285101	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500205
J	Hobson, KA; Anderson, RC; Soto, DX; Wassenaar, LI				Hobson, Keith A.; Anderson, R. Charles; Soto, David X.; Wassenaar, Leonard I.			Isotopic Evidence That Dragonflies (Pantala flavescens) Migrating through the Maldives Come from the Northern Indian Subcontinent	PLOS ONE			English	Article							HYDROGEN	Large numbers of the Globe Skimmer dragonfly (Pantala flavescens) appear in the Maldives every October-December. Since they cannot breed on these largely waterless islands, it has recently been suggested that they are "falling out" during a trans-oceanic flight from India to East Africa. In addition, it has been suggested that this trans-oceanic crossing is just one leg of a multi-generational migratory circuit covering about 14,000-18,000 km. The dragonflies are presumed to accomplish this remarkable feat by riding high-altitude winds associated with the Inter-tropical Convergence Zone (ITCZ). While there is considerable evidence for this migratory circuit, much of that evidence is circumstantial. Recent developments in the application of stable isotope analyses to track migratory dragonflies include the establishment of direct associations between dragonfly wing chitin delta H-2 values with those derived from long-term delta H-2 precipitation isoscapes. We applied this approach by measuring wing chitin delta H-2 values in 49 individual Pantala flavescens from the November-December migration through the Maldives. Using a previously established spatial calibration algorithm for dragonflies, the mean wing delta H-2 value of -117 +/- 16 parts per thousand corresponded to a predicted mean natal ambient water source of -81 parts per thousand, which resulted in a probabilistic origin of northern India, and possibly further north and east. This strongly suggests that the migratory circuit of this species in this region is longer than previously suspected, and could possibly involve a remarkable trans-Himalayan high-altitude traverse.	[Hobson, Keith A.; Soto, David X.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Anderson, R. Charles] Manta Marine Pvt Ltd, Male, Maldives; [Soto, David X.] Univ New Brunswick, Canadian Rivers Inst, Fredericton, NB, Canada; [Soto, David X.] Univ New Brunswick, Dept Biol, Fredericton, NB, Canada	Environment & Climate Change Canada; University of New Brunswick; University of New Brunswick	Hobson, KA (corresponding author), Environm Canada, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Hobson, Keith/Q-9306-2019; Soto, David X./B-2017-2018; Wassenaar, Leonard/AAY-7081-2020	Soto, David X./0000-0003-4210-293X; Wassenaar, Leonard/0000-0001-5532-0771	Environment Canada	Environment Canada(CGIAR)	The work was supported by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2009, J TROP ECOL, V25, P347, DOI 10.1017/S0266467409006087; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Corbet PS, 2004, DRAGONFLIES BEHAVIOR; Fein JS, 1987, MONSOON; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2012, METHODS ECOL EVOL, V3, P766, DOI 10.1111/j.2041-210X.2012.00202.x; Kumar A., 1984, Annals of Entomology (Dehra Dun), V2, P43; Solensky MJ, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P79; Suhling F, 2004, HYDROBIOLOGIA, V528, P75, DOI 10.1007/s10750-004-3047-8; Vick G.S., 1989, Opuscula Zoologica Fluminensia, P1; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; WOJTUSIAK J, 1974, Odonatologica, V3, P137	14	53	60	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52594	10.1371/journal.pone.0052594	http://dx.doi.org/10.1371/journal.pone.0052594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285106	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500207
J	Laddha, NC; Dwivedi, M; Begum, R				Laddha, Naresh C.; Dwivedi, Mitesh; Begum, Rasheedunnisa			Increased Tumor Necrosis Factor (TNF)-alpha and Its Promoter Polymorphisms Correlate with Disease Progression and Higher Susceptibility towards Vitiligo	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TNF-ALPHA POLYMORPHISMS; GENERALIZED VITILIGO; AUTOIMMUNE-DISEASES; LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; MONOCLONAL-ANTIBODY; GUJARAT POPULATION; ANTIOXIDANT STATUS; CLASS-II	Tumor Necrosis Factor (TNF)-alpha, is a paracrine inhibitor of melanocytes, which plays a critical role in the pathogenesis of several autoimmune diseases including vitiligo, as abnormal immune responses have frequently been observed in vitiligo patients. Moreover, vitiligo patients show higher lesion levels of TNF-alpha. Genetic polymorphisms in the promoter region of TNF-alpha are involved in the regulation of its expression. The present study explores TNF-alpha promoter polymorphisms and correlates them with TNF-alpha transcript and protein levels in vitiligo patients and controls of Gujarat along with its effect on disease onset and progression. PCR-RFLP technique was used for genotyping of these polymorphisms in 977 vitiligo patients and 990 controls. TNF-alpha transcript and protein levels were measured by Real time PCR and ELISA respectively. The genotype and allele frequencies for the investigated polymorphisms were significantly associated with vitiligo patients. The study revealed significant increase in TNF-alpha transcript and protein levels in vitiligo patients compared to controls. In particular, haplotypes: AATCC, AACCT, AGTCT, GATCT, GATCC and AGCCT were found to increase the TNF-alpha levels in vitiligo patients. Analysis of TNF-alpha levels based on the gender and disease progression suggests that female patients and patients with active vitiligo had higher levels of TNF-alpha. Also, the TNF-alpha levels were high in patients with generalized vitiligo as compared to localized vitiligo. Age of onset analysis of the disease suggests that the haplotypes: AACAT, AACCT, AATCC and AATCT had a profound effect in the early onset of the disease. Moreover, the analysis suggests that female patients had an early onset of vitiligo. Overall, our results suggest that TNF-alpha promoter polymorphisms may be genetic risk factors for susceptibility and progression of the disease. The up-regulation of TNF-alpha transcript and protein levels in individuals with susceptible haplotypes advocates the crucial role of TNF-alpha in autoimmune pathogenesis of vitiligo.	[Laddha, Naresh C.; Dwivedi, Mitesh; Begum, Rasheedunnisa] Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India	Maharaja Sayajirao University Baroda	Begum, R (corresponding author), Maharaja Sayajirao Univ Baroda, Dept Biochem, Fac Sci, Vadodara, Gujarat, India.	rasheedunnisab@yahoo.co.in	Begum, Rasheedunnisa/AAF-2981-2020; Dwivedi, Mitesh/Q-1276-2019	Dwivedi, Mitesh/0000-0001-8497-0765; BEGUM, RASHEEDUNNISA/0000-0003-3446-0980	UGC, New Delhi, India [36-158/2008(SR)]; DBT, New Delhi, India [BT/PR9024/MED/12/332/2007]; Council of Scientific and Industrial Research (New Delhi)	UGC, New Delhi, India(University Grants Commission, India); DBT, New Delhi, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (New Delhi)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants to RB ("F. No. 36-158/2008(SR)"), UGC, New Delhi, India and RB ("BT/PR9024/MED/12/332/2007") DBT, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all vitiligo patients and control subjects for their participation in this study. NCL thanks the Council of Scientific and Industrial Research (New Delhi) for awarding SRF.	Afshan G, 2012, CLIN LAB, V58, P567; Agrawal D, 2004, PIGM CELL RES, V17, P289, DOI 10.1111/j.1600-0749.2004.00149.x; ALBADRI AMT, 1993, J PATHOL, V169, P203, DOI 10.1002/path.1711690205; Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayley JP, 2001, CYTOKINE, V14, P316, DOI 10.1006/cyto.2001.0902; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; DAS S K, 1985, Genetic Epidemiology, V2, P71; Dwivedi M, 2009, BRIT J DERMATOL, V161, P63, DOI 10.1111/j.1365-2133.2009.09140.x; Dwivedi M, 2008, PIGM CELL MELANOMA R, V21, P407, DOI 10.1111/j.1755-148X.2008.00462.x; Dwivedi M, 2011, PIGM CELL MELANOMA R, V24, P737, DOI 10.1111/j.1755-148X.2011.00892.x; ELLIOTT MJ, 1994, LANCET, V344, P1125, DOI 10.1016/S0140-6736(94)90632-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feldmann M, 1998, Int Rev Immunol, V17, P217, DOI 10.3109/08830189809084493; Ferguson LR, 2008, WORLD J GASTROENTERO, V14, P4652, DOI 10.3748/wjg.14.4652; FONG CLW, 1994, NUCLEIC ACIDS RES, V22, P1108, DOI 10.1093/nar/22.6.1108; Grimes PE, 2004, J AM ACAD DERMATOL, V51, P52, DOI 10.1016/j.jaad.2003.12.031; Gupta S, 2006, AUTOIMMUN REV, V5, P264, DOI 10.1016/j.autrev.2005.09.007; Huang Carol L, 2002, Am J Clin Dermatol, V3, P301, DOI 10.2165/00128071-200203050-00001; Imran M, 2012, BRIT J DERMATOL, V167, P314, DOI 10.1111/j.1365-2133.2012.11000.x; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; Kamali-Sarvestani E, 2007, J INVEST ALLERG CLIN, V17, P361; Kemp E H, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003362; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Kim SM, 1998, INT J DERMATOL, V37, P908, DOI 10.1046/j.1365-4362.1998.00549.x; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kumar R, 2007, TISSUE ANTIGENS, V69, P557, DOI 10.1111/j.1399-0039.2007.00817.x; Laberge G, 2005, PIGM CELL RES, V18, P300, DOI 10.1111/j.1600-0749.2005.00242.x; Laddha NC, 2008, J DERMATOL SCI, V49, P260, DOI 10.1016/j.jdermsci.2007.10.002; Li CY, 2007, J INVEST DERMATOL, V127, P1886, DOI 10.1038/sj.jid.5700822; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martinez-Esparza M, 1998, EUR J BIOCHEM, V255, P139, DOI 10.1046/j.1432-1327.1998.2550139.x; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; MORELLI JG, 1993, J INVEST DERMATOL, V100, pS191; Moretti S, 2002, PIGM CELL RES, V15, P87, DOI 10.1034/j.1600-0749.2002.1o049.x; Namian AM, 2009, ARCH DERMATOL RES, V301, P21, DOI 10.1007/s00403-008-0904-8; Noble JA, 2006, HUM IMMUNOL, V67, P999, DOI 10.1016/j.humimm.2006.10.002; Nordlund JJ, 1997, CLIN DERMATOL, V15, P875, DOI 10.1016/S0738-081X(97)00128-4; Panchanathan R, 2013, MOL IMMUNOL, V53, P15, DOI 10.1016/j.molimm.2012.06.013; Rahman P, 2006, ANN RHEUM DIS, V65, P919, DOI 10.1136/ard.2005.039164; Rosenberg SA, 1997, IMMUNOL TODAY, V18, P175, DOI 10.1016/S0167-5699(97)84664-6; SCHALLREUTER KU, 1991, J INVEST DERMATOL, V97, P1081, DOI 10.1111/1523-1747.ep12492612; Shajil E. M., 2006, Indian Journal of Dermatology, V51, P100; Shajil E. M., 2006, Indian Journal of Experimental Biology, V44, P526; Shajil EM, 2006, PIGM CELL RES, V19, P179, DOI 10.1111/j.1600-0749.2006.00299.x; Shajil EM, 2007, THESIS MS U BARODA V; Sharma S, 2008, CLIN EXP IMMUNOL, V151, P251, DOI 10.1111/j.1365-2249.2007.03564.x; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Simmonds MJ, 2004, GENES IMMUN, V5, P267, DOI 10.1038/sj.gene.6364066; Simon JA, 2008, DERMATOLOGY, V216, P234, DOI 10.1159/000112932; Singh A, 2012, J INVEST DERMATOL, V132, P124, DOI 10.1038/jid.2011.240; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Spritz Richard A., 2008, V10, P244, DOI 10.1159/000131501; Spritz RA, 2007, PIGM CELL RES, V20, P271, DOI 10.1111/j.1600-0749.2007.00384.x; Spritz RA, 2011, J GENET GENOMICS, V38, P271, DOI 10.1016/j.jgg.2011.05.005; Spritz RA, 2010, GENOME MED, V2, DOI 10.1186/gm199; Suarez A, 2005, ANN RHEUM DIS, V64, P1605, DOI 10.1136/ard.2004.035048; Taieb A, 2009, NEW ENGL J MED, V360, P160, DOI 10.1056/NEJMcp0804388; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; Wankowicz-Kalinska A, 2003, LAB INVEST, V83, P683, DOI 10.1097/01.LAB.0000069521.42488.1B; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; Yazici AC, 2006, ARCH DERMATOL RES, V298, P46, DOI 10.1007/s00403-006-0664-2; YOHN JJ, 1990, J INVEST DERMATOL, V95, P233, DOI 10.1111/1523-1747.ep12478093	64	72	73	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52298	10.1371/journal.pone.0052298	http://dx.doi.org/10.1371/journal.pone.0052298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284977	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500138
J	Latasa, MU; Salis, F; Urtasun, R; Garcia-Irigoyen, O; Elizalde, M; Uriarte, I; Santamaria, M; Feo, F; Pascale, RM; Prieto, J; Berasain, C; Avila, MA				Latasa, Maria U.; Salis, Fabiana; Urtasun, Raquel; Garcia-Irigoyen, Oihane; Elizalde, Maria; Uriarte, Iker; Santamaria, Monica; Feo, Francesco; Pascale, Rosa M.; Prieto, Jesus; Berasain, Carmen; Avila, Matias A.			Regulation of Amphiregulin Gene Expression by beta-Catenin Signaling in Human Hepatocellular Carcinoma Cells: A Novel Crosstalk between FGF19 and the EGFR System	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIGAND AMPHIREGULIN; LIVER-CANCER; TUMOR-GROWTH; PATHWAY; TARGET; PROLIFERATION; THERAPIES; TRANSACTIVATION; OVEREXPRESSION	Hepatocellular carcinoma (HCC) is the most prevalent liver tumor and a deadly disease with limited therapeutic options. Dysregulation of cell signaling pathways is a common denominator in tumorigenesis, including hepatocarcinogenesis. The epidermal growth factor receptor (EGFR) signaling system is commonly activated in HCC, and is currently being evaluated as a therapeutic target in combination therapies. We and others have identified a central role for the EGFR ligand amphiregulin (AR) in the proliferation, survival and drug resistance of HCC cells. AR expression is frequently up-regulated in HCC tissues and cells through mechanisms not completely known. Here we identify the beta-catenin signaling pathway as a novel mechanism leading to transcriptional activation of the AR gene in human HCC cells. Activation of beta-catenin signaling, or expression of the T41A beta-catenin active mutant, led to the induction of AR expression involving three specific beta-catenin-Tcf responsive elements in its proximal promoter. We demonstrate that HCC cells expressing the T41A b-catenin active mutant show enhanced proliferation that is dependent in part on AR expression and EGFR signaling. We also demonstrate here a novel cross-talk of the EGFR system with fibroblast growth factor 19 (FGF19). FGF19 is a recently identified driver gene in hepatocarcinogenesis and an activator of b-catenin signaling in HCC and colon cancer cells. We show that FGF19 induced AR gene expression through the beta-catenin pathway in human HCC cells. Importantly, AR up-regulation and EGFR signaling participated in the induction of cyclin D1 and cell proliferation elicited by FGF19. Finally, we demonstrate a positive correlation between FGF19 and AR expression in human HCC tissues, therefore supporting in clinical samples our experimental observations. These findings identify the AR/EGFR system as a key mediator of FGF19 responses in HCC cells involving beta-catenin signaling, and suggest that combined targeting of FGF19 and AR/ EGFR may enhance therapeutic efficacy.	[Latasa, Maria U.; Urtasun, Raquel; Garcia-Irigoyen, Oihane; Elizalde, Maria; Santamaria, Monica; Prieto, Jesus; Berasain, Carmen; Avila, Matias A.] Univ Navarra, Div Hepatol & Gene Therapy, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Salis, Fabiana; Feo, Francesco; Pascale, Rosa M.] Univ Sassari, Div Expt Pathol & Oncol, Dept Clin & Expt Med & Oncol, I-07100 Sassari, Italy; [Uriarte, Iker; Prieto, Jesus; Berasain, Carmen; Avila, Matias A.] Univ Navarra, Ctr Invest Biomed Red el Area Temat Enfermedades, Univ Clin, E-31080 Pamplona, Spain	University of Navarra; University of Sassari; University of Navarra	Berasain, C (corresponding author), Univ Navarra, Div Hepatol & Gene Therapy, Ctr Appl Med Res, E-31080 Pamplona, Spain.	cberasain@unav.es; maavila@unav.es	Uriarte, Iker/AFP-1513-2022; URIARTE, IKER/Z-2161-2019; Garcia-Irigoyen, Oihane/HDM-3461-2022; Latasa, Maria Ujue/Z-2178-2019; M., Elizalde/Z-2691-2019; Santamaria, Monica/H-4737-2013; URTASUN, RAQUEL/AAD-1590-2021; Uriarte, Iker/AFP-1514-2022; Avila, Matias A/Y-6342-2019; Berasain, Carmen/E-4139-2016	URIARTE, IKER/0000-0001-5237-7799; Garcia-Irigoyen, Oihane/0000-0002-9964-3940; Latasa, Maria Ujue/0000-0002-0878-1337; M., Elizalde/0000-0002-7636-1836; Avila, Matias A/0000-0001-6570-3557; Berasain, Carmen/0000-0001-7075-2476; URTASUN, RAQUEL/0000-0003-2332-5361; Prieto, Jesus/0000-0002-1091-9593	Fundacion para la Investigacion Medica Aplicada; UTE project Centro de Investigacion Medica Aplicada; Fondo para la Investigacion Sanitaria (FIS) from Instituto de Salud Carlos III [PI070392, PI070402, PI10/00038, PI10/02642]; Ministerio de Educacion; Instituto de Salud Carlos III, FIS [CP04/00123]; Erasmus Program (European Union); Ministerio de Educacion, Cultura y Deporte, Spain	Fundacion para la Investigacion Medica Aplicada; UTE project Centro de Investigacion Medica Aplicada; Fondo para la Investigacion Sanitaria (FIS) from Instituto de Salud Carlos III; Ministerio de Educacion; Instituto de Salud Carlos III, FIS(Instituto de Salud Carlos IIIEuropean Commission); Erasmus Program (European Union); Ministerio de Educacion, Cultura y Deporte, Spain(Spanish Government)	Work in the authors' laboratory is supported by the agreement between Fundacion para la Investigacion Medica Aplicada and the "UTE project Centro de Investigacion Medica Aplicada". Red Tematica de Investigacion Cooperativa en Cancer RD06 00200061 (CB and MAA), Centro de Investigacion Biomedica en Red en el Area tematica de Enfermedades Hepaticas y Digestivas (JP), Fundacion Echebano, Fundacion Barriede la Maza y Condesa de Fenosa, and grants Fondo para la Investigacion Sanitaria (FIS) PI070392, PI070402, PI10/00038 and PI10/02642 from Instituto de Salud Carlos III. MUL and RU were supported by a "Ramon y Cajal" and a "Torres Quevedo" contract from Ministerio de Educacion, respectively. MS was supported by a contract (CP04/00123) from Instituto de Salud Carlos III, FIS. FS was supported by the Erasmus Program (European Union). ME was supported by a fellowship from Gobierno de Navarra. OGI was supported by a Formacion del Profesorado Universitario fellowship from Ministerio de Educacion, Cultura y Deporte, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Avila MA, 2006, ONCOGENE, V25, P3866, DOI 10.1038/sj.onc.1209550; Bade LK, 2011, J CELL SCI, V124, P3106, DOI 10.1242/jcs.082651; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Baillo A, 2011, J CELL PHYSIOL, V226, P2691, DOI 10.1002/jcp.22620; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Berasain C, 2007, CANCER LETT, V254, P30, DOI 10.1016/j.canlet.2007.01.015; Berasain C, 2004, BBA-MOL BASIS DIS, V1690, P276, DOI 10.1016/j.bbadis.2004.08.002; Berasain C, 2007, LIVER INT, V27, P174, DOI 10.1111/j.1478-3231.2006.01424.x; Berasain Carmen, 2011, Cancers (Basel), V3, P2444, DOI 10.3390/cancers3022444; Blivet-Van Eggelpoel MJ, 2012, J HEPATOL, V57, P108, DOI 10.1016/j.jhep.2012.02.019; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Breuhahn K, 2010, PROG MOL BIOL TRANSL, V97, P251, DOI 10.1016/B978-0-12-385233-5.00009-X; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Calvisi DF, 2012, BBA-REV CANCER, V1826, P215, DOI 10.1016/j.bbcan.2012.04.003; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Castillo J, 2009, GASTROENTEROLOGY, V137, P1805, DOI 10.1053/j.gastro.2009.07.065; Civenni G, 2003, EMBO REP, V4, P166, DOI 10.1038/sj.embor.embor735; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Desbois-Mouthon C, 2001, ONCOGENE, V20, P252, DOI 10.1038/sj.onc.1204064; Desbois-Mouthon C, 2006, INT J CANCER, V119, P2557, DOI 10.1002/ijc.22221; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ezzoukhry Z, 2012, INT J CANC; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; French DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036713; Gauglhofer C, 2011, HEPATOLOGY, V53, P854, DOI 10.1002/hep.24099; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Katoh Y, 2006, INT J MOL MED, V17, P1163; Lee JS, 2006, ONCOGENE, V25, P3801, DOI 10.1038/sj.onc.1209561; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Miyamoto S, 2009, ANTICANCER RES, V29, P823; Monga SPS, 2002, CANCER RES, V62, P2064; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Pardo-Saganta A, 2009, J HEPATOL, V51, P1010, DOI 10.1016/j.jhep.2009.06.030; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; PLOWMAN GD, 1990, MOL CELL BIOL, V10, P1969, DOI 10.1128/MCB.10.5.1969; Poh WJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-14; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013; Torre C, 2011, J HEPATOL, V55, P86, DOI 10.1016/j.jhep.2010.10.021; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; Villanueva A, 2012, CLIN CANCER RES, V18, P1824, DOI 10.1158/1078-0432.CCR-12-0151; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Vivanco I, 2010, CURR OPIN ONCOL, V22, P573, DOI 10.1097/CCO.0b013e32833edbdf; Wege H, 2011, MOL CANCER RES, V9, P1222, DOI 10.1158/1541-7786.MCR-10-0474; Wei Y, 2000, ONCOGENE, V19, P498, DOI 10.1038/sj.onc.1203356; White BD, 2012, GASTROENTEROLOGY, V142, P219, DOI 10.1053/j.gastro.2011.12.001; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469	69	43	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52711	10.1371/journal.pone.0052711	http://dx.doi.org/10.1371/journal.pone.0052711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285165	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500238
J	Mueller, JE; Yaro, S; Ouedraogo, MS; Levina, N; Njanpop-Lafourcade, BM; Tall, H; Idohou, RS; Sanou, O; Kroman, SS; Drabo, A; Nacro, B; Millogo, A; van der Linden, M; Gessner, BD				Mueller, Judith E.; Yaro, Seydou; Ouedraogo, Macaire S.; Levina, Natalia; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Idohou, Regina S.; Sanou, Oumarou; Kroman, Sita S.; Drabo, Aly; Nacro, Boubacar; Millogo, Athanase; van der Linden, Mark; Gessner, Bradford D.			Pneumococci in the African Meningitis Belt: Meningitis Incidence and Carriage Prevalence in Children and Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; BURKINA-FASO; SEROTYPE-1; NASOPHARYNGEAL; SURVEILLANCE; OUTBREAK; AGE	Background: The development of optimal vaccination strategies for pneumococcal conjugate vaccines requires serotype-specific data on disease incidence and carriage prevalence. This information is lacking for the African meningitis belt. Methods: We conducted hospital-based surveillance of acute bacterial meningitis in an urban and rural population of Burkina Faso during 2007-09. Cerebrospinal fluid was evaluated by polymerase chain reaction for species and serotype. In 2008, nasopharyngeal swabs were obtained from a representative population sample (1 month to 39 years; N = 519) and additional oropharyngeal swabs from 145 participants. Swabs were evaluated by culture. Results: Annual pneumococcal meningitis incidence rates were highest among <6-month-old (58/100,000) and 15- to 19-year-old persons (15/100,000). Annual serotype 1 incidence was around 5/100,000 in all age groups. Pneumococcal carriage prevalence in nasopharyngeal swabs was 63% among <5-year-old children and 22% among >= 5-year-old persons, but adding oropharyngeal to nasopharyngeal swabs increased the estimated carriage prevalence by 60%. Serotype 1 showed high propensity for invasive disease, particularly among persons aged >= 5 years. Conclusions: Serotype 1 causes the majority of cases with a relatively constant age-specific incidence. Pneumococcal carriage is common in all age groups including adults. Vaccination programs in this region may need to include older target age groups for optimal impact on disease burden.	[Mueller, Judith E.; Njanpop-Lafourcade, Berthe-Marie; Tall, Haoua; Idohou, Regina S.; Sanou, Oumarou; Kroman, Sita S.; Gessner, Bradford D.] Agence Med Prevent, Paris, France; [Yaro, Seydou; Drabo, Aly] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Ouedraogo, Macaire S.; Nacro, Boubacar; Millogo, Athanase] Ctr Hosp Univ Sourou Sanou, Bobo Dioulasso, Burkina Faso; [Levina, Natalia; van der Linden, Mark] GNRC Streptococci, Aachen, Germany	Agence de Medecine Preventive; Centre Muraz	Gessner, BD (corresponding author), Agence Med Prevent, Paris, France.	bgessner@aamp.org	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313	PneumoADIP; UK Medical Research Council; Sanofi Pasteur; GSK; Merck; Pfizer; Crucell; MSD	PneumoADIP; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sanofi Pasteur; GSK(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer); Crucell; MSD	The meningitis surveillance was supported by Sanofi Pasteur, Hib Initiative, PneumoADIP and the French Ministry of Foreign Affairs. The carriage study was supported by PneumoADIP and made possible through synergies with a seroprevalence study funded by the UK Medical Research Council (to Dr Caroline Trotter, Bristol University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JEM, HT, BMNL, RSI, and BDG work for AMP which receives unrestricted support from Sanofi Pasteur and grant specific support from Sanofi Pasteur, GSK, Merck, Pfizer, and Crucell. MVDL received research grants and honoraria from Pfizer, GSK, Sanofi Pasteur, and MSD. No other conflicts exist. For members of AMP, this relation was (and is) indirect via unrestricted funding from Sanofi Pasteur to AMP and specific project funding; no AMP authors have individual conflicts of interest (employment, consultancy, patents, products in development or marketed products etc). MVDL received consultancy and project funding, but not employment, patents, products in development or marketed products. At no time was the funder involved in analyses, interpretation of the results or manuscript writing. Altogether, these relations do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Cisse M F, 1989, Med Trop (Mars), V49, P265; Dagan R, 2000, CLIN INFECT DIS, V30, P319, DOI 10.1086/313645; Darboe MK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-195; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Fine PEM, 2008, VACCINES, P1573; GARCIA P, 1986, GENE, V43, P265, DOI 10.1016/0378-1119(86)90215-5; Gessner BD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-22; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Lafourcade BMN, 2010, J CLIN MICROBIOL, V48, P612, DOI 10.1128/JCM.01402-09; Lagos R, 2008, J INFECT DIS, V198, P1809, DOI 10.1086/593334; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Lepoutre A., 2007, Bulletin Epidemiologique Hebdomadaire, P37; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Rapola S, 1997, J CLIN MICROBIOL, V35, P1077, DOI 10.1128/JCM.35.5.1077-1079.1997; Sjolinder H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014034; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Tall H, 2012, 8 INT S PNEUM PNEUM; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Watt JP, 2004, J CLIN MICROBIOL, V42, P4974, DOI 10.1128/JCM.42.11.4974-4976.2004; WHO-AFRO, 2009, STANDARD OPERATING P; . World Health Organization, CHILD GROWTH STAND W; Yaro S, 2008, 6 INT S PNEUM PNEUM, P288	30	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52464	10.1371/journal.pone.0052464	http://dx.doi.org/10.1371/journal.pone.0052464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285051	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500175
J	VanDusen, BM; Fegley, SR; Peterson, CH				VanDusen, Beth M.; Fegley, Stephen R.; Peterson, Charles H.			Prey Distribution, Physical Habitat Features, and Guild Traits Interact to Produce Contrasting Shorebird Assemblages among Foraging Patches	PLOS ONE			English	Article							DUNLINS CALIDRIS-ALPINA; IDEAL FREE DISTRIBUTION; TIDAL CYCLE; DENSITY; WADERS; SELECTION; BEHAVIOR; CHOICE; COMMUNITIES; MANAGEMENT	Worldwide declines in shorebird populations, driven largely by habitat loss and degradation, motivate environmental managers to preserve and restore the critical coastal habitats on which these birds depend. Effective habitat management requires an understanding of the factors that determine habitat use and value to shorebirds, extending from individuals to the entire community. While investigating the factors that influenced shorebird foraging distributions among neighboring intertidal sand flats, we built upon species-level understandings of individual-based, small-scale foraging decisions to develop more comprehensive guild-and community-level insights. We found that densities and community composition of foraging shorebirds varied substantially among elevations within some tidal flats and among five flats despite their proximity (all located within a 400-m stretch of natural, unmodified inlet shoreline). Non-dimensional multivariate analyses revealed that the changing composition of the shorebird community among flats and tidal elevations correlated significantly (rho(s) = 0.56) with the spatial structure of the benthic invertebrate prey community. Sediment grain-sizes affected shorebird community spatial patterns indirectly by influencing benthic macroinvertebrate community compositions. Furthermore, combining sediment and macroinvertebrate information produced a 27% increase in correlation (rho(s) = 0.71) with shorebird assemblage patterns over the correlation of the bird community with the macroinvertebrate community alone. Beyond its indirect effects acting through prey distributions, granulometry of the flats influenced shorebird foraging directly by modifying prey availability. Our study highlights the importance of habitat heterogeneity, showing that no single patch type was ideal for the entire shorebird community. Generally, shorebird density and diversity were greatest at lower elevations on flats when they became exposed; these areas are at risk from human intervention by inlet sand mining, construction of groins and jetties that divert sediments from flats, and installation of seawalls on inlet shorelines that induce erosion of flats.	[VanDusen, Beth M.; Fegley, Stephen R.; Peterson, Charles H.] Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA; [VanDusen, Beth M.; Peterson, Charles H.] Univ N Carolina, Curriculum Environm & Ecol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	VanDusen, BM (corresponding author), Univ N Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA.	vandusen@unc.edu			Strategic Environmental Research and Development Program [W912HQ-07-C-0002]	Strategic Environmental Research and Development Program	This work was supported by the Strategic Environmental Research and Development Program (contract number W912HQ-07-C-0002), and conducted under the Defense Coastal/Estuarine Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Views, opinions, and/or findings contained in this document are those of the authors and should not be construed as an official United States Department of Defense position or decision unless so designated by other official documentation.	ABRAHAMS MV, 1986, BEHAV ECOL SOCIOBIOL, V19, P409, DOI 10.1007/BF00300543; Anderson M.J., 2008, PERMANOVA PRIMER GUI; BAKER MC, 1979, OIKOS, V33, P121, DOI 10.2307/3544520; BROOME SW, 1988, AQUAT BOT, V32, P1, DOI 10.1016/0304-3770(88)90085-X; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Brusati ED, 2001, WATERBIRDS, V24, P371, DOI 10.2307/1522067; Bryant DM, 1979, EST COAST MAR SCI, V9, P363; BURGER J, 1977, AUK, V94, P743, DOI 10.2307/4085271; Bush D.M., 2004, LIVING FLORIDAS ATLA; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Cohen JB, 2009, WILDLIFE MONOGR, P1, DOI 10.2193/2007-553; COLWELL MA, 1993, CONDOR, V95, P94, DOI 10.2307/1369390; Dekker D, 2004, CONDOR, V106, P415, DOI 10.1650/7364; Finn PG, 2008, ESTUAR COAST SHELF S, V80, P381, DOI 10.1016/j.ecss.2008.09.001; French P.W., 2001, COASTAL DEFENSES PRO; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GOSSCUSTARD JD, 1992, J APPL ECOL, V29, P330, DOI 10.2307/2404502; GOSSCUSTARD JD, 1970, J ANIM ECOL, V39, P91, DOI 10.2307/2891; GOSSCUSTARD JD, 1977, ESTUAR COAST MAR SCI, V5, P497, DOI 10.1016/0302-3524(77)90097-4; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Granadeiro JP, 2006, ACTA OECOL, V29, P293, DOI 10.1016/j.actao.2005.11.008; HOLLAND AF, 1977, CHESAPEAKE SCI, V18, P58, DOI 10.2307/1350364; Karpanty SM, 2006, J WILDLIFE MANAGE, V70, P1704, DOI 10.2193/0022-541X(2006)70[1704:HCEDRK]2.0.CO;2; KENNEDY M, 1993, OIKOS, V68, P158, DOI 10.2307/3545322; LEBER KM, 1982, MAR ECOL PROG SER, V7, P297, DOI 10.3354/meps007297; Mangel M., 1988, DYNAMIC MODELING BEH; Mazerolle MJ, 1999, ECOSCIENCE, V6, P117, DOI 10.1080/11956860.1999.11952204; METCALFE NB, 1987, IBIS, V129, P553, DOI 10.1111/j.1474-919X.1987.tb08243.x; MOURITSEN KN, 1992, MAR ECOL PROG SER, V85, P1, DOI 10.3354/meps085001; NEHLS G, 1993, NETH J SEA RES, V31, P375, DOI 10.1016/0077-7579(93)90054-V; NOL E, 1999, BIRDS N AM; Peterson CH, 2006, J EXP MAR BIOL ECOL, V338, P205, DOI 10.1016/j.jembe.2006.06.021; PIENKOWSKI MW, 1983, MAR ECOL PROG SER, V11, P141, DOI 10.3354/meps011141; QUAMMEN ML, 1982, MAR BIOL, V71, P339, DOI 10.1007/BF00397050; Quinn G.P., 2002, EXPT DESIGNS DATA AN; Reed DJ, 2012, J COASTAL RES, P51, DOI 10.2112/SI_60_6; Ribeiro PD, 2004, IBIS, V146, P672, DOI 10.1111/j.1474-919x.2004.00301.x; Rosa S, 2007, J EXP MAR BIOL ECOL, V353, P35, DOI 10.1016/j.jembe.2007.08.019; Safran RJ, 2000, CONDOR, V102, P211, DOI 10.1650/0010-5422(2000)102[0211:FSSBNW]2.0.CO;2; Sanders MD, 2000, J APPL ECOL, V37, P66, DOI 10.1046/j.1365-2664.2000.00469.x; Santos CD, 2010, J AVIAN BIOL, V41, P18, DOI 10.1111/j.1600-048X.2009.04860.x; Smart J, 2006, J APPL ECOL, V43, P454, DOI 10.1111/j.1365-2664.2006.01166.x; STINSON CH, 1980, OIKOS, V34, P35, DOI 10.2307/3544547; Vader W, 1964, NETH J SEA RES, V2, P189; Walters JR, 1984, WADER STUD GROUP B, V40, P27; Warnock N., 1996, BIRDS N AM; Watkinson AR, 2004, IBIS, V146, P4, DOI 10.1111/j.1474-919X.2004.00321.x; Watzin MC, 1984, THESIS U N CAROLINA; YATES MG, 1993, J APPL ECOL, V30, P599, DOI 10.2307/2404240	52	16	18	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52694	10.1371/journal.pone.0052694	http://dx.doi.org/10.1371/journal.pone.0052694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285153	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500233
J	Zhai, WG; Zhang, DN; Mai, C; Choy, J; Jian, G; Sra, K; Galinski, MS				Zhai, Weiguo; Zhang, Dan Ning; Mai, Cecilia; Choy, Justin; Jian, Gary; Sra, Kuldip; Galinski, Mark S.			Comparison of Different Cell Substrates on the Measurement of Human Influenza Virus Neutralizing Antibodies	PLOS ONE			English	Article							RESPIRATORY VIRUSES; ENZYME-IMMUNOASSAY; EPITHELIAL-CELLS; LINES; MDCK; SUSCEPTIBILITY; REPLICATION; APOPTOSIS; VACCINES; SYSTEM	Eight cell lines were systematically compared for their permissivity to primary infection, replication, and spread of seven human influenza viruses. Cell lines were of human origin (Caco-2, A549, HEp-2, and NCI-H292), monkey (Vero, LLC-MK2), mink (Mv1 Lu), and canine (MDCK). The influenza viruses included seasonal types and subtypes and a pandemic virus. The MDCK, Caco-2, and Mv1 Lu cells were subsequently compared for their capacity to report neutralization titers at day one, three and six post-infection. A gradient of sensitivity to primary infection across the eight cell lines was observed. Relative to MDCK cells, Mv1 Lu reported higher titers and the remaining six cell lines reported lower titers. The replication and spread of the seven influenza viruses in the eight cell substrates was determined using hemagglutinin expression, cytopathic effect, and neuraminidase activity. Virus growth was generally concordant with primary infection, with a gradient in virus replication and spread. However, Mv1 Lu cells poorly supported virus growth, despite a higher sensitivity to primary infection. Comparison of MDCK, Caco-2, and Mv1 Lu in neutralization assays using defined animal antiserum confirmed MDCK cells as the preferred cell substrate for influenza virus testing. The results observed for neutralization at one day post-infection showed MDCK cells were similar (<1 log(2) lower) or superior (>1 log(2) higher) for all seven viruses. Relative to Caco-2 and Mv1 Lu cells, MDCK generally reported the highest titers at three and six days post-infection for the type A viruses and lower titers for the type B viruses and the pandemic H9N2 virus. The reduction in B virus titer was attributed to the complete growth of type B viruses in MDCK cells before day three post-infection, resulting in the systematic underestimation of neutralization titers. This phenomenon was also observed with Caco-2 cells.	[Galinski, Mark S.] MedImmune, Vaccine Analyt Sci, Mountain View, CA 94089 USA; [Zhai, Weiguo; Zhang, Dan Ning; Mai, Cecilia; Choy, Justin; Jian, Gary; Sra, Kuldip] MedImmune, Analyt Biochem, Mountain View, CA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Galinski, MS (corresponding author), MedImmune, Vaccine Analyt Sci, Mountain View, CA 94089 USA.	GalinskiM@Medimmune.com						Andrewes CH, 1933, BRIT J EXP PATHOL, V14, P367; Barenfanger J, 2001, J CLIN VIROL, V22, P101, DOI 10.1016/S1386-6532(01)00171-8; BENNE CA, 1994, J CLIN MICROBIOL, V32, P987, DOI 10.1128/JCM.32.4.987-990.1994; Chiapponi C, 2010, J VIROL METHODS, V163, P162, DOI 10.1016/j.jviromet.2009.09.017; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; European Medicines Agency, 2010, EMA7328062010; FRANK AL, 1980, J CLIN MICROBIOL, V12, P426, DOI 10.1128/JCM.12.3.426-432.1980; Genzel Y, 2009, EXPERT REV VACCINES, V8, P1681, DOI [10.1586/erv.09.128, 10.1586/ERV.09.128]; Govorkova EA, 1996, J VIROL, V70, P5519, DOI 10.1128/JVI.70.8.5519-5524.1996; Granstrom M, 2011, VACCINE, V29, P7572, DOI 10.1016/j.vaccine.2011.08.017; Hamilton SB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-66; Hassantoufighi A, 2010, VACCINE, V28, P790, DOI 10.1016/j.vaccine.2009.10.066; HIERHOLZER JC, 1993, J CLIN MICROBIOL, V31, P1504, DOI 10.1128/JCM.31.6.1504-1510.1993; Hussain AI, 2010, VACCINE, V28, P3848, DOI 10.1016/j.vaccine.2010.03.005; Kim JS, 2008, J CLIN VIROL, V42, P264, DOI 10.1016/j.jcv.2008.03.015; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; ORSTAVIK I, 1981, ACTA PATH MICRO IM B, V89, P179; SCHEPETIUK SK, 1993, J VIROL METHODS, V42, P241, DOI 10.1016/0166-0934(93)90036-Q; Schultz-Cherry S, 1998, J CLIN MICROBIOL, V36, P3718, DOI 10.1128/JCM.36.12.3718-3720.1998; USUBA O, 1990, Viral Immunology, V3, P237, DOI 10.1089/vim.1990.3.237; WHO, 2011, MAN LAB DIAGN VIR SU; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	24	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52327	10.1371/journal.pone.0052327	http://dx.doi.org/10.1371/journal.pone.0052327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284988	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500144
J	Dukic-Stefanovic, S; Walther, J; Wosch, S; Zimmermann, G; Wiedemann, P; Alexander, H; Claudepierre, T				Dukic-Stefanovic, Sladjana; Walther, Jan; Wosch, Sebastian; Zimmermann, Gerolf; Wiedemann, Peter; Alexander, Henry; Claudepierre, Thomas			Chorionic Gonadotropin and Its Receptor Are Both Expressed in Human Retina, Possible Implications in Normal and Pathological Conditions	PLOS ONE			English	Article							DECREASES INTRAOCULAR-PRESSURE; HORMONE-RELEASING HORMONE; LUTEINIZING-HORMONE; PITUITARY APOPLEXY; CHILDREN BORN; HCG; RETINOBLASTOMA; CELLS; RAT; LOCALIZATION	Extra-gonadal role of gonadotropins has been re-evaluated over the last 20 years. In addition to pituitary secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH), the CNS has been clearly identified as a source of hCG acting locally to influence behaviour. Here we demonstrated that human retina is producing this gonadotropin that acts as a neuroactive molecule. Muller glial and retinal pigmented epithelial (RPE) cells are producing hCG that may affects neighbour cells expressing its receptor, namely cone photoreceptors. It was previously described that amacrine and retinal ganglion (RGC) cells are targets of the gonadotropin releasing hormone that control the secretion of all gonadotropins. Therefore our findings suggest that a complex neuroendocrine circuit exists in the retina, involving hCG secreting cells (glial and RPE), hCG targets (photoreceptors) and hCG-release controlling cells (amacrine and RGC). The exact physiological functions of this circuit have still to be identified, but the proliferation of photoreceptor-derived tumor induced by hCG demonstrated the need to control this neuroendocrine loop.	[Dukic-Stefanovic, Sladjana; Walther, Jan; Wosch, Sebastian; Wiedemann, Peter; Claudepierre, Thomas] Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany; [Zimmermann, Gerolf; Alexander, Henry] Univ Leipzig, Dept Obstet & Gynecol, Div Human Reprod & Endocrinol, Leipzig, Germany	Leipzig University; Leipzig University	Claudepierre, T (corresponding author), Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany.	thomas.claudepierre@medizin.uni-leipzig.de		Claudepierre, Thomas/0000-0001-6968-8518	German foundation "Stifterverband fur die Deutsche Wissenschaft"	German foundation "Stifterverband fur die Deutsche Wissenschaft"	This work was supported by the German foundation "Stifterverband fur die Deutsche Wissenschaft" (to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2004, RETINA-J RET VIT DIS, V24, P828, DOI 10.1097/00006982-200412000-00002; AlHader AA, 1997, BIOL REPROD, V56, P501, DOI 10.1095/biolreprod56.2.501; AlHader AA, 1997, BIOL REPROD, V56, P1071, DOI 10.1095/biolreprod56.5.1071; Anteby I, 2001, ARCH OPHTHALMOL-CHIC, V119, P1525; Apaja PM, 2004, J BIOL CHEM, V279, P1899, DOI 10.1074/jbc.M311395200; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Banerjee P, 2011, REV ENDOCR METAB DIS, V12, P323, DOI 10.1007/s11154-011-9193-1; BELLISARIO R, 1973, J BIOL CHEM, V248, P6796; Berndt S, 2009, J CLIN ENDOCR METAB, V94, P4567, DOI 10.1210/jc.2009-0443; Birken S, 1996, ENDOCRINOLOGY, V137, P1402, DOI 10.1210/en.137.4.1402; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Botul JB, 2002, ZYCIE SEKSUALNE IMMA; BOWEN DJ, 1992, APPETITE, V19, P233, DOI 10.1016/0195-6663(92)90164-2; Bukovsky Antonin, 2003, Reprod Biol Endocrinol, V1, P46, DOI 10.1186/1477-7827-1-46; CARMICHAEL DN, 1995, DIABETOLOGIA, V38, pA275; Chen HF, 1999, J CLIN ENDOCR METAB, V84, P743, DOI 10.1210/jc.84.2.743; Cole LA, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-24; Cole LA, 2012, AM J CANCER RES, V2, P22; Cole LA, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-102; Dinc H, 1998, ACTA RADIOL, V39, P64, DOI 10.3109/02841859809172152; Efe YK, 2012, CAN J OPHTHALMOL, V47, P150, DOI 10.1016/j.jcjo.2012.01.004; ELMAN J, 1987, INVEST OPHTH VIS SCI, V28, P197; EMANUELE NV, 1991, NEUROENDOCRINOL LETT, V13, P413; Foix-L'Helias L, 2012, HUM REPROD, V27, P2186, DOI 10.1093/humrep/des149; Gierkowa A, 1976, Klin Oczna, V46, P1005; Grens KE, 2005, BRAIN BEHAV EVOLUT, V66, P1, DOI 10.1159/000085043; Harrison GS, 2004, ENDOCR-RELAT CANCER, V11, P725, DOI 10.1677/erc.1.00777; Hiroi N, 2001, INTERNAL MED, V40, P747, DOI 10.2169/internalmedicine.40.747; Hollborn M, 2011, MOL VIS, V17, P2738; Hollborn M, 2010, INVEST OPHTH VIS SCI, V51, P2721, DOI 10.1167/iovs.09-4661; Hope AJ, 1998, P ROY SOC B-BIOL SCI, V265, P869, DOI 10.1098/rspb.1998.0372; Iles RK, 2010, MOL CELL ENDOCRINOL, V329, P62, DOI 10.1016/j.mce.2010.07.014; Inoue T, 2007, GRAEF ARCH CLIN EXP, V245, P1049, DOI 10.1007/s00417-006-0491-3; Jennes L, 1997, RECENT PROG HORM RES, V52, P475; Jorsal T, 2012, ACTA ONCOL, V51, P3, DOI 10.3109/0284186X.2011.586000; Kallen B, 2010, PEDIATRICS, V126, pE270, DOI 10.1542/peds.2009-3225; Kars M, 2006, EUR J ENDOCRINOL, V155, P523, DOI 10.1530/eje.1.02268; KASS MA, 1977, SURV OPHTHALMOL, V22, P153, DOI 10.1016/0039-6257(77)90053-4; KAWAKAMI M, 1959, ENDOCRINOLOGY, V65, P631, DOI 10.1210/endo-65-4-631; Lei ZM, 2001, SEMIN REPROD MED, V19, P103, DOI 10.1055/s-2001-13917; LEI ZM, 1995, MOL CELL ENDOCRINOL, V109, P151, DOI 10.1016/0303-7207(95)03497-U; Licht P, 2001, SEMIN REPROD MED, V19, P37, DOI 10.1055/s-2001-13909; Lidegaard O, 2005, HUM REPROD, V20, P950, DOI 10.1093/humrep/deh714; LIU JHK, 1988, CURR EYE RES, V7, P1035, DOI 10.3109/02713688809015151; LIU JHK, 1988, CURR EYE RES, V7, P737, DOI 10.3109/02713688809033203; Lukacs H, 2001, SEMIN REPROD MED, V19, P111, DOI 10.1055/s-2001-13918; LUKACS H, 1995, HORM BEHAV, V29, P42, DOI 10.1006/hbeh.1995.1004; Lustbader JW, 1998, RECENT PROG HORM RES, V53, P395; Marees T, 2009, HUM REPROD, V24, P3220, DOI 10.1093/humrep/dep335; Maruska KP, 2007, BRAIN BEHAV EVOLUT, V70, P40, DOI 10.1159/000101068; MASAGO A, 1995, SURG NEUROL, V43, P158, DOI 10.1016/0090-3019(95)80128-4; MASSON EA, 1993, CLIN ENDOCRINOL, V38, P109, DOI 10.1111/j.1365-2265.1993.tb00980.x; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Mendez-Hernandez C, 2012, CLIN OPHTHALMOL, V6, P1629, DOI 10.2147/OPTH.S36712; Moll AC, 2003, LANCET, V361, P309, DOI 10.1016/S0140-6736(03)12332-X; Pakarainen T, 2007, MOL CELL ENDOCRINOL, V269, P9, DOI 10.1016/j.mce.2006.10.019; PATIL AA, 1990, INT SURG, V75, P54; Putterman G J, 1986, J Ocul Pharmacol, V2, P121, DOI 10.1089/jop.1986.2.121; Sasaki K, 2011, CURR OPIN ENDOCRINOL, V18, P401, DOI 10.1097/MED.0b013e32834cd3b0; Schang AL, 2012, NEUROENDOCR IN PRESS; Talwar GP, 2011, AM J REPROD IMMUNOL, V66, P26, DOI 10.1111/j.1600-0897.2011.01002.x; TELEGDY G, 1971, ACTA PHYSIOL HUNG, V40, P209; Thomas D, 1996, MOL ENDOCRINOL, V10, P760, DOI 10.1210/me.10.6.760; Thompson DA, 1998, LIFE SCI, V63, P1057, DOI 10.1016/S0024-3205(98)00367-1; TOTH P, 1994, BRAIN RES, V654, P181, DOI 10.1016/0006-8993(94)90478-2; van Aerle R, 2008, PEPTIDES, V29, P57, DOI 10.1016/j.peptides.2007.10.018; VIRTANEN I, 1988, LAB INVEST, V59, P649; Wirsig-Wiechmann CR, 2002, BRAIN RES, V950, P210, DOI 10.1016/S0006-8993(02)03039-1; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Zhang W, 1999, LIFE SCI, V65, P2083, DOI 10.1016/S0024-3205(99)00474-9; ZIAI N, 1994, ARCH OPHTHALMOL-CHIC, V112, P801, DOI 10.1001/archopht.1994.01090180099043	72	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52567	10.1371/journal.pone.0052567	http://dx.doi.org/10.1371/journal.pone.0052567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285091	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300091
J	Wang, QD; Hu, C; Short, LA; Fu, GY				Wang, Qiandong; Hu, Chao; Short, Lindsey A.; Fu, Genyue			The Influence of Shyness on the Scanning of Own- and Other-Race Faces in Adults	PLOS ONE			English	Article							EYE-TO-EYE; SOCIAL ANXIETY; FACIAL EXPRESSIONS; INDIVIDUAL-DIFFERENCES; GAZE; ATTENTION; DISORDER; BEHAVIOR; CHILDREN; AREA	The current study explored the relationship between shyness and face scanning patterns for own- and other-race faces in adults. Participants completed a shyness inventory and a face recognition task in which their eye movements were recorded by a Tobii 1750 eye tracker. We found that: (1) Participants' shyness scores were negatively correlated with the fixation proportion on the eyes, regardless of the race of face they viewed. The shyer the participants were, the less time they spent fixating on the eye region; (2) High shyness participants tended to fixate significantly more than low shyness participants on the regions just below the eyes as if to avoid direct eye contact; (3) When participants were recognizing own-race faces, their shyness scores were positively correlated with the normalized criterion. The shyer they were, the more apt they were to judge the faces as novel, regardless of whether they were target or foil faces. The present results support an avoidance hypothesis of shyness, suggesting that shy individuals tend to avoid directly fixating on others' eyes, regardless of face race.	[Wang, Qiandong; Hu, Chao; Fu, Genyue] Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China; [Hu, Chao] Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada; [Short, Lindsey A.] Brock Univ, Dept Psychol, St Catharines, ON L2S 3A1, Canada; [Fu, Genyue] Zhejiang Normal Univ, Hangzhou Coll Kindergarten Teachers, Hangzhou, Zhejiang, Peoples R China	Zhejiang Normal University; University of Toronto; Brock University; Zhejiang Normal University	Fu, GY (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China.	fugy@zjnu.cn	Hu, Chao S./I-2666-2019	Hu, Chao S./0000-0003-3315-9651	National Natural Science Foundation of China [31070894]; Program for Innovative Research Team in Zhejiang Normal University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in Zhejiang Normal University	This research was funded by National Natural Science Foundation of China, No. 31070894 (http://www.nsfc.gov.cn/Portal0/default152.htm) and Program for Innovative Research Team in Zhejiang Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIEN JL, 1993, J AM ACAD CHILD PSY, V32, P617, DOI 10.1097/00004583-199305000-00019; Battaglia M, 2004, J AM ACAD CHILD PSY, V43, P358, DOI 10.1097/00004583-200403000-00019; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Brunet PM, 2009, J ANXIETY DISORD, V23, P909, DOI 10.1016/j.janxdis.2009.05.009; BUITELAAR JK, 1991, J CHILD PSYCHOL PSYC, V32, P995, DOI 10.1111/j.1469-7610.1991.tb01925.x; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Cheek J.M., 1990, HDB SOCIAL EVALUATIO, P47; Cheek J.M, 1983, REVISED CHEEK BUSS S; Chen YP, 2002, BEHAV RES THER, V40, P677, DOI 10.1016/S0005-7967(01)00086-9; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, P69, DOI DOI 10.1017/S1352465808004487; DALY S, 1978, BRIT J SOC CLIN PSYC, V17, P117, DOI 10.1111/j.2044-8260.1978.tb00252.x; FARABEE DJ, 1993, J RES PERS, V27, P365, DOI 10.1006/jrpe.1993.1025; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Hofmann SG, 1997, J ANXIETY DISORD, V11, P573, DOI 10.1016/S0887-6185(97)00040-6; Horley K, 2003, J ANXIETY DISORD, V17, P33, DOI 10.1016/S0887-6185(02)00180-9; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelly DJ, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00006; Mansell W, 1999, COGNITION EMOTION, V13, P673, DOI 10.1080/026999399379032; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mondloch CJ, 2010, PERCEPTION, V39, P819, DOI 10.1068/p6584; Perlman SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005952; PILKONIS PA, 1977, J PERS, V45, P596, DOI 10.1111/j.1467-6494.1977.tb00174.x; Rosenthal MZ, 2011, PERSONAL DISORD, V2, P327, DOI 10.1037/a0023672; Rubin K. H., 1993, SOCIAL WITHDRAWAL IN; Schmidt L. A., 2010, DEV SHYNESS SOCIAL W, P23; Strand PS, 2008, INFANT CHILD DEV, V17, P109, DOI 10.1002/icd.534; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Wang X., 1993, RATING SCALES MENTAL; Wieser MJ, 2009, J ANXIETY DISORD, V23, P93, DOI 10.1016/j.janxdis.2008.04.004; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	35	3	3	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52203	10.1371/journal.pone.0052203	http://dx.doi.org/10.1371/journal.pone.0052203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284933	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300080
J	Geissler, S; Textor, M; Kuhnisch, J; Konnig, D; Klein, O; Ode, A; Pfitzner, T; Adjaye, J; Kasper, G; Duda, GN				Geissler, Sven; Textor, Martin; Kuehnisch, Jirko; Koennig, Delia; Klein, Oliver; Ode, Andrea; Pfitzner, Tilman; Adjaye, James; Kasper, Grit; Duda, Georg N.			Functional Comparison of Chronological and In Vitro Aging: Differential Role of the Cytoskeleton and Mitochondria in Mesenchymal Stromal Cells	PLOS ONE			English	Article							STEM-CELLS; BETA-CATENIN; RAT-HEART; BONE; SENESCENCE; OSTEOBLAST; EXPRESSION; STRESS; LINES; INVOLVEMENT	Mesenchymal stromal cells (MSCs) are of high relevance for the regeneration of mesenchymal tissues such as bone and cartilage. The promising role of MSCs in cell-based therapies and tissue engineering appears to be limited due to a decline of their regenerative potential with increasing donor age, their limited availability in human tissues and the need of in vitro expansion prior to treatment. We therefore aimed to determine to which degree in vitro aging and chronological aging may be similar processes or if in vitro culture-related changes at the cellular and molecular level are at least altered as a function of donor age. For that purpose we established MSCs cultures from young (yMSCs) and aged (aMSCs) rats that were cultured for more than 100 passages. These long-term MSCs cultures were non-tumorigenic and exhibited similar surface marker patterns as primary MSCs of passage 2. During in vitro expansion, but not during chronological aging, MSCs progressively lose their progenitor characteristics, e.g., complete loss of osteogenic differentiation potential, diminished adipogenic differentiation, altered cell morphology and increased susceptibility towards senescence. Transcriptome analysis revealed that long-term in vitro MSCs cultivation leads to down-regulation of genes involved in cell differentiation, focal adhesion organization, cytoskeleton turnover and mitochondria function. Accordingly, functional analysis demonstrated altered mitochondrial morphology, decreased antioxidant capacities and elevated ROS levels in long-term cultivated yMSCs as well as aMSCs. Notably, only the MSC migration potential and their antioxidative capacity were altered by in vitro as well as chronological aging. Based on specific differences observed between the impact of chronological and in vitro MSC aging we conclude that both are distinct processes.	[Geissler, Sven; Textor, Martin; Koennig, Delia; Ode, Andrea; Pfitzner, Tilman; Kasper, Grit; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Geissler, Sven; Textor, Martin; Klein, Oliver; Ode, Andrea; Kasper, Grit; Duda, Georg N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Kuehnisch, Jirko; Klein, Oliver] Charite, Inst Med & Human Genet, D-13353 Berlin, Germany; [Koennig, Delia; Adjaye, James] Max Planck Inst Mol Genet, Dept Vertebrate Genom, Mol Embryol & Aging Grp, D-14195 Berlin, Germany; [Adjaye, James] Univ Dusseldorf, Inst Stem Cell Res & Regenerat Med, D-40225 Dusseldorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Heinrich Heine University Dusseldorf	Geissler, S (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	Sven.Geissler@charite.de	Duda, Georg N/H-2085-2016; Kühnisch, Jirko/M-3744-2019; Geißler, Sven/J-7275-2013; Kühnisch, Jirko/L-7761-2013; Ode, Andrea/B-6805-2015	Duda, Georg N/0000-0001-7605-3908; Kühnisch, Jirko/0000-0003-4744-5421; Geißler, Sven/0000-0002-8750-6324; Textor, Martin/0000-0001-8162-930X; klein, oliver/0000-0001-7984-7607	Federal Ministry of Education and Research (BMBF) through the BCRT; German Research Foundation (DFG) [GE2512/1-1]	Federal Ministry of Education and Research (BMBF) through the BCRT(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the Federal Ministry of Education and Research (BMBF) by funding through the BCRT and by the German Research Foundation (DFG) grant GE2512/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Berger JP, 2005, INT J OBESITY, V29, pS3, DOI 10.1038/sj.ijo.0802904; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Chanda D, 2010, J CELL BIOCHEM, V111, P249, DOI 10.1002/jcb.22701; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duda GN, 2008, HARRISONS INNERE MED; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Fehrer C, 2006, ANN NY ACAD SCI, V1067, P235, DOI 10.1196/annals.1354.030; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Kasper G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-12; Kasper G, 2007, STEM CELLS, V25, P1985, DOI 10.1634/stemcells.2006-0676; Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432; Kasper G, 2010, STEM CELLS, V28, P633, DOI 10.1002/stem.305; Kasper G, 2009, STEM CELLS, V27, P1288, DOI 10.1002/stem.49; Khosla S, 2010, STEM CELLS, V28, P2124, DOI 10.1002/stem.546; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Le Blanc K, 2005, CYTOTHERAPY, V7, P36, DOI 10.1080/14653240510018118; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Marcellini S, 2012, BIOESSAYS; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Muller M, 2009, ANTIOXID REDOX SIGN, V11, P59, DOI 10.1089/ars.2008.2104; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Ogrunc M, 2011, EUR J CANCER, V47, P1616, DOI 10.1016/j.ejca.2011.04.003; Paradies G, 2010, FREE RADICAL BIO MED, V48, P1286, DOI 10.1016/j.freeradbiomed.2010.02.020; Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Savitha S, 2006, MECH AGEING DEV, V127, P349, DOI 10.1016/j.mad.2005.12.004; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Strube P, 2008, BONE, V42, P758, DOI 10.1016/S0021-9290(08)70350-6; Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045; Xie XY, 2011, STEM CELLS DEV, V20, P127, DOI 10.1089/scd.2009.0475; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904; Zhang DL, 2001, CELL BIOL INT, V25, P997, DOI 10.1006/cbir.2001.0745	60	117	120	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52700	10.1371/journal.pone.0052700	http://dx.doi.org/10.1371/journal.pone.0052700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285157	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500049
J	Husse, J; Hintze, SC; Eichele, G; Lehnert, H; Oster, H				Husse, Jana; Hintze, Sophie Charlotte; Eichele, Gregor; Lehnert, Hendrik; Oster, Henrik			Circadian Clock Genes Per1 and Per2 Regulate the Response of Metabolism-Associated Transcripts to Sleep Disruption	PLOS ONE			English	Article							SHIFT WORK; ADIPOSE-TISSUE; PLASMA LEPTIN; FOOD-INTAKE; NIGHT-WORK; DEPRIVATION; OBESITY; RATS; EXPRESSION; DURATION	Human and animal studies demonstrate that short sleep or poor sleep quality, e.g. in night shift workers, promote the development of obesity and diabetes. Effects of sleep disruption on glucose homeostasis and liver physiology are well documented. However, changes in adipokine levels after sleep disruption suggest that adipocytes might be another important peripheral target of sleep. Circadian clocks regulate metabolic homeostasis and clock disruption can result in obesity and the metabolic syndrome. The finding that sleep and clock disruption have very similar metabolic effects prompted us to ask whether the circadian clock machinery may mediate the metabolic consequences of sleep disruption. To test this we analyzed energy homeostasis and adipocyte transcriptome regulation in a mouse model of shift work, in which we prevented mice from sleeping during the first six hours of their normal inactive phase for five consecutive days (timed sleep restriction - TSR). We compared the effects of TSR between wild-type and Per1/2 double mutant mice with the prediction that the absence of a circadian clock in Per1/2 mutants would result in a blunted metabolic response to TSR. In wild-types, TSR induces significant transcriptional reprogramming of white adipose tissue, suggestive of increased lipogenesis, together with increased secretion of the adipokine leptin and increased food intake, hallmarks of obesity and associated leptin resistance. Some of these changes persist for at least one week after the end of TSR, indicating that even short episodes of sleep disruption can induce prolonged physiological impairments. In contrast, Per1/2 deficient mice show blunted effects of TSR on food intake, leptin levels and adipose transcription. We conclude that the absence of a functional clock in Per1/2 double mutants protects these mice from TSR-induced metabolic reprogramming, suggesting a role of the circadian timing system in regulating the physiological effects of sleep disruption.	[Husse, Jana; Eichele, Gregor; Oster, Henrik] Max Planck Inst Biophys Chem, Gottingen, Germany; [Hintze, Sophie Charlotte; Lehnert, Hendrik; Oster, Henrik] Med Univ Lubeck, Dept Med 1, D-23538 Lubeck, Germany	Max Planck Society; University of Lubeck	Oster, H (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	henrik.oster@uksh.de	Oster, Henrik/D-2335-2013; Oster, Henrik/O-4426-2019	Oster, Henrik/0000-0002-1414-7068; Oster, Henrik/0000-0002-1414-7068	German Research Foundation (DFG) [SFB 654]; Max Planck Society	German Research Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work was supported by a grant from the German Research Foundation (DFG; SFB 654) to HO and HL. JH is supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Barclay JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037150; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biggi N, 2008, CHRONOBIOL INT, V25, P443, DOI 10.1080/07420520802114193; Boivin DB, 2007, SLEEP MED, V8, P578, DOI 10.1016/j.sleep.2007.03.015; Brondel L, 2010, AM J CLIN NUTR, V91, P1550, DOI 10.3945/ajcn.2009.28523; Broussard J, 2010, BEST PRACT RES CL EN, V24, P763, DOI 10.1016/j.beem.2010.08.007; CDC, 2012, MORBIDITY MORTALITY; Challet E, 2000, BRAIN RES, V859, P398, DOI 10.1016/S0006-8993(00)02040-0; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Donga E, 2010, J CLIN ENDOCR METAB, V95, P2963, DOI 10.1210/jc.2009-2430; Dufour CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002143; Dumont, 1997, Int J Occup Environ Health, V3, pS10; Esquirol Y, 2011, ARCH CARDIOVASC DIS, V104, P636, DOI 10.1016/j.acvd.2011.09.004; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; FRANKEN P, 1993, PHYSIOL BEHAV, V54, P885, DOI 10.1016/0031-9384(93)90297-S; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1999, SLEEP, V22, P155; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; *GALL ORG, 1995, SLEEP AM; Gluckman PD, 2012, NAT REV ENDOCRINOL, V8, P74, DOI 10.1038/nrendo.2011.226; Hairston KG, 2010, SLEEP, V33, P289, DOI 10.1093/sleep/33.3.289; Hasler G, 2004, SLEEP, V27, P661, DOI 10.1093/sleep/27.4.661; Hayes AL, 2011, SLEEP, V34, P147, DOI 10.1093/sleep/34.2.147; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Karlsson BH, 2003, INT ARCH OCC ENV HEA, V76, P424, DOI 10.1007/s00420-003-0440-y; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Knutson KL, 2008, ANN NY ACAD SCI, V1129, P287, DOI 10.1196/annals.1417.033; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Koban M, 2008, SLEEP, V31, P927; Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0; KRIPKE DF, 1979, ARCH GEN PSYCHIAT, V36, P103; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Mullington JM, 2003, J NEUROENDOCRINOL, V15, P851, DOI 10.1046/j.1365-2826.2003.01069.x; Naylor E, 2000, J NEUROSCI, V20, P8138; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Puttonen S, 2012, SCAND J WORK ENV HEA, V38, P343, DOI 10.5271/sjweh.3267; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Ripperger JA, 2011, FEBS LETT, V585, P1406, DOI 10.1016/j.febslet.2011.04.047; Neto JCR, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-125; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Salgado-Delgado R, 2010, ENDOCRINOLOGY, V151, P1019, DOI 10.1210/en.2009-0864; Savoye M, 2002, INT J OBESITY, V26, P942, DOI 10.1038/sj.ijo.0802018; Shea SA, 2005, J CLIN ENDOCR METAB, V90, P2537, DOI 10.1210/jc.2004-2232; Simon C, 1998, J CLIN ENDOCR METAB, V83, P1893, DOI 10.1210/jc.83.6.1893; Simpson NS, 2010, BIOL RES NURS, V12, P47, DOI 10.1177/1099800410366301; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; Szosland D, 2010, INT J OCCUP MED ENV, V23, P287, DOI 10.2478/v10001-010-0032-5; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; World Health Organization, 2012, WORLD HLTH STAT, P109; Zhao I, 2012, J OCCUP ENVIRON MED, V54, P525, DOI 10.1097/JOM.0b013e31824e1073; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zhong Sheng, 2004, Appl Bioinformatics, V3, P261, DOI 10.2165/00822942-200403040-00009; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	72	56	58	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52983	10.1371/journal.pone.0052983	http://dx.doi.org/10.1371/journal.pone.0052983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285241	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500093
J	Kelley, CF; Rosenberg, ES; O'Hara, BM; Frew, PM; Sanchez, T; Peterson, JL; del Rio, C; Sullivan, PS				Kelley, Colleen F.; Rosenberg, Eli S.; O'Hara, Brandon M.; Frew, Paula M.; Sanchez, Travis; Peterson, John L.; del Rio, Carlos; Sullivan, Patrick S.			Measuring Population Transmission Risk for HIV: An Alternative Metric of Exposure Risk in Men Who Have Sex with Men (MSM) in the US	PLOS ONE			English	Article							VIRAL LOAD; WHITE MEN; PREVENTION; INFECTION; BLACK; DISPARITIES; CARE	Background: Various metrics for HIV burden and treatment success [e.g. HIV prevalence, community viral load (CVL), population viral load (PVL), percent of HIV-positive persons with undetectable viral load] have important public health limitations for understanding disparities. Methods and Findings: Using data from an ongoing HIV incidence cohort of black and white men who have sex with men (MSM), we propose a new metric to measure the prevalence of those at risk of transmitting HIV and illustrate its value. MSM with plasma VL>400 copies/mL were defined as having 'transmission risk'. We calculated HIV prevalence, CVL, PVL, percent of HIV-positive with undetectable viral loads, and prevalence of plasma VL>400 copies/ml (%VL400) for black and white MSM. We used Monte Carlo simulation incorporating data on sexual mixing by race to estimate exposure of black and white HIV-negative MSM to a partner with transmission risk via unprotected anal intercourse (UAI). Of 709 MSM recruited, 42% (168/399) black and 14% (44/310) white MSM tested HIV-positive (p <.0001). No significant differences were seen in CVL, PVL, or percent of HIV positive with undetectable viral loads. The %VL400 was 25% (98/393) for black vs. 8% (25/310) for white MSM (p <.0001). Black MSM with 2 UAI partners were estimated to have 40% probability (95% CI: 35%, 45%) of having >= 1 UAI partner with transmission risk vs. 20% for white MSM (CI: 15%, 24%). Discussion: Despite similarities in other metrics, black MSM in our cohort are three times as likely as white MSM to have HIV transmission risk. With comparable risk behaviors, HIV-negative black MSM have a substantially higher likelihood of encountering a UAI partner at risk of transmitting HIV. Our results support increasing HIV testing, linkage to care, and antiretroviral treatment of HIV-positive MSM to reduce prevalence of those with transmission risk, particularly for black MSM.	[Kelley, Colleen F.; Frew, Paula M.; del Rio, Carlos] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Kelley, Colleen F.; Rosenberg, Eli S.; O'Hara, Brandon M.; Sanchez, Travis; Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Frew, Paula M.] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Peterson, John L.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [del Rio, Carlos] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University; Emory University; Rollins School Public Health	Kelley, CF (corresponding author), Emory Univ, Dept Med, Atlanta, GA 30322 USA.	colleen.kelley@emory.edu	Kelley, Colleen F/O-4819-2016; del Rio, Carlos/B-3763-2012; Frew, Paula/B-4774-2012	Kelley, Colleen F/0000-0001-5611-0119; del Rio, Carlos/0000-0002-0153-3517; Sullivan, Patrick Sean/0000-0002-7728-0587; sanchez, travis/0000-0003-1133-4762; Frew, Paula/0000-0002-3078-9124	National Institutes of Health [R01-MH085600, R01-HD067111, KL2 RR025009]; Emory Center for AIDS Research [P30 AI050409]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, KL2TR000455] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, KL2RR025009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory Center for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was supported by the National Institutes of Health R01-MH085600 and R01-HD067111 to PSS, KL2 RR025009 to CFK, and the Emory Center for AIDS Research P30 AI050409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NATL HIV AIDS STRATE; [Anonymous], 2008, MMWR MORB MORTAL WKL, V60, P694; [Anonymous], 2012, USING VIRAL LOAD DAT; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Castel AD, 2012, AIDS, V26, P345, DOI 10.1097/QAD.0b013e32834de5fe; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen Stacy M., 2011, Morbidity and Mortality Weekly Report, V60, P1618; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; Eaton LA, 2010, AM J PUBLIC HEALTH, V100, P503, DOI 10.2105/AJPH.2008.155903; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Golden MR, 2008, JAIDS-J ACQ IMM DEF, V49, P212, DOI 10.1097/QAI.0b013e31818455e8; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hollander M, 1973, NONPARAMETRIC STAT M; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; Kilmarx PH, 2012, JAIDS-J ACQ IMM DEF, V60, P219, DOI 10.1097/QAI.0b013e3182531ba2; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; McQuillan GM, 2009, J ACQUIR IMMUNE DEFI; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 2011, 6 IAS C HIV PATH TRE; Sanchez T.H., 2012, AIDS 2012 C WASH DC; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Sullivan PS, 2012, LANCET, V380, P388, DOI 10.1016/S0140-6736(12)60955-6; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Winter AK, 2012, JAIDS IN PRESS	34	55	55	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53284	10.1371/journal.pone.0053284	http://dx.doi.org/10.1371/journal.pone.0053284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285274	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500128
J	Wang, T; Xu, C; Liu, YL; Fan, K; Li, ZH; Sun, X; Ouyang, H; Zhang, XC; Zhang, JH; Li, YJ; MacKenzie, F; Min, JR; Tu, XM				Wang, Tao; Xu, Chao; Liu, Yanli; Fan, Kai; Li, Zhihong; Sun, Xing; Ouyang, Hui; Zhang, Xuecheng; Zhang, Jiahai; Li, Yanjun; MacKenzie, Farrell; Min, Jinrong; Tu, Xiaoming			Crystal Structure of the Human SUV39H1 Chromodomain and Its Recognition of Histone H3K9me2/3	PLOS ONE			English	Article							METHYLTRANSFERASE SUV39H1; H3; COMPLEX; BINDING; METHYLATION; SPECIFICITY; PROTEINS; RECRUITMENT; REFINEMENT; MARKS	SUV39H1, the first identified histone lysine methyltransferase in human, is involved in chromatin modification and gene regulation. SUV39H1 contains a chromodomain in its N-terminus, which potentially plays a role in methyl-lysine recognition and SUV39H1 targeting. In this study, the structure of the chromodomain of human SUV39H1 was determined by X-ray crystallography. The SUV39H1 chromodomain displays a generally conserved structure fold compared with other solved chromodomains. However, different from other chromodomains, the SUV39H1 chromodomain possesses a much longer helix at its C-terminus. Furthermore, the SUV39H1 chromodomain was shown to recognize histone H3K9me2/3 specifically.	[Xu, Chao; Liu, Yanli; Li, Zhihong; Sun, Xing; Ouyang, Hui; Li, Yanjun; MacKenzie, Farrell; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Xu, Chao; Liu, Yanli; Li, Zhihong; Sun, Xing; Ouyang, Hui; Li, Yanjun; MacKenzie, Farrell; Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Wang, Tao; Fan, Kai; Zhang, Jiahai; Tu, Xiaoming] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Liu, Yanli; Min, Jinrong] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Zhang, Xuecheng] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	University of Toronto; Structural Genomics Consortium; University of Toronto; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Central China Normal University; Anhui University	Min, JR (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca; xmtu@ustc.edu.cn	Liu, Yanli/AAA-3283-2019; Xu, Chao/G-3885-2010; Tu, Xiaoming/G-5090-2018; Min, Jinrong/G-3449-2011	Liu, Yanli/0000-0003-0197-7617; Xu, Chao/0000-0003-0444-7080; Min, Jinrong/0000-0001-5210-3130; Poh, Yukkee/0000-0001-6925-8614	National Basic Research Program of China (973 Program) [2009CB918804]; Knowledge Innovation Program of the Chinese Academy of Science [KSCX2-EW-Q-4]; Chinese National Natural Science Foundations [31270780]; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Knowledge Innovation Program of the Chinese Academy of Science(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese National Natural Science Foundations(National Natural Science Foundation of China (NSFC)); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Basic Research Program of China (973 Program), grant number 2009CB918804, the Knowledge Innovation Program of the Chinese Academy of Science, grant number KSCX2-EW-Q-4, and the Chinese National Natural Science Foundations, grant number 31270780. This work was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that they received funding from commercial sources - GlaxoSmithKline and Merck & Co., Inc. However, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Chakraborty S, 2003, ONCOGENE, V22, P5229, DOI 10.1038/sj.onc.1206600; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025104; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nayak V., 2011, NUCLEUS, V2; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	38	56	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52977	10.1371/journal.pone.0052977	http://dx.doi.org/10.1371/journal.pone.0052977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285239	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500092
J	Kraaijeveld, AR; Layen, SJ; Futerman, PH; Godfray, HCJ				Kraaijeveld, Alex R.; Layen, Sophie J.; Futerman, Peter H.; Godfray, H. Charles J.			Lack of Phenotypic and Evolutionary Cross-Resistance against Parasitoids and Pathogens in Drosophila melanogaster	PLOS ONE			English	Article							IMMUNE-RESPONSE; GLYPTAPANTELES-LIPARIDIS; GEOGRAPHICAL VARIATION; HEMOCYTE CHANGES; ASOBARA-TABIDA; HOST-DEFENSE; TRADE-OFFS; LARVAE; INFECTION; ENCAPSULATION	Background: When organisms are attacked by multiple natural enemies, the evolution of a resistance mechanism to one natural enemy will be influenced by the degree of cross-resistance to another natural enemy. Cross-resistance can be positive, when a resistance mechanism against one natural enemy also offers resistance to another; or negative, in the form of a trade-off, when an increase in resistance against one natural enemy results in a decrease in resistance against another. Using Drosophila melanogaster, an important model system for the evolution of invertebrate immunity, we test for the existence of cross-resistance against parasites and pathogens, at both a phenotypic and evolutionary level. Methods: We used a field strain of D. melanogaster to test whether surviving parasitism by the parasitoid Asobara tabida has an effect on the resistance against Beauveria bassiana, an entomopathogenic fungus; and whether infection with the microsporidian Tubulinosema kingi has an effect on the resistance against A. tabida. We used lines selected for increased resistance to A. tabida to test whether increased parasitoid resistance has an effect on resistance against B. bassiana and T. kingi. We used lines selected for increased tolerance against B. bassiana to test whether increased fungal resistance has an effect on resistance against A. tabida. Results/Conclusions: We found no positive cross-resistance or trade-offs in the resistance to parasites and pathogens. This is an important finding, given the use of D. melanogaster as a model system for the evolution of invertebrate immunity. The lack of any cross-resistance to parasites and pathogens, at both the phenotypic and the evolutionary level, suggests that evolution of resistance against one class of natural enemies is largely independent of evolution of resistance against the other.	[Kraaijeveld, Alex R.; Layen, Sophie J.; Futerman, Peter H.; Godfray, H. Charles J.] Univ London Imperial Coll Sci Technol & Med, NERC Ctr Populat Biol, London, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Kraaijeveld, AR (corresponding author), Univ Southampton, Ctr Biol Sci, Highfield Campus, Southampton, Hants, England.	arkraa@soton.ac.uk			NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research described in this manuscript was not funded by a specific grant, but via a general recurrent budget from the institution where the work took place. The institution itself was funded by NERC (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Becnel James J., 1999, P447; BOULETREAU M, 1986, ENTOMOL EXP APPL, V41, P107, DOI 10.1007/BF00195565; Carton Y., 1986, P347; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; DAVID L, 1994, J INVERTEBR PATHOL, V63, P212, DOI 10.1006/jipa.1994.1039; Delpuech JM, 1994, CAN J ZOOL, V71, P584; Eslin P, 1996, CAN J ZOOL, V74, P2193, DOI 10.1139/z96-248; Fellowes MDE, 1999, EVOLUTION, V53, P966, DOI 10.2307/2640737; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P281, DOI 10.1046/j.1365-2311.1998.00137.x; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; FRAENKEL G, 1947, PROC R SOC SER B-BIO, V134, P111, DOI 10.1098/rspb.1947.0006; Futerman PH, 2006, PARASITOLOGY, V132, P479, DOI 10.1017/S0031182005009339; Fuxa J. R., 1993, PARASITES PATHOGENS, V2, P197; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hoch G, 2004, ENTOMOL EXP APPL, V113, P77, DOI 10.1111/j.0013-8703.2004.00203.x; Hoch G, 2000, J INVERTEBR PATHOL, V75, P59, DOI 10.1006/jipa.1999.4894; Hoch G, 2001, J INVERTEBR PATHOL, V77, P37, DOI 10.1006/jipa.2000.4987; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HUNTER GW, 1961, EXP PARASITOL, V11, P133, DOI 10.1016/0014-4894(61)90018-2; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Kraaijeveld AR, 2008, HEREDITY, V100, P400, DOI 10.1038/sj.hdy.6801092; Kraaijeveld Alex R., 2009, P187; Kraaijeveld AR, 2009, ADV PARASIT, V70, P257, DOI 10.1016/S0065-308X(09)70010-7; KRAAIJEVELD AR, 1995, EVOL ECOL, V9, P10, DOI 10.1007/BF01237692; KRAAIJEVELD AR, 1994, PHYSIOL ENTOMOL, V19, P9, DOI 10.1111/j.1365-3032.1994.tb01068.x; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kraaijeveld AR, 2002, PARASITOLOGY, V125, pS71, DOI 10.1017/S0031182002001750; KRAAIJEVELD AR, 1994, ECOL ENTOMOL, V19, P221, DOI 10.1111/j.1365-2311.1994.tb00413.x; Kurtz J, 2000, J INVERTEBR PATHOL, V75, P237, DOI 10.1006/jipa.1999.4909; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Labrosse C, 2003, J INSECT PHYSIOL, V49, P513, DOI 10.1016/S0022-1910(03)00054-4; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; LEVIN DA, 1976, ANNU REV ECOL SYST, V7, P121, DOI 10.1146/annurev.es.07.110176.001005; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Maleck K, 1999, TRENDS PLANT SCI, V4, P215, DOI 10.1016/S1360-1385(99)01415-6; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Moret Y, 2001, NATURE, V414, P506, DOI 10.1038/35107138; Moret Y, 2003, P ROY SOC LOND B BIO, V270, P2475; NAPPI AJ, 1981, PARASITOLOGY, V83, P319, DOI 10.1017/S0031182000085322; Poitrineau K, 2003, J EVOLUTION BIOL, V16, P1319, DOI 10.1046/j.1420-9101.2003.00585.x; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Rizki T.M., 1984, P579; RIZKI TM, 1994, ANN NY ACAD SCI, V712, P178, DOI 10.1111/j.1749-6632.1994.tb33572.x; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; Russo J, 2001, J INSECT PHYSIOL, V47, P167, DOI 10.1016/S0022-1910(00)00102-5; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tinsley MC, 2006, PARASITOLOGY, V132, P767, DOI 10.1017/S0031182006009929; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Vijendravarma RK, 2009, EVOLUTION, V63, P104, DOI 10.1111/j.1558-5646.2008.00516.x; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94	55	16	16	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e53002	10.1371/journal.pone.0053002	http://dx.doi.org/10.1371/journal.pone.0053002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285247	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000313158800111
J	Altshuler, I; Vaillant, JJ; Xu, S; Cristescu, ME				Altshuler, Ianina; Vaillant, James J.; Xu, Sen; Cristescu, Melania E.			The Evolutionary History of Sarco(endo)plasmic Calcium ATPase (SERCA)	PLOS ONE			English	Article							RETICULUM CA2+-ATPASE SERCA; FUNCTIONAL COMPARISONS; EXPRESSION; ISOFORMS; PUMPS; FAMILIES; BIOLOGY; CLONING	Investigating the phylogenetic relationships within physiologically essential gene families across a broad range of taxa can reveal the key gene duplication events underlying their family expansion and is thus important to functional genomics studies. P-Type II ATPases represent a large family of ATP powered transporters that move ions across cellular membranes and includes Na+/K+ transporters, H+/K+ transporters, and plasma membrane Ca2+ pumps. Here, we examine the evolutionary history of one such transporter, the Sarco(endo)plasmic reticulum calcium ATPase (SERCA), which maintains calcium homeostasis in the cell by actively pumping Ca2+ into the sarco(endo)plasmic reticulum. Our protein-based phylogenetic analyses across Eukaryotes revealed two monophyletic clades of SERCA proteins, one containing animals, fungi, and plants, and the other consisting of plants and protists. Our analyses suggest that the three known SERCA proteins in vertebrates arose through two major gene duplication events after the divergence from tunicates, but before the separation of fishes and tetrapods. In plants, we recovered two SERCA clades, one being the sister group to Metazoa and the other to Apicomplexa clade, suggesting an ancient duplication in an early eukaryotic ancestor, followed by subsequent loss of one copy in Opisthokonta, the other in protists, and retention of both in plants. We also report relatively recent and independent gene duplication events within invertebrate taxa including tunicates and the leech Helobdella robusta. Thus, it appears that both ancient and recent gene duplication events have played an important role in the evolution of this ubiquitous gene family across the eukaryotic domain.	[Altshuler, Ianina; Vaillant, James J.; Xu, Sen; Cristescu, Melania E.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Xu, Sen] Indiana Univ, Dept Biol, Bloomington, IN USA; [Cristescu, Melania E.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Windsor; Indiana University System; Indiana University Bloomington; McGill University	Altshuler, I (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	altshuli@uwindsor.ca	Altshuler, Ianina/O-3206-2019	Xu, Sen/0000-0002-1304-9968; Altshuler, Ianina/0000-0003-2235-1664; Cristescu, Melania/0000-0002-0854-4040	Natural Sciences and Engineering Council (NSERC) of Canada	Natural Sciences and Engineering Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Council (NSERC) of Canada grant to Melania E. Cristescu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldauf SL, 2000, SCIENCE, V290, P972, DOI 10.1126/science.290.5493.972; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Benito B, 2004, EUKARYOT CELL, V3, P359, DOI 10.1128/EC.3.2.359-368.2004; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; CAMPBELL AM, 1991, J BIOL CHEM, V266, P16050; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Corradi N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-21; Cristescu ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-268; East JM, 2000, MOL MEMBR BIOL, V17, P189, DOI 10.1080/09687680010009646; Edgecombe GD, 2010, ARTHROPOD STRUCT DEV, V39, P74, DOI 10.1016/j.asd.2009.10.002; ESCALANTE R, 1993, J BIOL CHEM, V268, P14090; Fan WM, 2007, ACTA BIOCH BIOPH SIN, V39, P722, DOI 10.1111/j.1745-7270.2007.00330.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Harzsch S, 2002, J COMP NEUROL, V453, P10, DOI 10.1002/cne.10375; Hovnanian A., 2007, V45, P337; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Jenner RA, 2010, ARTHROPOD STRUCT DEV, V39, P143, DOI 10.1016/j.asd.2009.11.001; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kabala K, 2005, ACTA PHYSIOL PLANT, V27, P559, DOI 10.1007/s11738-005-0062-y; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kourakis MJ, 2001, EVOL DEV, V3, P145, DOI 10.1046/j.1525-142x.2001.003003145.x; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; LINGREL JB, 1992, J BIOENERG BIOMEMBR, V24, P263; LYTTON J, 1992, J BIOL CHEM, V267, P14483; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Mandal A, 2009, J COMP PHYSIOL B, V179, P205, DOI 10.1007/s00360-008-0303-7; Martin V, 2002, J BIOL CHEM, V277, P24442, DOI 10.1074/jbc.M202011200; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; Talla E, 1998, J BIOL CHEM, V273, P27831, DOI 10.1074/jbc.273.43.27831; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Mark, 2005, MRBAYES 3 1 MANUAL, P1; VERBOOMEN H, 1992, BIOCHEM J, V286, P591, DOI 10.1042/bj2860591; von Reumont BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-119; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wuytack F, 2002, CELL CALCIUM, V32, P279, DOI 10.1016/S0143416002001847	52	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52617	10.1371/journal.pone.0052617	http://dx.doi.org/10.1371/journal.pone.0052617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285113	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500210
J	Gonzalez, G; Vituret, C; Di Pietro, A; Chanson, M; Boulanger, P; Hong, SS				Gonzalez, Gaelle; Vituret, Cyrielle; Di Pietro, Attilio; Chanson, Marc; Boulanger, Pierre; Hong, Saw-See			Microparticle-Mediated Transfer of the Viral Receptors CAR and CD46, and the CFTR Channel in a CHO Cell Model Confers New Functions to Target Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; STOMATITIS-VIRUS GLYCOPROTEIN; RETROVIRUS-LIKE PARTICLES; CYSTIC-FIBROSIS; MEASLES-VIRUS; IN-VITRO; ENDOTHELIAL MICROPARTICLES; MEMBRANE MICROPARTICLES; HORIZONTAL TRANSFER; EPITHELIAL-CELLS	Cell microparticles (MPs) released in the extracellular milieu can embark plasma membrane and intracellular components which are specific of their cellular origin, and transfer them to target cells. The MP-mediated, cell-to-cell transfer of three human membrane glycoproteins of different degrees of complexity was investigated in the present study, using a CHO cell model system. We first tested the delivery of CAR and CD46, two monospanins which act as adenovirus receptors, to target CHO cells. CHO cells lack CAR and CD46, high affinity receptors for human adenovirus serotype 5 (HAdV5), and serotype 35 (HAdV35), respectively. We found that MPs derived from CHO cells (MP-donor cells) constitutively expressing CAR (MP-CAR) or CD46 (MP-CD46) were able to transfer CAR and CD46 to target CHO cells, and conferred selective permissiveness to HAdV5 and HAdV35. In addition, target CHO cells incubated with MP-CD46 acquired the CD46-associated function in complement regulation. We also explored the MP-mediated delivery of a dodecaspanin membrane glycoprotein, the CFTR to target CHO cells. CFTR functions as a chloride channel in human cells and is implicated in the genetic disease cystic fibrosis. Target CHO cells incubated with MPs produced by CHO cells constitutively expressing GFP-tagged CFTR (MP-GFP-CFTR) were found to gain a new cellular function, the chloride channel activity associated to CFTR. Time-course analysis of the appearance of GFP-CFTR in target cells suggested that MPs could achieve the delivery of CFTR to target cells via two mechanisms: the transfer of mature, membrane-inserted CFTR glycoprotein, and the transfer of CFTR-encoding mRNA. These results confirmed that cell-derived MPs represent a new class of promising therapeutic vehicles for the delivery of bioactive macromolecules, proteins or mRNAs, the latter exerting the desired therapeutic effect in target cells via de novo synthesis of their encoded proteins.	[Gonzalez, Gaelle; Vituret, Cyrielle; Boulanger, Pierre; Hong, Saw-See] Univ Lyon 1, UCBL INRA EPHE, UMR Retrovirus & Comparat Pathol 754, F-69365 Lyon, France; [Vituret, Cyrielle; Di Pietro, Attilio] Univ Lyon 1, Equipe Labellise Ligue 2009, Inst Biol & Chim Prot FR 3302, CNRS,UMR 5086, F-69365 Lyon, France; [Chanson, Marc] Univ Hosp Geneva, Fac Med, Dept Pediat, Lab Clin Invest 3, Geneva, Switzerland; [Chanson, Marc] Univ Geneva, Fdn Med Res, Geneva, Switzerland; [Hong, Saw-See] Inst Natl Sante & Rech Med, Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Geneva; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hong, SS (corresponding author), Univ Lyon 1, UCBL INRA EPHE, UMR Retrovirus & Comparat Pathol 754, F-69365 Lyon, France.	saw-see.hong@univ-lyon1.fr	Boulanger, Pierre/AFV-2750-2022; Hong, Saw See/M-9818-2017	Hong, Saw See/0000-0001-8871-0901; Chanson, Marc/0000-0001-8104-2090	Cystic Fibrosis French Association [GT2009-2010-2011]; Swiss Science Foundation [310030_134907/1]	Cystic Fibrosis French Association; Swiss Science Foundation(Swiss National Science Foundation (SNSF))	The work in Lyon was financed by the Cystic Fibrosis French Association (VLM Contract GT2009-2010-2011). The work in Geneva was supported by grant #310030_134907/1 from the Swiss Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1998, J VIROL, V72, P6159, DOI 10.1128/JVI.72.7.6159-6163.1998; Ahn YS, 2008, THROMB HAEMOSTASIS, V99, P657, DOI 10.1160/TH08-03-0135; Arnberg N, 2009, REV MED VIROL, V19, P165, DOI 10.1002/rmv.612; Baj-Krzyworzeka M, 2002, EXP HEMATOL, V30, P450, DOI 10.1016/S0301-472X(02)00791-9; Baj-Krzyworzeka M, 2007, IMMUNOL LETT, V113, P76, DOI 10.1016/j.imlet.2007.07.014; Bartoszewski R, 2008, J BIOL CHEM, V283, P12154, DOI 10.1074/jbc.M707610200; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; Benameur T, 2009, PHARMACOL REP, V61, P49, DOI 10.1016/S1734-1140(09)70006-4; Benharouga M, 2001, J CELL BIOL, V153, P957, DOI 10.1083/jcb.153.5.957; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Beyer C, 2010, NAT REV RHEUMATOL, V6, P21, DOI 10.1038/nrrheum.2009.229; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Boulanger CM, 2010, CURR OPIN NEPHROL HY, V19, P177, DOI 10.1097/MNH.0b013e32833640fd; Bradbury Neil A., 1999, Physiological Reviews, V79, pS175; Buchholz CJ, 1997, J BIOL CHEM, V272, P22072, DOI 10.1074/jbc.272.35.22072; Chaput N, 2005, BLOOD CELL MOL DIS, V35, P111, DOI 10.1016/j.bcmd.2005.05.009; Chow YH, 2000, MOL THER, V2, P359, DOI 10.1006/mthe.2000.0135; Christiansen D, 2000, J VIROL, V74, P4672, DOI 10.1128/JVI.74.10.4672-4678.2000; Coclet-Ninin J, 2002, EXP LUNG RES, V28, P181, DOI 10.1080/019021402753570491; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Corjon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018205; D'Souza-Schorey C, 2012, GENE DEV, V26, P1287, DOI 10.1101/gad.192351.112; DaFonseca S, 2007, ANTIVIR THER, V12, P1185; DAINIAK N, 1988, BLOOD, V72, P165; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Devaux P, 1996, J GEN VIROL, V77, P1477, DOI 10.1099/0022-1317-77-7-1477; DHALLUIN JC, 1980, NUCLEIC ACIDS RES, V8, P1625, DOI 10.1093/nar/8.7.1625; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Farley DC, 2007, J GENE MED, V9, P345, DOI 10.1002/jgm.1022; Franqueville L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002894; GAGGAR A, 2003, NAT MED, V8, P746; Gerlier D, 2009, CURR TOP MICROBIOL, V329, P163; Granio O, 2007, AM J RESP CELL MOL, V37, P631, DOI 10.1165/rcmb.2007-0026TE; Granio O, 2010, HUM GENE THER, V21, P251, DOI 10.1089/hum.2009.056; Granio O, 2009, J VIROL, V83, P6048, DOI 10.1128/JVI.00012-09; Grumelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018785; Guibinga GH, 2002, MOL THER, V5, P538, DOI 10.1006/mthe.2002.0578; Guibinga GH, 2005, MOL THER, V11, P645, DOI 10.1016/j.ymthe.2004.12.002; Guo Y, 2009, J HISTOCHEM CYTOCHEM, V57, P1113, DOI 10.1369/jhc.2009.953455; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Heda GD, 2001, AM J PHYSIOL-CELL PH, V280, pC166, DOI 10.1152/ajpcell.2001.280.1.C166; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jimenez JJ, 2005, ADV CLIN CHEM, V39, P131, DOI 10.1016/S0065-2423(04)39005-0; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Koppler B, 2006, EUR J IMMUNOL, V36, P648, DOI 10.1002/eji.200535435; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Liu R, 2009, EUR J HAEMATOL, V83, P220, DOI 10.1111/j.1600-0609.2009.01271.x; Mack M, 2000, NAT MED, V6, P769, DOI 10.1038/77498; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Mohamed A, 1997, BIOCHEM J, V322, P259, DOI 10.1042/bj3220259; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Okimoto T, 2001, MOL THER, V4, P232, DOI 10.1006/mthe.2001.0443; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Roche S, 2008, CELL MOL LIFE SCI, V65, P1716, DOI 10.1007/s00018-008-7534-3; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Sandrin V, 2005, J GEN VIROL, V86, P3189, DOI 10.1099/vir.0.81428-0; Segerman A, 2003, J VIROL, V77, P9183, DOI 10.1128/JVI.77.17.9183-9191.2003; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Shet AS, 2008, VASC HEALTH RISK MAN, V4, P769, DOI 10.2147/VHRM.S955; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Stepien E, 2012, EXPERT OPIN THER TAR, V16, P677, DOI 10.1517/14728222.2012.691471; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Taieb J, 2005, CRIT REV IMMUNOL, V25, P215, DOI 10.1615/CritRevImmunol.v25.i3.30; Thomas GM, 2009, J EXP MED, V206, P1913, DOI 10.1084/jem.20082297; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2012, CURR OPIN LIPIDOL, V23, P91, DOI 10.1097/MOL.0b013e328350a425; Walters RW, 1999, J BIOL CHEM, V274, P10219, DOI 10.1074/jbc.274.15.10219; Yanagi Y, 2006, J GEN VIROL, V87, P2767, DOI 10.1099/vir.0.82221-0; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722	82	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52326	10.1371/journal.pone.0052326	http://dx.doi.org/10.1371/journal.pone.0052326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284987	gold, Green Published, Green Accepted			2022-12-25	WOS:000312794500143
J	Hussey, GS; Link, LA; Brown, AS; Howley, BV; Chaudhury, A; Howe, PH				Hussey, George S.; Link, Laura A.; Brown, Andrew S.; Howley, Breege V.; Chaudhury, Arindam; Howe, Philip H.			Establishment of a TGF beta-Induced Post-Transcriptional EMT Gene Signature	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MESSENGER-RNAS; CANCER PROGRESSION; BREAST-CANCER; HNRNP E1; EXPRESSION; METASTASIS; CELLS; IDENTIFICATION; TRANSLATION	A major challenge in the clinical management of human cancers is to accurately stratify patients according to risk and likelihood of a favorable response. Stratification is confounded by significant phenotypic heterogeneity in some tumor types, often without obvious criteria for subdivision. Despite intensive transcriptional array analyses, the identity and validation of cancer specific 'signature genes' remains elusive, partially because the transcriptome does not mirror the proteome. The simplification associated with transcriptomic profiling does not take into consideration changes in the relative expression among transcripts that arise due to post-transcriptional regulatory events. We have previously shown that TGF beta post-transcriptionally regulates epithelial-mesenchymal transition (EMT) by causing increased expression of two transcripts, Dab2 and ILEI, by modulating hnRNP E1 phosphorylation. Using a genome-wide combinatorial approach involving expression profiling and RIP-Chip analysis, we have identified a cohort of translationally regulated mRNAs that are induced during TGF beta-mediated EMT. Coordinated translational regulation by hnRNP E1 constitutes a post-transcriptional regulon inhibiting the expression of related EMT-facilitating genes, thus enabling the cell to rapidly and coordinately regulate multiple EMT-facilitating genes. Citation: Hussey GS, Link LA, Brown AS, Howley BV, Chaudhury A, et al. (2012) Establishment of a TGF beta-Induced Post-Transcriptional EMT Gene Signature. PLoS ONE 7(12): e52624. doi:10.1371/journal.pone.0052624	[Hussey, George S.; Link, Laura A.; Brown, Andrew S.; Howley, Breege V.; Howe, Philip H.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Hussey, George S.; Link, Laura A.; Brown, Andrew S.; Howley, Breege V.; Howe, Philip H.] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC USA; [Hussey, George S.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Link, Laura A.; Brown, Andrew S.] Kent State Univ, Dept Biomed Sci, Kent, OH 44242 USA; [Chaudhury, Arindam] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; Cleveland State University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Baylor College of Medicine	Howe, PH (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	howep@musc.edu		Chaudhury, Arindam/0000-0001-5916-4534; CHAUDHURY, ARINDAM/0000-0002-5625-5278	National Cancer Institute [CA55536, CA154663]; American Heart Association [10PRE3870024]; NATIONAL CANCER INSTITUTE [R01CA055536, R29CA055536, R01CA154663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA55536 and CA154663 from the National Cancer Institute (to Philip H. Howe) (http://www.cancer.gov/). George S. Hussey was supported by an American Heart Association (Great Rivers Affiliate) Pre-doctoral Fellowship 10PRE3870024 (http://www.heart.org/HEARTORG/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnoy S, 2000, BIOCHEM J, V351, P413, DOI 10.1042/0264-6021:3510413; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Evdokimova V, 2012, SEMIN CANCER BIOL, V22, P437, DOI 10.1016/j.semcancer.2012.04.007; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazumder B, 1999, MOL CELL BIOL, V19, P6898; Merrick W C, 2001, Curr Protoc Cell Biol, VChapter 11, DOI 10.1002/0471143030.cb1109s08; Merritt C, 2008, CURR BIOL, V18, P1476, DOI 10.1016/j.cub.2008.08.013; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Penalva Luiz O F, 2004, Methods Mol Biol, V257, P125, DOI 10.1385/1-59259-750-5:125; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200; REICHMANN E, 1992, CELL, V71, P1103, DOI 10.1016/S0092-8674(05)80060-1; Reimann I, 2002, J MOL BIOL, V315, P965, DOI 10.1006/jmbi.2001.5315; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vyas K, 2009, MOL CELL BIOL, V29, P458, DOI 10.1128/MCB.00824-08; Waerner T, 2006, CANCER CELL, V10, P227, DOI 10.1016/j.ccr.2006.07.020; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Wang CC, 2012, HISTOPATHOLOGY, V61, P78, DOI 10.1111/j.1365-2559.2012.04204.x; Wang HH, 2010, CANCER CELL, V18, P52, DOI 10.1016/j.ccr.2010.04.028; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	43	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52624	10.1371/journal.pone.0052624	http://dx.doi.org/10.1371/journal.pone.0052624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285117	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500212
J	Leibly, DJ; Nguyen, TN; Kao, LT; Hewitt, SN; Barrett, LK; Van Voorhis, WC				Leibly, David J.; Trang Nhu Nguyen; Kao, Louis T.; Hewitt, Stephen N.; Barrett, Lynn K.; Van Voorhis, Wesley C.			Stabilizing Additives Added during Cell Lysis Aid in the Solubilization of Recombinant Proteins	PLOS ONE			English	Article							STRUCTURAL GENOMICS CENTER; MALTOSE-BINDING PROTEIN; THERMAL-STABILITY; MOLECULAR-MECHANISM; ESCHERICHIA-COLI; GLYCINE BETAINE; FUSION PROTEINS; AGGREGATION; TREHALOSE; ARGININE	Insoluble recombinant proteins are a major issue for both structural genomics and enzymology research. Greater than 30% of recombinant proteins expressed in Escherichia coli (E. coli) appear to be insoluble. The prevailing view is that insolubly expressed proteins cannot be easily solubilized, and are usually sequestered into inclusion bodies. However, we hypothesize that small molecules added during the cell lysis stage can yield soluble protein from insoluble protein previously screened without additives or ligands. We present a novel screening method that utilized 144 additive conditions to increase the solubility of recombinant proteins expressed in E. coli. These selected additives are natural ligands, detergents, salts, buffers, and chemicals that have been shown to increase the stability of proteins in vivo. We present the methods used for this additive solubility screen and detailed results for 41 potential drug target recombinant proteins from infectious organisms. Increased solubility was observed for 80% of the recombinant proteins during the primary and secondary screening of lysis with the additives; that is 33 of 41 target proteins had increased solubility compared with no additive controls. Eleven additives (trehalose, glycine betaine, mannitol, L-Arginine, potassium citrate, CuCl2, proline, xylitol, NDSB 201, CTAB and K2PO4) solubilized more than one of the 41 proteins; these additives can be easily screened to increase protein solubility. Large-scale purifications were attempted for 15 of the proteins using the additives identified and eight (40%) were prepared for crystallization trials during the first purification attempt. Thus, this protocol allowed us to recover about a third of seemingly insoluble proteins for crystallography and structure determination. If recombinant proteins are required in smaller quantities or less purity, the final success rate may be even higher.	[Leibly, David J.; Trang Nhu Nguyen; Kao, Louis T.; Hewitt, Stephen N.; Barrett, Lynn K.; Van Voorhis, Wesley C.] Univ Washington, Sch Med, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; [Leibly, David J.; Trang Nhu Nguyen; Kao, Louis T.; Hewitt, Stephen N.; Barrett, Lynn K.; Van Voorhis, Wesley C.] Seattle Struct Genom Ctr Infect Dis SSGCID, Seattle, WA USA	University of Washington; University of Washington Seattle	Van Voorhis, WC (corresponding author), Univ Washington, Sch Med, Dept Allergy & Infect Dis, Seattle, WA 98195 USA.	wesley@uw.edu			National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services [HHSN272200700057C]	National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded under Federal Contract No. HHSN272200700057C from the National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bandyopadhyay A, 2012, NAT CHEM BIOL, V8, P238, DOI [10.1038/NCHEMBIO.768, 10.1038/nchembio.768]; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Bryan CM, 2011, ACTA CRYSTALLOGR F, V67, P1010, DOI 10.1107/S1744309111018367; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; Choi R, 2011, ACTA CRYSTALLOGR F, V67, P998, DOI 10.1107/S1744309111017374; Collins T, 2006, ANAL BIOCHEM, V352, P299, DOI 10.1016/j.ab.2006.01.035; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; de Lencastre Novaes L. C., 2010, BIOTECHNOL PROGR, V27, P269; Derewenda ZS, 2004, METHODS, V34, P354, DOI 10.1016/j.ymeth.2004.03.024; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Expert-Bezancon N, 2003, BIOPHYS CHEM, V100, P469, DOI 10.1016/S0301-4622(02)00299-5; Fisher MT, 2006, P NATL ACAD SCI USA, V103, P13265, DOI 10.1073/pnas.0606106103; Ghosh R, 2009, BIOCHEMISTRY-US, V48, P1135, DOI 10.1021/bi802065j; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Hu CY, 2010, PROTEINS, V78, P695, DOI 10.1002/prot.22598; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Jain N. K., 2010, CURR PROTOC PROTEIN, V59, DOI [DOI 10.1002/0471140864.PS0409S59, 10.1002/0471140864.ps0409s59]; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jensen WA, 1996, BBA-PROTEIN STRUCT M, V1296, P23, DOI 10.1016/0167-4838(96)00049-0; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kaushik JK, 1998, J PHYS CHEM B, V102, P7058, DOI 10.1021/jp981119l; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Lawal OS, 2006, FOOD CHEM, V95, P101, DOI 10.1016/j.foodchem.2004.12.041; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Mello CC, 2003, PROTEIN SCI, V12, P1522, DOI 10.1110/ps.0372903; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Miller L K, 1988, Biotechnology, V10, P457; Myler P. J., 2009, Infectious Disorders - Drug Targets, V9, P493; PALEG LG, 1984, PLANT PHYSIOL, V75, P974, DOI 10.1104/pp.75.4.974; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Remmele RL, 1998, PHARMACEUT RES, V15, P200; Rishi V, 1998, BIOCHEM J, V329, P137, DOI 10.1042/bj3290137; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; Schneider CP, 2011, J PHYS CHEM B, V115, P7447, DOI 10.1021/jp111920y; Singh LR, 2009, BBA-PROTEINS PROTEOM, V1794, P929, DOI 10.1016/j.bbapap.2009.02.005; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tiwari A, 2006, BIOPHYS CHEM, V124, P90, DOI 10.1016/j.bpc.2006.06.003; WILLIAMS DC, 1982, SCIENCE, V215, P687, DOI 10.1126/science.7036343; Won CM, 1998, INT J PHARM, V167, P25; Yee A, 2003, ACCOUNTS CHEM RES, V36, P183, DOI 10.1021/ar010126g; Zhao DX, 2007, CHINESE CHEM LETT, V18, P355, DOI 10.1016/j.cclet.2007.01.017; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	54	62	69	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52482	10.1371/journal.pone.0052482	http://dx.doi.org/10.1371/journal.pone.0052482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285060	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500180
J	Lindstrom, MS				Lindstrom, Mikael S.			Elucidation of Motifs in Ribosomal Protein S9 That Mediate Its Nucleolar Localization and Binding to NPM1/Nucleophosmin	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; NUCLEAR IMPORT; MESSENGER-RNA; GRANULAR COMPONENT; B23; BIOGENESIS; ARF; NUCLEOPHOSMIN; REVEALS; IDENTIFICATION	Biogenesis of eukaryotic ribosomes occurs mainly in a specific subnuclear compartment, the nucleolus, and involves the coordinated assembly of ribosomal RNA and ribosomal proteins. Identification of amino acid sequences mediating nucleolar localization of ribosomal proteins may provide important clues to understand the early steps in ribosome biogenesis. Human ribosomal protein S9 (RPS9), known in prokaryotes as RPS4, plays a critical role in ribosome biogenesis and directly binds to ribosomal RNA. RPS9 is targeted to the nucleolus but the regions in the protein that determine its localization remains unknown. Cellular expression of RPS9 deletion mutants revealed that it has three regions capable of driving nuclear localization of a fused enhanced green fluorescent protein (EGFP). The first region was mapped to the RPS9 N-terminus while the second one was located in the proteins C-terminus. The central and third region in RPS9 also behaved as a strong nucleolar localization signal and was hence sufficient to cause accumulation of EGFP in the nucleolus. RPS9 was previously shown to interact with the abundant nucleolar chaperone NPM1 (nucleophosmin). Evaluating different RPS9 fragments for their ability to bind NPM1 indicated that there are two binding sites for NPM1 on RPS9. Enforced expression of NPM1 resulted in nucleolar accumulation of a predominantly nucleoplasmic RPS9 mutant. Moreover, it was found that expression of a subset of RPS9 deletion mutants resulted in altered nucleolar morphology as evidenced by changes in the localization patterns of NPM1, fibrillarin and the silver stained nucleolar organizer regions. In conclusion, RPS9 has three regions that each are competent for nuclear localization, but only the central region acted as a potent nucleolar localization signal. Interestingly, the RPS9 nucleolar localization signal is residing in a highly conserved domain corresponding to a ribosomal RNA binding site.	Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Lindstrom, MS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	mikael.lindstrom@ki.se	Lindström, Mikael S/AAA-1451-2019	Lindström, Mikael S/0000-0003-1148-8497	Eke Wiberg foundation; Karolinska Institutet funds; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden); Swedish research council VR-MH project [K2012-99X-21969-01-3]	Eke Wiberg foundation; Karolinska Institutet funds; Magnus Bergvall's foundation; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish research council VR-MH project	This study was made possible with financial support to M. L. from the Eke Wiberg foundation, Karolinska Institutet funds, and Magnus Bergvall's foundation. M. L. was a recipient of a fellowship award from the Swedish Cancer Society (Cancerfonden) 2007-2010, and is presently supported by the Swedish research council VR-MH project grant number K2012-99X-21969-01-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Amin MA, 2008, BIOCHEM J, V415, P345, DOI 10.1042/BJ20081411; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; BAKER AM, 1995, J BIOL CHEM, V270, P22939, DOI 10.1074/jbc.270.39.22939; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Chan HJ, 2005, BIOCHEM BIOPH RES CO, V333, P396, DOI 10.1016/j.bbrc.2005.04.176; Chang SN, 2000, FEBS LETT, V484, P22, DOI 10.1016/S0014-5793(00)02118-9; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Davies C, 1998, EMBO J, V17, P4545, DOI 10.1093/emboj/17.16.4545; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; DERENZINI M, 1992, HISTOCHEM J, V24, P951, DOI 10.1007/BF01046500; Eirin-Lopez JM, 2006, GENETICS, V173, P1835, DOI 10.1534/genetics.106.058990; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Enomoto T, 2006, J BIOL CHEM, V281, P18463, DOI 10.1074/jbc.M602788200; Falini B, 2006, BLOOD, V107, P4514, DOI 10.1182/blood-2005-11-4745; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Gallo S, 2011, IN VITRO CELL DEV-AN, V47, P132, DOI 10.1007/s11626-010-9370-7; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Goyal P, 2006, J BIOL CHEM, V281, P25223, DOI 10.1074/jbc.M603399200; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Hingorani K, 2000, J BIOL CHEM, V275, P24451, DOI 10.1074/jbc.M003278200; HUGLE B, 1985, J CELL BIOL, V100, P873, DOI 10.1083/jcb.100.3.873; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kubota S, 1999, ONCOGENE, V18, P1503, DOI 10.1038/sj.onc.1202429; Kundu-Michalik S, 2008, MOL BIOL EVOL, V25, P580, DOI 10.1093/molbev/msn002; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Latonen L, 2011, ONCOGENE, V30, P790, DOI 10.1038/onc.2010.469; Lechertier T, 2007, J CELL SCI, V120, P265, DOI 10.1242/jcs.03345; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Lindstrom MS, 2010, SILENCING RIBOSOMAL; Lohrum MAE, 2000, NAT CELL BIOL, V2, P179, DOI 10.1038/35004057; Markus MA, 1998, EMBO J, V17, P4559, DOI 10.1093/emboj/17.16.4559; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Mekhail K, 2007, MOL BIOL CELL, V18, P3966, DOI 10.1091/mbc.E07-03-0295; Michael WM, 1996, J BIOL CHEM, V271, P11571, DOI 10.1074/jbc.271.19.11571; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nishimura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2239, DOI 10.1271/bbb.66.2239; O'Donohue MF, 2010, J CELL BIOL, V190, P853, DOI 10.1083/jcb.201005117; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Perera Y, 2009, MOL CANCER THER, V5, P5; PERRY RP, 1968, J CELL PHYSIOL, V72, P235, DOI 10.1002/jcp.1040720311; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Pnueli L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-285; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; Rosorius O, 2000, J BIOL CHEM, V275, P12061, DOI 10.1074/jbc.275.16.12061; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SCHMIDT C, 1995, MOL BIOL CELL, V6, P1875, DOI 10.1091/mbc.6.12.1875; Scott MS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-317; Scott MS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-74; Scott MS, 2010, NUCLEIC ACIDS RES, V38, P7388, DOI 10.1093/nar/gkq653; Staker BL, 2000, EMBO J, V19, P749, DOI 10.1093/emboj/19.4.749; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Szebeni A, 1997, BIOCHEMISTRY-US, V36, P3941, DOI 10.1021/bi9627931; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; Timmers ACJ, 1999, FEBS LETT, V452, P335, DOI 10.1016/S0014-5793(99)00669-9; TSAY YF, 1994, J BIOL CHEM, V269, P7579; VALDEZ BC, 1994, J BIOL CHEM, V269, P23776; VINCENT A, 1992, GENETICS, V132, P375; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	83	19	19	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52476	10.1371/journal.pone.0052476	http://dx.doi.org/10.1371/journal.pone.0052476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285058	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500179
J	Law, LNC; Zentner, M				Law, Lily N. C.; Zentner, Marcel			Assessing Musical Abilities Objectively: Construction and Validation of the Profile of Music Perception Skills	PLOS ONE			English	Article							TEMPORAL RESOLUTION; RECOGNITION; LEVEL; CHILDREN; MEMORY; PITCH; TIME; NEGATIVITY; SEQUENCES; EMOTIONS	A common approach for determining musical competence is to rely on information about individuals' extent of musical training, but relying on musicianship status fails to identify musically untrained individuals with musical skill, as well as those who, despite extensive musical training, may not be as skilled. To counteract this limitation, we developed a new test battery (Profile of Music Perception Skills; PROMS) that measures perceptual musical skills across multiple domains: tonal (melody, pitch), qualitative (timbre, tuning), temporal (rhythm, rhythm-to-melody, accent, tempo), and dynamic (loudness). The PROMS has satisfactory psychometric properties for the composite score (internal consistency and test-retest r>.85) and fair to good coefficients for the individual subtests (.56 to.85). Convergent validity was established with the relevant dimensions of Gordon's Advanced Measures of Music Audiation and Musical Aptitude Profile (melody, rhythm, tempo), the Musical Ear Test (rhythm), and sample instrumental sounds (timbre). Criterion validity was evidenced by consistently sizeable and significant relationships between test performance and external musical proficiency indicators in all three studies (.38 to.62, p<.05 to p<.01). An absence of correlations between test scores and a nonmusical auditory discrimination task supports the battery's discriminant validity (-.05, ns). The interrelationships among the various subtests could be accounted for by two higher order factors, sequential and sensory music processing. A brief version of the full PROMS is introduced as a time-efficient approximation of the full version of the battery.	[Law, Lily N. C.; Zentner, Marcel] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	Zentner, M (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	m.zentner@psych.york.ac.uk	Zentner, Marcel/C-7106-2011		Holbeck Foundation, York	Holbeck Foundation, York	This research was supported in part by a grant from the Holbeck Foundation, York. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1966, MUSICAL ABILITY CHIL; [Anonymous], 2011, LOG PRO 9 LOG STUD C; Bertoli S, 2002, CLIN NEUROPHYSIOL, V113, P396, DOI 10.1016/S1388-2457(02)00013-5; British Society of Audiology, 2004, PUR TON AIR BON COND; Brown S, PSYCHOL MUS IN PRESS; Carson AD, 1998, J CAREER ASSESSMENT, V6, P311, DOI 10.1177/106907279800600303; Cook ND, 2009, MUSIC PERCEPT, V27, P25, DOI 10.1525/MP.2009.27.1.25; Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700; Cross I., 2007, OXFORD HDB EVOLUTION, P649, DOI DOI 10.1093/OXFORDHB/9780198568308.013.0045; Dahl S., 2003, P STOCKH MUS AC C SM, V2, P595; DOWLING WJ, 1995, PERCEPT PSYCHOPHYS, V57, P136, DOI 10.3758/BF03206500; Dreyer AA, 2008, J ACOUST SOC AM, V123, pEL1, DOI 10.1121/1.2820442; Ericsson KA, 2005, J EDUC GIFTED, V28, P287, DOI 10.4219/jeg-2005-335; Fabiani M, 2011, J ACOUST SOC AM, V130, pEL193, DOI 10.1121/1.3633687; Frey MC, 2004, PSYCHOL SCI, V15, P373, DOI 10.1111/j.0956-7976.2004.00687.x; Gabrielsson A, 1996, PSYCHOL MUSIC, V24, P69; Gagne F., 1999, PSYCHOL MUSIC, V27, P38, DOI [10.1177/0305735699271004, DOI 10.1177/0305735699271004]; Gaser C, 2003, J NEUROSCI, V23, P9240; Geringer JM, 2007, J RES MUSIC EDUC, V55, P289, DOI 10.1177/0022429408317366; Gibson C, 2009, BRAIN COGNITION, V69, P162, DOI 10.1016/j.bandc.2008.07.009; GLASBERG BR, 1992, HEARING RES, V64, P81, DOI 10.1016/0378-5955(92)90170-R; GLASBERG BR, 1989, SCAND AUDIOL, P1; Gordon E., 1965, B COUNC RES MUSIC ED, V6, P12; Gordon Edwin, 1990, PREDICTIVE VALIDITY; Gordon EE, 1995, MANUAL MUSICAL APTIT; Hailstone JC, 2009, Q J EXP PSYCHOL, V62, P2141, DOI 10.1080/17470210902765957; HALL JW, 1994, J ACOUST SOC AM, V96, P150, DOI 10.1121/1.410474; Haynes S.N., 2000, APPL CLIN P; Helmbold N., 2005, J INDIVID DIFFER, V26, P74, DOI [10.1027/1614-0001.26.2.74, DOI 10.1027/1614-0001.26.2.74]; Horwitz AR, 2011, J ACOUST SOC AM, V130, P2928, DOI 10.1121/1.3643829; HURFORD DP, 1990, J LEARN DISABIL, V23, P564, DOI 10.1177/002221949002300906; Jensen AR, 1998, EDUC PSYCHO, P111; Jones MR, 2010, SPRINGER HANDB AUDIT, V36, P1, DOI 10.1007/978-1-4419-6114-3_1; Kang R, 2009, EAR HEARING, V30, P411, DOI 10.1097/AUD.0b013e3181a61bc0; Karma K, 1973, RES B, V1; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Keating P., 2005, D PRIME SIGNAL DETEC; Kidd GR, 2007, J ACOUST SOC AM, V122, P418, DOI 10.1121/1.2743154; Kirby JR, 2003, J EDUC PSYCHOL, V80, P437; Lee CY, 2008, J ACOUST SOC AM, V124, P3235, DOI 10.1121/1.2990713; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LICKLIDER JCR, 1954, J ACOUST SOC AM, V26, P945, DOI 10.1121/1.1928005; Lima CF, 2011, EMOTION, V11, P1021, DOI 10.1037/a0024521; Macmillan N. A., 2005, DETECTION THEORY USE; McDermott H, 2012, SPRINGER HDB AUDITOR, V39, P305; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Micheyl C, 2008, PSYCHOL REV, V115, P1069, DOI 10.1037/a0013572; Moelants D, 2002, P 7 INT C MUSIC PERC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Mullensiefen D, 2012, 12 INT C MUS PERC CO; Muluk NB, 2011, AURIS NASUS LARYNX, V38, P6, DOI 10.1016/j.anl.2010.05.007; Murphy C., 1999, BRIT J MUSICAL ED, V16, P39, DOI DOI 10.1017/S0265051799000133; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Nettl Bruno, 2005, STUDY ETHNOMUSICOLOG; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Prince JB, 2009, J EXP PSYCHOL HUMAN, V35, P1598, DOI 10.1037/a0016456; Rammsayer T. H., 2003, PSYCHOL MUSIC, V31, P123, DOI [DOI 10.1177/0305735603031002290, 10.1177/0305735603031002290]; RATCLIFF R, 1994, J EXP PSYCHOL LEARN, V20, P763, DOI 10.1037/0278-7393.20.4.763; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Schulze K, 2012, MUSIC PERCEPT, V29, P255, DOI 10.1525/MP.2012.29.3.255; Seashore C. E., 1960, 2 REVISION MANUAL IN; Shuter-Dyson Rosamund., 1999, PSYCHOL MUSIC, V2nd ed., P627; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Sloboda J. A., 2000, MUSIC MIND SCI, P220; Sloboda J.A., 1991, PSYCHOL MUSIC, V19, P3, DOI [DOI 10.1177/0305735691191001, 10.1177/0305735691191001]; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Watt Roger J., 1998, MUSIC SCI, V2, P33, DOI [10.1177/102986499800200103, DOI 10.1177/102986499800200103]; Weise A, 2012, BRAIN RES, V1439, P73, DOI 10.1016/j.brainres.2011.12.044; WIGHTMAN F, 1989, CHILD DEV, V60, P611, DOI 10.1111/j.1467-8624.1989.tb02742.x; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Wing H., 1948, TESTS MUSICAL ABILIT; Wing H.D., 1968, TESTS MUSICAL ABILIT, V2nd ed.; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140; Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0	79	115	118	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52508	10.1371/journal.pone.0052508	http://dx.doi.org/10.1371/journal.pone.0052508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285071	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500032
J	Lima, MR; Macedo, RHF; Martins, TLF; Schrey, AW; Martin, LB; Bensch, S				Lima, Marcos R.; Macedo, Regina H. F.; Martins, Thais L. F.; Schrey, Aaron W.; Martin, Lynn B.; Bensch, Staffan			Genetic and Morphometric Divergence of an Invasive Bird: The Introduced House Sparrow (Passer domesticus) in Brazil	PLOS ONE			English	Article							STARLING STURNUS-VULGARIS; NEW-ZEALAND POPULATIONS; FOUNDER EVENTS; DIFFERENTIATION; EVOLUTION; NORTH; DIVERSITY; SOFTWARE; BIOLOGY; SIZE	Introduced species are interesting systems for the study of contemporary evolution in new environments because of their spatial and temporal scales. For this study we had three aims: (i) to determine how genetic diversity and genetic differentiation of introduced populations of the house sparrow (Passer domesticus) in Brazil varies with range expansion, (ii) to determine how genetic diversity and differentiation in Brazil compares to ancestral European populations; and (iii) to determine whether selection or genetic drift has been more influential on phenotypic divergence. We used six microsatellite markers to genotype six populations from Brazil and four populations from Europe. We found slightly reduced levels of genetic diversity in Brazilian compared to native European populations. However, among introduced populations of Brazil, we found no association between genetic diversity and time since introduction. Moreover, overall genetic differentiation among introduced populations was low indicating that the expansion took place from large populations in which genetic drift effects would likely have been weak. We found significant phenotypic divergence among sites in Brazil. Given the absence of a spatial genetic pattern, divergent selection and not genetic drift seems to be the main force behind most of the phenotypic divergence encountered. Unravelling whether microevolution (e.g., allele frequency change), phenotypic plasticity, or both mediated phenotypic divergence is challenging and will require experimental work (e.g., common garden experiments or breeding programs).	[Bensch, Staffan] Lund Univ, Dept Biol, Lund, Sweden; [Lima, Marcos R.] Univ Brasilia, Dept Ecol IB, Brasilia, DF, Brazil; [Macedo, Regina H. F.] Univ Brasilia, Dept Zool IB, Brasilia, DF, Brazil; [Martins, Thais L. F.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Schrey, Aaron W.; Martin, Lynn B.] Univ S Florida, Dept Integrat Biol, Tampa, FL USA	Lund University; Universidade de Brasilia; Universidade de Brasilia; University of Exeter; State University System of Florida; University of South Florida	Bensch, S (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Staffan.Bensch@biol.lu.se	Macedo, Regina/GSE-3916-2022; Lima, Marcos/A-4931-2013; Macedo, Regina H. F./C-1411-2013; Lima, Marcos Robalinho/R-8966-2019; Martin, Lynn/C-2037-2009	Lima, Marcos/0000-0002-5901-0911; Macedo, Regina H. F./0000-0003-3510-9172; Lima, Marcos Robalinho/0000-0002-5901-0911; Martin, Lynn/0000-0002-5887-4937; Schrey, Aaron/0000-0002-2165-7349	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BEX 5066/10-7]; The British Ecological Society; National Science Foundation [0920475]; Swedish Research Council [621-2010-5277]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); The British Ecological Society; National Science Foundation(National Science Foundation (NSF)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior awarded MRL a sandwich scholarship (Proc No: BEX 5066/10-7), The British Ecological Society to TLFM funded parts of the field work, National Science Foundation (No: 0920475) to LBM and the Swedish Research Council to SB funded parts of the laboratory work (No: 621-2010-5277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; BAKER AJ, 1987, EVOLUTION, V41, P525, DOI 10.1111/j.1558-5646.1987.tb05823.x; BAKER AJ, 1980, EVOLUTION, V34, P638, DOI 10.1111/j.1558-5646.1980.tb04003.x; BAKER AJ, 1992, EVOLUTION, V46, P1784, DOI 10.1111/j.1558-5646.1992.tb01169.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Borges Sergio Henrique, 1996, Ararajuba, V4, P116; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Cabe PR, 1998, HEREDITY, V80, P519, DOI 10.1038/sj.hdy.6882960; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cornuet JM, 1996, GENETICS, V144, P2001; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; DASILVA JMC, 1990, WILSON BULL, V102, P309; Dawson D, 2006, MOL ECOL, V15; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duncan RP, 2003, ANNU REV ECOL EVOL S, V34, P71, DOI 10.1146/annurev.ecolsys.34.011802.132353; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filzmoser P, 2011, MVOUTLIER MULTIVARIA; Goodman SJ, 1997, MOL ECOL, V6, P881, DOI 10.1046/j.1365-294X.1997.00260.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Griffith SC, 1999, BIOL J LINN SOC, V68, P303, DOI 10.1111/j.1095-8312.1999.tb01171.x; Hawley DM, 2006, MOL ECOL, V15, P263, DOI 10.1111/j.1365-294X.2005.02767.x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Huey RB, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P139; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jensen H, 2003, J EVOLUTION BIOL, V16, P1296, DOI 10.1046/j.1420-9101.2003.00614.x; JOHNSTON RE, 1971, EVOLUTION, V25, P1, DOI 10.1111/j.1558-5646.1971.tb01855.x; JOHNSTON RF, 1973, AM NAT, V107, P373, DOI 10.1086/282841; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kekkonen J, 2011, HEREDITY, V106, P183, DOI 10.1038/hdy.2010.32; Kekkonen J, 2012, IBIS, V154, P846, DOI 10.1111/j.1474-919X.2012.01252.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Loiseau C, 2009, MOL ECOL, V18, P1331, DOI 10.1111/j.1365-294X.2009.04105.x; Long JL, 1981, INTRO BIRDS WORLD; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; Merila J, 1996, HEREDITY, V77, P410, DOI 10.1038/hdy.1996.161; Moulton MP, 2010, BIOL INVASIONS, V12, P2955, DOI 10.1007/s10530-010-9692-0; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Neumann K, 1996, MOL ECOL, V5, P307; Oksanen J, 2011, VEGAN COMMUNITY ECOL, P20; PARKIN DT, 1985, HEREDITY, V54, P15, DOI 10.1038/hdy.1985.4; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Ramakrishnan AP, 2010, MOL ECOL, V19, P1134, DOI 10.1111/j.1365-294X.2010.04543.x; ROSS HA, 1983, J ZOOL, V201, P351; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sambrook J, 2001, MOL CLONING LAB MANU; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schrey AW, 2011, MOL ECOL, V20, P1133, DOI 10.1111/j.1365-294X.2011.05001.x; Sick H, 2001, ORNITOLOGIA BRASILEI; SICK HELMUT, 1959, BOL MUS NAC RIO DE JANEIRO ZOOL, V207, P1; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; SLATKIN M, 1995, GENETICS, V139, P457; SMITH NJH, 1980, CONDOR, V82, P109, DOI 10.2307/1366801; SMITH NJH, 1973, CONDOR, V75, P242, DOI 10.2307/1365873; SPITZE K, 1993, GENETICS, V135, P367; STLOUIS VL, 1988, EVOLUTION, V42, P266, DOI 10.1111/j.1558-5646.1988.tb04131.x; Suarez AV, 2008, MOL ECOL, V17, P351, DOI 10.1111/j.1365-294X.2007.03456.x; Taylor DR, 2007, EVOLUTION, V61, P334, DOI 10.1111/j.1558-5646.2007.00037.x; Uller T, 2011, GLOBAL CHANGE BIOL, V17, P3478, DOI 10.1111/j.1365-2486.2011.02509.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x	75	13	14	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53332	10.1371/journal.pone.0053332	http://dx.doi.org/10.1371/journal.pone.0053332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285283	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500137
J	Trejo-Becerril, C; Perez-Cardenas, E; Taja-Chayeb, L; Anker, P; Herrera-Goepfert, R; Medina-Velazquez, LA; Hidalgo-Miranda, A; Perez-Montiel, D; Chavez-Blanco, A; Cruz-Velazquez, J; Diaz-Chavez, J; Gaxiola, M; Duenas-Gonzalez, A				Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Anker, Philippe; Herrera-Goepfert, Roberto; Medina-Velazquez, Luis A.; Hidalgo-Miranda, Alfredo; Perez-Montiel, Delia; Chavez-Blanco, Alma; Cruz-Velazquez, Judith; Diaz-Chavez, Jose; Gaxiola, Miguel; Duenas-Gonzalez, Alfonso			Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model	PLOS ONE			English	Article							FREE NUCLEIC-ACIDS; DIRECT DNA UPTAKE; ENZYME THERAPY; TRANSFORMATION; PLASMA; ORIGIN; CELLS; INFORMATION; LYMPHOCYTES; DROSOPHILA	It is known that cancer progresses by vertical gene transfer, but this paradigm ignores that DNA circulates in higher organisms and that it is biologically active upon its uptake by recipient cells. Here we confirm previous observations on the ability of cell-free DNA to induce in vitro cell transformation and tumorigenesis by treating NIH3T3 recipient murine cells with serum of colon cancer patients and supernatant of SW480 human cancer cells. Cell transformation and tumorigenesis of recipient cells did not occur if serum and supernatants were depleted of DNA. It is also demonstrated that horizontal cancer progression mediated by circulating DNA occurs via its uptake by recipient cells in an in vivo model where immunocompetent rats subjected to colon carcinogenesis with 1,2-dimethylhydrazine had increased rate of colonic tumors when injected in the dorsum with human SW480 colon carcinoma cells as a source of circulating oncogenic DNA, which could be offset by treating these animals with DNAse I and proteases. Though the contribution of biologically active molecules other than DNA for this phenomenon to occur cannot be ruled out, our results support the fact that cancer cells emit into the circulation biologically active DNA to foster tumor progression. Further exploration of the horizontal tumor progression phenomenon mediated by circulating DNA is clearly needed to determine whether its manipulation could have a role in cancer therapy.	[Duenas-Gonzalez, Alfonso] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Trejo-Becerril, Catalina; Perez-Cardenas, Enrique; Taja-Chayeb, Lucia; Chavez-Blanco, Alma; Diaz-Chavez, Jose] Inst Nacl Cancerol, Basic Res Div, Mexico City, DF, Mexico; [Anker, Philippe] OncoXL, Geneva, Switzerland; [Herrera-Goepfert, Roberto; Perez-Montiel, Delia] Inst Nacl Cancerol, Dept Pathol, Mexico City, DF, Mexico; [Medina-Velazquez, Luis A.] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Fis, Mexico City 04510, DF, Mexico; [Hidalgo-Miranda, Alfredo] Inst Nacl Med Genom, Canc Genom Lab, Mexico City, DF, Mexico; [Cruz-Velazquez, Judith] Inst Nacl Cancerol, Dept Cytogenet, Mexico City, DF, Mexico; [Gaxiola, Miguel] Inst Nacl Enfermedades Resp, Unidad Invest, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Instituto Nacional de Cancerologia (INCAN)	Duenas-Gonzalez, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	alfonso_duenasg@yahoo.com	Díaz-Chávez, José/HGU-7481-2022; Hidalgo-Miranda, Alfredo/B-2123-2010	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Herrera-Goepfert, Roberto/0000-0001-7901-2378; Diaz-Chavez, Jose/0000-0001-9583-3790; PEREZ MONTIEL, MARIA DELIA/0000-0002-9338-2284	CONACyT [34649-M, 50699]; PAPIIT UNAM [IN214902]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by CONACyT grants 34649-M, 50699 and from PAPIIT UNAM IN214902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DH, 1985, INT J BIOCHEM, V17, P1133, DOI 10.1016/0020-711X(85)90001-1; ANKER P, 1975, CANCER RES, V35, P2375; ANKER P, 1980, J IMMUNOGENET, V7, P475; ANKER P, 1984, CELL BIOCHEM FUNCT, V2, P33, DOI 10.1002/cbf.290020110; ANKER P, 1994, CR ACAD SCI III-VIE, V317, P869; ANKER P, 1968, NATURE, V219, P932, DOI 10.1038/219932a0; BENOIT J, 1960, BIOCHEM PHARMACOL, V4, P181, DOI 10.1016/0006-2952(60)90056-3; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Beuth J, 2008, INTEGR CANCER THER, V7, P311, DOI 10.1177/1534735408327251; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; DELAMIRANDE G, 1961, NATURE, V192, P52, DOI 10.1038/192052a0; FAHMY OG, 1961, NATURE, V191, P776, DOI 10.1038/191776a0; FOX AS, 1970, P NATL ACAD SCI USA, V67, P1608, DOI 10.1073/pnas.67.3.1608; GAHAN P. B., 1965, INT REV CYTOL, V18, P223, DOI 10.1016/S0074-7696(08)60555-0; GAHAN PB, 1962, NATURE, V195, P1115, DOI 10.1038/1951115a0; GAHAN PB, 1973, ANN BOT-LONDON, V37, P681, DOI 10.1093/oxfordjournals.aob.a084735; Gahan PB, 2003, CELL BIOCHEM FUNCT, V21, P11, DOI 10.1002/cbf.986; Gahan PB, 2010, CELL BIOCHEM FUNCT, V28, P529, DOI 10.1002/cbf.1690; Gaiffe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036766; Garcia-Olmo DC, 2010, CANCER RES, V70, P560, DOI 10.1158/0008-5472.CAN-09-3513; HESS D, 1969, Z PFLANZENPHYSIOL, V61, P286; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Leipner J, 2000, DRUGS, V59, P769, DOI 10.2165/00003495-200059040-00004; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; NAWA S, 1968, GENETICS, V58, P573; Patutina O, 2011, BIOCHIMIE, V93, P689, DOI 10.1016/j.biochi.2010.12.011; PELC SR, 1968, NATURE, V219, P162, DOI 10.1038/219162a0; Perse M, 2005, RADIOL ONCOL, V39, P61; Puszyk WM, 2009, CLIN BIOCHEM, V42, P736, DOI 10.1016/j.clinbiochem.2008.11.006; Raptis L, 2001, METH MOL B, V165, P151; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; SENARATNA T, 1991, PLANT SCI, V79, P223, DOI 10.1016/0168-9452(91)90109-L; Shklyaeva OA, 2008, DOKL BIOCHEM BIOPHYS, V420, P108, DOI 10.1134/S1607672908030034; Sleator RD, 2011, ARCH MICROBIOL, V193, P235, DOI 10.1007/s00203-011-0677-x; SLOTOVA J, 1968, BIOL PLANTARUM, V10, P190, DOI 10.1007/BF02921036; SLOTOVA J, 1969, BIOL PLANTARUM, V11, P216, DOI 10.1007/BF02920800; SOARES MB, 1985, J MOL EVOL, V22, P117, DOI 10.1007/BF02101690; STROUN M, 1967, NATURE, V215, P975, DOI 10.1038/215975b0; STROUN M, 1989, ONCOLOGY, V46, P318; STROUN M, 1970, NATURE, V227, P607, DOI 10.1038/227607a0; Stroun M, 1972, BIOCHEM J, V128, p00P; Szeles A, 1996, CHROMOSOME RES, V4, P310, DOI 10.1007/BF02263683; Taback B, 2004, CURR OPIN MOL THER, V6, P273; van der Vaart M, 2009, CLIN CHIM ACTA, V409, P21, DOI 10.1016/j.cca.2009.08.011; Wald M, 1998, LIFE SCI, V63, pPL237, DOI 10.1016/S0024-3205(98)00425-1; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2	48	70	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52754	10.1371/journal.pone.0052754	http://dx.doi.org/10.1371/journal.pone.0052754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285175	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500055
J	van Engelen, K; Mommersteeg, MTM; Baars, MJH; Lam, J; Ilgun, A; van Trotsenburg, ASP; Smets, AMJB; Christoffels, VM; Mulder, BJM; Postma, AV				van Engelen, Klaartje; Mommersteeg, Mathilda T. M.; Baars, Marieke J. H.; Lam, Jan; Ilgun, Aho; van Trotsenburg, A. S. Paul; Smets, Anne M. J. B.; Christoffels, Vincent M.; Mulder, Barbara J. M.; Postma, Alex V.			The Ambiguous Role of NKX2-5 Mutations in Thyroid Dysgenesis	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; NON-AUTOIMMUNE HYPOTHYROIDISM; TRANSCRIPTION FACTOR NKX2-5; MOLECULAR ANALYSIS; GENE NKX2-5; PAX8; CELLS; THYROTROPIN; EXPRESSION; REGISTRY	NKX2-5 is a homeodomain-containing transcription factor implied in both heart and thyroid development. Numerous mutations in NKX2-5 have been reported in individuals with congenital heart disease (CHD), but recently a select few have been associated with thyroid dysgenesis, among which the p.A119S variation. We sequenced NKX2-5 in 303 sporadic CHD patients and 38 families with at least two individuals with CHD. The p.A119S variation was identified in two unrelated patients: one was found in the proband of a family with four affected individuals with CHD and the other in a sporadic CHD patient. Clinical evaluation of heart and thyroid showed that the mutation did not segregate with CHD in the familial case, nor did any of the seven mutation carriers have thyroid abnormalities. We tested the functional consequences of the p.A119S variation in a cellular context by performing transactivation assays with promoters relevant for both heart and thyroid development in rat heart derived H10 cells and HELA cells. There was no difference between wildtype NKX2-5 and p.A119S NKX2-5 in activation of the investigated promoters in both cell lines. Additionally, we reviewed the current literature on the topic, showing that there is no clear evidence for a major pathogenic role of NKX2-5 mutations in thyroid dysgenesis. In conclusion, our study demonstrates that p.A119S does not cause CHD or TD and that it is a rare variation that behaves equal to wildtype NKX2-5. Furthermore, given the wealth of published evidence, we suggest that NKX2-5 mutations do not play a major pathogenic role in thyroid dysgenesis, and that genetic testing of NKX2-5 in TD is not warranted.	[van Engelen, Klaartje; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van Engelen, Klaartje; Baars, Marieke J. H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [van Engelen, Klaartje; Mulder, Barbara J. M.] Interuniv Cardiol Inst Netherlands ICIN, Utrecht, Netherlands; [Mommersteeg, Mathilda T. M.; Ilgun, Aho; Christoffels, Vincent M.; Postma, Alex V.] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lam, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pediat Cardiol, NL-1105 AZ Amsterdam, Netherlands; [van Trotsenburg, A. S. Paul] Univ Amsterdam, Acad Med Ctr, Dept Pediat Endocrinol, NL-1105 AZ Amsterdam, Netherlands; [Smets, Anne M. J. B.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Engelen, K (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	k.vanengelen@amc.uva.nl	van Trotsenburg, Paul/ABC-2379-2020; Postma, Alex V/H-4806-2019	van Trotsenburg, Paul/0000-0002-9677-7441; Postma, Alex V/0000-0003-4874-2487; Mommersteeg, Mathilda/0000-0001-6624-3038	Academic Medical Center (government funding)	Academic Medical Center (government funding)	This study was funded by the Academic Medical Center (government funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Taji E, 2007, EUR J ENDOCRINOL, V156, P521, DOI 10.1530/EJE-06-0709; Bartlett H, 2010, PEDIATR CARDIOL, V31, P335, DOI 10.1007/s00246-009-9605-0; Beffagna G, 2012, J CARDIOVASC MED HAG; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brust ES, 2012, ARQ BRAS ENDOCRINOL, V56, P173, DOI 10.1590/S0004-27302012000300004; Cangul H, 2010, CLIN ENDOCRINOL, V73, P671, DOI 10.1111/j.1365-2265.2010.03849.x; Castanet M, 2001, J CLIN ENDOCR METAB, V86, P2009, DOI 10.1210/jc.86.5.2009; Clifton-Bligh RJ, 1998, NAT GENET, V19, P399, DOI 10.1038/1294; Dean DS, 2008, BEST PRACT RES CL EN, V22, P901, DOI 10.1016/j.beem.2008.09.019; Dentice M, 2006, J CLIN ENDOCR METAB, V91, P1428, DOI 10.1210/jc.2005-1350; Fagman H, 2011, J MOL ENDOCRINOL, V46, pR33, DOI 10.1677/JME-10-0084; GEY GO, 1952, CANCER RES, V12, P264; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hermanns P, 2011, J CLIN ENDOCR METAB, V96, pE977, DOI 10.1210/jc.2010-2341; Jahn L, 1996, J CELL SCI, V109, P397; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Kempers MJE, 2006, J CLIN ENDOCR METAB, V91, P3370, DOI 10.1210/jc.2006-0058; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LINTS TJ, 1993, DEVELOPMENT, V119, P419; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Macchia PE, 1998, NAT GENET, V19, P83, DOI 10.1038/ng0598-83; Narumi S, 2010, J CLIN ENDOCR METAB, V95, P1981, DOI 10.1210/jc.2009-2373; Olivieri A, 2002, J CLIN ENDOCR METAB, V87, P557, DOI 10.1210/jc.87.2.557; Passeri E, 2011, J CLIN ENDOCR METAB, V96, pE1115, DOI 10.1210/jc.2011-0057; Postma AV, 2008, CIRC RES, V102, P1433, DOI 10.1161/CIRCRESAHA.107.168294; Ramos HE, 2009, THYROID, V19, P61, DOI 10.1089/thy.2008.0116; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; SUNTHORNTHEPVARAKUL T, 1995, NEW ENGL J MED, V332, P155, DOI 10.1056/NEJM199501193320305; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Van der Velde ET, 2005, EUR J EPIDEMIOL, V20, P549, DOI 10.1007/s10654-005-4264-9; Van Vliet G, 2003, CLIN GENET, V63, P445	37	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52685	10.1371/journal.pone.0052685	http://dx.doi.org/10.1371/journal.pone.0052685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285148	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500048
J	Wootton, JT; Pfister, CA				Wootton, J. Timothy; Pfister, Catherine A.			Carbon System Measurements and Potential Climatic Drivers at a Site of Rapidly Declining Ocean pH	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; ACIDIFICATION; DIOXIDE; CO2; IMPACT; WATER; TRENDS; EXPORT	We explored changes in ocean pH in coastal Washington state, USA, by extending a decadal-scale pH data series, by reporting independent measures of dissolved inorganic carbon (DIC), spectrophotometric pH, and total alkalinity (TA), by exploring pH patterns over larger spatial scales, and by probing for long-term trends in environmental variables reflecting potentially important drivers of pH. We found that pH continued to decline in this area at a rapid rate, that pH exhibited high natural variability within years, that our measurements of pH corresponded well to spectrophotometric pH measures and expected pH calculated from DIC/TA, and that TA estimates based on salinity predicted well actual alkalinity. Multiple datasets reflecting upwelling, including water temperature, nutrient levels, phytoplankton abundance, the NOAA upwelling index, and data on local wind patterns showed no consistent trends over the period of our study. Multiple datasets reflecting precipitation change and freshwater runoff, including precipitation records, local and regional river discharge, salinity, nitrate and sulfate in rainwater, and dissolved organic carbon (DOC) in rivers also showed no consistent trends over time. Dissolved oxygen did not decline over time, indicating that long-term changes did not result from shifts in contributions of respiration to pH levels. These tests of multiple potential drivers of the observed rapid rate of pH decline indicate a primary role for inorganic carbon and suggest that geochemical models of coastal ocean carbon fluxes need increased investigation.	[Wootton, J. Timothy; Pfister, Catherine A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Wootton, JT (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	twootton@uchicago.edu	Wootton, J. Timothy/F-3191-2015	Wootton, J. Timothy/0000-0002-7715-0344	Andrew W. Mellon Foundation; Olympic Natural Resources Center; SeaDoc Society through the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; National Science Foundation [OCE 97-11802, OCE 01-17801, OCE 04-52678, OCE 09-28232, DEB 09-19420]; Direct For Biological Sciences [0919420] Funding Source: National Science Foundation; Division Of Ocean Sciences [0928232] Funding Source: National Science Foundation	Andrew W. Mellon Foundation; Olympic Natural Resources Center; SeaDoc Society through the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis(University of California System); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided in part by the Andrew W. Mellon Foundation; the Olympic Natural Resources Center; the SeaDoc Society through the Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; and the National Science Foundation (OCE 97-11802, OCE 01-17801, OCE 04-52678, OCE 09-28232, DEB 09-19420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1994, EVOL ECOL, V8, P150, DOI 10.1007/BF01238247; Antonov J. I., 2006, WORLD OCEAN ATLAS 20; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chesson P, 1990, ANNU REV ECOL SYST, V31, P343; Connolly TP, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005283; Cowles H.C., 1899, BOT GAZ, V27, P95, DOI [DOI 10.1086/327796, 10.1086/327796]; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; DICKSON AG, 1984, GEOCHIM COSMOCHIM AC, V48, P2299, DOI 10.1016/0016-7037(84)90225-4; DICKSON AG, 1993, MAR CHEM, V44, P131, DOI 10.1016/0304-4203(93)90198-W; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Evans W, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006625; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Freeman C, 2004, NATURE, V430, P195, DOI 10.1038/nature02707; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Gonzalez-Davila M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001993; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Knap A., 1996, 19 JGOFS UNESCO; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lee K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027207; LIKENS GE, 1970, ECOL MONOGR, V40, P23, DOI 10.2307/1942440; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Nevison CD, 2008, BIOGEOSCIENCES, V5, P875, DOI 10.5194/bg-5-875-2008; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paine Robert T., 2010, P229; PAINE RT, 1994, EXCELLENCE ECOLOGY, V4; Pfister CA, 2007, LIMNOL OCEANOGR, V52, P1767, DOI 10.4319/lo.2007.52.5.1767; Pfister CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025766; Pierrot D., 2006, ORNLCDIAC105A US DEP, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; Raven J., 2005, OCEAN ACIDIFICATION; Salisbury J., 2008, EOS T AM GEOPHYS UN, V89, P513, DOI [10.1029/2008EO500001, DOI 10.1029/2008EO500001]; Santana-Casiano JM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002788; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Striegl RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024413; Williams B, 2011, BIOGEOSCIENCES, V8, P165, DOI 10.5194/bg-8-165-2011; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; Worrall F, 2004, BIOGEOCHEMISTRY, V70, P369, DOI 10.1007/s10533-004-8131-7	49	52	54	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53396	10.1371/journal.pone.0053396	http://dx.doi.org/10.1371/journal.pone.0053396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285290	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500145
J	Zhang, L; Dong, XW; Wang, JN; Tang, JM; Yang, JY; Guo, LY; Zheng, F; Kong, X; Huang, YZ; Chen, SY				Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang; Chen, Shi-You			PEP-1-CAT-Transduced Mesenchymal Stem Cells Acquire an Enhanced Viability and Promote Ischemia-Induced Angiogenesis	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; STROMAL CELLS; HEART; SURVIVAL; THERAPY; MECHANISMS; APOPTOSIS; STRESS; DEATH	Objective: Poor survival of mesenchymal stem cells (MSC) compromised the efficacy of stem cell therapy for ischemic diseases. The aim of this study is to investigate the role of PEP-1-CAT transduction in MSC survival and its effect on ischemia-induced angiogenesis. Methods: MSC apoptosis was evaluated by DAPI staining and quantified by Annexin V and PI double staining and Flow Cytometry. Malondialdehyde (MDA) content, lactate dehydrogenase (LDH) release, and Superoxide Dismutase (SOD) activities were simultaneously measured. MSC mitochondrial membrane potential was analyzed with JC-1 staining. MSC survival in rat muscles with gender-mismatched transplantation of the MSC after lower limb ischemia was assessed by detecting SRY expression. MSC apoptosis in ischemic area was determined by TUNEL assay. The effect of PEP-1-CAT-transduced MSC on angiogenesis in vivo was determined in the lower limb ischemia model. Results: PEP-1-CAT transduction decreased MSC apoptosis rate while down-regulating MDA content and blocking LDH release as compared to the treatment with H2O2 or CAT. However, SOD activity was up-regulated in PEP-1-CAT-transduced cells. Consistent with its effect on MSC apoptosis, PEP-1-CAT restored H2O2-attenuated mitochondrial membrane potential. Mechanistically, PEP-1-CAT blocked H2O2-induced down-regulation of PI3K/Akt activity, an essential signaling pathway regulating MSC apoptosis. In vivo, the viability of MSC implanted into ischemic area in lower limb ischemia rat model was increased by four-fold when transduced with PEP-1-CAT. Importantly, PEP-1-CAT-transduced MSC significantly enhanced ischemia-induced angiogenesis by up-regulating VEGF expression. Conclusions: PEP-1-CAT-transduction was able to increase MSC viability by regulating PI3K/Akt activity, which stimulated ischemia-induced angiogenesis.	[Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang] Hubei Univ Med, Inst Clin Med, Shiyan, Hubei, Peoples R China; [Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang] Hubei Univ Med, Renmin Hosp, Dept Cardiol, Shiyan, Hubei, Peoples R China; [Zhang, Lei; Dong, Xiao-Wei; Wang, Jia-Ning; Tang, Jun-Ming; Yang, Jian-Ye; Guo, Ling-Yun; Zheng, Fei; Kong, Xia; Huang, Yong-Zhang] Hubei Univ Med, Key Lab Human Embryon Stem Cell Hubei Prov, Shiyan, Hubei, Peoples R China; [Tang, Jun-Ming] Hubei Univ Med, Dept Physiol, Shiyan, Hubei, Peoples R China; [Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, Athens, GA USA	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine; University System of Georgia; University of Georgia	Wang, JN (corresponding author), Hubei Univ Med, Inst Clin Med, Shiyan, Hubei, Peoples R China.	rywjn@vip.163.com			National Natural Science Foundation of China [81170095]; Hubei Health Department Science Foundation [JX5B24]; Hubei Education Department Science Foundation [T201112]; National Institutes of Health [HL093429, HL107526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107526, R01HL093429] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Health Department Science Foundation; Hubei Education Department Science Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from National Natural Science Foundation of China (81170095),http://www.nsfc.gov.cn/Portal0/default152.htm; Hubei Health Department Science Foundation (JX5B24),http://www.hbws.gov.cn/; Hubei Education Department Science Foundation (T201112),http://www.hbe.gov.cn/.China; and National Institutes of Health (HL093429 and HL107526),http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao CY, 2010, BIOCHEM CELL BIOL, V88, P629, DOI 10.1139/O10-018; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong Xiao, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P93; Foster KA, 2006, PROG NEUROBIOL, V79, P136, DOI 10.1016/j.pneurobio.2006.07.001; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Huang GQ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-73; Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mishra V, 2005, ANN CLIN BIOCHEM, V42, P269, DOI 10.1258/0004563054255461; Perin EC, 2006, TEX HEART I J, V33, P204; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Reinlib L, 2000, CIRCULATION, V101, pE182; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tsai RYL, 2002, DEV CELL, V2, P707, DOI 10.1016/S1534-5807(02)00195-8; Wei H, 2010, J CELL BIOCHEM, V111, P967, DOI 10.1002/jcb.22785; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367; Zhang YE, 2011, RESUSCITATION, V82, P1081, DOI 10.1016/j.resuscitation.2011.01.034	23	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52537	10.1371/journal.pone.0052537	http://dx.doi.org/10.1371/journal.pone.0052537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285080	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500033
J	Barreto-Valer, K; Lopez-Bellido, R; Sanchez-Simon, FM; Rodriguez, RE				Barreto-Valer, Katherine; Lopez-Bellido, Roger; Macho Sanchez-Simon, Fatima; Rodriguez, Raquel E.			Modulation by Cocaine of Dopamine Receptors through miRNA-133b in Zebrafish Embryos	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DELTA-OPIOID RECEPTOR; VIVO DRUG DISCOVERY; PRENATAL COCAINE; HUMAN-DISEASE; EXPRESSION; EXPOSURE; PITX3; GENES; DIFFERENTIATION	The use of cocaine during pregnancy can affect the mother and indirectly might alter the development of the embryo/foetus. Accordingly, in the present work our aim was to study in vivo (in zebrafish embryos) the effects of cocaine on the expression of dopamine receptors and on miR-133b. These embryos were exposed to cocaine hydrochloride (HCl) at 5 hours post-fertilization (hpf) and were then collected at 8, 16, 24, 48 and 72 hpf to study the expression of dopamine receptors, drd1, drd2a, drd2b and drd3, by quantitative real time PCR (qPCR) and in situ hybridization (ISH, only at 24 hpf). Our results indicate that cocaine alters the expression of the genes studied, depending on the stage of the developing embryo and the type of dopamine receptor. We found that cocaine reduced the expression of miR-133b at 24 and 48 hpf in the central nervous system (CNS) and at the periphery by qPCR and also that the spatial distribution of miR-133b was mainly seen in somites, a finding that suggests the involvement of miR-133b in the development of the skeletal muscle. In contrast, at the level of the CNS miR-133b had a weak and moderate expression at 24 and 48 hpf. We also analysed the interaction of miR-133b with the Pitx3 and Pitx3 target genes drd2a and drd2b, tyrosine hydroxylase (th) and dopamine transporter (dat) by microinjection of the Pitx3-3'UTR sequence. Microinjection of Pitx3-3'UTR affected the expression of pitx3, drd2a, drd2b, th and dat. In conclusion, in the present work we describe a possible mechanism to account for cocaine activity by controlling miR-133b transcription in zebrafish. Via miR-133b cocaine would modulate the expression of pitx3 and subsequently of dopamine receptors, dat and th. These results indicate that miRNAs can play an important role during embryogenesis and in drug addiction.	[Barreto-Valer, Katherine; Lopez-Bellido, Roger; Macho Sanchez-Simon, Fatima; Rodriguez, Raquel E.] Univ Salamanca, Dept Biochem & Mol Biol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain	University of Salamanca	Rodriguez, RE (corresponding author), Univ Salamanca, Dept Biochem & Mol Biol, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain.	requelmi@usal.es		Rodriguez Rodriguez, Raquel/0000-0003-1805-3066; Barreto Valer, Katherine/0000-0002-7709-3896	Spanish Ministry of Education and Science [SAF2010-18597]; Regional Government of Castilla y Leo'n [B1039/SA25/10]	Spanish Ministry of Education and Science(Spanish Government); Regional Government of Castilla y Leo'n	This work was supported by the Spanish Ministry of Education and Science (grant SAF2010-18597) and the Regional Government of Castilla y Leo'n (grant B1039/SA25/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KA, 2000, DEVELOPMENT, V127, P1857; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Barrallo A, 1998, BIOCHEM BIOPH RES CO, V245, P544, DOI 10.1006/bbrc.1998.8496; Boehmler W, 2007, GENES BRAIN BEHAV, V6, P155, DOI 10.1111/j.1601-183X.2006.00243.x; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Caine SB, 2002, J NEUROSCI, V22, P2977, DOI 10.1523/JNEUROSCI.22-07-02977.2002; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Chakraborty C, 2009, CURR DRUG METAB, V10, P116, DOI 10.2174/138920009787522197; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Choi SJ, 1998, ANN NY ACAD SCI, V844, P293, DOI 10.1111/j.1749-6632.1998.tb08243.x; Coulon V, 2007, J BIOL CHEM, V282, P33192, DOI 10.1074/jbc.M706119200; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; Darland T, 2001, P NATL ACAD SCI USA, V98, P11691, DOI 10.1073/pnas.191380698; DelaneyBlack V, 1996, PEDIATRICS, V98, P735; Dempsey D, 1999, J ANAL TOXICOL, V23, P24, DOI 10.1093/jat/23.1.24; Dienes-Nagy A, 1999, J CHROMATOGR A, V854, P109, DOI 10.1016/S0021-9673(99)00750-5; Dreyer JL, 2010, GENOME MED, V2, DOI 10.1186/gm213; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Eyler FD, 2009, DEV NEUROSCI-BASEL, V31, P121, DOI 10.1159/000207500; Fang YA, 1999, J NEUROSCI, V19, P8966, DOI 10.1523/JNEUROSCI.19-20-08966.1999; Feng QP, 2005, BRIT J PHARMACOL, V144, P887, DOI 10.1038/sj.bjp.0706130; Filippi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-135; Frederick AL, 2009, DEV NEUROSCI-BASEL, V31, P7, DOI 10.1159/000207490; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Harvey JA, 2004, NEUROSCI BIOBEHAV R, V27, P751, DOI 10.1016/j.neubiorev.2003.11.006; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; Huang CC, 2011, INT J NEUROPSYCHOPH, V14, P431, DOI 10.1017/S1461145710000258; Huang XQ, 2009, J PHYS CHEM B, V113, P15057, DOI 10.1021/jp900963n; Hummel M, 2002, J CELL PHYSIOL, V191, P17, DOI 10.1002/jcp.10078; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones LB, 2000, J NEUROSCI, V20, P4606, DOI 10.1523/JNEUROSCI.20-12-04606.2000; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kesrouani A, 2001, EARLY HUM DEV, V63, P79, DOI 10.1016/S0378-3782(01)00123-2; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Kubrusly RCC, 2010, NEUROPHARMACOLOGY, V58, P436, DOI 10.1016/j.neuropharm.2009.09.007; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li P, 2007, DEV DYNAM, V236, P1339, DOI 10.1002/dvdy.21130; Lidow MS, 2001, DEV BRAIN RES, V128, P45, DOI 10.1016/S0165-3806(01)00139-0; Little KY, 2009, PSYCHIAT RES, V168, P173, DOI 10.1016/j.psychres.2008.10.034; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Lohi O, 2012, ACTA PAEDIAT; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Mameli M, 2011, NEUROPHARMACOLOGY, V61, P1052, DOI 10.1016/j.neuropharm.2011.01.036; Masserano JM, 1996, NEUROSCI LETT, V217, P73, DOI 10.1016/S0304-3940(96)13047-0; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Messiah SE, 2011, PROG PEDIATR CARDIOL, V31, P59, DOI 10.1016/j.ppedcard.2010.11.010; MEYER JS, 1993, BRAIN RES, V608, P129, DOI 10.1016/0006-8993(93)90783-J; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morrow BA, 2001, SYNAPSE, V41, P337, DOI 10.1002/syn.1090; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Pinal-Seoane N, 2006, J MOL ENDOCRINOL, V37, P391, DOI 10.1677/jme.1.02136; Plessinger MA, 1998, OBSTET GYN CLIN N AM, V25, P99, DOI 10.1016/S0889-8545(05)70360-0; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salvatore MF, 2004, NEUROSCIENCE, V123, P481, DOI 10.1016/j.neuroscience.2003.10.002; Sanchez-Simon FM, 2008, NEUROSCIENCE, V151, P129, DOI 10.1016/j.neuroscience.2007.09.086; Santoriello C, 2012, J CLIN INVEST, V122, P2337, DOI 10.1172/JCI60434; SCHENKER S, 1993, CLIN PHARMACOL THER, V53, P329, DOI 10.1038/clpt.1993.29; Serafini G, 2012, NEUROSCI RES, V73, P179, DOI 10.1016/j.neures.2012.04.001; Shang EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000587; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Stanwood GD, 2003, NEUROSCIENCE, V122, P579, DOI 10.1016/j.neuroscience.2003.08.029; Stanwood GD, 2007, J NEUROSCI, V27, P152, DOI 10.1523/JNEUROSCI.4591-06.2007; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Ursitti F, 2001, THER DRUG MONIT, V23, P347, DOI 10.1097/00007691-200108000-00005; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Zeng Y, 2009, MOL PHARMACOL, V75, P259, DOI 10.1124/mol.108.052118; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	84	21	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52701	10.1371/journal.pone.0052701	http://dx.doi.org/10.1371/journal.pone.0052701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285158	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800090
J	Mellert, K; Lamla, M; Scheffzek, K; Wittig, R; Kaufmann, D				Mellert, Kevin; Lamla, Markus; Scheffzek, Klaus; Wittig, Rainer; Kaufmann, Dieter			Enhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; MACROMOLECULES; TRANSFECTION; DELIVERY; FUSION	Induced internalisation of functional proteins into cultured cells has become an important aspect in a rising number of in vitro and in vivo assays. The endo-lysosomal entrapment of the transduced proteins remains the major problem in all transduction protocols. In this study we compared the efficiency, cytotoxicity and protein targeting of different commercially available transduction reagents by transducing a well-studied fluorescently labelled protein (Atto488-bovine serum albumin) into cultured human sarcoma cells. The amount of internalised protein and toxicity differed between the different reagents, but the percentage of transduced cells was consistently high. Furthermore, in all protocols the signals of the transduced Atto488-BSA were predominantly punctual consistent with an endosomal localisation. To overcome the endosomal entrapment, the transduction protocols were combined with a photochemical internalisation (PCI) treatment. Using this combination revealed that an endosomal disruption is highly effective in cell penetrating peptide (CPP) mediated transduction, whereas lipid-mediated transductions lead to a lower signal spreading throughout the cytosol. No change in the signal distribution could be achieved in treatments using non-lipid polymers as a transduction reagent. Therefore, the combination of protein transduction protocols based on CPPs with the endosomolytic treatment PCI can facilitate protein transduction experiments in vitro.	[Mellert, Kevin; Kaufmann, Dieter] Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany; [Lamla, Markus] Univ Ulm, Inst Organ Chem Macromol Chem 3, D-89069 Ulm, Germany; [Scheffzek, Klaus] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Wittig, Rainer] Univ Ulm, Inst Lasertechnologien Med & Messtech ILM, D-89069 Ulm, Germany	Ulm University; Ulm University; Medical University of Innsbruck; Ulm University	Mellert, K (corresponding author), Univ Ulm, Inst Human Genet, D-89069 Ulm, Germany.	kevin.mellert@uni-ulm.de	Wittig, Rainer/AAT-5361-2021	Wittig, Rainer/0000-0002-3735-9370	Bundesministerium fur Bildung und Forschung (BMBF DLR G, Netzwerk Neurofibromatosis) [Verbundvorhaben 01GM0905]	Bundesministerium fur Bildung und Forschung (BMBF DLR G, Netzwerk Neurofibromatosis)	The financial support for this study was provided by the Bundesministerium fur Bildung und Forschung (BMBF DLR G, Verbundvorhaben 01GM0905 Netzwerk Neurofibromatosis, Teilprojekt 3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg K, 1999, CANCER RES, V59, P1180; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Gillmeister MP, 2011, BIOCONJUGATE CHEM, V22, P556, DOI 10.1021/bc900445g; Mellert K, 2011, GENES-BASEL, V2, P562, DOI 10.3390/genes2030562; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Neundorf I, 2009, PHARMACEUTICALS, V2, P49, DOI 10.3390/ph2020049; Norum OJ, 2009, PHOTOCH PHOTOBIO SCI, V8, P758, DOI 10.1039/b821129a; Oba M, 2012, BIOL PHARM BULL, V35, P1064, DOI 10.1248/bpb.b12-00001; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; RAAB GH, 1990, ARCH GYNECOL OBSTET, V248, P13, DOI 10.1007/BF02389584; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Selbo PK, 2001, INT J CANCER, V92, P761, DOI 10.1002/1097-0215(20010601)92:5<761::AID-IJC1238>3.0.CO;2-4; Sugita T, 2008, BRIT J PHARMACOL, V153, P1143, DOI 10.1038/sj.bjp.0707678; Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang JTW, 2012, J CONTROL RELEASE, V157, P305, DOI 10.1016/j.jconrel.2011.08.025; Weyergang A, 2011, LASER SURG MED, V43, P721, DOI 10.1002/lsm.21084; Yamaguchi K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/872065; Zhang H, 2012, BIOMATERIALS, V33, P5047, DOI 10.1016/j.biomaterials.2012.03.061	20	31	33	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52473	10.1371/journal.pone.0052473	http://dx.doi.org/10.1371/journal.pone.0052473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285056	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800068
J	Datta, R; Lee, J; Duda, J; Avants, BB; Vite, CH; Tseng, B; Gee, JC; Aguirre, GD; Aguirre, GK				Datta, Ritobrato; Lee, Jongho; Duda, Jeffrey; Avants, Brian B.; Vite, Charles H.; Tseng, Ben; Gee, James C.; Aguirre, Gustavo D.; Aguirre, Geoffrey K.			A Digital Atlas of the Dog Brain	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASES; LEBER CONGENITAL AMAUROSIS; SURFACE-BASED ANALYSIS; GENE-THERAPY; CANINE BRAIN; ANIMAL-MODELS; DOMESTIC DOG; IMAGE REGISTRATION; CEREBRAL ASYMMETRY; STANDARD POODLES	There is a long history and a growing interest in the canine as a subject of study in neuroscience research and in translational neurology. In the last few years, anatomical and functional magnetic resonance imaging (MRI) studies of awake and anesthetized dogs have been reported. Such efforts can be enhanced by a population atlas of canine brain anatomy to implement group analyses. Here we present a canine brain atlas derived as the diffeomorphic average of a population of fifteen mesaticephalic dogs. The atlas includes: 1) A brain template derived from in-vivo, T1-weighted imaging at 1 mm isotropic resolution at 3 Tesla (with and without the soft tissues of the head); 2) A co-registered, high-resolution (0.33 mm isotropic) template created from imaging of ex-vivo brains at 7 Tesla; 3) A surface representation of the gray matter/white matter boundary of the high-resolution atlas (including labeling of gyral and sulcal features). The properties of the atlas are considered in relation to historical nomenclature and the evolutionary taxonomy of the Canini tribe. The atlas is available for download (https://cfn.upenn.edu/aguirre/wiki/public:data_plosone_2012_datta).	[Datta, Ritobrato; Tseng, Ben; Aguirre, Geoffrey K.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Lee, Jongho; Duda, Jeffrey; Avants, Brian B.; Gee, James C.] Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Vite, Charles H.] Univ Penn, Sch Vet Med, Dept Clin Studies, Neurol Sect, Philadelphia, PA 19104 USA; [Aguirre, Gustavo D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Sect Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Aguirre, GK (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	aguirreg@mail.med.upenn.edu		Aguirre, Geoffrey/0000-0002-4028-3100; Aguirre, Gustavo/0000-0002-5228-256X; avants, brian/0000-0002-4212-3362	Burroughs-Wellcome Career development award; Hope for Vision foundation; Pennsylvania Lion's Foundation; National Eye Institute (NEI) / National Institutes of Health (NIH) [EY020516, -06855, -14579]; Foundation Fighting Blindness; ONCE International Price for R&D in Biomedicine and New Technologies for the Blind; NATIONAL EYE INSTITUTE [R01EY020516, R01EY017549] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	Burroughs-Wellcome Career development award(Burroughs Wellcome Fund); Hope for Vision foundation; Pennsylvania Lion's Foundation; National Eye Institute (NEI) / National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); ONCE International Price for R&D in Biomedicine and New Technologies for the Blind; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Burroughs-Wellcome Career development award to GKA, grants from the Hope for Vision foundation to GDA and GKA, a grant from the Pennsylvania Lion's Foundation to GKA, National Eye Institute (NEI) / National Institutes of Health (NIH) grants EY020516 (GKA), -06855 (GDA), and -14579 (GDA), Foundation Fighting Blindness (GDA), and the ONCE International Price for R&D in Biomedicine and New Technologies for the Blind (GDA, GKA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GD, 2007, DOG ITS GENOME; Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Atkins DL, 1978, COYOTES BEHAVIOR BIO; Avants B, 2004, NEUROIMAGE, V23, pS139, DOI 10.1016/j.neuroimage.2004.07.010; Avants B, 2008, UNBIASED DIFFEOMORPH; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; BLACK AH, 1972, J COMP PHYSIOL PSYCH, V79, P128, DOI 10.1037/h0032535; Bonin von G, 1960, SOME PAPERS ON THE C, Vxxiv; Budras K., 2007, ANATOMY OF THE DOG; Buxton DF, 1986, THE CANINE BRAIN BAS; Cahill LS, 2012, NEUROIMAGE, V60, P933, DOI 10.1016/j.neuroimage.2012.01.100; CLARKE PGH, 1976, J PHYSIOL-LONDON, V256, P497, DOI 10.1113/jphysiol.1976.sp011335; COHN HAROLD A., 1933, JOUR COMP NEUROL, V58, P593, DOI 10.1002/cne.900580304; Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Ellinwood NM, 2004, J GENE MED, V6, P481, DOI 10.1002/jgm.581; Ellis JL, 2009, J ANAT, V214, P362, DOI 10.1111/j.1469-7580.2008.01042.x; Evans HE, 1993, MILLERS ANATOMY OF T; Ferrier D, 1886, THE FUNCTIONS OF THE; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Fritsch GT, 1870, ARCH ANAT PHYSL WISS, P300; Ghosh SS, 2010, NEUROIMAGE, V53, P85, DOI 10.1016/j.neuroimage.2010.05.075; Gonzalez-Martinez A, 2011, EXP GERONTOL, V46, P590, DOI 10.1016/j.exger.2011.02.013; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greve DN, 2011, AUTOMATIC SURFACE BA; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hasegawa D, 2005, VET RADIOL ULTRASOUN, V46, P452, DOI 10.1111/j.1740-8261.2005.00083.x; Hasegawa D, 2012, SCI WORLD J, DOI 10.1100/2012/250197; Haskins M, 2009, ILAR J, V50, P112, DOI 10.1093/ilar.50.2.112; Helton WS, 2009, BEHAV PROCESS, V82, P355, DOI 10.1016/j.beproc.2009.08.004; Hernandez M, 2010, INVEST OPHTH VIS SCI, V51, P6793, DOI 10.1167/iovs.10-5213; HOERLEIN BF, 1978, CANINE NEUROLOGY DIA; Horsley V, 1915, BRIT MED J, V1915, P321; Huxley T.H., 1880, P ZOOL SOC LOND, V48, P238, DOI DOI 10.1111/J.1469-7998.1880.TB06558.X; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Jurney C, 2009, J VET INTERN MED, V23, P871, DOI 10.1111/j.1939-1676.2009.0338.x; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kang BT, 2009, VET RADIOL ULTRASOUN, V50, P615, DOI 10.1111/j.1740-8261.2009.01591.x; Klein A, 2010, NEUROIMAGE, V51, P214, DOI 10.1016/j.neuroimage.2010.01.091; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; KRAFT SL, 1989, VET RADIOLOGY, V30, P147, DOI 10.1111/j.1740-8261.1989.tb00767.x; Kuwabara T, 2010, VET RADIOL ULTRASOUN, V51, P485, DOI 10.1111/j.1740-8261.2010.01700.x; Langley JN, 1883, J PHYSIOL-LONDON, V4, P248; Lee KI, 2011, J VET MED SCI, V73, P1385, DOI 10.1292/jvms.11-0117; Leigh EJ, 2008, VET RADIOL ULTRASOUN, V49, P113, DOI 10.1111/j.1740-8261.2008.00336.x; Lim R. K. S., 1960, STEREOTAXIC ATLAS DO; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Lyras GA, 2003, ZOOL J LINN SOC-LOND, V138, P505, DOI 10.1046/j.1096-3642.2003.00067.x; Lyras GA, 2009, SCRIPTA GEOLOGICA, V139; MacKillop E, 2011, VET RADIOL ULTRASOUN, V52, pS42, DOI 10.1111/j.1740-8261.2010.01784.x; Martin-Vaquero P, 2011, VET RADIOL ULTRASOUN, V52, P25, DOI 10.1111/j.1740-8261.2010.01747.x; McGowan JC, 2000, J COMPUT ASSIST TOMO, V24, P316, DOI 10.1097/00004728-200003000-00025; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 2010, J VET BEHAV, V5, P318, DOI 10.1016/j.jveb.2010.05.001; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Miller ME, 1965, REPRINT; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Mogicato G, 2011, REV MED VET-TOULOUSE, V162, P400; Munk H, 1878, ARCH ANATOMY PHYSL, V2, P161; Natchev S, 2000, COMPTES RENDUS DE LA, V53, P121; Ofri R, 1993, THESIS, V1993; Palazzi X, 2011, THE BEAGLE BRAIN IN; Park HJ, 2009, NEUROIMAGE, V47, P98, DOI 10.1016/j.neuroimage.2009.03.076; Pavlov IP, 1995, LECTURES ON CONDITIO; Pellegrino FC, 2004, CLIN NEUROPHYSIOL, V115, P477, DOI 10.1016/S1388-2457(03)00347-X; RADINSKY L, 1973, BRAIN BEHAV EVOLUT, V7, P169, DOI 10.1159/000124409; Razran HS, 1929, PSYCHOL BULL, V26, P202, DOI 10.1037/h0073189; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Sarasa M, 2009, CURR ALZHEIMER RES, V6, P171, DOI 10.2174/156720509787602834; Sereno MI, 1991, THE NEURAL BASIS OF; Stein L, 2011, EXPERT OPIN BIOL TH, V11, P429, DOI 10.1517/14712598.2011.557358; TAN U, 1987, INT J NEUROSCI, V32, P943, DOI 10.3109/00207458709043351; Tapp PD, 2006, NEUROIMAGE, V29, P234, DOI 10.1016/j.neuroimage.2005.07.043; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; VANWINKLE TJ, 1994, PROG VET NEUROL, V5, P66; Vite CH, 2001, VET RADIOL ULTRASOUN, V42, P5, DOI 10.1111/j.1740-8261.2001.tb00896.x; Vite CH, 2011, VET RADIOL ULTRASOUN, V52, pS23, DOI 10.1111/j.1740-8261.2010.01782.x; Wang P, 2010, THE OPEN MEDICAL IMA, V4, P1; Wells DL, 2003, BEHAV PROCESS, V61, P27, DOI 10.1016/S0376-6357(02)00161-4; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x; Willis CKR, 2001, CAN J VET RES, V65, P188; Wolff CA, 2012, J VET INTERN MED, V26, P589, DOI 10.1111/j.1939-1676.2012.00899.x; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	89	60	60	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52140	10.1371/journal.pone.0052140	http://dx.doi.org/10.1371/journal.pone.0052140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284904	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500099
J	Moore, MM; Oteng-Pabi, SK; Pandelieva, AT; Mayo, SL; Chica, RA				Moore, Matthew M.; Oteng-Pabi, Samuel K.; Pandelieva, Antonia T.; Mayo, Stephen L.; Chica, Roberto A.			Recovery of Red Fluorescent Protein Chromophore Maturation Deficiency through Rational Design	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VARIANTS; MECHANISM; EMISSION; CORAL; CHROMOPROTEINS; MUTAGENESIS; MUTANTS; PATHWAY	Red fluorescent proteins (RFPs) derived from organisms in the class Anthozoa have found widespread application as imaging tools in biological research. For most imaging experiments, RFPs that mature quickly to the red chromophore and produce little or no green chromophore are most useful. In this study, we used rational design to convert a yellow fluorescent mPlum mutant to a red-emitting RFP without reverting any of the mutations causing the maturation deficiency and without altering the red chromophore's covalent structure. We also created an optimized mPlum mutant (mPlum-E16P) that matures almost exclusively to the red chromophore. Analysis of the structure/function relationships in these proteins revealed two structural characteristics that are important for efficient red chromophore maturation in DsRed-derived RFPs. The first is the presence of a lysine residue at position 70 that is able to interact directly with the chromophore. The second is an absence of non-bonding interactions limiting the conformational flexibility at the peptide backbone that is oxidized during red chromophore formation. Satisfying or improving these structural features in other maturation-deficient RFPs may result in RFPs with faster and more complete maturation to the red chromophore.	[Oteng-Pabi, Samuel K.; Pandelieva, Antonia T.; Chica, Roberto A.] Univ Ottawa, Dept Chem, Ottawa, ON, Canada; [Moore, Matthew M.; Mayo, Stephen L.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Mayo, Stephen L.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Chica, Roberto A.] Univ Ottawa, Ctr Catalysis Res & Innovat, Ottawa, ON, Canada	University of Ottawa; California Institute of Technology; California Institute of Technology; University of Ottawa	Chica, RA (corresponding author), Univ Ottawa, Dept Chem, Ottawa, ON, Canada.	rchica@uottawa.ca			Natural Sciences and Engineering Research Council of Canada; University of Ottawa; Defense Advanced Research Projects Agency Protein Design Processes; Gordon and Betty Moore Foundation; Department of Energy; National Institutes of Health	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Ottawa; Defense Advanced Research Projects Agency Protein Design Processes; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), the University of Ottawa (http://www.uottawa.ca), and the Defense Advanced Research Projects Agency Protein Design Processes (http://www.darpa.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marie L. Ary for help with the manuscript. We would like to acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at Caltech, and the Department of Energy and National Institutes of Health for supporting the Stanford Synchrotron Radiation Lightsource.	Abbyad P, 2007, P NATL ACAD SCI USA, V104, P20189, DOI 10.1073/pnas.0706185104; Afonine P., 2005, CCP4 NEWSLETTER, V42; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83; Bravaya KB, 2012, J AM CHEM SOC, V134, P2807, DOI 10.1021/ja2114568; Chica RA, 2010, P NATL ACAD SCI USA, V107, P20257, DOI 10.1073/pnas.1013910107; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mishin AS, 2008, BIOCHEMISTRY-US, V47, P4666, DOI 10.1021/bi702130s; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pouwels LJ, 2008, BIOCHEMISTRY-US, V47, P10111, DOI 10.1021/bi8007164; Rosenow MA, 2004, BIOCHEMISTRY-US, V43, P4464, DOI 10.1021/bi0361315; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Shu XK, 2009, PROTEIN SCI, V18, P460, DOI 10.1002/pro.66; Sniegowski JA, 2005, J BIOL CHEM, V280, P26248, DOI 10.1074/jbc.M412327200; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Strongin DE, 2007, PROTEIN ENG DES SEL, V20, P525, DOI 10.1093/protein/gzm046; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; Terskikh AV, 2002, J BIOL CHEM, V277, P7633, DOI 10.1074/jbc.C100694200; Tubbs JL, 2005, BIOCHEMISTRY-US, V44, P9833, DOI 10.1021/bi0472907; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Verkhusha VV, 2004, CHEM BIOL, V11, P845, DOI 10.1016/j.chembiol.2004.04.007; Verkhusha VV, 2004, NAT BIOTECHNOL, V22, P289, DOI 10.1038/nbt943; Wachter RM, 2010, BIOCHEMISTRY-US, V49, P7417, DOI 10.1021/bi100901h; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wall MA, 2000, NAT STRUCT BIOL, V7, P1133; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wiehler J, 2001, FEBS LETT, V487, P384, DOI 10.1016/S0014-5793(00)02365-6; Wilmann PG, 2005, J MOL BIOL, V349, P223, DOI 10.1016/j.jmb.2005.03.020; Yarbrough D, 2001, P NATL ACAD SCI USA, V98, P462, DOI 10.1073/pnas.98.2.462	42	14	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52463	10.1371/journal.pone.0052463	http://dx.doi.org/10.1371/journal.pone.0052463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285050	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000312794500174
J	Ye, ZX; Wang, YQ; Quan, X; Li, J; Hu, XY; Huang, JH; Luo, ZJ				Ye, Zhengxu; Wang, Yuqing; Quan, Xin; Li, Jing; Hu, Xueyu; Huang, Jinghui; Luo, Zhuojing			Effects of Mechanical Force on Cytoskeleton Structure and Calpain-Induced Apoptosis in Rat Dorsal Root Ganglion Neurons In Vitro	PLOS ONE			English	Article							SPINAL-CORD-INJURY; COLCHICINE-INDUCED APOPTOSIS; OXIDATIVE STRESS; EXPRESSION; INHIBITOR; PROTEASE; CALCIUM; CELLS; INVOLVEMENT; ACTIVATION	Background: A sudden mechanical insult to the spinal cord is usually caused by changing pressure on the surface of the spinal cord. Most of these insults are mechanical force injuries, and their mechanism of injury to the spinal cord is largely unknown. Methods: Using a compression-driven instrument to simulate mechanical force, we applied mechanical pressure of 0.5 MPa to rat dorsal root ganglion (DRG) neurons for 10 min to investigate cytoskeletal alterations and calpain-induced apoptosis after the mechanical force injury. Results: The results indicated that mechanical forces affect the structure of the cytoskeleton and cell viability, induce early apoptosis, and affect the cell cycle of DRG neurons. In addition, the calpain inhibitor PD150606 reduced cytoskeletal degradation and the rate of apoptosis after mechanical force injury. Conclusion: Thus, calpain may play an important role in DRG neurons in the regulation of apoptosis and cytoskeletal alterations induced by mechanical force. Moreover, cytoskeletal alterations may be substantially involved in the mechanotransduction process in DRG neurons after mechanical injury and may be induced by activated calpain. To our knowledge, this is the first report to demonstrate a relationship between cytoskeletal degradation and apoptosis in DRG neurons.	[Ye, Zhengxu; Wang, Yuqing; Quan, Xin; Hu, Xueyu; Huang, Jinghui; Luo, Zhuojing] Fourth Mil Med Univ, Dept Orthoped, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Li, Jing] Fourth Mil Med Univ, Dept Pathol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Luo, ZJ (corresponding author), Fourth Mil Med Univ, Dept Orthoped, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China.	yzengx@fmmu.edu.cn		xin, quan/0000-0003-2295-350X; Huang, Jinghui/0000-0002-0991-0591	National Natural Science Foundation of China [30901510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant (No. 30901510) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; Banik N.L, 1999, CALPAIN PHARM TOXICO, P211; Bareyre FM, 2008, J NEUROL SCI, V265, P63, DOI 10.1016/j.jns.2007.05.004; BARTUS RT, 1994, STROKE, V25, P2265, DOI 10.1161/01.STR.25.11.2265; BELOUSSOV LV, 1980, ROUX ARCH DEV BIOL, V188, P1, DOI 10.1007/BF00848603; Blomgren K, 1999, J BIOL CHEM, V274, P14046, DOI 10.1074/jbc.274.20.14046; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Corsini E, 2011, TOXICOL APPL PHARM, V250, P108, DOI 10.1016/j.taap.2010.11.004; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Dare E, 2001, NEUROTOX RES, V3, P501, DOI 10.1007/BF03033206; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Friedlander R.M., 2003, NEW ENGL J MED, V348, P1365; Guttman R. P, 1999, CALPAIN PHARM TOXICO, P229; JOHNSON P, 1990, INT J BIOCHEM, V22, P811, DOI 10.1016/0020-711X(90)90284-A; Jorda EG, 2005, BIOCHEM PHARMACOL, V70, P470, DOI 10.1016/j.bcp.2005.04.036; Jorda EG, 2003, NEUROPHARMACOLOGY, V45, P672, DOI 10.1016/S0028-3908(03)00204-1; Jorda EG, 2004, BIPOLAR DISORD, V6, P144, DOI 10.1046/j.1399-5618.2003.00090.x; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; LI ZH, 1995, NEUROCHEM INT, V27, P425, DOI 10.1016/0197-0186(95)00024-3; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Nicotera P, 1998, CELL CALCIUM, V23, P173, DOI 10.1016/S0143-4160(98)90116-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Ray SK, 2000, NEUROCHEM RES, V25, P1191, DOI 10.1023/A:1007631826160; Ray SK, 1999, BRAIN RES, V829, P18, DOI 10.1016/S0006-8993(99)01290-1; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2002, J NEUROSCI RES, V70, P561, DOI 10.1002/jnr.10414; Ray SK, 2001, BRAIN RES, V916, P115, DOI 10.1016/S0006-8993(01)02874-8; Ray SK, 2000, BRAIN RES, V867, P80, DOI 10.1016/S0006-8993(00)02260-5; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SANCES A, 1984, CRIT REV BIOMED ENG, V11, P1; Schotte P, 1998, BIOCHEM BIOPH RES CO, V251, P379, DOI 10.1006/bbrc.1998.9425; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Storch A, 2000, J NEUROCHEM, V75, P2259, DOI 10.1046/j.1471-4159.2000.0752259.x; Sui F, 2010, J ASIAN NAT PROD RES, V12, P76, DOI 10.1080/10286020903451732; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; YOUSEFIAN J, 1995, AM J ORTHOD DENTOFAC, V108, P402, DOI 10.1016/S0889-5406(95)70038-2	46	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52183	10.1371/journal.pone.0052183	http://dx.doi.org/10.1371/journal.pone.0052183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284927	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500108
J	Yin, DZ; Song, F; Xu, DR; Peterson, BS; Sun, LM; Men, WW; Yan, X; Fan, MX				Yin, Dazhi; Song, Fan; Xu, Dongrong; Peterson, Bradley S.; Sun, Limin; Men, Weiwei; Yan, Xu; Fan, Mingxia			Patterns in Cortical Connectivity for Determining Outcomes in Hand Function after Subcortical Stroke	PLOS ONE			English	Article							SENSORIMOTOR CORTEX ACTIVATION; MOTOR RECOVERY; RESTING-STATE; LONGITUDINAL FMRI; BRAIN ACTIVATION; MRI; NETWORK; REORGANIZATION; EXECUTION; IMAGERY	Background and Purpose: Previous studies have noted changes in resting-state functional connectivity during motor recovery following stroke. However, these studies always uncover various patterns of motor recovery. Moreover, subgroups of stroke patients with different outcomes in hand function have rarely been studied. Materials and Methods: We selected 24 patients who had a subcortical stroke in the left motor pathway and displayed only motor deficits. The patients were divided into two subgroups: completely paralyzed hands (CPH) ( 12 patients) and partially paralyzed hands (PPH) (12 patients). Twenty-four healthy controls (HC) were also recruited. We performed functional connectivity analysis in both the ipsilesional and contralesional primary motor cortex (M1) to explore the differences in the patterns between each pair of the three diagnostic groups. Results: Compared with the HC, the PPH group displays reduced connectivity of both the ipsilesional and contralesional M1 with bilateral prefrontal gyrus and contralesional cerebellum posterior lobe. The connectivity of both the ipsilesional and contralesional M1 with contralateral primary sensorimotor cortex was reduced in the CPH group. Additionally, the connectivity of the ipsilesional M1 with contralesional postcentral gyrus, superior parietal lobule and ipsilesional inferior parietal lobule was reduced in the CPH group compared with the PPH group. Moreover, the connectivity of these regions was positively correlated with the Fugl-Meyer Assessment scores (hand+wrist) across all stroke patients. Conclusions: Patterns in cortical connectivity may serve as a potential biomarker for the neural substratum associated with outcomes in hand function after subcortical stroke. Citation: Yin D, Song F, Xu D, Peterson BS, Sun L, et al. (2012) Patterns in Cortical Connectivity for Determining Outcomes in Hand Function after Subcortical Stroke. PLoS ONE 7(12): e52727. doi:10.1371/journal.pone.0052727	[Xu, Dongrong; Peterson, Bradley S.] New York State Psychiat Inst & Hosp, Dept Psychiat, MRI Unit, New York, NY 10032 USA; [Xu, Dongrong; Peterson, Bradley S.] Columbia Univ, New York, NY USA; [Yin, Dazhi; Men, Weiwei; Yan, Xu; Fan, Mingxia] E China Normal Univ, Key Lab Brain Funct Genom, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Song, Fan; Sun, Limin] Fudan Univ, Huashan Hosp, Dept Rehabil Med, Shanghai 200433, Peoples R China	New York State Psychiatry Institute; Columbia University; East China Normal University; Fudan University	Xu, DR (corresponding author), New York State Psychiat Inst & Hosp, Dept Psychiat, MRI Unit, New York, NY 10032 USA.	xud@nyspi.columbia.edu; mxfan@phy.ecnu.edu.cn			Excellent Young Teachers Program of Shanghai Medical College of Fudan University [124]; Shanghai Commission of Science and Technology [10440710200]	Excellent Young Teachers Program of Shanghai Medical College of Fudan University; Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the Excellent Young Teachers Program of Shanghai Medical College of Fudan University (Grant No. 124) and a grant from the Shanghai Commission of Science and Technology (Grant No. 10440710200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bianciardi M, 2009, NEUROIMAGE, V45, P160, DOI 10.1016/j.neuroimage.2008.10.034; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calautti C, 2001, STROKE, V32, P2534, DOI 10.1161/hs1101.097401; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2003, NEUROIMAGE, V19, P1650, DOI 10.1016/S1053-8119(03)00205-2; Cao XH, 2009, BRAIN RES, V1303, P195, DOI 10.1016/j.brainres.2009.08.029; Cao Y, 1998, STROKE, V29, P112, DOI 10.1161/01.STR.29.1.112; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; Cramer SC, 1997, STROKE, V28, P2518, DOI 10.1161/01.STR.28.12.2518; Cramer SC, 2000, STROKE, V31, P668, DOI 10.1161/01.STR.31.3.668; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Lewis GN, 2004, J MOTOR BEHAV, V36, P174, DOI 10.3200/JMBR.36.2.174-188; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Loubinoux I, 2003, NEUROIMAGE, V20, P2166, DOI 10.1016/j.neuroimage.2003.08.017; Loubinoux I, 2007, CEREB CORTEX, V17, P2980, DOI 10.1093/cercor/bhm023; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Netz J, 1997, BRAIN, V120, P1579, DOI 10.1093/brain/120.9.1579; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Pineiro R, 2001, STROKE, V32, P1134, DOI 10.1161/01.STR.32.5.1134; Rose DK, 2005, CLIN REHABIL, V19, P452, DOI 10.1191/0269215505cr806oa; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tombari D, 2004, NEUROIMAGE, V23, P827, DOI 10.1016/j.neuroimage.2004.07.058; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; WASSERMANN EM, 1991, NEUROLOGY, V41, P1795, DOI 10.1212/WNL.41.11.1795; WEILLER C, 1993, ANN NEUROL, V33, P181; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701	45	50	53	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52727	10.1371/journal.pone.0052727	http://dx.doi.org/10.1371/journal.pone.0052727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285171	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500242
J	Mok, KW; Mruk, DD; Lee, WM; Cheng, CY				Mok, Ka-Wai; Mruk, Dolores D.; Lee, Will M.; Cheng, C. Yan			Rictor/mTORC2 regulates blood-testis barrier dynamics via its effects on gap junction communications and actin filament network	FASEB JOURNAL			English	Article						spermatogenesis; seminiferous epithelial cycle; Sertoli cell; ectoplasmic specialization	ADHERENS JUNCTIONS; MAMMALIAN TARGET; CADMIUM CHLORIDE; TIGHT JUNCTIONS; PROTEIN COMPLEX; SERTOLI-CELLS; MTOR; CYTOSKELETON; CONNEXIN-43; TGF-BETA-3	In the mammalian testis, coexisting tight junctions (TJs), basal ectoplasmic specializations, and gap junctions (GJs), together with desmosomes near the basement membrane, constitute the blood-testis barrier (BTB). The most notable feature of the BTB, however, is the extensive network of actin filament bundles, which makes it one of the tightest blood-tissue barriers. The BTB undergoes restructuring to facilitate the transit of preleptotene spermatocytes at stage VIII-IX of the epithelial cycle. Thus, the F-actin network at the BTB undergoes cyclic reorganization via a yet-to-be explored mechanism. Rictor, the key component of mTORC2 that is known to regulate actin cytoskeleton, was shown to express stage-specifically at the BTB in the seminiferous epithelium. Its expression was down-regulated at the BTB in stage VIII-IX tubules, coinciding with BTB restructuring at these stages. Using an in vivo model, a down-regulation of rictor at the BTB was also detected during adjudin-induced BTB disruption, illustrating rictor expression is positively correlated with the status of the BTB integrity. Indeed, the knockdown of rictor by RNAi was found to perturb the Sertoli cell TJ-barrier function in vitro and the BTB integrity in vivo. This loss of barrier function was accompanied by changes in F-actin organization at the Sertoli cell BTB in vitro and in vivo, associated with a loss of interaction between actin and alpha-catenin or ZO-1. Rictor knockdown by RNAi was also found to impede Sertoli cell-cell GJ communication, disrupting protein distribution (e. g., occludin, ZO-1) at the BTB, illustrating that rictor is a crucial BTB regulator.-Mok, K., Mruk, D. D., Lee, W. M., Cheng, C. Y. Rictor/mTORC2 regulates blood-testis barrier dynamics via its effects on gap junction communications and actin filament network. FASEB J. 27, 1137-1152 (2013). www.fasebj.org	[Mok, Ka-Wai; Mruk, Dolores D.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA; [Mok, Ka-Wai; Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Population Council; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	hrszlwm@hku.hk; y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009	Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health (National Institute of Child Health and Human Development) [R01 HD056034, U54 HD029990, R03 HD061401]; University of Hong Kong Committee on Research and Conference Grants; University of Hong Kong; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034, U54HD029990] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD061401] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Hong Kong Committee on Research and Conference Grants; University of Hong Kong(University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the U.S. National Institutes of Health (National Institute of Child Health and Human Development, R01 HD056034 to C. Y. C.; U54 HD029990, Project 5, to C. Y. C.; R03 HD061401 to D. D. M.), and University of Hong Kong Committee on Research and Conference Grants seed funding to W. M. L. K. W. M. was supported by a University of Hong Kong Postgraduate Student Research award while all the experiments reported herein were conducted in the laboratory of C. Y. C. in New York.	Aravindan GR, 1996, J CELL PHYSIOL, V168, P123; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Grima J, 1998, J BIOL CHEM, V273, P21040, DOI 10.1074/jbc.273.33.21040; Hagan GN, 2008, MOL CELL BIOL, V28, P4215, DOI 10.1128/MCB.00867-07; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Huang SH, 2003, J CELL BIOCHEM, V90, P33, DOI 10.1002/jcb.10610; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; JANECKI A, 1992, TOXICOL APPL PHARM, V112, P51, DOI 10.1016/0041-008X(92)90278-Z; Jin EJ, 2008, J CELL PHYSIOL, V214, P345, DOI 10.1002/jcp.21202; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Lee NPY, 2004, J ANDROL, V25, P200; Li MWM, 2013, ADV EXP MED BIOL, V763, P260; Li MWM, 2010, P NATL ACAD SCI USA, V107, P17998, DOI 10.1073/pnas.1007047107; Li MWM, 2009, P NATL ACAD SCI USA, V106, P10213, DOI 10.1073/pnas.0901700106; Lie PPY, 2011, FASEB J, V25, P1244, DOI 10.1096/fj.10-169995; Lie PPY, 2010, P NATL ACAD SCI USA, V107, P11411, DOI 10.1073/pnas.1001823107; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Mahajan K., 2010, J CELL PHYSL, V227, P3178; Miyoshi J, 2008, BBA-BIOMEMBRANES, V1778, P670, DOI 10.1016/j.bbamem.2007.12.014; Mok KW, 2012, INT J ANDROL, V35, P86, DOI 10.1111/j.1365-2605.2011.01183.x; Mok KW, 2012, ENDOCRINOLOGY, V153, P5036, DOI 10.1210/en.2012-1665; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Oh WJ, 2011, CELL CYCLE, V10, P2305, DOI 10.4161/cc.10.14.16586; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; PINEAU C, 1993, J ANDROL, V14, P87; Pointis G, 2010, PHILOS T R SOC B, V365, P1607, DOI 10.1098/rstb.2009.0114; Putnam AJ, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-10; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SETCHELL BP, 1970, J ENDOCRINOL, V47, P81, DOI 10.1677/joe.0.0470081; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Zhou HY, 2010, CURR PROTEIN PEPT SC, V11, P409, DOI 10.2174/138920310791824093	47	61	64	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1137	1152		10.1096/fj.12-212977	http://dx.doi.org/10.1096/fj.12-212977			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23288930	Green Published			2022-12-25	WOS:000315585200027
J	Badri, DV; Chaparro, JM; Zhang, RF; Shen, QR; Vivanco, JM				Badri, Dayakar V.; Chaparro, Jacqueline M.; Zhang, Ruifu; Shen, Qirong; Vivanco, Jorge M.			Application of Natural Blends of Phytochemicals Derived from the Root Exudates of Arabidopsis to the Soil Reveal That Phenolic-related Compounds Predominantly Modulate the Soil Microbiome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL COMMUNITY STRUCTURE; RIBOSOMAL-RNA; PLANTS; PSEUDOMONAS; THALIANA; SIGNALS; IMPACT; ACTINOBACTERIA; STRIGOLACTONES; FLAVONOIDS	The roots of plants have the ability to influence its surrounding microbiology, the so-called rhizosphere microbiome, through the creation of specific chemical niches in the soil mediated by the release of phytochemicals. Here we report how these phytochemicals could modulate the microbial composition of a soil in the absence of the plant. For this purpose, root exudates of Arabidopsis were collected and fractionated to obtain natural blends of phytochemicals at various relative concentrations that were characterized by GC-MS and applied repeatedly to a soil. Soil bacterial changes were monitored by amplifying and pyro-sequencing the 16 S ribosomal small subunit region. Our analyses reveal that one phytochemical can culture different operational taxonomic units (OTUs), mixtures of phytochemicals synergistically culture groups of OTUs, and the same phytochemical can act as a stimulator or deterrent to different groups of OTUs. Furthermore, phenolic-related compounds showed positive correlation with a higher number of unique OTUs compared with other groups of compounds (i.e. sugars, sugar alcohols, and amino acids). For instance, salicylic acid showed positive correlations with species of Corynebacterineae, Pseudonocardineae and Streptomycineae, and GABA correlated with species of Sphingomonas, Methylobacterium, Frankineae, Variovorax, Micromonosporineae, and Skermanella. These results imply that phenolic compounds act as specific substrates or signaling molecules for a large group of microbial species in the soil.	[Badri, Dayakar V.; Chaparro, Jacqueline M.; Vivanco, Jorge M.] Colorado State Univ, Dept Hort & Landscape Architecture, Ft Collins, CO 80523 USA; [Badri, Dayakar V.; Chaparro, Jacqueline M.; Vivanco, Jorge M.] Colorado State Univ, Ctr Rhizosphere Biol, Ft Collins, CO 80523 USA; [Zhang, Ruifu; Shen, Qirong] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China	Colorado State University; Colorado State University; Nanjing Agricultural University	Zhang, RF (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210095, Jiangsu, Peoples R China.	rfzhang@njau.edu.cn; j.vivanco@colostate.edu	Zhang, Ruifu/HDN-0417-2022; Zhang, Ruifu/HDN-0340-2022; Shen, Qirong/AAB-6531-2020		National Science Foundation [MCB0950857]; National Natural Science Foundation of China [41271271]; Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 Project [B12009]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions; 111 Project(Ministry of Education, China - 111 Project)	This work was supported by National Science Foundation Grant MCB0950857 (to J.M.V.).; Supported by the National Natural Science Foundation of China (41271271) and the Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions.; Part of the 111 Project (B12009).	Abdel-Lateif K, 2012, PLANT SIGNAL BEHAV, V7, P636, DOI 10.4161/psb.20039; Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arndt D, 2012, NUCLEIC ACIDS RES, V40, pW88, DOI 10.1093/nar/gks497; Badri DV, 2008, NEW PHYTOL, V179, P209, DOI 10.1111/j.1469-8137.2008.02458.x; Badri DV, 2008, PLANT PHYSIOL, V146, P762, DOI 10.1104/pp.107.109587; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Badri Dayakar V, 2012, Front Plant Sci, V3, P149, DOI 10.3389/fpls.2012.00149; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2004, TRENDS PLANT SCI, V9, P26, DOI 10.1016/j.tplants.2003.11.008; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Baudoin E, 2003, SOIL BIOL BIOCHEM, V35, P1183, DOI 10.1016/S0038-0717(03)00179-2; BEHERA B, 1974, SOIL SCI SOC AM J, V38, P591, DOI 10.2136/sssaj1974.03615995003800040021x; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Broughton WJ, 2003, PLANT SOIL, V252, P129, DOI 10.1023/A:1024179717780; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cai T, 2009, MOL MICROBIOL, V73, P507, DOI 10.1111/j.1365-2958.2009.06790.x; Castillo UF, 2007, MICROB ECOL, V53, P12, DOI 10.1007/s00248-006-9129-6; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chaparro JM, 2012, BIOL FERT SOILS, V48, P489, DOI 10.1007/s00374-012-0691-4; Chen G, 2003, RES MICROBIOL, V154, P393, DOI 10.1016/S0923-2508(03)00082-2; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Conn VM, 2008, MOL PLANT MICROBE IN, V21, P208, DOI 10.1094/MPMI-21-2-0208; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Dennis PG, 2010, FEMS MICROBIOL ECOL, V72, P313, DOI 10.1111/j.1574-6941.2010.00860.x; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Doornbos RF, 2012, AGRON SUSTAIN DEV, V32, P227, DOI 10.1007/s13593-011-0028-y; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eilers KG, 2010, SOIL BIOL BIOCHEM, V42, P896, DOI 10.1016/j.soilbio.2010.02.003; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Li X, 2010, MOL PLANT, V3, P91, DOI 10.1093/mp/ssp090; Lin YT, 2012, APPL SOIL ECOL, V60, P49, DOI 10.1016/j.apsoil.2012.03.001; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Micallef SA, 2009, PLANT SIGNAL BEHAV, V4, P777, DOI 10.1093/jxb/erp053; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Neal AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035498; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Omrane S, 2009, PLANT SIGNAL BEHAV, V4, P1066, DOI 10.4161/psb.4.11.9735; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Prithiviraj B, 2005, INFECT IMMUN, V73, P5319, DOI 10.1128/IAI.73.9.5319-5328.2005; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Rudrappa T, 2008, PLANT PHYSIOL, V148, P1547, DOI 10.1104/pp.108.127613; Saleem M, 2007, J IND MICROBIOL BIOT, V34, P635, DOI 10.1007/s10295-007-0240-6; Sana TR, 2010, METABOLOMICS, V6, P451, DOI 10.1007/s11306-010-0218-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Somers E, 2004, CRIT REV MICROBIOL, V30, P205, DOI 10.1080/10408410490468786; Sood SG, 2003, FEMS MICROBIOL ECOL, V45, P219, DOI 10.1016/S0168-6496(03)00155-7; Speed T. P., 2003, STAT ANAL GENE EXPRE, P222; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Wallace RJ, 2004, P NUTR SOC, V63, P621, DOI 10.1079/PNS2004393; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yoneyama K, 2008, NEW PHYTOL, V179, P484, DOI 10.1111/j.1469-8137.2008.02462.x; Zhang J, 2009, PLANT J, V57, P171, DOI 10.1111/j.1365-313X.2008.03676.x	67	290	306	13	50	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4502	4512		10.1074/jbc.M112.433300	http://dx.doi.org/10.1074/jbc.M112.433300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293028	Green Published, hybrid			2022-12-25	WOS:000315340400001
J	Wang, Z; Anderson, NS; Benning, C				Wang, Zhen; Anderson, Nicholas Scott; Benning, Christoph			The Phosphatidic Acid Binding Site of the Arabidopsis Trigalactosyldiacylglycerol 4 (TGD4) Protein Required for Lipid Import into Chloroplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; TRAFFICKING; METABOLISM; ELECTROPHORESIS; ACTIVATION; SEQUENCE; GROWTH; ER	Chloroplast membrane lipid synthesis relies on the import of glycerolipids from the ER. The TGD (TriGalactosylDiacylglycerol) proteins are required for this lipid transfer process. The TGD1, -2, and -3 proteins form a putative ABC (ATP-binding cassette) transporter transporting ER-derived lipids through the inner envelope membrane of the chloroplast, while TGD4 binds phosphatidic acid (PtdOH) and resides in the outer chloroplast envelope. We identified two sequences in TGD4, amino acids 1-80 and 110-145, which are necessary and sufficient for PtdOH binding. Deletion of both sequences abolished PtdOH binding activity. We also found that TGD4 from 18: 3 plants bound specifically and with increased affinity PtdOH. TGD4 did not interact with other proteins and formed a homodimer both in vitro and in vivo. Our results suggest that TGD4 is an integral dimeric beta-barrel lipid transfer protein that binds PtdOH with its N terminus and contains dimerization domains at its C terminus.	[Wang, Zhen; Anderson, Nicholas Scott; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	benning@msu.edu	Benning, Christoph/Y-2528-2019; Wang, Zhen/B-5067-2014	Benning, Christoph/0000-0001-8585-3667; Wang, Zhen/0000-0003-4823-8002; Wang, Zhen/0000-0002-3244-690X	United States National Science Foundation [MCB 0741395, MCB 1157231]; Div Of Molecular and Cellular Bioscience [1157231] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in parts by Grants MCB 0741395 and MCB 1157231 from the United States National Science Foundation (to C. B.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Du ZY, 2010, PLANT PHYSIOL, V152, P1585, DOI 10.1104/pp.109.147066; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; FRENTZEN M, 1983, EUR J BIOCHEM, V129, P629; Haarmann R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454124; Hayat S, 2012, BIOINFORMATICS, V28, P516, DOI 10.1093/bioinformatics/btr710; HEINZ E, 1983, PLANT PHYSIOL, V72, P273, DOI 10.1104/pp.72.2.273; Imai K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-79; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lu BB, 2007, J BIOL CHEM, V282, P35945, DOI 10.1074/jbc.M704063200; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Mongrand S, 1998, PHYTOCHEMISTRY, V49, P1049, DOI 10.1016/S0031-9422(98)00243-X; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakamura Y, 2007, J BIOL CHEM, V282, P29013, DOI 10.1074/jbc.M704385200; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Roston R, 2011, PLANT J, V66, P759, DOI 10.1111/j.1365-313X.2011.04536.x; Roston RL, 2012, J BIOL CHEM, V287, P21406, DOI 10.1074/jbc.M112.370213; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SHAPIRO AL, 1969, ANAL BIOCHEM, V29, P505, DOI 10.1016/0003-2697(69)90335-2; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Wang Z, 2012, PLANT J, V70, P614, DOI 10.1111/j.1365-313X.2012.04900.x; Wang Z, 2012, BIOCHEM SOC T, V40, P457, DOI 10.1042/BST20110752; Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592; Xu CC, 2003, EMBO J, V22, P2370, DOI 10.1093/emboj/cdg234; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	34	46	48	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4763	4771		10.1074/jbc.M112.438986	http://dx.doi.org/10.1074/jbc.M112.438986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297418	Green Published, hybrid			2022-12-25	WOS:000315340400025
J	Bertran-Gonzalez, J; Chieng, BC; Laurent, V; Valjent, E; Balleine, BW				Bertran-Gonzalez, Jesus; Chieng, Billy C.; Laurent, Vincent; Valjent, Emmanuel; Balleine, Bernard W.			Striatal Cholinergic Interneurons Display Activity-Related Phosphorylation of Ribosomal Protein S6	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; CELL-SIZE; RAT NEOSTRIATUM; NEURONS; KINASE; DOPAMINE; BRAIN; IDENTIFICATION; TRANSLATION; ACTIVATION	Cholinergic interneurons (CINs) provide the main source of acetylcholine to all striatal regions, and strongly modulate dopaminergic actions through complex regulation of pre- and post-synaptic acetylcholine receptors. Although striatal CINs have a well-defined electrophysiological profile, their biochemical properties are poorly understood, likely due to their low proportion within the striatum (2-3%). We report a strong and sustained phosphorylation of ribosomal protein S6 on its serine 240 and 244 residues (p-Ser(240-244)-S6rp), a protein integrant of the ribosomal machinery related to the mammalian target of the rapamycin complex 1 (mTORC1) pathway, which we found to be principally expressed in striatal CINs in basal conditions. We explored the functional relevance of this cellular event by pharmacologically inducing various sustained physiological activity states in CINs and assessing the effect on the levels of S6rp phosphorylation. Cell-attached electrophysiological recordings from CINs in a striatal slice preparation showed an inhibitory effect of tetrodotoxin (TTX) on action potential firing paralleled by a decrease in the p-Ser(240-244)-S6rp signal as detected by immunofluorescence after prolonged incubation. On the other hand, elevation in extracellular potassium concentration and the addition of apamin generated an increased firing rate and a burst-firing activity in CINs, respectively, and both stimulatory conditions significantly increased Ser(240-244)-S6rp phosphorylation above basal levels when incubated for one hour. Apamin generated a particularly large increase in phosphorylation that was sensitive to rapamycin. Taken together, our results demonstrate for the first time a link between the state of neuronal activity and a biochemical signaling event in striatal CINs, and suggest that immunofluorescence can be used to estimate the cellular activity of CINs under different pharmacological and/or behavioral conditions.	[Bertran-Gonzalez, Jesus; Chieng, Billy C.; Laurent, Vincent; Balleine, Bernard W.] Univ Sydney, Brain & Mind Res Inst, Behav Neurosci Lab, Sydney, NSW 2006, Australia; [Valjent, Emmanuel] CNRS UMR 5203, Inserm U661, Inst Genom Fonct, Montpellier, France	University of Sydney; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Balleine, BW (corresponding author), Univ Sydney, Brain & Mind Res Inst, Behav Neurosci Lab, Sydney, NSW 2006, Australia.	bernard.balleine@sydney.edu.au	Bertran-Gonzalez, J/L-1410-2017; Laurent, Vincent/I-3975-2019; Laurent, Vincent/H-5737-2013	Bertran-Gonzalez, J/0000-0002-3794-1782; Laurent, Vincent/0000-0003-2333-8437; Valjent, Emmanuel/0000-0002-1034-606X; Chieng, Billy/0000-0003-0222-8001; Balleine, Bernard/0000-0001-8618-7950	Australian Research Council (ARC) [FL0992409]; National Health and Medical Research Council (NHMRC) [633267]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from the Australian Research Council (ARC #FL0992409; http://www.arc.gov.au), and the National Health and Medical Research Council (NHMRC #633267; http://www.nhmrc.gov.au) to Bernard Balleine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antion MD, 2008, LEARN MEMORY, V15, P29, DOI 10.1101/lm.661908; Bennett BD, 1999, J NEUROSCI, V19, P5586; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Berlanga ML, 2003, NEUROSCIENCE, V120, P1149, DOI 10.1016/S0306-4522(03)00378-6; BOLAM JP, 1984, CIBA F SYMP, V107, P30; Bolam JP, 1995, MOL CELLULAR MECH NE, P1; Bonsi P, 2004, LEARN MEMORY, V11, P755, DOI 10.1101/lm.82104; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Daigle TL, 2012, J NEUROSCI, V32, P11461, DOI 10.1523/JNEUROSCI.2234-12.2012; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; English DF, 2012, NAT NEUROSCI, V15, P123, DOI 10.1038/nn.2984; Fino E, 2008, J PHYSIOL-LONDON, V586, P265, DOI 10.1113/jphysiol.2007.144501; Fino E, 2011, NEUROPHARMACOLOGY, V60, P780, DOI 10.1016/j.neuropharm.2011.01.023; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Gangarossa G, 2012, NEUROPHARMACOLOGY, P1; Gangarossa G, 2012, BRAIN STRUCTURE FUNC; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Goldberg JA, 2011, NEUROSCIENCE, V198, P27, DOI 10.1016/j.neuroscience.2011.08.067; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KIMURA H, 1980, SCIENCE, V208, P1057, DOI 10.1126/science.6990490; Knight ZA, 2012, CELL, V151, P1126, DOI 10.1016/j.cell.2012.10.039; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Moore CEJ, 2009, J MOL BIOL, V389, P480, DOI 10.1016/j.jmb.2009.04.020; NYGARD O, 1990, EUR J BIOCHEM, V191, P1, DOI 10.1111/j.1432-1033.1990.tb19087.x; PARKER PJ, 1985, EUR J BIOCHEM, V148, P579, DOI 10.1111/j.1432-1033.1985.tb08879.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Schulz JM, 2011, J NEUROSCI, V31, P11133, DOI 10.1523/JNEUROSCI.0661-11.2011; SORIMACHI M, 1975, BRAIN RES, V94, P325, DOI 10.1016/0006-8993(75)90065-7; Sullivan MA, 2008, J NEUROSCI, V28, P8682, DOI 10.1523/JNEUROSCI.2411-08.2008; Suzuki T, 2001, J NEUROSCI, V21, P6492, DOI 10.1523/JNEUROSCI.21-17-06492.2001; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Threlfell S, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00011; Valjent E, 2011, NEUROPSYCHOPHARMACOL, V36, P2561, DOI 10.1038/npp.2011.144; Warner-Schmidt JL, 2012, P NATL ACAD SCI US; WILSON CJ, 1990, J NEUROSCI, V10, P508	44	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53195	10.1371/journal.pone.0053195	http://dx.doi.org/10.1371/journal.pone.0053195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285266	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500120
J	Huntjens, B; Charman, WN; Workman, H; Hosking, SL; O'Donnell, C				Huntjens, Byki; Charman, W. Neil; Workman, Helena; Hosking, Sarah L.; O'Donnell, Clare			Short-Term Stability in Refractive Status Despite Large Fluctuations in Glucose Levels in Diabetes Mellitus Type 1 and 2	PLOS ONE			English	Article							POLYOL PATHWAY; GLYCEMIC CONTROL; REPEATABILITY; THICKNESS; HYPERGLYCEMIA; SOMATOSTATIN; HYPEROPIA; AGREEMENT; ONSET; SHAPE	Purpose: This work investigates how short-term changes in blood glucose concentration affect the refractive components of the diabetic eye in patients with long-term Type 1 and Type 2 diabetes. Methods: Blood glucose concentration, refractive error components (mean spherical equivalent MSE, J0, J45), central corneal thickness (CCT), anterior chamber depth (ACD), crystalline lens thickness (LT), axial length (AL) and ocular aberrations were monitored at two-hourly intervals over a 12-hour period in: 20 T1DM patients (mean age +/- SD) 38 +/- 14 years, baseline HbA1c 8.6 +/- 1.9%; 21 T2DM patients (mean age +/- SD) 56 +/- 11 years, HbA1c 7.5 +/- 1.8%; and in 20 control subjects (mean age +/- SD) 49 +/- 23 years, HbA1c 5.5 +/- 0.5%. The refractive and biometric results were compared with the corresponding changes in blood glucose concentration. Results: Blood glucose concentration at different times was found to vary significantly within (p<0.0005) and between groups (p<0.0005). However, the refractive error components and ocular aberrations were not found to alter significantly over the day in either the diabetic patients or the control subjects (p>0.05). Minor changes of marginal statistical or optical significance were observed in some biometric parameters. Similarly there were some marginally significant differences between the baseline biometric parameters of well-controlled and poorly-controlled diabetic subjects. Conclusion: This work suggests that normal, short-term fluctuations (of up to about 6 mM/l on a timescale of a few hours) in the blood glucose levels of diabetics are not usually associated with acute changes in refractive error or ocular wavefront aberrations. It is therefore possible that factors other than refractive error fluctuations are sometimes responsible for the transient visual problems often reported by diabetic patients.	[Charman, W. Neil; O'Donnell, Clare] Univ Manchester, Fac Life Sci, London WC2N 6EZ, England; [Huntjens, Byki; Hosking, Sarah L.] City Univ London, Div Optometry & Visual Sci, London EC1V 0HB, England; [Workman, Helena; O'Donnell, Clare] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Hosking, Sarah L.] Univ Melbourne, Dept Ophthalmol, Melbourne, Vic, Australia; [O'Donnell, Clare] Optegra Eye Sci, Manchester, Lancs, England	University of Manchester; City University London; Aston University; University of Melbourne	O'Donnell, C (corresponding author), Univ Manchester, Fac Life Sci, 8 John Adam St, London WC2N 6EZ, England.	clare.odonnell@optegra.com		Huntjens, Byki/0000-0002-4864-0723	Lein Applied Diagnostics, United Kingdom; Lein Applied Diagnostics	Lein Applied Diagnostics, United Kingdom; Lein Applied Diagnostics	This work was supported by a PhD Research Scholarship from Lein Applied Diagnostics, United Kingdom (http://www.lein-ad.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Byki Huntjens received funding for her PhD studies from Lein Applied Diagnostics. The data presented here were collected during her PhD studentship, hence the acknowledgement. However, this does not affect the authors' adherence to the PLOS ONE policies on sharing data and materials. We declare there are no competing interests in this regard.	Agardh E, 2011, ACTA OPHTHALMOL, V89, P107, DOI 10.1111/j.1755-3768.2009.01664.x; [Anonymous], 1991, OPHTHALMOLOGY, V98, P786; Bennett R. R, 1998, CLIN VISUAL OPTICS; Bourne W M, 1998, Trans Am Ophthalmol Soc, V96, P229; BOURNE WM, 1998, T AM OPHTHAL SOC, V96, P239; Chan B, 2006, CLIN EXP OPTOM, V89, P160, DOI 10.1111/j.1444-0938.2006.00029.x; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; du Toit R, 2003, CORNEA, V22, P205, DOI 10.1097/00003226-200304000-00004; Elliott M, 1997, OPTOMETRY VISION SCI, V74, P434, DOI 10.1097/00006324-199706000-00028; EVA PR, 1982, BRIT J OPHTHALMOL, V66, P500, DOI 10.1136/bjo.66.8.500; FLEDELIUS HC, 1987, ACTA OPHTHALMOL, V65, P53; Furushima M, 1999, JPN J OPHTHALMOL, V43, P398, DOI 10.1016/S0021-5155(99)00098-2; Giusti C, 2003, SWISS MED WKLY, V133, P200; GONZALEZ RG, 1984, DIABETES, V33, P196, DOI 10.2337/diabetes.33.2.196; GWINUP G, 1976, DIABETES, V25, P29, DOI 10.2337/diabetes.25.1.29; Harper CL, 1996, BRIT J OPHTHALMOL, V80, P1068, DOI 10.1136/bjo.80.12.1068; Kato S, 2001, AM J OPHTHALMOL, V131, P301, DOI 10.1016/S0002-9394(00)00804-7; Kubo E, 2004, BIOCHEM BIOPH RES CO, V314, P1050, DOI 10.1016/j.bbrc.2004.01.002; Lane JT, 2001, AM J OPHTHALMOL, V132, P321, DOI 10.1016/S0002-9394(01)01048-0; LARSSON L, 1995, AM J OPHTHALMOL, V120, P362, DOI 10.1016/S0002-9394(14)72166-X; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; MANDELL RB, 1965, NATURE, V208, P292, DOI 10.1038/208292a0; McNamara NA, 1998, INVEST OPHTH VIS SCI, V39, P3; National Toxicology Program, 2010, Natl Toxicol Program Tech Rep Ser, P1; O'Donnell C, 2005, CORNEA, V24, P920, DOI 10.1097/01.ico.0000157422.01146.e9; Okamoto F, 2000, BRIT J OPHTHALMOL, V84, P1097, DOI 10.1136/bjo.84.10.1097; Olansky Leann, 2004, MedGenMed, V6, P14; PATERSON CA, 1972, DOC OPHTHALMOL, V31, P1; Pierro L, 1996, ACTA OPHTHALMOL SCAN, V74, P539; PLANTEN JT, 1979, DOC OPHTHALMOL, V46, P237, DOI 10.1007/BF00142613; Ramana KV, 2003, FASEB J, V17, P417, DOI 10.1096/fj.02-0722com; Rubin A, 2004, S AFR OPTOM, V63, P65; SAITO Y, 1993, BRIT J OPHTHALMOL, V77, P145, DOI 10.1136/bjo.77.3.145; Sonmez B, 2005, CORNEA, V24, P531, DOI 10.1097/01.ico.0000151545.00489.12; Steffes P G, 1999, Diabetes Technol Ther, V1, P129, DOI 10.1089/152091599317332; Stone RA, 2004, INVEST OPHTH VIS SCI, V45, P63, DOI 10.1167/iovs.03-0294; Taylor AW, 2003, INVEST OPHTH VIS SCI, V44, P2644, DOI 10.1167/iovs.02-1216; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; WALDHAUSL W, 1977, J CLIN ENDOCR METAB, V44, P876, DOI 10.1210/jcem-44-5-876; WESTON BC, 1995, INVEST OPHTH VIS SCI, V36, P586; Wiemer NGM, 2008, OPHTHALMOLOGY, V115, P1679, DOI 10.1016/j.ophtha.2008.03.019; Wiemer NGM, 2008, GRAEF ARCH CLIN EXP, V246, P993, DOI 10.1007/s00417-008-0810-y; Wiemer NGM, 2007, CORNEA, V26, P1165, DOI 10.1097/ICO.0b013e31814fa82f; Wiemer NGM, 2009, ACTA OPHTHALMOL, V87, P176, DOI 10.1111/j.1755-3768.2008.01212.x; ZADNIK K, 1992, INVEST OPHTH VIS SCI, V33, P2325	46	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52947	10.1371/journal.pone.0052947	http://dx.doi.org/10.1371/journal.pone.0052947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285232	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000313051500087
J	Zhao, K; Chen, G; Shi, XM; Gao, TT; Li, W; Zhao, Y; Zhang, FQ; Wu, J; Cui, XL; Wang, YF				Zhao, Kai; Chen, Gang; Shi, Xing-ming; Gao, Ting-ting; Li, Wei; Zhao, Yan; Zhang, Feng-qiang; Wu, Jin; Cui, Xianlan; Wang, Yun-feng			Preparation and Efficacy of a Live Newcastle Disease Virus Vaccine Encapsulated in Chitosan Nanoparticles	PLOS ONE			English	Article							INTRANASAL VACCINATION; DRUG-DELIVERY; IN-VITRO; PROTECTIVE IMMUNITY; NASAL DELIVERY; CHICKENS; DNA; MICROSPHERES; ANTIGEN; PROTEIN	Background: Newcastle disease (ND) is a highly contagious viral disease of poultry caused by pathogenic strains of the Newcastle disease virus (NDV). Live NDV vaccines are administered by drinking water, eyedrops or coarse aerosol spray. To further enhance mucosal immune responses, chitosan nanoparticles were developed for the mucosal delivery of a live NDV vaccine. Methodology/Principal Findings: A lentogenic live-virus vaccine (strain LaSota) against NDV encapsulated in chitosan nanoparticles were developed using an ionic crosslinking method. Chitosan nanoparticles containing the lentogenic live-virus vaccine against NDV (NDV-CS-NPs) were produced with good morphology, high stability, a mean diameter of 371.1 nm, an encapsulation rate of 77% and a zeta potential of +2.84 mV. The Western blotting analysis showed that NDV structural proteins were detected in NDV-CS-NPs. The virus release assay results of NDV-CS-NPs indicated that NDV was released from NDV-CS-NPs. Chickens immunized orally or intranasally with NDV-CS-NPs were fully protected whereas one out of five chickens immunized with the LaSota live NDV vaccine and three out of five chickens immunized with the inactivated NDV vaccine were dead after challenge with the highly virulent NDV strain F48E9. Conclusions/Significance: NDV-CS-NPs induced better protection of immunized specific pathogen free chickens compared to the live NDV vaccine strain LaSota and the inactivated NDV vaccine. This study lays a foundation for the further development of mucosal vaccines and drugs encapsulated in chitosan nanoparticles.	[Zhao, Kai; Chen, Gang; Gao, Ting-ting; Li, Wei; Zhang, Feng-qiang; Wu, Jin] Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China; [Zhao, Kai; Shi, Xing-ming; Li, Wei; Zhao, Yan; Wang, Yun-feng] CAAS, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Avian Infect Dis, Harbin, Peoples R China	Heilongjiang University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Zhao, K (corresponding author), Heilongjiang Univ, Coll Life Sci, Microbiol Lab, Harbin, Peoples R China.	zk395@yahoo.com.cn; xianlan.cui@dpipwe.tas.gov.au; yfwang@hvri.ac.cn	Cui, Xianlan/N-1734-2017	Cui, Xianlan/0000-0002-5029-1286; Zhao, Kai/0000-0001-6139-1912	National Natural Science Foundation of China [31072119]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [31110103064]; Program for New Century Excellent Talents in Heilongjiang Provincial University [1251-NCET-005]; Key Scientific and Technological Planning Project of Harbin [2009AA6CN125]; Innovation Foundation of Harbin [2010RFQXN091, 2011RFQXN039]; Education Committee Science and Technology Research General Projects of Heilongjiang Province [11541267]; High-level Talents (innovation team) Project of Heilongjiang University [Hdtd2010-17]; Heilongjiang Postdoctoral Foundation [LBH-Q07109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in Heilongjiang Provincial University(Program for New Century Excellent Talents in University (NCET)); Key Scientific and Technological Planning Project of Harbin; Innovation Foundation of Harbin; Education Committee Science and Technology Research General Projects of Heilongjiang Province; High-level Talents (innovation team) Project of Heilongjiang University; Heilongjiang Postdoctoral Foundation	This work was supported in part by National Natural Science Foundation of China (31072119), The Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (31110103064), Program for New Century Excellent Talents in Heilongjiang Provincial University (1251-NCET-005), Key Scientific and Technological Planning Project of Harbin (2009AA6CN125), Innovation Foundation of Harbin (2010RFQXN091 and 2011RFQXN039), Education Committee Science and Technology Research General Projects of Heilongjiang Province (11541267), High-level Talents (innovation team) Project of Heilongjiang University (Hdtd2010-17) and Heilongjiang Postdoctoral Foundation (LBH-Q07109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksungur P, 2004, J CONTROL RELEASE, V98, P269, DOI 10.1016/j.jconrel.2004.05.002; Alexander DJ, 2008, POULTRY DIS, P75; Amidi M, 2007, VACCINE, V25, P144, DOI 10.1016/j.vaccine.2006.06.086; Amidi M, 2010, ADV DRUG DELIVER REV, V62, P59, DOI 10.1016/j.addr.2009.11.009; Arifin MA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/586363; Aspden TJ, 1997, J PHARM SCI, V86, P509, DOI 10.1021/js960182o; Boyoglu S, 2009, NANOMED-NANOTECHNOL, V5, P463, DOI 10.1016/j.nano.2009.02.004; Bwala D. G., 2011, International Journal of Poultry Science, V10, P98; [陈英杰 CHEN Yingjie], 2007, [中国药科大学学报, Journal of China Pharmaceutical University], V38, P186; CORIA MF, 1972, APPL MICROBIOL, V23, P281, DOI 10.1128/AEM.23.2.281-284.1972; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; de Moura MR, 2008, J COLLOID INTERF SCI, V321, P477, DOI 10.1016/j.jcis.2008.02.006; Echeonwu GON, 2008, AFR J MICROBIOL RES, V2, P120; EWERT DL, 1977, INFECT IMMUN, V18, P146, DOI 10.1128/IAI.18.1.146-150.1977; Fan HR, 1999, NAT BIOTECHNOL, V17, P870, DOI 10.1038/12856; Fan M, 2009, CARBOHYD POLYM, V78, P66, DOI 10.1016/j.carbpol.2009.03.031; Gavini E, 2006, INT J PHARMACEUT, V307, P9, DOI 10.1016/j.ijpharm.2005.09.013; GHUMMAN JS, 1976, AVIAN DIS, V20, P18, DOI 10.2307/1589470; Henderson A, 2011, VACCINE, V29, P5304, DOI 10.1016/j.vaccine.2011.05.009; JAYAWARDANE GWL, 1995, VET MICROBIOL, V46, P69, DOI 10.1016/0378-1135(95)00073-J; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; Jin HL, 2004, VACCINE, V22, P2925, DOI 10.1016/j.vaccine.2003.12.026; Kang ML, 2008, J MICROBIOL BIOTECHN, V18, P1179; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kasturi SP, 2005, BIOMATERIALS, V26, P6375, DOI 10.1016/j.biomaterials.2005.03.043; Kavanagh OV, 2003, VACCINE, V21, P4472, DOI 10.1016/S0264-410X(03)00432-8; Liu HL, 2008, RES VET SCI, V85, P612, DOI 10.1016/j.rvsc.2008.02.013; Liu SW, 1998, CHIN J ANIMAL POULT, V20, P140; Malhotra M, 2011, INT J NANOMED, V6, P485, DOI 10.2147/IJN.S17190; MARINO OC, 1987, AVIAN DIS, V31, P293, DOI 10.2307/1590875; Merz D.C., 1981, VIROLOGY, V28, P208; Mok HJ, 2008, EUR J PHARM BIOPHARM, V68, P105, DOI 10.1016/j.ejpb.2007.04.022; Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019; Partidos, 2000, Pharm Sci Technol Today, V3, P273, DOI 10.1016/S1461-5347(00)00281-9; Reynolds DL, 2000, AVIAN DIS, V44, P145, DOI 10.2307/1592518; Reynolds DL, 2000, AVIAN DIS, V44, P138, DOI 10.2307/1592517; Rouse JJ, 2007, INT J PHARMACEUT, V339, P112, DOI 10.1016/j.ijpharm.2007.02.026; Ruberti M, 2004, J DRUG TARGET, V12, P195, DOI 10.1080/10611860410001723126; Russell PH, 1997, VET IMMUNOL IMMUNOP, V60, P171, DOI 10.1016/S0165-2427(97)00094-9; RUSSELL PH, 1995, VACCINE, V13, P61, DOI 10.1016/0264-410X(95)80012-3; Senel S, 2000, BIOMATERIALS, V21, P2067, DOI 10.1016/S0142-9612(00)00134-4; Sonia TA, 2011, CARBOHYD POLYM, V84, P103, DOI 10.1016/j.carbpol.2010.10.070; SPRADBROW PB, 1992, NEWCASTLE DIS VILLAG; Takada A, 1996, VET MICROBIOL, V50, P17, DOI 10.1016/0378-1135(96)00004-1; Tseng LP, 2009, J BIOMED MATER RES B, V91B, P621, DOI 10.1002/jbm.b.31437; Turker S, 2004, PHARM WORLD SCI, V26, P137, DOI 10.1023/B:PHAR.0000026823.82950.ff; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391; Varshosaz J, 2004, J MICROENCAPSUL, V21, P761, DOI 10.1080/02652040400015403; Wang JJ, 2011, INT J NANOMED, V6, P765, DOI 10.2147/IJN.S17296; World Organisation for Animal Health (OIE), 2012, TERR MAN 2012; Xu JH, 2011, CLIN VACCINE IMMUNOL, V18, P75, DOI 10.1128/CVI.00263-10; Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3; Yan ZG, 2011, PAK VET J, V31, P280; Yu W, 2012, J NANOMATER, V2012, DOI 10.1155/2012/435873; Zhao FJ, 2012, CAN J MICROBIOL, V58, P117, DOI [10.1139/W11-115, 10.1139/w11-115]; Zhao K, 2011, VACCINE, V29, P8549, DOI 10.1016/j.vaccine.2011.09.029; Zoth SC, 2008, BRAZ J MED BIOL RES, V41, P318, DOI 10.1590/S0100-879X2008000400010	58	68	72	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53314	10.1371/journal.pone.0053314	http://dx.doi.org/10.1371/journal.pone.0053314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285276	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500130
J	Murayama, A; Sugiyama, N; Yoshimura, S; Ishihara-Sugano, M; Masaki, T; Kim, S; Wakita, T; Mishiro, S; Kato, T				Murayama, Asako; Sugiyama, Nao; Yoshimura, Seiko; Ishihara-Sugano, Mitsuko; Masaki, Takahiro; Kim, Sulyi; Wakita, Takaji; Mishiro, Shunji; Kato, Takanobu			A Subclone of HuH-7 with Enhanced Intracellular Hepatitis C Virus Production and Evasion of Virus Related-Cell Cycle Arrest	PLOS ONE			English	Article							DOWN-REGULATION; S-PHASE; NON-A; INFECTION; PROGRESSION; CULTURE; LINES; REPLICATION; INTERFERON; EXPRESSION	Hepatitis C virus (HCV) cell culture system with JFH-1 strain and HuH-7 cells enabled us to produce infectious HCV particles in vitro, and such system is useful to explore the anti-HCV compounds and to develop the vaccine against HCV. In the present study, we describe the derivation of a cell line that permits improved production of HCV particles. Specifically, we characterized several subclones that were isolated from the original HuH-7 cell line by limiting dilution. These HuH-7 subclones displayed a notable range of HCV production levels following transfection by full-genome JFH-1 RNA. Among these subclones, HuH-7T1 produced HCV more efficiently than other subclones and Huh-7.5.1 that is known to be highly permissive for HCV replication. Upon transfection with full-genome RNA, HCV production was increased ten-fold in HuH-7T1 compared to Huh-7.5.1. This increase in viral production correlated with increased efficiency of intracellular infectious virus production. Furthermore, HCV replication did not induce cell cycle arrest in HuH-7T1, whereas it did in Huh-7.5.1. Consequently, the use of HuH-7T1 as host cells could provide increased population of HCV-positive cells and elevated viral titer. In conclusion, we isolated a HuH-7 subclone, HuH-7T1, that supports efficient HCV production. High efficiency of intracellular infectious virus production and evasion of cell cycle arrest were important for this phenotype. We expect that the use of this cell line will facilitate analysis of the underlying mechanisms for HCV particle assembly and the cell cycle arrest caused by HCV.	[Murayama, Asako; Sugiyama, Nao; Masaki, Takahiro; Kim, Sulyi; Wakita, Takaji; Kato, Takanobu] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Yoshimura, Seiko; Ishihara-Sugano, Mitsuko] Toshiba Co Ltd, Corp Res & Dev Ctr, Yokohama, Kanagawa, Japan; [Mishiro, Shunji] Toshiba Gen Hosp, Dept Med Sci, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Toshiba Corporation; Toshiba Corporation	Kato, T (corresponding author), Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan.	takato@nih.go.jp		Mishiro, Shunji/0000-0001-9618-6468	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [23790513] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, from the Ministry of Health, Labour and Welfare of Japan, and from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa D, 2007, J VIROL, V81, P5036, DOI 10.1128/JVI.01573-06; Alisi A, 2005, J CELL PHYSIOL, V205, P25, DOI 10.1002/jcp.20363; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Feld JJ, 2006, HEPATOLOGY, V43, pS194, DOI 10.1002/hep.21065; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gu BH, 2003, J VIROL, V77, P5352, DOI 10.1128/JVI.77.9.5352-5359.2003; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Murayama A, 2012, J VIROL, V86, P2143, DOI 10.1128/JVI.05386-11; Murayama A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000885; Naka K, 2006, VIROLOGY, V346, P348, DOI 10.1016/j.virol.2005.10.023; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Robinson M, 2010, ANTIMICROB AGENTS CH, V54, P3099, DOI 10.1128/AAC.00289-10; Saeed M, 2011, HEPATOLOGY, V54, P425, DOI 10.1002/hep.24399; Sainz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006561; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeda M, 2012, J GEN VIROL; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walters KA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000269; Wang YH, 2011, J BIOL CHEM, V286, P26603, DOI 10.1074/jbc.M111.225672; Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004; Yao ZQ, 2003, VIROLOGY, V314, P271, DOI 10.1016/S0042-6822(03)00419-7; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52697	10.1371/journal.pone.0052697	http://dx.doi.org/10.1371/journal.pone.0052697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285155	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500234
J	Buck, JR; St Clair, SB				Buck, Joshua R.; St Clair, Samuel B.			Aspen Increase Soil Moisture, Nutrients, Organic Matter and Respiration in Rocky Mountain Forest Communities	PLOS ONE			English	Article							NET ECOSYSTEM PRODUCTIVITY; CONIFER FORESTS; LITTER QUALITY; QUAKING ASPEN; CO2 EFFLUX; PURE ASPEN; DYNAMICS; BOREAL; SUCCESSION; PATTERNS	Development and change in forest communities are strongly influenced by plant-soil interactions. The primary objective of this paper was to identify how forest soil characteristics vary along gradients of forest community composition in aspen-conifer forests to better understand the relationship between forest vegetation characteristics and soil processes. The study was conducted on the Fishlake National Forest, Utah, USA. Soil measurements were collected in adjacent forest stands that were characterized as aspen dominated, mixed, conifer dominated or open meadow, which includes the range of vegetation conditions that exist in seral aspen forests. Soil chemistry, moisture content, respiration, and temperature were measured. There was a consistent trend in which aspen stands demonstrated higher mean soil nutrient concentrations than mixed and conifer dominated stands and meadows. Specifically, total N, NO3 and NH4 were nearly two-fold higher in soil underneath aspen dominated stands. Soil moisture was significantly higher in aspen stands and meadows in early summer but converged to similar levels as those found in mixed and conifer dominated stands in late summer. Soil respiration was significantly higher in aspen stands than conifer stands or meadows throughout the summer. These results suggest that changes in disturbance regimes or climate scenarios that favor conifer expansion or loss of aspen will decrease soil resource availability, which is likely to have important feedbacks on plant community development.	[Buck, Joshua R.; St Clair, Samuel B.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA	Brigham Young University	St Clair, SB (corresponding author), Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA.	stclair@byu.edu	St.Clair, Sam/GZA-4592-2022		Charles Redd Foundation	Charles Redd Foundation	The Charles Redd Foundation provided funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAATH E, 1995, SOIL BIOL BIOCHEM, V27, P229, DOI 10.1016/0038-0717(94)00140-V; BARTOS DL, 1981, FOREST SCI, V27, P381; BATES PC, 1992, SOIL SCI SOC AM J, V56, P295, DOI 10.2136/sssaj1992.03615995005600010047x; Beaty RM, 2008, FOREST ECOL MANAG, V255, P707, DOI 10.1016/j.foreco.2007.09.044; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Calder WJ, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00119.1; Calder WJ, 2011, TREE PHYSIOL, V31, P582, DOI 10.1093/treephys/tpr041; Clark AL, 2011, FOREST ECOL MANAG, V262, P203, DOI 10.1016/j.foreco.2011.03.024; Coleman MD, 2000, PLANT SOIL, V225, P129, DOI 10.1023/A:1026564228951; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; Doerr SH, 2009, J HYDROL, V371, P12, DOI 10.1016/j.jhydrol.2009.03.011; Fang C, 1998, PLANT SOIL, V205, P135, DOI 10.1023/A:1004304309827; Gallant AL, 2003, ECOL APPL, V13, P385, DOI 10.1890/1051-0761(2003)013[0385:VDUFEA]2.0.CO;2; GRANT RF, 1994, SOIL SCI SOC AM J, V58, P1681, DOI 10.2136/sssaj1994.03615995005800060015x; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Hannam KD, 2007, APPL SOIL ECOL, V35, P635, DOI 10.1016/j.apsoil.2006.09.005; Hansen AJ, 2000, LANDSCAPE ECOL, V15, P505, DOI 10.1023/A:1008127228878; Huang Y, 2005, COMMUN SOIL SCI PLAN, V36, P1385, DOI 10.1081/CSS-200058468; Jassal RS, 2008, GLOBAL CHANGE BIOL, V14, P1305, DOI 10.1111/j.1365-2486.2008.01573.x; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Kljun N, 2006, ECOSYSTEMS, V9, P1128, DOI 10.1007/s10021-005-0082-x; Kraus TEC, 2003, PLANT SOIL, V256, P41, DOI 10.1023/A:1026206511084; Krishnan P, 2006, AGR FOREST METEOROL, V139, P208, DOI 10.1016/j.agrformet.2006.07.002; Kuhn TJ, 2011, PLANT ECOL, V212, P1451, DOI 10.1007/s11258-011-9920-4; Kurzel BP, 2007, FOREST ECOL MANAG, V252, P176, DOI 10.1016/j.foreco.2007.06.027; Laganiere J, 2009, APPL SOIL ECOL, V41, P19, DOI 10.1016/j.apsoil.2008.08.005; Laganiere J, 2012, SOIL BIOL BIOCHEM, V53, P18, DOI 10.1016/j.soilbio.2012.04.024; Laganiere J, 2011, SOIL SCI SOC AM J, V75, P1125, DOI 10.2136/sssaj2010.0275; LaMalfa EM, 2008, ECOSYSTEMS, V11, P569, DOI 10.1007/s10021-008-9143-2; Legare S, 2005, PLANT SOIL, V275, P207, DOI 10.1007/s11104-005-1482-6; Leroy CJ, 2006, FRESHWATER BIOL, V51, P605, DOI 10.1111/j.1365-2427.2006.01512.x; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Mallik AU, 2003, CRIT REV PLANT SCI, V22, P341, DOI 10.1080/713610860; Mueggler W. F., 1985, ASPEN ECOLOGY MANAGE, P45; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; NIHLGARD B, 1971, OIKOS, V22, P302, DOI 10.2307/3543854; Normandin V, 1998, COMMUN SOIL SCI PLAN, V29, P1785, DOI 10.1080/00103629809370069; Ollinger SV, 2002, ECOLOGY, V83, P339, DOI 10.1890/0012-9658(2002)083[0339:RVIFCA]2.0.CO;2; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; POLLARD JH, 1971, BIOMETRICS, V27, P991, DOI 10.2307/2528833; POPENOE JH, 1992, SOIL SCI SOC AM J, V56, P1951, DOI 10.2136/sssaj1992.03615995005600060050x; Pregitzer CC, 2010, EVOL ECOL, V24, P1045, DOI 10.1007/s10682-010-9363-8; Preston CM, 2009, ECOSYSTEMS, V12, P1053, DOI 10.1007/s10021-009-9266-0; Reich PB, 2001, ECOLOGY, V82, P2731, DOI 10.1890/0012-9658(2001)082[2731:IOLFAF]2.0.CO;2; Smith AE, 2005, FOREST ECOL MANAG, V213, P338, DOI 10.1016/j.foreco.2005.03.018; Smith EA, 2011, FOREST ECOL MANAG, V262, P325, DOI 10.1016/j.foreco.2011.03.038; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; Ste-Marie C, 1999, SOIL BIOL BIOCHEM, V31, P1579, DOI 10.1016/S0038-0717(99)00086-3; Strand EK, 2009, ECOL MODEL, V220, P175, DOI 10.1016/j.ecolmodel.2008.09.010; STUMP LM, 1993, CAN J FOREST RES, V23, P492, DOI 10.1139/x93-067; Tobon C, 2004, BIOGEOCHEMISTRY, V69, P315, DOI 10.1023/B:BIOG.0000031051.29323.27; Uddling J, 2008, TREE PHYSIOL, V28, P1231, DOI 10.1093/treephys/28.8.1231; Wadleigh L, 1996, GREAT BASIN NAT, V56, P28; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Yarie J, 2008, FOREST ECOL MANAG, V256, P1055, DOI 10.1016/j.foreco.2008.06.022; Yuste JC, 2007, GLOBAL CHANGE BIOL, V13, P2018, DOI 10.1111/j.1365-2486.2007.01415.x	57	26	26	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52369	10.1371/journal.pone.0052369	http://dx.doi.org/10.1371/journal.pone.0052369			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285012	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900092
J	Liu, Q; Zhou, RL; Chen, SG; Tan, C				Liu, Qing; Zhou, Renlai; Chen, Shanguang; Tan, Cheng			Effects of Head-Down Bed Rest on the Executive Functions and Emotional Response	PLOS ONE			English	Article							RATE-VARIABILITY; COGNITIVE PERFORMANCE; STRESS	Prolonged bed rest may cause changes in the autonomic nervous system that are related to cognition and emotion. This study adopted an emotional flanker task to evaluate the effect of 45 days -6 degrees head-down bed rest (HDBR) on executive functioning in 16 healthy young men at each of six time points: the second-to-last day before the bed rest period, the eleventh, twentieth, thirty-second and fortieth day during the bed rest period, and the eighth day after the bed rest period. In addition, self-report inventories (Beck Anxiety Inventory, BAI; Beck Depression Inventory, BDI; Positive Affect and Negative Affect Scale, PANAS) were conducted to record emotional changes, and the participants' galvanic skin response (GSR), heart rate (HR) and heart rate variability (HRV) were assessed as measures of physiological activity. The results showed that the participants' reaction time on the flanker task increased significantly relative to their responses on the second-to-last day before the period of bed rest, their galvanic skin response weakened and their degrees of positive affect declined during the bed rest period. Our results provide some evidence for a detrimental effect of prolonged bed rest on executive functioning and positive affect. Whether this stems from a lack of aerobic physical activity and/or the effect of HDBR itself remains to be determined.	[Liu, Qing; Zhou, Renlai] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Zhou, Renlai] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Chen, Shanguang; Tan, Cheng] China Astronaut Res & Training Ctr, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University	Zhou, RL (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	rlzhou@bnu.edu.cn; tigercsg@163.com	liu, qingqing/HHD-0360-2022; Liu, Qing/GWC-9222-2022; Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097	National Basic Research Program of China [2011CB7110001]	National Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Basic Research Program of China (2011CB7110001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[陈思佚 CHEN Siyi], 2011, [航天医学与医学工程, Space Medicine & Medical Engineering], V24, P253; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Crucian BE, 2009, AVIAT SPACE ENVIR MD, V80, pA37, DOI 10.3357/ASEM.BR05.2009; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hirayanagi K, 2004, EUR J APPL PHYSIOL, V92, P160, DOI 10.1007/s00421-004-1067-8; Hockey GRJ, 1997, BIOL PSYCHOL, V45, P73; Ishizaki Y, 2002, ACTA ASTRONAUT, V50, P453, DOI 10.1016/S0094-5765(01)00189-8; Ishizaki Y, 2009, ACTA ASTRONAUT, V64, P864, DOI 10.1016/j.actaastro.2008.10.006; Jo NY, 2012, LECT NOTES ARTIF INT, V7198, P19, DOI 10.1007/978-3-642-28493-9_3; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Leon GR, 2011, J ENVIRON PSYCHOL, V31, P353, DOI 10.1016/j.jenvp.2011.08.001; Lipnicki DM, 2009, AVIAT SPACE ENVIR MD, V80, P1018, DOI 10.3357/ASEM.2581.2009; Lipnicki DM, 2009, EUR J APPL PHYSIOL, V105, P27, DOI 10.1007/s00421-008-0869-5; Messerotti Benvenuti S, 2011, PHYSIOL BEHAV, V104, P503, DOI 10.1016/j.physbeh.2011.05.019; Moore ST, 2010, EXP BRAIN RES, V204, P617, DOI 10.1007/s00221-010-2317-0; PAVYLETRAON A, 1994, ACTA ASTRONAUT, V32, P319, DOI 10.1016/0094-5765(94)90083-3; [秦海波 Qin Haibo], 2010, [航天医学与医学工程, Space Medicine & Medical Engineering], V23, P163; Qiu L., 2008, APPL PSYCHOL, P249, DOI 10.1093/molbev/msx285/4596561; Richard LH, 2009, RESP PHYSIOL NEUROBI, V169, P38; Shehab RL, 1998, ACTA ASTRONAUT, V43, P223, DOI 10.1016/S0094-5765(98)00156-8; Svensson EAI, 2002, INT J AVIAT PSYCHOL, V12, P95, DOI 10.1207/S15327108IJAP1201_8; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Traon APL, 2007, EUR J APPL PHYSIOL, V101, P143, DOI 10.1007/s00421-007-0474-z; Wang XD, 1999, MENTAL HLTH ASSESS S, P91; [王妍 Wang Yan], 2005, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V13, P396; Zhao X, 2011, ACTA ASTRONAUT, V69, P969, DOI 10.1016/j.actaastro.2011.07.003	26	13	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52160	10.1371/journal.pone.0052160	http://dx.doi.org/10.1371/journal.pone.0052160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055RZ	23284916	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900082
J	Kukreti, H; Amuthavalli, K; Harikumar, A; Sathiyamoorthy, S; Feng, PZ; Anantharaj, R; Tan, SLK; Lokireddy, S; Bonala, S; Sriram, S; McFarlane, C; Kambadur, R; Sharma, M				Kukreti, Himani; Amuthavalli, Kottaiswamy; Harikumar, Arigela; Sathiyamoorthy, Sushmitha; Feng, Peng Zhao; Anantharaj, Rengaraj; Tan, Suan Liang Kelvin; Lokireddy, Sudarsanareddy; Bonala, Sabeera; Sriram, Sandhya; McFarlane, Craig; Kambadur, Ravi; Sharma, Mridula			Muscle-specific MicroRNA1 (miR1) Targets Heat Shock Protein 70 (HSP70) during Dexamethasone-mediated Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FOXO TRANSCRIPTION FACTORS; SKELETAL-MUSCLE; GLUCOCORTICOID-RECEPTOR; PROTEOLYTIC SYSTEM; UBIQUITIN LIGASES; GENE-EXPRESSION; MYOSTATIN GENE; HEAT-SHOCK; DIFFERENTIATION	High doses of dexamethasone (Dex) or myostatin (Mstn) induce severe atrophy of skeletal muscle. Here we show a novel microRNA1 (miR1)-mediated mechanism through which Dex promotes skeletal muscle atrophy. Using both C2C12 myotubes and mouse models of Dex-induced atrophy we show that Dex induces miR1 expression through glucocorticoid receptor (GR). We further show that Mstn treatment facilitates GR nuclear translocation and thereby induces miR1 expression. Inhibition of miR1 in C2C12 myotubes attenuated the Dex-induced increase in atrophy-related proteins confirming a role for miR1 in atrophy. Analysis of miR1 targets revealed that HSP70 is regulated by miR1 during atrophy. Our results demonstrate that increased miR1 during atrophy reduced HSP70 levels, which resulted in decreased phosphorylation of AKT, as HSP70 binds to and protects phosphorylation of AKT. We further show that loss of pAKT leads to decreased phosphorylation, and thus, enhanced activation of FOXO3, up-regulation of MuRF1 and Atrogin-1, and progression of skeletal muscle atrophy. Based on these results, we propose a model whereby Dex- and Mstn-mediated atrophic signals are integrated through miR1, which then either directly or indirectly, inhibits the proteins involved in providing protection against atrophy.	[Kukreti, Himani; Amuthavalli, Kottaiswamy; Sathiyamoorthy, Sushmitha; Feng, Peng Zhao; Anantharaj, Rengaraj; Tan, Suan Liang Kelvin; Sharma, Mridula] Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Harikumar, Arigela; Lokireddy, Sudarsanareddy; Bonala, Sabeera; Sriram, Sandhya; Kambadur, Ravi] Nanyang Technol Univ, Sch Biol Sci, Dept Genom & Genet, Singapore 637551, Singapore; [McFarlane, Craig; Kambadur, Ravi] Brenner Ctr Mol Med, Growth Dev & Metab Program, Singapore Inst Clin Sci, Singapore 117609, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Sharma, M (corresponding author), Natl Univ Singapore, Dept Biochem, Yong Loo Lin Sch Med, 8 Med Dr MD7, Singapore 117597, Singapore.	bchmridu@nus.edu.sg	McFarlane, Craig/R-2968-2019; ARIGELA, HARIKUMAR/J-9872-2019	McFarlane, Craig/0000-0002-7056-8887; ARIGELA, HARIKUMAR/0000-0003-3293-7618; Bonala, Sabeerabi/0000-0002-0783-0862	BioMedical Research Council (BMRC); National Research Foundation (NRF), Republic of Singapore	BioMedical Research Council (BMRC)(Agency for Science Technology & Research (A*STAR)); National Research Foundation (NRF), Republic of Singapore	This work was supported by the BioMedical Research Council (BMRC) and National Research Foundation (NRF), Republic of Singapore.	Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonala S, 2012, J BIOL CHEM, V287, P12935, DOI 10.1074/jbc.M111.319145; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Dodd S, 2009, BIOGERONTOLOGY, V10, P605, DOI 10.1007/s10522-008-9203-1; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Kayama M, 2011, AM J PATHOL, V178, P1080, DOI 10.1016/j.ajpath.2010.11.072; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li BG, 2004, J BURN CARE REHABIL, V25, P112, DOI 10.1097/01.BCR.0000105100.44745.36; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Luo GJ, 2001, AM J PHYSIOL-REG I, V281, pR1193, DOI 10.1152/ajpregu.2001.281.4.R1193; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McArdle A, 2003, FASEB J, V17, P355, DOI 10.1096/fj.03-0395fje; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McFarlane C, 2011, AM J PHYSIOL-CELL PH, V301, pC195, DOI 10.1152/ajpcell.00012.2011; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Rachagani Satyanarayana, 2010, BMC Res Notes, V3, P297, DOI 10.1186/1756-0500-3-297; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Siriett V, 2007, MOL THER, V15, P1463, DOI 10.1038/sj.mt.6300182; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; WING SS, 1993, AM J PHYSIOL, V264, pE668, DOI 10.1152/ajpendo.1993.264.4.E668; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhao WD, 2009, BIOCHEM BIOPH RES CO, V378, P668, DOI 10.1016/j.bbrc.2008.11.123; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	45	90	93	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6663	6678		10.1074/jbc.M112.390369	http://dx.doi.org/10.1074/jbc.M112.390369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297411	Green Published, hybrid			2022-12-25	WOS:000315820700065
J	de Vries, S; Naarmann-de Vries, IS; Urlaub, H; Lue, HQ; Bernhagen, J; Ostareck, DH; Ostareck-Lederer, A				de Vries, Sebastian; Naarmann-de Vries, Isabel S.; Urlaub, Henning; Lue, Hongqi; Bernhagen, Juergen; Ostareck, Dirk H.; Ostareck-Lederer, Antje			Identification of DEAD-box RNA Helicase 6 (DDX6) as a Cellular Modulator of Vascular Endothelial Growth Factor Expression under Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; RIBOSOME ENTRY SITE; HIPPEL-LINDAU PROTEIN; TRANSLATION INITIATION; GENE-EXPRESSION; HNRNP-K; C-SRC; POSTTRANSCRIPTIONAL REGULATION; INDUCIBLE FACTOR-1; CYTOPLASMIC FOCI	Vascular endothelial growth factor A (VEGF) is a crucial proangiogenic factor, which regulates blood vessel supply under physiologic and pathologic conditions. The VEGF mRNA 5'-untranslated region (5'-UTR) bears internal ribosome entry sites (IRES), which confer sustained VEGF mRNA translation under hypoxia when 5'-cap-dependent mRNA translation is inhibited. VEGF IRES-mediated initiation of translation requires the modulated interaction of trans-acting factors. To identify trans-acting factors that control VEGF mRNA translation under hypoxic conditions we established an in vitro translation system based on human adenocarcinoma cells (MCF-7). Cytoplasmic extracts of MCF-7 cells grown under hypoxia (1% oxygen) recapitulate VEGF IRES-mediated reporter mRNA translation. Employing the VEGF mRNA 5'-UTR and 3'-UTR in an RNA affinity approach we isolated interacting proteins from translational active MCF-7 extract prepared from cells grown under normoxia or hypoxia. Interestingly, mass spectrometry analysis identified the DEAD-box RNA helicase 6 (DDX6) that interacts with the VEGF mRNA 5'-UTR. Recombinant DDX6 inhibits VEGF IRES-mediated translation in normoxic MCF-7 extract. Under hypoxia the level of DDX6 declines, and its interaction with VEGF mRNA is diminished in vivo. Depletion of DDX6 by RNAi further promotes VEGF expression in MCF-7 cells. Increased secretion of VEGF from DDX6 knockdown cells positively affects vascular tube formation of human umbilical vein endothelial cells (HUVEC) in vitro. Our results indicate that the decrease of DDX6 under hypoxia contributes to the activation of VEGF expression and promotes its proangiogenic function.	[de Vries, Sebastian; Naarmann-de Vries, Isabel S.; Ostareck, Dirk H.; Ostareck-Lederer, Antje] Rhein Westfal TH Aachen, Dept Intens Care & Intermediate Care, Univ Hosp, Expt Res Unit, D-52074 Aachen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Dept Bioanalyt Mass Spectrometry, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Lue, Hongqi; Bernhagen, Juergen] Rhein Westfal TH Aachen, Univ Hosp, Inst Biochem & Mol Cell Biol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Max Planck Society; University of Gottingen; RWTH Aachen University; RWTH Aachen University Hospital	Ostareck, DH (corresponding author), Rhein Westfal TH Aachen, Dept Intens Care & Intermediate Care, Univ Hosp, Expt Res Unit, D-52074 Aachen, Germany.	dostareck@ukaachen.de; aostareck@ukaachen.de		Ostareck, Dirk/0000-0001-9406-7190; Ostareck-Lederer, Antje/0000-0003-0733-7071	Deutsche Forschungsgemeinschaft Heisenberg Fellowship [OS290/1-2]; Deutsche Forschungsgemeinschaft [OS290/4-1, OS290/3-2]; IZKF Aachen [K-TV4]; European Community (EuCAR) [IRTG 1508/1-P13]	Deutsche Forschungsgemeinschaft Heisenberg Fellowship(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Aachen; European Community (EuCAR)	The work was supported by Deutsche Forschungsgemeinschaft Heisenberg Fellowship OS290/1-2 (to A. O.-L.) and Deutsche Forschungsgemeinschaft Grants OS290/4-1 (to A. O.-L. and D. H. O.) and OS290/3-2 (to D. H. O. and A. O.-L.).; Supported by Grants of the IZKF Aachen K-TV4 and the European Community (EuCAR) IRTG 1508/1-P13.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; BARTON DJ, 1993, J VIROL, V67, P822, DOI 10.1128/JVI.67.2.822-831.1993; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Ernoult-Lange M, 2012, RNA, V18, P1702, DOI 10.1261/rna.034314.112; Essafi-Benkhadir K, 2007, MOL BIOL CELL, V18, P4648, DOI 10.1091/mbc.E07-06-0570; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Fahling M, 2009, ACTA PHYSIOL, V195, P205, DOI 10.1111/j.1748-1716.2008.01894.x; Ferrara N, 2005, EXP SUPPL, V94, P209; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; Hamasaki K, 1998, BIOCHEMISTRY-US, V37, P656, DOI 10.1021/bi971095t; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Levy AP, 1996, J BIOL CHEM, V271, P25492, DOI 10.1074/jbc.271.41.25492; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Levy NS, 1997, BBA-GENE STRUCT EXPR, V1352, P167, DOI 10.1016/S0167-4781(97)00052-3; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsui T, 2006, GENES CELLS, V11, P439, DOI 10.1111/j.1365-2443.2006.00951.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Messias AC, 2006, J MOL BIOL, V361, P470, DOI 10.1016/j.jmb.2006.06.025; Miller DL, 1998, FEBS LETT, V434, P417, DOI 10.1016/S0014-5793(98)01025-4; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Saito K, 2011, NUCLEIC ACIDS RES, V39, P6086, DOI 10.1093/nar/gkr194; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Xin H, 2012, MOL CANCER RES, V10, P108, DOI 10.1158/1541-7786.MCR-11-0435; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zygalaki E, 2005, CLIN CHEM, V51, P1518, DOI 10.1373/clinchem.2004.046987	60	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5815	5827		10.1074/jbc.M112.420711	http://dx.doi.org/10.1074/jbc.M112.420711			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293030	Green Published, hybrid			2022-12-25	WOS:000315342500052
J	Ye, QQ; Lai, FF; Banerjee, M; Duan, QM; Li, ZC; Si, SY; Xie, ZJ				Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Si, Shuyi; Xie, Zijian			Expression of Mutant alpha 1 Na/K-ATPase Defective in Conformational Transition Attenuates Src-mediated Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ONSET DYSTONIA-PARKINSONISM; TRANSMEMBRANE SEGMENT M3; NA+-K+-ATPASE; PROTEIN-KINASE; TYROSINE KINASE; SODIUM-PUMP; NA+,K+-ATPASE; BINDING; ACTIVATION	The alpha 1 Na/K-ATPase possesses both pumping and signaling functions. Using purified enzyme we found that the alpha 1 Na/K-ATPase might interact with and regulate Src activity in a conformation-dependent manner. Here we further explored the importance of the conformational transition capability of alpha 1 Na/K-ATPase in regulation of Src-related signal transduction in cell culture. We first rescued the alpha 1-knockdown cells by wild-type rat alpha 1 or alpha 1 mutants (I279A and F286A) that are known to be defective in conformational transition. Stable cell lines with comparable expression of wild type alpha 1, I279A, and F286A were characterized. As expected, the defects in conformation transition resulted in comparable degree of inhibition of pumping activity in the mutant-rescued cell lines. However, I279A was more effective in inhibiting basal Src activity than either the wild-type or the F286A. Although much higher ouabain concentration was required to stimulate Src in I279A-rescued cells, extracellular K+ was comparably effective in regulating Src in both control and I279A cells. In contrast, ouabain and extracellular K+ failed to produce detectable changes in Src activity in F286A-rescued cells. Furthermore, expression of either mutant inhibited integrin-induced activation of Src/FAK pathways and slowed cell spreading processes. Finally, the expression of these mutants inhibited cell growth, with I279A being more potent than that of F286A. Taken together, the new findings suggest that the alpha 1 Na/K-ATPase may be a key player in dynamic regulation of cellular Src activity and that the capability of normal conformation transition is essential for both pumping and signaling functions of alpha 1 Na/K-ATPase.	[Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol, Toledo, OH 43614 USA; [Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Pharmacol, Toledo, OH 43614 USA; [Ye, Qiqi; Lai, Fangfang; Banerjee, Moumita; Duan, Qiming; Li, Zhichuan; Xie, Zijian] Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA; [Si, Shuyi] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Lai, Fangfang; Si, Shuyi] Peking Union Med Coll, Beijing 100050, Peoples R China; [Lai, Fangfang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017; Duan, Qiming/I-1822-2019; Banerjee, Moumita/Y-7651-2019	Duan, Qiming/0000-0002-6204-3028; Banerjee, Moumita/0000-0002-4463-7914	National Institutes of Health [HL-36573, HL-109015, GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109015, P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 and HL-109015 (NHLBI) and GM-78565 (NIGMS).	AKERA T, 1991, LIFE SCI, V48, P97, DOI 10.1016/0024-3205(91)90402-W; Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Aperia A, 2007, J INTERN MED, V261, P44, DOI 10.1111/j.1365-2796.2006.01745.x; Arnaud-Batista FJ, 2012, AM J PHYSIOL-RENAL, V302, pF959, DOI 10.1152/ajprenal.00130.2011; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Chen Y, 2008, J BIOL CHEM, V283, P1128, DOI 10.1074/jbc.M708025200; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Karpova LV, 2010, CELL BIOCHEM FUNCT, V28, P135, DOI 10.1002/cbf.1632; Khundmiri SJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1171, DOI 10.1152/ajpcell.00535.2006; Kirshenbaum GS, 2011, GENES BRAIN BEHAV, V10, P542, DOI 10.1111/j.1601-183X.2011.00691.x; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Nguyen ANT, 2011, AM J PHYSIOL-RENAL, V301, pF897, DOI 10.1152/ajprenal.00095.2011; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PENG ZY, 1995, ONCOGENE, V11, P1955; PERIYASAMY SM, 1983, COMP BIOCHEM PHYS B, V76, P449, DOI 10.1016/0305-0491(83)90274-2; Richardson A, 1997, MOL CELL BIOL, V17, P6906, DOI 10.1128/MCB.17.12.6906; Rodacker V, 2006, J BIOL CHEM, V281, P18539, DOI 10.1074/jbc.M601780200; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Schack VR, 2012, J BIOL CHEM, V287, P2191, DOI 10.1074/jbc.M111.323022; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1997, J BIOL CHEM, V272, P13189, DOI 10.1074/jbc.272.20.13189; Segall L, 2005, P NATL ACAD SCI USA, V102, P11106, DOI 10.1073/pnas.0504323102; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Toustrup-Jensen M, 2005, J BIOL CHEM, V280, P10210, DOI 10.1074/jbc.M411214200; Toustrup-Jensen M, 2003, ANN NY ACAD SCI, V986, P267, DOI 10.1111/j.1749-6632.2003.tb07181.x; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P38653, DOI 10.1074/jbc.M305521200; Toustrup-Jensen M, 2003, J BIOL CHEM, V278, P11402, DOI 10.1074/jbc.M212136200; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Uddin MN, 2008, J BIOL CHEM, V283, P17946, DOI 10.1074/jbc.M800958200; Vilsen B, 2003, ANN NY ACAD SCI, V986, P50, DOI 10.1111/j.1749-6632.2003.tb07138.x; WALLICK ET, 1980, ARCH BIOCHEM BIOPHYS, V202, P442, DOI 10.1016/0003-9861(80)90448-8; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yatime L, 2011, J STRUCT BIOL, V174, P296, DOI 10.1016/j.jsb.2010.12.004; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Zheng J, 2011, CARDIOVASC RES, V89, P51, DOI 10.1093/cvr/cvq263	57	36	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5803	5814		10.1074/jbc.M112.442608	http://dx.doi.org/10.1074/jbc.M112.442608			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288841	hybrid, Green Published			2022-12-25	WOS:000315342500051
J	Briones, JC; Tsai, CH; Nakazawa, T; Sakai, Y; Papa, RDS; Hsieh, CH; Okuda, N				Briones, Jonathan Carlo; Tsai, Cheng-Han; Nakazawa, Takefumi; Sakai, Yoichiro; Papa, Rey Donne S.; Hsieh, Chih-Hao; Okuda, Noboru			Long-Term Changes in the Diet of Gymnogobius isaza from Lake Biwa, Japan: Effects of Body Size and Environmental Prey Availability	PLOS ONE			English	Article							PELAGIC FOOD WEBS; JESOGAMMARUS-ANNANDALEI; SALVELINUS-ALPINUS; PREDATOR; ISOTOPE; FISHES; EUTROPHICATION; COMMUNITY; SHIFTS; ZOOPLANKTON	Body size and environmental prey availability are both key factors determining feeding habits of gape-limited fish predators. However, our understanding of their interactive or relative effects is still limited. In this study, we performed quantitative dietary analysis of different body sizes of goby (Gymnogobius isaza) specimens collected from Lake Biwa between 1962 and 2004. First, we report that the diet was composed mainly of zooplankton (cladocerans and copepods) before the 1980s, and thereafter, shifted to zoobenthos (gammarids). This foraging shift coincided with, and thus can be linked to, known historical events in the lake at that time: decrease in zooplankton abundance with the alleviation of eutrophication, increase in fish body size resulting from fish population collapse, and increase in gammarid abundance due to reduced fish predation pressure. Supporting this view, our data analyses revealed how the long-term changes in the diet composition would be co-mediated by changes in fish body size and environmental prey availability. Specifically, while zoobenthos abundance strongly affected the fish diet composition, larger (smaller) fish preferred zoobenthos (zooplankton). Furthermore, the body size effects were stronger than those of prey availability. These results provide the best long-term evidence that fish feeding habits vary over decades with its body size and prey community due to anthropogenic disturbances.	[Tsai, Cheng-Han; Nakazawa, Takefumi; Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Briones, Jonathan Carlo] Univ Santo Tomas, Grad Sch, Manila, Philippines; [Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Nakazawa, Takefumi; Sakai, Yoichiro; Okuda, Noboru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Papa, Rey Donne S.] Univ Santo Tomas, Dept Biol Sci, Manila, Philippines; [Papa, Rey Donne S.] Univ Santo Tomas, Res Ctr Nat & Appl Sci, Manila, Philippines	National Taiwan University; University of Santo Tomas; National Taiwan University; Kyoto University; University of Santo Tomas; University of Santo Tomas	Nakazawa, T (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan.	take.nkzw@gmail.com	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272; Papa, Rey Donne/0000-0003-0146-2525	Institute of Oceanography, National Taiwan University; Research Center for the Natural and Applied Sciences, University of Santo Tomas; Japan Society for the Promotion of Science Research Fellowship for Young Scientists [2103033]; Kurita Water and Environment Foundation [23299]; Frontier and Innovative Research of National Taiwan University; National Science Council of Taiwan; Environment Research and Technology Development Fund of the Ministry of the Environment of Japan [S-9-4]; Grants-in-Aid for Scientific Research [23657019] Funding Source: KAKEN	Institute of Oceanography, National Taiwan University; Research Center for the Natural and Applied Sciences, University of Santo Tomas; Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kurita Water and Environment Foundation(Kurita Water and Environment Foundation); Frontier and Innovative Research of National Taiwan University(National Taiwan University); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Environment Research and Technology Development Fund of the Ministry of the Environment of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a joint program between the Institute of Oceanography, National Taiwan University and the Research Center for the Natural and Applied Sciences, University of Santo Tomas. TN was supported by the Japan Society for the Promotion of Science Research Fellowship for Young Scientists (2103033) and Kurita Water and Environment Foundation (23299). CH was supported by a grant for Frontier and Innovative Research of National Taiwan University and National Science Council of Taiwan. NO was supported by the Environment Research and Technology Development Fund (S-9-4) of the Ministry of the Environment of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes C, 2010, ECOLOGY, V91, P222, DOI 10.1890/08-2061.1; Braga RR, 2012, REV FISH BI IN PRESS; Bronmark C., 2005, BIOL LAKES PONDS; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Corrigan LJ, 2011, ECOL FRESHW FISH, V20, P5, DOI 10.1111/j.1600-0633.2010.00446.x; Cortes E, 1997, CAN J FISH AQUAT SCI, V54, P726, DOI 10.1139/cjfas-54-3-726; Davis AM, 2012, FRESHWATER BIOL, V57, P2156, DOI 10.1111/j.1365-2427.2012.02858.x; DIEHL S, 1992, ECOLOGY, V73, P1646, DOI 10.2307/1940017; Gerking SD., 2014, FEEDING ECOLOGY FISH; Gregersen F, 2006, FISHERIES MANAG ECOL, V13, P243, DOI 10.1111/j.1365-2400.2006.00500.x; Hsieh CH, 2011, BIOGEOSCIENCES, V8, P1383, DOI 10.5194/bg-8-1383-2011; Hsieh CH, 2010, AQUAT SCI, V72, P467, DOI 10.1007/s00027-010-0149-4; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Ishikawa T, 2004, LIMNOL OCEANOGR, V49, P1840, DOI 10.4319/lo.2004.49.5.1840; Ishikawa T, 2002, FRESHWATER BIOL, V47, P1935, DOI 10.1046/j.1365-2427.2002.00942.x; Islam MS, 2006, ESTUAR COAST, V29, P519; Jacob U, 2011, ADV ECOL RES, V45, P181, DOI 10.1016/B978-0-12-386475-8.00005-8; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Kawabata K, 1998, FRESHWATER BIOL, V39, P199, DOI 10.1046/j.1365-2427.1998.00267.x; Koenker R., 2005, QUANTILE REGRESSION, DOI DOI 10.1017/CBO9780511754098; KOHLER CC, 1982, ENVIRON BIOL FISH, V7, P363, DOI 10.1007/BF00005571; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lewis-Beck MS, 1980, APPL REGRESSION INTR; Manly BF., 2006, RANDOMIZATION BOOTST; Nagoshi M., 1966, RES POPUL ECOL, V8, P20, DOI [10.1007/BF02524743, DOI 10.1007/BF02524743]; Nakai Katsuki, 1999, P227; NAKANISHI N, 1984, Japanese Journal of Limnology, V45, P279; Nakazawa T, 2007, ECOL FRESHW FISH, V16, P362, DOI 10.1111/j.1600-0633.2007.00234.x; Nakazawa T, 2011, ADV ECOL RES, V45, P269, DOI 10.1016/B978-0-12-386475-8.00007-1; Nakazawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009120; Ogawa NO, 2001, LIMNOL OCEANOGR, V46, P1228, DOI 10.4319/lo.2001.46.5.1228; Okuda N, 2012, LAKE BIWA INTERACTIO, P205; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Papa RDS, 2008, ZOOL STUD, V47, P535; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Post DM, 2000, ECOLOGY, V81, P8, DOI 10.2307/177129; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Shiga Statistics and Information Office, 1962, ANN REP AGR FOR FISH; Stephens D.W., 1986, pi; Tsugeki N, 2003, LIMNOLOGY, V4, P101, DOI 10.1007/s10201-003-0097-y; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Vadeboncoeur Y, 2005, ECOSYSTEMS, V8, P682, DOI 10.1007/s10021-003-0149-5; Vander Zanden MJ, 2011, ECOSYSTEMS, V14, P894, DOI 10.1007/s10021-011-9454-6; Vander Zanden MJ, 2002, ECOLOGY, V83, P2152, DOI 10.1890/0012-9658(2002)083[2152:FAIOBA]2.0.CO;2; Winfield IJ, 2012, FRESHWATER BIOL, V57, P373, DOI 10.1111/j.1365-2427.2011.02607.x; Wootton R.J., 1990, ECOLOGY TELEOST FISH; Xu J, 2007, ECOSCIENCE, V14, P170, DOI 10.2980/1195-6860(2007)14[170:SSIROB]2.0.CO;2; Yamada Yoshihiro, 1998, Japanese Journal of Limnology, V59, P409	54	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53167	10.1371/journal.pone.0053167	http://dx.doi.org/10.1371/journal.pone.0053167			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285262	Green Published, gold			2022-12-25	WOS:000313051500115
J	Casabonne, D; Almeida, J; Nieto, WG; Romero, A; Fernandez-Navarro, P; Rodriguez-Caballero, A; Munoz-Criado, S; Diaz, MG; Benavente, Y; de Sanjose, S; Orfao, A				Casabonne, Delphine; Almeida, Julia; Nieto, Wendy G.; Romero, Alfonso; Fernandez-Navarro, Paulino; Rodriguez-Caballero, Arancha; Munoz-Criado, Santiago; Gonzalez Diaz, Marcos; Benavente, Yolanda; de Sanjose, Silvia; Orfao, Alberto		Primary Hlth Care Grp Salamanca	Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy Adults	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; SUBSEQUENT RISK; LEUKEMIA; PREVALENCE; NUMBERS; CLONES; MBL	Background: Risk factors associated with monoclonal B-cell lymphocytosis (MBL), a potential precursor of chronic lymphocytic leukaemia (CLL), remain unknown. Methods: Using a cross-sectional study design, we investigated demographic, medical and behavioural risk factors associated with MBL. "Low-count" MBL (cases) were defined as individuals with very low median absolute count of clonal B-cells, identified from screening of healthy individuals and the remainder classified as controls. 452 individuals completed a questionnaire with their general practitioner, both blind to the MBL status of the subject. Odds ratios (OR) and 95% confidence interval (CI) for MBL were estimated by means of unconditional logistic regression adjusted for confounding factors. Results: MBL were detected in 72/452 subjects (16%). Increasing age was strongly associated with MBL (P-trend<0.001). MBL was significantly less common among individuals vaccinated against pneumococcal or influenza (OR 0.49, 95% confidence interval (CI): 0.25 to 0.95; P-value = 0.03 and OR: 0.52, 95% CI: 0.29 to 0.93, P-value = 0.03, respectively). Albeit based on small numbers, cases were more likely to report infectious diseases among their children, respiratory disease among their siblings and personal history of pneumonia and meningitis. No other distinguishing epidemiological features were identified except for family history of cancer and an inverse relationship with diabetes treatment. All associations described above were retained after restricting the analysis to CLL-like MBL. Conclusion: Overall, these findings suggest that exposure to infectious agents leading to serious clinical manifestations in the patient or its surroundings may trigger immune events leading to MBL. This exploratory study provides initial insights and directions for future research related to MBL, a potential precursor of chronic lymphocytic leukaemia. Further work is warranted to confirm these findings.	[Casabonne, Delphine; Benavente, Yolanda; de Sanjose, Silvia] Inst Catala Oncol, IDIBELL, Unit Infect & Canc UNIC, Barcelona, Spain; [Casabonne, Delphine; Benavente, Yolanda; de Sanjose, Silvia] CIBERESP, Barcelona, Spain; [Almeida, Julia; Nieto, Wendy G.; Rodriguez-Caballero, Arancha; Orfao, Alberto] Univ Salamanca, Dept Med & Cytometry Serv, IBSAL,IBMCC,CSIC, Inst Biol Mol & Celular Canc,Ctr Invest Canc,USAL, E-37008 Salamanca, Spain; [Romero, Alfonso] Sanidad Castilla Y Leon SACYL, Ctr Atenc Primaria Salud Miguel Armijo Salmanca, Castilla Y Leon, Spain; [Fernandez-Navarro, Paulino] Sanidad Castilla Y Leon SACYL, Ctr Atenc Primaria Salud Ledesma, Castilla Y Leon, Spain; [Munoz-Criado, Santiago] Univ Hosp Salamanca, Microbiol Serv, Salamanca, Spain; [Gonzalez Diaz, Marcos] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Gonzalez Diaz, Marcos] Univ Hosp Salamanca, IBMCC, IBSAL, Serv Hematol, Salamanca, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Casabonne, D (corresponding author), Inst Catala Oncol, IDIBELL, Unit Infect & Canc UNIC, Barcelona, Spain.	dcasabonne@iconcologia.net	de Sanjosé Llongueras, Silvia/H-6339-2014; Casabonne, Delphine/H-6425-2014; Orfao, Alberto/B-5801-2017; Benavente, Yolanda/H-9810-2014		Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER [RD06/0020/0035, 2006-RET2039-O, CIBERESP 06/02/0073]; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain [FIS PI06/0824-FEDER, PS09/02430-FEDER, PI11/01810-FEDER]; Gerencia Regional de Salud de Castilla y Leo n and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion [GRS206/A/08]; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain; Agencia de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya [AGAUR 2009SGR1465]; Fundacion Cientifica de la Asociacion Espanola contra el Cancer;  [SAN/1778/2009]	Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER; Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; Gerencia Regional de Salud de Castilla y Leo n and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion; Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain(Junta de Castilla y Leon); Agencia de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Fundacion Cientifica de la Asociacion Espanola contra el Cancer; 	This work was financially supported by the following grants: Red Tematica de Investigacion Cooperativa en Cancer del Instituto de Salud Carlos III - FONDOS FEDER (RD06/0020/0035, 2006-RET2039-O, CIBERESP 06/02/0073); FIS PI06/0824-FEDER, PS09/02430-FEDER and PI11/01810-FEDER, from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain; GRS206/A/08 from the Gerencia Regional de Salud de Castilla y Leo n and Ayuda al Grupo GR37 de Excelencia de Castilla y Leon, Consejeria de Educacion, and SAN/1778/2009, Consejeria de Sanidad, Junta de Castilla y Leon, Valladolid, Spain; and Agencia de Gestio d'Ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR 2009SGR1465). AR-C is supported by a grant from Fundacion Cientifica de la Asociacion Espanola contra el Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2011, LEUKEMIA, V25, P718, DOI 10.1038/leu.2010.305; Anderson LA, 2009, BRIT J HAEMATOL, V147, P444, DOI 10.1111/j.1365-2141.2009.07849.x; Clarke CA, 2011, CANCER EPIDEM BIOMAR, V20, P1064, DOI 10.1158/1055-9965.EPI-11-0038; D'Arena G, 2011, INT J IMMUNOPATH PH, V24, P915, DOI 10.1177/039463201102400410; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Fazi C, 2011, BLOOD, V118, P6618, DOI 10.1182/blood-2011-05-357251; Fazi C, 2010, CYTOM PART B-CLIN CY, V78B, pS61, DOI 10.1002/cyto.b.20545; Fortuny J, 2005, EUR J CANCER, V41, P1782, DOI 10.1016/j.ejca.2005.04.032; Ghia P, 2008, J INTERN MED, V264, P549, DOI 10.1111/j.1365-2796.2008.02030.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hauswirth AW, 2012, AM J HEMATOL, V87, P721, DOI 10.1002/ajh.23214; La Vecchia C, 2011, METABOLISM, V60, P1357, DOI 10.1016/j.metabol.2011.03.011; Landgren O, 2007, BRIT J HAEMATOL, V139, P791, DOI 10.1111/j.1365-2141.2007.06859.x; Landgren O, 2007, BLOOD, V109, P2198, DOI 10.1182/blood-2006-08-044008; Landgren O, 2009, NEW ENGL J MED, V360, P659, DOI 10.1056/NEJMoa0806122; Marti GE, 2005, BRIT J HAEMATOL, V130, P325, DOI 10.1111/j.1365-2141.2005.05550.x; Marti G, 2007, BRIT J HAEMATOL, V139, P701, DOI 10.1111/j.1365-2141.2007.06865.x; Marwick Charles, 2003, BMJ, V326, P242; Matos DM, 2009, BRIT J HAEMATOL, V147, P339, DOI 10.1111/j.1365-2141.2009.07861.x; Moreira J, 2012, LEUKEMIA, DOI 0.1038/leu.2012.187; Nieto WG, 2009, BLOOD, V114, P33, DOI 10.1182/blood-2009-01-197368; Rawstron AC, 2004, J BIOL REG HOMEOS AG, V18, P155; Rawstron AC, 2008, NEW ENGL J MED, V359, P575, DOI 10.1056/NEJMoa075290; Scarfo L, 2010, SEMIN CANCER BIOL, V20, P384, DOI 10.1016/j.semcancer.2010.08.005; Shim YK, 2007, CYTOM PART B-CLIN CY, V72B, P344, DOI 10.1002/cyto.b.20174; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2008, BLOOD, V111, P4029, DOI 10.1182/blood-2007-10-119974; Wu SJ, 2010, BLOOD, V116, P4430, DOI 10.1182/blood-2010-05-285221	28	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52808	10.1371/journal.pone.0052808	http://dx.doi.org/10.1371/journal.pone.0052808			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285188	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500064
J	Gotoh, K; Inoue, M; Shiraishi, K; Masaki, T; Chiba, S; Mitsutomi, K; Shimasaki, T; Ando, H; Fujiwara, K; Katsuragi, I; Kakuma, T; Seike, M; Sakata, T; Yoshimatsu, H				Gotoh, Koro; Inoue, Megumi; Shiraishi, Kentaro; Masaki, Takayuki; Chiba, Seiichi; Mitsutomi, Kimihiko; Shimasaki, Takanobu; Ando, Hisae; Fujiwara, Kansuke; Katsuragi, Isao; Kakuma, Tetsuya; Seike, Masataka; Sakata, Toshiie; Yoshimatsu, Hironobu			Spleen-Derived Interleukin-10 Downregulates the Severity of High-Fat Diet-Induced Non-Alcoholic Fatty Pancreas Disease	PLOS ONE			English	Article							ANTIINFLAMMATORY ROLE; METABOLIC SYNDROME; IMMUNE FUNCTION; ADIPOSE-TISSUE; STELLATE CELLS; INFLAMMATION; OBESITY; ACTIVATION; EXPRESSION; GHRELIN	Obesity is associated with systemic low-grade inflammation and is a risk factor for non-alcoholic fatty pancreas disease (NAFPD), but the molecular mechanisms of these associations are not clear. Interleukin (IL)-10, a potent anti-inflammatory cytokine, is released during acute pancreatitis and is known to limit inflammatory responses by downregulating the release of proinflammatory mediators. The origin of IL-10 that suppresses pancreatitis has not been investigated. Since obesity is known to reduce expression of proinflammatory cytokines in the spleen, we examined whether spleen-derived IL-10 regulates NAFPD caused by high-fat (HF) diet-induced obesity. The following investigations were performed: 1) IL-10 induction from spleen was examined in male mice fed a HF diet; 2) triglyceride content, expression of pro- and anti-inflammatory cytokines and infiltration of M1 and M2 macrophages were determined to evaluate ectopic fat accumulation and inflammatory responses in the pancreas of splenectomy (SPX)-treated mice fed HF diet; 3) exogenous IL-10 was systemically administered to SPX-treated obese mice and the resulting pathogenesis caused by SPX was assessed; and 4) IL-10 knockout (IL-10KO) mice were treated with SPX and ectopic fat deposition and inflammatory conditions in the pancreas were investigated. Obesity impaired the ability of the spleen to synthesize cytokines, including IL-10. SPX aggravated fat accumulation and inflammatory responses in the pancreas of HF diet-induced obese mice and these effects were inhibited by systemic administration of IL-10. Moreover, SPX had little effect on fat deposition and inflammatory responses in the pancreas of IL-10KO mice. Our findings indicate that obesity reduces IL-10 production by the spleen and that spleen-derived IL-10 may protect against the development of NAFPD.	[Gotoh, Koro; Inoue, Megumi; Shiraishi, Kentaro; Masaki, Takayuki; Chiba, Seiichi; Mitsutomi, Kimihiko; Shimasaki, Takanobu; Ando, Hisae; Fujiwara, Kansuke; Katsuragi, Isao; Kakuma, Tetsuya; Seike, Masataka; Sakata, Toshiie; Yoshimatsu, Hironobu] Oita Univ, Fac Med, Dept Internal Med 1, Yufu City, Oita, Japan	Oita University	Gotoh, K (corresponding author), Oita Univ, Fac Med, Dept Internal Med 1, Yufu City, Oita, Japan.	gotokoro@oita-u.ac.jp		Masaki, Takayuki/0000-0002-2378-849X	Research on Measures for Intractable Diseases from Japan's Ministry of Health, Labor, and Welfare	Research on Measures for Intractable Diseases from Japan's Ministry of Health, Labor, and Welfare	This work was supported by a grant for the Research on Measures for Intractable Diseases from Japan's Ministry of Health, Labor, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Andres-Hernando A, 2011, AM J PHYSIOL-RENAL, V301, pF907, DOI 10.1152/ajprenal.00107.2011; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Balasa B, 2000, CELL IMMUNOL, V202, P97, DOI 10.1006/cimm.2000.1658; Blewett HJ, 2009, BRIT J NUTR, V102, P526, DOI 10.1017/S0007114509231722; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Brock P, 2006, J CELL MOL MED, V10, P884, DOI 10.1111/j.1582-4934.2006.tb00532.x; Chowdhury P, 2000, P SOC EXP BIOL MED, V223, P310, DOI 10.1046/j.1525-1373.2000.22344.x; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Girndt M, 2001, KIDNEY INT, V60, P2385, DOI 10.1046/j.1523-1755.2001.00062.x; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gotoh K, 2012, DIABETES, V61, P1994, DOI 10.2337/db11-1688; Gotoh K, 2012, J NEUROCHEM, V120, P752, DOI 10.1111/j.1471-4159.2011.07617.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jiang Joy, 2008, Metabolic Syndrome and Related Disorders, V6, P1, DOI 10.1089/met.2007.0026; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Kerem M, 2007, DIGEST DIS SCI, V52, P950, DOI 10.1007/s10620-006-9150-0; KLOPPEL G, 1992, VIRCHOWS ARCH A, V420, P1, DOI 10.1007/BF01605976; Lamas O, 2004, J PHYSIOL BIOCHEM, V60, P279, DOI 10.1007/BF03167074; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Ostrowski SE, 2004, J VIROL, V78, P8229, DOI 10.1128/JVI.78.15.8229-8237.2004; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Sato-Mito N, 2009, J NUTR HEALTH AGING, V13, P602, DOI 10.1007/s12603-009-0170-2; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tsukamoto H, 1998, HEPATOLOGY, V28, P1707, DOI 10.1002/hep.510280635; Waters KA, 2007, J SLEEP RES, V16, P388, DOI 10.1111/j.1365-2869.2007.00614.x; Zhang XL, 2008, PANCREAS, V37, pE31, DOI 10.1097/MPA.0b013e3181744b50	37	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53154	10.1371/journal.pone.0053154	http://dx.doi.org/10.1371/journal.pone.0053154			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285260	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500112
J	Leelatanawit, R; Klanchui, A; Uawisetwathana, U; Karoonuthaisiri, N				Leelatanawit, Rungnapa; Klanchui, Amornpan; Uawisetwathana, Umaporn; Karoonuthaisiri, Nitsara			Validation of Reference Genes for Real-Time PCR of Reproductive System in the Black Tiger Shrimp	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HOUSEKEEPING GENES; BETA-ACTIN; INTERNAL CONTROL; RT-PCR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MOLECULAR-CLONING; ATLANTIC SALMON; DIFFERENTIAL EXPRESSION; TESTICULAR DEVELOPMENT	Gene expression of reproductive system of the black tiger shrimp (Peneaus monodon) has been widely studied to address poor maturation problem in captivity. However, a systematic evaluation of reference genes in quantitative real-time PCR (qPCR) for P. monodon reproductive organs is lacking. In this study, the stability of four potential reference genes (18s rRNA, GAPDH, beta-actin, and EF1-alpha) was examined in the reproductive tissues in various conditions using bioinformatic tools: NormFinder and geNorm. For NormFinder, EF1-alpha and GAPDH ranked first and second as the most stable genes in testis groups whereas GAPDH and EF1-alpha were for ovaries from wild-caught broodstock and domesticated groups. EF1-alpha and beta-actin ranked first and second for the eyestalk ablated ovaries. For geNorm, EF1-alpha and GAPDH had the best stability in all testis and ovaries from domesticated groups whereas EF1-alpha and beta-actin were the best for ovaries from wild-caught and eyestalk ablated groups. Moreover, the expression levels of two well-known reproductive genes, Dmc1 and Vitellogenin, were used to validate these reference genes. When normalized to EF1-alpha, the expected expression patterns were obtained in all cases. Therefore, this work suggests that EF1-alpha is more versatile as reference genes in qPCR analysis for reproductive system in P. monodon.	[Leelatanawit, Rungnapa; Klanchui, Amornpan; Uawisetwathana, Umaporn; Karoonuthaisiri, Nitsara] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Klongluang, Pathumthani, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Karoonuthaisiri, N (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Microarray Lab, Klongluang, Pathumthani, Thailand.	nitsara.kar@biotec.or.th	Uawisetwathana, Umaporn/E-8974-2011		National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand); Cluster and Program Management Office of the National Science and Technology Development Agency, Thailand [P10-10467]	National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand); Cluster and Program Management Office of the National Science and Technology Development Agency, Thailand	This research is supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC, Thailand) and Cluster and Program Management Office of the National Science and Technology Development Agency, Thailand (Grant number: P10-10467 and URL:http://www.nstda.or.th/scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Antony SP, 2011, IMMUNOBIOLOGY, V216, P184, DOI 10.1016/j.imbio.2010.05.030; Arts JAJ, 2007, FISH SHELLFISH IMMUN, V23, P504, DOI 10.1016/j.fsi.2006.08.018; Baillet A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026950; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Buaklin A, 2011, IDENTIFICATION EXPRE; Cale JM, 1997, J SOC GYNECOL INVEST, V4, P284, DOI 10.1016/S1071-5576(97)00067-1; Calvo EL, 1997, BIOCHEM BIOPH RES CO, V235, P636, DOI 10.1006/bbrc.1997.6716; Carlyle WC, 1996, J MOL CELL CARDIOL, V28, P53, DOI 10.1006/jmcc.1996.0006; Carrillo-Casas EM, 2008, CURR MICROBIOL, V56, P539, DOI 10.1007/s00284-008-9096-x; CHU KH, 1993, FISH RES, V18, P187, DOI 10.1016/0165-7836(93)90152-W; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Dhar AK, 2009, MOL IMMUNOL, V46, P1688, DOI 10.1016/j.molimm.2009.02.020; Ding ZJ, 2001, SEX PLANT REPROD, V13, P285, DOI 10.1007/s004970100065; DIRNHOFER S, 1995, TRENDS GENET, V11, P380, DOI 10.1016/S0168-9525(00)89115-5; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Foss DL, 1998, ANIM BIOTECHNOL, V9, P67, DOI 10.1080/10495399809525893; Goidin D, 2001, ANAL BIOCHEM, V295, P17, DOI 10.1006/abio.2001.5171; Habu T, 1996, NUCLEIC ACIDS RES, V24, P470, DOI 10.1093/nar/24.3.470; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Infante C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-28; Infante C, 2008, BMC MOL BIOL, V9, DOI [10.1186/1471-2199-9-19, 10.1186/1471-2199-9-28]; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jemiolo B, 2004, BIOCHEM BIOPH RES CO, V320, P1043, DOI 10.1016/j.bbrc.2004.05.223; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kajiura-Kobayashi H, 2005, DEV DYNAM, V232, P1115, DOI 10.1002/dvdy.20289; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Kim YK, 2005, ZOOL SCI, V22, P675, DOI 10.2108/zsj.22.675; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Krussel JS, 1998, J CLIN ENDOCR METAB, V83, P953, DOI 10.1210/jc.83.3.953; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; Leelatanawit R, 2008, BMB REP, V41, P796, DOI 10.5483/BMBRep.2008.41.11.796; Luo T, 2007, MOL IMMUNOL, V44, P1516, DOI 10.1016/j.molimm.2006.09.015; MANSUR NR, 1993, NUCLEIC ACIDS RES, V21, P993, DOI 10.1093/nar/21.4.993; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Okutsu T, 2010, FISHERIES SCI, V76, P961, DOI 10.1007/s12562-010-0295-6; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Ozaki Y, 2006, COMP BIOCHEM PHYS B, V143, P309, DOI 10.1016/j.cbpb.2005.12.008; Pfennig F, 2012, REPRODUCTION, V143, P71, DOI 10.1530/REP-11-0292; Phiriyangkul P, 2007, MOL REPROD DEV, V74, P1198, DOI 10.1002/mrd.20629; Pongsomboon S, 2008, DIFFERENTIALLY EXPRE; PUISSANT C, 1994, EUR J ENDOCRINOL, V130, P522, DOI 10.1530/eje.0.1300522; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Somboonwiwat K, 2006, DIFFERENTIALLY EXPRE; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Stielow B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001203; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; TANFERMIN JD, 1989, AQUACULTURE, V77, P229, DOI 10.1016/0044-8486(89)90205-6; Tharntada S, 2009, J GEN VIROL, V90, P1491, DOI 10.1099/vir.0.009621-0; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Uawisetwathana U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024427; Underwood DJ, 2010, AQUACULTURE, V308, P82, DOI 10.1016/j.aquaculture.2010.08.027; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wongsurawat T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-55; Yang YF, 2005, J APPL PHYSIOL, V98, P1745, DOI 10.1152/japplphysiol.01185.2004; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhang ZB, 2007, TOXICOL SCI, V95, P356, DOI 10.1093/toxsci/kfl161; Zhou FL, 2011, MOL BIOL REP, V38, P1921, DOI 10.1007/s11033-010-0312-y	67	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52677	10.1371/journal.pone.0052677	http://dx.doi.org/10.1371/journal.pone.0052677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285145	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500045
J	Qu, ZW; Miao, WY; Hu, SQ; Li, C; Zhuo, XL; Zong, YY; Wu, YP; Zhang, GY				Qu, Zhong-Wei; Miao, Wan-Ying; Hu, Shu-Qun; Li, Chong; Zhuo, Xing-Li; Zong, Yan-Yan; Wu, Yong-Ping; Zhang, Guang-Yi			N-Methyl-D-Aspartate Receptor-Dependent Denitrosylation of Neuronal Nitric Oxide Synthase Increase the Enzyme Activity	PLOS ONE			English	Article							PROTEIN-KINASE-II; S-NITROSYLATION; SER(847) PHOSPHORYLATION; THIOREDOXIN REDUCTASE; SIGNALING PATHWAY; NOS ACTIVITY; ISCHEMIA; BRAIN; EXPRESSION; HIPPOCAMPUS	Our laboratory once reported that neuronal nitric oxide synthase (nNOS) S-nitrosylation was decreased in rat hippocampus during cerebral ischemia-reperfusion, but the underlying mechanism was unclear. In this study, we show that nNOS activity is dynamically regulated by S-nitrosylation. We found that overexpressed nNOS in HEK293 (human embryonic kidney) cells could be S-nitrosylated by exogenous NO donor GSNO and which is associated with the enzyme activity decrease. Cys(331), one of the zinc-tetrathiolate cysteines, was identified as the key site of nNOS S-nitrosylation. In addition, we also found that nNOS is highly S-nitrosylated in resting rat hippocampal neurons and the enzyme undergos denitrosylation during the process of rat brain ischemia/reperfusion. Intrestingly, the process of nNOS denitrosylation is coupling with the decrease of nNOS phosphorylation at Ser(847), a site associated with nNOS activation. Further more, we document that nNOS denitrosylation could be suppressed by pretreatment of neurons with MK801, an antagonist of NMDAR, GSNO, EGTA, BAPTA, W-7, an inhibitor of calmodulin as well as TrxR1 antisense oligonucleotide (AS-ODN) respectively. Taken together, our data demonstrate that the denitrosylation of nNOS induced by calcium ion influx is a NMDAR-dependent process during the early stage of ischemia/reperfusion, which is majorly mediated by thioredoxin-1 (Trx1) system. nNOS dephosphorylation may be induced by the enzyme denitrosylation, which suggest that S-nitrosylation/denitrosylation of nNOS may be an important mechanism in regulating the enzyme activity.	[Qu, Zhong-Wei; Miao, Wan-Ying; Hu, Shu-Qun; Li, Chong; Zhuo, Xing-Li; Zong, Yan-Yan; Zhang, Guang-Yi] Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Res Ctr Biochem & Mol Biol, Xuzhou, Jiangsu, Peoples R China; [Wu, Yong-Ping] Xuzhou Med Coll, Jiangsu Key Lab Anesthesiol, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Jiangsu Key Lab Brain Dis Bioinformat, Res Ctr Biochem & Mol Biol, Xuzhou, Jiangsu, Peoples R China.	gyzhang@xzmc.edu.cn		Miao, Wanying/0000-0003-3972-2572; Zhongwei, Qu/0000-0002-6994-0530	National Natural Science Foudation of China [81271267, 31000360]; Education Departmental Nature Science Funds of Jiangsu Province [10KJA310053]; Science and Technology Bureau of Xuzhou [XF10C077]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project; "Six Talent Peaks Program'' of Jiangsu Province	National Natural Science Foudation of China(National Natural Science Foundation of China (NSFC)); Education Departmental Nature Science Funds of Jiangsu Province; Science and Technology Bureau of Xuzhou; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing Lan Project(Jiangsu Polytech Institute); "Six Talent Peaks Program'' of Jiangsu Province	This work was supported by grants from the National Natural Science Foudation of China (81271267; 31000360;), the Education Departmental Nature Science Funds of Jiangsu Province (10KJA310053), the Science and Technology Bureau of Xuzhou (XF10C077), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), the Qing Lan Project. Dr. Chong Li was supported by "Six Talent Peaks Program'' of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuSoud HM, 1996, J BIOL CHEM, V271, P32515, DOI 10.1074/jbc.271.51.32515; Andrew PJ, 1999, CARDIOVASC RES, V43, P521, DOI 10.1016/S0008-6363(99)00115-7; Anema SM, 1999, BIOCHEM J, V342, P111, DOI 10.1042/0264-6021:3420111; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Black SM, 1999, AM J PHYSIOL-HEART C, V277, pH1849, DOI 10.1152/ajpheart.1999.277.5.H1849; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; CHEN PF, 1995, BIOCHEM BIOPH RES CO, V215, P1119, DOI 10.1006/bbrc.1995.2579; Chvanov M, 2006, EMBO J, V25, P3024, DOI 10.1038/sj.emboj.7601207; Crane MS, 2009, BBA-GEN SUBJECTS, V1790, P1191, DOI 10.1016/j.bbagen.2009.07.001; Davis SM, 2000, STROKE, V31, P347, DOI 10.1161/01.STR.31.2.347; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; FIX AS, 1993, EXP NEUROL, V123, P204, DOI 10.1006/exnr.1993.1153; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hayashi Y, 1999, J BIOL CHEM, V274, P20597, DOI 10.1074/jbc.274.29.20597; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; HURSHMAN AR, 1995, BIOCHEMISTRY-US, V34, P5627, DOI 10.1021/bi00016a038; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2005, METHOD ENZYMOL, V396, P105, DOI 10.1016/S0076-6879(05)96011-4; Kalinina EV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1493, DOI 10.1134/S0006297908130099; KENNEDY MB, 1995, TRENDS BIOCHEM SCI, V20, P350, DOI 10.1016/S0968-0004(00)89074-X; Keynes RG, 2004, CURR MOL MED, V4, P179, DOI 10.2174/1566524043479176; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Komeima K, 2000, J BIOL CHEM, V275, P28139; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; Lopez-Sanchez LM, 2008, METHOD ENZYMOL, V440, P273, DOI [10.1016/S0076-6879(07)00877-8, 10.1016/S0076-6879(07)00817-8]; Ma KW, 2006, J BIOL CHEM, V281, P21250, DOI 10.1074/jbc.M600521200; Martasek P, 1998, J BIOL CHEM, V273, P34799, DOI 10.1074/jbc.273.52.34799; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Osuka K, 2002, J CEREBR BLOOD F MET, V22, P1098, DOI 10.1097/00004647-200209000-00007; Otani H, 2004, J PHARMACOL SCI, V96, P188, DOI 10.1254/jphs.FP0040385; Pei DS, 2008, J NEUROCHEM, V106, P1952, DOI 10.1111/j.1471-4159.2008.05531.x; Pei DS, 2009, NEUROCHEM RES, V34, P1507, DOI 10.1007/s11064-009-9938-3; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2000, NEUROPHARMACOLOGY, V39, P2255, DOI 10.1016/S0028-3908(00)00066-6; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Sheehy AM, 1998, AM J PHYSIOL-LUNG C, V274, pL833, DOI 10.1152/ajplung.1998.274.5.L833; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Stuart-Smith K, 2002, J CLIN PATHOL-MOL PA, V55, P360, DOI 10.1136/mp.55.6.360; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Watanabe Y, 2003, BIOCHEM J, V372, P465, DOI 10.1042/BJ20030380; Yan XB, 2004, ACTA PHARMACOL SIN, V25, P617; Yu HM, 2008, NEUROSCIENCE, V155, P1120, DOI 10.1016/j.neuroscience.2008.03.061; Yuan GJ, 2006, WORLD J GASTROENTERO, V12, P2375, DOI 10.3748/wjg.v12.i15.2375; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890; Zhang J, 2011, J BIOL CHEM, V286, P7669, DOI 10.1074/jbc.M110.156299; Zheng Y, 2005, J CELL PHYSIOL, V205, P97, DOI 10.1002/jcp.20378	54	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52788	10.1371/journal.pone.0052788	http://dx.doi.org/10.1371/journal.pone.0052788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285183	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500062
J	Shi, HT; Wang, YP; Cheng, ZM; Ye, TT; Chan, ZL				Shi, Haitao; Wang, Yanping; Cheng, Zhangmin; Ye, Tiantian; Chan, Zhulong			Analysis of Natural Variation in Bermudagrass (Cynodon dactylon) Reveals Physiological Responses Underlying Drought Tolerance	PLOS ONE			English	Article							WARM-SEASON TURFGRASSES; ARABIDOPSIS-THALIANA; RESISTANCE MECHANISMS; OXIDATIVE STRESS; SALT; PROTEINS; SURFACE; GENE; TRANSVAALENSIS; IDENTIFICATION	Bermudagrass (Cynodon dactylon) is a widely used warm-season turfgrass and one of the most drought tolerant species. Dissecting the natural variation in drought tolerance and physiological responses will bring us powerful basis and novel insight for plant breeding. In the present study, we evaluated the natural variation of drought tolerance among nine bermudagrass varieties by measuring physiological responses after drought stress treatment through withholding water. Three groups differing in drought tolerance were identified, including two tolerant, five moderately tolerant and two susceptible varieties. Under drought stress condition, drought sensitive variety (Yukon) showed relative higher water loss, more severe cell membrane damage (EL), and more accumulation of hydrogen peroxide (H2O2) and malondialdehyde (MDA), while drought tolerant variety (Tifgreen) exhibited significantly higher antioxidant enzymes activities. Further results indicated that drought induced cell injury in different varieties (Yukon, SR9554 and Tifgreen) exhibited liner correlation with leaf water content (LWC), H2O2 content, MDA content and antioxidant enzyme activities. Additionally, Tifgreen plants had significantly higher levels of osmolytes (proline level and soluble sugars) when compared with Yukon and SR9554 under drought stress condition. Taken together, our results indicated that natural variation of drought stress tolerance in bermudagrass varieties might be largely related to the induced changes of water status, osmolyte accumulation and antioxidant defense system.	[Shi, Haitao; Wang, Yanping; Cheng, Zhangmin; Ye, Tiantian; Chan, Zhulong] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China; [Cheng, Zhangmin; Ye, Tiantian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chan, ZL (corresponding author), Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China.	zhulongch@wbgcas.cn	Chan, Zhulong/AAM-5018-2020	Chan, Zhulong/0000-0002-1933-6837; Wang, Yanping/0000-0003-4391-0883	Hundred Talents Program; Knowledge Innovative Key Program of Chinese Academy of Sciences [54Y154761O01076]	Hundred Talents Program(Chinese Academy of Sciences); Knowledge Innovative Key Program of Chinese Academy of Sciences	This research was supported by "the Hundred Talents Program'', the Knowledge Innovative Key Program of Chinese Academy of Sciences (Grant No. 54Y154761O01076) to Z. Chan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bechtold U, 2010, PLANT CELL ENVIRON, V33, P1959, DOI 10.1111/j.1365-3040.2010.02198.x; Benfey PN, 2008, SCIENCE, V320, P495, DOI 10.1126/science.1153716; Bian SM, 2009, SCI HORTIC-AMSTERDAM, V120, P264, DOI 10.1016/j.scienta.2008.10.014; Bouchabke O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001705; Campbell SA, 1997, NEW PHYTOL, V137, P61, DOI 10.1046/j.1469-8137.1997.00831.x; Carmo-Silva AE, 2008, PHOTOSYNTH RES, V97, P223, DOI 10.1007/s11120-008-9329-7; Carmo-Silva AE, 2009, PHYTOCHEMISTRY, V70, P664, DOI 10.1016/j.phytochem.2009.03.001; CARROW RN, 1995, CROP SCI, V35, P1685, DOI 10.2135/cropsci1995.0011183X003500060029x; Carrow RN, 1996, CROP SCI, V36, P687, DOI 10.2135/cropsci1996.0011183X003600020026x; Chan ZL, 2012, PLANT BIOTECHNOL J, V10, P284, DOI 10.1111/j.1467-7652.2011.00661.x; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; He ZY, 2008, CELL BIOL INT, V32, P367, DOI 10.1016/j.cellbi.2007.12.003; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Hu LX, 2010, PHYSIOL PLANTARUM, V139, P93, DOI 10.1111/j.1399-3054.2010.01350.x; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Huang B, 1997, CROP SCI, V37, P1858, DOI 10.2135/cropsci1997.0011183X003700060032x; Huang B, 1997, CROP SCI, V37, P1863, DOI 10.2135/cropsci1997.0011183X003700060033x; Kim C, 2009, PLANT MOL BIOL, V70, P1, DOI 10.1007/s11103-009-9453-6; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lu SY, 2007, PLANT CELL REP, V26, P1413, DOI 10.1007/s00299-007-0339-2; Lu SY, 2009, PLANT CELL REP, V28, P517, DOI 10.1007/s00299-008-0649-z; Luo N, 2011, PHYSIOL PLANTARUM, V141, P19, DOI 10.1111/j.1399-3054.2010.01413.x; Luo Y, 2008, ENVIRON EXP BOT, V63, P378, DOI 10.1016/j.envexpbot.2007.11.016; MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Qian Y, 1997, CROP SCI, V47, P2162, DOI DOI 10.2135/CROPSCI1997.0011183X003700030034X; Shi HT, 2012, PLANT CELL PHYSIOL, V53, P344, DOI 10.1093/pcp/pcr181; Shukla N, 2012, PLANT PHYSIOL BIOCH, V54, P78, DOI 10.1016/j.plaphy.2012.02.001; Thamsen M, 2011, CURR OPIN CHEM BIOL, V15, P113, DOI 10.1016/j.cbpa.2010.11.013; Wang XL, 2010, BIOCHEMISTRY-MOSCOW+, V75, P201, DOI 10.1134/S0006297910020100; Xu CP, 2010, J PLANT PHYSIOL, V167, P1477, DOI 10.1016/j.jplph.2010.05.006; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	38	91	102	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53422	10.1371/journal.pone.0053422	http://dx.doi.org/10.1371/journal.pone.0053422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285294	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500149
J	Alwis, DS; Yan, EB; Morganti-Kossmann, MC; Rajan, R				Alwis, Dasuni S.; Yan, Edwin B.; Morganti-Kossmann, Maria-Cristina; Rajan, Ramesh			Sensory Cortex Underpinnings of Traumatic Brain Injury Deficits	PLOS ONE			English	Article							RAT BARREL CORTEX; VISUAL PROCESSING DEFICITS; DIFFUSE AXONAL INJURY; WHISKER VIBRATION; HIPPOCAMPAL CA1; CORTICAL INJURY; COMPLEX SOUNDS; LATE-ONSET; NEURONS; HYPEREXCITABILITY	Traumatic brain injury (TBI) can result in persistent sensorimotor and cognitive deficits including long-term altered sensory processing. The few animal models of sensory cortical processing effects of TBI have been limited to examination of effects immediately after TBI and only in some layers of cortex. We have now used the rat whisker tactile system and the cortex processing whisker-derived input to provide a highly detailed description of TBI-induced long-term changes in neuronal responses across the entire columnar network in primary sensory cortex. Brain injury (n = 19) was induced using an impact acceleration method and sham controls received surgery only (n = 15). Animals were tested in a range of sensorimotor behaviour tasks prior to and up to 6 weeks post-injury when there were still significant sensorimotor behaviour deficits. At 8-10 weeks post-trauma, in terminal experiments, extracellular recordings were obtained from barrel cortex neurons in response to whisker motion, including motion that mimicked whisker motion observed in awake animals undertaking different tasks. In cortex, there were lamina-specific neuronal response alterations that appeared to reflect local circuit changes. Hyper-excitation was found only in supragranular layers involved in intra-areal processing and long-range integration, and only for stimulation with complex, naturalistic whisker motion patterns and not for stimulation with simple trapezoidal whisker motion. Thus TBI induces long-term directional changes in integrative sensory cortical layers that depend on the complexity of the incoming sensory information. The nature of these changes allow predictions as to what types of sensory processes may be affected in TBI and contribute to post-trauma sensorimotor deficits.	[Alwis, Dasuni S.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Alwis, Dasuni S.; Yan, Edwin B.; Morganti-Kossmann, Maria-Cristina] Alfred Hosp, Natl Trauma Res Inst, Prahran, Vic 3181, Australia	Monash University; Florey Institute of Neuroscience & Mental Health	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	Ramesh.Rajan@monash.edu	rajan, ramesh/L-4842-2019	Rajan, Ramesh/0000-0001-9862-0520; Morganti-Kossmann, Cristina/0000-0002-0807-2063	NHMRC of Australia [APP 1029311]	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the NHMRC of Australia Grant No. APP 1029311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2009, SCHIZOPHRENIA BULL, V35, P1132, DOI 10.1093/schbul/sbp068; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Boddaert N, 2003, AM J PSYCHIAT, V160, P2057, DOI 10.1176/appi.ajp.160.11.2057; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; Butler PD, 2009, SCHIZOPHRENIA BULL, V35, P1095, DOI 10.1093/schbul/sbp109; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Carmichael ST, 2012, ARCH NEUROL-CHICAGO, V69, P161, DOI 10.1001/archneurol.2011.1175; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cook NL, 2010, J MOL NEUROSCI, V42, P192, DOI 10.1007/s12031-010-9347-8; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Davis AS, 2010, APPL NEUROPSYCHOL, V17, P104, DOI 10.1080/09084281003708951; Ding MC, 2008, NEUROSCIENCE, V154, P551, DOI 10.1016/j.neuroscience.2008.03.088; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Gibson JR, 2008, J NEUROPHYSIOL, V100, P2615, DOI 10.1152/jn.90752.2008; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Higley MJ, 2003, J NEUROSCI, V23, P10190; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Horton HK, 2011, SCHIZOPHRENIA BULL, V37, P716, DOI 10.1093/schbul/sbr055; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Kalauzi Aleksandar, 2009, Nonlinear Biomed Phys, V3, P8, DOI 10.1186/1753-4631-3-8; Kim D, 2006, SCHIZOPHR RES, V82, P1, DOI 10.1016/j.schres.2005.10.008; Korostenskaja M, 2010, EPILEPSY RES, V92, P63, DOI 10.1016/j.eplepsyres.2010.08.008; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Leitman DI, 2007, AM J PSYCHIAT, V164, P474, DOI 10.1176/appi.ajp.164.3.474; Leitman DI, 2005, BIOL PSYCHIAT, V58, P56, DOI 10.1016/j.biopsych.2005.02.034; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lewis DA, 2012, TRENDS NEUROSCI, V35, P57, DOI 10.1016/j.tins.2011.10.004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MANDELBROT BB, 1991, P ROY SOC LOND A MAT, V434, P79, DOI 10.1098/rspa.1991.0081; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI 10.1109/SPL.2011.5782616; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Paluszkiewicz SM, 2011, DEV NEUROSCI-BASEL, V33, P349, DOI 10.1159/000329420; Patel R, 2011, OPTOMETRY, V82, P284, DOI 10.1016/j.optm.2010.10.012; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Raghavendra BS, 2009, PHYSIOL MEAS, V30, P795, DOI 10.1088/0967-3334/30/8/005; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Rajan R, 2001, CEREB CORTEX, V11, P171, DOI 10.1093/cercor/11.2.171; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P; Raymond MJ, 1996, NEUROREHABILITATION, V6, P229, DOI 10.3233/NRE-1996-6309; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schmanke T, 1997, J NEUROTRAUM, V14, P459, DOI 10.1089/neu.1997.14.459; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolf DH, 2008, BRAIN IMAGING BEHAV, V2, P132, DOI 10.1007/s11682-008-9022-7; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; YU Z, 2009, EMBC 2009 ANN INT C, P1135	96	48	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52169	10.1371/journal.pone.0052169	http://dx.doi.org/10.1371/journal.pone.0052169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284921	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800036
J	Mlambo, G; Coppens, I; Kumar, N				Mlambo, Godfree; Coppens, Isabelle; Kumar, Nirbhay			Aberrant Sporogonic Development of Dmc1 (a Meiotic Recombinase) Deficient Plasmodium berghei Parasites	PLOS ONE			English	Article							ANTIGENIC VARIATION; ALLELIC RECOMBINATION; CHROMOSOME SYNAPSIS; STRAND EXCHANGE; PHASE-I; DNA; FALCIPARUM; PROTEIN; AGENT; VIVAX	Background: In Plasmodium, meiosis occurs in diploid zygotes as they develop into haploid motile ookinetes inside the mosquito. Further sporogonic development involves transformation of ookinetes into oocysts and formation of infective sporozoites. Methodology/Principal Findings: Reverse genetics was employed to examine the role of the meiotic specific recombinase Dmc1, a bacterial RecA homolog during sporogony in Plasmodium berghei. PbDmc1 knockout (KO) parasites showed normal asexual growth kinetics compared to WT parasites; however oocyst formation in mosquitoes was reduced by 50 to 80%. Moreover, the majority of oocysts were retarded in their growth and were smaller in size compared to WT parasites. Only a few Dmc1 KO parasites completed maturation resulting in formation of fewer sporozoites which were incapable of infecting naive mice or hepatocytes in vitro. PbDmc1 KO parasites were shown to be approximately 18 times more sensitive to Bizelesin, a DNA alkylating drug compared to WT parasites as reflected by impairment of oocyst formation and sporogonic development in the mosquito vector. Conclusions/Significance: Our findings suggest that PbDmc1 plays a critical role in malaria transmission biology.	[Mlambo, Godfree; Coppens, Isabelle; Kumar, Nirbhay] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Kumar, Nirbhay] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University	Kumar, N (corresponding author), Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	nkumar@tulane.edu			National Institutes of Health [R01 AI068052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI068052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by a National Institutes of Health grant R01 AI068052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya MK, 2003, INT J PARASITOL, V33, P1385, DOI 10.1016/S0020-7519(03)00212-1; Bhattacharyya MK, 2004, INFECT GENET EVOL, V4, P91, DOI 10.1016/j.meegid.2004.01.008; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Deitsch KW, 1999, MOL BIOCHEM PARASIT, V101, P107, DOI 10.1016/S0166-6851(99)00062-6; DING ZM, 1991, ANTI-CANCER DRUG DES, V6, P427; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEE CS, 1991, CANCER RES, V51, P6586; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lobo CA, 1999, MOL CELL, V3, P793, DOI 10.1016/S1097-2765(01)80011-3; Mambo G, 2008, INFECT IMMUN, V76, P2018, DOI 10.1128/IAI.01409-07; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Pan J, 2007, PLOS BIOL, V5, P2774, DOI 10.1371/journal.pbio.0050333; Pitot HC, 2002, CLIN CANCER RES, V8, P712; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Proudfoot C, 2006, MOL BIOCHEM PARASIT, V145, P245, DOI 10.1016/j.molbiopara.2005.10.007; Putaporntip C, 1997, MOL BIOCHEM PARASIT, V84, P49, DOI 10.1016/S0166-6851(96)02786-7; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; RANFORDCARTWRIGHT LC, 1991, MOL BIOCHEM PARASIT, V49, P239, DOI 10.1016/0166-6851(91)90067-G; Sakihama N, 1999, GENE, V230, P47, DOI 10.1016/S0378-1119(99)00069-4; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Schwartz GH, 2003, ANN ONCOL, V14, P775, DOI 10.1093/annonc/mdg215; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; SINDEN RE, 1985, J PROTOZOOL, V32, P742, DOI 10.1111/j.1550-7408.1985.tb03113.x; Sinden RE, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P139; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Yanow SK, 2008, J INFECT DIS, V197, P527, DOI 10.1086/526788	33	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52480	10.1371/journal.pone.0052480	http://dx.doi.org/10.1371/journal.pone.0052480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285059	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800070
J	Kapralov, MV; Smith, JAC; Filatov, DA				Kapralov, Maxim V.; Smith, J. Andrew C.; Filatov, Dmitry A.			Rubisco Evolution in C-4 Eudicots: An Analysis of Amaranthaceae Sensu Lato	PLOS ONE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE; CODON-SUBSTITUTION MODELS; AMINO-ACID SITES; MOLECULAR ADAPTATION; CHENOPODIACEAE IMPLICATIONS; PHYLOGENETIC ANALYSIS; S.L. CHENOPODIACEAE; POSITIVE SELECTION; ADAPTIVE EVOLUTION; KINETIC-PROPERTIES	Background: Rubisco (ribulose-1,5-bisphosphate carboxylase/oxygenase) catalyses the key reaction in the photosynthetic assimilation of CO2. In C-4 plants CO2 is supplied to Rubisco by an auxiliary CO2-concentrating pathway that helps to maximize the carboxylase activity of the enzyme while suppressing its oxygenase activity. As a consequence, C-4 Rubisco exhibits a higher maximum velocity but lower substrate specificity compared with the C-3 enzyme. Specific amino-acids in Rubisco are associated with C-4 photosynthesis in monocots, but it is not known whether selection has acted on Rubisco in a similar way in eudicots. Methodology/Principal Findings: We investigated Rubisco evolution in Amaranthaceae sensu lato (including Chenopodiaceae), the third-largest family of C-4 plants, using phylogeny-based maximum likelihood and Bayesian methods to detect Darwinian selection on the chloroplast rbcL gene in a sample of 179 species. Two Rubisco residues, 281 and 309, were found to be under positive selection in C-4 Amaranthaceae with multiple parallel replacements of alanine by serine at position 281 and methionine by isoleucine at position 309. Remarkably, both amino-acids have been detected in other C-4 plant groups, such as C-4 monocots, illustrating a striking parallelism in molecular evolution. Conclusions/Significance: Our findings illustrate how simple genetic changes can contribute to the evolution of photosynthesis and strengthen the hypothesis that parallel amino-acid replacements are associated with adaptive changes in Rubisco. Citation: Kapralov MV, Smith JAC, Filatov DA (2012) Rubisco Evolution in C-4 Eudicots: An Analysis of Amaranthaceae Sensu Lato. PLoS ONE 7(12): e52974. doi:10.1371/journal.pone.0052974	[Kapralov, Maxim V.; Smith, J. Andrew C.; Filatov, Dmitry A.] Univ Oxford, Dept Plant Sci, Oxford, England	University of Oxford	Kapralov, MV (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford, England.	maxim.kapralov@plants.ox.ac.uk	Smith, J.A.C./M-3338-2014	Smith, J.A.C./0000-0001-9188-0258; Kapralov, Maxim/0000-0001-7966-0295; Filatov, Dmitry/0000-0001-8077-5452	NERC [NE/H007741/1]; Natural Environment Research Council [NE/H007741/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC (http://www.nerc.ac.uk/; grant number NE/H007741/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhani H, 2007, INT J PLANT SCI, V168, P931, DOI 10.1086/518263; Bremer K, 1998, ANN MO BOT GARD, V85, P531, DOI 10.2307/2992015; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; Christin PA, 2010, TRENDS ECOL EVOL, V25, P403, DOI 10.1016/j.tree.2010.04.007; Edwards GE, 2004, ANNU REV PLANT BIOL, V55, P173, DOI 10.1146/annurev.arplant.55.031903.141725; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HUDSON GS, 1990, J BIOL CHEM, V265, P808; Iida S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004633; Ishikawa C, 2011, PLANT PHYSIOL, V156, P1603, DOI 10.1104/pp.111.177030; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; Kadereit G, 2003, INT J PLANT SCI, V164, P959, DOI 10.1086/378649; Kadereit G, 2012, P ROY SOC B-BIOL SCI, V279, P3304, DOI 10.1098/rspb.2012.0440; Kadereit G, 2011, TAXON, V60, P51, DOI 10.1002/tax.601006; Kadereit G, 2010, AM J BOT, V97, P1664, DOI 10.3732/ajb.1000169; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kapralov MV, 2006, SYST BOT, V31, P571, DOI 10.1600/036364406778388674; Kapralov MV, 2011, MOL BIOL EVOL, V28, P1491, DOI 10.1093/molbev/msq335; Kato S, 2011, J PHYCOL, V47, P999, DOI 10.1111/j.1529-8817.2011.01037.x; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; Kubien DS, 2008, J EXP BOT, V59, P1767, DOI 10.1093/jxb/erm283; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; Maddison WP, 2010, MESQUITE MODULAR SYS; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Miwa H, 2009, GENE, V441, P169, DOI 10.1016/j.gene.2008.11.020; Monson R.K., 1999, C4 PLANT BIOL, P215, DOI DOI 10.1016/B978-012614440-6/50008-2; Muller K, 2005, ANN MO BOT GARD, V92, P66; Nelson D., 2005, LEHNINGER PRINCIPLES; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pyankov VI, 2010, BOT J LINN SOC, V163, P283, DOI 10.1111/j.1095-8339.2010.01062.x; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Sen L, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-29; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith ME, 2009, FUNCT PLANT BIOL, V36, P770, DOI 10.1071/FP09120; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Taylor TC, 1996, J BIOL CHEM, V271, P32894, DOI 10.1074/jbc.271.51.32894; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Wang MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-266; Wen ZB, 2010, PLANT SYST EVOL, V288, P25, DOI 10.1007/s00606-010-0310-5; Whitney SM, 2011, P NATL ACAD SCI USA, V108, P14688, DOI 10.1073/pnas.1109503108; Whitney SM, 2011, PLANT PHYSIOL, V155, P27, DOI 10.1104/pp.110.164814; Witzel F, 2010, FEBS J, V277, P931, DOI 10.1111/j.1742-4658.2009.07541.x; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; YEOH HH, 1981, PLANT PHYSIOL, V67, P1151, DOI 10.1104/pp.67.6.1151; Young JN, 2012, PHILOS T R SOC B, V367, P483, DOI 10.1098/rstb.2011.0145; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	67	40	44	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52974	10.1371/journal.pone.0052974	http://dx.doi.org/10.1371/journal.pone.0052974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285238	Green Published, gold			2022-12-25	WOS:000312794500258
J	Miller-Sims, VC; Bottjer, SW				Miller-Sims, Vanessa C.; Bottjer, Sarah W.			Development of Auditory-Vocal Perceptual Skills in Songbirds	PLOS ONE			English	Article							SPEECH-PERCEPTION; ZEBRA FINCHES; POECILE-ATRICAPILLUS; INDIVIDUAL IDENTITY; PHONETIC PERCEPTION; SENSITIVE PERIOD; NEURAL CIRCUITS; LEARNED CALLS; BEGGING CALLS; BRAIN-STEM	Songbirds are one of the few groups of animals that learn the sounds used for vocal communication during development. Like humans, songbirds memorize vocal sounds based on auditory experience with vocalizations of adult "tutors", and then use auditory feedback of self-produced vocalizations to gradually match their motor output to the memory of tutor sounds. In humans, investigations of early vocal learning have focused mainly on perceptual skills of infants, whereas studies of songbirds have focused on measures of vocal production. In order to fully exploit songbirds as a model for human speech, understand the neural basis of learned vocal behavior, and investigate links between vocal perception and production, studies of songbirds must examine both behavioral measures of perception and neural measures of discrimination during development. Here we used behavioral and electrophysiological assays of the ability of songbirds to distinguish vocal calls of varying frequencies at different stages of vocal learning. The results show that neural tuning in auditory cortex mirrors behavioral improvements in the ability to make perceptual distinctions of vocal calls as birds are engaged in vocal learning. Thus, separate measures of neural discrimination and behavioral perception yielded highly similar trends during the course of vocal development. The timing of this improvement in the ability to distinguish vocal sounds correlates with our previous work showing substantial refinement of axonal connectivity in cortico-basal ganglia pathways necessary for vocal learning.	[Miller-Sims, Vanessa C.; Bottjer, Sarah W.] Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Bottjer, SW (corresponding author), Univ So Calif, Neurobiol Sect, Los Angeles, CA 90089 USA.	bottjer@usc.edu			National Institute of Neurological Disorders and Stroke (NINDS) [NS 037547]; National Institute on Deafness and Other Communication Disorders (NIDCD) [DC 009975]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012396, T32DC009975] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute of Neurological Disorders and Stroke (NINDS) grant NS 037547 and National Institute on Deafness and Other Communication Disorders (NIDCD) Training Fellowship DC 009975. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, J NEUROPHYSIOL, V97, P3517, DOI 10.1152/jn.01066.2006; ASLIN RN, 1981, CHILD DEV, V52, P1135, DOI 10.2307/1129499; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bottjer SW, 1997, ANNU REV NEUROSCI, V20, P459, DOI 10.1146/annurev.neuro.20.1.459; Braaten RF, 2006, J COMP PSYCHOL, V120, P79, DOI 10.1037/0735-7036.120.2.79; Charrier I, 2005, J COMP PSYCHOL, V119, P371, DOI 10.1037/0735-7036.119.4.371; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; D'Ausillo A, 2009, CURR BIOL, V19, P381, DOI 10.1016/j.cub.2009.01.017; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; de Villers-Sidani E, 2011, PROG BRAIN RES, V191, P119, DOI 10.1016/B978-0-444-53752-2.00009-6; Dhanjal NS, 2008, J NEUROSCI, V28, P9969, DOI 10.1523/JNEUROSCI.2607-08.2008; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EIMAS PD, 1971, SCIENCE, V171, P303, DOI 10.1126/science.171.3968.303; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Gobes SMH, 2009, J COMP NEUROL, V516, P312, DOI 10.1002/cne.22113; Guillette LM, 2010, J ACOUST SOC AM, V127, P1116, DOI 10.1121/1.3277247; Iyengar S, 2002, J NEUROSCI, V22, P946, DOI 10.1523/JNEUROSCI.22-03-00946.2002; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2010, NEURON, V67, P713, DOI 10.1016/j.neuron.2010.08.038; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuhl PK, 2006, DEVELOPMENTAL SCI, V9, pF13, DOI 10.1111/j.1467-7687.2006.00468.x; Levrero F, 2009, CR BIOL, V332, P579, DOI 10.1016/j.crvi.2009.02.006; Liu WC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005929; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; MARLER P, 1981, TRENDS NEUROSCI, V4, P88, DOI 10.1016/0166-2236(81)90029-1; Mello CV, 1998, J COMP NEUROL, V395, P137; Miller-Sims VC, 2012, J NEUROPHYSIOL, V107, P1142, DOI 10.1152/jn.00614.2011; Nottebohm F, 1970, ONTOGENY BIRD SONG S, V167, P950; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pienkowski M, 2011, NEUROSCI BIOBEHAV R, V35, P2117, DOI 10.1016/j.neubiorev.2011.02.002; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Riede T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011368; Rivera-Gaxiola M, 2005, DEVELOPMENTAL SCI, V8, P162, DOI 10.1111/j.1467-7687.2005.00403.x; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; RUBEL EW, 1975, J EXP PSYCHOL ANIM B, V1, P287; Saffran J. R., 2006, HDB CHILD PSYCHOL, P58, DOI DOI 10.1002/9780470147658.CHPSY0202; Sanes DH, 2011, NEURON, V72, P912, DOI 10.1016/j.neuron.2011.12.005; Sarro EC, 2010, DEV NEUROBIOL, V70, P636, DOI 10.1002/dneu.20801; Schneider D, 2012, COSYNE 9 ANN M, P85; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Solis MM, 1997, J NEUROSCI, V17, P6447; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Tsao FM, 2004, CHILD DEV, V75, P1067, DOI 10.1111/j.1467-8624.2004.00726.x; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; Vicario DS, 2002, J COMP PHYSIOL A, V188, P897, DOI 10.1007/s00359-002-0354-2; Vicario DS, 2001, ANIM BEHAV, V61, P805, DOI 10.1006/anbe.2000.1651; Vicario DS, 2001, J NEUROBIOL, V47, P109, DOI 10.1002/neu.1020; Vignal C, 2008, BEHAV PROCESS, V77, P191, DOI 10.1016/j.beproc.2007.09.003; Vignal C, 2011, J COMP PSYCHOL, V125, P150, DOI 10.1037/a0020865; Watkins K, 2004, J COGNITIVE NEUROSCI, V16, P978, DOI 10.1162/0898929041502616; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Woolley SMN, 2012, DEV PSYCHOBIOL, V54, P612, DOI 10.1002/dev.21014; ZANN R, 1990, ANIM BEHAV, V40, P811, DOI 10.1016/S0003-3472(05)80982-0; ZANN R, 1984, Z TIERPSYCHOL, V66, P328; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zhang Y, 2005, NEUROIMAGE, V26, P703, DOI 10.1016/j.neuroimage.2005.02.040; Zhang Y, 2009, NEUROIMAGE, V46, P226, DOI 10.1016/j.neuroimage.2009.01.028	69	3	4	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52365	10.1371/journal.pone.0052365	http://dx.doi.org/10.1371/journal.pone.0052365			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285011	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500154
J	Qu, ZP; Adelson, DL				Qu, Zhipeng; Adelson, David L.			Identification and Comparative Analysis of ncRNAs in Human, Mouse and Zebrafish Indicate a Conserved Role in Regulation of Genes Expressed in Brain	PLOS ONE			English	Article							LONG NONCODING RNAS; INTERGENIC TRANSCRIPTION; DARK-MATTER; GENOME; REVEALS; PLURIPOTENCY; ARCHITECTURE; COMPLEXITY; SEQUENCES; REPRESS	ncRNAs (non-coding RNAs), in particular long ncRNAs, represent a significant proportion of the vertebrate transcriptome and probably regulate many biological processes. We used publically available ESTs (Expressed Sequence Tags) from human, mouse and zebrafish and a previously published analysis pipeline to annotate and analyze the vertebrate non-protein-coding transcriptome. Comparative analysis confirmed some previously described features of intergenic ncRNAs, such as a positionally biased distribution with respect to regulatory or development related protein-coding genes, and weak but clear sequence conservation across species. Significantly, comparative analysis of developmental and regulatory genes proximate to long ncRNAs indicated that the only conserved relationship of these genes to neighbor long ncRNAs was with respect to genes expressed in human brain, suggesting a conserved, ncRNA cis-regulatory network in vertebrate nervous system development. Most of the relationships between long ncRNAs and proximate coding genes were not conserved, providing evidence for the rapid evolution of species-specific gene associated long ncRNAs. We have reconstructed and annotated over 130,000 long ncRNAs in these three species, providing a significantly expanded number of candidates for functional testing by the research community.	[Qu, Zhipeng; Adelson, David L.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Adelson, DL (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	david.adelson@adelaide.edu.au	Adelson, David L/E-5506-2011	Adelson, David L/0000-0003-2404-5636; Qu, Zhipeng/0000-0002-6841-0773	University of Adelaide; China Scholarship Council	University of Adelaide; China Scholarship Council(China Scholarship Council)	Funding from the University of Adelaide and a PhD scholarship to ZQ from the China Scholarship Council supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dinger Marcel E., 2009, Briefings in Functional Genomics & Proteomics, V8, P407, DOI 10.1093/bfgp/elp038; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Frith MC, 2005, EUR J HUM GENET, V13, P894, DOI 10.1038/sj.ejhg.5201459; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kurokawa R, 2011, ADV EXP MED BIOL, V722, P196, DOI 10.1007/978-1-4614-0332-6_12; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Qu ZP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042638; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P991, DOI 10.1016/j.bbrc.2007.04.034; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Shabalina SA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-105; Song XY, 2012, METHODS MOL BIOL, V809, P609, DOI 10.1007/978-1-61779-376-9_39; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707	57	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52275	10.1371/journal.pone.0052275	http://dx.doi.org/10.1371/journal.pone.0052275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284966	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500133
J	Soler, MA; Faisca, PFN				Soler, Miguel A.; Faisca, Patricia F. N.			How Difficult Is It to Fold a Knotted Protein? In Silico Insights from Surface-Tethered Folding Experiments	PLOS ONE			English	Article							SINGLE-DOMAIN PROTEINS; NONNATIVE INTERACTIONS; TRANSITION-STATE; MODEL PROTEINS; CONTACT ORDER; KINETICS; THERMODYNAMICS; SIMULATIONS; PERSPECTIVE; LANDSCAPE	We explore the effect of surface tethering on the folding process of a lattice protein that contains a trefoil knot in its native structure via Monte Carlo simulations. We show that the outcome of the tethering experiment depends critically on which terminus is used to link the protein to a chemically inert plane. In particular, if surface tethering occurs at the bead that is closer to the knotted core the folding rate becomes exceedingly slow and the protein is not able to find the native structure in all the attempted folding trajectories. Such low folding efficiency is also apparent from the analysis of the probability of knot formation, p(knot), as a function of nativeness. Indeed, p(knot) increases abruptly from similar to 0 to similar to 1 only when the protein has more than 80% of its native contacts formed, showing that a highly compact conformation must undergo substantial structural re-arrangement in order to get effectively knotted. When the protein is surface tethered by the bead that is placed more far away from the knotted core pknot is higher than in the other folding setups (including folding in the bulk), especially if conformations are highly native-like. These results show that the mobility of the terminus closest to the knotted core is critical for successful folding of trefoil proteins, which, in turn, highlights the importance of a knotting mechanism that is based on a threading movement of this terminus through a knotting loop. The results reported here predict that if this movement is blocked, knotting occurs via an alternative mechanism, the so-called spindle mechanism, which is prone to misfolding. Our simulations show that in the three considered folding setups the formation of the knot is typically a late event in the folding process. We discuss the implications of our findings for co-translational folding of knotted trefoils.	[Soler, Miguel A.; Faisca, Patricia F. N.] Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal; [Soler, Miguel A.; Faisca, Patricia F. N.] Univ Lisbon, Dept Fis, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Soler, MA (corresponding author), Univ Lisbon, Ctr Fis Mat Condensada, P-1699 Lisbon, Portugal.	migsoler@cii.fc.ul.pt; patricia.fn.faisca@gmail.com	SOLER, MIGUEL/J-2389-2013; Faisca, Patricia/E-9758-2010	SOLER, MIGUEL/0000-0002-5780-9949; Faisca, Patricia/0000-0002-2493-2748	Fundacao para a Ciencia e a Tecnologia [PTDC/QUIQUI/112358/2009]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia(PTDC/QUIQUI/112358/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Andersson FI, 2009, FEBS J, V276, P2625, DOI 10.1111/j.1742-4658.2009.06990.x; Bhattacherjee A, 2012, BIOPHYS J, V102, P569, DOI 10.1016/j.bpj.2011.12.008; Bolinger D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000731; CAMACHO CJ, 1993, P NATL ACAD SCI USA, V90, P6369, DOI 10.1073/pnas.90.13.6369; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Chodera JD, 2007, J CHEM THEORY COMPUT, V3, P26, DOI 10.1021/ct0502864; DILL KA, 1995, PROTEIN SCI, V4, P561; Faisca PFN, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973624; Faisca PFN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035599; Faisca PFN, 2010, PROTEIN SCI, V19, P2196, DOI 10.1002/pro.498; Faisca PFN, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016009; Faisca PFN, 2005, BIOPHYS CHEM, V115, P169, DOI 10.1016/j.bpc.2004.12.022; Faisca PFN, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051917; Faisca PFN, 2005, PROTEINS, V60, P712, DOI 10.1002/prot.20521; Faisca PFN, 2002, J CHEM PHYS, V116, P7231, DOI 10.1063/1.1466833; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Finkelstein A. V., 2002, PROTEIN PHYS; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Kaya H, 2003, PROTEINS, V52, P524, DOI 10.1002/prot.10478; King NP, 2010, P NATL ACAD SCI USA, V107, P20732, DOI 10.1073/pnas.1007602107; King NP, 2007, J MOL BIOL, V373, P153, DOI 10.1016/j.jmb.2007.07.042; Klimov DK, 1998, J MOL BIOL, V282, P471, DOI 10.1006/jmbi.1998.1997; Lai YL, 2012, NUCLEIC ACIDS RES, V40, pW228, DOI 10.1093/nar/gks592; Li L, 2000, NAT STRUCT BIOL, V7, P336; Li MS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.218101; Mallam AL, 2008, MOL CELL, V30, P642, DOI 10.1016/j.molcel.2008.03.019; Mallam AL, 2007, J MOL BIOL, V366, P650, DOI 10.1016/j.jmb.2006.11.014; Mallam AL, 2006, J MOL BIOL, V359, P1420, DOI 10.1016/j.jmb.2006.04.032; Mallam AL, 2012, NAT CHEM BIOL, V8, P147, DOI 10.1038/nchembio.742; Mallam AL, 2010, P NATL ACAD SCI USA, V107, P8189, DOI 10.1073/pnas.0912161107; Mallam AL, 2008, P NATL ACAD SCI USA, V105, P18740, DOI 10.1073/pnas.0806697105; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Noel JK, 2010, P NATL ACAD SCI USA, V107, P15403, DOI 10.1073/pnas.1009522107; O'Brien EP, 2012, J AM CHEM SOC, V134, P10920, DOI 10.1021/ja302305u; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; O'Brien EP, 2010, J AM CHEM SOC, V132, P16928, DOI 10.1021/ja106530y; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; QUAKE SR, 1995, PHYS REV E, V52, P1176, DOI 10.1103/PhysRevE.52.1176; Sayre TC, 2011, PROTEIN ENG DES SEL, V24, P627, DOI 10.1093/protein/gzr024; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Skrbic T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002504; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, P17783, DOI 10.1073/pnas.1201804109; Sulkowska JI, 2012, P NATL ACAD SCI USA, V109, pE1715, DOI 10.1073/pnas.1205918109; Sulkowska JI, 2010, J AM CHEM SOC, V132, P13954, DOI 10.1021/ja102441z; Sulkowska JI, 2009, P NATL ACAD SCI USA, V106, P3119, DOI 10.1073/pnas.0811147106; Sulkowska JI, 2008, P NATL ACAD SCI USA, V105, P19714, DOI 10.1073/pnas.0805468105; TAKETOMI H, 1975, INT J PEPT PROT RES, V7, P445; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122; Wallin S, 2007, J MOL BIOL, V368, P884, DOI 10.1016/j.jmb.2007.02.035; Wang PY, 2008, PROTEINS, V70, P925, DOI 10.1002/prot.21547; Yeates T, 2007, CURR OPIN CHEM BIOL, V11, P595, DOI 10.1016/j.cbpa.2007.10.002	54	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52343	10.1371/journal.pone.0052343	http://dx.doi.org/10.1371/journal.pone.0052343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284997	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500148
J	Svingen, T; Francois, M; Wilhelm, D; Koopman, P				Svingen, Terje; Francois, Mathias; Wilhelm, Dagmar; Koopman, Peter			Three-Dimensional Imaging of Prox1-EGFP Transgenic Mouse Gonads Reveals Divergent Modes of Lymphangiogenesis in the Testis and Ovary	PLOS ONE			English	Article							LYMPHATIC VASCULATURE; INTERSTITIAL-TISSUE; CORPUS-LUTEUM; EXPRESSION; MICE; SYSTEM; RAT; CAPILLARIES; MAINTENANCE; VESSELS	The lymphatic vasculature forms a specialized part of the circulatory system, being essential for maintaining tissue fluid homeostasis and for transport of hormones, macromolecules, and immune cells. Although lymphatic vessels are assumed to play an important role in most tissues, their morphogenesis and function in the gonads remains poorly understood. Here we have exploited a lymphatic-specific Prox1-EGFP reporter mouse model and optical projection tomography technology to characterize both the temporal and spatial development of the lymphatic vessel network in mouse testes and ovaries. We find that lymphangiogenesis in the testis is initiated during late gestation, but in contrast to other organs, lymphatic vessels remain confined to the testis cap and, unlike blood vessels, do not infiltrate the entire organ. Conversely, lymphatic vessels invade the ovarian tissue, beginning postnatally, and sprouting from preexisting lymphatic vessels at the extraovarian rete. The ovary develops a rich network of lymphatic vessels, extending from the medulla into the surrounding cortex adjacent to developing follicles. This study reveals distinct patterns of lymphangiogenesis in the testes and ovaries and will serve as the basis for the identification of the divergent molecular pathways that control morphogenesis and the function of the lymphatic vasculature in these two organs. Citation: Svingen T, Francois M, Wilhelm D, Koopman P (2012) Three-Dimensional Imaging of Prox1-EGFP Transgenic Mouse Gonads Reveals Divergent Modes of Lymphangiogenesis in the Testis and Ovary. PLoS ONE 7(12): e52620. doi:10.1371/journal.pone.0052620	[Svingen, Terje; Francois, Mathias; Wilhelm, Dagmar; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia	University of Queensland	Koopman, P (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol Genet & Dev, Brisbane, Qld, Australia.	p.koopman@imb.uq.edu.au	francois, mathias/A-9604-2014; Koopman, Peter A/C-9416-2009; Wilhelm, Dagmar/B-6915-2009; Svingen, Terje/A-5283-2010	francois, mathias/0000-0002-9846-6882; Koopman, Peter A/0000-0001-6939-0914; Wilhelm, Dagmar/0000-0002-7757-4075; Svingen, Terje/0000-0003-4650-7651	Australian Research Council (ARC) [FF0776096]	Australian Research Council (ARC)(Australian Research Council)	This work was supported by a research grant from the Australian Research Council (ARC grant FF0776096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Bott RC, 2008, REPROD DOMEST ANIM, V43, P310, DOI 10.1111/j.1439-0531.2008.01179.x; Bott RC, 2010, CELL TISSUE RES, V342, P117, DOI 10.1007/s00441-010-1038-9; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Brown HM, 2010, ENDOCRINOLOGY, V151, P5446, DOI 10.1210/en.2010-0629; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; CLARK RV, 1976, ANAT RECORD, V184, P203, DOI 10.1002/ar.1091840207; Cool J, 2011, P NATL ACAD SCI USA, V108, P167, DOI 10.1073/pnas.1010299108; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; Davis J.R., 1970, TESTICULAR CAPSULE T, P281; FAWCETT DW, 1973, BIOL REPROD, V9, P500, DOI 10.1093/biolreprod/9.5.500; FAWCETT DW, 1969, J REPROD FERTIL, V19, P109, DOI 10.1530/jrf.0.0190109; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Francois M, 2012, DEV BIOL, V364, P89, DOI 10.1016/j.ydbio.2011.12.032; Gordon EJ, 2008, DEV DYNAM, V237, P1901, DOI 10.1002/dvdy.21605; Hamasaki M, 1994, Kaibogaku Zasshi, V69, P669; Hirai S, 2012, J ANDROL, V33, P745, DOI 10.2164/jandrol.111.015156; Hirai S, 2010, MED MOL MORPHOL, V43, P37, DOI 10.1007/s00795-009-0473-8; ICHIKAWA S, 1987, LYMPHOLOGY, V20, P73; Itoh M, 1998, J ANDROL, V19, P466; JAPON MA, 1994, J HISTOCHEM CYTOCHEM, V42, P1117, DOI 10.1177/42.8.8027530; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; KAZEEM A, 1986, LYMPHOLOGY, V19, P172; KAZEEM AA, 1991, LYMPHOLOGY, V24, P140; LORENCE MC, 1991, MOL CELL ENDOCRINOL, V80, P21, DOI 10.1016/0303-7207(91)90139-J; MCCULLOUGH DL, 1975, INVEST UROL, V13, P211; O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Olszewski Waldemar L, 2003, Lymphat Res Biol, V1, P11, DOI 10.1089/15396850360495655; OTSUKI Y, 1987, LYMPHOLOGY, V20, P64; Polanco JC, 2010, HUM MOL GENET, V19, P506, DOI 10.1093/hmg/ddp520; ROBAIRE B, 1989, ANN NY ACAD SCI, V564, P250, DOI 10.1111/j.1749-6632.1989.tb25902.x; Sapoznik S, 2009, CANCER RES, V69, P9306, DOI 10.1158/0008-5472.CAN-09-1213; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Setchell BP, 1970, TESTIS, V1, P165; Shayan R, 2006, CARCINOGENESIS, V27, P1729, DOI 10.1093/carcin/bgl031; Sleeman J, 2009, SEMIN CANCER BIOL, V19, P285, DOI 10.1016/j.semcancer.2009.05.005; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2010, GENE DEV, V24, P696, DOI 10.1101/gad.1859310; Stefanczyk-Krzymowska S, 2002, EXP PHYSIOL, V87, P361, DOI 10.1113/eph8702338; Stefanczyk-Krzymowska Stanislawa, 2002, Reprod Biol, V2, P115; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wrobel T, 2005, LYMPHOLOGY, V38, P107; Xu Fuhua, 2009, Lymphatic Research and Biology, V7, P159, DOI 10.1089/lrb.2009.0009; Yuan L, 2002, DEVELOPMENT, V129, P4797	47	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52620	10.1371/journal.pone.0052620	http://dx.doi.org/10.1371/journal.pone.0052620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285114	Green Published, gold			2022-12-25	WOS:000312794500211
J	Tegge, AN; Caldwell, CW; Xu, D				Tegge, Allison N.; Caldwell, Charles W.; Xu, Dong			Pathway Correlation Profile of Gene-Gene Co-Expression for Identifying Pathway Perturbation	PLOS ONE			English	Article							SET ENRICHMENT; DIFFERENTIAL COEXPRESSION; ESCHERICHIA-COLI; EXPRESSION; DIAGNOSIS; RELAPSE; BIOTIN	Identifying perturbed or dysregulated pathways is critical to understanding the biological processes that change within an experiment. Previous methods identified important pathways that are significantly enriched among differentially expressed genes; however, these methods cannot account for small, coordinated changes in gene expression that amass across a whole pathway. In order to overcome this limitation, we use microarray gene expression data to identify pathway perturbation based on pathway correlation profiles. By identifying the distribution of gene-gene pair correlations within a pathway, we can rank the pathways based on the level of perturbation and dysregulation. We have shown this successfully for differences between two experimental conditions in Escherichia coli and changes within time series data in Saccharomyces cerevisiae, as well as two estrogen receptor response classes of breast cancer. Overall, our method made significant predictions as to the pathway perturbations that are involved in the experimental conditions.	[Tegge, Allison N.; Xu, Dong] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Caldwell, Charles W.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Xu, Dong] Univ Missouri, CS Bond Life Sci Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Xu, D (corresponding author), Univ Missouri, Inst Informat, Columbia, MO 65211 USA.	xudong@missouri.edu			National Library of Medicine Biomedical and Health Informatics Research Training Program [T15-LM07089]; NATIONAL LIBRARY OF MEDICINE [T15LM007089] Funding Source: NIH RePORTER	National Library of Medicine Biomedical and Health Informatics Research Training Program; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Library of Medicine Biomedical and Health Informatics Research Training Program T15-LM07089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Adewale AJ, 2008, J COMPUT BIOL, V15, P269, DOI 10.1089/cmb.2008.0002; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Cho SB, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-109; CRONAN JE, 1988, J BIOL CHEM, V263, P10332; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Freudenberg JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-234; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keller A, 2009, BIOINFORMATICS, V25, P2787, DOI 10.1093/bioinformatics/btp510; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lai YL, 2004, BIOINFORMATICS, V20, P3146, DOI 10.1093/bioinformatics/bth379; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Novak BA, 2006, BIOINFORMATICS, V22, P233, DOI 10.1093/bioinformatics/bti764; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Singh J, 2005, APPL ENVIRON MICROB, V71, P8752, DOI 10.1128/AEM.71.12.8752-8763.2005; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Staal FJT, 2003, LEUKEMIA, V17, P1324, DOI 10.1038/sj.leu.2402974; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P4542, DOI 10.1128/AEM.69.8.4542-4548.2003; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang JJ, 2008, BLOOD, V112, P4178, DOI 10.1182/blood-2008-06-165027	33	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52127	10.1371/journal.pone.0052127	http://dx.doi.org/10.1371/journal.pone.0052127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284898	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500097
J	Zhu, H; Yang, W; He, LJ; Ding, WJ; Zheng, L; Liao, SD; Huang, P; Lu, W; He, QJ; Yang, B				Zhu, Hong; Yang, Wei; He, Ling-juan; Ding, Wan-jing; Zheng, Lin; Liao, Si-da; Huang, Ping; Lu, Wei; He, Qiao-jun; Yang, Bo			Upregulating Noxa by ER Stress, Celastrol Exerts Synergistic Anti-Cancer Activity in Combination with ABT-737 in Human Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; IN-VITRO; MELANOMA-CELLS; INHIBITOR; MCL-1; PROTEASOME; APOPTOSIS; BCL-2; VIVO; DEGRADATION	The human hepatocellular carcinoma (HCC) represents biologically aggressive and chemo-resistant cancers. Owing to the low affinity with the apoptotic factor Mcl-1, the BH3 mimetic drug ABT-737 failed to exert potent cancer-killing activities in variety of cancer models including HCC. The current study demonstrated that combining ABT-737 and Celastrol synergistically suppressed HCC cell proliferation, and induced apoptosis which was accompanied with the activation of caspase cascade and release of cytochrome c from mitochondria. Further study revealed that the enhanced Noxa caused by Celastrol was the key factor for the synergy, since small interfering RNA-mediated knockdown of Noxa expression in HCC cells resulted in decreased apoptosis and attenuated anti-proliferative effects of the combination. In addition, our study unraveled that, upon Celastrol exposure, the activation of endoplasmic reticulum (ER) stress, specifically, the eIF2 alpha-ATF4 pathway played indispensable roles in the activation of Noxa, which was validated by the observation that depletion of ATF4 significantly abrogated the Noxa elevation by Celastrol. Our findings highlight a novel signaling pathway through which Celastrol increase Noxa expression, and suggest the potential use of ATF4-mediated regulation of Noxa as a promising strategy to improve the anti-cancer activities of ABT-737.	[Zhu, Hong; Yang, Wei; He, Ling-juan; Ding, Wan-jing; Zheng, Lin; Liao, Si-da; He, Qiao-jun; Yang, Bo] Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Ping] Zhejiang Acad Tradit Chinese Med, Tongde Hosp Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Lu, Wei] E China Normal Univ, Dept Chem, Inst Med Chem, Shanghai 200062, Peoples R China	Zhejiang University; East China Normal University	He, QJ (corresponding author), Zhejiang Univ, Inst Pharmacol & Toxicol, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qiaojunhe@zju.edu.cn; yang924@zju.edu.cn	Lu, Wei/P-6066-2014; Liao, Sida/AAI-8514-2021	Lu, Wei/0000-0003-3041-9200; Zhu, Hong/0000-0002-2575-4031; Liao, Sida/0000-0002-6233-0203	Fundamental Research Funds for the Central Universities [2011FZA7008]; Zhejiang Provincial Natural Science Foundation of China [Y2110933]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The authors gratefully acknowledge financial support from the Fundamental Research Funds for the Central Universities (No. 2011FZA7008) and Zhejiang Provincial Natural Science Foundation of China (No. Y2110933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Armstrong JL, 2010, J BIOL CHEM, V285, P6091, DOI 10.1074/jbc.M109.014092; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fleischer B, 2006, INT J ONCOL, V28, P25; Hann CL, 2008, CANCER RES, V68, P2321, DOI 10.1158/0008-5472.CAN-07-5031; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Ishitsuka K, 2012, CANCER LETT, V317, P218, DOI 10.1016/j.canlet.2011.11.030; Jayanthan A, 2011, PEDIATR BLOOD CANCER, V56, P353, DOI 10.1002/pbc.22760; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Lucas KM, 2012, CLIN CANCER RES, V18, P783, DOI 10.1158/1078-0432.CCR-11-1166; Meynet O, 2012, LEUKEMIA, V26, P1145, DOI 10.1038/leu.2011.327; Mologni L, 2009, INT J CANCER, V124, P1990, DOI 10.1002/ijc.24158; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; Okumura K, 2008, CLIN CANCER RES, V14, P8132, DOI 10.1158/1078-0432.CCR-08-1665; Patterson J, 2008, CANCER CHEMOTH PHARM, V61, P923, DOI 10.1007/s00280-007-0546-0; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Raats DAE, 2011, CELL ONCOL, V34, P307, DOI 10.1007/s13402-011-0026-8; Rosen A, 1997, J CELL BIOCHEM, V64, P50, DOI 10.1002/(SICI)1097-4644(199701)64:1<50::AID-JCB8>3.0.CO;2-Z; Shinoura N, 1999, ONCOGENE, V18, P5703, DOI 10.1038/sj.onc.1202966; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Taiyab A, 2009, BIOCHEM PHARMACOL, V78, P142, DOI 10.1016/j.bcp.2009.04.001; Tromp JM, 2012, CLIN CANCER RES, V18, P487, DOI 10.1158/1078-0432.CCR-11-1440; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang C, 2011, MOL CANCER THER, V10, P1264, DOI 10.1158/1535-7163.MCT-10-1091; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013910; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zheng L, 2011, CANCER LETT, V309, P27, DOI 10.1016/j.canlet.2011.05.011; Zhu H, 2010, CANCER INVEST, V28, P23, DOI 10.3109/07357900903095664	38	36	39	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52333	10.1371/journal.pone.0052333	http://dx.doi.org/10.1371/journal.pone.0052333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284992	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500146
J	Zhu, XJ; Yang, ZF; Chen, YY; Wang, JL; Rosmarin, AG				Zhu, Xue-Jun; Yang, Zhong-Fa; Chen, Yaoyu; Wang, Junling; Rosmarin, Alan G.			PU.1 Is Essential for CD11c Expression in CD8(+)/CD8(-) Lymphoid and Monocyte-Derived Dendritic Cells during GM-CSF or FLT3L-Induced Differentiation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR E2-2; REGULATORY FACTOR-4; CUTTING EDGE; MOUSE; GENERATION; ANTIGEN; LIGAND	Dendritic cells (DCs) regulate innate and acquired immunity through their roles as antigen-presenting cells. Specific subsets of mature DCs, including monocyte-derived and lymphoid-derived DCs, can be distinguished based on distinct immunophenotypes and functional properties. The leukocyte integrin, CD11c, is considered a specific marker for DCs and it is expressed by all DC subsets. We created a strain of mice in which DCs and their progenitors could be lineage traced based on activity of the CD11c proximal promoter. Surprisingly, we observed levels of CD11c promoter activity that were similar in DCs and in other mature leukocytes, including monocytes, granulocytes, and lymphocytes. We sought to identify DNA elements and transcription factors that regulate DC-associated expression of CD11c. The ets transcription factor, PU.1, is a key regulator of DC development, and expression of PU.1 varies in different DC subsets. GM-CSF increased monocyte-derived DCs in mice and from mouse bone marrow cultured in vitro, but it did not increase CD8(+) lymphoid-derived DCs or B220(+) plasmacytoid DCs. FLT3L increased both monocyte-derived DCs and lymphoid-derived DCs from mouse bone marrow cultured in vitro. GM-CSF increased the 5.3 Kb CD11c proximal promoter activity in monocyte-derived DCs and CD8(+) lymphoid-derived DCs, but not in B220(+) plasmacytoid DCs. In contrast, FLT3L increased the CD11c proximal promoter activity in both monocyte-derived DCs and B220(+) plasmacytoid DCs. We used shRNA gene knockdown and chromatin immunoprecipitation to demonstrate that PU.1 is required for the effects of GM-CSF or FLT3L on monocyte-derived DCs. We conclude that both GM-CSF and FLT3L act through PU.1 to activate the 5.3 Kb CD11c proximal promoter in DCs and to induce differentiation of monocyte-derived DCs. We also confirm that the CD11c proximal promoter is not sufficient to direct lineage specificity of CD11c expression, and that additional DNA elements are required for lineage-specific CD11c expression.	[Zhu, Xue-Jun] Jiangsu Prov Tradit Chinese Med Hosp, Cell & Mol Biol Lab, Div Hematol, Dept Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Xue-Jun; Yang, Zhong-Fa; Chen, Yaoyu; Wang, Junling; Rosmarin, Alan G.] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Zhu, XJ (corresponding author), Jiangsu Prov Tradit Chinese Med Hosp, Cell & Mol Biol Lab, Div Hematol, Dept Med, Nanjing, Jiangsu, Peoples R China.	Zhuxj2@hotmail.com; Alan.Rosmarin@umassmed.edu			Top Six Elite Scholar Program of Jiangsu Province China [2010-WS-012]; University of Massachusetts Medical School; Jiangsu Province Triditional Chinese Medicine Hospital scholar exchange fund	Top Six Elite Scholar Program of Jiangsu Province China; University of Massachusetts Medical School; Jiangsu Province Triditional Chinese Medicine Hospital scholar exchange fund	The Top Six Elite Scholar Program of Jiangsu Province China #2010-WS-012. University of Massachusetts Medical School startup funding; and Jiangsu Province Triditional Chinese Medicine Hospital scholar exchange fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2012, NAT REV IMMUNOL, V12, P101, DOI 10.1038/nri3149; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Suzuki S, 2004, P NATL ACAD SCI USA, V101, P8981, DOI 10.1073/pnas.0402139101; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tsujimura H, 2003, J IMMUNOL, V170, P1131, DOI 10.4049/jimmunol.170.3.1131; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107	23	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52141	10.1371/journal.pone.0052141	http://dx.doi.org/10.1371/journal.pone.0052141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284905	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500100
J	Jacobson, LS; Lima, H; Goldberg, MF; Gocheva, V; Tsiperson, V; Sutterwala, FS; Joyce, JA; Gapp, BV; Blomen, VA; Chandran, K; Brummelkamp, TR; Diaz-Griffero, F; Brojatsch, J				Jacobson, Lee S.; Lima, Heriberto, Jr.; Goldberg, Michael F.; Gocheva, Vasilena; Tsiperson, Vladislav; Sutterwala, Fayyaz S.; Joyce, Johanna A.; Gapp, Bianca V.; Blomen, Vincent A.; Chandran, Kartik; Brummelkamp, Thijn R.; Diaz-Griffero, Felipe; Brojatsch, Juergen			Cathepsin-mediated Necrosis Controls the Adaptive Immune Response by Th2 (T helper type 2)-associated Adjuvants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; ALUMINUM-HYDROXIDE; NALP3 INFLAMMASOME; VACCINE ADJUVANTS; SILICA CRYSTALS; TUMOR-CELLS; APOPTOSIS; NLRP3; ACTIVATION; SYSTEM	Immunologic adjuvants are critical components of vaccines, but it remains unclear how prototypical adjuvants enhance the adaptive immune response. Recent studies have shown that necrotic cells could trigger an immune response. Although most adjuvants have been shown to be cytotoxic, this activity has traditionally been considered a side effect. We set out to test the role of adjuvant-mediated cell death in immunity and found that alum, the most commonly used adjuvant worldwide, triggers a novel form of cell death in myeloid leukocytes characterized by cathepsin-dependent lysosome-disruption. We demonstrated that direct lysosome-permeabilization with a soluble peptide, Leu-Leu-OMe, mimics the alum-like form of necrotic cell death in terms of cathepsin dependence and cell-type specificity. Using a combination of a haploid genetic screen and cathepsin-deficient cells, we identified specific cathepsins that control lysosome-mediated necrosis. We identified cathepsin C as critical for Leu-Leu-OMe-induced cell death, whereas cathepsins B and S were required for alum-mediated necrosis. Consistent with a role of necrotic cell death in adjuvant effects, Leu-Leu-OMe replicated an alum-like immune response in vivo, characterized by dendritic cell activation, granulocyte recruitment, and production of Th2-associated antibodies. Strikingly, cathepsin C deficiency not only blocked Leu-Leu-OMe-mediated necrosis but also impaired Leu-Leu-OMe-enhanced immunity. Together our findings suggest that necrotic cell death is a powerful mediator of a Th2-associated immune response.	[Jacobson, Lee S.; Lima, Heriberto, Jr.; Goldberg, Michael F.; Tsiperson, Vladislav; Diaz-Griffero, Felipe; Brojatsch, Juergen] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Gocheva, Vasilena; Joyce, Johanna A.] Mem Sloan Kettering, Dept Canc Biol & Genet, New York, NY 10065 USA; [Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Iowa City, IA 52241 USA; [Gapp, Bianca V.; Blomen, Vincent A.; Brummelkamp, Thijn R.] Netherlands Canc Inst, Dept Biochem, NL-1066 CX Amsterdam, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; University of Iowa; Netherlands Cancer Institute	Brojatsch, J (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	jurgen.brojatsch@einstein.yu	blomen, vincent/AAE-1477-2020; Sutterwala, Fayyaz/AAH-5859-2021; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; brojatsch, jurgen/0000-0002-7424-365X	National Institutes of Health [1R56AI092497-01A1, 5R01CA125162-05, 5R01AI087630-02, 5R01AI088027-02]; Martin Turkish Foundation, Inc.; M-O'Connor-Foundation; NATIONAL CANCER INSTITUTE [R01CA125162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI092497, R01AI087390, R01AI088027, R01AI087630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martin Turkish Foundation, Inc.; M-O'Connor-Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R56AI092497-01A1 (to J. B.), 5R01CA125162-05 (to J. A. J.), 5R01AI087630-02 (to F. S. S.), and 5R01AI088027-02 (to K. C.). This work was also supported by the Martin Turkish Foundation, Inc. and the M-O'Connor-Foundation.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DRISCOLL KE, 1990, AM J RESP CELL MOL, V2, P381, DOI 10.1165/ajrcmb/2.4.381; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Fujisawa A, 2007, BLOOD, V109, P2903, DOI 10.1182/blood-2006-07-033597; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Gupta R C, 1993, IARC Sci Publ, P11; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hara H, 2007, INFECT IMMUN, V75, P3791, DOI 10.1128/IAI.01779-06; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; KELSO JM, 1993, J ALLERGY CLIN IMMUN, V91, P867, DOI 10.1016/0091-6749(93)90344-F; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Mckee AS, 2007, IMMUNITY, V27, P687, DOI 10.1016/j.immuni.2007.11.003; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Moore A, 1999, VACCINE, V17, P2517, DOI 10.1016/S0264-410X(99)00062-6; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Noe SM, 2010, VACCINE, V28, P3588, DOI 10.1016/j.vaccine.2010.02.085; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Petrovsky N, 2008, EXPERT REV VACCINES, V7, P7, DOI 10.1586/14760584.7.1.7; Przetak M, 2003, VACCINE, V21, P961, DOI 10.1016/S0264-410X(02)00737-5; Riese RJ, 1998, J CLIN INVEST, V101, P2351, DOI 10.1172/JCI1158; Roth W, 2000, FASEB J, V14, P2075, DOI 10.1096/fj.99-0970com; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Spreafico R, 2010, EUR J IMMUNOL, V40, P638, DOI 10.1002/eji.200940039; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THIELE DL, 1990, J EXP MED, V172, P183, DOI 10.1084/jem.172.1.183; THIELE DL, 1992, J IMMUNOL, V148, P3950; Ulanova M, 2001, INFECT IMMUN, V69, P1151, DOI 10.1128/IAI.69.2.1151-1159.2001; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Zhang HL, 2009, J IMMUNOL, V182, P6993, DOI 10.4049/jimmunol.0802502	54	58	61	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	2013	288	11					7481	7491		10.1074/jbc.M112.400655	http://dx.doi.org/10.1074/jbc.M112.400655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	110OW	23297415	hybrid, Green Published			2022-12-25	WOS:000316455300005
J	Chen, Q; Cao, H; Zhang, GC; Chen, LW; Chen, DZ; Li, QZ; Qiu, ZH				Chen, Qiang; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Chen, Dao-Zhong; Li, Qian-Zhen; Qiu, Zhi-Huang			Atrioventricular Block Subsequent to Intraoperative Device Closure Atrial Septal Defect with Transthoracic Minimal Invasion; A Rare and Serious Complication	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; TRANSCATHETER CLOSURE; AMPLATZER DEVICE; CHILDREN; OCCLUDER; SAFETY; ADULTS; EXPERIENCE; EFFICACY	Objectives: Atrioventricular block (AVB) is a infrequent and serious complication after percutaneous ASD closure. In this study, we report on the incidence of AVB associated with intraoperative device closure of the ASD with transthoracic minimal invasion, and the outcomes of this complication in our center. Methods: Between May 2006 and January 2011, a total of 213 secundum-type ASD patients were accepted in our hospital for intraoperative and transthoracic device closure with a domestic occluder. All patients were assessed by real-time transthoracic echocardiography (TTE) and electrocardiograph (ECG). Results: All patients were occluded successfully under this approach. Immediate postprocedure third-degree AVB was observed in two patients. Since heart rates were in the range of about 50 to 55 beats per minute, no intervention was needed except for close observation for one patient. Another patient who recovered sinus rhythm intermittently during the operation was fitted with a temporary pacemaker. Approximately one week following glucocorticoid treatment, the AVB resolved spontaneously in these two patients. Mobitz type II AVB occurred in three patients during the procedure. Two patients developed post-operative cardiac arrest and were rescued successfully with cardiopulmonary resuscitation. One other patient changed to Mobitz type I AVB after three days. During the follow-up period, which ranged from six months to five years, no further occurrence of AVB was found. Conclusions: Intraoperative and transthoracic device closure of secundum ASDs with domestic occluder resulted in excellent closure rate. AVB is an infrequent but serious complication during and after device closure of a secundum ASD. AVB is a complication that warrants greater attention and long-term follow-up.	[Chen, Qiang; Cao, Hua; Zhang, Gui-Can; Chen, Liang-Wan; Chen, Dao-Zhong; Li, Qian-Zhen; Qiu, Zhi-Huang] Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China	Fujian Medical University	Chen, Q (corresponding author), Fujian Med Univ, Union Hosp, Dept Cardiovasc Surg, Fuzhou, Peoples R China.	chenqiang2228@hotmail.com		Qiu, ZhiHuang/0000-0002-5917-8968				Al-Anani SJ, 2010, CATHETER CARDIO INTE, V75, P767, DOI 10.1002/ccd.22359; Bialkowski J, 2004, TEX HEART I J, V31, P220; Chen Q, 2012, EUR J CARDIO-THORAC, V41, P121, DOI 10.1016/j.ejcts.2011.04.001; Chen QA, 2011, J THORAC CARDIOV SUR, V141, P631, DOI 10.1016/j.jtcvs.2010.07.077; DICKINSON DF, 1981, BRIT HEART J, V46, P55; Formigari R, 2001, J AM COLL CARDIOL, V37, P1707, DOI 10.1016/S0735-1097(01)01213-X; Hannoush H, 2004, CLIN CARDIOL, V27, P236, DOI 10.1002/clc.4960270413; Hughes ML, 2002, HEART, V88, P67, DOI 10.1136/heart.88.1.67; Johnson JN, 2011, CATHETER CARDIO INTE, V78, P254, DOI 10.1002/ccd.23028; Li GS, 2009, ULTRASOUND MED BIOL, V35, P58, DOI 10.1016/j.ultrasmedbio.2008.06.008; Lin SM, 2007, J FORMOS MED ASSOC, V106, P1052, DOI 10.1016/S0929-6646(08)60083-2; Luermans JGLM, 2010, EUROINTERVENTION, V6, P604, DOI 10.4244/EIJV6I5A101; Majunke N, 2009, AM J CARDIOL, V103, P550, DOI 10.1016/j.amjcard.2008.10.018; Nehgme RA, 2009, PEDIATR CARDIOL, V30, P367, DOI 10.1007/s00246-008-9322-0; Pedra, 2000, Curr Interv Cardiol Rep, V2, P274; Rossi RI, 2008, CATHETER CARDIO INTE, V71, P231, DOI 10.1002/ccd.21361; Ryan WH, 2003, ANN THORAC SURG, V75, P1532, DOI 10.1016/S0003-4975(02)04720-3; Spence MS, 2005, HEART, V91, P1512, DOI 10.1136/hrt.2004.057562; Spies C, 2007, CLIN RES CARDIOL, V96, P340, DOI 10.1007/s00392-007-0502-3; Suda K, 2004, J AM COLL CARDIOL, V43, P1677, DOI 10.1016/j.jacc.2003.12.042; Zhang H, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-123	21	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52726	10.1371/journal.pone.0052726	http://dx.doi.org/10.1371/journal.pone.0052726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285170	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500053
J	Grauffel, C; Abboud, A; Liszczak, G; Marmorstein, R; Arnesen, T; Reuter, N				Grauffel, Cedric; Abboud, Angele; Liszczak, Glen; Marmorstein, Ronen; Arnesen, Thomas; Reuter, Nathalie			Specificity and Versatility of Substrate Binding Sites in Four Catalytic Domains of Human N-Terminal Acetyltransferases	PLOS ONE			English	Article							FREE-ENERGY DECOMPOSITION; MOLECULAR-MECHANICS; ACETYLATION; DYNAMICS; PROTEINS; COMPLEX; ELECTROSTATICS; SIMULATIONS	Nt-acetylation is among the most common protein modifications in eukaryotes. Although thought for a long time to protect proteins from degradation, the role of Nt-acetylation is still debated. It is catalyzed by enzymes called N-terminal acetyltransferases (NATs). In eukaryotes, several NATs, composed of at least one catalytic domain, target different substrates based on their N-terminal sequences. In order to better understand the substrate specificity of human NATs, we investigated in silico the enzyme-substrate interactions in four catalytic subunits of human NATs (Naa10p, Naa20p, Naa30p and Naa50p). To date hNaa50p is the only human subunit for which X-ray structures are available. We used the structure of the ternary hNaa50p/AcCoA/MLG complex and a structural model of hNaa10p as a starting point for multiple molecular dynamics simulations of hNaa50p/AcCoA/substrate (substrate = MLG, EEE, MKG), hNaa10p/AcCoA/substrate (substrate = MLG, EEE). Nine alanine point-mutants of the hNaa50p/AcCoA/MLG complex were also simulated. Homology models of hNaa20p and hNaa30p were built and compared to hNaa50p and hNaa10p. The simulations of hNaa50p/AcCoA/MLG reproduce the interactions revealed by the X-ray data. We observed strong hydrogen bonds between MLG and tyrosines 31, 138 and 139. Yet the tyrosines interacting with the substrate's backbone suggest that their role in specificity is limited. This is confirmed by the simulations of hNaa50p/AcCoA/EEE and hNaa10p/AcCoA/MLG, where these hydrogen bonds are still observed. Moreover these tyrosines are all conserved in hNaa20p and hNaa30p. Other amino acids tune the specificity of the S1' sites that is different for hNaa10p (acidic), hNaa20p (hydrophobic/basic), hNaa30p (basic) and hNaa50p (hydrophobic). We also observe dynamic correlation between the ligand binding site and helix alpha(2) that tightens under substrate binding. Finally, by comparing the four structures we propose maps of the peptide-enzyme interactions that should help rationalizing substrate-specificity and lay the ground for inhibitor design.	[Grauffel, Cedric; Arnesen, Thomas; Reuter, Nathalie] Univ Bergen, Dept Mol Biol, Bergen, Norway; [Grauffel, Cedric; Abboud, Angele; Reuter, Nathalie] Uni Res AS, Computat Biol Unit, Uni Comp, Bergen, Norway; [Liszczak, Glen; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA USA; [Liszczak, Glen; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Arnesen, Thomas] Univ Bergen, Dept Surg Sci, Bergen, Norway	University of Bergen; University of Bergen; The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Bergen	Reuter, N (corresponding author), Univ Bergen, Dept Mol Biol, Bergen, Norway.	Nathalie.Reuter@mbi.uib.no	Arnesen, Thomas/Q-8117-2019; Reuter, Nathalie/G-2037-2012; Arnesen, Thomas/J-7139-2017	Arnesen, Thomas/0000-0002-3005-147X; Reuter, Nathalie/0000-0002-3649-7675; Arnesen, Thomas/0000-0002-3005-147X	Bergen Research Foundation; Research Council of Norway [197136]; Norwegian Cancer Society [PR-2009-0222]; NIH [GM060293, GM071339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM071339] Funding Source: NIH RePORTER	Bergen Research Foundation; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Bergen Research Foundation (N.R., C.G. and T.A.), the Research Council of Norway (Project 197136 to T.A.), and the Norwegian Cancer Society (Project PR-2009-0222 to T.A.). URLs : http://www.bfstiftelse.no, http://www.forskningsradet.no, http://www.kreftforeningen.no/. Part of this work was supported by NIH (http://www.nih.gov) grant GM060293 awarded to R.M. and NIH training grant GM071339 awarded to G.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Evjenth R, 2009, J BIOL CHEM, V284, P31122, DOI 10.1074/jbc.M109.001347; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Hole K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024713; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; JORNVALL H, 1975, J THEOR BIOL, V55, P1, DOI 10.1016/S0022-5193(75)80105-6; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Liszczak G, 2011, J BIOL CHEM; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda Bogdan, 2009, BMC Proc, V3 Suppl 6, pS2, DOI 10.1186/1753-6561-3-S6-S2; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Scott DC, 2011, SCIENCE, V334, P674, DOI 10.1126/science.1209307; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Siehl DL, 2007, J BIOL CHEM, V282, P11446, DOI 10.1074/jbc.M610267200; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Zoete V, 2003, J COMPUT AID MOL DES, V17, P861, DOI 10.1023/B:JCAM.0000021882.99270.4c; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	34	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52642	10.1371/journal.pone.0052642	http://dx.doi.org/10.1371/journal.pone.0052642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285125	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500042
J	Zhou, YH; Cahan, SH				Zhou, Yihong; Cahan, Sara Helms			A Novel Family of Terminal-Repeat Retrotransposon in Miniature (TRIM) in the Genome of the Red Harvester Ant, Pogonomyrmex barbatus	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; DNA; EVOLUTION; GENE; DIVERSIFICATION; SPECIFICITY; SEQUENCE; ABUNDANT; CASTE	We report the first described non-plant family of TRIMs (terminal-repeat retrotransposons in miniature), which are small nonautonomous LTR retrotransposons, from the whole-genome sequence of the red harvester ant, Pogonomyrmex barbatus (Hymenoptera: Myrmicinae). Members of this retrotransposon family, named PbTRIM, have typical features of plant TRIMs in length and structure, although they share no overall sequence similarity. PbTRIM elements and their solo-LTRs are abundant in the host genome and exhibit an uneven distribution pattern. Elements are preferentially inserted into TA-rich regions with ATAT as the most common pattern of target site duplication (TSD). PbTRIM is most likely mobile as indicated by the young age of many complete elements, the high degree of sequence similarity among elements at different genomic locations, the abundance of elements in the host genome, and the presence of 4-bp target site duplications (TSDs) flanking the elements and solo-LTRs. Many PbTRIM elements and their solo-LTRs are located within or near genes, suggesting their potential roles in restructuring the host genes and genome. Database search, PCR and sequencing analysis revealed the presence of homologous PbTRIM elements in other ant species. The high sequence similarity between elements from distantly related ant species, the incongruence between the phylogenies of PbTRIM and its hosts, and the patchy distribution of the retroelement within the Myrmicinae subfamily indicate possible horizontal transfer events of the retroelement.	[Zhou, Yihong; Cahan, Sara Helms] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont	Cahan, SH (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	scahan@uvm.edu			National Science Foundation grant [DEB-0919052]	National Science Foundation grant(National Science Foundation (NSF))	This research was funded by National Science Foundation grant DEB-0919052 to Sara Helms Cahan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER J, 1992, P NATL ACAD SCI USA, V89, P7996, DOI 10.1073/pnas.89.17.7996; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Cahan SH, 2006, ECOLOGY, V87, P2160, DOI 10.1890/0012-9658(2006)87[2160:RIBPRA]2.0.CO;2; Cahan SH, 2002, P ROY SOC B-BIOL SCI, V269, P1871, DOI 10.1098/rspb.2002.2061; CHALKER DL, 1992, GENE DEV, V6, P117, DOI 10.1101/gad.6.1.117; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Gadau J, 2012, TRENDS GENET, V28, P14, DOI 10.1016/j.tig.2011.08.005; Gao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032010; Julian GE, 2002, P NATL ACAD SCI USA, V99, P8157, DOI 10.1073/pnas.112222099; Kalendar R, 2004, GENETICS, V166, P1437, DOI 10.1534/genetics.166.3.1437; Kalendar R, 2008, P NATL ACAD SCI USA, V105, P5833, DOI 10.1073/pnas.0709698105; Kalendar R, 2010, THEOR APPL GENET, V121, P1419, DOI 10.1007/s00122-010-1398-2; KAMINKER JS, 2002, GENOME BIOL, V0003; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kwon SJ, 2007, MOL GENET GENOMICS, V278, P361, DOI 10.1007/s00438-007-0249-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Grice SFJ, 2003, BIOCHEMISTRY-US, V42, P14349, DOI 10.1021/bi030201q; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Li W. H, 1997, MOL EVOLUTION; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Linheiro RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030008; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Majumdar A, 2011, J VIROL, V85, P519, DOI 10.1128/JVI.01719-10; McCollum AM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-5; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Munoz-Torres MC, 2011, NUCLEIC ACIDS RES, V39, pD658, DOI 10.1093/nar/gkq1145; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Nefedova LN, 2011, VIRUS GENES, V42, P297, DOI 10.1007/s11262-010-0566-4; Neumann P, 2003, PLANT MOL BIOL, V53, P399, DOI 10.1023/B:PLAN.0000006945.77043.ce; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Taber S. W., 1998, WORLD HARVESTER ANTS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMIN HM, 1981, CELL, V27, P1, DOI 10.1016/0092-8674(81)90353-6; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Wessler SR, 2006, P NATL ACAD SCI USA, V103, P17600, DOI 10.1073/pnas.0607612103; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; WILLIAMSON VM, 1983, INT REV CYTOL, V83, P1, DOI 10.1016/S0074-7696(08)61684-8; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang TJ, 2007, THEOR APPL GENET, V114, P627, DOI 10.1007/s00122-006-0463-3; Zhu YX, 2003, P NATL ACAD SCI USA, V100, P5891, DOI 10.1073/pnas.1036705100	49	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53401	10.1371/journal.pone.0053401	http://dx.doi.org/10.1371/journal.pone.0053401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285291	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500146
J	Le Gall, SM; Legrand, J; Benbijja, M; Safya, H; Benihoud, K; Kanellopoulos, JM; Bobe, P				Le Gall, Sylvain M.; Legrand, Julie; Benbijja, Mohcine; Safya, Hanaa; Benihoud, Karim; Kanellopoulos, Jean M.; Bobe, Pierre			Loss of P2X7 Receptor Plasma Membrane Expression and Function in Pathogenic B220(+) Double-Negative T Lymphocytes of Autoimmune MRL/lpr Mice	PLOS ONE			English	Article							MRL HEMATOPOIETIC CHIMERAS; P2X(7) RECEPTOR; CELL-ACTIVATION; L-SELECTIN; IMMUNE SUPPRESSION; CUTTING EDGE; ATP RELEASE; IN-VIVO; FAS; APOPTOSIS	Lupus is a chronic inflammatory autoimmune disease influenced by multiple genetic loci including Fas Ligand (FasL) and P2X7 receptor (P2X7R). The Fas/Fas Ligand apoptotic pathway is critical for immune homeostasis and peripheral tolerance. Normal effector T lymphocytes up-regulate the transmembrane tyrosine phosphatase B220 before undergoing apoptosis. Fas-deficient MRL/lpr mice (lpr mutation) exhibit lupus and lymphoproliferative syndromes due to the massive accumulation of B220(+) CD4(-)CD8(-) (DN) T lymphocytes. The precise ontogeny of B220(+) DN T cells is unknown. B220(+) DN T lymphocytes could be derived from effector CD4(+) and CD8(+) T lymphocytes, which have not undergone activation-induced cell death due to inactivation of Fas, or from a special cell lineage. P2X7R is an extracellular ATP-gated cell membrane receptor involved in the release of proinflammatory cytokines and TNFR1/Fas-independent cell death. P2X7R also regulate early signaling events involved in T-cell activation. We show herein that MRL/lpr mice carry a P2X7R allele, which confers a high sensitivity to ATP. However, during aging, the MRL/lpr T-cell population exhibits a drastically reduced sensitivity to ATP- or NAD-mediated stimulation of P2X7R, which parallels the increase in B220(+) DN T-cell numbers in lymphoid organs. Importantly, we found that this B220(+) DN T-cell subpopulation has a defect in P2X7R-mediated responses. The few B220(+) T cells observed in normal MRL+/+ and C57BL/6 mice are also resistant to ATP or NAD treatment. Unexpectedly, while P2X7R mRNA and proteins are present inside of B220(+) T cells, P2X7R are undetectable on the plasma membrane of these T cells. Our results prompt the conclusion that cell surface expression of B220 strongly correlates with the negative regulation of the P2X7R pathway in T cells.	[Le Gall, Sylvain M.; Benbijja, Mohcine; Safya, Hanaa; Bobe, Pierre] Univ Paris Diderot, CNRS, Inst Jacques Monod, Paris, France; [Legrand, Julie; Benbijja, Mohcine; Bobe, Pierre] Univ Paris 11, CNRS, Inst Andre Lwoff, Villejuif, France; [Benihoud, Karim] Univ Paris 11, CNRS, Inst Gustave Roussy, UMR 8203, Villejuif, France; [Kanellopoulos, Jean M.] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol & Cellulaire, UMR 8619, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bobe, P (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Paris, France.	pierre.bobe@u-psud.fr	, BENIHOUD/O-4334-2019	Bobe, Pierre/0000-0002-8835-6786	Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-07-BLAN-0089-02]	Centre Nationale de la Recherche Scientifique; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by the Centre Nationale de la Recherche Scientifique and grants from Agence Nationale de la Recherche (ANR-07-BLAN-0089-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Benihoud K, 2002, ONCOGENE, V21, P5593, DOI 10.1038/sj.onc.1205730; Benihoud K, 1997, EUR J IMMUNOL, V27, P415, DOI 10.1002/eji.1830270211; Bidere N, 2006, ANNU REV IMMUNOL, V24, P321, DOI 10.1146/annurev.immunol.24.021605.090513; Bleesing JJH, 2001, CELL IMMUNOL, V213, P72, DOI 10.1006/cimm.2001.1865; Bobe P, 1997, J IMMUNOL, V159, P4197; Bobe P, 2006, BLOOD, V108, P3967, DOI 10.1182/blood-2006-04-020610; Bonardelle D, 2005, J LEUKOCYTE BIOL, V78, P1052, DOI 10.1189/jlb.0904536; Bonardelle D, 2001, J RHEUMATOL, V28, P956; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brooks WP, 2001, CELL IMMUNOL, V212, P24, DOI 10.1006/cimm.2001.1845; Colomar A, 2003, J BIOL CHEM, V278, P30732, DOI 10.1074/jbc.M304534200; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Elliott JI, 2005, ARTHRITIS RES THER, V7, pR468, DOI 10.1186/ar1699; Elliott JI, 2005, NAT CELL BIOL, V7, P808, DOI 10.1038/ncb1279; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; GIESE T, 1992, J IMMUNOL, V149, P3097; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Gu B, 1998, BLOOD, V92, P946; Hamad ARA, 2003, J IMMUNOL, V171, P2421, DOI 10.4049/jimmunol.171.5.2421; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Holmes N, 2006, IMMUNOLOGY, V117, P145, DOI 10.1111/j.1365-2567.2005.02265.x; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; IZUI S, 1984, J IMMUNOL, V133, P227; Jiang H, 2006, NEW ENGL J MED, V354, P1166, DOI 10.1056/NEJMra055446; Khakh BS, 2001, PHARMACOL REV, V53, P107; Kinjyo I, 2010, J IMMUNOL, V185, P7151, DOI 10.4049/jimmunol.1003193; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Loomis WH, 2003, J BIOL CHEM, V278, P4590, DOI 10.1074/jbc.M207868200; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mohamood AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003465; Morel L, 2010, NAT REV RHEUMATOL, V6, P348, DOI 10.1038/nrrheum.2010.63; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Portales-Cervantes L, 2010, HUM IMMUNOL, V71, P818, DOI 10.1016/j.humimm.2010.05.008; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Taylor SRJ, 2007, J IMMUNOL, V178, P3474, DOI 10.4049/jimmunol.178.6.3474; Thomson CW, 2006, IMMUNOL RES, V35, P163, DOI 10.1385/IR:35:1:163; Tsukimoto M, 2006, J IMMUNOL, V177, P2842, DOI 10.4049/jimmunol.177.5.2842; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Virginio C, 1999, J PHYSIOL-LONDON, V519, P335, DOI 10.1111/j.1469-7793.1999.0335m.x; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458	53	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52161	10.1371/journal.pone.0052161	http://dx.doi.org/10.1371/journal.pone.0052161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284917	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800033
J	Norgan, AP; Lee, JRE; Oestreich, AJ; Payne, JA; Krueger, EW; Katzmann, DJ				Norgan, Andrew P.; Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Krueger, Eugene W.; Katzmann, David J.			ESCRT-Independent Budding of HIV-1 Gag Virus-Like Particles from Saccharomyces cerevisiae Spheroplasts	PLOS ONE			English	Article							ROUS-SARCOMA-VIRUS; UBIQUITIN LIGASE; LEUKEMIA-VIRUS; L-DOMAINS; PROTEIN; REPLICATION; EXPRESSION; YEAST; MOTIF; POLYPROTEIN	Heterologous expression of HIV-1 Gag in a variety of host cells results in its packaging into virus-like particles (VLPs) that are subsequently released into the extracellular milieu. This phenomenon represents a useful tool for probing cellular factors required for viral budding and has contributed to the discovery of roles for ubiquitin ligases and the endosomal sorting complexes required for transport (ESCRTs) in viral budding. These factors are highly conserved throughout eukaryotes and have been studied extensively in the yeast Saccharomyces cerevisiae, a model eukaryote previously utilized as a host for the production of VLPs. We used heterologous expression of HIV Gag in yeast spheroplasts to examine the role of ESCRTs and associated factors (Rsp5, a HECT ubiquitin ligase of the Nedd4 family; Bro1, a homolog of Alix; and Vps4, the AAA-ATPase required for ESCRT function in all contexts/organisms investigated) in the generation of VLPs. Our data reveal: 1) characterized Gag-ESCRT interaction motifs (late domains) are not required for VLP budding, 2) loss of function alleles of the essential HECT ubiquitin ligase Rsp5 do not display defects in VLP formation, and 3) ESCRT function is not required for VLP formation from spheroplasts. These results suggest that the egress of HIV Gag from yeast cells is distinct from the most commonly described mode of exit from mammalian cells, instead mimicking ESCRT-independent VLP formation observed in a subset of mammalian cells. As such, budding of Gag from yeast cells appears to represent ESCRT-independent budding relevant to viral replication in at least some situations. Thus the myriad of genetic and biochemical tools available in the yeast system may be of utility in the study of this aspect of viral budding.	[Norgan, Andrew P.; Lee, Jacqueline R. E.; Oestreich, Andrea J.; Payne, Johanna A.; Katzmann, David J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Krueger, Eugene W.] Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Katzmann, DJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Katzmann.David@mayo.edu		Eve, Jacqueline/0000-0002-3159-5620	American Heart Association Predoctoral Fellowship [09PRE2220147]; NIH [1F30DA26762]; University of Minnesota-Rochester Bioinformatics and Computational Biology Seed Grant; National Institute of General Medical Sciences [5R01GM073024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026762] Funding Source: NIH RePORTER	American Heart Association Predoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota-Rochester Bioinformatics and Computational Biology Seed Grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by an American Heart Association Predoctoral Fellowship 09PRE2220147 (APN), NIH Predoctoral Fellowship 1F30DA26762 (APN), University of Minnesota-Rochester Bioinformatics and Computational Biology Seed Grant (DJK), and National Institute of General Medical Sciences grant 5R01GM073024 (DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Barajas D, 2010, VIROLOGY, V397, P358, DOI 10.1016/j.virol.2009.11.010; Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09; BATHURST IC, 1989, J VIROL, V63, P3176, DOI 10.1128/JVI.63.7.3176-3179.1989; Bello NF, 2012, J VIROL, V86, P4182, DOI 10.1128/JVI.07105-11; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; BONNET D, 1990, J VIROL, V64, P5628, DOI 10.1128/JVI.64.11.5628-5632.1990; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Dussupt V, 2011, J VIROL, V85, P2304, DOI 10.1128/JVI.01562-10; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gottwein E, 2003, J VIROL, V77, P9474, DOI 10.1128/JVI.77.17.9474-9485.2003; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; JACOBS E, 1989, GENE, V79, P71, DOI 10.1016/0378-1119(89)90093-0; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; JANDA M, 1993, CELL, V72, P961, DOI 10.1016/0092-8674(93)90584-D; KARACOSTAS V, 1989, P NATL ACAD SCI USA, V86, P8964, DOI 10.1073/pnas.86.22.8964; Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Le Blanc I, 2002, J VIROL, V76, P10024, DOI 10.1128/JVI.76.19.10024-10029.2002; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; MAKAROW M, 1985, EMBO J, V4, P1855, DOI 10.1002/j.1460-2075.1985.tb03860.x; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Odorizzi G, 2003, J CELL SCI, V116, P1893, DOI 10.1242/jcs.00395; Oestreich AJ, 2007, MOL BIOL CELL, V18, P707, DOI 10.1091/mbc.E06-08-0680; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Popova E, 2010, J VIROL, V84, P6590, DOI 10.1128/JVI.00035-10; Price BD, 1996, P NATL ACAD SCI USA, V93, P9465, DOI 10.1073/pnas.93.18.9465; Puffer BA, 1997, J VIROL, V71, P6541, DOI 10.1128/JVI.71.9.6541-6546.1997; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; ROYER M, 1991, VIROLOGY, V184, P417, DOI 10.1016/0042-6822(91)90861-5; Sabo Y, 2008, J VIROL, V82, P9770, DOI 10.1128/JVI.00741-08; Sakuragi S, 2002, P NATL ACAD SCI USA, V99, P7956, DOI 10.1073/pnas.082281199; Sakuragi S, 2006, MICROBES INFECT, V8, P1875, DOI 10.1016/j.micinf.2006.02.027; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; SHIODA T, 1990, VIROLOGY, V175, P139, DOI 10.1016/0042-6822(90)90194-V; SMITH AJ, 1990, J VIROL, V64, P2743, DOI 10.1128/JVI.64.6.2743-2750.1990; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strecker T, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-93; Taylor GM, 2007, J VIROL, V81, P13631, DOI 10.1128/JVI.01688-07; Tsunetsugu-Yokota Y, 2003, J VIROL, V77, P10250, DOI 10.1128/JVI.77.19.10250-10259.2003; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Wang HT, 2002, J VIROL, V76, P8485, DOI 10.1128/JVI.76.16.8485-8493.2002; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; Weissenhorn W, 2011, CELL HOST MICROBE, V9, P172, DOI 10.1016/j.chom.2011.03.005; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998	77	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52603	10.1371/journal.pone.0052603	http://dx.doi.org/10.1371/journal.pone.0052603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285107	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800080
J	Xiao, S; Nayak, B; Samuel, A; Paldurai, A; Kanabagattebasavarajappa, M; Prajitno, TY; Bharoto, EE; Collins, PL; Samal, SK				Xiao, Sa; Nayak, Baibaswata; Samuel, Arthur; Paldurai, Anandan; Kanabagattebasavarajappa, Mallikarjuna; Prajitno, Teguh Y.; Bharoto, Eny E.; Collins, Peter L.; Samal, Siba K.			Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain	PLOS ONE			English	Article							PROTEIN CLEAVAGE SITE; SHEDDING FOLLOWING VACCINATION; FUSION PROTEIN; CHICKENS; IMMUNIZATION; DIVERSITY; CANDIDATE; SEQUENCES; WATERFOWL; OUTBREAKS	Newcastle disease virus (NDV) can cause severe disease in chickens. Although NDV vaccines exist, there are frequent reports of outbreaks in vaccinated chickens. During 2009-2010, despite intense vaccination, NDV caused major outbreaks among commercial poultry farms in Indonesia. These outbreaks raised concern regarding the protective immunity of current vaccines against circulating virulent strains in Indonesia. In this study, we investigated whether a recombinant attenuated Indonesian NDV strain could provide better protection against prevalent Indonesian viruses. A reverse genetics system for the highly virulent NDV strain Banjarmasin/010/10 (Ban/010) isolated in Indonesia in 2010 was constructed. The Ban/010 virus is classified in genotype VII of class II NDV, which is genetically distinct from the commercial vaccine strains B1 and LaSota, which belong to genotype II, and shares only 89 and 87% amino acid identity for the protective antigens F and HN, respectively. A mutant virus, named Ban/AF, was developed in which the virulent F protein cleavage site motif "RRQKR down arrow F" was modified to an avirulent motif "(G) under bar RQ (G) under barR down arrow(L) under bar" by three amino acid substitutions (underlined). The Ban/AF vaccine virus did not produce syncytia or plaques in cell culture, even in the presence of added protease. Pathogenicity tests showed that Ban/AF was completely avirulent. Ban/AF replicated efficiently during 10 consecutive passages in chickens and remained genetically stable. Serological analysis showed that Ban/AF induced higher neutralization and hemagglutination inhibition antibody titers against the prevalent viruses than the commercial vaccines B1 or LaSota. Both Ban/AF and commercial vaccines provided protection against clinical disease and mortality after challenge with virulent NDV strain Ban/010 (genotype VII) or GB Texas (genotype II). However, Ban/AF significantly reduced challenge virus shedding from the vaccinated birds compared to B1 vaccine. These results suggest that Ban/AF can provide better protection than commercial vaccines and is a promising vaccine candidate against NDV strains circulating in Indonesia.	[Xiao, Sa; Nayak, Baibaswata; Samuel, Arthur; Paldurai, Anandan; Kanabagattebasavarajappa, Mallikarjuna; Samal, Siba K.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Prajitno, Teguh Y.] Japfa Comfeed Indonesia, Jakarta, Indonesia; [Bharoto, Eny E.] Vaksindo Satwa Nusantara, Jakarta, Indonesia; [Collins, Peter L.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Samal, SK (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	ssamal@umd.edu	Nayak, Baibaswata/L-6156-2016		National Institute of Allergy and Infectious Diseases (NIAID) [N01A060009]; NIAID, National Institutes of Health (NIH) Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000938] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, National Institutes of Health (NIH) Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institute of Allergy and Infectious Diseases (NIAID) contract no. N01A060009 (85% support) and NIAID, National Institutes of Health (NIH) Intramural Research Program (15% support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2003, PARAMYXOVIRIDAE; Alexander D.J., 1997, DIS POULTRY, P541; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; de Leeuw OS, 2003, J GEN VIROL, V84, P475, DOI 10.1099/vir.0.18714-0; Gould AR, 2001, VIRUS RES, V77, P51, DOI 10.1016/S0168-1702(01)00265-9; Hu SL, 2009, VACCINE, V27, P904, DOI 10.1016/j.vaccine.2008.11.091; Hu ZL, 2011, AVIAN DIS, V55, P391, DOI 10.1637/9633-122410-Reg.1; Huang ZH, 2003, J VIROL, V77, P8676, DOI 10.1128/JVI.77.16.8676-8685.2003; Jeon WJ, 2008, J VET SCI, V9, P295, DOI 10.4142/jvs.2008.9.3.295; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Khattar SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016776; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; Miller PJ, 2009, AVIAN DIS, V53, P39, DOI 10.1637/8407-071208-Reg.1; MORRISON T, 1993, VIROLOGY, V193, P997, DOI 10.1006/viro.1993.1214; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHLOER GM, 1968, J VIROL, V2, P40, DOI 10.1128/JVI.2.1.40-47.1968; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; WINTERFIELD RW, 1957, POULTRY SCI, V36, P1076, DOI 10.3382/ps.0361076; Xiao S, 2012, J VIROL, V86, P5969, DOI 10.1128/JVI.00546-12; Xiao S, 2012, J VIROL, V86, P3828, DOI 10.1128/JVI.06765-11; Xiao S, 2011, VACCINE, V29, P5294, DOI 10.1016/j.vaccine.2011.05.010	30	60	68	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52751	10.1371/journal.pone.0052751	http://dx.doi.org/10.1371/journal.pone.0052751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285174	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800094
J	Bueno-Orovio, A; Hanson, BM; Gill, JS; Taggart, P; Rodriguez, B				Bueno-Orovio, Alfonso; Hanson, Ben M.; Gill, Jaswinder S.; Taggart, Peter; Rodriguez, Blanca			In Vivo Human Left-to-Right Ventricular Differences in Rate Adaptation Transiently Increase Pro-Arrhythmic Risk following Rate Acceleration	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; ACUTE MYOCARDIAL-INFARCTION; ONE-DIMENSIONAL CABLE; SHORT-TERM; HEART-RATE; RESTITUTION PROPERTIES; VULNERABLE WINDOW; POTASSIUM CURRENT; CONDUCTION BLOCK; CARDIAC-CELLS	Left-to-right ventricular (LV/RV) differences in repolarization have been implicated in lethal arrhythmias in animal models. Our goal is to quantify LV/RV differences in action potential duration (APD) and APD rate adaptation and their contribution to arrhythmogenic substrates in the in vivo human heart using combined in vivo and in silico studies. Electrograms were acquired from 10 LV and 10 RV endocardial sites in 15 patients with normal ventricles. APD and APD adaptation were measured during an increase in heart rate. Analysis of in vivo electrograms revealed longer APD in LV than RV (207.8 +/- 21.5 vs 196.7 +/- 20.1 ms; P<0.05), and slower APD adaptation in LV than RV (time constant tau(s) = 47.0 +/- 14.3 vs 35.6 +/- 6.5 s; P<0.05). Following rate acceleration, LV/RV APD dispersion experienced an increase of up to 91% in 12 patients, showing a strong correlation (r(2) = 0.90) with both initial dispersion and LV/RV difference in slow adaptation. Pro-arrhythmic implications of measured LV/RV functional differences were studied using in silico simulations. Results show that LV/RV APD and APD adaptation heterogeneities promote unidirectional block following rate acceleration, albeit being insufficient for establishment of reentry in normal hearts. However, in the presence of an ischemic region at the LV/RV junction, LV/RV heterogeneity in APD and APD rate adaptation promotes reentrant activity and its degeneration into fibrillatory activity. Our results suggest that LV/RV heterogeneities in APD adaptation cause a transient increase in APD dispersion in the human ventricles following rate acceleration, which promotes unidirectional block and wave-break at the LV/RV junction, and may potentiate the arrhythmogenic substrate, particularly in patients with ischemic heart disease.	[Bueno-Orovio, Alfonso; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Computat Biol Grp, Oxford, England; [Hanson, Ben M.] UCL, Dept Mech Engn, London, England; [Gill, Jaswinder S.] Guys & St Thomas Hosp, London SE1 9RT, England; [Taggart, Peter] Univ Coll London Hosp, Neurocardiol Res Unit, London, England	University of Oxford; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Bueno-Orovio, A (corresponding author), Univ Oxford, Dept Comp Sci, Computat Biol Grp, Oxford, England.	alfonso.bueno@cs.ox.ac.uk	Bueno-Orovio, Alfonso/K-7225-2013	Bueno-Orovio, Alfonso/0000-0002-1634-3601; Hanson, Benjamin/0000-0003-4661-6778; Rodriguez, Blanca/0000-0001-6361-3339	European Commission [DG-INFSO-224381]; United Kingdom Medical Research Council; Medical Research Council (MRC) [G0901819]; MRC [G0700278, G0901819] Funding Source: UKRI; Medical Research Council [G0901819, G0700278] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by European Commission preDiCT Grant DG-INFSO-224381; United Kingdom Medical Research Council Career Development award to BR; and Medical Research Council (MRC) grant G0901819 to BH and PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD L, 1982, CARDIOVASC RES, V16, P547, DOI 10.1093/cvr/16.10.547; Baher A, 2007, AM J PHYSIOL-HEART C, V292, pH180, DOI 10.1152/ajpheart.00944.2005; Bueno-Orovio A, 2008, J THEOR BIOL, V253, P544, DOI 10.1016/j.jtbi.2008.03.029; Bueno-Orovio A, 2006, SIAM J SCI COMPUT, V28, P886, DOI 10.1137/040607575; Clayton RH, 2005, BIOMED ENG ONLINE, V20, P4; Coronel R, 2006, HEART RHYTHM, V3, P1043, DOI 10.1016/j.hrthm.2006.05.027; Coronel R, 2009, HEART RHYTHM, V6, P537, DOI 10.1016/j.hrthm.2009.01.013; DiDiego JM, 1996, AM J PHYSIOL-HEART C, V271, pH548, DOI 10.1152/ajpheart.1996.271.2.H548; EISENBERG SJ, 1995, AM J CARDIOL, V75, P687, DOI 10.1016/S0002-9149(99)80654-7; Fenton FH, 1999, PHYS REV LETT, V83, P3964, DOI 10.1103/PhysRevLett.83.3964; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Ghanem RN, 2001, CIRCULATION, V104, P1306, DOI 10.1161/hc3601.094277; GILL JS, 1993, AM HEART J, V126, P1357, DOI 10.1016/0002-8703(93)90534-G; Haim M, 1997, AM J CARDIOL, V79, P717, DOI 10.1016/S0002-9149(96)00856-9; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Jiang Y, 2009, COMPUT CARDIOL, V36, P293; Komniski MS, 2011, AM J PHYSIOL-HEART C, V300, pH1645, DOI 10.1152/ajpheart.00220.2010; Kop WJ, 2001, J AM COLL CARDIOL, V38, P742, DOI 10.1016/S0735-1097(01)01451-6; KUO CS, 1983, CIRCULATION, V67, P1356, DOI 10.1161/01.CIR.67.6.1356; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lerma C, 2008, MED BIOL ENG COMPUT, V46, P715, DOI 10.1007/s11517-008-0326-y; Lysaker M, 2006, INT J NUMER ANAL MOD, V3, P377; Minchole A, 2011, IEEE T BIO-MED ENG, V58, P1172, DOI 10.1109/TBME.2010.2097597; Mironov S, 2008, CIRCULATION, V118, P17, DOI 10.1161/CIRCULATIONAHA.107.737254; MORGAN JM, 1992, J AM COLL CARDIOL, V19, P1244, DOI 10.1016/0735-1097(92)90331-G; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Pandit SV, 2011, HEART RHYTHM, V8, P1732, DOI 10.1016/j.hrthm.2011.06.028; Pitruzzello AM, 2007, AM J PHYSIOL-HEART C, V292, pH1568, DOI 10.1152/ajpheart.00619.2006; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Pueyo E, 2004, IEEE T BIO-MED ENG, V51, P1511, DOI 10.1109/TBME.2004.828050; Pueyo E, 2010, AM J PHYSIOL-HEART C, V298, pH1577, DOI 10.1152/ajpheart.00936.2009; Qu ZL, 2006, BIOPHYS J, V91, P793, DOI 10.1529/biophysj.106.080945; Qu ZL, 2006, BIOPHYS J, V91, P805, DOI 10.1529/biophysj.106.080952; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; Rodriguez B, 2005, CIRC RES, V97, P168, DOI 10.1161/01.RES.0000174429.00987.17; Romero L, 2009, AM J PHYSIOL-HEART C, V297, pH1436, DOI 10.1152/ajpheart.00263.2009; Samie FH, 2001, CIRC RES, V89, P1216, DOI 10.1161/hh2401.100818; STEINHAUS BM, 1989, CIRC RES, V64, P449, DOI 10.1161/01.RES.64.3.449; Szentadrassy N, 2005, CARDIOVASC RES, V65, P851, DOI 10.1016/j.cardiores.2004.11.022; Taggart P, 2000, J MOL CELL CARDIOL, V32, P621, DOI 10.1006/jmcc.2000.1105; Taggart P, 1999, PROG BIOPHYS MOL BIO, V71, P139, DOI 10.1016/S0079-6107(98)00039-X; Tolkacheva EG, 2006, BIOPHYS J, V91, P2735, DOI 10.1529/biophysj.106.083865; UDELNOV MG, 1961, CIRCULATION, V24, P110, DOI 10.1161/01.CIR.24.1.110; Volders PGA, 1999, CIRCULATION, V99, P206, DOI 10.1161/01.CIR.99.2.206; Warren M, 2003, J CARDIOVASC ELECTR, V14, P621, DOI 10.1046/j.1540-8167.2003.03006.x; Western D, 2010, IEEE ENG MED BIO, P114, DOI 10.1109/IEMBS.2010.5626087; YUAN S, 1995, EUR HEART J, V16, P68, DOI 10.1093/eurheartj/16.1.68; Yuan SW, 2001, PACE, V24, P1479, DOI 10.1046/j.1460-9592.2001.01479.x; Yue AM, 2004, CIRCULATION, V110, P1343, DOI 10.1161/01.CIR.0000141734.43393.BE	49	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52234	10.1371/journal.pone.0052234	http://dx.doi.org/10.1371/journal.pone.0052234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284948	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500121
J	Carneiro, MW; Santos, DM; Fukutani, KF; Clarencio, J; Miranda, JC; Brodskyn, C; Barral, A; Barral-Netto, M; Soto, M; de Oliveira, CI				Carneiro, Marcia W.; Santos, Diego M.; Fukutani, Kiyoshi F.; Clarencio, Jorge; Miranda, Jose Carlos; Brodskyn, Claudia; Barral, Aldina; Barral-Netto, Manoel; Soto, Manuel; de Oliveira, Camila I.			Vaccination with L. infantum chagasi Nucleosomal Histones Confers Protection against New World Cutaneous Leishmaniasis Caused by Leishmania braziliensis	PLOS ONE			English	Article							MURINE VISCERAL LEISHMANIASIS; PRIME-BOOST VACCINATION; SAND FLY SALIVA; IMMUNE-RESPONSE; BALB/C MICE; ANTIGENIC DETERMINANTS; LUTZOMYIA-LONGIPALPIS; DENDRITIC CELLS; CONSERVED PROTEINS; GLAND LYSATE	Background: Nucleosomal histones are intracellular proteins that are highly conserved among Leishmania species. After parasite destruction or spontaneous lysis, exposure to these proteins elicits a strong host immune response. In the present study, we analyzed the protective capability of Leishmania infantum chagasi nucleosomal histones against L. braziliensis infection using different immunization strategies. Methodology/Principal Findings: BALB/c mice were immunized with either a plasmid DNA cocktail (DNA) containing four Leishmania nucleosomal histones or with the DNA cocktail followed by the corresponding recombinant proteins plus CpG (DNA/Protein). Mice were later challenged with L. braziliensis, in the presence of sand fly saliva. Lesion development, parasite load and the cellular immune response were analyzed five weeks after challenge. Immunization with either DNA alone or with DNA/Protein was able to inhibit lesion development. This finding was highlighted by the absence of infected macrophages in tissue sections. Further, parasite load at the infection site and in the draining lymph nodes was also significantly lower in vaccinated animals. This outcome was associated with increased expression of IFN-gamma and down regulation of IL-4 at the infection site. Conclusion: The data presented here demonstrate the potential use of L. infantum chagasi nucleosomal histones as targets for the development of vaccines against infection with L. braziliensis, as shown by the significant inhibition of disease development following a live challenge.	[Carneiro, Marcia W.; Santos, Diego M.; Fukutani, Kiyoshi F.; Clarencio, Jorge; Miranda, Jose Carlos; Brodskyn, Claudia; Barral, Aldina; Barral-Netto, Manoel; de Oliveira, Camila I.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Brodskyn, Claudia; Barral, Aldina; Barral-Netto, Manoel; de Oliveira, Camila I.] Inst Invest Imunol, Salvador, BA, Brazil; [Soto, Manuel] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Consejo Super Invest Cient, Madrid, Spain	Fundacao Oswaldo Cruz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Oliveira, CI (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	camila@bahia.fiocruz.br	Barral-Netto, Manoel/B-3904-2009; Brodskyn, Cláudia/AAO-3288-2021; Barral, Aldina/B-4191-2009; Miranda, Jose/HCI-6099-2022; Fukutani, Kiyoshi/T-1630-2019; Fukutani, Kiyoshi/N-7905-2016; de Oliveira, Camila I/B-4358-2009; Álvarez, Manuel Soto/Q-5234-2018	Barral-Netto, Manoel/0000-0002-5823-7903; Brodskyn, Cláudia/0000-0003-3367-5365; Barral, Aldina/0000-0002-7177-464X; Fukutani, Kiyoshi/0000-0003-2223-0918; de Oliveira, Camila I/0000-0002-7868-5164; Álvarez, Manuel Soto/0000-0001-6825-841X; Weber Carneiro, Marcia/0000-0002-4220-5085; Clarencio, Jorge/0000-0002-4289-5450	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CYTED; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CYTED; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and CYTED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Almerio Noronha for help with histopathology analysis and documentation. MWC, DMS and KFF were supported by CAPES fellowships. MBN, AB, CB and CIO are senior investigators from CNPq.	Abdian N, 2011, EXP PARASITOL, V127, P627, DOI 10.1016/j.exppara.2010.12.007; Agallou M, 2012, VACCINE, V30, P5086, DOI 10.1016/j.vaccine.2012.05.075; Andrade BB, 2007, SCAND J IMMUNOL, V66, P122, DOI 10.1111/j.1365-3083.2007.01964.x; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bittencourt Achiléa, 2003, Braz J Infect Dis, V7, P229, DOI 10.1590/S1413-86702003000300009; Carmelo E, 2006, PARASITE, V13, P231, DOI 10.1051/parasite/2006133231; Carmelo E, 2002, CLIN DIAGN LAB IMMUN, V9, P808, DOI 10.1128/CDLI.9.4.808-811.2002; Carrion J, 2008, VACCINE, V26, P1155, DOI 10.1016/j.vaccine.2007.12.051; Carrion J, 2008, VACCINE, V26, P2537, DOI 10.1016/j.vaccine.2008.03.003; Carrion J, 2007, MICROBES INFECT, V9, P735, DOI 10.1016/j.micinf.2007.02.018; Cerna P, 2002, INSECT BIOCHEM MOLEC, V32, P1691, DOI 10.1016/S0965-1748(02)00109-1; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Chenik M, 2006, VACCINE, V24, P2521, DOI 10.1016/j.vaccine.2005.12.027; Costa DL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000965; de Carvalho LP, 2003, MICROBES INFECT, V5, P7, DOI 10.1016/S1286-4579(02)00051-5; de Moura TR, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000084; de Moura TR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000712; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; de Oliveira CI, 2009, PARASITOL INT, V58, P319, DOI 10.1016/j.parint.2009.07.013; Dondji B, 2005, INFECT IMMUN, V73, P5286, DOI 10.1128/IAI.73.8.5286-5289.2005; Donnelly KB, 1998, J PARASITOL, V84, P97, DOI 10.2307/3284537; Falcao SC, 2012, INT J PARASITOL, V42, P771, DOI 10.1016/j.ijpara.2012.05.006; Galanti N, 1998, PARASITOL TODAY, V14, P64, DOI 10.1016/S0169-4758(97)01162-9; Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105; Gomes R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001610; Gonzalo RM, 2002, VACCINE, V20, P1226, DOI 10.1016/S0264-410X(01)00427-3; Goto Y, 2011, CLIN VACCINE IMMUNOL, V18, P1118, DOI 10.1128/CVI.05024-11; Iborra S, 2004, VACCINE, V22, P3865, DOI 10.1016/j.vaccine.2004.04.015; Klinman DM, 1997, J IMMUNOL, V158, P3635; Klinman DM, 2000, SPRINGER SEMIN IMMUN, V22, P173, DOI 10.1007/s002810050027; Launois P, 2008, EXPERT REV VACCINES, V7, P1277, DOI 10.1586/14760584.7.8.1277; LERNER EA, 1991, J BIOL CHEM, V266, P11234; LIEW FY, 1990, J IMMUNOL, V145, P4306; Lima HC, 1996, INFECT IMMUN, V64, P5442, DOI 10.1128/IAI.64.12.5442-5445.1996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masina S, 2003, J INFECT DIS, V188, P1250, DOI 10.1086/378677; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Meddeb-Garnaoui A, 2010, VACCINE, V28, P1881, DOI 10.1016/j.vaccine.2009.11.075; Costa CHN, 2011, PLOS NEGLECT TROP D, V5, DOI [10.1371/journal.pntd.0000965, 10.1371/journal.pntd.0000943]; Norsworthy NB, 2004, INFECT IMMUN, V72, P1240, DOI 10.1128/IAI.72.3.1240-1247.2004; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484; Probst P, 2001, J IMMUNOL, V166, P498, DOI 10.4049/jimmunol.166.1.498; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; Rohousova I, 2005, PARASITE IMMUNOL, V27, P469, DOI 10.1111/j.1365-3024.2005.00787.x; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; SAMUELSON J, 1991, J EXP MED, V173, P49, DOI 10.1084/jem.173.1.49; Santarem N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/85154; Shi PY, 1997, BIOTECHNIQUES, V23, P1036, DOI 10.2144/97236bm15; Solioz N, 1999, VACCINE, V18, P850, DOI 10.1016/S0264-410X(99)00340-0; Soto M, 1996, CLIN EXP IMMUNOL, V106, P454, DOI 10.1046/j.1365-2249.1996.d01-865.x; Soto M, 1999, CLIN EXP IMMUNOL, V115, P342, DOI 10.1046/j.1365-2249.1999.00796.x; Soto M, 1995, IMMUNOL LETT, V48, P209, DOI 10.1016/0165-2478(95)02473-5; Tapia E, 2003, MICROBES INFECT, V5, P73, DOI 10.1016/S1286-4579(02)00077-1; Tavares NM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001169; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Valenzuela JG, 2001, J EXP MED, V194, P331, DOI 10.1084/jem.194.3.331	60	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52296	10.1371/journal.pone.0052296	http://dx.doi.org/10.1371/journal.pone.0052296			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284976	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500137
J	Di Franco, A; Coppini, G; Pujolar, JM; De Leo, GA; Gatto, M; Lyubartsev, V; Melia, P; Zane, L; Guidetti, P				Di Franco, Antonio; Coppini, Giovanni; Pujolar, Jose Martin; De Leo, Giulio A.; Gatto, Marino; Lyubartsev, Vladyslav; Melia, Paco; Zane, Lorenzo; Guidetti, Paolo			Assessing Dispersal Patterns of Fish Propagules from an Effective Mediterranean Marine Protected Area	PLOS ONE			English	Article							DIPLODUS-SARGUS-SARGUS; ADRIATIC SEA; LARVAL DISPERSAL; POPULATION CONNECTIVITY; REEF; RESERVES; RETENTION; SCALE; REPLENISHMENT; VARIABILITY	Successfully enforced marine protected areas (MPAs) have been widely demonstrated to allow, within their boundaries, the recovery of exploited species and beyond their boundaries, the spillover of juvenile and adult fish. Little evidence is available about the so-called 'recruitment subsidy', the augmented production of propagules (i.e. eggs and larvae) due to the increased abundance of large-sized spawners hosted within effective MPAs. Once emitted, propagules can be locally retained and/or exported elsewhere. Patterns of propagule retention and/or export from MPAs have been little investigated, especially in the Mediterranean. This study investigated the potential for propagule production and retention/export from a Mediterranean MPA (Torre Guaceto, SW Adriatic Sea) using the white sea bream, Diplodus sargus sargus, as a model species. A multidisciplinary approach was used combining 1) spatial distribution patterns of individuals (post-settlers and adults) assessed through visual census within Torre Guaceto MPA and in northern and southern unprotected areas, 2) Lagrangian simulations of dispersal based on an oceanographic model of the region and data on early life-history traits of the species (spawning date, pelagic larval duration) and 3) a preliminary genetic study using microsatellite loci. Results show that the MPA hosts higher densities of larger-sized spawners than outside areas, potentially guaranteeing higher propagule production. Model simulations and field observation suggest that larval retention within and long-distance dispersal across MPA boundaries allow the replenishment of the MPA and of exploited populations up to 100 km down-current (southward) from the MPA. This pattern partially agrees with the high genetic homogeneity found in the entire study area (no differences in genetic composition and diversity indices), suggesting a high gene flow. By contributing to a better understanding of propagule dispersal patterns, these findings provide crucial information for the design of MPAs and MPA networks effective to replenish fish stocks and enhance fisheries in unprotected areas.	[Di Franco, Antonio; Guidetti, Paolo] Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci & Tecnol Biol & Ambientali, Consorzio Nazl Interuniv Sci Mare, Lecce, Italy; [Di Franco, Antonio; Guidetti, Paolo] Univ Nice Sophia Antipolis, Lab ECOMERS, Fac Sci, Nice, France; [Coppini, Giovanni] Ist Nazl Geofis & Vulcanol, Bologna, Italy; [Pujolar, Jose Martin; Zane, Lorenzo] Univ Padua, Dept Biol, Padua, Italy; [De Leo, Giulio A.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy; [De Leo, Giulio A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Gatto, Marino; Melia, Paco] Politecn Milan, Dipartimento Elettron & Informaz, I-20133 Milan, Italy; [Lyubartsev, Vladyslav] Ctr Euromediterraneo & Cambiamenti Climat, Bologna, Italy	University of Salento; UDICE-French Research Universities; Universite Cote d'Azur; Istituto Nazionale Geofisica e Vulcanologia (INGV); University of Padua; University of Parma; Stanford University; Polytechnic University of Milan	Di Franco, A (corresponding author), Univ Salento, Lab Conservat & Management Marine & Coastal Resou, Dipartimento Sci & Tecnol Biol & Ambientali, Consorzio Nazl Interuniv Sci Mare, Lecce, Italy.	difry@libero.it	Zane, Lorenzo/G-6249-2010; Melià, Paco/E-8844-2012; De Leo, Giulio/AAC-5098-2019; Gatto, Marino/D-9531-2012; Di Franco, Antonio/A-8796-2010	Zane, Lorenzo/0000-0002-6963-2132; Melià, Paco/0000-0002-7763-9836; De Leo, Giulio/0000-0002-4186-3369; Guidetti, Paolo/0000-0002-7983-8775; pujolar, marti/0000-0002-5037-8840; Gatto, Marino/0000-0001-8063-9178; Di Franco, Antonio/0000-0003-3411-7015	Italian Ministero dell'Istruzione e dell'Universita [2008E7KBAE]	Italian Ministero dell'Istruzione e dell'Universita	This research was funded by the Italian Ministero dell'Istruzione e dell'Universita (PRIN Project: protocol no. 2008E7KBAE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Almany GR, 2009, CORAL REEFS, V28, P339, DOI 10.1007/s00338-009-0484-x; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; [Anonymous], 2002, FSTAT VERSION 2 9 3; Artegiani A, 1997, J PHYS OCEANOGR, V27, P1515, DOI 10.1175/1520-0485(1997)027<1515:TASGCP>2.0.CO;2; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; BAYLESEMPERE JT, 2002, ECOCEN V1 00 00 APPL; BELKHIR K, 2005, GENETIX 4 05 LOGICIE; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Branch GM, 2003, BIOL CONSERV, V114, P255, DOI 10.1016/S0006-3207(03)00045-4; Bussotti S, 2011, ITAL J ZOOL, V78, P243, DOI 10.1080/11250001003774652; Butler MJ, 2011, MAR ECOL PROG SER, V422, P223, DOI 10.3354/meps08878; Cheminee A, 2011, SCI MAR, V75, P181, DOI 10.3989/scimar.2011.75n1181; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Claudet Joachim, 2011, P37; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crec'hriou R, 2010, FISH OCEANOGR, V19, P135, DOI 10.1111/j.1365-2419.2010.00533.x; Cudney-Bueno R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004140; D'Anna G, 2011, ITAL J ZOOL, V78, P255, DOI 10.1080/11250000903464059; Di Franco A, 2011, ITAL J ZOOL, V78, P182, DOI 10.1080/11250003.2011.566227; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Diaz D, 2011, MAR ECOL PROG SER, V433, P149, DOI 10.3354/meps09182; Dobricic S, 2008, OCEAN MODEL, V22, P89, DOI 10.1016/j.ocemod.2008.01.004; Engie K, 2007, ESTUAR COAST, V30, P201, DOI 10.1007/BF02700164; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans RD, 2008, CORAL REEFS, V27, P179, DOI 10.1007/s00338-007-0309-8; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Fisher R, 2005, MAR BIOL, V147, P1201, DOI 10.1007/s00227-005-0001-x; Franch R, 2006, GENETICS, V174, P851, DOI 10.1534/genetics.106.059014; GAINES S, 1985, OECOLOGIA, V67, P267, DOI 10.1007/BF00384297; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; GOTELLI NJ, 1991, AM NAT, V138, P768, DOI 10.1086/285249; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guarnieri A, 2010, COASTAL GLOBAL OPERA, V28, p[20, 184]; Guarnieri G, 2012, J GEOPHYS R IN PRESS; Guidetti P, 2012, DESIGNING NETWORKS M; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Jones GP, 2005, CURR BIOL, V15, P1314, DOI 10.1016/j.cub.2005.06.061; Kingsford MJ, 2011, CORAL REEFS, V30, P203, DOI 10.1007/s00338-010-0692-4; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P122, DOI 10.1093/icesjms/fsn202; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lloret J, 2008, FISH RES, V91, P252, DOI 10.1016/j.fishres.2007.12.002; Lopez-Sanz A, 2011, ESTUAR COAST SHELF S, V92, P521, DOI 10.1016/j.ecss.2011.02.006; Lopez-Sanz A, 2009, J PLANKTON RES, V31, P763, DOI 10.1093/plankt/fbp024; MacPherson E, 1998, J EXP MAR BIOL ECOL, V220, P127, DOI 10.1016/S0022-0981(97)00086-5; Marinaro JY, 2005, CYBIUM, V29, P198; Massault C, 2011, ANIM GENET, V42, P191, DOI 10.1111/j.1365-2052.2010.02110.x; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Mouine N, 2007, SCI MAR, V71, P461, DOI 10.3989/scimar.2007.71n3461; Oddo P, 2005, SCI TOTAL ENVIRON, V353, P39, DOI 10.1016/j.scitotenv.2005.09.061; Olivar MP, 1997, MAR BIOL, V129, P289, DOI 10.1007/s002270050169; ORLIC M, 1994, CONT SHELF RES, V14, P91, DOI 10.1016/0278-4343(94)90007-8; Palumbi SR, 2003, SCIENCE, V299, P51, DOI 10.1126/science.1080775; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Pelc RA, 2010, P NATL ACAD SCI USA, V107, P18266, DOI 10.1073/pnas.0907368107; Pelc RA, 2009, MAR ECOL PROG SER, V394, P65, DOI 10.3354/meps08326; Pinardi N, 2010, OCEAN SCI, V6, P263, DOI 10.5194/os-6-263-2010; Pinsky ML, 2010, EVOLUTION, V64, P2688, DOI 10.1111/j.1558-5646.2010.01003.x; PISCO, 2011, SCI MAR RES; PISCO Partnership for Interdisciplinary Studies of Coastal Oceans, 2007, SCI MAR RES; Planes S, 2000, ENVIRON CONSERV, V27, P126, DOI 10.1017/S0376892900000175; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; Poulain PM, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL019121; Poulain PM, 2001, J MARINE SYST, V29, P3, DOI 10.1016/S0924-7963(01)00007-0; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Sundelof A, 2012, MAR ECOL-EVOL PERSP, V33, P183, DOI 10.1111/j.1439-0485.2011.00485.x; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Tonani M, 2008, OCEAN SCI, V4, P1, DOI 10.5194/os-4-1-2008; Tortonese E., 1965, RAPPORTS COMMISSION, P189; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Valles H, 2001, J FISH BIOL, V59, P152, DOI 10.1006/jfbi.2001.1763; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigliola L., 1998, THESIS U AIX MARSEIL THESIS U AIX MARSEIL; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Williamson DH, 2009, MAR BIOL, V156, P2517, DOI 10.1007/s00227-009-1276-0; Zavatarelli M, 2003, ANN GEOPHYS-GERMANY, V21, P345, DOI 10.5194/angeo-21-345-2003	104	38	38	0	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52108	10.1371/journal.pone.0052108	http://dx.doi.org/10.1371/journal.pone.0052108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284887	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500092
J	Hof, AR; Jansson, R; Nilsson, C				Hof, Anouschka R.; Jansson, Roland; Nilsson, Christer			Future Climate Change Will Favour Non-Specialist Mammals in the (Sub)Arctics	PLOS ONE			English	Article							BIOTIC INTERACTIONS; SPECIES DISTRIBUTIONS; DIVERSITY; RESPONSES; BIODIVERSITY; BUTTERFLIES; EXTINCTION; PATTERNS; RECOVERY; IMPACTS	Arctic and subarctic (i.e., [sub] arctic) ecosystems are predicted to be particularly susceptible to climate change. The area of tundra is expected to decrease and temperate climates will extend further north, affecting species inhabiting northern environments. Consequently, species at high latitudes should be especially susceptible to climate change, likely experiencing significant range contractions. Contrary to these expectations, our modelling of species distributions suggests that predicted climate change up to 2080 will favour most mammals presently inhabiting (sub) arctic Europe. Assuming full dispersal ability, most species will benefit from climate change, except for a few cold-climate specialists. However, most resident species will contract their ranges if they are not able to track their climatic niches, but no species is predicted to go extinct. If climate would change far beyond current predictions, however, species might disappear. The reason for the relative stability of mammalian presence might be that arctic regions have experienced large climatic shifts in the past, filtering out sensitive and range-restricted taxa. We also provide evidence that for most (sub) arctic mammals it is not climate change per se that will threaten them, but possible constraints on their dispersal ability and changes in community composition. Such impacts of future changes in species communities should receive more attention in literature.	[Hof, Anouschka R.; Jansson, Roland; Nilsson, Christer] Umea Univ, Landscape Ecol Grp, Dept Ecol & Environm Sci, Umea, Sweden; [Hof, Anouschka R.] Swedish Univ Agr Sci SLU, Dept Wildlife Fish & Environm Studies, Umea, Sweden	Umea University; Swedish University of Agricultural Sciences	Hof, AR (corresponding author), Umea Univ, Landscape Ecol Grp, Dept Ecol & Environm Sci, Umea, Sweden.	Anouschka.Hof@emg.umu.se	Nilsson, Christer/AAI-1354-2019; Jansson, Roland/B-7972-2013; Hof, Anouschka R/V-5994-2019; Nilsson, Christer/I-9407-2012	Jansson, Roland/0000-0003-1767-7010; Hof, Anouschka R/0000-0001-6743-0089; Nilsson, Christer/0000-0003-1186-8115	Nordic Council of Ministers [91228]	Nordic Council of Ministers	This project was funded by the Nordic Council of Ministers (http://www.norden.org/en/nordic-council-of-ministers), Project number: 91228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Angerbjorn A, 2005, SAVING ENDANGERED FE; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bright PW, 1998, ANIM BEHAV, V56, P1485, DOI 10.1006/anbe.1998.0921; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Flojgaard C, 2009, IOP C SER EARTH ENV, V8, DOI 10.1088/1755-1315/8/1/012016; Fuglei E, 1999, J COMP PHYSIOL B, V169, P361, DOI 10.1007/s003600050232; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; Huntley Brian, 2005, P109; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson CN, 2007, P R SOC B, V274, P341, DOI 10.1098/rspb.2006.3711; Kojola I, 2004, J ZOOL, V263, P229, DOI 10.1017/S0952836904005084; Levinsky I, 2007, BIODIVERS CONSERV, V16, P3803, DOI 10.1007/s10531-007-9181-7; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Nilsson C, 2010, AMBIO, V39, P81, DOI 10.1007/s13280-009-0010-y; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Roderfeld H, 2008, CLIMATIC CHANGE, V87, P283, DOI 10.1007/s10584-007-9350-4; Rodriguez-Castaneda G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044402; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Thulin CG, 2003, MAMMAL REV, V33, P29, DOI 10.1046/j.1365-2907.2003.00008.x; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wolf A, 2008, CLIMATIC CHANGE, V87, P91, DOI 10.1007/s10584-007-9340-6	40	44	44	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52574	10.1371/journal.pone.0052574	http://dx.doi.org/10.1371/journal.pone.0052574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285098	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500202
J	Huang, HB; Liu, NN; Yang, CS; Liao, SY; Guo, HP; Zhao, K; Li, XF; Liu, ST; Guan, LX; Liu, CJ; Xu, L; Zhang, CG; Song, WB; Li, B; Tang, P; Dou, QP; Liu, JB				Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Liao, Siyan; Guo, Haiping; Zhao, Kai; Li, Xiaofen; Liu, Shouting; Guan, Lixia; Liu, Chunjiao; Xu, Li; Zhang, Change; Song, Wenbin; Li, Bing; Tang, Ping; Dou, Q. Ping; Liu, Jinbao			HDAC Inhibitor L-Carnitine and Proteasome Inhibitor Bortezomib Synergistically Exert Anti-Tumor Activity In Vitro and In Vivo	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; 20 S PROTEASOME; HISTONE DEACETYLASE; PHASE-I; CANCER; APOPTOSIS; ACID; COMBINATION; THERAPY; PROTEIN	Combinations of proteasome inhibitors and histone deacetylases (HDAC) inhibitors appear to be the most potent to produce synergistic cytotoxicity in preclinical trials. We have recently confirmed that L-carnitine (LC) is an endogenous HDAC inhibitor. In the current study, the anti-tumor effect of LC plus proteasome inhibitor bortezomib (velcade, Vel) was investigated both in cultured hepatoma cancer cells and in Balb/c mice bearing HepG2 tumor. Cell death and cell viability were assayed by flow cytometry and MTS, respectively. Gene, mRNA expression and protein levels were detected by gene microarray, quantitative real-time PCR and Western blot, respectively. The effect of Vel on the acetylation of histone H3 associated with the p21(cip1) gene promoter was examined by using ChIP assay and proteasome peptidase activity was detected by cell-based chymotrypsin-like (CT-like) activity assay. Here we report that (i) the combination of LC and Vel synergistically induces cytotoxicity in vitro; (ii) the combination also synergistically inhibits tumor growth in vivo; (iii) two major pathways are involved in the synergistical effects of the combinational treatment: increased p21(cip1) expression and histone acetylation in vitro and in vivo and enhanced Vel-induced proteasome inhibition by LC. The synergistic effect of LC and Vel in cancer therapy should have great potential in the future clinical trials.	[Huang, Hongbiao; Liu, Ningning; Yang, Changshan; Liao, Siyan; Guo, Haiping; Zhao, Kai; Li, Xiaofen; Liu, Shouting; Guan, Lixia; Liu, Chunjiao; Xu, Li; Zhang, Change; Song, Wenbin; Tang, Ping; Dou, Q. Ping; Liu, Jinbao] Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China; [Xu, Li] Peoples Hosp Guangxi Autonomous Reg, Dept Hematol, Nanning, Guangxi, Peoples R China; [Li, Bing] Guangzhou Med Univ, Expt Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Tang, Ping] Guangzhou Med Univ, Affiliated Guangzhou Municipal Peoples Hosp 1, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Dou, Q. Ping] Wayne State Univ, Sch Med, Mol Therapeut Program, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Dou, Q. Ping] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; Wayne State University	Dou, QP (corresponding author), Guangzhou Med Univ, Dept Pathophysiol, Prot Modificat & Degradat Lab, Guangzhou, Guangdong, Peoples R China.	doup@karmanos.org; Liujinbao1@yahoo.com.cn		Liu, Ningning/0000-0002-9587-2332; Dou, Qingping/0000-0002-6465-1473	National High Technology Research and Development Program of China [2006AA02Z4B5]; National Natural Science Foundation of China [81070033, 30770835, 81170608, 81072091]; Guangdong Province Natural Science Foundation [9251018201002, 94510018201003604]; Foundation for Distinguished Young Talents in Higher Education of Guangdong; Foundation of Guangzhou Medical College for Doctor Scientists [2011C24]; Guangzhou Municipal Education Commission [10A057S, 08A108]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Talents in Higher Education of Guangdong; Foundation of Guangzhou Medical College for Doctor Scientists; Guangzhou Municipal Education Commission	This work was supported by the National High Technology Research and Development Program of China (Project 2006AA02Z4B5), National Natural Science Foundation of China (Project 81070033, 30770835, 81170608, 81072091) (to JL, PT, and CZ); Projects (9251018201002, 94510018201003604) of Guangdong Province Natural Science Foundation; Projects from Foundation for Distinguished Young Talents in Higher Education of Guangdong and the Foundation of Guangzhou Medical College for Doctor Scientists (2011C24), and projects from Guangzhou Municipal Education Commission (10A057S, 08A108) (to JL, HH and CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Badros A, 2009, CLIN CANCER RES, V15, P5250, DOI 10.1158/1078-0432.CCR-08-2850; Baiz D, 2009, BIOCHIMIE, V91, P373, DOI 10.1016/j.biochi.2008.10.015; Butler LM, 2000, CANCER RES, V60, P5165; Calvaruso G, 2007, ONCOL REP, V18, P447; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Fine-Schi S, 2008, AM J RESP CELL MOL, V39, P458, DOI 10.1165/rcmb.2007-0320OC; Gareau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020254; Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019; Heider U, 2008, EUR J HAEMATOL, V80, P133, DOI 10.1111/j.1600-0609.2007.00995.x; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049062; Huang Hongbiao, 2011, Front Biosci (Elite Ed), V3, P1315; Huang HB, 2011, CANCER LETT, V301, P221, DOI 10.1016/j.canlet.2010.12.015; Huang HB, 2010, CELL RES, V20, P1372, DOI 10.1038/cr.2010.123; Huber JM, 2009, AM J PHYSIOL-RENAL, V297, pF451, DOI 10.1152/ajprenal.90576.2008; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Kikuchi J, 2010, BLOOD, V116, P406, DOI 10.1182/blood-2009-07-235663; Kim J, 2010, MOL CANCER THER, V9, P1977, DOI 10.1158/1535-7163.MCT-10-0141; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kubicek GJ, 2009, INT J RADIAT ONCOL, V74, P433, DOI 10.1016/j.ijrobp.2008.08.050; Lancet JE, 2011, CLIN CANCER RES, V17, P1140, DOI 10.1158/1078-0432.CCR-10-1878; Lauricella M, 2006, APOPTOSIS, V11, P607, DOI 10.1007/s10495-006-4689-y; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Li J, 2011, J CLIN INVEST, V121, P3689, DOI 10.1172/JCI45709; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; Mackay H, 2005, CLIN CANCER RES, V11, P5526, DOI 10.1158/1078-0432.CCR-05-0081; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; McConkey D, 2010, BLOOD, V116, P308, DOI 10.1182/blood-2010-04-278507; Millward M, 2012, INVEST NEW DRUGS; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; O'Connor OA, 2009, CLIN CANCER RES, V15, P7085, DOI 10.1158/1078-0432.CCR-09-0822; Oakervee HE, 2005, BRIT J HAEMATOL, V129, P755, DOI 10.1111/j.1365-2141.2005.05519.x; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Orlowski M, 2000, ARCH BIOCHEM BIOPHYS, V383, P1, DOI 10.1006/abbi.2000.2036; Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sahlin K, 2010, J PHYSL, V589, P1509; Sakairi T, 2011, NEPHROLOGY, V16, P76, DOI 10.1111/j.1440-1797.2010.01367.x; Smith AJ, 2011, J BIOL CHEM, V286, P17682, DOI 10.1074/jbc.M110.189092; Steiber Alison, 2004, Molecular Aspects of Medicine, V25, P455, DOI 10.1016/j.mam.2004.06.006; Su YJ, 2010, CLIN CANCER RES, V16, P348, DOI 10.1158/1078-0432.CCR-09-2087; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225	51	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52576	10.1371/journal.pone.0052576	http://dx.doi.org/10.1371/journal.pone.0052576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285100	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500204
J	La Rosa, PS; Brooks, JP; Deych, E; Boone, EL; Edwards, DJ; Wang, Q; Sodergren, E; Weinstock, G; Shannon, WD				La Rosa, Patricio S.; Brooks, J. Paul; Deych, Elena; Boone, Edward L.; Edwards, David J.; Wang, Qin; Sodergren, Erica; Weinstock, George; Shannon, William D.			Hypothesis Testing and Power Calculations for Taxonomic-Based Human Microbiome Data	PLOS ONE			English	Article							NONPARAMETRIC MULTIVARIATE-ANALYSIS; COMMUNITIES; PROJECT; PROPORTIONS; INTEGRATION; STATISTICS; LIBRARIES; DIVERSITY; SAMPLES	This paper presents new biostatistical methods for the analysis of microbiome data based on a fully parametric approach using all the data. The Dirichlet-multinomial distribution allows the analyst to calculate power and sample sizes for experimental design, perform tests of hypotheses (e. g., compare microbiomes across groups), and to estimate parameters describing microbiome properties. The use of a fully parametric model for these data has the benefit over alternative non-parametric approaches such as bootstrapping and permutation testing, in that this model is able to retain more information contained in the data. This paper details the statistical approaches for several tests of hypothesis and power/sample size calculations, and applies them for illustration to taxonomic abundance distribution and rank abundance distribution data using HMP Jumpstart data on 24 subjects for saliva, subgingival, and supragingival samples. Software for running these analyses is available.	[La Rosa, Patricio S.; Deych, Elena; Shannon, William D.] Washington Univ, Sch Med, Dept Med, Div Gen Med Sci, St Louis, MO 63110 USA; [Brooks, J. Paul; Boone, Edward L.; Edwards, David J.; Wang, Qin] Virginia Commonwealth Univ, Dept Stat Sci & Operat Res, Richmond, VA USA; [Sodergren, Erica; Weinstock, George] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA	Washington University (WUSTL); Virginia Commonwealth University; Washington University (WUSTL)	Shannon, WD (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gen Med Sci, St Louis, MO 63110 USA.	wshannon@wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	National Institutes of Health (NIH) [U54 HG004968, 1UH2AI083265]; St. Louis Children's Hospital and Children Discovery Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083265] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Louis Children's Hospital and Children Discovery Institute Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grant U54 HG004968 "Human Microbiome Project Consortium Sequencing of Healthy People", NIH Grant 1UH2AI083265 "The Neonatal Microbiome and Necrotizing Enterocolotis", and St. Louis Children's Hospital and Children Discovery Institute Grant "The St. Louis Neonatal Gut Microbiome Initiative". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], HUM MICR PROJ 16S RR; BRIER SS, 1980, BIOMETRIKA, V67, P591; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; COX DR, 1983, BIOMETRIKA, V70, P269, DOI 10.1093/biomet/70.1.269; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; KIM BS, 1992, BIOMETRICS, V48, P711, DOI 10.2307/2532338; Kirk RE, 1968, EXPT DESIGN; KOEHLER KJ, 1986, COMMUN STAT-THEOR M, V15, P2977, DOI 10.1080/03610928608829290; La Rosa P, 2011, HMP HYPOTHESIS TESTI; Legendre P., 1998, DEV ENV MODELLING; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MANTEL N, 1970, BIOMETRICS, V26, P547, DOI 10.2307/2529108; MANTEL N, 1967, CANCER RES, V27, P209; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Vilo C, 2012, METAGENOMICS; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wilson JR, 1984, P JOINT STAT ASS M S; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	34	176	181	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52078	10.1371/journal.pone.0052078	http://dx.doi.org/10.1371/journal.pone.0052078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284876	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500086
J	Novak, P; Stampfer, MR; Munoz-Rodriguez, JL; Garbe, JC; Ehrich, M; Futscher, BW; Jensen, TJ				Novak, Petr; Stampfer, Martha R.; Munoz-Rodriguez, Jose L.; Garbe, James C.; Ehrich, Mathias; Futscher, Bernard W.; Jensen, Taylor J.			Cell-Type Specific DNA Methylation Patterns Define Human Breast Cellular Identity	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; DIFFERENTIAL METHYLATION; EPIGENETIC INACTIVATION; HYPERMETHYLATION; PLURIPOTENT; EXPRESSION; GROWTH; GENES; BARRIERS; CLUSTER	DNA methylation plays a role in a variety of biological processes including embryonic development, imprinting, X-chromosome inactivation, and stem cell differentiation. Tissue specific differential methylation has also been well characterized. We sought to extend these studies to create a map of differential DNA methylation between different cell types derived from a single tissue. Using three pairs of isogenic human mammary epithelial and fibroblast cells, promoter region DNA methylation was characterized using MeDIP coupled to microarray analysis. Comparison of DNA methylation between these cell types revealed nearly three thousand cell-type specific differentially methylated regions (ctDMRs). MassARRAY was performed upon 87 ctDMRs to confirm and quantify differential DNA methylation. Each of the examined regions exhibited statistically significant differences ranging from 10-70%. Gene ontology analysis revealed the overrepresentation of many transcription factors involved in developmental processes. Additionally, we have shown that ctDMRs are associated with histone related epigenetic marks and are often aberrantly methylated in breast cancer. Overall, our data suggest that there are thousands of ctDMRs which consistently exhibit differential DNA methylation and may underlie cell type specificity in human breast tissue. In addition, we describe the pathways affected by these differences and provide insight into the molecular mechanisms and physiological overlap between normal cellular differentiation and breast carcinogenesis.	[Novak, Petr; Stampfer, Martha R.; Munoz-Rodriguez, Jose L.; Futscher, Bernard W.; Jensen, Taylor J.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Munoz-Rodriguez, Jose L.; Futscher, Bernard W.; Jensen, Taylor J.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Stampfer, Martha R.; Garbe, James C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Novak, Petr] Acad Sci Czech Republ, Inst Plant Mol Biol, Vvi, Biol Ctr ASCR, CR-37005 Ceske Budejovice, Czech Republic; [Ehrich, Mathias] Sequenom Inc, San Diego, CA USA; [Jensen, Taylor J.] John Hopkins Ct, Sequenom Ctr Mol Med, San Diego, CA USA	Arizona Center Cancer Care; University of Arizona; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Sequenom; Sequenom	Novak, P (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA.	petr@umbr.cas.cz	Novak, Petr/A-3059-2013; Rodríguez, Jose Manuel JMMR Muñoz/A-7323-2016	Novak, Petr/0000-0002-5068-9681; Rodríguez, Jose Manuel JMMR Muñoz/0000-0002-4688-6420	BIO5 interdisciplinary biotechnology center at the UA; DOD [BCRP BC060444]; National Institutes of Health [U54 CA112970]; Office of Energy Research, Office of Health and Biological Research, U.S. Department of Energy [DE-AC03-76SF00098]; NIEHS [ES06694]; Academy of Sciences of the Czech Republic [AVOZ50510513];  [R01CA65662];  [R33CA091351];  [P30ES06694];  [P30CA023074];  [CA09213]; NATIONAL CANCER INSTITUTE [R01CA065662, U54CA112970, T32CA009213, R33CA091351, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	BIO5 interdisciplinary biotechnology center at the UA; DOD(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Energy Research, Office of Health and Biological Research, U.S. Department of Energy(United States Department of Energy (DOE)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grants R01CA65662 and R33CA091351 to BWF supported this work. Center Grants P30ES06694 and P30CA023074, and the BIO5 interdisciplinary biotechnology center at the UA supported the Genomics Shared Service. Training grant CA09213 helped support TJJ. JCG and MRS were supported by DOD BCRP BC060444, National Institutes of Health U54 CA112970, and the Office of Energy Research, Office of Health and Biological Research, U.S. Department of Energy under Contract No. DE-AC03-76SF00098. NIEHS Grant ES06694 and Grant AVOZ50510513 from the Academy of Sciences of the Czech Republic support PN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; BAYLIN SB, 1991, CANCER CELL-MON REV, V3, P383; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BEARD C, 1995, GENE DEV, V9, P2325, DOI 10.1101/gad.9.19.2325; Bernardino T, 1997, CANCER GENET CYTOGEN, V97, P83, DOI 10.1016/S0165-4608(96)00385-8; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Brenner AJ, 1998, ONCOGENE, V17, P199, DOI 10.1038/sj.onc.1201919; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Garbe JC, 2012, CANCER RES, V72, P3687, DOI 10.1158/0008-5472.CAN-12-0157; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; LaBarge MA, 2012, J VISUALIZE IN PRESS; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li YZ, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-7; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MAKOS M, 1993, CANCER RES, V53, P2715; MAKOS M, 1992, P NATL ACAD SCI USA, V89, P1929, DOI 10.1073/pnas.89.5.1929; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Novak P, 2006, CANCER RES, V66, P10664, DOI 10.1158/0008-5472.CAN-06-2761; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Ordway JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001314; Oshiro MM, 2005, NEOPLASIA, V7, P799, DOI 10.1593/neo.05274; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Sproul D, 2011, P NATL ACAD SCI USA, V108, P4364, DOI 10.1073/pnas.1013224108; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhang JM, 2006, CANCER RES, V66, P10325, DOI 10.1158/0008-5472.CAN-06-1594	50	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52299	10.1371/journal.pone.0052299	http://dx.doi.org/10.1371/journal.pone.0052299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284978	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500139
J	Raz, T; Avni, R; Addadi, Y; Cohen, Y; Jaffa, AJ; Hemmings, B; Garbow, JR; Neeman, M				Raz, Tal; Avni, Reut; Addadi, Yoseph; Cohen, Yoni; Jaffa, Ariel J.; Hemmings, Brian; Garbow, Joel R.; Neeman, Michal			The Hemodynamic Basis for Positional- and Inter-Fetal Dependent Effects in Dual Arterial Supply of Mouse Pregnancies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INTRAUTERINE POSITION; GROWTH-RETARDATION; MICE; MRI; EMBRYO; AKT1; PREECLAMPSIA; RESTRICTION; INHIBITION	In mammalian pregnancy, maternal cardiovascular adaptations must match the requirements of the growing fetus(es), and respond to physiologic and pathologic conditions. Such adaptations are particularly demanding for mammals bearing large-litter pregnancies, with their inherent conflict between the interests of each individual fetus and the welfare of the entire progeny. The mouse is the most common animal model used to study development and genetics, as well as pregnancy-related diseases. Previous studies suggested that in mice, maternal blood flow to the placentas occurs via a single arterial uterine loop generated by arterial-arterial anastomosis of the uterine artery to the uterine branch of the ovarian artery, resulting in counter bi-directional blood flow. However, we provide here experimental evidence that each placenta is actually supplied by two distinct arterial inputs stemming from the uterine artery and from the uterine branch of the ovarian artery, with position-dependent contribution of flow from each source. Moreover, we report significant positional- and inter-fetal dependent alteration of placental perfusion, which were detected by in vivo MRI and fluorescence imaging. Maternal blood flow to the placentas was dependent on litter size and was attenuated for placentas located centrally along the uterine horn. Distinctive apposing, inter-fetal hemodynamic effects of either reduced or elevated maternal blood flow, were measured for placenta of normal fetuses that are positioned adjacent to either pathological, or to hypovascular Akt1-deficient placentas, respectively. The results reported here underscore the critical importance of confounding local and systemic in utero effects on phenotype presentation, in general and in the setting of genetically modified mice. The unique robustness and plasticity of the uterine vasculature architecture, as reported in this study, can explain the ability to accommodate varying litter sizes, sustain large-litter pregnancies and overcome pathologic challenges. Remarkably, the dual arterial supply is evolutionary conserved in mammals bearing a single offspring, including primates.	[Raz, Tal; Avni, Reut; Addadi, Yoseph; Cohen, Yoni; Neeman, Michal] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Jaffa, Ariel J.] Lis Matern Hosp, Tel Aviv Souraski Med Ctr, Tel Aviv, Israel; [Hemmings, Brian] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Garbow, Joel R.] Washington Univ, Mallinckrodt Inst Radiol, Biomed MR Lab, St Louis, MO USA	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Friedrich Miescher Institute for Biomedical Research; Washington University (WUSTL)	Neeman, M (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	michal.neeman@weizmann.ac.il	Neeman, Michal/A-8264-2008; Neeman, Michal/AAH-9602-2019	Neeman, Michal/0000-0002-6296-816X; Neeman, Michal/0000-0002-6296-816X; Addadi, Sefi/0000-0001-9827-0436	7th Framework European Research Council [232640-IMAGO]; United States - Israel Binational Science Foundation [2011405]; STFC [ST/H005234/1] Funding Source: UKRI	7th Framework European Research Council(European Commission); United States - Israel Binational Science Foundation(US-Israel Binational Science Foundation); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the 7th Framework European Research Council Advanced grant 232640-IMAGO (to MN), and by the United States - Israel Binational Science Foundation grant 2011405 (BSF to MN, JRG and TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni R, 2012, MAGN RESON MED, V68, P560, DOI 10.1002/mrm.23246; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Berkane N, 2010, CURR OPIN OBSTET GYN, V22, P242, DOI 10.1097/GCO.0b013e328338c179; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cicinelli E, 2004, ANN NY ACAD SCI, V1034, P19, DOI 10.1196/annals.1335.002; Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; GINTHER OJ, 1974, J ANIM SCI, V39, P550, DOI 10.2527/jas1974.393550x; Girsh E, 2007, NMR BIOMED, V20, P28, DOI 10.1002/nbm.1087; GROENENBERG IAL, 1989, CIRCULATION, V80, P1711, DOI 10.1161/01.CIR.80.6.1711; Jayet PY, 2010, CIRCULATION, V122, P488, DOI 10.1161/CIRCULATIONAHA.110.941203; Kent LN, 2012, INT J DEV BIOL, V56, P255, DOI 10.1387/ijdb.113407lk; Khankin EV, 2010, SEMIN THROMB HEMOST, V36, P309, DOI 10.1055/s-0030-1253453; Kulandavelu S, 2006, HYPERTENSION, V47, P1175, DOI 10.1161/01.HYP.0000218440.71846.db; Magness RR, 1998, AM J PHYSIOL-HEART C, V275, pH731, DOI 10.1152/ajpheart.1998.275.3.H731; MCGRATH CJ, 1984, MOD VET PRACT, V65, P522; MCLAREN A, 1960, NATURE, V187, P363, DOI 10.1038/187363a0; Meyer KM, 2010, BIOL REPROD, V83, P799, DOI 10.1095/biolreprod.110.085381; Nagao T, 2004, REPROD TOXICOL, V18, P109, DOI 10.1016/j.reprotox.2003.10.009; Nieman BJ, 2010, METHOD ENZYMOL, V476, P379, DOI 10.1016/S0076-6879(10)76021-3; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; O'Leary-Moore SK, 2011, NEUROPSYCHOL REV, V21, P167, DOI 10.1007/s11065-011-9164-z; Orita J, 1996, EXP ANIM TOKYO, V45, P171, DOI 10.1538/expanim.45.171; Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008; Plaks V, 2006, MAGN RESON MED, V55, P1013, DOI 10.1002/mrm.20881; Plaks V, 2011, MOL IMAGING BIOL, V13, P481, DOI 10.1007/s11307-010-0390-1; Plaks V, 2011, BIOL REPROD, V84, P537, DOI 10.1095/biolreprod.110.085951; Poppas A, 1997, CIRCULATION, V95, P2407, DOI 10.1161/01.CIR.95.10.2407; RAMSEY EM, 1979, AM J OBSTET GYNECOL, V135, P247, DOI 10.1016/0002-9378(79)90353-3; Riesterer O, 2004, ONCOGENE, V23, P4624, DOI 10.1038/sj.onc.1207596; Riley JK, 2005, DEV BIOL, V284, P377, DOI 10.1016/j.ydbio.2005.05.033; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; SAAL FSV, 1992, PHYSIOL BEHAV, V52, P163, DOI 10.1016/0031-9384(92)90447-A; Salomon LJ, 2005, RADIOLOGY, V235, P73, DOI 10.1148/radiol.2351040192; Shen Y, 2005, PHYSIOL GENOMICS, V24, P23, DOI 10.1152/physiolgenomics.00129.2005; Spurney CF, 2006, ECHOCARDIOGR-J CARD, V23, P891, DOI 10.1111/j.1540-8175.2006.00335.x; Tobita K, 2010, BIRTH DEFECTS RES C, V90, P176, DOI 10.1002/bdrc.20187; Tomlinson TM, 2010, AM J PHYSIOL-REG I, V298, pR312, DOI 10.1152/ajpregu.00425.2009; Valdes G, 2011, INTEGR BLOOD PRESS C, V4, P45, DOI 10.2147/IBPC.S8393; VOMSAAL FS, 1981, J REPROD FERTIL, V62, P633, DOI [10.1530/jrf.0.0620633, 10.1530/jrf.0.0620033]; Walls JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002853; Wong AYH, 2002, AM J PHYSIOL-HEART C, V282, pH918, DOI 10.1152/ajpheart.00641.2001; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193	48	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52273	10.1371/journal.pone.0052273	http://dx.doi.org/10.1371/journal.pone.0052273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284965	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500132
J	Robert-Paganin, J; Nonin-Lecomte, S; Rety, S				Robert-Paganin, Julien; Nonin-Lecomte, Sylvie; Rety, Stephane			Crystal Structure of an EAL Domain in Complex with Reaction Product 5 '-pGpG	PLOS ONE			English	Article							CYCLIC DI-GMP; ACETOBACTER-XYLINUM; CATALYTIC MECHANISM; SIGNAL-TRANSDUCTION; CELLULOSE SYNTHESIS; TWITCHING MOTILITY; PHOSPHODIESTERASE; FIMX; HYDROLYSIS; SYSTEM	FimX is a large multidomain protein containing an EAL domain and involved in twitching motility in Pseudomonas aeruginosa. We present here two crystallographic structures of the EAL domain of FimX (residues 438-686): one of the apo form and the other of a complex with 5'-pGpG, the reaction product of the hydrolysis of c-di-GMP. In both crystal forms, the EAL domains form a dimer delimiting a large cavity encompassing the catalytic pockets. The ligand is trapped in this cavity by its sugar phosphate moiety. We confirmed by NMR that the guanine bases are not involved in the interaction in solution. We solved here the first structure of an EAL domain bound to the reaction product 5'-pGpG. Though isolated FimX EAL domain has a very low catalytic activity, which would not be significant compared to other catalytic EAL domains, the structure with the product of the reaction can provides some hints in the mechanism of hydrolysis of the c-di-GMP by EAL domains.	[Robert-Paganin, Julien; Nonin-Lecomte, Sylvie; Rety, Stephane] UMR 8015 Cente Natl Rech Sci, Lab Cristallog & RMN Biol, Paris, France; [Robert-Paganin, Julien; Nonin-Lecomte, Sylvie; Rety, Stephane] Univ Paris 05, Fac Pharm, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rety, S (corresponding author), UMR 8015 Cente Natl Rech Sci, Lab Cristallog & RMN Biol, Paris, France.	stephane.rety@parisdescartes.fr	Rety, Stephane/L-9870-2019	Rety, Stephane/0000-0002-2089-6727; Nonin-Lecomte, Sylvie/0000-0001-5155-8088	CNRS; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	This work was funded by CNRS. Publication costs were supported by the Institut Universitaire de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Chen AD, 2000, J AM CHEM SOC, V122, P414, DOI 10.1021/ja992588j; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Guzzo CR, 2009, J MOL BIOL, V393, P848, DOI 10.1016/j.jmb.2009.07.065; Hanes CS, 1932, BIOCHEM J, V26, P1406, DOI 10.1042/bj0261406; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2011, ENV MICROBIOL; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; ROSS P, 1990, J BIOL CHEM, V265, P18933; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schrodinger L., 2020, PYMOL; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Trimble MJ, 2011, P NATL ACAD SCI USA, V108, P18079, DOI 10.1073/pnas.1113790108	33	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52424	10.1371/journal.pone.0052424	http://dx.doi.org/10.1371/journal.pone.0052424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285035	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500163
J	Yao, J; Hong, WF; Huang, JJ; Zhan, K; Huang, H; Hong, M				Yao, Juan; Hong, Weifang; Huang, Jiujiu; Zhan, Kai; Huang, Hong; Hong, Mei			N-glycosylation Dictates Proper Processing of Organic Anion Transporting Polypeptide 1B1	PLOS ONE			English	Article							OATP TRANSPORTERS; DRUG; MEMBRANE; POLYMORPHISMS; DISPOSITION; KIDNEY; IMPACT; CELLS	Organic anion transporting polypeptides (OATPs) have been extensively recognized as key determinants of absorption, distribution, metabolism and excretion (ADME) of various drugs, xenobiotics and toxins. Putative N-glycosylation sites located in the extracellular loops 2 and 5 is considered a common feature of all OATPs and some members have been demonstrated to be glycosylated proteins. However, experimental evidence is still lacking on how such a post-translational modification affect the transport activity of OATPs and which of the putative glycosylation sites are utilized in these transporter proteins. In the present study, we substituted asparagine residues that are possibly involved in N-glycosylation with glutamine residues and identified three glycosylation sites (Asn134, Asn503 and Asn516) within the structure of OATP1B1, an OATP member that is mainly expressed in the human liver. Our results showed that Asn134 and Asn516 are used for glycosylation under normal conditions; however, when Asn134 was mutagenized, an additional asparagine at position 503 is involved in the glycosylation process. Simultaneously replacement of all three asparagines with glutamines led to significantly reduced protein level as well as loss of transport activity. Further studies revealed that glycosylation affected stability of the transporter protein and the unglycosylated mutant was retained within endoplasmic reticulum.	[Yao, Juan; Hong, Weifang; Huang, Jiujiu; Zhan, Kai; Hong, Mei] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Hong] Univ S Florida, Sch Informat, Tampa, FL USA	South China Agricultural University; State University System of Florida; University of South Florida	Hong, M (corresponding author), S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	mh2788@scau.edu.cn	Huang, Hong/G-5957-2016	Huang, Hong/0000-0002-8957-4881; Hong, Mei/0000-0001-9219-2844	Chinese Ministry of Human Resources and Social Security; National Natural Science Foundation of China [81141115]	Chinese Ministry of Human Resources and Social Security; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Returned high-level talents from abroad grant of the Chinese Ministry of Human Resources and Social Security and National Natural Science Foundation of China grant (81141115) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Ho RH, 2006, GASTROENTEROLOGY, V130, P1793, DOI 10.1053/j.gastro.2006.02.034; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Konig J, 2006, N-S ARCH PHARMACOL, V372, P432, DOI 10.1007/s00210-006-0040-y; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Lee W, 2005, J BIOL CHEM, V280, P9610, DOI 10.1074/jbc.M411092200; Li N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036647; Lodish H, 2000, MOL CELL BIOL; Mikkaichi Tsuyoshi, 2004, Drug Metab Pharmacokinet, V19, P171, DOI 10.2133/dmpk.19.171; Mochizuki K, 2007, AM J PHYSIOL-GASTR L, V292, pG818, DOI 10.1152/ajpgi.00415.2006; Nakanishi T, 2012, DRUG METAB PHARMACOK, V27, P106, DOI 10.2133/dmpk.DMPK-11-RV-099; OTT RJ, 1992, J BIOL CHEM, V267, P133; Poirier A, 2007, CURR OPIN DRUG DISC, V10, P74; Russell D, 2009, CARBOHYD RES, V344, P1508, DOI 10.1016/j.carres.2009.06.033; Sharon N, 1993, FEBS, V218, P1; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Tanaka K, 2004, J BIOL CHEM, V279, P14961, DOI 10.1074/jbc.M400197200; van Montfoort JE, 2003, CURR DRUG METAB, V4, P185, DOI 10.2174/1389200033489460; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang PJ, 2008, AM J PHYSIOL-GASTR L, V294, pG1052, DOI 10.1152/ajpgi.00584.2007	21	32	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52563	10.1371/journal.pone.0052563	http://dx.doi.org/10.1371/journal.pone.0052563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285087	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500195
J	Zhang, JY; Tong, W; Wu, F; Bi, SH; Xu, M; Jin, ZX; Yang, Y; Jiang, XF; Zhou, JJ				Zhang, Jian-Ying; Tong, Wei; Wu, Feng; Bi, Sheng-Hui; Xu, Ming; Jin, Zhen-Xiao; Yang, Yang; Jiang, Xiao-Fan; Zhou, Jing-Jun			Different Roles for Contracture and Calpain in Calcium Paradox-Induced Heart Injury	PLOS ONE			English	Article							RAT-HEART; MYOCARDIAL ISCHEMIA/REPERFUSION; VENTRICULAR MYOCYTES; NA+/CA2+ EXCHANGER; REVERSE MODE; REPERFUSION; ACTIVATION; ISCHEMIA; SODIUM; SYSTEM	The Ca2+ paradox represents a good model to study Ca2+ overload injury in ischemic heart diseases. We and others have demonstrated that contracture and calpain are involved in the Ca2+ paradox-induced injury. This study aimed to elucidate their roles in this model. The Ca2+ paradox was elicited by perfusing isolated rat hearts with Ca2+-free KH media for 3 min or 5 min followed by 30 min of Ca2+ repletion. The LVDP was measured to reflect contractile function, and the LVEDP was measured to indicate contracture. TTC staining and the quantification of LDH release were used to define cell death. Calpain activity and troponin I release were measured after Ca2+ repletion. Ca2+ repletion of the once 3-min Ca2+ depleted hearts resulted in almost no viable tissues and the disappearance of contractile function. Compared to the effects of the calpain inhibitor MDL28170, KB-R7943, an inhibitor of the Na+/Ca2+ exchanger, reduced the LVEDP level to a greater extent, which was well correlated with improved contractile function recovery and tissue survival. The depletion of Ca2+ for 5 min had the same effects on injury as the 3-min Ca2+ depletion, except that the LVEDP in the 5-min Ca2+ depletion group was lower than the level in the 3-min Ca2+ depletion group. KB-R7943 failed to reduce the level of LVEDP, with no improvement in the LVDP recovery in the hearts subjected to the 5-min Ca2+ depletion treatment; however, KB-R7943 preserved its protective effects in surviving tissue. Both KB-R7943 and MDL28170 attenuated the Ca2+ repletion-induced increase in calpain activity in 3 min or 5 min Ca2+ depleted hearts. However, only KB-R7943 reduced the release of troponin I from the Ca2+ paradoxic heart. These results provide evidence suggesting that contracture is the main cause for contractile dysfunction, while activation of calpain mediates cell death in the Ca2+ paradox.	[Jiang, Xiao-Fan] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China; [Zhang, Jian-Ying; Xu, Ming; Zhou, Jing-Jun] Fourth Mil Med Univ, Xijing Hosp, Dept Physiol, Xian 710032, Peoples R China; [Tong, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Out Patient Clin, Xian 710032, Peoples R China; [Wu, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Bi, Sheng-Hui; Jin, Zhen-Xiao; Yang, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jiang, XF (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Peoples R China.	jiangxf@fmmu.edu.cn; jjzhou71@yahoo.com	Jin, Zhenxiao/AAJ-5777-2020	xu, ming/0000-0001-5234-2203	Natural Science Foundation of China [30971196, 81100082]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (grant no. 30971196 and 81100082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis EE, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-67; BARRY WH, 1987, CIRC RES, V61, P726, DOI 10.1161/01.RES.61.5.726; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bi SH, 2012, CLIN EXP PHARMACOL P, V39, P385, DOI 10.1111/j.1440-1681.2012.05683.x; Chatamra KR, 1996, EXP PHYSIOL, V81, P203, DOI 10.1113/expphysiol.1996.sp003925; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; DALY MJ, 1987, CIRC RES, V61, P560, DOI 10.1161/01.RES.61.4.560; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Fozzard HA, 2002, CARDIOVASC RES, V55, P1, DOI 10.1016/S0008-6363(02)00407-8; Gaitanaki C, 2003, CELL PHYSIOL BIOCHEM, V13, P173, DOI 10.1159/000071868; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hernando V, 2010, J MOL CELL CARDIOL, V49, P271, DOI 10.1016/j.yjmcc.2010.02.024; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; Inserte J, 2009, CARDIOVASC RES, V81, P116, DOI 10.1093/cvr/cvn260; Iwamoto T, 1996, J BIOL CHEM, V271, P22391, DOI 10.1074/jbc.271.37.22391; Jin ZX, 2007, ANN THORAC SURG, V83, P2066, DOI 10.1016/j.athoracsur.2006.12.031; Kojima A, 2010, BRIT J PHARMACOL, V161, P1734, DOI 10.1111/j.1476-5381.2010.00986.x; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; Lompre AM, 2010, CIRCULATION, V121, P822, DOI 10.1161/CIRCULATIONAHA.109.890954; MacGowan GA, 2001, AM J PHYSIOL-HEART C, V280, pH835, DOI 10.1152/ajpheart.2001.280.2.H835; Makazan Z, 2009, CAN J PHYSIOL PHARM, V87, P789, DOI 10.1139/Y09-050; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; NAYLER WG, 1984, CIRC RES, V55, P227, DOI 10.1161/01.RES.55.2.227; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Piper HM, 2000, CARDIOVASC RES, V45, P123, DOI 10.1016/S0008-6363(99)00304-1; Sapia L, 2010, J MOL CELL CARDIOL, V49, P459, DOI 10.1016/j.yjmcc.2010.04.013; Satoh H, 2000, CIRCULATION, V101, P1441, DOI 10.1161/01.CIR.101.12.1441; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Shan LM, 2010, FREE RADICAL BIO MED, V49, P1804, DOI 10.1016/j.freeradbiomed.2010.09.018; SINGAL PK, 1979, BRIT J EXP PATHOL, V60, P96; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Talukder MAH, 2009, CARDIOVASC RES, V84, P345, DOI 10.1093/cvr/cvp264; VANDERHEIDE RS, 1986, AM J PATHOL, V123, P351; VANDERHEIDE RS, 1986, AM J PATHOL, V125, P55; Venge P, 2001, CLIN CHEM, V47, P959; Villars PS, 2004, AM J CRIT CARE, V13, P394, DOI 10.4037/ajcc2004.13.5.394; Wada T, 2010, AM J PHYSIOL-ENDOC M, V298, pE881, DOI 10.1152/ajpendo.00649.2009; Willis MS, 2009, CARDIOVASC RES, V81, P439, DOI 10.1093/cvr/cvn289; YOSHIDA K, 1995, CIRC RES, V77, P603, DOI 10.1161/01.RES.77.3.603; ZIMMERMAN AN, 1966, NATURE, V211, P646, DOI 10.1038/211646a0	43	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52270	10.1371/journal.pone.0052270	http://dx.doi.org/10.1371/journal.pone.0052270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284963	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500131
J	Zhou, SY; Hu, W; Deng, XM; Ma, ZB; Chen, LH; Huang, C; Wang, C; Wang, J; He, YZ; Yang, GX; He, GY				Zhou, Shiyi; Hu, Wei; Deng, Xiaomin; Ma, Zhanbing; Chen, Lihong; Huang, Chao; Wang, Chen; Wang, Jie; He, Yanzhen; Yang, Guangxiao; He, Guangyuan			Overexpression of the Wheat Aquaporin Gene, TaAQP7, Enhances Drought Tolerance in Transgenic Tobacco	PLOS ONE			English	Article							MEMBRANE INTRINSIC PROTEINS; ROOT WATER TRANSPORT; ABSCISIC-ACID; HYDRAULIC CONDUCTIVITY; HYDROGEN-PEROXIDE; ANTIOXIDANT DEFENSE; FUNCTIONAL-ANALYSIS; EXPRESSION ANALYSIS; SIGNALING MOLECULE; STRESS	Aquaporin (AQP) proteins have been shown to transport water and other small molecules through biological membranes, which is crucial for plants to combat stress caused by drought. However, the precise role of AQPs in drought stress response is not completely understood in plants. In this study, a PIP2 subgroup gene AQP, designated as TaAQP7, was cloned and characterized from wheat. Expression of TaAQP7-GFP fusion protein revealed its localization in the plasma membrane. TaAQP7 exhibited high water channel activity in Xenopus laevis oocytes and TaAQP7 transcript was induced by dehydration, and treatments with polyethylene glycol (PEG), abscisic acid (ABA) and H2O2. Further, TaAQP7 was upregulated after PEG treatment and was blocked by inhibitors of ABA biosynthesis, implying that ABA signaling was involved in the upregulation of TaAQP7 after PEG treatment. Overexpression of TaAQP7 increased drought tolerance in tobacco. The transgenic tobacco lines had lower levels of malondialdehyde (MDA) and H2O2, and less ion leakage (IL), but higher relative water content (RWC) and superoxide dismutase (SOD) and catalase (CAT) activities when compared with the wild type (WT) under drought stress. Taken together, our results show that TaAQP7 confers drought stress tolerance in transgenic tobacco by increasing the ability to retain water, reduce ROS accumulation and membrane damage, and enhance the activities of antioxidants.	[Zhou, Shiyi; Hu, Wei; Deng, Xiaomin; Ma, Zhanbing; Chen, Lihong; Huang, Chao; Wang, Chen; Wang, Jie; He, Yanzhen; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol HUST, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys,Chinese Minist Educ,Coll Life, Wuhan, Peoples R China	Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol HUST, Chinese Natl Ctr Plant Gene Res Wuhan HUST Part, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys,Chinese Minist Educ,Coll Life, Wuhan, Peoples R China.	ygx@mail.hust.edu.cn; hegy@mail.hust.edu.cn			International S & T Cooperation Key Projects of MoST [2009DFB30340]; National Genetically Modified New Varieties of Major Projects of China [2011ZX08002-004, 2011ZX08010-004]; Key Projects of S & T Research of MoE of China [109105]; Wuhan Municipal S & T research project [201120922286]	International S & T Cooperation Key Projects of MoST; National Genetically Modified New Varieties of Major Projects of China; Key Projects of S & T Research of MoE of China; Wuhan Municipal S & T research project	This work was supported by International S & T Cooperation Key Projects of MoST (Grant No. 2009DFB30340) (http://www.cistc.gov.cn/); National Genetically Modified New Varieties of Major Projects of China (2011ZX08002-004, 2011ZX08010-004) (http://www.nmp.gov.cn/); Key Projects of S & T Research of MoE of China (Grant No. 109105) (http://www.moe.edu.cn/); and Wuhan Municipal S & T research project (Grant No. 201120922286) (http://www.whst.gov.cn/whst_Index.chtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Aroca R, 2005, PLANT PHYSIOL, V137, P341, DOI 10.1104/pp.104.051045; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Benabdellah K, 2009, PLANT MOL BIOL, V70, P647, DOI 10.1007/s11103-009-9497-7; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Boursiac Y, 2008, PLANT SIGNAL BEHAV, V3, P1096, DOI 10.4161/psb.3.12.7002; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Cui XH, 2008, J PLANT RES, V121, P207, DOI 10.1007/s10265-007-0130-z; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Ehlert C, 2009, PLANT PHYSIOL, V150, P1093, DOI 10.1104/pp.108.131458; FLOWER DJ, 1986, PLANT CELL ENVIRON, V9, P33, DOI 10.1111/j.1365-3040.1986.tb01720.x; Forrest KL, 2008, FUNCT INTEGR GENOMIC, V8, P115, DOI 10.1007/s10142-007-0065-4; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Hanson MR, 2001, J EXP BOT, V52, P529, DOI 10.1093/jexbot/52.356.529; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Heinen RB, 2009, J EXP BOT, V60, P2971, DOI 10.1093/jxb/erp171; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hose E, 2000, PLANTA, V211, P874, DOI 10.1007/s004250000412; Hu XL, 2005, PLANTA, V223, P57, DOI 10.1007/s00425-005-0068-0; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Hung KT, 2004, J PLANT PHYSIOL, V161, P1347, DOI 10.1016/j.jplph.2004.05.011; Jaleel CA, 2009, ACTA PHYSIOL PLANT, V31, P427, DOI 10.1007/s11738-009-0275-6; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; KALDENHOFF R, 1993, PLANT MOL BIOL, V23, P1187, DOI 10.1007/BF00042352; Kim YX, 2009, J EXP BOT, V60, P547, DOI 10.1093/jxb/ern299; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Laloi C, 2004, PLANT PHYSIOL, V134, P1006, DOI 10.1104/pp.103.035782; Lee SH, 2004, J EXP BOT, V55, P1733, DOI 10.1093/jxb/erh189; Li DD, 2009, PLANT CELL REP, V28, P291, DOI 10.1007/s00299-008-0626-6; Li GW, 2008, PLANT CELL PHYSIOL, V49, P1851, DOI 10.1093/pcp/pcn166; Lian HL, 2004, PLANT CELL PHYSIOL, V45, P481, DOI 10.1093/pcp/pch058; Lian HL, 2006, CELL RES, V16, P651, DOI 10.1038/sj.cr.7310068; Lin CC, 2001, PLANT SCI, V160, P323, DOI 10.1016/S0168-9452(00)00396-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mariaux JB, 1998, PLANT MOL BIOL, V38, P1089, DOI 10.1023/A:1006013130681; Maurel C, 1997, ANNU REV PLANT PHYS, V48, P399, DOI 10.1146/annurev.arplant.48.1.399; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 1999, P NATL ACAD SCI USA, V96, P14165, DOI 10.1073/pnas.96.24.14165; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; North GB, 2000, ANN BOT-LONDON, V85, P247, DOI 10.1006/anbo.1999.1026; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Peng YH, 2008, PLANT CELL ENVIRON, V31, P1275, DOI 10.1111/j.1365-3040.2008.01840.x; Polle A, 2001, PLANT PHYSIOL, V126, P445, DOI 10.1104/pp.126.1.445; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Quintero JM, 1999, J EXP BOT, V50, P1607, DOI 10.1093/jexbot/50.339.1607; Rampino P, 2006, PLANT CELL ENVIRON, V29, P2143, DOI 10.1111/j.1365-3040.2006.01588.x; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Siefritz F, 2001, J EXP BOT, V52, P1953, DOI 10.1093/jexbot/52.363.1953; Suga S, 2002, PLANT CELL PHYSIOL, V43, P1229, DOI 10.1093/pcp/pcf148; Vera-Estrella R, 2004, PLANT PHYSIOL, V135, P2318, DOI 10.1104/pp.104.044891; Wan XC, 2004, J EXP BOT, V55, P411, DOI 10.1093/jxb/erh051; Wei H, 2006, PLANT CELL ENVIRON, V29, P558, DOI 10.1111/j.1365-3040.2005.01432.x; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Ye Q, 2008, PLANTA, V227, P1311, DOI 10.1007/s00425-008-0703-7; Yu X, 2006, CELL RES, V16, P599, DOI 10.1038/sj.cr.7310077; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang JF, 2008, PLANT MOL BIOL REP, V26, P32, DOI 10.1007/s11105-008-0020-0; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; Zhang YX, 2008, MOL BIOTECHNOL, V40, P280, DOI 10.1007/s12033-008-9084-1; Zhao CX, 2008, COLLOID SURFACE B, V62, P163, DOI 10.1016/j.colsurfb.2007.10.015	79	138	163	0	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52439	10.1371/journal.pone.0052439	http://dx.doi.org/10.1371/journal.pone.0052439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285044	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500170
J	Prowse, ABJ; Chong, F; Elliott, DA; Elefanty, AG; Stanley, EG; Gray, PP; Munro, TP; Osborne, GW				Prowse, Andrew B. J.; Chong, Fenny; Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.; Gray, Peter P.; Munro, Trent P.; Osborne, Geoffrey W.			Analysis of Mitochondrial Function and Localisation during Human Embryonic Stem Cell Differentiation In Vitro	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RECOMBINANT VITRONECTIN; ANTIOXIDANT ENZYMES; BIOGENESIS; DNA; LINES; PCR; QUANTIFICATION; MECHANISMS	Human embryonic stem cell (hESC) derivatives show promise as viable cell therapy options for multiple disorders in different tissues. Recent advances in stem cell biology have lead to the reliable production and detailed molecular characterisation of a range of cell-types. However, the role of mitochondria during differentiation has yet to be fully elucidated. Mitochondria mediate a cells response to altered energy requirements (e.g. cardiomyocyte contraction) and, as such, the mitochondrial phenotype is likely to change during the dynamic process of hESC differentiation. We demonstrate that manipulating mitochondrial biogenesis alters mesendoderm commitment. To investigate mitochondrial localisation during early lineage specification of hESCs we developed a mitochondrial reporter line, KMEL2, in which sequences encoding the green fluorescent protein (GFP) are targeted to the mitochondria. Differentiation of KMEL2 lines into the three germ layers showed that the mitochondria in these differentiated progeny are GFP positive. Therefore, KMEL2 hESCs facilitate the study of mitochondria in a range of cell types and, importantly, permit real-time analysis of mitochondria via the GFP tag.	[Prowse, Andrew B. J.; Chong, Fenny; Gray, Peter P.; Munro, Trent P.; Osborne, Geoffrey W.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia; [Elliott, David A.; Elefanty, Andrew G.; Stanley, Edouard G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Osborne, Geoffrey W.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Elefanty, Andrew G.; Stanley, Edouard G.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	University of Queensland; Monash University; University of Queensland; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Prowse, ABJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.	a.prowse@uq.edu.au	Elliott, David/H-3334-2012; Gray, Peter/AAC-3737-2019; Munro, Trent/AAC-1129-2020; Elefanty, Andrew G/A-6066-2008; Stanley, Ed G/A-2985-2013; Osborne, Geoffrey/G-4873-2010	Elliott, David/0000-0003-1052-7407; Munro, Trent/0000-0003-1987-2020; Stanley, Ed G/0000-0002-6389-3665; Osborne, Geoffrey/0000-0003-0472-6610; Elefanty, Andrew/0000-0001-6448-8314	The Australian Research Council; Australian Institute for Bioengineering and Nanotechnology; National Health and Medical Research Council (NHMRC) of Australia; Qatar National Research Fund	The Australian Research Council(Australian Research Council); Australian Institute for Bioengineering and Nanotechnology; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Qatar National Research Fund(Qatar National Research Fund (QNRF))	The authors would like to thank The Australian Research Council (A.B.J.P., P.P.G., A.G.E., E.G.S.), the Australian Institute for Bioengineering and Nanotechnology (http://www.aibn.uq.edu.au/), the National Health and Medical Research Council (NHMRC) of Australia (D.A.E., A.G.E., E.G.S.) and the Qatar National Research Fund (D.A.E., A.G.E., E.G.S.) for funding. A.G.E. and E.G.S. are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Elliott DA, 2011, NAT METHODS; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; FREY T, 1995, CYTOMETRY, V21, P265, DOI 10.1002/cyto.990210307; Fujisawa K, 2009, BIOCHEM BIOPH RES CO, V379, P43, DOI 10.1016/j.bbrc.2008.11.141; Gahan ME, 2001, J CLIN VIROL, V22, P241, DOI 10.1016/S1386-6532(01)00195-0; Gibson TC, 2006, REPROD BIOMED ONLINE, V12, P101, DOI 10.1016/S1472-6483(10)60987-X; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Kanazawa M, 1997, BIOCHEM BIOPH RES CO, V239, P580, DOI 10.1006/bbrc.1997.7448; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Larsson NG, 1997, HUM MOL GENET, V6, P185, DOI 10.1093/hmg/6.2.185; Lonergan T, 2007, MITOCHONDRION, V7, P289, DOI 10.1016/j.mito.2007.05.002; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Miller FJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng060; Narendra DP, 2012, NATURE, V483, P418, DOI 10.1038/nature10952; Nesti C, 2007, BIOSCIENCE REP, V27, P165, DOI 10.1007/s10540-007-9044-1; Ng ES, 2008, NAT PROTOC, V3, P768, DOI 10.1038/nprot.2008.42; Ng Elizabeth S, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01d03s4; Oh SK, 2005, STEM CELLS, V23, P211, DOI 10.1634/stemcells.2004-0122; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Prowse ABJ, 2009, STEM CELLS DEV, V18, P1135, DOI 10.1089/scd.2009.0080; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; San Martin N, 2011, STEM CELLS, V29, P1064, DOI 10.1002/stem.654; Sharma NS, 2009, TISSUE ENG PART C-ME, V15, P297, DOI 10.1089/ten.tec.2008.0303; Snyder DS, 2001, J IMMUNOL METHODS, V257, P35, DOI 10.1016/S0022-1759(01)00440-9; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; St John JC, 2006, METH MOL B, V331, P347; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	50	34	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52214	10.1371/journal.pone.0052214	http://dx.doi.org/10.1371/journal.pone.0052214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284940	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300081
J	Liu, H; Patil, HP; de Vries-Idema, J; Wilschut, J; Huckriede, A				Liu, Heng; Patil, Harshad P.; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke			Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PULMONARY DELIVERY; BELLS-PALSY; IMMUNITY; INFECTION; RESPONSES; ANTIBODY; PROTEIN; CELLS; TRACT	Identification of safe and effective adjuvants remains an urgent need for the development of inactivated influenza vaccines for mucosal administration. Here, we used a murine challenge model to evaluate the adjuvant activity of GPI-0100, a saponin-derived adjuvant, on influenza subunit vaccine administered via the intranasal or the intrapulmonary route. Balb/c mice were immunized with 1 mu g A/PR/8 (H1N1) subunit antigen alone or in combination with varying doses of GPI-0100. The addition of GPI-0100 was required for induction of mucosal and systemic antibody responses to intranasally administered influenza vaccine and significantly enhanced the immunogenicity of vaccine administered via the intrapulmonary route. Remarkably, GPI-0100-adjuvanted influenza vaccine given at a low dose of 2x1 mu g either in the nares or directly into the lungs provided complete protection against homologous influenza virus infection.	[Liu, Heng; Patil, Harshad P.; de Vries-Idema, Jacqueline; Wilschut, Jan; Huckriede, Anke] Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, Groningen, Netherlands	University of Groningen	Huckriede, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Mol Virol Sect, Dept Med Microbiol, Groningen, Netherlands.	a.l.w.huckriede@med.umcg.nl	Huckriede, Anke/P-3558-2019	Huckriede, Anke/0000-0002-2646-5143	Netherlands Influenza Vaccine Research Centre (NIVAREC); Netherlands Organisation for Health Research and Development (ZonMw); Jan Kornelis de cock stichting	Netherlands Influenza Vaccine Research Centre (NIVAREC); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Jan Kornelis de cock stichting	This study was conducted under the auspices of the Netherlands Influenza Vaccine Research Centre (NIVAREC), financially supported by the Netherlands Organisation for Health Research and Development (ZonMw). The study received a subsidy from Jan Kornelis de cock stichting (http://www.decockstichting.nl/subsidies.html). None of the funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorij JP, 2010, LANCET INFECT DIS, V10, P699, DOI 10.1016/S1473-3099(10)70157-2; Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Belshe Robert, 2004, Expert Rev Vaccines, V3, P643, DOI 10.1586/14760584.3.6.643; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Block Stan L, 2004, Paediatr Drugs, V6, P199, DOI 10.2165/00148581-200406040-00001; Boyce TG, 2000, VACCINE, V19, P217, DOI 10.1016/S0264-410X(00)00171-7; Brandt C, 1997, J INFECT DIS, V176, P884, DOI 10.1086/516503; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2009, SCAND J IMMUNOL, V70, P505, DOI 10.1111/j.1365-3083.2009.02319.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Constant SL, 2000, EUR J IMMUNOL, V30, P840, DOI 10.1002/1521-4141(200003)30:3<840::AID-IMMU840>3.0.CO;2-L; Constant SL, 2002, J CLIN INVEST, V110, P1441, DOI 10.1172/JCI200216109; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Coulter A, 2003, VACCINE, V21, P946, DOI 10.1016/S0264-410X(02)00545-5; Hagiwara Y, 1999, VACCINE, V17, P2918, DOI 10.1016/S0264-410X(99)00135-8; Hasegawa H, 2005, J MED VIROL, V75, P130, DOI 10.1002/jmv.20247; Jabbal-Gill I, 2010, J DRUG TARGET, V18, P771, DOI 10.3109/1061186X.2010.523790; Kistner O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009349; Lawson LB, 2011, CURR OPIN IMMUNOL, V23, P414, DOI 10.1016/j.coi.2011.03.009; Liu H, 2011, VACCINE, V29, P2037, DOI 10.1016/j.vaccine.2011.01.012; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Marciani DJ, 2000, VACCINE, V18, P3141, DOI 10.1016/S0264-410X(00)00118-3; Marciani DJ, 2003, VACCINE, V21, P3961, DOI 10.1016/S0264-410X(03)00298-6; Mbawuike IN, 1999, J IMMUNOL, V162, P2530; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Persson CGA, 1998, SCAND J IMMUNOL, V47, P302; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Renegar KB, 2004, J IMMUNOL, V173, P1978, DOI 10.4049/jimmunol.173.3.1978; Sanders MT, 2009, VACCINE, V27, P2475, DOI 10.1016/j.vaccine.2009.02.054; Sharma S, 2009, J PHARM SCI-US, V98, P812, DOI 10.1002/jps.21493; Slovin SF, 2005, VACCINE, V23, P3114, DOI 10.1016/j.vaccine.2005.01.072; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Vujanic A, 2012, VET IMMUNOL IMMUNOP, V148, P172, DOI 10.1016/j.vetimm.2011.03.004; Vujanic A, 2012, CLIN VACCINE IMMUNOL, V19, P79, DOI 10.1128/CVI.05265-11; Vujanic A, 2010, VACCINE, V28, P2593, DOI 10.1016/j.vaccine.2010.01.018; Wee JLK, 2008, MUCOSAL IMMUNOL, V1, P489, DOI 10.1038/mi.2008.59; Yamamoto M, 1996, ANN NY ACAD SCI, V778, P64, DOI 10.1111/j.1749-6632.1996.tb21115.x; Zhang P, 2003, VACCINE, V21, P4459, DOI 10.1016/S0264-410X(03)00438-9	45	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52135	10.1371/journal.pone.0052135	http://dx.doi.org/10.1371/journal.pone.0052135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284901	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900079
J	Yao, HH; Duan, M; Yang, L; Buch, S				Yao, Honghong; Duan, Ming; Yang, Lu; Buch, Shilpa			Nonmuscle myosin light-chain kinase mediates microglial migration induced by HIV Tat: Involvement of beta 1 integrins	FASEB JOURNAL			English	Article						neuroinflammation; nmMYLK	IN-VIVO; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; EXTRACELLULAR-MATRIX; BARRIER DYSFUNCTION; INTEGRIN REGULATION; ACTIVATION; PROTEIN; PHOSPHORYLATION; ATP	One of the hallmark features of HIV-associated neurological disease is increased activation and migration of microglia. HIV transactivator of transcription (Tat) is released from infected cells and has the ability to recruit microglia. The purpose of this study was to investigate molecular mechanisms by which recombinant Tat(1-72), but not heated-inactive Tat(1-72), induces migration of rat primary microglia. Using primary microglia in Boyden chambers, we demonstrated the role of nonmuscle myosin light-chain kinase (nmMYLK) in Tat(1-72) (14.4 nM)-mediated increased microglial migration (up to 171.85%). These findings were validated using microglia isolated from wild-type (WT) or nmMYLK(-/-) mice in Dunn chamber assays. Tat(1-72)-mediated activation of nmMYLK resulted in "inside-out" activation of beta 1 integrin, followed by "outside-in" activation of c-Src, Pyk2, and Cdc42-GTP (using GLISA in primary and nmMYLK(-/-) microglia) and, subsequently, actin polymerization (flow cytometry and Western blot assays). In vivo corroboration of these findings demonstrated decreased migration of nmMYLK(-/-) microglia (2 x 10(5) cells transplanted into corpus callosum) compared with WT microglia toward microinjected Tat(1-72) (2 mu g/mouse) in hippocampus. Up-regulation of nmMYLK in microglia was also detected in sections of basal ganglia from humans with HIV-encephalitis compared with uninfected controls. nmMYLK is thus critical for eliciting microglial migration during the innate immune response.-Yao, H., Duan, M., Yang, L., Buch, S. Nonmuscle myosin lightchain kinase mediates microglial migration induced by HIV Tat: Involvement of beta 1 integrins. FASEB J. 27, 1532-1548 (2013). www.fasebj.org	[Yao, Honghong; Yang, Lu; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Duan, Ming] Jilin Univ, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China	University of Nebraska System; University of Nebraska Medical Center; Jilin University	Buch, S (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, 985880 Nebraska Med Ctr,DRC 8011, Omaha, NE 68198 USA.	sbuch@unmc.edu	duan, ming/M-9892-2016	Buch, Shilpa/0000-0002-3103-6685	U.S. National Institutes of Health [MH-068212, DA020392, DA023397, DA024442, DA030285]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068212, P30MH062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020392, R21DA023397, R01DA024442, R21DA030285] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Yaman Lu for technical support. This work was supported by grants MH-068212, DA020392, DA023397, and DA024442 (S.B.), and DA030285 (H.Y.) from the U.S. National Institutes of Health. The authors declare no conflicts of interest.	ADELSTEIN RS, 1983, J CLIN INVEST, V72, P1863, DOI 10.1172/JCI111148; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Birukov KG, 2001, J BIOL CHEM, V276, P8567, DOI 10.1074/jbc.M005270200; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dudek SM, 2002, BIOCHEM BIOPH RES CO, V298, P511, DOI 10.1016/S0006-291X(02)02492-0; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Haorah J, 2005, J LEUKOCYTE BIOL, V78, P1223, DOI 10.1189/jlb.0605340; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hixenbaugh EA, 1997, AM J PHYSIOL-HEART C, V273, pH981, DOI 10.1152/ajpheart.1997.273.2.H981; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kudryashov DS, 1999, FEBS LETT, V463, P67, DOI 10.1016/S0014-5793(99)01591-4; Kurpius D, 2006, GLIA, V54, P58, DOI 10.1002/glia.20355; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Ley K, 2002, IMMUNOL REV, V186, P8, DOI 10.1034/j.1600-065X.2002.18602.x; Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313, DOI 10.1002/jlb.65.3.313; Lu SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023915; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Miao HX, 2010, INVEST OPHTH VIS SCI, V51, P4096, DOI 10.1167/iovs.10-5177; Miller AM, 2009, GLIA, V57, P875, DOI 10.1002/glia.20813; Milner R, 2003, J IMMUNOL, V170, P3850, DOI 10.4049/jimmunol.170.7.3850; Milner R, 2002, J NEUROSCI, V22, P1562, DOI 10.1523/JNEUROSCI.22-05-01562.2002; Minghetti L, 2004, NEUROCHEM RES, V29, P965, DOI 10.1023/B:NERE.0000021241.90133.89; Mitola S, 1997, BLOOD, V90, P1365, DOI 10.1182/blood.V90.4.1365.1365_1365_1372; MOY AB, 1993, J CLIN INVEST, V92, P1198, DOI 10.1172/JCI116690; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Peng FW, 2008, EUR J NEUROSCI, V28, P1255, DOI 10.1111/j.1460-9568.2008.06444.x; Ranaivo HR, 2007, AM J PATHOL, V170, P439, DOI 10.2353/ajpath.2007.060219; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Reynoso R, 2007, SHOCK, V28, P589, DOI 10.1097/SHK.0b013c31804d415f; Rostasy KM, 2005, NEUROPEDIATRICS, V36, P230, DOI 10.1055/s-2005-865864; Rumbaugh J, 2006, FASEB J, V20, P1736, DOI 10.1096/fj.05-5619fje; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Saito H, 1998, J IMMUNOL, V161, P1533; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; STULL JT, 1988, AM J MED SCI, V296, P241, DOI 10.1016/S0002-9629(15)40865-1; Sun CX, 2011, CIRCULATION, V124, P48, DOI 10.1161/CIRCULATIONAHA.110.988915; TAYLOR DA, 1988, J BIOL CHEM, V263, P14456; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Urbinati C, 2005, ARTERIOSCL THROM VAS, V25, P2315, DOI 10.1161/01.ATV.0000186182.14908.7b; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; Van Grol J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011733; Wainwright MS, 2003, P NATL ACAD SCI USA, V100, P6233, DOI 10.1073/pnas.1031595100; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb SE, 1996, J CELL SCI, V109, P793; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Xu JS, 2008, NAT IMMUNOL, V9, P880, DOI 10.1038/ni.1628; Yao HH, 2009, J NEUROSCI, V29, P1657, DOI 10.1523/JNEUROSCI.2781-08.2009; Zhou F, 2008, J CELL MOL MED, V12, P1559, DOI 10.1111/j.1582-4934.2007.00144.x	64	13	13	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1532	1548		10.1096/fj.12-219600	http://dx.doi.org/10.1096/fj.12-219600			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23292072	Green Published			2022-12-25	WOS:000316940800025
J	Yu, YM; Zhu, JH; Huang, PS; Wang, JH; Pullen, N; Springer, TA				Yu, Yamei; Zhu, Jianghai; Huang, Po-Ssu; Wang, Jia-huai; Pullen, Nick; Springer, Timothy A.			Domain 1 of Mucosal Addressin Cell Adhesion Molecule Has an I1-set Fold and a Flexible Integrin-binding Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-LEVEL EXPRESSION; STRUCTURAL SPECIALIZATIONS; CRYSTAL-STRUCTURE; I-DOMAIN; MADCAM-1; RECOGNITION; IMMUNOGLOBULIN; VCAM-1; ALPHA(4)BETA(7); FRAGMENT	Mucosal addressin cell adhesion molecule (MAdCAM) binds integrin alpha(4)beta(7). Their interaction directs lymphocyte homing to mucosa-associated lymphoid tissues. The interaction between the two immunoglobulin superfamily (IgSF) domains of MAdCAM and integrin alpha(4)beta(7) is unusual in its ability to mediate either rolling adhesion or firm adhesion of lymphocytes on vascular surfaces. We determined four crystal structures of the IgSF domains of MAdCAM to test for unusual structural features that might correlate with this functional diversity. Higher resolution 1.7- and 1.4-angstrom structures of the IgSF domains of MAdCAM in a previously described crystal lattice revealed two alternative conformations of the integrin-binding loop, which were deformed by large lattice contacts. New crystal forms in the presence of two different Fabs to MAdCAM demonstrate a shift in IgSF domain topology from the I2- to I1-set, with a switch of integrin-binding loop from CC' to CD. The I1-set fold and CD loop appear biologically relevant. The different conformations seen in crystal structures suggest that the integrin-binding loop of MAdCAM is inherently flexible. This contrasts with rigidity of the corresponding loops in vascular cell adhesion molecule, intercellular adhesion molecule (ICAM)-1, ICAM-2, ICAM-3, and ICAM-5 and may reflect a specialization of MAdCAM to mediate both rolling and firm adhesion by binding to different alpha(4)beta(7) integrin conformations.	[Yu, Yamei; Zhu, Jianghai; Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, Boston, MA 02215 USA; [Yu, Yamei; Zhu, Jianghai; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Huang, Po-Ssu] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02215 USA; [Pullen, Nick] Pfizer Global Res & Dev, Cambridge, MA 02140 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Pfizer	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Program Cellular & Mol Med, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu	Zhu, Jianghai/B-7339-2014	Huang, Possu/0000-0002-7948-2895	National Institutes of Health [HL103526]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL103526.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Baerga-Ortiz A, 2000, J MOL BIOL, V296, P651, DOI 10.1006/jmbi.1999.3447; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Briskin M, 1997, AM J PATHOL, V151, P97; Briskin MJ, 1996, J IMMUNOL, V156, P719; BRISKIN MJ, 1993, NATURE, V363, P461, DOI 10.1038/363461a0; Casasnovas JM, 1997, NATURE, V387, P312, DOI 10.1038/387312a0; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; CHIU HH, 1995, J IMMUNOL, V155, P5257; Dando J, 2002, ACTA CRYSTALLOGR D, V58, P233, DOI 10.1107/S0907444901020522; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Green N, 1999, CELL ADHES COMMUN, V7, P167, DOI 10.3109/15419069909010800; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES EY, 1995, NATURE, V373, P539, DOI 10.1038/373539a0; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; Parikh A, 2012, INFLAMM BOWEL DIS, V18, P1470, DOI 10.1002/ibd.21896; Pullen N, 2009, BRIT J PHARMACOL, V157, P281, DOI 10.1111/j.1476-5381.2009.00137.x; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Song G, 2005, P NATL ACAD SCI USA, V102, P3366, DOI 10.1073/pnas.0500200102; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; STREETER PR, 1988, NATURE, V331, P41, DOI 10.1038/331041a0; Sun H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208900; Tan K, 1998, STRUCTURE, V6, P793, DOI 10.1016/S0969-2126(98)00080-X; Taylor P, 2001, ACTA CRYSTALLOGR D, V57, P1579, DOI 10.1107/S0907444901011209; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Vermeire S, 2011, GUT, V60, P1068, DOI 10.1136/gut.2010.226548; Viney JL, 1996, J IMMUNOL, V157, P2488; WANG JH, 1995, P NATL ACAD SCI USA, V92, P5714, DOI 10.1073/pnas.92.12.5714; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang HM, 2008, MOL CELL, V31, P432, DOI 10.1016/j.molcel.2008.06.022	46	5	7	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6284	6294		10.1074/jbc.M112.413153	http://dx.doi.org/10.1074/jbc.M112.413153			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297416	Green Published, hybrid			2022-12-25	WOS:000315820700023
J	Frasch, SC; Fernandez-Boyanapalli, RF; Berry, KAZ; Murphy, RC; Leslie, CC; Nick, JA; Henson, PM; Bratton, DL				Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Berry, Karin A. Zemski; Murphy, Robert C.; Leslie, Christina C.; Nick, Jerry A.; Henson, Peter M.; Bratton, Donna L.			Neutrophils Regulate Tissue Neutrophilia in Inflammation via the Oxidant-modified Lipid Lysophosphatidylserine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC GRANULOMATOUS-DISEASE; APOPTOTIC CELL CLEARANCE; NADPH OXIDASE; RESOLUTION; MACROPHAGES; RECEPTOR; PHAGOCYTOSIS; ACTIVATION; RESPONSES; GAMMA	Resolution of neutrophilia characteristic of acute inflammation requires cessation of neutrophil recruitment and removal of tissue neutrophils. Based on in vitro studies, a role in these events was hypothesized for oxidant-generated lysophosphatidylserine (lyso-PS) on recruited neutrophils signaling via the G2A receptor on macrophages. Peritoneal exudate neutrophils harvested from wild type (WT) mice had 5-fold more lyso-PS (lyso-PShigh) than those of gp91(phox-/-) (lyso-PSlow) mice. Ex vivo engulfment of lyso-PShigh neutrophils (95% viable) by WT peritoneal macrophages was quantitatively similar to UV-irradiated apoptotic blood neutrophils, although the signaling pathway for the former was uniquely dependent on macrophage G2A. In contrast, lyso-PSlow neutrophils were poorly engulfed unless presented with exogenous lyso-PS. Enhanced clearance of lyso-PShigh neutrophils was also seen in vivo following their adoptive transfer into inflamed peritonea of WT but not G2A(-/-) mice, further supporting a requirement for signaling via G2A. To investigate downstream effects of lyso-PS/G2A signaling, antibody blockade of G2A in WT mice reduced macrophage CD206 expression and efferocytosis during peritonitis. Conversely, adoptive transfer of lyso-PShigh neutrophils early in inflammation in gp91(phox-/-) mice led to accelerated development of efferocytic(high) and CD206(high) macrophages. This macrophage reprogramming was associated with suppressed production of pro-inflammatory mediators and reduced neutrophilia. These effects were not seen if G2A was blocked or lyso-PSlow neutrophils were transferred. Taken together, the results demonstrate that oxidant-generated lyso-PS made by viable tissue neutrophils is an endogenous anti-inflammatory mediator working in vivo to orchestrate the "early" and rapid clearance of recruited neutrophils as well as the reprogramming of "resolving" macrophages.	[Frasch, S. Courtney; Fernandez-Boyanapalli, Ruby F.; Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Leslie, Christina C.; Henson, Peter M.; Bratton, Donna L.] Natl Jewish Hlth, Cell Biol Program, Denver, CO 80206 USA; [Berry, Karin A. Zemski; Murphy, Robert C.] Univ Colorado, Dept Pharmacol, Aurora, CO 80045 USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Frasch, SC (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	fraschc@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515	National Institutes of Health [AI058228, HL34303, HL81151]; Chronic Granulomatous Disorder Society; Catherine Kramer Foundation in Pediatric Medicine; Eugene F. and Easton M. Crawford Charitable Lead Unitrust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081151, P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058228, R56AI058228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chronic Granulomatous Disorder Society; Catherine Kramer Foundation in Pediatric Medicine; Eugene F. and Easton M. Crawford Charitable Lead Unitrust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI058228 (to D. L. B.), HL34303 (to D. L. B., C. C. L., P. M. H., and R. C. M.), and HL81151 (to P. M. H.). This work was also supported by the Chronic Granulomatous Disorder Society (to D. L. B.), the Catherine Kramer Foundation in Pediatric Medicine (to D. L. B.), and the Eugene F. and Easton M. Crawford Charitable Lead Unitrust (to R. F. F.-B.).	Bolick DT, 2007, CIRC RES, V100, P572, DOI 10.1161/01.RES.0000258877.57836.d2; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Brown JR, 2003, J LEUKOCYTE BIOL, V73, P591, DOI 10.1189/jlb.1202599; Bylund J, 2007, EUR J IMMUNOL, V37, P1087, DOI 10.1002/eji.200636651; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Fernandez-Boyanapalli R, 2010, BLOOD, V116, P4512, DOI 10.1182/blood-2010-02-272005; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Frasch SC, 2008, J BIOL CHEM, V283, P33736, DOI 10.1074/jbc.M807047200; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; GALLIN JI, 1983, INFLAMMATION, V7, P227, DOI 10.1007/BF00917259; HASLETT C, 1985, AM J PATHOL, V119, P101; Henson PM, 2009, PHAGOCYTE-PATHOGEN INTERACTIONS: MACROPHAGES AND THE HOST RESPONSE TO INFECTION, P341; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; Kabarowski JH, 2009, PROSTAG OTH LIPID M, V89, P73, DOI 10.1016/j.prostaglandins.2009.04.007; LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047; Lopes F, 2011, ARTHRITIS RHEUM-US, V63, P2651, DOI 10.1002/art.30448; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McIlroy D, 2000, GENE DEV, V14, P549; Medeiros AI, 2009, J EXP MED, V206, P61, DOI 10.1084/jem.20082058; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Mukaro VRS, 2011, CURR DRUG TARGETS, V12, P460; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; NIBBERING PH, 1990, J IMMUNOL METHODS, V129, P143, DOI 10.1016/0022-1759(90)90432-U; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Parks BW, 2005, J LIPID RES, V46, P1405, DOI 10.1194/jlr.M500085-JLR200; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Rajakariar R, 2009, J IMMUNOL, V182, P3262, DOI 10.4049/jimmunol.0801739; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Sanford AN, 2006, RHEUMATOLOGY, V45, P178, DOI 10.1093/rheumatology/kei135; Sanmun D, 2009, AM J PHYSIOL-CELL PH, V297, pC621, DOI 10.1152/ajpcell.00651.2008; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Voltan S, 2008, GASTROENTEROLOGY, V135, P1216, DOI 10.1053/j.gastro.2008.07.007; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200; Zhang Y, 2010, J INTERF CYTOK RES, V30, P113, DOI 10.1089/jir.2010.0004	54	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4583	4593		10.1074/jbc.M112.438507	http://dx.doi.org/10.1074/jbc.M112.438507			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293064	hybrid, Green Published			2022-12-25	WOS:000315340400008
J	Teh, PG; Chen, MJ; Engel, JL; Worby, CA; Manning, G; Dixon, JE; Zhang, J				Teh, Phildrich G.; Chen, Mark J.; Engel, James L.; Worby, Carolyn A.; Manning, Gerard; Dixon, Jack E.; Zhang, Ji			Identification of a Mammalian-type Phosphatidylglycerophosphate Phosphatase in the Eubacterium Rhodopirellula baltica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE PROTEIN-SEQUENCE; MITOCHONDRIAL PHOSPHATASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; LIPID 2ND-MESSENGER; WEB SERVER; PEL1 GENE; CARDIOLIPIN; DEPHOSPHORYLATES; BACTERIAL	Cardiolipin is a glycerophospholipid found predominantly in the mitochondrial membranes of eukaryotes and in bacterial membranes. Cardiolipin interacts with protein complexes and plays pivotal roles in cellular energy metabolism, membrane dynamics, and stress responses. We recently identified the mitochondrial phosphatase, PTPMT1, as the enzyme that converts phosphatidylglycerolphosphate (PGP) to phosphatidylglycerol, a critical step in the de novo biosynthesis of cardiolipin. Upon examination of PTPMT1 evolutionary distribution, we found a PTPMT1-like phosphatase in the bacterium Rhodopirellula baltica. The purified recombinant enzyme dephosphorylated PGP in vitro. Moreover, its expression restored cardiolipin deficiency and reversed growth impairment in a Saccharomyces cerevisiae mutant lacking the yeast PGP phosphatase, suggesting that it is a bona fide PTPMT1 ortholog. When ectopically expressed, this bacterial PGP phosphatase was localized in the mitochondria of yeast and mammalian cells. Together, our results demonstrate the conservation of function between bacterial and mammalian PTPMT1 orthologs.	[Teh, Phildrich G.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Engel, James L.; Worby, Carolyn A.; Dixon, Jack E.; Zhang, Ji] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Mark J.; Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA; [Chen, Mark J.; Manning, Gerard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Roche Holding; Genentech; Howard Hughes Medical Institute	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jedixon@ucsd.edu; jz3@ucsd.edu	Manning, Gerard/C-8308-2009; Chen, Mark/O-3937-2014	Chen, Mark/0000-0003-1169-563X; Manning, Gerard/0000-0002-5087-9151	National Institutes of Health [DK18024, DK18849, HG004164]; Barth Syndrome Foundation; American Heart Association [12SDG12070058]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; American Heart Association(American Heart Association)	This work was supported by Grants DK18024 and DK18849 (to J. E. D.), HG004164 (to G. M.) from the National Institutes of Health, the Barth Syndrome Foundation research grant and the American Heart Association Scientist Development Grant # 12SDG12070058 (to J. Z.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Brachmann CB, 1998, YEAST, V14, P115; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; CHANG YY, 1967, J LIPID RES, V8, P456; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Corcelli A, 2009, BBA-BIOMEMBRANES, V1788, P2101, DOI 10.1016/j.bbamem.2009.05.010; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Devos DP, 2010, SCIENCE, V330, P1187, DOI 10.1126/science.1196720; DOWHAN W, 1992, METHOD ENZYMOL, V209, P313; Fauman EB, 1996, TRENDS BIOCHEM SCI, V21, P413, DOI 10.1016/S0968-0004(96)10059-1; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Habib SJ, 2007, METHOD CELL BIOL, V80, P761, DOI 10.1016/S0091-679X(06)80035-X; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Papatheodorou P, 2006, CELL MICROBIOL, V8, P677, DOI 10.1111/j.1462-5822.2005.00660.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Tagliabracci VS, 2007, P NATL ACAD SCI USA, V104, P19262, DOI 10.1073/pnas.0707952104; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Winkelmann N, 2009, J MICROBIOL METH, V77, P276, DOI 10.1016/j.mimet.2009.03.002; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; Xiao JY, 2011, P NATL ACAD SCI USA, V108, P11860, DOI 10.1073/pnas.1109290108; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	51	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5176	5185		10.1074/jbc.M112.413617	http://dx.doi.org/10.1074/jbc.M112.413617			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293031	Green Published, hybrid			2022-12-25	WOS:000315340400065
J	Bucci, M; Papapetropoulos, A; Vellecco, V; Zhou, ZM; Zaid, A; Giannogonas, P; Cantalupo, A; Dhayade, S; Karalis, KP; Wang, R; Feil, R; Cirino, G				Bucci, Mariarosaria; Papapetropoulos, Andreas; Vellecco, Valentina; Zhou, Zongmin; Zaid, Altaany; Giannogonas, Panagiotis; Cantalupo, Anna; Dhayade, Sandeep; Karalis, Katia P.; Wang, Rui; Feil, Robert; Cirino, Giuseppe			cGMP-Dependent Protein Kinase Contributes to Hydrogen Sulfide-Stimulated Vasorelaxation	PLOS ONE			English	Article							NITRIC-OXIDE; INDUCED RELAXATION; CARBON-MONOXIDE; IN-VITRO; H2S; ENDOTHELIUM; ACTIVATION; INHIBITOR; RATS; ANGIOGENESIS	A growing body of evidence suggests that hydrogen sulfide (H2S) is a signaling molecule in mammalian cells. In the cardiovascular system, H2S enhances vasodilation and angiogenesis. H2S-induced vasodilation is hypothesized to occur through ATP-sensitive potassium channels (K-ATP); however, we recently demonstrated that it also increases cGMP levels in tissues. Herein, we studied the involvement of cGMP-dependent protein kinase-I in H2S-induced vasorelaxation. The effect of H2S on vessel tone was studied in phenylephrine-contracted aortic rings with or without endothelium. cGMP levels were determined in cultured cells or isolated vessel by enzyme immunoassay. Pretreatment of aortic rings with sildenafil attenuated NaHS-induced relaxation, confirming previous findings that H2S is a phosphodiesterase inhibitor. In addition, vascular tissue levels of cGMP in cystathionine gamma lyase knockouts were lower than those in wild-type control mice. Treatment of aortic rings with NaHS, a fast releasing H2S donor, enhanced phosphorylation of vasodilator-stimulated phosphoprotein in a time-dependent manner, suggesting that cGMP-dependent protein kinase (PKG) is activated after exposure to H2S. Incubation of aortic rings with a PKG-I inhibitor (DT-2) attenuated NaHS-stimulated relaxation. Interestingly, vasodilatory responses to a slowly releasing H2S donor (GYY 4137) were unaffected by DT-2, suggesting that this donor dilates mouse aorta through PKG-independent pathways. Dilatory responses to NaHS and L-cysteine (a substrate for H2S production) were reduced in vessels of PKG-I knockout mice (PKG-I-/-). Moreover, glibenclamide inhibited NaHS-induced vasorelaxation in vessels from wild-type animals, but not PKG-I-/-, suggesting that there is a cross-talk between K-ATP and PKG. Our results confirm the role of cGMP in the vascular responses to NaHS and demonstrate that genetic deletion of PKG-I attenuates NaHS and L-cysteine-stimulated vasodilation.	[Bucci, Mariarosaria; Vellecco, Valentina; Cantalupo, Anna; Cirino, Giuseppe] Univ Naples Federico II, Dept Expt Pharmacol, Fac Pharm, Naples, Italy; [Papapetropoulos, Andreas] Univ Patras, Dept Pharm, Mol Pharmacol Lab, Patras, Greece; [Papapetropoulos, Andreas; Giannogonas, Panagiotis; Karalis, Katia P.] Acad Athens, Dev Biol Sect, Ctr Basic Res, Biomed Res Fdn, Athens, Greece; [Zhou, Zongmin] Univ Athens, Sch Med, GP Livanos Lab, Dept Crit Care & Pulm Serv 1, GR-11527 Athens, Greece; [Zaid, Altaany; Wang, Rui] Lakehead Univ, Dept Biol, Thunder Bay, ON P7B 5E1, Canada; [Dhayade, Sandeep; Feil, Robert] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany	University of Naples Federico II; University of Patras; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; Lakehead University; Eberhard Karls University of Tubingen	Papapetropoulos, A (corresponding author), Univ Naples Federico II, Dept Expt Pharmacol, Fac Pharm, Naples, Italy.	apapapet@upatras.gr	Feil, Robert/B-8918-2014; Andreas, Papapetropoulos/AAJ-3089-2020; Wang, Rui/C-7824-2012	Feil, Robert/0000-0002-7335-4841; Wang, Rui/0000-0003-3825-3620; Vellecco, Valentina/0000-0002-5674-9112; Altaany, Zaid/0000-0002-3260-9078; Dhayade, Sandeep/0000-0002-1681-8216; Papapetropoulos, Andreas/0000-0002-4253-5930; Cirino, Giuseppe/0000-0003-3954-4083	Fondazione per la Ricerca Scientifica Termale FoRST (Rome, Italy); European Union (European Social Fund - ESF); Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; European Social Fund; Aristeia [1436]; EU FP7 REGPOT [CT-2011-285950]; COST Action (ENOG: European network on gasotransmitters) [BM1005]; Discovery grant from the Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation Canada	Fondazione per la Ricerca Scientifica Termale FoRST (Rome, Italy); European Union (European Social Fund - ESF)(European Social Fund (ESF)); Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; European Social Fund(European Social Fund (ESF)); Aristeia; EU FP7 REGPOT; COST Action (ENOG: European network on gasotransmitters); Discovery grant from the Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada)	This work has been funded by Fondazione per la Ricerca Scientifica Termale FoRST (Rome, Italy (to GC) and co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Thalis; Investing in knowledge society through the European Social Fund and Aristeia 2011 (1436) to AP, by EU FP7 REGPOT CT-2011-285950 - "SEE-DRUG" and by the COST Action BM1005 (ENOG: European network on gasotransmitters). This work has also been partially supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada and the Heart and Stroke Foundation Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Chai YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018191; Cheang WS, 2010, VASC PHARMACOL, V53, P94, DOI 10.1016/j.vph.2010.04.004; Cheng YQ, 2004, AM J PHYSIOL-HEART C, V287, pH2316, DOI 10.1152/ajpheart.00331.2004; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Costa ADT, 2005, CIRC RES, V97, P329, DOI 10.1161/01.RES.0000178451.08719.5b; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Dhaese I, 2009, EUR J PHARMACOL, V606, P180, DOI 10.1016/j.ejphar.2009.01.011; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Gambaryan S, 2012, BRIT J PHARMACOL, V167, P826, DOI 10.1111/j.1476-5381.2012.02044.x; Han J, 2002, AM J PHYSIOL-HEART C, V283, pH1545, DOI 10.1152/ajpheart.01052.2001; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Hu LF, 2011, J PHARMACOL EXP THER, V339, P726, DOI 10.1124/jpet.111.184754; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; Jiang B, 2010, ANTIOXID REDOX SIGN, V12, P1167, DOI 10.1089/ars.2009.2894; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Kubo S, 2007, TOXICOLOGY, V232, P138, DOI 10.1016/j.tox.2006.12.023; Lavu M, 2011, CLIN SCI, V120, P219, DOI 10.1042/CS20100462; Li L, 2011, ANN REV PHARM TOXICO, V51; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; LIU YH, 2011, J CARDIOVASC PHARM; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; PAPAPETROPOULOS A, 1994, HYPERTENSION, V23, P476, DOI 10.1161/01.HYP.23.4.476; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Roy A, 2012, AM J HYPERTENS, V25, P74, DOI 10.1038/ajh.2011.149; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Teixeira CE, 2006, J PHARMACOL EXP THER, V316, P654, DOI 10.1124/jpet.105.092544; Valtcheva N, 2009, J BIOL CHEM, V284, P556, DOI 10.1074/jbc.M806161200; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang R, 2011, CURR OPIN NEPHROL HY, V20, P107, DOI 10.1097/MNH.0b013e3283430651; Wang R, 2009, KIDNEY INT, V76, P700, DOI 10.1038/ki.2009.221; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Yan H, 2004, BIOCHEM BIOPH RES CO, V313, P22, DOI 10.1016/j.bbrc.2003.11.081; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Zhao W., 2002, AM J PHYSL HEART CIR, V283, pH474; Zhao WM, 2003, CAN J PHYSIOL PHARM, V81, P848, DOI 10.1139/Y03-077; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296; Zhou ZM, 2012, BIOORGAN MED CHEM, V20, P2675, DOI 10.1016/j.bmc.2012.02.028	48	111	114	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53319	10.1371/journal.pone.0053319	http://dx.doi.org/10.1371/journal.pone.0053319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285278	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500132
J	Linnebank, M; Moskau, S; Semmler, A; Hoefgen, B; Bopp, G; Kallweit, U; Maier, W; Schutz, CG; Wullner, U				Linnebank, Michael; Moskau, Susanna; Semmler, Alexander; Hoefgen, Barbara; Bopp, Gisela; Kallweit, Ulf; Maier, Wolfgang; Schuetz, Christian G.; Wuellner, Ullrich			A Possible Genetic Link between MTHFR Genotype and Smoking Behavior	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; HOMOCYSTEINE; POLYMORPHISMS	Background: Hyperhomocysteinemia is an independent risk factor for stroke and other vascular events. The variant methylenetetrahydrofolate reductase (MTHFR) C677T is associated with elevated homocysteine levels, cardiovascular disease and stroke, which supports a causal relationship between hyperhomocysteinemia and vascular disease. However, MTHFR variants have also been reported to be associated with smoking behavior, which could be an important confounder. Methodology/Principal Findings: We analyzed the MTHFR variants C677T and A1298C in two independent samples of 525 and 535 individuals, respectively. 21% of the non-smokers, but only 12% of the smokers were homozygous carriers of both MTHFR wildtype alleles, i.e. 677CC and 1298AA (Chi(2) = 15.8; p<0.001; binary regression). Plasma homocysteine levels were higher in smokers (13.9 +/- 4.1 mu mol/L) than in non-smokers (12.6 +/- 4.0 mu mol/L; F = 11.4; p = 0.001; ANOVA). Smoking MTHFR 677TT individuals had the highest plasma homocysteine levels (16.2 +/- 5.2 mu mol/L), non-smoking 677CC individuals had the lowest (12.2 +/- 13.6 mu mol/L). Conclusions/Significance: In our study samples, MTHFR variants and smoking behaviour were associated with homocysteine plasma levels. In addition, the MTHFR variants were associated with smoking behaviour. Such an association may be a relevant confounder between MTHFR variants, homocysteine plasma levels and vascular diseases.	[Linnebank, Michael; Moskau, Susanna; Semmler, Alexander; Wuellner, Ullrich] Univ Hosp Bonn, Dept Neurol, Bonn, Germany; [Hoefgen, Barbara; Bopp, Gisela; Maier, Wolfgang; Schuetz, Christian G.] Univ Hosp Bonn, Dept Psychiat, Bonn, Germany; [Linnebank, Michael; Semmler, Alexander; Kallweit, Ulf] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Schuetz, Christian G.] Univ British Columbia, Inst Mental Hlth, Vancouver, BC V5Z 1M9, Canada	University of Bonn; University of Bonn; University of Zurich; University Zurich Hospital; University of British Columbia	Linnebank, M (corresponding author), Univ Hosp Bonn, Dept Neurol, Bonn, Germany.	michael.linnebank@usz.ch	Kallweit, Ulf/AAM-3989-2021; Wüllner, Ullrich/R-6790-2019					Brown KS, 2004, ATHEROSCLEROSIS, V174, P315, DOI 10.1016/j.atherosclerosis.2004.01.023; Goyette P, 1998, MAMM GENOME, V9, P652, DOI 10.1007/s003359900838; Hankey GJ, 2005, LANCET, V365, P194; Husemoen LLN, 2004, EUR J CLIN NUTR, V58, P1142, DOI 10.1038/sj.ejcn.1601942; Imyanitov EN, 2004, CANCER LETT, V204, P3, DOI 10.1016/j.canlet.2003.09.026; Johnson WG, 2001, AM J MED GENET, V98, P361, DOI 10.1002/1096-8628(20010201)98:4<361::AID-AJMG1111>3.0.CO;2-F; Linnebank M, 2000, EUR J PEDIATR, V159, P472, DOI 10.1007/s004310051311; Liu Chiu-Shong, 2009, Cancer Genomics & Proteomics, V6, P325; Mudd S. H, 2001, DISORDERS TRANSSULFU, P2007	9	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53322	10.1371/journal.pone.0053322	http://dx.doi.org/10.1371/journal.pone.0053322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285280	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500134
J	Bobermin, LD; Quincozes-Santos, A; Guerra, MC; Leite, MC; Souza, DO; Goncalves, CA; Gottfried, C				Bobermin, Larissa Daniele; Quincozes-Santos, Andre; Guerra, Maria Cristina; Leite, Marina Concli; Souza, Diogo Onofre; Goncalves, Carlos-Alberto; Gottfried, Carmem			Resveratrol Prevents Ammonia Toxicity in Astroglial Cells	PLOS ONE			English	Article							C6 GLIOMA-CELLS; CORTICAL ASTROCYTE CULTURES; INCREASES GLUTAMATE UPTAKE; SYRUP-URINE-DISEASE; OXIDATIVE STRESS; S100B SECRETION; GLIAL-CELLS; LIVER-FAILURE; NITRIC-OXIDE; CYCLIC-AMP	Ammonia is implicated as a neurotoxin in brain metabolic disorders associated with hyperammonemia. Acute ammonia toxicity can be mediated by an excitotoxic mechanism, oxidative stress and nitric oxide (NO) production. Astrocytes interact with neurons, providing metabolic support and protecting against oxidative stress and excitotoxicity. Astrocytes also convert excess ammonia and glutamate into glutamine via glutamine synthetase (GS). Resveratrol, a polyphenol found in grapes and red wines, exhibits antioxidant and anti-inflammatory properties and modulates glial functions, such as glutamate metabolism. We investigated the effect of resveratrol on the production of reactive oxygen species (ROS), GS activity, S100B secretion, TNF-alpha, IL-1 beta and IL-6 levels in astroglial cells exposed to ammonia. Ammonia induced oxidative stress, decreased GS activity and increased cytokines release, probably by a mechanism dependent on protein kinase A (PKA) and extracellular signal-regulated kinase (ERK) pathways. Resveratrol prevented ammonia toxicity by modulating oxidative stress, glial and inflammatory responses. The ERK and nuclear factor-kappa B (NF-kappa B) are involved in the protective effect of resveratrol on cytokines proinflammatory release. In contrast, other antioxidants (e. g., ascorbic acid and trolox) were not effective against hyperammonemia. Thus, resveratrol could be used to protect against ammonia-induced neurotoxicity.	[Bobermin, Larissa Daniele; Quincozes-Santos, Andre; Guerra, Maria Cristina; Leite, Marina Concli; Souza, Diogo Onofre; Goncalves, Carlos-Alberto; Gottfried, Carmem] Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Quincozes-Santos, A (corresponding author), Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Dept Biochem, Porto Alegre, RS, Brazil.	andrequincozes@yahoo.com.br	Souza, Diogo O/J-8894-2014; Quincozes-Santos, André/AAO-2714-2020; Bobermin, Larissa/AGN-9475-2022; Goncalves, Carlos Alberto/K-1851-2014; Gottfried, Carmem/AAG-2355-2019	Souza, Diogo O/0000-0002-4322-0404; Gottfried, Carmem/0000-0001-8838-1300; /0000-0002-1907-6051; Quincozes-Santos, Andre/0000-0001-8611-4890	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FINEP/Rede IBN [01.06.0842-00]; INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP/Rede IBN(Financiadora de Inovacao e Pesquisa (Finep)); INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), FINEP/Rede IBN 01.06.0842-00 and INCTEN National Institute of Science and Technology for Excitotoxicity and Neuroprotection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Bastianetto S, 2010, EXP NEUROL, V225, P237, DOI 10.1016/j.expneurol.2010.06.019; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Buzanska L, 2000, NEUROCHEM INT, V37, P287, DOI 10.1016/S0197-0186(00)00030-9; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; dos Santos AQ, 2006, ARCH BIOCHEM BIOPHYS, V453, P161, DOI 10.1016/j.abb.2006.06.025; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felipo V, 1998, NEUROTOXICOLOGY, V19, P675; Fernandes A, 2007, EUR J NEUROSCI, V25, P1058, DOI 10.1111/j.1460-9568.2007.05340.x; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Funchal C, 2007, J NEUROL SCI, V260, P87, DOI 10.1016/j.jns.2007.04.011; Funchal C, 2006, NEUROCHEM INT, V49, P640, DOI 10.1016/j.neuint.2006.05.007; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Gorg B, 2008, HEPATOLOGY, V48, P567, DOI 10.1002/hep.22345; Goncalves D, 2002, NEUROREPORT, V13, P1533; Guerra MC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-128; Gutteridge JMC, 2010, BIOCHEM BIOPH RES CO, V393, P561, DOI 10.1016/j.bbrc.2010.02.071; Haussinger D, 2010, CURR OPIN CLIN NUTR, V13, P87, DOI 10.1097/MCO.0b013e328333b829; Haghighat N, 2000, NEUROCHEM RES, V25, P277, DOI 10.1023/A:1007535922977; Hamby ME, 2008, NEUROCHEM INT, V52, P962, DOI 10.1016/j.neuint.2007.10.010; He F, 2007, INT J BIOCHEM CELL B, V39, P661, DOI 10.1016/j.biocel.2006.10.022; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hillmann P, 2008, TOXICOL APPL PHARM, V227, P36, DOI 10.1016/j.taap.2007.10.012; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Huang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029102; Jayakumar AR, 2006, NEUROCHEM INT, V48, P623, DOI 10.1016/j.neuint.2005.11.017; Jayakumar AR, 2006, J NEUROSCI, V26, P4774, DOI 10.1523/JNEUROSCI.0120-06.2006; King CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018713; Kosenko E, 1997, METAB BRAIN DIS, V12, P69, DOI 10.1007/BF02676355; Kosenko E, 1997, FREE RADICAL RES, V27, P637, DOI 10.3109/10715769709097867; Kwon KJ, 2011, J PINEAL RES, V50, P110, DOI 10.1111/j.1600-079X.2010.00820.x; Lee EO, 2010, J NEUROCHEM, V112, P1477, DOI 10.1111/j.1471-4159.2009.06564.x; Leite MC, 2008, J NEUROSCI METH, V169, P93, DOI 10.1016/j.jneumeth.2007.11.021; Leite MC, 2006, BRAIN RES BULL, V70, P179, DOI 10.1016/j.brainresbull.2006.05.003; Leite MC, 2009, J NEUROSCI RES, V87, P2439, DOI 10.1002/jnr.22083; Lemberg A, 2009, ANN HEPATOL, V8, P95, DOI 10.1016/S1665-2681(19)31785-5; LISKOWSKY DR, 1986, BRAIN RES, V386, P386, DOI 10.1016/0006-8993(86)90176-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; Monfort P, 2002, METAB BRAIN DIS, V17, P237, DOI 10.1023/A:1021993431443; Monfort P, 2002, NEUROCHEM INT, V41, P95, DOI 10.1016/S0197-0186(02)00029-3; Nardin P, 2007, NEUROCHEM INT, V50, P774, DOI 10.1016/j.neuint.2007.01.013; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; Norenberg MD, 2003, HEPATOLOGY, V37, P245, DOI 10.1053/jhep.2003.50087; Pellerin L, 2002, DIABETES NUTR METAB, V15, P268; Quincozes-Santos A, 2011, GLIA, V59, pS80; Quincozes-Santos A, 2007, NEUROTOXICOLOGY, V28, P886, DOI 10.1016/j.neuro.2007.03.008; Quincozes-Santos A, 2011, ANN NY ACAD SCI, V1215, P72, DOI 10.1111/j.1749-6632.2010.05857.x; Quincozes-Santos A, 2010, METAB BRAIN DIS, V25, P191, DOI 10.1007/s11011-010-9203-0; Quincozes-Santos A, 2010, TOXICOL IN VITRO, V24, P916, DOI 10.1016/j.tiv.2009.11.016; Quincozes-Santos A, 2009, NEUROTOX RES, V16, P30, DOI 10.1007/s12640-009-9042-0; Rose C, 2005, METAB BRAIN DIS, V20, P275, DOI 10.1007/s11011-005-7906-4; Rose C, 2005, J BIOL CHEM, V280, P20937, DOI 10.1074/jbc.M412448200; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Sakata Y, 2010, EXP NEUROL, V224, P325, DOI 10.1016/j.expneurol.2010.03.032; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schliess F, 2009, METAB BRAIN DIS, V24, P119, DOI 10.1007/s11011-008-9125-2; Schroeter ML, 2011, J AFFECT DISORDERS, V134, P32, DOI 10.1016/j.jad.2010.11.008; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Steiner J, 2010, NEUROSCIENCE, V167, P1025, DOI 10.1016/j.neuroscience.2010.03.010; Svoboda N, 2007, EUR J NEUROSCI, V25, P2285, DOI 10.1111/j.1460-9568.2007.05452.x; Tanabe K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-68; Tanabe K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-16; Tiwari V, 2011, J NEUROCHEM, V117, P678, DOI 10.1111/j.1471-4159.2011.07236.x; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881; de Almeida LMV, 2008, ARCH BIOCHEM BIOPHYS, V480, P27, DOI 10.1016/j.abb.2008.09.006; de Almeida LMV, 2008, NEUROCHEM RES, V33, P8, DOI 10.1007/s11064-007-9399-5; de Almeida LMV, 2007, CELL MOL NEUROBIOL, V27, P661, DOI 10.1007/s10571-007-9152-2; Wakabayashi N., 2010, ANTIOXID REDOX SIGNA; WESTERGAARD N, 1995, DEV NEUROSCI-BASEL, V17, P203, DOI 10.1159/000111288; Wiltfang J, 1999, METAB BRAIN DIS, V14, P239, DOI 10.1023/A:1020785009005; Zielinska M, 2005, NEUROCHEM RES, V30, P349, DOI 10.1007/s11064-005-2608-1	88	58	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52164	10.1371/journal.pone.0052164	http://dx.doi.org/10.1371/journal.pone.0052164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284918	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800034
J	Hare, JA; Wuenschel, MJ; Kimball, ME				Hare, Jonathan A.; Wuenschel, Mark J.; Kimball, Matthew E.			Projecting Range Limits with Coupled Thermal Tolerance - Climate Change Models: An Example Based on Gray Snapper (Lutjanus griseus) along the US East Coast	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; COD GADUS-MORHUA; MARINE FISH; POPULATION-STRUCTURE; IMPACTS; RESPONSES; FISHERIES; DYNAMICS; BIODIVERSITY; BIOGEOGRAPHY	We couple a species range limit hypothesis with the output of an ensemble of general circulation models to project the poleward range limit of gray snapper. Using laboratory-derived thermal limits and statistical downscaling from IPCC AR4 general circulation models, we project that gray snapper will shift northwards; the magnitude of this shift is dependent on the magnitude of climate change. We also evaluate the uncertainty in our projection and find that statistical uncertainty associated with the experimentally-derived thermal limits is the largest contributor (similar to 65%) to overall quantified uncertainty. This finding argues for more experimental work aimed at understanding and parameterizing the effects of climate change and variability on marine species.	[Hare, Jonathan A.] NOAA NMFS Narragansett Lab, Narragansett, RI 02882 USA; [Wuenschel, Mark J.] NOAA NMFS Woods Hole Lab, Woods Hole, MA USA; [Kimball, Matthew E.] GTM Natl Estuarine Res Reserve, Ponte Vedra Beach, FL USA; [Kimball, Matthew E.] Univ N Florida, Dept Biol, Jacksonville, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; State University System of Florida; University of North Florida	Hare, JA (corresponding author), NOAA NMFS Narragansett Lab, Narragansett, RI 02882 USA.	jon.hare@noaa.gov		Wuenschel, Mark/0000-0002-9307-7319				Able K. W., 2010, ECOLOGY ESTUARINE FI; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Brander K, 2003, ICES MARINE SCI S, V219, P261; Brett JR, 1979, FISH PHYSIOL, V8, P599, DOI DOI 10.1016/S1546-5098(08)60033-3; Cheung WWL, 2011, ICES J MAR SCI, V68, P1008, DOI 10.1093/icesjms/fsr012; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Cheung WW., 2008, MODELLING PRESENT CL; DelSole T, 2010, J CLIMATE, V23, P4794, DOI 10.1175/2010JCLI3164.1; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Faunce CH, 2007, B MAR SCI, V80, P473; Figueira WF, 2010, GLOBAL CHANGE BIOL, V16, P506, DOI 10.1111/j.1365-2486.2009.01934.x; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; FRANK KT, 1990, T AM FISH SOC, V119, P353, DOI 10.1577/1548-8659(1990)119<0353:PRONAI>2.3.CO;2; Fry F.E.J., 1971, P1; Furrer R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027754; Gold JR, 2009, COPEIA, P277, DOI 10.1643/CI-08-071; Gold JR, 1998, J HERED, V89, P404, DOI 10.1093/jhered/89.5.404; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hare JA, 2007, FISH OCEANOGR, V16, P31, DOI 10.1111/j.1365-2419.2006.00407.x; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Helmuth B, 2009, J EXP BIOL, V212, P753, DOI 10.1242/jeb.023861; HETTLER WF, 1982, FISH B-NOAA, V80, P761; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Hollowed AB, 2009, ICES J MAR SCI, V66, P1584, DOI 10.1093/icesjms/fsp057; HUBBS CL, 1948, J MAR RES, V7, P459; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Hurst TP, 2002, CAN J FISH AQUAT SCI, V59, P787, DOI 10.1139/F02-051; HUTCHINS LW, 1947, ECOL MONOGR, V17, P325, DOI 10.2307/1948663; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jamison N, 2010, J CLIMATE, V23, P4619, DOI 10.1175/2010JCLI3598.1; Jones DL, 2010, MAR ECOL PROG SER, V401, P245, DOI 10.3354/meps08404; Joyce TM, 2002, J CLIMATE, V15, P1076, DOI 10.1175/1520-0442(2002)015<1076:OHPYOW>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KERR SR, 1980, T AM FISH SOC, V109, P254, DOI 10.1577/1548-8659(1980)109<254:NTIFE>2.0.CO;2; Knutson TR, 2006, J CLIMATE, V19, P1624, DOI 10.1175/JCLI3709.1; Lehodey P, 2010, PROG OCEANOGR, V86, P302, DOI 10.1016/j.pocean.2010.04.021; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Luo JG, 2009, MAR ECOL PROG SER, V380, P255, DOI 10.3354/meps07911; Madeira D, 2012, J SEA RES, V70, P32, DOI 10.1016/j.seares.2012.03.002; Magnuson J. J., 1997, THERMAL NICHE FISHES, P377; Manderson JP, 2002, MAR ECOL PROG SER, V228, P227, DOI 10.3354/meps228227; Maul GA, 2001, GEOPHYS RES LETT, V28, P3935, DOI 10.1029/2001GL013458; McAfee SA, 2011, CLIM DYNAM, V37, P2271, DOI 10.1007/s00382-011-1136-8; McBride RS, 2000, FISH B-NOAA, V98, P528; Mueter FJ, 2008, ECOL APPL, V18, P309, DOI 10.1890/07-0564.1; MURAWSKI SA, 1993, T AM FISH SOC, V122, P647, DOI 10.1577/1548-8659(1993)122<0647:CCAMFD>2.3.CO;2; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Parker RO, 1998, T AM FISH SOC, V127, P908, DOI 10.1577/1548-8659(1998)127<0908:CIANCR>2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Planque B, 2011, ICES J MAR SCI, V68, P1045, DOI 10.1093/icesjms/fsr007; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Robins C.R., 1999, FIELD GUIDE ATLANTIC; ROELOFS E. W., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P181; Sette O. E., 1950, Fishery Bulletin United States, V51, P251; SHANNON LV, 1988, J CONSEIL, V45, P5; Shearman RK, 2010, J PHYS OCEANOGR, V40, P1004, DOI 10.1175/2009JPO4300.1; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Starck WA II, 1971, STUD TROP OCEANOGR, V10, P1; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Taylor C. C., 1957, Fishery Bulletin United States, V57, P293; Teal LR, 2012, GLOBAL CHANGE BIOL, V18, P3291, DOI 10.1111/j.1365-2486.2012.02795.x; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tolan JM, 2009, FISH B-NOAA, V107, P36; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wright DG, 1986, CANADIAN TECHNICAL R, P78; Wuenschel MJ, 2012, J EXP MAR BIOL ECOL, V436, P19, DOI 10.1016/j.jembe.2012.08.012	76	33	34	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52294	10.1371/journal.pone.0052294	http://dx.doi.org/10.1371/journal.pone.0052294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284974	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500136
J	Markaki, A; Kyriazis, J; Stylianou, K; Fragkiadakis, GA; Perakis, K; Margioris, AN; Ganotakis, ES; Daphnis, E				Markaki, Anastasia; Kyriazis, John; Stylianou, Kostas; Fragkiadakis, George A.; Perakis, Kostas; Margioris, Andrew N.; Ganotakis, Emmanuel S.; Daphnis, Eugene			The Role of Serum Magnesium and Calcium on the Association between Adiponectin Levels and All-Cause Mortality in End-Stage Renal Disease Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; MAINTENANCE HEMODIALYSIS-PATIENTS; CORONARY-HEART-DISEASE; PLASMA ADIPONECTIN; CARDIOVASCULAR-DISEASE; PRIMARY HYPERPARATHYROIDISM; INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; MINERAL METABOLISM; RISK-FACTORS	Background: Adiponectin (ADPN) is the most abundant adipocyte-specific cytokine that plays an important role in energy homeostasis by regulating lipid and glucose metabolism. Studies of the impact of ADPN on clinical outcomes have yielded contradictory results so far. Here, we examined the association of ADPN with serum magnesium (s-Mg) and calcium (s-Ca) levels and explored the possibility whether these two factors could modify the relationship between ADPN and all-cause mortality in patients with end-stage renal disease. Methodology/Principal Findings: After baseline assessment, 47 hemodialysis and 27 peritoneal dialysis patients were followed-up for a median period of 50 months. S-Mg and s-Ca levels emerged as positive and negative predictors of ADPN levels, respectively. During the follow-up period 18 deaths occurred. There was a significant 4% increased risk for all-cause mortality for each 1-mu g/ml increment of ADPN (crude HR, 1.04; 95% CI, 1.01-1.07), even after adjustment for s-Mg and s-Ca levels, dialysis mode, age, albumin and C-reactive protein. Cox analysis stratified by s-Mg levels (below and above the median value of 2.45 mg/dl) and s-Ca levels (below and above the median value of 9.3 mg/dl), revealed ADPN as an independent predictor of total mortality only in the low s-Mg and high s-Ca groups. Furthermore, low s-Mg and high s-Ca levels were independently associated with malnutrition, inflammation, arterial stiffening and risk of death. Conclusions/Significance: The predictive value of ADPN in all-cause mortality in end-stage renal disease patients appears to be critically dependent on s-Mg and s-Ca levels. Conversely, s-Mg and s-Ca may impact on clinical outcomes by directly modifying the ADPN's bioactivity.	[Kyriazis, John] Gen Hosp Chios, Dept Nephrol, Chios, Greece; [Markaki, Anastasia; Fragkiadakis, George A.] Technol Educ Inst Crete, Dept Nutr & Dietet, Iraklion, Greece; [Stylianou, Kostas; Perakis, Kostas; Daphnis, Eugene] Univ Hosp Heraklion, Dept Nephrol, Iraklion, Crete, Greece; [Ganotakis, Emmanuel S.] Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece; [Margioris, Andrew N.] Univ Crete, Dept Clin Chem, Sch Med, Iraklion, Crete, Greece	Hellenic Mediterranean University; University Hospital of Heraklion; University Hospital of Heraklion; University of Crete	Kyriazis, J (corresponding author), Gen Hosp Chios, Dept Nephrol, Chios, Greece.	jks@otenet.gr	Markaki, Anastasia/D-3492-2013; Stylianou, Konstantinos/C-5868-2009; Stylianou, Konstantinos/H-2806-2019; Markaki, Anastasia/ABG-5865-2020	Stylianou, Konstantinos/0000-0003-3678-9421; Stylianou, Konstantinos/0000-0003-3678-9421; Fragkiadakis, Georgios A./0000-0002-7596-7676; GANOTAKIS, EMMANUEL/0000-0001-8093-7562				[Anonymous], 2011, KIDNEY INT S113, V76, pS50; Banga Anannya, 2008, Metabolic Syndrome and Related Disorders, V6, P103, DOI 10.1089/met.2007.0033; Becker B, 2005, J AM SOC NEPHROL, V16, P1091, DOI 10.1681/ASN.2004090742; Bollerslev J, 2009, J CLIN ENDOCR METAB, V94, P2255, DOI 10.1210/jc.2008-2742; Bosticardo G, 2012, NEPHROL DIAL TRANSPL, V27, P2489, DOI 10.1093/ndt/gfr733; Cassidy A, 2009, J NUTR, V139, P353, DOI 10.3945/jn.108.098681; Cavusoglu E, 2006, EUR HEART J, V27, P2300, DOI 10.1093/eurheartj/ehl153; Chandran M, 2003, DIABETES CARE, V26, P2442, DOI 10.2337/diacare.26.8.2442; Chudek J, 2003, TRANSPL P, V35, P2186, DOI 10.1016/j.transproceed.2003.08.001; Cunningham J, 2012, CLIN KIDNEY J, V5, P39, DOI 10.1093/ndtplus/sfr166; Dekker JM, 2008, J CLIN ENDOCR METAB, V93, P1489, DOI 10.1210/jc.2007-1436; Delfini E, 2007, METABOLISM, V56, P30, DOI 10.1016/j.metabol.2006.08.019; Diez JJ, 2009, AM J NEPHROL, V30, P244, DOI 10.1159/000221147; Guessous I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018865; Hsu CW, 2010, NEPHROLOGY, V15, P313, DOI 10.1111/j.1440-1797.2009.01202.x; Ignacy W, 2005, NEPHRON CLIN PRACT, V101, pC18, DOI 10.1159/000085707; Ishimura E, 2007, MAGNESIUM RES, V20, P237, DOI 10.1684/mrh.2007.0116; Iwashima Y, 2006, AM J CARDIOL, V98, P1603, DOI 10.1016/j.amjcard.2006.07.039; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Kollerits B, 2007, KIDNEY INT, V71, P1279, DOI 10.1038/sj.ki.5002191; Kotani K, 2009, ASIAN PAC J CANCER P, V10, P87; Kyriazis J, 2004, KIDNEY INT, V66, P1221, DOI 10.1111/j.1523-1755.2004.00875.x; Kyriazis J, 2002, KIDNEY INT, V61, P276, DOI 10.1046/j.1523-1755.2002.00100.x; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Lo MM, 2011, PEDIATR NEPHROL, V26, P2009, DOI 10.1007/s00467-011-1906-x; Mallamaci F, 2002, J NEPHROL, V15, P507; Mantzoros CS, 2005, J CLIN ENDOCR METAB, V90, P4542, DOI 10.1210/jc.2005-0372; Massy ZA, 2012, CLIN KIDNEY J, V5, P52, DOI 10.1093/ndtplus/sfr167; Menon V, 2006, J AM SOC NEPHROL, V17, P2599, DOI 10.1681/ASN.2006040331; Nishimura M, 2006, NEPHROL DIAL TRANSPL, V21, P1640, DOI 10.1093/ndt/gfk088; Ohashi N, 2008, INTERNAL MED, V47, P485, DOI 10.2169/internalmedicine.47.0614; Park SH, 2009, CLIN NEPHROL, V72, P87; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Pills S, 2006, J CLIN ENDOCR METAB, V91, P4277; Pischon T, 2003, CLIN CHEM, V49, P650, DOI 10.1373/49.4.650; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Qi L, 2005, DIABETES CARE, V28, P1022, DOI 10.2337/diacare.28.5.1022; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Rabin KR, 2005, EXPERT REV CARDIOVAS, V3, P465, DOI 10.1586/14779072.3.3.465; RESNICK LM, 1989, AM J MED, V87, pS17, DOI 10.1016/0002-9343(89)90490-7; Rizza S, 2010, J AM GERIATR SOC, V58, P702, DOI 10.1111/j.1532-5415.2010.02773.x; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; Sattar N, 2006, CIRCULATION, V114, P623, DOI 10.1161/CIRCULATIONAHA.106.618918; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Stenvinkel P, 2004, KIDNEY INT, V65, P274, DOI 10.1111/j.1523-1755.2004.00370.x; Sun G, 2005, DIABETES, V54, P3336, DOI 10.2337/diabetes.54.11.3336; Takaya J, 2007, PEDIATR RES, V62, P700, DOI 10.1203/PDR.0b013e318157d219; Tetta C, 2002, INT J ARTIF ORGANS, V25, P18, DOI 10.1177/039139880202500104; Tzanakis I, 2004, MAGNESIUM RES, V17, P102; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Ybarra J, 2007, NURS CLIN N AM, V42, P79, DOI 10.1016/j.cnur.2006.11.010; Young EW, 2007, ADV CHRONIC KIDNEY D, V14, P13, DOI 10.1053/j.ackd.2006.10.003; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x; Zoccali C, 2011, J INTERN MED, V269, P172, DOI 10.1111/j.1365-2796.2010.02288.x; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	58	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52350	10.1371/journal.pone.0052350	http://dx.doi.org/10.1371/journal.pone.0052350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285003	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500150
J	Nasir, A; Norton, JD; Baou, M; Zekavati, A; Bijlmakers, MJ; Thompson, S; Murphy, JJ				Nasir, Asghar; Norton, John D.; Baou, Maria; Zekavati, Anna; Bijlmakers, Marie-Jose; Thompson, Steve; Murphy, John J.			ZFP36L1 Negatively Regulates Plasmacytoid Differentiation of BCL1 Cells by Targeting BLIMP1 mRNA	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; EARLY RESPONSE GENE; ZINC-FINGER PROTEINS; B-CELLS; TRISTETRAPROLIN FAMILY; LYMPHOBLASTIC-LEUKEMIA; BINDING PROTEINS; EXPRESSION; TURNOVER; MYELOMA	The ZFP36/Tis11 family of zinc-finger proteins regulate cellular processes by binding to adenine uridine rich elements in the 3' untranslated regions of various mRNAs and promoting their degradation. We show here that ZFP36L1 expression is largely extinguished during the transition from B cells to plasma cells, in a reciprocal pattern to that of ZFP36 and the plasma cell transcription factor, BLIMP1. Enforced expression of ZFP36L1 in the mouse BCL1 cell line blocked cytokine-induced differentiation while shRNA-mediated knock-down enhanced differentiation. Reconstruction of regulatory networks from microarray gene expression data using the ARACNe algorithm identified candidate mRNA targets for ZFP36L1 including BLIMP1. Genes that displayed down-regulation in plasma cells were significantly over-represented (P = <0.0001) in a set of previously validated ZFP36 targets suggesting that ZFP36L1 and ZFP36 target distinct sets of mRNAs during plasmacytoid differentiation. ShRNA-mediated knock-down of ZFP36L1 in BCL1 cells led to an increase in levels of BLIMP1 mRNA and protein, but not for mRNAs of other transcription factors that regulate plasmacytoid differentiation (xbp1, irf4, bcl6). Finally, ZFP36L1 significantly reduced the activity of a BLIMP1 39 untranslated region-driven luciferase reporter. Taken together, these findings suggest that ZFP36L1 negatively regulates plasmacytoid differentiation, at least in part, by targeting the expression of BLIMP1.	[Nasir, Asghar; Zekavati, Anna; Bijlmakers, Marie-Jose; Thompson, Steve; Murphy, John J.] Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England; [Norton, John D.; Baou, Maria] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; [Murphy, John J.] Univ Westminster, Dept Biomed Sci, London W1R 8AL, England	University of London; King's College London; University of Essex; University of Westminster	Murphy, JJ (corresponding author), Kings Coll London, Div Immunol Infect & Inflammatory Dis, London WC2R 2LS, England.	j.murphy@westminster.ac.uk	bijlmakers, marie-jose/N-5369-2014; Baou, Maria/AAX-4674-2020	bijlmakers, marie-jose/0000-0001-6762-1168; 	government of Pakistan PhD. Scholarship; Leukaemia and Lymphoma Research United Kingdom	government of Pakistan PhD. Scholarship; Leukaemia and Lymphoma Research United Kingdom	The work was supported by a government of Pakistan PhD. Scholarship awarded to AN. This work was supported in part by Leukaemia and Lymphoma Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Baou M, 2009, LEUKEMIA, V23, P986, DOI 10.1038/leu.2008.340; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Baou M, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/634520; Basso K, 2010, BLOOD, V115, P975, DOI 10.1182/blood-2009-06-227017; Bell SE, 2006, DEV DYNAM, V235, P3144, DOI 10.1002/dvdy.20949; Bernard MP, 2010, IMMUNOLOGY, V129, P87, DOI 10.1111/j.1365-2567.2009.03152.x; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2005, BIOL REPROD, V73, P297, DOI 10.1095/biolreprod.105.040527; Borset M, 1996, J BIOL CHEM, V271, P24655, DOI 10.1074/jbc.271.40.24655; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; GREIL J, 1994, BRIT J HAEMATOL, V86, P275, DOI 10.1111/j.1365-2141.1994.tb04726.x; Gutierrez NC, 2007, LEUKEMIA, V21, P541, DOI 10.1038/sj.leu.2404520; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; HURWITZ R, 1979, INT J CANCER, V23, P174, DOI 10.1002/ijc.2910230206; Igarashi K, 2007, J BIOCHEM, V141, P783, DOI 10.1093/jb/mvm106; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; MURPHY JJ, 1990, BIOCHIM BIOPHYS ACTA, V1049, P261; NAMBA M, 1989, IN VITRO CELL DEV B, V25, P723; Ning ZQ, 1996, EUR J IMMUNOL, V26, P2356, DOI 10.1002/eji.1830261013; Ning ZQ, 1996, BIOCHEM J, V319, P59, DOI 10.1042/bj3190059; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Ohkubo Y, 2005, J IMMUNOL, V174, P7703, DOI 10.4049/jimmunol.174.12.7703; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shimada H, 2000, BLOOD, V96, P655; SNAPPER CM, 1995, J IMMUNOL, V154, P5842; Stoecklin G, 2000, MOL CELL BIOL, V20, P3753, DOI 10.1128/MCB.20.11.3753-3763.2000; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Stumpo DJ, 2004, MOL CELL BIOL, V24, P6445, DOI 10.1128/MCB.24.14.6445-6455.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TOGAWA A, 1982, INT J CANCER, V29, P495, DOI 10.1002/ijc.2910290502; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040; Wegmuller D, 2007, STEM CELLS, V25, P1178, DOI 10.1634/stemcells.2006-0106; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52187	10.1371/journal.pone.0052187	http://dx.doi.org/10.1371/journal.pone.0052187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284928	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000312794500109
J	Thorsen, VC; Sundby, J; Malata, A				Thorsen, Viva Combs; Sundby, Johanne; Malata, Address			Piecing Together the Maternal Death Puzzle through Narratives: The Three Delays Model Revisited	PLOS ONE			English	Article							TRADITIONAL BIRTH ATTENDANTS; HEALTH-CARE; MORTALITY; WOMEN; PREGNANCY; SYSTEMS; PREPAREDNESS; FRAMEWORK	Background: In Malawi maternal mortality continues to be a major public health challenge. Going beyond the numbers to form a more complete view of why women die is critical to improving access to and quality of emergency obstetric care. The objective of the current study was to identify the socio-cultural and facility-based factors that contributed to maternal deaths in the district of Lilongwe, Malawi. Methods: Retrospectively, 32 maternal death cases that occurred between January 1, 2011 and June 30, 2011 were reviewed independently by two gynecologists/obstetricians. Interviews were conducted with healthcare staff, family members, neighbors, and traditional birth attendants. Guided by the grounded theory approach, interview transcripts were analyzed manually and continuously. Emerging, recurring themes were identified and excerpts from the transcripts were categorized according to the Three Delays Model (3Ds). Results: Sixteen deaths were due to direct obstetric complications, sepsis and hemorrhage being most common. Sixteen deaths were due to indirect causes with the main cause being anemia, followed by HIV and heart disease. Lack of recognizing signs, symptoms, and severity of the situation; using traditional Birth Attendant services; low female literacy level; delayed access to transport; hardship of long distance and physical terrain; delayed prompt quality emergency obstetric care; and delayed care while at the hospital due to patient refusal or concealment were observed. According to the 3Ds, the most common delay observed was in receiving treatment upon reaching the facility due to referral delays, missed diagnoses, lack of blood, lack of drugs, or inadequate care, and severe mismanagement.	[Thorsen, Viva Combs; Sundby, Johanne] Univ Oslo, Dept Community Med, Oslo, Norway; [Malata, Address] Univ Malawi, Kamuzu Coll Nursing, Dept Maternal & Child Hlth, Lilongwe, Malawi	University of Oslo; University of Malawi	Thorsen, VC (corresponding author), Univ Oslo, Dept Community Med, Oslo, Norway.	v.c.thorsen@medisin.uio.no			Norwegian Research Council [177643]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was funded by the Norwegian Research Council (Project #177643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeleke N, 2011, NIGER MED PRACT, V59, P68; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Baby H, 2010, J BANGLADESH COLL PH, V28, P5; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Bisika Thomas, 2008, East Afr J Public Health, V5, P103; Cannoodt L, 2012, INT J HEALTH PLAN M, V27, pe104, DOI 10.1002/hpm.1098; Cham Mamady, 2005, Reprod Health, V2, P3, DOI 10.1186/1742-4755-2-3; CIA, 2009, WORLD FACTB 2009; Ebuehi OM, 2012, INT J WOMENS HEALTH, V4, P25, DOI 10.2147/IJWH.S23173; Essendi H, 2011, J URBAN HEALTH, V88, P356, DOI 10.1007/s11524-010-9481-1; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; Friis R, 2009, EPIDEMIOLOGY PUBLIC, P49; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ghebrehiwet B., 2007, J ERITREAN MED ASS, V2, P8; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hesse-Biber S, 2006, PRACTICE QUALITATIVE, P229; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huntington D, 2012, B WORLD HEALTH ORGAN, V90, P104, DOI 10.2471/BLT.11.092825; Jammeh Abdou, 2011, ISRN Obstet Gynecol, V2011, P981096, DOI 10.5402/2011/981096; JHPIEGO/MNH Program, 2004, MON BIRTH PREP COMPL; KHAN AA, 1994, EVAL HEALTH PROF, V17, P60, DOI 10.1177/016327879401700104; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Lewis G, 2008, BEST PRACT RES CL OB, V22, P447, DOI 10.1016/j.bpobgyn.2007.10.007; Lonkhujizen L, 2009, COCHRANE DATABASE SY, P3; Malawi Health Workforce Observatory, 2010, HUM RES HLTH COUNTR; Malawi Ministry of Development Planning and Cooperation, 2010, 2010 MAL MILL DEV GO; Mason M, 2010, FORUMQUALITATIVE SOZ, V11; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Moran AC, 2006, J HEALTH POPUL NUTR, V24, P489; National Statistical Office, 2011, MAL DEM HLTH SURV 20; Prata N, 2011, J HEALTH POPUL NUTR, V29, P81; Seljeskog Line, 2006, Afr J Reprod Health, V10, P66; Shah N, 2007, RAWAL MED J, V32, P163; Smit J J, 1994, Curationis, V17, P25; Stanton C, 2008, B WORLD HEALTH ORGAN, V86, P241; SUNDARI TK, 1992, INT J HEALTH SERV, V22, P513, DOI 10.2190/91YH-A52T-AFBB-1LEA; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; UNICEF, 2012, COUNTR STAT MAL; United Nations Development Program, 2010, HUM DEV REP 2010 REA; Urassa E, 1997, HEALTH POLICY PLANN, V12, P50, DOI 10.1093/heapol/12.1.50; van den Akker T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020776; White PM, 2002, J MIDWIFERY WOM HEAL, V47, P239, DOI 10.1016/S1526-9523(02)00266-0; WHO, 1996, MAT WAIT HOM REV EXP; WHO, 2010, TRENDS MAT MORT 1990; WHO UNFPA UNICEF and World Bank, 1999, RED MAT MORT JOINT S; WHO UNICEF and The World Bank, 2012, TRENDS MAT MORT 1990; World Health Organization, 2004, NUMB REV MAT DEATHS; World Health Organization, 2011, WORLD HLTH STAT 2011	50	65	65	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52090	10.1371/journal.pone.0052090	http://dx.doi.org/10.1371/journal.pone.0052090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284882	Green Submitted, Green Published, gold			2022-12-25	WOS:000312694300072
J	Tsui, H; Lau, JTF; Xiang, WN; Gu, J; Wang, ZX				Tsui, Hiyi; Lau, Joseph T. F.; Xiang, Weina; Gu, Jing; Wang, Zixin			Should Associations between HIV-Related Risk Perceptions and Behaviors or Intentions Be Positive or Negative?	PLOS ONE			English	Article							INJECTION-DRUG USERS; SELF-PERCEIVED RISK; SEXUAL-BEHAVIOR; PROTECTIVE BEHAVIOR; CHINA; PREVALENCE; PARTNER; TRANSMISSION; INFECTION; POPULATION	Risk perceptions are important in HIV research and interventions; mixed results were found between HIV-related perceptions and behaviors. We interviewed 377 sexually active injecting drug users in China, finding mixed associations between HIV-related risk perception assessed by two general measures and two previous risk behaviors (syringe sharing: p<.05; unprotected sex: p>.05) - partially supporting the 'reflective hypothesis' that reflection on previous behaviors increases risk perceptions. When we use specific measures for risk perceptions (HIV transmission via unprotected sex with specific types of sex partner and via syringe sharing) and use behavioral intention to adopt protective risk behaviors (condom use and avoid syringe sharing totally) as dependent variables, positive significant associations were observed - supporting the motivational hypothesis that risk perceptions motivate one to adopt protective behaviors. The direction and significance of the associations of concern depends on types of measures used. It has important implications on research design, data interpretation and services.	[Tsui, Hiyi; Lau, Joseph T. F.; Wang, Zixin] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Fac Med, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China; [Lau, Joseph T. F.; Gu, Jing] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Xiang, Weina] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Gu, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Emory University; Rollins School Public Health; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Fac Med, Ctr Hlth Behav Res, Hong Kong, Hong Kong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022					AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bailey SL, 2007, DRUG ALCOHOL DEPEN, V91, pS18, DOI 10.1016/j.drugalcdep.2007.02.014; Bang-Ping J, 2009, J SEX MED, V6, P1072, DOI 10.1111/j.1743-6109.2007.00707.x; CRISP BR, 1993, DRUG ALCOHOL DEPEN, V33, P73, DOI 10.1016/0376-8716(93)90035-O; Do M, 2009, AIDS CARE, V21, P1211, DOI 10.1080/09540120902730047; Ellen JM, 2002, J APPL SOC PSYCHOL, V32, P648, DOI 10.1111/j.1559-1816.2002.tb00235.x; Essien EJ, 2008, PUBLIC HEALTH, V122, P397, DOI 10.1016/j.puhe.2007.07.023; Fotopoulou A, 2007, NEUROCASE, V13, P6, DOI 10.1080/13554790601160566; Fraile JS, 1997, ACTAS LUSO-ESP NEUR, V25, P17; Gerrard M, 1996, PSYCHOL BULL, V119, P390, DOI 10.1037/0033-2909.119.3.390; Go VF, 2006, JAIDS-J ACQ IMM DEF, V42, P108, DOI 10.1097/01.qai.0000199354.88607.2f; Gu J, 2008, DRUG ALCOHOL DEPEN, V97, P257, DOI 10.1016/j.drugalcdep.2008.03.029; Gu J, 2009, AIDS CARE, V21, P31, DOI 10.1080/09540120802068787; HERSHEY JC, 1980, ORGAN BEHAV HUM PERF, V25, P395, DOI 10.1016/0030-5073(80)90037-9; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Khawcharoenporn T, 2012, AIDS PATIENT CARE ST, V26, P222, DOI 10.1089/apc.2011.0202; Kowalewski MR, 1997, HEALTH EDUC BEHAV, V24, P313, DOI 10.1177/109019819702400305; Lau J. T., 2012, AIDS BEHAV, DOI 10.1007/s10461-012-0244-8; Lau JTF, 2007, SEX TRANSM DIS, V34, P574, DOI 10.1097/01.olq.0000253339.49181.f9; Lau JTF, 2011, SEX TRANSM DIS, V38, P788, DOI 10.1097/OLQ.0b013e318218cc66; Lau JTF, 2009, AIDS CARE, V21, P909, DOI 10.1080/09540120802612790; Lau JTF, 2005, AIDS CARE, V17, P166, DOI 10.1080/09540120512331325662; Lawan U M, 2012, Afr J Reprod Health, V16, P61; Lin DH, 2010, AIDS EDUC PREV, V22, P344, DOI 10.1521/aeap.2010.22.4.344; Liu HJ, 2006, SEX TRANSM DIS, V33, P111, DOI 10.1097/01.olq.0000199762.28231.ee; LOXLEY W, 2000, SEX RELATSH THER, V15, P297, DOI DOI 10.1080/14681990050109872; Ma Y, 1990, ZHONGHUA LIU XING BI, V11, P184; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mehrotra P, 2009, AIDS EDUC PREV, V21, P39, DOI 10.1521/aeap.2009.21.1.39; Mills HL, 2012, DRUG ALCOHOL DEPEND; Ministry of Health of the People's Republic of China, 2012, 2012 CHIN AIDS RESP; Mitchell MM, 2009, AIDS CARE, V21, P221, DOI 10.1080/09540120801982897; Nunn A, 2011, AIDS PATIENT CARE ST, V25, P229, DOI 10.1089/apc.2010.0313; Pan Xiao-hong, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P499; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Pisani E, 2003, JAIDS-J ACQ IMM DEF, V34, P403, DOI 10.1097/00126334-200312010-00007; Poppen PJ, 1997, AIDS EDUC PREV, V9, P373; PROHASKA TR, 1990, J HEALTH SOC BEHAV, V31, P384, DOI 10.2307/2136821; Reisen CA, 1999, J APPL SOC PSYCHOL, V29, P667, DOI 10.1111/j.1559-1816.1999.tb02018.x; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Schwarzer R, 1999, J Health Psychol, V4, P115, DOI 10.1177/135910539900400208; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; SINGH K, 1992, SMJ Singapore Medical Journal, V33, P58; Teng Y, 2011, HEALTH PSYCHOL, V30, P119, DOI 10.1037/a0022023; Tenkorang EY, 2009, AIDS BEHAV, V13, P234, DOI 10.1007/s10461-008-9470-5; VanDerVelde FW, 1996, PSYCHOL HEALTH, V12, P87, DOI 10.1080/08870449608406924; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P324, DOI 10.1037/0278-6133.12.4.324; WEINSTEIN ND, 1993, HEALTH PSYCHOL, V12, P235, DOI 10.1037/0278-6133.12.3.235; *WHO, 2001, HIV AIDS AS PAC REG; Wood E, 2005, INT J EPIDEMIOL, V34, P152, DOI 10.1093/ije/dyh357; Wright PB, 2009, J DRUG ISSUES, V39, P577, DOI 10.1177/002204260903900306; Wu ZY, 1996, AIDS, V10, P1017, DOI 10.1097/00002030-199610090-00013; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yao Y, 2009, INT J INFECT DIS, V13, P154, DOI 10.1016/j.ijid.2008.05.1228; Yin L., 2007, CHINA HARM REDUCTION, V4, P6; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014	58	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52124	10.1371/journal.pone.0052124	http://dx.doi.org/10.1371/journal.pone.0052124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	059HF	23284896	Green Published, Green Submitted, gold			2022-12-25	WOS:000312694300073
J	Kim, HL; Jeon, JH; Koo, TH; Lee, UY; Jeong, E; Chun, MH; Moon, JI; Massey, SC; Kim, IB				Kim, Hong-Lim; Jeon, Ji Hyun; Koo, Tae-Hyung; Lee, U-Young; Jeong, Eojin; Chun, Myung-Hoon; Moon, Jung-Il; Massey, Stephen C.; Kim, In-Beom			Axonal Synapses Utilize Multiple Synaptic Ribbons in the Mammalian Retina	PLOS ONE			English	Article							DOPAMINERGIC AMACRINE CELLS; INNER PLEXIFORM LAYER; EXPRESSING GANGLION-CELLS; CONE BIPOLAR CELLS; PRIMATE RETINA; RABBIT RETINA; CAT RETINA; MOUSE RETINA; ON-CENTER; FUNCTIONAL-ORGANIZATION	In the mammalian retina, bipolar cells and ganglion cells which stratify in sublamina a of the inner plexiform layer (IPL) show OFF responses to light stimuli while those that stratify in sublamina b show ON responses. This functional relationship between anatomy and physiology is a key principle of retinal organization. However, there are at least three types of retinal neurons, including intrinsically photosensitive retinal ganglion cells (ipRGCs) and dopaminergic amacrine cells, which violate this principle. These cell types have light-driven ON responses, but their dendrites mainly stratify in sublamina a of the IPL, the OFF sublayer. Recent anatomical studies suggested that certain ON cone bipolar cells make axonal or ectopic synapses as they descend through sublamina a, thus providing ON input to cells which stratify in the OFF sublayer. Using immunoelectron microscopy with 3-dimensional reconstruction, we have identified axonal synapses of ON cone bipolar cells in the rabbit retina. Ten calbindin ON cone bipolar axons made en passant ribbon synapses onto amacrine or ganglion dendrites in sublamina a of the IPL. Compared to the ribbon synapses made by bipolar terminals, these axonal ribbon synapses were characterized by a broad postsynaptic element that appeared as a monad and by the presence of multiple short synaptic ribbons. These findings confirm that certain ON cone bipolar cells can provide ON input to amacrine and ganglion cells whose dendrites stratify in the OFF sublayer via axonal synapses. The monadic synapse with multiple ribbons may be a diagnostic feature of the ON cone bipolar axonal synapse in sublamina a. The presence of multiple ribbons and a broad postsynaptic density suggest these structures may be very efficient synapses. We also identified axonal inputs to ipRGCs with the architecture described above.	[Kim, Hong-Lim; Jeon, Ji Hyun; Lee, U-Young; Jeong, Eojin; Chun, Myung-Hoon; Kim, In-Beom] Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Hong-Lim] Catholic Univ Korea, Coll Med, Integrat Res Support Ctr, Seoul, South Korea; [Koo, Tae-Hyung; Moon, Jung-Il] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Lee, U-Young] Catholic Univ Korea, Coll Med, Catholic Inst Appl Anat, Seoul, South Korea; [Massey, Stephen C.] Univ Texas Hlth Sci Ctr Houston, Dept Ophthalmol & Visual Sci, Houston, TX USA	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of Texas System; University of Texas Health Science Center Houston	Kim, IB (corresponding author), Catholic Univ Korea, Coll Med, Dept Anat, Seoul, South Korea.	ibkimmd@catholic.ac.kr	Kim, In-Beom/A-6728-2011		National Research Foundation of Korea [20100022317]; Scientific Research Center; National Institutes of Health [EY06515, EY10608]; NATIONAL EYE INSTITUTE [R55EY006515, P30EY010608, R01EY006515] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Scientific Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Research Foundation of Korea grant # 20100022317 (I-BK), a Scientific Research Center grant (I-BK), and National Institutes of Health grants EY06515 and EY10608 (SCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Berson DM, 2003, TRENDS NEUROSCI, V26, P314, DOI 10.1016/S0166-2236(03)00130-9; BLOOMFIELD SA, 1986, J NEUROSCI, V6, P1; Boelen MK, 1998, VISUAL NEUROSCI, V15, P97, DOI 10.1017/S0952523898151040; Boycott B, 1999, INVEST OPHTH VIS SCI, V40, P1313; BOYCOTT BB, 1991, EUR J NEUROSCI, V3, P1069, DOI 10.1111/j.1460-9568.1991.tb00043.x; Calkins DJ, 1998, J NEUROSCI, V18, P3373; Contini M, 2010, J COMP NEUROL, V518, P2035, DOI 10.1002/cne.22320; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; DUBIN MW, 1970, J COMP NEUROL, V140, P479, DOI 10.1002/cne.901400406; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; EULER T, 1995, J COMP NEUROL, V361, P461, DOI 10.1002/cne.903610310; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Fu YB, 2005, CURR OPIN NEUROBIOL, V15, P415, DOI 10.1016/j.conb.2005.06.011; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Grunert U, 2011, VISUAL NEUROSCI, V28, P39, DOI 10.1017/S095252381000026X; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; HOKOC JN, 1988, BRAIN RES, V461, P17, DOI 10.1016/0006-8993(88)90721-4; HOKOC JN, 1987, J NEUROSCI, V7, P2785; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Hoshi H, 2009, J COMP NEUROL, V513, P69, DOI 10.1002/cne.21941; Kim SA, 2010, CELL TISSUE RES, V339, P311, DOI 10.1007/s00441-009-0895-6; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Lauritzen JS, 2013, J COMP NEUROL, V521, P977, DOI 10.1002/cne.23244; MacNeil MA, 2004, J COMP NEUROL, V472, P73, DOI 10.1002/cne.20063; Massey SC, 1996, J COMP NEUROL, V366, P15; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; MCGUIRE BA, 1986, J NEUROSCI, V6, P907; NELSON R, 1983, VISION RES, V23, P1183, DOI 10.1016/0042-6989(83)90032-9; NELSON R, 1978, J NEUROPHYSIOL, V41, P472, DOI 10.1152/jn.1978.41.2.472; PEICHL L, 1981, PROC R SOC SER B-BIO, V212, P139, DOI 10.1098/rspb.1981.0030; Pickard GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004984; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Shinohara Y, 2012, HIPPOCAMPUS, V22, P942, DOI 10.1002/hipo.20950; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Sterling P, 1995, FUNCTIONAL ARCHITECT; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Zhang J, 2005, VISUAL NEUROSCI, V22, P535, DOI 10.1017/S0952523805224148	54	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52295	10.1371/journal.pone.0052295	http://dx.doi.org/10.1371/journal.pone.0052295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284975	gold, Green Submitted, Green Published			2022-12-25	WOS:000312435900088
J	Meinecke, M; Boucrot, E; Camdere, G; Hon, WC; Mittal, R; McMahon, HT				Meinecke, Michael; Boucrot, Emmanuel; Camdere, Gamze; Hon, Wai-Ching; Mittal, Rohit; McMahon, Harvey T.			Cooperative Recruitment of Dynamin and BIN/Amphiphysin/Rvs (BAR) Domain-containing Proteins Leads to GTP-dependent Membrane Scission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; SH3 DOMAIN; CRYSTAL-STRUCTURE; NERVE-TERMINALS; COATED VESICLES; BINDING-SITE; AMPHIPHYSIN; ENDOPHILIN; CURVATURE	Dynamin mediates various membrane fission events, including the scission of clathrin-coated vesicles. Here, we provide direct evidence for cooperative membrane recruitment of dynamin with the BIN/ amphiphysin/Rvs (BAR) proteins, endophilin and amphiphysin. Surprisingly, endophilin and amphiphysin recruitment to membranes was also dependent on binding to dynamin due to auto-inhibition of BAR-membrane interactions. Consistent with reciprocal recruitment in vitro, dynamin recruitment to the plasma membrane in cells was strongly reduced by concomitant depletion of endophilin and amphiphysin, and conversely, depletion of dynamin dramatically reduced the recruitment of endophilin. In addition, amphiphysin depletion was observed to severely inhibit clathrin-mediated endocytosis. Furthermore, GTP-dependent membrane scission by dynamin was dramatically elevated by BAR domain proteins. Thus, BAR domain proteins and dynamin act in synergy in membrane recruitment and GTP-dependent vesicle scission.	[Meinecke, Michael; Boucrot, Emmanuel; Camdere, Gamze; Hon, Wai-Ching; Mittal, Rohit; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Meinecke, Michael] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Boucrot, Emmanuel] UCL, Inst Struct & Mol Biol, Div Biosci, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of Gottingen; University of London; Birkbeck University London; University College London	Meinecke, M (corresponding author), Univ Gottingen, Abt Biochem 2, D-37073 Gottingen, Germany.	michael.meinecke@med.uni-goettingen.de; hmm@mrc-lmb.cam.ac.uk	Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Boucrot, Emmanuel/0000-0001-7312-6462	Medical Research Council [U105178805]; Human Frontiers Science Program Fellowship; Deutsche Forschungsgemeinschaft [SFB 803]; Medical Research Council [MC_U105178795] Funding Source: researchfish; MRC [MC_U105178795] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontiers Science Program Fellowship(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council File Reference U105178805, a Human Frontiers Science Program Fellowship (to M. M.), and Deutsche Forschungsgemeinschaft Grant SFB 803 (to M. M.).	ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Lombardi R, 2001, J BIOL CHEM, V276, P6016, DOI 10.1074/jbc.M008735200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WANG LH, 1995, J BIOL CHEM, V270, P10079, DOI 10.1074/jbc.270.17.10079; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	47	99	101	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6651	6661		10.1074/jbc.M112.444869	http://dx.doi.org/10.1074/jbc.M112.444869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297414	hybrid, Green Published			2022-12-25	WOS:000315820700064
J	Panwar, P; Du, X; Sharma, V; Lamour, G; Castro, M; Li, HB; Bromme, D				Panwar, Preety; Du, Xin; Sharma, Vidhu; Lamour, Guillaume; Castro, Mickael; Li, Hongbin; Broemme, Dieter			Effects of Cysteine Proteases on the Structural and Mechanical Properties of Collagen Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT TAIL TENDON; ATOMIC-FORCE MICROSCOPY; I COLLAGEN; CATHEPSIN-K; DECORIN; GLYCOSAMINOGLYCANS; FIBRILS; COMPLEX; PROTEOGLYCAN; ORGANIZATION	Excessive cathepsin K (catK)-mediated turnover of fibrillar type I and II collagens in bone and cartilage leads to osteoporosis and osteoarthritis. However, little is known about how catK degrades compact collagen macromolecules. The present study is aimed to explore the structural and mechanical consequences of collagen fiber degradation by catK. Mouse tail type I collagen fibers were incubated with either catK or non-collagenase cathepsins. Methods used include scanning electron microscopy, protein electrophoresis, atomic force microscopy, and tensile strength testing. Our study revealed evidence of proteoglycan network degradation, followed by the progressive disassembly of macroscopic collagen fibers into primary structural elements by catK. Proteolytically released GAGs are involved in the generation of collagenolytically active catK-GAG complexes as shown by AFM. In addition to their structural disintegration, a decrease in the tensile properties of fibers was observed due to the action of catK. The Young's moduli of untreated collagen fibers versus catK-treated fibers in dehydrated conditions were 3.2 +/- 0.68 GPa and 1.9 +/- 0.65 GPa, respectively. In contrast, cathepsin L, V, B, and S revealed no collagenase activity, except the disruption of proteoglycan-GAG interfibrillar bridges, which slightly decreased the tensile strength of fibers.	[Panwar, Preety; Du, Xin; Sharma, Vidhu; Broemme, Dieter] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Broemme, Dieter] Univ British Columbia, Fac Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Lamour, Guillaume; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Castro, Mickael] Univ Bretagne Sud, Lab Ingn Mat Bretagne, European Univ Brittany, F-56100 Lorient, France	University of British Columbia; University of British Columbia; University of British Columbia	Bromme, D (corresponding author), Univ British Columbia, Fac Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	dbromme@dentistry.ubc.ca	Li, Hongbin/G-2949-2012; Lamour, Guillaume/D-6758-2015	Li, Hongbin/0000-0001-7813-1332; Lamour, Guillaume/0000-0002-9331-5532; CASTRO, Mickael/0000-0002-9694-9274; Sharma, Vidhu/0000-0003-3451-2736	Canadian Institutes of Health Research [MOP89974]; Canada Research Chair award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by Canadian Institutes of Health Research Grant MOP89974 and the Canada Research Chair award.	BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189; BASELT DR, 1993, BIOPHYS J, V65, P2644, DOI 10.1016/S0006-3495(93)81329-8; Bertini I, 2012, J AM CHEM SOC, V134, P2100, DOI 10.1021/ja208338j; Billinghurst RC, 2000, ARTHRITIS RHEUM, V43, P664, DOI 10.1002/1529-0131(200003)43:3<664::AID-ANR24>3.0.CO;2-D; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; BURLEIGH MC, 1974, BIOCHEM J, V137, P387, DOI 10.1042/bj1370387; Eppell SJ, 2006, J R SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fratzl P., 2008, COLLAGEN STRUCTURE M; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0; KIRSCHKE H, 1982, BIOCHEM J, V201, P367, DOI 10.1042/bj2010367; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Liu XH, 2005, BIOCHEM BIOPH RES CO, V338, P1342, DOI 10.1016/j.bbrc.2005.10.096; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; OKUYAMA K, 1977, POLYM J, V9, P341, DOI 10.1295/polymj.9.341; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8; Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033; Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430; RASPANTI M, 1989, INT J BIOL MACROMOL, V11, P367, DOI 10.1016/0141-8130(89)90009-3; Raspanti M, 2008, J STRUCT BIOL, V164, P134, DOI 10.1016/j.jsb.2008.07.001; Redaelli A, 2003, J BIOMECH, V36, P1555, DOI 10.1016/S0021-9290(03)00133-7; Rees SG, 2000, BIOCHEM J, V350, P181, DOI 10.1042/0264-6021:3500181; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; SCOTT JE, 1992, FASEB J, V6, P2639, DOI 10.1096/fasebj.6.9.1612287; Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0; Starborg T, 2008, METHODS, V45, P53, DOI 10.1016/j.ymeth.2008.01.004; Tan EPS, 2005, BIOMATERIALS, V26, P1453, DOI 10.1016/j.biomaterials.2004.05.021; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Vesentini S, 2005, J BIOMECH, V38, P433, DOI 10.1016/j.jbiomech.2004.04.032; Yamashita DS, 2000, CURR PHARM DESIGN, V6, P1, DOI 10.2174/1381612003401569; Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058; Yasuda Y, 2005, ADV DRUG DELIVER REV, V57, P973, DOI 10.1016/j.addr.2004.12.013; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	49	71	73	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5940	5950		10.1074/jbc.M112.419689	http://dx.doi.org/10.1074/jbc.M112.419689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297404	Green Published, hybrid			2022-12-25	WOS:000315342500062
J	Yang, RT; Lim, GL; Dong, ZH; Lee, AM; Yee, CT; Fuller, RS; Ritchie, HH				Yang, Robert T.; Lim, Glendale L.; Dong, Zhihong; Lee, Arthur M.; Yee, Colin T.; Fuller, Robert S.; Ritchie, Helena H.			The Efficiency of Dentin Sialoprotein-Phosphophoryn Processing Is Affected by Mutations Both Flanking and Distant from the Cleavage Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; SIALOPHOSPHOPROTEIN DSPP; PROTEASES; GENE; PROTEINS; SPECIFICITY; NUCLEOTIDE; INHIBITOR; UROKINASE; SUBSTRATE	Normal dentin mineralization re quires two highly acidic proteins, dentin sialoprotein (DSP) and phosphophoryn (PP). DSP and PP are synthesized as part of a single secreted precursor, DSP-PP, which is conserved in marsupial and placental mammals. Using a baculovirus expression system, we previously found that DSP-PP is accurately cleaved into DSP and PP after secretion into medium by an endogenous, secreted, zinc-dependent Sf9 cell activity. Here we report that mutation of conserved residues near and distant from the G(447)down arrow D-448 cleavage site in DSP-PP240 had dramatic effects on cleavage efficiency by the endogenous Sf9 cell processing enzyme. We found that: 1) mutation of residues flanking the cleavage site from P4 to P4' blocked, impaired, or enhanced DSP-PP240 cleavage; 2) certain conserved amino acids distant from the cleavage site were important for precursor cleavage; 3) modification of the C terminus by appending a C-terminal tag altered the pattern of processing; and 4) mutations in DSP-PP240 had similar effects on cleavage by recombinant human BMP1, a candidate physiological processing enzyme, as was seen with the endogenous Sf9 cell activity. An analysis of a partial TLR1 cDNA from Sf9 cells indicates that residues that line the substrate-binding cleft of Sf9 TLR1 and human BMP1 are nearly perfectly conserved, offering an explanation of why Sf9 cells so accurately process mammalian DSP-PP. The fact that several mutations in DSP-PP240 significantly modified the amount of PP240 product generated from DSP-PP240 precursor protein cleavage suggests that such mutation may affect the mineralization process.	[Yang, Robert T.; Lim, Glendale L.; Dong, Zhihong; Lee, Arthur M.; Yee, Colin T.; Ritchie, Helena H.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Fuller, Robert S.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fuller, RS (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 3220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	bfuller@umich.edu; helenar@umich.edu			National Institutes of Health from the NIDCR [DE18901]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018901] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE18901 from the NIDCR (to H.H.R.).	Butler W T, 1995, Connect Tissue Res, V33, P59, DOI 10.3109/03008209509016983; Crossen R., 1996, BACULOVIRUS EXPRESSI; DEBIE I, 1995, J BIOL CHEM, V270, P1020, DOI 10.1074/jbc.270.3.1020; Godovikova V, 2006, DEV BIOL, V289, P507, DOI 10.1016/j.ydbio.2005.10.002; Godovikova V, 2007, J BIOL CHEM, V282, P31341, DOI 10.1074/jbc.M702605200; Gu K, 2000, EUR J ORAL SCI, V108, P35, DOI 10.1034/j.1600-0722.2000.00765.x; Gu KN, 1998, EUR J ORAL SCI, V106, P1043, DOI 10.1046/j.0909-8836..t01-9-.x; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Ke SH, 1997, J BIOL CHEM, V272, P20456, DOI 10.1074/jbc.272.33.20456; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; LINDE A, 1989, ANAT REC, V224, P154, DOI 10.1002/ar.1092240206; Qin CL, 2001, J BIOL CHEM, V276, P904, DOI 10.1074/jbc.M006271200; Rajpar MH, 2002, HUM MOL GENET, V11, P2559, DOI 10.1093/hmg/11.21.2559; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Ritchie HH, 2000, BBA-GENE STRUCT EXPR, V1493, P27, DOI 10.1016/S0167-4781(00)00150-0; Ritchie HH, 2001, BBA-GENE STRUCT EXPR, V1520, P212, DOI 10.1016/S0167-4781(01)00274-3; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Rockwell NC, 2002, J BIOL CHEM, V277, P17531, DOI 10.1074/jbc.M111909200; ROEBROEK AJM, 1993, EMBO J, V12, P1853, DOI 10.1002/j.1460-2075.1993.tb05834.x; ROEBROEK AJM, 1995, DNA CELL BIOL, V14, P223, DOI 10.1089/dna.1995.14.223; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wermter C, 2007, BIOL CHEM, V388, P513, DOI 10.1515/BC.2007.054; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765	31	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					6024	6033		10.1074/jbc.M112.382952	http://dx.doi.org/10.1074/jbc.M112.382952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297400	Green Published, hybrid			2022-12-25	WOS:000315342500070
J	Casanova, JC; Badia-Careaga, C; Uribe, V; Sanz-Ezquerro, JJ				Casanova, Jesus C.; Badia-Careaga, Claudio; Uribe, Veronica; Jose Sanz-Ezquerro, Juan			Bambi and Sp8 Expression Mark Digit Tips and Their Absence Shows That Chick Wing Digits 2 and 3 Are Truncated	PLOS ONE			English	Article							LIMB DEVELOPMENT; MORPHOGENESIS; REGENERATION; OUTGROWTH; PATHWAYS; IDENTITY; BIRDS; MICE; BUD	An often overlooked aspect of digit development is the special nature of the terminal phalanx, a specialized structure with characteristics distinct from other phalanges, for example the presence of ectodermal derivatives such as nails and claws. Here, we describe the unique ossification pattern of distal phalanges and characteristic gene expression in the digit tips of chick and duck embryos. Our results show that the distal phalanx of chick wing digit 1 is a genuine tip with a characteristic ossification pattern and expression of Bambi and Sp8; however, the terminal phalanx of digits 2* and 3 is not a genuine tip, and these are therefore truncated digits. Bambi and Sp8 expression in the chick wing provides a direct molecular assessment of digit identity changes after experimental manipulations of digit primordia. In contrast, digits 1 and 2 of the duck wing both possess true tips. Although chick wing-tip development was not rescued by application of Fgf8, this treatment induced the development of extra phalanges. Grafting experiments show that competence for tip formation, including nails, is latent in the interdigital tissue. Our results deepen understanding of the mechanisms of digit tip formation, highlighting its developmental autonomy and modular nature, with implications for digit reduction or loss during evolution. * Numbering of wing digits is 1, 2, 3 from anterior to posterior.	[Casanova, Jesus C.; Badia-Careaga, Claudio; Uribe, Veronica; Jose Sanz-Ezquerro, Juan] CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Casanova, Jesus C.; Jose Sanz-Ezquerro, Juan] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Jose Sanz-Ezquerro, Juan] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sanz-Ezquerro, JJ (corresponding author), CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain.	jjsanz@cnb.csic.es	Ezquerro, Juan Jose Sanz/I-7905-2014	Ezquerro, Juan Jose Sanz/0000-0002-9084-6354	Spanish Ministerio de Ciencia y Tecnologia [BFU2003-06100, BFU2006-12859]; Fundacio La Marato TV3 [MTV082031]; Ramon y Cajal contract; FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacio La Marato TV3; Ramon y Cajal contract(Spanish Government); FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia	This work was supported by grants BFU2003-06100 and BFU2006-12859 from the Spanish Ministerio de Ciencia y Tecnologia and grant MTV082031 from Fundacio La Marato TV3 to JJSE. JJSE was the recipient of a Ramon y Cajal contract and JCC of a FPU fellowship from the Spanish Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; BORGENS RB, 1982, SCIENCE, V217, P747, DOI 10.1126/science.7100922; Casanova JC, 2007, DEV GROWTH DIFFER, V49, P479, DOI 10.1111/j.1440-169x.2007.00951.x; Casanova JC, 2011, DEVELOPMENT, V138, P1195, DOI 10.1242/dev.057570; Chen JQ, 2007, GENESIS, V45, P482, DOI 10.1002/dvg.20320; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; FISHER HARVEY I., 1940, AMER MIDLAND NAT, V23, P234, DOI 10.2307/2485270; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Hamburger H, 1951, J MORPHOL, V88, P49; Harman MT, 1938, AM NAT, V72, P59, DOI 10.1086/280765; HOLDER N, 1978, J EMBRYOL EXP MORPH, V44, P15; Kaltofen RS, 1971, EMBRYONIC DEV EGGS P; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kawakami Y, 2004, DEVELOPMENT, V131, P4763, DOI 10.1242/dev.01331; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lehoczky JA, 2011, P NATL ACAD SCI USA, V108, P20609, DOI 10.1073/pnas.1118017108; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; NIETO A, 1996, METHOD CELL BIOL, P219; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Sanz-Ezquerro JJ, 2003, J ANAT, V202, P51, DOI 10.1046/j.1469-7580.2003.00134.x; Stricker S, 2011, DEV DYNAM, V240, P990, DOI 10.1002/dvdy.22565; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Tamura K, 2011, SCIENCE, V331, P753, DOI 10.1126/science.1198229; Tickle C, 2004, MECH DEVELOP, V121, P1019, DOI 10.1016/j.mod.2004.05.015; Towers M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1437; Treichel D, 2003, GENE DEV, V17, P2630, DOI 10.1101/gad.274103; Uejima A, 2010, DEV GROWTH DIFFER, V52, P223, DOI 10.1111/j.1440-169X.2009.01161.x; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yu L, 2010, DEVELOPMENT, V137, P551, DOI 10.1242/dev.042424; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou J, 2007, BIOCHEM BIOPH RES CO, V363, P513, DOI 10.1016/j.bbrc.2007.08.198; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	39	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52781	10.1371/journal.pone.0052781	http://dx.doi.org/10.1371/journal.pone.0052781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285181	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500060
J	Rinkevich, FD; Hedtke, SM; Leichter, CA; Harris, SA; Su, C; Brady, SG; Taskin, V; Qiu, XH; Scott, JG				Rinkevich, Frank D.; Hedtke, Shannon M.; Leichter, Cheryl A.; Harris, Sarah A.; Su, Cathy; Brady, Sean G.; Taskin, Vatan; Qiu, Xinghui; Scott, Jeffrey G.			Multiple Origins of kdr-type Resistance in the House Fly, Musca domestica	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; APHID MYZUS-PERSICAE; IN-FIELD POPULATIONS; PEACH-POTATO APHIDS; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; MOLECULAR ANALYSIS; BEMISIA-TABACI; MUTATIONS; FREQUENCIES	Insecticide resistance is a model phenotype that can be used to investigate evolutionary processes underlying the spread of alleles across a global landscape, while offering valuable insights into solving the problems that resistant pests present to human health and agriculture. Pyrethroids are one of the most widely used classes of insecticides world-wide and they exert their toxic effects through interactions with the voltage-sensitive sodium channel (Vssc). Specific mutations in Vssc (kdr, kdr-his and super-kdr) are known to cause resistance to pyrethroid insecticides in house flies. In order to determine the number of evolutionary origins of kdr, kdr-his and super-kdr, we sequenced a region of Vssc from house flies collected in the USA, Turkey and China. Our phylogenetic analysis of Vssc unequivocally supports the hypothesis of multiple independent origins of kdr, super-kdr and kdr-his on an unprecedented geographic scale. The implications of these evolutionary processes on pest management are discussed.	[Rinkevich, Frank D.; Hedtke, Shannon M.; Leichter, Cheryl A.; Harris, Sarah A.; Su, Cathy; Scott, Jeffrey G.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Brady, Sean G.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; [Taskin, Vatan] Mugla Sitki Kocman Univ, Fac Sci, Dept Biol, Mugla, Turkey; [Qiu, Xinghui] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Cornell University; Smithsonian Institution; Smithsonian National Museum of Natural History; Mugla Sitki Kocman University; Chinese Academy of Sciences; Institute of Zoology, CAS	Scott, JG (corresponding author), Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.	JGS5@cornell.edu		Hedtke, Shannon/0000-0002-7499-7662	Hatch project [139 7416]	Hatch project(United States Department of Agriculture (USDA))	This work was supported by Hatch project 139 7416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2006, INSECT BIOCHEM MOLEC, V36, P71, DOI 10.1016/j.ibmb.2005.10.007; Andreev D, 1999, J MOL EVOL, V48, P615, DOI 10.1007/PL00006504; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; ANTHONY NM, 1995, PESTIC BIOCHEM PHYS, V51, P220, DOI 10.1006/pest.1995.1022; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; CAPRIO MA, 1992, J ECON ENTOMOL, V85, P611, DOI 10.1093/jee/85.3.611; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Dong K, 1998, PESTIC BIOCHEM PHYS, V60, P195, DOI 10.1006/pest.1998.2339; Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FARNHAM AW, 1987, PESTIC SCI, V19, P209, DOI 10.1002/ps.2780190306; ffrench-Constant RH, 2004, TRENDS GENET, V20, P163, DOI 10.1016/j.tig.2004.01.003; ffrenchConstant RH, 1996, ACS SYM SER, V645, P106; FFRENCHCONSTANT RH, 1993, NATURE, V363, P449, DOI 10.1038/363449a0; Field Linda M., 1994, Insect Molecular Biology, V3, P143, DOI 10.1111/j.1365-2583.1994.tb00161.x; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Foster SP, 1999, B ENTOMOL RES, V89, P133, DOI 10.1017/S0007485399000218; GEORGHIOU GP, 1977, J ECON ENTOMOL, V70, P319, DOI 10.1093/jee/70.3.319; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillis David M., 1996, P321; Keiding J, 1986, VECTOR BIOL CONTROL, V86, P937; KNIPPLE DC, 1994, P NATL ACAD SCI USA, V91, P2483, DOI 10.1073/pnas.91.7.2483; Krafsur ES, 2005, J HERED, V96, P502, DOI 10.1093/jhered/esi093; Maddison W, MESQUITE MODULAR SYS; Marquez JG, 2002, J HERED, V93, P254, DOI 10.1093/jhered/93.4.254; Marshall KL, 2012, J PESTIC SCI, V37, P169, DOI 10.1584/jpestics.D11-017; Milani R., 1957, Rivista di Parassitologia Roma, V18, P199; Newcomb RD, 2005, J MOL EVOL, V60, P207, DOI 10.1007/s00239-004-0104-x; Nyoni BN, 2011, PEST MANAG SCI, V67, P891, DOI 10.1002/ps.2145; Park Y, 1997, INSECT BIOCHEM MOLEC, V27, P9, DOI 10.1016/S0965-1748(96)00077-X; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Qiu XH, 2007, PESTIC BIOCHEM PHYS, V89, P146, DOI 10.1016/j.pestbp.2007.05.003; RAYMOND M, 1991, NATURE, V350, P151, DOI 10.1038/350151a0; Rinkevich FD, 2006, INSECT MOL BIOL, V15, P157, DOI 10.1111/j.1365-2583.2006.00620.x; Rinkevich FD, 2007, INSECT BIOCHEM MOLEC, V37, P550, DOI 10.1016/j.ibmb.2007.02.013; SCHOOF HERBERT F., 1959, PEST CONTROL, V27, P16; Seifert J, 2002, PESTIC BIOCHEM PHYS, V72, P40, DOI 10.1006/pest.2001.2577; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Taskin V, 2011, J VECTOR ECOL, V36, P239, DOI 10.1111/j.1948-7134.2011.00164.x; Wang QM, 2012, PESTIC BIOCHEM PHYS, V102, P153, DOI 10.1016/j.pestbp.2011.12.007; Whitten MJ, 1981, P 3 AUST C GRASSL IN; WILLIAMSON MS, 1993, MOL GEN GENET, V240, P17, DOI 10.1007/BF00276878; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Zwickl D., 2006, GARLI GENETIC ALGORI	46	40	41	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52761	10.1371/journal.pone.0052761	http://dx.doi.org/10.1371/journal.pone.0052761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285178	Green Submitted, gold, Green Published			2022-12-25	WOS:000313051500058
J	Rodrigues, F; Sousa, MJ; Ludovico, P; Santos, H; Corte-Real, M; Leao, C				Rodrigues, Fernando; Sousa, Maria Joao; Ludovico, Paula; Santos, Helena; Corte-Real, Manuela; Leao, Cecilia			The Fate of Acetic Acid during Glucose Co-Metabolism by the Spoilage Yeast Zygosaccharomyces bailii	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; C-13-NMR SPECTROSCOPY; MATHEMATICAL-MODEL; CARBOXYLIC-ACIDS; TRANSPORT; FERMENTATION; CYCLE; INHIBITION; ETHANOL; CELLS	Zygosaccharomyces bailii is one of the most widely represented spoilage yeast species, being able to metabolise acetic acid in the presence of glucose. To clarify whether simultaneous utilisation of the two substrates affects growth efficiency, we examined growth in single- and mixed-substrate cultures with glucose and acetic acid. Our findings indicate that the biomass yield in the first phase of growth is the result of the weighted sum of the respective biomass yields on single-substrate medium, supporting the conclusion that biomass yield on each substrate is not affected by the presence of the other at pH 3.0 and 5.0, at least for the substrate concentrations examined. In vivo C-13-NMR spectroscopy studies showed that the gluconeogenic pathway is not operational and that [2-C-13] acetate is metabolised via the Krebs cycle leading to the production of glutamate labelled on C-2, C-3 and C-4. The incorporation of [U-C-14] acetate in the cellular constituents resulted mainly in the labelling of the protein and lipid pools 51.5% and 31.5%, respectively. Overall, our data establish that glucose is metabolised primarily through the glycolytic pathway, and acetic acid is used as an additional source of acetyl-CoA both for lipid synthesis and the Krebs cycle. This study provides useful clues for the design of new strategies aimed at overcoming yeast spoilage in acidic, sugar-containing food environments. Moreover, the elucidation of the molecular basis underlying the resistance phenotype of Z. bailii to acetic acid will have a potential impact on the improvement of the performance of S. cerevisiae industrial strains often exposed to acetic acid stress conditions, such as in wine and bioethanol production.	[Sousa, Maria Joao; Corte-Real, Manuela] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Rodrigues, Fernando; Ludovico, Paula; Leao, Cecilia] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Rodrigues, Fernando; Ludovico, Paula; Leao, Cecilia] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Santos, Helena] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal	Universidade do Minho; Universidade do Minho; Universidade Nova de Lisboa	Corte-Real, M (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	mcortereal@bio.uminho.pt	Corte-Real, Manuela/B-6328-2013; Rodrigues, Fernando/T-5299-2018; Santos, Helena/B-9141-2011; Rodrigues, Fernando/A-3123-2011; Sousa, Maria/HCI-9642-2022; Ludovico, Paula/B-4338-2011; Leao, Cecília/B-5051-2013; Sousa, Maria João/H-8775-2013	Corte-Real, Manuela/0000-0002-1423-1331; Rodrigues, Fernando/0000-0001-8436-9398; Santos, Helena/0000-0002-8050-9485; Ludovico, Paula/0000-0003-4130-7167; Sousa, Maria João/0000-0001-9424-4150; Leao, Cecilia/0000-0003-1311-7884	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PTDC/AGR-ALI/102608/2008]; FEDER through POFC - COMPETE; FCT [PEst-C/BIA/UI4050/2011];  [FCOMP-01-0124-FEDER- 007047]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/102608/2008] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FEDER through POFC - COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ; Fundação para a Ciência e a Tecnologia	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal Grant PTDC/AGR-ALI/102608/2008 and by project FCOMP-01-0124-FEDER- 007047 and by FEDER through POFC - COMPETE and national funds from FCT - project PEst-C/BIA/UI4050/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneborg N, 2000, ARCH MICROBIOL, V174, P125, DOI 10.1007/s002030000185; CASAL M, 1995, BBA-MOL CELL RES, V1267, P122, DOI 10.1016/0167-4889(95)00067-3; CASSIO F, 1993, YEAST, V9, P743, DOI 10.1002/yea.320090708; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Dang TDT, 2009, FOOD MICROBIOL, V26, P320, DOI 10.1016/j.fm.2008.12.002; De VC, 1992, YEAST, V8, P1043; DEJONGGUBBELS P, 1995, YEAST, V11, P407, DOI 10.1002/yea.320110503; dos Santos MM, 2003, EUKARYOT CELL, V2, P599, DOI 10.1128/EC.2.3.599-608.2003; Fernandes L, 1997, LETT APPL MICROBIOL, V25, P249, DOI 10.1046/j.1472-765X.1997.00214.x; Fernandes L, 1999, LETT APPL MICROBIOL, V28, P345, DOI 10.1046/j.1365-2672.1999.00551.x; FIECHTER A, 1981, ADV MICROB PHYSIOL, V22, P123, DOI 10.1016/S0065-2911(08)60327-6; Geros H, 2000, J FOOD PROTECT, V63, P96, DOI 10.4315/0362-028X-63.1.96; Guerreiro JF, 2012, PROTEOMICS, V12, P2303, DOI 10.1002/pmic.201100457; JONES JG, 1993, BIOCHEMISTRY-US, V32, P12240, DOI 10.1021/bi00096a037; LEE YY, 1999, ADV BIOCHEM ENG BIOT, V65, P93, DOI DOI 10.1007/3-540-49194-5_5; Ludovico P, 2003, FEMS YEAST RES, V3, P449, DOI 10.1016/S1567-1356(03)00107-7; MAIORELLA B, 1983, BIOTECHNOL BIOENG, V25, P103, DOI 10.1002/bit.260250109; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; PRONK JT, 1994, MICROBIOL-SGM, V140, P601, DOI 10.1099/00221287-140-3-601; Prudencio C, 1998, CYTOMETRY, V31, P307, DOI 10.1002/(SICI)1097-0320(19980401)31:4<307::AID-CYTO11>3.0.CO;2-U; Rodrigues F, 2004, YEAST, V21, P325, DOI 10.1002/yea.1081; RONNE H, 1995, TRENDS GENET, V11, P12, DOI 10.1016/S0168-9525(00)88980-5; SANTOS H, 1986, J MAGN RESON, V68, P345, DOI 10.1016/0022-2364(86)90251-9; Sousa MJ, 1998, MICROBIOL-UK, V144, P665, DOI 10.1099/00221287-144-3-665; Sousa MJ, 1996, APPL ENVIRON MICROB, V62, P3152, DOI 10.1128/AEM.62.9.3152-3157.1996; Sousa MJ, 2012, CELL METABOLISM CELL; SUMEGI B, 1992, BIOCHEMISTRY-US, V31, P8720, DOI 10.1021/bi00152a006; TranDinh S, 1996, EUR J BIOCHEM, V242, P220, DOI 10.1111/j.1432-1033.1996.0220r.x; TranDinh S, 1997, EUR J BIOCHEM, V245, P497, DOI 10.1111/j.1432-1033.1997.t01-2-00497.x; TRANDINH S, 1991, EUR J BIOCHEM, V201, P715, DOI 10.1111/j.1432-1033.1991.tb16333.x; TSAI CS, 1989, BIOCHEM CELL BIOL, V67, P464, DOI 10.1139/o89-073; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; VANUDEN N, 1967, ARCH MIKROBIOL, V58, P155; Vilela-Moura A, 2008, APPL MICROBIOL BIOT, V80, P881, DOI 10.1007/s00253-008-1616-x	34	28	29	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52402	10.1371/journal.pone.0052402	http://dx.doi.org/10.1371/journal.pone.0052402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285028	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500029
J	Corella, D; Ortega-Azorin, C; Sorli, JV; Covas, MI; Carrasco, P; Salas-Salvado, J; Martinez-Gonzalez, MA; Aros, F; Lapetra, J; Serra-Majem, L; Lamuela-Raventos, R; Gomez-Gracia, E; Fiol, M; Pinto, X; Ros, E; Marti, A; Coltell, O; Ordovas, JM; Estruch, R				Corella, Dolores; Ortega-Azorin, Carolina; Sorli, Jose V.; Isabel Covas, M.; Carrasco, Paula; Salas-Salvado, Jordi; Angel Martinez-Gonzalez, Miguel; Aros, Fernando; Lapetra, Jose; Serra-Majem, Lluis; Lamuela-Raventos, Rosa; Gomez-Gracia, Enrique; Fiol, Miquel; Pinto, Xavier; Ros, Emilio; Marti, Amelia; Coltell, Oscar; Ordovas, Jose M.; Estruch, Ramon			Statistical and Biological Gene-Lifestyle Interactions of MC4R and FTO with Diet and Physical Activity on Obesity: New Effects on Alcohol Consumption	PLOS ONE			English	Article							BODY-MASS INDEX; COMMON VARIANTS; FAT MASS; ETHANOL INTAKE; ENERGY-INTAKE; FOOD-INTAKE; RS9939609 POLYMORPHISM; ACTIVITY QUESTIONNAIRE; MELANOCORTIN RECEPTOR; ASSOCIATION	Background: Fat mass and obesity (FTO) and melanocortin-4 receptor (MC4R) and are relevant genes associated with obesity. This could be through food intake, but results are contradictory. Modulation by diet or other lifestyle factors is also not well understood. Objective: To investigate whether MC4R and FTO associations with body-weight are modulated by diet and physical activity (PA), and to study their association with alcohol and food intake. Methods: Adherence to Mediterranean diet (AdMedDiet) and physical activity (PA) were assessed by validated questionnaires in 7,052 high cardiovascular risk subjects. MC4R rs17782313 and FTO rs9939609 were determined. Independent and joint associations (aggregate genetic score) as well as statistical and biological gene-lifestyle interactions were analyzed. Results: FTO rs9939609 was associated with higher bodymass index (BMI), waist circumference (WC) and obesity (P < 0.05 for all). A similar, but not significant trend was found for MC4R rs17782313. Their additive effects (aggregate score) were significant and we observed a 7% per-allele increase of being obese (OR = 1.07; 95% CI 1.01-1.13). We found relevant statistical interactions (P, 0.05) with PA. So, in active individuals, the associations with higher BMI, WC or obesity were not detected. A biological (non-statistical) interaction between AdMedDiet and rs9939609 and the aggregate score was found. Greater AdMedDiet in individuals carrying 4 or 3-risk alleles counterbalanced their genetic predisposition, exhibiting similar BMI (P = 0.502) than individuals with no risk alleles and lower AdMedDiet. They also had lower BMI (P = 0.021) than their counterparts with low AdMedDiet. We did not find any consistent association with energy or macronutrients, but found a novel association between these polymorphisms and lower alcohol consumption in variant-allele carriers (B+/-SE: -0.57+/-0.16 g/d per-score-allele; P = 0.001). Conclusion: Statistical and biological interactions with PA and diet modulate the effects of FTO and MC4R polymorphisms on obesity. The novel association with alcohol consumption seems independent of their effects on BMI.	[Corella, Dolores; Ortega-Azorin, Carolina; Sorli, Jose V.; Carrasco, Paula; Estruch, Ramon] Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Corella, Dolores; Ortega-Azorin, Carolina; Sorli, Jose V.; Isabel Covas, M.; Carrasco, Paula; Salas-Salvado, Jordi; Lapetra, Jose; Fiol, Miquel; Ros, Emilio; Coltell, Oscar] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Isabel Covas, M.] Municipal Inst Med Res IMIM, Cardiovasc Epidemiol Unit, Barcelona, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, IISPV, Fac Med, Human Nutr Unit, E-43201 Reus, Spain; [Angel Martinez-Gonzalez, Miguel] Univ Navarra, Sch Clin Med, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Aros, Fernando] Hosp Txagorritxu, Dept Cardiol, Vitoria, Spain; [Lapetra, Jose] San Pablo Hlth Ctr, Primary Care Div Sevilla, Dept Family Med, Seville, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Dept Clin Sci, Las Palmas Gran Canaria, Spain; [Lamuela-Raventos, Rosa] Univ Barcelona, Sch Pharm, Dept Nutr & Food Sci, Barcelona, Spain; [Gomez-Gracia, Enrique] Univ Malaga, Sch Med, Dept Epidemiol, Malaga, Spain; [Fiol, Miquel] Hosp Son Dureta, Univ Inst Hlth Sci Invest, Palma De Mallorca, Spain; [Pinto, Xavier] Hosp Llobregat, Hosp Univ Bellvitge, Lipids & Vasc Risk Unit, Barcelona, Spain; [Ros, Emilio] Hosp Clin Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Endocrinol & Nutr Serv, Lipid Clin, Barcelona, Spain; [Marti, Amelia] Univ Navarra, Dept Nutr Food Sci Physiol & Toxicol, E-31080 Pamplona, Spain; [Coltell, Oscar] Univ Jaume 1, Dept Comp Languages & Syst, Castellon de La Plana, Spain; [Ordovas, Jose M.] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Nutr & Genom Lab, Boston, MA 02111 USA; [Ordovas, Jose M.] CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] IMDEA Alimentac, Madrid, Spain; [Estruch, Ramon] IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); University of Navarra; University Hospital of Araba; Universidad de Las Palmas de Gran Canaria; University of Barcelona; Universidad de Malaga; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; Universitat Jaume I; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Corella, D (corresponding author), Univ Valencia, Sch Med, Dept Prevent Med & Publ Hlth, Valencia, Spain.	dolores.corella@uv.es	Pintó, Xavier/AGI-4297-2022; IBIS, ATENCION PRIMARIA/I-3524-2016; Estruch, Ramon/AAZ-3723-2020; Serra-Majem, Lluis/I-6708-2019; Fiol, Miguel/F-6793-2016; Salas-Salvado, Jordi/C-7229-2017; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Lapetra, Jose/F-2552-2015; Carrasco, Paula/D-7864-2019; Sorlí, José V/L-8758-2014; Marti, Amelia/M-2709-2019; Coltell, Oscar/AAA-9936-2019; Martí, Amelia/H-1192-2017; Lamuela-Raventos, Rosa M/F-3986-2016; Ordovas, Jose/B-8727-2013	Pintó, Xavier/0000-0002-2216-2444; Serra-Majem, Lluis/0000-0002-9658-9061; Fiol, Miguel/0000-0002-5370-1391; Salas-Salvado, Jordi/0000-0003-2700-7459; Carrasco, Paula/0000-0002-7170-4318; Sorlí, José V/0000-0002-0130-2006; Marti, Amelia/0000-0001-9832-7981; Coltell, Oscar/0000-0002-4518-8495; Martí, Amelia/0000-0001-9832-7981; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ordovas, Jose/0000-0002-7581-5680; Ros, Emilio/0000-0002-2573-1294; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Official funding agency for Biomedical Research of the Spanish Government; Instituto de Salud Carlos III (ISCIII); Fondo Europeo de Desarrollo Regional (FEDER) [RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI11/02505 PI11/01647 CNIC-06, AGL2010-22319-C03-03]; Generalitat Valenciana [AP-042/11, BEST11-263]	Official funding agency for Biomedical Research of the Spanish Government; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	The Official funding agency for Biomedical Research of the Spanish Government, Instituto de Salud Carlos III (ISCIII) and Fondo Europeo de Desarrollo Regional (FEDER), provided the grants for his study: RTIC G03/140, CIBERobn, RD 06/0045, PI04-2239, PI 05/2584, CP06/00100, PI07/0240, PI07/1138, PI07/0954, PI 07/0473, PI10/01407, PI11/02505 PI11/01647 CNIC-06 and AGL2010-22319-C03-03. The Generalitat Valenciana provided grants AP-042/11 and BEST11-263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 2005, EUR J EPIDEMIOL, V20, P563, DOI 10.1007/s10654-005-4410-4; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Baik I, 2012, NUTR RES PRACT, V6, P78, DOI 10.4162/nrp.2012.6.1.78; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cole SA, 2010, AM J CLIN NUTR, V91, P191, DOI 10.3945/ajcn.2009.28514; Corella D, 2012, NUTR METAB CARDIOVAS, V22, P651, DOI 10.1016/j.numecd.2010.10.006; Corella D, 2011, J NUTR, V141, P2219, DOI 10.3945/jn.111.143826; Corella D, 2009, CIRC-CARDIOVASC GENE, V2, P637, DOI 10.1161/CIRCGENETICS.109.891366; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Elosua R, 2000, MED SCI SPORT EXER, V32, P1431, DOI 10.1097/00005768-200008000-00011; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Grau K, 2009, INT J OBESITY, V33, P1227, DOI 10.1038/ijo.2009.159; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Hasselbalch AL, 2010, J NUTR, V140, P831, DOI 10.3945/jn.109.114439; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Hertel JK, 2011, DIABETES, V60, P1637, DOI 10.2337/db10-1340; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Lappalainen T, 2012, BR J NUTR, V23, P1, DOI DOI 10.1017/S0007114511007410; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Liu GF, 2011, EUR J EPIDEMIOL, V26, P463, DOI 10.1007/s10654-011-9583-4; Liu GF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-57; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Martinelli CE, 2011, J CLIN ENDOCR METAB, V96, pE181, DOI 10.1210/jc.2010-1369; Mataix J., 2003, TABLA COMPOSICION AL, V4th; Navarro M, 2005, ALCOHOL CLIN EXP RES, V29, P949, DOI 10.1097/01.ALC.0000167740.19702.8C; Navarro M, 2011, ALCOHOL CLIN EXP RES, V35, P1058, DOI 10.1111/j.1530-0277.2011.01438.x; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; Pearson TA, 1996, CIRCULATION, V94, P3023, DOI 10.1161/01.CIR.94.11.3023; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Phillips CM, 2012, J NUTR, V142, P824, DOI 10.3945/jn.111.153460; Polidori C, 2006, PEPTIDES, V27, P144, DOI 10.1016/j.peptides.2005.07.008; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Rampersaud E, 2008, ARCH INTERN MED, V168, P1791, DOI 10.1001/archinte.168.16.1791; Razquin C, 2010, INT J OBESITY, V34, P266, DOI 10.1038/ijo.2009.233; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Santoro N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-25; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Sobczyk-Kopciol A, 2011, ADDICTION, V106, P739, DOI 10.1111/j.1360-0443.2010.03248.x; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Taylor AE, 2011, J OBES, V2011, DOI 10.1155/2011/307542; Tenesa A, 2009, INT J OBESITY, V33, P284, DOI 10.1038/ijo.2008.257; Thomsen M, 2012, J CLIN ENDOCR METAB, V97, pE1074, DOI 10.1210/jc.2011-3282; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Vasan SK, 2012, OBESITY; Vimaleswaran KS, 2012, OBESITY, V20, P1669, DOI 10.1038/oby.2012.49; Wang XF, 2010, HUM HERED, V70, P269, DOI 10.1159/000321967; Wang XF, 2011, NAT REV GENET, V12, P74, DOI 10.1038/nrg2579-c2; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; York DA, 2011, PHARMACOL BIOCHEM BE, V98, P112, DOI 10.1016/j.pbb.2010.12.010	65	51	55	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52344	10.1371/journal.pone.0052344	http://dx.doi.org/10.1371/journal.pone.0052344			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284998	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800050
J	Legros, M; Xu, CG; Okamoto, K; Scott, TW; Morrison, AC; Lloyd, AL; Gould, F				Legros, Mathieu; Xu, Chonggang; Okamoto, Kenichi; Scott, Thomas W.; Morrison, Amy C.; Lloyd, Alun L.; Gould, Fred			Assessing the Feasibility of Controlling Aedes aegypti with Transgenic Methods: A Model-Based Evaluation	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; BORNE DISEASE-CONTROL; DENGUE CONTROL; COMMUNITY PARTICIPATION; MESOCYCLOPS COPEPODA; CULICIDAE PRODUCTION; DIPTERA-CULICIDAE; VECTOR MOSQUITOS; SOUTHERN MEXICO; GENETIC-CONTROL	Suppression of dengue and malaria through releases of genetically engineered mosquitoes might soon become feasible. Aedes aegypti mosquitoes carrying a conditionally lethal transgene have recently been used to suppress local vector populations in small-scale field releases. Prior to releases of transgenic insects on a wider scale, however, most regulatory authorities will require additional evidence that suppression will be effective in natural heterogeneous habitats. We use a spatially explicit stochastic model of an Ae. aegypti population in Iquitos, Peru, along with an uncertainty analysis of its predictions, to quantitatively assess the outcome of varied operational approaches for releases of transgenic strains with conditional death of females. We show that population elimination might be an unrealistic objective in heterogeneous populations. We demonstrate that substantial suppression can nonetheless be achieved if releases are deployed in a uniform spatial pattern using strains combining multiple lethal elements, illustrating the importance of detailed spatial models for guiding genetic mosquito control strategies.	[Legros, Mathieu; Xu, Chonggang; Okamoto, Kenichi; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Legros, Mathieu; Scott, Thomas W.; Morrison, Amy C.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Xu, Chonggang] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Scott, Thomas W.; Lloyd, Alun L.; Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lloyd, Alun L.] N Carolina State Univ, Grad Program, Dept Math & Biomath, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of California System; University of California Davis; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of North Carolina; North Carolina State University	Legros, M (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	legros.mathieu@gmail.com	Legros, Mathieu/E-6767-2011; Lloyd, Alun/AAN-6639-2020; Morrison, Amy/AAU-6511-2020; Lloyd, Alun L/H-4944-2012; Okamoto, Kenichi/AAA-3763-2021	Legros, Mathieu/0000-0003-3807-8594; Lloyd, Alun/0000-0002-6389-6321; Okamoto, Kenichi/0000-0002-1889-4538; Xu, Chonggang/0000-0002-0937-5744; Morrison, Amy/0000-0001-6224-5984	National Institutes of Health [R01-AI54954-0IA2]; Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054954, R01AI091980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant R01-AI54954-0IA2, and through the Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, AM J TROP MED HYG, V83, P305; Arredondo-Jimenez JI, 2006, ANN TROP MED PARASIT, V100, pS17, DOI 10.1179/136485906X105480; ASMAN SM, 1981, ANNU REV ENTOMOL, V26, P289, DOI 10.1146/annurev.en.26.010181.001445; Benedict M, 2008, VECTOR-BORNE ZOONOT, V8, P127, DOI 10.1089/vbz.2007.0273; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; BIDLINGMAYER WL, 1985, J AM MOSQUITO CONTR, V1, P328; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108; Enserink M, 2010, SCIENCE, V330, P1030, DOI 10.1126/science.330.6007.1030; FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Focks DA, 2006, TDRIRMDEN0601P WHO; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344; Gubler DJ, 1996, ACTA TROP, V61, P169, DOI 10.1016/0001-706X(95)00103-L; Hanh TTT, 2009, AM J TROP MED HYG, V80, P312, DOI 10.4269/ajtmh.2009.80.312; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503; Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Legros M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022701; Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Marshall JM, 2010, NAT BIOTECHNOL, V28, P896, DOI 10.1038/nbt0910-896; Marshall JM, 2009, J THEOR BIOL, V258, P250, DOI 10.1016/j.jtbi.2009.01.031; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67; Parks W, 2004, WHOCDSWMC20042; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1543, DOI 10.1603/0022-0493-93.6.1543; Schliekelman P, 2000, J ECON ENTOMOL, V93, P1566, DOI 10.1603/0022-0493-93.6.1566; SCOTT TW, 2008, LONGITUDINAL FIELD S, P132; SERVICE MW, 1993, ANN TROP MED PARASIT, V87, P223, DOI 10.1080/00034983.1993.11812760; Subbaraman N, 2011, NAT BIOTECHNOL, V29, P9, DOI 10.1038/nbt0111-9a; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Toledo ME, 2008, TROP MED INT HEALTH, V13, P728, DOI 10.1111/j.1365-3156.2008.02046.x; TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27; Valerio L, 2012, AM J TROP MED HYG, V86, P665, DOI 10.4269/ajtmh.2012.11-0513; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; White SM, 2010, J APPL ECOL, V47, P1329, DOI 10.1111/j.1365-2664.2010.01880.x; WINCH P, 1992, HEALTH POLICY PLANN, V7, P342, DOI 10.1093/heapol/7.4.342; World Health Organization, 2009, DENG DENG HAEM FEV F; Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830; Yakob L, 2008, THEOR POPUL BIOL, V74, P324, DOI 10.1016/j.tpb.2008.09.003; Yakob L, 2008, J APPL ECOL, V45, P1258, DOI 10.1111/j.1365-2664.2008.01498.x	55	25	25	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52235	10.1371/journal.pone.0052235	http://dx.doi.org/10.1371/journal.pone.0052235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284949	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800039
J	Lu, XH; An, SQ; Tang, DJ; McCarthy, Y; Tang, JL; Dow, JM; Ryan, RP				Lu, Xiu-Hong; An, Shi-Qi; Tang, Dong-Jie; McCarthy, Yvonne; Tang, Ji-Liang; Dow, John Maxwell; Ryan, Robert P.			RsmA Regulates Biofilm Formation in Xanthomonas campestris through a Regulatory Network Involving Cyclic di-GMP and the Clp Transcription Factor	PLOS ONE			English	Article							GYP DOMAIN PROTEIN; HD-GYP; PV. CAMPESTRIS; VIRULENCE; BINDING; PATHOGENICITY; EXPRESSION; BACTERIA	Biofilm formation and dispersal in the black rot pathogen Xanthomonas campestris pathovar campestris (Xcc) is influenced by a number of factors. The extracellular mannanase ManA has been implicated in biofilm dispersal whereas biofilm formation requires a putative glycosyl transferase encoded by the xag gene cluster. Previously we demonstrated that the post-transcriptional regulator RsmA exerts a negative regulatory influence on biofilm formation in Xcc. Here we address the mechanisms by which RsmA exerts this action. We show that RsmA binds to the transcripts of three genes encoding GGDEF domain diguanylate cyclases to influence their expression. Accordingly, mutation of rsmA leads to an increase in cellular levels of cyclic di-GMP. This effect is associated with a down-regulation of transcription of manA, but an upregulation of xag gene transcription. Mutation of clp, which encodes a cyclic di-GMP-responsive transcriptional regulator of the CRP-FNR family, has similar divergent effects on the expression of manA and xag. Nevertheless Clp binding to manA and xag promoters is inhibited by cyclic di-GMP. The data support the contention that, in common with other CRP-FNR family members, Clp can act as both an activator and repressor of transcription of different genes to influence biofilm formation as a response to cyclic di-GMP.	[Lu, Xiu-Hong; An, Shi-Qi; Tang, Dong-Jie; Tang, Ji-Liang] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Lu, Xiu-Hong; An, Shi-Qi; Tang, Dong-Jie; Tang, Ji-Liang] Guangxi Univ, Coll Life Sci & Technol, Nanning 530004, Peoples R China; [An, Shi-Qi; McCarthy, Yvonne; Dow, John Maxwell; Ryan, Robert P.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BioSci Inst, Cork, Ireland	Guangxi University; Guangxi University; University College Cork	Tang, JL (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	jltang@gxu.edu.cn; m.dow@ucc.ie		Dow, Max/0000-0001-8245-2294; Ryan, Rober/0000-0002-7353-0913; An, Shi-qi/0000-0002-2593-9642	Science Foundation Ireland [SFI 07/IN.1/B955, SFI 09/SIRG/B1654, 07/IN.1/B955/IRPs]; Royal Irish Academy fellowship; National Science Foundation of China [30810103912]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Royal Irish Academy fellowship; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work of the authors has been supported in part by grants awarded by the Science Foundation Ireland (SFI 07/IN.1/B955 to J.M.D. and SFI 09/SIRG/B1654 to R.P.R.), Royal Irish Academy fellowship (to R.R.P) and an International Research Partnership supported by Science Foundation Ireland (07/IN.1/B955/IRPs) and the National Science Foundation of China (30810103912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber CE, 1997, MOL MICROBIOL, V24, P555, DOI 10.1046/j.1365-2958.1997.3721736.x; Chao NX, 2008, MOL PLANT MICROBE IN, V21, P411, DOI 10.1094/MPMI-21-4-0411; Chin KH, 2010, J MOL BIOL, V396, P646, DOI 10.1016/j.jmb.2009.11.076; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Fazli M, 2011, MOL MICROBIOL, V82, P327, DOI 10.1111/j.1365-2958.2011.07814.x; Gomelsky M, 2009, J BACTERIOL, V191, P6785, DOI 10.1128/JB.01173-09; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hsiao YM, 2010, J AGR FOOD CHEM, V58, P1653, DOI 10.1021/jf903637s; Hsiao YM, 2005, FEBS LETT, V579, P3525, DOI 10.1016/j.febslet.2005.05.023; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Jonas K, 2010, ENVIRON MICROBIOL, V12, P524, DOI 10.1111/j.1462-2920.2009.02097.x; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Romling U, 2012, ENVIRON MICROBIOL, V14, P1817, DOI 10.1111/j.1462-2920.2011.02617.x; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sambrook J, 1989, MOL CLONING LAB MANU; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; SPIRO S, 1990, FEMS MICROBIOL REV, V6, P399; Srivastava D, 2012, J BACTERIOL, V194, P4485, DOI 10.1128/JB.00379-12; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Yakhnin AV, 2000, J BIOL CHEM, V275, P4519, DOI 10.1074/jbc.275.6.4519	34	27	32	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52646	10.1371/journal.pone.0052646	http://dx.doi.org/10.1371/journal.pone.0052646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285129	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000313158800085
J	Ochoa, MC; Fioravanti, J; Duitman, EH; Medina-Echeverz, J; Palazon, A; Arina, A; Dubrot, J; Alfaro, C; Morales-Kastresana, A; Murillo, O; Hervas-Stubbs, S; Prieto, J; Berraondo, P; Melero, I				Ochoa, Maria C.; Fioravanti, Jessica; Duitman, Erwin H.; Medina-Echeverz, Jose; Palazon, Asis; Arina, Ainhoa; Dubrot, Juan; Alfaro, Carlos; Morales-Kastresana, Aizea; Murillo, Oihana; Hervas-Stubbs, Sandra; Prieto, Jesus; Berraondo, Pedro; Melero, Ignacio			Liver Gene Transfer of Interkeukin-15 Constructs That Become Part of Circulating High Density Lipoproteins for Immunotherapy	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; ANTITUMOR-ACTIVITY; INTRATUMORAL INJECTION; MONOCLONAL-ANTIBODIES; MOUSE MODEL; T-CELLS; IL-15; INTERLEUKIN-15; NK	Apolipoprotein A-I (Apo A-I) is a major component of high density lipoproteins (HDL) that transport cholesterol in circulation. We have constructed an expression plasmid encoding a chimeric molecule encompassing interleukin-15 (IL-15) and Apo A-I (pApo-hIL15) that was tested by hydrodynamic injections into mice and was co-administered with a plasmid encoding the sushi domain of IL-15R alpha (pSushi) in order to enhance IL-15 trans-presentation and thereby bioactivity. The pharmacokinetics of the Apo A-I chimeric protein were much longer than non-stabilized IL-15 and its bioactivity was enhanced in combination with IL-15R alpha Sushi. Importantly, the APO-IL-15 fusion protein was incorporated in part into circulating HDL. Liver gene transfer of these constructs increased NK and memory-phenotype CD8 lymphocyte numbers in peripheral blood, spleen and liver as a result of proliferation documented by CFSE dilution and BrdU incorporation. Moreover, the gene transfer procedure partly rescued the NK and memory T-cell deficiency observed in IL-15R alpha(-/-) mice. pApo-hIL15+ pSushi gene transfer to the liver showed a modest therapeutic activity against subcutaneously transplanted MC38 colon carcinoma tumors, that was more evident when tumors were set up as liver metastases. The improved pharmacokinetic profile and the strong biological activity of APO-IL-15 fusion protein holds promise for further development in combination with other immunotherapies.	[Ochoa, Maria C.; Fioravanti, Jessica; Medina-Echeverz, Jose; Palazon, Asis; Dubrot, Juan; Alfaro, Carlos; Morales-Kastresana, Aizea; Hervas-Stubbs, Sandra; Prieto, Jesus; Berraondo, Pedro; Melero, Ignacio] Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Duitman, Erwin H.] Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany; [Arina, Ainhoa] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Murillo, Oihana] Stanford Univ, Dept Otolaryngol, Stanford Canc Ctr, Stanford, CA 94305 USA; [Murillo, Oihana] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	University of Navarra; Forschungszentrum Borstel; University of Chicago; Stanford Cancer Institute; Stanford University; Stanford University	Berraondo, P (corresponding author), Univ Navarra, Ctr Appl Med Res, E-31080 Pamplona, Spain.	pberraondol@unav.es; imelero@unav.es	Berraondo, Pedro/J-3154-2012; Palazon, Asis/ABI-1748-2020; Dubrot, Juan/ABI-1676-2020; Alfaro, Carlos/K-3566-2014; Fioravanti, Jessica/AAS-1245-2020; Murillo, Oihana/S-4162-2018; Melero, Ignacio/T-7600-2019; Ochoa, Maria C./K-4508-2017; Hervas-Stubbs, Sandra/C-9053-2018	Berraondo, Pedro/0000-0001-7410-1865; Palazon, Asis/0000-0002-7172-7229; Dubrot, Juan/0000-0002-8093-2208; Alfaro, Carlos/0000-0002-4812-7153; Fioravanti, Jessica/0000-0001-6263-4306; Murillo, Oihana/0000-0003-3963-7394; Melero, Ignacio/0000-0002-1360-348X; Ochoa, Maria C./0000-0001-9920-2144; Hervas-Stubbs, Sandra/0000-0003-3391-1516; Prieto, Jesus/0000-0002-1091-9593	Ministerio de Ciencia e Innovacion; Fundacion Cientifica of AECC; Ministerio de Educacion y Ciencia; Fondo de Investigacion Sanitaria (FIS); MEC/EI Ministerio de Ciencia e Innovacion [SAF2005-03131, SAF2008-03294]; RETIC [RD06/0020/0065]; European commission; Fundacion Mutua Madrilena; UTE for project FIMA;  [PI060932];  [FIS PI10/00264]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Cientifica of AECC; Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); MEC/EI Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)); RETIC; European commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); UTE for project FIMA; ; 	MCO receives a Sara Borrell contract from Ministerio de Ciencia e Innovacion. CA is supported by Fundacion Cientifica of AECC. SH-S receives a Ramon y Cajal contract from Ministerio de Educacion y Ciencia, and AM-K a scholarship from Ministerio de Ciencia e Innovacion. PB a Miguel Servet contract from Fondo de Investigacion Sanitaria (FIS); AP, JF and JM a scholarship from FIS. Financial support was from MEC/EI Ministerio de Ciencia e Innovacion (SAF2005-03131 and SAF2008-03294), RETIC (RD06/0020/0065), (PI060932 and FIS PI10/00264), European commission 7th famework program and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arina A, 2008, GENE THER, V15, P473, DOI 10.1038/gt.2008.4; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Bonamassa B, 2010, PHARM RES; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chang CM, 2010, HUM GENE THER, V21, P611, DOI 10.1089/hum.2009.187; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Croce M, 2005, CLIN CANCER RES, V11, P735; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1621, DOI 10.1007/s00262-010-0888-z; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fioravanti J, 2011, HEPATOLOGY; Fioravanti J, 2011, HEPATOLOGY, V53, P1864, DOI 10.1002/hep.24306; Francis GA, 2010, BBA-MOL CELL BIOL L, V1801, P1286, DOI 10.1016/j.bbalip.2010.08.009; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; He YK, 2000, HUM GENE THER, V11, P547, DOI 10.1089/10430340050015734; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lorenzen I, 2006, J BIOL CHEM, V281, P6642, DOI 10.1074/jbc.M513118200; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Martinez Forero Ivan, 2012, J Transl Med, V10, P108, DOI 10.1186/1479-5876-10-108; Meazza R, 2000, INT J CANCER, V87, P574, DOI 10.1002/1097-0215(20000815)87:4<574::AID-IJC18>3.3.CO;2-K; Melero I, 1999, GENE THER, V6, P1779, DOI 10.1038/sj.gt.3301010; Mignot G, 2008, J IMMUNOL, V180, P6477, DOI 10.4049/jimmunol.180.10.6477; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; MUNGER W, 1995, CELL IMMUNOL, V165, P289, DOI 10.1006/cimm.1995.1216; Oh S, 2003, P NATL ACAD SCI USA, V100, P3392, DOI 10.1073/pnas.0630592100; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Rodriguez-Sureda V, 2002, ANAL BIOCHEM, V303, P73, DOI 10.1006/abio.2001.5546; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Soman G, 2009, J IMMUNOL METHODS, V348, P83, DOI 10.1016/j.jim.2009.07.010; Steel JC, 2010, CANCER RES, V70, P1072, DOI 10.1158/0008-5472.CAN-09-1301; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093; Vera M, 2005, MOL THER, V12, P950, DOI 10.1016/j.ymthe.2005.03.030; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277; Yu P, 2010, CLIN CANCER RES, V16, P6019, DOI 10.1158/1078-0432.CCR-10-1966; Zabala M, 2007, J HEPATOL, V47, P807, DOI 10.1016/j.jhep.2007.07.025	49	11	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52370	10.1371/journal.pone.0052370	http://dx.doi.org/10.1371/journal.pone.0052370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285013	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800055
J	Sun, FJ; Gao, H; Zhang, YQ; Wang, L; Fang, N; Tan, YF; Guo, ZB; Xia, PY; Zhou, DS; Yang, RF				Sun, Fengjun; Gao, He; Zhang, Yiquan; Wang, Li; Fang, Nan; Tan, Yafang; Guo, Zhaobiao; Xia, Peiyuan; Zhou, Dongsheng; Yang, Ruifu			Fur Is a Repressor of Biofilm Formation in Yersinia pestis	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; DIGUANYLATE CYCLASE; RCS PHOSPHORELAY; FLEA VECTOR; PLAGUE; TRANSCRIPTION; EVOLUTION; INFECTION; VIRULENCE; BACTERIA	Background: Yersinia pestis synthesizes the attached biofilms in the flea proventriculus, which is important for the transmission of this pathogen by fleas. The hmsHFRS operons is responsible for the synthesis of exopolysaccharide (the major component of biofilm matrix), which is activated by the signaling molecule 39, 5'-cyclic diguanylic acid (c-di-GMP) synthesized by the only two diguanylate cyclases HmsT, and YPO0449 (located in a putative operonYPO0450-0448). Methodology/Principal Findings: The phenotypic assays indicated that the transcriptional regulator Fur inhibited the Y. pestis biofilm production in vitro and on nematode. Two distinct Fur box-like sequences were predicted within the promoter-proximal region of hmsT, suggesting that hmsT might be a direct Fur target. The subsequent primer extension, LacZ fusion, electrophoretic mobility shift, and DNase I footprinting assays disclosed that Fur specifically bound to the hmsT promoter-proximal region for repressing the hmsT transcription. In contrast, Fur had no regulatory effect on hmsHFRS and YPO0450-0448 at the transcriptional level. The detection of intracellular c-di-GMP levels revealed that Fur inhibited the c-di-GMP production. Conclusions/Significance: Y. pestis Fur inhibits the c-di-GMP production through directly repressing the transcription of hmsT, and thus it acts as a repressor of biofilm formation. Since the relevant genetic contents for fur, hmsT, hmsHFRS, and YPO0450-0448 are extremely conserved between Y. pestis and typical Y. pseudotuberculosis, the above regulatory mechanisms can be applied to Y. pseudotuberculosis.	[Sun, Fengjun; Gao, He; Zhang, Yiquan; Wang, Li; Fang, Nan; Tan, Yafang; Guo, Zhaobiao; Zhou, Dongsheng; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Sun, Fengjun; Xia, Peiyuan] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China; [Gao, He] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Army Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Xia, PY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China.	py_xia@yahoo.com.cn; dongshengzhou1977@gmail.com; ruifuyang@gmail.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [30930001, 30900823]; National Basic Research Program of China [2009CB522600]; Beijing Nova Program [Z12111000250000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	Financial support was provided by the National Natural Science Foundation of China (30930001, and 30900823), by the National Basic Research Program of China (2009CB522600), and by the Beijing Nova Program (Z12111000250000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chen YS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-274; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Darby C, 2002, NATURE, V417, P243, DOI 10.1038/417243a; Darby C, 2008, TRENDS MICROBIOL, V16, P158, DOI 10.1016/j.tim.2008.01.005; El-Robh MS, 2002, BIOCHEM J, V368, P835, DOI 10.1042/BJ20021003; Erickson DL, 2008, J BACTERIOL, V190, P8163, DOI 10.1128/JB.01181-08; Erickson DL, 2006, J BACTERIOL, V188, P1113, DOI 10.1128/JB.188.3.1113-1119.2006; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Forman S, 2006, MICROBIOL-SGM, V152, P3399, DOI 10.1099/mic.0.29224-0; Gao H, 2008, J BACTERIOL, V190, P3063, DOI 10.1128/JB.01910-07; Hinnebusch BJ, 2008, CURR TOP MICROBIOL, V322, P229; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Matthysse AG, 1996, FEMS MICROBIOL LETT, V145, P87, DOI 10.1016/0378-1097(96)00392-8; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Sun YC, 2012, J BACTERIOL, V194, P2020, DOI 10.1128/JB.06243-11; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wehland M, 2000, J BIOL CHEM, V275, P7013, DOI 10.1074/jbc.275.10.7013; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025484; Zhou DS, 2011, PROTEIN CELL, V2, P173, DOI 10.1007/s13238-011-1024-3; Zhou DS, 2006, FEMS MICROBIOL LETT, V258, P9, DOI 10.1111/j.1574-6968.2006.00208.x; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004	34	33	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52392	10.1371/journal.pone.0052392	http://dx.doi.org/10.1371/journal.pone.0052392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285021	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800060
J	Belle, L; Bruck, F; Foguenne, J; Gothot, A; Beguin, Y; Baron, F; Briquet, A				Belle, Ludovic; Bruck, France; Foguenne, Jacques; Gothot, Andre; Beguin, Yves; Baron, Frederic; Briquet, Alexandra			Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34(+) Cells	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW; STEM-CELLS; IN-VITRO; BCR-ABL; SELECTIVE INHIBITOR; PERIPHERAL-BLOOD	Background: The availability of tyrosine kinase inhibitors (TKIs) has considerably changed the management of Philadelphia chromosome positive leukemia. The BCR-ABL inhibitor imatinib is also known to inhibit the tyrosine kinase of the stem cell factor receptor, c-Kit. Nilotinib is 30 times more potent than imatinib towards BCR-ABL in vitro. Studies in healthy volunteers and patients with chronic myelogenous leukemia or gastrointestinal stromal tumors have shown that therapeutic doses of nilotinib deliver drug levels similar to those of imatinib. The aim of this study was to compare the inhibitory effects of imatinib and nilotinib on proliferation, differentiation, adhesion, migration and engraftment capacities of human cord blood CD34(+) cells. Design and Methods: After a 48-hour cell culture with or without TKIs, CFC, LTC-IC, migration, adhesion and cell cycle analysis were performed. In a second time, the impact of these TKIs on engraftment was assessed in a xenotransplantation model using NOD/SCID/IL-2R gamma (null) mice. Results: TKIs did not affect LTC-IC frequencies despite in vitro inhibition of CFC formation due to inhibition of CD34(+) cell cycle entry. Adhesion of CD34(+) cells to retronectin was reduced in the presence of either imatinib or nilotinib but only at high concentrations. Migration through a SDF-1 alpha gradient was not changed by cell culture in the presence of TKIs. Finally, bone marrow cellularity and human chimerism were not affected by daily doses of imatinib and nilotinib in a xenogenic transplantation model. No significant difference was seen between TKIs given the equivalent affinity of imatinib and nilotinib for KIT. Conclusions: These data suggest that combining non-myeloablative conditioning regimen with TKIs starting the day of the transplantation could be safe.	[Belle, Ludovic; Bruck, France; Gothot, Andre; Beguin, Yves; Baron, Frederic; Briquet, Alexandra] Univ Liege, Hematol Res Unit, Giga I3, Liege, Belgium; [Foguenne, Jacques; Gothot, Andre] Ctr Hosp Univ Liege, Dept Lab Hematol & Immunohematol, Liege, Belgium; [Beguin, Yves; Baron, Frederic] Ctr Hosp Univ Liege, Div Hematol, Dept Med, Liege, Belgium	University of Liege; University of Liege; University of Liege	Belle, L (corresponding author), Univ Liege, Hematol Res Unit, Giga I3, Liege, Belgium.	lbelle@ulg.ac.be			Novartis Pharmaceuticals; National Fund for Scientific Research (FNRS)	Novartis Pharmaceuticals(Novartis); National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS)	LB, F. Baron and YB have received travel grants from Novartis Pharmaceuticals. YB received unrestricted research grant from Novartis Pharmaceuticals. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. This study was supported by the National Fund for Scientific Research (FNRS; http://www1.frs-fnrs.be/). The travel grants and unrestricted research grants from Novartis Pharmaceuticals where not part of the funding for this study. The FNRS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Similarly Novartis Pharmaceuticals had no role in study design, data collection and analysis or decision to publish. They did however receive the final draft of the publication prior to submission since they kindly provided the authors with imatinib and nilotinib, and suggested a number of minor edits to the manuscript.	Baron F, 2005, CURR OPIN HEMATOL, V12, P435, DOI 10.1097/01.moh.0000177830.63033.9d; Bartolovic K, 2004, BLOOD, V103, P523, DOI 10.1182/blood-2003-05-1535; Breccia M, 2010, LEUKEMIA RES, V34, P143, DOI 10.1016/j.leukres.2009.04.036; Brendel C, 2007, LEUKEMIA, V21, P1267, DOI 10.1038/sj.leu.2404638; Carpenter PA, 2007, BLOOD, V109, P2791, DOI 10.1182/blood-2006-04-019836; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Gigant C, 2001, J HEMATOTH STEM CELL, V10, P807, DOI 10.1089/152581601317210908; HAYLOCK DN, 1992, BLOOD, V80, P1405; Heinrich MC, 2000, BLOOD, V96, P925, DOI 10.1182/blood.V96.3.925.015k50_925_932; Hoepfl J, 2002, LEUKEMIA, V16, P1584, DOI 10.1038/sj.leu.2402679; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Huygen S, 2002, BLOOD, V100, P2744, DOI 10.1182/blood.V100.8.2744; Jabbour E, 2007, CANCER-AM CANCER SOC, V110, P340, DOI 10.1002/cncr.22778; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kurzrock R, 2003, ANN INTERN MED, V138, P819, DOI 10.7326/0003-4819-138-10-200305200-00010; Lee SJ, 2008, BLOOD, V112, P3500, DOI 10.1182/blood-2008-02-141689; Levesque JP, 1999, EXP HEMATOL, V27, P579, DOI 10.1016/S0301-472X(98)00069-1; LEVESQUE JP, 1995, J EXP MED, V181, P1805, DOI 10.1084/jem.181.5.1805; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Mauro MJ, 2002, J CLIN ONCOL, V20, P325, DOI 10.1200/JCO.20.1.325; Miller CL, 1997, BLOOD, V89, P1214, DOI 10.1182/blood.V89.4.1214; Mohty M, 2008, HAEMATOLOGICA, V93, P303, DOI 10.3324/haematol.11960; O'Sullivan S, 2011, BONE, V49, P281, DOI 10.1016/j.bone.2011.04.014; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pirson L, 2006, STEM CELLS, V24, P1814, DOI 10.1634/stemcells.2005-0290; Ram R, 2011, HAEMATOL-HEMATOL J, V96, P1113, DOI 10.3324/haematol.2011.040261; ROSTI V, 1995, BLOOD, V86, P3387, DOI 10.1182/blood.V86.9.3387.bloodjournal8693387; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; von Bubnoff N, 2006, BLOOD, V108, P1328, DOI 10.1182/blood-2005-12-010132; Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1038/sj.bjc.6603170; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weisberg E, 2007, BLOOD, V109, P2112, DOI 10.1182/BLOOD-2006-06-026377; YEE NS, 1994, J EXP MED, V179, P1777, DOI 10.1084/jem.179.6.1777; Yong KL, 2002, BRIT J HAEMATOL, V119, P500, DOI 10.1046/j.1365-2141.2002.03837.x; Zheng Yi-zhou, 2004, Zhonghua Xue Ye Xue Za Zhi, V25, P736	37	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52564	10.1371/journal.pone.0052564	http://dx.doi.org/10.1371/journal.pone.0052564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285088	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500196
J	Hills, SFK; Crampton, JS; Trewick, SA; Morgan-Richards, M				Hills, Simon F. K.; Crampton, James S.; Trewick, Steven A.; Morgan-Richards, Mary			DNA and Morphology Unite Two Species and 10 Million Year Old Fossils	PLOS ONE			English	Article							CALIBRATION UNCERTAINTY; CONVERGENT EVOLUTION; GENUS; CALYPTRAEIDAE; GASTROPODA; TRAITS; SHAPE; SIZE	Species definition and delimitation is a non-trivial problem in evolutionary biology that is particularly problematic for fossil organisms. This is especially true when considering the continuity of past and present species, because species defined in the fossil record are not necessarily equivalent to species defined in the living fauna. Correctly assigned fossil species are critical for sensitive downstream analysis (e. g., diversification studies and molecular-clock calibration). The marine snail genus Alcithoe exemplifies many of the problems with species identification. The paucity of objective diagnostic characters, prevalence of morphological convergence between species and considerable variability within species that are observed in Alcithoe are typical of a broad range of fossilised organisms. Using a synthesis of molecular and morphometric approaches we show that two taxa currently recognised as distinct are morphological variants of a single species. Furthermore, we validate the fossil record for one of these morphotypes by finding a concordance between the palaeontological record and divergence time of the lineage inferred using molecular-clock analysis. This work demonstrates the utility of living species represented in the fossil record as candidates for molecular-clock calibration, as the veracity of fossil species assignment can be more rigorously tested.	[Hills, Simon F. K.; Trewick, Steven A.; Morgan-Richards, Mary] Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand; [Crampton, James S.] GNS Sci, Lower Hutt, New Zealand	Massey University; GNS Science - New Zealand	Hills, SFK (corresponding author), Massey Univ, Inst Nat Resources, Ecol Grp, Palmerston North, New Zealand.	s.f.hills@massey.ac.nz	Hills, Simon F K/L-3244-2016; Morgan-Richards, Mary/B-4444-2011; Crampton, James/G-1381-2012	Hills, Simon F K/0000-0002-9115-0375; Morgan-Richards, Mary/0000-0002-3913-9814; Trewick, Steven/0000-0002-4680-8457; Crampton, James/0000-0003-3270-9981	Marsden Fund [04 GNS 021]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was funded as part of the Marsden Fund contract 04 GNS 021, administered by the Royal Society of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2004, ZOOL J LINN SOC-LOND, V140, P577, DOI 10.1111/j.1096-3642.2003.00108.x; [Anonymous], 2010, R LANG ENV STAT COMP; Bail P, 2005, THE RECENT VOLUTES O; Barraclough TG, 2010, PHILOS T R SOC B, V365, P1801, DOI 10.1098/rstb.2009.0276; Beu AG, 1990, CENOZOIC MOLLUSCA OF; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; BOOTH CL, 1990, EVOLUTION, V44, P210, DOI 10.1111/j.1558-5646.1990.tb04291.x; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Chaparro OR, 1999, J EXP MAR BIOL ECOL, V232, P261, DOI 10.1016/S0022-0981(98)00115-4; Cooper R. A., 2004, I GEOLOGICAL NUCL SC, P1; Crampton JS, 2006, PALEOBIOLOGY, V32, P509, DOI 10.1666/06014.1; Crampton JS, 2010, PALEOBIOLOGY, V36, P204, DOI 10.1666/09010.1; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; DARRAGH T A, 1988, Memoirs of the Museum of Victoria, V49, P195; Darwin C, 1859, ON THE ORIGIN OF SPE; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DELL R K, 1978, National Museum of New Zealand Records, V1, P161; DRUMMOND A. J., 2007, GENEIOUS V3 8, P8; Foote M, 2007, PRINCIPLES OF PALEON; Foote M, 2007, SCIENCE, V318, P1131, DOI 10.1126/science.1146303; Forey PL, 2004, PHILOS T R SOC B, V359, P639, DOI 10.1098/rstb.2003.1453; Haines AJ, 2000, PALAEONTOLOGY, V43, P765, DOI 10.1111/1475-4983.00148; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hills SFK, 2011, BIOL J LINN SOC, V104, P770, DOI 10.1111/j.1095-8312.2011.01756.x; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Lee MSY, 2009, MOL PHYLOGENET EVOL, V50, P661, DOI 10.1016/j.ympev.2008.11.024; MALLET J, 1995, TRENDS ECOL EVOL, V10, P294, DOI 10.1016/0169-5347(95)90031-4; MICHAUX B, 1987, NEW ZEAL J ZOOL, V14, P359, DOI 10.1080/03014223.1987.10423006; Miloslavich P, 2001, NAUTILUS, V115, P39; Moore J, 1997, BIOL REV, V72, P1, DOI 10.1017/S0006323196004926; Near TJ, 2005, AM NAT, V165, P137, DOI 10.1086/427734; Nolte AW, 2005, FRONTIERS ZOOLOGY, V2; Olabarria C, 2004, J MOLLUS STUD, V70, P59, DOI 10.1093/mollus/70.1.59; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perez SI, 2006, J ANAT, V208, P769, DOI 10.1111/j.1469-7580.2006.00576.x; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Powell AWB, 1979, NEW ZEALAND MOLLUSCA; Rambaut A, 2002, SE AL SEQUENCE ALIGN; Reid DG, 1996, PHILOS T R SOC B, V351, P877, DOI 10.1098/rstb.1996.0082; Rohlf F. J., 2010, TPSDIG V 2 16; Rutschmann F, 2007, SYST BIOL, V56, P591, DOI 10.1080/10635150701491156; Sheets H. D., 2004, IMP INTEGRATED MORPH; Sheets H. David, 2006, Frontiers in Zoology, V3, pUnpaginated, DOI 10.1186/1742-9994-3-15; SLATKIN M, 1991, GENETICS, V129, P555; van Tuinen M, 2004, J MOL EVOL, V59, P267, DOI 10.1007/s00239-004-2624-9; Waggoner B, 2004, J PALEONTOL, V78, P51, DOI 10.1666/0022-3360(2004)078<0051:RAATTE>2.0.CO;2; Wallace AR, 1855, ANN MAGAZINE NATURAL, V16, P184, DOI DOI 10.1080/037454809495509; Webster M., 2010, PALEONTOL SOC PAP, DOI [10.1017/s1089332600001868, DOI 10.1017/S1089332600001868]; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; [No title captured]; [No title captured]	58	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52083	10.1371/journal.pone.0052083	http://dx.doi.org/10.1371/journal.pone.0052083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284880	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500087
J	Matsha, TE; Masconi, K; Yako, YY; Hassan, MS; Macharia, M; Erasmus, RT; Kengne, AP				Matsha, Tandi Edith; Masconi, Katya; Yako, Yandiswa Yolanda; Hassan, Mogamat Shafick; Macharia, Muiriri; Erasmus, Rajiv Timothy; Kengne, Andre Pascal			Polymorphisms in the Non-Muscle Myosin Heavy Chain Gene (MYH9) Are Associated with Lower Glomerular Filtration Rate in Mixed Ancestry Diabetic Subjects from South Africa	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; DISPARITIES; RISK; HIV; EPIDEMIOLOGY; ALBUMINURIA; NEPHROPATHY; MANAGEMENT; AMERICANS	Objective: Though single nucleotide polymorphisms (SNPs) in the non-muscle myosin gene (MYH9) have been reported to explain most of the excess risk of nondiabetic chronic kidney disease (CKD), in African-Americans, some studies have also shown associations with diabetic end-stage renal disease. We investigated the association of MYH9 SNPs with renal traits in a mixed-ancestry South African population prone to diabetes. Research Design and Methods: Three SNPs known to be associated with CKD (rs4821480, rs5756152 and rs12107) were genotyped using Taqman assay in 716 adults (198 with diabetes) from the Bellville-South community, Cape Town. Glomerular filtration rate was estimated (eGFR) and urinary albumin/creatinine ratio (ACR) assessed. Multivariable regressions were used to relate the SNPs with renal traits. Results: Mean age was 53.6 years, with the expected differences observed in characteristics by diabetic status. Significant associations were found between rs575152 and serum creatinine, and eGFR in the total population, and in diabetic participants (all p <= 0.003), but not in non-diabetics (all p >= 0.16), with significant interactions by diabetes status (interaction-p <= 0.009). The association with ACR was borderline in diabetic participants (p = 0.05) and non-significant in non-diabetics (p = 0.85), with significant interaction (interaction p = 0.02). rs12107 was associated with fasting-, 2-hour glucose and HbA1c in diabetic participants only (interaction-p <= 0.003), but not with renal traits. Conclusion: MYH9 SNPs were associated with renal traits only in diabetic participants in this population. Our findings and other studies suggest that MYH9 may have a broader genetic risk effect on kidney diseases.	[Kengne, Andre Pascal] S African MRC, NCRP Cardiovasc & Metab Dis, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Matsha, Tandi Edith] Cape Peninsula Univ Technol, Dept Biomed Sci, Fac Hlth & Wellness Sci, Cape Town, South Africa; [Masconi, Katya; Yako, Yandiswa Yolanda; Hassan, Mogamat Shafick; Macharia, Muiriri; Erasmus, Rajiv Timothy] Natl Hlth Lab Serv, Div Chem Pathol, Fac Hlth Sci, Cape Town, South Africa; [Masconi, Katya; Yako, Yandiswa Yolanda; Hassan, Mogamat Shafick; Macharia, Muiriri; Erasmus, Rajiv Timothy] Univ Stellenbosch, Cape Town, South Africa; [Hassan, Mogamat Shafick] Cape Peninsula Univ Technol, Dept Nursing & Radiog, Fac Hlth & Wellness Sci, Cape Town, South Africa	South African Medical Research Council; University of Cape Town; Cape Peninsula University of Technology; Stellenbosch University; Cape Peninsula University of Technology	Kengne, AP (corresponding author), S African MRC, NCRP Cardiovasc & Metab Dis, Cape Town, South Africa.	andre.kengne@mrc.ac.za	Lutermann, Heike/A-4692-2008; Kengne, Andre Pascal/ABB-3696-2020	Lutermann, Heike/0000-0002-7521-2302; Matsha, Tandi/0000-0001-5251-030X; Macharia, Muiruri/0000-0002-5508-274X; Kengne, Andre Pascal/0000-0002-5183-131X	Cape Peninsula University of Technology, South Africa	Cape Peninsula University of Technology, South Africa	This research was supported by a grant from the University Research Fund of the Cape Peninsula University of Technology, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Bostrom MA, 2010, CLIN J AM SOC NEPHRO, V5, P1107, DOI 10.2215/CJN.08721209; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Cordonnier D, 1996, NEPHROL DIAL TRANSPL, V11, P936; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; de Wit E, 2010, HUM GENET, V128, P145, DOI 10.1007/s00439-010-0836-1; Fernandez M, 2007, ARTHRIT RHEUM-ARTHR, V57, P576, DOI 10.1002/art.22672; Freedman BI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002150; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, AM J NEPHROL, V29, P626, DOI 10.1159/000194791; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Herrema H, 2006, MOL BIOL CELL, V17, P3291, DOI 10.1091/mbc.E06-01-0067; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kopp JB, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.63.s83.39.x; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kopp JB, 2010, KIDNEY INT, V78, P130, DOI 10.1038/ki.2010.82; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Levitt NS, 2006, DIABETIC MED, V23, P103, DOI 10.1111/j.1464-5491.2006.01768.x; Matsha TE, 2012, CARDIOVASC J AFR, V23, P5, DOI 10.5830/CVJA-2010-087; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Medapalli RK, 2012, JAIDS-J ACQ IMM DEF, V60, P393, DOI 10.1097/QAI.0b013e31825b70d9; O'Seaghdha CM, 2011, HUM MOL GENET, V20, P2450, DOI 10.1093/hmg/ddr118; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Perry J, 2006, J AM SOC NEPHROL, V17, P66, DOI 10.1681/ASN.2005060586; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Toto RD, 2004, KIDNEY INT, V66, pS102, DOI 10.1111/j.1523-1755.2004.09224.x; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; WHO consultation, 1999, DEF DIAGN CLASS DI 1; Winkler C, 2010, MT SINAI J MED, V77, P149, DOI 10.1002/msj.20172; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zemlin AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022558	39	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52529	10.1371/journal.pone.0052529	http://dx.doi.org/10.1371/journal.pone.0052529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285077	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500190
J	Pelosi, A; Piedrafita, D; De Guzman, G; Shepherd, R; Hamill, JD; Meeusen, E; Walmsley, AM				Pelosi, Assunta; Piedrafita, David; De Guzman, Giorgio; Shepherd, Robert; Hamill, John D.; Meeusen, Els; Walmsley, Amanda M.			The Effect of Plant Tissue and Vaccine Formulation on the Oral Immunogenicity of a Model Plant-Made Antigen in Sheep	PLOS ONE			English	Article							HEAT-LABILE ENTEROTOXIN; IMMUNE-RESPONSES; B-SUBUNIT; HEMAGGLUTININ PROTEIN; MUCOSAL; TOXIN; IMMUNIZATION; VIRUS; CELLS; MICE	Antigen-specific antibody responses against a model antigen (the B subunit of the heat labile toxin of enterotoxigenic Escherichia coli, LTB) were studied in sheep following oral immunisation with plant-made and delivered vaccines. Delivery from a root-based vehicle resulted in antigen-specific immune responses in mucosal secretions of the abomasum and small intestine and mesenteric lymph nodes. Immune responses from the corresponding leaf-based vaccine were more robust and included stimulation of antigen-specific antibodies in mucosal secretions of the abomasum. These findings suggest that oral delivery of a plant bioencapsulated antigen can survive passage through the rumen to elicit mucosal and systemic immune responses in sheep. Moreover, the plant tissue used as the vaccine delivery vehicle affects the magnitude of these responses. Citation: Pelosi A, Piedrafita D, De Guzman G, Shepherd R, Hamill JD, et al. (2012) The Effect of Plant Tissue and Vaccine Formulation on the Oral Immunogenicity of a Model Plant-Made Antigen in Sheep. PLoS ONE 7(12): e52907. doi: 10.1371/journal.pone.0052907	[Pelosi, Assunta; De Guzman, Giorgio; Shepherd, Robert; Hamill, John D.; Walmsley, Amanda M.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Piedrafita, David; Meeusen, Els] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University; Monash University	Walmsley, AM (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	amanda.walmsley@monash.edu	De Guzman, Giorgio/B-9227-2013	piedrafita, david/0000-0001-8692-990X; Meeusen, Els/0000-0003-1239-6287; Shepherd, Robert/0000-0003-3152-3122	Dow AgroSciences, LLC; Australian Research Council; Linkage Grant Scheme [LP088231]; Dow AgroSciences through the ARC Linkage Grant mechanism; Monash University	Dow AgroSciences, LLC; Australian Research Council(Australian Research Council); Linkage Grant Scheme(Australian Research Council); Dow AgroSciences through the ARC Linkage Grant mechanism; Monash University(Monash University)	Dow AgroSciences, LLC; http://www.dowagro.com/; Australian Research Council; Linkage Grant Scheme; Grant Number LP088231; http://www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The commercial partner Dow AgroSciences provided funds alone through the ARC Linkage Grant mechanism and therefore has no competing interest, provided no direct employment (other than personnel hired by Monash University to undertake the study using grant funds), provided no consultancy, filed no patent applications nor patents, has no related products in development or marketed related products and does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Chikwamba R, 2002, TRANSGENIC RES, V11, P479, DOI 10.1023/A:1020393426750; Chikwamba RK, 2003, P NATL ACAD SCI USA, V100, P11127, DOI 10.1073/pnas.1836901100; De Guzman G, 2011, BIOTECHNOL LETT, V33, P2495, DOI 10.1007/s10529-011-0710-9; De Haan L, 1998, IMMUNOLOGY, V94, P424, DOI 10.1046/j.1365-2567.1998.00535.x; HAQ TA, 1995, SCIENCE, V268, P714, DOI 10.1126/science.7732379; Holmgren J, 2003, VACCINE, V21, pS89, DOI 10.1016/S0264-410X(03)00206-8; HOLMGREN J, 1982, INFECT IMMUN, V38, P424, DOI 10.1128/IAI.38.2.424-433.1982; JEFFERSON RA, 1987, EMBO J, V6, P3901; Khandelwal A, 2003, VACCINE, V21, P3282, DOI 10.1016/S0264-410X(03)00192-0; Khandelwal A, 2011, VET IMMUNOL IMMUNOP, V140, P291, DOI 10.1016/j.vetimm.2010.12.007; Kirk DD, 2005, TRANSGENIC RES, V14, P449, DOI 10.1007/s11248-005-5697-3; Kirk DD, 2005, IMMUNOL CELL BIOL, V83, P248, DOI 10.1111/j.1440-1711.2005.01340.x; LOGAN AC, 1991, INFECT IMMUN, V59, P1024, DOI 10.1128/IAI.59.3.1024-1031.1991; Loza-Rubio E, 2012, VACCINE, V30, P5551, DOI 10.1016/j.vaccine.2012.06.039; Mason HS, 1998, VACCINE, V16, P1336, DOI 10.1016/S0264-410X(98)80020-0; McNeilly TN, 2008, SMALL RUMINANT RES, V76, P83, DOI 10.1016/j.smallrumres.2007.12.013; Meeusen EN, 2011, VACCINE, V29, P8506, DOI 10.1016/j.vaccine.2011.09.010; Pelosi A, 2011, CURR DRUG DELIV, V8, P612, DOI 10.2174/156720111797635513; POPPI DP, 1985, J AGR SCI, V105, P9, DOI 10.1017/S0021859600055623; Premier RR, 2004, VET IMMUNOL IMMUNOP, V98, P77, DOI 10.1016/j.vetimm.2003.10.005; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Reuter F, 2009, J CONTROL RELEASE, V137, P98, DOI 10.1016/j.jconrel.2009.03.015; Rigano MM, 2006, VACCINE, V24, P691, DOI 10.1016/j.vaccine.2005.08.009; RUDDOCK LW, 1995, J BIOL CHEM, V270, P29953; Sedgmen BJ, 2003, IMMUNOL CELL BIOL, V81, P305, DOI 10.1046/j.1440-1711.2003.t01-1-01173.x; Shewen PE, 2009, VET IMMUNOL IMMUNOP, V128, P192, DOI 10.1016/j.vetimm.2008.10.297; SIXMA TK, 1991, NATURE, V351, P371, DOI 10.1038/351371a0; SIXMA TK, 1993, J MOL BIOL, V230, P890, DOI 10.1006/jmbi.1993.1209; Swiatczak B, 2012, SEMIN IMMUNOL, V24, P43, DOI 10.1016/j.smim.2011.11.004; Tacket CO, 1998, NAT MED, V4, P607, DOI 10.1038/nm0598-607; Walmsley AM, 2003, PLANT CELL REP, V21, P1020, DOI 10.1007/s00299-003-0619-4; Webster DE, 2006, VACCINE, V24, P3538, DOI 10.1016/j.vaccine.2006.02.002; WESTON RH, 1968, AUST J AGR RES, V19, P261, DOI 10.1071/AR9680261; Yang WZ, 2002, J DAIRY SCI, V85, P1958, DOI 10.3168/jds.S0022-0302(02)74272-0; Young AR, 2009, GLYCOCONJUGATE J, V26, P423, DOI 10.1007/s10719-008-9190-0; ZEMELMAN BV, 1989, INFECT IMMUN, V57, P2947, DOI 10.1128/IAI.57.10.2947-2952.1989	36	13	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52907	10.1371/journal.pone.0052907	http://dx.doi.org/10.1371/journal.pone.0052907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285224	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500257
J	Schmidt, S; Hoving, JC; Horsnell, WGC; Mearns, H; Cutler, AJ; Brombacher, TM; Brombacher, F				Schmidt, Saskia; Hoving, J. Claire; Horsnell, William G. C.; Mearns, Helen; Cutler, Antony J.; Brombacher, Tiroyaone M.; Brombacher, Frank			Nippostrongylus-Induced Intestinal Hypercontractility Requires IL-4 Receptor Alpha-Responsiveness by T Cells in Mice	PLOS ONE			English	Article							ALTERNATIVE MACROPHAGE ACTIVATION; SMOOTH-MUSCLE CONTRACTILITY; STIMULATORY FACTOR-I; INFLAMMATION; INFECTION; CYTOKINE; STAT6; INTERLEUKIN-13; RESISTANCE; EXPRESSION	Gut-dwelling helminthes induce potent IL-4 and IL-13 dominated type 2 T helper cell (T(H)2) immune responses, with IL-13 production being essential for Nippostrongylus brasiliensis expulsion. This T(H)2 response results in intestinal inflammation associated with local infiltration by T cells and macrophages. The resulting increased IL-4/IL-13 intestinal milieu drives goblet cell hyperplasia, alternative macrophage activation and smooth muscle cell hypercontraction. In this study we investigated how IL-4-promoted T cells contributed to the parasite induced effects in the intestine. This was achieved using pan T cell-specific IL-4 receptor alpha-deficient mice (iLck(cre)IL-4R alpha(-/lox)) and IL-4R alpha-responsive control mice. Global IL-4R alpha(-/-) mice showed, as expected, impaired type 2 immunity to N. brasiliensis. Infected T cell-specific IL-4R alpha-deficient mice showed comparable worm expulsion, goblet cell hyperplasia and IgE responses to control mice. However, impaired IL-4-promoted T(H)2 cells in T cell-specific IL-4R alpha deficient mice led to strikingly reduced IL-4 production by mesenteric lymph node CD4(+) T cells and reduced intestinal IL-4 and IL-13 levels, compared to control mice. This reduced IL-4/IL-13 response was associated with an impaired IL-4/IL-13-mediated smooth muscle cell hypercontractility, similar to that seen in global IL-4R alpha(-/-) mice. These results demonstrate that IL-4-promoted T cell responses are not required for the resolution of a primary N. brasiliensis infection. However, they do contribute significantly to an important physiological manifestation of helminth infection; namely intestinal smooth muscle cell-driven hypercontractility.	[Brombacher, Frank] Univ Cape Town, ICGEB, ZA-7925 Cape Town, South Africa; Univ Cape Town, Div Immunol, IIDMM, Fac Hlth Sci, ZA-7925 Cape Town, South Africa	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Cape Town	Brombacher, F (corresponding author), Univ Cape Town, ICGEB, ZA-7925 Cape Town, South Africa.	fbrombac@mweb.co.za	Horsnell, William GC/A-9512-2013	Horsnell, William Gordon Charles/0000-0001-7172-408X; Cutler, Antony/0000-0002-9617-9994; Mearns, Helen/0000-0002-7971-1256	South African Research Chair initiative of the Department of Science and Technology (DST); National Research Foundation (NRF); South African Medical Research Council (MRC)	South African Research Chair initiative of the Department of Science and Technology (DST); National Research Foundation (NRF); South African Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African Research Chair initiative of the Department of Science and Technology (DST), National Research Foundation (NRF), and the South African Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Barner M, 1998, CURR BIOL, V8, P669, DOI 10.1016/S0960-9822(98)70256-8; Brombacher F, 2000, BIOESSAYS, V22, P646, DOI 10.1002/1521-1878(200007)22:7&lt;646::AID-BIES7&gt;3.0.CO;2-9; Brombacher Frank, 2009, V531, P225, DOI 10.1007/978-1-59745-396-7_15; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; Cohn L, 1997, J EXP MED, V186, P1737, DOI 10.1084/jem.186.10.1737; Cooney LA, 2011, J IMMUNOL, V187, P4440, DOI 10.4049/jimmunol.1002860; Dewals B, 2009, AM J PATHOL, V175, P706, DOI 10.2353/ajpath.2009.090137; DUNN A, 1986, J HELMINTHOL, V60, P260, DOI 10.1017/S0022149X00008464; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Galeazzi F, 2000, AM J PHYSIOL-GASTR L, V278, pG259, DOI 10.1152/ajpgi.2000.278.2.G259; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Hasnain SZ, 2011, J EXP MED, V208, P893, DOI 10.1084/jem.20102057; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; Inagaki-Ohara K, 2011, IMMUNOLOGY, V134, P448, DOI 10.1111/j.1365-2567.2011.03503.x; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Marillier RG, 2010, AM J PHYSIOL-GASTR L, V298, pG943, DOI 10.1152/ajpgi.00321.2009; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; Mearns H, 2008, INFECT IMMUN, V76, P5535, DOI 10.1128/IAI.00210-08; MILLER HRP, 1981, IMMUNOLOGY, V44, P419; Mohrs M, 1999, J IMMUNOL, V162, P7302; Moreels TG, 2004, GUT, V53, P99, DOI 10.1136/gut.53.1.99; Moreels TG, 2001, AM J PHYSIOL-GASTR L, V280, pG1030, DOI 10.1152/ajpgi.2001.280.5.G1030; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Radwanska M, 2007, PLOS PATHOG, V3, P619, DOI 10.1371/journal.ppat.0030068; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Stenzel W, 2009, AM J PATHOL, V174, P486, DOI 10.2353/ajpath.2009.080598; SVETIC A, 1993, J IMMUNOL, V150, P3434; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; URBAN JF, 1991, P NATL ACAD SCI USA, V88, P5513, DOI 10.1073/pnas.88.13.5513; Urban JF, 2001, J IMMUNOL, V167, P6078, DOI 10.4049/jimmunol.167.11.6078; Vallance BA, 1997, AM J PHYSIOL-GASTR L, V272, pG321, DOI 10.1152/ajpgi.1997.272.2.G321; Vallance BA, 1999, INFECT IMMUN, V67, P6090, DOI 10.1128/IAI.67.11.6090-6097.1999; VITETTA ES, 1985, J EXP MED, V162, P1726, DOI 10.1084/jem.162.5.1726; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; YAMAGUCHI Y, 1988, J EXP MED, V167, P43, DOI 10.1084/jem.167.1.43; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; ZURAWSKI G, 1994, IMMUNOL TODAY, V15, P19, DOI 10.1016/0167-5699(94)90021-3	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52211	10.1371/journal.pone.0052211	http://dx.doi.org/10.1371/journal.pone.0052211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284939	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500115
J	Simcic, M; Sosic, I; Hodoscek, M; Barreteau, H; Blanot, D; Gobec, S; Grdadolnik, SG				Simcic, Mihael; Sosic, Izidor; Hodoscek, Milan; Barreteau, Helene; Blanot, Didier; Gobec, Stanislav; Grdadolnik, Simona Golic			The Binding Mode of Second-Generation Sulfonamide Inhibitors of MurD: Clues for Rational Design of Potent MurD Inhibitors	PLOS ONE			English	Article							D-GLUTAMIC ACID; MOLECULAR-DYNAMICS SIMULATIONS; TRANSFER DIFFERENCE NMR; PEPTIDOGLYCAN BIOSYNTHESIS; ADDING ENZYME; L-ALANINE; PHOSPHINATE INHIBITORS; ESCHERICHIA-COLI; LIGASE MURD; PROTEINS	A series of optimized sulfonamide derivatives was recently reported as novel inhibitors of UDP-N-acetylmuramoyl-L-alanine: D-glutamate ligase (MurD). These are based on naphthalene-N-sulfonyl-D-glutamic acid and have the D-glutamic acid replaced with rigidified mimetics. Here we have defined the binding site of these novel ligands to MurD using H-1/C-13 heteronuclear single quantum correlation. The MurD protein was selectively C-13-labeled on the methyl groups of Ile (delta 1 only), Leu and Val, and was isolated and purified. Crucial Ile, Leu and Val methyl groups in the vicinity of the ligand binding site were identified by comparison of chemical shift perturbation patterns among the ligands with various structural elements and known binding modes. The conformational and dynamic properties of the bound ligands and their binding interactions were examined using the transferred nuclear Overhauser effect and saturation transfer difference. In addition, the binding mode of these novel inhibitors was thoroughly examined using unrestrained molecular dynamics simulations. Our results reveal the complex dynamic behavior of ligand-MurD complexes and its influence on ligand-enzyme contacts. We further present important findings for the rational design of potent Mur ligase inhibitors. Citation: Simcic. M, Sosic. I, Hodoscek M, Barreteau H, Blanot D, et al. (2012) The Binding Mode of Second-Generation Sulfonamide Inhibitors of MurD: Clues for Rational Design of Potent MurD Inhibitors. PLoS ONE 7(12): e52817. doi:10.1371/journal.pone.0052817	[Simcic, Mihael; Grdadolnik, Simona Golic] EN FIST Ctr Excellence, Ljubljana, Slovenia; [Simcic, Mihael; Grdadolnik, Simona Golic] Natl Inst Chem, Lab Biomol Struct, Ljubljana, Slovenia; [Sosic, Izidor; Gobec, Stanislav] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Hodoscek, Milan] Natl Inst Chem, Lab Mol Modeling, Ljubljana, Slovenia; [Barreteau, Helene; Blanot, Didier] Univ Paris 11, Lab Enveloppes Bacteriennes & Antibiot, Orsay, France; [Blanot, Didier] CNRS, F-91405 Orsay, France	National Institute of Chemistry - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Grdadolnik, SG (corresponding author), EN FIST Ctr Excellence, Ljubljana, Slovenia.	simona.grdadolnik@ki.si		Sosic, Izidor/0000-0002-3370-4587; Golic Grdadolnik, Simona/0000-0002-0873-9593; Gobec, Stanislav/0000-0002-9678-3083	Slovenian Research Agency [J1-0317-0104-08, P1-0010]; EN-FIST Centre of Excellence; European Union [LSHM-CT-2004-512138]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence; European Union(European Commission)	This work was supported by the Slovenian Research Agency (Project No. J1-0317-0104-08 and P1-0010), EN-FIST Centre of Excellence, and the European Union FP6 Integrated Project EUR-INTAFAR (Project No. LSHM-CT-2004-512138) under the thematic priority Life Sciences, Genomics and Biotechnology for Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bertrand JA, 1999, J MOL BIOL, V289, P579, DOI 10.1006/jmbi.1999.2800; Bertrand JA, 2000, J MOL BIOL, V301, P1257, DOI 10.1006/jmbi.2000.3994; Bertrand JA, 1997, EMBO J, V16, P3416, DOI 10.1093/emboj/16.12.3416; Borstnik U, 2004, J CHEM INF COMP SCI, V44, P359, DOI 10.1021/ci034261e; Bouhss A, 1999, BIOCHEMISTRY-US, V38, P12240, DOI 10.1021/bi990517r; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P725, DOI 10.1016/B978-012164491-8/50011-7; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Dalvit C, 1998, J BIOMOL NMR, V11, P437, DOI 10.1023/A:1008272928075; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Gegnas LD, 1998, BIOORG MED CHEM LETT, V8, P1643, DOI 10.1016/S0960-894X(98)00285-6; Goddard T. D., 2008, SPARKY 3; Humljan J, 2008, J MED CHEM, V51, P7486, DOI 10.1021/jm800762u; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Keeler J., 2003, ANGEW CHEM, V115, P4068, DOI [10.1002/ange.200351947, DOI 10.1002/ANGE.200351947]; Kotnik M, 2007, J MOL BIOL, V370, P107, DOI 10.1016/j.jmb.2007.04.048; Kristan K, 2009, J BIOMOL SCREEN, V14, P412, DOI 10.1177/1087057109332597; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; McCullough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033958; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Petek M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-159; PRATVIELSOSA F, 1994, FEMS MICROBIOL LETT, V115, P223, DOI 10.1111/j.1574-6968.1994.tb06642.x; Simcic M, 2009, J MED CHEM, V52, P2899, DOI 10.1021/jm900117n; Sosic I, 2011, EUR J MED CHEM, V46, P2880, DOI 10.1016/j.ejmech.2011.04.011; Strancar K, 2006, BIOORG MED CHEM LETT, V16, P343, DOI 10.1016/j.bmcl.2005.09.086; Tanner ME, 1996, J ORG CHEM, V61, P1756, DOI 10.1021/jo951780a; Tomasic T, 2011, J MED CHEM, V54, P4600, DOI 10.1021/jm2002525; Tomasic T, 2010, CHEMMEDCHEM, V5, P286, DOI 10.1002/cmdc.200900449; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Xu XP, 2001, J BIOMOL NMR, V21, P321, DOI 10.1023/A:1013324104681; Yan JL, 2003, J MAGN RESON, V163, P270, DOI 10.1016/S1090-7807(03)00106-X; Zidar N, 2010, J MED CHEM, V53, P6584, DOI 10.1021/jm100285g	42	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52817	10.1371/journal.pone.0052817	http://dx.doi.org/10.1371/journal.pone.0052817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285193	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500249
J	Sugiura, M; Nakamura, M; Ogawa, K; Ikoma, Y; Yano, M				Sugiura, Minoru; Nakamura, Mieko; Ogawa, Kazunori; Ikoma, Yoshinori; Yano, Masamichi			High Serum Carotenoids Associated with Lower Risk for Bone Loss and Osteoporosis in Post-Menopausal Japanese Female Subjects: Prospective Cohort Study	PLOS ONE			English	Article							MINERAL DENSITY; BETA-CRYPTOXANTHIN; DIETARY PATTERNS; CIGARETTE-SMOKING; OXIDATIVE STRESS; FEMORAL TISSUES; FREE-RADICALS; HIP FRACTURE; IN-VITRO; RESORPTION	Introduction: Recent epidemiological studies show that high intakes of carotenoids might be useful to maintain bone health, but little is known about the association of serum carotenoids with change of bone mineral density (BMD). The objective of this study was to investigate longitudinally whether serum carotenoids are associated with bone loss. Methods: We conducted a follow-up on 146 male and 99 pre- and 212 post-menopausal female subjects from the Mikkabi study. Those who participated in previous BMD surveys and completed four years of follow-up were examined longitudinally. Results: During a 4-year follow-up, 15 of the post-menopausal female subjects developed new-onset osteoporosis. In contrast, none of the male and pre-menopausal female subjects did. In male and pre-menopausal female subjects, the six serum carotenoids at the baseline were not associated with bone loss. On the other hand, in post-menopausal female subjects, the 4-year bone loss of radius was inversely associated with the serum carotenoid concentrations, especially in beta-carotene. After adjustments for confounders, the odds ratios (OR) for osteoporosis in the highest tertiles of serum beta-carotene and beta-cryptoxanthin against the lowest tertiles were 0.24 (95% confidence interval 0.05-1.21) and 0.07 (CI: 0.01-0.88), respectively. Serum b-cryptoxanthin was also inversely associated with the risk for osteopenia and/or osteoporosis (P for trend, 0.037). In addition, our retrospective analysis revealed that subjects who developed osteoporosis and/or osteopenia during the survey period had significantly lower serum concentrations of beta-cryptoxanthin and beta-carotene at the baseline than those in the normal group. Conclusions: Antioxidant carotenoids, especially beta-cryptoxanthin and beta-carotene, are inversely associated with the change of radial BMD in post-menopausal female subjects.	[Sugiura, Minoru; Ogawa, Kazunori; Ikoma, Yoshinori; Yano, Masamichi] Natl Inst Fruit Tree Sci, Citrus Res Div, Shizuoka, Japan; [Nakamura, Mieko] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Hamamatsu, Shizuoka 4313192, Japan	National Agriculture & Food Research Organization - Japan; Hamamatsu University School of Medicine	Sugiura, M (corresponding author), Natl Inst Fruit Tree Sci, Citrus Res Div, Shizuoka, Japan.	msugiura@affrc.go.jp	Nakamura, Mieko/AFS-0483-2022	Nakamura, Mieko/0000-0002-9411-8784	Ministry of Agriculture, Forestry, and Fisheries (MAFF); Council for advancement of Fruit Tree Science	Ministry of Agriculture, Forestry, and Fisheries (MAFF)(Ministry of Agriculture Forestry & Fisheries - Japan); Council for advancement of Fruit Tree Science	This work was supported by a grant from the Ministry of Agriculture, Forestry, and Fisheries (MAFF) for a food research project titled "Integrated Research on Safety and Physiological Function of Food" and a grant from the Council for advancement of Fruit Tree Science. The funders had a role in data collection and analysis.	Almeida M, 2007, J BIOL CHEM, V282, P27298, DOI 10.1074/jbc.M702811200; Baeuerle PA, 1996, PATHOL BIOL, V44, P29; Basu S, 2001, BIOCHEM BIOPH RES CO, V288, P275, DOI 10.1006/bbrc.2001.5747; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Christodoulou C, 2003, POSTGRAD MED J, V79, P133, DOI 10.1136/pmj.79.929.133; Egami I, 1999, J Epidemiol, V9, P227; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Gennari C, 2001, Public Health Nutr, V4, P547; GUTTERIDGE JMC, 1994, CHEM-BIOL INTERACT, V91, P133, DOI 10.1016/0009-2797(94)90033-7; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; Maggio D, 2006, BONE, V38, P244, DOI 10.1016/j.bone.2005.08.003; Maggio D, 2003, J CLIN ENDOCR METAB, V88, P1523, DOI 10.1210/jc.2002-021496; McGartland CP, 2004, AM J CLIN NUTR, V80, P1019, DOI 10.1093/ajcn/80.4.1019; Melhus H, 1999, J BONE MINER RES, V14, P129, DOI 10.1359/jbmr.1999.14.1.129; *MIN HLTH LAB WELF, 2004, COMPR SURV LIV COND; New SA, 1997, AM J CLIN NUTR, V65, P1831, DOI 10.1093/ajcn/65.6.1831; Okubo H, 2006, AM J CLIN NUTR, V83, P1185, DOI 10.1093/ajcn/83.5.1185; Orimo H, 2001, J BONE MINER METAB, V19, P331, DOI 10.1007/s007740170001; Prentice A, 2004, PUBLIC HEALTH NUTR, V7, P227, DOI 10.1079/PHN2003590; Prynne CJ, 2006, AM J CLIN NUTR, V83, P1420, DOI 10.1093/ajcn/83.6.1420; Rock CL, 1996, J AM DIET ASSOC, V96, P693, DOI 10.1016/S0002-8223(96)00190-3; Sahni S, 2009, OSTEOPOROSIS INT, V20, P1853, DOI 10.1007/s00198-009-0897-y; Sahni S, 2009, AM J CLIN NUTR, V89, P416, DOI 10.3945/ajcn.2008.26388; *SCI TECHN AG, 1983, STAND TABL FOOD COMP; Science and Technology Agency, 1997, STAND TABL FOOD COMP; Sugiura M, 2008, OSTEOPOROSIS INT, V19, P211, DOI 10.1007/s00198-007-0457-2; Sugiura M, 2005, J EPIDEMIOL, V15, P180, DOI 10.2188/jea.15.180; Sugiura M, 2011, OSTEOPOROSIS INT, V22, P143, DOI 10.1007/s00198-010-1239-9; Sugiura M, 2009, BRIT J NUTR, V102, P1211, DOI 10.1017/S0007114509382124; Tucker KL, 2002, AM J CLIN NUTR, V76, P245, DOI 10.1093/ajcn/76.1.245; Uchiyama S, 2004, BIOL PHARM BULL, V27, P232, DOI 10.1248/bpb.27.232; Wakai K, 1999, J Epidemiol, V9, P216; Wattanapenpaiboon N, 2003, ASIA PAC J CLIN NUTR, V12, P467; Yalin S, 2005, CLIN EXP RHEUMATOL, V23, P689; Yamaguchi M, 2004, MOL CELL BIOCHEM, V258, P137, DOI 10.1023/B:MCBI.0000012848.50541.19; Yamaguchi M, 2003, BIOL PHARM BULL, V26, P1188, DOI 10.1248/bpb.26.1188; Yang ZF, 2008, INT J VITAM NUTR RES, V78, P105, DOI 10.1024/0300-9831.78.3.105	40	63	69	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52643	10.1371/journal.pone.0052643	http://dx.doi.org/10.1371/journal.pone.0052643			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285126	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500217
J	Zhou, SS; Fu, YG; Li, J; He, LY; Cai, XS; Yan, QY; Rao, XQ; Huang, SF; Li, G; Wang, YQ; Xu, AL				Zhou, Sisi; Fu, Yonggui; Li, Jie; He, Lingyu; Cai, Xingsheng; Yan, Qingyu; Rao, Xingqiang; Huang, Shengfeng; Li, Guang; Wang, Yiquan; Xu, Anlong			HTS-PEG: A Method for High Throughput Sequencing of the Paired-Ends of Genomic Libraries	PLOS ONE			English	Article							STRUCTURAL VARIATION; BAC LIBRARY; CONSTRUCTION; GENERATION; EVOLUTION; DNA	Second generation sequencing has been widely used to sequence whole genomes. Though various paired-end sequencing methods have been developed to construct the long scaffold from contigs derived from shotgun sequencing, the classical paired-end sequencing of the Bacteria Artificial Chromosome (BAC) or fosmid libraries by the Sanger method still plays an important role in genome assembly. However, sequencing libraries with the Sanger method is expensive and time-consuming. Here we report a new strategy to sequence the paired-ends of genomic libraries with parallel pyrosequencing, using a Chinese amphioxus (Branchiostoma belcheri) BAC library as an example. In total, approximately 12,670 non-redundant paired-end sequences were generated. Mapping them to the primary scaffolds of Chinese amphioxus, we obtained 413 ultra-scaffolds from 1,182 primary scaffolds, and the N50 scaffold length was increased approximately 55 kb, which is about a 10% improvement. We provide a universal and cost-effective method for sequencing the ultra-long pairedends of genomic libraries. This method can be very easily implemented in other second generation sequencing platforms.	[Zhou, Sisi; Fu, Yonggui; Li, Jie; He, Lingyu; Cai, Xingsheng; Yan, Qingyu; Rao, Xingqiang; Huang, Shengfeng; Xu, Anlong] Sun Yat Sen Univ, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem, Higher Educ Mega Ctr,Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Li, Guang; Wang, Yiquan] Xiamen Univ, Minist Educ Coastal & Wetland Ecosyst, Key Lab, Sch Life Sci, Xiamen, Peoples R China	Sun Yat Sen University; Xiamen University	Xu, AL (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem, Higher Educ Mega Ctr,Coll Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	yan, qing/GZN-2287-2022; Li, Jie/N-5859-2015	Li, Jie/0000-0002-8328-3274; Fu, Yonggui/0000-0001-6469-3430	National Natural Science Foundation of China [30730089, 30801012, 31171193]; National Basic Research Program of China (973 Program) [2011CB946101, 2007CB815800]; Fundamental Research Funds for the Central Universities; State High-Tech Development Project (863 Project) [2008AA092601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State High-Tech Development Project (863 Project)	This work was supported by the key project (No. 30730089) of the National Natural Science Foundation of China (to AX), the National Basic Research Program of China (973 Program; No. 2011CB946101 and 2007CB815800) (to AX), Fundamental Research Funds for the Central Universities (to YF), the National Natural Science Foundation of China (No. 30801012) (to YF), the State High-Tech Development Project (863 Project 2008AA092601) (to SH) and the National Natural Science Foundation of China (No. 31171193) (to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bovee D, 2008, NAT GENET, V40, P96, DOI 10.1038/ng.2007.34; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; HONG GF, 1981, BIOSCIENCE REP, V1, P243, DOI 10.1007/BF01114911; Hong YS, 2003, MOL GENET GENOMICS, V268, P720, DOI 10.1007/s00438-003-0813-7; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Nachman MW, 2000, GENETICS, V156, P297; Peng Z, 2010, LARGE GAP SIZE PAIRE; Peng Z, 2008, MODIFICATION GS LT P; Peng Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029437; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Siegel AF, 2000, GENOMICS, V68, P237, DOI 10.1006/geno.2000.6303; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Williams LJ, 2012, GENOME RES; Wu C-C, 2012, NAT METH, P9; Zhang Ju-Yong, 2010, Yichuan, V32, P67, DOI 10.3724/SP.J.1005.2010.00067; Zhao SY, 2001, GENOME RES, V11, P1736, DOI 10.1101/gr.179201	24	0	0	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52257	10.1371/journal.pone.0052257	http://dx.doi.org/10.1371/journal.pone.0052257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284958	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500126
J	Lautenschlager, S; Rayfield, EJ; Altangerel, P; Zanno, LE; Witmer, LM				Lautenschlager, Stephan; Rayfield, Emily J.; Altangerel, Perle; Zanno, Lindsay E.; Witmer, Lawrence M.			The Endocranial Anatomy of Therizinosauria and Its Implications for Sensory and Cognitive Function	PLOS ONE			English	Article							SEMICIRCULAR CANAL SYSTEM; COMPUTED-TOMOGRAPHY; FALCARIUS-UTAHENSIS; FOSSIL EVIDENCE; DINOSAURIA; THEROPODA; BRAIN; BIRDS; EVOLUTION; BEHAVIOR	Background: Therizinosauria is one of the most enigmatic and peculiar clades among theropod dinosaurs, exhibiting an unusual suite of characters, such as lanceolate teeth, a rostral rhamphotheca, long manual claws, and a wide, opisthopubic pelvis. This specialized anatomy has been associated with a shift in dietary preferences and an adaptation to herbivory. Despite a large number of discoveries in recent years, the fossil record for Therizinosauria is still relatively poor, and cranial remains are particularly rare. Methodology/Principal Findings: Based on computed tomographic (CT) scanning of the nearly complete and articulated skull of Erlikosaurus andrewsi, as well as partial braincases of two other therizinosaurian taxa, the endocranial anatomy is reconstructed and described. The wider phylogenetic range of the described specimens permits the evaluation of sensory and cognitive capabilities of Therizinosauria in an evolutionary context. The endocranial anatomy reveals a mosaic of plesiomorphic and derived characters in therizinosaurians. The anatomy of the olfactory apparatus and the endosseous labyrinth suggests that olfaction, hearing, and equilibrium were well-developed in therizinosaurians and might have affected or benefited from an enlarged telencephalon. Conclusion/Significance: This study presents the first appraisal of the evolution of endocranial anatomy and sensory adaptations in Therizinosauria. Despite their phylogenetically basal position among maniraptoran dinosaurs, therizinosaurians had developed the neural pathways for a well developed sensory repertoire. In particular olfaction and hearing may have played an important role in foraging, predator evasion, and/or social complexity.	[Lautenschlager, Stephan; Rayfield, Emily J.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Altangerel, Perle] Natl Univ Mongolia, Ulaanbaatar, Mongolia; [Zanno, Lindsay E.] NC Museum Nat Sci, Nat Res Ctr, Raleigh, NC USA; [Zanno, Lindsay E.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Witmer, Lawrence M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of Bristol; National University of Mongolia; University of North Carolina; North Carolina State University; University System of Ohio; Ohio University	Lautenschlager, S (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	glzsl@bristol.ac.uk	Rayfield, Emily/F-5038-2010	Rayfield, Emily/0000-0002-2618-750X; Witmer, Lawrence/0000-0002-7610-0118; Lautenschlager, Stephan/0000-0003-3472-814X; Zanno, Lindsay/0000-0002-1654-1990	Volkswagen Foundation (Volkswagen Stiftung), Hannover; United States National Science Foundation [IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems [1050154] Funding Source: National Science Foundation	Volkswagen Foundation (Volkswagen Stiftung), Hannover; United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputing Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	SL is supported by a doctoral fellowship by the Volkswagen Foundation (Volkswagen Stiftung), Hannover. LMW acknowledges funding support from the United States National Science Foundation (IBN-9601174, IBN-0343744, IOB-0517257, IOS-1050154) and the Ohio University Heritage College of Osteopathic Medicine. The Ohio Supercomputing Center also provided support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Ali F, 2008, J VERTEBR PALEONTOL, V28, P123, DOI 10.1671/0272-4634(2008)28[123:HOTECO]2.0.CO;2; Alifanov VR, 2011, PALEONTOL J+, V45, P183, DOI 10.1134/S0031030111020031; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P151, DOI 10.1159/000111461; Balanoff AM, 2009, AM MUS NOVIT, P1, DOI 10.1206/644.1; Barsbold R., 1980, Acta Palaeontologica Polonica, V25, P187; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Brochu CA, 2000, J VERTEBR PALEONTOL, V20, P1, DOI 10.1671/0272-4634(2000)020[0001:ADREFT]2.0.CO;2; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Chure Daniel J., 2000, Gaia (Lisboa), V15, P233; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Clark James M., 1994, American Museum Novitates, V3115, P1; Clark JM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)364<0001:CAOCOT>2.0.CO;2; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; CREPET WL, 1991, PHILOS T ROY SOC B, V333, P187, DOI 10.1098/rstb.1991.0067; CURRIE PJ, 1985, CAN J EARTH SCI, V22, P1643, DOI 10.1139/e85-173; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC, 2005, ACTA PALAEONTOL POL, V50, P617; Franzosa J, 2005, J VERTEBR PALEONTOL, V25, P859, DOI 10.1671/0272-4634(2005)025[0859:CEOTCT]2.0.CO;2; Franzosa J.W., 2004, THESIS U TEXAS; Friis EM, 1987, ORIGINS ANGIOSPERMS, P145; Giffin E.B., 1989, Journal of Vertebrate Paleontology, V9, P67; Gleich O, 2005, NATURWISSENSCHAFTEN, V92, P595, DOI 10.1007/s00114-005-0050-5; Gleich O, 2000, SPR HDB AUD, V13, P70; Hall MI, 2007, J ZOOL, V271, P437, DOI 10.1111/j.1469-7998.2006.00227.x; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Hullar TE, 2006, ANAT REC PART A, V288A, P466, DOI 10.1002/ar.a.20304; Hurlburt G.R., 1996, THESIS U TORONTO; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kirkland JI, 2005, NATURE, V435, P84, DOI 10.1038/nature03468; Kirkland JI, 2005, LIFE O PAST, P87; Kirkland JI, 2001, J VERTEBR PALEONTOL, V21, P410, DOI 10.1671/0272-4634(2001)021[0410:FDTDTF]2.0.CO;2; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; Kundrat M, 2008, ACTA ZOOL-STOCKHOLM, V89, P231, DOI 10.1111/j.1463-6395.2007.00311.x; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P499, DOI 10.1007/s00114-007-0219-1; Larsson Hans C.E., 2001, P19; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Makovicky Peter J., 1998, American Museum Novitates, V3247, P1; Makovicky PJ, 2003, AM MUS NOVIT, P1; MANLEY GA, 1972, EVOLUTION, V26, P608, DOI 10.1111/j.1558-5646.1972.tb01968.x; Martin Graham R., 1993, P5; Norell MA, 2009, AM MUS NOVIT, P1; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; Carabajal AP, 2010, NEUES JAHRB GEOL P-A, V258, P249, DOI 10.1127/0077-7749/2010/0104; Perle A., 1981, JOINT SOVIET MONGOLI, V8, P45; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; Rogers SW, 1999, ANAT RECORD, V257, P162; Rozhdestvensky A.K, 1970, PALEONTOL ZH, P131; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2107, DOI 10.1139/e93-183; RUSSELL DA, 1993, RES EXPLOR, V9, P70; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Sanders RK, 2005, ACTA PALAEONTOL POL, V50, P601; Saveliev SV, 2007, PALEONTOL J+, V41, P281, DOI 10.1134/S0031030107030070; Schmitz L, 2011, SCIENCE, V332, P705, DOI 10.1126/science.1200043; Schmitz L, 2009, J MORPHOL, V270, P759, DOI 10.1002/jmor.10720; Senter P, 2007, J SYST PALAEONTOL, V5, P429, DOI 10.1017/S1477201907002143; Senter P, 2008, HIST BIOL, V20, P255, DOI 10.1080/08912960903033327; Sipla J, 2004, J VERTEBR PALEONTOL, V24, p113A; Smith DK, 2011, J VERTEBR PALEONTOL, V31, P387, DOI 10.1080/02724634.2011.549442; Spoor F, 2003, COUR FOR SEKENBG, V243, P93; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Weishampel DB, 1997, BIOSCIENCE, V47, P150, DOI 10.2307/1313034; Wharton DS, 2002, THESIS U BRISTOL; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer Lawrence M., 2008, P117; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Zanno L, 2006, J VERTEBR PALEONTOL, V26, p143A; Zanno LE, 2011, P NATL ACAD SCI USA, V108, P232, DOI 10.1073/pnas.1011924108; Zanno LE, 2010, J SYST PALAEONTOL, V8, P503, DOI 10.1080/14772019.2010.488045; Zanno LE, 2010, ZOOL J LINN SOC-LOND, V158, P196, DOI 10.1111/j.1096-3642.2009.00464.x; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075; Zhou Chang-Fu, 2007, Palaeoworld, V16, P285, DOI 10.1016/j.palwor.2007.07.002	79	54	55	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52289	10.1371/journal.pone.0052289	http://dx.doi.org/10.1371/journal.pone.0052289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284972	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300085
J	Parrish, DD; Blevins, M; Stinnette, SE; Rebeiro, PF; Shepherd, BE; Sterling, TR; McGowan, CC; Wester, CW				Parrish, Deidra D.; Blevins, Meridith; Stinnette, Samuel E.; Rebeiro, Peter F.; Shepherd, Bryan E.; Sterling, Timothy R.; McGowan, Catherine C.; Wester, C. William			Virologic, Immunologic and Clinical Responses in Foreign-Born versus US-Born HIV-1 Infected Adults Initiating Antiretroviral Therapy: An Observational Cohort Study	PLOS ONE			English	Article							1ST YEAR; MORTALITY; HIV	Introduction: Mortality rates within the first year of combination antiretroviral therapy (cART) initiation are several-fold higher in resource-limited countries than in resource-replete settings. However studies in western countries examining virologic, immunologic and clinical responses after cART initiation in indigenous versus non-indigenous populations have shown mixed results. This study aimed to determine whether there is a difference in these outcomes in a United States setting between foreign-born and US-born patients. Methods: This retrospective observational cohort study of HIV-1 infected adults in one urban clinic in the United States compared virologic suppression, immune recovery and rates of AIDS defining events (ADEs) within the first year of cART using linear mixed effect models, log rank tests and Cox proportional hazard models. Data were analyzed for 94 foreign-born and 1242 US-born patients. Results: Foreign-born patients were younger (31.7 years versus 38.5 years), more often female (38.3% versus 27.1%), less often injection drug users (3.2% versus 9.5%) or men who have sex with men (19.0% versus 54.5%), and had higher loss to follow-up rates (14.9% versus 6.2%). No significant differences were detected between the groups in suppression of plasma HIV-1 RNA, CD4+ cell recovery or development of ADEs. Conclusions: During the first year on cART, virologic suppression, immune recovery and development of ADEs were comparable between foreign-born and US-born patients in care in a US clinic. Differential rates of loss to follow-up warrant further investigation in the foreign-born population.	[Parrish, Deidra D.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA; [Blevins, Meridith; Shepherd, Bryan E.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Stinnette, Samuel E.; Rebeiro, Peter F.; Sterling, Timothy R.; McGowan, Catherine C.; Wester, C. William] Vanderbilt Univ, Sch Med, Div Infect Dis, Nashville, TN 37212 USA; [McGowan, Catherine C.] Vanderbilt Comprehens Care Clin, Nashville, TN USA; [Wester, C. William] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health	Parrish, DD (corresponding author), Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA.	d.parrish@vanderbilt.edu		Blevins, Meridith/0000-0002-3861-9859; Rebeiro, Peter/0000-0003-1951-9104	National Institutes of Health [T32A107474, P30AI54999, K24AI065298, K23AI073141, P30AI 060354]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI073141, K24AI065298, P30AI054999, P30AI060354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the following research grants from the National Institutes of Health: T32A107474 (DDP), P30AI54999 to Vanderbilt-Meharry Center for AIDS Research (SES, BES, PFR, and TRS), K24AI065298 (SES, TRS), K23AI073141 (CWW) and P30AI 060354 to Harvard Center for AIDS Research (CWW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Carten ML, 2012, J IMMIGRANT MIN 0505; Crawford T, 2011, J IMMIGRANT MIN 0217; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Frater AJ, 2002, AIDS, V16, P1139, DOI 10.1097/00002030-200205240-00007; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Nellen JF, 2004, JAIDS-J ACQ IMM DEF, V36, P943, DOI 10.1097/00126334-200408010-00008; Perez-Molina JA, 2010, CURR HIV RES, V8, P521, DOI 10.2174/157016210793499178; Prosser AT, 2012, JAMA-J AM MED ASSOC, V308, P601, DOI 10.1001/jama.2012.9046; Staehelin C, 2003, AIDS, V17, P2237, DOI 10.1097/00002030-200310170-00012; Tuboi SH, 2009, JAIDS-J ACQ IMM DEF, V51, P615, DOI 10.1097/QAI.0b013e3181a44f0a; van den Berg JB, 2005, HIV MED, V6, P299, DOI 10.1111/j.1468-1293.2005.00304.x	13	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52336	10.1371/journal.pone.0052336	http://dx.doi.org/10.1371/journal.pone.0052336			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284994	Green Published, gold			2022-12-25	WOS:000312694300087
J	Kumsa, B; Socolovschi, C; Parola, P; Rolain, JM; Raoult, D				Kumsa, Bersissa; Socolovschi, Cristina; Parola, Philippe; Rolain, Jean-Marc; Raoult, Didier			Molecular Detection of Acinetobacter Species in Lice and Keds of Domestic Animals in Oromia Regional State, Ethiopia	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; BACTERIAL DIVERSITY; RPOB GENE; BAUMANNII; IDENTIFICATION; SPP.; ECTOPARASITES; BARTONELLA; MICROBIOTA; HORSES	This study was conducted to determine the presence of Acinetobacter and Rickettsia species DNA in lice and Melophagus ovinus (sheep ked) of animals from Oromia Regional State in Ethiopia. From September through November 2011, a total of 207 cattle, 85 sheep, 47 dogs and 16 cats were examined for ectoparasites. Results of morphological identification revealed several species of ectoparasites: Linognathus vituli (L. vituli), Bovicola bovis (B. bovis) and Solenopotes capillatus (S. capillatus) on cattle; B. ovis and Melophagus ovinus (M. ovinus) on sheep; and Heterodoxus spiniger (H. spiniger) on dogs. There was a significantly (p <= 0.0001) higher prevalence of L. vituli observed in cattle than both S. capillatus and B. bovis. Molecular identification of lice using an 18S rRNA gene analysis confirms the identified lice species by morphological methods. We detected different Acinetobacter species among lice (11.1%) and keds (86.4%) including A. soli in L. vituli of cattle, A. lowffii in M. ovinus of sheep, A. pittii in H. spiniger of dogs, 1 new Acinetobacter spp. in M. ovinus and 2 new Acinetobacter spp. in H. spiniger of dogs using partial rpoB gene sequence analysis. There was a significantly higher prevalence of Acinetobacter spp. in keds than in lice (p <= 0.00001). Higher percentage of Acinetobacter spp. DNA was detected in H. spiniger than in both B. ovis and L. vituli (p <= 0.00001). Carbapenemase resistance encoding genes for blaOXA-23, blaOXA-24, blaOXA-58, blaNDM-1 and blaOXA-51 were not found in any lice and keds. These findings suggest that synanthropic animals and their ectoparasites might increase the risk of human exposure to zoonotic pathogens and could be a source for Acinetobacter spp. infections in humans. However, additional epidemiological data are required to determine whether ectoparasites of animals can act as environmental reservoirs and play a role in spreading these bacteria to both animal and human hosts.	[Kumsa, Bersissa; Socolovschi, Cristina; Parola, Philippe; Rolain, Jean-Marc; Raoult, Didier] Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France; [Kumsa, Bersissa] Univ Addis Ababa, Coll Vet Med & Agr, Dept Parasitol, Bishoftu, Ethiopia	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Addis Ababa University	Raoult, D (corresponding author), Aix Marseille Univ, URMITE, UM63, CNRS 7278,IRD 198,Inserm 1095, Marseille, France.	didier.raoult@gmail.com	Kumsa, Bersissa/I-3144-2019; RAOULT, Didier/A-8434-2008; Parola, Philippe/AAY-4346-2021; Rolain, Jean-Marc/Y-3788-2019	Kumsa, Bersissa/0000-0003-4737-3106; RAOULT, Didier/0000-0002-0633-5974; Parola, Philippe/0000-0002-1061-1927; Rolain, Jean-Marc/0000-0002-2402-4467				Abebayehu T, 2010, TROP ANIM HEALTH PRO, V42, P1719, DOI 10.1007/s11250-010-9625-z; Barker SC, 2003, ZOOL SCR, V32, P407, DOI 10.1046/j.1463-6409.2003.00120.x; Bouvresse S, 2011, COMP IMMUNOL MICROB, V34, P475, DOI 10.1016/j.cimid.2011.08.007; Central Statistical Agency, 2008, ETH AGR SAMPL SURV R, VII; Chanie M, 2010, TROP ANIM HEALTH PRO, V42, P1103, DOI 10.1007/s11250-010-9531-4; Choi JY, 2012, DIAGN MICR INFEC DIS, V74, P177, DOI 10.1016/j.diagmicrobio.2012.06.023; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484; Endimiani A, 2011, J ANTIMICROB CHEMOTH, V66, P2248, DOI 10.1093/jac/dkr289; Francey T, 2000, J VET INTERN MED, V14, P177, DOI 10.1892/0891-6640(2000)014&lt;0177:TROBAA&gt;2.3.CO;2; Geiger A, 2011, MICROB ECOL, V62, P632, DOI 10.1007/s00248-011-9830-y; Geiger A, 2009, INFECT GENET EVOL, V9, P1364, DOI 10.1016/j.meegid.2009.09.013; Gouveia C, 2008, NEOTROP ENTOMOL, V37, P597, DOI 10.1590/S1519-566X2008000500016; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hamouda A, 2011, INT J ANTIMICROB AG, V38, P314, DOI 10.1016/j.ijantimicag.2011.06.007; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hornok S, 2010, VET PARASITOL, V174, P355, DOI 10.1016/j.vetpar.2010.09.003; Hornok S, 2011, VECTOR-BORNE ZOONOT, V11, P1319, DOI 10.1089/vbz.2011.0649; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Kempf M, 2012, INT J INFECT DIS; Kempf M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039495; Kumsa B., 2008, Bulletin of Animal Health and Production in Africa, V56, P213; Kumsa B, 2011, ONDERSTEPOORT J VET, V78; Kumsa B, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.442; Kusradze I, 2011, INT J ANTIMICROB AG, V38, P164, DOI 10.1016/j.ijantimicag.2011.03.021; La Scola B, 2004, EMERG INFECT DIS, V10, P1671, DOI 10.3201/eid1009.040242; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Light JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-292; Murrell A, 2003, PARASITOL RES, V89, P326, DOI 10.1007/s00436-002-0722-4; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakwan N, 2011, RES REPORTS NEONATAT; Narciso-da-Rocha C, 2012, APPL MICROBIOL BIOTE; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pellegrino FLPC, 2011, J CLIN MICROBIOL, V49, P2283, DOI 10.1128/JCM.00326-11; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Reed DL, 2002, MICROB ECOL, V44, P78, DOI 10.1007/s00248-002-0009-4; Regalado NG, 2009, TRAVEL MED INFECT DI, V7, P316, DOI 10.1016/j.tmaid.2009.06.001; Reid NM, 2011, APPL ENVIRON MICROB, V77, P7000, DOI 10.1128/AEM.05609-11; Saisongkorh Watcharee, 2009, Journal of the Medical Association of Thailand, V92, P707; Sant'Anna MRV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042531; Sertse T, 2007, SMALL RUMINANT RES, V69, P55, DOI 10.1016/j.smallrumres.2005.12.011; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Small RW, 2005, VET PARASITOL, V130, P141, DOI 10.1016/j.vetpar.2005.03.005; Smet A, 2012, J ANTIMICROB CHEMOTH, V67, P3009, DOI 10.1093/jac/dks311; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1495, DOI 10.3201/eid1609.100258; Taylor M. A., 2007, VET PARASITOL, V3rd; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Vaz-Moreira I, 2011, INT J SYST EVOL MICR, V61, P2837, DOI 10.1099/ijs.0.027045-0; Wall R, 1997, VET ENTOMOLOGY, V1; Walter G, 2012, AM J TROP MED HYG, V86, P1049, DOI 10.4269/ajtmh.2012.11-0794; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008; Yacob HT, 2008, ENTOM RES, V28, P26; Yong Z, 2003, CR BIOL, V326, P565, DOI 10.1016/S1631-0691(03)00153-7; Zordan S, 2011, EMERG INFECT DIS, V17, P1751, DOI 10.3201/eid1709.101931; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	57	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52377	10.1371/journal.pone.0052377	http://dx.doi.org/10.1371/journal.pone.0052377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23285015	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900093
J	Hussain, A; Mohammad, DK; Gustafsson, MO; Uslu, M; Hamasy, A; Nore, BF; Mohamed, AJ; Smith, CIE				Hussain, Alamdar; Mohammad, Dara K.; Gustafsson, Manuela O.; Uslu, Merve; Hamasy, Abdulrahman; Nore, Beston F.; Mohamed, Abdalla J.; Smith, C. I. Edvard			Signaling of the ITK (Interleukin 2-inducible T Cell Kinase)-SYK (Spleen Tyrosine Kinase) Fusion Kinase Is Dependent on Adapter SLP-76 and on the Adapter Function of the Kinases SYK and ZAP70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ZAP-70; PHOSPHORYLATION; RECEPTOR; DOMAIN; ACTIVATION; TRANSDUCTION; LYMPHOMA; MUTATION; COMPLEX	The inducible T cell kinase-spleen tyrosine kinase (ITK-SYK) oncogene consists of the Tec homology-pleckstrin homology domain of ITK and the kinase domain of SYK, and it is believed to be the cause of peripheral T cell lymphoma. We and others have recently demonstrated that this fusion protein is constitutively tyrosine-phosphorylated and is transforming both in vitro and in vivo. To gain a deeper insight into the molecular mechanism( s) underlying its activation and signaling, we mutated a total of eight tyrosines located in the SYK portion of the chimera into either phenylalanine or to the negatively charged glutamic acid. Although mutations in the interdomain-B region affected ITK-SYK kinase activity, they only modestly altered downstream signaling events. In contrast, mutations that were introduced in the kinase domain triggered severe impairment of downstream signaling. Moreover, we show here that SLP-76 is critical for ITK-SYK activation and is particularly required for the ITK-SYK-dependent phosphorylation of SYK activation loop tyrosines. In Jurkat cell lines, we demonstrate that expression of ITK-SYK fusion requires an intact SLP-76 function and significantly induces IL-2 secretion and CD69 expression. Furthermore, the SLP-76-mediated induction of IL-2 and CD69 could be further enhanced by SYK or ZAP-70, but it was independent of their kinase activity. Notably, ITK-SYK expression in SYF cells phosphorylates SLP-76 in the absence of SRC family kinases. Altogether, our data suggest that ITK-SYK exists in the active conformation state and is therefore capable of signaling without SRC family kinases or stimulation of the T cell receptor.	[Hussain, Alamdar; Mohammad, Dara K.; Gustafsson, Manuela O.; Uslu, Merve; Hamasy, Abdulrahman; Nore, Beston F.; Mohamed, Abdalla J.; Smith, C. I. Edvard] Karolinska Inst, Karolinska Hosp, Dept Lab Med, SE-14186 Stockholm, Sweden; [Hussain, Alamdar] COMSATS Inst Informat Technol, Dept Biosci, Islamabad 44000, Pakistan; [Nore, Beston F.] Univ Sulaimani, Fac Med Sci, Sch Med, Dept Biochem, Sulaimani 46001, Kurdistan Regio, Iraq; [Mohamed, Abdalla J.] Univ Brunei Darussalam, Fac Sci, Dept Biol, Bandar Seri Begawan, Brunei	Karolinska Institutet; Karolinska University Hospital; COMSATS University Islamabad (CUI); University of Sulimanyah; University Brunei Darussalam	Hussain, A (corresponding author), Karolinska Inst, Dept Lab Med, Unit Mol Cell Biol & Gene Therapy Sci, Kliniskt Forskningscentrum, SE-14186 Stockholm, Sweden.	alamdar.hussain@ki.se; edvard.smith@ki.se	Nore, Beston F./N-9288-2016	Nore, Beston F./0000-0003-3865-2920; SMITH, C. I. Edvard/0000-0003-1907-3392; Mohammad, Dara K./0000-0001-9201-0991; gustafsson, manuela/0000-0002-0268-9476	Swedish Cancer Society; Swedish Research Council; European Council FP7 Grant EURO-PAD net; Stockholm County Council; Karolinska Institutet; Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government/Iraq; Sodertorn University-College, Stockholm, Sweden	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Council FP7 Grant EURO-PAD net; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government/Iraq; Sodertorn University-College, Stockholm, Sweden	This work was supported in part by the Swedish Cancer Society, the Swedish Research Council, European Council FP7 Grant EURO-PAD net, and the regional agreement on medical training and clinical research (Avtalet mellan Landstinget och staten om samarbete om Lakarutbildning och Forskning) between Stockholm County Council and Karolinska Institutet.; Recipient of a Ph.D. fellowship from Ministry of Higher Education and Scientific Research in Kurdistan Regional-Government/Iraq.; Recipient of a Ph.D. scholarship from Sodertorn University-College, Stockholm, Sweden.	Abudula A, 2007, J BIOL CHEM, V282, P29059, DOI 10.1074/jbc.M704043200; Ashe JM, 1999, J EXP MED, V189, P1163, DOI 10.1084/jem.189.7.1163; Atwell S, 2004, J BIOL CHEM, V279, P55827, DOI 10.1074/jbc.M409792200; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Carsetti L, 2009, CELL SIGNAL, V21, P1187, DOI 10.1016/j.cellsig.2009.03.007; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dierks C, 2010, CANCER RES, V70, P6193, DOI 10.1158/0008-5472.CAN-08-3719; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Huang YL, 2009, AM J SURG PATHOL, V33, P682, DOI 10.1097/PAS.0b013e3181971591; Hussain A, 2011, FEBS J, V278, P2001, DOI 10.1111/j.1742-4658.2011.08134.x; Hussain A, 2009, BIOCHEM BIOPH RES CO, V390, P892, DOI 10.1016/j.bbrc.2009.10.070; Jin L, 2004, J BIOL CHEM, V279, P42818, DOI 10.1074/jbc.M407096200; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Pechloff K, 2010, J EXP MED, V207, P1031, DOI 10.1084/jem.20092042; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Rigby S, 2009, J BIOL CHEM, V284, P26871, DOI 10.1074/jbc.M109.034272; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Streubel B, 2006, LEUKEMIA, V20, P313, DOI 10.1038/sj.leu.2404045; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Yu L, 2011, FEBS J, V278, P1969, DOI 10.1111/j.1742-4658.2011.08135.x; Zeitlmann L, 1998, J BIOL CHEM, V273, P15445, DOI 10.1074/jbc.273.25.15445; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhao QH, 1996, MOL CELL BIOL, V16, P6765	38	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 8	2013	288	10					7338	7350		10.1074/jbc.M112.374967	http://dx.doi.org/10.1074/jbc.M112.374967			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	104NY	23293025	hybrid, Green Published			2022-12-25	WOS:000316002400053
J	Sucic, S; Koban, F; El-Kasaby, A; Kudlacek, O; Stockner, T; Sitte, HH; Freissmuth, M				Sucic, Sonja; Koban, Florian; El-Kasaby, Ali; Kudlacek, Oliver; Stockner, Thomas; Sitte, Harald H.; Freissmuth, Michael			Switching the Clientele A LYSINE RESIDING IN THE C TERMINUS OF THE SEROTONIN TRANSPORTER SPECIFIES ITS PREFERENCE FOR THE COAT PROTEIN COMPLEX II COMPONENT SEC24C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER-1; DEPENDENT NEUROTRANSMITTER TRANSPORTERS; EARLY SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM; GABA TRANSPORTER-1; OLIGOMER FORMATION; BACTERIAL HOMOLOG; GOLGI TRAFFICKING; PROTEIN-KINASE; EXPORT	The serotonin transporter (SERT) maintains serotonergic neurotransmission via rapid reuptake of serotonin from the synaptic cleft. SERT relies exclusively on the coat protein complex II component SEC24C for endoplasmic reticulum (ER) export. The closely related transporters for noradrenaline and dopamine depend on SEC24D. Here, we show that discrimination between SEC24C and SEC24D is specified by the residue at position +2 downstream from the ER export motif ((RI608)-R-607 in SERT). Substituting Lys(610) with tyrosine, the corresponding residue found in the noradrenaline and dopamine transporters, switched the SEC24 isoform preference: SERT-K610Y relied solely on SEC24D to reach the cell surface. This analysis was extended to other SLC6 (solute carrier 6) transporter family members: siRNA-dependent depletion of SEC24C, but not of SEC24D, reduced surface levels of the glycine transporter-1a, the betaine/GABA transporter and the GABA transporter-4. Experiments with dominant negative versions of SEC24C and SEC24D recapitulated these findings. We also verified that the presence of two ER export motifs (in concatemers of SERT and GABA transporter-1) supported recruitment of both SEC24C and SEC24D. To the best of our knowledge, this is the first report to document a change in SEC24 specificity by mutation of a single residue in the client protein. Our observations allowed for deducing a rule for SLC6 family members: a hydrophobic residue (Tyr or Val) in the + 2 position specifies interaction with SEC24D, and a hydrophilic residue (Lys, Asn, or Gln) recruits SEC24C. Variations in SEC24C are linked to neuropsychiatric disorders. The present findings provide a mechanistic explanation. Variations in SEC24C may translate into distinct surface levels of neurotransmitter transporters.	[Sucic, Sonja; Koban, Florian; El-Kasaby, Ali; Kudlacek, Oliver; Stockner, Thomas; Sitte, Harald H.; Freissmuth, Michael] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [El-Kasaby, Ali] Mansoura Univ, Dept Pharmacol, Fac Vet Med, Mansoura 35516, Egypt	Medical University of Vienna; Egyptian Knowledge Bank (EKB); Mansoura University	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Stockner, Thomas/A-9509-2014; Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Stockner, Thomas/0000-0002-7071-8283; Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Koban, Florian/0000-0003-0912-3114; Kudlacek, Oliver/0000-0002-3086-8551; Freissmuth, Michael/0000-0001-9398-1765; Sucic, Sonja/0000-0001-5136-8022	Austrian Science Fund/FWF [SFB35]	Austrian Science Fund/FWF(Austrian Science Fund (FWF))	This work was supported by Project Program Grant SFB35 from the Austrian Science Fund/FWF (to M.F.).	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; El-Kasaby A, 2010, J BIOL CHEM, V285, P39201, DOI 10.1074/jbc.M110.118000; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Korkhov VM, 2004, J BIOL CHEM, V279, P55728, DOI 10.1074/jbc.M409449200; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Lee SA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S20; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Morgan AR, 2007, AM J MED GENET B, V144B, P762, DOI 10.1002/ajmg.b.30509; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Prasad HC, 2005, P NATL ACAD SCI USA, V102, P11545, DOI 10.1073/pnas.0501432102; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sharpe LJ, 2011, TRAFFIC, V12, P19, DOI 10.1111/j.1600-0854.2010.01133.x; Steinkellner T, 2012, J BIOL CHEM, V287, P29627, DOI 10.1074/jbc.M112.367219; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Wansleeben C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019357; Wansleeben C, 2010, DEVELOPMENT, V137, P1067, DOI 10.1242/dev.041434; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	38	41	41	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5330	5341		10.1074/jbc.M112.408237	http://dx.doi.org/10.1074/jbc.M112.408237			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288844	hybrid, Green Published			2022-12-25	WOS:000315342500007
J	Chakroborty, S; Briggs, C; Miller, MB; Goussakov, I; Schneider, C; Kim, J; Wicks, J; Richardson, JC; Conklin, V; Cameransi, BG; Stutzmann, GE				Chakroborty, Shreaya; Briggs, Clark; Miller, Megan B.; Goussakov, Ivan; Schneider, Corinne; Kim, Joyce; Wicks, Jaime; Richardson, Jill C.; Conklin, Vincent; Cameransi, Benjamin G.; Stutzmann, Grace E.			Stabilizing ER Ca2+ Channel Function as an Early Preventative Strategy for Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; MEDIATED CALCIUM-RELEASE; A-BETA-DEPOSITION; RYANODINE RECEPTOR; MOUSE MODEL; NEUROPATHOLOGY; ACTIVATION; PHOSPHORYLATION; HOMEOSTASIS; HYPOTHESIS	Alzheimer's disease (AD) is a devastating neurodegenerative condition with no known cure. While current therapies target late-stage amyloid formation and cholinergic tone, to date, these strategies have proven ineffective at preventing disease progression. The reasons for this may be varied, and could reflect late intervention, or, that earlier pathogenic mechanisms have been overlooked and permitted to accelerate the disease process. One such example would include synaptic pathology, the disease component strongly associated with cognitive impairment. Dysregulated Ca2+ homeostasis may be one of the critical factors driving synaptic dysfunction. One of the earliest pathophysiological indicators in mutant presenilin (PS) AD mice is increased intracellular Ca2+ signaling, predominantly through the ER-localized inositol triphosphate (IP3) and ryanodine receptors (RyR). In particular, the RyR-mediated Ca2+ upregulation within synaptic compartments is associated with altered synaptic homeostasis and network depression at early (presymptomatic) AD stages. Here, we offer an alternative approach to AD therapeutics by stabilizing early pathogenic mechanisms associated with synaptic abnormalities. We targeted the RyR as a means to prevent disease progression, and sub-chronically treated AD mouse models (4-weeks) with a novel formulation of the RyR inhibitor, dantrolene. Using 2-photon Ca2+ imaging and patch clamp recordings, we demonstrate that dantrolene treatment fully normalizes ER Ca2+ signaling within somatic and dendritic compartments in early and later-stage AD mice in hippocampal slices. Additionally, the elevated RyR2 levels in AD mice are restored to control levels with dantrolene treatment, as are synaptic transmission and synaptic plasticity. A beta deposition within the cortex and hippocampus is also reduced in dantrolene-treated AD mice. In this study, we highlight the pivotal role of Ca2+ aberrations in AD, and propose a novel strategy to preserve synaptic function, and thereby cognitive function, in early AD patients.	[Chakroborty, Shreaya; Briggs, Clark; Schneider, Corinne; Kim, Joyce; Wicks, Jaime; Stutzmann, Grace E.] Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA; [Miller, Megan B.] Univ Connecticut, Dept Neurosci, Farmington, CT USA; [Goussakov, Ivan] Univ Chicago, Neurol Sect, Chicago, IL 60637 USA; [Richardson, Jill C.] GlaxoSmithKline, United Kingdom Grp, Res & Dev China, Stevenage, Herts, England; [Conklin, Vincent; Cameransi, Benjamin G.] Lyotrop Therapeut, Ashland, VA USA	Chicago Medical School; Rosalind Franklin University Medical & Science; University of Connecticut; University of Chicago; GlaxoSmithKline	Stutzmann, GE (corresponding author), Rosalind Franklin Univ, Chicago Med Sch, Dept Neurosci, N Chicago, IL USA.	grace.stutzmann@rosalindfranklin.edu		Richardson, Jill/0000-0001-6564-3187	National Institutes of Health [AG030205]; Alzheimer's Drug Discovery Foundation; American Health Assistance Foundation; NATIONAL INSTITUTE ON AGING [R01AG030205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Drug Discovery Foundation; American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support to GES was provided by National Institutes of Health AG030205, the Alzheimer's Drug Discovery Foundation and the American Health Assistance Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Avila J, 2004, NEUROTOX RES, V6, P477, DOI 10.1007/BF03033284; Bruno AM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.03.011; Chakroborty S, 2012, J NEUROSCI, V32, P8341, DOI 10.1523/JNEUROSCI.0936-12.2012; Chakroborty S, 2009, J NEUROSCI, V29, P9458, DOI 10.1523/JNEUROSCI.2047-09.2009; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Extance A, 2010, NAT REV DRUG DISCOV, V9, P749, DOI 10.1038/nrd3288; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Filbert MLEBG, 2005, J MED CBR DEF, V3, P21; Galimberti Daniela, 2011, Ther Adv Neurol Disord, V4, P203, DOI 10.1177/1756285611404470; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goldman WP, 2001, NEUROLOGY, V56, P361, DOI 10.1212/WNL.56.3.361; Goussakov I, 2011, CHANNELS, V5, P9, DOI 10.4161/chan.5.1.14124; Goussakov I, 2010, J NEUROSCI, V30, P12128, DOI 10.1523/JNEUROSCI.2474-10.2010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003529; Howlett DR, 2008, HISTOL HISTOPATHOL, V23, P67, DOI 10.14670/HH-23.67; Howlett DR, 2004, BRAIN RES, V1017, P130, DOI 10.1016/j.brainres.2004.05.029; Itkin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018250; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kawahara Masahiro, 2011, Int J Alzheimers Dis, V2011, P304583, DOI 10.4061/2011/304583; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Peng J, 2012, NEUROSCI LETT, V516, P274, DOI 10.1016/j.neulet.2012.04.008; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Pierrot N, 2006, J BIOL CHEM, V281, P39907, DOI 10.1074/jbc.M606015200; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; QUERFURTH HW, 1994, BIOCHEMISTRY-US, V33, P4550, DOI 10.1021/bi00181a016; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Scheff SW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P101; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Stutzmann GE, 2005, PHYSIOLOGY, V20, P15, DOI 10.1152/physiol.00028.2004; Stutzmann GE, 2004, J NEUROSCI, V24, P508, DOI 10.1523/JNEUROSCI.4386-03.2004; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Supnet C, 2006, J BIOL CHEM, V281, P38440, DOI 10.1074/jbc.M606736200; Supnet C, 2010, J NEUROCHEM, V112, P356, DOI 10.1111/j.1471-4159.2009.06487.x; Zhang H, 2010, J NEUROSCI, V30, P8566, DOI 10.1523/JNEUROSCI.1554-10.2010; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	49	94	96	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52056	10.1371/journal.pone.0052056	http://dx.doi.org/10.1371/journal.pone.0052056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284867	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800026
J	Hughes, CE; Radhakrishnan, UP; Lordkipanidze, M; Egginton, S; Dijkstra, JM; Jagadeeswaran, P; Watson, SP				Hughes, Craig E.; Radhakrishnan, Uvaraj P.; Lordkipanidze, Marie; Egginton, Stuart; Dijkstra, Johannes M.; Jagadeeswaran, Pudur; Watson, Stephen P.			G6f-Like Is an ITAM-Containing Collagen Receptor in Thrombocytes	PLOS ONE			English	Article							GLYCOPROTEIN-VI; VASCULAR OCCLUSION; THROMBUS FORMATION; GAMMA-CHAIN; CELL-LINES; IN-VIVO; ZEBRAFISH; PLATELETS; CLEC-2; HEMOSTASIS	Collagen activates mammalian platelets through a complex of the immunoglobulin (Ig) receptor GPVI and the Fc receptor gamma-chain, which has an immunoreceptor tyrosine-based activation motif (ITAM). Cross-linking of GPVI mediates activation through the sequential activation of Src and Syk family kinases and activation of PLC gamma 2. Nucleated thrombocytes in fish are activated by collagen but lack an ortholog of GPVI. In this study we show that collagen activates trout thrombocytes in whole blood and under flow conditions through a Src kinase driven pathway. We identify the Ig receptor G6f-like as a collagen receptor and demonstrate in a cell line assay that it signals through its cytoplasmic ITAM. Using a morpholino for in vivo knock-down of G6f-like levels in zebrafish, we observed a marked delay or absence of occlusion of the venous and arterial systems in response to laser injury. Thus, G6f-like is a physiologically relevant collagen receptor in fish thrombocytes which signals through the same ITAM-based signalling pathway as mammalian GPVI, providing a novel example of convergent evolution.	[Hughes, Craig E.; Lordkipanidze, Marie; Egginton, Stuart; Watson, Stephen P.] Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Radhakrishnan, Uvaraj P.; Jagadeeswaran, Pudur] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Dijkstra, Johannes M.] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi, Japan	University of Birmingham; University of North Texas System; University of North Texas Denton; Fujita Health University	Hughes, CE (corresponding author), Univ Birmingham, Inst Biomed Res, Ctr Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.	c.e.hughes@bham.ac.uk	Lordkipanidzé, Marie/E-6222-2011; Watson, Stephen P/Q-6292-2016	Lordkipanidzé, Marie/0000-0001-7418-6766; Watson, Stephen P/0000-0002-7846-7423; Hughes, Craig/0000-0002-9790-5820; Egginton, Stuart/0000-0002-3084-9692	Wellcome Trust [073107, 088410]; British Heart Foundation [PG/07/116, PG/05/134]; National Institutes of Health [HL077910]; British Heart Foundation [PG/11/31/28835, RG/09/007/27917] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077910] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Wellcome Trust (073107 and 088410), the British Heart Foundation (PG/07/116 and PG/05/134), and the National Institutes of Health (HL077910). SPW holds a BHF Chair (CH/03/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; BorschHaubold AG, 1997, EUR J BIOCHEM, V245, P751, DOI 10.1111/j.1432-1033.1997.t01-1-00751.x; Dawood BB, 2007, PLATELETS, V18, P329, DOI 10.1080/09537100601024111; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Gibbins J, 1996, J BIOL CHEM, V271, P18095, DOI 10.1074/jbc.271.30.18095; Gregory M, 2002, BLOOD CELL MOL DIS, V29, P286, DOI 10.1006/bcmd.2002.0568; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hechler B, 2009, J THROMB HAEMOST; Hughes CE, 2008, J THROMB HAEMOST, V6, P2152, DOI 10.1111/j.1538-7836.2008.03166.x; Hughes CE, 2010, BLOOD, V115, P2947, DOI 10.1182/blood-2009-08-237834; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Jagadeeswaran P, 2004, METHOD CELL BIOL, V76, P489; Jagadeeswaran P, 2005, J THROMB HAEMOST, V3, P46, DOI 10.1111/j.1538-7836.2004.00999.x; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Jagadeeswaran P, 2011, METHOD CELL BIOL, V101, P197, DOI 10.1016/B978-0-12-387036-0.00009-8; Kalia N, 2008, MICROCIRCULATION, V15, P325, DOI 10.1080/10739680701728822; Kim S, 2010, BLOOD CELL MOL DIS, V44, P169, DOI 10.1016/j.bcmd.2009.12.004; Kim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008403; Kollner B, 2004, DEV COMP IMMUNOL, V28, P1049, DOI 10.1016/j.dci.2004.03.004; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; Munnix ICA, 2005, ARTERIOSCL THROM VAS, V25, P2673, DOI 10.1161/01.ATV.0000193568.71980.4a; Nash CA, 2010, J THROMB HAEMOST, V8, P2273, DOI 10.1111/j.1538-7836.2010.03992.x; Ohashi K, 2010, IMMUNOGENETICS, V62, P543, DOI 10.1007/s00251-010-0460-1; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; Tomlinson MG, 2004, MOL CELL BIOL, V24, P2455, DOI 10.1128/MCB.24.6.2455-2466.2004	27	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52622	10.1371/journal.pone.0052622	http://dx.doi.org/10.1371/journal.pone.0052622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285115	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000313158800082
J	Srivastava, SK; Robins, HS				Srivastava, Santosh K.; Robins, Harlan S.			Palindromic Nucleotide Analysis in Human T Cell Receptor Rearrangements	PLOS ONE			English	Article							V(D)J RECOMBINATION; JUNCTIONAL DIVERSITY; IMMUNOGLOBULIN; COMPLEX; MECHANISM	Diversity of T cell receptor (TCR) genes is primarily generated by nucleotide insertions upon rearrangement from their germ line-encoded V, D and J segments. Nucleotide insertions at V-D and D-J junctions are random, but some small subsets of these insertions are exceptional, in that one to three base pairs inversely repeat the sequence of the germline DNA. These short complementary palindromic sequences are called P nucleotides. We apply the ImmunoSeq deep-sequencing assay to the third complementarity determining region (CDR3) of the beta chain of T cell receptors, and use the resulting data to study P nucleotides in the repertoire of naive and memory CD8(+) and CD4(+) T cells. We estimate P nucleotide distributions in a cross section of healthy adults and different T cell subtypes. We show that P nucleotide frequency in all T cell subtypes ranges from 1% to 2%, and that the distribution is highly biased with respect to the coding end of the gene segment. Classification of observed palindromic sequences into P nucleotides using a maximum conditional probability model shows that single base P nucleotides are very rare in VDJ recombination; P nucleotides are primarily two bases long. To explore the role of P nucleotides in thymic selection, we compare P nucleotides in productive and non-productive sequences of CD8(+) naive T cells. The naive CD8(+) T cell clones with P nucleotides are more highly expanded.	[Srivastava, Santosh K.] IBM Res Lab, New Delhi, India; [Robins, Harlan S.] Fred Hutchinson Canc Res Ctr, Programs Computat Biol, Seattle, WA 98104 USA	International Business Machines (IBM); Fred Hutchinson Cancer Center	Robins, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Programs Computat Biol, 1124 Columbia St, Seattle, WA 98104 USA.	hrobins@fhcrc.org			Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This study was supported by the Ellison Medical Foundation New Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gauss GH, 1996, MOL CELL BIOL, V16, P258; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; LIEBER MR, 1991, FASEB J, V5, P2934, DOI 10.1096/fasebj.5.14.1752360; Lu H, 2007, NUCLEIC ACIDS RES, V35, P6917, DOI 10.1093/nar/gkm823; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MEIER JT, 1993, MOL CELL BIOL, V13, P1078, DOI 10.1128/MCB.13.2.1078; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Nadel B, 1997, MOL CELL BIOL, V17, P3768, DOI 10.1128/MCB.17.7.3768; PANDEY A, 1993, J EXP MED, V177, P329, DOI 10.1084/jem.177.2.329; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591	13	11	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52250	10.1371/journal.pone.0052250	http://dx.doi.org/10.1371/journal.pone.0052250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284955	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800040
J	Benkert, TF; Dietz, L; Hartmann, EM; Leich, E; Rosenwald, A; Serfling, E; Buttmann, M; Berberich-Siebelt, F				Benkert, Thomas F.; Dietz, Lena; Hartmann, Elena M.; Leich, Ellen; Rosenwald, Andreas; Serfling, Edgar; Buttmann, Mathias; Berberich-Siebelt, Friederike			Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; FOCAL ADHESION KINASE; REGULATORY T-CELLS; ALPHA-4-BETA-1 INTEGRIN; ACTIVATION; EXPRESSION; UPDATE; LYMPHOCYTES; ANTIBODIES; RESPONSES	Natalizumab is a recombinant monoclonal antibody raised against integrin alpha-4 (CD49d). It is approved for the treatment of patients with multiple sclerosis (MS), a chronic inflammatory autoimmune disease of the CNS. While having shown high therapeutic efficacy, treatment by natalizumab has been linked to progressive multifocal leukoencephalopathy (PML) as a serious adverse effect. Furthermore, drug cessation sometimes induces rebound disease activity of unknown etiology. Here we investigated whether binding of this adhesion-blocking antibody to T lymphocytes could modulate their phenotype by direct induction of intracellular signaling events. Primary CD4(+) T lymphocytes either from healthy donors and treated with natalizumab in vitro or from MS patients receiving their very first dose of natalizumab were analyzed. Natalizumab induced a mild upregulation of IL-2, IFN-gamma and IL-17 expression in activated primary human CD4(+) T cells propagated ex vivo from healthy donors, consistent with a pro-inflammatory costimulatory effect on lymphokine expression. Along with this, natalizumab binding triggered rapid MAPK/ERK phosphorylation. Furthermore, it decreased CD49d surface expression on effector cells within a few hours. Sustained CD49d downregulation could be attributed to integrin internalization and degradation. Importantly, also CD4(+) T cells from some MS patients receiving their very first dose of natalizumab produced more IL-2, IFN-gamma and IL-17 already 24 h after infusion. Together these data indicate that in addition to its adhesion-blocking mode of action natalizumab possesses mild direct signaling capacities, which can support a pro-inflammatory phenotype of peripheral blood T lymphocytes. This might explain why a rebound of disease activity or IRIS is observed in some MS patients after natalizumab cessation.	[Benkert, Thomas F.; Dietz, Lena; Serfling, Edgar; Berberich-Siebelt, Friederike] Univ Wurzburg, Dept Mol Pathol, Wurzburg, Germany; [Benkert, Thomas F.; Dietz, Lena; Hartmann, Elena M.; Leich, Ellen; Rosenwald, Andreas; Serfling, Edgar; Berberich-Siebelt, Friederike] Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; [Buttmann, Mathias] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Berberich-Siebelt, F (corresponding author), Univ Wurzburg, Dept Mol Pathol, Wurzburg, Germany.	path230@mail.uni-wuerzburg.de	Buttmann, Mathias/R-7301-2019; Serfling, Edgar/X-7212-2019; Buttmann, Mathias/AAD-7488-2021	Buttmann, Mathias/0000-0001-8309-7685; Buttmann, Mathias/0000-0001-8309-7685	Interdisciplinary Center for Clinical Research, University of Wurzburg; Federal Ministry for Education and Research; German Research Foundation DFG [SPP1365, TRR52/A3]; German research Foundation (DFG); University of Wuerzburg; Biogen Idec; Merck Serono; Sanofi Aventis; Teva Pharmaceutical Industries Ltd.; Novartis	Interdisciplinary Center for Clinical Research, University of Wurzburg; Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation DFG(German Research Foundation (DFG)); German research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg; Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); Teva Pharmaceutical Industries Ltd.(Teva Pharmaceutical Industries); Novartis(Novartis)	This work was mainly supported by the Interdisciplinary Center for Clinical Research, University of Wurzburg, provided by the Federal Ministry for Education and Research (T. B., E. M. H., E. L., A. R., M. B., F.B.-S.) as well as by the German Research Foundation DFG (SPP1365 and TRR52/A3 to F.B.-S.). The cost of publication were funded by the German research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing.; M.B. received a travel grant from Biogen Idec, the manufacturer of natalizumab (Tysabri (R)), which was not related to this manuscript. Furthermore, he received travel grants, speaker's fees and a research grant from Merck Serono, served on an advisory board for Almirall Hermal GmbH, and received research grants from Sanofi Aventis and Teva Pharmaceutical Industries Ltd. as well as from Novartis. The other authors declare no competing interests. Biogen Idec/Elan had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; Beck O, 2006, BLOOD, V107, P2562, DOI 10.1182/blood-2005-04-1660; BENVENUTO R, 1992, ANN NY ACAD SCI, V650, P341; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Buttmann M, 2010, EXPERT REV NEUROTHER, V10, P791, DOI [10.1586/ern.10.38, 10.1586/ERN.10.38]; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; DOREDUFFY P, 1993, ADV EXP MED BIOL, V331, P243; Fleming JC, 2010, INFLAMM RES, V59, P647, DOI 10.1007/s00011-010-0177-5; Frisullo G, 2011, MULT SCLER J, V17, P556, DOI 10.1177/1352458510392263; Frisullo G, 2009, IMMUNOLOGY, V127, P418, DOI 10.1111/j.1365-2567.2008.02963.x; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Gomez IG, 2012, J BIOL CHEM, V287, P4581, DOI 10.1074/jbc.M111.321182; Hohlfeld R, 2001, CURR OPIN NEUROL, V14, P299, DOI 10.1097/00019052-200106000-00006; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; Kerbrat A, 2011, J NEUROL SCI, V308, P98, DOI 10.1016/j.jns.2011.05.043; Khademi M, 2008, EUR J NEUROL, V15, P309, DOI 10.1111/j.1468-1331.2007.02037.x; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Kim TK, 2010, HUM IMMUNOL, V71, P23, DOI 10.1016/j.humimm.2009.09.360; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kivisakk P, 2009, NEUROLOGY, V72, P1922, DOI 10.1212/WNL.0b013e3181a8266f; Kleinschmidt-DeMasters BK, 2012, J NEUROPATH EXP NEUR, V71, P604, DOI 10.1097/NEN.0b013e31825caf2c; Korn T, 2008, J NEUROL, V255, P2, DOI 10.1007/s00415-008-6001-2; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lindberg RLP, 2008, J NEUROIMMUNOL, V194, P153, DOI 10.1016/j.jneuroim.2007.11.007; McCombe JA, 2009, NEUROLOGY, V72, P835, DOI 10.1212/01.wnl.0000343854.80344.69; Millonig A, 2010, J NEUROIMMUNOL, V227, P190, DOI 10.1016/j.jneuroim.2010.07.012; Miravalle A, 2011, ARCH NEUROL-CHICAGO, V68, P186, DOI 10.1001/archneurol.2010.257; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Neumann F, 2009, EXPERT OPIN BIOL TH, V9, P1099, DOI 10.1517/14712590903055011; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; O'Connor PW, 2011, NEUROLOGY, V76, P1858, DOI 10.1212/WNL.0b013e31821e7c8a; Oreja-Guevara C, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-95; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramos-Cejudo J, 2011, J CLIN IMMUNOL, V31, P623, DOI 10.1007/s10875-011-9522-x; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Rigau V, 2012, NEUROLOGY; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Saure C, 2011, ARCH NEUROL-CHICAGO, V68, P1428, DOI 10.1001/archneurol.2011.238; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Tan IL, 2011, NEUROLOGY, V77, P1061, DOI 10.1212/WNL.0b013e31822e55e7; Vellinga MM, 2008, NEUROLOGY, V70, P1150, DOI 10.1212/01.wnl.0000265393.03231.e5; VOSKUHL RR, 1993, AUTOIMMUNITY, V15, P137, DOI 10.3109/08916939309043888; WASHINGTON R, 1994, ANN NEUROL, V35, P89, DOI 10.1002/ana.410350114; West TW, 2010, ANN NEUROL, V68, P395, DOI 10.1002/ana.22163; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	54	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52208	10.1371/journal.pone.0052208	http://dx.doi.org/10.1371/journal.pone.0052208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284936	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500113
J	Chalencon, S; Busso, T; Lacour, JR; Garet, M; Pichot, V; Connes, P; Gabel, CP; Roche, F; Barthelemy, JC				Chalencon, Sebastien; Busso, Thierry; Lacour, Jean-Rene; Garet, Martin; Pichot, Vincent; Connes, Philippe; Gabel, Charles Philip; Roche, Frederic; Barthelemy, Jean Claude			A Model for the Training Effects in Swimming Demonstrates a Strong Relationship between Parasympathetic Activity, Performance and Index of Fatigue	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SYSTEMS-MODEL; RESPONSES; EXERCISE; TAPER; FREQUENCY; DYNAMICS	Competitive swimming as a physical activity results in changes to the activity level of the autonomic nervous system (ANS). However, the precise relationship between ANS activity, fatigue and sports performance remains contentious. To address this problem and build a model to support a consistent relationship, data were gathered from national and regional swimmers during two 30 consecutive-week training periods. Nocturnal ANS activity was measured weekly and quantified through wavelet transform analysis of the recorded heart rate variability. Performance was then measured through a subsequent morning 400 meters freestyle time-trial. A model was proposed where indices of fatigue were computed using Banister's two antagonistic component model of fatigue and adaptation applied to both the ANS activity and the performance. This demonstrated that a logarithmic relationship existed between performance and ANS activity for each subject. There was a high degree of model fit between the measured and calculated performance (R-2 = 0.84 +/- 0.14, p<0.01) and the measured and calculated High Frequency (HF) power of the ANS activity (R-2 = 0.79 +/- 0.07, p<0.01). During the taper periods, improvements in measured performance and measured HF were strongly related. In the model, variations in performance were related to significant reductions in the level of 'Negative Influences' rather than increases in 'Positive Influences'. Furthermore, the delay needed to return to the initial performance level was highly correlated to the delay required to return to the initial HF power level (p<0.01). The delay required to reach peak performance was highly correlated to the delay required to reach the maximal level of HF power (p = 0.02). Building the ANS/performance identity of a subject, including the time to peak HF, may help predict the maximal performance that could be obtained at a given time. Citation: Chalencon S, Busso T, Lacour J-R, Garet M, Pichot V, et al. (2012) A Model for the Training Effects in Swimming Demonstrates a Strong Relationship between Parasympathetic Activity, Performance and Index of Fatigue. PLoS ONE 7(12): e52636. doi:10.1371/journal.pone. 0052636	[Chalencon, Sebastien; Lacour, Jean-Rene; Garet, Martin; Pichot, Vincent; Roche, Frederic; Barthelemy, Jean Claude] Univ St Etienne, PRES Lyon, SNA EPIS, Lab EA4607, St Etienne, France; [Busso, Thierry] Univ St Etienne, PRES Lyon, Exercise Physiol Lab, EA4338, St Etienne, France; [Connes, Philippe] Ricou Hosp, Acad Hosp Pointe A Pitre, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France; [Gabel, Charles Philip] Univ Sunshine Coast, Sippy Downs, Qld, Australia	Universite Jean Monnet; Universite Jean Monnet; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); University of the Sunshine Coast	Chalencon, S (corresponding author), Univ St Etienne, PRES Lyon, SNA EPIS, Lab EA4607, St Etienne, France.	seb.chalencon@gmail.com	Connes, Philippe/J-7835-2019; Busso, Thierry/AAG-1970-2019; Barthelemy, Jean-Claude/AAE-7180-2019	Connes, Philippe/0000-0002-9232-0268; Busso, Thierry/0000-0002-5042-4384; Philippe, Connes/0000-0001-8449-7998; Roche, Frederic/0000-0001-6115-7958; Gabel, Charles Philip/0000-0001-8354-4545				Banister E, 1982, PHYSL TESTING HIGH P; Banister E.W., 1975, J SCI MED SPORT, V7, P57; BANISTER EW, 1985, EUR J APPL PHYSIOL, V54, P16, DOI 10.1007/BF00426292; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Busso T, 2003, MED SCI SPORT EXER, V35, P1188, DOI 10.1249/01.MSS.0000074465.13621.37; BUSSO T, 1990, EUR J APPL PHYSIOL, V61, P48, DOI 10.1007/BF00236693; Busso T, 2002, J APPL PHYSIOL, V92, P572, DOI 10.1152/japplphysiol.00429.2001; BUSSO T, 1991, J APPL PHYSIOL, V71, P2044, DOI 10.1152/jappl.1991.71.5.2044; BUSSO T, 1992, EUR J APPL PHYSIOL, V64, P381, DOI 10.1007/BF00636228; CALVERT TW, 1976, IEEE T SYST MAN CYB, V6, P94, DOI 10.1109/TSMC.1976.5409179; Casey A, 2000, AM J PHYSIOL-ENDOC M, V278, pE65, DOI 10.1152/ajpendo.2000.278.1.E65; FITZCLARKE JR, 1991, J APPL PHYSIOL, V71, P1151, DOI 10.1152/jappl.1991.71.3.1151; FRY RW, 1992, CAN J SPORT SCI, V17, P241; FRY RW, 1992, EUR J APPL PHYSIOL O, V64, P335, DOI 10.1007/BF00636221; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Garet M, 2004, MED SCI SPORT EXER, V36, P2112, DOI 10.1249/01.MSS.0000147588.28955.48; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Hautala AJ, 2003, AM J PHYSIOL-HEART C, V285, pH1747, DOI 10.1152/ajpheart.00202.2003; Hedelin R, 2001, MED SCI SPORT EXER, V33, P1394, DOI 10.1097/00005768-200108000-00023; JensenUrstad K, 1997, SCAND J MED SCI SPOR, V7, P274; Kenney WL., 1988, EXERCISE PHYSL CURRE, P59; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; KUIPERS H, 1988, SPORTS MED, V6, P79, DOI 10.2165/00007256-198806020-00003; Mujika I, 1996, MED SCI SPORT EXER, V28, P251, DOI 10.1097/00005768-199602000-00015; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Mujika I, 2003, MED SCI SPORT EXER, V35, P1182, DOI 10.1249/01.MSS.0000074448.73931.11; Pichot V, 1999, J APPL PHYSIOL, V86, P1081, DOI 10.1152/jappl.1999.86.3.1081; Pichot V, 2002, PFLUG ARCH EUR J PHY, V445, P267, DOI 10.1007/s00424-002-0917-7; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Thomas L, 2005, MED SCI SPORT EXER, V37, P1615, DOI 10.1249/01.mss.0000177461.94156.4b; Thomas L, 2008, J SPORT SCI, V26, P643, DOI 10.1080/02640410701716782; Thomas L, 2009, J STRENGTH COND RES, V23, P1729, DOI 10.1519/JSC.0b013e3181b3dfa1; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH810, DOI 10.1152/ajpheart.1998.274.3.H810; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004	34	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52636	10.1371/journal.pone.0052636	http://dx.doi.org/10.1371/journal.pone.0052636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285121	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500215
J	Fatihah, HNN; Mat, N; Zaimah, ARN; Zuhailah, MN; Norhaslinda, H; Khairil, M; Ghani, AY; Ali, AM				Fatihah, Hasan N. N.; Mat, Nashriyah; Zaimah, Abdul R. N.; Zuhailah, Mazlan N.; Norhaslinda, Haron; Khairil, Mahmud; Ghani, Abdul Y.; Ali, Abdul M.			Morphological Phylogenetic Analysis of Seven Varieties of Ficus deltoidea Jack from the Malay Peninsula of Malaysia	PLOS ONE			English	Article							MORACEAE; EXTRACT	This study is the first report to suggest a morphological phylogenetic framework for the seven varieties of Ficus deltoidea Jack (Ficus: Moraceae) from the Malay Peninsula of Malaysia. Several molecular-based classifications on the genus Ficus had been proposed, but neither had discussed the relationship between seven varieties of F. deltoidea to its allies nor within the varieties. The relationship between seven varieties of F. deltoidea is still debated due to the extreme morphological variabilities and ambiguous boundaries between taxa. Thus, the correct identification of these varieties is important as several morphological characters are variety-specific. To test the monophyly and further resolved the relationship in F. deltoidea, a morphological phylogenetic analysis was conducted based on herbarium specimens representing the seven varieties of F. deltoidea that were collected from the Malay Peninsula of Malaysia, by using related species of the genus Ficus; F. grossularioides, F. ischnopoda and F. oleifolia as the outgroups. Parsimony and neighbour-joining analyses indicated that F. deltoidea is monophyletic, in that the seven varieties of F. deltoidea nested into two clades; clade subspecies deltoidea (var. deltoidea, var. bilobata, var. angustifolia, var. kunstleri and var. trengganuensis) and clade subspecies motleyana (var. intermedia and var. motleyana).	[Fatihah, Hasan N. N.; Mat, Nashriyah; Zaimah, Abdul R. N.; Zuhailah, Mazlan N.; Norhaslinda, Haron; Khairil, Mahmud; Ghani, Abdul Y.] Univ Sultan Zainal Abidin, Dept Agr Sci, Fac Agr & Biotechnol, Terengganu, Malaysia; [Ali, Abdul M.] Univ Sultan Zainal Abidin, Dept Biotechnol, Fac Agr & Biotechnol, Terengganu, Malaysia	Universiti Sultan Zainal Abidin; Universiti Sultan Zainal Abidin	Mat, N (corresponding author), Univ Sultan Zainal Abidin, Dept Agr Sci, Fac Agr & Biotechnol, Gong Badak Campus, Terengganu, Malaysia.	nashriyah@unisza.edu.my	Fatihah, Hasan Nudin Nur/G-1730-2013	Nur Fatihah, Hasan Nudin/0000-0002-6721-0067; Mahmud, Khairil/0000-0002-6758-2995	Universiti Sultan Zainal Abidin's grant [UDM/09/BR (0013)]	Universiti Sultan Zainal Abidin's grant	This study was supported by a Universiti Sultan Zainal Abidin's grant; with a reference number of UDM/09/BR (0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 2011, SAINS MALAYS, V40, P489; Bailey LH, 1976, HORTUS; Berg C., 2005, FLORA MALESIANA 1 2, V17; Berg CC, 2003, BLUMEA, V48, P529; Corner E.J.H., 1960, GARD B SINGAPORE, V17, P416; CORNER EJH, 1969, PHILOS T ROY SOC B, V256, P281, DOI 10.1098/rstb.1969.0043; Farsi E, 2011, AFR J BIOTECHNOL, V10, P15184, DOI 10.5897/AJB11.1365; Fatihah HNN, 2012, S AFR J BOT, V83, P78, DOI 10.1016/j.sajb.2012.07.010; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hoberg EP, 1999, SYST PARASITOL, V42, P51, DOI 10.1023/A:1006100629059; KAMARUDIN MS, 2002, TUMBUHAN UBATAN MALA; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochummen K. M., 1998, Gardens' Bulletin (Singapore), V50, P197; Kochummen KM, 1978, TREE FLORA MALAYA MA, V3, P119; Kress WJ, 2002, AM J BOT, V89, P1682, DOI 10.3732/ajb.89.10.1682; Mat N, 2012, SAINS MALAYS, V41, P527; Musa Y., 2005, B TEKNOL TANAM, V2, P35; Norhaniza Aminudin, 2007, Malaysian Journal of Science, V26, P73; Omar MH, 2011, J AGR FOOD CHEM, V59, P1363, DOI 10.1021/jf1032729; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pennington RT, 1996, SYST BIOL, V45, P496, DOI 10.2307/2413527; Ronsted N, 2008, SYMBIOSIS, V45, P45; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sata N., 1944, MONOGRAPHIC STUDY GE; Subhash JB, 2009, J FOR SCI, V25, P57; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; USDA, 2007, ARS NAT GEN RES PROG; WATROUS LE, 1981, SYST ZOOL, V30, P1, DOI 10.2307/2992297	30	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52441	10.1371/journal.pone.0052441	http://dx.doi.org/10.1371/journal.pone.0052441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285045	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500171
J	Gao, XL; Gigoux, M; Yang, J; Leconte, J; Yang, X; Suh, WK				Gao, Xiaoling; Gigoux, Mathieu; Yang, Jie; Leconte, Julien; Yang, Xi; Suh, Woong-Kyung			Anti-Chlamydial Th17 Responses Are Controlled by the Inducible Costimulator Partially through Phosphoinositide 3-Kinase Signaling	PLOS ONE			English	Article							GENITAL-TRACT INFECTION; CELL-DEFICIENT MICE; CD4(+) T-CELLS; IMMUNE-RESPONSES; MOLECULE ICOS; IFN-GAMMA; PROTECTIVE IMMUNITY; DENDRITIC CELLS; TRACHOMATIS; MURIDARUM	We previously showed that mice deficient in the Inducible Costimulator ligand (ICOSL-KO) develop more severe disease and lung pathology with delayed bacterial clearance upon respiratory infection of Chlamydia muridarum. Importantly, the exacerbation of disease in ICOSL-KO mice was seen despite heightened IFN-gamma/Th1 responses, the major defense mechanisms against Chlamydia. To gain insight into the mechanism of ICOS function in this model, we presently analyzed anti-Chlamydia immune responses in mice lacking the entire ICOS (ICOS-KO) versus knock-in mice expressing a mutant ICOS (ICOS-Y181F) that has selectively lost the ability to activate phosphoinositide 3-kinase (PI3K). Like ICOSL-KO mice, ICOS-KO mice showed worse disease with elevated IFN-gamma/Th1 responses compared to wild-type (WT) mice. ICOS-Y181F mice developed much milder disease compared to ICOS-KO mice, yet they were still not fully protected to the WT level. This partial protection in ICOS-Y181F mice could not be explained by the magnitude of IFN-gamma/Th1 responses since these mice developed a similar level of IFN-gamma response compared to WT mice. It was rather IL-17/Th17 responses that reflected disease severity: IL-17/Th17 response was partially impaired in ICOS-Y181F mice compared to WT, but was substantially stronger than that of ICOS-KO mice. Consistently, we found that both polarization and expansion of Th17 cells were partially impaired in ICOS-Y181F CD4 T cells, and was further reduced in ICOS-KO CD4 T cells in vitro. Our results indicate that once the IFN-gamma/Th1 response is above a threshold level, the IL-17/Th17 response becomes a limiting factor in controlling Chlamydia lung infection, and that ICOS plays an important role in promoting Th17 responses in part through the activation of PI3K.	[Gao, Xiaoling; Yang, Jie; Yang, Xi] Univ Manitoba, Fac Med, Lab Infect & Immun, Dept Med Microbiol, Winnipeg, MB, Canada; [Gigoux, Mathieu; Leconte, Julien; Suh, Woong-Kyung] Inst Rech Clin Montreal, Immune Regulat Lab, Montreal, PQ H2W 1R7, Canada; [Gigoux, Mathieu; Suh, Woong-Kyung] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Leconte, Julien; Suh, Woong-Kyung] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Suh, Woong-Kyung] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	University of Manitoba; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal	Yang, X (corresponding author), Univ Manitoba, Fac Med, Lab Infect & Immun, Dept Med Microbiol, Winnipeg, MB, Canada.	yangxi@cc.umanitoba.ca; woong-kyung.suh@ircm.qc.ca	Gao, xiao ling/GQI-2790-2022	Suh, Woong-Kyung/0000-0002-6420-3283; Yang, Xi/0000-0002-8831-7488; Gigoux, Mathieu/0000-0002-1831-7597	Canadian Institutes of Health Research (CIHR) [ROP100410, MOP84544]; Manitoba Health Research Council	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council	This work was supported by grants from Canadian Institutes of Health Research (CIHR)(http://www.cihr-irsc.gc.ca/) [ROP100410 (XY) and MOP84544 (WKS)] and Manitoba Health Research Council (XY). XY holds Canada Research Chair in Infection and Immunity and W-KS is a CIHR New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bilenki L, 2006, J IMMUNOL, V177, P7067, DOI 10.4049/jimmunol.177.10.7067; Bonhagen K, 2003, EUR J IMMUNOL, V33, P392, DOI 10.1002/immu.200310013; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; BYRNE GI, 1987, J INFECT DIS, V156, P993, DOI 10.1093/infdis/156.6.993; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Farris CM, 2010, INFECT IMMUN, V78, P4374, DOI 10.1128/IAI.00622-10; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Gondek DC, 2009, J IMMUNOL, V183, P1313, DOI 10.4049/jimmunol.0900295; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Haylock-Jacobs S, 2011, J AUTOIMMUN, V36, P278, DOI 10.1016/j.jaut.2011.02.006; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jiao L, 2011, J IMMUNOL, V187, P401, DOI 10.4049/jimmunol.1002519; Johansson M, 1997, IMMUNOLOGY, V92, P422, DOI 10.1046/j.1365-2567.1997.00378.x; Kadkhoda K, 2010, J IMMUNOL, V184, P3780, DOI 10.4049/jimmunol.0901384; Khader SA, 2010, VIRULENCE, V1, P423, DOI 10.4161/viru.1.5.12862; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li WD, 2008, J IMMUNOL, V180, P3375, DOI 10.4049/jimmunol.180.5.3375; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lu H, 2002, J IMMUNOL, V169, P6324, DOI 10.4049/jimmunol.169.11.6324; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paulos CM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000448; Qiu HY, 2008, J IMMUNOL, V181, P2092, DOI 10.4049/jimmunol.181.3.2092; Rottman JB, 2001, NAT IMMUNOL, V2, P605, DOI 10.1038/89750; Schaefer JS, 2010, J LEUKOCYTE BIOL, V87, P301, DOI 10.1189/jlb.0409238; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Scurlock AM, 2011, INFECT IMMUN, V79, P1349, DOI 10.1128/IAI.00984-10; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; WILLIAMS DM, 1987, INFECT IMMUN, V55, P2387, DOI 10.1128/IAI.55.10.2387-2390.1987; WILLIAMS DM, 1988, INFECT IMMUN, V56, P3004, DOI 10.1128/IAI.56.11.3004-3006.1988; Yang X, 1996, J IMMUNOL, V156, P4338; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039214	40	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52657	10.1371/journal.pone.0052657	http://dx.doi.org/10.1371/journal.pone.0052657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285133	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500222
J	Lyabin, DN; Eliseeva, IA; Ovchinnikov, LP				Lyabin, Dmitry N.; Eliseeva, Irina A.; Ovchinnikov, Lev P.			YB-1 Synthesis Is Regulated by mTOR Signaling Pathway	PLOS ONE			English	Article							Y-BOX PROTEIN-1; TRANSCRIPTION FACTOR YB-1; MESSENGER-RNA; IN-VITRO; EXPRESSION; TRANSLATION; PROMOTES; CANCER; DNA; INITIATION	YB-1 is a eukaryotic protein with numerous intra-and extracellular functions based on its ability to interact with RNA, DNA, and many proteins. In spite of achievements in studying its functions, regulation of YB-1 synthesis in the cell remains poorly understood. In the current study Western and Northern blotting were used to determine the amounts of YB-1 and YB-1 mRNA in rabbit organs and several cell lines. As found, in the majority of studied eukaryotic cells a considerable proportion of YB-1 mRNA was stored in free mRNPs, i.e., was poorly translated. Also, we demonstrated that YB-1 synthesis depended on conditions that determined the rate of cell division. Specific suppression of YB-1 synthesis resulted from inhibition of the mTOR signaling pathway with inhibitor PP242, but not rapamycin. Experiments on reporter constructs showed that dependence of YB-1 mRNA translation on activity of the mTOR signaling pathway was dictated by 59 untranslated regions of this mRNA, irrelatively of the TOP-like sequences at the beginning of 5' UTR.	[Lyabin, Dmitry N.; Eliseeva, Irina A.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia	Russian Academy of Sciences	Ovchinnikov, LP (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia.	ovchinn@vega.protres.ru	Ovchinnikov, Lev/L-2397-2015; Lyabin, Dmitry/K-3178-2013; Irina, Eliseeva/J-8175-2015		Russian Academy of Sciences; Russian Foundation for Basic Research [11-04-00267, 12-04-31018]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Programs on "Molecular and Cellular Biology" and "Basic Sciences to Medicine" of the Russian Academy of Sciences and Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/), (#11-04-00267, #12-04-31018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader AG, 2005, MOL CELL BIOL, V25, P2095, DOI 10.1128/MCB.25.6.2095-2106.2005; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Basaki Y, 2010, EUR J CANCER, V46, P954, DOI 10.1016/j.ejca.2009.12.024; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Chansky HA, 2001, CANCER RES, V61, P3586; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Feng QC, 2009, NEPHRON EXP NEPHROL, V113, pE16, DOI 10.1159/000228079; Frye BC, 2009, EMBO REP, V10, P783, DOI 10.1038/embor.2009.81; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Gens G. P., 2010, Klinicheskaya Laboratornaya Diagnostika, P29; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Knosel T, 2005, NEOPLASIA, V7, P741, DOI 10.1593/neo.05178; Kuwano M, 2004, MOL CANCER THER, V3, P1485; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levenson VV, 2000, CANCER RES, V60, P5027; Lovett DH, 2010, BIOCHEM BIOPH RES CO, V398, P482, DOI 10.1016/j.bbrc.2010.06.104; Lyabin DN, 2011, RNA BIOL, V8, P883, DOI 10.4161/rna.8.5.16022; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Ohashi S, 2009, MOL CELL BIOCHEM, V327, P267, DOI 10.1007/s11010-009-0065-x; Ohga T, 1996, CANCER RES, V56, P4224; Pestryakov P, 2012, J MOL RECOGNIT, V25, P224, DOI 10.1002/jmr.2182; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Rauen T, 2009, J BIOL CHEM, V284, P26928, DOI 10.1074/jbc.M109.046599; Shiota M, 2008, CANCER RES, V68, P98, DOI 10.1158/0008-5472.CAN-07-2981; Shiota M, 2009, CANCER RES, V69, P3148, DOI 10.1158/0008-5472.CAN-08-2334; Skabkin MA, 2001, J BIOL CHEM, V276, P44841, DOI 10.1074/jbc.M107581200; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Stein U, 2001, J BIOL CHEM, V276, P28562, DOI 10.1074/jbc.M100311200; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Uramoto H, 2002, J BIOL CHEM, V277, P31694, DOI 10.1074/jbc.M200266200; Wakiyama M, 1997, BIOCHIMIE, V79, P781, DOI 10.1016/S0300-9084(97)86937-4; Wu Y, 2012, J SURG ONCOL, V105, P724, DOI 10.1002/jso.23030; Yokoyama H, 2003, BIOCHEM BIOPH RES CO, V303, P140, DOI 10.1016/S0006-291X(03)00296-1	44	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52527	10.1371/journal.pone.0052527	http://dx.doi.org/10.1371/journal.pone.0052527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285076	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500189
J	Yagi, S; Matsuda, M; Kiyokawa, E				Yagi, Shunsuke; Matsuda, Michiyuki; Kiyokawa, Etsuko			Chimaerin Suppresses Rac1 Activation at the Apical Membrane to Maintain the Cyst Structure	PLOS ONE			English	Article							PROTEIN N-CHIMAERIN; SPINDLE ORIENTATION; RHO-GTPASES; CDC42 GEF; KINASE-C; GAP; BETA-2-CHIMAERIN; DOMAIN; PHOSPHOINOSITIDES; DIACYLGLYCEROL	Epithelial organs are made of a well-polarized monolayer of epithelial cells, and their morphology is maintained strictly for their proper functions. Previously, we showed that Rac1 activation is suppressed at the apical membrane in the mature organoid, and that such spatially biased Rac1 activity is required for the polarity maintenance. Here we identify Chimaerin, a GTPase activating protein for Rac1, as a suppressor of Rac1 activity at the apical membrane. Depletion of Chimaerin causes over-activation of Rac1 at the apical membrane in the presence of hepatocyte growth factor (HGF), followed by luminal cell accumulation. Importantly, Chimaerin depletion did not inhibit extension formation at the basal membrane. These observations suggest that Chimaerin functions as the apical-specific Rac1 GAP to maintain epithelial morphology.	[Matsuda, Michiyuki; Kiyokawa, Etsuko] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Yagi, Shunsuke; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Sakyo Ku, Kyoto, Japan; [Kiyokawa, Etsuko] Kanazawa Med Univ, Dept Oncol Pathol, Uchinada, Ishikawa, Japan	Kyoto University; Kyoto University; Kanazawa Medical University	Kiyokawa, E (corresponding author), Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	kiyokawa@kanazawa-med.ac.jp		Matsuda, Michiyuki/0000-0002-5876-9969	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24112524, 22590358, 22113001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. S. Yagi was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Burbelo PD, 1995, J BIOL CHEM, V270, P30919, DOI 10.1074/jbc.270.52.30919; Caloca MJ, 1999, P NATL ACAD SCI USA, V96, P11854, DOI 10.1073/pnas.96.21.11854; Caloca MJ, 2003, BIOCHEM J, V375, P313, DOI 10.1042/BJ20030727; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; HALL C, 1993, MOL CELL BIOL, V13, P4986, DOI 10.1128/MCB.13.8.4986; Hall C, 2001, J NEUROSCI, V21, P5191, DOI 10.1523/JNEUROSCI.21-14-05191.2001; HALL C, 1990, J MOL BIOL, V211, P11, DOI 10.1016/0022-2836(90)90006-8; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Kiyokawa E, 2011, ANNU REV PHARMACOL, V51, P337, DOI 10.1146/annurev-pharmtox-010510-100234; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kozma R, 1996, MOL CELL BIOL, V16, P5069; Kumagai Y, 2011, ANAL BIOCHEM, V413, P192, DOI 10.1016/j.ab.2011.02.021; LEUNG T, 1994, J BIOL CHEM, V269, P12888; LEUNG T, 1993, J BIOL CHEM, V268, P3813; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Riccomagno MM, 2012, CELL, V149, P1594, DOI 10.1016/j.cell.2012.05.018; Rodriguez-Fraticelli AE, 2010, J CELL BIOL, V189, P725, DOI 10.1083/jcb.201002047; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sakurai A, 2012, J BIOL CHEM, V287, P31703, DOI 10.1074/jbc.M112.377804; Saras J, 1997, J BIOL CHEM, V272, P24333, DOI 10.1074/jbc.272.39.24333; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yagi S, 2012, EMBO REP, V13, P237, DOI 10.1038/embor.2011.249; Yang CF, 2005, J BIOL CHEM, V280, P24363, DOI 10.1074/jbc.M411629200; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52258	10.1371/journal.pone.0052258	http://dx.doi.org/10.1371/journal.pone.0052258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284959	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500127
J	Gumbel, JH; Patterson, EM; Owusu, SA; Kabat, BE; Jung, DO; Simmons, J; Hopkins, T; Ellsworth, BS				Gumbel, Jason H.; Patterson, Elizabeth M.; Owusu, Sarah A.; Kabat, Brock E.; Jung, Deborah O.; Simmons, Jasmine; Hopkins, Torin; Ellsworth, Buffy S.			The Forkhead Transcription Factor, Foxd1, Is Necessary for Pituitary Luteinizing Hormone Expression in Mice	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; HOMEOBOX GENE LHX3; ANTERIOR-PITUITARY; HPG MOUSE; DISEASE; DIFFERENTIATION; PROTEIN; GROWTH; FOXL2; ORGANOGENESIS	The pituitary gland regulates numerous physiological functions including growth, reproduction, temperature and metabolic homeostasis, lactation, and response to stress. Pituitary organogenesis is dependent on signaling factors that are produced in and around the developing pituitary. The studies described in this report reveal that the forkhead transcription factor, Foxd1, is not expressed in the developing mouse pituitary gland, but rather in the mesenchyme surrounding the pituitary gland, which is an essential source of signaling factors that regulate pituitary organogenesis. Loss of Foxd1 causes a morphological defect in which the anterior lobe of the pituitary gland protrudes through the cartilage plate that is developing ventral to the pituitary at embryonic days ( e) 14.5, e16.5, and e18.5. The number of proliferating pituitary cells is increased at e14.5 and e16.5. Loss of Foxd1 also results in significantly decreased levels of Lhb expression at e18.5. This decrease in Lhb expression does not appear to be due to a change in the number of gonadotrope cells in the pituitary gland. Previous studies have shown that loss of the LIM homeodomain factor, Lhx3, which is activated by the FGF signaling pathway, results in loss of LH production. Although there is a difference in Lhb expression in Foxd1 null mice, the expression pattern of LHX3 is not altered in Foxd1 null mice. These studies suggest that Foxd1 is indirectly required for normal Lhb expression and cartilage formation.	[Gumbel, Jason H.; Patterson, Elizabeth M.; Owusu, Sarah A.; Kabat, Brock E.; Jung, Deborah O.; Simmons, Jasmine; Hopkins, Torin; Ellsworth, Buffy S.] So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Ellsworth, BS (corresponding author), So Illinois Univ, Dept Physiol, Carbondale, IL 62901 USA.	bellsworth@siumed.edu		Gumbel, Jason/0000-0002-2302-3657; Jung, Deborah/0000-0002-8307-8772	Southern Illinois University School of Medicine	Southern Illinois University School of Medicine	This work was supported by a REACH award (E.M.P.), startup funds (B.S.E.), and an ORDA Faculty Seed Grant (B.S.E.) from Southern Illinois University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 2001, J PEDIATR ENDOCR MET, V14, P3; Arriola DJ, 2012, J BIOL CHEM, V287, P33424, DOI 10.1074/jbc.M112.362103; Brannick KE, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100636; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Brinkmeler ML, 2007, DEV BIOL, V311, P396, DOI 10.1016/j.ydbio.2007.08.046; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; CHARLTON HM, 1983, ENDOCRINOLOGY, V113, P535, DOI 10.1210/endo-113-2-535; Cirillo LA, 2008, EMBO REP, V9, P721, DOI 10.1038/embor.2008.130; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Cushman LJ, 2001, MAMM GENOME, V12, P485, DOI 10.1007/s003350040002; Dasen JS, 1999, CURR OPIN CELL BIOL, V11, P669, DOI 10.1016/S0955-0674(99)00034-4; Davis SW, 2007, DEV BIOL, V305, P145, DOI 10.1016/j.ydbio.2007.02.001; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2008, DEV BIOL, V313, P118, DOI 10.1016/j.ydbio.2007.10.006; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Ericson J, 1998, DEVELOPMENT, V125, P1005; GODFREY VL, 1991, P NATL ACAD SCI USA, V88, P5528, DOI 10.1073/pnas.88.13.5528; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Jung DO, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094904; Justice NJ, 2011, MOL ENDOCRINOL, V25, P1404, DOI 10.1210/me.2011-0093; Kalinichenko VV, 2003, GENE EXPR PATTERNS, V3, P153, DOI 10.1016/S1567-133X(03)00010-3; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon MF, 1986, MOUSE NEWS LETT, V74, P93; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Norquay LD, 2006, MOL ENDOCRINOL, V20, P598, DOI 10.1210/me.2005-0221; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Savage JJ, 2007, J CELL PHYSIOL, V212, P105, DOI 10.1002/jcp.21010; Savage JJ, 2003, GENE, V319, P1, DOI 10.1016/S0378-1119(03)00804-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; Sheng HZ, 1996, SCIENCE, V272, P1004, DOI 10.1126/science.272.5264.1004; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Zannini M, 1997, EMBO J, V16, P3185, DOI 10.1093/emboj/16.11.3185; Zhao YG, 2006, MECH DEVELOP, V123, P605, DOI 10.1016/j.mod.2006.06.005; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	45	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52156	10.1371/journal.pone.0052156	http://dx.doi.org/10.1371/journal.pone.0052156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284914	gold, Green Published, Green Submitted			2022-12-25	WOS:000312694300077
J	Churan, J; Guitton, D; Pack, CC				Churan, Jan; Guitton, Daniel; Pack, Christopher C.			Perisaccadic Remapping and Rescaling of Visual Responses in Macaque Superior Colliculus	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; UPDATING SPATIAL REPRESENTATIONS; PARIETAL CORTEX; COROLLARY DISCHARGE; AREA LIP; DYNAMIC CIRCUITRY; RECEPTIVE-FIELDS; MONKEY STRIATE; V4 NEURONS; BRAIN	Visual neurons have spatial receptive fields that encode the positions of objects relative to the fovea. Because foveate animals execute frequent saccadic eye movements, this position information is constantly changing, even though the visual world is generally stationary. Interestingly, visual receptive fields in many brain regions have been found to exhibit changes in strength, size, or position around the time of each saccade, and these changes have often been suggested to be involved in the maintenance of perceptual stability. Crucial to the circuitry underlying perisaccadic changes in visual receptive fields is the superior colliculus (SC), a brainstem structure responsible for integrating visual and oculomotor signals. In this work we have studied the time-course of receptive field changes in the SC. We find that the distribution of the latencies of SC responses to stimuli placed outside the fixation receptive field is bimodal: The first mode is comprised of early responses that are temporally locked to the onset of the visual probe stimulus and stronger for probes placed closer to the classical receptive field. We suggest that such responses are therefore consistent with a perisaccadic rescaling, or enhancement, of weak visual responses within a fixed spatial receptive field. The second mode is more similar to the remapping that has been reported in the cortex, as responses are time-locked to saccade onset and stronger for stimuli placed in the postsaccadic receptive field location. We suggest that these two temporal phases of spatial updating may represent different sources of input to the SC.	[Churan, Jan; Guitton, Daniel; Pack, Christopher C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Churan, J (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	jan.churan@gmail.com			CIHR [MOP-115178, MOP-9222]; NSERC [341534-12]; EJLB Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); EJLB Foundation	CIHR grant to C. Pack MOP-115178, CIHR grant to D. Guitton MOP-9222, NSERC grant to C. Pack 341534-12, and EJLB Foundation grant to C. Pack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman RA, 2007, J NEUROPHYSIOL, V98, P105, DOI 10.1152/jn.00330.2007; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Choi WY, 2006, NEURON, V50, P491, DOI 10.1016/j.neuron.2006.03.032; Churan J, 2011, J NEUROPHYSIOL, V106, P1862, DOI 10.1152/jn.00288.2011; Crapse TB, 2008, CURR OPIN NEUROBIOL, V18, P552, DOI 10.1016/j.conb.2008.09.017; DUFFY FH, 1975, BRAIN RES, V89, P121; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Dunn CA, 2010, J NEUROPHYSIOL, V104, P1267, DOI 10.1152/jn.00675.2009; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P542, DOI 10.1152/jn.1972.35.4.542; Han X, 2009, P NATL ACAD SCI USA, V106, P13046, DOI 10.1073/pnas.0902412106; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Heiser LM, 2006, J NEUROPHYSIOL, V95, P2751, DOI 10.1152/jn.00054.2005; Heiser LM, 2005, J NEUROPHYSIOL, V94, P3249, DOI 10.1152/jn.00029.2005; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Li XB, 2008, J NEUROSCI, V28, P4561, DOI 10.1523/JNEUROSCI.5683-07.2008; Lynch JC, 2006, PROG BRAIN RES, V151, P461, DOI 10.1016/S0079-6123(05)51015-X; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; MAYS LE, 1980, SCIENCE, V208, P1163, DOI 10.1126/science.6769161; Nakamura K, 2002, P NATL ACAD SCI USA, V99, P4026, DOI 10.1073/pnas.052379899; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RICHMOND BJ, 1980, J NEUROPHYSIOL, V43, P1156, DOI 10.1152/jn.1980.43.4.1156; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Sommer MA, 2002, SCIENCE, V296, P1480, DOI 10.1126/science.1069590; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sommer MA, 2008, PERCEPTION, V37, P408, DOI 10.1068/p5873; Sommer MA, 2006, NATURE, V444, P374, DOI 10.1038/nature05279; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; Umeno MM, 2001, J NEUROPHYSIOL, V86, P2344, DOI 10.1152/jn.2001.86.5.2344; Vaziri S, 2006, J NEUROSCI, V26, P4188, DOI 10.1523/JNEUROSCI.4747-05.2006; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P745, DOI 10.1152/jn.1976.39.4.745; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Wurtz RH, 2008, VISION RES, V48, P2070, DOI 10.1016/j.visres.2008.03.021; ZARETSKY M, 1979, NATURE, V280, P583, DOI 10.1038/280583a0	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52195	10.1371/journal.pone.0052195	http://dx.doi.org/10.1371/journal.pone.0052195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284931	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900085
J	Conte, D; Huh, M; Goodall, E; Delorme, M; Parks, RJ; Picketts, DJ				Conte, Damiano; Huh, Michael; Goodall, Emma; Delorme, Marilyne; Parks, Robin J.; Picketts, David J.			Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways	PLOS ONE			English	Article							X SYNDROME PROTEIN; MENTAL-RETARDATION; TARGETED DISRUPTION; NUCLEAR-BODIES; CANCER-THERAPY; FREQUENT ATRX; HELPER VIRUS; MUTATIONS; CHROMATIN; EXPRESSION	Prevalent cell death in forebrain- and Sertoli cell-specific Atrx knockout mice suggest that Atrx is important for cell survival. However, conditional ablation in other tissues is not associated with increased death indicating that diverse cell types respond differently to the loss of this chromatin remodeling protein. Here, primary macrophages isolated from Atrx(f/f) mice were infected with adenovirus expressing Cre recombinase or beta-galactosidase, and assayed for cell survival under different experimental conditions. Macrophages survive without Atrx but undergo rapid apoptosis upon lipopolysaccharide (LPS) activation suggesting that chromatin reorganization in response to external stimuli is compromised. Using this system we next tested the effect of different apoptotic stimuli on cell survival. We observed that survival of Atrx-null cells were similar to wild type cells in response to serum withdrawal, anti-Fas antibody, C2 ceramide or dexamethasone treatment but were more sensitive to 5-fluorouracil (5-FU). Cell survival could be rescued by re-introducing Atrx or by removal of p53 demonstrating the cell autonomous nature of the effect and its p53-dependence. Finally, we demonstrate that multiple primary cell types (myoblasts, embryonic fibroblasts and neurospheres) were sensitive to 5-FU, cisplatin, and UV light treatment. Together, our results suggest that cells lacking Atrx are more sensitive to DNA damaging agents and that this may result in enhanced death during development when cells are at their proliferative peak. Moreover, it identifies potential treatment options for cancers associated with ATRX mutations, including glioblastoma and pancreatic neuroendocrine tumors.	[Conte, Damiano; Huh, Michael; Goodall, Emma; Delorme, Marilyne; Parks, Robin J.; Picketts, David J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Goodall, Emma] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Delorme, Marilyne; Parks, Robin J.; Picketts, David J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Parks, Robin J.; Picketts, David J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Picketts, DJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	dpicketts@ohri.ca			Canadian Institutes of Health Research [MOP-84412]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	DJP is funded by operating grant MOP-84412 from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison CL, 1997, J GEN VIROL, V78, P1653, DOI 10.1099/0022-1317-78-7-1653; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Aucott R, 2008, J CELL BIOL, V183, P597, DOI 10.1083/jcb.200804041; Bagheri-Fam S, 2011, HUM MOL GENET, V20, P2213, DOI 10.1093/hmg/ddr109; Berube NG, 2008, EUR J HUM GENET, V16, P192, DOI 10.1038/sj.ejhg.5201943; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Berube NG, 2000, HUM MOL GENET, V9, P539, DOI 10.1093/hmg/9.4.539; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hogan B, 1994, MANIPULATING MOUSE E; Hong YK, 2009, BIOCHEM BIOPH RES CO, V384, P160, DOI 10.1016/j.bbrc.2009.04.112; Hubberstey AV, 2002, CANCER GENE THER, V9, P321, DOI 10.1038/sj.cgt.7700436; Imreh G, 2011, J CELL SCI, V124, P2951, DOI 10.1242/jcs.081612; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lebel M, 1998, P NATL ACAD SCI USA, V95, P13097, DOI 10.1073/pnas.95.22.13097; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lee NG, 2007, FEBS LETT, V581, P2625, DOI 10.1016/j.febslet.2007.05.005; LEWIS PW, 2010, P NATL ACAD SCI US; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Picketts DJ, 1998, MAMM GENOME, V9, P400, DOI 10.1007/s003359900781; Ritchie K, 2008, J CELL BIOL, V180, P315, DOI 10.1083/jcb.200706083; Ross PJ, 2009, COLD SPRING HARB PRO, V2009; Sargent KL, 2004, GENE THER, V11, P504, DOI 10.1038/sj.gt.3302107; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008; Sladek Z, 2009, RES VET SCI, V86, P235, DOI 10.1016/j.rvsc.2008.07.016; Solomon LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007106; Steensma DP, 2004, BLOOD, V103, P2019, DOI 10.1182/blood-2003-09-3360; Tan TLR, 1999, CURR BIOL, V9, P325, DOI 10.1016/S0960-9822(99)80142-0; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897	61	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52167	10.1371/journal.pone.0052167	http://dx.doi.org/10.1371/journal.pone.0052167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284920	Green Published, gold, Green Submitted			2022-12-25	WOS:000312435900083
J	Corbin, KD; Abdelmalek, MF; Spencer, MD; da Costa, KA; Galanko, JA; Sha, W; Suzuki, A; Guy, CD; Cardona, DM; Torquati, A; Diehl, AM; Zeisel, SH				Corbin, Karen D.; Abdelmalek, Manal F.; Spencer, Melanie D.; da Costa, Kerry-Ann; Galanko, Joseph A.; Sha, Wei; Suzuki, Ayako; Guy, Cynthia D.; Cardona, Diana M.; Torquati, Alfonso; Diehl, Anna Mae; Zeisel, Steven H.			Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis	FASEB JOURNAL			English	Article						single nucleotide polymorphisms; nutrition; nonalcoholic fatty liver disease; metabolic syndrome; obesity	FATTY LIVER-DISEASE; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; INSULIN-RESISTANCE; RISK-FACTORS; POLYMORPHISMS; VARIANTS; NUTRIENT; SUSCEPTIBILITY; REQUIREMENT; PROTEIN	Choline metabolism is important for very low-density lipoprotein secretion, making this nutritional pathway an important contributor to hepatic lipid balance. The purpose of this study was to assess whether the cumulative effects of multiple single nucleotide polymorphisms (SNPs) across genes of choline/1-carbon metabolism and functionally related pathways increase susceptibility to developing hepatic steatosis. In biopsy-characterized cases of nonalcoholic fatty liver disease and controls, we assessed 260 SNPs across 21 genes in choline/1-carbon metabolism. When SNPs were examined individually, using logistic regression, we only identified a single SNP (PNPLA3 rs738409) that was significantly associated with severity of hepatic steatosis after adjusting for confounders and multiple comparisons (P=0.02). However, when groupings of SNPs in similar metabolic pathways were defined using unsupervised hierarchical clustering, we identified groups of subjects with shared SNP signatures that were significantly correlated with steatosis burden (P=0.0002). The lowest and highest steatosis clusters could also be differentiated by ethnicity. However, unique SNP patterns defined steatosis burden irrespective of ethnicity. Our results suggest that analysis of SNP patterns in genes of choline/1-carbon metabolism may be useful for prediction of severity of steatosis in specific subsets of people, and the metabolic inefficiencies caused by these SNPs should be examined further.-Corbin, K. D., Abdelmalek, M. F., Spencer, M. D., da Costa, K.-A., Galanko, J. A., Sha, W., Suzuki, A., Guy, C. D., Cardona, D. M., Torquati, A., Diehl, A. M., Zeisel, S. H. Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis. FASEB J. 27, 1674-1689 (2013). www.fasebj.org	[Corbin, Karen D.; Spencer, Melanie D.; Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Kannapolis, NC 28081 USA; [Corbin, Karen D.; da Costa, Kerry-Ann; Zeisel, Steven H.] Univ N Carolina, Sch Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Spencer, Melanie D.; Galanko, Joseph A.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Abdelmalek, Manal F.; Suzuki, Ayako; Diehl, Anna Mae] Duke Univ, Med Ctr, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Guy, Cynthia D.; Cardona, Diana M.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Torquati, Alfonso] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Sha, Wei] Univ North Carolina Charlotte, Bioinformat Serv Div, Kannapolis, NC USA	University of North Carolina; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Charlotte	Zeisel, SH (corresponding author), Univ N Carolina, Inst Nutr Res, 500 Laureate Way,Rm 2218, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	Abdelmalek, Manal F/AAW-2203-2020	Corbin, Karen/0000-0003-2065-0003; Suzuki, Ayako/0000-0003-1824-1067; Abdelmalek, Manal/0000-0002-5001-8618; Cardona, Diana/0000-0002-6877-2280; Spencer, Melanie/0000-0003-0640-1123	U.S. National Institutes of Health (NIH) [R01DK055865, P30DK056350]; NIH [R01DK055865, P30DK056350, DK034987]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases K23 Career Development award [K23-DK062116]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK062116, R01DK055865, P30DK034987, P30DK056350, T32DK007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Diabetes and Digestive and Kidney Diseases K23 Career Development award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank their colleagues in Duke Division of Gastroenterology, Duke Bariatric Surgery Program, and Center of Human Genetics for assistance with patient recruitment, acquisition, and/or accessing Duke University Health Systems NAFLD Biorepository samples. The authors also thank the NAFLD Clinical Research study coordinators and support staff, clinical personnel, research and data management personnel, and the patients and their families, without whom, this study would not have been possible. The authors thank Yi-Ping Pan for assistance with review, interpretation, and extraction of all clinical data for the cohort of patients utilized in this analysis. The authors also thank her for obtaining consent and enrolling patients into the Duke Clinical Database and Biorepository, and for performing data entry and data management. This research was supported by grants from the U.S. National Institutes of Health (NIH; R01DK055865 and P30DK056350 to S.Z.). K. C. was supported by a Diversity Post-doctoral Supplement to grant R01DK055865 from the NIH. J.G was supported by grants from the NIH (DK034987 and P30DK056350). M. A. was supported by a NIH/National Institute of Diabetes and Digestive and Kidney Diseases K23 Career Development award (K23-DK062116).	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buchman AL, 2001, JPEN-PARENTER ENTER, V25, P260, DOI 10.1177/0148607101025005260; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; da Costa KA, 2011, AM J CLIN NUTR, V93, P968, DOI 10.3945/ajcn.110.011064; Davit-Spraul A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/s-0030-1253223; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156; Hochrath K, 2012, FASEB J, V26, P5081, DOI 10.1096/fj.12-209379; Hooper AJ, 2011, J LIPID RES, V52, P593, DOI 10.1194/jlr.R008896; Huang YC, 2011, J BIOL CHEM, V286, P37085, DOI 10.1074/jbc.M111.290114; Hung J, 2008, J AM COLL NUTR, V27, P253, DOI 10.1080/07315724.2008.10719697; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimm SYS, 2002, AM J CLIN NUTR, V75, P714, DOI 10.1093/ajcn/75.4.714; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohlmeier M, 2005, P NATL ACAD SCI USA, V102, P16025, DOI 10.1073/pnas.0504285102; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Kumar J, 2009, CIRC-CARDIOVASC GENE, V2, P599, DOI 10.1161/CIRCGENETICS.108.841411; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lambrinoudaki I, 2008, EUR J ENDOCRINOL, V159, P233, DOI 10.1530/EJE-07-0848; Lee HY, 2011, HEPATOLOGY, V54, P1650, DOI 10.1002/hep.24571; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Michel V, 2009, FASEB J, V23, P2749, DOI 10.1096/fj.08-121491; Miller M, 2007, ARCH MED RES, V38, P444, DOI 10.1016/j.arcmed.2006.10.013; Musso G, 2008, HEPATOLOGY, V47, P1167, DOI 10.1002/hep.22142; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Ong Janus P, 2007, Clin Liver Dis, V11, P1, DOI 10.1016/j.cld.2007.02.009; Peter A, 2012, INT J OBESITY, V36, P774, DOI 10.1038/ijo.2011.154; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pickett-Blakely OE, 2012, OBES SURG, V22, P838, DOI 10.1007/s11695-012-0629-9; Rey JW, 2010, WORLD J GASTROENTERO, V16, P5830, DOI 10.3748/wjg.v16.i46.5830; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Siddique A, 2011, CLIN LIVER DIS, V15, P281, DOI 10.1016/j.cld.2011.03.007; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Sookoian S, 2008, CYTOKINE, V44, P201, DOI 10.1016/j.cyto.2008.08.001; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Truong H, 2009, AM J CLIN NUTR, V89, P920, DOI 10.3945/ajcn.2008.27107; Valenti L, 2011, J HEPATOL, V55, P1409, DOI 10.1016/j.jhep.2011.03.035; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Warensjo E, 2007, OBESITY, V15, P1732, DOI 10.1038/oby.2007.206; Yki-Jarvinen H, 2010, CURR OPIN CLIN NUTR, V13, P709, DOI 10.1097/MCO.0b013e32833f4b34; Zeisel SH, 2009, NUTR REV, V67, P615, DOI 10.1111/j.1753-4887.2009.00246.x	56	29	31	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1674	1689		10.1096/fj.12-219097	http://dx.doi.org/10.1096/fj.12-219097			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23292069	Green Published, Green Submitted			2022-12-25	WOS:000316940800037
J	Fratangeli, A; Parmigiani, E; Fumagalli, M; Lecca, D; Benfante, R; Passafaro, M; Buffo, A; Abbracchio, MP; Rosa, P				Fratangeli, Alessandra; Parmigiani, Elena; Fumagalli, Marta; Lecca, Davide; Benfante, Roberta; Passafaro, Maria; Buffo, Annalisa; Abbracchio, Maria P.; Rosa, Patrizia			The Regulated Expression, Intracellular Trafficking, and Membrane Recycling of the P2Y-like Receptor GPR17 in Oli-neu Oligodendroglial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTOSIS; PROTEINS; BINDING; TARGET; DIFFERENTIATION; EXOCYTOSIS; ENDOSOMES; SENSOR; DAMAGE; RAB5	GPR17 is a G-protein-coupled receptor that is activated by two classes of molecules: uracil-nucleotides and cysteinyl-leukotrienes. GPR17 is required for initiating the differentiation of oligodendrocyte precursors but has to be down-regulated to allow cells to undergo terminal maturation. Although a great deal has been learned about GPR17 expression and signaling, no information is currently available about the trafficking of native receptors after the exposure of differentiating oligodendrocytes to endogenous agonists. Here, we demonstrate that neuron-conditioned medium induces the transcriptionally mediated, time-regulated expression of GPR17 in Oli-neu, an oligodendrocyte precursor cell line, making these cells suitable for studying the endocytic traffic of the native receptor. Agonist-induced internalization, intracellular trafficking, and membrane recycling of GPR17 were analyzed by biochemical and immunofluorescence assays using an ad hoc-developed antibody against the extracellular N-terminal of GPR17. Both UDP-glucose and LTD4 increased GPR17 internalization, although with different efficiency. At early time points, internalized GPR17 co-localized with transferrin receptor, whereas at later times it partially colocalized with the lysosomal marker Lamp1, suggesting that a portion of GPR17 is targeted to lysosomes upon ligand binding. Ananalysis of receptor recycling and degradation demonstrated that a significant aliquot of GPR17 is recycled to the cell surface. Furthermore, internalized GPR17 displayed a co-localization with the marker of the "short loop" recycling endosomes, Rab4, while showing very minor co-localization with the "long loop" recycling marker, Rab11. Our results provide the first data on the agonist-induced trafficking of native GPR17 in oligodendroglial cells and may have implications for both physiological and pathological myelination.	[Fratangeli, Alessandra; Parmigiani, Elena; Benfante, Roberta; Passafaro, Maria; Rosa, Patrizia] Univ Milan, Dept Med Biotechnol & Translat Med BIOMETRA, Consiglio Nazl Ric, Inst Neurosci, I-20129 Milan, Italy; [Fumagalli, Marta; Lecca, Davide; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol & Biomol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, I-20133 Milan, Italy; [Parmigiani, Elena; Buffo, Annalisa] Univ Turin, Physiol Sect, Neurosci Inst Turin, Neurosci Inst Cavalieri Ottolenghi,Dept Neurosci, I-10043 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Milan; University of Turin	Rosa, P (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.	p.rosa@in.cnr.it	Lecca, Davide/A-8850-2010; Abbracchio, Maria Pia/B-9342-2014; Fumagalli, Marta/AEP-4117-2022; Buffo, Annalisa/O-7207-2019; Benfante, Roberta/C-1513-2015; Parmigiani, Elena/AAD-7524-2021; Parmigiani, Elena/ABE-6167-2021	Lecca, Davide/0000-0002-3258-363X; Abbracchio, Maria Pia/0000-0002-7833-3388; Buffo, Annalisa/0000-0001-7637-0006; Benfante, Roberta/0000-0001-5396-5429; Parmigiani, Elena/0000-0002-3433-1823; Fumagalli, Marta/0000-0002-0158-842X; Rosa, Patrizia/0000-0002-2590-6955	Progetti di Ricerca di Interesse Nazionale, Ministero dell'Istruzione dell' Universita e Della Ricerca; Cariplo Fuondation [2012-0546]; FISM [2010/R2]; CNR-Progetto Invecchiamento [CUP B51J11000820005]	Progetti di Ricerca di Interesse Nazionale, Ministero dell'Istruzione dell' Universita e Della Ricerca; Cariplo Fuondation(Fondazione Cariplo); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); CNR-Progetto Invecchiamento	This work was supported by Progetti di Ricerca di Interesse Nazionale COFIN-PRIN 2008, Ministero dell'Istruzione dell' Universita e Della Ricerca "Purinoceptors and neuroprotection: focus on the new purinergic receptor GPR17," Regione Lombardia Project NUTEC ID 30263049 and Cariplo Fuondation rif.no. 2012-0546 (to P. R.). This work was supported in part by FISM Fondazione Italiana Sclerosi Multipla Grant 2010/R2 (to M. P. A.) and CNR-Progetto Invecchiamento, CUP B51J11000820005.	Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Ceruti S, 2011, GLIA, V59, P363, DOI 10.1002/glia.21107; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Conti F, 2009, AM J PHYSIOL-ENDOC M, V296, pE532, DOI 10.1152/ajpendo.90590.2008; Daniele S, 2011, J PHARMACOL EXP THER, V338, P559, DOI 10.1124/jpet.110.178715; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Jablonska B, 2012, J NEUROSCI, V32, P14775, DOI 10.1523/JNEUROSCI.2060-12.2012; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kippert A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-40; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maekawa A, 2009, P NATL ACAD SCI USA, V106, P11685, DOI 10.1073/pnas.0905364106; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Parravicini C, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-8; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Pugliese AM, 2009, AM J PHYSIOL-CELL PH, V297, pC1028, DOI 10.1152/ajpcell.00658.2008; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Taverna E, 2007, J NEUROCHEM, V100, P664, DOI 10.1111/j.1471-4159.2006.04225.x; von Zastrow M., 2000, REGULATION G PROTEIN, P4; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Winterstein C, 2008, J CELL SCI, V121, P834, DOI 10.1242/jcs.022731; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	40	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5241	5256		10.1074/jbc.M112.404996	http://dx.doi.org/10.1074/jbc.M112.404996			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288840	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000315340400071
J	Ambrose, KV; Belanger, FC				Ambrose, Karen V.; Belanger, Faith C.			SOLiD-SAGE of Endophyte-Infected Red Fescue Reveals Numerous Effects on Host Transcriptome and an Abundance of Highly Expressed Fungal Secreted Proteins	PLOS ONE			English	Article							CHITIN-TRIGGERED IMMUNITY; HORIZONTAL GENE-TRANSFER; LOLIUM-PERENNE; LARGE-SCALE; MEDIATED SUPPRESSION; EPICHLOE ENDOPHYTES; NEOTYPHODIUM-LOLII; MOLECULAR-CLONING; SERIAL ANALYSIS; TALL FESCUE	One of the most important plant-fungal symbiotic relationships is that of cool season grasses with endophytic fungi of the genera Epichloe and Neotyphodium. These associations often confer benefits, such as resistance to herbivores and improved drought tolerance, to the hosts. One benefit that appears to be unique to fine fescue grasses is disease resistance. As a first step towards understanding the basis of the endophyte-mediated disease resistance in Festuca rubra we carried out a SOLiD-SAGE quantitative transcriptome comparison of endophyte-free and Epichloe festucae-infected F. rubra. Over 200 plant genes involved in a wide variety of physiological processes were statistically significantly differentially expressed between the two samples. Many of the endophyte expressed genes were surprisingly abundant, with the most abundant fungal tag representing over 10% of the fungal mapped tags. Many of the abundant fungal tags were for secreted proteins. The second most abundantly expressed fungal gene was for a secreted antifungal protein and is of particular interest regarding the endophyte-mediated disease resistance. Similar genes in Penicillium and Aspergillus spp. have been demonstrated to have antifungal activity. Of the 10 epichloae whole genome sequences available, only one isolate of E. festucae and Neotyphodium gansuense var inebrians have an antifungal protein gene. The uniqueness of this gene in E. festucae from F. rubra, its transcript abundance, and the secreted nature of the protein, all suggest it may be involved in the disease resistance conferred to the host, which is a unique feature of the fine fescue-endophyte symbiosis.	[Ambrose, Karen V.; Belanger, Faith C.] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Belanger, FC (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	belanger@aesop.rutgers.edu			Rutgers Center for Turfgrass Science; NSF [EF-0523661]; USDA-NRI [2005-35319-16141]; National Institutes of Health [2 P20 RR-16481]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER	Rutgers Center for Turfgrass Science; NSF(National Science Foundation (NSF)); USDA-NRI(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported with funds provided by the Rutgers Center for Turfgrass Science. The genomic sequencing and genome annotation of Epichloe, Neotyphodium, Claviceps, Periglandula, and Aciculosporium (Genome Project at University of Kentucky, URL: http://www.endophyte.uky.edu/) were supported by grants to Dr. C. Schardl (NSF EF-0523661, USDA-NRI 2005-35319-16141, and National Institutes of Health 2 P20 RR-16481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2008, SYST BIOL, V57, P613, DOI 10.1080/10635150802306527; Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Alves SL, 2008, APPL ENVIRON MICROB, V74, P1494, DOI 10.1128/AEM.02570-07; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; [Anonymous], 2008, NAT METHODS, V5, P15, DOI 10.1038/NMETH1155; [Anonymous], APPL TURFGRASS SCI; Auer PL, 2012, BRIEF FUNCT GENOMICS, V11, P57, DOI 10.1093/bfgp/elr041; Batista AS, 2004, J MOL MICROB BIOTECH, V8, P26, DOI 10.1159/000082078; Bausher M, 2003, PLANT SCI, V165, P415, DOI 10.1016/S0168-9452(03)00202-4; Bettiga M, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-16; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brown DW, 2011, CURR GENET, V57, P51, DOI 10.1007/s00294-010-0326-y; Calsa T, 2007, PLANT MOL BIOL, V63, P745, DOI 10.1007/s11103-006-9121-z; Christensen MJ, 2008, FUNGAL GENET BIOL, V45, P84, DOI 10.1016/j.fgb.2007.07.013; Clarke BB, 2006, PLANT DIS, V90, P994, DOI 10.1094/PD-90-0994; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Dinkins RD, 2010, J PLANT PHYSIOL, V167, P1197, DOI 10.1016/j.jplph.2010.04.002; Dodge AG, 2005, APPL ENVIRON MICROB, V71, P876, DOI 10.1128/AEM.71.2.876-882.2005; Doehlemann G, 2005, FUNGAL GENET BIOL, V42, P601, DOI 10.1016/j.fgb.2005.03.001; Eaton CJ, 2010, PLANT PHYSIOL, V153, P1780, DOI 10.1104/pp.110.158451; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Fleetwood DJ, 2007, APPL ENVIRON MICROB, V73, P2571, DOI 10.1128/AEM.00257-07; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Ge XJ, 2006, BIOINFORMATICS, V22, P2475, DOI 10.1093/bioinformatics/btl429; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gibbings JG, 2003, PLANT BIOTECHNOL J, V1, P271, DOI 10.1046/j.1467-7652.2003.00026.x; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grobler J, 1995, YEAST, V11, P1485, DOI 10.1002/yea.320111503; Hamilton CE, 2012, FUNGAL DIVERS, V54, P1, DOI 10.1007/s13225-012-0158-9; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HINTON DM, 1985, CAN J BOT, V63, P36, DOI 10.1139/b85-006; Hong LZ, 2011, GENOME RES, V21, P1905, DOI 10.1101/gr.122135.111; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Johnson L, 2010, INOCULUM, V61, P58; Johnson LJ, 2003, PHYSIOL MOL PLANT P, V63, P305, DOI 10.1016/j.pmpp.2004.04.001; Johnson-Cicalese J, 2000, CROP SCI, V40, P1485, DOI 10.2135/cropsci2000.4051485x; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kuldau G, 2008, BIOL CONTROL, V46, P57, DOI 10.1016/j.biocontrol.2008.01.023; Kutil BL, 2007, FUNGAL GENET BIOL, V44, P1002, DOI 10.1016/j.fgb.2007.04.003; LAM CK, 1994, MYCOLOGIA, V86, P408, DOI 10.2307/3760573; Leandro MJ, 2006, BIOCHEM J, V395, P543, DOI 10.1042/BJ20051465; Li CJ, 2008, MICROBIOL RES, V163, P431, DOI 10.1016/j.micres.2006.07.007; Liberator P, 1998, J BIOL CHEM, V273, P4237, DOI 10.1074/jbc.273.7.4237; Lingner U, 2011, J BIOL CHEM, V286, P20913, DOI 10.1074/jbc.M110.213678; Link T, 2005, BIOCHEM J, V389, P289, DOI 10.1042/BJ20050301; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Marshall E, 2011, J EXP BOT, V62, P1677, DOI 10.1093/jxb/err002; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Marx F, 2004, APPL MICROBIOL BIOT, V65, P133, DOI 10.1007/s00253-004-1600-z; Matsumura H, 2005, CELL MICROBIOL, V7, P11, DOI 10.1111/j.1462-5822.2004.00478.x; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Meyer S, 2010, TRENDS PLANT SCI, V15, P40, DOI 10.1016/j.tplants.2009.10.002; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Moon CD, 2007, MYCOLOGIA, V99, P895, DOI 10.3852/mycologia.99.6.895; Moy M, 2002, PLANT PHYSIOL, V130, P1298, DOI 10.1104/pp.010108; Pang TL, 2010, J CELL SCI, V123, P3745, DOI 10.1242/jcs.064709; Plett JM, 2012, EFFECTORS PLANT MICR, P295; Poole RL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-475; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Quere R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh161; Rasmussen S, 2008, PLANT PHYSIOL, V146, P1440, DOI 10.1104/pp.107.111898; Rasmussen S, 2012, NEW PHYTOL, V196, P7, DOI 10.1111/j.1469-8137.2012.04250.x; Rasmussen S, 2009, PHYTOCHEM REV, V8, P535, DOI 10.1007/s11101-009-9136-6; Reddy PV, 1996, PLANT PHYSIOL, V111, P1209, DOI 10.1104/pp.111.4.1209; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; RICHARDSON MD, 1992, CROP SCI, V32, P1060, DOI 10.2135/cropsci1992.0011183X003200040045x; Robinson SJ, 2004, PLANT PHYSIOL, V136, P3223, DOI 10.1104/pp.104.043406; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rouxel T, 2012, EFFECTORS PLANT MICR, P195; Ruemmele BA, 2003, TURFGRASS BIOL GENET; Schardl C.L., 2009, PLANT RELATIONSHIPS, V5, P275, DOI [10.1007/978-3-540-87407-2_15, DOI 10.1007/978-3-540-87407-2_15]; Schardl CL, 2012, FUNGAL ECOL, V5, P331, DOI 10.1016/j.funeco.2011.04.005; Schardl CL, 2001, FUNGAL GENET BIOL, V33, P69, DOI 10.1006/fgbi.2001.1275; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Scott B, 2010, RECENT DEV MANAGEMEN, V1, P275; Scott B., 2012, TOPICS CURRENT GENET, P243, DOI DOI 10.1007/978-3-642-22916-9_12; Scott B, 2008, CURR OPIN MICROBIOL, V11, P488, DOI 10.1016/j.mib.2008.10.008; Siebert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022953; Smarda P, 2008, ANN BOT-LONDON, V101, P421, DOI 10.1093/aob/mcm307; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Spiering MJ, 2006, ANN BOT-LONDON, V98, P379, DOI 10.1093/aob/mcl108; Sterck L, 2007, CURR OPIN PLANT BIOL, V10, P199, DOI 10.1016/j.pbi.2007.01.004; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tadych M, 2012, FUNGAL DIVERS, V54, P117, DOI 10.1007/s13225-012-0170-0; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tanaka A, 2005, MOL MICROBIOL, V57, P1036, DOI 10.1111/j.1365-2958.2005.04747.x; Tanaka A, 2008, MOL MICROBIOL, V68, P1165, DOI 10.1111/j.1365-2958.2008.06217.x; Tanaka A, 2012, CURR OPIN PLANT BIOL, V15, P462, DOI 10.1016/j.pbi.2012.03.007; Teichert S, 2008, EUKARYOT CELL, V7, P187, DOI 10.1128/EC.00351-07; TEMPLETON MD, 1994, MOL PLANT MICROBE IN, V7, P320, DOI 10.1094/MPMI-7-0320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vazquez-de-Aldana BR, 2013, PLANT SOIL, V362, P201, DOI 10.1007/s11104-012-1283-7; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Werner A, 2010, BIOCHEM SOC T, V38, P1144, DOI 10.1042/BST0381144; White JF, 2010, PHYSIOL PLANTARUM, V138, P440, DOI 10.1111/j.1399-3054.2009.01332.x; Wilkinson HH, 2000, MOL PLANT MICROBE IN, V13, P1027, DOI 10.1094/MPMI.2000.13.10.1027; Young CA, 2005, MOL GENET GENOMICS, V274, P13, DOI 10.1007/s00438-005-1130-0; Young CA, 2006, FUNGAL GENET BIOL, V43, P679, DOI 10.1016/j.fgb.2006.04.004; Yue Q, 2000, J CHEM ECOL, V26, P279, DOI 10.1023/A:1005410115940; Zhang DX, 2009, PLANT PHYSIOL, V150, P1072, DOI 10.1104/pp.109.138222; Zhang N, 2011, MOL PLANT MICROBE IN, V24, P984, DOI 10.1094/MPMI-02-11-0028	120	54	56	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53214	10.1371/journal.pone.0053214	http://dx.doi.org/10.1371/journal.pone.0053214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285269	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500123
J	Buzdugan, R; Watadzaushe, C; Dirawo, J; Mundida, O; Langhaug, L; Willis, N; Hatzold, K; Ncube, G; Mugurungi, O; Benedikt, C; Copas, A; Cowan, FM				Buzdugan, Raluca; Watadzaushe, Constancia; Dirawo, Jeffrey; Mundida, Oscar; Langhaug, Lisa; Willis, Nicola; Hatzold, Karin; Ncube, Getrude; Mugurungi, Owen; Benedikt, Clemens; Copas, Andrew; Cowan, Frances M.			Positive Attitudes to Pediatric HIV Testing: Findings from a Nationally Representative Survey from Zimbabwe	PLOS ONE			English	Article							WESTERN KENYA; HEALTH-CARE; CHILDREN; ADOLESCENTS; INFECTION; AFRICA; ACCEPTABILITY; MORTALITY; INFANTS	Objective: Early HIV testing and diagnosis are paramount for increasing treatment initiation among children, necessary for their survival and improved health. However, uptake of pediatric HIV testing is low in high-prevalence areas. We present data on attitudes towards pediatric testing from a nationally representative survey in Zimbabwe. Methods: All 18-24 year olds and a proportion of 25-49 year olds living in randomly selected enumeration areas from all ten Zimbabwe provinces were invited to self-complete an anonymous questionnaire on a personal digital assistant, and 16,719 people agreed to participate (75% of eligibles). Results: Most people think children can benefit from HIV testing (91%), 81% of people who looked after children know how to access testing for their children and 92% would feel happier if their children were tested. Notably, 42% fear that, if tested, children may be discriminated against by some community members and 28% fear their children are HIV positive. People who fear discrimination against children who have tested for HIV are more likely than their counterparts to perceive their community as stigmatizing against HIV positive people (43% vs. 29%). They are also less likely to report positive attitudes to HIV themselves (49% vs. 74%). Only 28% think it is possible for children HIV-infected at birth to live into adolescence without treatment. Approximately 70% of people (irrespective of whether they are themselves parents) think HIV-infected children in their communities can access testing and treatment. Conclusions: Pediatric HIV testing is the essential gateway to prevention and care services. Our data indicate positive attitudes to testing children, suggesting a conducive environment for increasing uptake of pediatric testing in Zimbabwe. However, there is a need to better understand the barriers to pediatric testing, such as stigma and discrimination, and address the gaps in knowledge regarding HIV/AIDS in children.	[Buzdugan, Raluca; Copas, Andrew; Cowan, Frances M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Buzdugan, Raluca] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Watadzaushe, Constancia; Dirawo, Jeffrey; Langhaug, Lisa; Cowan, Frances M.] Univ Zimbabwe, ZAPP UZ, Harare, Zimbabwe; [Mundida, Oscar] Natl AIDS Council, Harare, Zimbabwe; [Willis, Nicola] Africaid, Harare, Zimbabwe; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Ncube, Getrude; Mugurungi, Owen] Minist Hlth & Child Welf, Harare, Zimbabwe; [Benedikt, Clemens] UNFPA, Harare, Zimbabwe	University of London; University College London; University of California System; University of California Berkeley; University of Zimbabwe	Buzdugan, R (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	rbuzdugan@berkeley.edu		Langhaug, Lisa/0000-0002-9131-8158; Cowan, Frances/0000-0003-3087-4422; Copas, Andrew/0000-0001-8968-5963	UNPFA Zimbabwe Soul City	UNPFA Zimbabwe Soul City	Funders: UNPFA Zimbabwe & Soul City. Soul City had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Clemens Benedikt from UNFPA provided substantive inputs into the study design and contributed to this manuscript.	Bandason T, 2011, 18 C RETR OPP INF CR; Berendes S, 2011, J ASSOC NURSE AIDS C, V22, P215, DOI 10.1016/j.jana.2010.08.005; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; Chhagan MK, 2011, TROP MED INT HEALTH, V16, P1490, DOI 10.1111/j.1365-3156.2011.02872.x; Donahue MC, 2012, AIDS CARE; Ferrand RA, 2011, AM J PUBLIC HEALTH, V101, P2325, DOI 10.2105/AJPH.2011.300250; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000178; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; Georgia, 2012, GLOBAL AIDS RESPONSE; Joint United Nations Programme on HIV/AIDS, 2012, TOG WE WILL END AIDS; Kankasa C, 2009, JAIDS-J ACQ IMM DEF, V51, P202, DOI 10.1097/QAI.0b013e31819c173f; McCollum ED, 2011, PEDIATR INFECT DIS J, V30, pE75, DOI 10.1097/INF.0b013e3182103f8a; Mutanga JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029656; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Oga MA, 2011, JAIDS-J ACQ IMM DEF, V57, pS16, DOI 10.1097/QAI.0b013e31821fd487; Ostermann J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016488; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Vreeman RC, 2010, JAIDS-J ACQ IMM DEF, V55, pE3, DOI 10.1097/QAI.0b013e3181f0758f; Wanyenze RK, 2010, TROP MED INT HEALTH, V15, P113, DOI 10.1111/j.1365-3156.2009.02417.x; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Yeap AD, 2010, AIDS CARE, V22, P1101, DOI 10.1080/09540121003602218	22	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53213	10.1371/journal.pone.0053213	http://dx.doi.org/10.1371/journal.pone.0053213			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285268	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500122
J	Wang, ZW; Feng, AZ; Cui, MB; Liu, YX; Wang, LZ; Wang, QM				Wang, Ziwen; Feng, Anzheng; Cui, Mingbo; Liu, Yuxiu; Wang, Lizhong; Wang, Qingmin			First Discovery and Stucture-Activity Relationship Study of Phenanthroquinolizidines as Novel Antiviral Agents against Tobacco Mosaic Virus (TMV)	PLOS ONE			English	Article							INHIBITORY-ACTIVITY; ALKALOIDS; CRYPTOPLEURINE; IDENTIFICATION; ANALOGS	A series of phenanthroquinolizidine alkaloids 1-24 were prepared and first evaluated for their antiviral activity against tobacco mosaic virus (TMV). The bioassay results showed that most of these compounds exhibited good to excellent in vivo anti-TMV activity, of which compounds 1, 2, 15 and 16 displayed significantly higher activity than (R)-antofine and commercial Ningnanmycin at the same test condition. The substituents on the phenanthrene moiety play an important role for maintaining high in vivo antiviral activity. The introduction of 6-hydroxyl, which is proposed to interact with TMV RNA, did increased anti-TMV activity. The 14aR-configuration was confirmed to be the preferred antiviral configuration for phenanthroquinolizidine alkaloids. Introduction of hydroxy group at 15-position of phenanthroquinolizidine alkaloids increased activity for S-configuration but decreased activity for R-configuration. Present study provides fundamental support for development and optimization of phenanthroquinolizidine alkaloids as potential inhibitors of plant virus.	[Wang, Ziwen; Feng, Anzheng; Cui, Mingbo; Liu, Yuxiu; Wang, Lizhong; Wang, Qingmin] Nankai Univ, State Key Lab Elementoorgan Chem, Res Inst Elementoorgan Chem, Tianjin 300071, Peoples R China	Nankai University	Wang, QM (corresponding author), Nankai Univ, State Key Lab Elementoorgan Chem, Res Inst Elementoorgan Chem, Tianjin 300071, Peoples R China.	wang98h@263.net			National Key Project for Basic Research [2010CB126106]; National Natural Science Foundation of China [21132003, 21121002, 30890143]; Tianjin Natural Science Foundation [11JCZDJC20500]; National Key Technology Research and Development Program [2011BAE06B05]; China Postdoctoral Science Foundation [2011M500519, 2012T50207]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); National Key Technology Research and Development Program(National Key Technology R&D Program); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors gratefully acknowledge assistance from the National Key Project for Basic Research (2010CB126106) and the National Natural Science Foundation of China (21132003, 21121002, 30890143) and the Tianjin Natural Science Foundation (11JCZDJC20500) and the National Key Technology Research and Development Program (2011BAE06B05) and the China Postdoctoral Science Foundation (2011M500519, 2012T50207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSHAMMA A, 1982, PHYTOCHEMISTRY, V21, P485, DOI 10.1016/S0031-9422(00)95304-4; An TY, 2001, PHYTOCHEMISTRY, V58, P1267, DOI 10.1016/S0031-9422(01)00382-X; Bos L., 1982, Crop Protection, V1, P263, DOI 10.1016/0261-2194(82)90002-3; Chen J, 2009, J AGR FOOD CHEM, V57, P6590, DOI 10.1021/jf901632j; Chen MH, 2009, J AGR FOOD CHEM, V57, P1383, DOI 10.1021/jf803215t; Cui MB, 2009, EUR J ORG CHEM, V2009, P5445, DOI 10.1002/ejoc.200900834; DELALANDE IS, 1948, AUST J EXP BIOL MED, V26, P181, DOI 10.1038/icb.1948.18; FARNSWORTH NR, 1969, AUST J CHEM, V22, P1805, DOI 10.1071/CH9691805; Gao S, 2012, CHEMBIOCHEM, V13, P1622, DOI 10.1002/cbic.201200313; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Ge YH, 2012, J AGR FOOD CHEM, V60, P4289, DOI 10.1021/jf205362d; GELLERT E, 1956, AUST J CHEM, V9, P489, DOI 10.1071/CH9560489; HANSEN AJ, 1989, CRIT REV PLANT SCI, V8, P45, DOI 10.1080/07352688909382270; Jin HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040355; KRMPOTIC E, 1972, J PHARM SCI-US, V61, P1508, DOI 10.1002/jps.2600610945; Luo YG, 2003, PLANTA MED, V69, P842, DOI 10.1055/s-2003-43215; Ouyang GP, 2008, J AGR FOOD CHEM, V56, P10160, DOI 10.1021/jf802489e; Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Seiber JN, 2011, J AGR FOOD CHEM, V59, P1, DOI 10.1021/jf1046078; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Song BA., 2009, ENV FRIENDLY ANTIPLA, P1; Wang KL, 2010, J AGR FOOD CHEM, V58, P2703, DOI 10.1021/jf902543r; Wang ZW, 2012, EUR J MED CHEM, V51, P250, DOI 10.1016/j.ejmech.2012.02.048; Wang ZW, 2010, TETRAHEDRON LETT, V51, P1377, DOI 10.1016/j.tetlet.2009.12.135; Wu M, 2011, ORG BIOMOL CHEM, V9, P141, DOI 10.1039/c0ob00287a; Xie L, 2009, IEEE POW ENER SOC GE, P4557; Yang CW, 2010, ANTIVIR RES, V88, P160, DOI 10.1016/j.antiviral.2010.08.009; Yang JQ, 2010, J AGR FOOD CHEM, V58, P2730, DOI 10.1021/jf902861m; Yuan DK, 2011, CHINESE CHEM LETT, V22, P18, DOI 10.1016/j.cclet.2010.07.011	30	25	27	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52933	10.1371/journal.pone.0052933	http://dx.doi.org/10.1371/journal.pone.0052933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285230	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500085
J	Gomes, MVM; Toffoli, LV; Arruda, DW; Soldera, LM; Pelosi, GG; Neves-Souza, RD; Freitas, ER; Castro, DT; Marquez, AS				Gomes, Marcus V. M.; Toffoli, Leandro V.; Arruda, Douglas W.; Soldera, Larissa M.; Pelosi, Gislaine G.; Neves-Souza, Rejane D.; Freitas, Eliane R.; Castro, Denilson T.; Marquez, Audrey S.			Age-Related Changes in the Global DNA Methylation Profile of Leukocytes Are Linked to Nutrition but Are Not Associated with the MTHFR C677T Genotype or to Functional Capacities	PLOS ONE			English	Article							MINI-MENTAL-STATE; GASTRIC-CANCER RISK; EPIGENETIC REGULATION; GENOMIC METHYLATION; COLORECTAL ADENOMA; BLADDER-CANCER; BREAST-CANCER; FOLATE STATUS; GENE; HYPOMETHYLATION	Global DNA methylation of peripheral blood leukocytes has been recently proposed as a potential biomarker for disease risk. However, the amplitude of the changes in DNA methylation associated with normal aging and the impacts of environmental changes on this variation are still unclear. In this context, we evaluated the association of global DNA methylation with nutritional habits, tobacco smoking, body mass index (BMI), clinical laboratory parameters, polymorphism C677T MTHFR, functional cognition and the daily practice of physical activity in a cancer-free older population. Leukocyte global DNA methylation from 126 older individuals was quantified using a high-throughput ELISA-based method. Global DNA hypomethylation was observed in older individuals when compared to a younger population (p = 0.0469), confirming changes in DNA methylation in the aging process. Furthermore, the methylation profile of elders was correlated with the daily ingestion of carbohydrates (p = 0.0494), lipids (p = 0.0494), vitamin B6 (p = 0.0421), magnesium (p = 0.0302), and also to the serum levels of total protein (p = 0.0004), alpha 2 globulin (p = 0.0013) and albumin (p = 0.0015). No statistically significant difference was observed when global DNA methylation were stratified according to C677T MTHFR genotypes (p = 0.7200), BMI (p = 0.1170), smoking habit (p = 0.4382), physical activity in daily life (p = 0.8492), scored cognitive function (p = 0.7229) or depression state (p = 0.8301). Our data indicate that age-related variations in the global DNA methylation profile of leukocytes might be modulated by the daily intake of carbohydrates, lipids, vitamin B6, and magnesium and be associated with serum protein levels, however it is independent of C677T MTHFR genotype and not correlated with BMI, smoking habit, cognitive function or the routine physical activities.	[Gomes, Marcus V. M.; Toffoli, Leandro V.; Arruda, Douglas W.; Soldera, Larissa M.; Neves-Souza, Rejane D.; Freitas, Eliane R.; Castro, Denilson T.; Marquez, Audrey S.] Univ No Parana UNOPAR, Res Ctr Hlth Sci, Londrina, Parana, Brazil; [Pelosi, Gislaine G.] State Univ Londrina UEL, Dept Physiol Sci, Ctr Biol Sci, Londrina, Parana, Brazil	University Norte Parana; Universidade Estadual de Londrina	Gomes, MVM (corresponding author), Univ No Parana UNOPAR, Res Ctr Hlth Sci, Londrina, Parana, Brazil.	mvmgomes@gmail.com	Pelosi, Gislaine/AAF-8585-2021		National Foundation for Development of Private Education (Funadesp) [5300665]	National Foundation for Development of Private Education (Funadesp)	This work was supported by a grant from the National Foundation for Development of Private Education (Funadesp) (no.5300665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanutrionline, 2012, SOFTW WIND; Axume J, 2007, NUTR RES, V27, P13, DOI 10.1016/j.nutres.2006.12.006; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; BERDYSHEV G. D., 1967, BIOKHIMIYA, V32, P988; Bestor TH, 1998, CIBA F SYMP, V214, P187; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Cash HL, 2012, INT J CANCER, V130, P1151, DOI 10.1002/ijc.26098; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Chouliaras L, 2011, BRAIN BEHAV IMMUN, V25, P616, DOI 10.1016/j.bbi.2010.11.016; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fraga MF, 2009, CURR OPIN IMMUNOL, V21, P446, DOI 10.1016/j.coi.2009.04.003; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Gao Y, 2012, BRIT J CANCER, V106, P585, DOI 10.1038/bjc.2011.562; Graff J, 2009, EUR J NEUROSCI, V30, P1, DOI 10.1111/j.1460-9568.2009.06787.x; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jung AY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024976; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-98; Li YY, 2010, FASEB J, V24, P1442, DOI 10.1096/fj.09-149328; Liao LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027361; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; MURDEN RA, 1991, J AM GERIATR SOC, V39, P149, DOI 10.1111/j.1532-5415.1991.tb01617.x; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ono H, 2012, CANC SCI, V7; Pallavi R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00318; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; Schiepers OJG, 2012, BRIT J NUTR, V107, P744, DOI 10.1017/S0007114511003576; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; So K, 2006, PATHOL INT, V56, P571, DOI 10.1111/j.1440-1827.2006.02010.x; Spirduso WW, 1995, PHYS DIMENSIONS AGIN; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tohgi H, 1999, MOL BRAIN RES, V70, P288, DOI 10.1016/S0169-328X(99)00163-1; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Wong CCY, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12226; Woo HD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034615; Wu HC, 2011, EPIGENETICS-US, V6, P29, DOI 10.4161/epi.6.1.13393; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335	60	46	47	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52570	10.1371/journal.pone.0052570	http://dx.doi.org/10.1371/journal.pone.0052570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285094	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500200
J	Gravning, J; Orn, S; Kaasboll, OJ; Martinov, VN; Manhenke, C; Dickstein, K; Edvardsen, T; Attramadal, H; Ahmed, MS				Gravning, Jorgen; Orn, Stein; Kaasboll, Ole Jorgen; Martinov, Vladimir N.; Manhenke, Cord; Dickstein, Kenneth; Edvardsen, Thor; Attramadal, Havard; Ahmed, Mohammed Shakil			Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction	PLOS ONE			English	Article							CARDIAC STEM-CELLS; MICROVASCULAR OBSTRUCTION; HEART; CTGF; FIBROBLASTS; REPERFUSION; MECHANISMS; EXPRESSION; ISCHEMIA; PROMOTER	Aims: Myocardial CCN2/CTGF is induced in heart failure of various etiologies. However, its role in the pathophysiology of left ventricular (LV) remodeling after myocardial infarction (MI) remains unresolved. The current study explores the role of CTGF in infarct healing and LV remodeling in an animal model and in patients admitted for acute ST-elevation MI. Methods and Results: Transgenic mice with cardiac-restricted overexpression of CTGF (Tg-CTGF) and non-transgenic littermate controls (NLC) were subjected to permanent ligation of the left anterior descending coronary artery. Despite similar infarct size (area of infarction relative to area at risk) 24 hours after ligation of the coronary artery in Tg-CTGF and NLC mice, Tg-CTGF mice disclosed smaller area of scar tissue, smaller increase of cardiac hypertrophy, and less LV dilatation and deterioration of LV function 4 weeks after MI. Tg-CTGF mice also revealed substantially reduced mortality after MI. Remote/peri-infarct tissue of Tg-CTGF mice contained reduced numbers of leucocytes, macrophages, and cells undergoing apoptosis as compared with NLC mice. In a cohort of patients with acute ST-elevation MI (n = 42) admitted to hospital for percutaneous coronary intervention (PCI) serum-CTGF levels (s-CTGF) were monitored and related to infarct size and LV function assessed by cardiac MRI. Increase in s-CTGF levels after MI was associated with reduced infarct size and improved LV ejection fraction one year after MI, as well as attenuated levels of CRP and GDF-15. Conclusion: Increased myocardial CTGF activities after MI are associated with attenuation of LV remodeling and improved LV function mediated by attenuation of inflammatory responses and inhibition of apoptosis.	[Gravning, Jorgen; Kaasboll, Ole Jorgen; Martinov, Vladimir N.; Edvardsen, Thor; Attramadal, Havard; Ahmed, Mohammed Shakil] Univ Oslo, Rikshosp, Inst Surg Res, Oslo Univ Hosp, N-0027 Oslo, Norway; [Gravning, Jorgen; Kaasboll, Ole Jorgen; Martinov, Vladimir N.; Edvardsen, Thor; Attramadal, Havard; Ahmed, Mohammed Shakil] Univ Oslo, Ctr Heart Failure Res, N-0027 Oslo, Norway; [Orn, Stein; Manhenke, Cord; Dickstein, Kenneth] Stavanger Univ Hosp, Div Cardiol, Stavanger, Norway; [Dickstein, Kenneth] Univ Bergen, Inst Internal Med, Bergen, Norway; [Edvardsen, Thor; Attramadal, Havard] Univ Oslo, Rikshosp, Dept Cardiol, Oslo Univ Hosp, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; Stavanger University Hospital; University of Bergen; University of Oslo; National Hospital Norway	Attramadal, H (corresponding author), Univ Oslo, Rikshosp, Inst Surg Res, Oslo Univ Hosp, N-0027 Oslo, Norway.	havard.attramadal@medisin.uio.no	Edvardsen, Thor/F-4079-2012; Ørn, Stein/ABD-5883-2020	Edvardsen, Thor/0000-0002-3800-765X; Ørn, Stein/0000-0002-5098-4592; Attramadal, Havard/0000-0001-9506-0687	South-Eastern Norway Regional Health Authority [2009086, 2011006]; Norwegian Council on Cardiovascular Disease [6484]; Norwegian Research Council	South-Eastern Norway Regional Health Authority; Norwegian Council on Cardiovascular Disease; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by grants from the South-Eastern Norway Regional Health Authority (grant numbers 2009086 and 2011006), The Norwegian Council on Cardiovascular Disease (grant number 6484), and The Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2011, AM J PHYSIOL-HEART C, V300, pH1291, DOI 10.1152/ajpheart.00604.2010; Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Angert D, 2011, CIRC RES, V108, P1226, DOI 10.1161/CIRCRESAHA.110.239046; Bergestuen DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-6; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Fonseca C, 2007, NEW ENGL J MED, V357, P1210, DOI 10.1056/NEJMoa067655; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gressner AM, 2006, CLIN CHEM, V52, P1815, DOI 10.1373/clinchem.2006.070466; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Koitabashi N, 2008, EUR J HEART FAIL, V10, P373, DOI 10.1016/j.ejheart.2008.02.011; Lakkisto P, 2011, EXP BIOL MED, V236, P1437, DOI 10.1258/ebm.2011.011148; Lin J, 1998, CARDIOVASC RES, V38, P802, DOI 10.1016/S0008-6363(98)00055-8; Manhenke C, 2011, INT J CARDIOLOGY; Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147, DOI 10.1152/ajpheart.1995.269.6.H2147; Orn S, 2007, AM J CARDIOL, V99, P1109, DOI 10.1016/j.amjcard.2006.11.059; Orn S, 2009, EUR HEART J, V30, P1978, DOI 10.1093/eurheartj/ehp219; Orn S, 2009, EUR HEART J, V30, P1180, DOI 10.1093/eurheartj/ehp070; Panek AN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006743; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Stastna M, 2010, PROTEOMICS, V10, P245, DOI 10.1002/pmic.200900515; Tateishi K, 2007, BIOCHEM BIOPH RES CO, V352, P635, DOI 10.1016/j.bbrc.2006.11.096; Touvron M, 2012, DIS MODEL MECH, V5, P481, DOI 10.1242/dmm.009456; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Wang B, 2010, J MED GENET, V47, P391, DOI 10.1136/jmg.2009.073098	25	49	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52120	10.1371/journal.pone.0052120	http://dx.doi.org/10.1371/journal.pone.0052120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284892	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500094
J	Jung, S; Kim, S; Gale, M; Cherni, I; Fonseca, R; Carpten, J; Salhia, B				Jung, Sungwon; Kim, Seungchan; Gale, Molly; Cherni, Irene; Fonseca, Rafael; Carpten, John; Salhia, Bodour			DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription	PLOS ONE			English	Article							FACTOR-I RECEPTOR; GROWTH-FACTOR; MONOCLONAL-ANTIBODY; CELL-PROLIFERATION; HIGH-FREQUENCY; HUMAN CANCER; INSULIN; GENOME; HYPERMETHYLATION; ISLANDS	Previous studies have now demonstrated that both genic and global hypomethylation characterizes the multiple myeloma (MM) epigenome. Whether these methylation changes are associated with global and corresponding increases (or decreases) in transcriptional activity are poorly understood. The purpose of our current study was to correlate DNA methylation levels in MM to gene expression. We analyzed matching datasets generated by the GoldenGate methylation BeadArray and Affymetrix gene expression platforms in 193 MM samples. We subsequently utilized two independent statistical approaches to identify methylation-expression correlations. In the first approach, we used a linear correlation parameter by computing a Pearson correlation coefficient. In the second approach, we discretized samples into low and high methylation groups and then compared the gene expression differences between the groups. Only methylation of 2.1% and 25.3% of CpG sites on the methylation array correlated to gene expression by Pearson correlation or the discretization method, respectively. Among the genes with methylation-expression correlations were IGF1R, DLC1, p16, and IL17RB. In conclusion, DNA methylation may directly regulate relatively few genes and suggests that additional studies are needed to determine the effects of genome-wide methylation changes in MM. Citation: Jung S, Kim S, Gale M, Cherni I, Fonseca R, et al. (2012) DNA Methylation in Multiple Myeloma Is Weakly Associated with Gene Transcription. PLoS ONE 7(12): e52626. doi:10.1371/journal.pone.0052626	[Jung, Sungwon; Kim, Seungchan; Gale, Molly; Cherni, Irene; Carpten, John; Salhia, Bodour] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA; [Fonseca, Rafael] Mayo Clin, Scottsdale, AZ USA	Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Salhia, B (corresponding author), Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85004 USA.	bsalhia@tgen.org		Kim, Seungchan/0000-0003-4183-4338; Fonseca, Rafael/0000-0002-5938-3769	Multiple Myeloma Research Foundation	Multiple Myeloma Research Foundation	This research was supported in part by the Multiple Myeloma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baumann P, 2009, ANTI-CANCER DRUG, V20, P259, DOI 10.1097/CAD.0b013e328328d18b; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen Wenming, 2002, Chinese Medical Sciences Journal, V17, P101; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Cheung HH, 2009, BIRTH DEFECTS RES C, V87, P335, DOI 10.1002/bdrc.20163; Chng WJ, 2006, LEUKEMIA, V20, P174, DOI 10.1038/sj.leu.2403997; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Descamps G, 2009, BRIT J CANCER, V100, P366, DOI 10.1038/sj.bjc.6604839; Dhodapkar KM, 2008, BLOOD, V112, P2878, DOI 10.1182/blood-2008-03-143222; Esteller M, 2003, ADV EXP MED BIOL, V532, P39; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Gonzalez-Paz N, 2007, BLOOD, V109, P1228, DOI 10.1182/blood-2006-05-024661; GOODMAN JI, 1993, ENVIRON HEALTH PERSP, V101, P169, DOI 10.2307/3431863; Guillerm GL, 2003, HAEMATOLOGICA, V88, P476; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Mateos MV, 2002, BRIT J HAEMATOL, V118, P1034, DOI 10.1046/j.1365-2141.2002.03749.x; Menu Eline, 2009, Archives of Physiology and Biochemistry, V115, P49, DOI 10.1080/13813450902736583; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Sabbatini P, 2009, CLIN CANCER RES, V15, P3058, DOI 10.1158/1078-0432.CCR-08-2530; Salhia B, 2010, CANCER RES, V70, P6934, DOI 10.1158/0008-5472.CAN-10-0282; Song YF, 2006, J CLIN PATHOL, V59, P947, DOI 10.1136/jcp.2005.031377; Sprynski AC, 2010, LEUKEMIA, V24, P1940, DOI 10.1038/leu.2010.192; Sprynski AC, 2009, BLOOD, V113, P4614, DOI 10.1182/blood-2008-07-170464; Stewart AK, 2007, LEUKEMIA, V21, P529, DOI 10.1038/sj.leu.2404516; Ullmannova-Benson V, 2009, LEUKEMIA, V23, P383, DOI 10.1038/leu.2008.285; Yuregir OO, 2009, INT J LAB HEMATOL	37	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52626	10.1371/journal.pone.0052626	http://dx.doi.org/10.1371/journal.pone.0052626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285118	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500213
J	Lei, C; Wang, YL; Huang, YR; Yu, H; Huang, YL; Wu, LT; Huang, LM				Lei, Cui; Wang, Yanlin; Huang, Yurong; Yu, Han; Huang, Yiling; Wu, Liting; Huang, Liming			Up-regulated miR155 Reverses the Epithelial-mesenchymal Transition Induced by EGF and Increases Chemo-sensitivity to Cisplatin in Human Caski Cervical Cancer Cells	PLOS ONE			English	Article							BREAST-CANCER; CYCLIN D1; GROWTH; EXPRESSION; MICRORNA-155; PROGRESSION; PATHWAY; CARCINOMA; MIR-155; GENE	The epithelial-mesenchymal transition (EMT) induced by EGF promotes cervical cancer progression; however, the mechanisms underlying the EGF-induced EMT remain unclear. In this study, we reported that miR155 overexpression suppressed EGF-induced EMT, decreased migration/invasion capacities, inhibited cell proliferation and increased the chemo-sensitivity to DDP in human Caski cervical cancer cells. Further, the overexpression of miR155 increased TP53 expression but reduced SMAD2, and CCND1 expression levels. These data suggest that miR155 negatively regulates EGF-induced EMT. We conclude that miR155 does not act as an oncogene but as a tumour suppressor in Caski cells.	[Lei, Cui; Wang, Yanlin; Huang, Yurong; Yu, Han; Huang, Yiling; Wu, Liting; Huang, Liming] Three Gorges Univ, Inst Mol Biol, Yichang, Peoples R China; [Lei, Cui; Wang, Yanlin] Wuhan Univ, Zhongnan Hosp, Dept Oncol, Wuhan 430072, Peoples R China; [Lei, Cui] Three Gorges Univ, Dept Gynecol, Renhe Hosp, Yichang, Peoples R China	China Three Gorges University; Wuhan University; China Three Gorges University	Huang, LM (corresponding author), Three Gorges Univ, Inst Mol Biol, Yichang, Peoples R China.	Hlmyj8265@sina.com			Natural Science Foundation of Hubei province [2011CDB181]; Independent Research Fund, Wuhan University [201130302020016]	Natural Science Foundation of Hubei province(Natural Science Foundation of Hubei Province); Independent Research Fund, Wuhan University	Financial support for this work was provided by the Natural Science Foundation of Hubei province (Grant no. 2011CDB181), Independent Research Fund, Wuhan University (no. 201130302020016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Hagemann T, 2007, BRIT J CANCER, V96, P321, DOI 10.1038/sj.bjc.6603543; Iida K, 2011, BRIT J CANCER, V105, P420, DOI 10.1038/bjc.2011.222; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Kim NH, 2011, J CELL BIOL, V195, P417, DOI 10.1083/jcb.201103097; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Narayanan R, 2012, INT J ONCOL, V40, P13, DOI 10.3892/ijo.2011.1211; Ono Y, 2012, CANCER SCI, V103, P317, DOI 10.1111/j.1349-7006.2011.02133.x; Polyak K, 2009, NAT REV CANCER, P9265; Qi ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038842; Ryu JK, 2010, PANCREATOLOGY, V10, P66, DOI 10.1159/000231984; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Xia H, 2012, CANC GENE THER, DOI 10.1038; Xiang X, 2011, ONCOGENE, V30, P3440, DOI 10.1038/onc.2011.54; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019390	25	43	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52310	10.1371/journal.pone.0052310	http://dx.doi.org/10.1371/journal.pone.0052310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284982	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500142
J	Oni, T; Tsekela, R; Kwaza, B; Manjezi, L; Bangani, N; Wilkinson, KA; Coetzee, D; Wilkinson, RJ				Oni, Tolu; Tsekela, Relebohile; Kwaza, Bekekile; Manjezi, Lulama; Bangani, Nonzwakazi; Wilkinson, Katalin A.; Coetzee, David; Wilkinson, Robert J.			A Recent HIV Diagnosis Is Associated with Non-Completion of Isoniazid Preventive Therapy in an HIV-Infected Cohort in Cape Town	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; ADHERENCE; IMPLEMENTATION; BARRIERS; FAILURE; ADULTS	Introduction: Despite high rates of successful treatment TB incidence in South Africa remains high, suggesting ongoing transmission and a large reservoir of latently infected persons. Isoniazid preventive therapy (IPT) is recommended as preventive therapy in HIV-infected persons. However, implementation has been slow, impeded by barriers and challenges including the fear of non-adherence. Objective and Methods: The aim was to evaluate predictors of IPT non-completion. One hundred and sixty four antiretroviral therapy (ART)-naive HIV-infected patients with tuberculin skin test >= 5 mm were recruited from Khayelitsha day hospital and followed up monthly. A questionnaire was used to collect demographic information. Results: The overall completion rate was 69%. In multivariable analysis, there was a 29% decrease in risk of non-completion for every year after HIV diagnosis (OR 0.81; 95% C.I. 0.68-0.98). Self-reported alcohol drinkers (OR 4.05; 95% C.I. 1.89-9.06) also had a four-fold higher risk of non-completion, with a strong association between alcohol drinkers and smoking (chi(2) 27.08; p<0.001). Conclusion: We identify patients with a recent HIV diagnosis, in addition to self-reported drinkers and smokers as being at higher risk of non-completion of IPT. The period of time since HIV diagnosis should therefore be taken into account when initiating IPT. Our results also suggest that smokers and alcohol drinkers should be identified and targeted for adherence interventions when implementing IPT on a wider scale. Citation: Oni T, Tsekela R, Kwaza B, Manjezi L, Bangani N, et al. (2012) A Recent HIV Diagnosis Is Associated with Non-Completion of Isoniazid Preventive Therapy in an HIV-Infected Cohort in Cape Town. PLoS ONE 7(12): e52489. doi:10.1371/journal.pone.0052489	[Oni, Tolu; Tsekela, Relebohile; Kwaza, Bekekile; Bangani, Nonzwakazi; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Fac Hlth Sci, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Oni, Tolu; Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England; [Oni, Tolu; Coetzee, David] Univ Cape Town, Ctr Infect Dis & Epidemiol Res, Sch Publ Hlth, ZA-7925 Cape Town, South Africa; [Manjezi, Lulama] Khayelitsha Day Hosp, Cape Town, South Africa; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Cape Town; Imperial College London; University of Cape Town; MRC National Institute for Medical Research	Oni, T (corresponding author), Univ Cape Town, Fac Hlth Sci, Clin Infect Dis Res Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	tolullahoni@doctors.org.uk	Wilkinson, Katalin/AAQ-7713-2021; Wilkinson, Katalin/AAF-6805-2020	Wilkinson, Katalin/0000-0002-9796-2040; Wilkinson, Robert/0000-0002-2753-1800; Oni, Tolu/0000-0003-4499-1910	Wellcome Trust [084323, 088316]; MRC [U1175.02.002.00014.01]; ILULU Consortium; European Union [Sante/2006/105-061]; EDCTP [IP.07.32080.002]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ILULU Consortium; European Union(European Commission); EDCTP	RJW is funded by the Wellcome Trust (084323, 088316) and MRC (U1175.02.002.00014.01). This study was supported by the ILULU Consortium, which is funded by a grant from the European Union (Sante/2006/105-061) and EDCTP (IP.07.32080.002). The funders had no role in the design of the study or preparation of the manuscript.	Anibarro L, 2010, INT J TUBERC LUNG D, V14, P701; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Getahun H, 2010, AIDS, V24, pS57, DOI 10.1097/01.aids.0000391023.03037.1f; Gust DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018435; Hirsch-Moverman Y, 2008, INT J TUBERC LUNG D, V12, P1235; Hirsch-Moverman Y, 2010, INT J TUBERC LUNG D, V14, P1104; Kwara A, 2008, CHEST, V133, P862, DOI 10.1378/chest.07-2024; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lester R, 2010, AIDS, V24, pS45, DOI 10.1097/01.aids.0000391021.18284.12; Li JH, 2010, INT J INFECT DIS, V14, pE292, DOI 10.1016/j.ijid.2009.05.007; Machado A, 2009, INT J TUBERC LUNG D, V13, P719; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Medecins Sans Frontieres, 2012, SUMM KHAYEL ACT REP; Ngamvithayapong J, 1997, AIDS, V11, P107, DOI 10.1097/00002030-199701000-00016; Pennell WT, 2011, TECHNICAL CHALLENGES OF MULTIPOLLUTANT AIR QUALITY MANAGEMENT, P1, DOI 10.1007/978-94-007-0304-9_1; Rowe KA, 2005, INT J TUBERC LUNG D, V9, P263; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Thirumurthy H, 2012, B WORLD HEALTH ORGAN, V90, P390, DOI 10.2471/BLT.11.099317; Trajman A, 2010, INT J TUBERC LUNG D, V14, P551	20	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52489	10.1371/journal.pone.0052489	http://dx.doi.org/10.1371/journal.pone.0052489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285064	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500183
J	Stoyanova, E; Cloutier, G; Felfly, H; Lemsaddek, W; Ah-Son, N; Trudel, M				Stoyanova, Ekatherina; Cloutier, Guy; Felfly, Hady; Lemsaddek, Wafaa; Ah-Son, Nicolas; Trudel, Marie			Evidence for a Novel Mechanism Independent of Myocardial Iron in beta-Thalassemia Cardiac Pathogenesis	PLOS ONE			English	Article							SICKLE-CELL-DISEASE; ECHOCARDIOGRAPHIC-ASSESSMENT; MAGNETIC-RESONANCE; MAJOR PATIENTS; HEART-FAILURE; M-MODE; ANEMIA; OVERLOAD; DEFEROXAMINE; HYPERTROPHY	Human beta-thalassemia major is one of the most prevalent genetic diseases characterized by decrease/absence of beta-globin chain production with reduction of erythrocyte number. The main cause of death of treated beta-thalassemia major patients with chronic blood transfusion is early cardiac complications that have been attributed to secondary iron overload despite optimal chelation. Herein, we investigated pathophysiological mechanisms of cardiovascular dysfunction in a severe murine model of beta-thalassemia from 6 to 15-months of age in the absence of confounding effects related to transfusion. Our longitudinal echocardiography analysis showed that beta-thalassemic mice first display a significant increase of cardiac output in response to limited oxygen-carrying erythrocytes that progressed rapidly to left ventricular hypertrophy and structural remodeling. Following this compensated hypertrophy, beta-thalassemic mice developed age-dependent deterioration of left ventricular contractility and dysfunction that led toward decompensated heart failure. Consistently, murine beta-thalassemic hearts histopathology revealed cardiac remodeling with increased interstitial fibrosis but virtual absence of myocardial iron deposits. Importantly, development of thalassemic cardiac hypertrophy and dysfunction independently of iron overload has uncoupled these cardiopathogenic processes. Altogether our study on beta-thalassemia major hemoglobinopathy points to two successive phases resulting from severe chronic anemia and from secondarily induced mechanisms as pathophysiologic contributors to thalassemic cardiopathy.	[Stoyanova, Ekatherina; Felfly, Hady; Lemsaddek, Wafaa; Ah-Son, Nicolas; Trudel, Marie] Univ Montreal, Fac Med, Inst Rech Clin Montreal Mol Genet & Dev, Montreal, PQ H3C 3J7, Canada; [Cloutier, Guy] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Trudel, M (corresponding author), Univ Montreal, Fac Med, Inst Rech Clin Montreal Mol Genet & Dev, Montreal, PQ H3C 3J7, Canada.	trudelm@ircm.qc.ca		Trudel, Marie/0000-0003-0057-2669	Canadian Blood Services/Canadian Institute for Health Research (CBS/CIHR); National Institute of Health [R01HL078655]; Programme canadien des bourses de la francophonie (PCBF) studentship	Canadian Blood Services/Canadian Institute for Health Research (CBS/CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Programme canadien des bourses de la francophonie (PCBF) studentship	This study was supported by grants from the Canadian Blood Services/Canadian Institute for Health Research (CBS/CIHR) to MT, the National Institute of Health (R01HL078655 to MT and GC. HF is a recipient from the Programme canadien des bourses de la francophonie (PCBF) studentship and WL is a recipient from CBS/CIHR fellowship award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aessopos A, 2004, EUR J HAEMATOL, V73, P359, DOI 10.1111/j.1600-0609.2004.00304.x; Aessopos A, 2005, CHEST, V127, P1523, DOI 10.1378/chest.127.5.1523; Aessopos A, 2004, CLIN INVEST MED, V27, P265; Aessopos A, 2008, EUR J HAEMATOL, V80, P93, DOI 10.1111/j.1600-0609.2007.01018.x; Anand IS, 2008, HEART FAIL REV, V13, P379, DOI 10.1007/s10741-008-9088-8; Anderson LJ, 2001, EUR HEART J, V22, P2171, DOI 10.1053/euhj.2001.2822; BAHL VK, 1992, AM HEART J, V124, P1516, DOI 10.1016/0002-8703(92)90066-5; Beauchemin H, 2004, J BIOL CHEM, V279, P19471, DOI 10.1074/jbc.M309989200; BOWENS C, 1993, ANESTH ANALG, V76, P1027; Brili SV, 1997, CLIN CARDIOL, V20, P541, DOI 10.1002/clc.4960200607; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; Engle M A, 1985, Trans Am Clin Climatol Assoc, V96, P24; Felfly H, 2007, MOL THER, V15, P1701, DOI 10.1038/sj.mt.6300204; Felfly H, 2010, BRIT J HAEMATOL, V148, P646, DOI 10.1111/j.1365-2141.2009.07985.x; Hahalis G, 2005, AM J MED, V118, P957, DOI 10.1016/j.amjmed.2005.02.021; IIMOTO DS, 1988, CIRC RES, V63, P399, DOI 10.1161/01.RES.63.2.399; Jensen PD, 2004, BRIT J HAEMATOL, V124, P697, DOI 10.1111/j.1365-2141.2004.04838.x; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kawabata H, 2001, BLOOD, V98, P1949, DOI 10.1182/blood.V98.6.1949; LOMBARDO T, 1995, ANN HEMATOL, V71, P135, DOI 10.1007/s002770050097; Mavrogeni SI, 2005, EUR J HAEMATOL, V75, P241, DOI 10.1111/j.1600-0609.2005.00474.x; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; Morris Claudia R, 2008, Hematology Am Soc Hematol Educ Program, P177, DOI 10.1182/asheducation-2008.1.177; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; OLIVETTI G, 1992, AM J PATHOL, V141, P227; Origa R, 2008, HAEMATOL-HEMATOL J, V93, P1095, DOI 10.3324/haematol.12484; Papakonstantinou O, 2009, J MAGN RESON IMAGING, V29, P853, DOI 10.1002/jmri.21707; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pereira AA, 2003, KIDNEY INT, V64, pS32, DOI 10.1046/j.1523-1755.64.s87.6.x; Pollick C, 1995, J Am Soc Echocardiogr, V8, P602, DOI 10.1016/S0894-7317(05)80373-6; Qian ZM, 2007, BBA-MOL BASIS DIS, V1772, P527, DOI 10.1016/j.bbadis.2007.02.006; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; ROY SB, 1963, CIRCULATION, V28, P346, DOI 10.1161/01.CIR.28.3.346; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Schrier SL, 2005, ANNU REV MED, V56, P157, DOI 10.1146/annurev.med.56.082103.104718; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Stoyanova E, 2007, PHYSIOL GENOMICS, V29, P84, DOI 10.1152/physiolgenomics.00305.2005; Stoyanova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038089; Sun XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006596; Tanner MA, 2006, J CARDIOVASC MAGN R, V8, P543, DOI 10.1080/10976640600698155; Telfer PT, 2009, HAEMATOL-HEMATOL J, V94, P1777, DOI 10.3324/haematol.2009.009118; Wandt B, 1999, HEART, V82, P192, DOI 10.1136/hrt.82.2.192; Weatherhall DJ, 2001, THALASSEMIA SYNDROME; Wood JC, 2004, BLOOD, V103, P1934, DOI 10.1182/blood-2003-06-1919; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52128	10.1371/journal.pone.0052128	http://dx.doi.org/10.1371/journal.pone.0052128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284899	gold, Green Published, Green Submitted			2022-12-25	WOS:000312435900078
J	Wettstein, G; Bellaye, PS; Kolb, M; Hammann, A; Crestani, B; Soler, P; Marchal-Somme, J; Hazoume, A; Gauldie, J; Gunther, A; Micheau, O; Gleave, M; Camus, P; Garrido, C; Bonniaud, P				Wettstein, Guillaume; Bellaye, Pierre-Simon; Kolb, Martin; Hammann, Arlette; Crestani, Bruno; Soler, Paul; Marchal-Somme, Joelle; Hazoume, Adonis; Gauldie, Jack; Gunther, Andreas; Micheau, Olivier; Gleave, Martin; Camus, Philippe; Garrido, Carmen; Bonniaud, Philippe			Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation	FASEB JOURNAL			English	Article						epithelial-to-mesenchymal transition; mesothelial; pleura; transforming growth factor	HEAT-SHOCK-PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; IDIOPATHIC PULMONARY-FIBROSIS; ACTIN DYNAMICS; CELL-DEATH; BINDING; KINASE; STRESS; PHOSPHORYLATION	Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by myofibroblast proliferation. Transition of epithelial/mesothelial cells into myofibroblasts [epithelial-to-mesenchymal transition (EMT)] occurs under the influence of transforming growth factor (TGF)-beta 1, with Snail being a major transcription factor. We study here the role of the heat-shock protein HSP27 in fibrogenesis and EMT. In vitro, we have up-and down-modulated HSP27 expression in mesothelial and epithelial cell lines and studied the expression of different EMT markers induced by TGF-beta 1. In vivo, we inhibited HSP27 with the antisense oligonucleotide OGX-427 (in phase II clinical trials as anticancer agent) in our rat subpleural/pulmonary fibrosis models. We demonstrate that HSP27 is strongly expressed during the fibrotic process in patients with IPF and in different in vivo models. We showed that HSP27 binds to and stabilizes Snail and consequently induces EMT. Conversely, HSP27 knockdown leads to Snail proteasomal degradation, thus inhibiting TGF-beta 1-induced EMT. Inhibition of HSP27 with OGX-427 efficiently blocks EMT and fibrosis development. Controls in vivo were an empty adenovirus that did not induce fibrosis and a control antisense oligonucleotide. The present work opens the possibility of a new therapeutic use for HSP27 inhibitors against IPF, for which there is no conclusively effective treatment.-Wettstein, G., Bellaye, P.-S., Kolb, M., Hammann, A., Crestani, B., Soler, P., Marchal-Somme, J., Hazoume, A., Gauldie, J., Gunther, A., Micheau, O., Gleave, M., Camus, P., Garrido, C., Bonniaud, P. Inhibition of HSP27 blocks fibrosis development and EMT features by promoting Snail degradation. FASEB J. 27, 1549-1560 (2013). www.fasebj.org	[Wettstein, Guillaume; Bellaye, Pierre-Simon; Hammann, Arlette; Hazoume, Adonis; Micheau, Olivier; Camus, Philippe; Garrido, Carmen; Bonniaud, Philippe] INSERM, U866, Dijon, France; [Wettstein, Guillaume; Bellaye, Pierre-Simon; Hammann, Arlette; Hazoume, Adonis; Micheau, Olivier; Camus, Philippe; Garrido, Carmen; Bonniaud, Philippe] Univ Burgundy, Fac Med & Pharm, Dijon, France; [Kolb, Martin; Gauldie, Jack] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada; [Kolb, Martin; Gauldie, Jack] McMaster Univ, Firestone Inst Resp Hlth, Hamilton, ON, Canada; [Crestani, Bruno; Soler, Paul; Marchal-Somme, Joelle] INSERM, U700, Paris, France; [Crestani, Bruno; Soler, Paul; Marchal-Somme, Joelle] Univ Paris Diderot, Paris, France; [Crestani, Bruno; Soler, Paul; Marchal-Somme, Joelle] Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Pneumol A, Fac Med Bichat, F-75877 Paris, France; [Gunther, Andreas] Univ Giessen, Lung Ctr, D-35390 Giessen, Germany; [Gleave, Martin] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada; [Camus, Philippe; Bonniaud, Philippe] Ctr Hosp Univ, Serv Pneumol, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; McMaster University; McMaster University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Justus Liebig University Giessen; University of British Columbia; CHU Dijon Bourgogne	Bonniaud, P (corresponding author), CHU Bocage, 14 Rue Gaffarel, F-21079 Dijon, France.	philippe.bonniaud@chu-dijon.fr	Garrido, Carolina/GWM-5557-2022; Garrido, carmen/G-1633-2018; micheau, olivier/C-3574-2011	Garrido, carmen/0000-0003-1368-1493; micheau, olivier/0000-0001-8499-7984; Gleave, Martin/0000-0003-4235-0167; Bellaye, Pierre-Simon/0000-0002-8498-5163	European Community [HEALTH-F2-2007-202224 eurIPFnet]; Agence Nationale de la Recherche Blanc [11-BSV-011-01 meso-IPF]; La Ligue Regionale Grand Est Contre le Cancer; EU [HEALTH-F2-2007-202224 eurIPFnet]; La Recherche en Sante Respiratoire et la Societe de Pneumologie de Langue Francaise	European Community(European Commission); Agence Nationale de la Recherche Blanc(French National Research Agency (ANR)); La Ligue Regionale Grand Est Contre le Cancer; EU(European Commission); La Recherche en Sante Respiratoire et la Societe de Pneumologie de Langue Francaise	The research leading to these results has received funding from the European Community 7th Framework Programme (FP7/2007-2013) under grant agreement HEALTH-F2-2007-202224 eurIPFnet, Agence Nationale de la Recherche Blanc 11-BSV-011-01 meso-IPF and La Ligue Regionale Grand Est Contre le Cancer. G. W. is supported by the EU 7th Framework Programme (2007-2013 agreement HEALTH-F2-2007-202224 eurIPFnet.) and La Recherche en Sante Respiratoire et la Societe de Pneumologie de Langue Francaise. C. G. team has the label from La Ligue National Contre le Cancer.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andrieu C, 2010, ONCOGENE, V29, P1883, DOI 10.1038/onc.2009.479; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BETT AJ, 1994, P NATL ACAD SCI USA, V91, P8802, DOI 10.1073/pnas.91.19.8802; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Bruey JM, 2000, ONCOGENE, V19, P4855, DOI 10.1038/sj.onc.1203850; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Chilosi M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-95; de Thonel A, 2010, BLOOD, V116, P85, DOI 10.1182/blood-2009-09-241778; Decologne N, 2010, EUR RESPIR J, V35, P176, DOI 10.1183/09031936.00181808; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Garrido C, 2003, CELL DEATH DIFFER, V10, P619, DOI 10.1038/sj.cdd.4401229; Garrido C, 1998, CANCER RES, V58, P5495; Garrido C, 1997, CANCER RES, V57, P2661; Hadaschik BA, 2008, BJU INT, V102, P610, DOI 10.1111/j.1464-410X.2008.07669.x; Hadchity E, 2009, MOL THER, V17, P1387, DOI 10.1038/mt.2009.90; Jayachandran A, 2009, THORAX, V64, P1053, DOI 10.1136/thx.2009.121798; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Korfei M, 2011, J PROTEOME RES, V10, P2185, DOI 10.1021/pr1009355; Landry J, 1995, BIOCHEM CELL BIOL, V73, P703, DOI 10.1139/o95-078; Landry J, 1999, BIOCHEM SOC SYMP, P79; Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152; Matsui Y, 2009, MOL CANCER THER, V8, P2402, DOI 10.1158/1535-7163.MCT-09-0148; Mubarak KK, 2012, EUR RESPIR J, V39, P133, DOI 10.1183/09031936.00141010; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Parcellier A, 2005, ANTIOXID REDOX SIGN, V7, P404, DOI 10.1089/ars.2005.7.404; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parcellier A, 2006, FASEB J, V20, P1179, DOI 10.1096/fj.05-4184fje; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rocchi P, 2006, BJU INT, V98, P1082, DOI 10.1111/j.1464-410X.2006.06425.x; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Simioni MB, 2009, ONCOGENE, V28, P3332, DOI 10.1038/onc.2009.188; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Vargha R, 2008, NEPHROL DIAL TRANSPL, V23, P3494, DOI 10.1093/ndt/gfn353; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Wei L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3042; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	50	77	83	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2013	27	4					1549	1560		10.1096/fj.12-220053	http://dx.doi.org/10.1096/fj.12-220053			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23288928				2022-12-25	WOS:000316940800026
J	Aukrust, I; Bjorkhaug, L; Negahdar, M; Molnes, J; Johansson, BB; Muller, Y; Haas, W; Gygi, SP; Sovik, O; Flatmark, T; Kulkarni, RN; Njolstad, PR				Aukrust, Ingvild; Bjorkhaug, Lise; Negahdar, Maria; Molnes, Janne; Johansson, Bente B.; Muller, Yvonne; Haas, Wilhelm; Gygi, Steven P.; Sovik, Oddmund; Flatmark, Torgeir; Kulkarni, Rohit N.; Njolstad, Pal R.			SUMOylation of Pancreatic Glucokinase Regulates Its Cellular Stability and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME UBC9; PROTEIN; GLUCOSE; CELLS; SUMO; IDENTIFICATION; MUTATIONS; BINDING; YOUNG; GENE	Glucokinase is the predominant hexokinase expressed in hepatocytes and pancreatic beta-cells, with a pivotal role in regulating glucose-stimulated insulin secretion, illustrated by glucokinase gene mutations causing monogenic diabetes and congenital hyperinsulinemic hypoglycemia. A complex tissue-specific network of mechanisms regulates this enzyme, and a major unanswered question in glucokinase biology is how post-translational modifications control the function of the enzyme. Here, we show that the pancreatic isoform of human glucokinase is SUMOylated in vitro, using recombinant enzymes, and in insulin-secreting model cells. Three N-terminal lysines unique for the pancreatic isoform (Lys-12/Lys-13 and/or Lys-15) may represent one SUMOylation site, with an additional site (Lys-346) common for the pancreatic and the liver isoform. SUMO-1 and E2 overexpression stabilized preferentially the wild-type human pancreatic enzyme in MIN6 beta-cells, and SUMOylation increased the catalytic activity of recombinant human glucokinase in vitro and also of glucokinase in target cells. Small ubiquitin-like modifier conjugation represents a novel form of post-translational modification of the enzyme, and it may have an important regulatory function in pancreatic beta-cells.	[Aukrust, Ingvild; Bjorkhaug, Lise; Negahdar, Maria; Molnes, Janne; Johansson, Bente B.; Muller, Yvonne; Sovik, Oddmund; Njolstad, Pal R.] KG Jebsen Ctr Diabet Res, Dept Clin Med, N-5020 Bergen, Norway; [Aukrust, Ingvild; Bjorkhaug, Lise; Molnes, Janne; Muller, Yvonne; Flatmark, Torgeir] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Aukrust, Ingvild; Bjorkhaug, Lise; Negahdar, Maria; Johansson, Bente B.; Muller, Yvonne] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Aukrust, Ingvild; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Joslin Diabet Ctr, Boston, MA 02215 USA; [Molnes, Janne; Johansson, Bente B.; Njolstad, Pal R.] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Haas, Wilhelm; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Bergen; University of Bergen; Haukeland University Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Bergen; Haukeland University Hospital; Harvard University; Harvard Medical School	Bjorkhaug, L (corresponding author), Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway.	lise.gundersen@pedi.uib.no; pal.njolstad@uib.no	Aukrust, Ingvild/AAY-9434-2020; Johansson, Bente Berg/AAE-7666-2022; Aukrust, Ingvild/ABB-4526-2021; Bjørkhaug, Lise/AAA-4356-2021; Aukrust, Ingvild/ABG-2219-2021	Bjørkhaug, Lise/0000-0002-9695-4559; Johansson, Bente Berg/0000-0001-8893-1915	National Institutes of Health [RO1 DK067536]; Helse Vest, Innovest; Novo Nordisk Foundation; Bergen Medical Research Foundation; University of Bergen; Nils Norman Foundation; Norwegian Diabetes Association; Meltzer Foundation; KG Jebsen Foundation; European Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helse Vest, Innovest; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Bergen Medical Research Foundation; University of Bergen; Nils Norman Foundation; Norwegian Diabetes Association; Meltzer Foundation; KG Jebsen Foundation; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK067536 (to R.N.K.). This work was also supported by Helse Vest, Innovest, the Novo Nordisk Foundation, the Bergen Medical Research Foundation, the University of Bergen, the Nils Norman Foundation, the Norwegian Diabetes Association, the Meltzer Foundation, the KG Jebsen Foundation, and the European Research Council (to P.R.N.).	Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Baltrusch S, 2001, J BIOL CHEM, V276, P43915, DOI 10.1074/jbc.M105470200; Bjorkhaug L, 2007, J BIOL CHEM, V282, P22757, DOI 10.1074/jbc.M700517200; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Charbonnier S, 2006, PROTEIN EXPRES PURIF, V50, P89, DOI 10.1016/j.pep.2006.06.010; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Christesen HBT, 2002, DIABETES, V51, P1240, DOI 10.2337/diabetes.51.4.1240; Christesen HBT, 2008, EUR J ENDOCRINOL, V159, P27, DOI 10.1530/EJE-08-0203; Dai XQ, 2011, DIABETES, V60, P838, DOI 10.2337/db10-0440; Dai XQ, 2009, J CELL SCI, V122, P775, DOI 10.1242/jcs.036632; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; DeLano S.L., 2008, PYMOL MOL GRAPHICS S; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Fox JEM, 2012, CAN J PHYSIOL PHARM, V90, P765, DOI 10.1139/Y11-134; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Galan M, 2006, BIOCHEM J, V393, P389, DOI 10.1042/BJ20051137; Galisson F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004796; Garzon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028557; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; JETTON TL, 1994, J BIOL CHEM, V269, P3641; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; KORANYI LI, 1992, DIABETES, V41, P807, DOI 10.2337/diabetes.41.7.807; Kovalenko OV, 1996, P NATL ACAD SCI USA, V93, P2958, DOI 10.1073/pnas.93.7.2958; Larion M, 2010, BIOCHEMISTRY-US, V49, P7969, DOI 10.1021/bi101098f; Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; MEGLASSON MD, 1984, AM J PHYSIOL, V246, pE1, DOI 10.1152/ajpendo.1984.246.1.E1; Molnes J, 2008, FEBS J, V275, P2467, DOI 10.1111/j.1742-4658.2008.06391.x; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Murata T, 1997, FEBS LETT, V406, P109, DOI 10.1016/S0014-5793(97)00253-6; Mziaut H, 2006, NAT CELL BIOL, V8, P435, DOI 10.1038/ncb1395; Negahdar M, 2012, BBA-MOL BASIS DIS, V1822, P1705, DOI 10.1016/j.bbadis.2012.07.005; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Park J, 2007, P NATL ACAD SCI USA, V104, P17028, DOI 10.1073/pnas.0609852104; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Rallabhandi P, 2002, J BIOL CHEM, V277, P40020, DOI 10.1074/jbc.M200388200; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Saitoh H, 2002, J BIOL CHEM, V277, P4755, DOI 10.1074/jbc.M104453200; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Tolonen AC, 2011, MOL SYST BIOL, V7, DOI [10.1038/msb.2010.116, 10.1038/MSB.2010.116]; VANSCHAFTINGEN E, 1994, FASEB J, V8, P414, DOI 10.1096/fasebj.8.6.8168691; Watts FZ, 2004, SEMIN CELL DEV BIOL, V15, P211, DOI 10.1016/j.semcdb.2003.12.002; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Xu X, 2010, EMBO REP, V11, P299, DOI 10.1038/embor.2010.18	57	29	29	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5951	5962		10.1074/jbc.M112.393769	http://dx.doi.org/10.1074/jbc.M112.393769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297408	Green Published, hybrid			2022-12-25	WOS:000315342500063
J	Poole, DP; Amadesi, S; Veldhuis, NA; Abogadie, FC; Lieu, T; Darby, W; Liedtke, W; Lew, MJ; McIntyre, P; Bunnett, NW				Poole, Daniel P.; Amadesi, Silvia; Veldhuis, Nicholas A.; Abogadie, Fe C.; Lieu, TinaMarie; Darby, William; Liedtke, Wolfgang; Lew, Michael J.; McIntyre, Peter; Bunnett, Nigel W.			Protease-activated Receptor 2 (PAR(2)) Protein and Transient Receptor Potential Vanilloid 4 (TRPV4) Protein Coupling Is Required for Sustained Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; NEUROGENIC INFLAMMATION; NOCICEPTIVE NEURONS; PHOSPHOLIPASE A(2); SENSORY NEURONS; PAIN PATHWAY; ION-CHANNEL; KINASE-A; HYPERALGESIA	G protein-coupled receptors of nociceptive neurons can sensitize transient receptor potential (TRP) ion channels, which amplify neurogenic inflammation and pain. Protease-activated receptor 2 (PAR(2)), a receptor for inflammatory proteases, is a major mediator of neurogenic inflammation and pain. We investigated the signaling mechanisms by which PAR(2) regulates TRPV4 and determined the importance of tyrosine phosphorylation in this process. Human TRPV4 was expressed in HEK293 cells under control of a tetracycline-inducible promoter, allowing controlled and graded channel expression. In cells lacking TRPV4, the PAR(2) agonist stimulated a transient increase in [Ca2+](i). TRPV4 expression led to a markedly sustained increase in [Ca2+](i). Removal of extracellular Ca2+ and treatment with the TRPV4 antagonists Ruthenium Red or HC067047 prevented the sustained response. Inhibitors of phospholipase A(2) and cytochrome P450 epoxygenase attenuated the sustained response, suggesting that PAR(2) generates arachidonic acid-derived lipid mediators, such as 5',6'-EET, that activate TRPV4. Src inhibitor 1 suppressed PAR(2)-induced activation of TRPV4, indicating the importance of tyrosine phosphorylation. The TRPV4 tyrosine mutants Y110F, Y805F, and Y110F/Y805F were expressed normally at the cell surface. However, PAR(2) was unable to activate TRPV4 with the Y110F mutation. TRPV4 antagonism suppressed PAR(2) signaling to primary nociceptive neurons, and TRPV4 deletion attenuated PAR(2)-stimulated neurogenic inflammation. Thus, PAR(2) activation generates a signal that induces sustained activation of TRPV4, which requires a key tyrosine residue (TRPV4-Tyr-110). This mechanism partly mediates the proinflammatory actions of PAR(2).	[Poole, Daniel P.; Veldhuis, Nicholas A.; Lieu, TinaMarie; Bunnett, Nigel W.] Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Darby, William; Lew, Michael J.; McIntyre, Peter] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3010, Australia; [Amadesi, Silvia] Univ Reading, Sch Pharm, Reading RG6 6UR, Berks, England; [Abogadie, Fe C.; McIntyre, Peter] RMIT Univ, Sch Med Sci, Bundoora, Vic 3083, Australia; [Abogadie, Fe C.; McIntyre, Peter] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic 3083, Australia; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Div Neurol, Dept Med, Durham, NC 27710 USA	University of Melbourne; University of Melbourne; University of Reading; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT); Duke University	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu	Mcintyre, Peter/N-4109-2013; Poole, Daniel/AET-6645-2022; Liedtke, Wolfgang/GNH-1878-2022; Lieu, TinaMarie/AAM-7691-2020	Poole, Daniel/0000-0002-6168-8422; McIntyre, Peter/0000-0001-9506-5998; Lew, Michael/0000-0002-2523-7990; Veldhuis, Nicholas/0000-0002-8902-9365; Bunnett, Nigel W./0000-0003-3367-0644	National Institutes of Health [DK57840, DK43207]; National Health and Medical Research Council [1049682, 633033, 1024683, 1046860, 454858]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057840, R56DK043207, R01DK043207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57840 and DK43207 (to N. W. B.). This work was also supported by National Health and Medical Research Council Grants 1049682 and 633033 (to N. W. B.), 1024683 and 1046860 (to P. M. and N. W. B.), and 454858 (to D. P. P.).	Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Aley KO, 1999, J NEUROSCI, V19, P2181; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Andre E, 2008, J CLIN INVEST, V118, P2574, DOI 10.1172/JCI34886; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Birder L, 2007, J PHARMACOL EXP THER, V323, P227, DOI 10.1124/jpet.107.125435; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cattaruzza F, 2010, AM J PHYSIOL-GASTR L, V298, pG81, DOI 10.1152/ajpgi.00221.2009; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Cenac N, 2008, GASTROENTEROLOGY, V135, P937, DOI 10.1053/j.gastro.2008.05.024; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Ceppa EP, 2011, AM J PHYSIOL-GASTR L, V300, pG1033, DOI 10.1152/ajpgi.00305.2010; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Ducret T, 2008, CELL CALCIUM, V43, P315, DOI 10.1016/j.ceca.2007.05.018; Ferreira J, 2004, BRIT J PHARMACOL, V141, P787, DOI 10.1038/sj.bjp.0705546; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Hoogerwerf WA, 2001, J NEUROSCI, V21, P9036, DOI 10.1523/JNEUROSCI.21-22-09036.2001; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jacob C, 2005, J BIOL CHEM, V280, P31936, DOI 10.1074/jbc.M506338200; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; Kim YH, 2009, J NEUROSCI, V29, P10000, DOI 10.1523/JNEUROSCI.5030-08.2009; Kong WY, 1997, P NATL ACAD SCI USA, V94, P8884, DOI 10.1073/pnas.94.16.8884; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Materazzi S, 2008, P NATL ACAD SCI USA, V105, P12045, DOI 10.1073/pnas.0802354105; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; McLean PG, 2002, CIRC RES, V90, P465, DOI 10.1161/hh0402.105372; Moriyama T, 2003, J NEUROSCI, V23, P6058, DOI 10.1523/JNEUROSCI.23-14-06058.2003; Moriyama T, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-3; Nagataki M, 2008, CELL BIOCHEM FUNCT, V26, P279, DOI 10.1002/cbf.1434; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Sculptoreanu A, 2008, EUR J NEUROSCI, V27, P3171, DOI 10.1111/j.1460-9568.2008.06267.x; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sipe WEB, 2008, AM J PHYSIOL-GASTR L, V294, pG1288, DOI 10.1152/ajpgi.00002.2008; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Steinhoff M, 2000, NAT MED, V6, P151, DOI 10.1038/72247; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Vellani V, 2006, J NEUROSCI, V26, P5109, DOI 10.1523/JNEUROSCI.3870-05.2006; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443; Xu HS, 2003, J BIOL CHEM, V278, P11520, DOI 10.1074/jbc.M211061200; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang H, 2007, J NEUROSCI, V27, P12067, DOI 10.1523/JNEUROSCI.0496-07.2007	70	111	112	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5790	5802		10.1074/jbc.M112.438184	http://dx.doi.org/10.1074/jbc.M112.438184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23288842	Green Published, hybrid			2022-12-25	WOS:000315342500050
J	Thom, SR; Bhopale, VM; Milovanova, TN; Yang, M; Bogush, M; Buerk, DG				Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina; Buerk, Donald G.			Nitric-oxide Synthase-2 Linkage to Focal Adhesion Kinase in Neutrophils Influences Enzyme Activity and beta(2) Integrin Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERBARIC-OXYGEN THERAPY; ACTIN S-NITROSYLATION; MYOCARDIAL-INFARCTION; REPERFUSION; INHIBITION; MECHANISM; BETA(2)-INTEGRIN; SEQUESTRATION; THROMBOLYSIS; INJURY	This investigation was to elucidate the basis for augmentation of nitric-oxide synthesis in neutrophils exposed to hyperbaric oxygen. Hyperoxia increases synthesis of reactive species leading to S-nitrosylation of beta-actin, which causes temporary inhibition of beta(2) integrin adherence. Impaired beta(2) integrin function and actin S-nitrosylation do not occur in neutrophils from mice lacking type-2 nitric-oxide synthase (iNOS) or when incubated with 1400W, an iNOS inhibitor. Similarly, effects of hyperoxia were abrogated in cells depleted of focal adhesion kinase (FAK) by treatment with small inhibitory RNA and those exposed to a specific FAK inhibitor concurrent with hyperoxia. Nitric oxide production doubles within 10 min exposure to hyperoxia but declines to approximately half-maximum production over an additional 10 min. Elevated nitric oxide production did not occur after FAK depletion or inhibition, or when filamentous actin formation was inhibited by cytochalasin D. Intracellular content of iNOS triples over the course of a 45-min exposure to hyperoxia and iNOS dimers increase in a commensurate fashion. Confocal microscopy and immunoprecipitation demonstrated that co-localization/linkage of FAK, iNOS, and filamentous actin increased within 15 min exposure to hyperoxia but then decreased below the control level. Using isolated enzymes in ex vivo preparations an association between iNOS and filamentous actin mediated by FAK could be demonstrated and complex formation was impeded when actin was S-nitrosylated. We conclude that iNOS activity is increased by an FAK-mediated association with actin filaments but peak nitric oxide production is transient due to actin S-nitrosylation during exposure to hyperoxia.	[Thom, Stephen R.] Univ Penn, Dept Emergency Med, Med Ctr, Philadelphia, PA 19104 USA; [Thom, Stephen R.; Bhopale, Veena M.; Milovanova, Tatyana N.; Yang, Ming; Bogush, Marina] Univ Penn, Inst Environm Med, Med Ctr, Philadelphia, PA 19104 USA; [Buerk, Donald G.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Drexel University	Thom, SR (corresponding author), Univ Penn, Inst Environm Med, Med Ctr, 1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	sthom@mail.med.upenn.edu	Buerk, Donald G/F-6888-2014		Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research.	Alex J, 2005, J THORAC CARDIOV SUR, V130, P1623, DOI 10.1016/j.jtcvs.2005.08.018; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Brown EJ, 1996, ANN MED, V28, P201, DOI 10.3109/07853899609033121; Buerk DG, 1996, MICROVASC RES, V52, P13, DOI 10.1006/mvre.1996.0040; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; de Frutos T, 2001, J AM COLL CARDIOL, V37, P800, DOI 10.1016/S0735-1097(00)01185-2; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gatto EM, 2000, NITRIC OXIDE-BIOL CH, V4, P534, DOI 10.1006/niox.2000.0288; Greenberg SS, 1998, NITRIC OXIDE-BIOL CH, V2, P203, DOI 10.1006/niox.1998.0176; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Labrouche S, 1999, THROMB RES, V96, P309, DOI 10.1016/S0049-3848(99)00107-3; MADER JT, 1980, J INFECT DIS, V142, P915, DOI 10.1093/infdis/142.6.915; Martin JD, 2002, AVIAT SPACE ENVIR MD, V73, P565; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Sada K, 1997, EUR J BIOCHEM, V248, P827, DOI 10.1111/j.1432-1033.1997.00827.x; SCHALLER MD, 1995, J CELL BIOL, V130, P1181, DOI 10.1083/jcb.130.5.1181; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Sethi S, 2001, NITRIC OXIDE-BIOL CH, V5, P482, DOI 10.1006/niox.2001.0375; Shandling AH, 1997, AM HEART J, V134, P544, DOI 10.1016/S0002-8703(97)70093-0; Sharifi M, 2004, AM J CARDIOL, V93, P1533, DOI 10.1016/j.amjcard.2004.03.009; Sharifi Mohsen, 2002, Cardiovasc Radiat Med, V3, P124, DOI 10.1016/S1522-1865(03)00104-5; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Stavitsky Y, 1998, CARDIOLOGY, V90, P131, DOI 10.1159/000006832; Su YC, 2005, CELL BIOCHEM BIOPHYS, V43, P439, DOI 10.1385/CBB:43:3:439; Tabassam FH, 1999, CELL IMMUNOL, V193, P179, DOI 10.1006/cimm.1999.1472; Tahepold P, 2003, J THORAC CARDIOV SUR, V125, P650, DOI 10.1067/mtc.2003.36; Tahepold P, 2001, LIFE SCI, V68, P1629, DOI 10.1016/S0024-3205(01)00964-X; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 1997, AM J PHYSIOL-CELL PH, V272, pC770, DOI 10.1152/ajpcell.1997.272.3.C770; Thom SR, 2002, J NEUROBIOL, V51, P85, DOI 10.1002/neu.10044; THOM SR, 1986, J INFECT DIS, V154, P504, DOI 10.1093/infdis/154.3.504; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Totani L, 2006, BIOCHEM J, V396, P89, DOI 10.1042/BJ20051924; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Wong Howard P., 1996, Surgical Forum, V47, P705; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; Zheng DH, 2009, BIOCHEM BIOPH RES CO, V388, P301, DOI 10.1016/j.bbrc.2009.07.156	46	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4810	4818		10.1074/jbc.M112.426353	http://dx.doi.org/10.1074/jbc.M112.426353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23297409	hybrid, Green Published			2022-12-25	WOS:000315340400030
J	Bhattacharya, A; Chen, CY; Ho, S; Mitchell, JA				Bhattacharya, Anandi; Chen, Chih-Yu; Ho, Sara; Mitchell, Jennifer A.			Upstream Distal Regulatory Elements Contact the Lmo2 Promoter in Mouse Erythroid Cells	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GLOBIN LOCUS REQUIRES; LIM PROTEIN RBTN2; CHIP-SEQ; INTERGENIC TRANSCRIPTION; HYPERSENSITIVE SITES; GENE ACTIVATION; BETA; CHROMATIN; EXPRESSION	The Lim domain only 2 (Lmo2) gene encodes a transcriptional cofactor critical for the development of hematopoietic stem cells. Several distal regulatory elements have been identified upstream of the Lmo2 gene in the human and mouse genomes that are capable of enhancing reporter gene expression in erythroid cells and may be responsible for the high level transcription of Lmo2 in the erythroid lineage. In this study we investigate how these elements regulate transcription of Lmo2 and whether or not they function cooperatively in the endogenous context. Chromosome conformation capture (3C) experiments show that chromatin-chromatin interactions exist between upstream regulatory elements and the Lmo2 promoter in erythroid cells but that these interactions are absent from kidney where Lmo2 is transcribed at twelve fold lower levels. Specifically, long range chromatin-chromatin interactions occur between the Lmo2 proximal promoter and two broad regions, 3-31 and 66-105 kb upstream of Lmo2, which we term the proximal and distal control regions for Lmo2 (pCR and dCR respectively). Each of these regions is bound by several transcription factors suggesting that multiple regulatory elements cooperate in regulating high level transcription of Lmo2 in erythroid cells. Binding of CTCF and cohesin which support chromatin loops at other loci were also found within the dCR and at the Lmo2 proximal promoter. Intergenic transcription occurs throughout the dCR in erythroid cells but not in kidney suggesting a role for these intergenic transcripts in regulating Lmo2, similar to the broad domain of intergenic transcription observed at the human beta-globin locus control region. Our data supports a model in which the dCR functions through a chromatin looping mechanism to contact and enhance Lmo2 transcription specifically in erythroid cells. Furthermore, these chromatin loops are supported by the cohesin complex recruited to both CTCF and transcription factor bound regions.	[Bhattacharya, Anandi; Chen, Chih-Yu; Ho, Sara; Mitchell, Jennifer A.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Mitchell, JA (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	ja.mitchell@utoronto.ca	Chen, Chih-yu/AAX-3735-2020; cheng, yong/I-4270-2012	Chen, Chih-yu/0000-0003-4790-0025; Mitchell, Jennifer/0000-0002-7147-4604	Natural Sciences and Engineering Research Council of Canada; Department of Cell and Systems Biology; Department of Economics, University of Toronto; Ontario Graduate Scholarship; National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Cell and Systems Biology; Department of Economics, University of Toronto; Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant held by JAM). AB was funded by the Department of Cell and Systems Biology and the Department of Economics, University of Toronto. CYC was supported in part by an Ontario Graduate Scholarship. The ENCODE project is funded by the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Anderson KP, 1998, J BIOL CHEM, V273, P14347, DOI 10.1074/jbc.273.23.14347; Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-152; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Crable SC, 2003, BLOOD, V101, P4757, DOI 10.1182/blood-2002-09-2702; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Cuylen S, 2010, CELL STEM CELL, V7, P424, DOI 10.1016/j.stem.2010.09.006; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Faure AJ, 2012, GENOME RES; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; FISCH P, 1992, ONCOGENE, V7, P2389; FITZGERALD TJ, 1992, BLOOD, V80, P3189; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; FORRESTER WC, 1986, P NATL ACAD SCI USA, V83, P1359, DOI 10.1073/pnas.83.5.1359; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; GARCIA IS, 1991, ONCOGENE, V6, P577; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Grill B, 2004, J IMMUNOL, V172, P2389, DOI 10.4049/jimmunol.172.4.2389; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kooren J, 2007, J BIOL CHEM, V282, P16544, DOI 10.1074/jbc.M701159200; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LARSON RC, 1994, ONCOGENE, V9, P3675; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; MOON AM, 1990, P NATL ACAD SCI USA, V87, P7693, DOI 10.1073/pnas.87.19.7693; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Ono Y, 1998, MOL CELL BIOL, V18, P6939, DOI 10.1128/MCB.18.12.6939; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pilon AM, 2011, BLOOD; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; ROYERPOKORA B, 1995, ONCOGENE, V10, P1353; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Song SH, 2010, BLOOD, V116, P2356, DOI 10.1182/blood-2010-03-272252; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Tallack MR, 2010, GENOME RES, V20, P1052, DOI 10.1101/gr.106575.110; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002	78	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52880	10.1371/journal.pone.0052880	http://dx.doi.org/10.1371/journal.pone.0052880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285212	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800103
J	Bader, O; Schwarz, A; Kraneveld, EA; Tangwattanchuleeporn, M; Schmidt, P; Jacobsen, MD; Gross, U; De Groot, PWJ; Weig, M				Bader, Oliver; Schwarz, Alexander; Kraneveld, Eefje A.; Tangwattanchuleeporn, Marut; Schmidt, Pia; Jacobsen, Mette D.; Gross, Uwe; De Groot, Piet W. J.; Weig, Michael			Gross Karyotypic and Phenotypic Alterations among Different Progenies of the Candida glabrata CBS138/ATCC2001 Reference Strain	PLOS ONE			English	Article							WALL PROTEINS; ELECTROPHORETIC KARYOTYPES; CHROMOSOME INSTABILITY; GEL-ELECTROPHORESIS; BIOFILM FORMATION; GENE-EXPRESSION; CELL-WALL; ALBICANS; YEAST; EVOLUTION	Genomic plasticity is a mechanism for adaptation to environmental cues such as host responses and antifungal drug pressure in many fungi including the human pathogenic yeast Candida glabrata. In this study we evaluated the phenotypic and genotypic stability of the world-wide used C. glabrata reference strain CBS138/ ATCC2001 under laboratory conditions. A set of ten lineages of this wild type strain and genetically modified progenies were obtained from different scientific laboratories, and analyzed for genotypic and phenotypic alterations. Even though the derivates were indistinguishable by multi locus sequence typing, different phenotypic groups that correlated with specific karyotypic changes were observed. In addition, modifications in the adherence capacity to plastic surface emerged that were shown to correlate with quantitative changes in adhesin gene expression rather than subtelomeric gene loss or differences in the number of macrosatellite repeats within adhesin genes. These results confirm the genomic plasticity of C. glabrata and show that chromosomal aberrations and functional adaptations may occur not only during infection and under antimicrobial therapy, but also under laboratory conditions without extreme selective pressures. These alterations can significantly affect phenotypic properties such as cell surface attributes including adhesion and the cell wall carbohydrate composition and therefore, if unnoticed, may adulterate the outcome of genetic studies.	[Bader, Oliver; Schwarz, Alexander; Tangwattanchuleeporn, Marut; Schmidt, Pia; Gross, Uwe; Weig, Michael] Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany; [Bader, Oliver; Schwarz, Alexander; Tangwattanchuleeporn, Marut; Schmidt, Pia; Gross, Uwe; Weig, Michael] Univ Med Ctr Gottingen, German Natl Reference Ctr System Mycoses, Gottingen, Germany; [Kraneveld, Eefje A.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Kraneveld, Eefje A.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Jacobsen, Mette D.] Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland; [De Groot, Piet W. J.] Univ Castilla La Mancha, Reg Ctr Biomed Res, Albacete, Spain	University of Gottingen; University of Gottingen; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Aberdeen; Universidad de Castilla-La Mancha	Weig, M (corresponding author), Univ Med Ctr Gottingen, Inst Med Microbiol, Gottingen, Germany.	mweig@gwdg.de	De Groot, Piet/L-7737-2014; Bader, Oliver/C-7650-2015	De Groot, Piet/0000-0002-3112-6947; Bader, Oliver/0000-0002-1534-440X	German Research Foundation (DFG) [WE 3537/1-2]; DFG; Gottingen University, Germany; BBSRC [BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00513X/1] Funding Source: researchfish	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Gottingen University, Germany; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work and its publication was supported by the German Research Foundation (DFG) grants WE 3537/1-2 to MW and the Open Access funding program of the DFG and the publishing funds of the Gottingen University, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, YEAST, V25, P433, DOI 10.1002/yea.1597; Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; ASAKURA K, 1991, J GEN MICROBIOL, V137, P2531, DOI 10.1099/00221287-137-11-2531; Bader O, 2001, MOL MICROBIOL, V41, P1431, DOI 10.1046/j.1365-2958.2001.02614.x; Barchiesi F, 1999, EUR J CLIN MICROBIOL, V18, P184, DOI 10.1007/s100960050255; Bouchonville K, 2009, EUKARYOT CELL, V8, P1554, DOI 10.1128/EC.00209-09; Brisse S, 2009, EUKARYOT CELL, V8, P287, DOI 10.1128/EC.00215-08; Calcagno AM, 2003, MOL MICROBIOL, V50, P1309, DOI 10.1046/j.1365-2958.2003.03755.x; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; de Meeus T, 2002, J CLIN MICROBIOL, V40, P2199, DOI 10.1128/JCM.40.6.2199-2206.2002; Dodgson AR, 2003, J CLIN MICROBIOL, V41, P5709, DOI 10.1128/JCM.41.12.5709-5717.2003; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Gregori C, 2007, EUKARYOT CELL, V6, P1635, DOI 10.1128/EC.00106-07; HITCHCOCK CA, 1993, ANTIMICROB AGENTS CH, V37, P1962, DOI 10.1128/AAC.37.9.1962; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; Juarez-Reyes A, 2012, GENETICS, V190, P101, DOI 10.1534/genetics.111.135251; KAUFMANN CS, 1989, J CLIN MICROBIOL, V27, P2165, DOI 10.1128/JCM.27.10.2165-2168.1989; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Klempp-Selb B, 2000, MYCOSES, V43, P159, DOI 10.1046/j.1439-0507.2000.00555.x; Klis FM, 2010, YEAST, V27, P489, DOI 10.1002/yea.1747; Kraneveld EA, 2011, MYCOPATHOLOGIA, V172, P415, DOI 10.1007/s11046-011-9446-2; Lin CY, 2007, J CLIN MICROBIOL, V45, P2452, DOI 10.1128/JCM.00699-07; Lowman DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027614; Muller H, 2009, FUNGAL GENET BIOL, V46, P264, DOI 10.1016/j.fgb.2008.11.006; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Polakova S, 2009, P NATL ACAD SCI USA, V106, P2688, DOI 10.1073/pnas.0809793106; Rolland T, 2010, NUCLEIC ACIDS RES, V38, P4731, DOI 10.1093/nar/gkq207; Rustchenko E, 2007, FEMS YEAST RES, V7, P2, DOI 10.1111/j.1567-1364.2006.00150.x; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; Shin JH, 2007, J CLIN MICROBIOL, V45, P2385, DOI 10.1128/JCM.00381-07; Ueno K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024759; Verstrepen KJ, 2006, MOL MICROBIOL, V60, P5, DOI 10.1111/j.1365-2958.2006.05072.x; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Weig M, 2004, MICROBIOL-SGM, V150, P3129, DOI 10.1099/mic.0.27256-0; Weig M, 2001, MICROBIOL-SGM, V147, P2007, DOI 10.1099/00221287-147-8-2007; Zepelin MBV, 2007, J ANTIMICROB CHEMOTH, V60, P424, DOI 10.1093/jac/dkm145	42	26	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52218	10.1371/journal.pone.0052218	http://dx.doi.org/10.1371/journal.pone.0052218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284942	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500117
J	Nakayama, T; Ishida, K; Archibald, JM				Nakayama, Takuro; Ishida, Ken-ichiro; Archibald, John M.			Broad Distribution of TPI-GAPDH Fusion Proteins among Eukaryotes: Evidence for Glycolytic Reactions in the Mitochondrion?	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHOGLYCERATE KINASE; PHYLOGENY; EVOLUTION; GENOME; ORIGIN; APICOMPLEXAN; METABOLISM; ENZYMES; SUPPORT	Glycolysis is a central metabolic pathway in eukaryotic and prokaryotic cells. In eukaryotes, the textbook view is that glycolysis occurs in the cytosol. However, fusion proteins comprised of two glycolytic enzymes, triosephosphate isomerase (TPI) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), were found in members of the stramenopiles (diatoms and oomycetes) and shown to possess amino-terminal mitochondrial targeting signals. Here we show that mitochondrial TPI-GAPDH fusion protein genes are widely spread across the known diversity of stramenopiles, including non-photosynthetic species (Bicosoeca sp. and Blastocystis hominis). We also show that TPI-GAPDH fusion genes exist in three cercozoan taxa (Paulinella chromatophora, Thaumatomastix sp. and Mataza hastifera) and an apusozoan protist, Thecamonas trahens. Interestingly, subcellular localization predictions for other glycolytic enzymes in stramenopiles and a cercozoan show that a significant fraction of the glycolytic enzymes in these species have mitochondrial-targeted isoforms. These results suggest that part of the glycolytic pathway occurs inside mitochondria in these organisms, broadening our knowledge of the diversity of mitochondrial metabolism of protists.	[Nakayama, Takuro; Archibald, John M.] Dalhousie Univ, Canadian Inst Adv Res, Dept Biochem & Mol Biol, Program Integrated Microbial Biodivers, Halifax, NS, Canada; [Ishida, Ken-ichiro] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Canadian Institute for Advanced Research (CIFAR); Dalhousie University; University of Tsukuba	Archibald, JM (corresponding author), Dalhousie Univ, Canadian Inst Adv Res, Dept Biochem & Mol Biol, Program Integrated Microbial Biodivers, Halifax, NS, Canada.	jmarchib@dal.ca	NAKAYAMA, Takuro/AAT-9444-2020	NAKAYAMA, Takuro/0000-0001-5135-0156	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NSERC; CIHR	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	The work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. J.M.A. is supported by an NSERC Discovery Grant. J.M.A. is the holder of a CIHR New Investigator Award and is a Fellow of the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. T.N. is a JSPS Postdoctoral Fellow for Research Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2009, CURR BIOL, V19, pR81, DOI 10.1016/j.cub.2008.11.067; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Banuls AL, 2007, ADV PARASIT, V64, P1, DOI 10.1016/S0065-308X(06)64001-3; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Brandina I, 2006, BBA-BIOENERGETICS, V1757, P1217, DOI 10.1016/j.bbabio.2006.07.001; Branny P, 1998, MICROBIOL-SGM, V144, P905, DOI 10.1099/00221287-144-4-905; Burki F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000790; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Burki F, 2009, GENOME BIOL EVOL, V1, P231, DOI 10.1093/gbe/evp022; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Chevalier N, 2000, EUR J BIOCHEM, V267, P1464, DOI 10.1046/j.1432-1327.2000.01145.x; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Giege P, 2003, PLANT CELL, V15, P2140, DOI 10.1105/tpc.012500; Ginger ML, 2010, PHILOS T R SOC B, V365, P831, DOI 10.1098/rstb.2009.0259; Glucksman E, 2011, PROTIST, V162, P207, DOI 10.1016/j.protis.2010.06.004; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; GRANA X, 1995, COMP BIOCHEM PHYS B, V112, P287, DOI 10.1016/0305-0491(95)00076-3; Gray MW, 1998, NATURE, V396, P109, DOI 10.1038/24030; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; HART DT, 1984, MOL BIOCHEM PARASIT, V13, P159, DOI 10.1016/0166-6851(84)90110-5; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kamikawa R, 2011, EUR J PROTISTOL, V47, P24, DOI 10.1016/j.ejop.2010.08.002; Kamoun S, 2003, EUKARYOT CELL, V2, P191, DOI 10.1128/EC.2.2.191-199.2003; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Liaud MF, 2000, MOL BIOL EVOL, V17, P213, DOI 10.1093/oxfordjournals.molbev.a026301; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Michel G, 2010, NEW PHYTOL, V188, P67, DOI 10.1111/j.1469-8137.2010.03345.x; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; Nowack ECM, 2011, MOL BIOL EVOL, V28, P407, DOI 10.1093/molbev/msq209; Petsalaki Evangelia I., 2006, Genomics Proteomics & Bioinformatics, V4, P48, DOI 10.1016/S1672-0229(06)60016-8; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Riisberg I, 2009, PROTIST, V160, P191, DOI 10.1016/j.protis.2008.11.004; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Saito T, 2008, J BIOL CHEM, V283, P14041, DOI 10.1074/jbc.M709015200; SCHURIG H, 1995, EMBO J, V14, P442, DOI 10.1002/j.1460-2075.1995.tb07020.x; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smith DGS, 2007, J MOL BIOL, V374, P837, DOI 10.1016/j.jmb.2007.09.051; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Takishita K, 2005, J EUKARYOT MICROBIOL, V52, P343, DOI 10.1111/j.1550-7408.2005.00042x; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Tsaousis AD, 2010, ANAEROBIC PARASITIC PROTOZOA: GENOMICS AND MOLECULAR BIOLOGY, P205; VISSER N, 1981, EUR J BIOCHEM, V118, P521, DOI 10.1111/j.1432-1033.1981.tb05550.x; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Yabuki A, 2011, J EUKARYOT MICROBIOL, V58, P94, DOI 10.1111/j.1550-7408.2010.00524.x; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	66	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52340	10.1371/journal.pone.0052340	http://dx.doi.org/10.1371/journal.pone.0052340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284996	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500147
J	Savarese, M; Piluso, G; Orteschi, D; Di Fruscio, G; Dionisi, M; Blanco, FD; Torella, A; Giugliano, T; Iacomino, M; Zollino, M; Neri, G; Nigro, V				Savarese, Marco; Piluso, Giulio; Orteschi, Daniela; Di Fruscio, Giuseppina; Dionisi, Manuela; Blanco, Francesca del Vecchio; Torella, Annalaura; Giugliano, Teresa; Iacomino, Michele; Zollino, Marcella; Neri, Giovanni; Nigro, Vincenzo			Enhancer Chip: Detecting Human Copy Number Variations in Regulatory Elements	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ULTRACONSERVED ELEMENTS; MICROARRAY; TRANSLOCATION; DATABASE; DNA	Critical functional properties are embedded in the non-coding portion of the human genome. Recent successful studies have shown that variations in distant-acting gene enhancer sequences can contribute to disease. In fact, various disorders, such as thalassaemias, preaxial polydactyly or susceptibility to Hirschsprung's disease, may be the result of rearrangements of enhancer elements. We have analyzed the distribution of enhancer loci in the genome and compared their localization to that of previously described copy-number variations (CNVs). These data suggest a negative selection of copy number variable enhancers. To identify CNVs covering enhancer elements, we have developed a simple and cost-effective test. Here we describe the gene selection, design strategy and experimental validation of a customized oligonucleotide Array-Based Comparative Genomic Hybridization (aCGH), designated Enhancer Chip. It has been designed to investigate CNVs, allowing the analysis of all the genome with a 300 Kb resolution and specific disease regions (telomeres, centromeres and selected disease loci) at a tenfold higher resolution. Moreover, this is the first aCGH able to test over 1,250 enhancers, in order to investigate their potential pathogenic role. Validation experiments have demonstrated that Enhancer Chip efficiently detects duplications and deletions covering enhancer loci, demonstrating that it is a powerful instrument to detect and characterize copy number variable enhancers.	[Savarese, Marco; Piluso, Giulio; Di Fruscio, Giuseppina; Dionisi, Manuela; Blanco, Francesca del Vecchio; Torella, Annalaura; Giugliano, Teresa; Iacomino, Michele; Nigro, Vincenzo] Seconda Univ Napoli, Dipartimento Patol Gen, Naples, Italy; [Orteschi, Daniela; Zollino, Marcella; Neri, Giovanni] Univ Cattolica Sacro Cuore, Ist Genet Med, Policlin A Gemelli, Rome, Italy; [Savarese, Marco; Nigro, Vincenzo] Telethon Inst Genet & Med TIGEM, Naples, Italy	Universita della Campania Vanvitelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Nigro, V (corresponding author), Seconda Univ Napoli, Dipartimento Patol Gen, Naples, Italy.	vinnigro@gmail.com	PILUSO, Giulio/AAA-3400-2019; Iacomino, Michele/AAB-2366-2019; Nigro, Vincenzo/AAB-2274-2022; Savarese, Marco/J-8307-2016; Piluso, Giulio/AAA-3661-2019; Zollino, Marcella/AAC-3891-2022	PILUSO, Giulio/0000-0001-9418-125X; Iacomino, Michele/0000-0003-4788-9719; Savarese, Marco/0000-0002-2591-244X; Zollino, Marcella/0000-0003-4871-9519; Nigro, Vincenzo/0000-0002-3378-5006; Torella, Annalaura/0000-0003-2479-6018	Ministero della Salute [223143, RF-MUL-2007-666195]; Telethon-UILDM (Italy)	Ministero della Salute(Ministry of Health, Italy); Telethon-UILDM (Italy)(Fondazione Telethon)	This study was supported by grants from FP7/2007-2013 under grant agreement number 223143 (project acronym: TECHGENE), from Ministero della Salute (RF-MUL-2007-666195) and from Telethon-UILDM (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Crolla JA, 2002, AM J HUM GENET, V71, P1138, DOI 10.1086/344396; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Klopocki E, 2011, ANNU REV GENOM HUM G, V12, P53, DOI 10.1146/annurev-genom-082410-101404; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Marcinkowska M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-183; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Narlikar Leelavati, 2009, Briefings in Functional Genomics & Proteomics, V8, P215, DOI 10.1093/bfgp/elp014; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pfeifer D, 1999, AM J HUM GENET, V65, P111, DOI 10.1086/302455; Piluso G, 2011, CLIN CHEM, V57, P1584, DOI 10.1373/clinchem.2011.168898; Taylor James, 2007, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1005s19; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wong LJC, 2008, CLIN CHEM, V54, P1141, DOI 10.1373/clinchem.2008.103721; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yatsenko SA, 2009, J MOL DIAGN, V11, P226, DOI 10.2353/jmoldx.2009.080064	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52264	10.1371/journal.pone.0052264	http://dx.doi.org/10.1371/journal.pone.0052264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284961	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500129
J	Yue, GH; Xia, JH; Liu, P; Liu, F; Sun, F; Lin, G				Yue, Gen Hua; Xia, Jun Hong; Liu, Peng; Liu, Feng; Sun, Fei; Lin, Grace			Tracing Asian Seabass Individuals to Single Fish Farms Using Microsatellites	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; LATES-CALCARIFER; POPULATION ASSIGNMENT; GENETIC ASSIGNMENT; COMPUTER-PROGRAM; DNA MARKERS; TRACEABILITY; ESCAPEES; LOCI; IDENTIFICATION	Traceability through physical labels is well established, but it is not highly reliable as physical labels can be easily changed or lost. Application of DNA markers to the traceability of food plays an increasingly important role for consumer protection and confidence building. In this study, we tested the efficiency of 16 polymorphic microsatellites and their combinations for tracing 368 fish to four populations where they originated. Using the maximum likelihood and Bayesian methods, three most efficient microsatellites were required to assign over 95% of fish to the correct populations. Selection of markers based on the assignment score estimated with the software WHICHLOCI was most effective in choosing markers for individual assignment, followed by the selection based on the allele number of individual markers. By combining rapid DNA extraction, and high-throughput genotyping of selected microsatellites, it is possible to conduct routine genetic traceability with high accuracy in Asian seabass. Citation: Yue GH, Xia JH, Liu P, Liu F, Sun F, et al. (2012) Tracing Asian Seabass Individuals to Single Fish Farms Using Microsatellites. PLoS ONE 7(12): e52721. doi:10.1371/journal.pone.0052721	[Yue, Gen Hua; Xia, Jun Hong; Liu, Peng; Liu, Feng; Sun, Fei; Lin, Grace] Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Yue, GH (corresponding author), Natl Univ Singapore, Mol Populat Genet Grp, Temasek Life Sci Lab, 1 Res Link, Singapore 117548, Singapore.	genhua@tll.org.sg	Yue, GH/F-4801-2015	Yue, GH/0000-0002-3537-2248	National Research Foundation (NRF), Singapore	National Research Foundation (NRF), Singapore(National Research Foundation, Singapore)	This study is supported by the National Research Foundation (NRF), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MA, 2003, BIOINFORMATICS, V19, P1436, DOI 10.1093/bioinformatics/btg172; Banks MA, 2000, J HERED, V91, P87, DOI 10.1093/jhered/91.1.87; Cirillo A, 2009, EUR FOOD RES TECHNOL, V228, P875, DOI 10.1007/s00217-008-1000-1; Dalvit C, 2007, MEAT SCI, V77, P437, DOI 10.1016/j.meatsci.2007.05.027; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fan B, 2005, ASIAN AUSTRAL J ANIM, V18, P1529, DOI 10.5713/ajas.2005.1529; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Glover KA, 2008, ICES J MAR SCI, V65, P912, DOI 10.1093/icesjms/fsn056; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Glover KA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-2; Glover KA, 2009, AQUACULTURE, V290, P37, DOI 10.1016/j.aquaculture.2009.01.034; Glover KA, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-87; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guerard F, 2005, ADV BIOCHEM ENG BIOT, V96, P127, DOI 10.1007/b135783; Hansen MM, 2001, FISH FISH, V2, P93, DOI 10.1046/j.1467-2960.2001.00043.x; Hastein T, 2001, REV SCI TECH OIE, V20, P564, DOI 10.20506/rst.20.2.1300; Hayes B, 2005, AQUACULTURE, V250, P70, DOI 10.1016/j.aquaculture.2005.03.008; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lewis PO, 2000, GENETIC DATA ANAL; Liu Z, 2011, NEXT GENRATION SEQUE; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Loftus R, 2005, REV SCI TECH OIE, V24, P231, DOI 10.20506/rst.24.1.1563; Maldini M, 2006, AQUACULTURE, V261, P487, DOI 10.1016/j.aquaculture.2006.07.010; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Opara LU, 2003, J FOOD AGRIC ENVIRON, V1, P101; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Rodriguez-Ramirez R, 2011, ANAL CHIM ACTA, V685, P120, DOI 10.1016/j.aca.2010.11.021; Sargent J.R., 2001, FARMED FISH QUALITY, P3; SHEARER KD, 2001, FARMED FISH QUALITY, P31; Wang CM, 2011, MAR BIOTECHNOL, V13, P74, DOI 10.1007/s10126-010-9271-5; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; WEBER JL, 1989, AM J HUM GENET, V44, P388; Yue G, 2001, MAR BIOTECHNOL, V3, P1, DOI 10.1007/s101260000043; Yue GH, 2009, AQUACULTURE, V293, P22, DOI 10.1016/j.aquaculture.2009.03.053; Yue GH, 2005, ELECTROPHORESIS, V26, P3081, DOI 10.1002/elps.200410411; Yue GH, 2002, MAR BIOTECHNOL, V4, P503, DOI 10.1007/s10126-002-0037-6; Yue GH, 1999, ELECTROPHORESIS, V20, P3358, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3358::AID-ELPS3358>3.0.CO;2-B; Zhu ZY, 2006, GENOME, V49, P969, DOI 10.1139/G06-080; Zhu ZY, 2010, ANIM GENET, V41, P208, DOI 10.1111/j.1365-2052.2009.01973.x; Zhu ZY, 2006, AQUACULTURE, V256, P167, DOI 10.1016/j.aquaculture.2006.02.033	42	10	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52721	10.1371/journal.pone.0052721	http://dx.doi.org/10.1371/journal.pone.0052721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285169	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500241
J	Monteserin-Garcia, J; Al-Massadi, O; Seoane, LM; Alvarez, CV; Shan, B; Stalla, J; Paez-Pereda, M; Casanueva, FF; Stalla, GK; Theodoropoulou, M				Monteserin-Garcia, Jose; Al-Massadi, Omar; Seoane, Luisa M.; Alvarez, Clara V.; Shan, Bing; Stalla, Johanna; Paez-Pereda, Marcelo; Casanueva, Felipe F.; Stalla, Guenter K.; Theodoropoulou, Marily			Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis	FASEB JOURNAL			English	Article						resveratrol; GSK3 beta; phosphatase; acetylation	GLYCOGEN-SYNTHASE KINASE-3-BETA; LIFE-SPAN EXTENSION; FACTOR-I AXIS; CALORIE RESTRICTION; GENE-EXPRESSION; PROTEIN PHOSPHATASE-1; LIPID-METABOLISM; CELL-GROWTH; CYCLIC-AMP; RESVERATROL	Growth hormone (GH) is a major anabolic hormone and the primary regulator of organism growth. Its transcription is triggered by GH-releasing hormone (GHRH) through the transcription factor cAMP response element-binding protein (CREB) and by caloric intake. In contrast, the deacetylase Sirt1 is activated by caloric restriction. Therefore, the present study investigates how Sirt1 affects CREB function and GH synthesis. Sirt1 pharmacological activation with resveratrol (IC50 =87 mu M) suppressed GHRH-induced GH secretion from rat anterior pituitary cells in vivo and in vitro, while vehicle controls showed no effect. Resveratrol's effects were abolished after knocking down Sirt1 with RNA interference, but not in control scrambled siRNA-transfected rat somatotrophs, confirming the Sirt1 specificity. Sirt1 activation and overexpression suppressed forskolin-induced CREB-Ser(133) phosphorylation, but no effect was seen with vehicle and empty plasmid controls. The deacetylase-dead mutant Sirt1 retained CREB-Ser133 phosphorylation by keeping protein phosphatase protein phosphatase 1 activity low. Sirt1 activation suppressed glycogen synthase kinase 3 beta acetylation, and a mutation on the GSK3 beta-Lys(205) residue mimicking a hypoacetylated form revealed increased activity. In summary, this is a novel mechanism through which Sirt1 intercepts the cAMP pathway by suppressing CREB transcriptional activation, resulting in decreased GH synthesis.-Monteserin-Garcia, J., Al-Massadi, O., Seoane, L. M., Alvarez, C. V., Shan, B., Stalla, J., Paez-Pereda, M., Casanueva, F. F., Stalla, G. K., Theodoropoulou, M. Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis. FASEB J. 27, 1561-1571 (2013). www.fasebj.org	[Monteserin-Garcia, Jose; Shan, Bing; Stalla, Johanna; Paez-Pereda, Marcelo; Stalla, Guenter K.; Theodoropoulou, Marily] Max Planck Inst Psychiat, Dept Endocrinol, D-80804 Munich, Germany; [Al-Massadi, Omar; Seoane, Luisa M.] Univ Hosp Complex Santiago de Compostela, Serv Galego Saude SERGAS, Endocrine Physiopathol Grp, Santiago De Compostela, Spain; [Al-Massadi, Omar; Seoane, Luisa M.; Casanueva, Felipe F.] Univ Santiago de Compostela, Sch Med, Dept Med, Santiago De Compostela, Spain; [Alvarez, Clara V.] Univ Santiago de Compostela, Sch Med, Ctr Invest Med, Santiago De Compostela, Spain; [Alvarez, Clara V.] Univ Santiago de Compostela, Sch Med, Dept Physiol, Inst Invest Sanitarias CIMUS IDIS, Santiago De Compostela, Spain	Max Planck Society; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Theodoropoulou, M (corresponding author), Max Planck Inst Psychiat, Dept Endocrinol, Kraepelinstr 10, D-80804 Munich, Germany.	marily@mpipsykl.mpg.de	Alvarez, Clara V/AAN-4173-2020; Monteserin-Garcia, Jose Luis/AAC-7052-2020; Theodoropoulou, Marily/S-9546-2017; Al-Massadi, Omar/C-1526-2017; Álvarez, Carmen/B-2582-2015; seoane, luisa M/E-6570-2013	Monteserin-Garcia, Jose Luis/0000-0002-4508-6771; Theodoropoulou, Marily/0000-0002-7378-4374; Al-Massadi, Omar/0000-0003-0645-6159; Álvarez, Carmen/0000-0003-1874-1045; Shan, Bing/0000-0003-4178-3526; Paez-Pereda, Marcelo/0000-0001-6029-0706; Alvarez, Clara V/0000-0003-1500-4058	Pfizer Young Investigator research fellowship	Pfizer Young Investigator research fellowship	The authors are grateful to A. Gutierrez-Hartman (University of Colorado Health Sciences Center, Denver, CO, USA) for the pA3GHluc reporter plasmid and M. Bidlingmaier (Ludwig-Maximilians University, Munich, Germany) for the mouse monoclonal GH antibody. The study was supported in part by a Pfizer Young Investigator research fellowship to M. T. The funding source had no role in the conceptualization, interpretation, and writing of this study. The authors declare no conflicts of interest.	Aggen JB, 2000, CHEM BIOL, V7, pR13, DOI 10.1016/S1074-5521(00)00069-7; Akieda-Asai S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011755; Alao JP, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-40; ARZT E, 1993, ENDOCRINOLOGY, V132, P459, DOI 10.1210/en.132.1.459; Bakhtiarova A, 2006, BIOCHEM BIOPH RES CO, V351, P481, DOI 10.1016/j.bbrc.2006.10.057; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; DIEGUEZ C, 1995, TRENDS ENDOCRIN MET, V6, P55, DOI 10.1016/1043-2760(94)00206-J; Dunn SE, 1997, CANCER RES, V57, P4667; Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Garcia A, 2001, MOL ENDOCRINOL, V15, P1484, DOI 10.1210/me.15.9.1484; Gehm BD, 1997, P NATL ACAD SCI USA, V94, P14138, DOI 10.1073/pnas.94.25.14138; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Guevara-Aguirre J., 2011, SCI TRANSL MED, V3, pra13; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; HEMMINGS BA, 1982, FEBS LETT, V150, P319, DOI 10.1016/0014-5793(82)80760-6; Holzenberger M, 2004, EUR J ENDOCRINOL, V151, pS23, DOI 10.1530/eje.0.151S023; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Li MG, 2007, BIOCHEMISTRY-US, V46, P2380, DOI 10.1021/bi602369m; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; OSTER MH, 1995, J CLIN INVEST, V95, P2258, DOI 10.1172/JCI117916; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Schenk S, 2011, J CLIN INVEST, V121, P4281, DOI 10.1172/JCI58554; Seoane LM, 2004, EUR J ENDOCRINOL, V150, P731, DOI 10.1530/eje.0.1500731; SHEPARD AR, 1994, J BIOL CHEM, V269, P1804; Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje; STALLA GK, 1989, ENDOCRINOLOGY, V125, P699, DOI 10.1210/endo-125-2-699; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; TANSEY WP, 1993, J BIOL CHEM, V268, P14906; Theodoropoulou M, 2004, ENDOCR-RELAT CANCER, V11, P333, DOI 10.1677/erc.0.0110333; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Yu JJ, 2010, PHARMACOL RES, V62, P35, DOI 10.1016/j.phrs.2009.12.006; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019	71	53	55	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	APR	2013	27	4					1561	1571		10.1096/fj.12-220129	http://dx.doi.org/10.1096/fj.12-220129			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	117GF	23292070	Bronze			2022-12-25	WOS:000316940800027
J	Chen, PW; Jian, XY; Yoon, HY; Randazzo, PA				Chen, Pei-Wen; Jian, Xiaoying; Yoon, Hye-Young; Randazzo, Paul A.			ARAP2 Signals through Arf6 and Rac1 to Control Focal Adhesion Morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; ADP-RIBOSYLATION FACTOR; DOWNSTREAM ACTIVATION; CELL-MIGRATION; ACTIN DYNAMICS; LEADING-EDGE; RHO GTPASES; COMPLEX; MICROTUBULE; INTERACTS	Focal adhesions (FAs) are dynamic structures that connect the actin cytoskeleton with the extracellular matrix. At least six ADP-ribosylation factor (Arf) GTPase-activating proteins (GAPs), including ARAP2 (an Arf6 GAP), are implicated in regulation of FAs but the mechanisms for most are not well defined. Although Rac1 has been reported to function downstream of Arf6 to control membrane ruffling and cell migration, this pathway has not been directly examined as a regulator of FAs. Here we test the hypothesis that ARAP2 promotes the growth of FAs by converting Arf6.GTP to Arf6.GDP thereby preventing the activation of the Rho family GTP-binding protein Rac1. Reduced expression of ARAP2 decreased the number and size of FAs in cells and increased cellular Arf6.GTP and Rac1.GTP levels. Overexpression of ARAP2 had the opposite effects. The effects of ARAP2 on FAs and Rac1 were dependent on a functional ArfGAP domain. Constitutively active Arf6 affected FAs in the same way as did reduced ARAP2 expression and dominant negative mutants of Arf6 and Rac1 reversed the effect of reduced ARAP2 expression. However, neither dominant negative Arf6 nor Rac1 had the same effect as ARAP2 overexpression. We conclude that changes in Arf6 and Rac1 activities are necessary but not sufficient for ARAP2 to promote the growth of FAs and we speculate that ARAP2 has additional functions that are effector in nature to promote or stabilize FAs.	[Chen, Pei-Wen; Jian, Xiaoying; Yoon, Hye-Young; Randazzo, Paul A.] NCI, Lab Cellular & Mol Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Randazzo, PA (corresponding author), NCI, Lab Cellular & Mol Biol, Bldg 37 Room 2042, Bethesda, MD 20892 USA.	randazzp@mail.nih.gov	Chen, Pei-Wen/B-7142-2015		NCI, National Institutes of Health [BC 007365]; NATIONAL CANCER INSTITUTE [ZIABC007365] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the intramural program of the NCI, National Institutes of Health (Project BC 007365).	Benard V, 2002, METHOD ENZYMOL, V345, P349; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Campa F, 2009, J BIOL CHEM, V284, P28069, DOI 10.1074/jbc.M109.028266; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Chen P.W., 2010, CELL ADH MIGR, V4; Chen P. W., 2012, CURR PROTOCOLS CELL; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; Daher Z, 2008, CELL SIGNAL, V20, P2256, DOI 10.1016/j.cellsig.2008.08.021; Dunphy JL, 2006, CURR BIOL, V16, P315, DOI 10.1016/j.cub.2005.12.032; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Funakoshi Y, 2010, ADV ENZYME REGUL, V50, P72, DOI 10.1016/j.advenzreg.2009.11.001; Gambardella L, 2011, BLOOD, V118, P1087, DOI 10.1182/blood-2010-10-312959; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Geiger C, 2000, EMBO J, V19, P2525, DOI 10.1093/emboj/19.11.2525; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Ha VL, 2005, METHOD ENZYMOL, V404, P164, DOI 10.1016/S0076-6879(05)04016-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hasegawa J, 2012, MOL BIOL CELL, V23, P2481, DOI 10.1091/mbc.E12-01-0017; HAUN RS, 1993, J BIOL CHEM, V268, P7064; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Luo RB, 2007, BIOCHEM J, V402, P439, DOI 10.1042/BJ20061217; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Mazaki Y, 2001, MOL BIOL CELL, V12, P645, DOI 10.1091/mbc.12.3.645; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Quast T, 2009, BLOOD, V113, P5801, DOI 10.1182/blood-2008-08-176123; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1999, J CELL SCI, V112, P855; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; RANDAZZO PA, 1994, J BIOL CHEM, V269, P10758; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; RANDAZZO PA, 1995, J BIOL CHEM, V270, P14809, DOI 10.1074/jbc.270.24.14809; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Sakurai A, 2011, J BIOL CHEM, V286, P34335, DOI 10.1074/jbc.M111.259499; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Tong WY, 2010, MOL CELL PROTEOMICS, V9, P2089, DOI 10.1074/mcp.M110.001966; Torii T, 2010, J BIOL CHEM, V285, P24270, DOI 10.1074/jbc.M110.125658; Vitale N, 2000, J BIOL CHEM, V275, P13901, DOI 10.1074/jbc.275.18.13901; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2005, J CELL BIOL, V169, P929, DOI 10.1083/jcb.200412114; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Yoon HY, 2005, METHOD ENZYMOL, V404, P316, DOI 10.1016/S0076-6879(05)04028-0; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Yoon HY, 2011, BIOL CELL, V103, P171, DOI 10.1042/BC20100154; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhu YJ, 2009, J BIOL CHEM, V284, P13489, DOI 10.1074/jbc.M900469200	71	22	22	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5849	5860		10.1074/jbc.M112.415778	http://dx.doi.org/10.1074/jbc.M112.415778			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23295182	hybrid, Green Published			2022-12-25	WOS:000315342500055
J	Andrews, WJ; Panova, T; Normand, C; Gadal, O; Tikhonova, IG; Panov, KI				Andrews, William J.; Panova, Tatiana; Normand, Christophe; Gadal, Olivier; Tikhonova, Irina G.; Panov, Konstantin I.			Old Drug, New Target ELLIPTICINES SELECTIVELY INHIBIT RNA POLYMERASE I TRANSCRIPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; ANTICANCER AGENT ELLIPTICINE; UPSTREAM BINDING-FACTOR; CANCER-CELLS; RIBOSOMAL DNA; G-QUADRUPLEX; III TRANSCRIPTION; COMPLEX-FORMATION; DOWN-REGULATION; HUMAN BRAIN	Transcription by RNA polymerase I (Pol-I) is the main driving force behind ribosome biogenesis, a fundamental cellular process that requires the coordinated transcription of all three nuclear polymerases. Increased Pol-I transcription and the concurrent increase in ribosome biogenesis has been linked to the high rates of proliferation in cancers. The ellipticine family contains a number of potent anticancer therapeutic agents, some having progressed to stage I and II clinical trials; however, the mechanism by which many of the compounds work remains unclear. It has long been thought that inhibition of Top2 is the main reason behind the drugs antiproliferative effects. Here we report that a number of the ellipticines, including 9-hydroxyellipticine, are potent and specific inhibitors of Pol-I transcription, with IC50 in vitro and in cells in the nanomolar range. Essentially, the drugs did not affect Pol-II and Pol-III transcription, demonstrating a high selectivity. Wehave shown that Pol-I inhibition occurs by a p53-, ATM/ATR-, and Top2-independent mechanism. We discovered that the drug influences the assembly and stability of preinitiation complexes by targeting the interaction between promoter recognition factor SL1 and the rRNA promoter. Our findings will have an impact on the design and development of novel therapeutic agents specifically targeting ribosome biogenesis.	[Andrews, William J.; Panova, Tatiana; Panov, Konstantin I.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Panov, Konstantin I.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Normand, Christophe; Gadal, Olivier] CNRS, Lab Biol Mol Eucaryotes, F-31000 Toulouse, France; [Normand, Christophe; Gadal, Olivier] Univ Toulouse, F-31000 Toulouse, France	Queens University Belfast; Queens University Belfast; Queens University Belfast; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Panov, KI (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland.	k.panov@qub.ac.uk	Gadal, Olivier/A-4731-2008; Normand, Christophe/C-5281-2009; Normand, Christophe/C-2879-2013	Gadal, Olivier/0000-0001-9421-0831; Normand, Christophe/0000-0001-6104-1285; Panov, Konstantin/0000-0003-1375-7814	Medical Research Council New Investigator Award [89365]; DEL (The Department for Employment and Learning) postgraduate studentship; ATIP-plus (Actions Thematiques et Incitatives sur Programme) grant from CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recherche (Nucleopol); Agence Nationale de la Recherche (Ribeuc); Agence Nationale de la Recherche (Jeune Chercheur Program); Medical Research Council [G0801834] Funding Source: researchfish; MRC [G0801834] Funding Source: UKRI	Medical Research Council New Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DEL (The Department for Employment and Learning) postgraduate studentship; ATIP-plus (Actions Thematiques et Incitatives sur Programme) grant from CNRS (Centre National de la Recherche Scientifique); Agence Nationale de la Recherche (Nucleopol)(French National Research Agency (ANR)); Agence Nationale de la Recherche (Ribeuc)(French National Research Agency (ANR)); Agence Nationale de la Recherche (Jeune Chercheur Program)(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council New Investigator Award Grant 89365 (to K. P.).; Recipient a DEL (The Department for Employment and Learning) postgraduate studentship.; Supported by an ATIP-plus (Actions Thematiques et Incitatives sur Programme) grant from CNRS (Centre National de la Recherche Scientifique) and by Agence Nationale de la Recherche (Nucleopol, Ribeuc, and the Jeune Chercheur Program).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; BERTRAND JR, 1985, CHEMIOTERAPIA, V4, P445; Brown RV, 2011, J BIOL CHEM, V286, P41018, DOI 10.1074/jbc.M111.274720; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; BUHLER JM, 1974, J BIOL CHEM, V249, P5963; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Canals A, 2005, ACTA CRYSTALLOGR D, V61, P1009, DOI 10.1107/S0907444905015404; Carpenter AJ, 2004, MOL BIOL CELL, V15, P5700, DOI 10.1091/mbc.E04-08-0732; Daly NL, 2005, ONCOGENE, V24, P880, DOI 10.1038/sj.onc.1208031; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Elcock AH, 1996, BIOPOLYMERS, V39, P309, DOI 10.1002/(SICI)1097-0282(199609)39:3<309::AID-BIP4>3.3.CO;2-O; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P14998, DOI 10.1074/jbc.270.25.14998; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Godard T, 2002, MUTAT RES-GEN TOX EN, V520, P47, DOI 10.1016/S1383-5718(02)00174-2; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; KENNEY S, 1995, BIOCHEM PHARMACOL, V49, P23, DOI 10.1016/0006-2952(94)00471-W; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kim JY, 2011, TOXICOLOGY, V289, P91, DOI 10.1016/j.tox.2011.07.014; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; KULKENS T, 1991, NUCLEIC ACIDS RES, V19, P5363, DOI 10.1093/nar/19.19.5363; Kuo PL, 2005, ANTI-CANCER DRUG, V16, P789, DOI 10.1097/01.cad.0000171768.36317.93; Kuo PL, 2005, CANCER LETT, V223, P293, DOI 10.1016/j.canlet.2004.09.046; Kuo YC, 2006, LIFE SCI, V78, P2550, DOI 10.1016/j.lfs.2005.10.041; LEARNED RM, 1983, P NATL ACAD SCI-BIOL, V80, P3558, DOI 10.1073/pnas.80.12.3558; LEPECQ JB, 1973, CR ACAD SCI D NAT, V277, P2289; LESCA P, 1978, BIOCHEM PHARMACOL, V27, P1203, DOI 10.1016/0006-2952(78)90453-7; Mathe G, 1998, BIOMED PHARMACOTHER, V52, P391, DOI 10.1016/S0753-3322(99)80007-9; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; OHASHI M, 1995, JPN J CANCER RES, V86, P819, DOI 10.1111/j.1349-7006.1995.tb03091.x; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Panov KI, 2001, MOL CELL BIOL, V21, P2641, DOI 10.1128/MCB.21.8.2641-2649.2001; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Panov KI, 2006, MOL CELL BIOL, V26, P5436, DOI 10.1128/MCB.00230-06; Panova TB, 2006, MOL CELL BIOL, V26, P5957, DOI 10.1128/MCB.00673-06; RENAULT G, 1987, TOXICOL APPL PHARM, V89, P281, DOI 10.1016/0041-008X(87)90049-4; ROSS WE, 1978, BIOCHIM BIOPHYS ACTA, V519, P23, DOI 10.1016/0005-2787(78)90059-X; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Sato N, 1998, FEBS LETT, V441, P318, DOI 10.1016/S0014-5793(98)01571-3; Schneider DA, 2012, GENE, V493, P176, DOI 10.1016/j.gene.2011.08.006; Shahabuddin MS, 2011, INVEST NEW DRUG, V29, P523, DOI 10.1007/s10637-009-9379-5; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stiborova M, 2003, INT J CANCER, V107, P885, DOI 10.1002/ijc.11511; Stiborova M, 2001, BIOCHEM PHARMACOL, V62, P1675, DOI 10.1016/S0006-2952(01)00806-1; Stiborova Marie, 2006, Biomedical Papers (Olomouc), V150, P13; Stiborova Marie, 2011, Interdiscip Toxicol, V4, P98, DOI 10.2478/v10102-011-0017-7; Sugikawa E, 1999, ANTICANCER RES, V19, P3099; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; VISTICA DT, 1994, BIOCHEM BIOPH RES CO, V200, P1762, DOI 10.1006/bbrc.1994.1657; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023	62	53	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					4567	4582		10.1074/jbc.M112.411611	http://dx.doi.org/10.1074/jbc.M112.411611			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23293027	Green Published, hybrid			2022-12-25	WOS:000315340400007
J	Krishnan, S; Zhou, XS; Paredes, JA; Kuiper, RV; Curbo, S; Karlsson, A				Krishnan, Shuba; Zhou, Xiaoshan; Paredes, Joao A.; Kuiper, Raoul V.; Curbo, Sophie; Karlsson, Anna			Transgene Expression of Drosophila melanogaster Nucleoside Kinase Reverses Mitochondrial Thymidine Kinase 2 Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTISUBSTRATE DEOXYRIBONUCLEOSIDE KINASE; DEOXYNUCLEOSIDE SALVAGE ENZYMES; CANCER CELL-LINES; DNA; POOLS; DEOXYURIDINE; MECHANISM; SUBSTRATE; P53R2; GENE	A strategy to reverse the symptoms of thymidine kinase 2 (TK2) deficiency in a mouse model was investigated. The nucleoside kinase from Drosophila melanogaster (Dm-dNK) was expressed in TK2-deficient mice that have been shown to present with a severe phenotype caused by mitochondrial DNA depletion. The Dm-dNK(+/-) transgenic mice were shown to be able to rescue the TK2-deficient mice. TheDm-dNK(+/-)TK2(-/-) mice were normal as judged by growth and behavior during the observation time of 6 months. The Dm-dNK-expressing mice showed a substantial increase in thymidine-phosphorylating activity in investigated tissues. The Dm-dNK expression also resulted in highly elevated dTTP pools. The dTTP pool alterations did not cause specific mitochondrial DNA mutations or deletions when 6-month-old mice were analyzed. The mitochondrial DNA was also detected at normal levels. In conclusion, the Dm-dNK(+/-)TK2(-/-) mouse model illustrates how dTMP synthesized in the cell nucleus can compensate for loss of intramitochondrial dTMP synthesis in differentiated tissue. The data presented open new possibilities to treat the severe symptoms of TK2 deficiency.	[Krishnan, Shuba; Zhou, Xiaoshan; Paredes, Joao A.; Curbo, Sophie; Karlsson, Anna] Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol, SE-14186 Huddinge, Sweden; [Kuiper, Raoul V.] Karolinska Univ Hosp, Dept Lab Med, Div Pathol, Karolinska Inst, SE-14186 Huddinge, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Karlsson, A (corresponding author), Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol, F68, SE-14186 Huddinge, Sweden.	anna.karlsson@ki.se	curbo, sophie/AAA-8614-2020; Karlsson, Anna/E-7945-2018	curbo, sophie/0000-0002-0964-0712; Kuiper, Raoul/0000-0001-5645-2389; Karlsson, Anna/0000-0001-6843-6685; Paredes, Joao/0000-0002-7788-8939	Swedish Cancer Society [CAN 2011/1277]; Swedish Research Council [2010-2828]; Karolinska Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institute(Karolinska Institutet)	This work was supported by the Swedish Cancer Society (Grant CAN 2011/1277), Swedish Research Council (Grant 2010-2828), and Karolinska Institute.	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Babinet C, 2000, J AM SOC NEPHROL, V11, pS88; Bertoli A, 2005, FEBS J, V272, P3918, DOI 10.1111/j.1742-4658.2005.04808.x; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Bridges EG, 1999, J BIOL CHEM, V274, P4620, DOI 10.1074/jbc.274.8.4620; ERIKSSON S, 1994, ADV ENZYME REGUL, V34, P13, DOI 10.1016/0065-2571(94)90006-X; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Gisch N, 2008, J MED CHEM, V51, P6752, DOI 10.1021/jm800853p; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Johansson M, 1999, J BIOL CHEM, V274, P23814, DOI 10.1074/jbc.274.34.23814; Kumar D, 2010, NUCLEIC ACIDS RES, V38, P3975, DOI 10.1093/nar/gkq128; Lopez LC, 2009, HUM MOL GENET, V18, P714, DOI 10.1093/hmg/ddn401; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Mehellou Y, 2009, CHEMMEDCHEM, V4, P1779, DOI 10.1002/cmdc.200900289; Meier C, 2008, Nucleic Acids Symp Ser (Oxf), P83, DOI 10.1093/nass/nrn042; Munch-Petersen B, 2000, J BIOL CHEM, V275, P6673, DOI 10.1074/jbc.275.9.6673; Munch-Petersen B, 1998, J BIOL CHEM, V273, P3926, DOI 10.1074/jbc.273.7.3926; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Rampazzo C, 2007, J BIOL CHEM, V282, P34758, DOI 10.1074/jbc.M705923200; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Solaroli N, 2007, GENE THER, V14, P86, DOI 10.1038/sj.gt.3302835; Solaroli N, 2007, MOL PHARMACOL, V72, P1593, DOI 10.1124/mol.107.037051; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Valentino ML, 2007, FEBS LETT, V581, P3410, DOI 10.1016/j.febslet.2007.06.042; Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P370, DOI 10.1080/15257771003729732; Wang L, 2010, NUCLEOS NUCLEOT NUCL, V29, P400, DOI 10.1080/15257771003741042; Wang LY, 2008, NUCLEOS NUCLEOT NUCL, V27, P858, DOI 10.1080/15257770802146510; Zegerman P, 2009, DNA REPAIR, V8, P1077, DOI 10.1016/j.dnarep.2009.04.023; Zheng XY, 2001, MOL PHARMACOL, V60, P262, DOI 10.1124/mol.60.2.262; Zheng XY, 2000, J BIOL CHEM, V275, P39125, DOI 10.1074/jbc.M006212200; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133; Zhou XS, 2010, J INHERIT METAB DIS, V33, P231, DOI 10.1007/s10545-010-9102-x	37	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2013	288	7					5072	5079		10.1074/jbc.M112.437152	http://dx.doi.org/10.1074/jbc.M112.437152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095ND	23288848	Green Published, hybrid			2022-12-25	WOS:000315340400055
J	Barbati, E; Specchia, C; Villella, M; Rossi, ML; Barlera, S; Bottazzi, B; Crociati, L; d'Arienzo, C; Fanelli, R; Garlanda, C; Gori, F; Mango, R; Mantovani, A; Merla, G; Nicolis, EB; Pietri, S; Presbitero, P; Sudo, Y; Villella, A; Franzosi, MG				Barbati, Elisa; Specchia, Claudia; Villella, Massimo; Rossi, Marco Luciano; Barlera, Simona; Bottazzi, Barbara; Crociati, Luisa; d'Arienzo, Carmela; Fanelli, Raffaele; Garlanda, Cecilia; Gori, Francesca; Mango, Ruggiero; Mantovani, Alberto; Merla, Giuseppe; Nicolis, Enrico B.; Pietri, Silvia; Presbitero, Patrizia; Sudo, Yukio; Villella, Alessandro; Franzosi, Maria Grazia			Influence of Pentraxin 3 (PTX3) Genetic Variants on Myocardial Infarction Risk and PTX3 Plasma Levels	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; TOLL-LIKE RECEPTOR-4; LONG PENTRAXIN; VASCULAR INFLAMMATION; INNATE IMMUNITY; UNSTABLE ANGINA; ATHEROSCLEROSIS; ASSOCIATION; MARKER	PTX3 is a long pentraxin of the innate immune system produced by different cell types (mononuclear phagocytes, dendritic cells, fibroblasts and endothelial cells) at the inflammatory site. It appears to have a cardiovascular protective function by acting on the immune-inflammatory balance in the cardiovascular system. PTX3 plasma concentration is an independent predictor of mortality in patients with acute myocardial infarction (AMI) but the influence of PTX3 genetic variants on PTX3 plasma concentration has been investigated very little and there is no information on the association between PTX3 variations and AMI. Subjects of European origin (3245, 1751 AMI survivors and 1494 controls) were genotyped for three common PTX3 polymorphisms (SNPs) (rs2305619, rs3816527, rs1840680). Genotype and allele frequencies of the three SNPs and the haplotype frequencies were compared for the two groups. None of the genotypes, alleles or haplotypes were significantly associated with the risk of AMI. However, analysis adjusted for age and sex indicated that the three PTX3 SNPs and the corresponding haplotypes were significantly associated with different PTX3 plasma levels. There was also a significant association between PTX3 plasma concentrations and the risk of all-cause mortality at three years in AMI patients (OR 1.10, 95% CI: 1.01-1.20, p = 0.02). Our study showed that PTX3 plasma levels are influenced by three PTX3 polymorphisms. Genetically determined high PTX3 levels do not influence the risk of AMI, suggesting that the PTX3 concentration itself is unlikely to be even a modest causal factor for AMI. Analysis also confirmed that PTX3 is a prognostic marker after AMI.	[Specchia, Claudia; Barlera, Simona; Crociati, Luisa; Gori, Francesca; Nicolis, Enrico B.; Pietri, Silvia; Franzosi, Maria Grazia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Barbati, Elisa; Bottazzi, Barbara; Garlanda, Cecilia; Mantovani, Alberto] Humanitas Clin & Res Ctr, Dept Inflammat & Immunol, Milan, Italy; [Barbati, Elisa; Mantovani, Alberto] Univ Milan, Dept Translat Med, Milan, Italy; [Specchia, Claudia] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Villella, Massimo; d'Arienzo, Carmela; Fanelli, Raffaele] IRCCS Casa Sollievo Sofferenza, Dept Cardiol, San Giovanni Rotondo, Italy; [Rossi, Marco Luciano; Mango, Ruggiero; Presbitero, Patrizia] Humanitas Clin & Res Ctr, Dept Intervent Cardiol, Milan, Italy; [Merla, Giuseppe] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Sudo, Yukio] Perseus Prote Inc, Tokyo, Japan; [Villella, Alessandro] F Lastaria Hosp, Dept Cardiol, Lucera, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Brescia; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Franzosi, MG (corresponding author), Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy.	mariagrazia.franzosi@marionegri.it	bottazzi, barbara/ABH-9274-2020; Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022; Nicolis, Enrico Bjørn/ABG-8467-2020; merla, giuseppe/K-4627-2012	bottazzi, barbara/0000-0002-1930-9257; Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X; Nicolis, Enrico Bjørn/0000-0001-9246-2533; merla, giuseppe/0000-0001-5078-928X	Italian Minister of Health (Ricerca Finalizzata IRCCS) [RF-OGR-2007-661844]; Ricerca Indipendente; Cariplo Foundation [2009/2582]; European Research Council (ERC-HIIS); Tolerage (TOLERAGE Health research grant) [HEALTH-F4-2008-202156]	Italian Minister of Health (Ricerca Finalizzata IRCCS); Ricerca Indipendente; Cariplo Foundation(Fondazione Cariplo); European Research Council (ERC-HIIS); Tolerage (TOLERAGE Health research grant)	This work has been supported by the Italian Minister of Health (Ricerca Finalizzata IRCCS no RF-OGR-2007-661844, to CS, MV, SB, LC, CdA, RF, FG, RM, GM, EN, SP, PP, AV, MGF); Ricerca Indipendente 2009 (to EB, MLR, CG, SB, LC, EN, SP, PP, MGF), Cariplo Foundation (2009/2582, to BB, AM), European Research Council (ERC-HIIS, to AM, CG) and Tolerage (TOLERAGE Health research grant; HEALTH-F4-2008-202156, to AM, BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Espliguero R, 2004, HEART, V90, P983, DOI 10.1136/hrt.2002.001297; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chiarini M, 2010, GENES IMMUN, V11, P665, DOI 10.1038/gene.2010.41; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Diamond JM, 2012, AM J RESP CRIT CARE, V186, P546, DOI 10.1164/rccm.201204-0692OC; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inoue K, 2007, ARTERIOSCL THROM VAS, V27, P161, DOI 10.1161/01.ATV.0000252126.48375.d5; Jenny NS, 2009, ARTERIOSCL THROM VAS, V29, P594, DOI 10.1161/ATVBAHA.108.178947; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kotooka N, 2008, ATHEROSCLEROSIS, V197, P368, DOI 10.1016/j.atherosclerosis.2007.05.031; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Matsui S, 2010, ATHEROSCLEROSIS, V210, P220, DOI 10.1016/j.atherosclerosis.2009.10.033; May L, 2010, BIOL REPROD, V82, P299, DOI 10.1095/biolreprod.109.079111; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Pasterkamp G, 2004, EUR J CLIN INVEST, V34, P328, DOI 10.1111/j.1365-2362.2004.01338.x; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Suzuki S, 2008, AM HEART J, V155, P75, DOI 10.1016/j.ahj.2007.08.013; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	39	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53030	10.1371/journal.pone.0053030	http://dx.doi.org/10.1371/journal.pone.0053030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285251	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500102
J	Kao, HK; Chen, WF; Chen, CH; Shyu, VBH; Cheng, MH; Chang, KP				Kao, Huang-Kai; Chen, Wei F.; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Cheng, Ming-Huei; Chang, Kai-Ping			The Roles of Albumin Levels in Head and Neck Cancer Patients with Liver Cirrhosis Undergoing Tumor Ablation and Microsurgical Free Tissue Transfer	PLOS ONE			English	Article							POSTOPERATIVE MORBIDITY; MALNUTRITION; MORTALITY; HYPOALBUMINEMIA; PREDICTOR; ADMISSION; LENGTH	Objective: To evaluate the changes of serum albumin levels during the peri-operative period, and correlate these changes to surgical outcomes, postoperative morbidity and mortality in head and neck cancer patients with cirrhosis. Methods: 57 patients with liver cirrhosis out of 3,022 patients who underwent immediate free flap reconstruction after surgical ablation of head and neck cancer performed over a 9-year period were included in the study. Two sets of groups were arranged based on the preoperative albumin (>3.5 g/dL vs. <= 3.5 g/dL) and POD1 albumin (>2.7 g/dL vs. <= 2.7 g/dL) levels and were compared with respect to patient-related variables, surgical outcomes, medical and surgical complications, and mortalities. Results: All patients had significant decreases in albumin levels postoperatively. Hypoalbuminemia, both preoperative and postoperative, was associated with the model for end-stage liver disease (MELD) score, the amount of blood loss, the duration of ICU stay and hospital stay, and postoperative medical and surgical complications. In particular, preoperative hypoalbuminemia (serum albumin <= 3.5 g/dL) was associated strongly with medical complications and mortality, while postoperative hypoalbuminemia (serum albumin <= 2.7 g/dL) with surgical complications. Conclusion: Our study demonstrated the prognostic values of albumin levels in head and neck cancer patient with liver cirrhosis. The perioperative albumin levels can be utilized for risk stratification to potentially improve surgical and postoperative management of these challenging patients.	[Chang, Kai-Ping] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan; [Kao, Huang-Kai; Chen, Chih-Hao; Shyu, Victor Bong-Hang; Cheng, Ming-Huei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Tao Yuan, Taiwan; [Chen, Wei F.] Univ Iowa Hosp & Clin, Dept Surg, Div Plast & Reconstruct Surg, Iowa City, IA 52242 USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; University of Iowa	Chang, KP (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Tao Yuan, Taiwan.	dr.kpchang@gmail.com	Cheng, Ming-Huei/AAD-8579-2019	Chen, Wei/0000-0002-4163-6641				Aguilar OG, 2001, INT SURG, V86, P42; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; ALBERTS WM, 1991, ARCH INTERN MED, V151, P2383, DOI 10.1001/archinte.151.12.2383; Fuhrman P, 2004, J AM DIET ASSOC, V104, P1258, DOI 10.1016/j.jada.2004.05.213; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Gibbs J, 1999, ARCH SURG-CHICAGO, V134, P36, DOI 10.1001/archsurg.134.1.36; HERRMANN FR, 1992, ARCH INTERN MED, V152, P125, DOI 10.1001/archinte.152.1.125; Hussain M, 1991, CANCER, V67, P717; IRVIN TT, 1974, ANN SURG, V180, P765, DOI 10.1097/00000658-197411000-00010; Kao HK, 2011, HEAD NECK-J SCI SPEC, V33, P529, DOI 10.1002/hed.21486; Kao HK, 2010, ANN SURG ONCOL, V17, P536, DOI 10.1245/s10434-009-0805-x; Kao HK, 2009, ORAL ONCOL, V45, P1058, DOI 10.1016/j.oraloncology.2009.07.010; Kuzu MA, 2006, WORLD J SURG, V30, P378, DOI 10.1007/s00268-005-0163-1; Marinella MA, 1998, SOUTHERN MED J, V91, P851, DOI 10.1097/00007611-199809000-00009; MATTHEWS TW, 1995, J OTOLARYNGOL, V24, P87; Rivadeneira DE, 2001, SURGERY, V129, P617, DOI 10.1067/msy.2001.112963; Schwartz SR, 2004, OTOLARYNG HEAD NECK, V131, P61, DOI 10.1016/j.otohns.2003.08.028; Sullivan DH, 2005, J AM GERIATR SOC, V53, P1222, DOI 10.1111/j.1532-5415.2005.53369.x; WARD MWN, 1982, BRIT J SURG, V69, P308, DOI 10.1002/bjs.1800690604	19	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52678	10.1371/journal.pone.0052678	http://dx.doi.org/10.1371/journal.pone.0052678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285146	gold, Green Submitted, Green Published			2022-12-25	WOS:000313051500046
J	Bandelj, V; Solidoro, C; Curiel, D; Cossarini, G; Canu, DM; Rismondo, A				Bandelj, Vinko; Solidoro, Cosimo; Curiel, Daniele; Cossarini, Gianpiero; Canu, Donata Melaku; Rismondo, Andrea			Fuzziness and Heterogeneity of Benthic Metacommunities in a Complex Transitional System	PLOS ONE			English	Article							TRANSPORT TIME SCALES; LAGOON-OF-VENICE; ESTUARINE QUALITY; DRAINAGE-BASIN; HARD BOTTOMS; COMMUNITY; ASSEMBLAGES; VARIABILITY; CONTINUUM; PARADOX	We propose an extension to the metacommunity (MC) concept and a novel operational methodology that has the potential to refine the analysis of MC structure at different hierarchical levels. We show that assemblages of species can also be seen as assemblages of abstract subregional habitat-related metacommunities (habMCs). This intrinsically fuzzy concept recognizes the existence of habMCs that are typically associated with given habitats, while allowing for the mixing and superposition of different habMCs in all sites and for boundaries among subregions that are neither spatially sharp nor temporally constant. The combination of fuzzy clustering and direct gradient analysis permits us to 1) objectively identify the number of habMCs that are present in a region as well as their spatial distributions and relative weights at different sites; 2) associate different subregions with different biological communities; and 3) quantitatively assess the affinities between habMCs and physical, morphological, biogeochemical, and environmental properties, thereby enabling an analysis of the roles and relative importance of various environmental parameters in shaping the spatial structure of a metacommunity. This concept and methodology offer the possibility of integrating the continuum and community unit concepts and of developing the concept of a habMC ecological niche. This approach also facilitates the practical application of the MC concept, which are not currently in common use. Applying these methods to macrophytobenthic and macrozoobenthic hard-substrate assemblages in the Venetian Lagoon, we identified a hierarchical organization of macrobenthic communities that associated different habMCs with different habitats. Our results demonstrate that different reference terms should be applied to different subregions to assess the ecological status of a waterbody and show that a combination of several environmental parameters describes the spatial heterogeneity of benthic communities much better than any single property can. Our results also emphasize the importance of considering heterogeneity and fuzziness when working in natural systems.	[Bandelj, Vinko; Solidoro, Cosimo; Cossarini, Gianpiero; Canu, Donata Melaku] Ist Nazl Oceanog & Geofis Sperimentale, OGS, Sgonico, Italy; [Curiel, Daniele; Rismondo, Andrea] SELC, Venice, Italy	Istituto Nazionale di Oceanografia e di Geofisica Sperimentale	Solidoro, C (corresponding author), Ist Nazl Oceanog & Geofis Sperimentale, OGS, Sgonico, Italy.	csolidoro@inogs.it	Melaku Canu, Donata/O-9290-2015; Bandelj, Vinko/J-2129-2019; Cossarini, Gianpiero/AAV-5489-2020	Melaku Canu, Donata/0000-0002-1853-2115; Bandelj, Vinko/0000-0003-0455-1806; Cossarini, Gianpiero/0000-0001-7803-8568; solidoro, cosimo/0000-0003-2354-4302	Magistato alle Acque - Consorzio Venezia Nuova	Magistato alle Acque - Consorzio Venezia Nuova	The study was funded by Magistato alle Acque - Consorzio Venezia Nuova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1958, LIMNOL OCEANOGR, V3, P346; ARIAS AM, 1994, MAR ECOL PROG SER, V115, P151, DOI 10.3354/meps115151; Bandelj V, 2008, MAR ECOL PROG SER, V368, P23, DOI 10.3354/meps07565; Bandelj V, 2009, ECOL MODEL, V220, P2838, DOI 10.1016/j.ecolmodel.2009.04.024; Bellucci LG, 2002, SCI TOTAL ENVIRON, V295, P35, DOI 10.1016/S0048-9697(02)00040-2; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; Bezdek JC, 1987, NATO ASI SERIES; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; BOUDOURESQUE C-F, 1971, Tethys, V3, P79; Brown DG, 1998, PLANT ECOL, V134, P97, DOI 10.1023/A:1009796502293; Canu DM, 2012, MAR POLLUT BULL, V64, P2391, DOI 10.1016/j.marpolbul.2012.08.007; Clements FE, 1936, J ECOL, V24, P252, DOI 10.2307/2256278; Collavini F, 2005, ENVIRON INT, V31, P939, DOI 10.1016/j.envint.2005.05.003; COLLINS SL, 1993, J VEG SCI, V4, P149, DOI 10.2307/3236099; Corriero G, 2007, ITAL J ZOOL, V74, P21, DOI 10.1080/11250000601084100; Cossarini G, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005080; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cucco A, 2009, ECOL MODEL, V220, P913, DOI 10.1016/j.ecolmodel.2009.01.008; Dauvin JC, 2007, MAR POLLUT BULL, V55, P271, DOI 10.1016/j.marpolbul.2006.08.017; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Equihua M, 1990, J ECOL, V78, P19; Gacic M, 2005, FLOODING ENV CHALLEN, P431; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilpin M.E., 1991, METAPOPULATION DYNAM; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; GOODALL DW, 1963, VEGETATIO, V11, P297; Guelorget O., 1992, Vie et Milieu, V42, P215; GUERZONI S, 2006, ATLANTE LAGUNA VENEZ; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Leathwick JR, 2001, ECOLOGY, V82, P2560, DOI 10.1890/0012-9658(2001)082[2560:CIBTSI]2.0.CO;2; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Losso C, 2010, ENVIRON INT, V36, P92, DOI 10.1016/j.envint.2009.07.017; Marchini A, 2006, ECOL MODEL, V193, P105, DOI 10.1016/j.ecolmodel.2005.07.041; MILLET B, 1994, MAR ECOL PROG SER, V108, P161, DOI 10.3354/meps108161; Molinaroli E, 2007, J MARINE SYST, V68, P303, DOI 10.1016/j.jmarsys.2006.12.003; Occhipinti Ambrogi A, 1998, B MUS CIV ST NAT VEN, V49, P145; ODEH IOA, 1992, SOIL SCI SOC AM J, V56, P505, DOI 10.2136/sssaj1992.03615995005600020027x; Olano JM, 1998, PLANT ECOL, V134, P113, DOI 10.1023/A:1009767714612; Orfanidis S., 2007, Transitional Waters Bulletin, V1, P45; RAO CR, 1952, ADV STAT METHODS BIO; ROUBENS M, 1982, EUR J OPER RES, V10, P294, DOI 10.1016/0377-2217(82)90228-4; Sconfietti R, 2003, OCEANOL ACTA, V26, P47, DOI 10.1016/S0399-1784(02)01228-8; SHIPLEY B, 1987, VEGETATIO, V69, P47, DOI 10.1007/BF00038686; Silvert W, 2000, ECOL MODEL, V130, P111, DOI 10.1016/S0304-3800(00)00204-0; Solidoro C, 2004, J MARINE SYST, V51, P7, DOI 10.1016/j.jmarsys.2004.05.024; Solidoro C, 2004, J MARINE SYST, V51, P147, DOI 10.1016/j.jmarsys.2004.05.010; Solidoro C., 2010, COASTAL LAGOONS SYST, P483, DOI DOI 10.1201/EBK1420088304-C19; TAKEOKA H, 1984, CONT SHELF RES, V3, P311, DOI 10.1016/0278-4343(84)90014-1; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Umgiesser G, 2004, J MARINE SYST, V51, P123, DOI 10.1016/j.jmarsys.2004.05.009; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; WHITTAKER RH, 1953, ECOL MONOGR, V23, P41, DOI 10.2307/1943519; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zuliani A, 2005, ENVIRON INT, V31, P929, DOI 10.1016/j.envint.2005.05.004	63	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52395	10.1371/journal.pone.0052395	http://dx.doi.org/10.1371/journal.pone.0052395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285023	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800061
J	Clouthier, CM; Morin, S; Gobeil, SMC; Doucet, N; Blanchet, J; Nguyen, E; Gagne, SM; Pelletier, JN				Clouthier, Christopher M.; Morin, Sebastien; Gobeil, Sophie M. C.; Doucet, Nicolas; Blanchet, Jonathan; Nguyen, Elisabeth; Gagne, Stephane M.; Pelletier, Joelle N.			Chimeric beta-Lactamases: Global Conservation of Parental Function and Fast Time-Scale Dynamics with Increased Slow Motions	PLOS ONE			English	Article							BACKBONE RESONANCE ASSIGNMENTS; MODEL-FREE APPROACH; MOLECULAR-DYNAMICS; RELAXATION DATA; TEM-1; NMR; ENZYME; PSE-4; MACROMOLECULES; RECOMBINATION	Enzyme engineering has been facilitated by recombination of close homologues, followed by functional screening. In one such effort, chimeras of two class-A beta-lactamases - TEM-1 and PSE-4 - were created according to structure-guided protein recombination and selected for their capacity to promote bacterial proliferation in the presence of ampicillin (Voigt et al., Nat. Struct. Biol. 2002 9: 553). To provide a more detailed assessment of the effects of protein recombination on the structure and function of the resulting chimeric enzymes, we characterized a series of functional TEM-1/PSE-4 chimeras possessing between 17 and 92 substitutions relative to TEM-1 beta-lactamase. Circular dichroism and thermal scanning fluorimetry revealed that the chimeras were generally well folded. Despite harbouring important sequence variation relative to either of the two 'parental' beta-lactamases, the chimeric beta-lactamases displayed substrate recognition spectra and reactivity similar to their most closely-related parent. To gain further insight into the changes induced by chimerization, the chimera with 17 substitutions was investigated by NMR spin relaxation. While high order was conserved on the ps-ns timescale, a hallmark of class A beta-lactamases, evidence of additional slow motions on the ms-ms timescale was extracted from model-free calculations. This is consistent with the greater number of resonances that could not be assigned in this chimera relative to the parental beta-lactamases, and is consistent with this well-folded and functional chimeric beta-lactamase displaying increased slow time-scale motions.	[Clouthier, Christopher M.; Morin, Sebastien; Gobeil, Sophie M. C.; Doucet, Nicolas; Blanchet, Jonathan; Nguyen, Elisabeth; Gagne, Stephane M.; Pelletier, Joelle N.] Univ Laval, Quebec Network Res Prot Struct Funct & Engn, PROTEO, Laval, PQ, Canada; [Clouthier, Christopher M.; Blanchet, Jonathan; Nguyen, Elisabeth; Pelletier, Joelle N.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Morin, Sebastien; Gagne, Stephane M.] Univ Laval, Dept Biochim Microbiol & Bioinformat, Laval, PQ, Canada; [Doucet, Nicolas] Univ Quebec, INRS Inst Armand Frappier, Laval, PQ, Canada; [Gobeil, Sophie M. C.; Pelletier, Joelle N.] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Laval University; Universite de Montreal; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS); Universite de Montreal	Pelletier, JN (corresponding author), Univ Laval, Quebec Network Res Prot Struct Funct & Engn, PROTEO, Laval, PQ, Canada.	joelle.pelletier@umontreal.ca		gobeil, sophie/0000-0002-0057-2477; Morin, Sebastien/0000-0003-4426-326X	Fonds de la recherche en sante du Quebec (FRSQ); PROTEO-Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (Innovation and New Opportunity); NSERC; FRSQ; PROTEO; FQRNT	Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); PROTEO-Fonds quebecois de la recherche sur la nature et les technologies (FQRNT); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (Innovation and New Opportunity)(Canada Foundation for Innovation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRSQ(Fonds de la Recherche en Sante du Quebec); PROTEO; FQRNT(FQRNT)	This work was supported by operating grants from the Fonds de la recherche en sante du Quebec (FRSQ), PROTEO-Fonds quebecois de la recherche sur la nature et les technologies (FQRNT) and the Natural Sciences and Engineering Research Council of Canada (NSERC), and infrastructure grants from the Canada Foundation for Innovation (Innovation and New Opportunity). S. Morin is the recipient of scholarships from NSERC and FRSQ. S. Gobeil is the recipient of scholarships from PROTEO and FQRNT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Balamurali MM, 2008, PROTEIN SCI, V17, P1815, DOI 10.1110/ps.036376.108; Bebrone C, 2001, ANTIMICROB AGENTS CH, V45, P1868, DOI 10.1128/AAC.45.6.1868-1871.2001; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; Bos F, 2009, BIOPHYS J, V97, P2550, DOI 10.1016/j.bpj.2009.08.031; Bolduc OR, 2009, ANAL CHEM, V81, P6779, DOI 10.1021/ac900956y; Bouthors AT, 1998, BIOCHEM J, V330, P1443, DOI 10.1042/bj3301443; Bush K, 2010, CRIT CARE, V14, DOI 10.1186/cc8892; Cantu C, 1998, J BIOL CHEM, V273, P26603, DOI 10.1074/jbc.273.41.26603; Carbone MN, 2007, CURR OPIN STRUC BIOL, V17, P454, DOI 10.1016/j.sbi.2007.08.005; Carroll MJ, 2012, NAT CHEM BIOL, V8, P246, DOI [10.1038/NCHEMBIO.769, 10.1038/nchembio.769]; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; d'Auvergne EJ, 2006, J BIOMOL NMR, V35, P117, DOI 10.1007/s10858-006-9007-z; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; De Wals PY, 2009, PROTEIN SCI, V18, P147, DOI 10.1002/pro.25; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doucet N, 2004, J BIOL CHEM, V279, P46295, DOI 10.1074/jbc.M407606200; DOUCET N, 2009, PROTEIN ENG HDB, P187; Doucet N, 2007, J BIOL CHEM, V282, P21448, DOI 10.1074/jbc.M609777200; Doucet N, 2007, PROTEINS, V69, P340, DOI 10.1002/prot.21485; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P5380, DOI 10.1073/pnas.0500729102; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Fisette O, 2010, BIOPHYS J, V98, P637, DOI 10.1016/j.bpj.2009.08.061; Heinzelman P, 2009, J BIOL CHEM, V284, P26229, DOI 10.1074/jbc.C109.034058; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hiraga K, 2003, J MOL BIOL, V330, P287, DOI 10.1016/S0022-2836(03)00590-4; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; LeMaster DM, 2005, STRUCTURE, V13, P1153, DOI 10.1016/j.str.2005.05.007; Lim D, 2001, BIOCHEMISTRY-US, V40, P395, DOI 10.1021/bi001653v; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, BIOPHYS J, V37, pA380; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; Meyer MM, 2003, PROTEIN SCI, V12, P1686, DOI 10.1110/ps.0306603; Morin S, 2006, J BIOMOL NMR, V36, P11, DOI 10.1007/s10858-005-5343-7; Morin S, 2011, PROG NUCL MAG RES SP, V59, P245, DOI 10.1016/j.pnmrs.2010.12.003; Morin S, 2010, BIOMOL NMR ASSIGN, V4, P127, DOI 10.1007/s12104-010-9227-8; Morin S, 2009, J BIOMOL NMR, V45, P361, DOI 10.1007/s10858-009-9381-4; Morin S, 2009, BIOPHYS J, V96, P4681, DOI 10.1016/j.bpj.2009.02.068; Nagel ZD, 2009, NAT CHEM BIOL, V5, P696, DOI 10.1038/nchembio0909-696c; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Maille PE, 2002, J MOL BIOL, V321, P677, DOI 10.1016/S0022-2836(02)00675-7; Otey CR, 2004, CHEM BIOL, V11, P309, DOI 10.1016/j.chembiol.2004.02.018; Roccatano D, 2005, J COMPUT AID MOL DES, V19, P329, DOI 10.1007/s10822-005-7003-0; Savard PY, 2006, BIOCHEMISTRY-US, V45, P11414, DOI 10.1021/bi060414q; Savard PY, 2004, J BIOMOL NMR, V29, P433, DOI 10.1023/B:JNMR.0000032503.96942.68; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Savoie A, 2000, PROTEIN ENG, V13, P267, DOI 10.1093/protein/13.4.267; Sosa-Peinado A, 2000, PROTEIN EXPRES PURIF, V19, P235, DOI 10.1006/prep.2000.1243; Stec B, 2005, ACTA CRYSTALLOGR D, V61, P1072, DOI 10.1107/S0907444905014356; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wang XJ, 2002, PROTEINS, V47, P86, DOI 10.1002/prot.10058; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	64	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52283	10.1371/journal.pone.0052283	http://dx.doi.org/10.1371/journal.pone.0052283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284969	gold, Green Published			2022-12-25	WOS:000313158800042
J	Cruz-Cordova, A; Rocha-Ramirez, LM; Ochoa, SA; Gonzalez-Pedrajo, B; Espinosa, N; Eslava, C; Hernandez-Chinas, U; Mendoza-Hernandez, G; Rodriguez-Leviz, A; Valencia-Mayoral, P; Sadowinski-Pine, S; Hernandez-Castro, R; Estrada-Garcia, I; Munoz-Hernandez, O; Rosas, I; Xicohtencatl-Cortes, J				Cruz-Cordova, Ariadnna; Rocha-Ramirez, Luz M.; Ochoa, Sara A.; Gonzalez-Pedrajo, Bertha; Espinosa, Norma; Eslava, Carlos; Hernandez-Chinas, Ulises; Mendoza-Hernandez, Guillermo; Rodriguez-Leviz, Alejandra; Valencia-Mayoral, Pedro; Sadowinski-Pine, Stanislaw; Hernandez-Castro, Rigoberto; Estrada-Garcia, Iris; Munoz-Hernandez, Onofre; Rosas, Irma; Xicohtencatl-Cortes, Juan			Flagella from Five Cronobacter Species Induce Pro-Inflammatory Cytokines in Macrophage Derivatives from Human Monocytes	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; MEMBRANE PROTEIN-A; DUBLINENSIS SP-NOV; ENTEROBACTER-SAKAZAKII; NECROTIZING ENTEROCOLITIS; BIOFILM FORMATION; EPITHELIAL-CELLS; STAINLESS-STEEL; RAT MODEL	Cronobacter spp. are opportunistic pathogens linked to lie-threatening infections in neonates and contaminated powdered infant formula that has been epidemiologically associated with these cases. Clinical symptoms of Cronobacter include necrotizing enterocolitis, bacteremia, and meningitis. Flagella from C. sakazakii are involved in biofilm formation and its adhesion to epithelial cells. We investigated the role of flagella from C. sakazakii ST1 and ST4, C. malonaticus, C. muytjensii, C. turicensis and C. dublinensis during the activation of cytokines (IL-8, TNF-alpha, and IL-10) in macrophage derivatives from human monocytes, which has not been extensively studied. The production and identity of flagella from the five Cronobacter species were visualized and recognized with anti-flagella antibodies by immunogold labeling through transmission electron microscopy. Purified flagella were dissociated into monomers in 12% SDS-PAGE Coomassie blue-stained gels showing a band of similar to 28 kDa and, in addition, mass spectrometry revealed the presence of several peptides that correspond to flagellin. Flagella (100 ng) induced the release of IL-8 (3314-6025 pg/ml), TNF-alpha (39-359 pg/ml), and IL-10 (2-96 pg/ml), in macrophage isolates from human monocytes and similar results were obtained when flagella were dissociated into monomers. Inhibition assays using three dilutions of anti-flagella antibodies (1: 10, 1: 100, and 1: 200) suppressed the secretion of IL-8, TNF-alpha, and IL-10 between 95-100% using 100 ng of protein. A transfection assay using 293-hTLR5 cells showed IL-8 release of 197 pg/ml and suppression in the secretion of IL-8 when anti-hTLR5-IgA antibodies were used at different concentrations. These observations suggest that flagella and flagellin are involved in an inflammatory response dependent on TLR5 recognition, which could contribute to the pathogenesis of the bacteria.	[Cruz-Cordova, Ariadnna; Rocha-Ramirez, Luz M.; Ochoa, Sara A.; Munoz-Hernandez, Onofre; Xicohtencatl-Cortes, Juan] Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico; [Gonzalez-Pedrajo, Bertha; Espinosa, Norma] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Mexico City 04510, DF, Mexico; [Eslava, Carlos; Hernandez-Chinas, Ulises] Univ Nacl Autonoma Mexico, Fac Med, Dept Salud Publ, Mexico City 04510, DF, Mexico; [Mendoza-Hernandez, Guillermo] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Rodriguez-Leviz, Alejandra; Valencia-Mayoral, Pedro; Sadowinski-Pine, Stanislaw] Hosp Infantil Mexico Federico Gomez Dr Marquez 16, Dept Patol, Mexico City, DF, Mexico; [Hernandez-Castro, Rigoberto] Hosp Gen Dr Manuel Gea Gonzalez, Dept Ecol Agentes Patogenos, Tlalpan, Mexico; [Estrada-Garcia, Iris] Univ Nacl Autonoma Mexico, Ctr Ciencias Atmosfera, Mexico City 04510, DF, Mexico; [Rosas, Irma] IPN Unidad Profes Prolongac, Escuela Nacl Ciencias Biol, Dept Inmunol Mol, Miguel Hidalgo, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Hospital Infantil de Mexico Federico Gomez; Universidad Nacional Autonoma de Mexico	Xicohtencatl-Cortes, J (corresponding author), Hosp Infantil Mexico Dr Federico Gomez, Dept Infectol, Lab Bacteriol Intestinal, Mexico City, DF, Mexico.	juanxico@yahoo.com	Córdova, Ariadnna Cruz/AAF-9654-2021; Xicohtencatl-Cortes, Juan/ABD-5463-2020	HERNANDEZ, ULISES/0000-0003-4708-8807	Hospital Infantil de Mexico Federico Gomez [HIM/2010/026, HIM/2011/082]; CONACyT (Consejo Nacional de Ciencia y Tecnologia.) [133451]	Hospital Infantil de Mexico Federico Gomez; CONACyT (Consejo Nacional de Ciencia y Tecnologia.)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the grant number HIM/2010/026 and HIM/2011/082 of Federal Funds from Hospital Infantil de Mexico Federico Gomez and CONACyT (Consejo Nacional de Ciencia y Tecnologia.) 133451. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Beuchat LR, 2009, INT J FOOD MICROBIOL, V136, P204, DOI 10.1016/j.ijfoodmicro.2009.02.029; Bowen AB, 2006, EMERG INFECT DIS, V12, P1185, DOI 10.3201/eid1708.051509; Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297; Cruz A, 2011, CAN J MICROBIOL, V57, P735, DOI [10.1139/W11-063, 10.1139/w11-063]; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Emami CN, 2012, J SURG RES, V172, P18, DOI 10.1016/j.jss.2011.04.019; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Giron JA, 2005, COLONIZATION OF MUCOSAL SURFACES, P213; Grimm M, 2008, J FOOD PROTECT, V71, P13, DOI 10.4315/0362-028X-71.1.13; Gurtler JB, 2005, INT J FOOD MICROBIOL, V104, P1, DOI 10.1016/j.ijfoodmicro.2005.02.013; Hamby SE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-204; Hartmann I, 2010, APPL ENVIRON MICROB, V76, P2251, DOI 10.1128/AEM.00930-09; Hilbert DW, 2008, MICROBES INFECT, V10, P114, DOI 10.1016/j.micinf.2007.10.012; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Huang LY, 2009, J CLIN MICROBIOL, V47, P3427, DOI 10.1128/JCM.00373-09; Hunter CJ, 2008, J INFECT DIS, V198, P586, DOI 10.1086/590186; Hurrell E, 2009, INT J FOOD MICROBIOL, V136, P227, DOI 10.1016/j.ijfoodmicro.2009.08.007; Hurrell E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-146; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2008, INT J SYST EVOL MICR, V58, P1442, DOI 10.1099/ijs.0.65577-0; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Jandhyala DM, 2010, INFECT IMMUN, V78, P2984, DOI 10.1128/IAI.00383-10; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Joshep S, 2012, IJSEM, V62, P1277; Kandhai MC, 2004, LANCET, V363, P39, DOI 10.1016/S0140-6736(03)15169-0; Kim H, 2008, J FOOD PROTECT, V71, P940, DOI 10.4315/0362-028X-71.5.940; Kim H, 2007, APPL ENVIRON MICROB, V73, P1256, DOI 10.1128/AEM.01766-06; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Kucerova E, 2011, QUAL ASSUR SAF CROP, V3, P104, DOI 10.1111/j.1757-837X.2011.00104.x; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Ledesma MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012127; Lehner A, 2005, J FOOD PROTECT, V68, P2287, DOI 10.4315/0362-028X-68.11.2287; Lopez-Boado YS, 2005, INFECT IMMUN, V73, P7525, DOI 10.1128/IAI.73.11.7525-7534.2005; Mange JP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-58; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Mittal R, 2009, J IMMUNOL, V183, P6588, DOI 10.4049/jimmunol.0902029; Mittal R, 2009, LAB INVEST, V89, P263, DOI 10.1038/labinvest.2008.164; Mullane N, 2008, APPL ENVIRON MICROB, V74, P5913, DOI 10.1128/AEM.00745-08; Newton K., 2012, COLD SPRING HARB PER, V4; Pagotto FJ, 2003, J FOOD PROTECT, V66, P370, DOI 10.4315/0362-028X-66.3.370; Quintero M, 2011, CURR MICROBIOL, V62, P1448, DOI 10.1007/s00284-011-9882-8; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Singamsetty VK, 2008, MICROB PATHOGENESIS, V45, P181, DOI 10.1016/j.micpath.2008.05.006; Smith K, 2003, POETRY REV, V93, P5; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Ulises HC, 2009, PEPTIDES, V30, P2127, DOI 10.1016/j.peptides.2009.09.019; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Wyant TL, 1999, INFECT IMMUN, V67, P3619, DOI 10.1128/IAI.67.7.3619-3624.1999; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172/JCI30727; Xicohtencatl-Cortes J, 2006, MOL CELL PROTEOMICS, V5, P2374, DOI 10.1074/mcp.M600228-MCP200; Yan XH, 2011, APPL ENVIRON MICROB, V77, P1833, DOI 10.1128/AEM.02374-10; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003; Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003	62	41	43	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52091	10.1371/journal.pone.0052091	http://dx.doi.org/10.1371/journal.pone.0052091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284883	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800029
J	Liao, JM; Zeng, SX; Zhou, X; Lu, H				Liao, Jun-Ming; Zeng, Shelya X.; Zhou, Xiang; Lu, Hua			Global Effect of Inauhzin on Human p53-Responsive Transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION; P53 FUNCTION; DNA-DAMAGE; DOWN-REGULATION; TUMOR-GROWTH; C-MYC; ACETYLATION; ACTIVATION; RESTORATION; BINDING	Background: Previously, we reported that Inauhzin (INZ) induces p53 activity and suppresses tumor growth by inhibiting Sirt1. However, it remains unknown whether INZ may globally affect p53-dependent gene expression or not. Herein, we have conducted microarray and real-time PCR analyses of gene expression to determine the global effect of INZ on human p53-responsive transcriptome. Methodology/Principal Findings: In this study, we conducted microarray analysis followed by PCR validation of general gene expression in HCT116(p53+/+) and HCT116(p53-/-) cells treated with or without INZ. Microarray data showed that 324 genes were up-regulated by >= 2.3-fold and 266 genes were down-regulated by >= 2-fold in response to INZ treatment in a p53-dependent manner. GO analysis for these genes further revealed that INZ affects several biological processes, including apoptosis (GO:0006915), cell cycle (GO:0007049), immune system process (GO:0002376), and cell adhesion (GO:0007155), which are in line with p53 functions in cells. Also, pathway and STRING analyses of these genes indicated that the p53-signaling pathway is the most significant pathway responsive to INZ treatment as predicted, since a number of these p53 target genes have been previously reported and some of them were validated by RT-qPCR. Finally, among the 9 tested and highly expressed genes, ACBD4, APOBEC3C, and FLJ14327 could be novel p53 target genes, for they were up-regulated by INZ in HCT116(p53+/+) cells, but not in HCT116(p53-/-) cells. Conclusions/Significance: From our whole genome microarray analysis followed by validation with RT-qPCR, we found that INZ can indeed induce the expression of p53 target genes at a larger scale or globally. Our findings not only verify that INZ indeed activates the p53 signaling pathway, but also provide useful information for identifying novel INZ and/or p53 targets. The global effect of INZ on human p53-responsive transcriptome could also be instrumental to the future design of INZ clinical trials.	[Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Tulane Univ, Sch Med, Tulane Canc Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Zhou, Xiang/J-5046-2017	Zhou, Xiang/0000-0002-1172-7948	NIH-NCI [CA095441, CA 079721, CA129828, CA172468]; NATIONAL CANCER INSTITUTE [R01CA079721, R01CA095441, R01CA129828, R01CA172468] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	HL was supported in part by NIH-NCI grants CA095441, CA 079721, CA129828, and CA172468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Bansal N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026156; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Barsotti A, 2011, J BIOL CHEM; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Chang RL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000938; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; de Lange J, 2012, ONCOGENE, V31, P1105, DOI 10.1038/onc.2011.309; Di Giovanni S, 2006, EMBO J, V25, P4084, DOI 10.1038/sj.emboj.7601292; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Knouf E.C., 2011, NUCL ACIDS RES; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Lee MLT, 2000, P NATL ACAD SCI USA, V97, P9834, DOI 10.1073/pnas.97.18.9834; Liao JM, 2012, CELL CYCLE, V11, P2624, DOI 10.4161/cc.20809; Liao JM, 2011, J BIOL CHEM, V286, P33901, DOI 10.1074/jbc.M111.262030; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Mutharasan RK, 2011, AM J PHYSIOL-HEART C, V301, pH1519, DOI 10.1152/ajpheart.01080.2010; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Scarola M, 2010, CANCER RES, V70, P6925, DOI 10.1158/0008-5472.CAN-10-0141; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; St Clair S, 2004, MOL CELL, V16, P725; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042; Zauli G, 2012, HAEMATOLOGICA; Zhang Q, 2012, EMBO MOL MED, V4, P298, DOI 10.1002/emmm.201100211; Zhang Y, 2012, CANC BIOL THER, P13; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98; Zhou X, 2012, ONCOGENE	63	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52172	10.1371/journal.pone.0052172	http://dx.doi.org/10.1371/journal.pone.0052172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284922	Green Submitted, Green Published, gold			2022-12-25	WOS:000313158800037
J	Nichele, I; Zamo, A; Bertolaso, A; Bifari, F; Tinelli, M; Franchini, M; Stradoni, R; Aprili, F; Pizzolo, G; Krampera, M				Nichele, Ilaria; Zamo, Alberto; Bertolaso, Anna; Bifari, Francesco; Tinelli, Martina; Franchini, Marta; Stradoni, Roberta; Aprili, Fiorenza; Pizzolo, Giovanni; Krampera, Mauro			VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CHRONIC LYMPHOCYTIC-LEUKEMIA; WALDENSTROM MACROGLOBULINEMIA; LYMPHOPLASMACYTIC LYMPHOMA; MUTATIONS; PROTEIN; MICE	Background: small B-cell neoplasms can show plasmacytic differentiation and may potentially progress to aggressive lymphoma (DLBCL). Epstein-Barr virus (EBV) infection may cause the transformation of malignant cells in vitro. Design and Method: we established VR09 cell line with plasmacytic differentiation, obtained from a case of atypical, non-CLL B-cell chronic lymphoproliferative disease with plasmacytic features. We used flow cytometry, immunohistochemistry, polymerase chain reaction, cytogenetic analysis and florescence in situ hybridization in the attempt at thoroughly characterizing the cell line. We showed VR09 tumorigenic potential in vivo, leading to the development of activated DLBCL with plasmacytic features. Results: VR09 cells displayed plasmacytic appearance and grew as spherical tumors when inoculated subcutaneously into immunodeficient Rag2(-/-) c-chain(-/-) mice. VR09 cell line and tumors displayed the phenotype of activated stage of B cell maturation, with secretory differentiation (CD19+ CD20+ CD79a+ CD79b+/- CD138+ cyclin D1-Ki67 80% IgM+ IgD+ MUM1+ MNDA+ CD10-CD22+ CD23+ CD43+ K+, lambda-Bcl2+Bcl6-) and they presented episomal EBV genome, chromosome 12 trisomy, lack of c-MYC rearrangement and Myd88 gene mutation, presence of somatic hypermutation in the VH region, and wild-type p53. Conclusion: This new EBV-positive cell line may be useful to further characterize in vivo activated DLBCL with plasmacytic features.	[Nichele, Ilaria; Bifari, Francesco; Tinelli, Martina; Stradoni, Roberta; Pizzolo, Giovanni; Krampera, Mauro] Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy; [Zamo, Alberto; Bertolaso, Anna; Franchini, Marta] Univ Verona, Dept Pathol & Diagnost, Sect Pathol Anat, I-37100 Verona, Italy; [Aprili, Fiorenza] Azienda Osped Univ Integrata Verona, Dept Pathol & Diagnost, Lab Cytogenet, Verona, Italy	University of Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Krampera, M (corresponding author), Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy.	mauro.krampera@univr.it	KRAMPERA, MAURO/K-5596-2018; Bifari, Francesco/M-3430-2014; Zamò, Alberto/ABF-4436-2020	Bifari, Francesco/0000-0003-2028-3012; KRAMPERA, Mauro/0000-0002-7280-2040; Zamo, Alberto/0000-0001-6203-7966	Italian Ministry of University and Scientific Research; Fondazione CARIVERONA; Fondazione AIRC	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIVERONA(Fondazione Cariverona); Fondazione AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Italian Ministry of University and Scientific Research (PRIN 2005, PRIN 2007), Fondazione CARIVERONA, (Bando 2003 and 2008) and Fondazione AIRC (MFAG 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Ansell SM, 1999, AM J HEMATOL, V60, P99, DOI 10.1002/(SICI)1096-8652(199902)60:2<99::AID-AJH3>3.0.CO;2-T; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Brothman AR, 2009, CYTOGENET GENOME RES, V127, P1, DOI 10.1159/000279442; Brunelli M, 2008, MODERN PATHOL, V21, P1, DOI 10.1038/modpathol.3800967; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Chen MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00005; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Drexler HG, 2000, LEUKEMIA RES, V24, P881, DOI 10.1016/S0145-2126(00)00070-9; Falini B, 2000, BLOOD, V95, P2084, DOI 10.1182/blood.V95.6.2084; Hjalmar V, 1998, HAEMATOLOGICA, V83, P602; Kanellis G, 2009, LEUKEMIA, V23, P1847, DOI 10.1038/leu.2009.108; Kojima M, 2010, PATHOBIOLOGY, V77, P218, DOI 10.1159/000301154; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lin P, 2003, AM J CLIN PATHOL, V120, P246, DOI 10.1039/R01VXG46MFCDVNHL; Montes-Moreno S, 2010, HAEMATOL-HEMATOL J, V95, P1342, DOI 10.3324/haematol.2009.016113; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nilsson K, 1999, HUM CELL, V5, P25; Pangalis GA, 1999, SEMIN HEMATOL, V36, P104; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Ross D, 2009, HEMATOL ONCOL, V27, P1, DOI 10.1002/hon.880; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stilgenbauer S, 1998, ANN HEMATOL, V76, P101, DOI 10.1007/s002770050373; Tarrand JJ, 2010, CANCER-AM CANCER SOC, V116, P880, DOI 10.1002/cncr.24839; Tsimberidou AM, 2005, CANCER-AM CANCER SOC, V103, P216, DOI 10.1002/cncr.20773; van Rijn RS, 2007, EXP HEMATOL, V35, P117, DOI 10.1016/j.exphem.2006.09.018; Varghese AM, 2008, LEUKEMIA LYMPHOMA, V49, P1618, DOI 10.1080/10428190802123481; Zamo A, 2006, HAEMATOLOGICA, V91, P40	29	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52811	10.1371/journal.pone.0052811	http://dx.doi.org/10.1371/journal.pone.0052811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285191	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800096
J	Yiallourou, TI; Kroger, JR; Stergiopulos, N; Maintz, D; Martin, BA; Bunck, AC				Yiallourou, Theresia I.; Kroeger, Jan Robert; Stergiopulos, Nikolaos; Maintz, David; Martin, Bryn A.; Bunck, Alexander C.			Comparison of 4D Phase-Contrast MRI Flow Measurements to Computational Fluid Dynamics Simulations of Cerebrospinal Fluid Motion in the Cervical Spine	PLOS ONE			English	Article							PRESSURE WAVE-PROPAGATION; CHIARI-I MALFORMATION; SUBARACHNOID SPACE; MAGNETIC-RESONANCE; FORAMEN MAGNUM; CSF FLOW; HYDRODYNAMICS; MODEL; ARACHNOIDITIS; 3RD-VENTRICLE	Cerebrospinal fluid (CSF) dynamics in the cervical spinal subarachnoid space (SSS) have been thought to be important to help diagnose and assess craniospinal disorders such as Chiari I malformation (CM). In this study we obtained time-resolved three directional velocity encoded phase-contrast MRI (4D PC MRI) in three healthy volunteers and four CM patients and compared the 4D PC MRI measurements to subject-specific 3D computational fluid dynamics (CFD) simulations. The CFD simulations considered the geometry to be rigid-walled and did not include small anatomical structures such as nerve roots, denticulate ligaments and arachnoid trabeculae. Results were compared at nine axial planes along the cervical SSS in terms of peak CSF velocities in both the cranial and caudal direction and visual interpretation of thru-plane velocity profiles. 4D PC MRI peak CSF velocities were consistently greater than the CFD peak velocities and these differences were more pronounced in CM patients than in healthy subjects. In the upper cervical SSS of CM patients the 4D PC MRI quantified stronger fluid jets than the CFD. Visual interpretation of the 4D PC MRI thru-plane velocity profiles showed greater pulsatile movement of CSF in the anterior SSS in comparison to the posterior and reduction in local CSF velocities near nerve roots. CFD velocity profiles were relatively uniform around the spinal cord for all subjects. This study represents the first comparison of 4D PC MRI measurements to CFD of CSF flow in the cervical SSS. The results highlight the utility of 4D PC MRI for evaluation of complex CSF dynamics and the need for improvement of CFD methodology. Future studies are needed to investigate whether integration of fine anatomical structures and gross motion of the brain and/or spinal cord into the computational model will lead to a better agreement between the two techniques.	[Yiallourou, Theresia I.; Stergiopulos, Nikolaos; Martin, Bryn A.] Ecole Polytech Fed Lausanne, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland; [Kroeger, Jan Robert; Bunck, Alexander C.] Univ Hosp Munster, Dept Clin Radiol, Munster, Germany; [Maintz, David; Bunck, Alexander C.] Univ Hosp Cologne, Dept Radiol, Cologne, Germany; [Martin, Bryn A.] Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Munster; University of Cologne; University System of Ohio; University of Akron	Martin, BA (corresponding author), Ecole Polytech Fed Lausanne, Lab Hemodynam & Cardiovasc Technol, Lausanne, Switzerland.	director@chiari-research.org	Martin, Bryn A./N-6640-2016; Bunck, Alexander C/M-6389-2014; Maintz, David/ABG-3220-2020; Kroeger, Jan Robert/GNP-1512-2022	Martin, Bryn A./0000-0003-1234-7880; Bunck, Alexander C/0000-0003-0986-0042; Kroeger, Jan Robert/0000-0003-1218-7610; Stergiopulos, Nikolaos/0000-0002-0519-0160	Swiss National Science Foundation [205321_132695/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Source of funding: Swiss National Science Foundation, Grant No. 205321_132695/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baledent O, 2004, INVEST RADIOL, V39, P45, DOI 10.1097/01.rli.0000100892.87214.49; Baledent O, 2001, INVEST RADIOL, V36, P368, DOI 10.1097/00004424-200107000-00003; Berkouk K, 2003, J BIOMECH ENG-T ASME, V125, P852, DOI 10.1115/1.1634280; Bertram CD, 2008, MED BIOL ENG COMPUT, V46, P701, DOI 10.1007/s11517-008-0332-0; Bertram CD, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001165; Bertram CD, 2009, J FLUID STRUCT, V25, P1189, DOI 10.1016/j.jfluidstructs.2009.06.008; Bertram CD, 2005, J BIOMECH ENG-T ASME, V127, P1099, DOI 10.1115/1.2073607; Bilston LE, 2006, CLIN BIOMECH, V21, P579, DOI 10.1016/j.clinbiomech.2006.01.009; Bottan S, 2012, IEEE T BIOMEDICAL EN; BRUNHOLZL C, 1989, VASA-J VASCULAR DIS, V18, P205; Bunck AC, 2012, EUR RADIOL, V22, P1860, DOI 10.1007/s00330-012-2457-7; Bunck AC, 2011, EUR RADIOL, V21, P1788, DOI 10.1007/s00330-011-2105-7; Carpenter PW, 2003, J BIOMECH ENG-T ASME, V125, P857, DOI 10.1115/1.1634281; Cirovic S, 2002, J FLUID STRUCT, V16, P1029, DOI 10.1006/jfls.2002.0457; Cirovic S, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005853; Cirovic S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005159; CLOYD MW, 1974, J COMP NEUROL, V153, P325, DOI 10.1002/cne.901530402; Cousins J, 2009, AM J NEURORADIOL, V30, P1587, DOI 10.3174/ajnr.A1507; Daners MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037502; Elliott NSJ, 2011, MED ENG PHYS, V33, P874, DOI 10.1016/j.medengphy.2010.07.009; Elliott NSJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3072894; Gupta A, 2009, ANN ONCOL, V20, P399, DOI 10.1093/annonc/mdp021; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Gupta S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3005171; Hentschel S, 2010, AM J NEURORADIOL, V31, P997, DOI 10.3174/ajnr.A1995; Iskandar BJ, 2004, J NEUROSURG, V101, P169, DOI 10.3171/ped.2004.101.2.0169; Johnson KM, 2010, MAGN RESON MED, V63, P349, DOI 10.1002/mrm.22202; Kalata W, 2009, IEEE T BIO-MED ENG, V56, P1765, DOI 10.1109/TBME.2008.2011647; Krueger KD, 2010, AM J NEURORADIOL, V31, P1837, DOI 10.3174/ajnr.A2268; Kurtcuoglu V, 2005, LECT NOTES COMPUT SC, V3749, P786; Kurtcuoglu V, 2007, J BIOMECH, V40, P1235, DOI 10.1016/j.jbiomech.2006.05.031; Linge SO, 2010, AM J NEURORADIOL, V31, P185, DOI 10.3174/ajnr.A1766; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Martin BA, 2005, J BIOMECH ENG-T ASME, V127, P1110, DOI 10.1115/1.2073687; Martin BA, 2009, CEREBROSPINAL FLUID, V31, P6; Martin BA, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000089; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Quigley MF, 2004, RADIOLOGY, V232, P229, DOI 10.1148/radiol.2321030666; Roldan A, 2009, AM J NEURORADIOL, V30, P941, DOI 10.3174/ajnr.A1489; ROSSITTI S, 1995, ARQ NEURO-PSIQUIAT, V53, P333, DOI 10.1590/S0004-282X1995000200028; Rutkowska G, 2012, AJNR AM J NEURORADIO; Santini F, 2009, MAGN RESON MED, V62, P966, DOI 10.1002/mrm.22087; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Sigmund EE, 2011, NMR BIOMED; Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7; Stadlbauer A, 2010, NEUROIMAGE, V51, P42, DOI 10.1016/j.neuroimage.2010.01.110; Stockman HW, 2007, J BIOMECH ENG-T ASME, V129, P666, DOI 10.1115/1.2768112; Wagshul ME, 2006, J NEUROSURG, V104, P810, DOI 10.3171/jns.2006.104.5.810; YAMADA S, 1975, CHILD BRAIN, V1, P187	50	54	54	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52284	10.1371/journal.pone.0052284	http://dx.doi.org/10.1371/journal.pone.0052284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284970	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800043
J	Zhang, J; Huang, ZH; Qiu, XH; Yang, YM; Zhu, DY; Xu, W				Zhang, Jing; Huang, Zhi Hai; Qiu, Xiao Hui; Yang, Yi Ming; Zhu, Da Yuan; Xu, Wen			Neutral Fragment Filtering for Rapid Identification of New Diester-Diterpenoid Alkaloids in Roots of Aconitum carmichaeli by Ultra-High-Pressure Liquid Chromatography Coupled with Linear Ion Trap-Orbitrap Mass Spectrometry	PLOS ONE			English	Article							C-19-DITERPENOID ALKALOIDS; NORDITERPENOID ALKALOIDS; CHEMISTRY; TOXICITY; MODE; MSN	A rapid and effective method was developed for separation and identification of diester-diterpenoid alkaloids (DDA) in the roots of Aconitum carmichaeli by ultra-high-pressure liquid chromatography coupled with high resolution LTQ-Orbitrap tandem mass spectrometry (UHPLC-LTQ-Orbitrap-MSn). According to accurate mass measurement and the characteristic neutral loss filtering strategy, a total of 42 diester-diterpenoid alkaloids (DDA) were rapidly detected and characterized or tentatively identified. Meanwhile, the proposed fragmentation pathways and the major diagnostic fragment ions of aconitine, mesaconitine and hypaconitine were investigated to trace DDA derivatives in crude plant extracts. 23 potential new compounds were successfully screened and characterized in Aconitum carmichaeli, including 16 short chain fatty acyls DDA, 4 N-dealkyl DDA and several isomers of aconitine, mesaconitine and hypaconitine.	[Zhang, Jing; Qiu, Xiao Hui; Yang, Yi Ming; Zhu, Da Yuan; Xu, Wen] Guangzhou Univ Chinese Med, Clin Coll 2, Lab Chinese Mat Med Preparat, Guangzhou, Guangdong, Peoples R China; [Huang, Zhi Hai] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Xu, W (corresponding author), Guangzhou Univ Chinese Med, Clin Coll 2, Lab Chinese Mat Med Preparat, Guangzhou, Guangdong, Peoples R China.	freexuwen@163.com	Butane, Lynn/M-9514-2014; Xu, Wen/H-6226-2011	, Wen/0000-0002-3913-3607; Zhang, Jing/0000-0003-2411-4734				Ameri A, 1998, PROG NEUROBIOL, V56, P211, DOI 10.1016/S0301-0082(98)00037-9; Bello-Ramirez AM, 2004, FUND CLIN PHARMACOL, V18, P699, DOI 10.1111/j.1472-8206.2004.00280.x; BISSET NG, 1981, J ETHNOPHARMACOL, V4, P247, DOI 10.1016/0378-8741(81)90001-5; Chan TYK, 2009, HUM EXP TOXICOL, V28, P795, DOI 10.1177/0960327109353056; Chan TYK, 2009, CLIN TOXICOL, V47, P279, DOI 10.1080/15563650902904407; Chan TYK, 2002, DRUG SAFETY, V25, P823, DOI 10.2165/00002018-200225110-00006; Chen DL, 2003, ACTA CHIM SINICA, V61, P901; Chen LH, 2005, CHEM J CHINESE U, V26, P2340; DICKENS P, 1994, FORENSIC SCI INT, V67, P55, DOI 10.1016/0379-0738(94)90412-X; Dunn WB, 2008, J CHROMATOGR B, V871, P288, DOI 10.1016/j.jchromb.2008.03.021; Hu R, 2009, RAPID COMMUN MASS SP, V23, P1619, DOI 10.1002/rcm.4038; KONNO C, 1979, PLANTA MED, V35, P150, DOI 10.1055/s-0028-1097196; Li R, 2006, RAPID COMMUN MASS SP, V20, P157, DOI 10.1002/rcm.2283; Lim HK, 2007, RAPID COMMUN MASS SP, V21, P1821, DOI 10.1002/rcm.3024; Lin CC, 2004, ANN EMERG MED, V43, P574, DOI 10.1016/j.annemergmed.2003.10.046; Liu WL, 2010, J SEP SCI, V33, P2898, DOI 10.1002/jssc.201000285; Liu XX, 2012, CHEM PHARM BULL, V60, P144, DOI 10.1248/cpb.60.144; Malik AK, 2010, J CHROMATOGR A, V1217, P4018, DOI 10.1016/j.chroma.2010.03.015; Mitamura M, 2002, EUR J PHARMACOL, V436, P217, DOI 10.1016/S0014-2999(01)01623-5; MURAYAMA M, 1984, EUR J PHARMACOL, V101, P29, DOI 10.1016/0014-2999(84)90027-X; Shim SH, 2003, CHEM PHARM BULL, V51, P999; Sleno L, 2005, J AM SOC MASS SPECTR, V16, P183, DOI 10.1016/j.jasms.2004.10.001; TAI YT, 1992, LANCET, V340, P1254, DOI 10.1016/0140-6736(92)92951-B; Tan GG, 2011, BIOMED CHROMATOGR, V25, P1343, DOI 10.1002/bmc.1607; Turabekova MA, 2004, MOLECULES, V9, P1194, DOI 10.3390/91201194; Turabekova MA, 2008, ENVIRON TOXICOL PHAR, V25, P310, DOI 10.1016/j.etap.2007.10.035; Wang FP, 2010, NAT PROD REP, V27, P529, DOI 10.1039/b916679c; Wang Y, 2002, RAPID COMMUN MASS SP, V16, P2075, DOI 10.1002/rcm.828; Werner E, 2008, ANAL CHEM, V80, P4918, DOI 10.1021/ac800094p; Wu W, 2007, J MASS SPECTROM, V42, P58, DOI 10.1002/jms.1138; Xie GB, 2003, HETEROCYCLES, V60, P631; Xie Y, 2005, J CHROMATOGR A, V1093, P195, DOI 10.1016/j.chroma.2005.07.071; Yang JH, 1999, PHYTOCHEMISTRY, V50, P345, DOI 10.1016/S0031-9422(98)00387-2; Yue H, 2009, TALANTA, V77, P1800, DOI 10.1016/j.talanta.2008.10.022; Yue H, 2008, ACTA CHIM SINICA, V66, P211; Zhang F, 2005, CHINESE CHEM LETT, V16, P1043	36	18	20	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52352	10.1371/journal.pone.0052352	http://dx.doi.org/10.1371/journal.pone.0052352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285005	gold, Green Submitted, Green Published			2022-12-25	WOS:000313158800053
J	Alexander, HM; Reed, AW; Kettle, WD; Slade, NA; Roels, SAB; Collins, CD; Salisbury, V				Alexander, Helen M.; Reed, Aaron W.; Kettle, W. Dean; Slade, Norman A.; Roels, Sarah A. Bodbyl; Collins, Cathy D.; Salisbury, Vaughn			Detection and Plant Monitoring Programs: Lessons from an Intensive Survey of Asclepias meadii with Five Observers	PLOS ONE			English	Article							MARK-RECAPTURE MODELS; DEMOGRAPHIC PARAMETERS; IMPERFECT DETECTION; DENSITY-ESTIMATION; POPULATION-SIZE; SURVIVAL; DORMANCY; ORCHID; CONSEQUENCES; CONSERVATION	Monitoring programs, where numbers of individuals are followed through time, are central to conservation. Although incomplete detection is expected with wildlife surveys, this topic is rarely considered with plants. However, if plants are missed in surveys, raw count data can lead to biased estimates of population abundance and vital rates. To illustrate, we had five independent observers survey patches of the rare plant Asclepias meadii at two prairie sites. We analyzed data with two mark-recapture approaches. Using the program CAPTURE, the estimated number of patches equaled the detected number for a burned site, but exceeded detected numbers by 28% for an unburned site. Analyses of detected patches using Huggins models revealed important effects of observer, patch state (flowering/nonflowering), and patch size (number of stems) on probabilities of detection. Although some results were expected (i.e. greater detection of flowering than nonflowering patches), the importance of our approach is the ability to quantify the magnitude of detection problems. We also evaluated the degree to which increased observer numbers improved detection: smaller groups (3-4 observers) generally found 90 - 99% of the patches found by all five people, but pairs of observers or single observers had high error and detection depended on which individuals were involved. We conclude that an intensive study at the start of a long-term monitoring study provides essential information about probabilities of detection and what factors cause plants to be missed. This information can guide development of monitoring programs. Citation: Alexander HM, Reed AW, Kettle WD, Slade NA, Bodbyl Roels SA, et al. (2012) Detection and Plant Monitoring Programs: Lessons from an Intensive Survey of Asclepias meadii with Five Observers. PLoS ONE 7(12): e52762. doi:10.1371/journal.pone.0052762	[Alexander, Helen M.; Slade, Norman A.; Roels, Sarah A. Bodbyl] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Reed, Aaron W.] Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; [Kettle, W. Dean; Salisbury, Vaughn] Univ Kansas, Kansas Biol Survey, Lawrence, KS 66045 USA; [Slade, Norman A.] Univ Kansas, Museum Nat Hist, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Collins, Cathy D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA	University of Kansas; University of Missouri System; University of Missouri Kansas City; University of Kansas; University of Kansas; Colby College	Alexander, HM (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	halexander@ku.edu	Roels, Sarah A Bodbyl/K-1221-2012	Bodbyl, Sarah/0000-0001-7590-677X	Kansas Biological Survey at the University of Kansas; University of Kansas Field Station (KUFS), a research unit of the Kansas Biological Survey; University of Kansas	Kansas Biological Survey at the University of Kansas; University of Kansas Field Station (KUFS), a research unit of the Kansas Biological Survey; University of Kansas	This work was supported by the Kansas Biological Survey at the University of Kansas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was conducted at and supported by the University of Kansas Field Station (KUFS), a research unit of the Kansas Biological Survey and the University of Kansas. This is publication number 912.	Alexander HM, 2009, J ECOL, V97, P267, DOI 10.1111/j.1365-2745.2008.01468.x; Alexander HM, 1997, ECOLOGY, V78, P1230, DOI 10.2307/2265872; Amstrup S. C., 2003, HDB CAPTURE RECAPTUR; [Anonymous], 1998, 17301 BLM; Betz, 1989, P 11 N AM PRAIR C, P13; Bouldin J, 2008, J BIOGEOGR, V35, P2000, DOI 10.1111/j.1365-2699.2008.01940.x; Bowles ML, 1998, ANN MO BOT GARD, V85, P110, DOI 10.2307/2992001; Buckland ST, 2007, BIOMETRICS, V63, P989, DOI 10.1111/j.1541-0420.2007.00798.x; Buckland S.T., 2001, pi; Burnham K. P., 1998, MODEL SELECTION INFE; Cahill JF, 2002, AM J BOT, V89, P1401, DOI 10.3732/ajb.89.9.1401; Chen GK, 2009, J ECOL, V97, P1383, DOI 10.1111/j.1365-2745.2009.01560.x; COLE DN, 1995, J APPL ECOL, V32, P215, DOI 10.2307/2404430; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Emry DJ, 2011, J APPL ECOL, V48, P1391, DOI 10.1111/j.1365-2664.2011.02050.x; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Goodwin KM, 2010, INVAS PLANT SCI MANA, V3, P113, DOI 10.1614/IPSM-D-09-00025.1; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Kery M, 2003, J ECOL, V91, P265, DOI 10.1046/j.1365-2745.2003.00759.x; Kery M, 2005, OIKOS, V108, P307, DOI 10.1111/j.0030-1299.2005.13589.x; Kery M, 2004, J ECOL, V92, P686, DOI 10.1111/j.0022-0477.2004.00885.x; Kery M, 2004, CONSERV BIOL, V18, P570, DOI 10.1111/j.1523-1739.2004.00105.x; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kettle WD, 2000, AM MIDL NAT, V144, P66, DOI 10.1674/0003-0031(2000)144[0066:AYESOA]2.0.CO;2; Kissa DO, 2012, FOREST ECOL MANAG, V263, P114, DOI 10.1016/j.foreco.2011.09.020; Lahoreau G., 2004, Animal Biodiversity and Conservation, V27, P549; Lesica P, 2007, J ECOL, V95, P1360, DOI 10.1111/j.1365-2745.2007.01291.x; Moore CT, 2011, J FISH WILDL MANAG, V2, P247, DOI 10.3996/012011-JFWM-007; Moore JL, 2011, ECOL APPL, V21, P601, DOI 10.1890/10-0590.1; NICHOLS JD, 1992, BIOSCIENCE, V42, P94, DOI 10.2307/1311650; Philippi T, 2001, NAT AREA J, V21, P111; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Regan TJ, 2011, J APPL ECOL, V48, P76, DOI 10.1111/j.1365-2664.2010.01915.x; Rexstad E., 1991, USERS GUIDE INTERACT; Ros M, 2004, COMMUN SOIL SCI PLAN, V35, P1591, DOI 10.1081/CSS-120038556; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Shefferson RP, 2001, ECOLOGY, V82, P145, DOI 10.2307/2680092; Shefferson RP, 2003, ECOLOGY, V84, P1199, DOI 10.1890/0012-9658(2003)084[1199:LHTIAR]2.0.CO;2; Slade NA, 2003, ECOLOGY, V84, P791, DOI 10.1890/0012-9658(2003)084[0791:EOPSAP]2.0.CO;2; Tecic DL, 1998, ANN MO BOT GARD, V85, P97, DOI 10.2307/2992000; U.S. Fish and WildlifeService, 2003, MEADS MILKW ASLC MEA; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 1982, LA8787NERP LOS AL NA; Williams B. K., 2002, ANAL MANAGEMENT ANIM	46	16	16	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52762	10.1371/journal.pone.0052762	http://dx.doi.org/10.1371/journal.pone.0052762			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285179	Green Published, gold			2022-12-25	WOS:000312794500244
J	Duan, W; Ran, H; Zhou, ZJ; He, QF; Zheng, J				Duan, Wei; Ran, Hong; Zhou, Zhujuan; He, Qifen; Zheng, Jian			Adenosine A2A Receptor Deficiency Up-Regulates Cystatin F Expression in White Matter Lesions Induced by Chronic Cerebral Hypoperfusion	PLOS ONE			English	Article							A(2A) RECEPTORS; DENDRITIC CELLS; CYSTEINE CATHEPSINS; GENE-EXPRESSION; INNATE IMMUNITY; BRAIN-INJURY; ACTIVATION; MICROGLIA; STRIATUM; ISCHEMIA	In previous studies, we have shown that the inactivation of the adenosine A2A receptor exacerbates chronic cerebral hypoperfusion-induced white matter lesions (WMLs) by enhancing neuroinflammatory responses. However, the molecular mechanism underlying the effect of the adenosine A2A receptor remains unknown. Recent studies have demonstrated that cystatin F, a potent endogenous cysteine protease inhibitor, is selectively expressed in immune cells in association with inflammatory demyelination in central nervous system diseases. To understand the expression of cystatin F and its potential role in the effect of A2A receptor on WMLs induced through chronic cerebral hypoperfusion, we investigated cystatin F expression in the WMLs of A2A receptor gene knockout mice, the littermate wild-type mice and wild-type mice treated daily with the A2A receptor agonist CGS21680 or both CGS21680 and A2A receptor antagonist SCH58261 after chronic cerebral hypoperfusion. The results of quantitative-PCR and western blot analysis revealed that cystatin F mRNA and protein expression were significantly up-regulated in the WMLs after chronic cerebral hypoperfusion. In addition, cystatin F expression in the corpus callosum was significantly increased in A2A receptor gene knockout mice and markedly decreased in mice treated with CGS21680 on both the mRNA and protein levels. Additionally, SCH58261 counteracted the attenuation of cystatin F expression produced by CGS21680 after chronic cerebral hypoperfusion. Moreover, double immunofluorescence staining revealed that cystatin F was co-localized with the activated microglia marker CD11b. In conclusion, the cystatin F expression in the activated microglia is closely associated with the effect of the A2A receptors, which may be related to the neuroinflammatory responses occurring during the pathological process.	[Duan, Wei; Ran, Hong; Zhou, Zhujuan; He, Qifen; Zheng, Jian] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China	Army Medical University	Zheng, J (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, Chongqing, Peoples R China.	jzheng59@hotmail.com	zhou, zhou/HCH-1084-2022		National Natural Science Foundation of China [81100891, 81070933]; Youth Creation Foundation of Third Military Medical University [2010XQN29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Creation Foundation of Third Military Medical University	This work was supported by grants from the National Natural Science Foundation of China (No. 81100891, No. 81070933) and the Youth Creation Foundation of Third Military Medical University (No.2010XQN29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangert C, 2003, J INVEST DERMATOL, V121, P1409, DOI 10.1111/j.1523-1747.2003.12623.x; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Colbert JD, 2011, J BIOL CHEM, V286, P42082, DOI 10.1074/jbc.M111.253914; Colbert JD, 2009, TRAFFIC, V10, P425, DOI 10.1111/j.1600-0854.2009.00881.x; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Deng YY, 2008, BRAIN PATHOL, V18, P387, DOI 10.1111/j.1750-3639.2008.00138.x; Duan W, 2009, J NEUROL SCI, V285, P39, DOI 10.1016/j.jns.2009.05.010; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Hashimoto S, 2000, BLOOD, V96, P2206, DOI 10.1182/blood.V96.6.2206.h8002206_2206_2214; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hof PR., 2000, COMP CYTOARCHITECTON; Itziou A, 2009, CHEMOSPHERE, V76, P1315, DOI 10.1016/j.chemosphere.2009.06.032; Izzotti A, 2009, BRAIN PATHOL, V19, P650, DOI 10.1111/j.1750-3639.2008.00229.x; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Langerholc T, 2005, FEBS J, V272, P1535, DOI 10.1111/j.1742-4658.2005.04594.x; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Ma JM, 2011, J NEUROSCI RES, V89, P639, DOI 10.1002/jnr.22567; Magister S, 2012, EUR J CELL BIOL, V91, P391, DOI 10.1016/j.ejcb.2012.01.001; Mayne M, 2001, ANN NEUROL, V49, P727, DOI 10.1002/ana.1010; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Monopoli A, 1998, J PHARMACOL EXP THER, V285, P9; Moorhouse P, 2008, LANCET NEUROL, V7, P246, DOI 10.1016/S1474-4422(08)70040-1; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Omori K, 2007, CELL TISSUE RES, V330, P75, DOI 10.1007/s00441-007-0457-8; Orru M, 2011, NEUROPHARMACOLOGY, V61, P967, DOI 10.1016/j.neuropharm.2011.06.025; Pintor A, 2001, EUR J PHARMACOL, V421, P177, DOI 10.1016/S0014-2999(01)01058-5; Popoli P, 2002, J NEUROSCI, V22, P1967, DOI 10.1523/JNEUROSCI.22-05-01967.2002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reece TB, 2004, J SURG RES, V121, P130, DOI 10.1016/j.jss.2004.04.006; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Verdot L, 1999, EUR J BIOCHEM, V266, P1111, DOI 10.1046/j.1432-1327.1999.00964.x; Wakita H, 1999, NEUROREPORT, V10, P1461, DOI 10.1097/00001756-199905140-00013; Yu LQ, 2004, NAT MED, V10, P1081, DOI 10.1038/nm1103	42	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52566	10.1371/journal.pone.0052566	http://dx.doi.org/10.1371/journal.pone.0052566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285090	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500197
J	Lin, SL; Tarrant, M; Hui, LL; Kwok, MK; Lam, TH; Leung, GM; Schooling, CM				Lin, Shi Lin; Tarrant, Marie; Hui, Lai Ling; Kwok, Man Ki; Lam, Tai Hing; Leung, Gabriel M.; Schooling, C. Mary			The Role of Dairy Products and Milk in Adolescent Obesity: Evidence from Hong Kong's "Children of 1997" Birth Cohort	PLOS ONE			English	Article							BODY-FAT; BEVERAGE CONSUMPTION; SOCIOECONOMIC-STATUS; MULTIPLE IMPUTATION; DIETARY CALCIUM; WEIGHT-GAIN; CHILDHOOD; ADIPOSITY; CHINESE; BONE	Background: Observational studies, mainly from Western populations, suggest dairy consumption is inversely associated with adiposity. However, in these populations the intake range is limited and both diet and obesity may share social patterning. Evidence from non-Western developed settings with different social patterning, is valuable in distinguishing whether observed associations are biologically mediated or socially confounded. Objective: To examine the associations of milk or other dairy product consumption with adolescent obesity. Methods: We used multivariable linear regression models to examine the associations of milk or other dairy product consumption, obtained from a food frequency questionnaire, at 11 years with body mass index (BMI) z-scores at 13 years and waist hip ratio (WHR) at 11 years, in 5,968 adolescents from a Chinese birth cohort, comprising 88% of births in April and May 1997. We used multiple imputation for missing exposures and confounders. Results: Only 65.7% regularly consumed milk and 72.4% other dairy products. Milk and other dairy product consumption was positively associated with socio-economic position but not with BMI z-score or WHR, with or without adjustment for sex, mother's birthplace, parental education, physical activity and other food consumption. Conclusions: The lack of association of milk and other dairy product consumption with adiposity in a non-Western setting was not consistent with the majority of evidence from Western settings. Observed anti-obesigenic effects in Western settings may be due to socially patterned confounding.	[Lin, Shi Lin; Hui, Lai Ling; Kwok, Man Ki; Lam, Tai Hing; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Tarrant, Marie] Univ Hong Kong, Li Ka Shing Fac Med, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA	University of Hong Kong; University of Hong Kong; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Lifestyle & Life Course Epidemiol Grp, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	cms1@hkucc.hku.hk	Hui, Lai Ling/C-4528-2009; Lam, Tai Hing/C-4317-2009	HUI, Lai Ling/0000-0003-0688-3329; Kwok, Man Ki/0000-0003-3777-4766; Leung, Gabriel/0000-0002-2503-6283; Lam, Tai Hing/0000-0002-2033-9971; Schooling, Mary/0000-0001-9933-5887	Health Care and Promotion Fund, Health and Welfare Bureau, Government of Hong Kong (HCPF) [216106]; Health and Health Services Research Fund (HHSRF) [03040771, 07080751, 08090761]; Research Fund for the Control of Infectious Diseases in Hong Kong (RFCID), Government of the Hong Kong SAR [04050172]; University Research Committee Strategic Research Theme (SRT) of Public Health Granted Research, The University of Hong Kong	Health Care and Promotion Fund, Health and Welfare Bureau, Government of Hong Kong (HCPF); Health and Health Services Research Fund (HHSRF); Research Fund for the Control of Infectious Diseases in Hong Kong (RFCID), Government of the Hong Kong SAR; University Research Committee Strategic Research Theme (SRT) of Public Health Granted Research, The University of Hong Kong	The initial "Infant health and lifestyle survey" was funded by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of Hong Kong (HCPF Grant # 216106). Since 2005, the "Children of 1997" birth cohort has been funded by the Health and Health Services Research Fund (HHSRF Grants #03040771, #07080751, #08090761) and the Research Fund for the Control of Infectious Diseases in Hong Kong (RFCID Grant # 04050172), Government of the Hong Kong SAR. The "Children of 1997" birth cohort has also received funding from the University Research Committee Strategic Research Theme (SRT) of Public Health Granted Research, The University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Barba G, 2005, BRIT J NUTR, V93, P15, DOI 10.1079/BJN20041300; Berkey CS, 2005, ARCH PEDIAT ADOL MED, V159, P543, DOI 10.1001/archpedi.159.6.543; Cadogan J, 1997, BMJ-BRIT MED J, V315, P1255, DOI 10.1136/bmj.315.7118.1255; Carruth BR, 2001, INT J OBESITY, V25, P559, DOI 10.1038/sj.ijo.0801562; Census and Statistics Department, 2007, HEALTH; Central Health Education Unit Centre for Health Protection, 2006, BAS ASS PROM HLTH EA; CHAN GM, 1995, J PEDIATR-US, V126, P551, DOI 10.1016/S0022-3476(95)70348-9; Development Core Team, 2005, R LANG ENV STAT COMP; Fiorito LM, 2009, AM J CLIN NUTR, V90, P935, DOI 10.3945/ajcn.2009.27623; Harrell, 2010, HMISC HARRELL MISCEL; Harrell FE, 2001, REGRESSION MODELING; Hoglund D, 1998, EUR J CLIN NUTR, V52, P784, DOI 10.1038/sj.ejcn.1600644; Huh SY, 2010, J AM DIET ASSOC, V110, P563, DOI 10.1016/j.jada.2009.12.025; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Johnson L, 2007, NUTRITION, V23, P557, DOI 10.1016/j.nut.2007.05.005; Lam TH, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e91; Lin SL, 2011, INT J EPIDEMIOL, V40, P1238, DOI 10.1093/ije/dyr086; Louie JCY, 2011, OBES REV, V12, pE582, DOI 10.1111/j.1467-789X.2011.00881.x; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Merrilees MJ, 2000, EUR J NUTR, V39, P256, DOI 10.1007/s003940070004; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Moore LL, 2006, OBESITY, V14, P1010, DOI 10.1038/oby.2006.116; NeumarkSztainer D, 1997, J NUTR EDUC, V29, P12, DOI 10.1016/S0022-3182(97)70141-9; Newby PK, 2004, J AM DIET ASSOC, V104, P1086, DOI 10.1016/j.jada.2004.04.020; Novotny R, 2004, J NUTR, V134, P1905, DOI 10.1093/jn/134.8.1905; Phillips SM, 2003, INT J OBESITY, V27, P1106, DOI 10.1038/sj.ijo.0802370; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Schooling CM, 2010, ARCH DIS CHILD, V95, P437, DOI 10.1136/adc.2009.168542; Schooling CM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-49; Schooling CM, 2006, INT J EPIDEMIOL, V35, P418, DOI 10.1093/ije/dyi296; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; Tam CS, 2006, INT J OBESITY, V30, P1091, DOI 10.1038/sj.ijo.0803328; WHO, 2007, WHO GROWTH REF 5 19; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2005, INT J OBESITY, V29, P391, DOI 10.1038/sj.ijo.0802880; Zemel MB, 2004, OBES RES, V12, P582, DOI 10.1038/oby.2004.67	41	19	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52575	10.1371/journal.pone.0052575	http://dx.doi.org/10.1371/journal.pone.0052575			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285099	gold, Green Published			2022-12-25	WOS:000312794500203
J	Rathakrishnan, A; Wang, SM; Hu, YL; Khan, AM; Ponnampalavanar, S; Lum, LCS; Manikam, R; Sekaran, SD				Rathakrishnan, Anusyah; Wang, Seok Mui; Hu, Yongli; Khan, Asif M.; Ponnampalavanar, Sasheela; Lum, Lucy Chai See; Manikam, Rishya; Sekaran, Shamala Devi			Cytokine Expression Profile of Dengue Patients at Different Phases of Illness	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; NECROSIS-FACTOR-ALPHA; VIRUS-INFECTION; HEMORRHAGIC-FEVER; INTERFERON-GAMMA; LIVER-INJURY; INDUCIBLE PROTEIN-10; ADHESION MOLECULES; ENDOTHELIAL-CELLS; DISEASE SEVERITY	Background: Dengue is an important medical problem, with symptoms ranging from mild dengue fever to severe forms of the disease, where vascular leakage leads to hypovolemic shock. Cytokines have been implicated to play a role in the progression of severe dengue disease; however, their profile in dengue patients and the synergy that leads to continued plasma leakage is not clearly understood. Herein, we investigated the cytokine kinetics and profiles of dengue patients at different phases of illness to further understand the role of cytokines in dengue disease. Methods and Findings: Circulating levels of 29 different types of cytokines were assessed by bead-based ELISA method in dengue patients at the 3 different phases of illness. The association between significant changes in the levels of cytokines and clinical parameters were analyzed. At the febrile phase, IP-10 was significant in dengue patients with and without warning signs. However, MIP-1 beta was found to be significant in only patients with warning signs at this phase. IP-10 was also significant in both with and without warning signs patients during defervescence. At this phase, MIP-1b beta and G-CSF were significant in patients without warning signs, whereas MCP-1 was noted to be elevated significantly in patients with warning signs. Significant correlations between the levels of VEGF, RANTES, IL-7, IL-12, PDGF and IL-5 with platelets; VEGF with lymphocytes and neutrophils; G-CSF and IP-10 with atypical lymphocytes and various other cytokines with the liver enzymes were observed in this study. Conclusions: The cytokine profile patterns discovered between the different phases of illness indicate an essential role in dengue pathogenesis and with further studies may serve as predictive markers for progression to dengue with warning signs.	[Rathakrishnan, Anusyah; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Wang, Seok Mui] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia; [Hu, Yongli; Khan, Asif M.] Perdana Univ, Grad Sch Med, Serdang, Selangor, Malaysia; [Khan, Asif M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Ponnampalavanar, Sasheela] Univ Malaya, Med Ctr, Dept Infect Dis, Kuala Lumpur, Malaysia; [Lum, Lucy Chai See] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Manikam, Rishya] Univ Malaya, Med Ctr, Dept Trauma & Emergency Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Teknologi MARA; Perdana University; Johns Hopkins University; Universiti Malaya; Universiti Malaya; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	shamalamy@yahoo.com	Lum, Lucy/Q-9871-2017; Wang, Seok Mui/X-5856-2019; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Manikam, Rishya/F-5908-2014; Devi, Shamala Devi/B-9735-2010; wang, seok mui/C-3205-2011; Khan, Mohammad Asif/F-4663-2010; Sekaran, Shamala Devi/B-8482-2008; Khan, M. Asif/ABE-7839-2021	Lum, Lucy/0000-0002-7452-4208; Wang, Seok Mui/0000-0002-3631-6504; Devi, Shamala Devi/0000-0002-0478-0425; Khan, Mohammad Asif/0000-0001-9202-279X; Sekaran, Shamala Devi/0000-0002-0478-0425; Khan, M. Asif/0000-0001-9202-279X; sri la sri ponnampalavanar, sasheela/0000-0002-4506-1304	High Impact Research (HIR) [J-00000-73560]; University Malaya Research Grant (UMRG) [RG081/09HTM]; University Malaya Peruntukan Jangka Pendek (UMPJP) [FS245/008B]	High Impact Research (HIR); University Malaya Research Grant (UMRG); University Malaya Peruntukan Jangka Pendek (UMPJP)	Project was funded by High Impact Research (HIR) J-00000-73560; University Malaya Research Grant (UMRG) RG081/09HTM; and University Malaya Peruntukan Jangka Pendek (UMPJP) FS245/008B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 1997, J VIROL, V71, P4226, DOI 10.1128/JVI.71.6.4226-4232.1997; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Azeredo EL, 2006, CLIN EXP IMMUNOL, V143, P345, DOI 10.1111/j.1365-2249.2006.02996.x; Becerra A, 2009, J MED VIROL, V81, P1403, DOI 10.1002/jmv.21538; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Bruno CM, 2011, ANN SAUDI MED, V31, P360, DOI 10.4103/0256-4947.83215; BURKEGAFFNEY A, 1993, IMMUNOPHARMACOLOGY, V25, P1, DOI 10.1016/0162-3109(93)90025-L; Bussolati B, 2000, CLIN EXP IMMUNOL, V122, P471, DOI 10.1046/j.1365-2249.2000.01392.x; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cardier JE, 2006, ENDOTHELIUM-J ENDOTH, V13, P335, DOI 10.1080/10623320600972135; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; Chaturvedi UC, 2009, INDIAN J MED RES, V129, P1; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-165; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; CZAJA MJ, 1994, J LEUKOCYTE BIOL, V55, P120, DOI 10.1002/jlb.55.1.120; DAHINDEN CA, 1994, J EXP MED, V179, P751, DOI 10.1084/jem.179.2.751; Dewberry RM, 2003, CIRC RES, V92, P1285, DOI 10.1161/01.RES.0000078172.52740.9B; Dinarello CA, 1999, METHODS, V19, P121, DOI 10.1006/meth.1999.0837; Elsammak MY, 2008, PARASITE IMMUNOL, V30, P603, DOI 10.1111/j.1365-3024.2008.01061.x; Gabay C, 1997, J CLIN INVEST, V99, P2930, DOI 10.1172/JCI119488; Gear ARL, 2003, MICROCIRCULATION, V10, P335, DOI 10.1038/sj.mn.7800198; Gonzalez D, 2005, INT J INFECT DIS, V9, P280, DOI 10.1016/j.ijid.2004.07.012; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Heil M, 2000, EUR J CELL BIOL, V79, P850, DOI 10.1078/0171-9335-00113; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Jamaluddin MS, 2009, ARTERIOSCL THROM VAS, V29, P2146, DOI 10.1161/ATVBAHA.109.194134; Khongphatthanayothin A, 2006, JPN J INFECT DIS, V59, P186; Kishimoto S, 1996, J IMMUNOL, V157, P4126; Kohno K, 1997, J IMMUNOL, V158, P1541; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1289, DOI 10.1152/ajpgi.2001.280.6.G1289; Koraka P, 2001, J CLIN MICROBIOL, V39, P4332, DOI 10.1128/JCM.39.12.4332-4338.2001; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kurane I, 1992, Semin Immunol, V4, P121; LAM S K, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P532; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Leifeld L, 2002, HEPATOLOGY, V36, P1001, DOI 10.1053/jhep.2002.35532; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Narumi S, 1997, J IMMUNOL, V158, P5536; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Seki T, 2012, INFECT IMMUN, V80, P159, DOI 10.1128/IAI.05581-11; Sierra B, 2010, CYTOKINE, V52, P175, DOI 10.1016/j.cyto.2010.06.010; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; [TDR WHO World Health O Special Programme for R Training in Tropical D World Health Organization Department of Control of Neglected Tropical D World Health Organization E], 2009, DENGUE GUIDELINES FO; Tung KH, 2010, J CHIN MED ASSOC, V73, P67, DOI 10.1016/S1726-4901(10)70004-6; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Wasilewska A, 2005, PEDIATR INT, V47, P424, DOI 10.1111/j.1442-200x.2005.02078.x; Watt G, 2003, AM J TROP MED HYG, V68, P536, DOI 10.4269/ajtmh.2003.68.536; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662; Yoshidome H, 1999, AM J PATHOL, V155, P1059, DOI 10.1016/S0002-9440(10)65208-X	64	124	125	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52215	10.1371/journal.pone.0052215	http://dx.doi.org/10.1371/journal.pone.0052215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284941	gold, Green Published			2022-12-25	WOS:000312794500116
J	Voets, GM; Platteel, TN; Fluit, AC; Scharringa, J; Schapendonk, CM; Stuart, JC; Bonten, MJM; Leverstein-van Hal, MA				Voets, Guido M.; Platteel, Tamara N.; Fluit, Ad C.; Scharringa, Jelle; Schapendonk, Claudia M.; Stuart, James Cohen; Bonten, Marc J. M.; Leverstein-van Hal, Maurine A.		Natl ESBL Surveillance Working Grp	Population Distribution of Beta-Lactamase Conferring Resistance to Third-Generation Cephalosporins in Human Clinical Enterobacteriaceae in The Netherlands	PLOS ONE			English	Article							ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; CANADIAN HOSPITALS; NATIONWIDE SURVEY; PREVALENCE; AMPC; EPIDEMIOLOGY; EVOLUTION; ANIMALS; CLOACAE	There is a global increase in infections caused by Enterobacteriaceae with plasmid-borne beta-lactamases that confer resistance to third-generation cephalosporins. The epidemiology of these bacteria is not well understood, and was, therefore, investigated in a selection of 636 clinical Enterobacteriaceae with a minimal inhibitory concentration >1 mg/L for ceftazidime/ceftriaxone from a national survey (75% E. coli, 11% E. cloacae, 11% K. pneumoniae, 2% K. oxytoca, 2% P. mirabilis). Isolates were investigated for extended-spectrum beta-lactamases (ESBLs) and ampC genes using microarray, PCR, gene sequencing and molecular straintyping (Diversilab and multi-locus sequence typing (MLST)). ESBL genes were demonstrated in 512 isolates (81%); of which 446 (87%) belonged to the CTX-M family. Among 314 randomly selected and sequenced isolates, bla(CTX-M-15) was most prevalent (n = 124, 39%), followed by bla(CTX-M-1) (n = 47, 15%), bla(CTX-M-14) (n = 15, 5%), bla(SHV-12) (n = 24, 8%) and bla(TEM-52) (n = 13, 4%). Among 181 isolates with MIC >= 16 mg/L for cefoxitin plasmid encoded AmpCs were detected in 32 and 27 were of the CMY-2 group. Among 102 E. coli isolates with MIC >= 16 mg/L for cefoxitin ampC promoter mutations were identified in 29 (28%). Based on Diversilab genotyping of 608 isolates (similarity cut-off >98%) discriminatory indices of bacteria with ESBL and/or ampC genes were 0.994, 0.985 and 0.994 for E. coli, K. pneumoniae and E. cloacae, respectively. Based on similarity cut-off >95% two large clusters of E. coli were apparent (of 43 and 30 isolates) and 21 of 21 that were typed by belonged to ST131 of which 13 contained bla(CTX-M-15). Our findings demonstrate that bla(CTX-M-15) is the most prevalent ESBL and we report a larger than previously reported prevalence of ampC genes among Enterobacteriaceae responsible for resistance to third-generation cephalosporins.	[Voets, Guido M.; Platteel, Tamara N.; Fluit, Ad C.; Scharringa, Jelle; Schapendonk, Claudia M.; Stuart, James Cohen; Bonten, Marc J. M.; Leverstein-van Hal, Maurine A.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Platteel, Tamara N.] SALTRO, Dept Med Microbiol, Utrecht, Netherlands; [Leverstein-van Hal, Maurine A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Voets, GM (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	g.voets@umcutrecht.nl						Al Naiemi N, 2005, J CLIN MICROBIOL, V43, P4862, DOI 10.1128/JCM.43.9.4862-4864.2005; Bogaerts P, 2010, PATHOL BIOL, V58, P78, DOI 10.1016/j.patbio.2009.07.035; Brigante G, 2005, INT J ANTIMICROB AG, V25, P157, DOI 10.1016/j.ijantimicag.2004.09.013; Caroff N, 1999, FEMS MICROBIOL LETT, V173, P459, DOI 10.1016/S0378-1097(99)00111-1; Cortes P, 2010, APPL ENVIRON MICROB, V76, P2799, DOI 10.1128/AEM.02421-09; Corvec S, 2010, DIAGN MICR INFEC DIS, V67, P277, DOI 10.1016/j.diagmicrobio.2010.02.007; Dierikx C, 2010, VET MICROBIOL, V145, P273, DOI 10.1016/j.vetmic.2010.03.019; Empel J, 2008, ANTIMICROB AGENTS CH, V52, P2449, DOI 10.1128/AAC.00043-08; Fluit AC, 2010, J CLIN MICROBIOL, V48, P3979, DOI 10.1128/JCM.01191-10; Galas M, 2008, ANTIMICROB AGENTS CH, V52, P786, DOI 10.1128/AAC.00906-07; Gniadkowski M, 2008, CLIN MICROBIOL INFEC, V14, P11, DOI 10.1111/j.1469-0691.2007.01854.x; Haldorsen B, 2008, J ANTIMICROB CHEMOTH, V62, P694, DOI 10.1093/jac/dkn257; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Luzzaro F, 2006, J CLIN MICROBIOL, V44, P1659, DOI 10.1128/JCM.44.5.1659-1664.2006; Mulvey MR, 2005, ANTIMICROB AGENTS CH, V49, P358, DOI 10.1128/AAC.49.1.358-365.2005; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Paniague R, 2010, DIAGN MICR INFEC DIS, V67, P376, DOI 10.1016/j.diagmicrobio.2010.03.012; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Rottman M, 2002, FEMS MICROBIOL LETT, V210, P87, DOI 10.1016/S0378-1097(02)00613-4; Siu LK, 2003, ANTIMICROB AGENTS CH, V47, P2138, DOI 10.1128/AAC.47.7.2138-2144.2003; Smet A, 2008, ANTIMICROB AGENTS CH, V52, P1238, DOI 10.1128/AAC.01285-07; Sturm PDJ, 2010, MICROB DRUG RESIST, V16, P55, DOI 10.1089/mdr.2009.0107; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Wiegand I, 2007, J CLIN MICROBIOL, V45, P1167, DOI 10.1128/JCM.01988-06; Woodford N, 2007, J ANTIMICROB CHEMOTH, V59, P102, DOI 10.1093/jac/dkl456; Zhanel GG, 2010, ANTIMICROB AGENTS CH, V54, P4684, DOI 10.1128/AAC.00469-10	30	45	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52102	10.1371/journal.pone.0052102	http://dx.doi.org/10.1371/journal.pone.0052102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284886	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500091
J	Westerman, LJ; Stel, HV; Schipper, MEI; Bakker, LJ; Neefjes-Borst, EA; van den Brande, JHM; Boel, ECH; Seldenrijk, KA; Siersema, PD; Bonten, MJM; Kusters, JG				Westerman, Laurens J.; Stel, Herbert V.; Schipper, Marguerite E. I.; Bakker, Leendert J.; Neefjes-Borst, Eskelina A.; van den Brande, Jan H. M.; Boel, Edwin C. H.; Seldenrijk, Kees A.; Siersema, Peter D.; Bonten, Marc J. M.; Kusters, Johannes G.			Development of a Real-Time PCR for Identification of Brachyspira Species in Human Colonic Biopsies	PLOS ONE			English	Article							HUMAN INTESTINAL SPIROCHETOSIS; 16S RIBOSOMAL-RNA; IN-SITU HYBRIDIZATION; SEQUENCE ALIGNMENT; TREPONEMA-HYODYSENTERIAE; CLINICAL-SIGNIFICANCE; SERPULINA PILOSICOLI; SWINE DYSENTERY; SP-NOV; AALBORGI	Background: Brachyspira species are fastidious anaerobic microorganisms, that infect the colon of various animals. The genus contains both important pathogens of livestock as well as commensals. Two species are known to infect humans: B. aalborgi and B. pilosicoli. There is some evidence suggesting that the veterinary pathogenic B. pilosicoli is a potential zoonotic agent, however, since diagnosis in humans is based on histopathology of colon biopsies, species identification is not routinely performed in human materials. Methods: The study population comprised 57 patients with microscopic evidence of Brachyspira infection and 26 patients with no histopathological evidence of Brachyspira infection. Concomitant faecal samples were available from three infected patients. Based on publically available 16S rDNA gene sequences of all Brachyspira species, species-specific primer sets were designed. DNA was extracted and tested by real-time PCR and 16S rDNA was sequenced. Results: Sensitivity and specificity for identification of Brachyspira species in colon biopsies was 100% and 87.7% respectively. Sequencing revealed B. pilosicoli in 15.4% of patients, B. aalborgi in 76.9% and a third species, tentatively named "Brachyspira hominis", in 26.2%. Ten patients (12.3%) had a double and two (3.1%) a triple infection. The presence of Brachyspira pilosicoli was significantly associated with inflammatory changes in the colon-biopsy (p = 0.028). Conclusions: This newly designed PCR allows for sub-differentiation of Brachyspira species in patient material and thus allows large-scaled surveillance studies to elucidate the pathogenicity of human Brachyspira infections. One-third of affected patients appeared to be infected with a novel species.	[Westerman, Laurens J.; Boel, Edwin C. H.; Bonten, Marc J. M.; Kusters, Johannes G.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Stel, Herbert V.] Tergooiziekenhuizen, Dept Pathol, Hilversum, Netherlands; [Schipper, Marguerite E. I.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bakker, Leendert J.] Tergooiziekenhuizen, Cent Lab Bacteriol & Serol, Hilversum, Netherlands; [Neefjes-Borst, Eskelina A.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [van den Brande, Jan H. M.] Tergooiziekenhuizen, Dept Internal Med, Hilversum, Netherlands; [Seldenrijk, Kees A.] St Antonius Hosp, Dept Pathol, Nieuwegein, Netherlands; [Siersema, Peter D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Kusters, JG (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	H.Kusters@UMCUtrecht.nl	Siersema, Peter/V-1636-2019; Westerman, Laurens/H-1630-2013	Neefjes-Borst, Andra/0000-0001-7945-7916				Atyeo RF, 1999, VET MICROBIOL, V67, P47, DOI 10.1016/S0378-1135(99)00030-9; Bait-Merabet Lilia, 2008, Ann Clin Microbiol Antimicrob, V7, P19, DOI 10.1186/1476-0711-7-19; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; GLOCK RD, 1972, VET MED SM ANIM CLIN, V67, P65; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GREER CE, 1991, AM J CLIN PATHOL, V95, P117, DOI 10.1093/ajcp/95.2.117; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; HARRIS DL, 1972, J AM VET MED ASSOC, V160, P561; HOVINDHOUGEN K, 1982, J CLIN MICROBIOL, V16, P1127, DOI 10.1128/JCM.16.6.1127-1136.1982; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jensen TK, 2004, J MED MICROBIOL, V53, P341, DOI 10.1099/jmm.0.05402-0; Jensen TK, 2001, J CLIN MICROBIOL, V39, P4111, DOI 10.1128/JCM.39.11.4111-4118.2001; KASBOHRER A, 1990, DEUT MED WOCHENSCHR, V115, P1499, DOI 10.1055/s-2008-1065183; Korner M, 2003, INFECTION, V31, P341, DOI 10.1007/s15010-003-3145-y; LEE FD, 1971, GUT, V12, P126, DOI 10.1136/gut.12.2.126; LEE JI, 1994, J MED MICROBIOL, V40, P365, DOI 10.1099/00222615-40-5-365; McLaren AJ, 1997, J CLIN MICROBIOL, V35, P412, DOI 10.1128/JCM.35.2.412-417.1997; Mikosza Andrew S. J., 2001, Animal Health Research Reviews, V2, P101; Mikosza ASJ, 2003, J CLIN MICROBIOL, V41, P4492, DOI 10.1128/JCM.41.9.4492.2003; Mikosza ASJ, 2004, J MED MICROBIOL, V53, P333, DOI 10.1099/jmm.0.05430-0; Mikosza ASJ, 2001, FEMS MICROBIOL LETT, V197, P167, DOI 10.1111/j.1574-6968.2001.tb10599.x; Mikosza ASJ, 2001, J CLIN MICROBIOL, V39, P347, DOI 10.1128/JCM.39.1.347-350.2001; Munshi MA, 2003, J CLIN MICROBIOL, V41, P1187, DOI 10.1128/JCM.41.3.1187-1191.2003; NEEF NA, 1994, INFECT IMMUN, V62, P2395, DOI 10.1128/IAI.62.6.2395-2403.1994; Niesters HGM, 2002, J CLIN VIROL, V25, pS3; Pettersson B, 1996, J BACTERIOL, V178, P4189, DOI 10.1128/jb.178.14.4189-4199.1996; Pettersson B, 2000, SYST APPL MICROBIOL, V23, P355, DOI 10.1016/S0723-2020(00)80065-X; Phillips ND, 2006, VET MICROBIOL, V116, P239, DOI 10.1016/j.vetmic.2006.03.020; Prim N, 2011, J CLIN MICROBIOL, V49, P3697, DOI 10.1128/JCM.00680-11; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato H, 2010, J MED MICROBIOL, V59, P791, DOI 10.1099/jmm.0.017376-0; Songer JG, 1976, INT PIG VET SOC 4 IN; Stanton TB, 1998, INT J SYST BACTERIOL, V48, P669, DOI 10.1099/00207713-48-3-669; Stanton TB, 1996, FEMS MICROBIOL LETT, V136, P181, DOI 10.1111/j.1574-6968.1996.tb08046.x; Stephens C. P., 2001, Animal Health Research Reviews, V2, P83; TAYLOR DJ, 1980, VET REC, V106, P326, DOI 10.1136/vr.106.15.326; TROTT DJ, 1995, INFECT IMMUN, V63, P3705, DOI 10.1128/IAI.63.9.3705-3710.1995; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; van Mook WNKA, 2004, EUR J GASTROEN HEPAT, V16, P83, DOI 10.1097/00042737-200401000-00013; Weisheit B, 2007, SCAND J GASTROENTERO, V42, P1422, DOI 10.1080/00365520701245629	45	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52281	10.1371/journal.pone.0052281	http://dx.doi.org/10.1371/journal.pone.0052281			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284968	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500134
J	Vasaturo, A; Caserta, S; Russo, I; Preziosi, V; Ciacci, C; Guido, S				Vasaturo, Angela; Caserta, Sergio; Russo, Ilaria; Preziosi, Valentina; Ciacci, Carolina; Guido, Stefano			A Novel Chemotaxis Assay in 3-D Collagen Gels by Time-Lapse Microscopy	PLOS ONE			English	Article							LEUKOCYTE MIGRATION; CONTACT GUIDANCE; CELL CHEMOTAXIS; RAT MODEL; INTERLEUKIN-8; CHEMOKINES; INFLAMMATION; ORIENTATION; NEUTROPHILS; LOCOMOTION	The directional cell response to chemical gradients, referred to as chemotaxis, plays an important role in physiological and pathological processes including development, immune response and tumor cell invasion. Despite such implications, chemotaxis remains a challenging process to study under physiologically-relevant conditions in-vitro, mainly due to difficulties in generating a well characterized and sustained gradient in substrata mimicking the in-vivo environment while allowing dynamic cell imaging. Here, we describe a novel chemotaxis assay in 3D collagen gels, based on a reusable direct-viewing chamber in which a chemoattractant gradient is generated by diffusion through a porous membrane. The diffusion process has been analysed by monitoring the concentration of FITC-labelled dextran through epifluorescence microscopy and by comparing experimental data with theoretical and numerical predictions based on Fick's law. Cell migration towards chemoattractant gradients has been followed by time-lapse microscopy and quantified by cell tracking based on image analysis techniques. The results are expressed in terms of chemotactic index (I) and average cell velocity. The assay has been tested by comparing the migration of human neutrophils in isotropic conditions and in the presence of an Interleukin-8 (IL-8) gradient. In the absence of IL-8 stimulation, 80% of the cells showed a velocity ranging from 0 to 1 mm/min. However, in the presence of an IL-8 gradient, 60% of the cells showed an increase in velocity reaching values between 2 and 7 mm/min. Furthermore, after IL-8 addition, I increased from 0 to 0.25 and 0.25 to 0.5, respectively, for the two donors examined. These data indicate a pronounced directional migration of neutrophils towards the IL-8 gradient in 3D collagen matrix. The chemotaxis assay described here can be adapted to other cell types and may serve as a physiologically relevant method to study the directed locomotion of cells in a 3D environment in response to different chemoattractants.	[Vasaturo, Angela; Caserta, Sergio; Preziosi, Valentina; Guido, Stefano] Univ Naples Federico II, Dipartimento Ingn Chim, Naples, Italy; [Caserta, Sergio; Guido, Stefano] CEINGE Adv Biotechnol, Naples, Italy; [Russo, Ilaria; Ciacci, Carolina] Univ Salerno, Sch Med, Gastrointestinal Unit Baronissi, I-84100 Salerno, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Salerno	Caserta, S (corresponding author), Univ Naples Federico II, Dipartimento Ingn Chim, Naples, Italy.	sergio.caserta@unina.it	Russo, Ilaria/V-2549-2017; Caserta, Sergio/E-4602-2012; Guido, Stefano/B-9928-2011; ciacci, carolina/A-2594-2012	Caserta, Sergio/0000-0002-4400-0059; Guido, Stefano/0000-0002-9247-6852; ciacci, carolina/0000-0002-7426-1145; Preziosi, Valentina/0000-0002-8852-5703; VASATURO, ANGELA/0000-0001-7985-3820	Italian Ministry of Research [prot. 2006099155, prot. 2008W3WBMH]	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR))	Financial support from the Italian Ministry of Research (PRIN 2006, prot. 2006099155 and PRIN 2008, prot. 2008W3WBMH) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggiolini M, 2000, IMMUNOL TODAY, V21, P418, DOI 10.1016/S0167-5699(00)01672-8; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bonvin C, 2010, BIOTECHNOL BIOENG, V105, P982, DOI 10.1002/bit.22608; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Buonomo R, 2012, J CELL PHYSIOL, V227, P2106, DOI 10.1002/jcp.22944; Caserta S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.137801; Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3; Cristini V, 2005, CLIN CANCER RES, V11, P6772, DOI 10.1158/1078-0432.CCR-05-0852; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; D'Argenio G, 2012, DIGEST LIVER DIS, V44, P555, DOI 10.1016/j.dld.2012.01.009; Dallon JC, 1999, J THEOR BIOL, V199, P449, DOI 10.1006/jtbi.1999.0971; De Luca AC, 2008, MACROMOLECULES, V41, P5512, DOI 10.1021/ma800866m; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Di Costanzo A, 2012, J BIOL CHEM, V287, P30170, DOI 10.1074/jbc.M112.349951; DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241; FREVERT CW, 1995, J IMMUNOL, V154, P335; Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl Peter, 2004, Methods Mol Biol, V239, P77; Gionchetti P, 1997, GUT, V40, P102, DOI 10.1136/gut.40.1.102; Gobeaux F, 2008, J MOL BIOL, V376, P1509, DOI 10.1016/j.jmb.2007.12.047; GUIDO S, 1993, J CELL SCI, V105, P317; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Haugh JM, 2006, CHEM ENG SCI, V61, P5603, DOI 10.1016/j.ces.2006.04.041; Herzmark P, 2007, P NATL ACAD SCI USA, V104, P13349, DOI 10.1073/pnas.0705889104; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jonas A, 2010, LANGMUIR, V26, P14223, DOI 10.1021/la101498h; Kinoshita M, 2011, INFECT IMMUN, V79, P2670, DOI 10.1128/IAI.01298-10; Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2009, METHOD ENZYMOL, V461, P333, DOI 10.1016/S0076-6879(09)05415-9; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; MOGHE PV, 1995, J IMMUNOL METHODS, V180, P193, DOI 10.1016/0022-1759(94)00314-M; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; NELSON RD, 1975, J IMMUNOL, V115, P1650; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Pommella A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.138301; Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Shao JB, 2009, LAB CHIP, V9, P3118, DOI 10.1039/b909312e; Silano M., 2012, PEDIAT RES; Sixt M, 2011, METHODS MOL BIOL, V769, P149, DOI 10.1007/978-1-61779-207-6_11; Tsai WC, 2000, INFECT IMMUN, V68, P4289, DOI 10.1128/IAI.68.7.4289-4296.2000; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	56	22	22	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52251	10.1371/journal.pone.0052251	http://dx.doi.org/10.1371/journal.pone.0052251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284956	Green Published, gold, Green Submitted			2022-12-25	WOS:000312694300083
J	Smith, LM; Schiess, MC; Coffey, MP; Klaver, AC; Loeffler, DA				Smith, Lynnae M.; Schiess, Mya C.; Coffey, Mary P.; Klaver, Andrea C.; Loeffler, David A.			alpha-Synuclein and Anti-alpha-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; LEWY BODY; ELEVATED LEVELS; HUMAN PLASMA; AUTOANTIBODIES; AGGREGATION; DUPLICATION; BIOMARKER; DEMENTIA; MUTATION	alpha-synuclein is thought to play a key role in Parkinson's disease (PD) because it is the major protein in Lewy bodies, and because its gene mutations, duplication, and triplication are associated with early-onset PD. There are conflicting reports as to whether serum and plasma concentrations of alpha-synuclein and anti-alpha-synuclein antibodies differ between PD and control subjects. The objectives of this study were to compare the levels of alpha-synuclein and its antibodies between individuals with typical PD (n = 14), atypical Parkinson syndromes (n = 11), idiopathic rapid eye movement sleep behavior disorder (n = 10), and healthy controls (n = 9), to assess the strength of association between these serum proteins, and to determine group sizes needed for a high probability (80% power) of detecting statistical significance for 25% or 50% differences between typical PD and control subjects for these measurements. Analysis of log-transformed data found no statistically significant differences between groups for either alpha-synuclein or its antibodies. The concentrations of these proteins were weakly correlated (Spearman rho = 0.16). In subjects with typical PD and atypical Parkinson syndromes, anti-alpha-synuclein antibody levels above 1.5 mu g/ ml were detected only in subjects with no more than four years of clinical disease. Power analysis indicated that 236 and 73 samples per group would be required for an 80% probability that 25% and 50% differences, respectively, in mean alpha-synuclein levels between typical PD and control subjects would be statistically significant; for anti-asynuclein antibodies, 283 and 87 samples per group would be required. Our findings are consistent with those previous studies which suggested that serum concentrations of alpha-synuclein and its antibodies are not significantly altered in PD.	[Smith, Lynnae M.; Klaver, Andrea C.; Loeffler, David A.] Beaumont Hlth Syst, Dept Neurol Res, Royal Oak, MI USA; [Schiess, Mya C.] Univ Texas Houston, Sch Med, Dept Neurol, Houston, TX USA; [Coffey, Mary P.] Beaumont Hlth Syst, Dept Biostat, Royal Oak, MI USA	Beaumont Health; University of Texas System; University of Texas Health Science Center Houston; Beaumont Health	Loeffler, DA (corresponding author), Beaumont Hlth Syst, Dept Neurol Res, Royal Oak, MI USA.	DLoeffler@beaumont.edu			Oakland University - Beaumont Hospital	Oakland University - Beaumont Hospital	This study was supported by an Oakland University - Beaumont Hospital Multidisciplinary Grant and a donation from the family of Mr. Norman Merollis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1998, AM J PATHOL, V152, P879; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Gruden MA, 2012, NEUROIMMUNOMODULAT, V19, P334, DOI 10.1159/000341400; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Hintze J., 2011, PASS11; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Iranzo A, 2011, J NEUROL SCI, V310, P283, DOI 10.1016/j.jns.2011.07.049; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jellinger KA, 2003, MOVEMENT DISORD, V18, pS2, DOI 10.1002/mds.10557; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Laske C, 2011, DEMENT GERIATR COGN, V31, P413, DOI 10.1159/000329763; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Maetzler W, 2011, J ALZHEIMERS DIS, V26, P171, DOI 10.3233/JAD-2011-110221; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Patrias LM, 2010, CLIN EXP IMMUNOL, V161, P527, DOI 10.1111/j.1365-2249.2010.04214.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; *SAS I, 2008, SAS SYST WIND VERS 9; Schenck CH, 1996, NEUROLOGY, V46, P388, DOI 10.1212/WNL.46.2.388; Schrag A, 2006, LANCET NEUROL, V5, P355, DOI 10.1016/S1474-4422(06)70411-2; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Smith LM, 2012, INT IMMUNOPHARMACOL, V14, P550, DOI 10.1016/j.intimp.2012.09.007; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Woulfe J, 2000, NEUROLOGY, V55, P1398, DOI 10.1212/WNL.55.9.1398; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	43	44	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52285	10.1371/journal.pone.0052285	http://dx.doi.org/10.1371/journal.pone.0052285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055RZ	23284971	Green Published, Green Submitted, gold			2022-12-25	WOS:000312435900087
J	Delbin, MA; Davel, APC; Couto, GK; de Araujo, GG; Rossoni, LV; Antunes, E; Zanesco, A				Delbin, Maria A.; Davel, Ana Paula C.; Couto, Gisele Kruger; de Araujo, Gustavo G.; Rossoni, Luciana Venturini; Antunes, Edson; Zanesco, Angelina			Interaction between Advanced Glycation End Products Formation and Vascular Responses in Femoral and Coronary Arteries from Exercised Diabetic Rats	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; INSULIN-RESISTANCE; HYPERPOLARIZING FACTOR; OXIDANT STRESS; SMOOTH-MUSCLE; MOLECULAR-MECHANISMS; PHYSICAL-ACTIVITY; CAROTID ARTERIES; BLOOD-PRESSURE; UP-REGULATION	Background: The majority of studies have investigated the effect of exercise training (TR) on vascular responses in diabetic animals (DB), but none evaluated nitric oxide (NO) and advanced glycation end products (AGEs) formation associated with oxidant and antioxidant activities in femoral and coronary arteries from trained diabetic rats. Our hypothesis was that 8-week TR would alter AGEs levels in type 1 diabetic rats ameliorating vascular responsiveness. Methodology/Principal Findings: Male Wistar rats were divided into control sedentary (C/SD), sedentary diabetic (SD/DB), and trained diabetic (TR/DB). DB was induced by streptozotocin (i.p.: 60 mg/kg). TR was performed for 60 min per day, 5 days/week, during 8 weeks. Concentration-response curves to acetylcholine (ACh), sodium nitroprusside (SNP), phenylephrine (PHE) and tromboxane analog (U46619) were obtained. The protein expressions of eNOS, receptor for AGEs (RAGE), Cu/Zn-SOD and Mn-SOD were analyzed. Tissues NO production and reactive oxygen species (ROS) generation were evaluated. Plasma nitrate/nitrite (NOx-), superoxide dismutase (SOD), catalase (CAT), thiobarbituric acid reactive substances (TBARS) and N-epsilon-(carboxymethyl) lysine (CML, AGE biomarker). A rightward shift in the concentration-response curves to ACh was observed in femoral and coronary arteries from SD/DB that was accompanied by an increase in TBARS and CML levels. Decreased in the eNOS expression, tissues NO production and NOx- levels were associated with increased ROS generation. A positive interaction between the beneficial effect of TR on the relaxing responses to ACh and the reduction in TBARS and CML levels were observed without changing in antioxidant activities. The eNOS protein expression, tissues NO production and ROS generation were fully re-established in TR/DB, but plasma NOx- levels were partially restored. Conclusion: Shear stress induced by TR fully restores the eNOS/NO pathway in both preparations from non-treated diabetic rats, however, a massive production of AGEs still affecting relaxing responses possibly involving other endothelium-dependent vasodilator agents, mainly in coronary artery.	[Delbin, Maria A.; de Araujo, Gustavo G.; Zanesco, Angelina] Univ Sao Paulo State UNESP, Dept Phys Educ, Inst Biosci, Sao Paulo, Brazil; [Davel, Ana Paula C.] Univ Estadual Campinas, Dept Anat Cellular Biol Physiol & Biophys, Inst Biol, Sao Paulo, Brazil; [Couto, Gisele Kruger; Rossoni, Luciana Venturini] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Antunes, Edson] Univ Estadual Campinas, Dept Pharmacol, Fac Med Sci, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Zanesco, A (corresponding author), Univ Sao Paulo State UNESP, Dept Phys Educ, Inst Biosci, Sao Paulo, Brazil.	azanesco@rc.unesp.br	ANTUNES, EDSON/F-6731-2012; Zanesco, Angelina/V-6154-2019; Fisiologia comparada, Inct/I-2427-2013; Davel, Ana P/L-8801-2013; Zanesco, Angelina/N-3632-2013; Zanesco, Angelina/AAF-6370-2019; de Araujo, Gustavo Gomes/C-9172-2013; Rossoni, Luciana Venturini/C-7226-2012; Rossoni, Luciana Venturini/AFR-0021-2022; Delbin, Maria A/F-4233-2012	ANTUNES, EDSON/0000-0003-2201-8247; Zanesco, Angelina/0000-0002-2515-1871; Davel, Ana P/0000-0002-9862-4262; Rossoni, Luciana Venturini/0000-0002-0944-9483; Delbin, Maria/0000-0002-3537-055X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avogaro A, 2008, DIABETES RES CLIN PR, V82, pS94, DOI 10.1016/j.diabres.2008.09.021; Bavenholm PN, 2000, DIABETES, V49, P1078, DOI 10.2337/diabetes.49.7.1078; Belotto MF, 2010, CLIN EXP IMMUNOL, V162, P237, DOI 10.1111/j.1365-2249.2010.04240.x; BLONDEL O, 1989, DIABETES METAB, V15, P382; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Brandes RP, 2000, P NATL ACAD SCI USA, V97, P9747, DOI 10.1073/pnas.97.17.9747; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Cao J, 2008, INT J MOL SCI, V9, P2388, DOI 10.3390/ijms9122388; Chakraphan D, 2005, CLIN HEMORHEOL MICRO, V32, P217; Chimen M, 2012, DIABETOLOGIA, V55, P542, DOI 10.1007/s00125-011-2403-2; Christopher MJ, 2003, J APPL PHYSIOL, V95, P1523, DOI 10.1152/japplphysiol.00199.2003; Claudino MA, 2011, LIFE SCI, V88, P272, DOI 10.1016/j.lfs.2010.11.018; Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098; Colberg SR, 2007, CURR DIABETES REV, V3, P176; Colleran PN, 2010, J PHYSIOL-LONDON, V588, P1293, DOI 10.1113/jphysiol.2009.186247; Cong L, 2001, Wei Sheng Yan Jiu, V30, P158; Davel AP, 2012, TOXICOLOGY, V295, P39, DOI 10.1016/j.tox.2012.02.004; de Moraes C, 2008, BMC PHYSL, V29, P8; Delbin MA, 2011, INFLAMMATION, V34, P319, DOI 10.1007/s10753-010-9237-9; Di Pascoli M, 2006, BIOCHEM BIOPH RES CO, V340, P935, DOI 10.1016/j.bbrc.2005.12.082; Dong L, 2008, J CEREBR BLOOD F MET, V28, P377, DOI 10.1038/sj.jcbfm.9600536; Farmer DGS, 2009, PHARMACOL THERAPEUT, V124, P185, DOI 10.1016/j.pharmthera.2009.06.013; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fuchsjager-Mayrl G, 2002, DIABETES CARE, V25, P1795, DOI 10.2337/diacare.25.10.1795; Fukao M, 1997, BRIT J PHARMACOL, V121, P1383, DOI 10.1038/sj.bjp.0701258; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gupte S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011800; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Harthmann AD, 2007, AUTON NEUROSCI-BASIC, V133, P115, DOI 10.1016/j.autneu.2006.10.004; HATTORI Y, 1991, AM J PHYSIOL, V261, pH1086, DOI 10.1152/ajpheart.1991.261.4.H1086; Janghorbani M, 2007, DIABETES CARE, V30, P1730, DOI 10.2337/dc06-2363; Kamata K, 2000, N-S ARCH PHARMACOL, V362, P52, DOI 10.1007/s002100000248; Kamper M, 2010, TRANSL RES, V156, P26, DOI 10.1016/j.trsl.2010.05.004; Kojda G, 2005, CARDIOVASC RES, V67, P187, DOI 10.1016/j.cardiores.2005.04.032; Koltai MZ, 1997, CARDIOVASC RES, V34, P157; Kuru O, 2009, J APPL PHYSIOL, V107, P896, DOI 10.1152/japplphysiol.91180.2008; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Lu X, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-48; Malakul W, 2008, CLIN EXP PHARMACOL P, V35, P192, DOI 10.1111/j.1440-1681.2007.04811.x; McAllister RM, 1996, J APPL PHYSIOL, V80, P216, DOI 10.1152/jappl.1996.80.1.216; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Nemoto S, 2012, PEPTIDES, V33, P109, DOI 10.1016/j.peptides.2011.11.018; Nin JW, 2011, DIABETES CARE, V34, P442, DOI 10.2337/dc10-1087; Okamoto MM, 2011, J ENDOCRINOL, V211, P55, DOI 10.1530/JOE-11-0105; Parker JL, 1997, J APPL PHYSIOL, V83, P434, DOI 10.1152/jappl.1997.83.2.434; Perseghin G, 2003, AM J PHYSIOL-ENDOC M, V285, pE1174, DOI 10.1152/ajpendo.00279.2003; Pieper GM, 1997, CARDIOVASC RES, V34, P145, DOI 10.1016/S0008-6363(96)00237-4; Pieper GM, 1999, DIABETOLOGIA, V42, P204, DOI 10.1007/s001250051140; Pieper GM, 1998, J CARDIOVASC PHARM, V32, P101, DOI 10.1097/00005344-199807000-00016; Ramalho AC, 2006, DIABETES RES CLIN PR, V72, P271, DOI 10.1016/j.diabres.2005.11.011; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Rojas A, 2000, CIRC RES, V86, pE50, DOI 10.1161/01.RES.86.3.e50; SCHMIDT AM, 1994, ARTERIOSCLER THROMB, V14, P1521, DOI 10.1161/01.ATV.14.10.1521; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Seeger JPH, 2011, DIABETES OBES METAB, V13, P382, DOI 10.1111/j.1463-1326.2011.01361.x; Shao CH, 2009, J APPL PHYSIOL, V106, P1280, DOI 10.1152/japplphysiol.91280.2008; Shi Y, 2008, BRIT J PHARMACOL, V154, P639, DOI 10.1038/bjp.2008.110; Shi Y, 2006, J PHARMACOL EXP THER, V318, P276, DOI 10.1124/jpet.105.099739; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Sponton CHG, 2010, EUR J CARDIOV PREV R, V17, P676, DOI 10.1097/HJR.0b013e32833a1301; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Wang RX, 2012, CHINESE MED J-PEKING, V125, P2548, DOI 10.3760/cma.j.issn.0366-6999.2012.14.028; Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685, DOI 10.1152/ajpendo.2001.280.5.E685; Wenzel P, 2008, FREE RADICAL BIO MED, V45, P619, DOI 10.1016/j.freeradbiomed.2008.05.009; Williams RS, 2005, PLOS MED, V2, P209, DOI 10.1371/journal.pmed.0020068; Wu Y, 2000, Zhonghua Yi Xue Za Zhi, V80, P172; Xu B, 2003, FASEB J, V17, P1289, DOI 10.1096/fj.02-0490fje; YAN SD, 1994, J BIOL CHEM, V269, P9889; YKIJARVINEN H, 1984, DIABETES CARE, V7, P520, DOI 10.2337/diacare.7.6.520; Zanesco A, 1997, J PHARMACOL EXP THER, V280, P677; Zanesco A, 2007, PHARMACOL THERAPEUT, V114, P307, DOI 10.1016/j.pharmthera.2007.03.010; Zaros P. R., 2009, BMC WOMENS HEALTH, V19, P9; Zhao ZW, 2011, ARZNEIMITTEL-FORSCH, V61, P239, DOI 10.1055/s-0031-1296194	79	38	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53318	10.1371/journal.pone.0053318	http://dx.doi.org/10.1371/journal.pone.0053318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285277	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500131
J	Liu, JY; Ulloa, A; Perrone-Bizzozero, N; Yeo, R; Chen, JY; Calhoun, VD				Liu, Jingyu; Ulloa, Alvaro; Perrone-Bizzozero, Nora; Yeo, Ronald; Chen, Jiayu; Calhoun, Vince D.			A Pilot Study on Collective Effects of 22q13.31 Deletions on Gray Matter Concentration in Schizophrenia	PLOS ONE			English	Article							COPY-NUMBER VARIATION; INDEPENDENT COMPONENT ANALYSIS; FMRI DATA; GENES; GENOME; SUSCEPTIBILITY; METAANALYSIS; ASSOCIATION; VARIANTS; PATHWAYS	The association of copy number variation (CNV) with schizophrenia has been reported with evidence of increased frequency of both rare and large CNVs. Yet, little is known about the impact of CNVs in brain structure. In this pilot study, we explored collective effects of all CNVs in each cytogenetic band on the risk of schizophrenia and gray matter variation measured in structural magnetic resonance imaging. With 324 participants' CNV profiles (151 schizophrenia patients and 173 healthy controls), we first extracted specific CNV features that differ between patients and controls using a two sample t-test, and then tested their associations with gray matter concentration using a linear regression model in a subset of 301 participants. Our data first provided evidence of population structure in CNV features where elevated rare CNV burden in schizophrenia patients was confounded by the levels associated with African American subjects. We considered this ethnic group difference in the following cytoband analyses. Deletions in one cytoband 22q13.31 were observed significantly (p<0.05) more in patients than controls from all samples after controlling ethnicity, and the deletion load was also significantly (p = 1.44 x 10(-4)) associated with reduced gray matter concentration of a brain network mainly comprised of the cingulate gyrus and insula. Since 80% deletion carriers were patients, patients with deletions also showed reduced gray matter concentration compared with patients without deletions (p = 3.36 x 10(-4)). Our findings indicate that regional CNVs at 22q13.31, no matter the size, may influence the risk of schizophrenia with a remarkably increased mutation rate and with reduced gray matter concentration in the peri-limbic cortex. This proof-of-concept study suggests that the CNVs occurring at some 'hotspots' may in fact cause biological downstream effects and larger studies are important for confirming our initial results.	[Liu, Jingyu; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Liu, Jingyu; Ulloa, Alvaro; Chen, Jiayu; Calhoun, Vince D.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Perrone-Bizzozero, Nora; Calhoun, Vince D.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Yeo, Ronald] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Liu, JY (corresponding author), Mind Res Network, Albuquerque, NM USA.	jliu@mrn.org	Chen, Jiayu/Q-9042-2017; Ulloa, Alvaro/ABD-3900-2021; Calhoun, Vince D./ACN-9399-2022	Calhoun, Vince D./0000-0001-9058-0747; Ulloa-Cerna, Alvaro/0000-0001-8899-0026; Liu, Jingyu/0000-0002-1724-7523	NIH, Centers of Biomedical Research Excellence [5P20 RR021938]; Department of Energy [DE-FG02-99ER62764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER	NIH, Centers of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This project was funded by NIH, Centers of Biomedical Research Excellence; Contract grant number: 5P20 RR021938. The data collection was funded by the Department of Energy, grant DE-FG02-99ER62764. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Burbach JPH, 2009, TRENDS NEUROSCI, V32, P69, DOI 10.1016/j.tins.2008.11.002; Calhoun VD, 2006, IEEE ENG MED BIOL, V25, P79, DOI 10.1109/MEMB.2006.1607672; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P598, DOI 10.1002/hbm.20204; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Chen JY, 2011, IEEE ENG MED BIO, P6975, DOI 10.1109/IEMBS.2011.6091763; Chen JY, 2010, IEEE INT C BIO BIO W, P827, DOI 10.1109/BIBMW.2010.5703928; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dauber A, 2011, AM J HUMAN GENETICS; Dhar SU, 2010, AM J MED GENET A, V152A, P573, DOI 10.1002/ajmg.a.33253; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Goldmuntz E, 2005, CLIN PERINATOL, V32, P963, DOI 10.1016/j.clp.2005.09.006; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lachman HM, 2007, AM J MED GENET B, V144B, P259, DOI 10.1002/ajmg.b.30498; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Liu J, 2011, ADDICTION BIOL; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Meyer-Lindenberg Andreas, 2010, Dialogues Clin Neurosci, V12, P449; Momma K, 1999, PEDIATR CARDIOL, V20, P97, DOI 10.1007/s002469900414; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pearlson GD, 1999, BIOL PSYCHIAT, V46, P627, DOI 10.1016/S0006-3223(99)00071-2; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Xu L, 2009, HUM BRAIN MAPP, V30, P711, DOI 10.1002/hbm.20540; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yeo RA, 2011, BIOL PSYCHIAT; Yeo RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016339	55	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52865	10.1371/journal.pone.0052865	http://dx.doi.org/10.1371/journal.pone.0052865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285208	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500073
J	Vigneswara, V; Berry, M; Logan, A; Ahmed, Z				Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair			Pharmacological Inhibition of Caspase-2 Protects Axotomised Retinal Ganglion Cells from Apoptosis in Adult Rats	PLOS ONE			English	Article							OPTIC-NERVE LESION; CPP32-LIKE PROTEASES; DELAYED DEATH; CLEAVAGE; DEGENERATION; NEUROPROTECTION; REGENERATION; ACTIVATION; NEURONS; TARGET	Severing the axons of retinal ganglion cells (RGC) by crushing the optic nerve (ONC) causes the majority of RGC to degenerate and die, primarily by apoptosis. We showed recently that after ONC in adult rats, caspase-2 activation occurred specifically in RGC while no localisation of caspase-3 was observed in ganglion cells but in cells of the inner nuclear layer. We further showed that inhibition of caspase-2 using a single injection of stably modified siRNA to caspase-2 protected almost all RGC from death at 7 days, offering significant protection for up to 1 month after ONC. In the present study, we confirmed that cleaved caspase-2 was localised and activated in RGC (and occasional neurons in the inner nuclear layer), while TUNEL+ RGC were also observed after ONC. We then investigated if suppression of caspase-2 using serial intravitreal injections of the pharmacological inhibitor z-VDVAD-fmk (z-VDVAD) protected RGC from death for 15 days after ONC. Treatment of eyes with z-VDVAD suppressed cleaved caspase-2 activation by >85% at 3-4 days after ONC. Increasing concentrations of z-VDVAD protected greater numbers of RGC from death at 15 days after ONC, up to a maximum of 60% using 4000 ng/ml of z-VDVAD, compared to PBS treated controls. The 15-day treatment with 4000 ng/ml of z-VDVAD after ONC suppressed levels of cleaved caspase-2 but no significant changes in levels of cleaved caspase-3, -6, -7 or -8 were detected. Although suppression of caspase-2 protected 60% of RGC from death, RGC axon regeneration was not promoted. These results suggest that caspase-2 specifically mediates death of RGC after ONC and that suppression of caspase-2 may be a useful therapeutic strategy to enhance RGC survival not only after axotomy but also in diseases where RGC death occurs such as glaucoma and optic neuritis.	[Vigneswara, Vasanthy; Berry, Martin; Logan, Ann; Ahmed, Zubair] Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of Birmingham	Ahmed, Z (corresponding author), Univ Birmingham, Neurotrauma & Neurodegenerat Sect, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England.	z.ahmed.1@bham.ac.uk	Ahmed, Zubair/AAN-1869-2021	Logan, Ann/0000-0003-3215-5042	Wellcome Trust [092539/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a grant from the Wellcome Trust, grant no: 092539/Z/10/Z to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2008, MOL VIS, V14, P1050; Ahmed Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.54; Ahmed Z, 2005, MOL CELL NEUROSCI, V28, P64, DOI 10.1016/j.mcn.2004.08.013; Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Ahmed Z, 2010, NEUROBIOL DIS, V37, P441, DOI 10.1016/j.nbd.2009.10.024; Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Baltmr A, 2010, EXP EYE RES, V91, P554, DOI 10.1016/j.exer.2010.08.009; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bernstein SL, 2011, PROG RETIN EYE RES, V30, P167, DOI 10.1016/j.preteyeres.2011.02.003; Berry M, 1996, J NEUROCYTOL, V25, P147, DOI 10.1007/BF02284793; Berry M, 1999, J NEUROCYTOL, V28, P721, DOI 10.1023/A:1007086004022; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; CASCIOLAROSEN LA, 1994, J BIOL CHEM, V269, P30757; Chauvier D, 2007, CELL DEATH DIFFER, V14, P387, DOI 10.1038/sj.cdd.4402044; Chierzi S, 1998, VISION RES, V38, P1537, DOI 10.1016/S0042-6989(97)00332-5; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Ehrenschwender M, 2010, CELL DEATH DIFFER, V17, P1435, DOI 10.1038/cdd.2010.36; Finn JT, 2000, J NEUROSCI, V20, P1333; Fischer U, 2006, ONCOGENE, V25, P152, DOI 10.1038/sj.onc.1209015; GARCIAVALENZUELA E, 1994, J NEUROBIOL, V25, P431, DOI 10.1002/neu.480250408; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Kermer P, 1999, FEBS LETT, V453, P361, DOI 10.1016/S0014-5793(99)00747-4; Kermer P, 1998, J NEUROSCI, V18, P4656; Kermer P, 1998, EUR J NEUROSCI, V10, P202; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Koeberle PD, 1998, VISION RES, V38, P1505, DOI 10.1016/S0042-6989(97)00364-7; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kurokawa T, 1999, INVEST OPHTH VIS SCI, V40, P3006; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lucius R, 1997, MOL BRAIN RES, V48, P181, DOI 10.1016/S0169-328X(97)00170-8; Monnier PP, 2011, J NEUROSCI, V31, P10494, DOI 10.1523/JNEUROSCI.0148-11.2011; Niizuma K, 2008, P NATL ACAD SCI USA, V105, P16368, DOI 10.1073/pnas.0806222105; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Porter AG, 1997, BIOESSAYS, V19, P501, DOI 10.1002/bies.950190609; RABACCHI SA, 1994, J NEUROSCI, V14, P5292; Ribe EM, 2012, BIOCHEM J, V444, P591, DOI 10.1042/BJ20111588; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Singh M, 2001, J NEUROCHEM, V77, P466, DOI 10.1046/j.1471-4159.2001.00258.x; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Troy CM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.138pe42; Troy CM, 2000, J NEUROSCI, V20, P1386; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Weishaupt JH, 2003, NEUROBIOL DIS, V13, P124, DOI 10.1016/S0969-9961(03)00032-9; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200	55	37	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53473	10.1371/journal.pone.0053473	http://dx.doi.org/10.1371/journal.pone.0053473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285297	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500152
J	Wang, CJ; Yang, W; Wang, C; Gu, C; Niu, DD; Liu, HX; Wang, YP; Guo, JH				Wang, Chun-Juan; Yang, Wei; Wang, Chao; Gu, Chun; Niu, Dong-Dong; Liu, Hong-Xia; Wang, Yun-Peng; Guo, Jian-Hua			Induction of Drought Tolerance in Cucumber Plants by a Consortium of Three Plant Growth-Promoting Rhizobacterium Strains	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; STRESS-INDUCED CHANGES; SUPEROXIDE-DISMUTASE; ACTIVE OXYGEN; RESISTANCE; EXPRESSION; L.; INOCULATION; ALLEVIATION; SUBSTANCES	Our previous work showed that a consortium of three plant growth-promoting rhizobacterium (PGPR) strains (Bacillus cereus AR156, Bacillus subtilis SM21, and Serratia sp. XY21), termed as BBS for short, was a promising biocontrol agent. The present study investigated its effect on drought tolerance in cucumber plants. After withholding watering for 13 days, BBS-treated cucumber plants had much darker green leaves and substantially lighter wilt symptoms than control plants. Compared to the control, the BBS treatment decreased the leaf monodehydroascorbate (MDA) content and relative electrical conductivity by 40% and 15%, respectively; increased the leaf proline content and the root recovery intension by 3.45-fold and 50%, respectively; and also maintained the leaf chlorophyll content in cucumber plants under drought stress. Besides, in relation to the control, the BBS treatment significantly enhanced the superoxide dismutase (SOD) activity and mitigated the drought-triggered down-regulation of the expression of the genes cAPX, rbcL, and rbcS encoding cytosolic ascorbate peroxidase, and ribulose-1,5-bisphosphate carboxy/oxygenase (Rubisco) large and small subunits, respectively, in cucumber leaves. However, 1-aminocyclopropane-1-carboxylate (ACC) deaminase activity was undetected in none of the culture solutions of three BBS constituent strains. These results indicated that BBS conferred induced systemic tolerance to drought stress in cucumber plants, by protecting plant cells, maintaining photosynthetic efficiency and root vigor and increasing some of antioxidase activities, without involving the action of ACC deaminase to lower plant ethylene levels.	[Wang, Chun-Juan; Yang, Wei; Wang, Chao; Niu, Dong-Dong; Liu, Hong-Xia; Wang, Yun-Peng; Guo, Jian-Hua] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Wang, Chun-Juan; Yang, Wei; Wang, Chao; Niu, Dong-Dong; Liu, Hong-Xia; Wang, Yun-Peng; Guo, Jian-Hua] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Nanjing, Jiangsu, Peoples R China; [Gu, Chun; Guo, Jian-Hua] Anfeng Biogen Pesticide Engn Ctr Jiangsu Prov, Taicang, Peoples R China; [Yang, Wei] Huaiyin Normal Univ, Sch Life Sci, Jiangsu Key Lab Ecoagr Biotechnol Hongze Lake, Huaian, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Huaiyin Normal University	Wang, YP (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ypwang@njau.edu.cn; jhguo@njau.edu.cn			National Natural Science Foundation of China [30971956, 31000876, 31171809]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100097120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (30971956, 31000876, and 31171809) and the Specialized Research Fund for the Doctoral Program of Higher Education of China (20100097120012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogadallah GM, 2011, PLANT SCI, V180, P540, DOI 10.1016/j.plantsci.2010.12.004; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Ashraf M, 2005, FLORA, V200, P535, DOI 10.1016/j.flora.2005.06.005; Asrar AWA, 2011, SAUDI J BIOL SCI, V18, P93, DOI 10.1016/j.sjbs.2010.06.007; Ben Romdhane S, 2009, SOIL BIOL BIOCHEM, V41, P2568, DOI 10.1016/j.soilbio.2009.09.020; Benabdellah K, 2011, EUR J SOIL BIOL, V47, P303, DOI 10.1016/j.ejsobi.2011.07.004; Borowicz VA, 2010, PEDOBIOLOGIA, V53, P265, DOI 10.1016/j.pedobi.2010.01.001; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chen Xing-du, 2008, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V28, P136; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dobra J, 2011, J PLANT PHYSIOL, V168, P1588, DOI 10.1016/j.jplph.2011.02.009; Figueiredo MVB, 2008, APPL SOIL ECOL, V40, P182, DOI 10.1016/j.apsoil.2008.04.005; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Glombitza S, 2004, PLANT MOL BIOL, V54, P817, DOI 10.1007/s11103-004-0274-3; Guo JH, 2009, State Intellectual Property Office of the People's Republic of China. Patent, Patent No. [ZL 200810088388.X, 200810088388]; Guo JH, 2009, [Trademark Office of The State Administration For Industry & Commerce of the People'S Republic of China, Patent application number], Patent No. 7823197; Guo JH, 2011, State Intellectual Property Office of the People's Republic of China. Patent, Patent No. [200710130838.2, 2007101308382]; Hu HuiFang, 2008, Journal of Shenyang Agricultural University, V39, P83; Franzini VI, 2010, J PLANT PHYSIOL, V167, P614, DOI 10.1016/j.jplph.2009.11.010; Jaleel CA, 2007, COLLOID SURFACE B, V60, P201, DOI 10.1016/j.colsurfb.2007.06.010; Kane KH, 2011, ENVIRON EXP BOT, V71, P337, DOI 10.1016/j.envexpbot.2011.01.002; Kohler J, 2008, FUNCT PLANT BIOL, V35, P141, DOI 10.1071/FP07218; Li KR, 2008, NEW FOREST, V35, P255, DOI 10.1007/s11056-007-9075-2; Liu RX, 2008, AGR WATER MANAGE, V95, P1261, DOI 10.1016/j.agwat.2008.05.002; Liu Ruizhi, 2009, Journal of Ocean University of China, V8, P303, DOI 10.1007/s11802-009-0303-6; Lu SY, 2009, PLANT PHYSIOL BIOCH, V47, P132, DOI 10.1016/j.plaphy.2008.10.006; Mascher R, 2005, PLANT SCI, V168, P691, DOI 10.1016/j.plantsci.2004.09.036; Mayak S, 2004, PLANT SCI, V166, P525, DOI 10.1016/j.plantsci.2003.10.025; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moore BD, 1999, PLANT CELL ENVIRON, V22, P567, DOI 10.1046/j.1365-3040.1999.00432.x; Garcia AN, 2011, MYCORRHIZA, V21, P53, DOI 10.1007/s00572-010-0310-x; Niu DD, 2012, BIOCONTROL SCI TECHN, V22, P991, DOI 10.1080/09583157.2012.706595; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; OSONUBI O, 1991, PLANT SOIL, V136, P131, DOI 10.1007/BF02465228; Patnaik D, 2001, ELECT J BIOTECH, V4, P74; Qiu ZB, 2007, J PHOTOCHEMISTRY PHO, V90, P17; Sharp RG, 2011, SCI HORTIC-AMSTERDAM, V129, P804, DOI 10.1016/j.scienta.2011.03.016; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Sun CA, 2010, J PLANT PHYSIOL, V167, P1009, DOI 10.1016/j.jplph.2010.02.013; TANAKA K, 1990, AGR BIOL CHEM TOKYO, V54, P2629, DOI 10.1080/00021369.1990.10870355; Timmusk S, 1999, MOL PLANT MICROBE IN, V12, P951, DOI 10.1094/MPMI.1999.12.11.951; Vazquez MM, 2001, PLANT SCI, V161, P347, DOI 10.1016/S0168-9452(01)00416-2; Wei LH, 2010, BIOCONTROL SCI TECHN, V20, P739, DOI 10.1080/09583151003714109; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Xu XF, 2009, NO HORTICULTURE, V2, P12; Xue Q.Y., 2008, STUDIES SCREENING ST; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yang S, 2011, J PLANT PHYSIOL, V168, P1804, DOI 10.1016/j.jplph.2011.05.017; Yuan GF, 2010, SCI HORTIC-AMSTERDAM, V126, P103, DOI 10.1016/j.scienta.2010.06.014; ZHANG JX, 1994, PLANT CELL PHYSIOL, V35, P785, DOI 10.1093/oxfordjournals.pcp.a078658; Zheng Y, 2010, EFFECTS BIOPESTICIDE; Zhou QJ, 2007, ACTA AGR BOREALI SIN, V22, P79; Zhuang ZG, 2010, EFFECTS BIOPESTICIDE, P372; 郑颖, 2011, [江苏农业科学, Jiangsu Agricultural Sciences], V39, P199	56	184	197	5	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52565	10.1371/journal.pone.0052565	http://dx.doi.org/10.1371/journal.pone.0052565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285089	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500035
J	Achille, C; Sundaresh, S; Chu, B; Hadjiargyrou, M				Achille, Clement; Sundaresh, Sowmya; Chu, Benjamin; Hadjiargyrou, Michael			Cdk2 Silencing via a DNA/PCL Electrospun Scaffold Suppresses Proliferation and Increases Death of Breast Cancer Cells	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; IN-VITRO; NANOFIBROUS SCAFFOLDS; RNA INTERFERENCE; SIRNA DELIVERY; NANOSTRUCTURED SCAFFOLDS; SUSTAINED DELIVERY; CONTROLLED-RELEASE; DRUG-DELIVERY; DNA	RNA interference (RNAi) is a promising approach for cancer treatment. Site specific and controlled delivery of RNAi could be beneficial to the patient, while at the same time reducing undesirable off-target side effects. We utilized electrospinning to generate a biodegradable scaffold capable of incorporating and delivering a bioactive plasmid encoding for short hairpin (sh) RNA against the cell cycle specific protein, Cdk2. Three electrospun scaffolds were constructed, one using polycaprolactone (PCL) alone (Control) and PCL with plasmid DNA encoding for either Cdk2 (Cdk2i) and EGFP (EGFPi, also served as a control) shRNA. Scaffold fiber diameters ranged from 1 to 20 mm (DNA containing) and 0.2-3 mu m (Control). While the electrospun fibers remained intact for more than two weeks in physiological buffer, degradation was visible during the third week of incubation. Approximately 20-60 ng/ml (similar to 2.5% cumulative release) of intact and bioactive plasmid DNA was released over 21 days. Further, Cdk2 mRNA expression in cells plated on the Cdk2i scaffold was decreased by similar to 51% and 30%, in comparison with that of cells plated on Control or EGFPi scaffold, respectively. This decrease in Cdk2 mRNA by the Cdk2i scaffold translated to a similar to 40% decrease in the proliferation of the breast cancer cell line, MCF-7, as well as the presence of increased number of dead cells. Taken together, these results represent the first successful demonstration of the delivery of bioactive RNAi-based plasmid DNA from an electrospun polymer scaffold, specifically, in disrupting cell cycle regulation and suppressing proliferation of cancer cells.	[Hadjiargyrou, Michael] New York Inst Technol, Dept Life Sci, Old Westbury, NY 11568 USA; [Achille, Clement] Univ Paris Est Creteil, Inst Super Biosci Paris, Creteil, France; [Sundaresh, Sowmya] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Chu, Benjamin] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	New York Institute Technology; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hadjiargyrou, M (corresponding author), New York Inst Technol, Dept Life Sci, Old Westbury, NY 11568 USA.	mhadji@nyit.edu	Hadjiargyrou, Michael/H-7191-2018	Hadjiargyrou, Michael/0000-0001-8927-2333				Andersen MO, 2010, MOL THER, V18, P2018, DOI 10.1038/mt.2010.166; Cao HQ, 2010, J CONTROL RELEASE, V144, P203, DOI 10.1016/j.jconrel.2010.02.003; Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279; Chiu JB, 2005, J BIOMED NANOTECHNOL, V1, P115, DOI 10.1166/jbn.2005.018; Chu B, 2006, J PHYS-CONDENS MAT, V18, pS2513, DOI 10.1088/0953-8984/18/36/S21; Dimitrova M, 2008, P NATL ACAD SCI USA, V105, P16320, DOI 10.1073/pnas.0800156105; Fan XY, 2010, PHARMAZIE, V65, P830, DOI 10.1691/ph.2010.0156; Gersch RP, 2009, BONE, V45, P330, DOI 10.1016/j.bone.2009.04.245; Hadjiargyrou M, 2008, EXPERT OPIN DRUG DEL, V5, P1093, DOI [10.1517/17425247.5.10.1093, 10.1517/17425247.5.10.1093 ]; Hadjiargyrou M, 2011, NANOFIBERS - PRODUCTION, PROPERTIES AND FUNCTIONAL APPLICATIONS, P383; Han HD, 2011, CANCER BIOL THER, V11, P839, DOI 10.4161/cbt.11.9.15185; Holladay C, 2009, J CONTROL RELEASE, V136, P220, DOI 10.1016/j.jconrel.2009.02.006; Hong JK, 2011, TISSUE ENG PART B-RE, V17, P125, DOI [10.1089/ten.teb.2010.0552, 10.1089/ten.TEB.2010.0552]; Kim HS, 2010, J CONTROL RELEASE, V145, P264, DOI 10.1016/j.jconrel.2010.03.006; Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009; Krebs MD, 2009, J AM CHEM SOC, V131, P9204, DOI 10.1021/ja9037615; Li J, 2010, NANOMEDICINE-UK, V5, P1483, DOI 10.2217/NNM.10.124; Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni171; Liu C, 2010, AM J PHYSIOL-CELL PH, V298, pC1100, DOI 10.1152/ajpcell.00553.2009; Long XE, 2010, BMB REP, V43, P291, DOI 10.5483/BMBRep.2010.43.4.291; Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X; Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929; Monaghan M, 2011, ADV DRUG DELIVER REV, V63, P197, DOI 10.1016/j.addr.2011.01.006; Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Rahman MA, 2012, J CONTROL RELEASE, V159, P384, DOI 10.1016/j.jconrel.2012.01.045; Rujitanaroj PO, 2011, BIOMATERIALS, V32, P5915, DOI 10.1016/j.biomaterials.2011.04.065; Sakai S, 2009, J BIOMED MATER RES A, V88A, P281, DOI 10.1002/jbm.a.31870; San Juan A, 2009, BIOMACROMOLECULES, V10, P3074, DOI 10.1021/bm900740g; Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009; Shen XX, 2011, INT J PHARMACEUT, V408, P200, DOI 10.1016/j.ijpharm.2011.01.058; Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001; Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f; Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019; Takanashi M, 2009, GENE THER, V16, P982, DOI 10.1038/gt.2009.66; Tzeng SY, 2011, INT J NANOMED, V6, P3309, DOI 10.2147/IJN.S27269; Vinas-Castells R, 2009, BIOCONJUGATE CHEM, V20, P2262, DOI 10.1021/bc900241w; Wu SY, 2009, AAPS J, V11, P639, DOI 10.1208/s12248-009-9140-1; Yang DJ, 2009, J BIOMAT SCI-POLYM E, V20, P1321, DOI 10.1163/156856209X453024; Yang Y, 2011, ACTA BIOMATER, V7, P2533, DOI 10.1016/j.actbio.2011.02.031; Zhang J, 2011, J BIOMED MATER RES A, V96A, P212, DOI 10.1002/jbm.a.32962; Zhang X, 2010, BIOMATERIALS, V31, P6013, DOI 10.1016/j.biomaterials.2010.04.024; Zhao X, 2011, J BIOMED NANOTECHNOL, V7, P823, DOI 10.1166/jbn.2011.1342	43	31	31	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52356	10.1371/journal.pone.0052356	http://dx.doi.org/10.1371/journal.pone.0052356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285007	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500151
J	Elfawal, MA; Towler, MJ; Reich, NG; Golenbock, D; Weathers, PJ; Rich, SM				Elfawal, Mostafa A.; Towler, Melissa J.; Reich, Nicholas G.; Golenbock, Douglas; Weathers, Pamela J.; Rich, Stephen M.			Dried Whole Plant Artemisia annua as an Antimalarial Therapy	PLOS ONE			English	Article							IN-VITRO; THIOREDOXIN REDUCTASE; MALARIA; FLAVONOIDS; RESISTANCE; EFFICACY; DRUGS; HEMIN; L.	Drugs are primary weapons for reducing malaria in human populations. However emergence of resistant parasites has repeatedly curtailed the lifespan of each drug that is developed and deployed. Currently the most effective anti-malarial is artemisinin, which is extracted from the leaves of Artemisia annua. Due to poor pharmacokinetic properties and prudent efforts to curtail resistance to monotherapies, artemisinin is prescribed only in combination with other anti-malarials composing an Artemisinin Combination Therapy (ACT). Low yield in the plant, and the added cost of secondary anti-malarials in the ACT, make artemisinin costly for the developing world. As an alternative, we compared the efficacy of oral delivery of the dried leaves of whole plant (WP) A. annua to a comparable dose of pure artemisinin in a rodent malaria model (Plasmodium chabaudi). We found that a single dose of WP (containing 24 mg/kg artemisinin) reduces parasitemia more effectively than a comparable dose of purified drug. This increased efficacy may result from a documented 40-fold increase in the bioavailability of artemisinin in the blood of mice fed the whole plant, in comparison to those administered synthetic drug. Synergistic benefits may derive from the presence of other anti-malarial compounds in A. annua. If shown to be clinically efficacious, well-tolerated, and compatible with the public health imperative of forestalling evolution of drug resistance, inexpensive, locally grown and processed A. annua might prove to be an effective addition to the global effort to reduce malaria morbidity and mortality. Citation: Elfawal MA, Towler MJ, Reich NG, Golenbock D, Weathers PJ, et al. (2012) Dried Whole Plant Artemisia annua as an Antimalarial Therapy. PLoS ONE 7(12): e52746. doi:10.1371/journal.pone.0052746	[Elfawal, Mostafa A.; Rich, Stephen M.] Univ Massachusetts, Dept Microbiol, Lab Med Zool, Amherst, MA 01003 USA; [Towler, Melissa J.; Weathers, Pamela J.] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA; [Reich, Nicholas G.] Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Golenbock, Douglas] Univ Massachusetts, Sch Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Amherst; Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Worcester	Rich, SM (corresponding author), Univ Massachusetts, Dept Microbiol, Lab Med Zool, Amherst, MA 01003 USA.	smrich@psis.umass.edu	Rich, Stephen/AAX-6953-2020; Reich, Nicholas/L-1168-2019	Reich, Nicholas/0000-0003-3503-9899	UMass Medical School Center for Clinical and Translational Science [CCTS-20110001]; National Institutes of Health [R01-AI079293]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079293] Funding Source: NIH RePORTER	UMass Medical School Center for Clinical and Translational Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by UMass Medical School Center for Clinical and Translational Science (grant CCTS-20110001 and the National Institutes of Health (grant R01-AI079293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIN MH, 1994, AM J TROP MED HYG, V50, P771, DOI 10.4269/ajtmh.1994.50.771; Arsenault PR, 2008, CURR MED CHEM, V15, P2886, DOI 10.2174/092986708786242813; Atkinson B, 1991, BIOCH ENG BIOTECHNOL; Avery MA, 2003, J MED CHEM, V46, P4244, DOI 10.1021/jm030181q; Barbacka K, 2011, CURR PHARM BIOTECHNO, V12, P1743, DOI 10.2174/138920111798376923; Bilia AR, 2008, NAT PROD COMMUN, V3, P1999; Bilia AR, 2002, LIFE SCI, V70, P769, DOI 10.1016/S0024-3205(01)01447-3; Carlton JMR, 2001, TRENDS PARASITOL, V17, P236, DOI 10.1016/S1471-4922(01)01899-2; Cox F.E.G., 1978, P309; de Ridder S, 2008, J ETHNOPHARMACOL, V120, P302, DOI 10.1016/j.jep.2008.09.017; de Vries P, 1999, PRODUCTION APPL ARTE; Douglas Bates, 2011, LME4 LINEAR MIXED EF; Duke J.A, 2001, HDB PHYTOCHEMICAL CO, P70; Efferth T, 2009, HERBAL DRUGS ETHNOME, P179; ELFORD BC, 1987, T ROY SOC TROP MED H, V81, P434, DOI 10.1016/0035-9203(87)90161-1; Ferreira JFS, 2010, MOLECULES, V15, P3135, DOI 10.3390/molecules15053135; Firestone GL, 2009, MOL ENDOCRINOL, V23, P1940, DOI 10.1210/me.2009-0149; Gordi T, 2002, ANTIMICROB AGENTS CH, V46, P1026, DOI 10.1128/AAC.46.4.1026-1031.2002; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Hsu E, 2006, T ROY SOC TROP MED H, V100, P505, DOI 10.1016/j.trstmh.2005.09.020; Kindermans JM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-125; Kraft C, 2003, PHYTOTHER RES, V17, P123, DOI 10.1002/ptr.1066; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Kumar S, 2004, IND CROP PROD, V19, P77, DOI 10.1016/j.indcrop.2003.07.003; LIU KCSC, 1992, PLANT CELL REP, V11, P637, DOI 10.1007/BF00236389; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Mishina YV, 2007, ANTIMICROB AGENTS CH, V51, P1852, DOI 10.1128/AAC.01544-06; OTT KJ, 1968, J PROTOZOOL, V15, P365, DOI 10.1111/j.1550-7408.1968.tb02138.x; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodger WS, 2012, ORG PROCESS RES DEV, V16, P764; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Svensson USH, 1999, BRIT J CLIN PHARMACO, V48, P528, DOI 10.1046/j.1365-2125.1999.00044.x; Team RDC, 2012, R LANG ENV STAT COMP; Utzinger J, 2001, CURR MED CHEM, V8, P1841, DOI 10.2174/0929867013371581; van der Kooy F, 2011, PLANTA MED, V77, P1754, DOI 10.1055/s-0030-1271065; Weathers PJ, 2011, PHYTOCHEM REV, V10, P173, DOI 10.1007/s11101-010-9166-0; Weathers PJ, 2012, PLANTA MED; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2010, GUID TREATM MAL, V2nd; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willcox M, 2009, J ALTERN COMPLEM MED, V15, P101, DOI 10.1089/acm.2008.0327; Zhu CY, 2012, J AM CHEM SOC, V134, P13577, DOI 10.1021/ja3061479	47	61	61	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52746	10.1371/journal.pone.0052746	http://dx.doi.org/10.1371/journal.pone.0052746			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23289055	Green Published, gold			2022-12-25	WOS:000312794500243
J	Mitchell, PL; Karakach, TK; Currie, DL; McLeod, RS				Mitchell, Patricia L.; Karakach, Tobias K.; Currie, Deborah L.; McLeod, Roger S.			t-10, c-12 CLA Dietary Supplementation Inhibits Atherosclerotic Lesion Development Despite Adverse Cardiovascular and Hepatic Metabolic Marker Profiles	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; PROLIFERATOR-ACTIVATED RECEPTOR; INSULIN-RESISTANCE; PEROXISOME PROLIFERATION; TRANS-10,CIS-12 ISOMER; GLUCOSE-TOLERANCE; DEFICIENCY LEADS; LIPID-METABOLISM; FATTY LIVER; OBESE MEN	Animal and human studies have indicated that fatty acids such as the conjugated linoleic acids (CLA) found in milk could potentially alter the risk of developing metabolic disorders including diabetes and cardiovascular disease (CVD). Using susceptible rodent models (apoE(-/-) and LDLr-/- mice) we investigated the interrelationship between mouse strain, dietary conjugated linoleic acids and metabolic markers of CVD. Despite an adverse metabolic risk profile, atherosclerosis (measured directly by lesion area), was significantly reduced with t-10, c-12 CLA and mixed isomer CLA (Mix) supplementation in both apoE(-/-) (p<0.05, n = 11) and LDLr-/- mice (p<0.01, n = 10). Principal component analysis was utilized to delineate the influence of multiple plasma and tissue metabolites on the development of atherosclerosis. Group clustering by dietary supplementation was evident, with the t-10, c-12 CLA supplemented animals having distinct patterns, suggestive of hepatic insulin resistance, regardless of mouse strain. The effect of CLA supplementation on hepatic lipid and fatty acid composition was explored in the LDLr-/- strain. Dietary supplementation with t-10, c-12 CLA significantly increased liver weight (p<0.05, n = 10), triglyceride (p<0.01, n = 10) and cholesterol ester content (p<0.01, n = 10). Furthermore, t-10, c-12 CLA also increased the ratio of 18:1 to 18:0 fatty acid in the liver suggesting an increase in the activity of stearoyl-CoA desaturase. Changes in plasma adiponectin and liver weight with t-10, c-12 CLA supplementation were evident within 3 weeks of initiation of the diet. These observations provide evidence that the individual CLA isomers have divergent mechanisms of action and that t-10, c-12 CLA rapidly changes plasma and liver markers of metabolic syndrome, despite evidence of reduction in atherosclerosis. Citation: Mitchell PL, Karakach TK, Currie DL, McLeod RS (2012) t-10, c-12 CLA Dietary Supplementation Inhibits Atherosclerotic Lesion Development Despite Adverse Cardiovascular and Hepatic Metabolic Marker Profiles. PLoS ONE 7(12): e52634. doi:10.1371/journal.pone.0052634	[Mitchell, Patricia L.; Karakach, Tobias K.; Currie, Deborah L.; McLeod, Roger S.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University	McLeod, RS (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	rmcleod2@dal.ca	Mitchell, Patricia/AAB-7801-2021; McLeod, Roger/F-8014-2015	Mitchell, Patricia/0000-0002-0773-1047; McLeod, Roger/0000-0002-6740-5569; Karakach, Tobias/0000-0003-2460-3781	Advanced Foods and Materials Network (AFMnet); Dairy Farmers of Canada	Advanced Foods and Materials Network (AFMnet); Dairy Farmers of Canada	The authors acknowledge the financial support of the Advanced Foods and Materials Network (AFMnet), and Dairy Farmers of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli MF, 2009, NUTRITION, V25, P445, DOI 10.1016/j.nut.2008.10.015; Arbones-Mainar JM, 2006, J NUTR, V136, P353, DOI 10.1093/jn/136.2.353; Arbones-Mainar JM, 2006, ATHEROSCLEROSIS, V189, P318, DOI 10.1016/j.atherosclerosis.2006.01.015; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Choi YJ, 2000, J NUTR, V130, P1920, DOI 10.1093/jn/130.8.1920; Cimini AM, 2005, INT J CANCER, V117, P923, DOI 10.1002/ijc.21272; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Cooper MH, 2008, ATHEROSCLEROSIS, V200, P294, DOI 10.1016/j.atherosclerosis.2007.12.040; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; de Deckere EAM, 1999, BRIT J NUTR, V82, P309, DOI 10.1017/S0007114599001518; de Roos B, 2005, FASEB J, V19, P813, DOI 10.1096/fj.04-2974fje; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franczyk-Zarow M, 2008, BRIT J NUTR, V99, P49, DOI 10.1017/S0007114507793893; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Haas JT, 2009, CURR OPIN LIPIDOL, V20, P206, DOI 10.1097/MOL.0b013e32832b2024; Houseknecht KL, 1998, BIOCHEM BIOPH RES CO, V244, P678, DOI 10.1006/bbrc.1998.8303; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Lee KN, 1998, BIOCHEM BIOPH RES CO, V248, P817, DOI 10.1006/bbrc.1998.8994; Lichtman AH, 1999, ARTERIOSCL THROM VAS, V19, P1938, DOI 10.1161/01.ATV.19.8.1938; LISSNER L, 1995, EUR J CLIN NUTR, V49, P79; Liu LF, 2007, AM J PHYSIOL-GASTR L, V292, P1671, DOI 10.1152/ajpgi.00523.2006; Macarulla MT, 2005, NUTRITION, V21, P512, DOI 10.1016/j.nut.2004.07.011; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Malinowski E. R., 1980, FACTOR ANAL CHEM; McGuinness OP, 2009, AM J PHYSIOL-ENDOC M, V297, pE849, DOI 10.1152/ajpendo.90996.2008; McLeod RS, 2004, AM J CLIN NUTR, V79, p1169S, DOI 10.1093/ajcn/79.6.1169S; Mitchell PL, 2008, BIOCHEM CELL BIOL, V86, P293, DOI [10.1139/O08-070, 10.1139/o08-070]; Mitchell PL, 2005, BBA-MOL CELL BIOL L, V1734, P269, DOI 10.1016/j.bbalip.2005.04.007; Moloney F, 2004, AM J CLIN NUTR, V80, P887; Moya-Camarena SY, 1999, BBA-MOL CELL BIOL L, V1436, P331, DOI 10.1016/S0005-2760(98)00121-0; Navarro Maria A, 2010, Front Biosci (Elite Ed), V2, P87, DOI 10.2741/e69; Nestel P, 2006, ATHEROSCLEROSIS, V189, P282, DOI 10.1016/j.atherosclerosis.2005.12.020; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Noone EJ, 2002, BRIT J NUTR, V88, P243, DOI 10.1079/BJN2002615; Oikawa D, 2009, BRIT J NUTR, V101, P1558, DOI 10.1017/S0007114508091253; Okamoto Y, 2006, CLIN SCI, V110, P267, DOI 10.1042/CS20050182; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Parra Pilar, 2010, Nutr Metab (Lond), V7, P5, DOI 10.1186/1743-7075-7-5; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Poirier H, 2005, BIOCHIMIE, V87, P73, DOI 10.1016/j.biochi.2004.11.006; Purushotham A, 2007, J LIPID RES, V48, P444, DOI 10.1194/jlr.M600393-JLR200; Ringseis R, 2006, BBA-GEN SUBJECTS, V1760, P290, DOI 10.1016/j.bbagen.2005.12.002; Riserus U, 2004, AM J CLIN NUTR, V80, P279; Riserus U, 2004, DIABETOLOGIA, V47, P1016, DOI 10.1007/s00125-004-1421-8; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Roche HM, 2002, DIABETES, V51, P2037, DOI 10.2337/diabetes.51.7.2037; Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149; Semenkovich CF, 2006, J CLIN INVEST, V116, P1813, DOI 10.1172/JCI29024; Sobel BE, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2007.07.002; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Svenson KL, 2007, J APPL PHYSIOL, V102, P2369, DOI 10.1152/japplphysiol.01077.2006; Syvertsen C, 2007, INT J OBESITY, V31, P1148, DOI 10.1038/sj.ijo.0803482; Taylor CG, 2004, AM J CLIN NUTR, V79, p1164S, DOI 10.1093/ajcn/79.6.1164S; Terpstra AHM, 2002, J NUTR, V132, P940, DOI 10.1093/jn/132.5.940; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Toomey S, 2006, ATHEROSCLEROSIS, V187, P40, DOI 10.1016/j.atherosclerosis.2005.08.024; Tricon S, 2004, AM J CLIN NUTR, V80, P614; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Valeille K, 2004, BRIT J NUTR, V91, P191, DOI 10.1079/BJN20031057; Wilson TA, 2006, LIPIDS, V41, P41, DOI 10.1007/s11745-006-5068-8; Wu L, 2006, J LIPID RES, V47, P2215, DOI 10.1194/jlr.M600146-JLR200; Yurawecz MP, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P64; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	66	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52634	10.1371/journal.pone.0052634	http://dx.doi.org/10.1371/journal.pone.0052634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285120	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500214
J	Rottman, M; Goldberg, J; Hacking, SA				Rottman, Martin; Goldberg, Joel; Hacking, S. Adam			Titanium-Tethered Vancomycin Prevents Resistance to Rifampicin in Staphylococcus aureus in vitro	PLOS ONE			English	Article							BIOFILM FORMATION; SURFACE; ALLOY; INHIBITION; ATTACHMENT; REPLACEMENT; INFECTION; MODEL; HIP	Rifampicin is currently recognized as the most potent drug against Gram positive implant related infections. The use of rifampicin is limited by the emergence of bacterial resistance, which is often managed by coadministration of a second antibiotic. The purpose of this study was to determine the effectiveness of soluble rifampicin in combination with vancomycin tethered to titanium metal as a means to control bacterial growth and resistance in vitro. Bacterial growth was inhibited when the vancomycin-tethered titanium discs were treated with Staphylococcus aureus inocula of >= 2 x 10(6) CFU, however inocula greater than 2 x 10(6) CFU/disc adhered and survived. The combination of surface-tethered vancomycin with soluble rifampicin enhanced the inhibitory effect of rifampicin for an inoculum of 10(6) CFU/cm(2) by one dilution (combination MIC of 0.008 mg/L versus 0.015 mg/L for rifampicin alone). Moreover, surface tethered vancomycin prevented the emergence of a rifampicin resistant population in an inoculum of 2 x 10(8) CFU. Citation: Rottman M, Goldberg J, Hacking SA (2012) Titanium-Tethered Vancomycin Prevents Resistance to Rifampicin in Staphylococcus aureus in vitro. PLoS ONE 7(12): e52883. doi: 10.1371/journal.pone.0052883	[Rottman, Martin; Goldberg, Joel; Hacking, S. Adam] Harvard Univ, Sch Med, Lab Musculoskeletal Res & Innovat, Dept Orthopaed, Boston, MA 02114 USA; [Rottman, Martin; Goldberg, Joel; Hacking, S. Adam] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Rottman, Martin] Harvard Univ, Sch Med, Wyss Inst, Boston, MA USA; [Rottman, Martin] Univ Versailles St Quentin, EA Physiopathol & Diagnost Infect Microbiennes 36, Garches, France; [Rottman, Martin] Hop Raymond Poincare, AP HP, Microbiol Lab, Garches, France	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP	Hacking, SA (corresponding author), Harvard Univ, Sch Med, Lab Musculoskeletal Res & Innovat, Dept Orthopaed, Boston, MA 02114 USA.	ahacking@partners.org	Rottman, Martin/I-3005-2012; Rottman, Martin/AAD-9075-2021	Rottman, Martin/0000-0001-5953-3344; 				Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348; Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016; Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t; Baker P, 2012, KNEE SURG SPORT TR A; Byren I, 2012, ANTIMICROB AGENTS CH; Chen CP, 2010, BIOCONJUGATE CHEM, V21, P1978, DOI 10.1021/bc100136e; Courvalin P, 2006, CLIN INFECT DIS, V42, pS25, DOI 10.1086/491711; Edupuganti OP, 2007, BIOORG MED CHEM LETT, V17, P2692, DOI 10.1016/j.bmcl.2007.03.005; Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638; Fitzgerald Steven J, 2011, Surg Technol Int, V21, P204; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Gawalt ES, 2003, LANGMUIR, V19, P200, DOI 10.1021/la0203436; Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013; Ketonis C, 2009, CLIN ORTHOP RELAT R, V467, P1678, DOI 10.1007/s11999-009-0828-4; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; MOORMAN DR, 1981, ANTIMICROB AGENTS CH, V20, P709, DOI 10.1128/AAC.20.6.709; Moyad TF, 2008, ORTHOPEDICS, V31, P581, DOI 10.3928/01477447-20080601-22; Murphy CK, 2006, ANTIMICROB AGENTS CH, V50, P827, DOI 10.1128/AAC.50.3.827-834.2006; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45; Pettit RK, 2005, ANTIMICROB AGENTS CH, V49, P2612, DOI 10.1128/AAC.49.7.2612-2617.2005; Poultsides Lazaros A, 2010, J Bone Joint Surg Am, V92, pe13, DOI 10.2106/JBJS.I.01131; Roux AL, 2011, CLIN MICROBIOL INFEC, V17, P447, DOI 10.1111/j.1469-0691.2010.03359.x; Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9; Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la048227l; Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886; Tote K, 2008, LETT APPL MICROBIOL, V46, P249, DOI 10.1111/j.1472-765X.2007.02298.x; Tote K, 2009, INT J ANTIMICROB AG, V33, P525, DOI 10.1016/j.ijantimicag.2008.11.004; Vanhegan IS, 2012, J BONE JOINT SURG BR, V94B, P875, DOI 10.1302/0301-620X.94B7.28710; Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943	32	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52883	10.1371/journal.pone.0052883	http://dx.doi.org/10.1371/journal.pone.0052883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285213	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500253
J	Tan, MP; Jamsari, AFJ; Azizah, MNS				Tan, Min Pau; Jamsari, Amirul Firdaus Jamaluddin; Azizah, Mohd Nor Siti			Phylogeographic Pattern of the Striped Snakehead, Channa striata in Sundaland: Ancient River Connectivity, Geographical and Anthropogenic Singnatures	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; FISHES; INTROGRESSION; EXTINCTION; CYPRINIDAE; HISTORY	A phylogeographic study of an economically important freshwater fish, the striped snakehead, Channa striata in Sundaland was carried out using data from mtDNA ND5 gene target to elucidate genetic patterning. Templates obtained from a total of 280 individuals representing 24 sampling sites revealed 27 putative haplotypes. Three distinct genetic lineages were apparent; 1) northwest Peninsular Malaysia, 2) southern Peninsular, east Peninsular, Sumatra and SW (western Sarawak) and 3) central west Peninsular and Malaysian Borneo (except SW). Genetic structuring between lineages showed a significant signature of natural geographical barriers that have been acting as effective dividers between these populations. However, genetic propinquity between the SW and southern Peninsular and east Peninsular Malaysia populations was taken as evidence of ancient river connectivity between these regions during the Pleistocene epoch. Alternatively, close genetic relationship between central west Peninsular Malaysia and Malaysian Borneo populations implied anthropogenic activities. Further, haplotype sharing between the east Peninsular Malaysia and Sumatra populations revealed extraordinary migration ability of C. striata (>500 km) through ancient connectivity. These results provide interesting insights into the historical and contemporary landscape arrangement in shaping genetic patterns of freshwater species in Sundaland.	[Tan, Min Pau; Jamsari, Amirul Firdaus Jamaluddin; Azizah, Mohd Nor Siti] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia; [Azizah, Mohd Nor Siti] Univ Sains Malaysia, Ctr Marine & Coastal Studies, Minden, Penang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Tan, MP (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia.	minpau_84@yahoo.com	Nor, Siti Azizah Mohd/A-8275-2011; Jamaluddin, Jamsari Amirul Firdaus/AAP-4224-2020; Tan, Min Pau/S-4797-2019	Tan, Min Pau/0000-0003-0149-5247; JAMALUDDIN, JAMSARI AMIRUL FIRDAUS/0000-0002-3792-6873	Universiti Sains Malaysia under Research University Grant [1001/PBIOLOGI/8150123]	Universiti Sains Malaysia under Research University Grant(Universiti Sains Malaysia)	This research was funded by Universiti Sains Malaysia under Research University Grant (1001/PBIOLOGI/8150123). The funder had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson EAS, 2010, THESIS QUEENSLAND U; Ambak Mohd Azmi, 2006, Biotechnology, V5, P104; Amilhat E, 2005, J FISH BIOL, V67, P23, DOI 10.1111/j.0022-1112.2005.00927.x; Baie SH, 2000, J ETHNOPHARMACOL, V71, P93, DOI 10.1016/S0378-8741(99)00184-1; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezina G, 2011, MED HLTH SCI J MHSJ, V6, P2, DOI DOI 10.15208/MHSJ.2010.99; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Chubb AL, 1998, J HERED, V89, P8, DOI 10.1093/jhered/89.1.8; Courtenay Jr WR, 2004, IDENTITY INTRO SNAKE; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; DODSON JJ, 1995, MOL ECOL, V4, P331, DOI 10.1111/j.1365-294X.1995.tb00226.x; Dominguez-Dominguez O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-161; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Esa YB, 2008, ZOOL STUD, V47, P360; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hauser L, 2002, P NATL ACAD SCI USA, V99, P11742, DOI 10.1073/pnas.172242899; Helgason A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000343; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Inger RF, 1962, FRESH WATER FISHES N; JAIS AMM, 1994, GEN PHARMACOL, V25, P947, DOI 10.1016/0306-3623(94)90101-5; Jamsari AFJ, 2010, GENET MOL RES, V9, P1836, DOI 10.4238/vol9-3gmr933; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Jiggins FM, 2003, GENETICS, V164, P5; Kamarudin K.R., 2009, J TROPICAL BIOL CONS, V5, P1; Kapuscinski AR, 2007, GENETIC GUIDELINES F; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Kottelat M., 1993, FRESHWATER FISHES W; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Leong KO, 2003, THESIS U SAINS MALAY; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Michel C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-49; Miya M, 2006, ICHTHYOL RES, V53, P75, DOI 10.1007/s10228-005-0303-5; Mohsin A. K. M., 1983, FRESHWATER FISHES PE; Mu XD, 2011, J ANIM VET ADV, V10, P555, DOI 10.3923/javaa.2011.555.561; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Nguyen TTT, 2006, NACA MONOGRAPH; NorKarmila D, 2009, THESIS U SAINS MALAY; Posada D., 2004, COLLAPSE VER 1 2 TOO; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2009, FIGTREE V1 3 1; Ramstad KM, 2004, MOL ECOL, V13, P277, DOI 10.1046/j.1365-294X.2003.2062.x; Roos H., 2004, THESIS U PRETORIA; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruzainah A, 2008, THESIS U SAINS MALAY; Ryan JRJ, 2006, ZOOL SCI, V23, P893, DOI 10.2108/zsj.23.893; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuster W. H., 1952, 3 IPFC FISH S, P187; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner TF, 2004, J FISH BIOL, V64, P186, DOI 10.1111/j.1095-8649.2004.00299.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang JL, 2011, MITOCHONDR DNA, V22, P120, DOI 10.3109/19401736.2011.624599; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; Wang ZW, 2006, ENVIRON BIOL FISH, V75, P455, DOI 10.1007/s10641-006-0035-z; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Zakharov EV, 2009, HEREDITY, V102, P590, DOI 10.1038/hdy.2009.26; Zwick A, 2011, SYST ENTOMOL, V36, P31, DOI 10.1111/j.1365-3113.2010.00543.x	69	21	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52089	10.1371/journal.pone.0052089	http://dx.doi.org/10.1371/journal.pone.0052089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284881	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500088
J	Steel, R; Cross, RS; Ellis, SL; Anderson, RL				Steel, Rohan; Cross, Ryan S.; Ellis, Sarah L.; Anderson, Robin L.			Hsp70 Architecture: The Formation of Novel Polymeric Structures of Hsp70.1 and Hsc70 after Proteotoxic Stress	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; INDUCED APOPTOSIS; MOLECULAR CHAPERONES; INHIBITS APOPTOSIS; APAF-1 APOPTOSOME; MAMMALIAN-CELLS; HEAT-SHOCK-PROTEIN-70; MITOCHONDRIA; BINDING; ASSOCIATION	Heat induces Hsp70.1 (HSPA1) and Hsc70 (HSPA8) to form complex detergent insoluble cytoplasmic and nuclear structures that are distinct from the cytoskeleton and internal cell membranes. These novel structures have not been observed by earlier immunofluorescence studies as they are obscured by the abundance of soluble Hsp70.1/Hsc70 present in cells. While resistant to detergents, these Hsp70 structures display complex intracellular dynamics and are efficiently disaggregated by ATP, indicating that this pool of Hsp70.1/Hsc70 retains native function and regulation. Hsp70.1 promotes the repair of proteotoxic damage and cell survival after stress. In heated fibroblasts expressing Hsp70.1, Hsp70.1 and Hsc70 complexes are efficiently disaggregated before the cells undergo-heat induced apoptosis. In the absence of Hsp70.1, fibroblasts have increased rates of heat-induced apoptosis and maintain stable insoluble Hsc70 structures. The differences in the intracellular distribution of Hsp70.1 and Hsc70, combined with the ability of Hsp70.1, but not Hsc70, to promote the disaggregation of insoluble Hsp70.1/Hsc70 complexes, indicate that these two closely related proteins perform distinctly different cellular functions in heated cells.	[Steel, Rohan; Cross, Ryan S.; Ellis, Sarah L.; Anderson, Robin L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Ellis, Sarah L.; Anderson, Robin L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Anderson, RL (corresponding author), Peter MacCallum Canc Ctr, St Andrews Pl, Melbourne, Vic, Australia.	robin.anderson@petermac.org	Anderson, Robin/I-2306-2013; Anderson, Robin/K-6966-2019; Anderson, Robin/S-1005-2017	/0000-0002-0423-6120; Anderson, Robin/0000-0002-6841-7422; Ellis, Sarah/0000-0002-5772-6051; Cross, Ryan/0000-0002-8573-8551	National Institute of Health/National Cancer Institute [CA81421]; National Breast Cancer Foundation (NBCF Australia); NATIONAL CANCER INSTITUTE [R01CA081421] Funding Source: NIH RePORTER	National Institute of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Breast Cancer Foundation (NBCF Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the National Institute of Health/National Cancer Institute Grant CA81421. RLA is supported by a fellowship from the National Breast Cancer Foundation (NBCF Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Buzzard KA, 1998, J BIOL CHEM, V273, P17147, DOI 10.1074/jbc.273.27.17147; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; Dittmar KD, 1997, J BIOL CHEM, V272, P13047, DOI 10.1074/jbc.272.20.13047; Ellis S, 2000, J HISTOCHEM CYTOCHEM, V48, P321, DOI 10.1177/002215540004800302; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Irmer H, 1997, J BIOL CHEM, V272, P2230; JAATTELA M, 1992, EMBO J, V11, P3507, DOI 10.1002/j.1460-2075.1992.tb05433.x; KAMPINGA HH, 1993, INT J HYPERTHER, V9, P89, DOI 10.3109/02656739309061481; KIM DH, 1992, J CELL PHYSIOL, V153, P353, DOI 10.1002/jcp.1041530215; KING C, 1995, J BIOL CHEM, V270, P22535, DOI 10.1074/jbc.270.38.22535; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI LG, 1995, EXP CELL RES, V217, P460, DOI 10.1006/excr.1995.1110; Liang P, 1997, J CELL SCI, V110, P1431; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARGULIS BA, 1991, J BIOL CHEM, V266, P9295; MILARSKI KL, 1989, J CELL BIOL, V108, P413, DOI 10.1083/jcb.108.2.413; Minami Y, 1999, GENES CELLS, V4, P721, DOI 10.1046/j.1365-2443.1999.00299.x; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; Oh WK, 2003, MOL CELLS, V16, P84; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PELHAM H, 1984, PHILOS T ROY SOC B, V307, P301, DOI 10.1098/rstb.1984.0131; RAMSBY ML, 1994, ELECTROPHORESIS, V15, P265, DOI 10.1002/elps.1150150146; Raynes DA, 1998, J BIOL CHEM, V273, P32883, DOI 10.1074/jbc.273.49.32883; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; SIMON MM, 1995, J CLIN INVEST, V95, P926, DOI 10.1172/JCI117800; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Steel R, 2004, J BIOL CHEM, V279, P51490, DOI 10.1074/jbc.M401314200; SUGITO K, 1995, FEBS LETT, V358, P161, DOI 10.1016/0014-5793(94)01417-Y; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; YAMANE M, 1995, CELL STRUCT FUNCT, V20, P157, DOI 10.1247/csf.20.157; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373	44	8	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52351	10.1371/journal.pone.0052351	http://dx.doi.org/10.1371/journal.pone.0052351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285004	Green Published, gold			2022-12-25	WOS:000312694300088
J	Fryer, RM; Muthukumarana, A; Harrison, PC; Mazurek, SN; Chen, RR; Harrington, KE; Dinallo, RM; Horan, JC; Patnaude, L; Modis, LK; Reinhart, GA				Fryer, Ryan M.; Muthukumarana, Akalushi; Harrison, Paul C.; Mazurek, Suzanne Nodop; Chen, Rong Rhonda; Harrington, Kyle E.; Dinallo, Roger M.; Horan, Joshua C.; Patnaude, Lori; Modis, Louise K.; Reinhart, Glenn A.			The Clinically-tested S1P Receptor Agonists, FTY720 and BAF312, Demonstrate Subtype-Specific Bradycardia (S1P(1)) and Hypertension (S1P(3)) in Rat	PLOS ONE			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; TYROSINE KINASE INHIBITOR; PIG ATRIAL MYOCYTES; MULTIPLE-SCLEROSIS; BLOOD-PRESSURE; FINGOLIMOD FTY720; ORAL FINGOLIMOD; SPHINGOSINE-1-PHOSPHATE; HEART; IMMUNOSUPPRESSANT	Sphingosine-1-phospate (S1P) and S1P receptor agonists elicit mechanism-based effects on cardiovascular function in vivo. Indeed, FTY720 (non-selective S1P(X) receptor agonist) produces modest hypertension in patients (2-3 mmHg in 1-yr trial) as well as acute bradycardia independent of changes in blood pressure. However, the precise receptor subtypes responsible is controversial, likely dependent upon the cardiovascular response in question (e.g. bradycardia, hypertension), and perhaps even species-dependent since functional differences in rodent, rabbit, and human have been suggested. Thus, we characterized the S1P receptor subtype specificity for each compound in vitro and, in vivo, the cardiovascular effects of FTY720 and the more selective S1P(1,5) agonist, BAF312, were tested during acute i.v. infusion in anesthetized rats and after oral administration for 10 days in telemetry-instrumented conscious rats. Acute i.v. infusion of FTY720 (0.1, 0.3, 1.0 mg/kg/20 min) or BAF312 (0.5, 1.5, 5.0 mg/kg/20 min) elicited acute bradycardia in anesthetized rats demonstrating an S1P(1) mediated mechanism-of-action. However, while FTY720 (0.5, 1.5, 5.0 mg/kg/d) elicited dose-dependent hypertension after multiple days of oral administration in rat at clinically relevant plasma concentrations (24-hr mean blood pressure = 8.4, 12.8, 16.2 mmHg above baseline vs. 3 mmHg in vehicle controls), BAF312 (0.3, 3.0, 30.0 mg/kg/d) had no significant effect on blood pressure at any dose tested suggesting that hypertension produced by FTY720 is mediated S1P(3) receptors. In summary, in vitro selectivity results in combination with studies performed in anesthetized and conscious rats administered two clinically tested S1P agonists, FTY720 or BAF312, suggest that S1P(1) receptors mediate bradycardia while hypertension is mediated by S1P(3) receptor activation.	[Fryer, Ryan M.; Muthukumarana, Akalushi; Harrison, Paul C.; Mazurek, Suzanne Nodop; Chen, Rong Rhonda; Reinhart, Glenn A.] Boehringer Ingelheim Pharmaceut Inc, Dept Cardiometab Dis Res, Ridgefield, CT 06877 USA; [Harrington, Kyle E.; Dinallo, Roger M.] Boehringer Ingelheim Pharmaceut Inc, Dept Drug Discovery Support, Ridgefield, CT 06877 USA; [Horan, Joshua C.] Boehringer Ingelheim Pharmaceut Inc, Dept Med Chem, Ridgefield, CT 06877 USA; [Patnaude, Lori; Modis, Louise K.] Boehringer Ingelheim Pharmaceut Inc, Dept Immunol & Inflammat, Ridgefield, CT 06877 USA	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Fryer, RM (corresponding author), Boehringer Ingelheim Pharmaceut Inc, Dept Cardiometab Dis Res, 90 E Ridge POB 368, Ridgefield, CT 06877 USA.	ryan.fryer@boehringer-ingelheim.com						Banfor PN, 2009, J CARDIOVASC PHARM, V53, P173, DOI 10.1097/FJC.0b013e3181993493; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Bunemann M, 1995, J PHYSIOL-LONDON, V489, P701; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Demont EH, 2011, J MED CHEM, V54, P6724, DOI 10.1021/jm200609t; Durand P, 2000, SYNTHESIS-STUTTGART, P505; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; Forrest MJ, 2008, BRIT J PHARMACOL, V154, P1465, DOI 10.1038/bjp.2008.229; Franklin PH, 2009, J PHARMACOL EXP THER, V329, P928, DOI 10.1124/jpet.108.144816; Fryer RM, 2012, J CARDIOVASC PHARM, V59, P369, DOI 10.1097/FJC.0b013e31824485dd; Fujishiro J, 2006, TRANSPLANTATION, V82, P804, DOI 10.1097/01.tp.0000232687.78242.cd; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Gergely P, 25 C EUR COMM TREATM; Guo J, 1999, PFLUG ARCH EUR J PHY, V438, P642, DOI 10.1007/s004240051088; Hale JJ, 2004, BIOORG MED CHEM LETT, V14, P3501, DOI 10.1016/j.bmcl.2004.04.070; Himmel HM, 2000, MOL PHARMACOL, V58, P449, DOI 10.1124/mol.58.2.449; Igarashi J, 2008, BBA-MOL CELL BIOL L, V1781, P489, DOI 10.1016/j.bbalip.2008.06.008; Igarashi J, 2009, CARDIOVASC RES, V82, P212, DOI 10.1093/cvr/cvp064; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Jongsma M, 2009, BRIT J PHARMACOL, V156, P1305, DOI 10.1111/j.1476-5381.2009.00134.x; Kym PR, 2006, J MED CHEM, V49, P2339, DOI 10.1021/jm0512286; Lewis N, 2012, J IMMUNOLOGY; Liu Y., 2010, Patent No. [WO2010071794, 2010071794]; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Means CK, 2008, J BIOL CHEM, V283, P11954, DOI 10.1074/jbc.M707422200; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; O'Connor P, 2009, NEUROLOGY, V72, P73, DOI 10.1212/01.wnl.0000338569.32367.3d; Ochi R, 2006, CARDIOVASC RES, V70, P88, DOI 10.1016/j.cardiores.2006.01.010; Ota Hiroki, 2011, Pulm Circ, V1, P399, DOI 10.4103/2045-8932.87309; Pan S., 2004, PCT Int. Appl, Patent No. [WO2004103306, 2004103306]; Saha AK, 2011, ACS MED CHEM LETT, V2, P97, DOI 10.1021/ml100227q; Schmouder R, 2006, J CLIN PHARMACOL, V46, P895, DOI 10.1177/0091270006289853; Schubert R, 2006, CARDIOVASC RES, V70, P9, DOI 10.1016/j.cardiores.2006.02.012; Segreti JA, 2008, J PHARMACOL EXP THER, V325, P331, DOI 10.1124/jpet.107.132530; Shimizu H, 2005, CIRCULATION, V111, P222, DOI 10.1161/01.CIR.0000152101.41037.AB; Sugiyama A, 2000, JPN J PHARMACOL, V82, P338, DOI 10.1254/jjp.82.338; Sugiyama A, 2000, CARDIOVASC RES, V46, P119, DOI 10.1016/S0008-6363(00)00013-4; Tao R, 2009, J CARDIOVASC PHARM, V53, P486, DOI 10.1097/FJC.0b013e3181a7b58a; Tawadrous MN, 2002, TRANSPLANTATION, V74, P602, DOI 10.1097/00007890-200209150-00004; Wallstrom E, 2010, AM AC NEUR 62 ANN M	43	68	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52985	10.1371/journal.pone.0052985	http://dx.doi.org/10.1371/journal.pone.0052985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285242	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500094
J	Rossi, R; Hale, C; Goulding, D; Andrews, R; Abdellah, Z; Fairchild, PJ; Dougan, G				Rossi, Raffaella; Hale, Christine; Goulding, David; Andrews, Robert; Abdellah, Zarah; Fairchild, Paul J.; Dougan, Gordon			Interaction of Salmonella Typhimurium with Dendritic Cells Derived from Pluripotent Embryonic Stem Cells	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; EXPRESSION; IMMUNITY; DIFFERENTIATION; MACROPHAGES; ANTIGENS; SURVIVAL; BACTERIA; IL-23; INFECTIONS	Using an in vitro differentiation protocol we isolated cells with the properties of dendritic cells (DCs) from immunologically refractive pluripotent murine embryonic stem cells (ESCs). These ES-derived dendritic cells (ESDCs) expressed cytokines and were able to present antigen to a T cell line. Infection of ESDCs with Salmonella Typhimurium stimulated the expression of immune cell markers and thousands of murine genes, many associated with the immune response. Consequently, this system provides a novel in vitro model, amenable to genetic modification, for monitoring host/pathogen interactions.	[Rossi, Raffaella; Hale, Christine; Goulding, David; Andrews, Robert; Abdellah, Zarah; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Fairchild, Paul J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Wellcome Trust Sanger Institute; University of Oxford	Dougan, G (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.	gd1@sanger.ac.uk			Wellcome Trust [098051]; MRC [G0802538] Funding Source: UKRI; Medical Research Council [G0802538] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Wellcome Trust grant number 098051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; Cheminay C, 2005, J IMMUNOL, V174, P2892, DOI 10.4049/jimmunol.174.5.2892; Cid VJ, 2009, MICROBIOL-SGM, V155, P2461, DOI 10.1099/mic.0.032219-0; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Fairchild Paul J, 2007, Methods Mol Biol, V380, P59; Fairchild PJ, 2000, CURR BIOL, V10, P1515, DOI 10.1016/S0960-9822(00)00824-1; Fairchild PJ, 2003, METHOD ENZYMOL, V365, P169; Garcia-Del Portillo F, 2000, INFECT IMMUN, V68, P2985, DOI 10.1128/IAI.68.5.2985-2991.2000; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Horie K, 2011, NAT METHODS, V8, P1071, DOI [10.1038/NMETH.1739, 10.1038/nmeth.1739]; Huang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr908; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Kim H, 2011, BIOCHEM J, V440, P309, DOI 10.1042/BJ20110419; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kirby AC, 2001, J IMMUNOL, V166, P6802, DOI 10.4049/jimmunol.166.11.6802; Layton AN, 2005, J BACTERIOL, V187, P3565, DOI 10.1128/JB.187.10.3565-3571.2005; Lee VT, 1999, IMMUNOL REV, V168, P241, DOI 10.1111/j.1600-065X.1999.tb01296.x; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; MacLennan C, 2004, J INFECT DIS, V190, P1755, DOI 10.1086/425021; McKelvie ND, 2004, VACCINE, V22, P3243, DOI 10.1016/j.vaccine.2004.05.014; Morelli AE, 2001, BLOOD, V98, P1512, DOI 10.1182/blood.V98.5.1512; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Persson J, 2007, IMMUNOGENETICS, V59, P761, DOI 10.1007/s00251-007-0248-0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rescigno M, 2007, ADV M C M, P81; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Shen ZH, 1997, J IMMUNOL, V158, P2723; Silk KM, 2011, GENE THER; Skinner JA, 2005, J IMMUNOL, V175, P4647, DOI 10.4049/jimmunol.175.7.4647; Smits HH, 2004, EUR J IMMUNOL, V34, P1371, DOI 10.1002/eji.200324815; Steele-Mortimer O, 1999, CELL MICROBIOL, V1, P33, DOI 10.1046/j.1462-5822.1999.00003.x; Sundquist M, 2004, CELL MICROBIOL, V6, P1, DOI 10.1046/j.1462-5822.2003.00336.x; Uchiya K, 2005, INFECT IMMUN, V73, P5587, DOI 10.1128/IAI.73.9.5587-5594.2005; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08	46	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52232	10.1371/journal.pone.0052232	http://dx.doi.org/10.1371/journal.pone.0052232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284947	gold, Green Published			2022-12-25	WOS:000313051500026
J	Arruvito, L; Sabatte, J; Pandolfi, J; Baz, P; Billordo, LA; Lasala, MB; Salomon, H; Geffner, J; Fainboim, L				Arruvito, Lourdes; Sabatte, Juan; Pandolfi, Julieta; Baz, Placida; Billordo, Luis A.; Lasala, Maria B.; Salomon, Horacio; Geffner, Jorge; Fainboim, Leonardo			Analysis of Suppressor and Non-Suppressor FOXP3+T Cells in HIV-1-Infected Patients	PLOS ONE			English	Article							REGULATORY T-CELLS; HIV-INFECTION; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; EXPRESSION; CD4(+)CD25(+); PHENOTYPE; FREQUENCY; SUBSETS	Recently, it was shown that peripheral blood FOXP3+CD4+ T cells are composed of three phenotypic and functionally distinct subpopulations. Two of them having in vitro suppressive effects were characterized as resting Treg cells (rTregs) and activated Treg cells (aTregs). A third subset, identified as FOXP3+ non-Tregs, does not display any suppressor activity and produce high levels of Th1 and Th17 cytokines upon stimulation. In the present study we focus on the characteristics of these three subsets of FOXP3+CD4+ T cells in untreated HIV-1-infected patients. We found that the absolute counts of rTregs, aTregs and FOXP3+ non-Tregs were reduced in HIV-1 patients compared with healthy donors. The relative frequency of rTregs and aTregs was similar in HIV-1 patients and healthy donors, while the frequency of FOXP3+ non-Tregs was significantly higher in HIV-1 patients, reaching a maximum in those patients with the lower values of CD4 counts. Contrasting with the observations made in FOXP3-CD4+ T cells, we did not find a negative correlation between the number of rTregs, aTregs or FOXP3+ non-Tregs and virus load. Studies performed with either whole PBMCs or sorted aTregs and FOXP3+ non-Tregs cells showed that these two populations of FOXP3+ T cells were highly permissive to HIV-1 infection. Upon infection, FOXP3+ non-Tregs markedly down-regulates its capacity to produce Th1 and Th17 cytokines, however, they retain the ability to produce substantial amounts of Th2 cytokines. This suggests that FOXP3+ non-Tregs might contribute to the polarization of CD4+ T cells into a Th2 profile, predictive of a poor outcome of HIV-1-infected patients.	[Arruvito, Lourdes; Pandolfi, Julieta; Baz, Placida; Billordo, Luis A.; Fainboim, Leonardo] Univ Buenos Aires, Inst Immunol Genet & Metab INIGEM, Clin Hosp, Natl Council Sci & Technol Res, Buenos Aires, DF, Argentina; [Sabatte, Juan; Salomon, Horacio; Geffner, Jorge] Univ Buenos Aires, Sch Med, Dept Microbiol, Inst Biomed Res Retroviruses & AIDS, Buenos Aires, DF, Argentina; [Lasala, Maria B.] Univ Buenos Aires, Clin Hosp, Dept Infect Dis, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Fainboim, L (corresponding author), Univ Buenos Aires, Inst Immunol Genet & Metab INIGEM, Clin Hosp, Natl Council Sci & Technol Res, Buenos Aires, DF, Argentina.	lfainboim@hospitaldeclinicas.uba.ar		Fainboim, Leonardo/0000-0002-8907-0341	CONICET - PMO BID - PICT, Argentina [2339- PAE 37011]	CONICET - PMO BID - PICT, Argentina	This work was supported by grants from CONICET - PMO BID - PICT No 2339- PAE 37011 -Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Apoil PA, 2005, JAIDS-J ACQ IMM DEF, V39, P381, DOI 10.1097/01.qai.0000169662.30783.2d; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Baker CAR, 2007, CLIN EXP IMMUNOL, V147, P533, DOI 10.1111/j.1365-2249.2006.03319.x; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bi X, 2009, EUR J IMMUNOL, V39, P301, DOI 10.1002/eji.200838667; Di Mitri D, 2011, J IMMUNOL, V187, P2093, DOI 10.4049/jimmunol.1100978; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Fazekas de St Groth B, 2008, AIDS, V22, P671, DOI 10.1097/QAD.0b013e3282f466da; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hunt PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015924; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundgren JD, 2008, HIV MED, V9, P72, DOI 10.1111/j.1468-1293.2007.00534.x; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Sousa AE, 1999, J IMMUNOL, V162, P3718; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	29	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52580	10.1371/journal.pone.0052580	http://dx.doi.org/10.1371/journal.pone.0052580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285102	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500206
J	Chae, CS; Kwon, HK; Hwang, JS; Kim, JE; Im, SH				Chae, Chang-Suk; Kwon, Ho-Keun; Hwang, Ji-Sun; Kim, Jung-Eun; Im, Sin-Hyeog			Prophylactic Effect of Probiotics on the Development of Experimental Autoimmune Myasthenia Gravis	PLOS ONE			English	Article							REGULATORY T-CELLS; PLACEBO-CONTROLLED TRIAL; TOLEROGENIC DENDRITIC CELLS; INFLAMMATORY-BOWEL-DISEASE; ACETYLCHOLINE-RECEPTOR; LACTOBACILLUS-CASEI; C57BL/6 MICE; IFN-GAMMA; EXPERIMENTAL ARTHRITIS; MAINTAINING REMISSION	Probiotics are live bacteria that confer health benefits to the host physiology. Although protective role of probiotics have been reported in diverse diseases, no information is available whether probiotics can modulate neuromuscular immune disorders. We have recently demonstrated that IRT5 probiotics, a mixture of 5 probiotics, could suppress diverse experimental disorders in mice model. In this study we further investigated whether IRT5 probiotics could modulate the progression of experimental autoimmune myasthenia gravis (EAMG). Myasthenia gravis (MG) is a T cell dependent antibody mediated autoimmune disorder in which acetylcholine receptor (AChR) at the neuromuscular junction is the major autoantigen. Oral administration of IRT5 probiotics significantly reduced clinical symptoms of EAMG such as weight loss, body trembling and grip strength. Prophylactic effect of IRT5 probiotics on EMAG is mediated by down-regulation of effector function of AChR-reactive T cells and B cells. Administration of IRT5 probiotics decreased AChR-reactive lymphocyte proliferation, anti-AChR reactive IgG levels and inflammatory cytokine levels such as IFN-gamma, TNF-alpha, IL-6 and IL-17. Downregulation of inflammatory mediators in AChR-reactive lymphocytes by IRT5 probiotics is mediated by the generation of regulatory dendritic cells (rDCs) that express increased levels of IL-10, TGF-beta, arginase 1 and aldh1a2. Furthermore, DCs isolated from IRT5 probiotics-fed group effectively converted CD4(+) T cells into CD4+ Foxp3(+) regulatory T cells compared with control DCs. Our data suggest that IRT5 probiotics could be applicable to modulate antibody mediated autoimmune diseases including myasthenia gravis.	[Im, Sin-Hyeog] GIST, Sch Life Sci, Kwangju, South Korea; GIST, Immune Synapse Res Ctr, Kwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Im, SH (corresponding author), GIST, Sch Life Sci, Kwangju, South Korea.	imsh@gist.ac.kr	Im, Sin-Hyeog/AAM-9586-2021; Im, Sin-Hyeog/E-6811-2013	Im, Sin-Hyeog/0000-0002-3173-1856; Im, Sin-Hyeog/0000-0002-3173-1856; KWON, HOKEUN/0000-0003-3175-0376	Regional Technology Innovation Program of the MOCIE [RTI05-01-01]; Mid-career Researcher Program through NRF (National Research Foundation, KOREA) [2011-0000126]; GIST (Gwangju Institute of Science and Technology)	Regional Technology Innovation Program of the MOCIE(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Mid-career Researcher Program through NRF (National Research Foundation, KOREA); GIST (Gwangju Institute of Science and Technology)	This research was supported by grants from the Regional Technology Innovation Program of the MOCIE (RTI05-01-01), Mid-career Researcher Program through NRF (National Research Foundation, KOREA) (2011-0000126) and by a Systems Biology Infrastructure Establishment Grant provided by GIST (Gwangju Institute of Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin AS, 1997, J DAIRY SCI, V80, P2721, DOI 10.3168/jds.S0022-0302(97)76233-7; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; Balasa B, 1998, J IMMUNOL, V161, P2856; Balasa B, 1997, J EXP MED, V186, P385, DOI 10.1084/jem.186.3.385; Baroja ML, 2007, CLIN EXP IMMUNOL, V149, P470, DOI 10.1111/j.1365-2249.2007.03434.x; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bowman LM, 2001, INFECT IMMUN, V69, P3719, DOI 10.1128/IAI.69.6.3719-3727.2001; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; de Roos NM, 2000, AM J CLIN NUTR, V71, P405; Deng CS, 2002, J IMMUNOL, V169, P1077, DOI 10.4049/jimmunol.169.2.1077; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; Foligne B, 2005, GUT, V54, P727; Gervasio OL, 2005, J PHYSIOL-LONDON, V562, P673, DOI 10.1113/jphysiol.2004.077685; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Goluszko E, 2002, J NEUROIMMUNOL, V122, P85, DOI 10.1016/S0165-5728(01)00474-X; Gomez AM, 2011, J IMMUNOL, V186, P2503, DOI 10.4049/jimmunol.1002539; Gomez AM, 2010, AUTOIMMUNITY, V43, P353, DOI 10.3109/08916930903555943; GOMEZ CM, 1983, P NATL ACAD SCI-BIOL, V80, P4089, DOI 10.1073/pnas.80.13.4089; HOHLFELD R, 1984, NATURE, V310, P244, DOI 10.1038/310244a0; Im SH, 2001, FASEB J, V15, P2140, DOI 10.1096/fj.01-0072com; Im SH, 1999, J CLIN INVEST, V104, P1723, DOI 10.1172/JCI8121; Isolauri E, 2002, GUT, V50, P54, DOI 10.1136/gut.50.suppl_3.iii54; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; ITOH T, 1995, LETT APPL MICROBIOL, V21, P137, DOI 10.1111/j.1472-765X.1995.tb01025.x; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Karachunski PI, 2000, J IMMUNOL, V164, P5236, DOI 10.4049/jimmunol.164.10.5236; Kato I, 1998, LIFE SCI, V63, P635, DOI 10.1016/S0024-3205(98)00315-4; Kim N, 2007, CLIN IMMUNOL, V123, P30, DOI 10.1016/j.clim.2006.11.005; Kuhbacher T, 2006, GUT, V55, P833, DOI 10.1136/gut.2005.078303; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; LENNON VA, 1978, J EXP MED, V147, P973, DOI 10.1084/jem.147.4.973; Losen M, 2008, ANN NY ACAD SCI, V1132, P174, DOI 10.1196/annals.1405.034; Mahnke K, 2007, J DERMATOL SCI, V46, P159, DOI 10.1016/j.jdermsci.2007.03.002; Maiti PK, 2004, J NEUROIMMUNOL, V152, P112, DOI 10.1016/j.jneuroim.2004.04.010; Martinez-Martinez P, 2009, NEUROBIOL DIS, V35, P14, DOI 10.1016/j.nbd.2009.03.008; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mu LL, 2009, IMMUNOLOGY, V128, pe826, DOI 10.1111/j.1365-2567.2009.03089.x; NEWSOMDAVIS J, 1978, NEUROLOGY, V28, P266, DOI 10.1212/WNL.28.3.266; Ostlie N, 2003, J IMMUNOL, V170, P604, DOI 10.4049/jimmunol.170.1.604; PACHNER AR, 1987, YALE J BIOL MED, V60, P169; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; PERDIGON G, 1995, J DAIRY SCI, V78, P1597, DOI 10.3168/jds.S0022-0302(95)76784-4; PINCHING AJ, 1976, LANCET, V2, P1373; Pochard P, 2002, J ALLERGY CLIN IMMUN, V110, P617, DOI 10.1067/mai.2002.128528; Reddy BS, 1999, J NUTR, V129, p1478S, DOI 10.1093/jn/129.7.1478S; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; SAHASHI K, 1980, J NEUROPATH EXP NEUR, V39, P160, DOI 10.1097/00005072-198003000-00005; Sheil B, 2004, GUT, V53, P694, DOI 10.1136/gut.2003.027789; Shida K, 1998, INT ARCH ALLERGY IMM, V115, P278, DOI 10.1159/000069458; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; So JS, 2008, MOL IMMUNOL, V46, P172, DOI 10.1016/j.molimm.2008.07.038; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; So JS, 2011, LIFE SCI, V88, P358, DOI 10.1016/j.lfs.2010.12.013; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Viljanen M, 2005, J ALLERGY CLIN IMMUN, V115, P1254, DOI 10.1016/j.jaci.2005.03.047; Wang HB, 2000, INT IMMUNOL, V12, P1381, DOI 10.1093/intimm/12.10.1381; Wang W, 2007, J IMMUNOL, V178, P7072, DOI 10.4049/jimmunol.178.11.7072; Yi HJ, 2008, MOL IMMUNOL, V46, P192, DOI 10.1016/j.molimm.2008.08.264; Zocco MA, 2006, ALIMENT PHARM THER, V23, P1567, DOI 10.1111/j.1365-2036.2006.02927.x	62	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52119	10.1371/journal.pone.0052119	http://dx.doi.org/10.1371/journal.pone.0052119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284891	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500093
J	Farre, JC; Aknin, C; Araya, A; Castandet, B				Farre, Jean-Claude; Aknin, Cindy; Araya, Alejandro; Castandet, Benoit			RNA Editing in Mitochondrial Trans-Introns Is Required for Splicing	PLOS ONE			English	Article							GROUP-II INTRON; PLANT-MITOCHONDRIA; GENE-EXPRESSION; TRANSSPLICING MODEL; LARIAT FORMATION; BRANCH-SITE; WHEAT; TRANSCRIPTION; OENOTHERA; SEQUENCE	In plant mitochondria, gene expression of translatable mRNAs is a complex process with two critical steps, RNA editing and splicing. We studied the role of RNA editing on non-coding regions of the mat-r-nad1e-nad5c transcript from wheat mitochondria. This RNA contains two trans-introns, 3'-nad1-I4 and 3'-nad5-I2, involved in different trans-splicing events, ensuring the association of nad1d-nad1e and nad5b-nad5c exons from nad1 and nad5 mRNAs respectively. The C-to-U editing changes studied here affect homologous positions on 3'-nad1-I4 and 3'-nad5-I2. It is proposed that these base changes are necessary to place an Adenosine residue in a bulging conformation characteristic of domain VI (D6) from group II introns. In this work, we investigated the role of RNA editing events on 3'-nad1-I4 and 3'-nad5-I2 in the trans-splicing process using in vivo and in organello approaches. When the branched intermediates formed during the splicing process were analyzed, the C residues from D6 intron domains from 3'-nad1-I4 and 3'-nad5-I2 were found changed to U, suggesting that RNA editing of these residues could be mandatory for splicing. This assumption was tested by expressing recombinant mat-r-nad1e transgenes introduced into mitochondria by electroporation. Mutation of the editing target residue dramatically affected trans-splicing. Interestingly, the exon joining efficiency was not recovered by compensatory mutations, suggesting that the role of RNA editing is not confined to the restoration of the secondary structure of domain D6 of the intron. Our results strongly support the hypothesis that RNA editing in trans-introns precedes maturation, and is required for the splicing reaction. In addition, this is the first report using an in organello approach to study the trans-splicing process, opening the way to future studies of this peculiar mechanism.	[Farre, Jean-Claude; Aknin, Cindy; Araya, Alejandro; Castandet, Benoit] CNRS, Microbiol Fondamentale & Pathol UMR5234, Bordeaux, France; [Farre, Jean-Claude; Aknin, Cindy; Araya, Alejandro; Castandet, Benoit] Univ Bordeaux Segalen, Bordeaux, France; [Araya, Alejandro] Ctr INRA Bordeaux, Inst Biol Vegetale Mol, Biol Fruit & Pathol UMR1332, Vilenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Araya, A (corresponding author), CNRS, Microbiol Fondamentale & Pathol UMR5234, Bordeaux, France.	aaraya@reger.u-bordeaux2.fr			Centre National de la Recherche Scientifique; Universite Bordeaux Segalen, France; PICS-CNRS program [3641]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen, France; PICS-CNRS program	This research was supported by the Centre National de la Recherche Scientifique, the Universite Bordeaux Segalen, France, and the PICS-CNRS program no 3641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begu D, 1998, CURR GENET, V33, P420, DOI 10.1007/s002940050355; BEGU D, 1990, PLANT CELL, V2, P1283, DOI 10.1105/tpc.2.12.1283; Begu D, 2011, CURR GENET, V57, P317, DOI 10.1007/s00294-011-0349-z; BINDER S, 1992, J BIOL CHEM, V267, P7615; BLANC V, 1995, FEBS LETT, V373, P56, DOI 10.1016/0014-5793(95)00991-H; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; BORNER GV, 1995, MOL GEN GENET, V246, P739, DOI 10.1007/BF00290721; Carrillo C, 1997, NUCLEIC ACIDS RES, V25, P403, DOI 10.1093/nar/25.2.403; Carrillo C, 2001, MOL GEN GENET, V264, P595, DOI 10.1007/s004380000345; Castandet B, 2011, BIOCHEMISTRY-MOSCOW+, V76, P924, DOI 10.1134/S0006297911080086; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chanfreau G, 1996, EMBO J, V15, P3466, DOI 10.1002/j.1460-2075.1996.tb00713.x; CHAPDELAINE Y, 1991, CELL, V65, P465, DOI 10.1016/0092-8674(91)90464-A; Choury D, 2005, NUCLEIC ACIDS RES, V33, P7058, DOI 10.1093/nar/gki1017; Chu VT, 1998, RNA, V4, P1186, DOI 10.1017/S1355838298980724; Costa M, 1997, J MOL BIOL, V267, P520, DOI 10.1006/jmbi.1996.0882; COVELLO PS, 1990, FEBS LETT, V268, P5, DOI 10.1016/0014-5793(90)80958-L; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; de Longevialle AF, 2007, PLANT CELL, V19, P3256, DOI 10.1105/tpc.107.054841; de Longevialle AF, 2010, MOL PLANT, V3, P691, DOI 10.1093/mp/ssq025; DESOUZA AP, 1991, PLANT CELL, V3, P1363, DOI 10.1105/tpc.3.12.1363; Elina H, 2010, NUCLEIC ACIDS RES, V38, P996, DOI 10.1093/nar/gkp994; Farre JC, 2002, PLANT J, V29, P203, DOI 10.1046/j.1365-313x.2002.01207.x; Farre JC, 1999, PLANT MOL BIOL, V40, P959, DOI 10.1023/A:1006296422485; Farre JC, 2001, NUCLEIC ACIDS RES, V29, P2484, DOI 10.1093/nar/29.12.2484; Farre JC, 2007, METHOD ENZYMOL, V424, P483, DOI 10.1016/S0076-6879(07)24022-4; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; Hamill S, 2006, MOL CELL, V23, P831, DOI 10.1016/j.molcel.2006.07.017; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Laurencikiene J, 2006, EMBO REP, V7, P303, DOI 10.1038/sj.embor.7400621; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Li CF, 2011, EMBO J, V30, P3040, DOI 10.1038/emboj.2011.214; Li CF, 2011, RNA, V17, P1321, DOI 10.1261/rna.2655911; Li-Pook-Than J, 2006, NUCLEIC ACIDS RES, V34, P2782, DOI 10.1093/nar/gkl328; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Schlatterer JC, 2006, J AM CHEM SOC, V128, P3866, DOI 10.1021/ja0578754; SCHMELZER C, 1986, CELL, V46, P557, DOI 10.1016/0092-8674(86)90881-0; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Toor N, 2006, NUCLEIC ACIDS RES, V34, P6461, DOI 10.1093/nar/gkl820; VANDERVEEN R, 1987, EMBO J, V6, P3827, DOI 10.1002/j.1460-2075.1987.tb02719.x; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Waldsich C, 2007, NAT STRUCT MOL BIOL, V14, P37, DOI 10.1038/nsmb1181; WISSINGER B, 1991, CELL, V65, P473, DOI 10.1016/0092-8674(91)90465-B; Zabaleta E, 1996, P NATL ACAD SCI USA, V93, P11259, DOI 10.1073/pnas.93.20.11259; ZANLUNGO S, 1995, CURR GENET, V27, P565, DOI 10.1007/BF00314449	53	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52644	10.1371/journal.pone.0052644	http://dx.doi.org/10.1371/journal.pone.0052644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285127	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500218
J	Goertz, DE; Todorova, M; Mortazavi, O; Agache, V; Chen, B; Karshafian, R; Hynynen, K				Goertz, David E.; Todorova, Margarita; Mortazavi, Omid; Agache, Vlad; Chen, Branson; Karshafian, Raffi; Hynynen, Kullervo			Antitumor Effects of Combining Docetaxel (Taxotere) with the Antivascular Action of Ultrasound Stimulated Microbubbles	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; VASCULAR DISRUPTING AGENTS; TEMPERATURE-SENSITIVE LIPOSOMES; TUMOR BLOOD-VESSELS; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; SOLID TUMORS; IN-VIVO; DRUG-DELIVERY; INERTIAL CAVITATION; TARGETING AGENTS	Ultrasound stimulated microbubbles (USMB) are being investigated for their potential to promote the uptake of anticancer agents into tumor tissue by exploiting their ability to enhance microvascular permeability. At sufficiently high ultrasound transmit amplitudes it has also recently been shown that USMB treatments can, on their own, induce vascular damage, shutdown blood flow, and inhibit tumor growth. The objective of this study is to examine the antitumor effects of 'antivascular' USMB treatments in conjunction with chemotherapy, which differs from previous work which has sought to enhance drug uptake with USMBs by increasing vascular permeability. Conceptually this is a strategy similar to combining vascular disrupting agents with a chemotherapy, and we have selected the taxane docetaxel (Taxotere) for evaluating this approach as it has previously been shown to have potent antitumor effects when combined with small molecule vascular disrupting agents. Experiments were conducted on PC3 tumors implanted in athymic mice. USMB treatments were performed at a frequency of 1 MHz employing sequences of 50 ms bursts (0.00024 duty cycle) at 1.65 MPa. USMB treatments were administered on a weekly basis for 4 weeks with docetaxel (DTX) being given intravenously at a dose level of 5 mg/kg. The USMB treatments, either alone or in combination with DTX, induced an acute reduction in tumor perfusion which was accompanied at the 24 hour point by significantly enhanced necrosis and apoptosis. Longitudinal experiments showed a modest prolongation in survival but no significant growth inhibition occurred in DTX-only and USMB-only treatment groups relative to control tumors. The combined USMB-DTX treatment group produced tumor shrinkage in weeks 4-6, and significant growth inhibition and survival prolongation relative to the control (p<0.001), USMB-only (p<0.01) and DTX-only treatment groups (p<0.01). These results suggest the potential of enhancing the antitumor activity of docetaxel by combining it with antivascular USMB effects.	[Goertz, David E.; Todorova, Margarita; Hynynen, Kullervo] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Goertz, David E.; Todorova, Margarita; Mortazavi, Omid; Agache, Vlad; Chen, Branson; Hynynen, Kullervo] Sunnybrook Res Inst, Toronto, ON, Canada; [Karshafian, Raffi] Ryerson Univ, Dept Phys, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Toronto Metropolitan University	Goertz, DE (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	goertz@sri.utoronto.ca		Chen, Branson/0000-0002-4224-0753	Ontario Research Fund	Ontario Research Fund	This work was funded by the Ontario Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekeredjian R, 2007, ULTRASOUND MED BIOL, V33, P1592, DOI 10.1016/j.ultrasmedbio.2007.05.003; Bissery MC, 1995, SEMIN ONCOL, V22, P3; Bohmer MR, 2010, J CONTROL RELEASE, V148, P18, DOI 10.1016/j.jconrel.2010.06.012; Burke CW, 2011, J NEUROSURG, V114, P1654, DOI 10.3171/2010.11.JNS101201; Chappell JC, 2005, ULTRASOUND MED BIOL, V31, P1411, DOI 10.1016/j.ultrasmedbio.2005.06.010; Chen H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.034301; Ching LM, 2004, BRIT J CANCER, V90, P906, DOI 10.1038/sj.bjc.6601606; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; Deckers R, 2010, J CONTROL RELEASE, V148, P25, DOI 10.1016/j.jconrel.2010.07.117; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; Duan WR, 2003, J PATHOL, V199, P221, DOI 10.1002/path.1289; Fenton BM, 1999, BRIT J CANCER, V79, P464, DOI 10.1038/sj.bjc.6690072; Goertz DE, 2008, ULTRASON, P670, DOI 10.1109/ULTSYM.2008.0161; Goertz DE, 2009, IEEE ULTRASON S, P89; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; Heath CH, 2012, OTOLARYNG HEAD NECK, V146, P938, DOI 10.1177/0194599812436648; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Helfield BL, 2012, ULTRASOUND MED BIOL, V38, P1298, DOI 10.1016/j.ultrasmedbio.2012.03.005; Hori K, 2010, J PHARM SCI-US, V99, P2914, DOI 10.1002/jps.22038; Horsman MR, 2006, CANCER RES, V66, P11520, DOI 10.1158/0008-5472.CAN-06-2848; Hu X, INVEST RADIOL, V47, P398; Hwang JH, 2005, ULTRASOUND MED BIOL, V31, P553, DOI 10.1016/j.ultrasmedbio.2004.12.014; Hwang JH, 2006, ULTRASOUND MED BIOL, V32, P1611, DOI 10.1016/j.ultrasmedbio.2006.07.016; Hynynen K, 1996, ULTRASOUND MED BIOL, V22, P193, DOI 10.1016/0301-5629(95)02044-6; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Karshafian R, 2009, ULTRASOUND MED BIOL, V35, P847, DOI 10.1016/j.ultrasmedbio.2008.10.013; Kim TJ, 2007, CANCER RES, V67, P9337, DOI 10.1158/0008-5472.CAN-06-4018; Krix M, 2003, ULTRASOUND MED BIOL, V29, P1093, DOI 10.1016/S0301-5629(03)00060-7; Leighton T., 1997, ACOUSTIC BUBBLE; Lin CY, 2012, INT J NANOMED, V7, P2143, DOI 10.2147/IJN.S29514; Lin CY, 2010, J CONTROL RELEASE, V146, P291, DOI 10.1016/j.jconrel.2010.05.033; Lin CY, 2010, ULTRASOUND MED BIOL, V36, P1460, DOI 10.1016/j.ultrasmedbio.2010.06.003; McDannold NJ, 2006, RADIOLOGY, V241, P95, DOI 10.1148/radiol.2411051170; McKeage M, 2006, CLIN CANCER RES, V12, P1776, DOI 10.1158/1078-0432.CCR-05-1939; McKeage MJ, 2008, EXPERT OPIN INV DRUG, V17, P23, DOI 10.1517/13543784.17.1.23; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; Miller DL, 2007, PROG BIOPHYS MOL BIO, V93, P314, DOI 10.1016/j.pbiomolbio.2006.07.027; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Pili R, 2010, CLIN CANCER RES, V16, P2906, DOI 10.1158/1078-0432.CCR-09-3026; Quesson B, 2010, MED PHYS, V37, P2533, DOI 10.1118/1.3413996; Ranjan A, 2012, J CONTROL RELEASE, V158, P487, DOI 10.1016/j.jconrel.2011.12.011; Rapoport N, 2007, JNCI-J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/djm043; Schwartz EL, 2009, CLIN CANCER RES, V15, P2594, DOI 10.1158/1078-0432.CCR-08-2710; Shaked Y, 2007, CANCER RES, V67, P7055, DOI 10.1158/0008-5472.CAN-07-0905; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; Shaked Y, 2010, VASCULAR DISRUPTIVE AGENTS FOR THE TREATMENT OF CANCER, P117, DOI 10.1007/978-1-4419-6609-4_6; Siemann DW, 2008, ANTICANCER RES, V28, P2027; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Siemann DW, 2004, INT J RADIAT ONCOL, V60, P1233, DOI 10.1016/j.ijrobp.2004.08.002; Siemann DW, 2002, INT J CANCER, V99, P1, DOI 10.1002/ijc.10316; Siim BG, 2003, CANCER CHEMOTH PHARM, V51, P43, DOI 10.1007/s00280-002-0529-0; Skeel R.T, 2007, HDB CANC CHEMOTHERAP; Song J, 2002, CIRCULATION, V106, P1550, DOI 10.1161/01.CIR.0000028810.33423.95; Sorace AG, 2012, J DRUG TARGET, V20, P43, DOI 10.3109/1061186X.2011.622397; Staruch R, 2011, INT J HYPERTHER, V27, P156, DOI 10.3109/02656736.2010.518198; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Tannock IF, 2002, CLIN CANCER RES, V8, P878; Taraboletti G, 2010, VASCULAR DISRUPTIVE AGENTS FOR THE TREATMENT OF CANCER, P77, DOI 10.1007/978-1-4419-6609-4_4; Tartis MS, 2006, ULTRASOUND MED BIOL, V32, P1771, DOI 10.1016/j.ultrasmedbio.2006.03.017; ter Haar GR, 2001, ECHOCARDIOGR-J CARD, V18, P317, DOI 10.1046/j.1540-8175.2001.00317.x; Ting CY, 2012, BIOMATERIALS, V33, P704, DOI 10.1016/j.biomaterials.2011.09.096; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Treat LH, 2009, IMPACT FOCUSED ULTRA; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Turnbull DH, 1996, ULTRASOUND MED BIOL, V22, P845, DOI 10.1016/0301-5629(96)00107-X; Unger EC, 2004, ADV DRUG DELIVER REV, V56, P1291, DOI 10.1016/j.addr.2003.12.006; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Wood AKW, 2005, ULTRASOUND MED BIOL, V31, P1403, DOI 10.1016/j.ultrasmedbio.2005.06.008; Wood AKW, 2008, ACAD RADIOL, V15, P1133, DOI 10.1016/j.acra.2008.04.012; Wood AKW, 2010, ULTRASOUND MED BIOL, V36, P853, DOI 10.1016/j.ultrasmedbio.2010.02.001; Wu F, 2002, ULTRASOUND MED BIOL, V28, P535, DOI 10.1016/S0301-5629(01)00515-4; Yeung SCJ, 2007, J CLIN ENDOCR METAB, V92, P2902, DOI 10.1210/jc.2007-0027; Zhao YZ, 2011, J DRUG TARGET, V19, P154, DOI 10.3109/10611861003801834	74	74	76	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52307	10.1371/journal.pone.0052307	http://dx.doi.org/10.1371/journal.pone.0052307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284980	gold, Green Published, Green Submitted			2022-12-25	WOS:000312794500141
J	Leigh, R; Jen, SS; Varma, DD; Hillis, AE; Barker, PB				Leigh, Richard; Jen, Shyian S.; Varma, Daniel D.; Hillis, Argye E.; Barker, Peter B.			Arrival Time Correction for Dynamic Susceptibility Contrast MR Permeability Imaging in Stroke Patients	PLOS ONE			English	Article							BRAIN-BARRIER DISRUPTION; CEREBRAL BLOOD-VOLUME; ACUTE ISCHEMIC-STROKE; HEMORRHAGIC TRANSFORMATION; PARENCHYMAL ENHANCEMENT; PREDICTION; THERAPY; GRADE	Purpose: To determine if applying an arrival time correction (ATC) to dynamic susceptibility contrast (DSC) based permeability imaging will improve its ability to identify contrast leakage in stroke patients for whom the shape of the measured curve may be very different due to hypoperfusion. Materials and Methods: A technique described in brain tumor patients was adapted to incorporate a correction for delayed contrast delivery due to perfusion deficits. This technique was applied to the MRIs of 9 stroke patients known to have blood-brain barrier (BBB) disruption on T1 post contrast imaging. Regions of BBB damage were compared with normal tissue from the contralateral hemisphere. Receiver operating characteristic (ROC) analysis was performed to compare the detection of BBB damage before and after ATC. Results: ATC improved the area under the curve (AUC) of the ROC from 0.53 to 0.70. The sensitivity improved from 0.51 to 0.67 and the specificity improved from 0.57 to 0.66. Visual inspection of the ROC curve revealed that the performance of the uncorrected analysis was worse than random guess at some thresholds. Conclusions: The ability of DSC permeability imaging to identify contrast enhancing tissue in stroke patients improved considerably when an ATC was applied. Using DSC permeability imaging in stroke patients without an ATC may lead to false identification of BBB disruption.	[Leigh, Richard; Jen, Shyian S.; Hillis, Argye E.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Barker, Peter B.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Varma, Daniel D.] Flinders Comprehens Stroke Ctr, Bedford Pk, SA, Australia; [Barker, Peter B.] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Flinders University South Australia; Kennedy Krieger Institute	Leigh, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	rleigh4@jhu.edu	Leigh, Richard/K-8401-2013	Leigh, Richard/0000-0002-8285-1815	NINDS NIH HHS [R01 NS047691] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047691] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bang OY, 2007, ANN NEUROL, V62, P170, DOI 10.1002/ana.21174; Bang OY, 2009, STROKE, V40, P454, DOI 10.1161/STROKEAHA.108.522847; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Hjort N, 2008, STROKE, V39, P1025, DOI 10.1161/STROKEAHA.107.497719; Jiang Q, 2002, J CEREBR BLOOD F MET, V22, P559, DOI 10.1097/00004647-200205000-00007; Kim EY, 2005, AM J NEURORADIOL, V26, P1050; Knight RA, 1998, STROKE, V29, P144, DOI 10.1161/01.STR.29.1.144; Latour LL, 2004, ANN NEUROL, V56, P468, DOI 10.1002/ana.20199; Provenzale JM, 2002, AM J ROENTGENOL, V178, P711, DOI 10.2214/ajr.178.3.1780711; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wintermark M, 2008, STROKE, V39, P1621, DOI 10.1161/STROKEAHA.107.512319; Wu SP, 2009, INVEST RADIOL, V44, P662, DOI 10.1097/RLI.0b013e3181ae9c40; Zaharchuk G, 2007, AM J NEURORADIOL, V28, P1850, DOI 10.3174/ajnr.A0831	14	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52656	10.1371/journal.pone.0052656	http://dx.doi.org/10.1371/journal.pone.0052656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285132	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500221
J	Matsuura, K; Wada, M; Konishi, K; Sato, M; Iwamoto, U; Sato, Y; Tachibana, A; Kikuchi, T; Iwamiya, T; Shimizu, T; Yamashita, JK; Yamato, M; Hagiwara, N; Okano, T				Matsuura, Katsuhisa; Wada, Masanori; Konishi, Kanako; Sato, Michi; Iwamoto, Ushio; Sato, Yuko; Tachibana, Aki; Kikuchi, Tetsutaro; Iwamiya, Takahiro; Shimizu, Tatsuya; Yamashita, Jun K.; Yamato, Masayuki; Hagiwara, Nobuhisa; Okano, Teruo			Fabrication of Mouse Embryonic Stem Cell-Derived Layered Cardiac Cell Sheets Using a Bioreactor Culture System	PLOS ONE			English	Article							HEART FUNCTION; IN-VITRO; CARDIOMYOCYTES; TISSUE; EXPANSION; NEOVASCULARIZATION; DIFFERENTIATION; MYOCARDIUM; INDUCTION; APOPTOSIS	Bioengineered functional cardiac tissue is expected to contribute to the repair of injured heart tissue. We previously developed cardiac cell sheets using mouse embryonic stem (mES) cell-derived cardiomyocytes, a system to generate an appropriate number of cardiomyocytes derived from ES cells and the underlying mechanisms remain elusive. In the present study, we established a cultivation system with suitable conditions for expansion and cardiac differentiation of mES cells by embryoid body formation using a three-dimensional bioreactor. Daily conventional medium exchanges failed to prevent lactate accumulation and pH decreases in the medium, which led to insufficient cell expansion and cardiac differentiation. Conversely, a continuous perfusion system maintained the lactate concentration and pH stability as well as increased the cell number by up to 300-fold of the seeding cell number and promoted cardiac differentiation after 10 days of differentiation. After a further 8 days of cultivation together with a purification step, around 1 x 10(8) cardiomyocytes were collected in a 1-L bioreactor culture, and additional treatment with noggin and granulocyte colony stimulating factor increased the number of cardiomyocytes to around 5.5 x 10(8). Co-culture of mES cell-derived cardiomyocytes with an appropriate number of primary cultured fibroblasts on temperature-responsive culture dishes enabled the formation of cardiac cell sheets and created layered-dense cardiac tissue. These findings suggest that this bioreactor system with appropriate medium might be capable of preparing cardiomyocytes for cell sheet-based cardiac tissue.	[Matsuura, Katsuhisa; Kikuchi, Tetsutaro; Iwamiya, Takahiro; Shimizu, Tatsuya; Yamato, Masayuki; Okano, Teruo] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan; [Matsuura, Katsuhisa; Hagiwara, Nobuhisa] Tokyo Womens Med Univ, Dept Cardiol, Tokyo, Japan; [Wada, Masanori; Tachibana, Aki] ABLE Corp, Tokyo, Japan; [Konishi, Kanako; Sato, Michi; Iwamoto, Ushio; Sato, Yuko] Asahi Kasei Co LTD, Tokyo, Japan; [Kikuchi, Tetsutaro] CellSeed Inc, Tokyo, Japan; [Yamashita, Jun K.] Kyoto Univ, Lab Stem Cell Differentiat, Stem Cell Res Ctr, Inst Frontier Med, Kyoto, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Asahi Kasei Corporation; Kyoto University	Okano, T (corresponding author), Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan.	tokano@abmes.twmu.ac.jp	Kikuchi, Tetsutaro/ABB-4442-2021; Tatsuya, Shimizu/AAN-5675-2021	Kikuchi, Tetsutaro/0000-0001-9119-1444; Okano, Teruo/0000-0002-4470-9842; Iwamiya, Takahiro/0000-0001-6616-1104	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; Council for Science and Technology Policy (CSTP)	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research was funded by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. This research is fully granted by the Japan Society for the Promotion of Science (JSPS*) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)," initiated by the Council for Science and Technology Policy (CSTP). ABLE Corporation, Asahi Kasei Co. LTD and CellSeed Inc. have participated in the research as a collaborating institution, commissioned by the operational support institution of the research, Japan Science and Technology Agency (JST*). Although Tatsuya Shimizu and Masayuki Yamato are consultants for CellSeed, Inc., and Teruo Okano is an investor in CellSeed, Inc., this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. *JSPS is an independent administrative institution, established by way of a national law for the purpose of contributing to the advancement of science in all fields of the natural and social sciences and the humanities. *JST is an integrated organization of science and technology in Japan that establishes an infrastructure for the entire process from the creation of knowledge to the return the society.	Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343; Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7; Masumoto H, 2012, STEM CELLS, V30, P1196, DOI 10.1002/stem.1089; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Memon IA, 2005, J THORAC CARDIOV SUR, V130, P1333, DOI 10.1016/j.jtcvs.2005.07.023; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Niebruegge S, 2008, TISSUE ENG PT A, V14, P1591, DOI 10.1089/ten.tea.2007.0247; OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Ream M, 2008, AM J PHYSIOL-REG I, V295, pR583, DOI 10.1152/ajpregu.00771.2007; Sasaki D, 2009, BIOMATERIALS, V30, P4384, DOI 10.1016/j.biomaterials.2009.05.003; Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668; Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286; Sekine H, 2012, CELL TISSUE RES, V347, P775, DOI 10.1007/s00441-011-1267-6; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Thatte HS, 2004, ANN THORAC SURG, V77, P1376, DOI 10.1016/j.athoracsur.2003.07.047; Wang XL, 2006, BIOTECHNOL PROGR, V22, P811, DOI 10.1021/bp060018z; Want AJ, 2012, REGEN MED, V7, P71, DOI [10.2217/RME.11.101, 10.2217/rme.11.101]; Webster KA, 1999, J CLIN INVEST, V104, P239; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023	30	29	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52176	10.1371/journal.pone.0052176	http://dx.doi.org/10.1371/journal.pone.0052176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284924	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500106
J	Schmidt-Lauber, C; Harrach, S; Pap, T; Fischer, M; Victor, M; Heitzmann, M; Hansen, U; Fobker, M; Brand, SM; Sindic, A; Pavenstadt, H; Edemir, B; Schlatter, E; Bertrand, J; Ciarimboli, G				Schmidt-Lauber, Christian; Harrach, Saliha; Pap, Thomas; Fischer, Meike; Victor, Marion; Heitzmann, Marianne; Hansen, Uwe; Fobker, Manfred; Brand, Stefan-Martin; Sindic, Aleksandra; Pavenstaedt, Hermann; Edemir, Bayram; Schlatter, Eberhard; Bertrand, Jessica; Ciarimboli, Giuliano			Transport Mechanisms and Their Pathology-Induced Regulation Govern Tyrosine Kinase Inhibitor Delivery in Rheumatoid Arthritis	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTER; CHRONIC MYELOID-LEUKEMIA; GROWTH-FACTOR; DRUG TRANSPORTER; IMATINIB; EXPRESSION; PHARMACOKINETICS; PROLIFERATION; DISEASES; HOCT1	Background: Tyrosine kinase inhibitors (TKIs) are effective in treating malignant disorders and were lately suggested to have an impact on non-malignant diseases. However, in some inflammatory conditions like rheumatoid arthritis (RA) the in vivo effect seemed to be moderate. As most TKIs are taken up actively into cells by cell membrane transporters, this study aimed to evaluate the role of such transporters for the accumulation of the TKI Imatinib mesylates in RA synovial fibroblasts as well as their regulation under inflammatory conditions. Methodology/Principal Findings: The transport and accumulation of Imatinib was investigated in transporter-transfected HEK293 cells and human RA synovial fibroblasts (hRASF). Transporter expression was quantified by qRT-PCR. In transfection experiments, hMATE1 showed the highest apparent affinity for Imatinib among all known Imatinib transporters. Experiments quantifying the Imatinib uptake in the presence of specific transporter inhibitors and after siRNA knockdown of hMATE1 indeed identified hMATE1 to mediate Imatinib transport in hRASF. The anti-proliferative effect of Imatinib on PDGF stimulated hRASF was quantified by cell counting and directly correlated with the uptake activity of hMATE1. Expression of hMATE1 was investigated by Western blot and immuno-fluorescence. Imatinib transport under disease-relevant conditions, such as an altered pH and following stimulation with different cytokines, was also investigated by HPLC. The uptake was significantly reduced by an acidic extracellular pH as well as by the cytokines TNF alpha, IL-1 beta and IL-6, which all decreased the expression of hMATE1-mRNA and protein. Conclusion/Significance:The regulation of Imatinib uptake via hMATE1 in hRASF and resulting effects on their proliferation may explain moderate in vivo effects on RA. Moreover, our results suggest that investigating transporter mediated drug processing under normal and pathological conditions is important for developing intracellular acting drugs used in inflammatory diseases.	[Schmidt-Lauber, Christian; Harrach, Saliha; Fischer, Meike; Victor, Marion; Pavenstaedt, Hermann; Edemir, Bayram; Schlatter, Eberhard; Ciarimboli, Giuliano] Univ Hosp Munster, Dept Internal Med D, Munster, Germany; [Schmidt-Lauber, Christian; Harrach, Saliha; Pap, Thomas; Heitzmann, Marianne; Bertrand, Jessica] Univ Hosp Munster, Inst Expt Musculoskeletal Med, Munster, Germany; [Hansen, Uwe] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Munster, Germany; [Fobker, Manfred] Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Brand, Stefan-Martin] Univ Hosp Munster, Leibniz Inst Arteriosclerosis Res, Munster, Germany; [Brand, Stefan-Martin] Univ Hosp Munster, Inst Sports Med, Munster, Germany; [Sindic, Aleksandra] Univ Zagreb, Croatian Inst Brain Res, Dept Physiol, Zagreb 41000, Croatia	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Munster; University of Zagreb	Ciarimboli, G (corresponding author), Univ Hosp Munster, Dept Internal Med D, Munster, Germany.	gciari@uni-muenster.de	Edemir, Bayram/AAF-6845-2020; Dugandzic, Aleksandra/AAL-7581-2020	Ciarimboli, Giuliano/0000-0002-4365-3656	"Innovative Medizinische Forschung" of the Medical Faculty of Munster University [BE121009]	"Innovative Medizinische Forschung" of the Medical Faculty of Munster University	This work was funded by the "Innovative Medizinische Forschung" of the Medical Faculty of Munster University (BE121009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi N, 2011, MOD RHEUMATOL, V21, P267, DOI 10.1007/s10165-010-0392-5; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Ciarimboli G, 2004, J CELL PHYSIOL, V201, P420, DOI 10.1002/jcp.20081; Distler JHW, 2010, ANN RHEUM DIS, V69, P48, DOI 10.1136/ard.2009.120196; FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99; Bonilla-Hernan MG, 2011, RHEUMATOLOGY, V50, P1542, DOI 10.1093/rheumatology/ker192; Grigat S, 2009, DRUG METAB DISPOS, V37, P330, DOI 10.1124/dmd.108.023929; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; GRONOWICZ G, 1992, J PERIODONTAL RES, V27, P562, DOI 10.1111/j.1600-0765.1992.tb01737.x; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Ito S, 2010, J PHARMACOL EXP THER, V333, P341, DOI 10.1124/jpet.109.163642; Kameda H, 2006, CLIN EXP IMMUNOL, V144, P335, DOI 10.1111/j.1365-2249.2006.03067.x; Kay J, 2008, ARTHRITIS RHEUM, V58, P2543, DOI 10.1002/art.23696; Kido Y, 2011, J MED CHEM, V54, P4548, DOI 10.1021/jm2001629; le Coutre P, 2004, CANCER CHEMOTH PHARM, V53, P313, DOI 10.1007/s00280-003-0741-6; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Minematsu T, 2011, MOL CANCER THER, V10, P531, DOI 10.1158/1535-7163.MCT-10-0731; Paniagua RT, 2007, NAT CLIN PRACT RHEUM, V3, P190, DOI 10.1038/ncprheum0465; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Rosengren S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2981; Sandler C, 2006, BIOCHEM BIOPH RES CO, V347, P31, DOI 10.1016/j.bbrc.2006.06.052; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Thomas J, 2004, BLOOD, V104, P3739, DOI 10.1182/blood-2003-12-4276; Wang L, 2008, CLIN PHARMACOL THER, V83, P258, DOI 10.1038/sj.clpt.6100268; Widmer N, 2004, J CHROMATOGR B, V803, P285, DOI 10.1016/j.jchromb.2004.01.006; Wilde S, 2009, CELL MOL LIFE SCI, V66, P1729, DOI 10.1007/s00018-009-9145-z; Zhang L, 1997, MOL PHARMACOL, V51, P913, DOI 10.1124/mol.51.6.913	29	20	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52247	10.1371/journal.pone.0052247	http://dx.doi.org/10.1371/journal.pone.0052247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284953	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500124
J	Serva, A; Knapp, B; Tsai, YT; Claas, C; Lisauskas, T; Matula, P; Harder, N; Kaderali, L; Rohr, K; Erfle, H; Eils, R; Braga, V; Starkuviene, V				Serva, Andrius; Knapp, Bettina; Tsai, Yueh-Tso; Claas, Christoph; Lisauskas, Tautvydas; Matula, Petr; Harder, Nathalie; Kaderali, Lars; Rohr, Karl; Erfle, Holger; Eils, Roland; Braga, Vania; Starkuviene, Vytaute			miR-17-5p Regulates Endocytic Trafficking through Targeting TBC1D2/Armus	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; E-CADHERIN; BREAST-CANCER; DOWN-REGULATION; IMAGE-ANALYSIS; LUNG CANCERS; MICRORNA; CLUSTER; EXPRESSION; MEMBRANE	miRNA cluster miR-17-92 is known as oncomir-1 due to its potent oncogenic function. miR-17-92 is a polycistronic cluster that encodes 6 miRNAs, and can both facilitate and inhibit cell proliferation. Known targets of miRNAs encoded by this cluster are largely regulators of cell cycle progression and apoptosis. Here, we show that miRNAs encoded by this cluster and sharing the seed sequence of miR-17 exert their influence on one of the most essential cellular processes - endocytic trafficking. By mRNA expression analysis we identified that regulation of endocytic trafficking by miR-17 can potentially be achieved by targeting of a number of trafficking regulators. We have thoroughly validated TBC1D2/Armus, a GAP of Rab7 GTPase, as a novel target of miR-17. Our study reveals regulation of endocytic trafficking as a novel function of miR-17, which might act cooperatively with other functions of miR-17 and related miRNAs in health and disease.	[Lisauskas, Tautvydas; Harder, Nathalie; Rohr, Karl; Eils, Roland; Starkuviene, Vytaute] Heidelberg Univ, DKFZ, BioQuant, Heidelberg, Germany; [Knapp, Bettina; Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, Dresden, Germany; [Matula, Petr; Harder, Nathalie; Rohr, Karl; Eils, Roland] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Matula, Petr] Masaryk Univ, Fac Informat, Ctr Biomed Image Anal, Brno, Czech Republic; [Braga, Vania] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Ruprecht Karls University Heidelberg; Masaryk University Brno; Imperial College London	Starkuviene, V (corresponding author), Heidelberg Univ, DKFZ, BioQuant, Heidelberg, Germany.	vytaute.starkuviene@bioquant.uni-heidelberg.de	Matula, Petr/L-2119-2013; Starkuviene, Vytaute/AAG-9378-2021; Braga, Vania MM/C-7345-2008; Eils, Roland/B-6121-2009	Matula, Petr/0000-0003-4125-1597; Eils, Roland/0000-0002-0034-4036; Harder, Nathalie/0000-0002-6171-6462; Kaderali, Lars/0000-0002-2359-2294; Lisauskas, Tautvydas/0000-0001-9954-0469; Braga, Vania/0000-0003-0546-7163	BMBF FORSYS ViroQuant [0313923]; BMBF SysTec [0315523A]; Baden Wurttemberg Stiftung [P-LS-Meth/ 11]; LGFG fellowship of Graduate Academy of Heidelberg University; Grant Agency of the Czech Republic [P302/12/G157]; MRC [G0600791] Funding Source: UKRI; Cancer Research UK [11980] Funding Source: researchfish; Medical Research Council [G0600791] Funding Source: researchfish	BMBF FORSYS ViroQuant(Federal Ministry of Education & Research (BMBF)); BMBF SysTec(Federal Ministry of Education & Research (BMBF)); Baden Wurttemberg Stiftung; LGFG fellowship of Graduate Academy of Heidelberg University; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BMBF FORSYS ViroQuant (#0313923), BMBF SysTec (0315523A) and Baden Wurttemberg Stiftung (P-LS-Meth/ 11). AS is supported by LGFG fellowship of Graduate Academy of Heidelberg University. PM is partially supported by the Grant Agency of the Czech Republic (P302/12/G157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2002, J CELL BIOL, V158, P659, DOI 10.1083/jcb.200204081; Andreev J, 1999, MOL CELL BIOL, V19, P2338; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BAKER ME, 1988, BIOCHEM J, V255, P1057, DOI 10.1042/bj2551057; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; BIRCHMEIER C, 1993, ANNU REV CELL BIOL, V9, P511, DOI 10.1146/annurev.cb.09.110193.002455; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CARPENTER G, 1976, J CELL BIOL, V71, P159, DOI 10.1083/jcb.71.1.159; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chotard L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015662; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Frasa MAM, 2010, CURR BIOL, V20, P198, DOI 10.1016/j.cub.2009.12.053; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GHOSH RN, 1994, J CELL SCI, V107, P2177; Gilbert DF, 2009, J BIOMOL SCREEN, V14, P944, DOI 10.1177/1087057109339523; Grillari J, 2010, BIOGERONTOLOGY, V11, P501, DOI 10.1007/s10522-010-9272-9; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Harder N, 2008, METHOD CELL BIOL, V85, P539, DOI 10.1016/S0091-679X(08)85023-6; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hirota Y, 2009, CELL MOL LIFE SCI, V66, P2913, DOI 10.1007/s00018-009-0080-9; HOPKINS CR, 1983, CELL, V35, P321, DOI 10.1016/0092-8674(83)90235-0; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Jadhav V, 2012, BIOTECHNOL BIOENG, V109, P1376, DOI 10.1002/bit.24490; Kanzaki H, 2011, PROTEOMICS, V11, P3531, DOI 10.1002/pmic.201000501; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; LEE I, 2009, GENOME RES; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li WD, 2009, DEVELOPMENT, V136, P2445, DOI 10.1242/dev.035949; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Matula P, 2009, CYTOM PART A, V75A, P309, DOI 10.1002/cyto.a.20662; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; McCaffrey MW, 2001, FEBS LETT, V495, P21, DOI 10.1016/S0014-5793(01)02359-6; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rieber N, 2009, BIOINFORMATICS, V25, P678, DOI 10.1093/bioinformatics/btp014; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Scherr M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm971; Schmidt-Glenewinkel H, 2009, J BIOL CHEM, V284, P17243, DOI 10.1074/jbc.M809586200; SCHNEIDER WJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P303, DOI 10.1016/0304-4157(89)90023-3; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Serva A, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/870903; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	83	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52555	10.1371/journal.pone.0052555	http://dx.doi.org/10.1371/journal.pone.0052555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285084	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500193
J	Zhang, XH; Zhang, J; Huang, HQ; Xue, RZ; Hu, XC; Li, MR; Zhong, Y; Yuan, LY				Zhang, Xiaohui; Zhang, Jing; Huang, Huaiqiu; Xue, Ruzeng; Hu, Xuchu; Li, Meirong; Zhong, Yi; Yuan, Liyan			Taenia taeniaeformis in Rat Favors Protracted Skin Lesions Caused by Sporothrix schenckii Infection: Dectin-1 and IL-17 Are Dispensable for Clearance of This Fungus	PLOS ONE			English	Article							RIO-DE-JANEIRO; CYTOKINE PRODUCTION; IMMUNE-RESPONSE; SPOROTRICHOSIS; CELLS; MACROPHAGES; EXPRESSION; RESISTANCE; ACTIVATION	We occasionally found that cestode Taenia taeniaeformis in rats favored Sporothrix schenckii infection and survival, causing protracted cutaneous lesions. In this study, we compared the pathology and cytokines profile of rats co-infected with the two pathogens and infected with S. schenckii alone to explore underlying mechanisms. In the co-infection group, there was high expression of beta-glucan receptor Dectin-1 in the cutaneous lesions and no multinucleated giant cells, but in the S. schenckii infection group the opposite was observed. Cytokines profiles demonstrated an expected finding that IL-4, commonly expressed in helminth and fungus infection, is undetectable in the two infection groups. In the single fungal infection group, cytokines IFN-gamma, IL-10 and IL-17 kept increasing in the first few weeks of infection to a peak which was followed by gradual decrease. This study showed that Dectin-1 and IL-17, which were believed to be the major anti-fungus mechanisms, are Th2 independent and dispensable for clearance of S. schenckii infection, suggesting that S. schenckii has a different molecular recognition pattern and evokes anti-infection mechanisms other than Dectin-1 and IL-17. Citation: Zhang X, Zhang J, Huang H, Xue R, Hu X, et al. (2012) Taenia taeniaeformis in Rat Favors Protracted Skin Lesions Caused by Sporothrix schenckii Infection: Dectin-1 and IL-17 Are Dispensable for Clearance of This Fungus. PLoS ONE 7(12): e52514. doi:10.1371/journal.pone.0052514	[Zhang, Xiaohui; Huang, Huaiqiu; Li, Meirong; Zhong, Yi; Yuan, Liyan] Sun Yat Sen Univ, Dept Dermatol & Venereol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xiaohui; Xue, Ruzeng] Guangdong Prov Ctr Skin Dis & STIs Control & Prev, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Zhang, Jing] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Dermatol & Venereol, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Xuchu] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Huang, HQ (corresponding author), Sun Yat Sen Univ, Dept Dermatol & Venereol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China.	hhuaiqiu@medmail.com.cn; hnhxch@hotmail.com		huaiqiu, HUANG/0000-0002-6320-8031				Alonso-Trujillo J, 2007, PARASITOL RES, V100, P1341, DOI 10.1007/s00436-006-0424-4; Bhatia S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015943; Burns MJ, 2009, WEST J EMERG MED, V10, P204; Carlos IZ, 2009, MYCOPATHOLOGIA, V168, P1, DOI 10.1007/s11046-009-9190-z; de Miranda LHM, 2009, MYCOPATHOLOGIA, V168, P79, DOI 10.1007/s11046-009-9198-4; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; Fujimura T, 1996, ACTA DERM-VENEREOL, V76, P321; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; Guasconi L, 2011, IMMUNOLOGY, V133, P386, DOI 10.1111/j.1365-2567.2011.03449.x; Gutierrez-Galhardo MC, 2010, MYCOSES, V53, P78, DOI 10.1111/j.1439-0507.2008.01655.x; Guzman-Beltran S, 2012, MICROBES INFECT, V14, P1093, DOI 10.1016/j.micinf.2012.06.001; Koga T, 2002, MED MYCOL, V40, P111, DOI 10.1080/mmy.40.2.111.114; KOGA T, 1994, ACTA DERM-VENEREOL, V74, P328; Kumar JM, 2006, VET PARASITOL, V141, P362, DOI 10.1016/j.vetpar.2006.05.029; Lopes-Bezerra LM, 2006, AN ACAD BRAS CIENC, V78, P293, DOI 10.1590/S0001-37652006000200009; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pappas PW, 1999, EXP PARASITOL, V91, P315, DOI 10.1006/expr.1998.4392; Ramos-e-Silva M, 2007, CLIN DERMATOL, V25, P181, DOI 10.1016/j.clindermatol.2006.05.006; Rice PJ, 2005, J PHARMACOL EXP THER, V314, P1079, DOI 10.1124/jpet.105.085415; Schubach TMP, 2002, MYCOPATHOLOGIA, V153, P83, DOI 10.1023/A:1014449621732; Tachibana T, 1999, MED MYCOL, V37, P397, DOI 10.1046/j.1365-280X.1999.00239.x; Uenotsuchi T, 2006, INT IMMUNOL, V18, P1637, DOI 10.1093/intimm/dxl097; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Willment JA, 2003, J IMMUNOL, V171, P4569, DOI 10.4049/jimmunol.171.9.4569; Xie Z, 2010, MED MYCOL, V48, P201, DOI 10.3109/13693780902785320; Xu SL, 2009, J BIOL CHEM, V284, P22005, DOI 10.1074/jbc.M109.009076; Yang Z, 2009, IMMUNOBIOLOGY, V214, P321, DOI 10.1016/j.imbio.2008.09.002	28	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52514	10.1371/journal.pone.0052514	http://dx.doi.org/10.1371/journal.pone.0052514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285072	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500185
J	Chowdhary, A; Kathuria, S; Xu, JP; Sharma, C; Sundar, G; Singh, PK; Gaur, SN; Hagen, F; Klaassen, CH; Meis, JF				Chowdhary, Anuradha; Kathuria, Shallu; Xu, Jianping; Sharma, Cheshta; Sundar, Gandhi; Singh, Pradeep Kumar; Gaur, Shailendra N.; Hagen, Ferry; Klaassen, Corne H.; Meis, Jacques F.			Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India	PLOS ONE			English	Article							AZOLE RESISTANCE; INVASIVE ASPERGILLOSIS; CROSS-RESISTANCE; TR/L98H MUTATION; THERAPY; DRUGS; PLANT; RECOMBINATION; ITRACONAZOLE; POSACONAZOLE	Azole resistance is an emerging problem in Aspergillus which impacts the management of aspergillosis. Here in we report the emergence and clonal spread of resistance to triazoles in environmental Aspergillus fumigatus isolates in India. A total of 44 (7%) A. fumigatus isolates from 24 environmental samples were found to be triazole resistant. The isolation rate of resistant A. fumigatus was highest (33%) from soil of tea gardens followed by soil from flower pots of the hospital garden (20%), soil beneath cotton trees (20%), rice paddy fields (12.3%), air samples of hospital wards (7.6%) and from soil admixed with bird droppings (3.8%). These strains showed cross-resistance to voriconazole, posaconazole, itraconazole and to six triazole fungicides used extensively in agriculture. Our analyses identified that all triazole-resistant strains from India shared the same TR34/L98H mutation in the cyp51 gene. In contrast to the genetic uniformity of azole-resistant strains the azole-susceptible isolates from patients and environments in India were genetically very diverse. All nine loci were highly polymorphic in populations of azole-susceptible isolates from both clinical and environmental samples. Furthermore, all Indian environmental and clinical azole resistant isolates shared the same multilocus microsatellite genotype not found in any other analyzed samples, either from within India or from the Netherlands, France, Germany or China. Our population genetic analyses suggest that the Indian azole-resistant A. fumigatus genotype was likely an extremely adaptive recombinant progeny derived from a cross between an azole-resistant strain migrated from outside of India and a native azole-susceptible strain from within India, followed by mutation and then rapid dispersal through many parts of India. Our results are consistent with the hypothesis that exposure of A. fumigatus to azole fungicides in the environment causes cross-resistance to medical triazoles. The study emphasises the need of continued surveillance of resistance in environmental and clinical A. fumigatus strains.	[Chowdhary, Anuradha; Kathuria, Shallu; Sharma, Cheshta; Sundar, Gandhi; Singh, Pradeep Kumar] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Gaur, Shailendra N.] Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Pulm Med, Delhi 110007, India; [Hagen, Ferry; Klaassen, Corne H.; Meis, Jacques F.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Meis, Jacques F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of Delhi; McMaster University; University of Delhi; Canisius-Wilhelmina Hospital; Radboud University Nijmegen	Chowdhary, A (corresponding author), Univ Delhi, Vallabhbhai Patel Chest Inst, Dept Med Mycol, Delhi 110007, India.	dranuradha@hotmail.com	Meis, Jacques F/A-9241-2010; Hagen, Ferry/B-9044-2009; Sharma, Cheshta/J-7966-2019; Kathuria, Shallu/AAN-5835-2020; Chowdhary, Anuradha/ABF-1252-2020	Meis, Jacques F/0000-0003-3253-6080; Hagen, Ferry/0000-0002-5622-1916; Chowdhary, Anuradha/0000-0002-2028-7462; Singh, Pradeep Kumar/0000-0003-1492-598X; Sharma, Cheshta/0000-0003-3216-263X	Department of Biotechnology New Delhi, India [BT/39/NE/TBP/2010]; Astellas; Merck; Schering Plough; Gilead; Janssen Pharmaceuticals; Pfizer; NSERC of Canada	Department of Biotechnology New Delhi, India(Department of Biotechnology (DBT) India); Astellas(Astellas Pharmaceuticals); Merck(Merck & Company); Schering Plough(Merck & CompanySchering Plough Corporation); Gilead(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported with a grant from the Department of Biotechnology (Grant Reference Number: BT/39/NE/TBP/2010), New Delhi, India. J.F. Meis received grants from Astellas, Merck, Schering Plough, Gilead and Janssen Pharmaceuticals. C.H. Klaassen received a grant from Pfizer. J.P. Xu received grants from NSERC of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; J.F. Meis received grants from Astellas, Merck, Schering-Plough, Gilead and Janssen Pharmaceuticals, is a consultant to Basilea and Merck and received speaker's fees from Merck, Schering-Plough, Gilead and Janssen Pharmaceutica. C.H. Klaassen received a grant from Pfizer. J.P. Xu received grants from NSERC of Canada. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Arendrup MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010080; Burgel PR, 2012, ANTIMICROB AGENTS CH, V56, P869, DOI 10.1128/AAC.05077-11; Camps SMT, 2012, ANTIMICROB AGENTS CH, V56, P10, DOI 10.1128/AAC.05088-11; Chakrabarti A, 2011, MED MYCOL, V49, pS35, DOI 10.3109/13693786.2010.505206; Chowdhary A, 2012, J ANTIMICROB CHEMOTH, V67, P362, DOI 10.1093/jac/dkr443; CLSI, 2008, REFERENCE METHOD BRO, P2; Cornely OA, 2007, NEW ENGL J MED, V356, P348, DOI 10.1056/NEJMoa061094; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Denning DW, 2011, FUTURE MICROBIOL, V6, P1229, DOI [10.2217/FMB.11.118, 10.2217/fmb.11.118]; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fisher MC, 2012, MOL ECOL, V21, P1305, DOI 10.1111/j.1365-294X.2012.05506.x; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hof H, 2001, ANTIMICROB AGENTS CH, V45, P2987, DOI 10.1128/AAC.45.11.2987-2990.2001; Hong SB, 2006, INT J SYST EVOL MICR, V56, P477, DOI 10.1099/ijs.0.63980-0; Howard SJ, 2010, CLIN MICROBIOL INFEC, V16, P683, DOI 10.1111/j.1469-0691.2009.02911.x; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Howard SJ, 2011, MED MYCOL, V49, pS90, DOI 10.3109/13693786.2010.508469; Klaassen CHW, 2012, MOL ECOL, V21, P57, DOI 10.1111/j.1365-294X.2011.05364.x; Klaassen CHW, 2010, J ANTIMICROB CHEMOTH, V65, P901, DOI 10.1093/jac/dkq041; Kuipers S, 2011, ANTIMICROB AGENTS CH, V55, P3564, DOI 10.1128/AAC.01544-10; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Rodriguez-Tudela JL, 2008, ANTIMICROB AGENTS CH, V52, P2468, DOI 10.1128/AAC.00156-08; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; Muller FMC, 2007, ANTIMICROB AGENTS CH, V51, P3014, DOI 10.1128/AAC.00459-07; NETHMAP, 2012, CONS ANT AG ANT RES; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rath PM, 2012, ANTIMICROB AGENTS CH, V56, P6060, DOI 10.1128/AAC.01017-12; Serfling A, 2007, ANTIMICROB AGENTS CH, V51, P3672, DOI 10.1128/AAC.00654-07; Singh N, 2000, J ENVIRON SCI HEAL B, V35, P549, DOI 10.1080/03601230009373291; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031801; Snelders E, 2011, FUTURE MICROBIOL, V6, P335, DOI [10.2217/FMB.11.4, 10.2217/fmb.11.4]; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Stensvold CR, 2012, CURR FUNGAL INFECT R, V6, P178, DOI 10.1007/s12281-012-0097-7; Thind TS, 2007, INDIAN PHYTOPATHOL, V60, P421; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Verweij PE, 1997, INT J INFECT DIS, V2, P61; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	42	146	149	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52871	10.1371/journal.pone.0052871	http://dx.doi.org/10.1371/journal.pone.0052871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285210	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500074
J	Liu, FC; Yu, HP; Hwang, TL; Tsai, YF				Liu, Fu-Chao; Yu, Huang-Ping; Hwang, Tsong-Long; Tsai, Yung-Fong			Protective Effect of Tropisetron on Rodent Hepatic Injury after Trauma-Hemorrhagic Shock through P38 MAPK-Dependent Hemeoxygenase-1 Expression	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; INFLAMMATORY CYTOKINE PRODUCTION; CHEMOTHERAPY-INDUCED NAUSEA; 5-HT3 RECEPTOR ANTAGONISTS; HEME OXYGENASE-1; UP-REGULATION; MEDIATED CARDIOPROTECTION; MECHANISM; LUNG; AKT	Tropisetron can decrease inflammatory cell responses and alleviate organ damage caused by trauma-hemorrhage, but the mechanism of these effects remains unknown. The p38 mitogen-activated protein kinase/hemeoxygenase-1 (p38 MAPK/HO-1) pathway exerts anti-inflammatory effects on different tissues. The aim of this study was to investigate whether p38 MAPK/HO-1 plays any role in the tropisetron-mediated attenuation of hepatic injury after trauma-hemorrhage. Male Sprague-Dawley rats underwent trauma-hemorrhage (mean blood pressure maintained at approximately 35-40 mmHg for 90 min), followed by fluid resuscitation. During resuscitation, several treatment regimens were administered: four doses of tropisetron alone (0.1, 0.3, 1, 3 mg/kg body weight), or a single dose of tropisetron (1 mg/kg body weight) with and without a p38 MAPK inhibitor (SB-203580, 2 mg/kg body weight) or HO antagonist (chromium-mesoporphyrin, 2.5 mg/kg body weight). Various parameters were measured, and the animals were sacrificed at 24 h post-resuscitation. The results showed that trauma-hemorrhage increased the following parameters: plasma concentrations of aspartate (AST) and alanine aminotransferases (ALT), hepatic myeloperoxidase (MPO) activity, and levels of cytokine-induced neutrophil chemoattractant-1 and -3 (CINC-1 and CINC-3), intercellular adhesion molecule-1 (ICAM-1), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and macrophage inflammatory protein-1 alpha (MIP-1 alpha). These parameters were significantly improved in the tropisetron-treated rats subjected to trauma-hemorrhage. Tropisetron treatment also increased hepatic p38 MAPK and HO-1 expression compared with vehicle-treated trauma-hemorrhaged rats. Co-administration of SB-203580 or chromium-mesoporphyrin with tropisetron abolished the tropisetron-induced beneficial effects on the above parameters and hepatic injury. These results suggest that the protective effect of tropisetron administration on alleviation of hepatic injury after trauma-hemorrhage is likely mediated through p38 MAPK-dependent HO-1 expression.	[Liu, Fu-Chao; Yu, Huang-Ping; Tsai, Yung-Fong] Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan; [Liu, Fu-Chao; Yu, Huang-Ping; Tsai, Yung-Fong] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Tao Yuan, Taiwan; [Tsai, Yung-Fong] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Tao Yuan, Taiwan.	yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021; Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977; Liu, F-C/0000-0003-1712-4053	National Science Council [NSC98-2314-B-182A-034-MY3, NSC 101-2314-B-182 -082]; Chang Gung Memorial Hospital [CMRPG381073, CMRPG 392122]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council (NSC98-2314-B-182A-034-MY3) and Chang Gung Memorial Hospital (CMRPG381073) to HPY and from the National Science Council (NSC 101-2314-B-182 -082) and Chang Gung Memorial Hospital (CMRPG 392122) to FCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Nasim, 2011, J Emerg Trauma Shock, V4, P114, DOI 10.4103/0974-2700.76846; Alten JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001605; An L, 2012, EUR J PHARMACOL, V677, P1, DOI 10.1016/j.ejphar.2011.12.010; Aoudjit L, 2003, AM J PHYSIOL-RENAL, V285, pF765, DOI 10.1152/ajprenal.00100.2003; Dorman Robert B, 2004, Comp Hepatol, V3 Suppl 1, pS42, DOI 10.1186/1476-5926-2-S1-S42; Douzinas EE, 2012, CRIT CARE MED, V40, P1348, DOI 10.1097/CCM.0b013e31823e9501; Drechsler Y, 2006, J IMMUNOL, V177, P2592, DOI 10.4049/jimmunol.177.4.2592; Faerber L, 2007, EUR J PHARMACOL, V560, P1, DOI 10.1016/j.ejphar.2007.01.028; Fiebich BL, 2004, SCAND J RHEUMATOL, V33, P28, DOI 10.1080/03009740410006998; Grochot-Przeczek A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005803; Haines DD, 2012, ACTA PHYSIOL, V204, P487, DOI 10.1111/j.1748-1716.2011.02387.x; Hesketh PJ, 2000, CANCER INVEST, V18, P163, DOI 10.3109/07357900009038248; Hsu JT, 2008, SHOCK, V30, P372, DOI 10.1097/SHK.0b013e318164f25c; Hsu JT, 2008, AM J PHYSIOL-REG I, V294, pR1825, DOI 10.1152/ajpregu.00112.2008; Hsu JT, 2007, AM J PHYSIOL-HEART C, V292, pH2982, DOI 10.1152/ajpheart.01303.2006; Kan WH, 2008, AM J PHYSIOL-HEART C, V294, pH2627, DOI 10.1152/ajpheart.91444.2007; Li J, 2011, J TRAUMA, V71, P1262, DOI 10.1097/TA.0b013e31821280c5; Liu FC, 2008, ACTA ANAESTH SCAND, V52, P635, DOI 10.1111/j.1399-6576.2008.01592.x; Liu FC, 2012, SHOCK, V38, P76, DOI 10.1097/SHK.0b013e318259ad51; Liu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025907; Liu FC, 2011, RESUSCITATION, V82, P335, DOI 10.1016/j.resuscitation.2010.11.007; Liu FC, 2009, ANESTH ANALG, V108, P1855, DOI 10.1213/ane.0b013e3181a1a194; Lv KY, 2012, J SURG RES, V178, P827, DOI 10.1016/j.jss.2012.04.006; MENEGAUX F, 1993, J TRAUMA, V35, P865, DOI 10.1097/00005373-199312000-00011; Okamoto K, 2006, NEUROSCIENCE, V143, P597, DOI 10.1016/j.neuroscience.2006.08.009; Rahimian R, 2011, BRAIN RES, V1392, P101, DOI 10.1016/j.brainres.2011.03.053; Sato H, 2005, SHOCK, V24, P488, DOI 10.1097/01.shk.0000176594.64626.7f; Sato H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030124; Shen XD, 2005, AM J TRANSPLANT, V5, P1793, DOI 10.1111/j.1600-6143.2005.00932.x; Shifflett DE, 2004, AM J PHYSIOL-GASTR L, V286, pG906, DOI 10.1152/ajpgi.00478.2003; Shimizu T, 2007, ANN SURG, V245, P297, DOI 10.1097/01.sla.0000232523.88621.17; Simpson K, 2000, DRUGS, V59, P1297, DOI 10.2165/00003495-200059060-00008; Suda K, 2010, SHOCK, V33, P526, DOI 10.1097/SHK.0b013e3181cc064b; Tsai YF, 2012, J SURG RES, V176, P171, DOI 10.1016/j.jss.2011.05.039; Yu HP, 2008, SHOCK, V30, P324, DOI 10.1097/SHK.0b013e318164f013; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P277, DOI 10.1189/jlb.0705363; Yu HP, 2006, J LEUKOCYTE BIOL, V79, P963, DOI 10.1189/jlb.1005596; Zeng Z, 2010, WORLD J GASTROENTERO, V16, P1285, DOI 10.3748/wjg.v16.i10.1285; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	40	27	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53203	10.1371/journal.pone.0053203	http://dx.doi.org/10.1371/journal.pone.0053203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285267	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500121
J	Fang, GZ; Yang, P; Cui, JG; Yao, DZ; Brauth, SE; Tang, YZ				Fang, Guangzhan; Yang, Ping; Cui, Jianguo; Yao, Dezhong; Brauth, Steven E.; Tang, Yezhong			Mating Signals Indicating Sexual Receptiveness Induce Unique Spatio-Temporal EEG Theta Patterns in an Anuran Species	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; EARLY GENE-EXPRESSION; FEMALE TUNGARA FROGS; MATE CHOICE; WORKING-MEMORY; COGNITIVE-PROCESSES; BRAIN OSCILLATIONS; ALZHEIMERS-DISEASE; CEREBRAL ASYMMETRY; AUDITORY MIDBRAIN	Female mate choice is of importance for individual fitness as well as a determining factor in genetic diversity and speciation. Nevertheless relatively little is known about how females process information acquired from males during mate selection. In the Emei music frog, Babina daunchina, males normally call from hidden burrows and females in the reproductive stage prefer male calls produced from inside burrows compared with ones from outside burrows. The present study evaluated changes in electroencephalogram (EEG) power output in four frequency bands induced by male courtship vocalizations on both sides of the telencephalon and mesencephalon in females. The results show that (1) both the values of left hemispheric theta relative power and global lateralization in the theta band are modulated by the sexual attractiveness of the acoustic stimulus in the reproductive stage, suggesting the theta oscillation is closely correlated with processing information associated with mate choice; (2) mean relative power in the beta band is significantly greater in the mesencephalon than the left telencephalon, regardless of reproductive status or the biological significance of signals, indicating it is associated with processing acoustic features and (3) relative power in the delta and alpha bands are not affected by reproductive status or acoustic stimuli. The results imply that EEG power in the theta and beta bands reflect different information processing mechanisms related to vocal recognition and auditory perception in anurans.	[Fang, Guangzhan; Yang, Ping; Cui, Jianguo; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuroinformat, Minist Educ, Chengdu 610054, Peoples R China; [Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Electronic Science & Technology of China; University System of Maryland; University of Maryland College Park	Tang, YZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	tangyz@cib.ac.cn	fang, guangzhan/AAH-1098-2020	Fang, Guangzhan/0000-0003-1803-6610	National Natural Science Foundation of China [31270042, 2011CB707803]; Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (31270042 to Jianguo Cui, 2011CB707803 to Dezhong Yao), and the Ministry of Education of China (the "111" Project) to Dezhong Yao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Akre KL, 2010, CURR BIOL, V20, P502, DOI 10.1016/j.cub.2010.01.021; Alexander Richard D., 1997, P4, DOI 10.1017/CBO9780511721946.002; Baijal S, 2010, COGN PROCESS, V11, P31, DOI 10.1007/s10339-009-0272-0; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Brismar T, 2007, PHYSIOL BEHAV, V92, P141, DOI 10.1016/j.physbeh.2007.05.047; Burmeister SS, 2008, BRAIN RES, V1190, P105, DOI 10.1016/j.brainres.2007.11.008; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Cui JG, 2012, BIOL LETTERS, V8, P337, DOI 10.1098/rsbl.2011.1091; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; Davidson R.J., 1984, EMOTIONS COGNITION B, P320; Davidson R.J., 1984, APPROACHES EMOTION, P39; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fang GZ, 2012, J COMP PHYSIOL A, V198, P119, DOI 10.1007/s00359-011-0693-y; FENG AS, 1990, PROG NEUROBIOL, V34, P313, DOI 10.1016/0301-0082(90)90008-5; FENG AS, 1981, HEARING RES, V5, P201, DOI 10.1016/0378-5955(81)90046-0; FERNANDEZ T, 1995, ELECTROEN CLIN NEURO, V94, P175, DOI 10.1016/0013-4694(94)00262-J; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; HOBSON JA, 1968, NATURE, V220, P386, DOI 10.1038/220386a0; Huang C, 2000, CLIN NEUROPHYSIOL, V111, P1961, DOI 10.1016/S1388-2457(00)00454-5; Jacobs J, 2006, NEUROIMAGE, V32, P978, DOI 10.1016/j.neuroimage.2006.02.018; JANETOS AC, 1980, BEHAV ECOL SOCIOBIOL, V7, P107, DOI 10.1007/BF00299515; JOHN ER, 1980, SCIENCE, V210, P1255, DOI 10.1126/science.7434026; Kirkpatrick M, 2006, ANIM BEHAV, V71, P1215, DOI 10.1016/j.anbehav.2005.11.010; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; KOSTOWSKI WOJCIECH, 1967, BRAIN RES, V6, P783, DOI 10.1016/0006-8993(67)90137-0; LAMING PR, 1982, BEHAV NEURAL BIOL, V34, P296, DOI 10.1016/S0163-1047(82)91678-8; Lee H, 2005, NEURON, V45, P147, DOI 10.1016/j.neuron.2004.12.025; Leonard AS, 2009, BEHAV ECOL, V20, P1175, DOI 10.1093/beheco/arp115; Lynch KS, 2006, HORM BEHAV, V49, P450, DOI 10.1016/j.yhbeh.2005.10.001; Mangiamele LA, 2008, BRAIN BEHAV EVOLUT, V72, P239, DOI 10.1159/000171481; Montgomery SM, 2009, J NEUROSCI, V29, P1381, DOI 10.1523/JNEUROSCI.4339-08.2009; MOORE AJ, 1988, EVOLUTION, V42, P387, DOI [10.2307/2409241, 10.1111/j.1558-5646.1988.tb04141.x]; Moretti DV, 2004, CLIN NEUROPHYSIOL, V115, P299, DOI 10.1016/S1388-2457(03)00345-6; Neary T.J., 1990, Cerebral Cortex, V8A, P107; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; ONO K, 1980, INT J NEUROSCI, V11, P9, DOI 10.3109/00207458009147573; Parker G.A., 1983, P141; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Phelps SM, 2006, AM NAT, V167, P28, DOI 10.1086/498538; Philiastides MG, 2007, J NEUROSCI, V27, P13082, DOI 10.1523/JNEUROSCI.3540-07.2007; RAY WJ, 1985, SCIENCE, V228, P750, DOI 10.1126/science.3992243; Rickard Nikki S, 2005, Behav Cogn Neurosci Rev, V4, P235, DOI 10.1177/1534582305285869; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Sauseng P, 2010, NEUROSCI BIOBEHAV R, V34, P1015, DOI 10.1016/j.neubiorev.2009.12.006; SERVIT Z, 1965, ELECTROEN CLIN NEURO, V19, P162, DOI 10.1016/0013-4694(65)90226-9; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Utts JM, 2006, STAT IDEAS METHODS, P361; WALKER SF, 1980, BRIT J PSYCHOL, V71, P329, DOI 10.1111/j.2044-8295.1980.tb01750.x; Westhoff G, 2002, J COMP NEUROL, V445, P97, DOI 10.1002/cne.10136; Wilczynski W., 2006, HEARING SOUND COMMUN, P221; Wittenberger J.F., 1983, P435	66	15	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52364	10.1371/journal.pone.0052364	http://dx.doi.org/10.1371/journal.pone.0052364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285010	gold, Green Published			2022-12-25	WOS:000313158800054
J	Kuhs, KAL; Toporovski, R; Ginsberg, AA; Shedlock, DJ; Weiner, DB				Kuhs, Krystle A. Lang; Toporovski, Roberta; Ginsberg, Arielle A.; Shedlock, Devon J.; Weiner, David B.			Induction of Intrahepatic HCV NS4B, NS5A and NS5B-Specific Cellular Immune Responses following Peripheral Immunization	PLOS ONE			English	Article							HEPATITIS-C VIRUS; T-CELLS; SELECTIVE RETENTION; MEDIATED-IMMUNITY; VIRAL CLEARANCE; DNA VACCINE; INFECTION; LIVER; TOLERANCE; PROTEIN	Numerous studies have suggested that an effective Hepatitis C Virus (HCV) vaccine must induce strong cytotoxic and IFN-gamma+ T cell responses targeting the non-structural region of the virus. Most importantly, these responses must be able to migrate into and remain functional within the liver, an organ known to cause T cell tolerance. Using three novel HCV DNA vaccines encoding non-structural proteins NS4B, NS5A and NS5B, we assessed the ability of peripheral immunization to induce functional intrahepatic immunity both in the presence and absence of cognate HCV antigen expression within the liver. We have shown that these constructs induced potent HCV-specific CD4+ and CD8+ T cell responses in the spleen of C57BL/6 mice and that these responses were detected within the liver following peripheral immunization. Additionally, using a transfection method to express HCV antigen within the liver, we showed that intrahepatic HCV-specific T cells remained highly functional within the liver and retained the ability to become highly activated as evidenced by upregulation of IFN-gamma and clearance of HCV protein expressing hepatocytes. Taken together, these findings suggest that peripheral immunization can induce potent HCV-specific T cell responses able to traffic to and function within the tolerant environment of the liver.	[Kuhs, Krystle A. Lang; Toporovski, Roberta; Ginsberg, Arielle A.; Shedlock, Devon J.; Weiner, David B.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania	Weiner, DB (corresponding author), Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA.	dbweiner@mail.med.upenn.edu	Weiner, David B/H-8579-2014	Shedlock, Devon/0000-0003-1018-7510	Commonwealth Universal Research Enhancement (CURE) competitive grant program; Pennsylvania's share of the national tobacco settlement [RFA 08-07-07];  [SAP 4100051718]	Commonwealth Universal Research Enhancement (CURE) competitive grant program; Pennsylvania's share of the national tobacco settlement; 	This manuscript was supported by the Commonwealth Universal Research Enhancement (CURE) competitive grant program funded through Pennsylvania's share of the 2009-2010 national tobacco settlement (RFA 08-07-07). The title of the grant is "Development of a DNA Vaccine Strategy for Hepatitis C Virus" (SAP 4100051718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen G, 2005, J INFECT DIS, V192, P2112, DOI 10.1086/498218; Bassett SE, 2001, HEPATOLOGY, V33, P1479, DOI 10.1053/jhep.2001.24371; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bowen DG, 2004, J CLIN INVEST, V114, P701, DOI 10.1172/JCI200421593; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Crispe IN, 2000, IMMUNOL REV, V174, P47, DOI 10.1034/j.1600-0528.2002.017412.x; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Folgori A, 2006, NAT MED, V12, P190, DOI 10.1038/nm1353; GORCZYNSKI RM, 1994, TRANSPLANTATION, V58, P816, DOI 10.1097/00007890-199410150-00012; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Kuhs KAL, 2011, HUM VACCINES, V7, P1326, DOI 10.4161/hv.7.12.18279; Laddy DJ, 2007, VACCINE, V25, P2984, DOI 10.1016/j.vaccine.2007.01.063; Limmer A, 2005, EUR J IMMUNOL, V35, P2970, DOI 10.1002/eji.200526034; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Qian S, 1997, TRANSPL P, V29, P1168, DOI 10.1016/S0041-1345(96)00521-0; Qin WP, 2002, J BIOL CHEM, V277, P2132, DOI 10.1074/jbc.M106880200; Rolland M, 2007, J VIROL, V81, P8507, DOI 10.1128/JVI.02683-06; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; THOMAS HC, 1976, CLIN EXP IMMUNOL, V26, P574; Yan J, 2007, MOL THER, V15, P411, DOI 10.1038/sj.mt.6300036; Yu GY, 2006, J VIROL, V80, P6013, DOI 10.1128/JVI.00053-06; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	28	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52165	10.1371/journal.pone.0052165	http://dx.doi.org/10.1371/journal.pone.0052165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284919	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800035
J	Castellano-Pozo, M; Garcia-Muse, T; Aguilera, A				Castellano-Pozo, Maikel; Garcia-Muse, Tatiana; Aguilera, Andres			The Caenorhabditis elegans THO Complex Is Required for the Mitotic Cell Cycle and Development	PLOS ONE			English	Article							DAMAGE-INDUCED APOPTOSIS; C-ELEGANS; TRANSCRIPTION ELONGATION; GENOME INSTABILITY; MESSENGER-RNA; R-LOOPS; RECOMBINATION; REPLICATION; PATHWAY; PROTEIN	THO is a conserved eukaryotic complex involved in mRNP biogenesis and RNA export that plays an important role in preventing transcription- and RNA-mediated genome instability in mitosis and meiosis. In mammals THO is essential for embryogenesis, which limits our capacity to analyze the physiological relevance of THO during development and in adult organisms. Using Caenorhabditis elegans as a model system we show that the THO complex is essential for mitotic genome integrity and the developmentally regulated mitotic cell cycles occurring during late postembryonic stages.	[Castellano-Pozo, Maikel; Garcia-Muse, Tatiana; Aguilera, Andres] Univ Seville, Dept Mol Biol, Ctr Andaluz Biol Mol & Med Regenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Garcia-Muse, T (corresponding author), Univ Seville, Dept Mol Biol, Ctr Andaluz Biol Mol & Med Regenerat, Seville, Spain.	tatiana.muse@cabimer.es	Aguilera, Andres/L-1825-2014; Castellano-Pozo, Maikel/AAV-5232-2020; Garcia-Muse, Tatiana/F-1339-2016; Castellano, Maikel/AAX-8510-2020	Aguilera, Andres/0000-0003-4782-1714; Garcia-Muse, Tatiana/0000-0002-3195-2261; Castellano, Maikel/0000-0003-4134-9025	Spanish Ministry of Science and Innovation [BFU2010-16372, CSD2007-0015]; European Union (FEDER); Junta de Andalucia [CVI4567]; Spanish National Institute of Health Carlos III	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union (FEDER)(European Commission); Junta de Andalucia(Junta de Andalucia); Spanish National Institute of Health Carlos III(Instituto de Salud Carlos III)	This work was supported by grants from the Spanish Ministry of Science and Innovation (BFU2010-16372 and Consolider Ingenio 2010 CSD2007-0015), the European Union (FEDER) and the Junta de Andalucia (CVI4567). MCP was the recipient of a predoctoral training fellowship from the Spanish National Institute of Health Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; BRENNER S, 1974, GENETICS, V77, P71; Castellano-Pozo M, 2012, EMBO REP, V13, P923, DOI 10.1038/embor.2012.119; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gomez-Gonzalez B, 2009, MOL CELL BIOL, V29, P5203, DOI 10.1128/MCB.00402-09; Gomez-Gonzalez B, 2009, NUCLEIC ACIDS RES, V37, P4315, DOI 10.1093/nar/gkp385; Grigsby IF, 2009, DEV BIOL, V329, P64, DOI 10.1016/j.ydbio.2009.02.015; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jaramillo-Lambert A, 2007, DEV BIOL, V308, P206, DOI 10.1016/j.ydbio.2007.05.019; Jeong J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001348; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kawasaki L, 2004, GENETICS, V167, P645, DOI 10.1534/genetics.103.023093; Kim KW, 2009, DEV CELL, V16, P723, DOI 10.1016/j.devcel.2009.04.002; Kimble Judith, 2005, WormBook, P1; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kuersten S, 2004, MOL CELL, V14, P599, DOI 10.1016/j.molcel.2004.05.004; L'Hernault Steven W, 2006, WormBook, P1; Lee Min-Ho, 2006, WormBook, P1; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Luna R, 2012, BBA-GENE REGUL MECH, V1819, P514, DOI 10.1016/j.bbagrm.2011.11.012; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; O'Connell KF, 1998, GENETICS, V149, P1303; Okkema P, 2005, WORMBOOK, DOI [10.1895/worm-book.1.45.1, DOI 10.1895/WORMBOOK.1.45.1, 10.1895/wormbook.1.45.1]; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; Suh N, 2009, GENETICS, V181, P1249, DOI 10.1534/genetics.108.099440; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Wang XL, 2006, MOL CELL BIOL, V26, P4362, DOI 10.1128/MCB.02163-05; WARD S, 1986, J CELL BIOL, V102, P1778, DOI 10.1083/jcb.102.5.1778; Weidhaas JB, 2006, P NATL ACAD SCI USA, V103, P9946, DOI 10.1073/pnas.0603791103	41	12	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52447	10.1371/journal.pone.0052447	http://dx.doi.org/10.1371/journal.pone.0052447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285047	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500172
J	Hirose, M; Takeishi, Y; Nakada, T; Shimojo, H; Kashihara, T; Nishio, A; Suzuki, S; Mende, U; Matsumoto, K; Matsushita, N; Taira, E; Sato, F; Yamada, M				Hirose, Masamichi; Takeishi, Yasuchika; Nakada, Tsutomu; Shimojo, Hisashi; Kashihara, Toshihide; Nishio, Ayako; Suzuki, Satoshi; Mende, Ulrike; Matsumoto, Kiyoshi; Matsushita, Naoko; Taira, Eiichi; Sato, Fumika; Yamada, Mitsuhiko			Nicorandil Prevents G alpha(q)-Induced Progressive Heart Failure and Ventricular Arrhythmias in Transgenic Mice	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; INDUCED APOPTOSIS; FLOW RESERVE; HYPERTROPHY; RAT; MODEL; ACTIVATION; MECHANISMS	Background: Beneficial effects of nicorandil on the treatment of hypertensive heart failure (HF) and ischemic heart disease have been suggested. However, whether nicorandil has inhibitory effects on HF and ventricular arrhythmias caused by the activation of G protein alpha q (G alpha(q)) -coupled receptor (GPCR) signaling still remains unknown. We investigated these inhibitory effects of nicorandil in transgenic mice with transient cardiac expression of activated G alpha(q) (G alpha(q)-TG). Methodology/Principal Findings: Nicorandil (6 mg/kg/day) or vehicle was chronically administered to G alpha(q)-TG from 8 to 32 weeks of age, and all experiments were performed in mice at the age of 32 weeks. Chronic nicorandil administration prevented the severe reduction of left ventricular fractional shortening and inhibited ventricular interstitial fibrosis in G alpha(q)-TG. SUR-2B and SERCA2 gene expression was decreased in vehicle-treated G alpha(q)-TG but not in nicorandil-treated G alpha(q)-TG. eNOS gene expression was also increased in nicorandil-treated G alpha(q)-TG compared with vehicle-treated G alpha(q)-TG. Electrocardiogram demonstrated that premature ventricular contraction (PVC) was frequently (more than 20 beats/min) observed in 7 of 10 vehicle-treated G alpha(q)-TG but in none of 10 nicorandil-treated G alpha(q)-TG. The QT interval was significantly shorter in nicorandil-treated G alpha(q)-TG than vehicle-treated G alpha(q)-TG. Acute nicorandil administration shortened ventricular monophasic action potential duration and reduced the number of PVCs in Langendorff-perfused G alpha(q)-TG mouse hearts. Moreover, HMR1098, a blocker of cardiac sarcolemmal K-ATP channels, significantly attenuated the shortening of MAP duration induced by nicorandil in the G alpha(q)-TG heart. Conclusions/Significance: These findings suggest that nicorandil can prevent the development of HF and ventricular arrhythmia caused by the activation of GPCR signaling through the shortening of the QT interval, action potential duration, the normalization of SERCA2 gene expression. Nicorandil may also improve the impaired coronary circulation during HF.	[Hirose, Masamichi; Sato, Fumika] Iwate Med Univ, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, Shiwa, Iwate, Japan; [Takeishi, Yasuchika; Suzuki, Satoshi] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan; [Nakada, Tsutomu; Kashihara, Toshihide; Yamada, Mitsuhiko] Shinshu Univ, Sch Med, Dept Mol Pharmacol, Matsumoto, Nagano 390, Japan; [Shimojo, Hisashi] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 390, Japan; [Nishio, Ayako; Matsumoto, Kiyoshi] Shinshu Univ, Res Ctr Human & Environm Sci, Matsumoto, Nagano 390, Japan; [Mende, Ulrike] Brown Univ, Rhode Isl Hosp, Cardiovasc Res Ctr, Div Cardiol, Providence, RI 02903 USA; [Mende, Ulrike] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Matsushita, Naoko; Taira, Eiichi] Iwate Med Univ, Dept Pharmacol, Sch Med, Shiwa, Iwate, Japan	Iwate Medical University; Fukushima Medical University; Shinshu University; Shinshu University; Shinshu University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Iwate Medical University	Hirose, M (corresponding author), Iwate Med Univ, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, Shiwa, Iwate, Japan.	mhirose@iwate-med.ac.jp	yamada, Mitsuhiko/V-1269-2019	yamada, Mitsuhiko/0000-0002-7515-3824; Kashihara, Toshihide/0000-0001-8787-5376	Ministry of Education, Culture, Sports, Science and Technology, Japan [21590276]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 21590276) (to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bogoyevitch MA, 1996, INT J BIOCHEM CELL B, V28, P1, DOI 10.1016/1357-2725(95)00142-5; Canetti M, 2003, AM J CARDIOL, V92, P1246, DOI 10.1016/j.amjcard.2003.08.002; Coma-Canella I, 2003, REV ESP CARDIOL, V56, P354, DOI 10.1157/13045650; Date T, 2005, J CARDIOVASC PHARM, V46, P721, DOI 10.1097/01.fjc.0000184466.37951.76; Hirose M, 2008, BASIC CLIN PHARMACOL, V102, P504, DOI 10.1111/j.1742-7843.2008.00242.x; Hirose M, 2011, CIRC J, V75, P2333, DOI 10.1253/circj.CJ-10-1213; Hirose M, 2009, HEART RHYTHM, V6, P78, DOI 10.1016/j.hrthm.2008.10.018; HOLZMANN S, 1983, J CARDIOVASC PHARM, V5, P364, DOI 10.1097/00005344-198305000-00004; Hongo M, 2005, J CARDIOVASC PHARM, V46, P452, DOI 10.1097/01.fjc.0000176728.74690.09; Horinaka S, 2001, J CARDIOVASC PHARM, V38, P200, DOI 10.1097/00005344-200108000-00005; Hunter JJ, 1999, NEW ENGL J MED, V341, P1276, DOI 10.1056/NEJM199910213411706; Hwang GS, 2006, EUR J PHARMACOL, V540, P131, DOI 10.1016/j.ejphar.2006.04.031; Izawa H, 2003, EUR HEART J, V24, P1340, DOI 10.1016/S0195-668X(03)00236-7; Kaab S, 1996, CIRC RES, V78, P262, DOI 10.1161/01.RES.78.2.262; Kamiyoshi Y, 2005, J MOL CELL CARDIOL, V39, P467, DOI 10.1016/j.yjmcc.2005.04.004; Koitabashi N, 2005, BIOCHEM BIOPH RES CO, V328, P116, DOI 10.1016/j.bbrc.2004.12.139; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; LEFER DJ, 1988, LIFE SCI, V42, P1907, DOI 10.1016/0024-3205(88)90031-8; Liou JY, 2011, PHARMACOLOGY, V87, P144, DOI 10.1159/000323555; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; Niizeki T, 2008, AM J PHYSIOL-HEART C, V295, pH245, DOI 10.1152/ajpheart.00066.2008; Niizeki T, 2008, CIRC J, V72, P309, DOI 10.1253/circj.72.309; Noguchi K, 1998, FUNDAM CLIN PHARM, V12, P270, DOI 10.1111/j.1472-8206.1998.tb00954.x; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Takeishi Y, 1999, CIRC RES, V85, P264, DOI 10.1161/01.RES.85.3.264; Teshima Y, 2003, BRAIN RES, V990, P45, DOI 10.1016/S0006-8993(03)03383-3; TREASURE CB, 1990, CIRCULATION, V81, P772, DOI 10.1161/01.CIR.81.3.772; Xu JL, 2005, HYPERTENSION, V46, P719, DOI 10.1161/01.HYP.0000185189.46698.15; Yamada M, 2004, MOL PHARMACOL, V65, P1198, DOI 10.1124/mol.65.5.1198; Zhao X, 2002, AM J PHYSIOL-HEART C, V283, pH2371, DOI 10.1152/ajpheart.00383.2002; Zhou M, 2007, J HISTOCHEM CYTOCHEM, V55, P795, DOI 10.1369/jhc.6A7104.2007	32	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52667	10.1371/journal.pone.0052667	http://dx.doi.org/10.1371/journal.pone.0052667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285142	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500227
J	Koch, G; Bozzali, M; Bonni, S; Giacobbe, V; Caltagirone, C; Cercignani, M				Koch, Giacomo; Bozzali, Marco; Bonni, Sonia; Giacobbe, Viola; Caltagirone, Carlo; Cercignani, Mara			fMRI Resting Slow Fluctuations Correlate with the Activity of Fast Cortico-Cortical Physiological Connections	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; IPSILATERAL MOTOR CORTEX; HUMAN BRAIN; MAGNETIC STIMULATION; POSTERIOR PARIETAL; COMPONENT ANALYSIS; NETWORKS; SPACE; VARIABILITY; SIGNALS	Recording of slow spontaneous fluctuations at rest using functional magnetic resonance imaging (fMRI) allows distinct long-range cortical networks to be identified. The neuronal basis of connectivity as assessed by resting-state fMRI still needs to be fully clarified, considering that these signals are an indirect measure of neuronal activity, reflecting slow local variations in de-oxyhaemoglobin concentration. Here, we combined fMRI with multifocal transcranial magnetic stimulation (TMS), a technique that allows the investigation of the causal neurophysiological interactions occurring in specific cortico-cortical connections. We investigated whether the physiological properties of parieto-frontal circuits mapped with short-latency multifocal TMS at rest may have some relationship with the resting-state fMRI measures of specific resting-state functional networks (RSNs). Results showed that the activity of fast cortico-cortical physiological interactions occurring in the millisecond range correlated selectively with the coupling of fMRI slow oscillations within the same cortical areas that form part of the dorsal attention network, i.e., the attention system believed to be involved in reorientation of attention. We conclude that resting-state fMRI ongoing slow fluctuations likely reflect the interaction of underlying physiological cortico-cortical connections.	[Bozzali, Marco; Cercignani, Mara] Santa Lucia Fdn IRCCS, Neuroimaging Lab, Rome, Italy; [Koch, Giacomo; Bonni, Sonia; Giacobbe, Viola; Caltagirone, Carlo] Santa Lucia Fdn IRCCS, Lab Clin & Behav Neurol, Rome, Italy; [Koch, Giacomo; Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Cercignani, Mara] Univ Sussex, Clin Imaging Sci Ctr, Brighton & Sussex Med Sch, Falmer, England	IRCCS Santa Lucia; IRCCS Santa Lucia; University of Rome Tor Vergata; University of Brighton; University of Sussex	Cercignani, M (corresponding author), Santa Lucia Fdn IRCCS, Neuroimaging Lab, Rome, Italy.	m.cercignani@bsms.ac.uk	Bozzali, Marco/AAC-1031-2022; Caltagirone, Carlo/B-4930-2013; Koch, Giacomo/G-3155-2012	KOch, Giacomo/0000-0001-6155-9439; Bozzali, Marco/0000-0002-0568-2026; Cercignani, Mara/0000-0002-4550-2456	Italian Ministry of Health [RF 08.18, GR 08.22]	Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by grants from the Italian Ministry of Health to GK (RF 08.18) and MB (GR 08.22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; He BYJ, 2008, P NATL ACAD SCI USA, V105, P16039, DOI 10.1073/pnas.0807010105; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Koch G, 2008, J NEUROSCI, V28, P5944, DOI 10.1523/JNEUROSCI.0957-08.2008; Koch G, 2007, J NEUROSCI, V27, P6815, DOI 10.1523/JNEUROSCI.0598-07.2007; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; Koch G, 2011, J NEUROSCI, V31, P8967, DOI 10.1523/JNEUROSCI.6567-10.2011; Koch G, 2010, NEUROIMAGE, V51, P300, DOI 10.1016/j.neuroimage.2010.02.022; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Musso F, 2010, NEUROIMAGE, V52, P1149, DOI 10.1016/j.neuroimage.2010.01.093; Nir Y, 2008, NAT NEUROSCI, V11, P1100, DOI 10.1038/nn.2177; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozaki TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020079; Rosazza C, 2012, AM J NEURORADIOL, V33, P180, DOI 10.3174/ajnr.A2733; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52660	10.1371/journal.pone.0052660	http://dx.doi.org/10.1371/journal.pone.0052660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285136	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000312794500223
J	Lichtenauer, M; Mildner, M; Werba, G; Beer, L; Hoetzenecker, K; Baumgartner, A; Hasun, M; Nickl, S; Mitterbauer, A; Zimmermann, M; Gyongyosi, M; Podesser, BK; Klepetko, W; Ankersmit, HJ				Lichtenauer, Michael; Mildner, Michael; Werba, Gregor; Beer, Lucian; Hoetzenecker, Konrad; Baumgartner, Andrea; Hasun, Matthias; Nickl, Stefanie; Mitterbauer, Andreas; Zimmermann, Matthias; Gyoengyoesi, Mariann; Podesser, Bruno Karl; Klepetko, Walter; Ankersmit, Hendrik Jan			Anti-Thymocyte Globulin Induces Neoangiogenesis and Preserves Cardiac Function after Experimental Myocardial Infarction	PLOS ONE			English	Article							REGULATORY T-CELLS; BLOOD MONONUCLEAR-CELLS; NONHUMAN PRIMATE MODEL; BONE-MARROW-CELLS; TIME RT-PCR; ANTITHYMOCYTE GLOBULIN; IN-VITRO; CORONARY-DISEASE; DENDRITIC CELLS; HEART-FAILURE	Rationale: Acute myocardial infarction (AMI) followed by ventricular remodeling is the major cause of congestive heart failure and death in western world countries. Objective: Of relevance are reports showing that infusion of apoptotic leucocytes or anti-lymphocyte serum after AMI reduces myocardial necrosis and preserves cardiac function. In order to corroborate this therapeutic mechanism, the utilization of an immunosuppressive agent with a comparable mechanism, such as anti-thymocyte globulin (ATG) was evaluated in this study. Methods and Results: AMI was induced in rats by ligation of the left anterior descending artery. Initially after the onset of ischemia, rabbit ATG (10 mg/rat) was injected intravenously. In vitro and in vivo experiments showed that ATG induced a pronounced release of pro-angiogenic and chemotactic factors. Moreover, paracrine factors released from ATG co-incubated cell cultures conferred a down-regulation of p53 in cardiac myocytes. Rats that were injected with ATG evidenced higher numbers of CD68+ macrophages in the ischemic myocardium. Animals injected with ATG evidenced less myocardial necrosis, showed a significant reduction of infarct dimension and an improvement of post-AMI remodeling after six weeks (infarct dimension 24.9% vs. 11.4%, p<0.01). Moreover, a higher vessel density in the peri-infarct region indicated a better collateralization in rats that were injected with ATG. Conclusions: These data indicate that ATG, a therapeutic agent successfully applied in clinical transplant immunology, triggered cardioprotective effects after AMI that salvaged ischemic myocardium by down-regulation of p53. This might have raised the resistance against apoptotic cell death during ischemia. The combination of these mechanisms seems to be causative for improved cardiac function and less ventricular remodeling after experimental AMI.	[Lichtenauer, Michael; Werba, Gregor; Beer, Lucian; Hoetzenecker, Konrad; Nickl, Stefanie; Mitterbauer, Andreas; Zimmermann, Matthias; Ankersmit, Hendrik Jan] Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Lichtenauer, Michael] Univ Hosp Jena, Dept Cardiol, Clin Internal Med 1, Jena, Germany; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Werba, Gregor; Beer, Lucian; Hoetzenecker, Konrad; Nickl, Stefanie; Mitterbauer, Andreas; Zimmermann, Matthias; Klepetko, Walter; Ankersmit, Hendrik Jan] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Baumgartner, Andrea; Hasun, Matthias; Podesser, Bruno Karl] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria; [Gyoengyoesi, Mariann] Med Univ Vienna, Dept Cardiol, Vienna, Austria	Friedrich Schiller University of Jena; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna	Ankersmit, HJ (corresponding author), Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria.	hendrik.ankersmit@meduniwien.ac.at	Zimmermann, Matthias/AAE-9681-2020; Lichtenauer, Michael/H-5139-2019	Lichtenauer, Michael/0000-0001-8403-3931; Werba, Gregor/0000-0003-1464-9065; Mildner, Michael/0000-0002-6892-925X; Hoetzenecker, Konrad/0000-0001-6775-7460; Lichtenauer, Michael/0000-0003-0755-7955; Podesser, Bruno/0000-0002-4641-7202; Zimmermann, Matthias/0000-0002-4610-7853; Nickl, Stefanie/0000-0002-3762-4840; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Beer, Lucian/0000-0003-4388-7580	Christian Doppler Research Association; APOSCIENCE AG; Medical University Vienna	Christian Doppler Research Association; APOSCIENCE AG; Medical University Vienna	The study was funded by the Christian Doppler Research Association, APOSCIENCE AG and the Medical University Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankersmit HJ, 2009, EUR J CLIN INVEST, V39, P445, DOI 10.1111/j.1365-2362.2009.02111.x; Ankersmit HJ, 2002, CLIN EXP IMMUNOL, V128, P175, DOI 10.1046/j.1365-2249.2002.01836.x; Becker LC, 2005, CIRC RES, V96, P812, DOI 10.1161/01.RES.0000165652.82726.d9; Beiras-Fernandez A, 2004, TRANSPL INT, V17, P453, DOI 10.1007/s00147-004-0736-1; Beiras-Fernandez A, 2006, TRANSPL IMMUNOL, V15, P273, DOI 10.1016/j.trim.2006.02.003; Boenisch O, 2012, AM J TRANSPLANT, V12, P856, DOI 10.1111/j.1600-6143.2011.03978.x; Crow MT, 2006, CARDIOVASC RES, V70, P401, DOI 10.1016/j.cardiores.2006.04.003; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Dubey S, 2002, ANN HEMATOL, V81, P249, DOI 10.1007/s00277-002-0454-7; FOLDES I, 1970, EXPERIENTIA, V26, P741, DOI 10.1007/BF02232519; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Geng YJ, 2003, ANN NY ACAD SCI, V1010, P687, DOI 10.1196/annals.1299.126; Gillet-Hladky S, 2006, TRANSPLANTATION, V82, P965, DOI 10.1097/01.tp.0000235549.47976.d0; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; HOLZINGER C, 1994, EUR J VASCULAR SURG, V8, P351, DOI 10.1016/S0950-821X(05)80155-0; Kadl A, 2002, VASC PHARMACOL, V38, P219, DOI 10.1016/S1537-1891(02)00172-6; Korf-Klingebiel M, 2008, EUR HEART J, V29, P2851, DOI 10.1093/eurheartj/ehn456; Lichtenauer M, 2011, BASIC RES C IN PRESS; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P645, DOI 10.1007/s00395-011-0173-0; Liehn EA, 2010, J AM COLL CARDIOL, V56, P1847, DOI 10.1016/j.jacc.2010.04.066; Liu H, 2011, CARDIOVASC RES, V89, P119, DOI 10.1093/cvr/cvq265; Liu P, 2008, SHOCK, V30, P545, DOI 10.1097/SHK.0b013e31816a192d; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Mocanu MM, 2003, FEBS LETT, V555, P302, DOI 10.1016/S0014-5793(03)01260-2; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Monti P, 2003, INT IMMUNOPHARMACOL, V3, P189, DOI 10.1016/S1567-5769(02)00253-9; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Park HJ, 2008, INT J CARDIOL, V130, P409, DOI 10.1016/j.ijcard.2007.08.128; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schuh A, 2009, BASIC RES CARDIOL, V104, P403, DOI 10.1007/s00395-008-0763-7; Shimony O, 2012, J CLIN IMMUNOL, V32, P173, DOI 10.1007/s10875-011-9599-2; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Thum T, 2005, J AM COLL CARDIOL, V46, P1799, DOI 10.1016/j.jacc.2005.07.053; Velagaleti RS, 2008, CIRCULATION, V118, P2057, DOI 10.1161/CIRCULATIONAHA.108.784215; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Zhang Y, 2011, J MOL CELL CARDIOL, V50, P471, DOI 10.1016/j.yjmcc.2010.11.006	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52101	10.1371/journal.pone.0052101	http://dx.doi.org/10.1371/journal.pone.0052101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284885	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500090
J	Potthoff, E; Guillaume-Gentil, O; Ossola, D; Polesel-Maris, J; LeibundGut-Landmann, S; Zambelli, T; Vorholt, JA				Potthoff, Eva; Guillaume-Gentil, Orane; Ossola, Dario; Polesel-Maris, Jerome; LeibundGut-Landmann, Salome; Zambelli, Tomaso; Vorholt, Julia A.			Rapid and Serial Quantification of Adhesion Forces of Yeast and Mammalian Cells	PLOS ONE			English	Article							SURFACES; MICROSCOPY; STRENGTH; MANIPULATION; EXPRESSION; PROTEINS; GROWTH	Cell adhesion to surfaces represents the basis for niche colonization and survival. Here we establish serial quantification of adhesion forces of different cell types using a single probe. The pace of single-cell force-spectroscopy was accelerated to up to 200 yeast and 20 mammalian cells per probe when replacing the conventional cell trapping cantilever chemistry of atomic force microscopy by underpressure immobilization with fluidic force microscopy (FluidFM). In consequence, statistically relevant data could be recorded in a rapid manner, the spectrum of examinable cells was enlarged, and the cell physiology preserved until approached for force spectroscopy. Adhesion forces of Candida albicans increased from below 4 up to 16 nN at 37 degrees C on hydrophobic surfaces, whereas a Delta hgc1-mutant showed forces consistently below 4 nN. Monitoring adhesion of mammalian cells revealed mean adhesion forces of 600 nN of HeLa cells on fibronectin and were one order of magnitude higher than those observed for HEK cells.	[Ossola, Dario; Zambelli, Tomaso] ETH, Inst Biomed Engn, Zurich, Switzerland; [Potthoff, Eva; Guillaume-Gentil, Orane; LeibundGut-Landmann, Salome; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Polesel-Maris, Jerome] CEA Saclay Commissariat Energie Atom, SPCSI, Gif Sur Yvette, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; CEA; UDICE-French Research Universities; Universite Paris Saclay	Zambelli, T (corresponding author), ETH, Inst Biomed Engn, Zurich, Switzerland.	zambelli@biomed.ee.ethz.ch; vorholt@micro.biol.ethz.ch	Guillaume-Gentil, Orane/B-2570-2015; Vorholt, Julia/K-3514-2016; Polesel, Jerome/AFT-7323-2022	Guillaume-Gentil, Orane/0000-0002-5987-3709; Vorholt, Julia/0000-0002-6011-4910; Polesel, Jerome/0000-0003-0457-619X; LeibundGut-Landmann, Salome/0000-0002-5724-4837; Dague, Etienne/0000-0003-3290-9166	Swiss innovation promotion agency KTI-CTI [11722.1 PFNM-NM]; Swiss National Science Foundation (SNSF)	Swiss innovation promotion agency KTI-CTI; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This study was supported by the Swiss innovation promotion agency KTI-CTI (11722.1 PFNM-NM) (to TZ and JAV) and a grant from the Swiss National Science Foundation (SNSF) (to TZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; BAROR Y, 1990, EXPERIENTIA, V46, P823, DOI 10.1007/BF01935532; Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000; Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964; Berne BJ, 2009, ANNU REV PHYS CHEM, V60, P85, DOI 10.1146/annurev.physchem.58.032806.104445; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Charnley M, 2011, REACT FUNCT POLYM, V71, P329, DOI 10.1016/j.reactfunctpolym.2010.10.013; Dorig P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462979; Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u; Eun CS, 2011, J PHYS CHEM A, V115, P6059, DOI 10.1021/jp110608p; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; FRANCIS GW, 1987, J CELL SCI, V87, P519; Friedrichs J, 2010, PROTEOMICS, V10, P1455, DOI 10.1002/pmic.200900724; Gigler A, 2007, J PHYS CONF SER, V61, P780, DOI 10.1088/1742-6596/61/1/156; GLEE PM, 1995, INFECT IMMUN, V63, P1373, DOI 10.1128/IAI.63.4.1373-1379.1995; Graziano G, 2009, J PHYS CHEM B, V113, P11232, DOI 10.1021/jp9025738; HAZEN BW, 1988, INFECT IMMUN, V56, P2521, DOI 10.1128/IAI.56.9.2521-2525.1988; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KLEBE RJ, 1974, NATURE, V250, P248, DOI 10.1038/250248a0; Meister A, 2009, NANO LETT, V9, P2501, DOI 10.1021/nl901384x; Muller DJ, 2009, NAT CHEM BIOL, V5, P383, DOI 10.1038/nchembio.181; Pelling AE, 2004, SCIENCE, V305, P1147, DOI 10.1126/science.1097640; Prechtel K, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.028101; Puech PH, 2006, ULTRAMICROSCOPY, V106, P637, DOI 10.1016/j.ultramic.2005.08.003; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Shao JY, 2004, FRONT BIOSCI-LANDMRK, V9, P2183, DOI 10.2741/1386; Taubenberger A, 2011, LIFE AT THE NANOSCALE: ATOMIC FORCE MICROSCOPY OF LIVE CELLS, P209; Tosatti S, 2002, LANGMUIR, V18, P3537, DOI 10.1021/la011459p; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u; Weder G, 2010, BIOMATERIALS, V31, P6436, DOI 10.1016/j.biomaterials.2010.04.068; Weder G, 2010, LANGMUIR, V26, P8180, DOI 10.1021/la904526u; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wojcikiewicz Ewa P., 2004, Biol Proced Online, V6, P1, DOI 10.1251/bpo67; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	48	87	89	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52712	10.1371/journal.pone.0052712	http://dx.doi.org/10.1371/journal.pone.0052712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285166	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000312794500239
J	Skaaby, T; Husemoen, LLN; Pisinger, C; Jorgensen, T; Thuesen, BH; Fenger, M; Linneberg, A				Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Pisinger, Charlotta; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Fenger, Mogens; Linneberg, Allan			Vitamin D Status and Cause-Specific Mortality: A General Population Study	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE MORTALITY; NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; LIVER-DISEASE; D DEFICIENCY; D SUPPLEMENTATION; D LEVEL	Background: Vitamin D deficiency is associated with an increased risk of all-cause mortality in observational studies. The specific causes of death underlying this association lack clarity. We investigated the association between vitamin D status and cause-specific mortality. Methods: We included a total of 9,146 individuals from the two population-based studies, Monica10 and Inter99, conducted in 1993-94 and 1999-2001, respectively. Vitamin D status was assessed as serum 25-hydroxyvitamin D. Information on causes of death was obtained from The Danish Register of Causes of Death until 31 December 2009. There were a total of 832 deaths (median follow-up 10.3 years). Results: Multivariable Cox regression analyses with age as underlying time axis and vitamin D quartiles showed significant associations between vitamin D status and death caused by diseases of the respiratory system, the digestive system, and endocrine, nutritional and metabolic diseases with hazard ratios (HRs) 0.26 (p(trend) = 0.0042), 0.28 (p(trend) = 0.0040), and 0.21 (p(trend) = 0.035), respectively, for the fourth vitamin D quartile compared to the first. We found non-significantly lower HRs for death caused by mental and behavioural diseases and diseases of the nervous system, but no association between vitamin D status and death caused by neoplasms or diseases of the circulatory system. Conclusion: The associations of vitamin D status and cause-specific mortality suggest that we also look elsewhere (than to cardiovascular disease and cancer) to explain the inverse association between vitamin D status and mortality.	[Skaaby, Tea; Husemoen, Lise Lotte Nystrup; Pisinger, Charlotta; Jorgensen, Torben; Thuesen, Betina Heinsbaek; Linneberg, Allan] Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Jorgensen, Torben] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark; [Fenger, Mogens] Univ Copenhagen, Hvidovre Hosp, Dept Clin Biochem, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen; Aalborg University; University of Copenhagen	Skaaby, T (corresponding author), Glostrup Cty Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	tea.skaaby.01@regionh.dk	Jørgensen, Torben/Z-1335-2018	Jorgensen, Torben/0000-0001-9453-2830; Pisinger, Charlotta/0000-0002-7970-3168; Skaaby, Tea/0000-0003-0031-5726; Linneberg, Allan/0000-0002-0994-0184; Thuesen, Betina/0000-0001-9772-4344	Health Insurance Foundation [2010 B 131]	Health Insurance Foundation	The present study was supported by The Health Insurance Foundation (grant number 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Alvarez JA, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/351385; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Annweiler C, 2012, J GERONTOL A; Annweiler C, 2011, NEUROEPIDEMIOLOGY, V37, P249, DOI 10.1159/000334177; Arteh J, 2010, DIGEST DIS SCI, V55, P2624, DOI 10.1007/s10620-009-1069-9; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85; Bikle DD, 2007, J BONE MINER RES, V22, pV50, DOI 10.1359/JBMR.07S208; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Dobak John, 1994, Journal of Dermatological Science, V8, P18, DOI 10.1016/0923-1811(94)90316-6; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Grant WB, 2011, DERM-ENDOCRINOL, V3, P199, DOI [10.4161/derm.3.3.15364, 10.4161/derm.15364]; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Hogberg G, 2012, ACTA PAEDIAT; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hutchinson MS, 2010, EUR J ENDOCRINOL, V162, P935, DOI 10.1530/EJE-09-1041; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; [IARC WHO], 2008, VIT D CANC; Jakobsen J, 2009, SCAND J CLIN LAB INV, V69, P190, DOI 10.1080/00365510802471570; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Llewellyn DJ, 2010, ARCH INTERN MED, V170, P1135, DOI 10.1001/archinternmed.2010.173; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Malham M, 2011, WORLD J GASTROENTERO, V17, P922, DOI 10.3748/wjg.v17.i7.922; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Olsen MH, 2007, EUR HEART J, V28, P1374, DOI 10.1093/eurheartj/ehl448; Pappa HM, 2008, CURR OPIN GASTROEN, V24, P176, DOI 10.1097/MOG.0b013e3282f4d2f3; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Pilz S, 2009, CLIN ENDOCRINOL, V71, P666, DOI 10.1111/j.1365-2265.2009.03548.x; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Putz-Bankuti C, 2012, LIVER INT, V32, P845, DOI 10.1111/j.1478-3231.2011.02735.x; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Romme EA, 2012, ANN MED; Semba RD, 2010, EUR J CLIN NUTR, V64, P203, DOI 10.1038/ejcn.2009.140; Thomas GN, 2012, DIABETES CARE, V35, P1158, DOI 10.2337/dc11-1714; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Thyssen JP, 2012, J ALLERGY CLIN IMMUN; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; World Health Organization, 2000, WHO TECH REP SER, V894, pi; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037	53	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52423	10.1371/journal.pone.0052423	http://dx.doi.org/10.1371/journal.pone.0052423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285034	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500162
J	Zuccotti, P; Cartelli, D; Stroppi, M; Pandini, V; Venturin, M; Aliverti, A; Battaglioli, E; Cappelletti, G; Riva, P				Zuccotti, Paola; Cartelli, Daniele; Stroppi, Michela; Pandini, Vittorio; Venturin, Marco; Aliverti, Alessandro; Battaglioli, Elena; Cappelletti, Graziella; Riva, Paola			Centaurin-alpha(2) Interacts with beta-Tubulin and Stabilizes Microtubules	PLOS ONE			English	Article							NF1 MICRODELETION INTERVAL; GTPASE-ACTIVATING PROTEIN; SUBCELLULAR-LOCALIZATION; EXPRESSION ANALYSIS; CANDIDATE GENES; BRAIN; P42(IP4); RANBPM; P42(IP4)/CENTAURIN-ALPHA-1; IDENTIFICATION	Centaurin-alpha(2) is a GTPase-activating protein for ARF (ARFGAP) showing a diffuse cytoplasmic localization capable to translocate to membrane, where it binds phosphatidylinositols. Taking into account that Centaurin-alpha(2) can localize in cytoplasm and that its cytoplasmatic function is not well defined, we searched for further interactors by yeast two-hybrid assay to investigate its biological function. We identified a further Centaurin-alpha(2) interacting protein, beta-Tubulin, by yeast two-hybrid assay. The interaction, involving the C-terminal region of beta-Tubulin, has been confirmed by coimmunoprecipitation experiments. After Centaurin-alpha(2) overexpression in HeLa cells and extraction of soluble (alpha beta dimers) and insoluble (microtubules) fractions of Tubulin, we observed that Centaurin-alpha(2) mainly interacts with the polymerized Tubulin fraction, besides colocalizing with microtubules (MTs) in cytoplasm accordingly. Even following the depolimerizing Tubulin treatments Centaurin-alpha(2) remains mainly associated to nocodazole-and cold-resistant MTs. We found an increase of MT stability in transfected HeLa cells, evaluating as marker of stability the level of MT acetylation. In vitro assays using purified Centaurin-alpha(2) and tubulin confirmed that Centaurin-alpha(2) promotes tubulin assembly and increases microtubule stability. The biological effect of Centaurin-alpha(2) overexpression, assessed through the detection of an increased number of mitotic HeLa cells with bipolar spindles and with the correct number of centrosomes in both dividing and not dividing cells, is consistent with the Centaurin-alpha(2) role on MT stabilization. Centaurin-alpha(2) interacts with beta-Tubulin and it mainly associates to MTs, resistant to destabilizing agents, in vitro and in cell. We propose Centaurin-alpha(2) as a new microtubule-associated protein (MAP) increasing MT stability. Citation: Zuccotti P, Cartelli D, Stroppi M, Pandini V, Venturin M, et al. (2012) Centaurin-alpha(2) Interacts with beta-Tubulin and Stabilizes Microtubules. PLoS ONE 7(12): e52867. doi:10.1371/journal.pone.0052867	[Cartelli, Daniele; Pandini, Vittorio; Aliverti, Alessandro; Cappelletti, Graziella] Univ Milan, Dipartimento Biosci, Milan, Italy; [Zuccotti, Paola; Stroppi, Michela; Venturin, Marco; Battaglioli, Elena; Riva, Paola] Univ Milan, Dipartimento Biotecnol Med & Med Traslaz, Milan, Italy	University of Milan; University of Milan	Cappelletti, G (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	graziella.cappelletti@unimi.it; paola.riva@unimi.it	Cartelli, Daniele/AAI-3424-2021; Cappelletti, Graziella/AAS-7780-2021; Venturin, Marco/J-8735-2017; Cartelli, Daniele/K-5110-2018; Riva, Paola/K-7871-2016; battaglioli, elena/H-9350-2017; Aliverti, Alessandro/B-7875-2017	Cartelli, Daniele/0000-0002-7069-420X; Venturin, Marco/0000-0002-5871-9689; Cartelli, Daniele/0000-0002-7069-420X; Riva, Paola/0000-0001-6481-8467; Aliverti, Alessandro/0000-0002-1226-3655; Cappelletti, Graziella/0000-0003-0903-5392; Battaglioli, Elena/0000-0001-9168-7212	academic grant (PUR); "Dote ricerca", FSE, Regione Lombardia	academic grant (PUR); "Dote ricerca", FSE, Regione Lombardia(Regione Lombardia)	This work was supported by an academic grant (PUR 2008) to PR and "Dote ricerca", FSE, Regione Lombardia to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Bartelt-Kirbach B, 2009, NEUROGENETICS, V10, P79, DOI 10.1007/s10048-008-0154-0; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brinkley BR, 2001, TRENDS CELL BIOL, V11, P18, DOI 10.1016/S0962-8924(00)01872-9; Cartelli D, 2010, J NEUROCHEM, V115, P247, DOI 10.1111/j.1471-4159.2010.06924.x; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chang JS, 2005, J BIOL CHEM, V280, P6897, DOI 10.1074/jbc.M406350200; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Eot-Houllier G, 2010, J BIOL CHEM, V285, P29556, DOI 10.1074/jbc.M110.144220; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Geyp M, 1996, CANCER GENET CYTOGEN, V87, P117, DOI 10.1016/0165-4608(95)00235-9; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Haase A, 2008, J NEUROCHEM, V105, P2237, DOI 10.1111/j.1471-4159.2008.05308.x; Hanck T, 2004, J NEUROCHEM, V88, P326, DOI 10.1046/j.1471-4159.2003.02143.x; Hinchcliffe EH, 2001, CURR BIOL, V11, pR698, DOI 10.1016/S0960-9822(01)00412-2; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Krauss SW, 2008, MOL CELL BIOL, V28, P2283, DOI 10.1128/MCB.02021-07; Lee J, 2010, J BIOL CHEM, V285, P24576; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Nakamura M, 1998, J CELL BIOL, V143, P1041, DOI 10.1083/jcb.143.4.1041; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sedehizade F, 2002, MOL BRAIN RES, V99, P1, DOI 10.1016/S0169-328X(01)00335-7; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stricker R, 2006, J NEUROCHEM, V98, P343, DOI 10.1111/j.1471-4159.2006.03869.x; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Venkateswarlu K, 2005, J CELL SCI, V118, P2471, DOI 10.1242/jcs.02369; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Venturin M, 2005, ANN HUM GENET, V69, P508, DOI 10.1111/j.1529-8817.2005.00203.x; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012	41	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52867	10.1371/journal.pone.0052867	http://dx.doi.org/10.1371/journal.pone.0052867			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285209	gold, Green Published			2022-12-25	WOS:000312794500252
J	Avila, JL; Troutman, S; Durham, A; Kissil, JL				Avila, Jacqueline L.; Troutman, Scott; Durham, Amy; Kissil, Joseph L.			Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							LINEAGE TRACING REVEALS; CELL TRANSDIFFERENTIATION; INTRAEPITHELIAL NEOPLASIA; TUMOR-SUPPRESSOR; INACTIVATION; INDUCTION; PATHWAY; TRANSFORMATION; PROGRESSION; EXPRESSION	Pancreatic ductal adenocarcinoma is believed to arise from precursor lesions termed pancreatic intraepithelial neoplasia (PanIN). Mouse models have demonstrated that targeted expression of activated K-ras to mature acinar cells in the pancreas induces the spontaneous development of PanIN lesions; implying acinar-to-ductal metaplasia (ADM) is a key event in this process. Recent studies suggest Notch signaling is a key regulator of ADM. To assess if Notch1 is required for K-ras driven ADM we employed both an in vivo mouse model and in vitro explant culture system, in which an oncogenic allele of K-ras is activated and Notch1 is deleted simultaneously in acinar cells. Our results demonstrate that oncogenic K-ras is sufficient to drive ADM both in vitro and in vivo but that loss of Notch1 has a minimal effect on this process. Interestingly, while loss of Notch1 in vivo does not affect the severity of PanIN lesions observed, the overall numbers of lesions were greater in mice with deleted Notch1. This suggests Notch1 deletion renders acinar cells more susceptible to formation of K-ras-induced PanINs.	[Avila, Jacqueline L.; Troutman, Scott; Kissil, Joseph L.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Durham, Amy] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Kissil, JL (corresponding author), Scripps Res Inst, Jupiter, FL USA.	jkissil@scripps.edu			NIH [CA124495]; NATIONAL CANCER INSTITUTE [R01CA124495] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grant NIH CA124495 (J.K.). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Aichler M, 2012, J PATHOL, V226, P723, DOI 10.1002/path.3017; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Cook N, 2012, J EXP MED, V209, P437, DOI 10.1084/jem.20111923; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rooman I, 2006, AM J PATHOL, V169, P1206, DOI 10.2353/ajpath.2006.050926; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Scotti ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030509; Sivere JT, 2008, GASTROENTEROLOGY, V134, P544, DOI 10.1053/j.gastro.2007.11.003; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Zhao YT, 2007, J BIOL CHEM, V282, P11969, DOI 10.1074/jbc.M608974200; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176	39	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52133	10.1371/journal.pone.0052133	http://dx.doi.org/10.1371/journal.pone.0052133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23284900	gold, Green Submitted, Green Published			2022-12-25	WOS:000312694300074
J	Jalah, R; Rosati, M; Ganneru, B; Pilkington, GR; Valentin, A; Kulkarni, V; Bergamaschi, C; Chowdhury, B; Zhang, GM; Beach, RK; Alicea, C; Broderick, KE; Sardesai, NY; Pavlakis, GN; Felber, BK				Jalah, Rashmi; Rosati, Margherita; Ganneru, Brunda; Pilkington, Guy R.; Valentin, Antonio; Kulkarni, Viraj; Bergamaschi, Cristina; Chowdhury, Bhabadeb; Zhang, Gen-Mu; Beach, Rachel Kelly; Alicea, Candido; Broderick, Kate E.; Sardesai, Niranjan Y.; Pavlakis, George N.; Felber, Barbara K.			The p40 Subunit of Interleukin (IL)-12 Promotes Stabilization and Export of the p35 Subunit IMPLICATIONS FOR IMPROVED IL-12 CYTOKINE PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL STIMULATORY FACTOR; PLASMID DNA VACCINE; HUMORAL IMMUNE-RESPONSES; GENE-THERAPY; IL-12 FAMILY; INTRATUMORAL INJECTION; RECEPTOR-ALPHA; NK CELLS; EXPRESSION; CYTOKINE	IL-12 is a 70-kDa heterodimeric cytokine composed of the p35 and p40 subunits. To maximize cytokine production from plasmid DNA, molecular steps controlling IL-12p70 biosynthesis at the posttranscriptional and posttranslational levels were investigated. We show that the combination of RNA/codon-optimized gene sequences and fine-tuning of the relative expression levels of the two subunits within a cell resulted in increased production of the IL-12p70 heterodimer. We found that the p40 subunit plays a critical role in enhancing the stability, intracellular trafficking, and export of the p35 subunit. This posttranslational regulation mediated by the p40 subunit is conserved in mammals. Based on these findings, dual gene expression vectors were generated, producing an optimal ratio of the two subunits, resulting in a similar to 1 log increase in human, rhesus, and murine IL-12p70 production compared with vectors expressing the wild type sequences. Such optimized DNA plasmids also produced significantly higher levels of systemic bioactive IL-12 upon in vivo DNA delivery in mice compared with plasmids expressing the wild type sequences. A single therapeutic injection of an optimized murine IL-12 DNA plasmid showed significantly more potent control of tumor development in the B16 melanoma cancer model in mice. Therefore, the improved IL-12p70 DNA vectors have promising potential for in vivo use as molecular vaccine adjuvants and in cancer immunotherapy.	[Zhang, Gen-Mu; Beach, Rachel Kelly; Alicea, Candido; Felber, Barbara K.] Frederick Natl Lab Canc Res, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21702 USA; [Rosati, Margherita; Ganneru, Brunda; Valentin, Antonio; Bergamaschi, Cristina; Chowdhury, Bhabadeb; Zhang, Gen-Mu; Beach, Rachel Kelly; Pavlakis, George N.] Frederick Natl Lab Canc Res, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21702 USA; [Broderick, Kate E.; Sardesai, Niranjan Y.] Inovio Pharmaceut Inc, Blue Bell, PA 19422 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Felber, BK (corresponding author), Frederick Natl Lab Canc Res, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21702 USA.	felberb@mail.nih.gov		Sardesai, Niranjan/0000-0001-6920-1167	National Institutes of Health, NCI, Intramural Research Program; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010750, ZIABC010350, ZIABC010334] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Intramural Research Program.	Anderson R, 1997, HUM GENE THER, V8, P1125, DOI 10.1089/hum.1997.8.9-1125; Anwer K, 2010, GENE THER, V17, P360, DOI 10.1038/gt.2009.159; Babik JM, 1999, J IMMUNOL, V162, P4069; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bergamaschi C, 2009, J IMMUNOL, V183, P3064, DOI 10.4049/jimmunol.0900693; Boyer JD, 2005, J MED PRIMATOL, V34, P262, DOI 10.1111/j.1600-0684.2005.00124.x; Carra G, 2000, J IMMUNOL, V164, P4752, DOI 10.4049/jimmunol.164.9.4752; CASSATELLA MA, 1995, EUR J IMMUNOL, V25, P1, DOI 10.1002/eji.1830250102; Chong SY, 2007, VACCINE, V25, P4967, DOI 10.1016/j.vaccine.2006.11.070; Cole DJ, 2012, BLOOD, V120, P1, DOI 10.1182/blood-2012-04-425306; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Duitman EH, 2011, EUR J CELL BIOL, V90, P476, DOI 10.1016/j.ejcb.2011.01.010; Egan MA, 2005, AIDS RES HUM RETROV, V21, P629, DOI 10.1089/aid.2005.21.629; Egan MA, 2006, VACCINE, V24, P4510, DOI 10.1016/j.vaccine.2005.08.024; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Heinzerling L, 2005, HUM GENE THER, V16, P35, DOI 10.1089/hum.2005.16.35; Heller LC, 2010, CURR GENE THER, V10, P312; Heller R, 2001, DNA CELL BIOL, V20, P21, DOI 10.1089/10445490150504666; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kulkarni V, 2011, VACCINE, V29, P6742, DOI 10.1016/j.vaccine.2010.12.056; Lieschke GJ, 1997, NAT BIOTECHNOL, V15, P35, DOI 10.1038/nbt0197-35; LING P, 1995, J IMMUNOL, V154, P116; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu WT, 2004, BIOCHEM BIOPH RES CO, V313, P287, DOI 10.1016/j.bbrc.2003.11.125; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Mahvi DM, 2007, CANCER GENE THER, V14, P717, DOI 10.1038/sj.cgt.7701064; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Murphy FJ, 2000, J IMMUNOL, V164, P839, DOI 10.4049/jimmunol.164.2.839; NASIOULAS G, 1994, J VIROL, V68, P2986, DOI 10.1128/JVI.68.5.2986-2993.1994; Ortaldo JR, 2005, J IMMUNOL, V175, P693, DOI 10.4049/jimmunol.175.2.693; Portielje JEA, 2003, CANCER IMMUNOL IMMUN, V52, P133, DOI 10.1007/s00262-002-0356-5; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Sangro B, 2005, CURR GENE THER, V5, P573, DOI 10.2174/156652305774964712; Schadeck EB, 2006, VACCINE, V24, P4677, DOI 10.1016/j.vaccine.2005.10.035; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; Snijders A, 1996, J IMMUNOL, V156, P1207; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Vaidyanathan H, 2003, CYTOKINE, V21, P120, DOI 10.1016/S1043-4666(03)00016-4; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Villinger Francois, 2003, Expert Rev Vaccines, V2, P317, DOI 10.1586/14760584.2.2.317; Waldner MJ, 2009, CURR GENE THER, V9, P239, DOI 10.2174/156652309788921099; Weiss JM, 2007, EXPERT OPIN BIOL TH, V7, P1705, DOI 10.1517/14712598.7.11.1705; Whitworth JM, 2011, EXPERT OPIN BIOL TH, V11, P751, DOI 10.1517/14712598.2011.566854; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; WOLF SF, 1991, J IMMUNOL, V146, P3074; Xu ML, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/832454; Zhang L, 2011, MOL THER, V19, P751, DOI 10.1038/mt.2010.313	68	54	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 1	2013	288	9					6763	6776		10.1074/jbc.M112.436675	http://dx.doi.org/10.1074/jbc.M112.436675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	102CJ	23297419	Green Published, hybrid			2022-12-25	WOS:000315820700073
J	Huang, WG; Barrett, M; Hajicek, N; Hicks, S; Harden, TK; Sondek, J; Zhang, QS				Huang, Weigang; Barrett, Matthew; Hajicek, Nicole; Hicks, Stephanie; Harden, T. Kendall; Sondek, John; Zhang, Qisheng			Small Molecule Inhibitors of Phospholipase C from a Novel High-throughput Screen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; POTENT INHIBITOR; CONTINUOUS ASSAY; AURINTRICARBOXYLIC ACID; PROMISCUOUS INHIBITORS; FLUOROGENIC SUBSTRATE; FLUORESCENT SUBSTRATE; HUMAN PLATELETS; IN-VITRO; U73122	Phospholipase C (PLC) isozymes are important signaling molecules, but few small molecule modulators are available to pharmacologically regulate their function. With the goal of developing a general approach for identification of novel PLC inhibitors, we developed a high-throughput assay based on the fluorogenic substrate reporter WH-15. The assay is highly sensitive and reproducible: screening a chemical library of 6280 compounds identified three novel PLC inhibitors that exhibited potent activities in two separate assay formats with purified PLC isozymes in vitro. Two of the three inhibitors also inhibited G protein-coupled receptor-stimulated PLC activity in intact cell systems. These results demonstrate the power of the high-throughput assay for screening large collections of small molecules to identify novel PLC modulators. Potent and selective modulators of PLCs will ultimately be useful for dissecting the roles of PLCs in cellular processes, as well as provide lead compounds for the development of drugs to treat diseases arising from aberrant phospholipase activity.	[Huang, Weigang; Zhang, Qisheng] Univ N Carolina, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Barrett, Matthew; Hajicek, Nicole; Hicks, Stephanie; Harden, T. Kendall; Sondek, John] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, QS (corresponding author), Univ N Carolina, Div Chem Biol & Med Chem, 120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	qszhang@unc.edu	Huang, Weigang/D-2948-2013	Sondek, John/0000-0002-1127-8310; Zhang, Qisheng/0000-0001-9808-5038	National Institutes of Health [R01 GM098894, GM57391, GM38213]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038213, R01GM098894, R01GM057391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM098894 (to Q. Z. and J. S.), GM57391 (to J. S. and T. K. H.), and GM38213 (to T. K. H.).	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; BALA GA, 1990, BIOL REPROD, V43, P704, DOI 10.1095/biolreprod43.4.704; Bembenek ME, 2003, ASSAY DRUG DEV TECHN, V1, P435, DOI 10.1089/154065803322163740; BENCHOKROUN Y, 1995, BIOCHEM PHARMACOL, V49, P305, DOI 10.1016/0006-2952(94)00465-X; Bertagnolo V, 2007, CARCINOGENESIS, V28, P1638, DOI 10.1093/carcin/bgm078; BERVEN LA, 1995, BIOCHEM PHARMACOL, V49, P1373, DOI 10.1016/0006-2952(95)00050-A; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bourdon D. M., 2006, METHOD ENZYMOL, V406, P489; Burgdorf C, 2010, J CARDIOVASC PHARM, V55, P555, DOI 10.1097/FJC.0b013e3181d8bec5; Carter RL, 2009, MOL PHARMACOL, V76, P1341, DOI 10.1124/mol.109.058578; Feisst C, 2005, MOL PHARMACOL, V67, P1751, DOI 10.1124/mol.105.011007; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718; Follo MY, 2009, J CLIN ONCOL, V27, P782, DOI 10.1200/JCO.2008.19.3748; Gerber AN, 2009, P NATL ACAD SCI USA, V106, P4929, DOI 10.1073/pnas.0812308106; Harden TK, 2006, ANNU REV PHARMACOL, V46, P355, DOI 10.1146/annurev.pharmtox.46.120604.141223; HARDEN TK, 1982, MOL PHARMACOL, V21, P570; Heiduschka P, 2000, NEUROPHARMACOLOGY, V39, P889, DOI 10.1016/S0028-3908(99)00245-2; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; HENDRICKSON EK, 1991, BIOORG MED CHEM LETT, V1, P619, DOI 10.1016/S0960-894X(01)81164-1; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hollywood MA, 2010, BRIT J PHARMACOL, V160, P1293, DOI 10.1111/j.1476-5381.2010.00795.x; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; Kassis J, 1999, CLIN CANCER RES, V5, P2251; Klein RR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191783; Kurian MA, 2010, BRAIN, V133, P2964, DOI 10.1093/brain/awq238; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Liu Y, 2007, CHEMBIOCHEM, V8, P1430, DOI 10.1002/cbic.200700061; Lo Vasco VR, 2004, LEUKEMIA, V18, P1122, DOI 10.1038/sj.leu.2403368; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McOmish CE, 2008, HIPPOCAMPUS, V18, P824, DOI 10.1002/hipo.20443; Milanovic M, 2012, INT J CANCER, V130, P1060, DOI 10.1002/ijc.26066; Owens MR, 1996, THROMB RES, V81, P177, DOI 10.1016/0049-3848(95)00234-0; Pulcinelli FM, 1998, BIOCHEM PHARMACOL, V56, P1481, DOI 10.1016/S0006-2952(98)00146-4; Rebecchi M. J., 1993, J BIOL CHEM, V268, P1735; Rose TM, 2006, ORG LETT, V8, P2575, DOI 10.1021/ol060773d; Rukavishnikov AV, 1998, TETRAHEDRON LETT, V39, P6637, DOI 10.1016/S0040-4039(98)01429-4; Rukavishnikov AV, 1999, BIOORG MED CHEM LETT, V9, P1133, DOI 10.1016/S0960-894X(99)00166-3; Sala G, 2008, CANCER RES, V68, P10187, DOI 10.1158/0008-5472.CAN-08-1181; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Scholze H, 1999, ANAL BIOCHEM, V276, P72, DOI 10.1006/abio.1999.4278; SHASHIDHAR MS, 1991, ANAL BIOCHEM, V198, P10, DOI 10.1016/0003-2697(91)90498-I; Shepard CR, 2007, ONCOGENE, V26, P3020, DOI 10.1038/sj.onc.1210115; VICKERS JD, 1993, J PHARMACOL EXP THER, V266, P1156; Wang JP, 1996, N-S ARCH PHARMACOL, V353, P599, DOI 10.1007/BF00167177; Wang ZL, 2008, J CLIN INVEST, V118, P195, DOI 10.1172/JCI33139; Wilsher N, 2007, DRUG METAB DISPOS, V35, P1017, DOI 10.1124/dmd.106.014498; Woodcock EA, 2010, CURR DRUG TARGETS, V11, P1032, DOI 10.2174/138945010791591331; Zaikova TO, 2001, BIOCONJUGATE CHEM, V12, P307, DOI 10.1021/bc0001138; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	53	21	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5840	5848		10.1074/jbc.M112.422501	http://dx.doi.org/10.1074/jbc.M112.422501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23297405	Green Published, hybrid			2022-12-25	WOS:000315342500054
J	Yu, HY; He, K; Li, LJ; Sun, L; Tang, F; Li, RZ; Ning, W; Jin, Y				Yu, Hongyao; He, Ke; Li, Lingjie; Sun, Lei; Tang, Fan; Li, Ruizhen; Ning, Wen; Jin, Ying			Deletion of STK40 Protein in Mice Causes Respiratory Failure and Death at Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG MORPHOGENESIS; MOUSE LUNG; BRANCHING MORPHOGENESIS; SURFACTANT HOMEOSTASIS; BINDING-PROTEIN; C/EBP-ALPHA; FETAL LUNG; GENE; TRANSCRIPTION; DISEASE	STK40 is a putative serine/threonine kinase and was shown to induce extraembryonic endoderm differentiation from mouse embryonic stem cells. However, little is known about its physiological function in vivo. Here, we generate Stk40 knock-out mice and demonstrate that loss of the Stk40 gene causes neonatal lethality at birth. Further examination reveals that the respiratory distress and atelectasis occur in the homozygous mutants. The maturation of lung and alveolar epithelium is delayed in the mutant, as indicated by narrowed air spaces, thickened interstitial septa, and increased glycogen content in the lungs of Stk40(-/-) mice. The reduction in levels of T1-alpha, SP-B, and SP-C indicates delayed maturation of both type I and type II respiratory epithelial cells in Stk40(-/-) lungs. Moreover, Stk40 is found to be most highly expressed in lungs of both fetal and adult mice among all organs tested. Mechanistically, a genome-wide RNA microarray analysis reveals significantly altered expression of multiple genes known to participate in lung development. The expression of some genes involved in lipid metabolism, immune response, and glycogen metabolism is also disrupted in the lung of Stk40(-/-) mice. Protein affinity purification identifies RCN2, an activator ofERK/MAPKsignaling, as an STK40-associated protein. Consistently, Stk40 deficiency attenuates the ERK/MAPK activation, and inhibition of ERK/MAPK activities reduces surfactant protein gene expression in lung epithelial cells. Collectively, this study uncovers an important role of STK40 for lung maturation and neonatal survival. STK40 may associate with RCN2 to activate ERK/MAPK signaling and control the expression of multiple key regulators of lung development.	[Yu, Hongyao; Li, Lingjie; Sun, Lei; Jin, Ying] Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med,Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [He, Ke; Tang, Fan; Li, Ruizhen] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Lab Mol Dev Biol, Shanghai 200025, Peoples R China; [Ning, Wen] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Yu, Hongyao; Jin, Ying] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Nankai University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci,Sch Med,Key Lab Stem Cell Biol, 225 South Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Sun, Lei/J-9943-2015; Fang, Fengqin/F-4387-2016	, jin ying/0000-0003-0070-2048; Yu, Hongyao/0000-0003-3752-8442	National Natural Science Foundation of China [91919023, 30911130361]; Ministry of Science and Technology China [2010CB945201, 2011CB965101, 2009CB941103]; Chinese Academy of Science [XDA01010102]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Science(Chinese Academy of Sciences); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China Grants 91919023 and 30911130361; Ministry of Science and Technology China Grants 2010CB945201, 2011CB965101, and 2009CB941103; and Chinese Academy of Science Grant XDA01010102. This study was also supported by Shanghai Leading Academic Discipline Project S30201.	AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Bellusci S, 1997, DEVELOPMENT, V124, P4867; BOHINSKI RJ, 1994, MOL CELL BIOL, V14, P5671, DOI 10.1128/MCB.14.9.5671; BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai T, 1997, BIOCHEM BIOPH RES CO, V233, P765, DOI 10.1006/bbrc.1997.6531; Kaplan F, 2000, MOL GENET METAB, V71, P321, DOI 10.1006/mgme.2000.3040; Kimura S, 1999, BIOCHIMIE, V81, P321, DOI 10.1016/S0300-9084(99)80077-7; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Li FF, 2012, J IMMUNOL, V189, P3159, DOI 10.4049/jimmunol.1200197; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Ridsdale R, 2004, AM J PHYSIOL-LUNG C, V287, pL743, DOI 10.1152/ajplung.00146.2004; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; TENHAVEOPBROEK AAW, 1991, EXP LUNG RES, V17, P111, DOI 10.3109/01902149109064406; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Usui H, 2004, BIOCHEM BIOPH RES CO, V322, P887, DOI 10.1016/j.bbrc.2004.07.198; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Whitsett JA, 2004, HUM MOL GENET, V13, pR207, DOI 10.1093/hmg/ddh252; Wongtrakool C, 2003, J BIOL CHEM, V278, P46911, DOI 10.1074/jbc.M307977200; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zhang X, 2012, FASEB J, V26, P2338, DOI 10.1096/fj.11-200139	44	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5342	5352		10.1074/jbc.M112.409433	http://dx.doi.org/10.1074/jbc.M112.409433			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23293024	Green Published, hybrid			2022-12-25	WOS:000315342500008
J	Palomares, F; Roques, S; Chavez, C; Silveira, L; Keller, C; Sollmann, R; do Prado, DM; Torres, PC; Adrados, B; Godoy, JA; Jacomo, ATDA; Torres, NM; Furtado, MM; Lopez-Bao, JV				Palomares, Francisco; Roques, Severine; Chavez, Cuauhtemoc; Silveira, Leandro; Keller, Claudia; Sollmann, Rahel; do Prado, Denise Mello; Torres, Patricia Carignano; Adrados, Begona; Godoy, Jose Antonio; de Almeida Jacomo, Anah Tereza; Torres, Natalia Mundim; Furtado, Mariana Malzoni; Lopez-Bao, Jose Vicente			High Proportion of Male Faeces in Jaguar Populations	PLOS ONE			English	Article							PUMAS PUMA-CONCOLOR; PANTHERA-ONCA; CENTRAL BRAZIL; ATLANTIC FOREST; HABITAT USE; SYMPATRIC JAGUARS; SCENT MARKING; NATIONAL-PARK; MELES-MELES; DENSITY	Faeces provide relevant biological information which includes, with the application of genetic techniques, the sex and identity of individuals that defecated, thus providing potentially useful data on the behaviour and ecology of individuals, as well as the dynamics and structure of populations. This paper presents estimates of the sex ratio of different felid species (jaguar, Panthera onca; puma, Puma concolor; and ocelot/margay, Leopardus pardalis/Leopardus wiedi) as observed in field collected faeces, and proposes several hypotheses that could explain the strikingly high proportion of faeces from male jaguars. The proportion of male and female faeces was estimated using a non-invasive faecal sampling method in 14 study areas in Mexico and Brazil. Faecal samples were genetically analysed to identify the species, the sex and the individual (the latter only for samples identified as belonging to jaguars). Considering the three species, 72.6% of faeces (n = 493) were from males; however, there were significant differences among them, with the proportion from males being higher for jaguars than for pumas and ocelots/margays. A male-bias was consistently observed in all study areas for jaguar faeces, but not for the other species. For jaguars the trend was the same when considering the number of individuals identified (n = 68), with an average of 4.2 +/- 0.56 faeces per male and 2.0 +/- 0.36 per female. The observed faecal marking patterns might be related to the behaviour of female jaguars directed toward protecting litters from males, and in both male and female pumas, to prevent interspecific aggressions from male jaguars. The hypothesis that there are effectively more males than females in jaguar populations cannot be discarded, which could be due to the fact that females are territorial and males are not, or a tendency for males to disperse into suboptimal areas for the species.	[Palomares, Francisco; Roques, Severine; Adrados, Begona; Lopez-Bao, Jose Vicente] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Chavez, Cuauhtemoc] Univ Autonoma Metropolitana, Unidad Lerma, Mexico City, DF, Mexico; [Silveira, Leandro; de Almeida Jacomo, Anah Tereza; Torres, Natalia Mundim] Jaguar Conservat Fund, Mineiros, Go, Brazil; [Keller, Claudia; do Prado, Denise Mello; Torres, Patricia Carignano] INPA, Manaus, Amazonas, Brazil; [Sollmann, Rahel] N Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Godoy, Jose Antonio] CSIC, Estn Biol Donana, Dept Integrat Ecol, E-41080 Seville, Spain; [Furtado, Mariana Malzoni] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Autonoma Metropolitana - Mexico; Institute Nacional de Pesquisas da Amazonia; University of North Carolina; North Carolina State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Sao Paulo	Palomares, F (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	ffpaloma@ebd.csic.es	Carignano Torres, Patricia/F-2794-2016; CHAVEZ, CUAUHTÉMOC/C-5754-2019; Keller, Claudia/C-2493-2012; Furtado, Mariana/ABH-2648-2021; Palomares, Francisco/F-5327-2016; Godoy, José Antonio/B-9288-2008	Carignano Torres, Patricia/0000-0003-0426-8277; CHAVEZ, CUAUHTÉMOC/0000-0003-2201-4748; Palomares, Francisco/0000-0002-4655-7205; Godoy, José Antonio/0000-0001-7502-9471; Roques, Severine/0000-0002-9029-7789; Lopez-Bao, Jose Vicente/0000-0001-9213-998X; Torres, Natalia Mundim/0000-0001-7123-5112; Furtado, Mariana Malzoni/0000-0001-5147-7202	Fundacion BBVA [BIOCON 05 - 100/06]; Spanish Ministry of Science and Innovation [CGL2010-16902]; Memphis Zoo; Earthwatch Institute	Fundacion BBVA(BBVA Foundation); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Memphis Zoo; Earthwatch Institute	The research was carried out under projects BIOCON 05 - 100/06 of Fundacion BBVA and CGL2010-16902 of the Spanish Ministry of Science and Innovation, the Memphis Zoo and Earthwatch Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brashares JS, 1999, ANIM BEHAV, V57, P11, DOI 10.1006/anbe.1998.0942; de Azevedo FCC, 2008, BIOTROPICA, V40, P494, DOI 10.1111/j.1744-7429.2008.00404.x; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Chavez C, 2010, THESIS U GRANADA SPA; Chavez C, 2006, THESIS U NACL AUTONO; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Dillon A, 2008, J ZOOL, V275, P391, DOI 10.1111/j.1469-7998.2008.00452.x; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Goulart FVB, 2009, MAMM BIOL, V74, P182, DOI 10.1016/j.mambio.2009.02.006; Green Rosemary, 2000, IUCN Otter Specialist Group Bulletin, V17, P20; Haines Aaron M., 2006, Acta Zoologica Sinica, V52, P1142; Harmsen BJ, 2010, J MAMMAL, V91, P1225, DOI 10.1644/09-MAMM-A-416.1; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Janecka JE, 2007, WILDLIFE BIOL, V13, P38, DOI 10.2981/0909-6396(2007)13[38:EFMDIB]2.0.CO;2; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Kruuk H., 1995, WILD OTTERS PREDATIO; Logan Kenneth A., 2010, P105; Long RA, 2007, J WILDLIFE MANAGE, V71, P2007, DOI 10.2193/2006-230; MACDONALD DW, 1980, S ZOOL SOC LONDON, V45, P107; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Nunez R, 2006, THESIS U NACL AUTONO; Oliveira de TG, 2010, BIOL CONSERVATION WI; Pickett EJ, 2012, WILDLIFE RES, V39, P350, DOI 10.1071/WR11193; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; ROBINSON IH, 1988, J ZOOL, V216, P577, DOI 10.1111/j.1469-7998.1988.tb02453.x; Romero-Munoz A, 2010, J TROP ECOL, V26, P303, DOI 10.1017/S0266467410000052; ROPER TJ, 1993, BEHAVIOUR, V127, P289, DOI 10.1163/156853993X00074; Roques S, 2011, MOL ECOL RESOUR, V11, P171, DOI 10.1111/j.1755-0998.2010.02878.x; Roques S., ORYX IN PRESS; Salom-Perez R, 2007, ORYX, V41, P51, DOI 10.1017/S0030605307001615; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Silveira L., 2004, THESIS U BRASILIA BR; Smith DA, 2001, SCIENCE, V291, P435, DOI 10.1126/science.291.5503.435B; SMITH JLD, 1989, ANIM BEHAV, V37, P1; Soares TN, 2006, GENET MOL BIOL, V29, P735, DOI 10.1590/S1415-47572006000400025; Sollmann R, 2012, MAMM BIOL, V77, P41, DOI 10.1016/j.mambio.2011.06.011; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Sunquist ME., 1981, SMITHSON CONTRIB ZOO, DOI DOI 10.5479/SI.00810282.336; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2	52	17	18	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52923	10.1371/journal.pone.0052923	http://dx.doi.org/10.1371/journal.pone.0052923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285226	Green Published, gold			2022-12-25	WOS:000313051500081
J	Chen, X; Li, M; Chen, DH; Gao, WT; Guan, JL; Komatsu, M; Yin, XM				Chen, Xi; Li, Min; Chen, Daohong; Gao, Wentao; Guan, Jun-Lin; Komatsu, Massaki; Yin, Xiao-Ming			Autophagy Induced by Calcium Phosphate Precipitates Involves Endoplasmic Reticulum Membranes in Autophagosome Biogenesis	PLOS ONE			English	Article							REGULATES ATG9; MACROAUTOPHAGY; PROTEINS; TRAFFICKING; COMPLEX; STRESS; GOLGI; MITOCHONDRIA; COMPARTMENTS; INDUCTION	Calcium can play an important role in the regulation of autophagy. We previously reported that exogenously introduced calcium in the form of calcium phosphate precipitates (CPP) induces autophagy. Here we showed that CPP-induced autophagy required the classical autophagic machinery, including the autophagosome initiating molecules FIP200 and Beclin 1, as well as molecules involved in the autophagosome membrane extension, Atg4, Atg5 and Atg3. On the other hand, Atg9 seemed to place a restriction on CPP-induced autophagy. Loss of Atg9 led to enhanced LC3 punctation and enhanced p62 degradation. CPP-induced autophagy was independent of mTOR and reactive oxygen species. It also did not affect MAP kinase activation and ER stress. DFCP1 is an ER-resident molecule that binds to phosphatidylinositol 3-phosphate. CPP activated DFCP1 punctation in a class III phosphatidylinositol-3-kinase and calcium dependent manner, and caused the association of DFCP1 puncta with the autophagosomes. Consistently, ER membranes, but not Golgi or mitochondrial membranes, colocalized with CPP-induced LC3 positive autophagosomes. These data suggest that CPP-induced autophagosome formation involves the interaction with the ER membrane.	[Chen, Xi; Li, Min; Chen, Daohong; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Chen, Xi] Zhejiang Univ, Sch Med, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Gao, Wentao] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Komatsu, Massaki] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan	Indiana University System; Indiana University Bloomington; Zhejiang University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Tokyo Metropolitan Institute of Medical Science	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA.	xmyin@iupui.edu	Komatsu, Masaaki/B-8321-2011; Li, Min/B-1281-2011	Komatsu, Masaaki/0000-0001-7672-7722; 	National Institutes of Health [CA111456]; NATIONAL CANCER INSTITUTE [R01CA111456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Institutes of Health (CA111456) to XMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Gao WT, 2010, J BIOL CHEM, V285, P1371, DOI 10.1074/jbc.M109.054197; Geng JF, 2010, AUTOPHAGY, V6, P950, DOI 10.4161/auto.6.7.13009; GORDON PB, 1993, J BIOL CHEM, V268, P26107; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; He CC, 2009, AUTOPHAGY, V5, P385, DOI 10.4161/auto.5.3.7699; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jaboin JJ, 2007, TECHNOL CANCER RES T, V6, P443, DOI 10.1177/153303460700600510; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Ridley SH, 2001, J CELL SCI, V114, P3991; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Takahashi Y, 2011, AUTOPHAGY, V7, P61, DOI 10.4161/auto.7.1.14015; Tang HW, 2011, EMBO J, V30, P636, DOI 10.1038/emboj.2010.338; Webber JL, 2010, AUTOPHAGY, V6, P292, DOI 10.4161/auto.6.2.11128; Webber JL, 2010, FEBS LETT, V584, P1319, DOI 10.1016/j.febslet.2010.01.020; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Young AJ, 2006, MED SCI SPORT EXER, V38, P1, DOI 10.1249/01.mss.0000196708.08925.8b; Yue Z, 2007, AUTOPHAGY, V3, P139, DOI 10.4161/auto.3602; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	49	29	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52347	10.1371/journal.pone.0052347	http://dx.doi.org/10.1371/journal.pone.0052347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285000	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800051
J	Cristina, ML; Spagnolo, AM; Sartini, M; Panatto, D; Gasparini, R; Orlando, P; Ottria, G; Perdelli, F				Cristina, Maria Luisa; Spagnolo, Anna Maria; Sartini, Marina; Panatto, Donatella; Gasparini, Roberto; Orlando, Paolo; Ottria, Gianluca; Perdelli, Fernanda			Can Particulate Air Sampling Predict Microbial Load in Operating Theatres for Arthroplasty?	PLOS ONE			English	Article							SURGERY; QUALITY; ROOM; FLOW	Several studies have proposed that the microbiological quality of the air in operating theatres be indirectly evaluated by means of particle counting, a technique derived from industrial clean-room technology standards, using airborne particle concentration as an index of microbial contamination. However, the relationship between particle counting and microbiological sampling has rarely been evaluated and demonstrated in operating theatres. The aim of the present study was to determine whether particle counting could predict microbiological contamination of the air in an operating theatre during 95 surgical arthroplasty procedures. This investigation was carried out over a period of three months in 2010 in an orthopedic operating theatre devoted exclusively to prosthetic surgery. During each procedure, the bacterial contamination of the air was determined by means of active sampling; at the same time, airborne particulate contamination was assessed throughout the entire procedure. On considering the total number of surgical operations, the mean value of the total bacterial load in the center of the operating theatre proved to be 35 CFU/m(3); the mean particle count was 4,194,569 no./m(3) for particles of diameter >= 0.5 mu m and 13,519 no./m(3) for particles of diameter >= 5 mu m. No significant differences emerged between the median values of the airborne microbial load recorded during the two types of procedure monitored. Particulates with a diameter of >= 0.5 mm were detected in statistically higher concentrations (p<0.001) during knee-replacement procedures. By contrast, particulates with a diameter of >= 5 mu m displayed a statistically higher concentration during hip-replacement procedures (p<0.05). The results did not reveal any statistically significant correlation between microbial loads and particle counts for either of the particle diameters considered (>= 0.5 mu m and >= 5 mu m). Consequently, microbiological monitoring remains the most suitable method of evaluating the quality of air in operating theatres.	[Cristina, Maria Luisa; Spagnolo, Anna Maria; Sartini, Marina; Panatto, Donatella; Gasparini, Roberto; Orlando, Paolo; Ottria, Gianluca; Perdelli, Fernanda] Univ Genoa, Dept Hlth Sci, Genoa, Italy	University of Genoa	Cristina, ML (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	cristinaml@unige.it	Sartini, Marina/I-2950-2012; Bragazzi, Nicola Luigi/G-1672-2011	Bragazzi, Nicola Luigi/0000-0001-8409-868X; CRISTINA, Maria Luisa/0000-0002-7926-7108; Gasparini, Roberto/0000-0002-1012-6913; Panatto, Donatella/0000-0002-2677-0551; Spagnolo, Anna Maria/0000-0001-6559-3626; Orlando, Paolo/0000-0002-6576-9860; Sartini, Marina/0000-0002-7127-2893				Al-Waked R, 2010, ENG APPL COMP FLUID, V4, P1; Andersson AE, 2012, AM J INFECT CONTROL, V40, P750, DOI 10.1016/j.ajic.2011.09.015; [Anonymous], 1999, 146441 EB ISO TECHN; [Anonymous], 2003, S90351 NF AFNOR; Bruske-Hohlfeld Irene, 2008, J Occup Med Toxicol, V3, P31, DOI 10.1186/1745-6673-3-31; Cristina ML, 2012, ADV MED BIOL, V34, P63; Dharan S, 2002, J HOSP INFECT, V51, P79, DOI 10.1053/jhin.2002.1217; Diab-Elschahawi M, 2011, AM J INFECT CONTROL, V39, pE25, DOI 10.1016/j.ajic.2010.10.035; Gould D, 2001, Nurs Stand, V15, P45; Istituto Superiore per la Prevenzione e Sicurezza sul Lavoro (ISPESL), 2010, LIN GUID STAND SIC I; Landrin A, 2005, J HOSP INFECT, V61, P27, DOI 10.1016/j.jhin.2005.03.002; Orlando P., 1999, Igiene Moderna, V112, P1253; Sartini M, 2006, J Prev Med Hyg, V47, P155; Scaltriti S, 2007, J HOSP INFECT, V66, P320, DOI 10.1016/j.jhin.2007.05.019; SEAL DV, 1990, J APPL BACTERIOL, V68, P225, DOI 10.1111/j.1365-2672.1990.tb02568.x; Stocks GW, 2010, AM J INFECT CONTROL, V38, P199, DOI 10.1016/j.ajic.2009.07.006; Wan GH, 2011, AM J INFECT CONTROL, V39, P302, DOI 10.1016/j.ajic.2010.07.006; Weaving Paul, 2008, J Perioper Pract, V18, P199	18	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52809	10.1371/journal.pone.0052809	http://dx.doi.org/10.1371/journal.pone.0052809			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285189	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800095
J	Kowall, B; Ebert, N; Then, C; Thiery, J; Koenig, W; Meisinger, C; Rathmann, W; Seissler, J				Kowall, Bernd; Ebert, Nina; Then, Cornelia; Thiery, Joachim; Koenig, Wolfgang; Meisinger, Christa; Rathmann, Wolfgang; Seissler, Jochen			Associations between Blood Glucose and Carotid Intima-Media Thickness Disappear after Adjustment for Shared Risk Factors: The KORA F4 Study	PLOS ONE			English	Article							POSTCHALLENGE PLASMA-GLUCOSE; IMPAIRED FASTING GLUCOSE; TYPE-2 DIABETIC-PATIENTS; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS RISK; SUBCLINICAL ATHEROSCLEROSIS; NONDIABETIC INDIVIDUALS; ARTERY ATHEROSCLEROSIS; GLYCATED HEMOGLOBIN; WALL THICKNESS	Objective: The association between blood glucose and carotid intima-media thickness (CIMT) is considered to be established knowledge. We aimed to assess whether associations between different measures of glycaemia and CIMT are actually independent of anthropometric variables and metabolic risk factors. Moreover, we checked published studies for the adjustment for shared risk factors of blood glucose and CIMT. Methods: Fasting glucose, 2-hour glucose, HbA1c, and CIMT were measured in 31-81-years-old participants of the population-based Cooperative Health Research in the Region of Augsburg (KORA) F4 study in Southern Germany (n = 2,663). CIMT was assessed according to the Rotterdam protocol. Linear and logistic regression models with adjustment for age, sex, anthropometric measures, hypertension, and dyslipidaemia were fitted to assess the association between continuous measures of glycaemia, and categories of glucose regulation, respectively, with CIMT. Results: We found a 0.10 mm increase (95%-confidence interval: 0.08-0.12) in CIMT in subjects with compared to subjects without diabetes in crude analysis. This increase was not significant in age-sex adjusted models (p = 0.17). Likewise, neither impaired fasting glucose (p = 0.22) nor impaired glucose tolerance (p = 0.93) were associated with CIMT after adjustment for age, sex, and waist circumference. In multivariable adjusted models, age, sex, hypertension, waist circumference, HDL and LDL cholesterol, but neither fasting glucose nor 2-hour glucose nor HbA1c were associated with elevated CIMT. Literature findings are inconclusive regarding an independent association of glucose levels and CIMT. Conclusion: CIMT is highly dependent on traditional cardiovascular risk factors, but no relationships between blood glucose and CIMT were found after adjustment for age, sex, and anthropometric variables.	[Kowall, Bernd; Ebert, Nina; Rathmann, Wolfgang] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, D-40225 Dusseldorf, Germany; [Then, Cornelia; Seissler, Jochen] Klinikum Ludwig Maximilians Univ, Diabet Zentrum, Med Klin & Poliklin 4, Munich, Germany; [Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Meisinger, Christa] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Seissler, Jochen] Univ Munich, Clin Cooperat Grp Diabet, Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Munich; Leipzig University; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Kowall, B (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, D-40225 Dusseldorf, Germany.	bernd.kowall@ddz.uni-duesseldorf.de	Meisinger, Christine/B-5358-2014	Meisinger, Christa/0000-0002-9026-6544; Koenig, Wolfgang/0000-0002-2064-9603	German Research Foundation (DFG) [RA 459/2-1]; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia; Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; project Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [03IS2061D]; NATIONAL INSTITUTE ON AGING [P30AG013846] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westfalia; Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; project Greifswald Approach to Individualized Medicine (GANI_MED); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Diabetes Cohort Study was funded by a German Research Foundation project grant to WR (DFG; RA 459/2-1). The German Diabetes Center is funded by the German Federal Ministry of Health, and the Ministry of School, Science and Research of the State of North-Rhine-Westfalia. The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. This work is also funded by the project Greifswald Approach to Individualized Medicine (GANI_MED). The GANI_MED consortium is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (support codes: 03IS2061D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bobbert T, 2010, DIABETES CARE, V33, P203, DOI 10.2337/dc09-1009; Bonora E, 2000, DIABETOLOGIA, V43, P156, DOI 10.1007/s001250050024; BOTS ML, 1994, J CLIN EPIDEMIOL, V47, P921, DOI 10.1016/0895-4356(94)90196-1; Brohall G, 2006, DIABETIC MED, V23, P609, DOI 10.1111/j.1464-5491.2005.01725.x; Brohall G, 2009, NUTR METAB CARDIOVAS, V19, P327, DOI 10.1016/j.numecd.2008.02.002; Chamnan P, 2011, DIABETOLOGIA, V54, P291, DOI 10.1007/s00125-010-1914-6; Choi SW, 2011, J DIABETES COMPLICAT, V25, P7, DOI 10.1016/j.jdiacomp.2009.12.001; de Kreutzenberg SV, 2009, NUTR METAB CARDIOVAS, V19, P667, DOI 10.1016/j.numecd.2009.03.014; Einarson TR, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-37; Faeh D, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-32; Fitch KV, 2011, ATHEROSCLEROSIS, V217, P437, DOI 10.1016/j.atherosclerosis.2011.04.009; FOLSOM AR, 1994, STROKE, V25, P66, DOI 10.1161/01.STR.25.1.66; Ford ES, 2010, J AM COLL CARDIOL, V55, P1310, DOI 10.1016/j.jacc.2009.10.060; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Goya K, 2003, METABOLISM, V52, P1302, DOI 10.1016/S0026-0495(03)00197-5; Hanefeld M, 1999, DIABETIC MED, V16, P212, DOI 10.1046/j.1464-5491.1999.00072.x; Hanefeld M, 1999, ATHEROSCLEROSIS, V144, P229, DOI 10.1016/S0021-9150(99)00059-3; Hu YM, 2010, ATHEROSCLEROSIS, V210, P302, DOI 10.1016/j.atherosclerosis.2009.11.015; Huang Y, 2011, J CLIN ENDOCR METAB, V96; Ishizaka N, 2009, ATHEROSCLEROSIS, V204, P619, DOI 10.1016/j.atherosclerosis.2008.10.022; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; O'Leary DH, 2002, AM J CARDIOL, V90, p18L, DOI 10.1016/S0002-9149(02)02957-0; Okada M, 2000, INTERNAL MED, V39, P362, DOI 10.2169/internalmedicine.39.362; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Rajala U, 2003, J HUM HYPERTENS, V17, P705, DOI 10.1038/sj.jhh.1001594; Rasmussen-Torvik LJ, 2011, DIABETES, V60, P331, DOI 10.2337/db10-0839; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Selvin E, 2005, DIABETES CARE, V28, P1965, DOI 10.2337/diacare.28.8.1965; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stern MP, 2002, DIABETES CARE, V25, P1851, DOI 10.2337/diacare.25.10.1851; Su TC, 2012, J ATHEROSCLER THROMB, V19, P872, DOI 10.5551/jat.10728; Temelkova-Kurktschiev T, 1998, DIABETOLOGIA, V41, P706, DOI 10.1007/s001250050972; Temelkova-Kurktschiev TS, 2000, DIABETES CARE, V23, P1830, DOI 10.2337/diacare.23.12.1830; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Zhang YF, 2006, CLIN ENDOCRINOL, V64, P153, DOI 10.1111/j.1365-2265.2005.02440.x; Zhu W, 2010, CLIN CARDIOL, V33, P542, DOI 10.1002/clc.20788	40	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52590	10.1371/journal.pone.0052590	http://dx.doi.org/10.1371/journal.pone.0052590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285104	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800079
J	Taiwo, EO; Yorio, JT; Yan, JS; Gerber, DE				Taiwo, Evelyn O.; Yorio, Jeffrey T.; Yan, Jingsheng; Gerber, David E.			How Have We Diagnosed Early-Stage Lung Cancer without Radiographic Screening? A Contemporary Single-Center Experience	PLOS ONE			English	Article							ACTION PROJECT; NEW-HAMPSHIRE; CELL TYPE; RADIATION; HISTORY	Background: The National Lung Screening Trial (NLST), which demonstrated a reduction in lung cancer mortality, may result in widespread computed tomography (CT)-based screening of select populations. How early-stage lung cancer has been diagnosed without screening, and what proportion of these cases would be captured by a screening program modeled on the NLST, is not currently known. We therefore evaluated current patterns of early-stage lung cancer presentation. Methodology/Principal Findings: We performed a single-institution retrospective analysis of patients diagnosed with stage I-II non-small cell lung cancer (NSCLC) from 2000-2009. Associations between patient and imaging characteristics were assessed using univariate and multivariate analyses. A total of 412 patients met criteria for analysis. Among those with available reason for initial imaging, the reason was symptoms in 51%, follow-up of other conditions in 43%, and screening in 6%. Reason for imaging was associated with race (P < 0.001), insurance type (P = 0.005), and disease stage (P < 0.001). Type of initial imaging was associated with reason for imaging (P < 0.001), year (chest x-ray 67% in 2000-2004 vs. 49% in 2005-2009; P < 0.001), and disease stage (P = 0.005). Among patients with available quantified smoking history, 48% were age 55-74 years and smoked 30-plus pack-years, therefore meeting NLST entry criteria. Conclusions/Significance: Symptoms remain a dominant but declining reason for detection of early-stage NSCLC. The proportion of cases detected initially by CT scan without antecedent chest x-ray has increased considerably. Because as few as half of cases meet NLST eligibility criteria, clinicians should remain aware of the diverse circumstances of early-stage lung cancer presentation to expedite therapy.	[Taiwo, Evelyn O.; Yorio, Jeffrey T.; Gerber, David E.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Taiwo, Evelyn O.; Gerber, David E.] Univ Texas SW Med Ctr Dallas, Div Hematol Oncol, Dallas, TX 75390 USA; [Yan, Jingsheng] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA; [Yan, Jingsheng; Gerber, David E.] Univ Texas SW Med Ctr Dallas, Harold C Simmons Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gerber, DE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	david.gerber@utsouthwestern.edu		Gerber, David/0000-0002-7812-6741	National Institutes of Health CTSA [KL2RR024983]; National Cancer Institute Clinical Investigator Team Leadership Award [1P30 CA142543-01]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024983] Funding Source: NIH RePORTER	National Institutes of Health CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Cancer Institute Clinical Investigator Team Leadership Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding provided by the National Institutes of Health CTSA Grant KL2RR024983 (North and Central Texas Clinical and Translational Science Initiative) (to DEG) and National Cancer Institute Clinical Investigator Team Leadership Award (1P30 CA142543-01 supplement) (to DEG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; [Anonymous], [No title captured]; [Anonymous], SEER FAST STATS; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cardis E, 2005, BMJ-BRIT MED J, V331, P77, DOI 10.1136/bmj.38499.599861.E0; CHUTE CG, 1985, CANCER, V56, P2107, DOI 10.1002/1097-0142(19851015)56:8<2107::AID-CNCR2820560837>3.0.CO;2-T; Cuffe S, 2011, J THORAC ONCOL, V6, P818, DOI 10.1097/JTO.0b013e31820c2f2e; FEINSTEIN AR, 1964, ANN INTERN MED, V61, P27, DOI 10.7326/0003-4819-61-1-27; FONTANA RS, 1984, AM REV RESPIR DIS, V130, P561; Fontham ETH, 2012, AM CANC SOC INT GUID; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; GREENBERG ER, 1984, J NATL CANCER I, V72, P599; Henschke CI, 2001, ONCOLOGIST, V6, P147, DOI 10.1634/theoncologist.6-2-147; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Heuvers ME, 2012, NEW ENGL J MED, V366, P192, DOI 10.1056/NEJMc1111935; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Huerta M, 2005, PREV MED, V41, P646, DOI 10.1016/j.ypmed.2005.01.011; HUHTI E, 1980, THORAX, V35, P660, DOI 10.1136/thx.35.9.660; HYDE L, 1974, CHEST, V65, P299, DOI 10.1378/chest.65.3.299; Kenkel D, 2003, ADDICTION, V98, P1307, DOI 10.1046/j.1360-0443.2003.00445.x; Klabunde CN, 2010, AM J PREV MED, V39, P411, DOI 10.1016/j.amepre.2010.07.004; Larson DB, 2011, RADIOLOGY, V258, P164, DOI 10.1148/radiol.10100640; Lewis Carmen L, 2006, BMC Geriatr, V6, P10, DOI 10.1186/1471-2318-6-10; Lewis CL, 2009, J GEN INTERN MED, V24, P816, DOI 10.1007/s11606-009-1006-9; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; NCCN Guidelines &REG, 2012, NONSM CELL LUNG CANC; Port JL, 2011, ANN THORAC SURG, V92, P1951, DOI 10.1016/j.athoracsur.2011.06.082; TALA E, 1967, ACTA RADIOL DIAGN S, V268, P261	29	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52313	10.1371/journal.pone.0052313	http://dx.doi.org/10.1371/journal.pone.0052313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284984	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800046
J	Agarwal, D; Dange, RB; Vila, J; Otamendi, AJ; Francis, J				Agarwal, Deepmala; Dange, Rahul B.; Vila, Jorge; Otamendi, Arturo J.; Francis, Joseph			Detraining Differentially Preserved Beneficial Effects of Exercise on Hypertension: Effects on Blood Pressure, Cardiac Function, Brain Inflammatory Cytokines and Oxidative Stress	PLOS ONE			English	Article							II-INDUCED HYPERTENSION; CENTRAL-NERVOUS-SYSTEM; FACTOR-KAPPA-B; ANGIOTENSIN-II; PARAVENTRICULAR NUCLEUS; HEART-FAILURE; SUPEROXIDE-DISMUTASE; NAD(P)H OXIDASE; NADPH OXIDASE; ORGAN DAMAGE	Aims: This study sought to investigate the effects of physical detraining on blood pressure (BP) and cardiac morphology and function in hypertension, and on pro-and anti-inflammatory cytokines (PICs and AIC) and oxidative stress within the brain of hypertensive rats. Methods and Results: Hypertension was induced in male Sprague-Dawley rats by delivering AngiotensinII for 42 days using implanted osmotic minipumps. Rats were randomized into sedentary, trained, and detrained groups. Trained rats underwent moderate-intensity exercise (ExT) for 42 days, whereas, detrained groups underwent 28 days of exercise followed by 14 days of detraining. BP and cardiac function were evaluated by radio-telemetry and echocardiography, respectively. At the end, the paraventricular nucleus (PVN) was analyzed by Real-time RT-PCR and Western blot. ExT in AngII-infused rats caused delayed progression of hypertension, reduced cardiac hypertrophy, and improved diastolic function. These results were associated with significantly reduced PICs, increased AIC (interleukin (IL)-10), and attenuated oxidative stress in the PVN. Detraining did not abolish the exercise-induced attenuation in MAP in hypertensive rats; however, detraining failed to completely preserve exercise-mediated improvement in cardiac hypertrophy and function. Additionally, detraining did not reverse exercise-induced improvement in PICs in the PVN of hypertensive rats; however, the improvements in IL-10 were abolished. Conclusion: These results indicate that although 2 weeks of detraining is not long enough to completely abolish the beneficial effects of regular exercise, continuing cessation of exercise may lead to detrimental effects.	[Agarwal, Deepmala; Dange, Rahul B.; Vila, Jorge; Otamendi, Arturo J.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu			National Heart, Lung, and Blood Institute [HL-80544]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080544] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (Grant number HL-80544 to Joseph Francis). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2011, BASIC RES CARDIOL, V106, P1069, DOI 10.1007/s00395-011-0231-7; Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Agarwal D, 2009, HYPERTENSION, V54, P1393, DOI 10.1161/HYPERTENSIONAHA.109.135459; Ahmed Nazir, 2008, J Ayub Med Coll Abbottabad, V20, P66; Allen AM, 2000, AM J HYPERTENS, V13, p31S, DOI 10.1016/S0895-7061(99)00249-6; Badoer E, 2010, AM J PHYSIOL-RENAL, V298, pF839, DOI 10.1152/ajprenal.00734.2009; Bai Y, 2009, AM J NEPHROL, V29, DOI 10.1159/000178817; Bocalini DS, 2010, EUR J APPL PHYSIOL, V109, P909, DOI 10.1007/s00421-010-1406-x; Boissiere J, 2008, J APPL PHYSIOL, V104, P321, DOI 10.1152/japplphysiol.00442.2007; Campos RR, 2009, HYPERTENS RES, V32, P1047, DOI 10.1038/hr.2009.180; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Chicco AJ, 2008, HYPERTENSION, V51, P1096, DOI 10.1161/HYPERTENSIONAHA.107.107078; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Dorffel Y, 1999, HYPERTENSION, V34, P113, DOI 10.1161/01.HYP.34.1.113; Fujita M, 2007, HYPERTENSION, V50, P360, DOI 10.1161/HYPERTENSIONAHA.107.091009; Gao L, 2005, CIRCULATION, V112, P1763, DOI 10.1161/CIRCULATIONAHA.105.552174; Graham DA, 2004, J APPL PHYSIOL, V96, P2088, DOI 10.1152/japplphysiol.01252.2003; Jennings JR, 2009, NEUROIMAGE, V47, P914, DOI 10.1016/j.neuroimage.2009.04.072; Kang YM, 2009, CARDIOVASC RES, V82, P503, DOI 10.1093/cvr/cvp073; Kannan H, 1996, AM J PHYSIOL-REG I, V270, pR479, DOI 10.1152/ajpregu.1996.270.2.R479; Kar S, 2010, J APPL PHYSIOL, V108, P923, DOI 10.1152/japplphysiol.00840.2009; KIMURA T, 1993, ANN NY ACAD SCI, V689, P330, DOI 10.1111/j.1749-6632.1993.tb55558.x; Kobayashi Seiichi, 2002, J Atheroscler Thromb, V9, P184; Kohno H, 2002, JPN HEART J, V43, P25, DOI 10.1536/jhj.43.25; Kump DS, 2005, J PHYSIOL-LONDON, V562, P829, DOI 10.1113/jphysiol.2004.073593; Law M, 2003, Health Technol Assess, V7, P1; Lehnen AM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-67; Lu Y, 2009, NEUROL RES, V31, P420, DOI 10.1179/174313208X353677; Mayorov DN, 2004, HYPERTENSION, V44, P101, DOI 10.1161/01.HYP.0000131290.12255.04; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mostarda C, 2009, AUTON NEUROSCI-BASIC, V145, P11, DOI 10.1016/j.autneu.2008.10.010; Murdoch CE, 2011, BASIC RES CARDIOL, V106, P527, DOI 10.1007/s00395-011-0179-7; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; NEUFER PD, 1992, CAN J PHYSIOL PHARM, V70, P1286, DOI 10.1139/y92-178; Nomoto T, 2009, GENE THER, V16, P383, DOI 10.1038/gt.2008.151; Nonaka-Sarukawa M, 2008, J GENE MED, V10, P368, DOI 10.1002/jgm.1166; PAVLIK G, 1985, ACTA PHYSIOL HUNG, V66, P27; Peeters ACTM, 2001, EUR J CLIN INVEST, V31, P31, DOI 10.1046/j.1365-2362.2001.00743.x; Pellett AA, 2004, ECHOCARDIOGR-J CARD, V21, P669, DOI 10.1111/j.0742-2822.2004.04052.x; Qi J, 2012, CARDIOVASC TOXICOL; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shi P, 2010, CLIN EXP PHARMACOL P, V37, pE52, DOI 10.1111/j.1440-1681.2009.05234.x; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; Sriramula S, 2011, CARDIOVASC RES, V92, P401, DOI 10.1093/cvr/cvr242; Sun CW, 2005, CIRC RES, V96, P659, DOI 10.1161/01.RES.0000161257.02571.4b; Sun MW, 2008, HYPERTENS RES, V31, P543, DOI 10.1291/hypres.31.543; Vaziri ND, 2003, KIDNEY INT, V63, P186, DOI 10.1046/j.1523-1755.2003.00711.x; Veras-Silva AS, 1997, AM J PHYSIOL-HEART C, V273, pH2627, DOI 10.1152/ajpheart.1997.273.6.H2627; Xia HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022682; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4; Zimmerman MC, 2002, CIRC RES, V91, P1038, DOI 10.1161/01.RES.0000043501.47934.FA	51	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52569	10.1371/journal.pone.0052569	http://dx.doi.org/10.1371/journal.pone.0052569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285093	Green Submitted, gold, Green Published			2022-12-25	WOS:000312794500199
J	Anderson, OD; Dong, LL; Huo, NX; Gu, YQ				Anderson, Olin D.; Dong, Lingli; Huo, Naxin; Gu, Yong Q.			A New Class of Wheat Gliadin Genes and Proteins	PLOS ONE			English	Article							DISULFIDE BONDS; GAMMA-3 HORDEIN; FAMILY; SEQUENCE; LOCATION; GLUTEN; BARLEY; BREAD	The utility of mining DNA sequence data to understand the structure and expression of cereal prolamin genes is demonstrated by the identification of a new class of wheat prolamins. This previously unrecognized wheat prolamin class, given the name delta-gliadins, is the most direct ortholog of barley gamma 3-hordeins. Phylogenetic analysis shows that the orthologous delta-gliadins and gamma 3-hordeins form a distinct prolamin branch that existed separate from the gamma-gliadins and gamma-hordeins in an ancestral Triticeae prior to the branching of wheat and barley. The expressed delta-gliadins are encoded by a single gene in each of the hexaploid wheat genomes. This single delta-gliadin/gamma 3-hordein ortholog may be a general feature of the Triticeae tribe since examination of ESTs from three barley cultivars also confirms a single gamma 3-hordein gene. Analysis of ESTs and cDNAs shows that the genes are expressed in at least five hexaploid wheat cultivars in addition to diploids Triticum monococcum and Aegilops tauschii. The latter two sequences also allow assignment of the delta-gliadin genes to the A and D genomes, respectively, with the third sequence type assumed to be from the B genome. Two wheat cultivars for which there are sufficient ESTs show different patterns of expression, i.e., with cv Chinese Spring expressing the genes from the A and B genomes, while cv Recital has ESTs from the A and D genomes. Genomic sequences of Chinese Spring show that the D genome gene is inactivated by tandem premature stop codons. A fourth delta-gliadin sequence occurs in the D genome of both Chinese Spring and Ae. tauschii, but no ESTs match this sequence and limited genomic sequences indicates a pseudogene containing frame shifts and premature stop codons. Sequencing of BACs covering a 3 Mb region from Ae. tauschii locates the delta-gliadin gene to the complex Gli-1 plus Glu-3 region on chromosome 1.	[Anderson, Olin D.; Dong, Lingli; Huo, Naxin; Gu, Yong Q.] ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA; [Huo, Naxin] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Dong, Lingli] Chinese Acad Sci, Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China	United States Department of Agriculture (USDA); University of California System; University of California Davis; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Anderson, OD (corresponding author), ARS, Genom & Gene Discovery Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.	olin.anderson@ars.usda.gov			Agricultural Research Service, United States Department of Agriculture; United States National Science Foundation [DBI-0701916, DBI-0822100]	Agricultural Research Service, United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); United States National Science Foundation(National Science Foundation (NSF))	This work was supported by the Agricultural Research Service, United States Department of Agriculture and by United States National Science Foundation grants DBI-0701916 and DBI-0822100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson OD, 1997, THEOR APPL GENET, V95, P59, DOI 10.1007/s001220050532; Anderson OD, 2001, THEOR APPL GENET, V103, P323, DOI 10.1007/s00122-001-0551-3; Armstrong MJ, 2012, CURR OPIN GASTROEN, V28, P104, DOI 10.1097/MOG.0b013e32834d0844; Brenchley R, 2012, NATURE IN PRESS; CAMERONMILLS V, 1988, PLANT MOL BIOL, V11, P449, DOI 10.1007/BF00039026; Cassidy BG, 1998, THEOR APPL GENET, V96, P743, DOI 10.1007/s001220050797; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; DOVIDIO R, 1995, CEREAL CHEM, V72, P443; Gil-Humanes J, 2008, J CEREAL SCI, V48, P565, DOI 10.1016/j.jcs.2008.03.005; KECK B, 1995, Z LEBENSM UNTERS FOR, V200, P432, DOI 10.1007/BF01193253; Kong XY, 2004, PLANT MOL BIOL, V54, P55, DOI 10.1023/B:PLAN.0000028768.21587.dc; MacRitchie F., 1992, Advances in Food and Nutrition Research, V36, P1, DOI 10.1016/S1043-4526(08)60104-7; MULLER S, 1995, J CEREAL SCI, V22, P21, DOI 10.1016/S0733-5210(05)80004-9; Muller S, 1997, J CEREAL SCI, V26, P169, DOI 10.1006/S0733-5210(97)90100-4; Piston F, 2004, THEOR APPL GENET, V108, P1359, DOI 10.1007/s00122-003-1548-x; RECHINGER KB, 1993, THEOR APPL GENET, V85, P829, DOI 10.1007/BF00225026; RECHINGER KB, 1993, PLANT J, V4, P841, DOI 10.1046/j.1365-313X.1993.04050841.x; SABELLI PA, 1991, THEOR APPL GENET, V83, P209, DOI 10.1007/BF00226253; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; SHEWRY PR, 1985, FEBS LETT, V190, P61, DOI 10.1016/0014-5793(85)80427-0; Shewry PR, 2003, ADV GENET, V49, P111, DOI 10.1016/S0065-2660(03)01003-4; Snegaroff J, 2006, INT ARCH ALLERGY IMM, V139, P201, DOI 10.1159/000091165; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747	23	33	35	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52139	10.1371/journal.pone.0052139	http://dx.doi.org/10.1371/journal.pone.0052139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284903	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500098
J	Oshima, K; Sugimoto, Y; Irving, TC; Wakabayashi, K				Oshima, Kanji; Sugimoto, Yasunobu; Irving, Thomas C.; Wakabayashi, Katsuzo			Head-Head Interactions of Resting Myosin Crossbridges in Intact Frog Skeletal Muscles, Revealed by Synchrotron X-Ray Fiber Diffraction	PLOS ONE			English	Article							BINDING-PROTEIN-C; FISH MUSCLE; A-BAND; 3-DIMENSIONAL STRUCTURE; 3D STRUCTURE; MYBP-C; VERTEBRATE MUSCLE; STRIATED-MUSCLE; FINE-STRUCTURE; ATP TURNOVER	The intensities of the myosin-based layer lines in the x-ray diffraction patterns from live resting frog skeletal muscles with full thick-thin filament overlap from which partial lattice sampling effects had been removed were analyzed to elucidate the configurations of myosin crossbridges around the thick filament backbone to nanometer resolution. The repeat of myosin binding protein C (C-protein) molecules on the thick filaments was determined to be 45.33 nm, slightly longer than that of myosin crossbridges. With the inclusion of structural information for C-proteins and a pre-powerstroke head shape, modeling in terms of a mixed population of regular and perturbed regions of myosin crown repeats along the filament revealed that the myosin filament had azimuthal perturbations of crossbridges in addition to axial perturbations in the perturbed region, producing pseudo-six-fold rotational symmetry in the structure projected down the filament axis. Myosin crossbridges had a different organization about the filament axis in each of the regular and perturbed regions. In the regular region that lacks C-proteins, there were inter-molecular interactions between the myosin heads in axially adjacent crown levels. In the perturbed region that contains C-proteins, in addition to inter-molecular interactions between the myosin heads in the closest adjacent crown levels, there were also intra-molecular interactions between the paired heads on the same crown level. Common features of the interactions in both regions were interactions between a portion of the 50-kDa-domain and part of the converter domain of the myosin heads, similar to those found in the phosphorylation-regulated invertebrate myosin. These interactions are primarily electrostatic and the converter domain is responsible for the head-head interactions. Thus multiple head-head interactions of myosin crossbridges also characterize the switched-off state and have an important role in the regulation or other functions of myosin in thin filament-regulated muscles as well as in the thick filament-regulated muscles.	[Sugimoto, Yasunobu; Wakabayashi, Katsuzo] Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Toyonaka, Osaka 560, Japan; [Oshima, Kanji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Irving, Thomas C.] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA	Osaka University; Osaka University; Illinois Institute of Technology	Wakabayashi, K (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Biophys Engn, Toyonaka, Osaka 560, Japan.	waka@bpe.es.osaka-u.ac.jp			Special Coordination Funds from the Ministry of Education, Science, Sports and Culture of Japan; National Center for Research Resource from the National Institute of Health [2P41RR008630-17]; National Institute of General Medical Sciences from the National Institute of Health [9P41GM103622-17]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	Special Coordination Funds from the Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Research Resource from the National Institute of Health; National Institute of General Medical Sciences from the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Special Coordination Funds from the Ministry of Education, Science, Sports and Culture of Japan. This project was also supported by grants from the National Center for Research Resource (2P41RR008630-17) and the National Institute of General Medical Sciences (9P41GM103622-17) from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs Y. Takezawa, T. Kobayashi, H. Tanaka and D. B. Gore for their kind help with physiological and x-ray experiments at the Photon Factory and the Advanced Photon Source, Dr T. Arata for invaluable discussions and Prof H. Nakamura for stimulating suggestions and support. This work was approved by the Photon Factory Advisory Committee. Use of the Advanced Photon Source was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Al-Khayat HA, 2004, J MUSCLE RES CELL M, V25, P635, DOI 10.1007/s10974-004-5333-5; AL-Khayat HA, 2003, BIOPHYS J, V85, P1063, DOI 10.1016/S0006-3495(03)74545-7; Al-Khayat HA, 2008, J STRUCT BIOL, V163, P117, DOI 10.1016/j.jsb.2008.03.011; Al-Khayat HA, 2006, J STRUCT BIOL, V155, P202, DOI 10.1016/j.jsb.2006.01.014; Al-Khayat HA, 2006, J STRUCT BIOL, V155, P218, DOI 10.1016/j.jsb.2006.03.029; Al-Khayat HA, 2009, J STRUCT BIOL, V166, P183, DOI 10.1016/j.jsb.2009.02.006; Alamo L, 2008, J MOL BIOL, V384, P780, DOI 10.1016/j.jmb.2008.10.013; AMEMIYA Y, 1987, SCIENCE, V237, P164, DOI 10.1126/science.3496662; Amemiya Y., 1998, PHOTON FACTORY NEWS, V16, P9; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Craig R, 2006, CURR OPIN STRUC BIOL, V16, P204, DOI 10.1016/j.sbi.2006.03.006; CRAIG R, 1977, J MOL BIOL, V109, P69, DOI 10.1016/S0022-2836(77)80046-6; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Fujiwara S, 2009, J STRUCT BIOL, V167, P25, DOI 10.1016/j.jsb.2009.03.018; Fukunishi Y, 2003, J PHYS CHEM B, V107, P13201, DOI 10.1021/jp035478e; HARFORD J, 1994, J MOL BIOL, V239, P500, DOI 10.1006/jmbi.1994.1391; Haselgrove J C, 1980, J Muscle Res Cell Motil, V1, P177, DOI 10.1007/BF00711798; Higo J, 2001, J COMPUT CHEM, V22, P1983, DOI 10.1002/jcc.1147; Hudson L, 1997, J MOL BIOL, V273, P440, DOI 10.1006/jmbi.1997.1321; HUXLEY HE, 1982, J MOL BIOL, V158, P637, DOI 10.1016/0022-2836(82)90253-4; IRVING TC, 1989, J MUSCLE RES CELL M, V10, P385, DOI 10.1007/BF01758435; Juanhuix J, 2001, BIOPHYS J, V80, P1429, DOI 10.1016/S0006-3495(01)76115-2; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Luther PK, 1996, J MORPHOL, V229, P325, DOI 10.1002/(SICI)1097-4687(199609)229:3<325::AID-JMOR7>3.0.CO;2-X; LUTHER PK, 1980, J MOL BIOL, V141, P409, DOI 10.1016/0022-2836(80)90254-5; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; MALINCHIK SB, 1992, J MUSCLE RES CELL M, V13, P406, DOI 10.1007/BF01738036; Matsuo Tatsuhito, 2010, Biophysics (Nagoya-shi), V6, P13, DOI 10.2142/biophysics.6.13; Naber N, 2011, J MOL BIOL, V411, P943, DOI 10.1016/j.jmb.2011.06.051; NAMBA K, 1980, J MOL BIOL, V138, P1, DOI 10.1016/S0022-2836(80)80002-7; Oshima K, 2007, J MOL BIOL, V367, P275, DOI 10.1016/j.jmb.2006.12.036; Oshima K, 2011, J APPL CRYSTALLOGR, V44, P398, DOI 10.1107/S0021889811006455; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; ROME E, 1973, NATURE-NEW BIOL, V244, P152, DOI 10.1038/newbio244152a0; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; SJOSTROM M, 1977, J MOL BIOL, V109, P49, DOI 10.1016/S0022-2836(77)80045-4; Squire JM, 2005, ADV PROTEIN CHEM, V71, P17, DOI 10.1016/S0065-3233(04)71002-5; Squire JM, 2004, J MOL BIOL, V343, P1345, DOI 10.1016/j.jmb.2004.08.084; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; SQUIRE JM, 1982, J MOL BIOL, V155, P467, DOI 10.1016/0022-2836(82)90482-X; Squire JM, 1981, STRUCTURAL BASIS MUS, P330; Standley DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-116; Stewart MA, 2010, P NATL ACAD SCI USA, V107, P430, DOI 10.1073/pnas.0909468107; SUGIMOTO Y, 1995, BIOPHYS J, V68, pS29; Swank DM, 2002, NAT CELL BIOL, V4, P312, DOI 10.1038/ncb776; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; WAKABAYASHI K, 1991, HDB SYNCHROTRON RAD, V4, P597; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; YU LC, 1989, BIOPHYS J, V55, P433, DOI 10.1016/S0006-3495(89)82837-1; Zhao FQ, 2008, BIOPHYS J, V95, P3322, DOI 10.1529/biophysj.108.137067; Zhao FQ, 2009, J MOL BIOL, V385, P423, DOI 10.1016/j.jmb.2008.10.038; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	60	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52421	10.1371/journal.pone.0052421	http://dx.doi.org/10.1371/journal.pone.0052421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285033	Green Submitted, Green Published, gold			2022-12-25	WOS:000312794500161
J	Thomson, SR; Nahon, JE; Mutsaers, CA; Thomson, D; Hamilton, G; Parson, SH; Gillingwater, TH				Thomson, Sophie R.; Nahon, Joya E.; Mutsaers, Chantal A.; Thomson, Derek; Hamilton, Gillian; Parson, Simon H.; Gillingwater, Thomas H.			Morphological Characteristics of Motor Neurons Do Not Determine Their Relative Susceptibility to Degeneration in a Mouse Model of Severe Spinal Muscular Atrophy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; SELECTIVE VULNERABILITY; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; SYNAPSE ELIMINATION; IN-VIVO; MICE; PATHOLOGY; GENE	Spinal muscular atrophy (SMA) is a leading genetic cause of infant mortality, resulting primarily from the degeneration and loss of lower motor neurons. Studies using mouse models of SMA have revealed widespread heterogeneity in the susceptibility of individual motor neurons to neurodegeneration, but the underlying reasons remain unclear. Data from related motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), suggest that morphological properties of motor neurons may regulate susceptibility: in ALS larger motor units innervating fast-twitch muscles degenerate first. We therefore set out to determine whether intrinsic morphological characteristics of motor neurons influenced their relative vulnerability to SMA. Motor neuron vulnerability was mapped across 10 muscle groups in SMA mice. Neither the position of the muscle in the body, nor the fibre type of the muscle innervated, influenced susceptibility. Morphological properties of vulnerable and disease-resistant motor neurons were then determined from single motor units reconstructed in Thy. 1-YFP-H mice. None of the parameters we investigated in healthy young adult mice - including motor unit size, motor unit arbor length, branching patterns, motor endplate size, developmental pruning and numbers of terminal Schwann cells at neuromuscular junctions - correlated with vulnerability. We conclude that morphological characteristics of motor neurons are not a major determinant of disease-susceptibility in SMA, in stark contrast to related forms of motor neuron disease such as ALS. This suggests that subtle molecular differences between motor neurons, or extrinsic factors arising from other cell types, are more likely to determine relative susceptibility in SMA.	[Thomson, Sophie R.; Nahon, Joya E.; Mutsaers, Chantal A.; Thomson, Derek; Hamilton, Gillian; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Thomson, Sophie R.; Nahon, Joya E.; Mutsaers, Chantal A.; Hamilton, Gillian; Parson, Simon H.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Gillingwater, TH (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	T.Gillingwater@ed.ac.uk	Hunter, Gillian/A-1952-2015	Gillingwater, Thomas/0000-0002-0306-5577; Parson, Simon/0000-0002-8848-8738	Wellcome Trust; SMA Trust; Muscular Dystrophy Campaign; Motor Neuron Disease Scotland; Euan MacDonald Centre for Motor Neuron Disease	Wellcome Trust(Wellcome TrustEuropean Commission); SMA Trust; Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Motor Neuron Disease Scotland; Euan MacDonald Centre for Motor Neuron Disease	This work was funded by grants from the Wellcome Trust, SMA Trust, the Muscular Dystrophy Campaign, Motor Neuron Disease Scotland, and the Euan MacDonald Centre for Motor Neuron Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGAUTPETIT D, 1987, NEUROSCI LETT, V82, P83, DOI 10.1016/0304-3940(87)90175-3; BRADLEY WG, 1983, ANN NEUROL, V14, P267, DOI 10.1002/ana.410140304; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng Z, 2008, ANN NY ACAD SCI, V1132, P19, DOI 10.1196/annals.1405.016; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2012, HUM MOL GENET, V21, P3421, DOI 10.1093/hmg/dds174; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2012, HUM MOL GENET, V21, P185, DOI 10.1093/hmg/ddr453; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lionikas A, 2005, PHYSIOL GENOMICS, V21, P184, DOI 10.1152/physiolgenomics.00209.2004; Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; McCann CM, 2007, J NEUROSCI, V27, P6064, DOI 10.1523/JNEUROSCI.0627-07.2007; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Murray LM, 2010, NEUROMUSCULAR DISORD, V20, P740, DOI 10.1016/j.nmd.2010.06.013; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Ruggiu M, 2012, MOL CELL BIOL, V32, P126, DOI 10.1128/MCB.06077-11; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Sleigh JN, 2011, DIS MODEL MECH, V4, P457, DOI 10.1242/dmm.007245; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Thomson SR, 2012, J ANAT, V220, P122, DOI 10.1111/j.1469-7580.2011.01459.x; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Vrbova G, 2012, NEUROMUSCULAR DISORD, V22, P381, DOI 10.1016/j.nmd.2011.12.002; Wirth B, 1999, AM J HUM GENET, V64, P1340, DOI 10.1086/302369; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025	41	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52605	10.1371/journal.pone.0052605	http://dx.doi.org/10.1371/journal.pone.0052605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285108	Green Published, gold, Green Submitted			2022-12-25	WOS:000312794500208
J	Winter, C; Payet, JP; Suttle, CA				Winter, Christian; Payet, Jerome P.; Suttle, Curtis A.			Modeling the Winter-to-Summer Transition of Prokaryotic and Viral Abundance in the Arctic Ocean	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; NUCLEIC-ACID CONTENT; NATURAL PLANKTONIC BACTERIA; FLOW-CYTOMETRY; BEAUFORT SEA; AQUATIC SYSTEMS; CANADIAN SHELF; ALGAL BLOOM; VIRUSES; BACTERIOPLANKTON	One of the challenges in oceanography is to understand the influence of environmental factors on the abundances of prokaryotes and viruses. Generally, conventional statistical methods resolve trends well, but more complex relationships are difficult to explore. In such cases, Artificial Neural Networks (ANNs) offer an alternative way for data analysis. Here, we developed ANN-based models of prokaryotic and viral abundances in the Arctic Ocean. The models were used to identify the best predictors for prokaryotic and viral abundances including cytometrically-distinguishable populations of prokaryotes (high and low nucleic acid cells) and viruses (high-and low-fluorescent viruses) among salinity, temperature, depth, day length, and the concentration of Chlorophyll-a. The best performing ANNs to model the abundances of high and low nucleic acid cells used temperature and Chl-a as input parameters, while the abundances of high-and low-fluorescent viruses used depth, Chl-a, and day length as input parameters. Decreasing viral abundance with increasing depth and decreasing system productivity was captured well by the ANNs. Despite identifying the same predictors for the two populations of prokaryotes and viruses, respectively, the structure of the best performing ANNs differed between high and low nucleic acid cells and between high-and low-fluorescent viruses. Also, the two prokaryotic and viral groups responded differently to changes in the predictor parameters; hence, the cytometric distinction between these populations is ecologically relevant. The models imply that temperature is the main factor explaining most of the variation in the abundances of high nucleic acid cells and total prokaryotes and that the mechanisms governing the reaction to changes in the environment are distinctly different among the prokaryotic and viral populations. Citation: Winter C, Payet JP, Suttle CA (2012) Modeling the Winter-to-Summer Transition of Prokaryotic and Viral Abundance in the Arctic Ocean. PLoS ONE 7(12): e52794. doi:10.1371/journal.pone.0052794	[Winter, Christian] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Payet, Jerome P.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Suttle, Curtis A.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Suttle, Curtis A.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Suttle, Curtis A.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Vienna; Oregon State University; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Winter, C (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	christian.winter@univie.ac.at	suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008	suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Winter, Christian/0000-0001-6327-0209	NSERC through the Canadian Arctic Shelf Exchange Study (CASES); Discovery Grant; TULA foundation; University of Vienna	NSERC through the Canadian Arctic Shelf Exchange Study (CASES); Discovery Grant; TULA foundation; University of Vienna	Field sampling was funded by NSERC through the Canadian Arctic Shelf Exchange Study (CASES) and a Discovery Grant to C. A. Suttle. C. Winter was financially supported by a grant to the Centre for Microbial Diversity and Evolution (CMDE) at the University of British Columbia from the TULA foundation. Additional financial support was provided by the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Basheer IA, 2000, J MICROBIOL METH, V43, P3, DOI 10.1016/S0167-7012(00)00201-3; Baudoux AC, 2007, LIMNOL OCEANOGR, V52, P2519, DOI 10.4319/lo.2007.52.6.2519; Belgrano A, 2001, J PLANKTON RES, V23, P651, DOI 10.1093/plankt/23.6.651; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P287, DOI 10.1111/j.1462-2920.2006.01137.x; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Carmack EC, 2002, ARCTIC, V55, P29; Carmack EC, 2004, MAR ECOL PROG SER, V277, P37, DOI 10.3354/meps277037; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; HAYKIN S, 1999, NEURAL NETWORKS; Hodges LR, 2005, AQUAT MICROB ECOL, V40, P217, DOI 10.3354/ame040217; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; Lebaron P, 2002, AQUAT MICROB ECOL, V28, P131, DOI 10.3354/ame028131; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Li WKW, 2001, CYTOMETRY, V44, P236, DOI 10.1002/1097-0320(20010701)44:3<236::AID-CYTO1116>3.0.CO;2-5; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; MARANGER R, 1994, MAR ECOL PROG SER, V111, P121, DOI 10.3354/meps111121; Marie D, 1996, APPL ENVIRON MICROB, V62, P1649, DOI 10.1128/AEM.62.5.1649-1655.1996; Marie D, 1999, CURRENT PROTOCOLS CY; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Middelboe M, 2002, DEEP-SEA RES PT II, V49, P5063, DOI 10.1016/S0967-0645(02)00178-9; MURRAY AG, 1992, MAR ECOL PROG SER, V89, P103, DOI 10.3354/meps089103; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Peterson BJ, 2006, SCIENCE, V313, P1061, DOI 10.1126/science.1122593; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Scardi M, 1996, MAR ECOL PROG SER, V139, P289, DOI 10.3354/meps139289; Scharek R, 2007, AQUAT MICROB ECOL, V46, P153, DOI 10.3354/ame046153; Shimada K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025624; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; Steele M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031651; Stein R., 2004, ORGANIC CARBON CYCLE; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wells LE, 2006, AQUAT MICROB ECOL, V43, P209, DOI 10.3354/ame043209; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winter C, 2005, ENVIRON MICROBIOL, V7, P881, DOI 10.1111/j.1462-2920.2005.00768.x; Winter C, 2010, MICROBIOL MOL BIOL R, V74, P42, DOI 10.1128/MMBR.00034-09; Winter C, 2009, DEEP-SEA RES PT I, V56, P1972, DOI 10.1016/j.dsr.2009.07.003; Woodd-Walker RS, 2001, J PLANKTON RES, V23, P875, DOI 10.1093/plankt/23.8.875; Yager PL, 2001, LIMNOL OCEANOGR, V46, P790, DOI 10.4319/lo.2001.46.4.0790; Yamamoto-Kawai M, 2006, NATURE, V443, P43, DOI 10.1038/443043a; Zubkov MV, 2001, APPL ENVIRON MICROB, V67, P5210, DOI 10.1128/AEM.67.11.5210-5218.2001	50	9	9	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52794	10.1371/journal.pone.0052794	http://dx.doi.org/10.1371/journal.pone.0052794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285186	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500246
J	Zhang, JP; Lu, HY; Gu, WF; Wu, NQ; Zhou, KS; Hu, YY; Xin, YJ; Wang, C				Zhang, Jianping; Lu, Houyuan; Gu, Wanfa; Wu, Naiqin; Zhou, Kunshu; Hu, Yayi; Xin, Yingjun; Wang, Can			Early Mixed Farming of Millet and Rice 7800 Years Ago in the Middle Yellow River Region, China	PLOS ONE			English	Article							PHYTOLITH EVIDENCE; LOWER YANGTZE; DOMESTICATION; AGRICULTURE; WILD; CLASSIFICATION; RECONSTRUCTION; CULTIVATION; GRASSES; ORIGINS	The Peiligang Culture (9000-7000 cal. yr BP) in the Middle Yellow River region, North China, has long been considered representative of millet farming. It is still unclear, however, if broomcorn millet or foxtail millet was the first species domesticated during the Peiligang Culture. Furthermore, it is also unknown whether millet was cultivated singly or together with rice at the same period. In this study, phytolith analysis of samples from the Tanghu archaeological site reveals early crop information in the Middle Yellow River region, China. Our results show that broomcorn millet was the early dry farming species in the Peiligang Culture at 7800 cal. yr BP, while rice cultivation took place from 7800 to 4500 cal. yr BP. Our data provide new evidence of broomcorn millet and rice mixed farming at 7800 cal. yr BP in the Middle Yellow River region, which has implications for understanding the domestication process of the two crops, and the formation and continuance of the Ancient Yellow River Civilization.	[Zhang, Jianping; Lu, Houyuan; Wu, Naiqin; Zhou, Kunshu; Wang, Can] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China; [Gu, Wanfa; Hu, Yayi; Xin, Yingjun] Zhengzhou Prov Cultural Relics & Archaeol Res Ins, Zhengzhou, Peoples R China; [Wang, Can] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, JP (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing, Peoples R China.	jpzhang@mail.iggcas.ac.cn	WANG, CAN/GWV-0969-2022; Lu, houyuan/AAD-3100-2019; Zhang, Jianping/A-8167-2014; Lu, houyuan/L-8661-2019; Liu, Kam-Biu/B-4966-2012	Lu, houyuan/0000-0001-5721-6679; Zhang, Jianping/0000-0003-0815-009X; Liu, Kam-Biu/0000-0002-0038-2198	National Natural Science Foundation of China [41102111]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDA05130401, XDA05130602]; Key Program of the National Science Foundation of China [41230104]; National Basic Research Program of China [2010CB950201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Program of the National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 41102111), "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant Nos. XDA05130401 and XDA05130602), the Key Program of the National Science Foundation of China (Grant No. 41230104), and the National Basic Research Program of China (Grant No. 2010CB950201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton L, 2009, P NATL ACAD SCI USA, V106, P5523, DOI 10.1073/pnas.0809960106; Chang, 1986, ARCHAEOLOGY ANCIENT; Chen X, 2003, ACTA ARCHAEOLOGICA S, P161; Cohen DJ, 2011, CURR ANTHROPOL, V52, pS273, DOI 10.1086/659965; Crawford G.W., 2006, E ASIA ARCHAEOLOGY, V3, P247; Crawford GW, 2006, BLACKW STUD GLOB ARC, P77, DOI 10.1002/9780470774670.ch5; Fujiwara H., 1976, ARCHAEOLOGY NATURE S, V9, P15; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gu Y, 2012, QUATERN INT IN PRESS; Itzstein-Davey F, 2007, J ARCHAEOL SCI, V34, P2101, DOI 10.1016/j.jas.2007.02.018; Kondo R., 1994, OPAL PHYTOLITHS NZ; Lee GA, 2007, P NATL ACAD SCI USA, V104, P1087, DOI 10.1073/pnas.0609763104; Li XQ, 2007, HOLOCENE, V17, P555, DOI 10.1177/0959683607078978; Ling Q, 2006, DONGFANG KAOGU, V3, P307; Liu C, 2004, CULTURAL RELICS CENT, P26; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L, 2007, HOLOCENE, V17, P1059, DOI 10.1177/0959683607085121; Liu L, 2010, ANTIQUITY, V84, P816, DOI 10.1017/S0003598X00100249; Liu Li, 2004, CHINESE NEOLITHIC TR; Lu HY, 2006, QUATERNARY SCI REV, V25, P945, DOI 10.1016/j.quascirev.2005.07.014; Lu HY, 2009, P NATL ACAD SCI USA, V106, P7367, DOI 10.1073/pnas.0900158106; Lu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004448; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lu HY, 2003, ESTUAR COAST SHELF S, V58, P587, DOI 10.1016/S0272-7714(03)00137-9; Lu HY, 2003, DIVERS DISTRIB, V9, P73, DOI 10.1046/j.1472-4642.2003.00166.x; Lu HY, 2002, BOREAS, V31, P378, DOI 10.1080/030094802320942581; Lu HY, 1998, THESIS CHINESE ACAD; Lu Q.S., 1999, SORGHUM; Lu T.L.D., 2002, ASIAN PERSPECT, V41, P1, DOI [10.1353/asi.2002.0007, DOI 10.1353/asi.2002.0007]; Lu TLD, 2006, ASIAN PERSPECT, V45, P129; Mulholland S. C., 1992, PHYTOLITH SYSTEMATIC, P65; Pearsall DM., 2015, PALEOETHNOBOTANY HDB; Pearson GW, 1993, RADIOCARBON, V35, P193; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; Piperno DR, 2009, QUATERN INT, V193, P146, DOI 10.1016/j.quaint.2007.11.011; Piperno DR, 2006, PHYTOLITH COMPREHENS; Qin L., 2009, NANJIAOKOU SANMENXIA, P427; Qin L., 2012, ARCHAEOBOTANICAL RES, P260; Runge F, 1999, REV PALAEOBOT PALYNO, V107, P23, DOI 10.1016/S0034-6667(99)00018-4; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TWISS PC, 1969, SOIL SCI SOC AM PRO, V33, P109, DOI 10.2136/sssaj1969.03615995003300010030x; Wang J, 1984, AGR ARCHAEOLOGY, P276; Wang Y., 1993, STUDY PHYTOLITH ITS; Xin Y, 2010, ARCHAEOLOGY, P387; Xu T, 1998, CULTURAL RELICS CENT, P12; Zhang JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019726; Zhang JP, 2010, BOREAS, V39, P592, DOI 10.1111/j.1502-3885.2010.00145.x; Zhang JZ, 1998, ANTIQUITY, V72, P897; Zhang S, 2007, CHINA CULTURAL RELIC; Zhang S, 2008, ARCHAEOLOGY, P387; [张永辉 Zhang Yonghui], 2011, [第四纪研究, Quaternary Sciences], V31, P891; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhao ZJ, 1998, ECON BOT, V52, P134, DOI 10.1007/BF02861201; Zhao ZJ, 1998, ANTIQUITY, V72, P885, DOI 10.1017/S0003598X00087524; Zheng YF, 2003, J ARCHAEOL SCI, V30, P1215, DOI 10.1016/S0305-4403(02)00248-0; Zheng YunFei, 2003, Environmental Archaeology, V8, P177, DOI 10.1179/env.2003.8.2.177; Zheng YunFei, 1999, Chinese Journal of Rice Science, V13, P25; Zheng YunFei, 2004, Chinese Journal of Rice Science, V18, P119; [No title captured]	60	66	83	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2012	7	12							e52146	10.1371/journal.pone.0052146	http://dx.doi.org/10.1371/journal.pone.0052146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	055RZ	23284907	Green Submitted, Green Published, gold			2022-12-25	WOS:000312435900080
J	Labeit, AM; Klotsche, J; Pieper, L; Pittrow, D; Einsle, F; Stalla, GK; Lehnert, H; Silber, S; Zeiher, AM; Marz, W; Wehling, M; Wittchen, HU				Labeit, Alexander Michael; Klotsche, Jens; Pieper, Lars; Pittrow, David; Einsle, Franziska; Stalla, Guenter Karl; Lehnert, Hendrik; Silber, Sigmund; Zeiher, Andreas Michael; Maerz, Winfried; Wehling, Martin; Wittchen, Hans-Ulrich			Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; EUROPEAN COUNTRIES; RISK-FACTORS; MANAGEMENT; POPULATION; TRENDS; RECOMMENDATIONS; AWARENESS; CANADA; HEALTH	Introduction: Medical societies have developed guidelines for the detection, treatment and control of hypertension (HTN). Our analysis assessed the extent to which such guidelines were implemented in Germany in 2003 and 2001. Methods: Using standardized clinical diagnostic and treatment appraisal forms, blood pressure levels and patient questionnaires for 55,518 participants from the cross-sectional Targets and Essential Data for Commitment of Treatment (DETECT) study (2003) were analyzed. Physician's diagnosis of hypertension (HTNdoc) was defined as coding hypertension in the clinical appraisal questionnaire. Alternative definitions used were physician's diagnosis or the patient's self-reported diagnosis of hypertension (HTNdoc,pat), physician's or patient's self-reported diagnosis or a BP measurement with a systolic BP >= 140 mmHg and/or a diastolic BP >= 90 (HTNdoc,pat,bp) and diagnosis according to the National Health and Nutrition Examination Survey (HTNNHANES). The results were compared with the similar German HYDRA study to examine whether changes had occurred in diagnosis, treatment and adequate blood pressure control (BP below 140/90 mmHg) since 2001. Factors associated with pharmacotherapy and control were determined. Results: The overall prevalence rate for hypertension was 35.5% according to HTNdoc and 56.0% according to NHANES criteria. Among those defined by NHANES criteria, treatment and control rates were 56.0% and 20.3% in 2003, and these rates had improved from 55.3% and 18.0% in 2001. Significant predictors of receiving antihypertensive medication were: increasing age, female sex, obesity, previous myocardial infarction and the prevalence of comorbid conditions such as coronary heart disease (CHD), hyperlipidemia and diabetes mellitus (DM). Significant positive predictors of adequate blood pressure control were CHD and antihypertensive medication. Inadequate control was associated with increasing age, male sex and obesity. Conclusions: Rates of treated and controlled hypertension according to NHANES criteria in DETECT remained low between 2001 and 2003, although there was some minor improvement.	[Labeit, Alexander Michael; Wehling, Martin] Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Heidelberg, Germany; [Labeit, Alexander Michael] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Klotsche, Jens; Pieper, Lars; Pittrow, David; Einsle, Franziska; Wittchen, Hans-Ulrich] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Klotsche, Jens; Pieper, Lars; Pittrow, David; Einsle, Franziska; Wittchen, Hans-Ulrich] Tech Univ Dresden, Ctr Clin Epidemiol & Longitudinal Studies, Dresden, Germany; [Lehnert, Hendrik] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany; [Stalla, Guenter Karl] Max Planck Inst Psychiat, D-8000 Munich, Germany; [Zeiher, Andreas Michael] Goethe Univ Frankfurt, Dept Internal Med 3, Frankfurt, Germany; [Maerz, Winfried] Synlab Serv GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Heidelberg Univ, Mannheim Inst Publ Hlth, Med Fac Mannheim, D-6800 Mannheim, Germany; [Maerz, Winfried] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Ruprecht Karls University Heidelberg; University of Leicester; Technische Universitat Dresden; Technische Universitat Dresden; University of Lubeck; Max Planck Society; Goethe University Frankfurt; SYNLAB Group; Ruprecht Karls University Heidelberg; Medical University of Graz	Labeit, AM (corresponding author), Heidelberg Univ, Inst Expt & Clin Pharmacol & Toxicol, Med Fac Mannheim, Heidelberg, Germany.	al247@le.ac.uk	Wittchen, Hans-Ulrich/ABA-8901-2020; Labeit, Alexander/AAB-2707-2019; Wittchen, Hans-Ulrich/A-8507-2014; Pittrow, David/AAY-5042-2021	Wittchen, Hans-Ulrich/0000-0002-6311-7711; 	Pfizer; Sanofi-Aventis; Novartis; Takeda; Roche; Bristol-Myers; Daichii-Sankyo; Lilly; Novo-Nordisk	Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Roche(Roche Holding); Bristol-Myers(Bristol-Myers Squibb); Daichii-Sankyo(Daiichi Sankyo Company Limited); Lilly(Eli Lilly); Novo-Nordisk(Novo Nordisk)	The study was supported by an unrestricted educational grant from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; The authors have read the journal's policy and have the following conflicts: Alexander Michael Labeit, Jens Klotsche, Lars Pieper, David Pittrow, Franziska Einsle, Gunter Karl Stalla, Hendrik Lehnert, Andreas Michael Zeiher, Hans-Ulrich Wittchen: none. Sigmund Silber: The author served as an advisor or consultant for Abbott Laboratories, Boston Scientific, Medtronic. Martin Wehling: The author was employed by AstraZeneca R&D, Molndal, as director of discovery medicine (translational medicine) from 2003-2006, while on sabbatical leave from his professorship at the University of Heidelberg. After return to this position in January 2007, he receives lecturing and consulting fees from Sanofi-Aventis, Novartis, Takeda, Roche, Pfizer, Bristol-Myers, Daichii-Sankyo, Lilly and Novo-Nordisk. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Winfried Marz is affiliated with Synlab Academy, Synlab Services GmbH, Mannheim, Germany, though it has no bearing on this manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Duggirala MK, 2005, AM J HYPERTENS, V18, P833, DOI 10.1016/j.amjhyper.2004.12.016; Gasse C, 2001, J HUM HYPERTENS, V15, P27, DOI 10.1038/sj.jhh.1001120; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Janhsen K, 2008, HYPERTONIE; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Meisinger C, 2006, J HYPERTENS, V24, P293, DOI 10.1097/01.hjh.0000200508.10324.8e; National Institute for Health and Clinical Excellence, 2011, HYPERT CLIN MAN PRI; National Institute for Health and Clinical Excellence, 2008, PREV CARD DIS POP LE, V25; Pieper L, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1374, DOI 10.1007/s00103-005-1164-9; Pittrow D, 2004, EUR J CLIN PHARMACOL, V60, P135, DOI 10.1007/s00228-004-0731-6; Powers BJ, 2011, ANN INTERN MED, V154, P781, DOI 10.7326/0003-4819-154-12-201106210-00005; Raum E, 2008, PHARMACOEPIDEM DR S, V17, P485, DOI 10.1002/pds.1589; Sharma AM, 2004, J HYPERTENS, V22, P479, DOI 10.1097/00004872-200403000-00009; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STOCKWELL DH, 1994, AM J PUBLIC HEALTH, V84, P1768, DOI 10.2105/AJPH.84.11.1768; Thamm M, 1999, Gesundheitswesen, V61 Spec No, pS90; Turnbull F, 2005, ARCH INTERN MED, V165, P1410; Wang YR, 2007, ARCH INTERN MED, V167, P141, DOI 10.1001/archinte.167.2.141; Wittchen H U, 2003, Fortschr Med Orig, V121 Suppl 1, P2; Wittchen HU, 2005, CURR MED RES OPIN, V21, P619, DOI 10.1185/030079905X38187; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, 2008, 2008 2013 ACT PLAN G; Zanchetti A, 2009, J HYPERTENS, V27, P923, DOI 10.1097/HJH.0b013e32832aa6b5	31	34	64	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52229	10.1371/journal.pone.0052229	http://dx.doi.org/10.1371/journal.pone.0052229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23284945	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500025
J	Laigle, C; Confort-Gouny, S; Le Fur, Y; Cozzone, PJ; Viola, A				Laigle, Christophe; Confort-Gouny, Sylviane; Le Fur, Yann; Cozzone, Patrick J.; Viola, Angele			Deletion of TRAAK Potassium Channel Affects Brain Metabolism and Protects against Ischemia	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; FOCAL CEREBRAL-ISCHEMIA; CELL-VOLUME REGULATION; DOMAIN K+ CHANNELS; APPARENT DIFFUSION-COEFFICIENT; COTRANSPORTER MESSENGER-RNA; MAGNETIC-RESONANCE; RAT-BRAIN; IN-VIVO; FUNCTIONAL-SIGNIFICANCE	Cerebral stroke is a worldwide leading cause of disability. The two-pore domain K+ channels identified as background channels are involved in many functions in brain under physiological and pathological conditions. We addressed the hypothesis that TRAAK, a mechano-gated and lipid-sensitive two-pore domain K+ channel, is involved in the pathophysiology of brain ischemia. We studied the effects of TRAAK deletion on brain morphology and metabolism under physiological conditions, and during temporary focal cerebral ischemia in Traak(-/-) mice using a combination of in vivo magnetic resonance imaging (MRI) techniques and multinuclear magnetic resonance spectroscopy (MRS) methods. We provide the first in vivo evidence establishing a link between TRAAK and neurometabolism. Under physiological conditions, Traak(-/-) mice showed a particular metabolic phenotype characterized by higher levels of taurine and myo-inositol than Traak(+/+) mice. Upon ischemia, Traak(-/-) mice had a smaller infarcted volume, with lower contribution of cellular edema than Traak(+/+) mice. Moreover, brain microcirculation was less damaged, and brain metabolism and pH were preserved. Our results show that expression of TRAAK strongly influences tissue levels of organic osmolytes. Traak(-/-) mice resilience to cellular edema under ischemia appears related to their physiologically high levels of myo-inositol and of taurine, an aminoacid involved in the modulation of mitochondrial activity and cell death. The beneficial effects of TRAAK deletion designate this channel as a promising pharmacological target for the treatment against stroke.	[Laigle, Christophe; Confort-Gouny, Sylviane; Le Fur, Yann; Cozzone, Patrick J.; Viola, Angele] Aix Marseille Univ, Natl Ctr Sci Res CNRS, CRMBM, Joint Res Unit 7339,UMR 7339, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite	Viola, A (corresponding author), Aix Marseille Univ, Natl Ctr Sci Res CNRS, CRMBM, Joint Res Unit 7339,UMR 7339, Marseille, France.	angele.viola@univ-amu.fr			National Center for Scientific Research (CNRS); Aix-Marseille University	National Center for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University	This work was supported by the National Center for Scientific Research (CNRS) and Aix-Marseille University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2005, NEUROSCIENCE, V133, P1007, DOI 10.1016/j.neuroscience.2005.03.041; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Ay H, 1999, NEUROLOGY, V52, P1784, DOI 10.1212/WNL.52.9.1784; Beetsch JW, 1998, AM J PHYSIOL-CELL PH, V274, pC866, DOI 10.1152/ajpcell.1998.274.4.C866; Berthet C, 2011, STROKE, V42, P799, DOI 10.1161/STROKEAHA.110.603647; Bitoun M, 2000, GLIA, V32, P165, DOI 10.1002/1098-1136(200011)32:2<165::AID-GLIA60>3.0.CO;2-2; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Brand A, 1997, CELL MOL BIOL, V43, P645; Brand A, 1998, J NEUROCHEM, V71, P827; Bryan RM, 2006, AM J PHYSL HEART CIR; Bulley S, 2012, J PHYSL; Butcher K, 2008, STROKE, V39, P75, DOI 10.1161/STROKEAHA.107.490524; Cardin V, 1999, J NEUROSCI RES, V56, P659; Cho TH, 2009, STROKE, V40, P3400, DOI 10.1161/STROKEAHA.109.563064; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Doubal FN, 2011, J NEUROL NEUROSUR PS, V82, P540, DOI 10.1136/jnnp.2009.190298; Fink M, 1998, EMBO J, V17, P3297, DOI 10.1093/emboj/17.12.3297; Fisher SK, 2002, J NEUROCHEM, V82, P736, DOI 10.1046/j.1471-4159.2002.01041.x; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Hayward NMEA, 2011, J CEREBR BLOOD F MET, V31, P1119, DOI 10.1038/jcbfm.2010.202; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Hoehn M, 2001, J MAGN RESON IMAGING, V14, P491, DOI 10.1002/jmri.1213; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Huang CS, 1997, J PHARMACOL EXP THER, V282, P1280; Inoue K, 1996, NEUROREPORT, V7, P1195, DOI 10.1097/00001756-199604260-00020; Judge Susan I V, 2007, Recent Pat CNS Drug Discov, V2, P200, DOI 10.2174/157488907782411765; Kang JX, 1996, P NATL ACAD SCI USA, V93, P3542, DOI 10.1073/pnas.93.8.3542; Kim Y, 2001, PFLUG ARCH EUR J PHY, V442, P64, DOI 10.1007/s004240000496; Kimelberg HK, 2005, GLIA, V50, P389, DOI 10.1002/glia.20174; Lambert IH, 2008, ACTA PHYSIOL, V194, P255, DOI 10.1111/j.1748-1716.2008.01910.x; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Leon R, 2009, J NEUROSCI RES, V87, P1185, DOI 10.1002/jnr.21926; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Lesage F, 2000, FEBS LETT, V471, P137, DOI 10.1016/S0014-5793(00)01388-0; Lesage F, 2003, NEUROPHARMACOLOGY, V44, P1, DOI 10.1016/S0028-3908(02)00339-8; Liu KF, 2001, STROKE, V32, P1897, DOI 10.1161/01.STR.32.8.1897; Lopes CMB, 2005, J PHYSIOL-LONDON, V564, P117, DOI 10.1113/jphysiol.2004.081935; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Maingret F, 1999, J BIOL CHEM, V274, P1381, DOI 10.1074/jbc.274.3.1381; Mathie A, 2007, CURR OPIN INVEST DR, V8, P555; Mathie A, 2007, J PHYSIOL-LONDON, V578, P377, DOI 10.1113/jphysiol.2006.121582; McNaughton NCL, 2000, NEUROPHARMACOLOGY, V39, P1247, DOI 10.1016/S0028-3908(99)00201-4; Meadows HJ, 2001, BRAIN RES, V892, P94, DOI 10.1016/S0006-8993(00)03239-X; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Molchanova SM, 2006, BRAIN RES, V1099, P64, DOI 10.1016/j.brainres.2006.04.105; MORAN J, 1994, NEUROCHEM RES, V19, P415, DOI 10.1007/BF00967318; Nicoli F, 2003, STROKE, V34, pE82, DOI 10.1161/01.STR.0000078659.43423.0A; Noel J, 2009, EMBO J, V28, P1308, DOI 10.1038/emboj.2009.57; Olson JE, 2006, J NEUROCHEM, V96, P1375, DOI 10.1111/j.1471-4159.2006.03652.x; Pasler D, 2007, BRAIN RES, V1173, P14, DOI 10.1016/j.brainres.2007.07.013; Parsons MW, 2000, NEUROLOGY, V55, P498, DOI 10.1212/WNL.55.4.498; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Penet MF, 2006, BEHAV GENET, V36, P732, DOI 10.1007/s10519-006-9077-4; Penet MF, 2005, J NEUROSCI, V25, P7352, DOI 10.1523/JNEUROSCI.1002-05.2005; Pow DV, 2002, GLIA, V37, P153, DOI 10.1002/glia.10026; Ren L, 2010, NEUROL RES, V32, P763, DOI 10.1179/016164109X12445616596481; Reyes R, 2000, NEUROSCIENCE, V95, P893; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rumpel H, 2003, J MAGN RESON IMAGING, V17, P11, DOI 10.1002/jmri.10233; Sabbadini M, 2009, J MOL BIOL, V385, P1331, DOI 10.1016/j.jmb.2008.11.048; Saransaari P, 1999, NEUROSCIENCE, V94, P949, DOI 10.1016/S0306-4522(99)00384-X; Saransaari P, 2008, AMINO ACIDS, V34, P429, DOI 10.1007/s00726-007-0553-9; Saransaari P, 2000, AMINO ACIDS, V19, P509, DOI 10.1007/s007260070003; SAUNDERS DE, 1995, STROKE, V26, P1007, DOI 10.1161/01.STR.26.6.1007; Schaffer S, 2000, AMINO ACIDS, V19, P527, DOI 10.1007/s007260070004; SCHURR A, 1987, LIFE SCI, V40, P2059, DOI 10.1016/0024-3205(87)90098-1; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; SMITH SE, 1993, NEUROREPORT, V4, P1339, DOI 10.1097/00001756-199309150-00013; Stefani A, 1997, EXP NEUROL, V147, P115, DOI 10.1006/exnr.1997.6554; Strange K, 2004, ADV PHYSIOL EDUC, V28, P155, DOI 10.1152/advan.00034.2004; Sun M, 2008, CELL MOL NEUROBIOL, V28, P71, DOI 10.1007/s10571-007-9250-1; Sun M, 2011, AMINO ACIDS, V40, P1419, DOI 10.1007/s00726-010-0751-8; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Taranukhin AG, 2008, AMINO ACIDS, V34, P169, DOI 10.1007/s00726-006-0405-z; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Viola A, 2011, AM J NEURORADIOL, V32, P1451, DOI 10.3174/ajnr.A2555; Viola A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000157; Vitvitsky V, 2011, J BIOL CHEM, V286, P32002, DOI 10.1074/jbc.M111.253344; Wang GH, 2007, NEUROPHARMACOLOGY, V52, P1199, DOI 10.1016/j.neuropharm.2006.10.022; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Yamashita T, 1996, J CEREBR BLOOD F MET, V16, P1203, DOI 10.1097/00004647-199611000-00014; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhou F, 2006, ADV EXP MED BIOL, V583, P353	89	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53266	10.1371/journal.pone.0053266	http://dx.doi.org/10.1371/journal.pone.0053266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285272	Green Submitted, Green Published, gold			2022-12-25	WOS:000313051500126
J	Liu, C; Xu, DW; Han, HY; Fan, YD; Schain, F; Xu, ZH; Claesson, HE; Bjorkholm, M; Sjoberg, J				Liu, Cheng; Xu, Dawei; Han, Hongya; Fan, Yidong; Schain, Frida; Xu, Zhonghua; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan			Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/Demethylation	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; METHYLTRANSFERASE SMYD3; HODGKIN LYMPHOMA; PROSTATE-CANCER; UP-REGULATION; TUMOR-GROWTH; GENE; METHYLATION; BINDING; CELLS	15-Lipoxygenase-1 (15-LOX-1) oxidizes polyunsaturated fatty acids to a rich spectrum of biologically active metabolites and is implicated in physiological membrane remodelling, inflammation and apoptosis. Its deregulation is involved in the pathogenesis of diverse cancer and immune diseases. Recent experimental evidence reveals that dynamic histone methylation/demethylation mediated by histone methyltransferases and demethylases plays a critical role in regulation of chromatin remodelling and gene expression. In the present study, we compared the histone 3 lysine 4 (H3-K4) methylation status of the 15-LOX-1 promoter region of the two Hodgkin lymphoma (HL) cell lines L1236 and L428 with abundant and undetectable 15-LOX-1 expression, respectively. We identified a potential role of H3-K4 methylation in positive regulation of 15-LOX-1 transcription. Furthermore, we found that histone methyltransferase SMYD3 inhibition reduced 15-LOX-1 expression by decreasing promoter activity in L1236 cells. SMYD3 knock down in these cells abolished di-/trimethylation of H3-K4, attenuated the occupancy by the transactivator STAT6, and led to diminished histone H3 acetylation at the 15-LOX-1 promoter. In contrast, inhibition of SMCX, a JmjC-domain-containing H3-K4 tri-demethylase, upregulated 15-LOX-1 expression through induction of H3-K4 trimethylation, histone acetylation and STAT6 recruitment at the 15-LOX-1 promoter in L428 cells. In addition, we observed strong SMYD3 expression in the prostate cancer cell line LNCaP and its inhibition led to decreased 15-LOX-1 expression. Taken together, our data suggest that regulation of histone methylation/demethylation at the 15-LOX-1 promoter is important in 15-LOX-1 expression.	[Liu, Cheng; Xu, Dawei; Han, Hongya; Schain, Frida; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Univ, Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Liu, Cheng; Xu, Dawei; Han, Hongya; Schain, Frida; Claesson, Hans-Erik; Bjorkholm, Magnus; Sjoberg, Jan] Karolinska Inst, Stockholm, Sweden; [Liu, Cheng; Fan, Yidong; Xu, Zhonghua] Shandong Univ, Qilu Hosp, Dept Urol, Jinan 250100, Peoples R China	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Shandong University	Liu, C (corresponding author), Karolinska Univ, Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden.	Cheng.Liu@ki.se		Claesson, Hans-Erik/0000-0002-1960-6542; Xu, Dawei/0000-0003-3141-4524	Swedish Cancer Society; Stockholm County Council; Karolinska Institutet; Biolipox AB; National Natural Science Foundationg of China [30901497]; Shandong Province Natural Science Foundation [Y2003C08]; Promotive research fund for excellent young and middle-aged scientists of Shandong Province [BS2010YY027]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Biolipox AB; National Natural Science Foundationg of China; Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Promotive research fund for excellent young and middle-aged scientists of Shandong Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The study was supported by grants from the Swedish Cancer Society, Stockholm County Council, Karolinska Institutet, an unrestricted grant from Biolipox AB, National Natural Science Foundationg of China (30901497); the Shandong Province Natural Science Foundation (Y2003C08); Promotive research fund for excellent young and middle-aged scientists of Shandong Province (BS2010YY027); the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, BBA-MOL CELL BIOL L, V1761, P1498, DOI 10.1016/j.bbalip.2006.09.007; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Chen BL, 2006, J BIOL CHEM, V281, P18296, DOI 10.1074/jbc.M603484200; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; Cock-Rada AM, 2012, CANCER RES, V72, P810, DOI 10.1158/0008-5472.CAN-11-1052; Conrad DJ, 2000, AM J RESP CELL MOL, V22, P226, DOI 10.1165/ajrcmb.22.2.3786; Das S, 2007, PROSTATE, V67, P1550, DOI 10.1002/pros.20640; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Ezaki J, 2011, IUBMB LIFE, V63, P1001, DOI 10.1002/iub.537; Ge Z, 2006, MOL CELL BIOL, V26, P230, DOI 10.1128/MCB.26.1.230-237.2006; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kamitani H, 2001, CARCINOGENESIS, V22, P187, DOI 10.1093/carcin/22.1.187; Kelavkar U, 1998, MOL BIOL REP, V25, P173, DOI 10.1023/A:1006813009006; Kelavkar UP, 2007, PROSTAG OTH LIPID M, V82, P185, DOI 10.1016/j.prostaglandins.2006.05.015; Kelavkar Uddhav, 2006, J Carcinog, V5, P9, DOI 10.1186/1477-3163-5-9; Kelavkar UP, 2009, NEOPLASIA, V11, P692, DOI 10.1593/neo.09334; Kim H, 2009, J BIOL CHEM, V284, P19867, DOI 10.1074/jbc.M109.021485; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Liu C, 2004, EXP CELL RES, V297, P61, DOI 10.1016/j.yexcr.2004.02.014; Liu C, 2007, CANCER RES, V67, P2626, DOI 10.1158/0008-5472.CAN-06-4126; Liu C, 2012, EXP CELL RES, V318, P169, DOI 10.1016/j.yexcr.2011.10.017; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Quina AS, 2006, BIOCHEM PHARMACOL, V72, P1563, DOI 10.1016/j.bcp.2006.06.016; Rong SX, 2012, J LIPID RES, V53, P686, DOI 10.1194/jlr.M022723; Schewe T, 2002, BIOL CHEM, V383, P365, DOI 10.1515/BC.2002.041; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Silva FP, 2007, ONCOGENE; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; van Leyen K, 1998, NATURE, V395, P392, DOI 10.1038/26500; Wittwer J, 2006, HUM MUTAT, V27, P78, DOI 10.1002/humu.20273; Wu SH, 2009, AM J PATHOL, V174, P115, DOI 10.2353/ajpath.2009.080671; Xu DW, 1998, BRIT J HAEMATOL, V102, P1367, DOI 10.1046/j.1365-2141.1998.00969.x; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zuo X, 2008, FASEB J; Zuo XS, 2008, J BIOL CHEM, V283, P31341, DOI 10.1074/jbc.M803729200; Zuo XS, 2012, J NATL CANCER I, V104, P709, DOI 10.1093/jnci/djs187	41	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52703	10.1371/journal.pone.0052703	http://dx.doi.org/10.1371/journal.pone.0052703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285160	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500050
J	Peng, ZH; Yang, HT; Norris, J; Chen, X; Huan, XP; Yu, RB; Wang, N; Shen, HB; Chen, F				Peng, Zhihang; Yang, Haitao; Norris, Jessie; Chen, Xin; Huan, Xiping; Yu, Rongbin; Wang, Ning; Shen, Hongbing; Chen, Feng			HIV Incidence and Predictors Associated with Retention in a Cohort of Men Who have Sex with Men in Yangzhou, Jiangsu Province, China	PLOS ONE			English	Article							HEPATITIS-B; UNITED-STATES; POSITIVE MEN; SYPHILIS; INFECTIONS; PREVALENCE; RISK; HIV/AIDS; EPIDEMIC; BEHAVIOR	Background: The study was to investigate the incidence of HIV-1 and related factors, as well as predictors associated with retention in a cohort study among men who have sex with men (MSM) in Yangzhou, Jiangsu Province, China. A carefully designed 12-month prospective cohort study was conducted. Methodology/Principal Findings: A total of 278 sero-negative MSM were recruited and followed up for 12 months starting from May, 2008. Participants were tested for HIV-1 at baseline, 6-month, and 12-month follow-up visits. Questionnaire interviews were conducted to collect information. The retention rate and HIV incidence were analyzed as functions of demographic and behavioral variables. Risk factors were identified by estimating the relative risks (RR) and respective 95% confidence intervals (CI) using a Poisson regression model, univariate and multivariate analyses and risk factors analyses. 71 (25.5%) and 45 (16.2%) of the 278 participants were retained at the 6-month and 12-month follow-up visits respectively. The incidence rates of HIV-1 were 5.65 and 6.67 per 100 person years (PY) respectively. Both having received condoms and having received lubricant were negatively associated with HIV sero-conversion at the 12 months' follow-up. Predictors associated with 12-month retention rate include Yangzhou residency (RR = 0.471, 95% CI: 0.275 similar to 0.807, P = 0.006), having received condoms (RR = 0.065, 95% CI: 0.007 similar to 0.572, P = 0.014), and having received VCTs (RR = 0.093, 95% CI: 0.010 similar to 0.818, P = 0.032). Conclusions/Significance: The incidence of HIV-1 among MSM in Yangzhou is relatively high and effective interventions are needed urgently. More attention should be focused on maintaining a higher retention rate.	[Peng, Zhihang; Chen, Xin; Yu, Rongbin; Shen, Hongbing; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Yang, Haitao; Huan, Xiping] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Norris, Jessie; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Nanjing Medical University; Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn		Chen, Feng/0000-0002-2699-7190	National S&T Major Project Foundation of China [2012ZX10001-001, 2011ZX10004-90]; National Natural Science Foundation of China [81001288]	National S&T Major Project Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National S&T Major Project Foundation of China (No. 2012ZX10001-001 and No. 2011ZX10004-902); National Natural Science Foundation of China (81001288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Yu-gang, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P981; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Bezemer D, 2010, AIDS, V24, P271, DOI 10.1097/QAD.0b013e328333ddee; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; *CDCP, 2008, HIV AIDS SURV REP CA; Centers for Disease Control and Prevention (CDC), 1989, MMWR-MORBID MORTAL W, V30, P250; Choi KH, 2003, LANCET, V361, P2125, DOI 10.1016/S0140-6736(03)13690-2; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; Li A, 2009, AIDS BEHAV, V13, P318, DOI 10.1007/s10461-008-9448-3; Li Dong-Liang, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P663; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Li Shu-ming, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P118; Li Xinxu, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P99; Liu HJ, 2009, AIDS BEHAV, V13, P652, DOI 10.1007/s10461-008-9475-0; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Magnus M, 2010, JAIDS-J ACQ IMM DEF, V53, P529, DOI 10.1097/QAI.0b013e3181b56404; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; State Council AIDS Working Committee Office and UN Theme Group on HIV/AIDS in China, 2005, JOINT ASS HIV AIDS P; State Council AIDS Working Committee Office and Un Theme Group on HIV/AIDS in China, 2008, JOINT ASS HIV AIDS P; The Ministry of Health of the People's Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, 2008, 2005 UPD HIV AIDS EP; UNAIDS, 2010, UNAIDS REP GLOB AIDS; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; van Kesteren NMC, 2007, ARCH SEX BEHAV, V36, P437, DOI 10.1007/s10508-006-9125-4; Wang Yi, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P636; Wong WCW, 2007, AIDS CARE, V19, P850, DOI 10.1080/09540120601086808; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Zhang Bei-chuan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P32	39	14	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52731	10.1371/journal.pone.0052731	http://dx.doi.org/10.1371/journal.pone.0052731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	064DQ	23285172	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500054
J	Sun, J; Zhang, X; Deng, SR; Zhang, CL; Wang, MJ; Ding, MQ; Zhao, R; Shen, X; Zhou, XY; Lu, CF; Chen, SL				Sun, Jian; Zhang, Xuan; Deng, Shurong; Zhang, Chunlan; Wang, Meijuan; Ding, Mingquan; Zhao, Rui; Shen, Xin; Zhou, Xiaoyang; Lu, Cunfu; Chen, Shaoliang			Extracellular ATP Signaling Is Mediated by H2O2 and Cytosolic Ca2+ in the Salt Response of Populus euphratica Cells	PLOS ONE			English	Article							NITRIC-OXIDE PRODUCTION; ARABIDOPSIS-THALIANA; K+/NA+ HOMEOSTASIS; NA+/H+ ANTIPORTER; NUCLEOTIDES; TRANSPORT; STRESS; TOLERANCE; SALINITY; PROTEIN	Extracellular ATP (eATP) has been implicated in mediating plant growth and antioxidant defense; however, it is largely unknown whether eATP might mediate salinity tolerance. We used confocal microscopy, a non-invasive vibrating ion-selective microelectrode, and quantitative real time PCR analysis to evaluate the physiological significance of eATP in the salt resistance of cell cultures derived from a salt-tolerant woody species, Populus euphratica. Application of NaCl (200 mM) shock induced a transient elevation in [eATP]. We investigated the effects of eATP by blocking P2 receptors with suramin and PPADS and applying an ATP trap system of hexokinase-glucose. We found that eATP regulated a wide range of cellular processes required for salt adaptation, including vacuolar Na+ compartmentation, Na+/H+ exchange across the plasma membrane (PM), K+ homeostasis, reactive oxygen species regulation, and salt-responsive expression of genes related to K+/Na+ homeostasis and PM repair. Furthermore, we found that the eATP signaling was mediated by H2O2 and cytosolic Ca2+ released in response to high salt in P. euphratica cells. We concluded that salt-induced eATP was sensed by purinoceptors in the PM, and this led to the induction of downstream signals, like H2O2 and cytosolic Ca2+, which are required for the upregulation of genes linked to K+/Na+ homeostasis and PM repair. Consequently, the viability of P. euphratica cells was maintained during a prolonged period of salt stress.	[Sun, Jian; Zhang, Xuan; Deng, Shurong; Zhang, Chunlan; Wang, Meijuan; Ding, Mingquan; Zhao, Rui; Shen, Xin; Zhou, Xiaoyang; Lu, Cunfu; Chen, Shaoliang] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Sun, Jian] Jiangsu Normal Univ, Coll Life Sci, Xuzhou, Peoples R China	Beijing Forestry University; Jiangsu Normal University	Chen, SL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	Lschen@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [JC2011-2, BLYJ200903]; Beijing Natural Science Foundation [6112017]; National Natural Science Foundation of China [31170570]; Foundation for the Supervisors of Beijing Excellent Doctoral Dissertations [YB20081002201]; Scientific Research Support Project for Teachers with Doctor's Degrees, Jiangsu Normal University, China [11XLR23]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Supervisors of Beijing Excellent Doctoral Dissertations; Scientific Research Support Project for Teachers with Doctor's Degrees, Jiangsu Normal University, China	This work was supported by the Fundamental Research Funds for the Central Universities (JC2011-2, BLYJ200903), Beijing Natural Science Foundation (6112017), National Natural Science Foundation of China (31170570), Foundation for the Supervisors of Beijing Excellent Doctoral Dissertations (YB20081002201), and the Scientific Research Support Project for Teachers with Doctor's Degrees, Jiangsu Normal University, China (No.11XLR23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batelli G, 2007, MOL CELL BIOL, V27, P7781, DOI 10.1128/MCB.00430-07; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen ZH, 2007, PLANT PHYSIOL, V145, P1714, DOI 10.1104/pp.107.110262; Chivasa S, 2005, PLANT CELL, V17, P3019, DOI 10.1105/tpc.105.036806; Chivasa S, 2009, PLANT J, V60, P436, DOI 10.1111/j.1365-313X.2009.03968.x; Chung JS, 2008, PLANT J, V53, P554, DOI 10.1111/j.1365-313X.2007.03364.x; Clark G, 2011, PLANT PHYSIOL, V156, P1740, DOI 10.1104/pp.111.174466; Clark G, 2010, PLANT PHYSIOL, V152, P1073, DOI 10.1104/pp.109.147637; Clark G, 2009, PLANT SCI, V177, P239, DOI 10.1016/j.plantsci.2009.05.004; Demidchik V, 2003, PLANT PHYSIOL, V133, P456, DOI 10.1104/pp.103.024091; Demidchik V, 2007, PLANT J, V49, P377, DOI 10.1111/j.1365-313X.2006.02971.x; Demidchik V, 2009, PLANT J, V58, P903, DOI 10.1111/j.1365-313X.2009.03830.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Foresi NP, 2007, PLANT PHYSIOL, V145, P589, DOI 10.1104/pp.107.106518; Fraile-Escanciano A, 2010, NEW PHYTOL, V188, P750, DOI 10.1111/j.1469-8137.2010.03405.x; Hao LH, 2012, MOL PLANT, V5, P852, DOI 10.1093/mp/ssr095; Jeter CR, 2004, PLANT CELL, V16, P2652, DOI 10.1105/tpc.104.023945; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Kim SH, 2009, BIOSCI BIOTECH BIOCH, V73, P1252, DOI 10.1271/bbb.80660; Kim SY, 2006, PLANT PHYSIOL, V142, P984, DOI 10.1104/pp.106.085670; Konrad KR, 2008, PLANT J, V55, P161, DOI 10.1111/j.1365-313X.2008.03498.x; Lew RR, 2000, PLANT SCI, V153, P1, DOI 10.1016/S0168-9452(99)00242-3; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Oh DH, 2009, PLANT PHYSIOL, V151, P210, DOI 10.1104/pp.109.137802; Pottosin I, 2009, FEBS LETT, V583, P921, DOI 10.1016/j.febslet.2009.02.009; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Reichler SA, 2009, J EXP BOT, V60, P2129, DOI 10.1093/jxb/erp091; Roux SJ, 2007, TRENDS PLANT SCI, V12, P522, DOI 10.1016/j.tplants.2007.09.003; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Shabala S, 2000, ANN BOT-LONDON, V85, P681, DOI 10.1006/anbo.2000.1131; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Silva P, 2010, J PLANT GROWTH REGUL, V29, P23, DOI 10.1007/s00344-009-9110-y; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Sueldo DJ, 2010, NEW PHYTOL, V185, P909, DOI 10.1111/j.1469-8137.2009.03165.x; Sun J, 2012, PLANT CELL ENVIRON, V35, P893, DOI 10.1111/j.1365-3040.2011.02461.x; Sun JA, 2010, PLANT CELL TISS ORG, V103, P205, DOI 10.1007/s11240-010-9768-7; Sun J, 2010, PLANT CELL ENVIRON, V33, P943, DOI 10.1111/j.1365-3040.2010.02118.x; Sun J, 2009, TREE PHYSIOL, V29, P1175, DOI 10.1093/treephys/tpp048; Sun J, 2009, PLANT PHYSIOL, V149, P1141, DOI 10.1104/pp.108.129494; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; Tang RJ, 2010, PLANT MOL BIOL, V74, P367, DOI 10.1007/s11103-010-9680-x; Tang WQ, 2003, PLANT PHYSIOL, V131, P147, DOI 10.1104/pp.013672; Tracy FE, 2008, PLANT CELL ENVIRON, V31, P1063, DOI 10.1111/j.1365-3040.2008.01817.x; Vranova E, 2002, J EXP BOT, V53, P1227, DOI 10.1093/jexbot/53.372.1227; Wang RG, 2008, TREE PHYSIOL, V28, P947, DOI 10.1093/treephys/28.6.947; Wang RG, 2007, TREES-STRUCT FUNCT, V21, P581, DOI 10.1007/s00468-007-0154-y; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679; Yu LJ, 2010, NEW PHYTOL, V188, P762, DOI 10.1111/j.1469-8137.2010.03422.x; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang F, 2007, PLANT CELL ENVIRON, V30, P775, DOI 10.1111/j.1365-3040.2007.01667.x; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	57	22	36	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53136	10.1371/journal.pone.0053136	http://dx.doi.org/10.1371/journal.pone.0053136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285259	Green Published, gold, Green Submitted			2022-12-25	WOS:000313051500111
J	Xue, T; Yuan, K; Zhao, L; Yu, DH; Zhao, LM; Dong, T; Cheng, P; von Deneen, KM; Qin, W; Tian, J				Xue, Ting; Yuan, Kai; Zhao, Ling; Yu, Dahua; Zhao, Limei; Dong, Tao; Cheng, Ping; von Deneen, Karen M.; Qin, Wei; Tian, Jie			Intrinsic Brain Network Abnormalities in Migraines without Aura Revealed in Resting-State fMRI	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; PAIN-MATRIX; BASE-LINE; CORTEX; PERCEPTION; POPULATION; FIBROMYALGIA; DISTURBANCES	Background: Previous studies have defined low-frequency, spatially consistent intrinsic connectivity networks (ICN) in resting functional magnetic resonance imaging (fMRI) data which reflect functional interactions among distinct brain areas. We sought to explore whether and how repeated migraine attacks influence intrinsic brain connectivity, as well as how activity in these networks correlates with clinical indicators of migraine. Methods/Principal Findings: Resting-state fMRI data in twenty-three patients with migraines without aura (MwoA) and 23 age- and gender-matched healthy controls (HC) were analyzed using independent component analysis (ICA), in combination with a "dual-regression'' technique to identify the group differences of three important pain-related networks [default mode network (DMN), bilateral central executive network (CEN), salience network (SN)] between the MwoA patients and HC. Compared with the HC, MwoA patients showed aberrant intrinsic connectivity within the bilateral CEN and SN, and greater connectivity between both the DMN and right CEN (rCEN) and the insula cortex - a critical region involving in pain processing. Furthermore, greater connectivity between both the DMN and rCEN and the insula correlated with duration of migraine. Conclusions: Our findings may provide new insights into the characterization of migraine as a condition affecting brain activity in intrinsic connectivity networks. Moreover, the abnormalities may be the consequence of a persistent central neural system dysfunction, reflecting cumulative brain insults due to frequent ongoing migraine attacks.	[Xue, Ting; Yuan, Kai; Yu, Dahua; Zhao, Limei; Dong, Tao; Cheng, Ping; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Tian, Jie] Chinese Acad Sci, Intelligent Med Res Ctr, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Inner Mongolia University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Life, PAM/M-9552-2013; Yuan, Kai/I-4150-2016; 秦, 伟/J-9770-2016; Yu, Dahua/N-7242-2013; Tian, Jie/H-1190-2011; Yuan, Kai/M-9403-2013; tian, jie/M-6336-2013	Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Yu, Dahua/0000-0001-7850-7512; Tian, Jie/0000-0003-0498-0432; 	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171, 30901900]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Inner Mongolia [2012MS0908]; Innovation Fund Project of Inner Mongolia University of Science and Technology [2010NC030, 2010NC037]	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Inner Mongolia; Innovation Fund Project of Inner Mongolia University of Science and Technology	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702, 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 60901064, 30873462, 81000640, 81000641, 81071217, 81101036, 81101108, 31150110171, 30901900, the Fundamental Research Funds for the Central Universities, the Natural Science Foundation of Inner Mongolia under Grant No. 2012MS0908 and the Innovation Fund Project of Inner Mongolia University of Science and Technology Nos. 2010NC030, 2010NC037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Aurora SK, 2007, CEPHALALGIA, V27, P1442, DOI 10.1111/j.1468-2982.2007.01502.x; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boly M, 2007, P NATL ACAD SCI USA, V104, P12187, DOI 10.1073/pnas.0611404104; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Calandre EP, 2002, CEPHALALGIA, V22, P291, DOI 10.1046/j.1468-2982.2002.00370.x; Cauda F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041929; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Chiapparini L, 2010, NEUROL SCI, V31, P19, DOI 10.1007/s10072-010-0266-9; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fox MD, 2006, NAT NEUROSCI, V9, P23, DOI 10.1038/nn1616; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Jin C, 2012, NMR BIOMEDI IN PRESS; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Le Pira F, 2000, CEPHALALGIA, V20, P475, DOI 10.1046/j.1468-2982.2000.00074.x; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lipton RB, 2000, NEUROLOGY, V55, P629, DOI 10.1212/WNL.55.5.629; Lorenz J, 1997, PAIN, V73, P369, DOI 10.1016/S0304-3959(97)00123-1; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Mainero C, 2011, ANN NEUROL, V70, P838, DOI 10.1002/ana.22537; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyer JS, 2000, ANN NEUROL, V48, P430; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otti A, 2010, NEUROSCIENCE, V169, P143, DOI 10.1016/j.neuroscience.2010.04.072; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Palaniyappan L, 2012, J PSYCHIATR NEUROSCI, V37, P17, DOI 10.1503/jpn.100176; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Qi RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037400; Raichle ME, 2005, J COMP NEUROL, V493, P167, DOI 10.1002/cne.20752; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rocca MA, 2010, CEPHALALGIA, V30, P1383, DOI 10.1177/0333102410365164; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Russo A, 2012, J NEUROL, V259, P1903, DOI 10.1007/s00415-012-6438-1; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seifert F, 2012, HUMAN BRAIN MAPPING; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Terwindt GM, 2000, NEUROLOGY, V55, P624, DOI 10.1212/WNL.55.5.624; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Uddin L. Q., 2010, FRONTIERS SYSTEMS NE, V4; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Veldhuijzen DS, 2006, PAIN, V121, P60, DOI 10.1016/j.pain.2005.12.004; Wager TD, 2009, NEUROIMAGE, V45, pS210, DOI 10.1016/j.neuroimage.2008.10.061; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/nmeth.1635, 10.1038/NMETH.1635]; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033	79	125	129	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52927	10.1371/journal.pone.0052927	http://dx.doi.org/10.1371/journal.pone.0052927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285228	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500083
J	Zhang, HN; Wu, SW; Yang, YH; Tabashnik, BE; Wu, YD				Zhang, Haonan; Wu, Shuwen; Yang, Yihua; Tabashnik, Bruce E.; Wu, Yidong			Non-Recessive Bt Toxin Resistance Conferred by an Intracellular Cadherin Mutation in Field-Selected Populations of Cotton Bollworm	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; HELICOVERPA-ARMIGERA HUBNER; CRY1AC DELTA-ENDOTOXIN; INSECT RESISTANCE; DIAMONDBACK MOTH; PINK-BOLLWORM; HELIOTHIS-VIRESCENS; PECTINOPHORA-GOSSYPIELLA; EVOLVED RESISTANCE; BOMBYX-MORI	Transgenic crops producing Bacillus thuringiensis (Bt) toxins have been planted widely to control insect pests, yet evolution of resistance by the pests can reduce the benefits of this approach. Recessive mutations in the extracellular domain of toxin-binding cadherin proteins that confer resistance to Bt toxin Cry1Ac by disrupting toxin binding have been reported previously in three major lepidopteran pests, including the cotton bollworm, Helicoverpa armigera. Here we report a novel allele from cotton bollworm with a deletion in the intracellular domain of cadherin that is genetically linked with non-recessive resistance to Cry1Ac. We discovered this allele in each of three field-selected populations we screened from northern China where Bt cotton producing Cry1Ac has been grown intensively. We expressed four types of cadherin alleles in heterologous cell cultures: susceptible, resistant with the intracellular domain mutation, and two complementary chimeric alleles with and without the mutation. Cells transfected with each of the four cadherin alleles bound Cry1Ac and were killed by Cry1Ac. However, relative to cells transfected with either the susceptible allele or the chimeric allele lacking the intracellular domain mutation, cells transfected with the resistant allele or the chimeric allele containing the intracellular domain mutation were less susceptible to Cry1Ac. These results suggest that the intracellular domain of cadherin is involved in post-binding events that affect toxicity of Cry1Ac. This evidence is consistent with the vital role of the intracellular region of cadherin proposed by the cell signaling model of the mode of action of Bt toxins. Considered together with previously reported data, the results suggest that both pore formation and cell signaling pathways contribute to the efficacy of Bt toxins.	[Zhang, Haonan; Wu, Shuwen; Yang, Yihua; Wu, Yidong] Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Nanjing Agricultural University; University of Arizona	Wu, YD (corresponding author), Nanjing Agr Univ, Key Lab Integrated Management Crop Dis & Pests, Minist Educ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	wyd@njau.edu.cn	ZHANG, HAONAN/N-6395-2018; Wu, Yidong/E-9720-2012; Zhang, Haonan/J-2245-2019	ZHANG, HAONAN/0000-0003-1196-2750; Wu, Yidong/0000-0003-3456-3373; Zhang, Haonan/0000-0003-1196-2750	Ministry of Agriculture of China [2011ZX08012-004]; National Natural Science Foundation of China [31272382]; 111 program [B07030]; U.S. Department of Agriculture-Agriculture and Food Research Initiative [2008-35302-0390]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 program(Ministry of Education, China - 111 Project); U.S. Department of Agriculture-Agriculture and Food Research Initiative	This work was funded by research grants from the Ministry of Agriculture of China (2011ZX08012-004), the National Natural Science Foundation of China (31272382), the 111 program (B07030), and the U.S. Department of Agriculture-Agriculture and Food Research Initiative (2008-35302-0390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2003, J ECON ENTOMOL, V96, P1290, DOI 10.1603/0022-0493-96.4.1290; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gonzalez-Cabrera J, 2003, INSECT BIOCHEM MOLEC, V33, P929, DOI 10.1016/S0965-1748(03)00099-7; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Heckel DG, 1999, P NATL ACAD SCI USA, V96, P8373, DOI 10.1073/pnas.96.15.8373; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Kranthi KR, 2006, CROP PROT, V25, P119, DOI 10.1016/j.cropro.2005.03.011; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu CX, 2010, J INSECT PHYSIOL, V56, P718, DOI 10.1016/j.jinsphys.2009.12.012; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Nagamatsu Y, 1998, BIOSCI BIOTECH BIOCH, V62, P718, DOI 10.1271/bbb.62.718; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 1998, PHILOS T R SOC B, V353, P1751, DOI 10.1098/rstb.1998.0327; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Tang Q., 2007, DPS DATA PROCESSING; Tiewsiri K, 2011, P NATL ACAD SCI USA, V108, P14037, DOI 10.1073/pnas.1102555108; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu Y, 2009, J APPL ENTOMOL, V133, P375, DOI 10.1111/j.1439-0418.2008.01368.x; Xu XJ, 2008, J INVERTEBR PATHOL, V97, P27, DOI 10.1016/j.jip.2007.04.009; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Yang YH, 2009, B ENTOMOL RES, V99, P175, DOI 10.1017/S0007485308006226; Yang YJ, 2007, APPL ENVIRON MICROB, V73, P6939, DOI 10.1128/AEM.01703-07; Yang YJ, 2006, INSECT BIOCHEM MOLEC, V36, P735, DOI 10.1016/j.ibmb.2006.06.003; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001	54	50	53	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e53418	10.1371/journal.pone.0053418	http://dx.doi.org/10.1371/journal.pone.0053418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23285292	gold, Green Published, Green Submitted			2022-12-25	WOS:000313051500147
J	Bogdanov, AM; Kudryavtseva, EI; Lukyanov, KA				Bogdanov, Alexey M.; Kudryavtseva, Elena I.; Lukyanov, Konstantin A.			Anti-Fading Media for Live Cell GFP Imaging	PLOS ONE			English	Article							FLUORESCENT PROTEINS; LIVING CELLS	Photostability is one of the most important characteristic of a dye for fluorescence microscopy. Recently we demonstrated that vitamins present in imaging media dramatically accelerate photobleaching of Enhanced Green Fluorescent Protein (EGFP) and many other green fluorescent and photoactivatable proteins. Here we tested all vitamins of commonly used media (such as Dulbecco's Modified Eagle Medium, DMEM) one-by-one and found that only two vitamins, riboflavin and pyridoxal, decrease photostability of EGFP. Thus, DMEM without riboflavin and pyridoxal can be used as an imaging medium, which ensures high photostability of GFPs at the expense of minimal biochemical disturbance. Then, we tested some antioxidants and found that a plant flavonoid rutin greatly enhances photostability of EGFP during live cell microscopy. In complete DMEM, rutin increased EGFP photostability up to the level of vitamin-depleted DMEM. Moreover, being added to vitamin-depleted DMEM, rutin was able to further suppress EGFP photobleaching. Potentially, new medium formulations can be widely used for fluorescence microscopy of GFP-expressing cells and model multicellular organisms in a variety of imaging applications, where photostability represents a challenge.	[Bogdanov, Alexey M.; Kudryavtseva, Elena I.; Lukyanov, Konstantin A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Lukyanov, KA (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	kluk@ibch.ru	Bogdanov, Alexey/Q-7926-2019; Lukyanov, Konstantin A/D-4030-2013; Bogdanov, Alexey M/S-2759-2018	Bogdanov, Alexey/0000-0002-5346-789X; Lukyanov, Konstantin A/0000-0001-9845-2088; Bogdanov, Alexey M/0000-0002-5346-789X	Dinasty Foundation; Russian Foundation for Basic Research [11-04-01861a]	Dinasty Foundation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Dinasty Foundation and Russian Foundation for Basic Research grant 11-04-01861a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bhandary B, 2012, ARCH PHARM RES, V35, P1091, DOI 10.1007/s12272-012-0617-6; Bogdanov AM, 2009, NAT METHODS, V6, P859, DOI 10.1038/nmeth1209-859; Bogdanov AM, 2009, NAT CHEM BIOL, V5, P459, DOI 10.1038/nchembio.174; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X; Huvaere K, 2012, J AGR FOOD CHEM, V60, P9261, DOI 10.1021/jf301823h; Kohl T, 2005, ADV BIOCHEM ENG BIOT, V95, P107; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; MIKHAILOV AV, 1995, CELL MOTIL CYTOSKEL, V32, P173, DOI 10.1002/cm.970320303	11	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e53004	10.1371/journal.pone.0053004	http://dx.doi.org/10.1371/journal.pone.0053004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285248	Green Submitted, gold, Green Published			2022-12-25	WOS:000313158800112
J	Bragonzi, A; Farulla, I; Paroni, M; Twomey, KB; Pirone, L; Lore, NI; Bianconi, I; Dalmastri, C; Ryan, RP; Bevivino, A				Bragonzi, Alessandra; Farulla, Ilaria; Paroni, Moira; Twomey, Kate B.; Pirone, Luisa; Lore, Nicola Ivan; Bianconi, Irene; Dalmastri, Claudia; Ryan, Robert P.; Bevivino, Annamaria			Modelling Co-Infection of the Cystic Fibrosis Lung by Pseudomonas aeruginosa and Burkholderia cenocepacia Reveals Influences on Biofilm Formation and Host Response	PLOS ONE			English	Article							CEPACIA; INFECTIONS; APOPTOSIS; VIRULENCE; DYNAMICS; STRAINS	The Gram-negative bacteria Pseudomonas aeruginosa and Burkholderia cenocepacia are opportunistic human pathogens that are responsible for severe nosocomial infections in immunocompromised patients and those suffering from cystic fibrosis (CF). These two bacteria have been shown to form biofilms in the airways of CF patients that make such infections more difficult to treat. Only recently have scientists begun to appreciate the complicated interplay between microorganisms during polymicrobial infection of the CF airway and the implications they may have for disease prognosis and response to therapy. To gain insight into the possible role that interaction between strains of P. aeruginosa and B. cenocepacia may play during infection, we characterised co-inoculations of in vivo and in vitro infection models. Co-inoculations were examined in an in vitro biofilm model and in a murine model of chronic infection. Assessment of biofilm formation showed that B. cenocepacia positively influenced P. aeruginosa biofilm development by increasing biomass. Interestingly, co-infection experiments in the mouse model revealed that P. aeruginosa did not change its ability to establish chronic infection in the presence of B. cenocepacia but co-infection did appear to increase host inflammatory response. Taken together, these results indicate that the co-infection of P. aeruginosa and B. cenocepacia leads to increased biofilm formation and increased host inflammatory response in the mouse model of chronic infection. These observations suggest that alteration of bacterial behavior due to interspecies interactions may be important for disease progression and persistent infection.	[Bragonzi, Alessandra; Paroni, Moira; Lore, Nicola Ivan; Bianconi, Irene] Ist Sci San Raffaele, Infect & Cyst Fibrosis Unit, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [Farulla, Ilaria; Pirone, Luisa; Dalmastri, Claudia; Bevivino, Annamaria] ENEA Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy; [Twomey, Kate B.; Ryan, Robert P.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BioSci Inst, Cork, Ireland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Italian National Agency New Technical Energy & Sustainable Economics Development; University College Cork	Bevivino, A (corresponding author), ENEA Casaccia Res Ctr, Tech Unit Sustainable Dev & Innovat Agroind Syst, Rome, Italy.	annamaria.bevivino@enea.it	Bragonzi, Alessandra/AAC-6751-2022; Lorè, Nicola Ivan/K-9285-2016; Paroni, Moira/K-6470-2016; Dalmastri, Claudia/AAD-1627-2021; Bevivino, Annamaria/F-4060-2015	Lorè, Nicola Ivan/0000-0001-9159-1632; Paroni, Moira/0000-0001-8199-3128; Bevivino, Annamaria/0000-0003-4277-7048; Bianconi, Irene/0000-0002-5923-4296; Ryan, Rober/0000-0002-7353-0913; Bragonzi, Alessandra/0000-0002-5808-7669	Italian Cystic Fibrosis Research Foundation (FCC) [7/2006, 7/2008]; Science Foundation of Ireland [SFI 09/SIRG/B1654]	Italian Cystic Fibrosis Research Foundation (FCC); Science Foundation of Ireland(Science Foundation Ireland)	This research was supported by grants from the Italian Cystic Fibrosis Research Foundation (FCC) (http://www.fibrosicisticaricerca.it/) to A. Bevivino (project FFC #7/2006, with the contribution of "Delegazione FFC di Latina"; project FFC #7/2008, with the contribution of "Associazione Siciliana Fibrosi Cistica"). K. B. T. and R. P. R. were supported in part by grants awarded by the Science Foundation of Ireland (SFI 09/SIRG/B1654 to R. P. R.). The funders had no role in study design, data collection, analysis and interpretation of the data, decision to publish, or preparation of the manuscript.	Al-Bakri AG, 2004, J APPL MICROBIOL, V96, P455, DOI 10.1111/j.1365-2672.2004.02201.x; Bevivino A, 2012, MICROBIOL-SGM, V158, P1325, DOI 10.1099/mic.0.056986-0; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Bragonzi A, 2010, INT J MED MICROBIOL, V300, P584, DOI 10.1016/j.ijmm.2010.08.012; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Coenye T, 2010, FUTURE MICROBIOL, V5, P1087, DOI 10.2217/FMB.10.68; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Eberl L, 2004, INT J MED MICROBIOL, V294, P123, DOI 10.1016/j.ijmm.2004.06.022; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Hutchison ML, 1998, INFECT IMMUN, V66, P2033, DOI 10.1128/IAI.66.5.2033-2039.1998; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Kosai K, 2011, JPN J INFECT DIS, V64, P451; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lopes SP, 2012, INT J ANTIMICROB AG, V40, P260, DOI 10.1016/j.ijantimicag.2012.04.020; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; McCloskey M, 2001, IRISH J MED SCI, V170, P28, DOI 10.1007/BF03167716; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Paroni M, 2013, J INFECT DIS, V208, P130, DOI 10.1093/infdis/jis636; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Rajan Sujatha, 2002, Semin Respir Infect, V17, P47, DOI 10.1053/srin.2002.31690; Rogers GB, 2010, TRENDS MICROBIOL, V18, P357, DOI 10.1016/j.tim.2010.04.005; Rogers GB, 2009, J MED MICROBIOL, V58, P1401, DOI 10.1099/jmm.0.013334-0; Ryan RP, 2008, MOL MICROBIOL, V68, P75, DOI 10.1111/j.1365-2958.2008.06132.x; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Sibley CD, 2006, FUTURE MICROBIOL, V1, P53, DOI 10.2217/17460913.1.1.53; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Stoicov C, 2004, J IMMUNOL, V173, P3329, DOI 10.4049/jimmunol.173.5.3329; Stressmann FA, 2011, J CLIN MICROBIOL, V49, P281, DOI 10.1128/JCM.01650-10; Tomlin KL, 2001, CAN J MICROBIOL, V47, P949, DOI 10.1139/cjm-47-10-949; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; WHITEFORD ML, 1995, THORAX, V50, P1194, DOI 10.1136/thx.50.11.1194; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	46	66	68	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52330	10.1371/journal.pone.0052330	http://dx.doi.org/10.1371/journal.pone.0052330			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284990	gold, Green Published, Green Submitted			2022-12-25	WOS:000313158800049
J	Gambardella, C; Pignatelli, A; Belluzzi, O				Gambardella, Cristina; Pignatelli, Angela; Belluzzi, Ottorino			The h-Current in the Substantia Nigra pars Compacta Neurons: A Re-examination	PLOS ONE			English	Article							ACTIVATED CATION CURRENT; CURRENT I-H; VENTRAL TEGMENTAL AREA; VOLTAGE-CLAMP ANALYSIS; PACE-MAKER CURRENT; DOPAMINERGIC-NEURONS; SINOATRIAL NODE; MIDBRAIN DOPAMINE; PACEMAKER CHANNELS; INWARD CURRENT	The properties of the hyperpolarization-activated cation current (I-h) were investigated in rat substantia nigra - pars compacta (SNc) principal neurons using patch-clamp recordings in thin slices. A reliable identification of single dopaminergic neurons was made possible by the use of a transgenic line of mice expressing eGFP under the tyrosine hydroxylase promoter. The effects of temperature and different protocols on the I-h kinetics showed that, at 37 degrees C and minimizing the disturbance of the intracellular milieu with perforated patch, this current actually activates at potentials more positive than what is generally indicated, with a half-activation potential of -77.05 mV and with a significant level of opening already at rest, thereby substantially contributing to the control of membrane potential, and ultimately playing a relevant function in the regulation of the cell excitability. The implications of the known influence of intracellular cAMP levels on I-h amplitude and kinetics were examined. The direct application of neurotransmitters (DA, 5-HT and noradrenaline) physiologically released onto SNc neurons and known to act on metabotropic receptors coupled to the cAMP pathway modify the I-h amplitude. Here, we show that direct activation of dopaminergic and of 5-HT receptors results in I-h inhibition of SNc DA cells, whereas noradrenaline has the opposite effect. Together, these data suggest that the modulation of I-h by endogenously released neurotransmitters acting on metabotropic receptors -mainly but not exclusively linked to the cAMP pathway-could contribute significantly to the control of SNc neuron excitability.	[Belluzzi, Ottorino] Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy; Ist Nazl Neurosci, Ferrara, Italy	University of Ferrara	Belluzzi, O (corresponding author), Univ Ferrara, Dipartimento Sci Vita & Biotecnol, I-44100 Ferrara, Italy.	mk5@unife.it	Pignatelli, Angela/L-4490-2013	Pignatelli, Angela/0000-0002-7160-1597; Belluzzi, Ottorino/0000-0002-7543-3818	Ministero della Universita e della Ricerca Scientifica (MIUR)	Ministero della Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR))	The research was supported by a grant from the Ministero della Universita e della Ricerca Scientifica (MIUR) - PRIN 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1977, N-S ARCH PHARMACOL, V297, P1, DOI 10.1007/BF00508803; [Anonymous], [No title captured]; Arencibia-Albite F, 2007, NEUROSCIENCE, V149, P303, DOI 10.1016/j.neuroscience.2007.08.009; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; BANKS MI, 1993, J NEUROPHYSIOL, V70, P1420, DOI 10.1152/jn.1993.70.4.1420; BEAVO JA, 1970, MOL PHARMACOL, V6, P597; BERGER F, 1994, N-S ARCH PHARMACOL, V350, P677; BERNARDINI GL, 1991, J NEURAL TRANSM-GEN, V84, P183, DOI 10.1007/BF01244969; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; BOBKER DH, 1989, NEURON, V2, P1535, DOI 10.1016/0896-6273(89)90041-X; Bois P, 1996, BRIT J PHARMACOL, V118, P1051, DOI 10.1111/j.1476-5381.1996.tb15505.x; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; Brent R. P., 1973, ALGORITHMS MINIMIZAT; Brown MTC, 2009, J NEUROSCI, V29, P2915, DOI 10.1523/JNEUROSCI.4423-08.2009; BROWN SJ, 1982, BRAIN RES, V234, P275, DOI 10.1016/0006-8993(82)90868-X; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Bucchi A, 2006, J PHYSIOL-LONDON, V572, P335, DOI 10.1113/jphysiol.2005.100776; Cathala L, 1999, EUR J NEUROSCI, V11, P398, DOI 10.1046/j.1460-9568.1999.00452.x; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; Chevallier S, 2006, J PHYSIOL-LONDON, V570, P525, DOI 10.1113/jphysiol.2005.098970; Cuevas J, 1997, J NEUROPHYSIOL, V78, P1890, DOI 10.1152/jn.1997.78.4.1890; Di Giovanni G, 2008, PROG BRAIN RES, V172, P45, DOI 10.1016/S0079-6123(08)00903-5; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0; DIFRANCESCO D, 1980, J PHYSIOL-LONDON, V308, P353, DOI 10.1113/jphysiol.1980.sp013475; DIFRANCESCO D, 1981, J PHYSIOL-LONDON, V314, P377, DOI 10.1113/jphysiol.1981.sp013714; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; FIBIGER HC, 1977, NEUROSCIENCE, V2, P975, DOI 10.1016/0306-4522(77)90120-8; Fogle KJ, 2007, J NEUROSCI, V27, P2802, DOI 10.1523/JNEUROSCI.4376-06.2007; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Forsythe G.E., 1976, COMPUTER METHODS MAT; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Gasparini S, 1999, EUR J NEUROSCI, V11, P3093, DOI 10.1046/j.1460-9568.1999.00728.x; GEFFEN LB, 1976, NATURE, V260, P258, DOI 10.1038/260258a0; Ghamari-Langroudi M, 2000, J NEUROSCI, V20, P4855; GRACE AA, 1989, J NEUROSCI, V9, P3463; GRENHOFF J, 1995, EUR J NEUROSCI, V7, P1707, DOI 10.1111/j.1460-9568.1995.tb00692.x; Guatteo E, 2005, J NEUROPHYSIOL, V94, P3069, DOI 10.1152/jn.00066.2005; GULLEY RL, 1971, TISSUE CELL, V3, P691, DOI 10.1016/S0040-8166(71)80014-9; Hahn J, 2003, J NEUROSCI, V23, P10859; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; HART G, 1983, J PHYSIOL-LONDON, V337, P401, DOI 10.1113/jphysiol.1983.sp014631; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; IMAI H, 1986, J COMP NEUROL, V243, P363, DOI 10.1002/cne.902430307; Inyushin MU, 2010, NEUROSCIENCE, V167, P287, DOI 10.1016/j.neuroscience.2010.01.052; JONES BE, 1977, BRAIN RES, V127, P23, DOI 10.1016/0006-8993(77)90378-X; KAMONDI A, 1991, J NEUROPHYSIOL, V66, P1902, DOI 10.1152/jn.1991.66.6.1902; KANG Y, 1993, NEUROSCI RES, V18, P209, DOI 10.1016/0168-0102(93)90056-V; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; Kiyatkin EA, 2010, FRONT BIOSCI-LANDMRK, V15, P73, DOI 10.2741/3608; Kjaerulff O, 2001, J NEUROPHYSIOL, V85, P580, DOI 10.1152/jn.2001.85.2.580; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Korotkova TM, 2004, MOL NEUROBIOL, V29, P243, DOI 10.1385/MN:29:3:243; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; LACEY MG, 1989, J NEUROSCI, V9, P1233; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee CR, 2009, J NEURAL TRANSM-SUPP, P71, DOI 10.1007/978-3-211-92660-4_6; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; MANSOUR A, 1990, J NEUROSCI, V10, P2587; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; MAYER ML, 1983, J PHYSIOL-LONDON, V340, P19, DOI 10.1113/jphysiol.1983.sp014747; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P319, DOI 10.1113/jphysiol.1990.sp018332; MEADORWOODRUFF JH, 1989, P NATL ACAD SCI USA, V86, P7625, DOI 10.1073/pnas.86.19.7625; MENGOD G, 1989, P NATL ACAD SCI USA, V86, P8560, DOI 10.1073/pnas.86.21.8560; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moore RY., 1984, CLASSICAL TRANSMIT 1, P123; MORI S, 1987, ANAT EMBRYOL, V176, P13, DOI 10.1007/BF00309747; Mrejeru A, 2011, J PHYSIOL-LONDON, V589, P2497, DOI 10.1113/jphysiol.2011.206631; NEDERGAARD S, 1991, NEUROREPORT, V2, P329; NEDERGAARD S, 1992, NEUROSCIENCE, V48, P423, DOI 10.1016/0306-4522(92)90502-S; NEDERGAARD S, 1988, NATURE, V333, P174, DOI 10.1038/333174a0; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Olijslagers JE, 2006, CURR NEUROPHARMACOL, V4, P59, DOI 10.2174/157015906775203020; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Parent M, 2011, J CHEM NEUROANAT, V41, P256, DOI 10.1016/j.jchemneu.2011.04.005; Pena F, 2006, EXP BRAIN RES, V173, P282, DOI 10.1007/s00221-006-0473-z; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; PUCAK ML, 1995, CRIT REV NEUROBIOL, V9, P67; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; Seutin V, 2001, NEUROREPORT, V12, P255, DOI 10.1097/00001756-200102120-00015; Seutin V, 2010, J NEUROPHYSIOL, V103, P3099, DOI 10.1152/jn.00513.2009; Shi WX, 2009, J NEURAL TRANSM-SUPP, P103, DOI 10.1007/978-3-211-92660-4_8; SILVA NL, 1990, J NEUROPHYSIOL, V64, P262, DOI 10.1152/jn.1990.64.1.262; STEINBUSCH HWM, 1981, NEUROSCIENCE, V6, P557, DOI 10.1016/0306-4522(81)90146-9; Suenari K, 2012, J CARDIOVASC ELECTRO; Svoboda KR, 1998, J NEUROSCI, V18, P7084; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Vandecasteele M, 2008, P NATL ACAD SCI USA, V105, P4904, DOI 10.1073/pnas.0703121105; Vargas G, 1999, J NEUROPHYSIOL, V81, P149, DOI 10.1152/jn.1999.81.1.149; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Watts AE, 1996, J NEUROPHYSIOL, V76, P2262, DOI 10.1152/jn.1996.76.4.2262; WHITE FJ, 1984, J PHARMACOL EXP THER, V231, P275; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; Yagi J, 1998, J NEUROPHYSIOL, V80, P1094, DOI 10.1152/jn.1998.80.3.1094; Yanagida H, 2000, AM J PHYSIOL-CELL PH, V278, pC40, DOI 10.1152/ajpcell.2000.278.1.C40; Yanovsky Y, 2005, NEUROSCIENCE, V136, P1027, DOI 10.1016/j.neuroscience.2005.08.026; YUNG WH, 1991, J PHYSIOL-LONDON, V436, P643, DOI 10.1113/jphysiol.1991.sp018571; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	119	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52329	10.1371/journal.pone.0052329	http://dx.doi.org/10.1371/journal.pone.0052329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23284989	Green Published, gold, Green Submitted			2022-12-25	WOS:000313158800048
J	Mamber, C; Kamphuis, W; Haring, NL; Peprah, N; Middeldorp, J; Hol, EM				Mamber, Carlyn; Kamphuis, Willem; Haring, Nina L.; Peprah, Nuzrat; Middeldorp, Jinte; Hol, Elly M.			GFAP delta Expression in Glia of the Developmental and Adolescent Mouse Brain	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; CENTRAL-NERVOUS-SYSTEM; SUBVENTRICULAR ZONE; MESSENGER-RNA; PROGENITOR CELLS; GENE-EXPRESSION; CEREBRAL-CORTEX; RADIAL GLIA; STEM-CELLS; RAT-BRAIN	Glial fibrillary acidic protein (GFAP) is the major intermediate filament (IF) protein in astrocytes. In the human brain, GFAP isoforms have unique expression patterns, which indicate that they play distinct functional roles. One isoform, GFAP delta, is expressed by proliferative radial glia in the developing human brain. In the adult human, GFAP delta is a marker for neural stem cells. However, it is unknown whether GFAP delta marks the same population of radial glia and astrocytes in the developing mouse brain as it does in the developing human brain. This study characterizes the expression pattern of GFAP delta throughout mouse embryogenesis and into adolescence. GFAP delta transcripts are expressed from E12, but immunohistochemistry shows GFAP delta staining only from E18. This finding suggests a translational uncoupling. GFAP delta expression increases from E18 to P5 and then decreases until its expression plateaus around P25. During development, GFAP delta is expressed by radial glia, as denoted by the co-expression of markers like vimentin and nestin. GFAP delta is also expressed in other astrocytic populations during development. A similar pattern is observed in the adolescent mouse, where GFAP delta marks both neural stem cells and mature astrocytes. Interestingly, the GFAP delta/Gfap alpha transcript ratio remains stable throughout development as well as in primary astrocyte and neurosphere cultures. These data suggest that all astroglia cells in the developing and adolescent mouse brain express GFAP delta, regardless of their neurogenic capabilities. GFAP delta may be an integral component of all mouse astrocytes, but it is not a specific neural stem cell marker in mice as it is in humans.	[Mamber, Carlyn; Kamphuis, Willem; Haring, Nina L.; Peprah, Nuzrat; Middeldorp, Jinte; Hol, Elly M.] Inst Royal Netherlands Acad Arts & Sci KNAW, Dept Astrocyte Biol & Neurodegenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Middeldorp, Jinte] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Hol, Elly M.] Univ Amsterdam, Swammerdam Inst Life Sci, Ctr Neurosci, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Stanford University; University of Amsterdam	Hol, EM (corresponding author), Inst Royal Netherlands Acad Arts & Sci KNAW, Dept Astrocyte Biol & Neurodegenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands.	e.hol@nin.knaw.nl	Hol, Elly/J-2025-2019; , Jinte/AHA-6575-2022; Hol, Elly M/F-1891-2013; Middeldorp, Jinte/M-2352-2016	Hol, Elly/0000-0001-5604-2603; , Jinte/0000-0002-9198-8020; Hol, Elly M/0000-0001-5604-2603; Middeldorp, Jinte/0000-0002-9198-8020	Netherlands Organization for Scientific Research (NWO) [865.09.003]; NANONET COST [BM1002]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NANONET COST(European Cooperation in Science and Technology (COST))	This project is funded by the Netherlands Organization for Scientific Research (NWO; VICI grant to E.M.H. [865.09.003]; URL: http://www.nwo.nl/) and NANONET COST [BM1002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 1912, J COMP NEUROL, V22, P547; ALTMAN J, 1966, J COMP NEUROL, V126, P337, DOI 10.1002/cne.901260302; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andrae J, 2001, MECH DEVELOP, V107, P181, DOI 10.1016/S0925-4773(01)00460-9; Baba H, 1997, DEV NEUROSCI-BASEL, V19, P49, DOI 10.1159/000111185; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; BIGNAMI A, 1989, INT J DEV NEUROSCI, V7, P343, DOI 10.1016/0736-5748(89)90056-7; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Bruni JE, 1998, AID JEMT2 3 0 CO 2 Z; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Condorelli DF, 1999, NEUROCHEM RES, V24, P709, DOI 10.1023/A:1021016828704; Dijk F, 2004, INVEST OPHTH VIS SCI, V45, P330, DOI 10.1167/iovs.03-0285; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; DUPREY P, 1995, INT J DEV BIOL, V39, P443; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fox IJ, 2004, DEV BRAIN RES, V153, P121, DOI 10.1016/j.devbrainres.2004.07.011; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Imura T, 2003, J NEUROSCI, V23, P2824; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kamphuis W, 2012, GLIA, V60, P615, DOI 10.1002/glia.22295; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kimelberg HK, 2004, NEUROCHEM INT, V45, P191, DOI 10.1016/j.neuint.2003.08.015; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Leprince P, 2001, Prog Brain Res, V132, P13; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lindwall C, 2007, CURR OPIN NEUROBIOL, V17, P3, DOI 10.1016/j.conb.2007.01.008; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Oland LA, 2011, GLIA, V59, P1273, DOI 10.1002/glia.21096; Pallari Hanna-Mari, 2006, Sci STKE, V2006, ppe53, DOI 10.1126/stke.3662006pe53; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; ROLLAND B, 1990, DEV BRAIN RES, V56, P144, DOI 10.1016/0165-3806(90)90175-X; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SANCHOTELLO M, 1995, GLIA, V15, P157, DOI 10.1002/glia.440150208; Sarnat HB, 1998, AID JEMT3 3 0 CO 2 U; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; Singh R, 2003, GENOMICS, V82, P185, DOI 10.1016/S0888-7543(03)00106-X; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; Takemura M, 2002, J NEUROSCI, V22, P6972; Valles S, 2002, J NEUROCHEM, V69, P2484, DOI [10.1046/j.1471-4159.1997.69062484.x, DOI 10.1046/J.1471-4159.1997.69062484.X]; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; van Strien ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025037; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709; Zhou M, 2000, MOL BRAIN RES, V76, P121, DOI 10.1016/S0169-328X(99)00341-1	61	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2012	7	12							e52659	10.1371/journal.pone.0052659	http://dx.doi.org/10.1371/journal.pone.0052659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065OW	23285135	Green Published, Green Submitted, gold			2022-12-25	WOS:000313158800086
J	Ji, JJ; Chen, LW; Duan, XZ; Song, XQ; Su, WT; Zhang, P; Li, L; Bai, SY; Sun, YC; Inagaki, N				Ji, Juan Juan; Chen, Lianwan; Duan, Xuezhi; Song, Xueqin; Su, Wenting; Zhang, Peng; Li, Li; Bai, Shuyun; Sun, Yingchun; Inagaki, Nobuya			BK Channels Reveal Novel Phosphate Sensitivity in SNr Neurons	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ACTIVATED POTASSIUM CHANNEL; LARGE-CONDUCTANCE; SUBSTANTIA-NIGRA; NEOCORTICAL NEURONS; PYRAMIDAL NEURONS; RAT-BRAIN; ATP; DEPRIVATION; SUBUNIT	Whether large conductance Ca2+-activated potassium (BK) channels are present in the substantia nigra pars reticulata (SNr) is a matter of debate. Using the patch-clamp technique, we examined the functional expression of BK channels in neurons of the SNr and showed that the channels were activated or inhibited by internal high-energy phosphates (IHEPs) at positive and negative membrane potentials, respectively. SNr neurons showed membrane potential hyperpolarization under glucose-deprivation conditions which was attenuated by paxilline, a specific BK channel blocker. In addition, Fluo-3 fluorescence recording detected an increase in the level of internal free calcium ([Ca2+](i)) during ischemic hyperpolarization. These results confirm that BK channels are present in SNr neurons and indicate that their unique IHEP sensitivity is requisite in neuronal ischemic responses. Bearing in mind that the K-ATP channel blocker tolbutamide also attenuated the hyperpolarization, we suggest that BK channels may play a protective role in the basal ganglia by modulating the excitability of SNr neurons along with K-ATP channels under ischemic stresses.	[Ji, Juan Juan; Chen, Lianwan; Song, Xueqin; Su, Wenting; Zhang, Peng; Li, Li; Bai, Shuyun] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Duan, Xuezhi; Sun, Yingchun] NE Normal Univ, Dept Phys, Changchun 130024, Peoples R China; [Inagaki, Nobuya] Kyoto Univ, Dept Diabet & Clin Nutr, Grad Sch Med, Sakyo Ku, Kyoto, Japan	Chinese Academy of Sciences; Institute of Biophysics, CAS; Northeast Normal University - China; Kyoto University	Ji, JJ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jijj@ibp.ac.cn	Duan, Xuezhi/AHC-2964-2022	Inagaki, Nobuya/0000-0001-8261-2593	Chinese Academy of Sciences [KSCX2-SW-217]; National Natural Science Foundation of China [30370459]; National Key Basic Research and Development Program [2005CB522804, 2006CB504101]; Akita university school	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); Akita university school	This work was supported by grants from the 100 Talents Program of the Chinese Academy of Sciences, the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-SW-217), the National Natural Science Foundation of China (30370459), the National Key Basic Research and Development Program(2005CB522804, 2006CB504101), and the international fund of Akita university school. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Benhassine N, 2009, PFLUG ARCH EUR J PHY, V457, P1133, DOI 10.1007/s00424-008-0569-3; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Brodie MS, 2007, ALCOHOL CLIN EXP RES, V31, P1625, DOI 10.1111/j.1530-0277.2007.00469.x; Chang CP, 1997, MOL BRAIN RES, V45, P33, DOI 10.1016/S0169-328X(96)00230-6; Chen L, 2007, ACTA BIOPHYSICA SINI, V23, P7; Chen LW, 2011, BRAIN RES, V1390, P99, DOI 10.1016/j.brainres.2011.03.022; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Gessner G, 2012, P NATL ACAD SCI USA, V109, P3552, DOI 10.1073/pnas.1114321109; Gong LW, 2002, BRAIN RES, V951, P130, DOI 10.1016/S0006-8993(02)03151-7; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hall AC, 1997, J BIOL RHYTHM, V12, P388, DOI 10.1177/074873049701200501; Jiang C, 1997, J NEUROPHYSIOL, V77, P93, DOI 10.1152/jn.1997.77.1.93; JIANG C, 1994, J NEUROSCI, V14, P5590; Kandel ER, 2001, PRINCIPLES NEURAL SC, P1302; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1994, BIOCHEMISTRY-US, V33, P5819, DOI 10.1021/bi00185a021; LEE K, 1995, J PHYSIOL-LONDON, V488, P319, DOI 10.1113/jphysiol.1995.sp020969; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Liu HJ, 1999, J CLIN INVEST, V104, P577, DOI 10.1172/JCI7291; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Marinelli S, 2000, NEUROPHARMACOLOGY, V39, P1021, DOI 10.1016/S0028-3908(99)00186-0; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; MINTA A, 1989, J BIOL CHEM, V264, P8171; MOURRE C, 1989, BRAIN RES, V486, P159, DOI 10.1016/0006-8993(89)91288-2; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; Pisani A, 1999, J NEUROPHYSIOL, V81, P2508, DOI 10.1152/jn.1999.81.5.2508; Piwonska M, 2008, NEUROSCIENCE, V153, P446, DOI 10.1016/j.neuroscience.2008.01.050; Redgrave P, 2010, NAT REV NEUROSCI, V11, P760, DOI 10.1038/nrn2915; Richards CD, 1997, NEUROSCIENCE, V80, P545, DOI 10.1016/S0306-4522(97)00093-6; Roman GC, 2002, LANCET NEUROL, V1, P426, DOI 10.1016/S1474-4422(02)00190-4; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Song X, 2010, NEUROSCIENCE, V169, P1548, DOI 10.1016/j.neuroscience.2010.06.026; Stanford IM, 1996, NEUROSCIENCE, V74, P499, DOI 10.1016/0306-4522(96)00151-0; Strobaek D, 1996, NEUROPHARMACOLOGY, V35, P903, DOI 10.1016/0028-3908(96)00096-2; Su WT, 2010, NEUROSCI LETT, V471, P1, DOI 10.1016/j.neulet.2009.12.058; Thanvi B, 2005, AGE AGEING, V34, P114, DOI 10.1093/ageing/afi025; TREHERNE JM, 1991, J NEUROENDOCRINOL, V3, P323, DOI 10.1111/j.1365-2826.1991.tb00282.x; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; YOSHIDA A, 1991, JPN J PHYSIOL, V41, P297, DOI 10.2170/jjphysiol.41.297	47	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52148	10.1371/journal.pone.0052148	http://dx.doi.org/10.1371/journal.pone.0052148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23284908	gold, Green Submitted, Green Published			2022-12-25	WOS:000312794500101
J	Zhang, ZH; Wang, K; Guo, L; Zhu, YJ; Fan, YY; Cheng, SH; Zhuang, JY				Zhang, Zhen-Hua; Wang, Kai; Guo, Liang; Zhu, Yu-Jun; Fan, Ye-Yang; Cheng, Shi-Hua; Zhuang, Jie-Yun			Pleiotropism of the Photoperiod-Insensitive Allele of Hd1 on Heading Date, Plant Height and Yield Traits in Rice	PLOS ONE			English	Article							NATURAL VARIATION; SHORT ARM; GENE; HD3A; CHROMOSOME-6; EXPRESSION; REGULATOR; SIGNAL; EHD1	Five populations segregated in isogenic backgrounds and three sets of near isogenic lines (NILs) overlapping in a 362.3-kb region covering heading date gene Hd1 were developed from the indica rice cross Zhenshan97 (ZS97)/Milyang 46 (MY46). They were used to analyze the effects of Hd1 on heading date, plant height and yield traits. In a background of the parental mixtures, the photoperiod-sensitive allele derived from ZS97 functioned in promoting and delaying flowering in the natural short-day and long-day conditions, respectively. In the background of ZS97, no response to the photoperiod was observed, whereas the photoperiod-insensitive allele derived from MY46 functioned in delaying flowering, increasing plant height, and enhancing grain productivity. The additive effects estimated in two NIL sets were 6.14 and 6.14 d for heading date, 4.46 and 5.55 cm for plant height, 10.82 and 11.54 for the number of spikelets per panicle, 6.82 and 8.00 for the number of grains per panicle, and 2.16 and 2.23 g for grain yield per plant, which explained 94.1% and 96.3%, 70.5% and 84.8%, 52.4% and 55.2%, 28.9% and 39.2%, and 36.5% and 26.9% of the phenotypic variances, respectively. Since the photoperiod-insensitive allele of Hd1 confers a long vegetative phase, it is a good candidate for breeding rice varieties with high yielding potential for low latitudes.	[Zhang, Zhen-Hua; Wang, Kai; Guo, Liang; Zhu, Yu-Jun; Fan, Ye-Yang; Cheng, Shi-Hua; Zhuang, Jie-Yun] China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Zhen-Hua; Wang, Kai; Guo, Liang; Zhu, Yu-Jun; Fan, Ye-Yang; Cheng, Shi-Hua; Zhuang, Jie-Yun] China Natl Rice Res Inst, Chinese Natl Ctr Rice Improvement, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS	Cheng, SH (corresponding author), China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China.	shcheng@mail.hz.zj.cn; jz1803@hzcnc.com	Zhuang, Jie-Yun/B-4131-2012; Zhu, Yujun/GYU-5471-2022	Zhuang, Jie-Yun/0000-0002-1439-5061; Zhu, Yujun/0000-0001-6409-1990; Zhang, Zhen-Hua/0000-0003-0711-7466	Chinese 863 Program [2012AA101102-2]; Chinese High-yielding Transgenic Program [2011ZX08001-004]; China National Rice Research Institute [2012RG002-3]	Chinese 863 Program(National High Technology Research and Development Program of China); Chinese High-yielding Transgenic Program; China National Rice Research Institute	This work was funded by the Chinese 863 Program (No. 2012AA101102-2), the Chinese High-yielding Transgenic Program (No. 2011ZX08001-004), and research funding from the China National Rice Research Institute (No. 2012RG002-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian XF, 2011, PLANT CELL REP, V30, P2243, DOI 10.1007/s00299-011-1129-4; Chen X, 1997, THEOR APPL GENET, V95, P553, DOI 10.1007/s001220050596; Dai WM, 2008, EUPHYTICA, V160, P317, DOI 10.1007/s10681-007-9501-8; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Gong JY, 2010, AGR SCI CHINA, V9, P1085, DOI 10.1016/S1671-2927(09)60194-2; Guo L, 2012, RICE SCI IN PRESS; Ishikawa R, 2011, MOL GENET GENOMICS, V285, P461, DOI 10.1007/s00438-011-0621-4; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; Nishida H, 2002, CROP SCI, V42, P348, DOI 10.2135/cropsci2002.0348; Ogiso E, 2010, PLANT PHYSIOL, V152, P808, DOI 10.1104/pp.109.148908; Rychlik W., 2008, OLIGO PRIMER ANAL SO; SAS Institute Inc, 1999, SAS STAT US GUID; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Wang S., 2011, WINDOWS QTL CARTOGRA; Wei XiangJin, 2012, Acta Agronomica Sinica, V38, P10; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Wei XJ, 2010, MOL BREEDING, V25, P287, DOI 10.1007/s11032-009-9332-5; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yuan QB, 2009, THEOR APPL GENET, V119, P675, DOI 10.1007/s00122-009-1078-2; Zheng KL, 1995, IRRI DISCUSSION PAPE, V12	27	43	47	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2012	7	12							e52538	10.1371/journal.pone.0052538	http://dx.doi.org/10.1371/journal.pone.0052538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	060RA	23285081	Green Published, Green Submitted, gold			2022-12-25	WOS:000312794500192
J	Fang, L; Hemion, C; Goldblum, D; Meyer, P; Orgul, S; Frank, S; Flammer, J; Neutzner, A				Fang, Lei; Hemion, Charles; Goldblum, David; Meyer, Peter; Orguel, Selim; Frank, Stephan; Flammer, Josef; Neutzner, Albert			Inactivation of MARCH5 Prevents Mitochondrial Fragmentation and Interferes with Cell Death in a Neuronal Cell Model	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN; PEROXISOMAL FISSION; OPTIC ATROPHY; APOPTOSIS; NEURODEGENERATION; FUSION; LINE; DRP1; MAINTENANCE; OPA1	Purpose: To study the impact of the mitochondrial ubiquitin ligase MARCH5 on mitochondrial morphology and induction of apoptosis using an in vitro model of neuronal precursor cells exposed to glaucoma-relevant stress conditions. Methods: RGC5 cells transfected with expression constructs for MARCH5, MARCH5(H43W), Dpr1(K38A) or vector control were exposed to either elevated pressure of 30 mmHg, oxidative stress caused by mitochondrial electron transport chain (ETC) inhibition, or hypoxia-reoxygenation conditions. Mitochondrial morphology of RGC5 cells was analyzed following staining of the mitochondrial marker cytochrome c and photoactivatable GFP (PAGFP) diffusion assay. Induction of apoptotic cell death in these cells was determined by analyzing the release of cytochrome c from mitochondria into the cytosol and flow cytometry. Results: Exposure of RGC5 cells to oxidative stress conditions as well as to elevated pressure resulted in the fragmentation of the mitochondrial network in control cells as well as in cells expressing MARCH5. In cells expressing inactive MARCH5(H43W) or inactive Drp(K38A), mitochondrial fragmentation was significantly blocked and mitochondrial morphology was comparable to that of control cells under normal conditions. Exposure of RGC5 cells to elevated pressure or oxidative stress conditions induced apoptotic cell death as assessed by cytochrome c release and DNA staining, while expression of dominant-negative MARCH5(H43W) or Drp1(K38A) did significantly delay cell death. Conclusion: Preventing mitochondrial fragmentation through interference with the mitochondrial fission machinery protects neuronal cells from programmed cell death following exposure to stressors physiologically relevant to the pathogenesis of glaucoma.	[Fang, Lei; Hemion, Charles; Meyer, Peter; Neutzner, Albert] Univ Basel, Dept Biomed, Basel, Switzerland; [Goldblum, David; Meyer, Peter; Orguel, Selim; Flammer, Josef; Neutzner, Albert] Univ Basel, Dept Ophthalmol, Basel, Switzerland; [Frank, Stephan] Univ Basel, Inst Pathol, Div Neuropathol, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Neutzner, A (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	albert.neutzner@unibas.ch	Neutzner, Albert/ABC-4368-2020; Goldblum, David/G-8559-2014	Goldblum, David/0000-0002-2119-1710; Neutzner, Albert/0000-0001-9254-5558	China Scholarship Council (CSC); Swiss National Foundation [31003A_129798]; Gottfried and Julia Bangerter-Rhyner foundation	China Scholarship Council (CSC)(China Scholarship Council); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Gottfried and Julia Bangerter-Rhyner foundation	This work was supported by a grant of the China Scholarship Council (CSC) to LF and a grant from the Swiss National Foundation (31003A_129798) and the Gottfried and Julia Bangerter-Rhyner foundation to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M.J., 2011, COLD SPRING HARB PER, V3; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Flammer J, 2008, CAN J OPHTHALMOL, V43, P317, DOI 10.3129/i08-056; Frank S, 2003, BIOCHEM BIOPH RES CO, V304, P481, DOI 10.1016/S0006-291X(03)00620-X; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Grohm J, 2012, CELL DEATH DIFFER; Ju WK, 2010, MOL VIS, V16, P1331; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Nickells RW, 2012, ANN REV NEUROSCI; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Schnichels S, 2012, NEUROCHEM INT, V60, P581, DOI 10.1016/j.neuint.2012.02.017; Sugiura A, 2011, MITOCHONDRION, V11, P139, DOI 10.1016/j.mito.2010.09.001; Tang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024367; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xin XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020142; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Yonashiro R, 2012, P NATL ACAD SCI USA, V109, P2382, DOI 10.1073/pnas.1114985109; Yonashiro R, 2009, MOL BIOL CELL, V20, P4524, DOI 10.1091/mbc.E09-02-0112	32	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2012	7	12							e52637	10.1371/journal.pone.0052637	http://dx.doi.org/10.1371/journal.pone.0052637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HF	23285122	Green Submitted, gold, Green Published			2022-12-25	WOS:000312694300095
J	Cao, WQ; Ma, ZF; Rasenick, MM; Yeh, SY; Yu, JZ				Cao, WenQing; Ma, ZhiFan; Rasenick, Mark M.; Yeh, ShuYan; Yu, JiangZhou			N-3 Poly-Unsaturated Fatty Acids Shift Estrogen Signaling to Inhibit Human Breast Cancer Cell Growth	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LIPID RAFTS; INDUCED APOPTOSIS; ADENYLYL-CYCLASE; GENE-EXPRESSION; GPR30; PROLIFERATION; PATHWAY; ALPHA; CAMP	Although evidence has shown the regulating effect of n-3 poly-unsaturated fatty acid (n-3 PUFA) on cell signaling transduction, it remains unknown whether n-3 PUFA treatment modulates estrogen signaling. The current study showed that docosahexaenoic acid (DHA, C22:6), eicosapentaenoic acid (EPA, C20:5) shifted the pro-survival and proliferative effect of estrogen to a pro-apoptotic effect in human breast cancer (BCa) MCF-7 and T47D cells. 17 beta-estradiol (E2) enhanced the inhibitory effect of n-3 PUFAs on BCa cell growth. The IC50 of DHA or EPA in MCF-7 cells decreased when combined with E2 (10 nM) treatment (from 173 mu M for DHA only to 113 mu M for DHA+E2, and from 187 mu m for EPA only to 130 mu m for EPA+E2). E2 also augmented apoptosis in n-3 PUFA-treated BCa cells. In contrast, in cells treated with stearic acid (SA, C18:0) as well as cells not treated with fatty acid, E2 promoted breast cancer cell growth. Classical (nuclear) estrogen receptors may not be involved in the pro-apoptotic effects of E2 on the n-3 PUFA-treated BCa cells because ER alpha agonist failed to elicit, and ER alpha knockdown failed to block E2 pro-apoptotic effects. Subsequent studies reveal that G protein coupled estrogen receptor 1 (GPER1) may mediate the pro-apoptotic effect of estrogen. N-3 PUFA treatment initiated the pro-apoptotic signaling of estrogen by increasing GPER1-cAMP-PKA signaling response, and blunting EGFR, Erk 1/2, and AKT activity. These findings may not only provide the evidence to link n-3 PUFAs biologic effects and the pro- apoptotic signaling of estrogen in breast cancer cells, but also shed new insight into the potential application of n-3 PUFAs in BCa treatment.	[Cao, WenQing; Ma, ZhiFan; Yeh, ShuYan; Yu, JiangZhou] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL USA; [Rasenick, Mark M.] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL USA; [Rasenick, Mark M.] Jesse Brown VA Med Ctr, Chicago, IL USA; [Yeh, ShuYan] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Ma, ZhiFan] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan, Shanxi, Peoples R China	University of Rochester; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Rochester; Shanxi Medical University	Yu, JZ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	jiangzhou_yu@urmc.rochester.edu	Cao, Wenqing/GPF-9107-2022	Cao, Wenqing/0000-0002-2761-3355	Department of Pathology and Lab Medicine, University of Rochester Medical Center, Rochester, NY, USA	Department of Pathology and Lab Medicine, University of Rochester Medical Center, Rochester, NY, USA	Funding for this project was provided by Department of Pathology and Lab Medicine, University of Rochester Medical Center, Rochester, NY, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151; Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Allen JA, 2009, MOL PHARMACOL, V76, P1082, DOI 10.1124/mol.109.060160; Altenburg JD, 2009, MOL CANCER RES, V7, P1013, DOI 10.1158/1541-7786.MCR-08-0385; Ariazi EA, 2011, P NATL ACAD SCI USA, V108, P18879, DOI 10.1073/pnas.1115188108; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; ARONICA SM, 1994, P NATL ACAD SCI USA, V91, P8517, DOI 10.1073/pnas.91.18.8517; BOE R, 1995, BRIT J CANCER, V72, P1151, DOI 10.1038/bjc.1995.479; Castoria G, 2008, FRONT BIOSCI-LANDMRK, V13, P1318, DOI 10.2741/2764; Chen JH, 1998, P NATL ACAD SCI USA, V95, P2648, DOI 10.1073/pnas.95.5.2648; Chen M, 2009, CARCINOGENESIS, V30, P841, DOI 10.1093/carcin/bgn288; Chow SKY, 2004, J ENDOCRINOL, V182, P325, DOI 10.1677/joe.0.1820325; Corsetto PA, 2012, CELL BIOCHEM BIOPHYS, V64, P45, DOI 10.1007/s12013-012-9365-y; Corsetto PA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-73; Dimri M, 2010, CARCINOGENESIS, V31, P489, DOI 10.1093/carcin/bgp305; Evinger AJ, 2005, STEROIDS, V70, P361, DOI 10.1016/j.steroids.2005.02.015; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Files J A, 2012, Minerva Ginecol, V64, P223; Jordan VC, 2005, BREAST, V14, P624, DOI 10.1016/j.breast.2005.08.022; Kang KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010296; Kastrati I, 2010, ENDOCRINOLOGY, V151, P5602, DOI 10.1210/en.2010-0378; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kelly MJ, 2001, TRENDS ENDOCRIN MET, V12, P152, DOI 10.1016/S1043-2760(01)00377-0; Kelly MJ, 1999, TRENDS ENDOCRIN MET, V10, P369, DOI 10.1016/S1043-2760(99)00190-3; KENNEDY BJ, 1962, CANCER, V15, P641, DOI 10.1002/1097-0142(196205/06)15:3<641::AID-CNCR2820150330>3.0.CO;2-9; KENNEDY BJ, 1962, CANCER CHEMOTH REP, P283; Kim SN, 2001, INT J CANCER, V93, P33, DOI 10.1002/ijc.1308; Lewis JS, 2005, JNCI-J NATL CANCER I, V97, P1746, DOI 10.1093/jnci/dji400; Ligumsky H, 2012, BREAST CANCER RES TR, V132, P449, DOI 10.1007/s10549-011-1585-0; Madak-Erdogan Z, 2011, MOL CELL BIOL, V31, P226, DOI 10.1128/MCB.00821-10; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Notas G, 2012, STEROIDS, V77, P943, DOI 10.1016/j.steroids.2011.11.005; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Prossnitz ER, 2008, J STEROID BIOCHEM, V109, P350, DOI 10.1016/j.jsbmb.2008.03.006; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rogers KR, 2010, CARCINOGENESIS, V31, P1523, DOI 10.1093/carcin/bgq111; Santen RJ, 2009, STEROIDS, V74, P586, DOI 10.1016/j.steroids.2008.11.020; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; Schley PD, 2005, BREAST CANCER RES TR, V92, P187, DOI 10.1007/s10549-005-2415-z; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Signori C, 2011, CANCER RES, V71, P6091, DOI 10.1158/0008-5472.CAN-11-0977; Song RXD, 2003, APOPTOSIS, V8, P55, DOI 10.1023/A:1021649019025; Song RXD, 2001, J NATL CANCER I, V93, P1714, DOI 10.1093/jnci/93.22.1714; Stillwell W, 2005, REPROD NUTR DEV, V45, P559, DOI 10.1051/rnd:2005046; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Sun HG, 2011, CARCINOGENESIS, V32, P1518, DOI 10.1093/carcin/bgr132; Thangavel M, 2009, CELL SIGNAL, V21, P301, DOI 10.1016/j.cellsig.2008.10.017; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Williams JA, 2012, BIOPHYS J, V103, P228, DOI 10.1016/j.bpj.2012.06.016; Wu M, 2005, INT J CANCER, V117, P340, DOI 10.1002/ijc.21238; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200; Zambon AC, 2011, J BIOL CHEM, V286, P33260, DOI 10.1074/jbc.M111.268979; Zhang DX, 2011, J BIOL CHEM, V286, P17746, DOI 10.1074/jbc.M110.206029; Zivadinovic D, 2005, BREAST CANCER RES, V7, pR101, DOI 10.1186/bcr958	59	60	61	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2012	7	12							e52838	10.1371/journal.pone.0052838	http://dx.doi.org/10.1371/journal.pone.0052838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064DQ	23145098	Green Published, Green Submitted, gold			2022-12-25	WOS:000313051500068
J	Lin, YW; Lin, HY; Tsou, YL; Chitra, E; Hsiao, KN; Shao, HY; Liu, CC; Sia, C; Chong, P; Chow, YH				Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung			Human SCARB2-Mediated Entry and Endocytosis of EV71	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; RESPIRATORY SYNCYTIAL VIRUS; SELECTIN GLYCOPROTEIN LIGAND-1; NEUROGENIC PULMONARY-EDEMA; ENTEROVIRUS 71; CELLULAR RECEPTOR; P-SELECTIN; DEPENDENT ENDOCYTOSIS; MOUTH-DISEASE; PUBLIC-HEALTH	Enterovirus (EV) 71 infection is known to cause hand-foot-and-mouth disease (HFMD) and in severe cases, induces neurological disorders culminating in fatality. An outbreak of EV71 in South East Asia in 1997 affected over 120,000 people and caused neurological disorders in a few individuals. The control of EV71 infection through public health interventions remains minimal and treatments are only symptomatic. Recently, human scavenger receptor class B, member 2 (SCARB2) has been reported to be a cellular receptor of EV71. We expressed human SCARB2 gene in NIH3T3 cells (3T3-SCARB2) to study the mechanisms of EV71 entry and infection. We demonstrated that human SCARB2 serves as a cellular receptor for EV71 entry. Disruption of expression of SCARB2 using siRNAs can interfere EV71 infection and subsequent inhibit the expression of viral capsid proteins in RD and 3T3-SCARB2 but not Vero cells. SiRNAs specific to clathrin or dynamin or chemical inhibitor of clathrin-mediated endocytosis were all capable of interfering with the entry of EV71 into 3T3-SCARB2 cells. On the other hand, caveolin specific siRNA or inhibitors of caveolae-mediated endocytosis had no effect, confirming that only clathrin-mediated pathway was involved in EV71 infection. Endocytosis of EV71 was also found to be pH-dependent requiring endosomal acidification and also required intact membrane cholesterol. In summary, the mechanism of EV71 entry through SCARB2 as the receptor for attachment, and its cellular entry is through a clathrin-mediated and pHdependent endocytic pathway. This study on the receptor and endocytic mechanisms of EV71 infection is useful for the development of effective medications and prophylactic treatment against the enterovirus.	[Lin, Yi-Wen; Lin, Hsiang-Yin; Tsou, Yueh-Liang; Chitra, Ebenezer; Hsiao, Kuang-Nan; Shao, Hsiao-Yun; Liu, Chia-Chyi; Sia, Charles; Chong, Pele; Chow, Yen-Hung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan; [Lin, Yi-Wen] Natl Tsing Hua Univ, Inst Mol Med, Grad Program Biotechnol Med, Hsinchu, Taiwan; [Tsou, Yueh-Liang] Natl Def Med Ctr, Grad Sch Life Sci, Taipei, Taiwan; [Sia, Charles; Chong, Pele] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; National Defense Medical Center; China Medical University Taiwan	Lin, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Taipei, Taiwan.	pelechong@nhri.org.tw; choeyenh@nhri.org.tw	Liu, Chia-Chyi/A-8215-2012; Sia, Dwo-Yuan/E-3860-2010; Chong, Pele/E-3855-2010; Chitra, Ebenezer/F-5984-2019; Chow, Yen-Hung/E-3863-2010	Liu, Chia-Chyi/0000-0002-6257-0389; Chitra, Ebenezer/0000-0002-5818-6587; 	National Health Research Institutes [99A1-VCPP08-014]; National Science Council (NSC) of Taiwan [99-2323-B-400-014-]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council (NSC) of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Health Research Institutes' intramural grant (99A1-VCPP08-014) (www.nhri.org.tw) and a grant (99-2323-B-400-014-) from the National Science Council (NSC) (http://web1.nsc.gov.tw) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Bayer N, 2001, J BIOL CHEM, V276, P3952, DOI 10.1074/jbc.M004722200; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; BROWN MS, 1980, J LIPID RES, V21, P505; Chang JY, 1998, BIOCHEM BIOPH RES CO, V249, P817, DOI 10.1006/bbrc.1998.9237; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Danthi P, 2004, J VIROL, V78, P33, DOI 10.1128/JVI.78.1.33-41.2004; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Hailstones D, 1998, J LIPID RES, V39, P369; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lin YC, 2002, VACCINE, V20, P2485, DOI 10.1016/S0264-410X(02)00182-2; Liu CC, 2011, VACCINE, V29, P4362, DOI 10.1016/j.vaccine.2011.04.010; Liu PS, 1999, BIOCHEM BIOPH RES CO, V261, P695, DOI 10.1006/bbrc.1999.1082; LONBERGHOLM K, 1972, J VIROL, V9, P29, DOI 10.1128/JVI.9.1.29-40.1972; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; Lum LCS, 1998, LANCET, V352, P1391, DOI 10.1016/S0140-6736(05)60789-1; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McMinn PC, 2003, NEUROL J SE ASIA, V8, P57; Melnick J L, 1980, Intervirology, V12, P297; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Parton RG, 1999, IMMUNOL REV, V168, P23, DOI 10.1111/j.1600-065X.1999.tb01280.x; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Smaby JM, 1996, BIOPHYS J, V70, P868, DOI 10.1016/S0006-3495(96)79629-7; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; SRINIVASAKUMAR N, 1991, J VIROL, V65, P4063, DOI 10.1128/JVI.65.8.4063-4069.1991; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Tung Wong Siew, 2007, Genet Vaccines Ther, V5, P6, DOI 10.1186/1479-0556-5-6; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wu TN, 1999, EMERG INFECT DIS, V5, P458, DOI 10.3201/eid0503.990321; Xing L, 2000, EMBO J, V19, P1207, DOI 10.1093/emboj/19.6.1207; Yamayoshi S, 2011, J VIROL, V85, P4937, DOI 10.1128/JVI.02358-10; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992	83	76	89	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30507	10.1371/journal.pone.0030507	http://dx.doi.org/10.1371/journal.pone.0030507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272359	gold, Green Published, Green Submitted			2022-12-25	WOS:000301454400137
J	Wang, F; Bobrow, L; Liu, J; Spencer, L; Blumberg, HP				Wang, Fei; Bobrow, Laurel; Liu, Jie; Spencer, Linda; Blumberg, Hilary P.			Corticolimbic Functional Connectivity in Adolescents with Bipolar Disorder	PLOS ONE			English	Article							EMOTIONAL FACES; ANTERIOR CINGULATE; PREFRONTAL CORTEX; RESTING STATE; FACIAL EXPRESSIONS; NEURAL SYSTEMS; AMYGDALA; TRAIT; CHILDREN; ABNORMALITIES	Convergent evidence supports regional dysfunction within a corticolimbic neural system that subserves emotional processing and regulation in adolescents and adults with bipolar disorder (BD), with abnormalities prominent within the amygdala and its major anterior paralimbic cortical connection sites including ventral anterior cingulate, orbitofrontal, insular and temporopolar cortices. Recent studies of adults with BD demonstrate abnormalities in the functional connectivity between the amygdala and anterior paralimbic regions suggesting an important role for the connections between these regions in the development of the disorder. This study tests the hypothesis that these functional connectivity abnormalities are present in adolescents with BD. Fifty-seven adolescents, twenty-one with BD and thirty-six healthy comparison (HC) adolescents, participated in functional magnetic resonance imaging while processing emotional face stimuli. The BD and HC groups were compared in the strength of functional connectivity from amygdala to the anterior paralimbic cortical regions, and explored in remaining brain regions. Functional connectivity was decreased in the BD group, compared to the HC group, during processing of emotional faces in ventral anterior cingulate (VACC), orbitofrontal, insular and temporopolar cortices (p<0.005). Orbitofrontal and VACC findings for the happy condition, and additionally right insula for the neutral condition, survived multiple comparison correction. Exploratory analyses did not reveal additional regions of group differences. This study provides evidence for decreased functional connectivity between the amygdala and anterior paralimbic cortices in adolescents with BD. This suggests that amygdala-anterior paralimbic connectivity abnormalities are early features of BD that emerge at least by adolescence in the disorder.	[Wang, Fei; Bobrow, Laurel; Liu, Jie; Spencer, Linda; Blumberg, Hilary P.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Blumberg, Hilary P.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Blumberg, Hilary P.] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Blumberg, HP (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA.	Hilary.blumberg@yale.edu	Liu, Jie/K-3142-2015	Blumberg, Hilary/0000-0002-6363-4698	National Institute of Health (NIH) [R01MH69747, RC1MH088366, R01MH070902, RL1DA024856, K01MH086621]; CTSA from the NIH National Center for Research Resources [UL1RR0249139]; National Alliance for Research on Schizophrenia and Depression (Great Neck, New York); Attias Family Foundation; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut); Klingenstein Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069747, K01MH086621, RC1MH088366, R01MH070902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RL1DA024856] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from the NIH National Center for Research Resources; National Alliance for Research on Schizophrenia and Depression (Great Neck, New York)(NARSAD); Attias Family Foundation; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute of Health (NIH) R01MH69747 [HPB], RC1MH088366 [HPB], R01MH070902 [HPB], RL1DA024856 [HPB, FW], K01MH086621 [FW]; CTSA UL1RR0249139 from the NIH National Center for Research Resources [HPB, FW] the National Alliance for Research on Schizophrenia and Depression (Great Neck, New York) [FW, HPB]; The Attias Family Foundation [HPB]; Women's Health Research at Yale - The Ethel F. Donaghue Women's Health Investigator Program at Yale (New Haven, Connecticut) [HPB]; and the Klingenstein Foundation [FW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Blumberg HP, 2003, ARCH GEN PSYCHIAT, V60, P1201, DOI 10.1001/archpsyc.60.12.1201; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cerullo MA, 2012, BIPOLAR DISORD, V14, P175, DOI 10.1111/j.1399-5618.2012.01002.x; Chang K, 2005, J AM ACAD CHILD PSY, V44, P565, DOI 10.1097/01.chi.0000159948.75136.0d; Chang K, 2004, ARCH GEN PSYCHIAT, V61, P781, DOI 10.1001/archpsyc.61.8.781; Chen BK, 2004, BIOL PSYCHIAT, V56, P399, DOI 10.1016/j.biopsych.2004.06.024; Chen CH, 2006, BIOL PSYCHIAT, V59, P31, DOI 10.1016/j.biopsych.2005.06.008; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; Chiu S, 2008, J AFFECT DISORDERS, V105, P93, DOI 10.1016/j.jad.2007.04.019; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; DelBello MP, 2004, BIPOLAR DISORD, V6, P43, DOI 10.1046/j.1399-5618.2003.00087.x; Dickstein DP, 2007, BIPOLAR DISORD, V9, P679, DOI 10.1111/j.1399-5618.2007.00418.x; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Farrow TFD, 2005, BIOL PSYCHIAT, V58, P713, DOI 10.1016/j.biopsych.2005.04.033; Foland LC, 2008, PSYCHIAT RES-NEUROIM, V162, P27, DOI 10.1016/j.pscychresns.2007.04.007; Frazier JA, 2005, BIPOLAR DISORD, V7, P555, DOI 10.1111/j.1399-5618.2005.00258.x; Gogtay N, 2007, J CHILD PSYCHOL PSYC, V48, P852, DOI 10.1111/j.1469-7610.2007.01747.x; Kalmar JH, 2009, J AM ACAD CHILD PSY, V48, P636, DOI 10.1097/CHI.0b013e31819f6fbc; Kaur S, 2005, AM J PSYCHIAT, V162, P1637, DOI 10.1176/appi.ajp.162.9.1637; Kim E, 2009, PROG NEURO-PSYCHOPH, V33, P1409, DOI 10.1016/j.pnpbp.2009.07.019; Ladouceur CD, 2011, J AM ACAD CHILD PSY, V50, P1275, DOI 10.1016/j.jaac.2011.09.023; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Liu J, 2012, BIPOLAR DISORD, V14, P432, DOI 10.1111/j.1399-5618.2012.01018.x; Liu J, 2012, J AM ACAD CHILD PSY, V51, P304, DOI 10.1016/j.jaac.2011.12.014; Mesulam MM, 1985, CEREBRAL CORTEX; Najt P, 2007, NEUROSCI LETT, V413, P183, DOI 10.1016/j.neulet.2006.10.016; Passarotti AM, 2010, J INT NEUROPSYCH SOC, V16, P106, DOI 10.1017/S1355617709991019; Pavuluri MN, 2007, BIOL PSYCHIAT, V62, P158, DOI 10.1016/j.biopsych.2006.07.011; Pavuluri MN, 2009, J AM ACAD CHILD PSY, V48, P308, DOI 10.1097/CHI.0b013e3181948fc7; Perlman SB, 2012, BIPOLAR DISORD, V14, P162, DOI 10.1111/j.1399-5618.2012.00999.x; Rich BA, 2008, J CHILD PSYCHOL PSYC, V49, P88, DOI 10.1111/j.1469-7610.2007.01819.x; Rich BA, 2006, P NATL ACAD SCI USA, V103, P8900, DOI 10.1073/pnas.0603246103; Shah MP, 2009, NEUROPSYCHOPHARMACOL, V34, P1301, DOI 10.1038/npp.2008.204; Van der Schot A, 2010, PSYCHIAT RES-NEUROIM, V184, P135, DOI 10.1016/j.pscychresns.2010.07.009; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Wang F, 2011, BRAIN, V134, P2005, DOI 10.1093/brain/awr124; Wang F, 2009, BIOL PSYCHIAT, V66, P516, DOI 10.1016/j.biopsych.2009.03.023; Wilke M, 2004, PSYCHIAT RES-NEUROIM, V131, P57, DOI 10.1016/j.pscychresns.2004.01.004; Womer FY, 2009, ACTA NEUROPSYCHIATR, V21, P228, DOI 10.1111/j.1601-5215.2009.00414.x	45	41	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50177	10.1371/journal.pone.0050177	http://dx.doi.org/10.1371/journal.pone.0050177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185566	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000194
J	Li, JL; Qin, HR; Wu, J; Sadd, BM; Wang, XH; Evans, JD; Peng, WJ; Chen, YP				Li, Jilian; Qin, Haoran; Wu, Jie; Sadd, Ben M.; Wang, Xiuhong; Evans, Jay D.; Peng, Wenjun; Chen, Yanping			The Prevalence of Parasites and Pathogens in Asian Honeybees Apis cerana in China	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; BEE COLONY COLLAPSE; NOSEMA-CERANAE; GUT BACTERIA; MELLIFERA L.; MOLECULAR DIAGNOSIS; BOMBUS-TERRESTRIS; VARROA-JACOBSONI; PARALYSIS VIRUS; BUMBLE BEES	Pathogens and parasites represent significant threats to the health and well-being of honeybee species that are key pollinators of agricultural crops and flowers worldwide. We conducted a nationwide survey to determine the occurrence and prevalence of pathogens and parasites in Asian honeybees, Apis cerana, in China. Our study provides evidence of infections of A. cerana by pathogenic Deformed wing virus (DWV), Black queen cell virus (BQCV), Nosema ceranae, and C. bombi species that have been linked to population declines of European honeybees, A. mellifera, and bumble bees. However, the prevalence of DWV, a virus that causes widespread infection in A. mellifera, was low, arguably a result of the greater ability of A. cerana to resist the ectoprasitic mite Varroa destructor, an efficient vector of DWV. Analyses of microbial communities from the A. cerana digestive tract showed that Nosema infection could have detrimental effects on the gut microbiota. Workers infected by N. ceranae tended to have lower bacterial quantities, with these differences being significant for the Bifidobacterium and Pasteurellaceae bacteria groups. The results of this nationwide screen show that parasites and pathogens that have caused serious problems in European honeybees can be found in native honeybee species kept in Asia. Environmental changes due to new agricultural practices and globalization may facilitate the spread of pathogens into new geographic areas. The foraging behavior of pollinators that are in close geographic proximity likely have played an important role in spreading of parasites and pathogens over to new hosts. Phylogenetic analyses provide insights into the movement and population structure of these parasites, suggesting a bidirectional flow of parasites among pollinators. The presence of these parasites and pathogens may have considerable implications for an observed population decline of Asian honeybees.	[Li, Jilian; Qin, Haoran; Wu, Jie; Wang, Xiuhong; Peng, Wenjun] Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing 100193, Peoples R China; [Evans, Jay D.; Chen, Yanping] ARS, USDA, Bee Res Lab, Beltsville, MD USA; [Sadd, Ben M.] Eth Zurich Univ Str, Inst Integrat Biol, Zurich, Switzerland	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA)	Peng, WJ (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Minist Agr, Key Lab Pollinating Insect Biol, Beijing 100193, Peoples R China.	bumblebeeljl@hotmail.com; judy.chen@ars.usda.gov	Evans, Jay D/C-8408-2012	Evans, Jay D/0000-0002-0036-4651; Chen, Chen/0000-0001-6741-7036; Sadd, Ben/0000-0003-3136-5144	Chinese Academy of Agricultural Sciences (CAAS), Beijing, China; Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland [2009DFA32600]; Beijing Natural Science Foundation [6122032]; Chinese National Natural Science Foundation [30700606, 30972149]; China Agriculture Research System (CARS-45) [201203080-4]; Special Fund for Agricultural Research in the Public Interest [201203080-4]	Chinese Academy of Agricultural Sciences (CAAS), Beijing, China; Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Agriculture Research System (CARS-45); Special Fund for Agricultural Research in the Public Interest	Funding was provided by an international joint research project between the Chinese Academy of Agricultural Sciences (CAAS), Beijing, China and Eidgenosische Technische Hochschule (ETH), Zurich, Switzerland (No. 2009DFA32600), Beijing Natural Science Foundation (No. 6122032), Chinese National Natural Science Foundation (No. 30700606, 30972149), the China Agriculture Research System (CARS-45) (201203080-4), the Special Fund for Agricultural Research in the Public Interest (201203080-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Berenyi O, 2006, APPL ENVIRON MICROB, V72, P2414, DOI 10.1128/AEM.72.4.2414-2420.2006; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carreck NL, 2010, J APICULT RES, V49, P93, DOI 10.3896/IBRA.1.49.1.13; Chaimanee V, 2011, J INVERTEBR PATHOL, V107, P229, DOI 10.1016/j.jip.2011.05.012; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2004, J INVERTEBR PATHOL, V87, P84, DOI 10.1016/j.jip.2004.07.005; Chen YP, 2004, AM BEE J, V144, P557; Choe SE, 2012, J INVERTEBR PATHOL, V109, P330, DOI 10.1016/j.jip.2012.01.003; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; GILLIAM M, 1988, MICROBIOS, V55, P95; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; He X., 2011, APICULTURE CHINA, V62, P21; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huang WF, 2008, J INVERTEBR PATHOL, V97, P9, DOI 10.1016/j.jip.2007.07.001; Inglis GD, 1998, APIDOLOGIE, V29, P327, DOI 10.1051/apido:19980403; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; [季荣 Ji Rong], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P70; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mohr KI, 2007, APPL MICROBIOL BIOT, V75, P573, DOI 10.1007/s00253-007-0846-7; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Pedersen AB, 2005, INT J PARASITOL, V35, P647, DOI 10.1016/j.ijpara.2005.01.005; Peng WJ, 2011, APIDOLOGIE, V42, P650, DOI 10.1007/s13592-011-0061-5; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Singh R, 2010, PLOS ONE, V5, P1, DOI DOI 10.1371/J0URNAL.P0NE.0014357; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Wu J, 2006, AM BEE J, V146, P153; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Yoshiyama M, 2009, J INVERTEBR PATHOL, V102, P91, DOI 10.1016/j.jip.2009.07.005; Yourth CP, 2008, INSECT SOC, V55, P86, DOI 10.1007/s00040-007-0974-1	70	67	88	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e47955	10.1371/journal.pone.0047955	http://dx.doi.org/10.1371/journal.pone.0047955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23144838	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800030
J	Liang, S; Hu, JS; Cao, WJ; Cai, SJ				Liang, Shuo; Hu, Jingsong; Cao, Weijun; Cai, Sanjun			Meta-Analysis of Cytochrome P-450 2C9 Polymorphism and Colorectal Cancer Risk	PLOS ONE			English	Article							XENOBIOTIC-METABOLIZING ENZYMES; GENE POLYMORPHISMS; CIGARETTE-SMOKING; CYP2C9 GENOTYPES; IN-VITRO; ASSOCIATION; CARCINOMA; CELECOXIB; P4502C9; OXIDOREDUCTASE	Background: CYP2C9 encodes a member of the cytochrome P450 superfamily of enzymes which play a central role in activating and detoxifying many carcinogens and endogenous compounds thought to be involved in the development of colorectal cancer (CRC). In the past decade, the relationship between CYP2C9 common polymorphisms (R144C and 1359L) and CRC has been reported in various ethnic groups; however, these studies have yielded contradictory results. To investigate this inconsistency, we performed this meta-analysis. Methods: Databases including Pubmed, EMBASE, Web of Science and China National Knowledge Infrastructure (CNKI) were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association. Results: A total of 13 articles involving 9,463 cases and 11,416 controls were included. Overall, the summary odds ratio of CRC was 0.98 (95% CI: 0.89-1.06) and 0.99 (95% CI: 0.87-1.14) for CYP2C9 144C and 359L alleles, respectively. No significant results were observed using dominant or recessive genetic model for these polymorphisms. In the stratified analyses according to ethnicity and sex, no evidence of any gene-disease association was obtained. Conclusions: This meta-analysis suggests that the CYP2C9 may not be associated with colorectal cancer development.	[Liang, Shuo; Cao, Weijun] Tongji Univ, Sch Med, Dept Resp, Pulm Hosp Shanghai, Shanghai 200092, Peoples R China; [Hu, Jingsong; Cai, Sanjun] Fudan Univ, Sch Med, Dept Colorectal Canc, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Cao, WJ (corresponding author), Tongji Univ, Sch Med, Dept Resp, Pulm Hosp Shanghai, Shanghai 200092, Peoples R China.	Weijun_Cao@163.com; Sanjun_Cai@163.com	Cao, Wenqing/GPF-9107-2022	Cao, Wenqing/0000-0002-2761-3355	Natural Science Foundation of Shanghai [10ZR1425000]; Doctoral Fund of Ministry of Education of China [20100072120060]; key projects of Shanghai Municipal Health Bureau [2010006]; Science and Technology Commission of Shanghai Municipality [0852nm05600, 09411951500]; National Science Foundation of China [30971323]; Shanghai Subject Chief Scientist [08XD14034]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); key projects of Shanghai Municipal Health Bureau; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Subject Chief Scientist	This work was supported by the Natural Science Foundation of Shanghai (10ZR1425000), Doctoral Fund of Ministry of Education of China (20100072120060), key projects of Shanghai Municipal Health Bureau (2010006), the Science and Technology Commission of Shanghai Municipality (0852nm05600, 09411951500), National Science Foundation of China (30971323) and Shanghai Subject Chief Scientist (08XD14034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Buyukdogan M, 2009, UHOD-ULUSLAR HEMATOL, V19, P134; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Chan AT, 2004, CLIN GASTROENTEROL H, V2, P704, DOI 10.1016/S1542-3565(04)00294-0; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; Crespi CL, 1997, PHARMACOGENETICS, V7, P203, DOI 10.1097/00008571-199706000-00005; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gertig DM, 1998, SEMIN CANCER BIOL, V8, P285, DOI 10.1006/scbi.1998.0078; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; ILETT KF, 1994, BIOCHEM PHARMACOL, V47, P914, DOI 10.1016/0006-2952(94)90493-6; Inoue K, 1997, PHARMACOGENETICS, V7, P103, DOI 10.1097/00008571-199704000-00003; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Lafuente MJ, 2000, CARCINOGENESIS, V21, P1813, DOI 10.1093/carcin/21.10.1813; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; Liao LH, 2007, CLIN CHIM ACTA, V380, P191, DOI 10.1016/j.cca.2007.02.033; Marchand Loic Le, 1999, Journal of the National Cancer Institute Monographs, P101; Martinez C, 2001, CARCINOGENESIS, V22, P1323, DOI 10.1093/carcin/22.8.1323; McGreavey LE, 2005, PHARMACOGENET GENOM, V15, P713, DOI 10.1097/01.fpc.0000174786.85238.63; Northwood EL, 2010, PHARMACOGENET GENOM, V20, P315, DOI 10.1097/FPC.0b013e3283395c6a; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Samowitz WS, 2006, CLIN GASTROENTEROL H, V4, P894, DOI 10.1016/j.cgh.2006.04.021; Sandberg M, 2002, BRIT J CLIN PHARMACO, V54, P423, DOI 10.1046/j.1365-2125.2002.01660.x; Takahashi H, 1998, PHARMACOGENETICS, V8, P365, DOI 10.1097/00008571-199810000-00001; Takanashi K, 2000, PHARMACOGENETICS, V10, P95, DOI 10.1097/00008571-200003000-00001; Tang CY, 2000, J PHARMACOL EXP THER, V293, P453; Tang CY, 2000, DRUG METAB DISPOS, V28, P567; Tang CY, 2001, PHARMACOGENETICS, V11, P223, DOI 10.1097/00008571-200104000-00006; Tranah GJ, 2005, MOL CARCINOGEN, V44, P21, DOI 10.1002/mc.20112; Windmill KF, 1997, MUTAT RES-FUND MOL M, V376, P153, DOI 10.1016/S0027-5107(97)00038-9; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Xiong YY, 2011, GENOMICS, V97, P277, DOI 10.1016/j.ygeno.2010.11.004; Zhou SF, 2009, CURR MED CHEM, V16, P3480, DOI 10.2174/092986709789057635	34	60	61	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e49134	10.1371/journal.pone.0049134	http://dx.doi.org/10.1371/journal.pone.0049134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23145098	Green Published, Green Submitted, gold			2022-12-25	WOS:000311935800217
J	Wang, W; Ao, L; Rayburn, ER; Xu, HX; Zhang, XR; Zhang, X; Nag, SA; Wu, XM; Wang, MH; Wang, H; Van Meir, EG; Zhang, R				Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Wang, Ming-Hai; Wang, Hui; Van Meir, Erwin G.; Zhang, Ruiwen			KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PRIVILEGED STRUCTURES; HIF-1 INHIBITORS; TUMOR HYPOXIA; HIF-1-ALPHA; PATHWAY; BIOLOGY; IDENTIFICATION; ANGIOGENESIS; CHECKPOINTS	The purpose of the present study was to determine the in vitro and in vivo anti-cancer activity and pharmacological properties of 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, KCN1. In the present study, we investigated the in vitro activity of KCN1 on cell proliferation and cell cycle distribution of pancreatic cancer cells, using the MTT and BrdUrd assays, and flow cytometry. The in vivo anti-cancer effects of KCN1 were evaluated in two distinct xenograft models of pancreatic cancer. We also developed an HPLC method for the quantitation of the compound, and examined its stability in mouse plasma, plasma protein binding, and degradation by mouse S9 microsomal enzymes. Furthermore, we examined the pharmacokinetics of KCN1 following intravenous or intraperitoneal injection in mice. Results showed that, in a dose-dependent manner, KCN1 inhibited cell growth and induced cell cycle arrest in human pancreatic cancer cells in vitro, and showed in vivo anticancer efficacy in mice bearing Panc-1 or Mia Paca-2 tumor xenografts. The HPLC method provided linear detection of KCN1 in all of the matrices in the range from 0.1 to 100 mu M, and had a lower limit of detection of 0.085 mu M in mouse plasma. KCN1 was very stable in mouse plasma, extensively plasma bound, and metabolized by S9 microsomal enzymes. The pharmacokinetic studies indicated that KCN1 could be detected in all of the tissues examined, most for at least 24 h. In conclusion, our preclinical data indicate that KCN1 is a potential therapeutic agent for pancreatic cancer, providing a basis for its future development.	[Wang, Wei; Ao, Lin; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Nag, Subhasree Ashok; Wu, Xuming; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wang, Wei; Wang, Ming-Hai; Zhang, Ruiwen] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Canc Biol Ctr, Amarillo, TX USA; [Wang, Wei; Ao, Lin; Rayburn, Elizabeth R.; Xu, Hongxia; Zhang, Xiangrong; Zhang, Xu; Zhang, Ruiwen] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Div Clin Pharmacol, Birmingham, AL USA; [Wu, Xuming] Nantong Univ, Nantong Canc Hosp, Nantong, Peoples R China; [Wang, Ming-Hai] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX USA; [Wang, Hui] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Van Meir, Erwin G.] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; University of Alabama System; University of Alabama Birmingham; Nantong University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Emory University; Emory University; Emory University	Wang, W (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	evanmei@emory.edu; ruiwen.zhang@ttuhsc.edu	Nag, subhasree/T-1505-2019; Xu, Hongxia/AAN-8608-2021	Nag, subhasree/0000-0001-6933-4349; xu, hongxia/0000-0001-5215-734X; Van Meir, Erwin G./0000-0003-2444-7707	National Institutes of Health grant [R01 CA116804, R01 CA91980]; National Institutes of Health [R01 CA112029, R01 CA121211]; EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation [30870513, 31070680, 91029715, 81025017]; Ministry of Science and Technology of China [2007CB947100]; National Science and Technology Major Project Key New Drug Creation and Manufacturing Program [2009ZX09102-114, 2009ZX09301-011]; NATIONAL CANCER INSTITUTE [R01CA112029, R01CA091980, R01CA116804, R01CA121211] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EmTechBio; University Research Committee of Emory University; Brain Tumor Foundation for Children; V Foundation for Cancer Research; One Hundred Talents Program, Chinese Academy of Sciences; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science and Technology Major Project Key New Drug Creation and Manufacturing Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health grant R01 CA116804 (to EGVM). RZ was also supported by National Institutes of Health grants R01 CA112029 and R01 CA121211. EGVM was also supported by EmTechBio, the University Research Committee of Emory University, the Brain Tumor Foundation for Children, and the V Foundation for Cancer Research. HW was supported by the One Hundred Talents Program, Chinese Academy of Sciences, grants from National Nature Science Foundation (30870513, 31070680, 91029715 and 81025017) and Ministry of Science and Technology of China (2007CB947100), National Science and Technology Major Project Key New Drug Creation and Manufacturing Program 2009ZX09102-114, 2009ZX09301-011). MW was supported by National Institutes of Health grant R01 CA91980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 1998, J DRUG TARGET, V5, P303, DOI 10.3109/10611869808995883; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Belozerov VE, 2006, CURR OPIN INVEST DR, V7, P1067; BOWERS VD, 1991, TRANSPLANTATION, V51, P847, DOI 10.1097/00007890-199104000-00021; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dorr R T, 1994, Ann Pharmacother, V28, pS11; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Janssen A, 2011, ONCOGENE, V30, P2799, DOI 10.1038/onc.2011.30; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Knisely JPS, 2002, NEUROIMAG CLIN N AM, V12, P525, DOI 10.1016/S1052-5149(02)00032-1; Koh MY, 2010, RECENT RESULTS CANC, V180, P15, DOI 10.1007/978-3-540-78281-0_3; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Mooring SR, 2011, J MED CHEM, V54, P8471, DOI 10.1021/jm201018g; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mun J, 2012, J MED CHEM, V55, P6738, DOI 10.1021/jm300752n; Mun JY, 2012, BIOORGAN MED CHEM, V20, P4590, DOI 10.1016/j.bmc.2012.04.064; Narita T, 2009, CLIN CANCER RES, V15, P6128, DOI 10.1158/1078-0432.CCR-08-3180; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9939, DOI 10.1021/ja002033k; Nicolaou KC, 2000, J AM CHEM SOC, V122, P9954, DOI 10.1021/ja002034c; Nojima Hiroshi, 2004, Methods Mol Biol, V280, P3; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Pancreatic Cancer. National Cancer Institute, PANCR CANC; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, CURR PHARM DESIGN, V15, P3839, DOI 10.2174/138161209789649402; Shi Q, 2012, ACS MED CHEM LETT, V3, P620, DOI 10.1021/ml300042k; Tan C, 2005, CANCER RES, V65, P605; Tan C, 2011, BIOORG MED CHEM LETT, V21, P5528, DOI 10.1016/j.bmcl.2011.06.099; Tohma Y, 1998, J NEUROPATH EXP NEUR, V57, P239, DOI 10.1097/00005072-199803000-00005; Tsaioun K, 2009, ATLA-ALTERN LAB ANIM, V37, P47, DOI 10.1177/026119290903701S10; van der Groep P, 2008, BREAST CANCER RES TR, V111, P475, DOI 10.1007/s10549-007-9817-z; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Wang JL, 2009, CURR PHARM DESIGN, V15, P2195, DOI 10.2174/138161209788682514; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; Weinmann M, 2004, ONKOLOGIE, V27, P83, DOI 10.1159/000075611; Wilson GD, 2007, FRONT BIOSCI-LANDMRK, V12, P3502, DOI 10.2741/2330; Yin S, 2012, CLIN CANC R IN PRESS; Zhang XR, 2012, MAR DRUGS, V10, P1138, DOI 10.3390/md10051138	46	50	53	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2012	7	9							e44883	10.1371/journal.pone.0044883	http://dx.doi.org/10.1371/journal.pone.0044883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005ZK	23028659	Green Published, gold, Green Submitted			2022-12-25	WOS:000308788700049
J	Song, YX; Zhou, X; Wang, ZN; Gao, P; Li, AL; Liang, JW; Zhu, JL; Xu, YY; Xu, HM				Song, Yong-Xi; Zhou, Xin; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian			The Association between Individual SNPs or Haplotypes of Matrix Metalloproteinase 1 and Gastric Cancer Susceptibility, Progression and Prognosis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; MALDI-TOF MS; PROMOTER POLYMORPHISM; NO ASSOCIATION; RISK; MMP-1; MATRIX-METALLOPROTEINASE-1; GENES; EPIDEMIOLOGY; GENOTYPES	Background: The single nucleotide polymorphisms (SNPs) in matrix metalloproteinase 1(MMP-1) play important roles in some cancers. This study examined the associations between individual SNPs or haplotypes in MMP-1 and susceptibility, clinicopathological parameters and prognosis of gastric cancer in a large sample of the Han population in northern China. Methods: In this case-controlled study, there were 404 patients with gastric cancer and 404 healthy controls. Seven SNPs were genotyped using the MALDI-TOF MS system. Then, SPSS software, Haploview 4.2 software, Haplo. states software and THEsias software were used to estimate the association between individual SNPs or haplotypes of MMP-1 and gastric cancer susceptibility, progression and prognosis. Results: Among seven SNPs, there were no individual SNPs correlated to gastric cancer risk. Moreover, only the rs470206 genotype had a correlation with histologic grades, and the patients with GA/AA had well cell differentiation compared to the patients with genotype GG (OR = 0.573; 95% CI: 0.353-0.929; P = 0.023). Then, we constructed a four-marker haplotype block that contained 4 common haplotypes: TCCG, GCCG, TTCG and TTTA. However, all four common haplotypes had no correlation with gastric cancer risk and we did not find any relationship between these haplotypes and clinicopathological parameters in gastric cancer. Furthermore, neither individual SNPs nor haplotypes had an association with the survival of patients with gastric cancer. Conclusions: This study evaluated polymorphisms of the MMP-1 gene in gastric cancer with a MALDI-TOF MS method in a large northern Chinese case-controlled cohort. Our results indicated that these seven SNPs of MMP-1 might not be useful as significant markers to predict gastric cancer susceptibility, progression or prognosis, at least in the Han population in northern China.	[Song, Yong-Xi; Wang, Zhen-Ning; Gao, Peng; Li, Ai-Lin; Liang, Ji-Wang; Zhu, Jin-Liang; Xu, Ying-Ying; Xu, Hui-Mian] China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China; [Zhou, Xin] China Med Univ, Dept Gynecol & Obstet, ShengJing Hosp, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Wang, ZN (corresponding author), China Med Univ, Dept Surg Oncol & Gen Surg, Hosp 1, Shenyang 110001, Peoples R China.	josieon826@yahoo.com.cn	Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013; wang, zhen ning/E-1878-2011	Xu, Yingying/0000-0003-4924-9379; wang, zhen ning/0000-0003-0557-3097; Yu, Jiguo/0000-0001-7607-475X; Stal, Per/0000-0002-9340-5298	National Science Foundation of China [30972879, 81172370]; Program of Scientific and Technological Department of Liaoning Province [2010225032]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Scientific and Technological Department of Liaoning Province; Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), the Program of Scientific and Technological Department of Liaoning Province (No. 2010225032) and Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beeghly-Fadiel A, 2009, CANCER EPIDEM BIOMAR, V18, P1324, DOI 10.1158/1055-9965.EPI-09-0046; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Camp NJ, 2012, CANCER EPIDEM BIOMAR, V21, P176, DOI 10.1158/1055-9965.EPI-11-0845; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fang WL, 2010, ASS MATRIX METALLOPR; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Hagleitner MM, 2011, PEDIATR BLOOD CANCER, V56, P35, DOI 10.1002/pbc.22654; Hettiaratchi A, 2007, BRIT J CANCER, V96, P783, DOI 10.1038/sj.bjc.6603630; Hinoda Y, 2002, INT J CANCER, V102, P526, DOI 10.1002/ijc.10750; Horn H, 2010, PHARMACOGENET GENOM, V20, P598, DOI 10.1097/FPC.0b013e32833deb16; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Jaremko M, 2005, HUM MUTAT, V25, P232, DOI 10.1002/humu.20141; Jin X, 2005, WORLD J GASTROENTERO, V11, P2385, DOI 10.3748/wjg.v11.i16.2385; Justenhoven C, 2004, CANCER EPIDEM BIOMAR, V13, P2059; Krejs GJ, 2010, DIGEST DIS, V28, P600, DOI 10.1159/000320277; Li AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030277; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Matsumura S, 2004, J CANCER RES CLIN, V130, P259, DOI 10.1007/s00432-004-0543-1; Nam SI, 2011, LARYNGOSCOPE, V121, P171, DOI 10.1002/lary.21334; Ostrovsky O, 2009, J LEUKOCYTE BIOL, V86, P445, DOI 10.1189/jlb.1208735; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Przybylowska K, 2006, BREAST CANCER RES TR, V95, P65, DOI 10.1007/s10549-005-9042-6; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Shimizu Y, 2008, AURIS NASUS LARYNX, V35, P381, DOI 10.1016/j.anl.2007.12.002; Su L, 2006, CARCINOGENESIS, V27, P1024, DOI 10.1093/carcin/bgi283; Su L, 2005, CANCER EPIDEM BIOMAR, V14, P567, DOI 10.1158/1055-9965.EPI-04-0482; Sun T, 2006, CLIN CANCER RES, V12, P7009, DOI 10.1158/1078-0432.CCR-06-0464; Tregouet DA, 2004, EUR J HUM GENET, V12, P971, DOI 10.1038/sj.ejhg.5201238; Xu EP, 2005, J BIOCHEM BIOPH METH, V63, P222, DOI 10.1016/j.jbbm.2005.03.007; Yu CY, 2004, CANCER RES, V64, P7622, DOI 10.1158/0008-5472.CAN-04-1521; Yue ZY, 2010, J SURG ONCOL, V102, P68, DOI 10.1002/jso.21584; Zinzindohoue F, 2005, CLIN CANCER RES, V11, P594	39	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2012	7	5							e38002	10.1371/journal.pone.0038002	http://dx.doi.org/10.1371/journal.pone.0038002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UB	23284946	Green Published, Green Submitted, gold			2022-12-25	WOS:000305338900072
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23110176	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110176	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Development Core Team, 2009, R FDN STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	23110176	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200040
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
